PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tachmazidou, I; Suveges, D; Min, JL; Ritchie, GRS; Steinberg, J; Walter, K; Iotchkova, V; Schwartzentruber, J; Huang, J; Memari, Y; McCarthy, S; Crawford, AA; Bombieri, C; Cocca, M; Farmaki, AE; Gaunt, TR; Jousilahti, P; Kooijman, MN; Lehne, B; Malerba, G; Mannisto, S; Matchan, A; Medina-Gomez, C; Metrustry, SJ; Nag, A; Ntalla, I; Paternoster, L; Rayner, NW; Sala, C; Scott, WR; Shihab, HA; Southam, L; St Pourcain, B; Traglia, M; Trajanoska, K; Zaza, G; Zhang, WH; Artigas, MS; Bansal, N; Benn, M; Chen, ZS; Danecek, P; Lin, WY; Locke, A; Luan, JA; Manning, AK; Mulas, A; Sidore, C; Tybjaerg-Hansen, A; Varbo, A; Zoledziewska, M; Finan, C; Hatzikotoulas, K; Hendricks, AE; Kemp, JP; Moayyeri, A; Panoutsopoulou, K; Szpak, M; Wilson, SG; Boehnke, M; Cucca, F; Di Angelantonio, E; Langenberg, C; Lindgren, C; McCarthy, MI; Morris, AP; Nordestgaard, BG; Scott, RA; Tobin, MD; Wareham, NJ; Burton, P; Chambers, JC; Smith, GD; Dedoussis, G; Felix, JF; Franco, OH; Gambaro, G; Gasparini, P; Hammond, CJ; Hofman, A; Jaddoe, VWV; Kleber, M; Kooner, JS; Perola, M; Relton, C; Ring, SM; Rivadeneira, F; Salomaa, V; Spector, TD; Stegle, O; Toniolo, D; Uitterlinden, AG; Barroso, I; Greenwood, CMT; Perry, JRB; Walker, BR; Butterworth, AS; Xue, YL; Durbin, R; Small, KS; Soranzo, N; Timpson, NJ; Zeggini, E				Tachmazidou, Ioanna; Suveges, Daniel; Min, Josine L.; Ritchie, Graham R. S.; Steinberg, Julia; Walter, Klaudia; Iotchkova, Valentina; Schwartzentruber, Jeremy; Huang, Jie; Memari, Yasin; McCarthy, Shane; Crawford, Andrew A.; Bombieri, Cristina; Cocca, Massimiliano; Farmaki, Aliki-Eleni; Gaunt, Tom R.; Jousilahti, Pekka; Kooijman, Marjolein N.; Lehne, Benjamin; Malerba, Giovanni; Mannisto, Satu; Matchan, Angela; Medina-Gomez, Carolina; Metrustry, Sarah J.; Nag, Abhishek; Ntalla, Ioanna; Paternoster, Lavinia; Rayner, Nigel W.; Sala, Cinzia; Scott, William R.; Shihab, Hashem A.; Southam, Lorraine; St Pourcain, Beate; Traglia, Michela; Trajanoska, Katerina; Zaza, Gialuigi; Zhang, Weihua; Artigas, Maria S.; Bansal, Narinder; Benn, Marianne; Chen, Zhongsheng; Danecek, Petr; Lin, Wei-Yu; Locke, Adam; Luan, Jian'an; Manning, Alisa K.; Mulas, Antonella; Sidore, Carlo; Tybjaerg-Hansen, Anne; Varbo, Anette; Zoledziewska, Magdalena; Finan, Chris; Hatzikotoulas, Konstantinos; Hendricks, Audrey E.; Kemp, John P.; Moayyeri, Alireza; Panoutsopoulou, Kalliope; Szpak, Michal; Wilson, Scott G.; Boehnke, Michael; Cucca, Francesco; Di Angelantonio, Emanuele; Langenberg, Claudia; Lindgren, Cecilia; McCarthy, Mark I.; Morris, Andrew P.; Nordestgaard, Borge G.; Scott, Robert A.; Tobin, Martin D.; Wareham, Nicholas J.; Burton, Paul; Chambers, John C.; Smith, George Davey; Dedoussis, George; Felix, Janine F.; Franco, Oscar H.; Gambaro, Giovanni; Gasparini, Paolo; Hammond, Christopher J.; Hofman, Albert; Jaddoe, Vincent W. V.; Kleber, Marcus; Kooner, Jaspal S.; Perola, Markus; Relton, Caroline; Ring, Susan M.; Rivadeneira, Fernando; Salomaa, Veikko; Spector, Timothy D.; Stegle, Oliver; Toniolo, Daniela; Uitterlinden, Andre G.; Barroso, Ines; Greenwood, Celia M. T.; Perry, John R. B.; Walker, Brian R.; Butterworth, Adam S.; Xue, Yali; Durbin, Richard; Small, Kerrin S.; Soranzo, Nicole; Timpson, Nicholas J.; Zeggini, Eleftheria		SpiroMeta Consortium; GoT2D Consortium; ArcOGEN Consortium; Understanding Soc Sci Grp; UK10KConsortium	Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; TARGETED DISRUPTION; RARE VARIANTS; KNOCKOUT MICE; HOMEOBOX GENE; LOW-FREQUENCY; LOCI; DISEASE; RISK; METAANALYSIS	Deep sequence-based imputation can enhance the discovery power of genome-wide association studies by assessing previously unexplored variation across the common-and low-frequency spectra. We applied a hybrid whole-genome sequencing (WGS) and deep imputation approach to examine the broader allelic architecture of 12 anthropometric traits associated with height, body mass, and fat distribution in up to 267,616 individuals. We report 106 genome-wide significant signals that have not been previously identified, including 9 low-frequency variants pointing to functional candidates. Of the 106 signals, 6 are in genomic regions that have not been implicated with related traits before, 28 are independent signals at previously reported regions, and 72 represent previously reported signals for a different anthropometric trait. 71% of signals reside within genes and fine mapping resolves 23 signals to one or two likely causal variants. We confirm genetic overlap between human monogenic and polygenic anthropometric traits and find signal enrichment in cis expression QTLs in relevant tissues. Our results highlight the potential of WGS strategies to enhance biologically relevant discoveries across the frequency spectrum.	[Tachmazidou, Ioanna; Suveges, Daniel; Ritchie, Graham R. S.; Steinberg, Julia; Walter, Klaudia; Iotchkova, Valentina; Schwartzentruber, Jeremy; Memari, Yasin; McCarthy, Shane; Matchan, Angela; Rayner, Nigel W.; Southam, Lorraine; Hatzikotoulas, Konstantinos; Hendricks, Audrey E.; Panoutsopoulou, Kalliope; Szpak, Michal; Barroso, Ines; Xue, Yali; Durbin, Richard; Soranzo, Nicole; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Min, Josine L.; Crawford, Andrew A.; Gaunt, Tom R.; Paternoster, Lavinia; Shihab, Hashem A.; St Pourcain, Beate; Kemp, John P.; Smith, George Davey; Relton, Caroline; Ring, Susan M.; Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Ritchie, Graham R. S.] Univ Edinburgh, Usher Inst Populat Hlth Sci Informat, Edinburgh EH16 4UX, Midlothian, Scotland; [Ritchie, Graham R. S.] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh EH16 4UX, Midlothian, Scotland; [Iotchkova, Valentina; Stegle, Oliver] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton CB10 1SD, England; [Huang, Jie] Boston VA Res Inst, Boston, MA 02130 USA; [Crawford, Andrew A.; Walker, Brian R.] Univ Edinburgh, Queens Med Res Inst, BHF Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Bombieri, Cristina; Malerba, Giovanni] Univ Verona, Dept Neurol Biomed & Movement Sci, I-37134 Verona, Italy; [Cocca, Massimiliano; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, I-34100 Trieste, Italy; [Farmaki, Aliki-Eleni; Dedoussis, George] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens 17671, Greece; [Jousilahti, Pekka; Mannisto, Satu; Perola, Markus; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Hlth, Helsinki 00271, Finland; [Kooijman, Marjolein N.; Felix, Janine F.; Jaddoe, Vincent W. V.] Univ Med Ctr, Erasmus Med Ctr, Generat Study Grp R, NL-3000 CA Rotterdam, Netherlands; [Kooijman, Marjolein N.; Felix, Janine F.; Jaddoe, Vincent W. V.] Univ Med Ctr, Dept Epidemiol, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Kooijman, Marjolein N.; Felix, Janine F.; Jaddoe, Vincent W. V.] Univ Med Ctr, Dept Pediat, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Lehne, Benjamin; Scott, William R.; Zhang, Weihua; Chambers, John C.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Medina-Gomez, Carolina; Trajanoska, Katerina; Rivadeneira, Fernando; Uitterlinden, Andre G.] Univ Med Ctr, Erasmus Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Metrustry, Sarah J.; Nag, Abhishek; Moayyeri, Alireza; Wilson, Scott G.; Hammond, Christopher J.; Spector, Timothy D.; Perry, John R. B.; Small, Kerrin S.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Ntalla, Ioanna] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Rayner, Nigel W.; Southam, Lorraine; Lindgren, Cecilia; McCarthy, Mark I.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Rayner, Nigel W.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Sala, Cinzia; Traglia, Michela; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Scott, William R.; Zhang, Weihua; Chambers, John C.; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Dept Cardiol, Southall UB1 3EU, Middx, England; [St Pourcain, Beate] Max Planck Inst Psycholinguist, NL-6500 Nijmegen, Netherlands; [Zaza, Gialuigi] Verona Univ Hosp, Dept Med, Renal Unit, I-37126 Verona, Italy; [Artigas, Maria S.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester LE1 7RH, Leics, England; [Bansal, Narinder; Lin, Wei-Yu; Di Angelantonio, Emanuele; Butterworth, Adam S.] Univ Cambridge, Dept Publ Hlth Primary Care, Cardiovasc Epidemiol Unit, Cambridge CB1 8RN, England; [Benn, Marianne; Danecek, Petr; Tybjaerg-Hansen, Anne; Varbo, Anette; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Chen, Zhongsheng; Locke, Adam; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Chen, Zhongsheng; Locke, Adam; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Benn, Marianne; Danecek, Petr; Tybjaerg-Hansen, Anne; Varbo, Anette; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, DK-2100 Copenhagen, Denmark; [Locke, Adam] Washington Univ, McDonnell Genome Inst, Sch Med, St Louis, MO 63108 USA; [Luan, Jian'an; Langenberg, Claudia; Scott, Robert A.; Wareham, Nicholas J.; Perry, John R. B.] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Cambridge CB2 0QQ, England; [Manning, Alisa K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Manning, Alisa K.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Manning, Alisa K.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Mulas, Antonella; Cucca, Francesco] Ist Ric Genet & Biomed IRGB CNR, I-09100 Cagliari, Italy; Univ Sassari, I-07100 Sassari, Italy; [Finan, Chris] UCL, Inst Cardiovasc Sci, Fac Populat Hlth, London WC1E 6BT, England; [Hendricks, Audrey E.] Univ Colorado Denver, Math & Stat Sci, Denver, CO 80204 USA; [Kemp, John P.] Univ Queensland Diamantina Inst, Translat Res Inst, Brisbane, Qld 4072, Australia; [Moayyeri, Alireza] UCL, Inst Hlth Informat, London NW1 2DA, England; [Wilson, Scott G.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Wilson, Scott G.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Di Angelantonio, Emanuele; Butterworth, Adam S.; Soranzo, Nicole] Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Unit NIHR B, Cambridge CB1 8RN, England; [Lindgren, Cecilia] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford OX3 7BN, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England; [Morris, Andrew P.; Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Tartumaa, Estonia; [Tobin, Martin D.] Glenfield Hosp, Leicester Resp Biomed Res Unit, NIHR, Leicester LE3 9QP, Leics, England; [Burton, Paul] Univ Bristol, D2K Res Grp, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London W2 1NY, England; [Gambaro, Giovanni] Catholic Univ, Columbus Gemelli Univ Hosp, Div Nephrol & Dialysis, I-00168 Rome, Italy; [Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofol, Med Genet, I-34100 Trieste, Italy; [Kleber, Marcus] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, D-68167 Mannheim, Germany; [Kooner, Jaspal S.] Imperial Coll London, Natl Heart & Lung Inst, Hammersmith Hosp Campus, London W12 0NN, England; [Perola, Markus] Univ Helsinki, Inst Mol Med FIMM, Helsinki 00290, Finland; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Barroso, Ines] Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Greenwood, Celia M. T.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge CB2 0AH, England	Wellcome Trust Sanger Institute; University of Bristol; University of Edinburgh; University of Edinburgh; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Edinburgh; University of Verona; University of Trieste; Harokopio University Athens; Finland National Institute for Health & Welfare; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Max Planck Society; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Leicester; University of Cambridge; University of Copenhagen; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rigshospitalet; University of Copenhagen; Washington University (WUSTL); University of Cambridge; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of London; University College London; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Queensland; University of London; University College London; University of Western Australia; University of Western Australia; University of Cambridge; University of Oxford; University of Oxford; University of Liverpool; University of Tartu; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Bristol; Imperial College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Burlo Garofolo; Ruprecht Karls University Heidelberg; Imperial College London; University of Helsinki; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Lady Davis Institute; McGill University; McGill University; McGill University; University of Cambridge	Zeggini, E (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	eleftheria@sanger.ac.uk	Manning, Alisa Knodle/ABC-7711-2021; Durbin, Richard/AAE-7178-2019; Steinberg, Julia/S-2007-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Attrill, Lauren/V-1688-2018; Gaunt, Tom R/O-3918-2014; Timpson, Nicholas John/O-7548-2015; Relton, Caroline/AAC-5904-2019; Cocca, Massimiliano/J-2951-2018; Medina-Gomez, Carolina/I-1725-2019; Dedoussis, George/AAN-7252-2021; Malerba, Giovanni/T-3278-2019; Hendricks, Audrey/I-4127-2016; Stegle, Oliver/AAU-9177-2020; Traglia, Michela/AAX-5816-2020; Rivadeneira, Fernando/O-5385-2015; Langenberg, Claudia/ABG-9067-2021; Kemp, John P./R-3091-2018; Sidore, Carlo/AAV-7967-2020; Gasparini, Paolo/B-6173-2014; Lin, Wei-Yu/F-4505-2010; Mulas, Antonella/B-4231-2015; Locke, Adam/K-2000-2019; Franco, Óscar H/ABE-2305-2020; zhang, weihua/GXV-1334-2022; Fox, Laura J/C-6249-2016; Sala, Cinzia Felicita/AAN-1900-2020; Benn, Marianne/O-4164-2019; Zaza, Gianluigi/K-3827-2018; Davey Smith, George/A-7407-2013; Toniolo, Daniela/AAE-2969-2019; DiAngelantonio, Emanuele/ABE-6852-2020; Soler Artigas, Maria/L-6529-2013; Paternoster, Lavinia/C-1292-2015; McCarthy, Mark/M-3763-2015	Durbin, Richard/0000-0002-9130-1006; Steinberg, Julia/0000-0002-0585-2312; Gaunt, Tom R/0000-0003-0924-3247; Timpson, Nicholas John/0000-0002-7141-9189; Cocca, Massimiliano/0000-0002-1127-7596; Medina-Gomez, Carolina/0000-0001-7999-5538; Dedoussis, George/0000-0002-7798-6221; Hendricks, Audrey/0000-0002-7152-0287; Stegle, Oliver/0000-0002-8818-7193; Rivadeneira, Fernando/0000-0001-9435-9441; Langenberg, Claudia/0000-0002-5017-7344; Kemp, John P./0000-0002-9105-2249; Sidore, Carlo/0000-0001-7504-7477; Lin, Wei-Yu/0000-0002-9267-7988; Locke, Adam/0000-0001-6227-198X; Franco, Óscar H/0000-0002-4606-4929; Benn, Marianne/0000-0002-1701-595X; Davey Smith, George/0000-0002-1407-8314; Toniolo, Daniela/0000-0001-9545-6032; Crawford, Andrew/0000-0002-9260-0315; Klenerman, David/0000-0001-7116-6954; Tobin, Martin/0000-0002-3596-7874; Bansal, Narinder/0000-0002-6925-1719; Butterworth, Adam/0000-0002-6915-9015; Szpak, Michal/0000-0002-9096-852X; Di Angelantonio, Emanuele/0000-0001-8776-6719; Wilson, Scott/0000-0002-0357-1373; CUCCA, Francesco/0000-0002-7414-1995; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Mulas, Antonella/0000-0002-6856-1483; Lindgren, Cecilia/0000-0002-4903-9374; Soler Artigas, Maria/0000-0002-3213-1107; Trajanoska, Katerina/0000-0002-3792-4296; s, hema/0000-0002-3440-9475; Scott, William/0000-0001-5467-114X; Suveges, Daniel/0000-0003-4133-0447; Schwartzentruber, Jeremy/0000-0002-6183-2092; Nordestgaard, Borge/0000-0002-1954-7220; Relton, Caroline/0000-0003-2052-4840; Zaza, Gianluigi/0000-0002-6004-6196; Greenwood, Celia/0000-0002-2427-5696; Zoledziewska, Magdalena/0000-0002-3033-6133; Kelly, Kirsten/0000-0003-4234-543X; St Pourcain, Beate/0000-0002-4680-3517; Gambaro, Giovanni/0000-0001-5733-2370; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Soranzo, Nicole/0000-0003-1095-3852; Barroso, Ines/0000-0001-5800-4520; Paternoster, Lavinia/0000-0003-2514-0889; Gasparini, Paolo/0000-0002-0859-0856; Small, Kerrin/0000-0003-4566-0005; Hatzikotoulas, Konstantinos/0000-0002-4699-3672; McCarthy, Mark/0000-0002-4393-0510; Finan, Chris/0000-0002-3319-1937; Iotchkova, Valentina/0000-0001-5057-0210	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, U01DK062370] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/H029745/1] Funding Source: researchfish; Medical Research Council [G9815508, MC_PC_13048, MC_PC_13046] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, NF-SI-0611-10099, NF-SI-0512-10135] Funding Source: researchfish; British Heart Foundation [RG/11/4/28734, RG/08/014/24067] Funding Source: Medline; European Research Council [648916] Funding Source: Medline; Medical Research Council [MC_UU_12015/2, G0901461, MR/J012165/1, G0100594, G0600237, MC_UU_12015/1, MR/K002279/1, G0900753, G0902313, MR/N01104X/2, MR/N01104X/1, MR/K002414/1, MC_PC_15018, MC_UU_12013/2, MC_UU_12013/8, MC_UU_12013/1, MR/N011317/1, MR/L003120/1, MC_UU_12013/3] Funding Source: Medline; NIDDK NIH HHS [U01 DK062370, P30 DK020572] Funding Source: Medline; Versus Arthritis [20308] Funding Source: Medline; Chief Scientist Office [CZB/4/733] Funding Source: Medline; ESRC [ES/H029745/1] Funding Source: UKRI; MRC [MC_UU_12013/2, G0600237, G0901461, MC_UU_12013/1, MC_UU_12015/1, MR/N01104X/1, G0100594, G0900753, MR/L003120/1, MC_UU_12013/8, G0902313, MR/K002279/1, MR/N011317/1, MR/J012165/1, MC_UU_12015/2, MR/K002414/1, MR/N01104X/2] Funding Source: UKRI	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Versus Arthritis(Versus Arthritis); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akazawa H, 2000, GENES CELLS, V5, P499, DOI 10.1046/j.1365-2443.2000.00339.x; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Barrow JR, 1996, DEVELOPMENT, V122, P3817; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bolton JL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004474; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bryois J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004461; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chen W, 2015, GENETICS, V200, P719, DOI 10.1534/genetics.115.176107; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Delaunay A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001609; Durand C, 2013, NAT REV ENDOCRINOL, V9, P171, DOI 10.1038/nrendo.2012.251; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Gurnett CA, 2008, AM J HUM GENET, V83, P616, DOI 10.1016/j.ajhg.2008.10.004; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hellemans J, 2009, AM J HUM GENET, V85, P916, DOI 10.1016/j.ajhg.2009.11.005; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Iotchkova V, 2016, NAT GENET, V48, P1303, DOI 10.1038/ng.3668; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Izidoro MA, 2009, ARCH BIOCHEM BIOPHYS, V487, P105, DOI 10.1016/j.abb.2009.05.013; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Naeem H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-51; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; North TL, 2016, J MED GENET, V53, P280, DOI 10.1136/jmedgenet-2015-103342; Peltonen L, 2006, HUM MOL GENET, V15, pR67, DOI 10.1093/hmg/ddl060; Phillips DIW, 2008, AM J HUM BIOL, V20, P712, DOI 10.1002/ajhb.20803; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046038; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Relton CL, 2015, INT J EPIDEMIOL, V44, P1181, DOI 10.1093/ije/dyv072; Rickard DJ, 2008, ENDOCRINOLOGY, V149, P2383, DOI 10.1210/en.2007-1247; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Rolfe ED, 2010, AM J CLIN NUTR, V92, P347, DOI 10.3945/ajcn.2010.29247; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Setoh K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8754; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tribioli C, 1999, DEVELOPMENT, V126, P5699; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; VELINOV M, 1993, CONNECT TISSUE RES, V29, P13, DOI 10.3109/03008209309061962; Verzi MP, 2009, GASTROENTEROLOGY, V136, P1701, DOI 10.1053/j.gastro.2009.01.009; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	98	75	77	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					865	884		10.1016/j.ajhg.2017.04.014	http://dx.doi.org/10.1016/j.ajhg.2017.04.014			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28552196	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000402700600004
J	Guan, B; Welch, JM; Sapp, JC; Ling, H; Li, YL; Johnston, JJ; Kebebew, E; Biesecker, LG; Simonds, WF; Marx, SJ; Agarwal, SK				Guan, Bin; Welch, James M.; Sapp, Julie C.; Ling, Hua; Li, Yulong; Johnston, Jennifer J.; Kebebew, Electron; Biesecker, Leslie G.; Simonds, William F.; Marx, Stephen J.; Agarwal, Sunita K.			GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; AUTOSOMAL-DOMINANT HYPOPARATHYROIDISM; PARATHYROID-GLAND DEVELOPMENT; CELLS-MISSING-HOMOLOG; TRANSCRIPTION FACTOR; GCMB MUTATION; GENE; HORMONE; EXPRESSION; MANAGEMENT	Primary hyperparathyroidism (PHPT) is a common endocrine disease characterized by parathyroid hormone excess and hypercalcemia and caused by hypersecreting parathyroid glands. Familial PHPT occurs in an isolated nonsyndromal form, termed familial isolated hyperparathyroidism (FIHP), or as part of a syndrome, such as multiple endocrine neoplasia type 1 or hyperparathyroidism-jaw tumor syndrome. The specific genetic or other cause(s) of FIHP are unknown. We performed exome sequencing on germline DNA of eight index-case individuals from eight unrelated kindreds with FIHP. Selected rare variants were assessed for co-segregation in affected family members and screened for in an additional 32 kindreds with FIHP. In eight kindreds with FIHP, we identified three rare missense variants in GCM2, a gene encoding a transcription factor required for parathyroid development. Functional characterization of the GCM2 variants and deletion analyses revealed a small C-terminal conserved inhibitory domain (CCID) in GCM2. Two of the three rare variants were recurrent, located in the GCM2 CCID, and found in seven of the 40 (18%) kindreds with FIHP. These two rare variants acted as gain-of-function mutations that increased the transcriptional activity of GCM2, suggesting that GCM2 is a parathyroid proto-oncogene. Our results demonstrate that germline-activating mutations affecting the CCID of GCM2 can cause FIHP.	[Guan, Bin; Welch, James M.; Li, Yulong; Simonds, William F.; Marx, Stephen J.; Agarwal, Sunita K.] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD 20892 USA; [Sapp, Julie C.; Johnston, Jennifer J.; Biesecker, Leslie G.] NHGRI, Bethesda, MD 20892 USA; [Ling, Hua] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; [Kebebew, Electron] NCI, Bethesda, MD 20892 USA; [Marx, Stephen J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Guan, B; Agarwal, SK (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD 20892 USA.	bin.guan@nih.gov; sunitaa@mail.nih.gov	Agarwal, Sunita K/D-1428-2016; Biesecker, Leslie/AAG-2526-2021	Agarwal, Sunita K/0000-0002-7557-3191; Sapp, Julie/0000-0002-4003-258X	NIH; NIDDK; National Human Genome Research Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075035, ZIADK043012] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to the participants in this study. We thank members at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Clinical Laboratory Core for storage of DNA samples. We would like to thank Mr. Craig Cochran and the NIH 5NW nursing staff for their expert patient care. We also thank our colleagues Drs. Lee Weinstein, Monica Skarulis, and Michael Collins, as well as the past and present fellows of the National Institute of Child Health and Human Development (NICHD)-NIDDK Interinstitute Endocrine Training Program. This work was supported by the Intramural Research Program of the NIH, the NIDDK (S.J.M., S.K.A., and W.F.S.), the National Human Genome Research Institute (L.G.B., J.C.S., and J.J.J.), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (S.J.M.), and the National Cancer Institute (E.K.).	Adereth Y, 2005, BIOTECHNIQUES, V38, P864, DOI 10.2144/05386BM03; Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083; Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Canaff L, 2009, HUM MUTAT, V30, P85, DOI 10.1002/humu.20827; Correa P, 2002, CLIN ENDOCRINOL, V57, P501, DOI 10.1046/j.1365-2265.2002.01627.x; D'Agruma L, 2014, J CLIN ENDOCR METAB, V99, pE2794, DOI 10.1210/jc.2014-2857; Ding CL, 2001, J CLIN INVEST, V108, P1215, DOI 10.1172/JCI13180; Grigorieva IV, 2011, ANN NY ACAD SCI, V1237, P24, DOI 10.1111/j.1749-6632.2011.06221.x; Gross I, 2015, J PEDIATR ENDOCR MET, V28, P943, DOI 10.1515/jpem-2014-0188; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Han S, 2015, MOL CELL ENDOCRINOL, V411, P113, DOI 10.1016/j.mce.2015.04.018; Hannan FM, 2008, NAT CLIN PRACT ENDOC, V4, P53, DOI 10.1038/ncpendmet0718; Hendy GN, 2013, FRONT HORM RES, V41, P149, DOI 10.1159/000345675; Iacobone M, 2015, LANGENBECK ARCH SURG, V400, P867, DOI 10.1007/s00423-015-1342-7; Johnston JJ, 2015, AM J HUM GENET, V97, P465, DOI 10.1016/j.ajhg.2015.07.009; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kamitani-Kawamoto A, 2011, J BONE MINER RES, V26, P2463, DOI 10.1002/jbmr.458; Kebebew E, 2004, SURGERY, V136, P1261, DOI 10.1016/j.surg.2004.06.056; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Lee M, 2013, FRONT HORM RES, V41, P63, DOI 10.1159/000345670; Li D, 2016, J CLIN ENDOCR METAB, V101, P2196, DOI 10.1210/jc.2016-1211; Li YL, 2016, ENDOCR-RELAT CANCER, V23, pR229, DOI 10.1530/ERC-16-0059; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; MALLETTE LE, 1974, AM J MED, V57, P642, DOI 10.1016/0002-9343(74)90018-7; Mannstadt M, 2008, J CLIN ENDOCR METAB, V93, P3568, DOI 10.1210/jc.2007-2167; Mannstadt M, 2011, J ENDOCRINOL, V210, P165, DOI 10.1530/JOE-10-0247; Mao HA, 2012, DEV BIOL, V370, P63, DOI 10.1016/j.ydbio.2012.07.018; Marcocci C, 2014, J CLIN ENDOCR METAB, V99, P3607, DOI 10.1210/jc.2014-1417; Marcocci C, 2011, NEW ENGL J MED, V365, P2389, DOI 10.1056/NEJMcp1106636; Marx SJ, 2011, ENDOCR PRACT, V17, P18, DOI 10.4158/EP11067.RA; Mirczuk SM, 2010, J CLIN ENDOCR METAB, V95, P3512, DOI 10.1210/jc.2009-2532; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Silverberg SJ, 2006, NAT CLIN PRACT ENDOC, V2, P494, DOI 10.1038/ncpendmet0265; Simonds WF, 2004, J CLIN ENDOCR METAB, V89, P96, DOI 10.1210/jc.2003-030675; Simonds WF, 2002, MEDICINE, V81, P1, DOI 10.1097/00005792-200201000-00001; Starker LF, 2012, HORM CANCER-US, V3, P44, DOI 10.1007/s12672-011-0100-8; Thomee C, 2005, J CLIN ENDOCR METAB, V90, P2487, DOI 10.1210/jc.2004-2450; Tuerk EE, 2000, J BIOL CHEM, V275, P4774, DOI 10.1074/jbc.275.7.4774; Warner J, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.035766; Warner J, 2004, J MED GENET, V41, P155, DOI 10.1136/jmg.2003.016725; Yuan ZQ, 2014, TRANSGENIC RES, V23, P631, DOI 10.1007/s11248-014-9799-7	42	75	78	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1034	1044		10.1016/j.ajhg.2016.08.018	http://dx.doi.org/10.1016/j.ajhg.2016.08.018			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27745835	Green Published, Bronze			2022-12-18	WOS:000387529600003
J	Lindstrand, A; Frangakis, S; Carvalho, CMB; Richardson, EB; McFadden, KA; Willer, JR; Pehlivan, D; Liu, PF; Pediaditakis, IL; Sabo, A; Lewis, RA; Banin, E; Lupski, JR; Davis, EE; Katsanis, N				Lindstrand, Anna; Frangakis, Stephan; Carvalho, Claudia M. B.; Richardson, Ellen B.; McFadden, Kelsey A.; Willer, Jason R.; Pehlivan, Davut; Liu, Pengfei; Pediaditakis, Igor L.; Sabo, Aniko; Lewis, Richard Alan; Banin, Eyal; Lupski, James R.; Davis, Erica E.; Katsanis, Nicholas			Copy-Number Variation Contributes to the Mutational Load of Bardet-Biedl Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINAL DEGENERATION; COMPLEX REARRANGEMENTS; STRUCTURAL FEATURES; CENTROSOMAL PROTEIN; GENOMIC DISORDERS; NPHP1 LOCUS; HIGH-RISK; GENE; IDENTIFICATION; ALLELES	Bardet-Biedl syndrome (BBS) is a defining ciliopathy, notable for extensive allelic and genetic heterogeneity, almost all of which has been identified through sequencing. Recent data have suggested that copy-number variants (CNVs) also contribute to BBS. We used a custom oligonucleotide array comparative genomic hybridization (aCGH) covering 20 genes that encode intraflagellar transport (IFT) components and 74 ciliopathy loci to screen 92 unrelated individuals with BBS, irrespective of their known mutational burden. We identified 17 individuals with exon-disruptive CNVs (18.5%), including 13 different deletions in eight BBS genes (BBS1,BBS2,ARL6/BBS3,BBS4,BBS5,BBS7,BBS9, and NPHP1) and a deletion and a duplication in other ciliopathy-associated genes (ALMS1 and NPHP4, respectively). By contrast, we found a single heterozygous exon-disruptive event in a BBS-associated gene ( BBS9) in 229 control subjects. Superimposing these data with resequencing revealed CNVs to (1) be sufficient to cause disease, (2) Mendelize heterozygous deleterious alleles, and (3) contribute oligogenic alleles by combining point mutations and exonic CNVs in multiple genes. Finally, we report a deletion and a splice site mutation in IFT74, inherited under a recessive paradigm, defining a candidate BBS locus. Our data suggest that CNVs contribute pathogenic alleles to a substantial fraction of BBS-affected individuals and highlight how either deletions or point mutations in discrete splice isoforms can induce hypomorphic mutations in genes otherwise intolerant to deleterious variation. Our data also suggest that CNV analyses and resequencing studies unbiased for previous mutational burden is necessary to delineate the complexity of disease architecture.	[Lindstrand, Anna; Frangakis, Stephan; Richardson, Ellen B.; McFadden, Kelsey A.; Willer, Jason R.; Pediaditakis, Igor L.; Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Sch Med, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Carvalho, Claudia M. B.; Pehlivan, Davut; Liu, Pengfei; Sabo, Aniko; Lewis, Richard Alan; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Carvalho, Claudia M. B.] Ctr Pesquisas Rene Rachou FIOCRUZ, BR-30190002 Belo Horizonte, MG, Brazil; [Sabo, Aniko; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Banin, Eyal] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Ctr Retinal & Macular Degenerat, IL-91120 Jerusalem, Israel; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lindstrand, Anna] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden	Duke University; Baylor College of Medicine; Fundacao Oswaldo Cruz; Baylor College of Medicine; Baylor College of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Baylor College of Medicine; Baylor College of Medicine; Karolinska Institutet	Davis, EE; Katsanis, N (corresponding author), Duke Univ, Sch Med, Ctr Human Dis Modeling, Durham, NC 27701 USA.	erica.davis@duke.edu; katsanis@cellbio.duke.edu	Frangakis, Stephan/GLQ-5773-2022; Lindstrand, Anna/AAT-9969-2021; Lindstrand, Anna M/J-3566-2012; Liu, Pengfei/U-9743-2019; Pehlivan, Davut/I-3235-2019	Lindstrand, Anna/0000-0003-0806-5602; Lindstrand, Anna M/0000-0003-0806-5602; Liu, Pengfei/0000-0002-4177-709X; Davis, Erica/0000-0002-2412-8397; Willer, Jason/0000-0002-5869-3992	NIH [DK075972, HD042601, DK096415, DK072301, DK096493, EY021872, NS058529, HG006542]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [402520/2012-2]; EU [241955]; Swedish Research Council [2010-978, 2012-1526]; Research to Prevent Blindness; Regeneron Pharmaceuticals; Rescindo Therapeutics, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002520, R01EY021872] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493, R01DK072301, P50DK096415, R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121317, T32GM007171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Regeneron Pharmaceuticals(Regeneron); Rescindo Therapeutics, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals with BBS and their families for their continued participation in our studies. We also thank Richard Gibbs and Donna Muzny for assistance with sequence analysis and advice, Christelle Golzio for assistance in designing and developing CRISPR protocols, and Julien Philippe for assistance with the analysis of qPCR data. This work was funded by NIH grants DK075972, HD042601, and DK096415 (N.K.), DK072301 and DK096493 (N.K. and E.E.D.), EY021872 (E.E.D.), and NS058529 and HG006542 (J.R.L.); the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through the Young Investigator fellowship (Science without Borders Program) grant 402520/2012-2 to C.M.B.C.; funding from EU 7th FP under GA nr. 241955, project SYSCILIA to N.K.; and by the Swedish Research Council grants 2010-978 and 2012-1526 (A.L.). R.A.L. is a Senior Scientific Investigator of Research to Prevent Blindness, whose unrestricted funds supported parts of these investigations. N.K. is a distinguished Jean and George Brumley Professor. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting, and is on the Scientific Advisory Board of Baylor Genetics. N.K. is a paid consultant for and holds significant stock of Rescindo Therapeutics, Inc.	Aldahmesh MA, 2014, HUM MOL GENET, V23, P3307, DOI 10.1093/hmg/ddu044; Aliferis K, 2012, OPHTHALMIC GENET, V33, P18, DOI 10.3109/13816810.2011.620055; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Bayer DK, 2014, CLIN EXP IMMUNOL, V178, P459, DOI 10.1111/cei.12421; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Boone PM, 2013, GENOME RES, V23, P1383, DOI 10.1101/gr.156075.113; Boone PM, 2011, GENET MED, V13, P582, DOI 10.1097/GIM.0b013e3182106775; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Bujakowska KM, 2015, HUM MOL GENET, V24, P230, DOI 10.1093/hmg/ddu441; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen JJ, 2011, INVEST OPHTH VIS SCI, V52, P5317, DOI 10.1167/iovs.11-7554; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gu S, 2015, HUM MOL GENET, V24, P4061, DOI 10.1093/hmg/ddv146; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lee MS, 2015, DEV BIOL, V400, P248, DOI 10.1016/j.ydbio.2015.02.009; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lindstrand A, 2014, AM J HUM GENET, V94, P745, DOI 10.1016/j.ajhg.2014.03.017; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Lupski JR, 2009, GENOME MED, V1, DOI 10.1186/gm42; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marion V, 2012, J MED GENET, V49, P317, DOI 10.1136/jmedgenet-2012-100737; McIntyre JC, 2012, NAT MED, V18, P1423, DOI 10.1038/nm.2860; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Migliavacca E, 2015, AM J HUM GENET, V96, P784, DOI 10.1016/j.ajhg.2015.04.002; Muller J, 2010, HUM GENET, V127, P583, DOI 10.1007/s00439-010-0804-9; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pereiro I, 2011, EUR J HUM GENET, V19, P485, DOI 10.1038/ejhg.2010.207; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Redin C, 2012, J MED GENET, V49, P502, DOI 10.1136/jmedgenet-2012-100875; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Scheidecker S, 2014, J MED GENET, V51, P132, DOI 10.1136/jmedgenet-2013-101785; Shlien A, 2010, AM J HUM GENET, V87, P631, DOI 10.1016/j.ajhg.2010.10.007; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Verdin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003358; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zhang Y, 2014, HUM MOL GENET, V23, P40, DOI 10.1093/hmg/ddt394; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	91	75	78	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					318	336		10.1016/j.ajhg.2015.04.023	http://dx.doi.org/10.1016/j.ajhg.2015.04.023			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27486776	Bronze, Green Published			2022-12-18	WOS:000381617200005
J	Massink, MPG; Creton, MA; Spanevello, F; Fennis, WMM; Cune, MS; Savelberg, SMC; Nijman, IJ; Maurice, MM; van den Boogaard, MJH; van Haaften, G				Massink, Maarten P. G.; Creton, Marijn A.; Spanevello, Francesca; Fennis, Willem M. M.; Cune, Marco S.; Savelberg, Sanne M. C.; Nijman, Isaac J.; Maurice, Madelon M.; van den Boogaard, Marie-Jose H.; van Haaften, Gijs			Loss-of-Function Mutations in the WNT Co-receptor LRP6 Cause Autosomal-Dominant Oligodontia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCING DATA; TOOTH AGENESIS; HYPODONTIA; DISEASE; POPULATION; FRAMEWORK; AXIN2; TEETH; MICE; MSX1	Tooth agenesis is one of the most common developmental anomalies in man. Oligodontia, a severe form of tooth agenesis, occurs both as an isolated anomaly and as a syndromal feature. We performed exome sequencing on 20 unrelated individuals with apparent non-syndromic oligodontia and failed to detect mutations in genes previously associated with oligodontia. In three of the probands, we detected heterozygous variants in LRP6, and sequencing of additional oligodontia-affected individuals yielded one additional mutation in LRP6. Three mutations (c.1144_1145dupAG [p.Ala383Glyfs*8], c.1779dupT [p.Glu594*], and c.2224_2225dupTT [p.Leu742Phwefs*7]) are predicted to truncate the protein, whereas the fourth (c.56C>T [p.Ala19Val]) is a missense variant of a conserved residue located at the cleavage site of the protein's signal peptide. All four affected individuals harboring a LRP6 mutation had a family history of tooth agenesis. LRP6 encodes a transmembrane cell-surface protein that functions as a co-receptor with members from the Frizzled protein family in the canonical Wnt/beta-catenin signaling cascade. In this same pathway, WNT10A was recently identified as a major contributor in the etiology of non-syndromic oligodontia. We show that the LRP6 missense variant (c.56C>T) results in altered glycosylation and improper subcellular localization of the protein, resulting in abrogated activation of the Wnt pathway. Our results identify LRP6 variants as contributing to the etiology of non-syndromic autosomal-dominant oligodontia and suggest that this gene is a candidate for screening in DNA diagnostics.	[Massink, Maarten P. G.; Savelberg, Sanne M. C.; Nijman, Isaac J.; van den Boogaard, Marie-Jose H.; van Haaften, Gijs] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Creton, Marijn A.; Fennis, Willem M. M.] Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg, Prosthodont & Special Dent Care, NL-3508 AB Utrecht, Netherlands; [Spanevello, Francesca; Maurice, Madelon M.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Cune, Marco S.] Univ Groningen, Univ Med Ctr Groningen, Ctr Dent & Oral Hyg, Dept Fixed & Removable Prosthodont, NL-9700 RB Groningen, Netherlands; [Cune, Marco S.] Antonius Hosp, NL-3435 CM Nieuwegein, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen	van Haaften, G (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3508 AB Utrecht, Netherlands.	g.vanhaaften@umcutrecht.nl	van Haaften, Gijs/G-7832-2012	van Haaften, Gijs/0000-0003-3033-0329; Massink, Maarten/0000-0002-7845-6038; Maurice, Madelon/0000-0001-6885-5361	Utrecht University; European Union [ITN 608180]; Netherlands Organization for Scientific Research NWO	Utrecht University; European Union(European Commission); Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO))	We gratefully acknowledge the affected individuals and their families whose participation made this research possible. We kindly thank Hans Clevers (Hubrecht Institute, Utrecht, the Netherlands) for providing us the mouse Lrp6 plasmid (pcDNA3). This work was supported by Utrecht University (seed grant to M.M.M.), the European Union (FP7 Marie-Curie ITN 608180 "WntsApp" to M.M.M.), and the Netherlands Organization for Scientific Research NWO (VICI grant to M.M.M.).	Arte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073705; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Brook AH, 2009, ARCH ORAL BIOL, V54, pS3, DOI 10.1016/j.archoralbio.2009.09.005; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Creton M, 2010, CLIN ORAL INVEST, V14, P467, DOI 10.1007/s00784-009-0308-y; Creton MA, 2007, INT J PROSTHODONT, V20, P409; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Han D, 2008, EUR J MED GENET, V51, P536, DOI 10.1016/j.ejmg.2008.06.002; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Singh R, 2013, HUM MUTAT, V34, P1221, DOI 10.1002/humu.22360; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Xu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084345; Yang J, 2015, MOL GENET GENOM MED, V3, P40, DOI 10.1002/mgg3.111	30	75	78	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					621	626		10.1016/j.ajhg.2015.08.014	http://dx.doi.org/10.1016/j.ajhg.2015.08.014			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26387593	Green Published, Bronze			2022-12-18	WOS:000362617300012
J	Mendoza-Londono, R; Fahiminiya, S; Majewski, J; Tetreault, M; Nadaf, J; Kannu, P; Sochett, E; Howard, A; Stimec, J; Dupuis, L; Roschger, P; Klaushofer, K; Palomo, T; Ouellet, J; Al-Jallad, H; Mort, JS; Moffatt, P; Boudko, S; Bachinger, HP; Rauch, F				Mendoza-Londono, Roberto; Fahiminiya, Somayyeh; Majewski, Jacek; Tetreault, Martine; Nadaf, Javad; Kannu, Peter; Sochett, Etienne; Howard, Andrew; Stimec, Jennifer; Dupuis, Lucie; Roschger, Paul; Klaushofer, Klaus; Palomo, Telma; Ouellet, Jean; Al-Jallad, Hadil; Mort, John S.; Moffatt, Pierre; Boudko, Sergei; Baechinger, Hans-Peter; Rauch, Frank		Care4Rare Canada Consortium	Recessive Osteogenesis Imperfecta Caused by Missense Mutations in SPARC	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MINERALIZATION DENSITY DISTRIBUTION; WNT1 MUTATIONS; BONE; MICE; OSTEOPOROSIS; DEFICIENT; VARIANTS; DISEASE; PROTEIN	Secreted protein, acidic, cysteine-rich (SPARC) is a glycoprotein that binds to collagen type I and other proteins in the extracellular matrix. Using whole-exome sequencing to identify the molecular defect in two unrelated girls with severe bone fragility and a clinical diagnosis of osteogenesis imperfecta type IV, we identified two homozygous variants in SPARC (GenBank: NM_ 003118.3; c.497G>A [p.Arg166His] in individual 1; c.787G>A [p.Glu263Lys] in individual 2). Published modeling and site-directed mutagenesis studies had previously shown that the residues substituted by these mutations form an intramolecular salt bridge in SPARC and are essential for the binding of SPARC to collagen type I. The amount of SPARC secreted by skin fibroblasts was reduced in individual 1 but appeared normal in individual 2. The migration of collagen type I alpha chains produced by these fibroblasts was mildly delayed on SDS-PAGE gel, suggesting some overmodification of collagen during triple helical formation. Pulse-chase experiments showed that collagen type I secretion was mildly delayed in skin fibroblasts from both individuals. Analysis of an iliac bone sample from individual 2 showed that trabecular bone was hypermineralized on the material level. In conclusion, these observations show that homozygous mutations in SPARC can give rise to severe bone fragility in humans.	[Mendoza-Londono, Roberto; Kannu, Peter; Dupuis, Lucie] Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Mendoza-Londono, Roberto; Kannu, Peter; Sochett, Etienne; Howard, Andrew; Dupuis, Lucie] Univ Toronto, Toronto, ON M5G 1X8, Canada; [Mendoza-Londono, Roberto; Kannu, Peter; Sochett, Etienne; Howard, Andrew; Stimec, Jennifer; Dupuis, Lucie] Hosp Sick Children, Bone Hlth Ctr, Toronto, ON M5G 1X8, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek; Tetreault, Martine; Nadaf, Javad] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek; Tetreault, Martine; Nadaf, Javad] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1B1, Canada; [Sochett, Etienne] Hosp Sick Children, Div Endocrinol, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Howard, Andrew] Hosp Sick Children, Dept Orthopaed Surg, Toronto, ON M5G 1X8, Canada; [Stimec, Jennifer] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Roschger, Paul; Klaushofer, Klaus] WGKK & AUVA Trauma Ctr Meidling, Ludwig Boltzmann Inst Osteol, Med Dept 1, Hanusch Hosp, A-1140 Vienna, Austria; [Palomo, Telma; Ouellet, Jean; Al-Jallad, Hadil; Mort, John S.; Moffatt, Pierre; Rauch, Frank] Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; [Boudko, Sergei; Baechinger, Hans-Peter] Shriners Hosp Children, Portland, OR 97239 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; McGill University	Rauch, F (corresponding author), Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada.	frauch@shriners.mcgill.ca	Rauch, Frank/D-1554-2009	Palomo, Telma/0000-0002-1655-7319; Howard, Andrew/0000-0001-7226-6471; Moffatt, Pierre/0000-0002-5793-1944; Boudko, Sergei/0000-0003-3856-4859; Rauch, Frank/0000-0002-6261-0360	Chercheur-Boursier Clinicien program of the Fonds de Recherche du Quebec - Sante; Canada Research Chair; AUVA (Austrian Social Insurance for Occupational Risk); WGKK (Social Health Insurance Vienna); Shriners of North America; Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Hospital for Sick Children	Chercheur-Boursier Clinicien program of the Fonds de Recherche du Quebec - Sante; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); AUVA (Austrian Social Insurance for Occupational Risk); WGKK (Social Health Insurance Vienna); Shriners of North America; Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Hospital for Sick Children(University of Toronto)	We thank Patty Mason for technical assistance and Mark Lepik for the preparation of the figures. F.R. received support from the Chercheur-Boursier Clinicien program of the Fonds de Recherche du Quebec - Sante. J.M. is a recipient of a Canada Research Chair. We also wish to acknowledge the contribution of the high-throughput and Sanger sequencing platforms of the McGill University and Genome Quebec Innovation Centre (Montreal, Canada). Quantitative backscattered electron imaging was performed at the Bone Material Laboratory of the Ludwig Boltzmann Institute of Osteology, Vienna, Austria. We thank D. Gabriel, P. Keplinger, S. Lueger, and P. Messmer for technical assistance with sample preparation and backscattered electron imaging measurements. This work was supported by the AUVA (Austrian Social Insurance for Occupational Risk) and the WGKK (Social Health Insurance Vienna). This study was also supported by the Shriners of North America. This disorder was selected for study by the Care4Rare Canada (Enhanced Care for Rare Genetic Diseases in Canada) Consortium Gene Discovery Steering Committee: Kym Boycott (lead; University of Ottawa), Alex MacKenzie (co-lead; University of Ottawa), J.M. (McGill University), Michael Brudno (University of Toronto), Dennis Bulman (University of Ottawa), and David Dyment (University of Ottawa). It was funded, in part, by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, Children's Hospital of Eastern Ontario Foundation, and the Hospital for Sick Children.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Delany AM, 2008, OSTEOPOROSIS INT, V19, P969, DOI 10.1007/s00198-007-0523-9; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; Dole NS, 2015, J BONE MINER RES, V30, P723, DOI 10.1002/jbmr.2378; Fahiminiya S, 2013, BONE, V57, P41, DOI 10.1016/j.bone.2013.07.020; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; FISHER LW, 1987, CALCIFIED TISSUE INT, V40, P260, DOI 10.1007/BF02555258; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Fratzl-Zelman N, 2009, BONE, V44, P1043, DOI 10.1016/j.bone.2009.02.021; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; McDonald-McGinn DM, 2013, J MED GENET, V50, P80, DOI 10.1136/jmedgenet-2012-101320; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; MUNDLOS S, 1992, J HISTOCHEM CYTOCHEM, V40, P283, DOI 10.1177/40.2.1552170; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Nagaraju GP, 2014, CARCINOGENESIS, V35, P967, DOI 10.1093/carcin/bgu072; Palomo T, 2014, BONE, V67, P63, DOI 10.1016/j.bone.2014.06.041; Rauch F, 2012, J CLIN ENDOCR METAB, V97, pE1550, DOI 10.1210/jc.2012-1827; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Trombetta-Esilva Jessica, 2012, Open Rheumatol J, V6, P146, DOI 10.2174/1874312901206010146; Vincent AJ, 2008, DEV DYNAM, V237, P1449, DOI 10.1002/dvdy.21495; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	37	75	80	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					979	985		10.1016/j.ajhg.2015.04.021	http://dx.doi.org/10.1016/j.ajhg.2015.04.021			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26027498	Green Published, Bronze			2022-12-18	WOS:000355931200012
J	Masotti, A; Uva, P; Davis-Keppen, L; Basel-Vanagaite, L; Cohen, L; Pisaneschi, E; Celluzzi, A; Bencivenga, P; Fang, MY; Tian, MY; Xu, X; Cappa, M; Dallapiccola, B				Masotti, Andrea; Uva, Paolo; Davis-Keppen, Laura; Basel-Vanagaite, Lina; Cohen, Lior; Pisaneschi, Elisa; Celluzzi, Antonella; Bencivenga, Paola; Fang, Mingyan; Tian, Mingyu; Xu, Xun; Cappa, Marco; Dallapiccola, Bruno			Keppen-Lubinsky Syndrome Is Caused by Mutations in the Inwardly Rectifying K+ Channel Encoded by KCNJ6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESENCHYMAL STEM-CELLS; HUMAN PROTEIN ATLAS; POTASSIUM CHANNELS; WEAVER MUTATION; GIRK2; DIFFERENTIATION; FRAMEWORK; VARIANTS; SODIUM; MOUSE	Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper lip, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy. We sequenced the exomes of three unrelated individuals affected by KPLBS and found de novo heterozygous mutations in KCNJ6 (GIRK2), which encodes an inwardly rectifying potassium channel and maps to the Down syndrome critical region between DIRK1A and DSCR4. In particular, two individuals shared an in-frame heterozygous deletion of three nucleotides (c.455_457del) leading to the loss of one amino acid (p.Thr152del). The third individual was heterozygous for a missense mutation (c.460G>A) which introduces an amino acid change from glycine to serine (p.Gly154Ser). In agreement with animal models, the present data suggest that these mutations severely impair the correct functioning of this potassium channel. Overall, these results establish KPLBS as a channelopathy and suggest that KCNJ6 (GIRK2) could also be a candidate gene for other lipodystrophies. We hope that these results will prompt investigations in this unexplored class of inwardly rectifying K+ channels.	[Masotti, Andrea; Pisaneschi, Elisa; Celluzzi, Antonella; Bencivenga, Paola; Cappa, Marco; Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy; [Uva, Paolo] Parco Sci & Tecnol POLARIS, Bioinformat Lab CRS4, I-09010 Cagliari, Italy; [Davis-Keppen, Laura] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD 57105 USA; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, Pediat Genet Unit, IL-49202 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Cohen, Lior] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; [Fang, Mingyan; Xu, Xun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Tian, Mingyu] BGI Tech Hong Kong, Hong Kong 518083, Hong Kong, Peoples R China	IRCCS Bambino Gesu; University of South Dakota; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Masotti, A (corresponding author), Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy.	andrea.masotti@opbg.net; xuxun@genomics.cn	Uva, Paolo/A-2877-2011; Celluzzi, Antonella/K-6683-2016; Fang, Mingyan/M-9171-2019; Masotti, Andrea/D-5306-2009; Bencivenga, Paola/AAA-5228-2020; Fang, Mingyan/B-8505-2017; Xu, Xun/AAI-6763-2020; pisaneschi, elisa/AAC-2538-2019; Dallapiccola, Bruno/K-8692-2016	Uva, Paolo/0000-0002-9524-8492; Celluzzi, Antonella/0000-0001-7045-4196; Fang, Mingyan/0000-0001-7185-6445; Masotti, Andrea/0000-0002-2511-5088; Xu, Xun/0000-0002-5338-5173; pisaneschi, elisa/0000-0001-5912-8269; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Dallapiccola, Bruno/0000-0002-5031-1013; CAPPA, MARCO/0000-0001-5647-7519	Italian Ministry of Health; company BVLGARI	Italian Ministry of Health(Ministry of Health, Italy); company BVLGARI	The authors are indebted to the families who contributed to this study. The financial support of the Italian Ministry of Health and the company BVLGARI is fully acknowledged.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Basel-Vanagaite L, 2009, AM J MED GENET A, V149A, P1827, DOI 10.1002/ajmg.a.32975; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Cooper A, 2012, P NATL ACAD SCI USA, V109, P2642, DOI 10.1073/pnas.1109099109; De Brasi D, 2003, AM J MED GENET A, V117A, P194, DOI 10.1002/ajmg.a.10936; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gorlin R.J., 2001, SYNDROMES HEAD NECK, V4th ed., DOI 10.17245/jdapm.2019.19.5.261; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Herrup K, 1996, P NATL ACAD SCI USA, V93, P10541, DOI 10.1073/pnas.93.20.10541; Hou P, 2000, AM J PHYSIOL-CELL PH, V278, pC1038, DOI 10.1152/ajpcell.2000.278.5.C1038; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Schaarschmidt G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006168; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Surmeier DJ, 1996, P NATL ACAD SCI USA, V93, P11191, DOI 10.1073/pnas.93.20.11191; Thiriet M., 2012, SIGNALING CELL SURFA; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; You MH, 2013, ACTA PHARMACOL SIN, V34, P129, DOI 10.1038/aps.2012.142	26	75	78	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					295	300		10.1016/j.ajhg.2014.12.011	http://dx.doi.org/10.1016/j.ajhg.2014.12.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25620207	Bronze, Green Published			2022-12-18	WOS:000349276700011
J	Liu, Y; Li, X; Aryee, MJ; Ekstrom, TJ; Padyukov, L; Klareskog, L; Vandiver, A; Moore, AZ; Tanaka, T; Ferrucci, L; Fallin, MD; Feinberg, AP				Liu, Yun; Li, Xin; Aryee, Martin J.; Ekstrom, Tomas J.; Padyukov, Leonid; Klareskog, Lars; Vandiver, Amy; Moore, Ann Zenobia; Tanaka, Toshiko; Ferrucci, Luigi; Fallin, M. Daniele; Feinberg, Andrew P.			GeMes, Clusters of DNA Methylation under Genetic Control, Can Inform Genetic and Epigenetic Analysis of Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIGENOME-WIDE ASSOCIATION; PATTERNS; SMOKING	Epigenetic marks such as DNA methylation have generated great interest in the study of human disease. However, studies of DNA methylation have not established population-epigenetics principles to guide design, efficient statistics, or interpretation. Here, we show that the clustering of correlated DNA methylation at CpGs was similar to that of linkage-disequilibrium (LD) correlation in genetic SNP variation but for much shorter distances. Some clustering of methylated CpGs appeared to be genetically driven. Further, a set of correlated methylated CpGs related to a single SNP-based LD block was not always physically contiguous-segments of uncorrelated methylation as long as 300 kb could be interspersed in the cluster. Thus, we denoted these sets of correlated CpGs as GeMes, defined as potentially noncontiguous methylation clusters under the control of one or more methylation quantitative trait loci. This type of correlated methylation structure has implications for both biological functions of DNA methylation and for the design, analysis, and interpretation of epigenome-wide association studies.	[Liu, Yun; Li, Xin; Aryee, Martin J.; Vandiver, Amy; Fallin, M. Daniele; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Liu, Yun; Li, Xin; Vandiver, Amy; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Aryee, Martin J.] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02114 USA; [Aryee, Martin J.] Harvard Univ, Sch Med, Charlestown, MA 02114 USA; [Ekstrom, Tomas J.; Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Ekstrom, Tomas J.; Padyukov, Leonid; Klareskog, Lars] Univ Hosp, S-17176 Stockholm, Sweden; [Ekstrom, Tomas J.] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Moore, Ann Zenobia; Tanaka, Toshiko; Ferrucci, Luigi] NIA, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Fallin, M. Daniele] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Deparment Mental Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fallin, MD (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA.	dfallin@jhsph.edu; afeinberg@jhu.edu	Aryee, Martin/AAC-8113-2020; Feinberg, Andrew/AAY-7666-2020; Ekström, Tomas/B-7764-2013; Padyukov, Leonid/A-4890-2009; Li, Xin/A-4137-2011	Liu, Yun/0000-0001-5753-1265; Feinberg, Andrew/0000-0002-8364-1991; Padyukov, Leonid/0000-0003-2950-5670; Li, Xin/0000-0001-8328-4894; Klareskog, Lars/0000-0001-9601-6186	National Institutes of Health (NIH) [HG003233, AG042187]; Swedish AFA Insurance grants; Swedish Strategic Research Foundation; European Research Council; Intramural Research Program of the NIH National Institute on Aging; MedStar Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000015, R01AG042187, ZIAAG000965] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish AFA Insurance grants; Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission); Intramural Research Program of the NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MedStar Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Rafael Irizarry for the idea of using 450K array replicates to estimate and describe between-CpG correlations across the genome. This work was supported by National Institutes of Health (NIH) grants HG003233 (A.P.F) and AG042187 (to A.P.F. and M.D.F.), by Swedish AFA Insurance grants to T.J.E., and by grants to L.K. from the Swedish Strategic Research Foundation and European Research Council. The Baltimore Longitudinal Study of Aging was supported in part by the Intramural Research Program of the NIH National Institute on Aging. A portion of that support was through a research-and-development contract with MedStar Research Institute.	Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hindorff LA, CATALOG PUBLISHED GE; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Inouye M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002907; Jaffe AE, 2012, BIOSTATISTICS, V13, P166, DOI 10.1093/biostatistics/kxr013; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mill J, 2013, NAT REV GENET, V14, P585, DOI 10.1038/nrg3405; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Paliwal A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003622; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Shock NW., 1984, NORMAL HUMAN AGING B; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	44	75	75	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					485	495		10.1016/j.ajhg.2014.02.011	http://dx.doi.org/10.1016/j.ajhg.2014.02.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24656863	Green Published, Bronze			2022-12-18	WOS:000333765300001
J	Bosch, DGM; Boonstra, FN; Gonzaga-Jauregui, C; Xu, MF; de Ligt, J; Jhangiani, S; Wiszniewski, W; Muzny, DM; Yntema, HG; Pfundt, R; Vissers, LELM; Spruijt, L; Blokland, EAW; Chen, CA; Lewis, RA; Tsai, SY; Gibbs, RA; Tsai, MJ; Lupski, JR; Zoghbi, HY; Cremers, FPM; de Vries, BBA; Schaaf, CP				Bosch, Danielle G. M.; Boonstra, F. Nienke; Gonzaga-Jauregui, Claudia; Xu, Mafei; de Ligt, Joep; Jhangiani, Shalini; Wiszniewski, Wojciech; Muzny, Donna M.; Yntema, Helger G.; Pfundt, Rolph; Vissers, Lisenka E. L. M.; Spruijt, Liesbeth; Blokland, Ellen A. W.; Chen, Chun-An; Lewis, Richard A.; Tsai, Sophia Y.; Gibbs, Richard A.; Tsai, Ming-Jer; Lupski, James R.; Zoghbi, Huda Y.; Cremers, Frans P. M.; de Vries, Bert B. A.; Schaaf, Christian P.		Baylor-Hopkins Ctr Mendelian Genom	NR2F1 Mutations Cause Optic Atrophy with Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORTICAL VISUAL IMPAIRMENT; RECEPTOR COUP-TFI; PERIVENTRICULAR LEUKOMALACIA; CHILDREN; GENE; ORPHAN; DIFFERENTIATION; EXPRESSION; MORPHOGENESIS; TRANSCRIPTION	Optic nerve atrophy and hypoplasia can be primary disorders or can result from trans-synaptic degeneration arising from cerebral visual impairment (CVI). Here we report six individuals with CVI and/or optic nerve abnormalities, born after an uneventful pregnancy and delivery, who have either de novo heterozygous missense mutations in NR2F1, also known as COUP-TFI, or deletions encompassing NR2F1. All affected individuals show mild to moderate intellectual impairment. NR2F1 encodes a nuclear receptor protein that regulates transcription. A reporter assay showed that missense mutations in the zinc-finger DNA-binding domain and the putative ligand-binding domain decrease NR2F1 transcriptional activity. These findings indicate that NR2F1 plays an important role in the neurodevelopment of the visual system and that its disruption can lead to optic atrophy with intellectual disability.	[Bosch, Danielle G. M.; Yntema, Helger G.; Pfundt, Rolph; Vissers, Lisenka E. L. M.; Blokland, Ellen A. W.; Cremers, Frans P. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Bosch, Danielle G. M.; Boonstra, F. Nienke] Inst Visually Impaired, NL-3700 BA Zeist, Netherlands; [Bosch, Danielle G. M.; de Ligt, Joep; Blokland, Ellen A. W.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Bosch, Danielle G. M.; Boonstra, F. Nienke; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Gonzaga-Jauregui, Claudia; Wiszniewski, Wojciech; Lewis, Richard A.; Gibbs, Richard A.; Lupski, James R.; Zoghbi, Huda Y.; Schaaf, Christian P.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Xu, Mafei; Tsai, Sophia Y.; Tsai, Ming-Jer] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [de Ligt, Joep; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Jhangiani, Shalini; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Wiszniewski, Wojciech; Lewis, Richard A.; Lupski, James R.; Schaaf, Christian P.] Texas Childrens Hosp, Houston, TX 77030 USA; [Spruijt, Liesbeth] Radboud Univ Nijmegen, Med Ctr, Oncol Res Inst, NL-6500 HB Nijmegen, Netherlands; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard A.; Lupski, James R.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Program Dev Biol, Houston, TX 77030 USA; [Chen, Chun-An; Zoghbi, Huda Y.; Schaaf, Christian P.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Baylor College of Medicine; Baylor College of Medicine; Radboud University Nijmegen; Baylor College of Medicine; Baylor College of Medicine; Radboud University Nijmegen; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	Bert.deVries@radboudumc.nl; schaaf@bcm.edu	Schaaf, Christian P/AAJ-7318-2021; Gonzaga-Jauregui, Claudia/H-4752-2019; Cremers, Frans/A-5625-2014; XU, MAFEI/AAN-6198-2021; Vissers, Lisenka ELM/A-2598-2015; Spruijt, L./L-4664-2015; Yntema, H.G./L-4771-2015; Pfundt, Rolph/L-4576-2015	Schaaf, Christian P/0000-0002-2148-7490; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Cremers, Frans/0000-0002-4954-5592; Vissers, Lisenka ELM/0000-0001-6470-5497; Zoghbi, Huda/0000-0002-0700-3349; de Ligt, Joep/0000-0002-0348-419X	Stichting ODAS through UitZicht; Vereniging Bartimeus-Sonneheerdt [5781251]; Netherlands Organisation for Health Research and Development (ZON-MW) [917-86-319]; National Institutes of Health (NIH); National Human Genome Research Institute [U54HG006542]; Clinical Scientist Development Award by the Doris Duke Charitable Foundation; Stanford and Joan Alexander Family; NIH [DK45641, HL114539]; NINDS [K23NS078056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114539] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, R37DK045641, R01DK045641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS078056] Funding Source: NIH RePORTER	Stichting ODAS through UitZicht; Vereniging Bartimeus-Sonneheerdt; Netherlands Organisation for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Clinical Scientist Development Award by the Doris Duke Charitable Foundation; Stanford and Joan Alexander Family; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the individuals involved and their families for their support and cooperation. This work has been supported by grants from Stichting ODAS that contributed through UitZicht (to F.N.B. and F.P.M.C.), Vereniging Bartimeus-Sonneheerdt (5781251 to F.N.B. and F.P.M.C.), and the Netherlands Organisation for Health Research and Development (ZON-MW grant 917-86-319 to B.B.A.d.V). Additionally, this study was accomplished in part through the Center for Mendelian Genomics research effort funded by The National Institutes of Health (NIH) and supported by the National Human Genome Research Institute grant U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics. C.P.S. is a recipient of a Clinical Scientist Development Award by the Doris Duke Charitable Foundation. His work is generously supported by the Stanford and Joan Alexander Family. M.-J.T. and S.Y.T. are supported by NIH grants (DK45641 and HL114539). W.W. is supported by a K23NS078056 grant from the NINDS. R.A.L. is a Senior Scientific Investigator of Research to Prevent Blindness, New York.	Al-Kateb H, 2013, AM J MED GENET A, V161A, P377, DOI 10.1002/ajmg.a.35650; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Antonarakis SE, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P31, DOI 10.1007/978-3-540-37654-5_2; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Azuma N, 2003, AM J HUM GENET, V72, P1565, DOI 10.1086/375555; Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Boonstra N, 2012, ACTA OPHTHALMOL, V90, P277, DOI 10.1111/j.1755-3768.2011.02205.x; Brown KK, 2009, AM J MED GENET A, V149A, P931, DOI 10.1002/ajmg.a.32764; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078; Faedo A, 2008, CEREB CORTEX, V18, P2117, DOI 10.1093/cercor/bhm238; Fazzi E, 2007, J CHILD NEUROL, V22, P294, DOI 10.1177/08830738070220030801; Gonzaga-Jauregui C, 2013, JAMA NEUROL, V70, P1491, DOI 10.1001/jamaneurol.2013.4598; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003; Huo R, 1999, BRIT J OPHTHALMOL, V83, P670, DOI 10.1136/bjo.83.6.670; Ishii S., 2009, HDB CELL SIGNALING, VVolume 3, P2021; Jacobson L, 2003, BRIT J OPHTHALMOL, V87, P1345, DOI 10.1136/bjo.87.11.1345; Jacobson L, 1997, ARCH OPHTHALMOL-CHIC, V115, P1263, DOI 10.1001/archopht.1997.01100160433007; Jacobson LK, 2000, SURV OPHTHALMOL, V45, P1, DOI 10.1016/S0039-6257(00)00134-X; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Khetpal V, 2007, J AAPOS, V11, P235, DOI 10.1016/j.jaapos.2007.01.122; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; NEUMAN K, 1995, J NEUROSCI RES, V41, P39, DOI 10.1002/jnr.490410106; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576; Ruberto G, 2006, INVEST OPHTH VIS SCI, V47, P484, DOI 10.1167/iovs.05-0529; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Satoh S, 2009, J NEUROSCI, V29, P12401, DOI 10.1523/JNEUROSCI.0951-09.2009; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Uggetti C, 1997, AM J NEURORADIOL, V18, P233; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamaguchi H, 2004, DEV BIOL, V266, P238, DOI 10.1016/j.ydbio.2003.10.038; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	48	75	81	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					303	309		10.1016/j.ajhg.2014.01.002	http://dx.doi.org/10.1016/j.ajhg.2014.01.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24462372	Green Published, Bronze			2022-12-18	WOS:000331419500014
J	Howard, MF; Murakami, Y; Pagnamenta, AT; Daumer-Haas, C; Fischer, B; Hecht, J; Keays, DA; Knight, SJL; Kolsch, U; Kruger, U; Leiz, S; Maeda, Y; Mitchell, D; Mundlos, S; Phillips, JA; Robinson, PN; Kini, U; Taylor, JC; Horn, D; Kinoshita, T; Krawitz, PM				Howard, Malcolm F.; Murakami, Yoshiko; Pagnamenta, Alistair T.; Daumer-Haas, Cornelia; Fischer, Bjoern; Hecht, Jochen; Keays, David A.; Knight, Samantha J. L.; Koelsch, Uwe; Krueger, Ulrike; Leiz, Steffen; Maeda, Yusuke; Mitchell, Daphne; Mundlos, Stefan; Phillips, John A., III; Robinson, Peter N.; Kini, Usha; Taylor, Jenny C.; Horn, Denise; Kinoshita, Taroh; Krawitz, Peter M.			Mutations in PGAP3 Impair GPI-Anchor Maturation, Causing a Subtype of Hyperphosphatasia with Mental Retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; INTELLECTUAL DISABILITY; SYNTHESIS PATHWAY; PROTEINS; SEIZURES	Glycosylphophatidylinositol (GPO-anchored proteins play important roles in many biological processes, and mutations affecting proteins involved in the synthesis of the GPI anchor are reported to cause a wide spectrum of intellectual disabilities (IDs) with characteristic additional phenotypic features. Here, we describe a total of five individuals (from three unrelated families) in whom we identified mutations in PGAP3, encoding a protein that is involved in GPI-anchor maturation. Three siblings in a consanguineous Pakistani family presented with profound developmental delay, severe ID, no speech, psychomotor delay, and postnatal microcephaly. A combination of autozygosity mapping and exome sequencing identified a 13.8 Mb region harboring a homozygous c.275G>A (p.Gly92Asp) variant in PGAP3 region 17q11.2-q21.32. Subsequent testing showed elevated serum alkaline phosphatase (ALP), a GPI-anchored enzyme, in all three affected children. In two unrelated individuals in a cohort with developmental delay, ID, and elevated ALP, we identified compound-heterozygous variants c.439dupC (p.Leu147Profs*16) and c.914A>G (p.Asp305Gly) and homozygous variant c.314C>G (p.Pro105Arg). The 1 bp duplication causes a frameshift and nonsense-mediated decay. Further evidence supporting pathogenicity of the missense mutations c.275G>A, c.314C>G, and c.914A>G was provided by the absence of the variants from ethnically matched controls, phylogenetic conservation, and functional studies on Chinese hamster ovary cell lines. Taken together with recent data on PGAP2, these results confirm the importance of the later GPI-anchor remodelling steps for normal neuronal development. Impairment of PGAP3 causes a subtype of hyperphosphatasia with ID, a congenital disorder of glycosylation that is also referred to as Mabry syndrome.	[Howard, Malcolm F.; Pagnamenta, Alistair T.; Knight, Samantha J. L.; Taylor, Jenny C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7BN, England; [Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Osaka 5650871, Japan; [Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ Osaka, World Premier Int Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Daumer-Haas, Cornelia] Pranatal Med Munchen, D-80637 Munich, Germany; [Fischer, Bjoern; Krueger, Ulrike; Mundlos, Stefan; Robinson, Peter N.; Horn, Denise; Krawitz, Peter M.] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Hecht, Jochen; Mundlos, Stefan; Robinson, Peter N.; Krawitz, Peter M.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Fischer, Bjoern; Hecht, Jochen; Mundlos, Stefan; Robinson, Peter N.; Krawitz, Peter M.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Keays, David A.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Koelsch, Uwe] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Leiz, Steffen] Klinikum Dritter Orden, Dept Pediat, D-80638 Munich, Germany; [Mitchell, Daphne; Phillips, John A., III] Vanderbilt Univ, Sch Med, Dept Pediat, Div Med Genet & Genom Med, Nashville, TN 37232 USA; [Kini, Usha] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; Osaka University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vanderbilt University; Oxford University Hospitals NHS Foundation Trust	Kini, U (corresponding author), Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford OX3 9DU, England.	usha.kini@ouh.nhs.uk; peter.krawitz@charite.de	Mundlos, Stefan/ABH-9585-2020; Krawitz, Peter M/F-3142-2012; Fischer-Zirnsak, Björn/D-7487-2013; Kinoshita, Taroh/C-7353-2009	Krawitz, Peter M/0000-0002-3194-8625; Fischer-Zirnsak, Björn/0000-0002-1075-7571; Knight, Samantha/0000-0002-6047-3462; Mundlos, Stefan/0000-0002-9788-3166; Taylor, Jenny/0000-0003-3602-5704	National Institute for Health Research (NIHR) Biomedical Research Centre Oxford; Department of Health's NIHR Biomedical Research Centres funding scheme; German Ministry of Research and Education [0313911]; Deutsche Forschungsgemeinschaft [KR 3985/1-1, SFB 665]; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan; Wellcome Trust grant [090532/Z/09/Z]; Medical Research Council Hub grant [G0900747 91070]	National Institute for Health Research (NIHR) Biomedical Research Centre Oxford(National Institute for Health Research (NIHR)); Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Wellcome Trust grant(Wellcome Trust); Medical Research Council Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre Oxford with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The work was also supported by a grant from the German Ministry of Research and Education to S.M. (0313911), by Deutsche Forschungsgemeinschaft grants to P.M.K. (KR 3985/1-1) and S.M. (SFB 665), and by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labour, and Welfare of Japan to Y.M. and T.K. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and Medical Research Council Hub grant G0900747 91070) for generating the sequencing data, John Broxholme for assisting with downloading BAM files from the 1000 Genomes Project, Kevin Leyden for performing flow cytometry, Christian Babbs for sharing DNA from Arabic controls, and Kana Miyanagi for assisting in functional analysis of PGAP3. We would also like to thank all three families for their participation in this study and the 500 Whole-Genome Sequences Consortium and Illumina for use of the in-house database of variant calls for 274 individuals.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Heinrich V, 2013, GENOME MED, V5, DOI 10.1186/gm473; Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kamphans T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070151; Kamphans T, 2012, BIOINFORMATICS, V28, P2515, DOI 10.1093/bioinformatics/bts462; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; McKean DM, 2012, BIOL OPEN, V1, P874, DOI 10.1242/bio.20121982; Murakami H, 2012, BIOCHEM BIOPH RES CO, V417, P1235, DOI 10.1016/j.bbrc.2011.12.116; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Nozaki M, 1999, LAB INVEST, V79, P293; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Rudd PM, 1998, ADV EXP MED BIOL, V435, P153; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Thompson MD, 2012, AM J MED GENET A, V158A, P553, DOI 10.1002/ajmg.a.35202; Wang YT, 2013, J BIOL CHEM, V288, P25490, DOI 10.1074/jbc.M113.492611	26	75	81	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					278	287		10.1016/j.ajhg.2013.12.012	http://dx.doi.org/10.1016/j.ajhg.2013.12.012			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24439110	Green Published, hybrid			2022-12-18	WOS:000331419500011
J	de Candia, TR; Lee, SH; Yang, J; Browning, BL; Gejman, PV; Levinson, DF; Mowry, BJ; Hewitt, JK; Goddard, ME; O'Donovan, MC; Purcell, SM; Posthuma, D; Visscher, PM; Wray, NR; Keller, MC				de Candia, Teresa R.; Lee, S. Hong; Yang, Jian; Browning, Brian L.; Gejman, Pablo V.; Levinson, Douglas F.; Mowry, Bryan J.; Hewitt, John K.; Goddard, Michael E.; O'Donovan, Michael C.; Purcell, Shaun M.; Posthuma, Danielle; Visscher, Peter M.; Wray, Naomi R.; Keller, Matthew C.		Int Schizophrenia Consortium; Mol Genetics Schizophrenia	Additive Genetic Variation in Schizophrenia Risk Is Shared by Populations of African and European Descent	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMMON; VARIANTS; GENOMICS; ASSOCIATION; SNPS; TWIN	To investigate the extent to which the proportion of schizophrenia's additive genetic variation tagged by SNPs is shared by populations of European and African descent, we analyzed the largest combined African descent (AD [n = 2,142]) and European descent (ED [n = 4,990]) schizophrenia case-control genome-wide association study (GWAS) data set available, the Molecular Genetics of Schizophrenia (MGS) data set. We show how a method that uses genomic similarities at measured SNPs to estimate the additive genetic correlation (SNP correlation [SNP-r(g)]) between traits can be extended to estimate SNP-r(g) for the same trait between ethnicities. We estimated SNP-r(g) for schizophrenia between the MGS ED and MGS AD samples to be 0.66 (SE = 0.23), which is significantly different from 0 (P(SNP-rg (= 0)) = 0.0003), but not 1 (p((SNP-rg = 1)) = 0.26). We re-estimated SNP-r(g) between an independent ED data set (n = 6,665) and the MGS AD sample to be 0.61 (SE = 0.21, P(SNP-rg = 0) = 0.0003, p((SNP-rg = 1)) = 0.16). These results suggest that many schizophrenia risk alleles are shared across ethnic groups and predate African-European divergence.	[de Candia, Teresa R.; Hewitt, John K.; Keller, Matthew C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80302 USA; [de Candia, Teresa R.; Hewitt, John K.; Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80302 USA; [Lee, S. Hong; Yang, Jian; Mowry, Bryan J.; Visscher, Peter M.; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Brisbane, Qld 4072, Australia; [Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Gejman, Pablo V.] Northshore Univ Hlth Syst, Dept Psychiat & Behav Sci, Evanston, IL 60601 USA; [Gejman, Pablo V.] Univ Chicago, Evanston, IL 60601 USA; [Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA; [Mowry, Bryan J.] Queensland Ctr Mental Hlth Res, Brisbane, Qld 4076, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Melbourne, Vic 3001, Australia; [O'Donovan, Michael C.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF14 4XN, S Glam, Wales; [Purcell, Shaun M.] Broad Inst, Cambridge, MA 02141 USA; [Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands; [Posthuma, Danielle] Erasmus Univ, Sophia Child Hosp, Dept Child & Adolescent Psychiat, NL-3000 CB Rotterdam, Netherlands	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Queensland; University of Queensland; University of Washington; University of Washington Seattle; NorthShore University Health System; University of Chicago; Stanford University; Queensland Centre for Mental Health Research; University of Melbourne; Cardiff University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam	de Candia, TR (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80302 USA.	teresa.decandia@colorado.edu; matthew.c.keller@gmail.com	McQuillin, Andrew/C-1623-2008; Wray, Naomi/C-8639-2015; Lee, Sang Hong/A-2569-2011; Browning, Brian L/A-1178-2010; Bergen, Sarah/I-8313-2012; Visscher, Peter/ABB-6151-2020; Fanous, Ayman H/O-1263-2017; O'Donovan, Michael C/P-7005-2018; Yang, Jian/A-5852-2010; Mowry, Bryan/G-5046-2010	McQuillin, Andrew/0000-0003-1567-2240; Wray, Naomi/0000-0001-7421-3357; Lee, Sang Hong/0000-0001-9701-2718; Browning, Brian L/0000-0001-6454-6633; Bergen, Sarah/0000-0002-5888-0034; Visscher, Peter/0000-0002-2143-8760; O'Donovan, Michael C/0000-0001-7073-2379; Yang, Jian/0000-0003-2001-2474; KELLER, MATTHEW/0000-0002-6075-9882; Goddard, Michael/0000-0001-9917-7946; Bass, Nicholas James/0000-0002-4481-778X; Mowry, Bryan/0000-0002-4115-5645; Posthuma, Danielle/0000-0001-7582-2365; lichtenstein, paul/0000-0003-3037-5287	National Institute of Mental Health [K01MH085812, R01MH100141, 5T32MH016880-30, R01HG004960, R01HG005701]; Australian National Health and Medical Research Council [389892, 442915, 496688, 613672, 613601, 1047956, 1052684]; Australian Research Council [DP0770096, DP1093502, FT0991360, DE130100614]; MRC [G0800509] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004960, R01HG005701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071681, K01MH085812, R01MH061675, P50MH066392, U01MH079470, R01MH077139, U01MH046318, R01MH060870, R01MH081800, R01MH059565, R01MH059587, R01MH060879, T32MH016880, R01MH080403, U01MH079469, R01MH100141, R01MH059588, R01MH059586, R01MH059571, U01MH046289, U01MH046276, R01MH074027, R01MH067257, R01MH059566] Funding Source: NIH RePORTER; Medical Research Council [G0800509, G0801418B] Funding Source: researchfish	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge funding from the National Institute of Mental Health (grants K01MH085812 and R01MH100141 to M.C.K., 5T32MH016880-30 to J.K.H., and R01HG004960 and R01HG005701 to B.L.B.), the Australian National Health and Medical Research Council (grants 389892, 442915, 496688, 613672, 613601, 1047956, and 1052684), and the Australian Research Council (grants DP0770096, DP1093502, FT0991360, and DE130100614). The Molecular Genetics of Schizophrenia data set described in this manuscript was obtained from dbGaP, found at http://www.ncbi.nlm.nih.gov/gap, through study accession numbers phs000021.v3.p2 and phs000167.v1.p1. This manuscript does not necessarily reflect the opinions or views of the funding agencies or institutes who helped in collection of this data. Acknowledgments for the International Schizophrenia Consortium and the Molecular Genetics of Schizophrenia Collaboration can be found in the Supplemental Data.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Chang MH, 2011, CIRC-CARDIOVASC GENE, V4, P523, DOI 10.1161/CIRCGENETICS.111.959577; Fesinmeyer MD, 2013, OBESITY, V21, P835, DOI 10.1002/oby.20268; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Haga SB, 2010, GENET MED, V12, P81, DOI 10.1097/GIM.0b013e3181ca2bbf; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shriner D, 2010, GENET EPIDEMIOL, V34, P258, DOI 10.1002/gepi.20457; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sved JA, 2009, TWIN RES HUM GENET, V12, P35, DOI 10.1375/twin.12.1.35; Sved JA, 2008, AM J HUM GENET, V83, P737, DOI 10.1016/j.ajhg.2008.10.019; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zuo LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026726	30	75	75	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					463	470		10.1016/j.ajhg.2013.07.007	http://dx.doi.org/10.1016/j.ajhg.2013.07.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23954163	Green Published, hybrid			2022-12-18	WOS:000330268900005
J	Santos-Cortez, RLP; Lee, K; Azeem, Z; Antonellis, PJ; Pollock, LM; Khan, S; Irfanullah; Andrade-Elizondo, PB; Chiu, I; Adams, MD; Basit, S; Smith, JD; Nickerson, DA; McDermott, BM; Ahmad, W; Leal, SM				Santos-Cortez, Regie Lyn P.; Lee, Kwanghyuk; Azeem, Zahid; Antonellis, Patrick J.; Pollock, Lana M.; Khan, Saadullah; Irfanullah; Andrade-Elizondo, Paula B.; Chiu, Ilene; Adams, Mark D.; Basit, Sulman; Smith, Joshua D.; Nickerson, Deborah A.; McDermott, Brian M., Jr.; Ahmad, Wasim; Leal, Suzanne M.		Univ Washington	Mutations in KARS, Encoding Lysyl-tRNA Synthetase, Cause Autosomal-Recessive Nonsyndromic Hearing Impairment DFNB89	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUALITY-OF-LIFE; PLATFORM; HEALTH; GALAXY; LEAD	Previously, DFNB89, a locus associated with autosomal-recessive nonsyndromic hearing impairment (ARNSHI), was mapped to chromosomal region 16q21-q23.2 in three unrelated, consanguineous Pakistani families. Through whole-exome sequencing of a hearing-impaired individual from each family, missense mutations were identified at highly conserved residues of lysyl-tRNA synthetase (KARS): the c.1129G>A (p.Asp377Asn) variant was found in one family, and the c.517T>C (p.Tyr173His) variant was found in the other two families. Both variants were predicted to be damaging by multiple bioinformatics tools. The two variants both segregated with the nonsyndromic-hearing-impairment phenotype within the three families, and neither mutation was identified in ethnically matched controls or within variant databases. Individuals homozygous for KARS mutations had symmetric, severe hearing impairment across all frequencies but did not show evidence of auditory or limb neuropathy. It has been demonstrated that KARS is expressed in hair cells of zebrafish, chickens, and mice. Moreover, KARS has strong localization to the spiral ligament region of the cochlea, as well as to Deiters' cells, the sulcus epithelium, the basilar membrane, and the surface of the spiral Embus. It is hypothesized that KARS variants affect aminoacylation in inner-ear cells by interfering with binding activity to tRNA or p38 and with tetramer formation. The identification of rare KARS variants in ARNSHI-affected families defines a gene that is associated with ARNSHI.	[Santos-Cortez, Regie Lyn P.; Lee, Kwanghyuk; Andrade-Elizondo, Paula B.; Chiu, Ilene; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Azeem, Zahid; Khan, Saadullah; Irfanullah; Basit, Sulman; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 45320, Pakistan; [Azeem, Zahid] Azad Jammu Kashmir Med Coll, Dept Biochem, Muzaffarabad 13100, Azad Jammu & Ka, Pakistan; [Antonellis, Patrick J.; Pollock, Lana M.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Antonellis, Patrick J.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Pollock, Lana M.; Adams, Mark D.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Baylor College of Medicine; Quaid I Azam University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Washington; University of Washington Seattle	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA.	sleal@bcm.edu	, Irfanullah/I-2221-2019; Basit, Sulman/F-6395-2015; Khan, Saadullah/K-4489-2016; Azeem, Zahid/J-2158-2015; Basit, Sulman/Q-7939-2018; Basit, Sulman/AAY-9763-2021; Ahmad, Wasim/E-9713-2015; Ahmad, Wasim/GSD-8904-2022	Khan, Saadullah/0000-0001-5037-1473; Basit, Sulman/0000-0003-4294-6825; Basit, Sulman/0000-0003-4294-6825; Lee, Kwanghyuk/0000-0003-1389-1220	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (NIH) [DC003594, DC011651, DC009437]; National Human Genome Research Institute of the NIH [HG006493]; Higher Education Commission of Pakistan; NIH [N01-HG-065403]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, N01HG065403, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011651, R29DC003594, R01DC009437, R01DC003594] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (NIH); National Human Genome Research Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are very thankful to the families who participated in the study. This study was funded by grants DC003594, DC011651, and DC009437 from the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (NIH), grant HG006493 from the National Human Genome Research Institute of the NIH, and the Higher Education Commission of Pakistan. Genotyping of the families was performed at the Center for Inherited Disease Research, which is funded through the NIH to The Johns Hopkins University under contract number N01-HG-065403.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2011, AM J HUM GENET, V88, P19, DOI 10.1016/j.ajhg.2010.11.010; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Alexandrescu AT, 1999, J MOL BIOL, V289, P1041, DOI 10.1006/jmbi.1999.2813; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banerjee R, 2011, J MOL BIOL, V410, P280, DOI 10.1016/j.jmb.2011.05.011; Basit S, 2011, HUM GENET, V129, P379, DOI 10.1007/s00439-010-0934-0; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Fellinger J, 2008, EUR CHILD ADOLES PSY, V17, P414, DOI 10.1007/s00787-008-0683-y; Fukushima K, 1996, GENES CELLS, V1, P1087, DOI 10.1046/j.1365-2443.1996.d01-225.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Glamuzina E, 2012, J INHERIT METAB DIS, V35, P459, DOI 10.1007/s10545-011-9413-6; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; RACINE FM, 1974, J BACTERIOL, V120, P372, DOI 10.1128/JB.120.1.372-383.1974; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rozen S, 2000, Methods Mol Biol, V132, P365; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yaeger D, 2006, AM J MED GENET A, V140A, P827, DOI 10.1002/ajmg.a.31179; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	46	75	85	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					132	140		10.1016/j.ajhg.2013.05.018	http://dx.doi.org/10.1016/j.ajhg.2013.05.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23768514	Bronze, Green Published			2022-12-18	WOS:000321804500013
J	Parry, DA; Poulter, JA; Logan, CV; Brookes, SJ; Jafri, H; Ferguson, CH; Anwari, BM; Rashid, Y; Zhao, HQ; Johnson, CA; Inglehearn, CF; Mighell, AJ				Parry, David A.; Poulter, James A.; Logan, Clare V.; Brookes, Steven J.; Jafri, Hussain; Ferguson, Christopher H.; Anwari, Babra M.; Rashid, Yasmin; Zhao, Haiqing; Johnson, Colin A.; Inglehearn, Chris F.; Mighell, Alan J.			Identification of Mutations in SLC24A4, Encoding a Potassium-Dependent Sodium/Calcium Exchanger, as a Cause of Amelogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KOHLSCHUTTER-TONZ SYNDROME; SODIUM-CALCIUM EXCHANGER; DNA-SEQUENCING DATA; CONE-ROD DYSTROPHY; DENTAL ENAMEL; GENE; RESIDUES; PROTEIN; FRAMEWORK; FAMILIES	A combination of autozygosity mapping and exome sequencing identified a null mutation in SLC24A4 in a family with hypomineralized amelogenesis imperfect a (AI), a condition in which tooth enamel formation fails. SLC24A4 encodes a calcium transporter upregulated in ameloblasts during the maturation stage of amelogenesis. Screening of further AT families identified a missense mutation in the ion-binding site of SLC24A4 expected to severely diminish or abolish the ion transport function of the protein. Furthermore, examination of previously generated Slc24a4 null mice identified a severe defect in tooth enamel that reflects impaired amelogenesis. These findings support a key role for SLC24A4 in calcium transport during enamel formation.	[Parry, David A.; Poulter, James A.; Logan, Clare V.; Jafri, Hussain; Johnson, Colin A.; Inglehearn, Chris F.; Mighell, Alan J.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Brookes, Steven J.; Mighell, Alan J.] Univ Leeds, Leeds Dent Inst, Leeds LS2 9LU, W Yorkshire, England; [Jafri, Hussain; Rashid, Yasmin] Gene Tech Lab, Lahore 54000, Pakistan; [Ferguson, Christopher H.; Zhao, Haiqing] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Anwari, Babra M.] deMontmorency Coll Dent, Lahore 54000, Pakistan	Saint James's University Hospital; University of Leeds; University of Leeds; Johns Hopkins University	Mighell, AJ (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	a.j.mighell@leeds.ac.uk	Inglehearn, Chris/GYD-9783-2022; Poulter, James A/A-8190-2013	Poulter, James A/0000-0003-2048-5693; Logan, Clare/0000-0003-4323-1602; BROOKES, STEVEN/0000-0002-9097-7311; Parry, David/0000-0003-0376-7736; Johnson, Colin/0000-0002-2979-8234	Wellcome Trust [082448, 093113]; Sir Jules Thorn Award for Biomedical Research [JTA/09]; National Institute of Health [DC007395]; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007395] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Sir Jules Thorn Award for Biomedical Research; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Sir Jules Thorn Charitable Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank the families for participating in this study. This work was supported by grants from The Wellcome Trust (to A.J.M., H.J., Y.R., and C.F.I. grant # 082448 and S.J.B. grant #093113), the Sir Jules Thorn Award for Biomedical Research (to C.A.J. and C.F.I. grant #JTA/09) and National Institute of Health (to H.Z. grant # DC007395).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BACKMAN B, 1986, COMMUNITY DENT ORAL, V14, P43, DOI 10.1111/j.1600-0528.1986.tb01493.x; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Coffield KD, 2005, J AM DENT ASSOC, V136, P620, DOI 10.14219/jada.archive.2005.0233; Corral J, 2006, BLOOD, V108, P177, DOI 10.1182/blood-2005-08-3249; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hu P, 2012, CELLS TISSUES ORGANS, V196, P501, DOI 10.1159/000337493; Hubbard MJ, 2000, CRIT REV ORAL BIOL M, V11, P437, DOI 10.1177/10454411000110040401; Iwamoto T, 2000, J BIOL CHEM, V275, P38571, DOI 10.1074/jbc.M003788200; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Lacruz RS, 2012, J CELL PHYSIOL, V227, P2264, DOI 10.1002/jcp.22965; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mory A, 2012, AM J HUM GENET, V90, P708, DOI 10.1016/j.ajhg.2012.03.005; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Parry DA, 2012, AM J HUM GENET, V91, P565, DOI 10.1016/j.ajhg.2012.07.020; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Schossig A, 2012, AM J HUM GENET, V90, P701, DOI 10.1016/j.ajhg.2012.02.012; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Van de Water N, 2004, BRIT J HAEMATOL, V127, P190, DOI 10.1111/j.1365-2141.2004.05189.x; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x; Witkop CJ, 1976, ORAL FACIAL GENETICS, P151	38	75	81	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					307	312		10.1016/j.ajhg.2013.01.003	http://dx.doi.org/10.1016/j.ajhg.2013.01.003			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23375655	hybrid, Green Published			2022-12-18	WOS:000315179600017
J	Ahmed, ZM; Yousaf, R; Lee, BC; Khan, SN; Lee, S; Lee, K; Husnain, T; Rehman, AU; Bonneux, S; Ansar, M; Ahmad, W; Leal, SM; Gladyshev, VN; Belyantseva, IA; Van Camp, G; Riazuddin, S; Friedman, TB; Riazuddin, S				Ahmed, Zubair M.; Yousaf, Rizwan; Lee, Byung Cheon; Khan, Shaheen N.; Lee, Sue; Lee, Kwanghyuk; Husnain, Tayyab; Rehman, Atteeq Ur; Bonneux, Sarah; Ansar, Muhammad; Ahmad, Wasim; Leal, Suzanne M.; Gladyshev, Vadim N.; Belyantseva, Inna A.; Van Camp, Guy; Riazuddin, Sheikh; Friedman, Thomas B.; Riazuddin, Saima			Functional Null Mutations of MSRB3 Encoding Methionine Sulfoxide Reductase Are Associated with Human Deafness DFNB74	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; OXIDATIVE STRESS; INNER-EAR; MACULAR DEGENERATION; GAMMA-ACTIN; AGE; GENE; CELLS; APOPTOSIS; DYSTONIA	The DFNB74 locus for autosomal-recessive, nonsyndromic deafness segregating in three families was previously mapped to a 5.36 Mb interval on chromosome 12q14.2-q15. Subsequently, we ascertained five additional consanguineous families in which deafness segregated with markers at this locus and refined the critical interval to 2.31 Mb. We then sequenced the protein-coding exons of 18 genes in this interval. The affected individuals of six apparently unrelated families were homozygous for the same transversion (c.265T>G) in MSRB3, which encodes a zinc-containing methionine sulfoxide reductase B3. c.265T>G results in a substitution of glycine for cysteine (p.Cys89Gly), and this substitution cosegregates with deafness in the six DFNB74 families. This cysteine residue of MSRB3 is conserved in orthologs from yeast to humans and is involved in binding structural zinc. In vitro, p.Cys89Gly abolished zinc binding and MSRB3 enzymatic activity, indicating that p.Cys89Gly is a loss-of-function allele. The affected individuals in two other families were homozygous for a transition mutation (c.55T>C), which results in a nonsense mutation (p.Arg19X) in alternatively spliced exon 3, encoding a mitochondrial localization signal. This finding suggests that DFNB74 deafness is due to a mitochondrial dysfunction. In a cohort of 1,040 individuals (aged 53-67 years) of European ancestry, we found no association between 17 tagSNPs for MSRB3 and age-related hearing loss. Mouse Msrb3 is expressed widely. In the inner ear, it is found in the sensory epithelium of the organ of Corti and vestibular end organs as well as in cells of the spiral ganglion. Taken together, MSRB3-catalyzed reduction of methionine sulfoxides to methionine is essential for hearing.	[Ahmed, Zubair M.; Yousaf, Rizwan; Riazuddin, Saima] Cincinnati Childrens Hosp Res Fdn, Div Pediat Otolaryngol Head & Neck Surg, Mol Genet Lab, Cincinnati, OH 45229 USA; [Ahmed, Zubair M.; Yousaf, Rizwan; Riazuddin, Saima] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH 45229 USA; [Ahmed, Zubair M.; Riazuddin, Saima] Cincinnati Childrens Hosp Res Fdn, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Ahmed, Zubair M.; Riazuddin, Saima] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Lee, Byung Cheon; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Lee, Byung Cheon; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Yousaf, Rizwan; Khan, Shaheen N.; Husnain, Tayyab; Rehman, Atteeq Ur] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 54500, Pakistan; [Lee, Sue; Rehman, Atteeq Ur; Belyantseva, Inna A.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bonneux, Sarah; Van Camp, Guy] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Ansar, Muhammad; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 45320, Pakistan; [Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Jinnah Hosp Complex, Lahore 54500, Pakistan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Baylor College of Medicine; University of Antwerp; Quaid I Azam University; University of Health Science - Pakistan	Riazuddin, S (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Pediat Otolaryngol Head & Neck Surg, Mol Genet Lab, Cincinnati, OH 45229 USA.	saima.riazuddin@cchmc.org	Gladyshev, Vadim N/A-9894-2013; Husnain, Tayyab/AAE-9033-2019; Ansar, Muhammad/H-5967-2011; Ahmad, Wasim/E-9713-2015; Nasim Khan, Shaheen/F-2135-2015; Ahmad, Wasim/GSD-8904-2022; Yousaf, Rizwan/AAJ-8437-2020; Gladyshev, Vadim N/J-6187-2013; Ansar, Muhammad/F-4808-2015; Husnain, Tayyab/G-3805-2015; Rehman, Atteeq/AAG-8342-2020; Van Camp, Guy/F-3386-2013	Ansar, Muhammad/0000-0001-5891-7063; Van Camp, Guy/0000-0001-5105-9000; Yousaf, Rizwan/0000-0003-2323-0004; Lee, Kwanghyuk/0000-0001-7781-9696; Lee, Byung Cheon/0000-0003-1467-1940; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Kwanghyuk/0000-0003-1389-1220	Cincinnati Children's Hospital Research Foundation (CCHMC); National Institute on Deafness and Other Communication Disorders, National Institutes of Health (NIDCD/NIH) [R00-DC009287-03, DC03594, DC00039-14]; National Institute on Aging, NIH [AG021518]; Higher Education Commission; World Health Organization Regional Office for the Eastern Mediterranean (EMRO); COMSTECH (Organization of the Islamic Conference [OIC] Standing Committee on Scientific and Technological Cooperation); Ministry of Science and Technology (MOST); International Center for Genetic Engineering and Biotechnology, Trieste, Italy [CRP/PAK08-01, 08/009]; Higher Education Commission (HEC), Government of Pakistan; Center for Inherited Disease Research (CIDR); NIH [N01-HG-65403]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation (CCHMC); National Institute on Deafness and Other Communication Disorders, National Institutes of Health (NIDCD/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); World Health Organization Regional Office for the Eastern Mediterranean (EMRO); COMSTECH (Organization of the Islamic Conference [OIC] Standing Committee on Scientific and Technological Cooperation); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); International Center for Genetic Engineering and Biotechnology, Trieste, Italy; Higher Education Commission (HEC), Government of Pakistan(Higher Education Commission of Pakistan); Center for Inherited Disease Research (CIDR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We wish to thank all participants in this study. We thank Shannon Bell for technical assistance and Dennis Drayna and Karen Friderici for critiques of the manuscript. This work was supported by Cincinnati Children's Hospital Research Foundation (CCHMC) intramural research funds to SR and ZA, the National Institute on Deafness and Other Communication Disorders, National Institutes of Health (NIDCD/NIH) research grant R00-DC009287-03, a Career Development Award from Research to Prevent Blindness (to Z.A.), and National Institute on Aging, NIH grant AG021518 (to V.N.G.). S. B. is a fellow of the Research Foundation Flanders (FWO-Vlaanderen). Work in Pakistan was supported by the Higher Education Commission to S.R. (Lahore); funding from World Health Organization Regional Office for the Eastern Mediterranean (EMRO) and COMSTECH (Organization of the Islamic Conference [OIC] Standing Committee on Scientific and Technological Cooperation) and from the Ministry of Science and Technology (MOST) to S.R. (Lahore); the International Center for Genetic Engineering and Biotechnology, Trieste, Italy under project CRP/PAK08-01 contract no. 08/009 to SR., (Islamabad). Part of the work was funded by the Higher Education Commission (HEC), Government of Pakistan, and the NIH National Institute of Deafness and other Communication Disorders grant DC03594 to S.M.L. Genotyping services were partially provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to The Johns Hopkins University, contract number N01-HG-65403. Work at NIDCD/NIH was supported by intramural funds DC00039-14 to T.B.F.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Coling D, 2009, NEUROSCI LETT, V464, P22, DOI 10.1016/j.neulet.2009.08.015; DAVIS A, 1994, HEARING ADULTS, P43; De Martinis M, 2007, CURR MED CHEM, V14, P1389, DOI 10.2174/092986707780831122; Fransen E, 2004, EAR HEARING, V25, P133, DOI 10.1097/01.AUD.0000120362.69077.0B; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Huyghe JR, 2008, AM J HUM GENET, V83, P401, DOI 10.1016/j.ajhg.2008.08.002; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim HY, 2004, BIOCHEM BIOPH RES CO, V320, P1277, DOI 10.1016/j.bbrc.2004.06.078; Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; Marchetti MA, 2005, INVEST OPHTH VIS SCI, V46, P2107, DOI 10.1167/iovs.05-0018; Morishita H, 2001, BIOCHEM BIOPH RES CO, V284, P142, DOI 10.1006/bbrc.2001.4939; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Novoselov SV, 2010, ANTIOXID REDOX SIGN, V12, P829, DOI 10.1089/ars.2009.2895; Olry A, 2005, PROTEIN SCI, V14, P2828, DOI 10.1110/ps.051711105; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Roesch K, 2004, HUM MOL GENET, V13, P2101, DOI 10.1093/hmg/ddh217; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Tranebjaerg L, 2000, EUR J HUM GENET, V8, P464, DOI 10.1038/sj.ejhg.5200483; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Van Eyken E, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049205; Van Eyken E, 2007, OTOL NEUROTOL, V28, P970; Van Laer L, 1998, NAT GENET, V20, P194; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Walss-Bass C, 2009, AM J MED GENET B, V150B, P219, DOI 10.1002/ajmg.b.30791; Waryah AM, 2009, CLIN GENET, V76, P270, DOI 10.1111/j.1399-0004.2009.01209.x; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Zheng QY, 2009, NEUROBIOL AGING, V30, P1693, DOI 10.1016/j.neurobiolaging.2007.12.011; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	49	75	80	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					19	29		10.1016/j.ajhg.2010.11.010	http://dx.doi.org/10.1016/j.ajhg.2010.11.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21185009	Green Published, Bronze			2022-12-18	WOS:000286501500002
J	Bandah-Rozenfeld, D; Collin, RWJ; Banin, E; van den Born, LI; Coene, KLM; Siemiatkowska, AM; Zelinger, L; Khan, MI; Lefeber, DJ; Erdinest, I; Testa, F; Simonelli, F; Voesenek, K; Blokland, EAW; Strom, TM; Klaver, CCW; Qamar, R; Banfi, S; Cremers, FPM; Sharon, D; den Hollander, AI				Bandah-Rozenfeld, Dikla; Collin, Rob W. J.; Banin, Eyal; van den Born, L. Ingeborgh; Coene, Karlien L. M.; Siemiatkowska, Anna M.; Zelinger, Lina; Khan, Muhammad I.; Lefeber, Dirk J.; Erdinest, Inbar; Testa, Francesco; Simonelli, Francesca; Voesenek, Krysta; Blokland, Ellen A. W.; Strom, Tim M.; Klaver, Caroline C. W.; Qamar, Raheel; Banfi, Sandro; Cremers, Frans P. M.; Sharon, Dror; den Hollander, Anneke I.			Mutations in IMPG2, Encoding Interphotoreceptor Matrix Proteoglycan 2, Cause Autosomal-Recessive Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPACRCAN; GENE; GLYCOSAMINOGLYCANS; IDENTIFICATION; HYALURONAN; ORTHOLOG; BINDING	Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal diseases caused by progressive degeneration of the photoreceptor cells. Using autozygosity mapping, we identified two families, each with three affected siblings sharing large overlapping homozygous regions that harbored the IMPG2 gene on chromosome 3. Sequence analysis of IMPG2 in the two index cases revealed homozygous mutations cosegregating with the disease in the respective families: three affected siblings of Iraqi Jewish ancestry displayed a nonsense mutation, and a Dutch family displayed a 1.8 kb genomic deletion that removes exon 9 and results in the absence of seven amino acids in a conserved SEA domain of the IMPG2 protein. Transient transfection of COS-1 cells showed that a construct expressing the wild-type SEA domain is properly targeted to the plasma membrane, whereas the mutant lacking the seven amino acids appears to be retained in the endoplasmic reticulum. Mutation analysis in ten additional index cases that were of Dutch, Israeli, Italian, and Pakistani origin and had homozygous regions encompassing IMPG2 revealed five additional mutations; four nonsense mutations and one missense mutation affecting a highly conserved phenylalanine residue. Most patients with IMPG2 mutations showed an early-onset form of RP with progressive visual-field loss and deterioration of visual acuity. The patient with the missense mutation, however, was diagnosed with maculopathy. The IMPG2 gene encodes the interphotoreceptor matrix proteoglycan IMPG2, which is a constituent of the interphotoreceptor matrix. Our data therefore show that mutations in a structural component of the interphotoreceptor matrix can cause arRP.	[Bandah-Rozenfeld, Dikla; Banin, Eyal; Zelinger, Lina; Erdinest, Inbar; Sharon, Dror] Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Collin, Rob W. J.; Coene, Karlien L. M.; Siemiatkowska, Anna M.; Khan, Muhammad I.; Voesenek, Krysta; Blokland, Ellen A. W.; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; Coene, Karlien L. M.; Siemiatkowska, Anna M.; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, Rotterdam, Netherlands; [Khan, Muhammad I.; Qamar, Raheel] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Testa, Francesco; Simonelli, Francesca] Univ Naples 2, Dept Ophthalmol, Naples, Italy; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Qamar, Raheel] Shifa Coll Med, Islamabad, Pakistan; [Banfi, Sandro] Telethon Inst Genet & Med, Naples, Italy	Hebrew University of Jerusalem; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Rotterdam Eye Hospital; COMSATS University Islamabad (CUI); Radboud University Nijmegen; Radboud University Nijmegen; Universita della Campania Vanvitelli; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Shifa College of Medicine; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Sharon, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, Jerusalem, Israel.	dror.sharon1@gmail.com; a.denhollander@antrg.umcn.nl	Qamar, Raheel/G-3355-2015; Zelinger, Lina/L-3272-2019; Lefeber, Dirk DJ/A-2146-2014; qamar, raheel/D-4543-2012; Banfi, Sandro/K-3963-2018; lefeber, dirk/G-5063-2012; Klaver, Caroline C.W./A-2013-2016; Coene, Karlien/K-7583-2016; Simonelli, Francesca/AHE-7571-2022; Cremers, Frans/A-5625-2014; Sharon, Dror/P-4539-2015; Collin, Rob/N-3575-2014; Hollander, Anneke den/N-4911-2014; Tracewska, Anna M/N-7087-2015; Testa, Francesco/J-3185-2012	Banfi, Sandro/0000-0002-6541-8833; Coene, Karlien/0000-0001-9873-1458; Simonelli, Francesca/0000-0001-8520-6769; Cremers, Frans/0000-0002-4954-5592; Sharon, Dror/0000-0002-1789-5811; Tracewska, Anna M/0000-0001-9690-4458; Testa, Francesco/0000-0002-1482-1577; Khan, Muhammad Imran/0000-0003-0276-5480; Zelinger, Lina/0000-0003-3028-7172; Klaver, Caroline/0000-0002-2355-5258	Foundation Fighting Blindness USA (FFB) [BR-GE-0607-0395-HUJ, BR-GE-0507-0381-RAD]; Italian Ministry of Health; Italian Telethon foundation; Yedidut 1 Research Fund	Foundation Fighting Blindness USA (FFB); Italian Ministry of Health(Ministry of Health, Italy); Italian Telethon foundation(Fondazione Telethon); Yedidut 1 Research Fund	We thank the patients and their families for participating in this study. We thank Alex Obolensky, Tamar Ben-Yosef, Saskia van der Velde-Visser, Christel Beumer, Maleeha Azam, Rolph Pfundt, Carmela Ziviello, Maria Teresa Pizzo, and the European Retinal Disease Consortium (Elfride de Baere, Carmen Ayuso, Christian Hamel, Susanne Kohl, and Rob Koenekoop) for excellent technical assistance and additional mutation analysis. This work was supported by the Foundation Fighting Blindness USA (FFB grant number BR-GE-0607-0395-HUJ to D.S. and BR-GE-0507-0381-RAD to A.I.d.H.), the Italian Ministry of Health (Progretto ricerca finalizzatta 2007), the Italian Telethon foundation, and the Yedidut 1 Research Fund.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Acharya S, 1998, J BIOL CHEM, V273, P31599, DOI 10.1074/jbc.273.47.31599; Acharya S, 2000, J BIOL CHEM, V275, P6945, DOI 10.1074/jbc.275.10.6945; ADLER AJ, 1982, EXP EYE RES, V34, P423, DOI 10.1016/0014-4835(82)90088-4; BERMAN ER, 1969, BIBL OPHTHALMOL, P5; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; BUNDEY S, 1984, J MED GENET, V21, P421, DOI 10.1136/jmg.21.6.421; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Chen QY, 2004, J BIOL CHEM, V279, P23142, DOI 10.1074/jbc.M401584200; Chen QY, 2003, EXP EYE RES, V76, P1, DOI 10.1016/S0014-4835(02)00273-7; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; Dryja TP, 1997, P NATL ACAD SCI USA, V94, P12117, DOI 10.1073/pnas.94.22.12117; ENOCH JM, 1971, INVEST OPHTH VISUAL, V10, P959; Gehrig A, 1998, J MED GENET, V35, P641, DOI 10.1136/jmg.35.8.641; HAGEMAN GS, 1991, RETINAL RES, P207; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HEWITT AT, 1989, RETINA, P57; Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5; Kuehn M H, 1999, Mol Cell Biol Res Commun, V2, P103, DOI 10.1006/mcbr.1999.0161; Kuehn MH, 2001, INVEST OPHTH VIS SCI, V42, P3123; LAZARUS HS, 1992, INVEST OPHTH VIS SCI, V33, P364; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Rosenberg T, 2003, DEV OPHTHALMOL, V37, P16; Rozen S, 2000, Methods Mol Biol, V132, P365; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; van Lith-Verhoeven JJC, 2004, INVEST OPHTH VIS SCI, V45, P30, DOI 10.1167/iovs.03-0392; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352	30	75	77	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					199	208		10.1016/j.ajhg.2010.07.004	http://dx.doi.org/10.1016/j.ajhg.2010.07.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20673862	Green Published, Bronze			2022-12-18	WOS:000281107000004
J	Spady, TC; Ostrander, EA				Spady, Tyrone C.; Ostrander, Elaine A.			Canine behavioral genetics: Pointing out the phenotypes and herding up the genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							DOMESTIC DOG; LINKAGE DISEQUILIBRIUM; AGGRESSIVE-BEHAVIOR; BREED DIFFERENCES; CLUSTER-ANALYSIS; NOVELTY SEEKING; GUIDE DOGS; PET DOGS; GENOME; TRAITS	An astonishing amount of behavioral variation is captured within the more than 350 breeds of dog recognized worldwide. Inherent in observations of dog behavior is the notion that much of what is observed is breed specific and will persist, even in the absence of training or motivation. Thus, herding, pointing, tracking, hunting, and so forth are likely to be controlled, at least in part at the genetic level. Recent studies in canine genetics suggest teat small numbers of genes control major morphologic phenotypes. By extension, we hypothesize that at least some canine behaviors will also be controlled by small numbers of genes that can be readily mapped. In this review, we describe our current understanding of a representative subset of canine behaviors, as well as approaches for phenotyping, genome-wide scans, and data analysis. Finally, we discuss the applicability of studies of canine behavior to human genetics.	[Spady, Tyrone C.; Ostrander, Elaine A.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Ostrander, EA (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Fiumefreddo, Andrea/T-2977-2019	Ostrander, Elaine/0000-0001-6075-9738	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200325, ZIAHG200325] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		American Kennel Club, 1998, COMPL DOG BOOK, V19th; BELYAEV DK, 1969, SCI J, V5, P47; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; Bentolila S, 1999, MAMM GENOME, V10, P699, DOI 10.1007/s003359901074; Bradshaw JWS, 1999, RES VET SCI, V66, P73, DOI 10.1053/rvsc.1998.0246; Chase K, 2006, INT J IMMUNOGENET, V33, P179, DOI 10.1111/j.1744-313X.2006.00593.x; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Clutton-Brock Juliet, 1995, P7; COLTMAN DW, 1994, NUCLEIC ACIDS RES, V22, P2726, DOI 10.1093/nar/22.14.2726; Coppinger Raymond, 1995, P21; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Fondon JW, 2007, DEV GENES EVOL, V217, P79, DOI 10.1007/s00427-006-0113-4; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein O, 2006, GENOMICS, V88, P541, DOI 10.1016/j.ygeno.2006.05.013; Goodloe L P, 1998, J Appl Anim Welf Sci, V1, P303, DOI 10.1207/s15327604jaws0104_1; Grados Marco, 2007, Expert Rev Neurother, V7, P967, DOI 10.1586/14737175.7.8.967; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hart BL, 2005, CURRENT ISSUES AND RESEARCH IN VETERINARY BEHAVIORAL MEDICINE, P107; HART BL, 1985, J AM VET MED ASSOC, V186, P1181; HART BL, 1985, J AM VET MED ASSOC, V186, P1175; HART BL, 1995, ANAL BREED GENDER DI; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; KIRKNESS EF, 2006, SINES CANINE GENOMIC; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kukekova AV, 2007, GENOME RES, V17, P387, DOI 10.1101/gr.5893307; KUKEKOVA AV, 2006, GENOME DOMESTIC DOG, P515; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lindberg J, 2005, CURR BIOL, V15, pR915, DOI 10.1016/j.cub.2005.11.009; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lowe JK, 2003, GENOMICS, V82, P86, DOI 10.1016/S0888-7543(03)00078-8; Masuda K, 2004, J VET MED SCI, V66, P183, DOI 10.1292/jvms.66.183; MIGNOT E, 1993, J NEUROSCI, V13, P1057; MIGNOT E, 1991, P NATL ACAD SCI USA, V88, P3475, DOI 10.1073/pnas.88.8.3475; MINNICK MF, 1992, GENE, V110, P235, DOI 10.1016/0378-1119(92)90654-8; Moon-Fanelli AA, 1998, J AM VET MED ASSOC, V212, P1252; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Murphy JA, 1998, APPL ANIM BEHAV SCI, V58, P163, DOI 10.1016/S0168-1591(97)00047-6; Ogata N, 2006, J VET MED SCI, V68, P157, DOI 10.1292/jvms.68.157; Ostrander EA, 2006, COLD SPRING HARB MON, V44, P1; Ostrander EA, 2000, GENOME RES, V10, P1271, DOI 10.1101/gr.155900; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; PARKER HG, 2007, IN PRESS GENOME RES; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Podberscek AL, 1997, VET REC, V141, P73, DOI 10.1136/vr.141.3.73; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reisner IR, 2005, JAVMA-J AM VET MED A, V227, P1594, DOI 10.2460/javma.2005.227.1594; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Saetre P, 2006, GENES BRAIN BEHAV, V5, P240, DOI 10.1111/j.1601-183X.2005.00155.x; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Scott JP., 1965, GENETICS SOCIAL BEHA; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Takeuchi Y, 2005, J VET MED SCI, V67, P861, DOI 10.1292/jvms.67.861; Takeuchi Y, 2006, J VET MED SCI, V68, P789, DOI 10.1292/jvms.68.789; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Trut L. N., 2001, The genetics of the dog, P15, DOI 10.1079/9780851995205.0015; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.2.160; van den Berg L, 2006, BEHAV GENET, V36, P882, DOI 10.1007/s10519-006-9089-0; Van den Berg L, 2005, J HERED, V96, P786, DOI 10.1093/jhered/esi108; Vassetzky NS, 2002, MAMM GENOME, V13, P50, DOI 10.1007/s00335-001-2111-1; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wilcox B, 1995, ATLAS DOG BREEDS WOR; Wilsson E, 1997, APPL ANIM BEHAV SCI, V54, P235, DOI 10.1016/S0168-1591(96)01175-6; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4	79	75	77	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					10	18		10.1016/j.ajhg.2007.12.001	http://dx.doi.org/10.1016/j.ajhg.2007.12.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179880	Bronze, Green Published			2022-12-18	WOS:000253223800002
J	Ropers, HH				Ropers, Hans-Hilger			New perspectives for the elucidation of genetic disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							LINKED MENTAL-RETARDATION; BALANCED CHROMOSOME REARRANGEMENTS; GENOME-WIDE ASSOCIATION; PITT-HOPKINS-SYNDROME; COMPLEX DISEASES; COMMON DISEASE; TRANSCRIPTION FACTOR; MENDELIAN DISORDERS; ADULT OBESITY; MUTATIONS	For almost 15 years, genome research has focused on the search for major risk factors in common diseases, with disappointing results. Only recently, whole-genome association studies have begun to deliver because of the introduction of high-density single-nucieotide-polymorphisim arrays and massive enlargement of cohort sizes, but most of the risk factors detected account for only a small proportion of the total genetic risk, and their diagnostic value is negligible. There is reason to believe that the complexity of many "multifactorial" disorders is primarily due to genetic heterogeneity, with defects of different genes causing the same disease. Moreover, de novo copy-number variation has been identified as a major cause of mental retardation and other complex disorders, suggesting that new mutations are an important, previously overlooked factor in the etiology of complex diseases. These observations support the notion that research into the previously neglected monogenic disorders should become a priority of genome research. Because of the introduction of novel high-throughput, low-cost sequencing methods, sequencing and genotyping will soon converge, with far-reaching implications for the elucidation of genetic disease and health care.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Max Planck Society	Ropers, HH (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	ropers@molgen.mpg.de						Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; Borck G, 2006, HUM MUTAT, V27, P731, DOI 10.1002/humu.20380; Bovie C, 2003, J MED GENET, V40, P682, DOI 10.1136/jmg.40.9.682; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Brinkman RR, 2006, NAT REV GENET, V7, P249, DOI 10.1038/nrg1828; Bugge M, 2000, J MED GENET, V37, P858, DOI 10.1136/jmg.37.11.858; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Campion D, 2001, M S-MED SCI, V17, P1139, DOI 10.1051/medsci/200117111139; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; CONSORTIUM TAG, 2007, NAT GENET, V39, P319; COX DR, 2007, HUM GEN M MONTR MAY; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; DEVRIES BB, 2007, 3 INT M CRYPT CHROM; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Erdogan F, 2006, CYTOGENET GENOME RES, V115, P247, DOI 10.1159/000095921; FISHBURN J, 1983, AM J MED GENET, V14, P713, DOI 10.1002/ajmg.1320140413; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Ghosh S, 1996, ANNU REV MED, V47, P333; Gibbs R, 2005, NATURE, V437, P1233, DOI 10.1038/4371233a; GUYER MS, 1993, AM J DIS CHILD, V147, P1145, DOI 10.1001/archpedi.1993.02160350019003; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jones C, 1997, AM J HUM GENET, V60, P1558; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lu WN, 2007, PLOS GENET, V3, P830, DOI 10.1371/journal.pgen.0030080; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MEFFORD H, 2007, 3 INT M CRYPT CHROM; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; MOELLER RM, 2007, HUM GEN M MONTR MAY; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; MOTAZACKER MM, 2007, IN PRESS AM J HUM GE; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; O'Connor TP, 2006, NAT REV GENET, V7, P261, DOI 10.1038/nrg1829; Oberstein L, 2006, AM J HUM GENET, V79, P985; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; PASSARGE E, 1993, NAT GENET, V4, P325, DOI 10.1038/ng0893-325; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Peltonen L, 2006, HUM MOL GENET, V15, pR67, DOI 10.1093/hmg/ddl060; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Richards Allan J, 2007, Hum Mutat, V28, P639, DOI 10.1002/humu.9497; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROBERTS AE, 2006, NAT GENET, V38, P331; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Sandhu S S, 2001, Indian J Exp Biol, V39, P650; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; THIENPONT B, 2007, EUR HEART J; TOMMERUP N, 1993, J MED GENET, V30, P713, DOI 10.1136/jmg.30.9.713; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Williamson RE, 2007, AM J MED GENET A, V143A, P1630, DOI 10.1002/ajmg.a.31724; Wirth J, 1999, J MED GENET, V36, P271; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; ZUFFARDI O, 2007, HUM GEN M MONTR MAY; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583; 2007, NAT GENET, V39, P569	109	75	125	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					199	207		10.1086/520679	http://dx.doi.org/10.1086/520679			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668371	Green Published, Bronze			2022-12-18	WOS:000248540400001
J	Zhao, XL; Sun, M; Zhao, J; Leyva, JA; Zhu, HW; Yang, W; Zeng, X; Ao, Y; Liu, Q; Liu, GY; Lo, WHY; Jabs, EW; Amzel, LM; Shan, XN; Zhang, X				Zhao, Xiuli; Sun, Miao; Zhao, Jin; Leyva, J. Alfonso; Zhu, Hongwen; Yang, Wei; Zeng, Xuan; Ao, Yang; Liu, Qing; Liu, Guoyang; Lo, Wilson H. Y.; Jabs, Ethylin Wang; Amzel, L. Mario; Shan, Xiangnian; Zhang, Xue			Mutations in HOXD13 underlie syndactyly type V and a novel brachydactyly-syndactyly syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMEODOMAIN-DNA COMPLEX; POLYALANINE TRACT EXPANSION; 2 UNRELATED FAMILIES; ENGRAILED HOMEODOMAIN; MOLECULAR-DYNAMICS; DEVELOPING LIMBS; GENES; PROTEIN; HOXA13; RECOGNITION	HOXD13, the homeobox-containing gene located at the most 5' end of the HOXD cluster, plays a critical role in limb development. It has been shown that mutations in human HOXD13 can give rise to limb malformations, with variable expressivity and a wide spectrum of clinical manifestations. Polyalanine expansions in HOXD13 cause synpolydactyly, whereas amino acid substitutions in the homeodomain are associated with brachydactyly types D and E. We describe two large Han Chinese families with different limb malformations, one with syndactyly type V and the other with limb features overlapping brachydactyly types A4, D, and E and mild syndactyly of toes 2 and 3. Two-point linkage analysis showed LOD scores > 3 (theta =0) for markers within and/or flanking the HOXD13 locus in both families. In the family with syndactyly type V, we identified a missense mutation in the HOXD13 homeodomain, c.950A -> G(p.Q317R), which leads to substitution of the highly conserved glutamine that is important for DNA-binding specificity and affinity. In the family with complex brachydactyly and syndactyly, we detected a deletion of 21 bp in the imperfect GCN ( where N denotes A, C, G, or T) triplet-containing exon 1 of HOXD13, which results in a polyalanine contraction of seven residues. Moreover, we found that the mutant HOXD13 with the p.Q317R substitution was unable to transactivate the human EPHA7 promoter. Molecular modeling data supported these experimental results. The calculated interactions energies were in agreement with the measured changes of the activity. Our data established the link between HOXD13 and two additional limb phenotypes-syndactyly type V and brachydactyly type A4-and demonstrated that a polyalanine contraction in HOXD13, most likely, led to other digital anomalies but not to synpolydactyly. We suggest the term "HOXD13 limb morphopathies" for the spectrum of limb disorders caused by HOXD13 mutations.	Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100005, Peoples R China; Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; Peking Union Med Coll, Beijing 100005, Peoples R China; Southeast Univ, Sch Med, Genet Res Ctr, Nanjing 210018, Peoples R China; Johns Hopkins Univ, Inst Med Genet, Ctr Craniofacial Dev & Disorders, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Lanzhou Univ, Ctr Genet Med, Lanzhou 730000, Peoples R China; China Med Univ, Res Ctr Med Genom, Shenyang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Southeast University - China; Johns Hopkins University; Johns Hopkins University; Lanzhou University; China Medical University	Zhang, X (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	xuezhang@pumc.edu.cn	zhu, hongwen/AAL-6757-2021; miao, sun/E-2834-2018; leyva, j Alfonso/AAF-8229-2019	Jabs, Ethylin/0000-0001-8983-5466; leyva, j alfonso/0000-0002-3050-1442; Amzel, L. Mario/0000-0002-0129-9572	FOGARTY INTERNATIONAL CENTER [D43TW006176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066895] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW06176, D43 TW006176] Funding Source: Medline; NIGMS NIH HHS [R01 GM066895, GM066895] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Albrecht AN, 2002, MECH DEVELOP, V112, P53, DOI 10.1016/S0925-4773(01)00639-6; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; BABERJEEBASU S, 2001, NUCLEIC ACIDS RES, V29, P3258; BAFFICO M, 1997, EUR J HUM GENET, V5, P142; Billeter M, 1996, CELL, V85, P1057, DOI 10.1016/S0092-8674(00)81306-9; Blondelle SE, 1997, BIOCHEMISTRY-US, V36, P8393, DOI 10.1021/bi963015b; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; BRUDEAU S, 2001, DEV BIOL, V237, P345; Calabrese Olga, 2000, European Journal of Human Genetics, V8, P140; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Caronia G, 2003, DEVELOPMENT, V130, P1701, DOI 10.1242/dev.00396; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Davis AP, 1996, DEVELOPMENT, V122, P1175; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; Debeer P, 2002, J MED GENET, V39, P852, DOI 10.1136/jmg.39.11.852; DOLLE P, 1989, EMBO J, V8, P1507, DOI 10.1002/j.1460-2075.1989.tb03535.x; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Goodman F, 1998, AM J HUM GENET, V63, P992, DOI 10.1086/302070; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Innis Jeffrey W, 2002, Hum Mutat, V19, P573; Johnson D, 2003, AM J HUM GENET, V72, P984, DOI 10.1086/374721; Johnson KR, 1998, HUM MOL GENET, V7, P1033, DOI 10.1093/hmg/7.6.1033; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kan P, 2003, J LIPOSOME RES, V13, P69; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Kjaer KW, 2005, AM J MED GENET A, V138A, P328, DOI 10.1002/ajmg.a.30971; Kjaer KW, 2002, AM J MED GENET, V110, P116, DOI 10.1002/ajmg.10397; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lavoie H, 2003, HUM MOL GENET, V12, P2967, DOI 10.1093/hmg/ddg329; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malik S, 2005, GENET COUNSEL, V16, P229; Mortlock DP, 2000, MAMM GENOME, V11, P151, DOI 10.1007/s003350010029; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; QIAN YQ, 1993, J AM CHEM SOC, V115, P1189, DOI 10.1021/ja00056a077; ROBINOW M, 1982, AM J MED GENET, V11, P475, DOI 10.1002/ajmg.1320110414; Salsi V, 2006, J BIOL CHEM, V281, P1992, DOI 10.1074/jbc.M510900200; SCOTT MP, 1993, NUCLEIC ACIDS RES, V21, P1687, DOI 10.1093/nar/21.8.1687; Temtamy SA, 1978, GENETICS HAND MALFOR, P301; TREISMAN J, 1989, CELL, V59, P553; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P206, DOI 10.1002/jez.b.21051; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zhao Xiu-li, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P5	55	75	83	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					361	371		10.1086/511387	http://dx.doi.org/10.1086/511387			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236141	Green Published, Bronze			2022-12-18	WOS:000243729500016
J	Billingsley, G; Santhiya, ST; Paterson, AD; Ogata, K; Wodak, S; Hosseini, SM; Manisastry, SM; Vijayalakshmi, P; Gopinath, PM; Graw, GJ; Heon, E				Billingsley, Gail; Santhiya, Sathiyavedu T.; Paterson, Andrew D.; Ogata, Koji; Wodak, Shoshana; Hosseini, S. Mohsen; Manisastry, Shyam Manohar; Vijayalakshmi, Perumalsamy; Gopinath, Pudhiya Mundyat; Graw, Jochen; Heon, Elise			CRYBA4, a novel human cataract gene, is also involved in microphthalmia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-CRYSTALLIN; CONGENITAL CATARACT; LENS CRYSTALLINS; T4 LYSOZYME; PROTEINS; MUTATION; SEQUENCE; BETA-B2-CRYSTALLIN; IDENTIFICATION; EXPRESSION	Genetic analysis of a large Indian family with an autosomal dominant cataract phenotype allowed us to identify a novel cataract gene, CRYBA4. After a genomewide screen, linkage analysis identified a maximum LOD score of 3.20 ( recombination fraction [theta] 0.001) with marker D22S1167 of the beta-crystallin gene cluster on chromosome 22. To date, CRYBA4 was the only gene in this cluster not associated with either human or murine cataracts. A pathogenic mutation was identified in exon 4 that segregated with the disease status. The c. 317T -> C sequence change is predicted to replace the highly conserved hydrophobic amino acid phenylalanine94 with the hydrophilic amino acid serine. Modeling suggests that this substitution would significantly reduce the intrinsic stability of the crystalline monomer, which would impair its ability to form the association modes critical for lens transparency. Considering that CRYBA4 associates with CRYBB2 and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye). We identified a c. 242T -> C (Leu69Pro) sequence change in exon 4 in one patient, which is predicted here to disrupt the beta-sheet structure in CRYBA4. Protein folding would consequently be impaired, most probably leading to a structure with reduced stability in the mutant. This is the first report linking mutations in CRYBA4 to cataractogenesis and microphthalmia.	Hosp Sick Children, Dept Ophthalmol & Visual Sci, Res Inst, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Ophthalmol & Visual Sci, Res Inst, Ctr Computat Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Madras, Dept Genet, Dr ALM Postgrad Inst Basic Med Sci, Madras, Tamil Nadu, India; GSF, Natl Res Ctr Environm & Hlth, Inst Dev Genet, Neuherberg, Germany; Arvind Eye Hosp, Madurai, Tamil Nadu, India; Post Grad Inst Ophthalmol, Madurai, Tamil Nadu, India; Manipal Acad Higher Educ, Ctr Sci, Manipal, India	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Madras; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Manipal Academy of Higher Education (MAHE)	Heon, E (corresponding author), Hosp Sick Children, Dept Ophthalmol & Visual Sci, Res Inst, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	eheon@attglobal.net	Paterson, Andrew D/A-4088-2011; Paterson, Andrew/AAQ-7511-2020; Graw, Jochen/D-9336-2013; Hosseini, S. Mohsen/K-7133-2013; Ogata, Koji/H-4925-2019	Paterson, Andrew D/0000-0002-9169-118X; Paterson, Andrew/0000-0002-9169-118X; Hosseini, S. Mohsen/0000-0003-3626-9928; Ogata, Koji/0000-0001-9002-9621; Graw, Jochen/0000-0003-0298-9660; wodak, shoshana/0000-0002-0701-6545				BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CLAESSENS M, 1989, PROTEIN ENG, V2, P335, DOI 10.1093/protein/2.5.335; COOPER JL, 1993, SPORTS MED ARTHROSC, V1, P2; COOPER PG, 1993, EUR J BIOCHEM, V213, P321, DOI 10.1111/j.1432-1033.1993.tb17765.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ERIKSSON AE, 1992, NATURE, V355, P371, DOI 10.1038/355371a0; Fu L, 2002, J STRUCT BIOL, V139, P191, DOI 10.1016/S1047-8477(02)00545-2; Gill D, 2000, INVEST OPHTH VIS SCI, V41, P159; Graw J, 2004, INT J DEV BIOL, V48, P1031, DOI 10.1387/ijdb.041854jg; Graw J, 1997, BIOL CHEM, V378, P1331; Harding JJ, 1984, EYE B, V1b, P207; Hejtmancik JF, 1998, AM J HUM GENET, V62, P520, DOI 10.1086/301774; Hejtmancik JF, 1997, PROTEIN ENG, V10, P1347, DOI 10.1093/protein/10.11.1347; Kramer P, 1996, GENOMICS, V35, P539, DOI 10.1006/geno.1996.0395; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Mackay DS, 2002, AM J HUM GENET, V71, P1216, DOI 10.1086/344212; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Norledge BV, 1997, PROTEIN SCI, V6, P1612, DOI 10.1002/pro.5560060802; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; PIATIGORSKY J, 1987, INVEST OPHTH VIS SCI, V28, P9; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Santhiya ST, 2004, INVEST OPHTH VIS SCI, V45, P3599, DOI 10.1167/iovs.04-0207; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Van Montfort RLM, 2003, PROTEIN SCI, V12, P2606, DOI 10.1110/ps.03265903; Willoughby CE, 2005, MOL VIS, V11, P587; Wilson KS, 1998, J MOL BIOL, V276, P417; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yao K, 2005, MOL VIS, V11, P758	35	75	80	1	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					702	709		10.1086/507712	http://dx.doi.org/10.1086/507712			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960806	Green Published, Bronze			2022-12-18	WOS:000240855900011
J	Barreiro, LB; Patin, E; Neyrolles, O; Cann, HM; Gicquel, B; Quintana-Murci, L				Barreiro, LB; Patin, E; Neyrolles, O; Cann, HM; Gicquel, B; Quintana-Murci, L			The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							C-TYPE LECTINS; HUMAN Y-CHROMOSOME; DC-SIGN; DENDRITIC CELL; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; POPULATION-STRUCTURE; SEQUENCE VARIATION; HUMAN GENOME	The innate immunity system constitutes the first line of host defense against pathogens. Two closely related innate immunity genes, CD209 and CD209L, are particularly interesting because they directly recognize a plethora of pathogens, including bacteria, viruses, and parasites. Both genes, which result from an ancient duplication, possess a neck region, made up of seven repeats of 23 amino acids each, known to play a major role in the pathogen-binding properties of these proteins. To explore the extent to which pathogens have exerted selective pressures on these innate immunity genes, we resequenced them in a group of samples from sub-Saharan Africa, Europe, and East Asia. Moreover, variation in the number of repeats of the neck region was defined in the entire Human Genome Diversity Panel for both genes. Our results, which are based on diversity levels, neutrality tests, population genetic distances, and neck-region length variation, provide genetic evidence that CD209 has been under a strong selective constraint that prevents accumulation of any amino acid changes, whereas CD209L variability has most likely been shaped by the action of balancing selection in non-African populations. In addition, our data point to the neck region as the functional target of such selective pressures: CD209 presents a constant size in the neck region populationwide, whereas CD209L presents an excess of length variation, particularly in non- African populations. An additional interesting observation came from the coalescent-based CD209 gene tree, whose binary topology and time depth (similar to 2.8 million years ago) are compatible with an ancestral population structure in Africa. Altogether, our study has revealed that even a short segment of the human genome can uncover an extraordinarily complex evolutionary history, including different pathogen pressures on host genes as well as traces of admixture among archaic hominid populations.	Inst Pasteur, FRE 2849, Unit Mol Prevent & Therapy Human Dis, CNRS, F-75724 Paris, France; Inst Pasteur, Unite Genet Mycobacterienne, F-75724 Paris, France; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Foundation Jean Dausset-CEPH	Quintana-Murci, L (corresponding author), Inst Pasteur, FRE 2849, Unit Mol Prevent & Therapy Human Dis, CNRS, 25,Rue Dr Roux, F-75724 Paris, France.	quintana@pasteur.fr	Neyrolles, Olivier B/A-3184-2011; Neyrolles, Olivier/AAG-3692-2019; Patin, Etienne/G-6768-2012; Barreiro, Luis/I-7772-2015; Quintana-Murci, Lluis/AAB-7468-2022	Neyrolles, Olivier/0000-0003-0047-5885; Patin, Etienne/0000-0002-9911-4459; Quintana-Murci, Lluis/0000-0003-2429-6320; Barreiro, Luis/0000-0001-9456-367X				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bashirova AA, 2003, J VIROL, V77, P217, DOI 10.1128/JVI.77.1.217-227.2003; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Bell G., 1982, MASTERPIECE NATURE E; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Cann HM, 2002, SCIENCE, V296, P261; Carroll L., 1872, LOOKING GLASS; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; Cook DN, 2003, CURR OPIN ALLERGY CL, V3, P523, DOI 10.1097/01.all.0000104443.09202.60; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Cornuet JM, 1996, GENETICS, V144, P2001; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; Fay JC, 2000, GENETICS, V155, P1405; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100; Garrigan D, 2005, GENETICS, V170, P1849, DOI 10.1534/genetics.105.041095; Garrigan D, 2005, MOL BIOL EVOL, V22, P189, DOI 10.1093/molbev/msi013; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; HALDANE JBS, 1949, RIC SCI S A, V8, P68; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; HUGHES AL, 1994, PHILOS T ROY SOC B, V346, P359, DOI 10.1098/rstb.1994.0153; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Labuda D, 2000, GENETICS, V156, P799; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Lederberg J, 1999, GENETICS, V153, P1; LEWIN R, 1987, SCIENCE, V237, P1292, DOI 10.1126/science.3114877; LEWONTIN RC, 1964, GENETICS, V50, P757; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGreal EP, 2004, MOL IMMUNOL, V41, P1109, DOI 10.1016/j.molimm.2004.06.013; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1991, P NATL ACAD SCI USA, V88, P6716, DOI 10.1073/pnas.88.15.6716; Ota T, 2000, CURR TOP MICROBIOL, V248, P221; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Przeworski M, 2002, GENETICS, V160, P1179; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satta Y, 2004, MOL ECOL, V13, P877, DOI 10.1046/j.1365-294X.2003.02069.x; Schneider S., 2000, GENETICS BIOMETRY LA; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Soilleux EJ, 2001, J PATHOL, V195, P586, DOI 10.1002/path.1026; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Trowsdale J, 2004, EUR J IMMUNOL, V34, P7, DOI 10.1002/eji.200324693; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Van Liempt E, 2004, J BIOL CHEM, V279, P33161, DOI 10.1074/jbc.M404988200; Van Valen L., 1973, EVOL THEOR, V1, P1, DOI DOI 10.1038/344864A0; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wakeley J, 2004, MOL ECOL, V13, P865, DOI 10.1111/j.1365-294X.2004.02086.x; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Webster MT, 2003, HUM GENET, V113, P123, DOI 10.1007/s00439-003-0954-0; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B, 1996, BIOESSAYS, V18, P945, DOI 10.1002/bies.950181204; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Wright S, 1931, GENETICS, V16, P0097; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	110	75	77	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					869	886		10.1086/497613	http://dx.doi.org/10.1086/497613			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252244	Bronze, Green Published			2022-12-18	WOS:000232569600014
J	Beuten, J; Ma, JZ; Payne, TJ; Dupont, RT; Crews, KM; Somes, G; Williams, NJ; Elston, RC; Li, M				Beuten, J; Ma, JZ; Payne, TJ; Dupont, RT; Crews, KM; Somes, G; Williams, NJ; Elston, RC; Li, M			Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SMOKING; SCAN; BEHAVIOR; ALCOHOL; TWINS; MICE	Twelve single-nucleotide polymorphisms (SNPs) in the human gamma-aminobutyric acid type B (GABA(B)) receptor subunit 2 gene (GABAB2) were tested for association with nicotine dependence (ND) in an extensively phenotyped cohort of 1,276 smokers and nonsmokers, representing similar to 404 nuclear families of African American (AA) or European American (EA) origin. The GABAB2 gene encodes a subunit of the GABA(B) receptor for GABA, an inhibitory neurotransmitter involved in the regulation of many physiological and psychological processes in the brain. The gene is located within a region of chromosome 9q22 that showed a "suggestive" linkage to ND. Individual SNP analysis performed using the PBAT-GEE program indicated that two SNPs in the AAs and four SNPs in the EAs were significantly associated with ND. Haplotype analysis using the Family-Based Association Test revealed that, even after Bonferroni correction, the haplotype C-C-G of rs2491397-rs2184026-rs3750344 had a significant positive association with ND in both the pooled and the AA samples. In the EAs, we identified two haplotypes, C-A-C-A and T-A-T-A, formed by SNPs rs1435252-rs378042-rs2779562-rs3750344, that showed a highly significant negative and positive association with ND, respectively. In summary, our findings provide evidence of a significant association of GABAB2 variants with ND, implying that this gene plays an important role in the etiology of this drug addiction.	Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78284 USA; Univ Mississippi, Med Ctr, Comprehens Tobacco Ctr, Jackson, MS 39216 USA; Univ Memphis, Dept Criminol & Criminal Justice, Memphis, TN 38152 USA; Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Dent Hyg, Memphis, TN 38163 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Texas System; University of Texas Health San Antonio; University of Mississippi; University of Mississippi Medical Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Case Western Reserve University	Li, M (corresponding author), MSC 7792,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	lim2@uthscsa.edu		Payne, Thomas/0000-0002-9839-6255	NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NIDA NIH HHS [DA12844, R01 DA012844] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, R01 GM028356, GM28356] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Bergen AW, 1999, GENET EPIDEMIOL, V17, pS55; Bierut LJ, 2004, AM J MED GENET A, V124A, P19, DOI 10.1002/ajmg.a.20329; Corrigall WA, 2000, PSYCHOPHARMACOLOGY, V149, P107, DOI 10.1007/s002139900355; Cousins M S, 2001, Nicotine Tob Res, V3, P123, DOI 10.1080/14622200110042624; Dewey SL, 1999, SYNAPSE, V31, P76; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Fattore L, 2002, ALCOHOL ALCOHOLISM, V37, P495, DOI 10.1093/alcalc/37.5.495; Gelernter J, 2004, AM J MED GENET B, V128B, P94, DOI 10.1002/ajmg.b.30019; Heath AC, 1999, BEHAV GENET, V29, P395, DOI 10.1023/A:1021670703806; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2004, CLIN GENET, V66, P382, DOI 10.1111/j.1399-0004.2004.00302.x; Li MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S103; Madden PAF, 1999, BEHAV GENET, V29, P423, DOI 10.1023/A:1021674804714; Martin SC, 2001, GENE, V278, P63, DOI 10.1016/S0378-1119(01)00678-3; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Sullivan P. F., 1999, NICOTINE TOB RES S2, V1, pS69; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; U.S. Department of Health and Human Services, 2000, RED TOB US REP SURG; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1	28	75	81	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					859	864		10.1086/429839	http://dx.doi.org/10.1086/429839			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15759211	Green Published, Bronze			2022-12-18	WOS:000228198300012
J	Jiang, Y; Wilk, JB; Borecki, I; Williamson, S; DeStefano, AL; Xu, G; Liu, J; Ellison, RC; Province, M; Myers, RH				Jiang, Y; Wilk, JB; Borecki, I; Williamson, S; DeStefano, AL; Xu, G; Liu, J; Ellison, RC; Province, M; Myers, RH			Common variants in the 5 ' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN OB GENE; 5' UNTRANSLATED REGION; HUMAN OBESE GENE; DIABETES-MELLITUS; SEQUENCE VARIANTS; MESSENGER-RNA; FAT MASS; IDENTIFICATION; POLYMORPHISM; PROMOTER	Linkage of body mass index (BMI) to a broad region of chromosome 7q22-35 has been reported in multiple studies. We previously published a multipoint LOD score of 4.9 at D7S1804 for BMI from the National Heart, Lung, and Blood Institute Family Heart Study. Leptin (LEP), the human homolog of the mouse obesity (ob) gene, is positioned near the linkage peak and is the most prominent candidate gene in this region. Interest in LEP as a susceptibility gene for human obesity has led to numerous linkage and association studies, but the results of these studies are still controversial. In the present study, we employed family-based tests of association with both a quantitative measure of BMI adjusted for age and sex and a dichotomously defined obesity trait. We genotyped 29 single-nucleotide polymorphisms (SNPs) spanning 240 kb around the LEP gene in the 82 extended pedigrees with the strongest evidence for linkage. When the programs TRANSMIT and FBAT were used, a number of SNPs showed association in men but not women, for both the quantitative and qualitative trait definitions (P < .05). Five SNPs (H1328084, H1328083, H1328082, H1328081, and H1328080) positioned 2 kb beyond the previously defined promoter region showed strong association in single-marker and multiple-marker haplotype analysis. This five-marker haplotype (frequency 49% in this sample) is overtransmitted to obese offspring (P = .00005). All five of these SNPs are predicted to modify transcription-factor binding sites. This may indicate new functional variants in an extended promoter region of LEP.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Evans Dept Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO USA	Boston University; Boston University; Boston University; Washington University (WUSTL)	Jiang, Y (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St E-338, Boston, MA 02118 USA.	ejiang@bu.edu		Ellison, Robert Curtis/0000-0002-0582-7467; DeStefano, Anita/0000-0002-9335-2819; Myers, Richard/0000-0002-8365-2674	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068891] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL068891, HL68891-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Allison DB, 1998, GENETICS, V148, P859; ATWOOD LD, 2003, 53 ANN M AM SOC HUM; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; Bouchard C., 1998, HDB OBESITY, P157; Carlsson B, 1997, OBES RES, V5, P30, DOI 10.1002/j.1550-8528.1997.tb00280.x; Chagnon YC, 2000, J CLIN ENDOCR METAB, V85, P29, DOI 10.1210/jc.85.1.29; Chagnon YC, 2003, OBES RES, V11, P313, DOI 10.1038/oby.2003.47; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; Feitosa MF, 2002, AM J HUM GENET, V70, P72, DOI 10.1086/338144; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gong DW, 1996, J BIOL CHEM, V271, P3971; Hager J, 1998, INT J OBESITY, V22, P200, DOI 10.1038/sj.ijo.0800567; HARRIS JR, 1995, GENET EPIDEMIOL, V12, P251, DOI 10.1002/gepi.1370120303; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Karvonen MK, 1998, J CLIN ENDOCR METAB, V83, P3239, DOI 10.1210/jc.83.9.3239; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Le Stunff C, 2000, DIABETES, V49, P2196, DOI 10.2337/diabetes.49.12.2196; Li WD, 1999, ANN HUM GENET, V63, P227, DOI 10.1046/j.1469-1809.1999.6330227.x; Li WD, 2003, DIABETES, V52, P1557, DOI 10.2337/diabetes.52.6.1557; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lucantoni R, 2000, J CLIN ENDOCR METAB, V85, P3589, DOI 10.1210/jc.85.10.3589; Maffei M, 1996, DIABETES, V45, P679, DOI 10.2337/diabetes.45.5.679; Mammes O, 1998, DIABETES, V47, P487, DOI 10.2337/diabetes.47.3.487; Mammes O, 2000, ANN HUM GENET, V64, P391, DOI 10.1017/S0003480000008277; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Montague CT, 1997, DIABETES, V46, P342, DOI 10.2337/diabetes.46.3.342; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Platte P, 2003, AM J MED GENET C, V121C, P71, DOI 10.1002/ajmg.c.20005; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Shigemoto M, 1997, EUR J ENDOCRINOL, V137, P511, DOI 10.1530/eje.0.1370511; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Tena-Sempere M, 2001, J ENDOCRINOL, V170, P413, DOI 10.1677/joe.0.1700413; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	50	75	79	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					220	230		10.1086/422699	http://dx.doi.org/10.1086/422699			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15197684	Green Published, Bronze			2022-12-18	WOS:000222702000006
J	Lowe, X; Eskenazi, B; Nelson, DO; Kidd, S; Alme, A; Wyrobek, AJ				Lowe, X; Eskenazi, B; Nelson, DO; Kidd, S; Alme, A; Wyrobek, AJ			Frequency of XY sperm increases with age in fathers of boys with Klinefelter syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; FLUORESCENCE INSITU HYBRIDIZATION; PATERNAL AGE; MULTICOLOR FISH; DOWN-SYNDROME; Y-CHROMOSOME; REDUCED RECOMBINATION; HUMAN SPERMATOZOA; GERM-CELLS; SEX-RATIOS	With increasing availability of drugs for impotence and advanced reproductive technologies for the treatment of subfertility, more men are fathering children at advanced ages. We conducted a study of the chromosomal content of sperm of healthy men aged 24-57 years to (a) determine whether father's age was associated with increasing frequencies of aneuploid sperm including XY, disomy X, disomy Y, disomy 21, and sperm diploidy, and (b) examine the association between the frequencies of disomy 21 and sex-chromosomal aneuploidies. The study group consisted of 38 fathers of boys with Klinefelter syndrome (47, XXY) recruited nationwide, and sperm aneuploidy was assessed using multicolor X-Y-21 sperm FISH (10,000 sperm per donor). Paternal age was significantly correlated with the sex ratio of sperm (Y/X; P=.006) and with the frequency of XY sperm (P=.02), with a clear trend with age by decades (P<.006). Compared with fathers in their 20s (who had an average frequency of 7.5 XY sperm per 10,000), the frequencies of XY sperm were 10% higher among fathers in their 30s, 31% higher among those in their 40s, and 160% higher among those in their 50s (95% CI 69%-300%). However, there was no evidence for age effects on frequencies of sperm carrying nullisomy sex; disomies X, Y, or 21; or meiosis I or II diploidies. The frequencies of disomy 21 sperm were significantly associated with sex-chromosomal aneuploidy (P=.04)-in particular, with disomy X (P=.004), but disomy 21 sperm did not preferentially carry either sex chromosome. These findings suggest that older fathers produce higher frequencies of XY sperm, which may place them at higher risk of fathering boys with Klinefelter syndrome, and that age effects on sperm aneuploidy are chromosome specific.	Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Wyrobek, AJ (corresponding author), Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, 7000 East Ave, Livermore, CA 94550 USA.	wyrobek1@llnl.gov		Wyrobek, Andrew/0000-0002-5921-5298	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER; NIEHS NIH HHS [P42 ES004705, P4ZEES04705] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANTONARAKIS SE, 1993, TRENDS GENET, V9, P142, DOI 10.1016/0168-9525(93)90210-9; Baumgartner A, 1999, ENVIRON MOL MUTAGEN, V33, P49, DOI 10.1002/(SICI)1098-2280(1999)33:1<49::AID-EM6>3.0.CO;2-F; Bishop J, 1997, AM J EPIDEMIOL, V145, P134; Bishop JB, 1996, ENVIRON MOL MUTAGEN, V28, P159; Blanco J, 1996, HUM REPROD, V11, P722; Bolognesi C, 1997, CANCER EPIDEM BIOMAR, V6, P249; BORDSON BL, 1991, FERTIL STERIL, V56, P397; Catalan J, 1998, AM J HUM GENET, V63, P1464, DOI 10.1086/302092; CREASY MR, 1978, LANCET, V1, P716; DEMICHELENA MI, 1993, AM J MED GENET, V45, P679, DOI 10.1002/ajmg.1320450605; EICHENLAUBRITTER U, 1994, CURR TOP DEV BIOL, V29, P281, DOI 10.1016/S0070-2153(08)60553-0; Estop AM, 1998, HUM REPROD, V13, P124, DOI 10.1093/humrep/13.1.124; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; Griffin DK, 1996, AM J HUM GENET, V59, P1108; Griffin DK, 1996, INT REV CYTOL, V167, P263, DOI 10.1016/S0074-7696(08)61349-2; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Guttenbach M, 1997, HUM GENET, V100, P1, DOI 10.1007/s004390050459; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; HASSOLD T, 1993, CURR OPIN GENET DEV, V3, P398, DOI 10.1016/0959-437X(93)90111-2; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Hecht F, 1987, ANEUPLOIDY A, P9; Hinney B, 1997, FERTIL STERIL, V68, P718, DOI 10.1016/S0015-0282(97)00280-X; Hook E B, 1985, Basic Life Sci, V36, P7; HOOK EB, 1976, LANCET, V2, P465; Huether CA, 1998, J MED GENET, V35, P482, DOI 10.1136/jmg.35.6.482; Huether CA, 1996, AM J MED GENET, V63, P492, DOI 10.1002/(SICI)1096-8628(19960614)63:3<492::AID-AJMG15>3.0.CO;2-H; INTVELD P, 1997, CYTOGENET CELL GENET, V78, P116; JACOBS PA, 1988, ANN HUM GENET, V52, P93, DOI 10.1111/j.1469-1809.1988.tb01084.x; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; Kinakin B, 1997, CYTOGENET CELL GENET, V78, P116, DOI 10.1159/000134641; Kranczer S, 1998, Stat Bull Metrop Insur Co, V79, P8; LIEBAERS I, 1995, LANCET, V346, P1095, DOI 10.1016/S0140-6736(95)91768-3; LORDASANCHEZ I, 1992, HUM GENET, V89, P524; LOWE X, 1995, MUTAT RES-DNAGING G, V338, P59, DOI 10.1016/0921-8734(95)00012-U; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MAGENIS RE, 1988, AM J HUM GENET, V42, P529; Martin RH, 1998, J ASSIST REPROD GEN, V15, P240, DOI 10.1023/A:1022528007564; MARTIN RH, 1987, AM J HUM GENET, V41, P484; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; MIHARU N, 1993, AM J HUM GENET, V53, P581; NATH J, 1995, CHROMOSOMA, V103, P725, DOI 10.1007/s004120050085; Ponsa I, 1998, ADV EXP MED BIOL, V444, P185; ROBBINS WA, 1993, AM J HUM GENET, V52, P799; Robbins WA, 1995, REPROD FERT DEVELOP, V7, P799, DOI 10.1071/RD9950799; ROSENBUSCH B, 1992, FERTIL STERIL, V58, P1071; Rousseaux S, 1998, MOL HUM REPROD, V4, P695, DOI 10.1093/molehr/4.7.695; Shi QH, 2001, AM J MED GENET, V99, P34, DOI 10.1002/1096-8628(20010215)99:1<34::AID-AJMG1106>3.0.CO;2-D; Spriggs EL, 1996, AM J HUM GENET, V58, P356; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y; VELD PI, 1995, LANCET, V346, P773, DOI 10.1016/S0140-6736(95)91531-1; Venables W., 2013, MODERN APPL STAT S, V53, P86; Ventura S. J., 1997, MONTHLY VITAL STAT R, V45, P1; WEISSENBACH J, 1987, DEVELOPMENT, V101, P67; WYROBEK AJ, 1994, AM J MED GENET, V53, P1, DOI 10.1002/ajmg.1320530102; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; WYROBEK AJ, 1994, REPROD BIOL, P1; WYROBEK AJ, 2000, HUMAN MONITORING ENV, P134	58	75	86	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1046	1054		10.1086/323763	http://dx.doi.org/10.1086/323763			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11582569	Green Published, Bronze			2022-12-18	WOS:000171413400012
J	Zhao, F; Weismann, CG; Satoda, M; Pierpont, MEM; Sweeney, E; Thompson, EM; Gelb, BD				Zhao, F; Weismann, CG; Satoda, M; Pierpont, MEM; Sweeney, E; Thompson, EM; Gelb, BD			Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; PATENT DUCTUS-ARTERIOSUS; MOUSE EMBRYOGENESIS; CLONING; EXPRESSION; AP-2-BETA; FAMILY	To elucidate further the role, in normal development and in disease pathogenesis, of TFAP2B, a transcription factor expressed in neuroectoderm, we studied eight patients with Char syndrome and their families. Four novel mutations were identified, three residing in the basic domain, which is responsible for DNA binding, and a fourth affecting a conserved PY motif in the transactivation domain. Functional analyses of the four mutants disclosed that two, R225C and R225S, failed to bind target sequence in vitro and that all four had dominant negative effects when expressed in eukaryotic cells. Our present findings, combined with data about two previously identified TFAP2B mutations, show that dominant negative effects consistently appear to be involved in the etiology of Char syndrome. Affected individuals in the family with the PY motif mutation, P62R, had a high prevalence of patent ductus arteriosus but had only mild abnormalities of facial features and no apparent hand anomalies, a phenotype different from that associated with the five basic domain mutations. This genotype-phenotype correlation supports the existence of TFAP2 coactivators that have tissue specificity and are important for ductal development but less critical for craniofacial and limb development.	Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Royal Liverpool Childrens Hosp, Merseyside & Cheshire Clin Genet Serv, Liverpool L7 7DG, Merseyside, England; Womens & Childrens Hosp, Ctr Genet Med, S Australian Clin Genet Serv, Adelaide, SA, Australia	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Womens & Childrens Hospital Australia	Gelb, BD (corresponding author), Mt Sinai Sch Med, Dept Pediat, 1 Gustave Levy Pl,Box 1498, New York, NY 10029 USA.	gelbb01@doc.mssm.edu		Satoda, Masahiko/0000-0003-0804-860X; Weismann, Constance/0000-0001-7477-7283	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038018] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD038018, HD38018] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Bauer R, 1998, ONCOGENE, V17, P1911, DOI 10.1038/sj.onc.1202114; Char F, 1978, Birth Defects Orig Artic Ser, V14, P303; Chazaud C, 1996, MECH DEVELOP, V54, P83, DOI 10.1016/0925-4773(95)00463-7; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Kannan F, 1999, MOL CELL BIOL, V19, P899; Kerber B, 2001, DEVELOPMENT, V128, P1231; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Monge I, 2001, DEVELOPMENT, V128, P1239; Moser M, 1997, GENE DEV, V11, P1938, DOI 10.1101/gad.11.15.1938; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; MOSER M, 1995, DEVELOPMENT, V121, P2779; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Satoda M, 1999, CIRCULATION, V99, P3036, DOI 10.1161/01.CIR.99.23.3036; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; SLETTEN LJ, 1995, AM J MED GENET, V57, P27, DOI 10.1002/ajmg.1320570108; Sweeney E, 2000, CLIN DYSMORPHOL, V9, P177, DOI 10.1097/00019605-200009030-00005; Wankhade S, 2000, J BIOL CHEM, V275, P29701, DOI 10.1074/jbc.M000931200; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Williamson JA, 1996, GENOMICS, V35, P262, DOI 10.1006/geno.1996.0351; WINNING RS, 1991, NUCLEIC ACIDS RES, V19, P3709, DOI 10.1093/nar/19.13.3709; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	26	75	79	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					695	703		10.1086/323410	http://dx.doi.org/10.1086/323410			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11505339	Green Published, Bronze			2022-12-18	WOS:000171008200003
J	Seltman, H; Roeder, K; Devlin, B				Seltman, H; Roeder, K; Devlin, B			Transmission/Disequilibrium test meets measured haplotype analysis: Family-based association analysis guided by evolution of haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLADISTIC-ANALYSIS; PHENOTYPIC ASSOCIATIONS; TRANSMISSION; GENE; DISEQUILIBRIUM; POPULATIONS; INFERENCE; ADMIXTURE; LINKAGE; MARKERS	Family data teamed with the transmission/disequilibrium test (TDT), which simultaneously evaluates linkage and association, is a powerful means of detecting disease-liability alleles. To increase the information provided by the test, various researchers have proposed TDT-based methods for haplotype transmission. Haplotypes indeed produce more-definitive transmissions than do the alleles comprising them, and this tends to increase power. However, the larger number of haplotypes, relative to alleles at individual loci, tends to decrease power, because of the additional degrees of freedom required for the test. An optimal strategy would focus the test on particular haplotypes or groups of haplotypes. In this report we develop such an approach by combining the theory of TDT with that of measured haplotype analysis (MHA). MHA uses the evolutionary relationships among haplotypes to produce a limited set of hypothesis tests and to increase the interpretability of these tests. The theory of our approach, called the "evolutionary tree" (ET)-TDT, is developed for two cases: when haplotype transmission is certain and when it is not. Simulations show the ET-TDT can be more powerful than other proposed methods under reasonable conditions. More importantly, our results show that, when multiple polymorphisms are found within the gene, the ET-TDT can be useful for determining which polymorphisms affect liability.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Devlin, B (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.			Roeder, Kathryn/0000-0002-8869-6254; Seltman, Howard/0000-0002-7543-3578	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057881, R37MH057881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011922] Funding Source: NIH RePORTER; NIDA NIH HHS [DA11922, R01 DA011922] Funding Source: Medline; NIMH NIH HHS [MH57881, R37 MH057881, R01 MH057881] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cervino ACL, 2000, AM J HUM GENET, V67, P120, DOI 10.1086/302992; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; HALLMAN DM, 1994, ANN HUM GENET, V58, P35, DOI 10.1111/j.1469-1809.1994.tb00724.x; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; LANGE K, 1997, MATH STAT METHODS GE, P105; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; Morris AP, 1997, ANN HUM GENET, V61, P49; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sinsheimer JS, 2000, AM J HUM GENET, V66, P1168, DOI 10.1086/302826; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Swofford D.L., 1996, PHYLOGENETIC INFEREN, P407; Swofford David L., 1996, P407; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1993, GENETICS, V134, P659; TEMPLETON AR, 1988, GENETICS, V120, P1145; TEMPLETON AR, 1995, GENETICS, V140, P403; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Wilson SR, 1997, ANN HUM GENET, V61, P151, DOI 10.1017/S0003480097006040; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	31	75	75	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1250	1263		10.1086/320110	http://dx.doi.org/10.1086/320110			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309689	Green Published, Bronze			2022-12-18	WOS:000168171200018
J	Van den Bogaert, K; Govaerts, PJ; Schatteman, I; Brown, MR; Caethoven, G; Offeciers, FE; Somers, T; Declau, F; Coucke, P; Van de Heyning, P; Smith, RJH; Van Camp, G				Van den Bogaert, K; Govaerts, PJ; Schatteman, I; Brown, MR; Caethoven, G; Offeciers, FE; Somers, T; Declau, F; Coucke, P; Van de Heyning, P; Smith, RJH; Van Camp, G			A second gene for otosclerosis, OTSC2, maps to chromosome 7q34-36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEASLES-VIRUS; LOCALIZATION; SURGERY; TISSUE	Otosclerosis due to abnormal bone homeostasis of the otic capsule is a frequent cause of hearing loss in adults. Usually, the hearing loss is conductive, resulting from fixation of the stapedial footplate, which prevents normal ossicular vibration in response to sound. An additional type of sensorineural hearing loss may be caused by otosclerotic damage to the cochlea. The etiology of the disease is unknown, and both environmental and genetic factors have been implicated. Autosomal dominant inheritance with reduced penetrance has been proposed, but large families are extremely rare. To elucidate the pathogenesis of the disease, identification of the responsible genes is essential. In this study, we completed linkage analysis in a Belgian family in which otosclerosis segregates as an autosomal dominant disease. After excluding linkage to a known locus on chromosome 15 (OTSC1), we found linkage on chromosome 7q, with a multipoint LOD score of 3.54. Analysis of key recombinant individuals maps this otosclerosis locus (OTSC2) to a 16-cM interval on chromosome 7q34-36 between markers D7S495 and D7S2426.	Univ Antwerp, Dept Med Genet, Wilrijk, Belgium; Univ Antwerp, Dept Otolaryngol, Wilrijk, Belgium; Univ Antwerp, St Augustinus Hosp, Dept Otolaryngol, Wilrijk, Belgium; Univ Iowa, Dept Otolaryngol, Mol Otolaryngol Res Labs, Iowa City, IA USA	University of Antwerp; University of Antwerp; University of Antwerp; University of Iowa	Van Camp, G (corresponding author), Univ Antwerp, Dept Med Genet, Univ Pl 1, Wilrijk, Belgium.	gvcamp@uia.ua.ac.be	Heyning, Paul H Vande/I-8278-2017; Van Camp, Guy/F-3386-2013; Declau, Frank/AAH-6784-2021; Coucke, Paul J/AAO-2954-2020	Heyning, Paul H Vande/0000-0002-8424-3717; Van Camp, Guy/0000-0001-5105-9000; Declau, Frank/0000-0001-6969-1565; Coucke, Paul J/0000-0001-7119-586X; Smith, Richard/0000-0003-1201-6731				Ah-Kim H, 2000, CYTOKINE, V12, P142, DOI 10.1006/cyto.1999.0539; ALBRECHT W, 1922, ARCH OHRENHEILK KEHL, V11, P244; Arnold W, 1996, ACTA OTO-LARYNGOL, V116, P705, DOI 10.3109/00016489609137910; BENARAB S, 1993, ANN GENET-PARIS, V36, P111; CAUSSE JR, 1984, AM J OTOL, V5, P211; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DECLAU F, 1996, GENETICS HEARING IMP, P221; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONNELL GN, 1980, LARYNGOSCOPE, V90, P40, DOI 10.1288/00005537-198001000-00004; Frenz DA, 1997, TERATOLOGY, V56, P233, DOI 10.1002/(SICI)1096-9926(199710)56:4<233::AID-TERA1>3.0.CO;2-#; GAPANYGAPANAVIS.B, 1975, OTOSCLEROSIS GENETIC; GORDON MA, 1989, AM J OTOL, V10, P426; Govaerts PJ, 1998, AM J OTOL, V19, P718; *INT ORG STAND, 1984, INT ORG STAND PUBL, V7029; LARSSON A, 1960, Acta Otolaryngol Suppl, V154, P1; LARSSON A, 1962, OTOSCLEROSIS, P109; McKenna MJ, 1996, AM J OTOL, V17, P827; MORRISON A W, 1970, Journal of Laryngology and Otology, V84, P921, DOI 10.1017/S0022215100072698; MORRISON A W, 1967, Annals of the Royal College of Surgeons of England, V41, P202; NIEDERMEYER H, 1994, ORL J OTO-RHINO-LARY, V56, P130, DOI 10.1159/000276627; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Shambaugh GE, 1949, ACTA OTO-LARYNGOL, V79, P1; SOMERS T, 1994, ANN OTO RHINOL LARYN, V103, P945, DOI 10.1177/000348949410301204; Somers T, 1997, J LARYNGOL OTOL, V111, P233, DOI 10.1017/S0022215100136989; Tomek MS, 1998, HUM MOL GENET, V7, P285, DOI 10.1093/hmg/7.2.285; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881	26	75	78	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					495	500		10.1086/318185	http://dx.doi.org/10.1086/318185			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170898	Green Published, Bronze			2022-12-18	WOS:000166524800020
J	Aula, N; Salomaki, P; Timonen, R; Verheijen, F; Mancini, G; Mansson, JE; Aula, P; Peltonen, L				Aula, N; Salomaki, P; Timonen, R; Verheijen, F; Mancini, G; Mansson, JE; Aula, P; Peltonen, L			The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SALLA-DISEASE; DISORDER; HERITAGE; FINLAND	Lysosomal free sialic acid-storage diseases include the allelic disorders Salla disease (SD) and infantile sialic acid-storage disease (ISSD). The defective gene, SLC17A5, coding for the lysosomal free sialic acid transporter was recently isolated by positional cloning. In the present study, we have identified a large number of mutations in SLC17A5 in patients presenting with either Salla disease or the ISSD phenotype. We also report for the first time the exon-intron boundaries of SLC17A5. All Finnish patients with SD (n = 80) had a missense mutation changing a highly conserved arginine to cysteine (R39C); 91% of them were homozygotes for this old founder mutation. The compound-heterozygote patients, with the founder mutation in only one allele, presented with a more severe phenotype than did the homozygote patients. The same R39C mutation was also found both in most of the Swedish patients with SD and in a heterozygous form in five patients from central Europe who presented with an unusually severe (intermediate) SD phenotype. Ten different mutations, including deletions, insertions, and missense and nonsense mutations, were identified in patients with the most severe ISSD phenotype, most of whom were compound heterozygotes. Our results indicate some genotype-phenotype correlation in free sialic acid-storage diseases, suggesting that the phenotype associated with the homozygote R39C mutation is milder than that associated with other mutations.	Univ Calif Los Angeles, Sch Med, Dept Human Genet, Gonda Ctr, Los Angeles, CA 90024 USA; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland; Univ Turku, Dept Med Genet, Turku, Finland; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Acad Hosp, Erasmus Med Ctr Rotterdam, Rotterdam, Netherlands; Univ Gothenburg, Dept Psychiat & Neurochem, Molndal, Sweden	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; University of Gothenburg	Peltonen, L (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Human Genet, Gonda Ctr, 695 Charles E Young Dr S, Los Angeles, CA 90024 USA.		Soriano, Vicente/O-5730-2018; Estrada, Vicente/G-7518-2015	Soriano, Vicente/0000-0002-4624-5199; 				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AULA P, 1986, J MENT DEFIC RES, V30, P365; AULA P, 1979, ARCH NEUROL-CHICAGO, V36, P88, DOI 10.1001/archneur.1979.00500380058006; AULA P, IN PRESS METABOLIC M; FOIS A, 1987, EUR J PEDIATR, V146, P195, DOI 10.1007/BF02343235; HAATAJA L, 1994, NEUROPEDIATRICS, V25, P238, DOI 10.1055/s-2008-1073028; MANCINI GMS, 1992, EUR J PEDIATR, V151, P590, DOI 10.1007/BF01957729; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; Peltonen L, 1997, ANN MED, V29, P553, DOI 10.3109/07853899709007481; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; Robinson RO, 1997, DEV MED CHILD NEUROL, V39, P153; SCHLEUTKER J, 1995, AM J HUM GENET, V57, P893; SCHLEUTKER J, 1995, GENOMICS, V27, P286, DOI 10.1006/geno.1995.1044; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; Varho T, 1999, NEUROLOGY, V52, P1668, DOI 10.1212/WNL.52.8.1668; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	19	75	78	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					832	840		10.1086/303077	http://dx.doi.org/10.1086/303077			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10947946	Green Published, Bronze			2022-12-18	WOS:000089651100007
J	Meira, LB; Graham, JM; Greenberg, CR; Busch, DB; Doughty, ATB; Ziffer, DW; Coleman, DM; Savre-Train, I; Friedberg, EC				Meira, LB; Graham, JM; Greenberg, CR; Busch, DB; Doughty, ATB; Ziffer, DW; Coleman, DM; Savre-Train, I; Friedberg, EC			Manitoba aboriginal kindred with original cerebro-oculo-facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; COFS SYNDROME; MARTSOLFS SYNDROME; ACTIVE GENES; CATARACTS; REPAIR; INHERITANCE; SIBLINGS; CELLS; ERCC6	Cerebro-oculo-facio-skeletal (COFS) syndrome is a rapidly progressive neurological disorder leading to brain atrophy with calcification, cataracts, microcornea, optic atrophy, progressive joint contractures, and growth failure. Cockayne syndrome (CS) is a recessively inherited neurodegenerative disorder characterized by low-to-normal birth weight; growth failure; brain dysmyelination with calcium deposits; cutaneous photosensitivity; pigmentary retinopathy, cataracts, or both; and sensorineural hearing loss. CS cells are hypersensitive to UV radiation because of impaired nucleotide excision repair of UV radiation-induced damage in actively transcribed DNA. The abnormalities in CS are associated with mutations in the CSA or CSB genes. In this report, we present evidence that two probands related to the Manitoba Aboriginal population group within which COFS syndrome was originally reported have cellular phenotypes indistinguishable from those in CS cells. The identical mutation was detected in the CSB gene from both children with COFS syndrome and in both parents of one of the patients. This mutation was also detected in three other patients with COFS syndrome from the Manitoba Aboriginal population group. These results suggest that CS and COFS syndrome share a common pathogenesis.	Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA; Univ Calif Las Vegas, Sch Med,SHAREs Child Disabil Ctr, Steven Spielberg Pediat Res Ctr, Dept Pediat,Div Clin Genet & Dysmorphol, Los Angeles, CA USA; Univ Manitoba, Sect Genet & Metab, Winnipeg, MB, Canada; Walter Reed Army Med Ctr, Armed Forces Inst Pathol, Dept Environm & Toxicol Pathol, Washington, DC 20307 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Cedars Sinai Medical Center; University of Manitoba; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Friedberg, EC (corresponding author), Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Graham, John M./J-1429-2019; Meira, Lisiane/AAA-4326-2020	Meira, Lisiane/0000-0003-4289-2986	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD22657-06, P01 HD022657] Funding Source: Medline; NIGMS NIH HHS [T32 GM008243, GM08243] Funding Source: Medline; PHS HHS [VS55357] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; CASTEELS I, 1991, Genetic Counseling, V2, P43; Cleaver J. E., 1989, METABOLIC BASIS INHE, V2, P2949; Colella S, 1999, HUM MOL GENET, V8, P935, DOI 10.1093/hmg/8.5.935; DelBigio MR, 1997, J NEUROPATH EXP NEUR, V56, P1147, DOI 10.1097/00005072-199710000-00009; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; GERSHONIBARUCH R, 1991, AM J MED GENET, V41, P74, DOI 10.1002/ajmg.1320410119; GRIZZARD WS, 1980, AM J OPHTHALMOL, V89, P293, DOI 10.1016/0002-9394(80)90127-0; HARBORD MG, 1989, J MED GENET, V26, P397, DOI 10.1136/jmg.26.6.397; HENNEKAM RCM, 1988, EUR J PEDIATR, V147, P539, DOI 10.1007/BF00441986; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; LINNA SL, 1982, PEDIATR RADIOL, V12, P28, DOI 10.1007/BF01221707; LOWRY RB, 1971, J PEDIATR-US, V79, P282, DOI 10.1016/S0022-3476(71)80114-2; LURIE IW, 1976, CLIN GENET, V10, P343; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; MARTSOLF JT, 1978, AM J MED GENET, V1, P291, DOI 10.1002/ajmg.1320010305; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; PATTON MA, 1989, J MED GENET, V26, P154, DOI 10.1136/jmg.26.3.154; Pena S D, 1978, Birth Defects Orig Artic Ser, V14, P205; PENA SDJ, 1974, CLIN GENET, V5, P285; PREUS M, 1977, AM J DIS CHILD, V131, P62, DOI 10.1001/archpedi.1977.02120140064010; PREUS M, 1974, CLIN GENET, V5, P294; SANCHEZ JM, 1985, J MED GENET, V22, P308, DOI 10.1136/jmg.22.4.308; SCOTTEMUAKPOR AB, 1977, AM J DIS CHILD, V131, P167, DOI 10.1001/archpedi.1977.02120150049010; SILENGO MC, 1984, CLIN GENET, V25, P201; STEIN A, 1992, NUCLEIC ACIDS RES, V20, P5237, DOI 10.1093/nar/20.19.5237; STRISCIUGLIO P, 1988, J MED GENET, V25, P267, DOI 10.1136/jmg.25.4.267; SURANA RB, 1978, CLIN GENET, V13, P486; TALWAR D, 1989, AM J MED GENET, V34, P194, DOI 10.1002/ajmg.1320340212; TEMTAMY SA, 1991, AM J MED GENET, V41, P432, DOI 10.1002/ajmg.1320410409; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; WINTER RM, 1981, J MED GENET, V18, P129, DOI 10.1136/jmg.18.2.129	34	75	79	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1221	1228		10.1086/302867	http://dx.doi.org/10.1086/302867			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739753	Bronze, Green Published			2022-12-18	WOS:000088373400006
J	Watnick, T; Phakdeekitcharoen, B; Johnson, A; Gandolph, M; Wang, M; Briefel, G; Klinger, KW; Kimberling, W; Gabow, P; Germino, GG				Watnick, T; Phakdeekitcharoen, B; Johnson, A; Gandolph, M; Wang, M; Briefel, G; Klinger, KW; Kimberling, W; Gabow, P; Germino, GG			Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; GENE; REGION; CHROMOSOME-16; SUPPORTS; DOMAINS; MODEL	It is known that several of the most severe complications of autosomal-dominant polycystic kidney disease, such as intracranial aneurysms, cluster in families. There have been no studies reported to date, however, that have attempted to correlate severely affected pedigrees with a particular genotype. Until recently, in fact, mutation detection for most of the PKD1 gene was virtually impossible because of the presence of several highly homologous loci also located on chromosome 16. In this report we describe a duster of 4 bp in exon 15 that are unique to PKD1. Forward and reverse PKD1-specific primers were designed in this location to amplify regions of the gene from exons 11-21 by use of long-range PCR, The two templates described were used to analyze 35 pedigrees selected for study because they included individuals with either intracranial aneurysms and/or very-early-onset disease. We identified eight novel truncating mutations, two missense mutations not found in a panel of controls, and several informative polymorphisms. Many of the polymorphisms were also present in the homologous loci, supporting the idea that they may serve as a reservoir for genetic variability in the PKD1 gene. Surprisingly, we found that three independently ascertained pedigrees had an identical 2-bp deletion in exon 15. This raises the possibility that particular genotypes may be associated with more-severe disease.	Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA; Johns Hopkins Bayview Hosp, Div Nephrol, Baltimore, MD USA; Univ Colorado, Hlth Sci Ctr, Polycyst Kidney Dis Res Grp, Denver, CO USA; Boys Town Natl Res Hosp, Dept Genet, Ctr Hereditary & Commun Disorders, Omaha, NE 68131 USA; Genzyme Corp, Framingham, MA 01701 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Boys Town National Research Hospital; Sanofi-Aventis; Genzyme Corporation	Germino, GG (corresponding author), Johns Hopkins Univ, Sch Med, Div Nephrol, Ross 970,720 Rutland Ave, Baltimore, MD 21205 USA.			Germino, Gregory/0000-0002-3609-5588; Johnson, Anne/0000-0003-1330-7100	FIC NIH HHS [F05 TW005393, TW05393] Funding Source: Medline; NIDDK NIH HHS [P01 DK034039, R37 DK048006, DK48006, DK4853, R01 DK048006] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F05TW005393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048006, P01DK034039, R01DK048006] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; CECCHERINI I, 1992, P NATL ACAD SCI USA, V89, P104, DOI 10.1073/pnas.89.1.104; CHAPMAN AB, 1992, NEW ENGL J MED, V327, P916, DOI 10.1056/NEJM199209243271303; FICK GM, 1993, J AM SOC NEPHROL, V3, P1863; GABOW PA, 1989, KIDNEY INT, V35, P675, DOI 10.1038/ki.1989.38; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GERMINO GG, 1990, AM J HUM GENET, V46, P925; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hateboer N, 1999, KIDNEY INT, V56, P34, DOI 10.1046/j.1523-1755.1999.00541.x; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Koptides M, 1999, HUM MOL GENET, V8, P509, DOI 10.1093/hmg/8.3.509; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Roelfsema JH, 1997, AM J HUM GENET, V61, P1044, DOI 10.1086/301600; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; SHOFFNER JM, 1998, CURRENT PROTOCOLS HU, V9; Thomas R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460; Thongnoppakhun W, 1999, BIOTECHNIQUES, V26, P126, DOI 10.2144/99261rr01; Van Raay T J, 1996, Microb Comp Genomics, V1, P317; WARD CJ, 1994, CELL, V77, P881; Watnick TJ, 1997, HUM MOL GENET, V6, P1473, DOI 10.1093/hmg/6.9.1473; Watnick TJ, 1998, HUM MOL GENET, V7, P1239, DOI 10.1093/hmg/7.8.1239; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583	28	75	86	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1561	1571		10.1086/302657	http://dx.doi.org/10.1086/302657			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577909	Green Published, Bronze			2022-12-18	WOS:000084282500010
J	Stallmeyer, B; Drugeon, G; Reiss, J; Haenni, AL; Mendel, RR				Stallmeyer, B; Drugeon, G; Reiss, J; Haenni, AL; Mendel, RR			Human molybdopterin synthase gene: Identification of a bicistronic transcript with overlapping reading frames	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; INTERNAL INITIATION; PRECURSOR-Z; TRANSLATION; PROTEINS; COMPLEMENTATION; SEQUENCE; ENCODES; ENZYMES; LOCUS	A universal molybdenum-containing cofactor (MoCo) is essential for the activity of all human molybdoenzymes, including sulphite oxidase. The free cofactor is highly unstable, and all organisms share a similar biosynthetic pathway. The involved enzymes exhibit homologies, even between bacteria and humans. We have exploited these homologies to isolate a cDNA for the heterodimeric molybdopterin (MPT)-synthase. This enzyme is necessary for the conversion of an unstable precursor into molybdopterin, the organic moiety of MoCo. The corresponding transcript shows a bicistronic structure, encoding the small and large subunits of the MPT-synthase in two different open reading frames (ORFs) that overlap by 77 nucleotides. In various human tissues, only one size of mRNA coinciding with the bicistronic transcript was detected. In vitro translation and mutagenesis experiments demonstrated that each ORF is translated independently, leading to the synthesis of a 10-kDa protein and a 21-kDa protein for the small and large subunits, respectively, and indicated that the 3'-proximal ORF of the bicistronic transcript is translated by leaky scanning.	Tech Univ Braunschweig, Inst Bot, D-38106 Braunschweig, Germany; Univ Gottingen, Inst Humangenet, D-3400 Gottingen, Germany; Inst Jaques Monod, Paris, France	Braunschweig University of Technology; University of Gottingen; UDICE-French Research Universities; Universite Paris Cite	Mendel, RR (corresponding author), Tech Univ Braunschweig, Inst Bot, Humboldtstr 1, D-38106 Braunschweig, Germany.	r.mendel@tu-bs.de	Stallmeyer, Birgit/AAE-3020-2020					AMY CM, 1992, P NATL ACAD SCI USA, V89, P1105, DOI 10.1073/pnas.89.3.1105; Andrews J, 1996, GENETICS, V143, P1699; DAM ET, 1995, THESIS U LEIDEN LEID; DAVIDSON JN, 1993, BIOESSAYS, V15, P157, DOI 10.1002/bies.950150303; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GEBALLE AP, 1996, TRANSLATIONAL CONTRO, P177; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HOFF T, 1995, J BIOL CHEM, V270, P6100, DOI 10.1074/jbc.270.11.6100; Iizuka N, 1995, CURR TOP MICROBIOL, V203, P155; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; JOBLING SA, 1988, NUCLEIC ACIDS RES, V16, P4483, DOI 10.1093/nar/16.10.4483; Johnson J.L, 1995, METABOLIC MOL BASES, V7th edition., P2271, DOI [10.1016/0168-9525(96)81407-7, DOI 10.1016/0168-9525(96)81407-7]; JOHNSON JL, 1989, J CLIN INVEST, V83, P897, DOI 10.1172/JCI113974; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; LENNON GG, 1995, GENOMICS, V33, P151; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Mendel RR, 1997, PLANTA, V203, P399, DOI 10.1007/s004250050206; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Reiss J, 1998, HUM GENET, V103, P639, DOI 10.1007/s004390050884; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Ritchie H, 1997, BIOCHEM BIOPH RES CO, V231, P425, DOI 10.1006/bbrc.1997.6126; Sambrook J, 1989, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STALLMEYER B, 1995, PLANT J, V8, P751, DOI 10.1046/j.1365-313X.1995.08050751.x; Stiefel EI, 1996, SCIENCE, V272, P1599, DOI 10.1126/science.272.5268.1599; Unkles SE, 1997, J BIOL CHEM, V272, P28381, DOI 10.1074/jbc.272.45.28381; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	32	75	80	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					698	705		10.1086/302295	http://dx.doi.org/10.1086/302295			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053003	Bronze, Green Published			2022-12-18	WOS:000079204700006
J	Teh, BT; Esapa, CT; Houlston, R; Grandell, U; Farnebo, F; Nordenskjold, M; Pearce, CJ; Carmichael, D; Larsson, C; Harris, PE				Teh, BT; Esapa, CT; Houlston, R; Grandell, U; Farnebo, F; Nordenskjold, M; Pearce, CJ; Carmichael, D; Larsson, C; Harris, PE			A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MULTIPLE ENDOCRINE NEOPLASIA; GENE; LINKAGE; DISEASE; MAPS		Karolinska Hosp, Dept Mol Med, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Surg, S-10401 Stockholm, Sweden; Kings Coll London, Sch Med & Dent, Dept Med, London, England; Inst Canc Res, Sutton, Surrey, England; Ipswich Hosp, Ipswich, Suffolk, England; Southend Hosp, Westcliff On Sea, England	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of London; King's College London; University of London; Institute of Cancer Research - UK; Ipswich Hospital NHS Trust; Ipswich Hospital	Larsson, C (corresponding author), Karolinska Hosp, Dept Mol Med, CMM L8-01, S-17176 Stockholm, Sweden.	Catharina.Larsson@cmm.ki.se		Nordenskjold, Magnus/0000-0002-4974-425X; Houlston, Richard/0000-0002-5268-0242; Teh, Bin Tean/0000-0003-1514-1124				Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; Bassett JHD, 1998, AM J HUM GENET, V62, P232, DOI 10.1086/301729; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Courseaux A, 1996, GENOMICS, V37, P354, DOI 10.1006/geno.1996.0570; Eng C, 1996, NEW ENGL J MED, V335, P943, DOI 10.1056/NEJM199609263351307; Farnebo F, 1998, J CLIN ENDOCR METAB, V83, P2627, DOI 10.1210/jc.83.8.2627; FRIEDMAN E, 1994, PARATHYROIDS BASIC C, V38, P647; Heppner C, 1997, NAT GENET, V16, P375, DOI 10.1038/ng0897-375; Huang SM, 1997, WORLD J SURG, V21, P22, DOI 10.1007/s002689900188; KASSEM M, 1994, CLIN ENDOCRINOL, V41, P415, DOI 10.1111/j.1365-2265.1994.tb02570.x; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; ROHDE K, 1995, HUM HERED, V45, P337, DOI 10.1159/000154302; SZABO J, 1995, AM J HUM GENET, V56, P944; Teh BT, 1998, J CLIN ENDOCR METAB, V83, P2621, DOI 10.1210/jc.83.8.2621; Teh BT, 1998, J CLIN ENDOCR METAB, V83, P2114, DOI 10.1210/jc.83.6.2114; Teh BT, 1996, ARCH SURG-CHICAGO, V131, P1230; Teh BT, 1996, J CLIN ENDOCR METAB, V81, P4204, DOI 10.1210/jc.81.12.4204; TEH BT, 1998, CURR OPIN ENDOCRINOL, V5, P35	19	75	76	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1544	1549		10.1086/302097	http://dx.doi.org/10.1086/302097			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792884	Green Published, Bronze			2022-12-18	WOS:000076985200031
J	Steinbach, P; Glaser, D; Vogel, W; Wolf, M; Schwemmle, S				Steinbach, P; Glaser, D; Vogel, W; Wolf, M; Schwemmle, S			The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; LIGATION MEDIATED PCR; TRINUCLEOTIDE REPEAT; TRIPLET REPEAT; CPG ISLAND; FMR-1 GENE; DNA METHYLATION; EXPANSION; EXPRESSION; SITE	Using methylation-sensitive restriction enzymes, we characterized the methylation pattern on the 5' side of the CTG repeat in the DMPK gene of normal individuals and of patients affected with myotonic dystrophy showing expansions of the repetitive sequence. The gene segment analyzed corresponds to the genomic SacI-HindIII fragment carrying exons 11-15. These is constitutive methylation in intron 12 at restriction sites of SacII and HhaI, localized 1,159-1,232 bp upstream of the CTG repeat, whereas most, if not all, of the other sites of SacII, HhaI, and HpaII in this region are unmethylated, in normal individuals and most of the patients. In a number of young and severely affected patients, however, complete methylation of these restriction sites was found in the mutated allele, In most of these patients, the onset of the disease was congenital. Preliminary in vivo footprinting data gave evidence for protein-DNA contact in normal genes at an Spl consensus binding site upstream of the CTG repeat and for a significant reduction of this interaction in cells with a hypermethylated DMPK gene.	Univ Ulm Klinikum, Abt Med Genet, D-7900 Ulm, Germany	Ulm University	Steinbach, P (corresponding author), Univ Ulm, Abt Med Genet, Park Str 11, D-89073 Ulm, Germany.							ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Hamshere MG, 1997, P NATL ACAD SCI USA, V94, P7394, DOI 10.1073/pnas.94.14.7394; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1992, AM J HUM GENET, V51, P10; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; HIRST MC, 1993, HUM MOL GENET, V2, P197, DOI 10.1093/hmg/2.2.197; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; JANSEN G, 1995, HUM MOL GENET, V4, P843, DOI 10.1093/hmg/4.5.843; JANSEN G, 1993, HUM MOL GENET, V2, P1221, DOI 10.1093/hmg/2.8.1221; JONES C, 1995, NATURE, V376, P145, DOI 10.1038/376145a0; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KRAHE R, 1995, AM J HUM GENET, V56, P1067; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PIZZUTI A, 1993, ARCH NEUROL-CHICAGO, V50, P1173, DOI 10.1001/archneur.1993.00540110053005; REARDON W, 1992, J MED GENET, V29, P770, DOI 10.1136/jmg.29.11.770; Schwemmle S, 1997, AM J HUM GENET, V60, P1354, DOI 10.1086/515456; SHAW DJ, 1993, J MED GENET, V30, P189, DOI 10.1136/jmg.30.3.189; SMITH SS, 1994, J MOL BIOL, V243, P143, DOI 10.1006/jmbi.1994.1640; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; TORNTON CA, 1997, NAT GENET, V16, P407; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; WONG LJC, 1995, AM J HUM GENET, V56, P114; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401	51	75	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					278	285		10.1086/301711	http://dx.doi.org/10.1086/301711			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463318	Bronze, Green Published			2022-12-18	WOS:000072416000010
J	Devriendt, K; Matthijs, G; Legius, E; Schollen, E; Blockmans, D; vanGeet, C; Degreef, H; Cassiman, JJ; Fryns, JP				Devriendt, K; Matthijs, G; Legius, E; Schollen, E; Blockmans, D; vanGeet, C; Degreef, H; Cassiman, JJ; Fryns, JP			Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROGENEITY; MOSAICISM; BLASCHKO; LINES; GENE; XQ28	In this study, we report on a family with X-linked dyskeratosis congenita (DC). Linkage analysis with markers in the factor Vm gene at Xq28 yielded a LOD score of 2 at a recombination of O. Clinical manifestations of DC, such as skin lesions following the Blaschko lines, were present in two obligate carrier females. Highly skewed X inactivation was observed in white blood cells, cultured skin fibroblasts, and buccal mucosa from female carriers of DC in this family. This suggests a critical role for the DC gene in bone marrow-cell and fibroblast-cell proliferation.	UNIV HOSP GASTHUISBERG,DEPT INTERNAL MED,B-3000 LOUVAIN,BELGIUM; UNIV HOSP GASTHUISBERG,DEPT PEDIAT,B-3000 LOUVAIN,BELGIUM; UNIV HOSP GASTHUISBERG,DEPT DERMATOL,B-3000 LOUVAIN,BELGIUM	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Devriendt, K (corresponding author), UNIV HOSP GASTHUISBERG,CTR HUMAN GENET,HERESTR 49,B-3000 LOUVAIN,BELGIUM.		Legius, Eric/H-1735-2011	Matthijs, Gert/0000-0001-6710-1912				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ARNGRIMSSON R, 1993, J MED GENET, V30, P618, DOI 10.1136/jmg.30.7.618; Belmont JW, 1996, AM J HUM GENET, V58, P1101; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; DAVIDSON HR, 1988, J MED GENET, V25, P843, DOI 10.1136/jmg.25.12.843; DEBOECK K, 1981, PEDIATRICS, V67, P898; DOKAL I, 1992, BLOOD, V80, P3090; DRACHTMAN RA, 1992, AM J PEDIAT HEMATOL, V14, P297; DRACHTMAN RA, 1995, DERMATOL CLIN, V13, P33, DOI 10.1016/S0733-8635(18)30104-9; HAPPLE R, 1985, HUM GENET, V70, P200; Hoffman E. P., 1995, American Journal of Human Genetics, V57, pA49; LANGLOIS S, 1993, AM J HUM GENET, V53, P1188; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MALEVILLE J, 1980, ANN DERMATOL VENER, V107, P1207; MARSH JCW, 1992, BLOOD, V79, P3138; MOSS C, 1993, J MED GENET, V30, P752, DOI 10.1136/jmg.30.9.752; Naumova AK, 1996, AM J HUM GENET, V58, P1111; PAI GS, 1989, AM J MED GENET, V32, P63, DOI 10.1002/ajmg.1320320114; SIRINAVIN C, 1975, J MED GENET, V12, P339, DOI 10.1136/jmg.12.4.339; THOMAS IT, 1989, AM J HUM GENET, V45, P193; VERRA F, 1992, EUR RESPIR J, V5, P497; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WOMER R, 1983, PEDIATRICS, V71, P603	23	75	75	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					581	587						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042917				2022-12-18	WOS:A1997WK40300014
J	Valdes, AM; Thomson, G				Valdes, AM; Thomson, G			Detecting disease-predisposing variants: The haplotype method	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; SHARED-EPITOPE HYPOTHESIS; HUMAN GENETIC-DISORDERS; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; HLA-DRB; ASSOCIATION; IDENTIFICATION; SARDINIA; MODELS	For many HLA-associated diseases, multiple alleles - and, in some cases, multiple loci - have been suggested as the causative agents. The haplotype method for identifying disease-predisposing amino acids in a genetic region is a stratification analysis. We show that, for each haplotype combination containing all the amino acid sites involved in the disease process, the relative frequencies of amino acid variants at sites not involved in disease but in linkage disequilibrium with the disease-predisposing sites are expected to be the same in patients and controls. The haplotype method is robust to mode of inheritance and penetrance of the disease and can be used to determine unequivocally whether all amino acid sites involved in the disease have not been identified. Using a resampling technique, we developed a statistical test that takes account of the nonindependence of the sites sampled. Further, when multiple sites in the genetic region are involved in disease, the test statistic gives a closer fit to the null expectation when some - compared with none - of the true predisposing factors are included in the haplotype analysis. Although the haplotype method cannot distinguish between very highly correlated sites in one population, ethnic comparisons may help identify the true predisposing factors. The haplotype method was applied to insulin-dependent diabetes mellitus (IDDM) HLA class II DQA1-DQB1 data from Caucasian, African, and Japanese populations. Our results indicate that the combination DQA1#52 (Arg predisposing) DQB1#57 (Asp protective), which has been proposed as an important IDDM agent, does not include all the predisposing elements. With rheumatoid arthritis HLA class II DRB1 data,the results were consistent with the-shared-epitope hypothesis.	UNIV CALIF BERKELEY, DEPT INTEGRAT BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				Valdes, Ana M./0000-0003-1141-4471	NICHD NIH HHS [HD12731] Funding Source: Medline; NIGMS NIH HHS [GM35326] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; DIZIER MH, 1993, AM J HUM GENET, V53, P715; Efron B, 1982, JACKKNIFE BOOTSTRAP; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; IMANISHI T, 1992, P 11 INT HIST WORKSH, V1, P1065; JENKINS D, 1990, DIABETOLOGIA, V33, P387, DOI 10.1007/BF00404086; KENDALL MG, 1979, ADV THEORY STATISTIC; KHALIL I, 1990, J CLIN INVEST, V85, P1315, DOI 10.1172/JCI114569; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; NEPOM GT, 1987, J CLIN IMMUNOL, V7, P1, DOI 10.1007/BF00915418; RENNINGEN KS, 1990, TISSUE ANTIGENS, V36, P235, DOI 10.1111/j.1399-0039.1990.tb01834.x; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; ROBINSON WP, 1991, GENETICS, V129, P925; RONNINGEN KS, 1991, TISSUE ANTIGENS, V37, P105, DOI 10.1111/j.1399-0039.1991.tb01854.x; RONNINGEN KS, 1992, HLA 1991, V1, P713; Salamon H, 1996, J COMPUT BIOL, V3, P407, DOI 10.1089/cmb.1996.3.407; SCHIFF B, 1982, ANN RHEUM DIS, V41, P403, DOI 10.1136/ard.41.4.403; TAIT BD, 1991, GENETICS DIABETES 1, P211; THOMSON G, 1977, GENETICS, V85, P753; THOMSON G, 1995, CRIT REV CL LAB SCI, V32, P183, DOI 10.3109/10408369509084684; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1995, AM J HUM GENET, V57, P487; THOMSON G, 1991, GENETICS DIABETES 1, P247; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TODD JA, 1995, P NATL ACAD SCI USA, V92, P8560, DOI 10.1073/pnas.92.19.8560; Valdes AM, 1997, AM J HUM GENET, V60, P717; VALDES AM, 1995, THESIS U CALIFORIA B; VICARIO JL, 1992, DIABETOLOGIA, V35, P475, DOI 10.1007/BF02342447; WATANABE Y, 1989, J EXP MED, V169, P2263, DOI 10.1084/jem.169.6.2263; Yasunaga S, 1996, TISSUE ANTIGENS, V47, P37, DOI 10.1111/j.1399-0039.1996.tb02512.x	35	75	76	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					703	716						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042931				2022-12-18	WOS:A1997WK40300028
J	Pignatti, PF; Bombieri, C; Benetazzo, M; Casartelli, A; Trabetti, E; Gile, LS; Martinati, LC; Boner, AL; Luisetti, M				Pignatti, PF; Bombieri, C; Benetazzo, M; Casartelli, A; Trabetti, E; Gile, LS; Martinati, LC; Boner, AL; Luisetti, M			CFTR gene variant IVS8-5T in disseminated bronchiectasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV VERONA,DEPT PEDIAT,I-37100 VERONA,ITALY; UNIV PAVIA,IRCCS SAN MATTEO,INST RESP DIS,I-27100 PAVIA,ITALY	University of Verona; IRCCS Fondazione San Matteo; University of Pavia	Pignatti, PF (corresponding author), UNIV VERONA,INST BIOL & GENET,I-37100 VERONA,ITALY.							CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; JARVI K, 1995, LANCET, V345, P1578, DOI 10.1016/S0140-6736(95)91131-6; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Kueppers F, 1992, GENETIC BASIS COMMON, P222; MARTINATI LC, IN PRESS AM J RESP C; NADEL JA, 1994, TXB RESP MED, P1245; PIGNATTI PF, 1995, HUM MOL GENET, V4, P635, DOI 10.1093/hmg/4.4.635; PIGNATTI PF, 1994, GENOTYPE PHENOTYPE, P19; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; ZIELENSKI J, 1995, AM J HUM GENET, V57, P958	11	75	75	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					889	892						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644755				2022-12-18	WOS:A1996UA38000029
J	Chung, E; Curtis, D; Chen, G; Marsden, PA; Twells, R; Xu, WM; Gardiner, M				Chung, E; Curtis, D; Chen, G; Marsden, PA; Twells, R; Xu, WM; Gardiner, M			Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NADPH DIAPHORASE; BRAIN	The etiological role of the gene for neuronal nitric oxide synthase (NOS1) in infantile pyloric stenosis (PS) was investigated by analysis of two intragenic polymerphisms (NOS1a and NOS1b) in 27 families. There was significant overall transmission disequilibrium between PS and NOS1a (P = .006). Consideration of each allele independently revealed a highly significant tendency for allele 7 (210 bp) to be preferentially transmitted to the affected offspring (P = .0006). These observations suggest that NOS1 is a susceptibility Locus for PS.	ST MARYS HOSP,SCH MED,INST PSYCHIAT,IMPERIAL COLL,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,IMPERIAL COLL,LONDON W2 1PG,ENGLAND; UNIV TORONTO,ST MICHAELS HOSP,DIV RENAL,TORONTO,ON M5B 1W8,CANADA; UNIV TORONTO,ST MICHAELS HOSP,DEPT MED,TORONTO,ON M5B 1W8,CANADA; INST ANIM PHYSIOL & GENET RES,DEPT NEUROBIOL,MRC,MOLEC NEUROSCI GRP,CAMBRIDGE,ENGLAND	Imperial College London; University of London; King's College London; Imperial College London; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Chung, E (corresponding author), UNIV LONDON UNIV COLL,RAYNE INST,SCH MED,DEPT PAEDIAT,5 UNIV ST,LONDON WC1E 6JJ,ENGLAND.		Xu, Weiming/A-6274-2008; Curtis, David/HGB-3921-2022; Marsden, Philip A/B-1441-2012	Xu, Weiming/0000-0002-7085-7814; Curtis, David/0000-0002-4089-9183; 				BULT H, 1990, NATURE, V345, P46; CARTER C O, 1969, Journal of Medical Genetics, V6, P233, DOI 10.1136/jmg.6.3.233; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P1, DOI 10.1002/gepi.1370030102; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Cockayne E. A., 1943, OHIO JOUR SCI, V43, P1; COCKAYNE EA, 1934, LANCET, V1, P898; CURTIS D, 1995, AM J HUM GENET, V56, P811; DAVISON G, 1946, ARCH DIS CHILD, V21, P113, DOI 10.1136/adc.21.106.113; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DODGE JA, 1975, ARCH DIS CHILD, V50, P171, DOI 10.1136/adc.50.3.171; FRIED K, 1981, CLIN GENET, V20, P328; HALL AV, 1994, J BIOL CHEM, V269, P33083; HAYES MA, 1957, INT ABSTR SURG, V104, P105; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; KEEF KD, 1994, NEUROPHARMACOLOGY, V33, P1303, DOI 10.1016/0028-3908(94)90030-2; KIDD KK, 1976, J MED GENET, V13, P290, DOI 10.1136/jmg.13.4.290; LALOUEL JM, 1977, J MED GENET, V14, P408, DOI 10.1136/jmg.14.6.408; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LI CG, 1990, EUR J PHARMACOL, V191, P303; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MACMAHON B, 1955, Acta Genet Med Gemellol (Roma), V4, P320; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MCLEAN MM, 1956, ARCH DIS CHILD, V31, P481, DOI 10.1136/adc.31.160.481; METRAKOS JD, 1953, ARCH DIS CHILD, V27, P351; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; RAYMOND M, IN PRESS J HERED; RISCH N, 1989, GENET EPIDEMIOL, V6, P473, DOI 10.1002/gepi.1370060402; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TAM PKH, 1991, ARCH DIS CHILD, V66, P530, DOI 10.1136/adc.66.4.530; TWELLS R, 1995, AM J HUM GENET, V56, P336; VANDERWINDEN JM, 1992, NEW ENGL J MED, V327, P511, DOI 10.1056/NEJM199208203270802; XU WM, 1993, CYTOGENET CELL GENET, V64, P62, DOI 10.1159/000133562	38	75	75	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					363	370						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571963				2022-12-18	WOS:A1996TR79100013
J	LAMMINEN, T; MAJANDER, A; JUVONEN, V; WIKSTROM, M; AULA, P; NIKOSKELAINEN, E; SAVONTAUS, ML				LAMMINEN, T; MAJANDER, A; JUVONEN, V; WIKSTROM, M; AULA, P; NIKOSKELAINEN, E; SAVONTAUS, ML			A MITOCHONDRIAL MUTATION AT NT-9101 IN THE ATP SYNTHASE-6 GENE ASSOCIATED WITH DEFICIENT OXIDATIVE-PHOSPHORYLATION IN A FAMILY WITH LEBER HEREDITARY OPTIC NEURORETINOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NEUROPATHY; DNA		TURKU UNIV,DEPT BIOL,TURKU,FINLAND; TURKU UNIV,DEPT OPHTHALMOL,TURKU,FINLAND; HELSINKI UNIV,INST BIOMED SCI,DEPT MED CHEM,HELSINKI BIOENERGET GRP,HELSINKI,FINLAND	University of Turku; University of Turku; University of Helsinki	LAMMINEN, T (corresponding author), TURKU UNIV,DEPT MED GENET,TURKU,FINLAND.		Wikstrom, Marten KF/A-4403-2008	Lamminen, Tarja/0000-0002-9556-687X	NEI NIH HHS [1-RO1 EY09040-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009040] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BROWN MD, 1992, GENETICS, V130, P163; DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319; FILLINGAME RH, 1992, ANN NY ACAD SCI, V671, P323, DOI 10.1111/j.1749-6632.1992.tb43806.x; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; HUOPONEN K, 1993, HUM GENET, V92, P37; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MARZUKI S, 1991, HUM GENET, V88, P139; VILKKI J, 1990, AM J HUM GENET, V47, P95; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	11	75	77	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1238	1240						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726182				2022-12-18	WOS:A1995QU58600030
J	SCOTT, HS; LITJENS, T; NELSON, PV; THOMPSON, PR; BROOKS, DA; HOPWOOD, JJ; MORRIS, CP				SCOTT, HS; LITJENS, T; NELSON, PV; THOMPSON, PR; BROOKS, DA; HOPWOOD, JJ; MORRIS, CP			IDENTIFICATION OF MUTATIONS IN THE ALPHA-L-IDURONIDASE GENE (IDUA) THAT CAUSE HURLER AND SCHEIE SYNDROMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; DEFICIENCY; EXPRESSION; MUCOPOLYSACCHARIDOSES; SUBSTITUTION; FIBROBLASTS; PHENOTYPE; DISEASE; REGION; CELLS	Mucopolysaccharidosis type I (MPS-I) is an autosomal recessive genetic disease caused by a deficiency of the lysosomal glycosidase alpha-L-iduronidase. Hurler (severe), Scheie (mild), and Hurler/Scheie (intermediate) syndromes are clinical subtypes of MPS-I, but it is difficult to distinguish between these subtypes by biochemical measurements. Mutation analysis was undertaken to provide a molecular explanation for the clinical variation seen in MPS-I. Using chemical cleavage and direct PCR sequencing, we have defined four previously undescribed mutations for MPS-I (delG1702, 1060+2t-->c, R89Q, and 678-7g-->a). R89Q and 678-7g-->a were found to be present in 40% of Scheie syndrome alleles. Expression of R89Q demonstrated reduced stability and activity of the mutant protein. The deleterious effect of R89Q may be potentiated by a polymorphism (A361T) to produce an intermediate phenotype. 678-7g-->a was found to be a mild mutation, since it was present in an index Scheie syndrome patient in combination with a severe allele (W402X). This mutation appears to allow a very small amount of normal mRNA to be produced from the allele which is likely to be responsible for the mild clinical phenotype observed. Both the 5' and 3' splice site mutations (1060+2t-->c and 678-7g-->a, respectively) result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations. The frameshift mutation (delG1702) and the 5' splice site mutation (1060+2t-->c) are both thought to be associated with severe MPS-I. The identification of these MPS-I mutations begins to document the expected genetic heterogeneity in MPS-I and provides the first molecular explanations for the broad range of clinical phenotypes observed.	ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,72 KING WILLIAM RD,ADELAIDE,SA 5006,AUSTRALIA				Scott, Hamish/B-2122-2009; Brooks, Doug A/K-6714-2012	Scott, Hamish/0000-0002-5813-631X; Morris, Phillip/0000-0001-8976-619X; Brooks, Doug/0000-0001-9098-3626				ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; ASHTON LJ, 1992, AM J HUM GENET, V50, P787; BACH G, 1972, P NATL ACAD SCI USA, V69, P2048, DOI 10.1073/pnas.69.8.2048; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; CULLEN BR, 1988, DNA-J MOLEC CELL BIO, V7, P645, DOI 10.1089/dna.1988.7.645; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; GLUKHOV AI, 1990, MOL CELL PROBE, V4, P435, DOI 10.1016/0890-8508(90)90002-H; HEDLEY ML, 1989, J IMMUNOL, V143, P1018; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; Hurler G, 1920, Z KINDERHEILKD, V24, P220; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MATALON R, 1983, J INHERIT METAB DIS, V6, P133, DOI 10.1007/BF01810363; MCKUSICK VA, 1965, MEDICINE, V44, P445, DOI 10.1097/00005792-196511000-00001; MCKUSICK VA, 1972, LANCET, V1, P993; MCKUSICK VA, 1983, METABOLIC BASIS INHE, P751; MCKUSICK VA, 1972, HERITABLE DISORDERS, P521; Moskowitz S. M., 1992, American Journal of Human Genetics, V51, pA173; MULLER VJ, 1984, CLIN GENET, V26, P414; NELSON C, 1992, J BIOL CHEM, V267, P3351; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; PATTERSON D, 1992, SOMAT CELL MOLEC GEN, V18, P65, DOI 10.1007/BF01233449; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; ROSSI AM, 1990, MUTAT RES, V244, P353, DOI 10.1016/0165-7992(90)90084-W; SAKURABA H, 1992, GENOMICS, V12, P643, DOI 10.1016/0888-7543(92)90288-4; SCHEIE HG, 1962, AM J OPHTHALMOL, V53, P753; Scott Hamish S., 1992, Human Mutation, V1, P333, DOI 10.1002/humu.1380010412; Scott Hamish S., 1992, Human Mutation, V1, P103, DOI 10.1002/humu.1380010204; SCOTT HS, 1991, NUCLEIC ACIDS RES, V19, P5796, DOI 10.1093/nar/19.20.5796-a; SCOTT HS, 1991, P NATL ACAD SCI USA, V88, P9695, DOI 10.1073/pnas.88.21.9695; SCOTT HS, 1992, HUM GENET, V90, P327; SCOTT HS, 1992, HUM GENET, V88, P701, DOI 10.1007/BF02265303; SCOTT HS, 1992, GENOMICS, V13, P1311, DOI 10.1016/0888-7543(92)90053-U; SCOTT HS, IN PRES HUM MOL GENE; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; WEIL D, 1988, J BIOL CHEM, V263, P8561; WIESMANN U, 1970, SCIENCE, V169, P72, DOI 10.1126/science.169.3940.72	38	75	77	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					973	986						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213840				2022-12-18	WOS:A1993MC33300001
J	MACKE, JP; HU, N; HU, S; BAILEY, M; KING, VL; BROWN, T; HAMER, D; NATHANS, J				MACKE, JP; HU, N; HU, S; BAILEY, M; KING, VL; BROWN, T; HAMER, D; NATHANS, J			SEQUENCE VARIATION IN THE ANDROGEN RECEPTOR GENE IS NOT A COMMON DETERMINANT OF MALE SEXUAL ORIENTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; SINGLE-BASE CHANGES; INSENSITIVITY SYNDROME; HOMOSEXUAL MEN; MUTATIONS; BEHAVIOR; REPEAT; BRAIN	To test the hypothesis that DNA sequence variation in the androgen receptor gene plays a causal role in the development of male sexual orientation, we have (1) measured the degree of concordance of androgen receptor alleles in 36 pairs of homosexual brothers, (2) compared the lengths of polyglutamine and polyglycine tracts in the amino-terminal domain of the androgen receptor in a sample of 197 homosexual males and 213 unselected subjects, and (3) screened the the entire androgen receptor coding region for sequence variation by PCR and denaturing gradient-gel electrophoresis (DGGE) and/or single-strand conformation polymorphism analysis in 20 homosexual males with homosexual or bisexual brothers and one homosexual male with no homosexual brothers, and screened the amino-terminal domain of the receptor for sequence variation in an additional 44 homosexual males, 37 of whom had one or more first- or second-degree male relatives who were either homosexual or bisexual. These analyses show that (1) homosexual brothers are as likely to be discordant as concordant for androgen receptor alleles; (2) there are no large-scale differences between the distributions of polyglycine or polyglutamine tract lengths in the homosexual and control groups; and (3) coding region sequence variation is not commonly found within the androgen receptor gene of homosexual men. The DGGE screen identified two rare amino acid substitutions, ser205-to-arg and glu793-to-asp, the biological significance of which is unknown.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,805 PCTB,725 N WOLFE ST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT POPULAT DYNAM,BALTIMORE,MD 21218; NCI,BIOCHEM LAB,BETHESDA,MD 20892; NORTHWESTERN UNIV,DEPT PSYCHOL,EVANSTON,IL 60201	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University				Bailey, Michael/0000-0003-4756-1705; Nathans, Jeremy/0000-0001-8106-5460	NIDDK NIH HHS [DK43147] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043147] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN LS, 1992, P NATL ACAD SCI USA, V89, P7199, DOI 10.1073/pnas.89.15.7199; BAILEY JM, 1993, ARCH GEN PSYCHIAT, V50, P217; BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; BATCH JA, 1992, HUM MOL GENET, V1, P497, DOI 10.1093/hmg/1.7.497; Bell Alan P., 1981, SEXUAL PREFERENCE IT; BROWN TR, 1990, MOL ENDOCRINOL, V4, P1759, DOI 10.1210/mend-4-12-1759; DORNER G, 1975, ARCH SEX BEHAV, V4, P1, DOI 10.1007/BF01541882; Dorner G, 1980, Vitam Horm, V38, P325; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EHRHARDT AA, 1981, SCIENCE, V211, P1312, DOI 10.1126/science.7209510; Friedman RC, 1988, MALE HOMOSEXUALITY C; Goy R. W., 1980, SEXUAL DIFFERENTIATI; GREEN R, 1985, AM J PSYCHIAT, V142, P339; GRIFFIN JE, 1992, WILLIAMS TXB ENDOCRI, P799; JENSTER G, 1992, J STEROID BIOCHEM, V41, P671, DOI 10.1016/0960-0760(92)90402-5; KALLMANN FJ, 1952, J NERV MENT DIS, V115, P283; KING M, 1992, BRIT J PSYCHIAT, V160, P407, DOI 10.1192/bjp.160.3.407; KINSEY AC, 1948, SEXUAL BEHAVIOR HUMA; KINSEY AC, 1953, SEXUAL BEHAVIOR HUMA; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; LUBAHN DB, 1989, P NATL ACAD SCI USA, V86, P9534, DOI 10.1073/pnas.86.23.9534; MCPHAUL MJ, 1993, J CLIN ENDOCR METAB, V76, P17, DOI 10.1210/jc.76.1.17; MEYERBAHLHURG HFL, 1984, BRAIN RES, V71, P375; MONEY J, 1984, PSYCHONEUROENDOCRINO, V9, P405, DOI 10.1016/0306-4530(84)90048-9; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; PILLARD RC, 1986, ARCH GEN PSYCHIAT, V43, P808; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; ZUGER B, 1984, J NERV MENT DIS, V172, P90, DOI 10.1097/00005053-198402000-00005	32	75	79	2	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					844	852						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213813				2022-12-18	WOS:A1993LY62700008
J	RICE, T; BORECKI, IB; BOUCHARD, C; RAO, DC				RICE, T; BORECKI, IB; BOUCHARD, C; RAO, DC			SEGREGATION ANALYSIS OF FAT MASS AND OTHER BODY-COMPOSITION MEASURES DERIVED FROM UNDERWATER WEIGHING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-ANALYSIS; UNIFIED MODEL; OBESITY; FAMILY; INHERITANCE; HEIGHT	Segregation patterns of three body composition measures which were derived from underwater weighing were evaluated in a random sample of 176 French-Canadian families. Two of the variables can be considered as primary partitions of weight (fat mass [FM] and fat-free mass [FFM]), while the remaining variable (percent body fat [%BF]) is a derived index combining the measures of both fat and fat-free weight. This study represents the first report investigating major gene effects for these measures. Segregation analyses revealed that a major locus hypothesis could not be rejected for two of the three phenotypes. The single exception was FFM, for which nearly 60% of the variance was accounted for by a non-Mendelian major effect, which may reflect environmentally based commingling or may be in part a function of gene-environment interactions or correlations. In contrast to the results for FFM, the results for each of FM and %BF were similar and suggested a major locus which accounted for 45% of the variance, with an additional 22%-26% due to a multifactorial component. Given the similarity of the major gene characteristics for these two phenotypes, the possibility that the same gene underlies both measures warrants investigation. A reasonable hypothesis is to consider genes that may influence nutrient partitioning, as the family of candidate genes to receive the major attention.	WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; LAVAL UNIV,PEPS,PHYS ACT SCI LAB,ST FOY,PQ,CANADA	Washington University (WUSTL); Washington University (WUSTL); Laval University	RICE, T (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,BOX 8067,660 S EUCLID,ST LOUIS,MO 63110, USA.		Bouchard, Claude/AAE-2035-2019; Bouchard, Claude/A-7637-2009; Rice, Treva K/D-1385-2009	Bouchard, Claude/0000-0002-0048-491X; Rice, Treva/0000-0001-7452-2600	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018281] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-47317] Funding Source: Medline; NICHD NIH HHS [HD-18281] Funding Source: Medline; NIGMS NIH HHS [GM-28719] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BORECKI IB, 1991, INT J OBESITY, V15, P763; BORECKI IB, UNPUB SINGLE GENE IN; BOUCHARD C, 1985, HUM BIOL, V57, P61; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; BOUCHARD C, 1988, INT J OBESITY, V12, P205; Bouchard C., 1985, BODY COMPOSITION ASS, P9; BURTON BT, 1985, INT J OBESITY, V9, P155; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; HIMES JH, 1985, AM J PUBLIC HEALTH, V75, P1076, DOI 10.2105/AJPH.75.9.1076; KARLIN S, 1981, AM J EPIDEMIOL, V113, P307, DOI 10.1093/oxfordjournals.aje.a113100; KRAL JG, 1985, ANN INTERN MED, V103, P1043, DOI 10.7326/0003-4819-103-6-1043; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MALINA RM, 1988, FAT DISTRIBUTION GRO, P63; MOLL PP, 1991, AM J HUM GENET, V49, P1243; Morton N.E., 1983, METHODS GENETIC EPID; PERUSSE L, 1989, AM J HUM GENET, V45, P240; PRICE RA, 1990, HUM BIOL, V62, P747; PROVINCE MA, 1990, AM J HUM GENET S, V47, pA143; RICE T, UNPUB SEGREGATION AN; ZONTA LA, 1987, HUM HERED, V37, P129, DOI 10.1159/000153690	24	75	75	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					967	973						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488846				2022-12-18	WOS:A1993LB88900014
J	TANZI, RE; WATKINS, PC; STEWART, GD; WEXLER, NS; GUSELLA, JF; HAINES, JL				TANZI, RE; WATKINS, PC; STEWART, GD; WEXLER, NS; GUSELLA, JF; HAINES, JL			A GENETIC-LINKAGE MAP OF HUMAN CHROMOSOME-21 - ANALYSIS OF RECOMBINATION AS A FUNCTION OF SEX AND AGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; HUMAN-BREAST CANCER; BETA-PROTEIN GENE; DEFECT; CDNA; REGION; CELLS	A genetic linkage map of human chromosome 21 has been constructed using 22 anonymous DNA markers and five complementary DNAs (cDNAs) encoding the amyloid beta-protein precursor (APP), superoxide dismutase 1 (SOD1), the ets-2 proto-oncogene (ETS2), the estrogen inducible breast cancer locus ((BCEI), and the leukocyte antigen, CD18 (CD18). Segregation of RFLPs detected by these DNA markers was traced in the Venezuelan Reference Pedigree (VRP). A comprehensive genetic linkage map consisting of the 27 DNA markers spans 102 cM on the long arm of chromosome 21. We have confirmed our initial findings of a dramatically increased rate of recombination at the telomere in both females and males and of significantly higher recombination in females in the pericentromeric region. By comparing patterns of recombination in specific regions of chromosome 21 with regard to both parental sex and age, we have now identified a statistically significant downward trend in the frequency of crossovers in the most telomeric portion of chromosome 21 with increasing maternal age. A less significant decrease in recombination with increasing maternal age was observed in the pericentromeric region of the chromosome. These results may help in ultimately understanding the physical relationship between recombination and nondisjunction in the occurrence of trisomy 21.	COLUMBIA UNIV,INST PSYCHIAT,NEW YORK,NY 10027; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,MOLEC NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; LIFE TECHNOL INC,GAITHERSBURG,MD; UNIV MICHIGAN,DEPT PEDIAT & COMMUNICABLE DIS,ANN ARBOR,MI 48109	Columbia University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Thermo Fisher Scientific; University of Michigan System; University of Michigan			Haines, Jonathan/C-3374-2012; Tanzi, Rudolph/AAE-9622-2019	Haines, Jonathan/0000-0002-4351-4728; Tanzi, Rudolph/0000-0002-7032-1454	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030428] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00169, HG00324] Funding Source: Medline; NINDS NIH HHS [NS30428] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; COHENHAGUENAUER O, 1985, CYTOGENET CELL GENET, V40, P606; Darlington C. D., 1937, RECENT ADV CYTOLOGY; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER K, 1988, SOMAT CELL MOLEC GEN, V14, P623, DOI 10.1007/BF01535316; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAINES JL, 1990, GENOMICS, V8, P1, DOI 10.1016/0888-7543(90)90218-J; HALLEWELL RA, 1985, NUCLEIC ACIDS RES, V13, P2017, DOI 10.1093/nar/13.6.2017; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; MARLIN SD, 1986, J EXP MED, V164, P855, DOI 10.1084/jem.164.3.855; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; MILLINGTONWARD A, 1985, CYTOGENET CELL GENET, V40, P699; PATTERSON D, 1988, P NATL ACAD SCI USA, V85, P8266, DOI 10.1073/pnas.85.21.8266; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; SMITH GF, 1985, ANN NY ACAD SCI, V450, P1, DOI 10.1111/j.1749-6632.1985.tb21478.x; SMITH GF, 1976, DOWNS ANOMALY; STEWART G D, 1988, American Journal of Human Genetics, V43, pA160; STEWART G D, 1986, American Journal of Human Genetics, V39, pA222; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; Tanzi R E, 1991, Curr Opin Neurobiol, V1, P455, DOI 10.1016/0959-4388(91)90069-J; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1991, J BIOL CHEM, V266, P20579; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WATKINS PC, 1987, CYTOGENET CELL GENET, V46, P712	35	75	79	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					551	558						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1347193				2022-12-18	WOS:A1992HH97400014
J	ELLISON, KA; FILL, CP; TERWILLIGER, J; DEGENNARO, LJ; MARTINGALLARDO, A; ANVRET, M; PERCY, AK; OTT, J; ZOGHBI, H				ELLISON, KA; FILL, CP; TERWILLIGER, J; DEGENNARO, LJ; MARTINGALLARDO, A; ANVRET, M; PERCY, AK; OTT, J; ZOGHBI, H			EXAMINATION OF X-CHROMOSOME MARKERS IN RETT SYNDROME - EXCLUSION MAPPING WITH A NOVEL VARIATION ON MULTILOCUS LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT; LOCUS; GENE; AMPLIFICATION; TRANSLOCATION; POLYMORPHISMS	Rett syndrome is a neurologic disorder characterized by early normal development followed by regression, acquired decleration of head growth, autism, ataxia, and stereotypic hand movements. The exclusive occurrence of the syndrome in females and the occurrence of a few familial cases with inheritance through maternal lines suggest that this disorder is most likely secondary to a mutation on the X chromosome. To address this hypothesis and to identify candidate regions for the Rett syndrome gene locus, genotypic analysis was performed in two families with maternally related affected half-sisters by using 63 DNA markers from the X chromosome. Maternal and paternal X chromosomes from the affected sisters were separated in somatic cell hybrids and were examined for concordance/discordance of maternal alleles at the tested loci. Thirty-six markers were informative in at least one of the two families, and 25 markers were informative in both families. Twenty loci were excluded as candidates for the Rett syndrome gene, on the basis of discordance for maternal alleles in the half-sisters. Nineteen of the loci studied were chosen for multipoint linkage analysis because they have been previously genetically mapped using a large number of meioses from reference families. Using the exclusion criterion of a lod score less than -2, we were able to exclude the region between the Duchenne muscular dystrophy locus and the DXS456 locus. This region extends from Xp21.2 to Xq21-q23. The use of the multipoint linkage analysis approach outlined in this study should allow the exclusion of additional regions of the X chromosome as new markers are analyzed. This in turn will result in a defined region of the X chromosome that should be searched for candidate sequences for the Rett syndrome gene in both familial and sporadic cases.	BAYLOR COLL MED,DEPT PEDIAT,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; COLUMBIA UNIV,DEPT GENET & PSYCHIAT,NEW YORK,NY 10027; UNIV MASSACHUSETTS,SCH MED,DEPT NEUROL & CELL BIOL,WORCESTER,MA 01605; NINCDS,BETHESDA,MD 20892; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM 60,SWEDEN	Baylor College of Medicine; Baylor College of Medicine; Columbia University; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Karolinska Institutet; Karolinska University Hospital				DeGennaro, Louis/0000-0002-2145-8382	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007102] Funding Source: NIH RePORTER; NEI NIH HHS [5 T32-EY07102] Funding Source: Medline; NICHD NIH HHS [HD24064, HD24234] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALITALO T, 1991, HUM GENET, V86, P599, DOI 10.1007/BF00201548; ARCHIDIACONO N, 1991, HUM GENET, V86, P604; BOYLAN KB, 1990, GENOMICS, V6, P16, DOI 10.1016/0888-7543(90)90443-X; DAVIES KE, 1990, CYTOGENET CELL GENET, V55, P254, DOI 10.1159/000133019; EDWARDS A, 1991, AM J HUM GENET, V49, P746; ELLISON KA, 1991, NUCLEIC ACIDS RES, V19, P5101, DOI 10.1093/nar/19.18.5101-a; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1986, AM J MED GENET, V24, P175; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P277, DOI 10.1016/S0387-7604(85)80028-0; HO L, 1989, P NATL ACAD SCI USA, V86, P5330, DOI 10.1073/pnas.86.14.5330; HUANG THM, 1991, AM J HUM GENET, V49, P1312; HUANG THM, UNPUB SIMULTANEOUS T; JOURNEL H, 1990, AM J MED GENET, V35, P142, DOI 10.1002/ajmg.1320350130; KEATS BJB, 1990, CYTOGENET CELL GENET, V55, P387, DOI 10.1159/000133023; KIRCHGESSNER CU, 1991, AM J HUM GENET, V49, P184; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; LITT M, 1989, AM J HUM GENET, V44, P397; LUTY JA, 1990, AM J HUM GENET, V46, P776; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; OZELIUS L, 1988, Genomics, V3, P53, DOI 10.1016/0888-7543(88)90159-0; RETT A, 1966, EIN ZEREBRAL ATROPHI; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SIDDIQUE T, 1989, NUCLEIC ACIDS RES, V17, P1785, DOI 10.1093/nar/17.4.1785; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIAMSON R, 1990, CYTOGENET CELL GENET, V55, P685; ZOGHBI H, 1988, J CHILD NEUROL, V3, pS76, DOI 10.1177/0883073888003001S15; ZOGHBI H Y, 1989, American Journal of Human Genetics, V45, pA232; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X; ZOGHBI HY, 1990, AM J MED GENET, V35, P148, DOI 10.1002/ajmg.1320350131; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877	35	75	75	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					278	287						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734712				2022-12-18	WOS:A1992HD00100004
J	GIEBEL, LB; TRIPATHI, RK; STRUNK, KM; HANIFIN, JM; JACKSON, CE; KING, RA; SPRITZ, RA				GIEBEL, LB; TRIPATHI, RK; STRUNK, KM; HANIFIN, JM; JACKSON, CE; KING, RA; SPRITZ, RA			TYROSINASE GENE-MUTATIONS ASSOCIATED WITH TYPE-IB (YELLOW) OCULOCUTANEOUS ALBINISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; PATIENT; CELLS; CDNA; SKIN; PCR	We have identified three different tyrosinase gene mutant alleles in four unrelated patients with type IB ("yellow") oculocutaneous albinism (OCA) and thus have demonstrated that type IB OCA is allelic to type IA (tyrosinase negative) OCA. In an inbred Amish kindred, type IB OCA results from homozygosity for a Pro --> Leu substitution at codon 406. In the second family, type IB OCA results from compound heterozygosity for a type IA OCA allele (codon 81 Pro --> Leu) and a novel type IB allele (codon 275 Val --> Phe). In the third patient, type IB OCA results from compound heterozygosity for the same type IB allele (codon 275 Val --> Phe) and a novel type IB OCA allele. In a fourth patient, type IB OCA results from compound heterozygosity for the codon 81 type IA OCA allele and a type IB allele that contains no identifiable abnormalities; dysfunction of this type IB allele apparently results from a mutation either well within one of the large introns or at some distance from the tyrosinase gene. In vitro expression of the Amish type IB allele in nonpigmented HeLa cells demonstrates that the Pro --> Leu substitution at codon 406 greatly reduces but does not abolish tyrosinase enzymatic activity, a finding consistent with the clinical phenotype.	UNIV WISCONSIN,DEPT MED GENET,GENET LAB 309,445 HENRY MALL,MADISON,WI 53706; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; OREGON HLTH SCI UNIV,DEPT DERMATOL,PORTLAND,OR 97201; HENRY FORD HOSP,DEPT MED,DIV CLIN & MOLEC GENET,DETROIT,MI 48202; UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; Henry Ford Health System; Henry Ford Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					NIAMS NIH HHS [AR-39892] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; BOUCHARD B, 1989, J EXP MED, V169, P2029, DOI 10.1084/jem.169.6.2029; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; GIEBEL LB, 1991, GENOMICS, V9, P435, DOI 10.1016/0888-7543(91)90409-8; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P4947, DOI 10.1093/nar/18.16.4947; GIEBEL LB, 1990, P NATL ACAD SCI USA, V87, P3255, DOI 10.1073/pnas.87.9.3255; GIEBEL LB, IN PRESS J MED GENET; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HU F, 1980, AM J HUM GENET, V32, P387; HUSAIN I, 1982, J INVEST DERMATOL, V78, P243, DOI 10.1111/1523-1747.ep12506603; KIKUCHI H, 1990, HUM GENET, V85, P123; KING RA, 1985, AM J MED GENET, V20, P49, DOI 10.1002/ajmg.1320200108; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; KOGAN SC, 1990, PCR PROTOCOLS, P288; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; NANCE WE, 1970, AM J HUM GENET, V22, P579; OTT J, 1974, AM J HUM GENET, V26, P588; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRITZ R, 1988, NUCLEIC ACIDS RES, V16, P9890, DOI 10.1093/nar/16.20.9890; SPRITZ RA, 1991, AM J HUM GENET, V48, P318; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; TAKEDA A, 1990, J BIOL CHEM, V265, P17792; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; TRIPATHI RK, 1988, BIOCHEM J, V252, P481, DOI 10.1042/bj2520481; TRIPATHI RK, IN PRESS GENE EXPRES; WITTBJER A, 1989, ACTA DERM-VENEREOL, V69, P125; ZHANG H, 1988, NUCLEIC ACIDS RES, V16, P1220, DOI 10.1093/nar/16.3.1220; [No title captured]	31	75	80	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1159	1167						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	1903591				2022-12-18	WOS:A1991FP09200019
J	BUETOW, KH; SHIANG, R; YANG, P; NAKAMURA, Y; LATHROP, GM; WHITE, R; WASMUTH, JJ; WOOD, S; BERDAHL, LD; LEYSENS, NJ; RITTY, TM; WISE, ME; MURRAY, JC				BUETOW, KH; SHIANG, R; YANG, P; NAKAMURA, Y; LATHROP, GM; WHITE, R; WASMUTH, JJ; WOOD, S; BERDAHL, LD; LEYSENS, NJ; RITTY, TM; WISE, ME; MURRAY, JC			A DETAILED MULTIPOINT MAP OF HUMAN CHROMOSOME-4 PROVIDES EVIDENCE FOR LINKAGE HETEROGENEITY AND POSITION-SPECIFIC RECOMBINATION RATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; FRAGMENT LENGTH POLYMORPHISMS; DNA MARKERS; GENOMIC CLONE; D4S10 G8; LONG ARM; RFLP; SEQUENCE; TELOMERE; LOCUS	Utilizing the CEPH reference panel and genotypic data for 53 markers, we have constructed a 20-locus multipoint genetic map of human chromosome 4. New RFLPs are reported for four loci. The map integrates a high-resolution genetic map of 4p16 into a continuous map extending to 4q31 and an unlinked cluster of three loci at 4q35. The 20 linked markers form a continuous linkage group of 152 cM in males and 202 cM in females. Likely genetic locations are provided for 25 polymorphic anonymous sequences and 28 gene-specific RFLPs. The map was constructed employing the LINKAGE and CRIMAP computational methodologies to build the multipoint map via a stepwise algorithm. A detailed 10-point map of the 4p16 region constructed from the CEPH panel provides evidence for heterogeneity in the linkage maps constructed from families segregating for Huntington disease (HD). It additionally provides evidence for position-specific recombination frequencies in the telomeric region of 4p.	UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA; UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA	University of Iowa; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; University of British Columbia	BUETOW, KH (corresponding author), FOX CHASE CANC INST,DIV POPULAT SCI,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.				NATIONAL CANCER INSTITUTE [R29CA047816, P30CA006927] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005895] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927, CA47816] Funding Source: Medline; NCRR NIH HHS [RR05895] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALTHERR MR, 1989, NUCLEIC ACIDS RES, V16, P8487; BATES G, 1989, CYTOGENET CELL GENET, V51, P959; BECK JS, 1989, NUCLEIC ACIDS RES, V17, P8895, DOI 10.1093/nar/17.21.8895; BERDAHL LD, 1988, NUCLEIC ACIDS RES, V16, P2743, DOI 10.1093/nar/16.6.2743; BERDAHL LD, 1988, NUCLEIC ACIDS RES, V16, P4740, DOI 10.1093/nar/16.10.4740; BOJKO M, 1985, CARLSBERG RES COMMUN, V50, P43, DOI 10.1007/BF02907137; BOOTSMA D, 1979, CYTOGENET CELL GENET, V25, P21, DOI 10.1159/000131396; BUCAN M, 1990, GENOMICS, V6, P1; CARLOCK LR, 1987, NUCLEIC ACIDS RES, V15, P377, DOI 10.1093/nar/15.1.377; CHANDLEY AC, 1988, CYTOGENET CELL GENET, V48, P152, DOI 10.1159/000132613; Charles DR, 1938, J GENET, V36, P103, DOI 10.1007/BF02982376; COLLICK A, 1990, NUCLEIC ACIDS RES, V18, P625, DOI 10.1093/nar/18.3.625; COX DR, 1989, CYTOGENET CELL GENET, V51, P121, DOI 10.1159/000132788; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DIETZ JN, 1986, GENET EPIDEMIOL, V3, P313, DOI 10.1002/gepi.1370030504; DOGGETT NA, 1989, P NATL ACAD SCI USA, V86, P10011, DOI 10.1073/pnas.86.24.10011; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EDWARDS JH, 1976, CYTOGENET CELL GENET, V16, P289, DOI 10.1159/000130612; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GEORGIOU C, 1989, NUCLEIC ACIDS RES, V17, P8894, DOI 10.1093/nar/17.21.8894; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GILLIAM TC, 1984, HUM GENET, V68, P154, DOI 10.1007/BF00279306; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUZZO C, 1987, NUCLEIC ACIDS RES, V15, P380, DOI 10.1093/nar/15.1.380; HAYDEN MR, 1988, AM J HUM GENET, V42, P125; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; HULTEN M, 1974, HEREDITAS, V76, P55; HUMPHRIES SE, 1984, HUM GENET, V68, P148, DOI 10.1007/BF00279305; KATO A, 1989, CYTOGENET CELL GENET, V52, P77, DOI 10.1159/000132844; KEATS BJB, 1981, LINKAGE CHROMOSOME M; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, GENOMICS, V2, P157; LEYSENS NJ, 1989, NUCLEIC ACIDS RES, V17, P5417, DOI 10.1093/nar/17.13.5417; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MIKKELSEN M, 1977, HUM HERED, V27, P105, DOI 10.1159/000152857; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; MODI WS, 1990, HUM GENET, V84, P185; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURRAY JC, 1988, AM J HUM GENET, V42, P490; MURRAY JC, 1983, P NATL ACAD SCI-BIOL, V80, P5951, DOI 10.1073/pnas.80.19.5951; MURRAY JC, 1987, HUM GENET, V76, P274; MURRAY JC, 1985, CYTOGENET CELL GENET, V40, P707; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4186, DOI 10.1093/nar/16.9.4186; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P6254, DOI 10.1093/nar/16.13.6254; PASQUINELLI C, 1988, J VIROL, V62, P629, DOI 10.1128/JVI.62.2.629-632.1988; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; PRITCHARD CA, 1989, GENOMICS, V4, P408, DOI 10.1016/0888-7543(89)90348-0; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; RITTY TM, 1989, NUCLEIC ACIDS RES, V17, P5870, DOI 10.1093/nar/17.14.5870; RITTY TM, IN PRSS NUCLEI ACIDS; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SCAMBLER PJ, 1985, NUCLEIC ACIDS RES, V13, P3016, DOI 10.1093/nar/13.8.3016; SHIANG R, 1989, GENOMICS, V4, P1; SKRAASTAD MI, 1989, CYTOGENET CELL GENET, V51, P1081; SMITH B, 1988, AM J HUM GENET, V42, P335; SMITH M, 1985, CYTOGENET CELL GENET, V40, P748; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SNELL RG, 1989, CYTOGENET CELL GENET, V51, P1083; SZAUTER P, 1984, GENETICS, V106, P45; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WEBER B, 1989, CYTOGENET CELL GENET, V51, P1104; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769; WOOD S, 1986, AM J HUM GENET, V39, P744; YOUNGMAN S, 1988, NUCLEIC ACIDS RES, V16, P1648, DOI 10.1093/nar/16.4.1648	66	75	78	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					911	925						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673289				2022-12-18	WOS:A1991FK89700010
J	GERMINO, GG; BARTON, NJ; LAMB, J; HIGGS, DR; HARRIS, P; XIAO, GH; SCHERER, G; NAKAMURA, Y; REEDERS, ST				GERMINO, GG; BARTON, NJ; LAMB, J; HIGGS, DR; HARRIS, P; XIAO, GH; SCHERER, G; NAKAMURA, Y; REEDERS, ST			IDENTIFICATION OF A LOCUS WHICH SHOWS NO GENETIC-RECOMBINATION WITH THE AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE GENE ON CHROMOSOME-16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT INTERNAL MED,NEPHROL SECT,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510; HOWARD HUGHES MED INST,NEW HAVEN,CT; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV OXFORD,NUFFIELD DEPT MED,OXFORD,ENGLAND; UNIV FREIBURG,INST HUMANGENET & ANTHROPOL,W-7800 FREIBURG,GERMANY; UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	Yale University; Howard Hughes Medical Institute; Yale University; University of Oxford; University of Freiburg; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah				Lamb, Janette/0000-0002-8926-0516; Germino, Gregory/0000-0002-3609-5588				BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; BREUNING MH, 1987, LANCET, V2, P1359; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARRIS P, 1987, HUM GENET, V77, P95, DOI 10.1007/BF00272372; JARMAN AP, 1988, AM J HUM GENET, V43, P249; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; LAMB J, 1989, LANCET, V2, P819; LATHROP GM, 1984, AM J HUM GENET, V36, P460; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3122, DOI 10.1093/nar/16.7.3122; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; REEDERS S T, 1988, Genomics, V3, P150, DOI 10.1016/0888-7543(88)90146-2; REEDERS ST, 1987, PEDIATR NEPHROL, V1, P405, DOI 10.1007/BF00849244; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; REEDERS ST, 1986, BRIT MED J, V292, P851, DOI 10.1136/bmj.292.6524.851; ROMEO G, 1988, LANCET, V2, P7; VILLEGAS A, IN PRESS EUR J HAEMA; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; WOLFF E, 1988, NUCLEIC ACIDS RES, V16, P9885, DOI 10.1093/nar/16.20.9885; XIAO GH, 1987, CYTOGENET CELL GENET, V46, P721	23	75	80	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					925	933						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339691				2022-12-18	WOS:A1990DD89600010
J	SHIBUYA, A; YOSHIDA, A				SHIBUYA, A; YOSHIDA, A			FREQUENCY OF THE ATYPICAL ALDEHYDE DEHYDROGENASE-2 GENE (ALDH-2(2)) IN JAPANESE AND CAUCASIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR, BECKMAN RES INT, DEPT BIOCHEM GENET, DUARTE, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope					NIAAA NIH HHS [AA05763] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005763] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; GOEDDE HW, 1979, HUM GENET, V51, P331; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HARADA S, 1980, AM J HUM GENET, V32, P8; HSU LC, 1987, AM J HUM GENET, V41, P996; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; Hsu LC, 1988, GENOMICS, V2, P57, DOI 10.1016/0888-7543(88)90109-7; IKAWA M, 1983, J BIOL CHEM, V258, P6282; IMPRAIM C, 1982, AM J HUM GENET, V34, P837; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; YOSHIDA A, 1983, ISOZYMES-CURR T BIOL, V8, P245	12	75	77	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					741	743						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189337				2022-12-18	WOS:A1988Q933600021
J	DRACOPOLI, NC; STANGER, BZ; ITO, CY; CALL, KM; LINCOLN, SE; LANDER, ES; HOUSMAN, DE				DRACOPOLI, NC; STANGER, BZ; ITO, CY; CALL, KM; LINCOLN, SE; LANDER, ES; HOUSMAN, DE			A GENETIC-LINKAGE MAP OF 27-LOCI FROM PND TO FY ON THE SHORT ARM OF HUMAN CHROMOSOME-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MIT,WHITEHEAD INST,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	DRACOPOLI, NC (corresponding author), MIT,CTR CANC RES,E17-536,77 MASSACHUSETTS AVE,CAMBRIDGE,MA 02139, USA.			Dracopoli, Nicholas/0000-0003-3962-4059	NCI NIH HHS [CA-40842, CA-44176, CA-08240] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA044176, R01CA040842, R23CA044176, F32CA008240] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BREAKEFIELD XO, 1984, P NATL ACAD SCI-BIOL, V81, P4213, DOI 10.1073/pnas.81.13.4213; DARBY JK, 1986, NUCLEIC ACIDS RES, V14, P9543, DOI 10.1093/nar/14.23.9543; DEAVEN LL, 1986, COLD SPRING HARB SYM, V51, P159, DOI 10.1101/SQB.1986.051.01.019; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRACOPOLI NC, 1987, CANCER RES, V47, P3995; DRACOPOLI NC, 1986, P NATL ACAD SCI USA, V83, P1822, DOI 10.1073/pnas.83.6.1822; DRACOPOLI NC, IN PRESS GENOMICS; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P9223, DOI 10.1093/nar/14.22.9223; GERHARD DS, 1987, NATURE, V325, P73, DOI 10.1038/325073a0; GREENE MH, 1983, P NATL ACAD SCI-BIOL, V80, P6071, DOI 10.1073/pnas.80.19.6071; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; MANIATIS T, 1982, MOL CLONING LABORATO; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NEMER M, 1986, NUCLEIC ACIDS RES, V14, P8696, DOI 10.1093/nar/14.21.8696; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OCONNELL P, 1988, CYTOGENET CELL GENET, V46, P672; POVEY S, 1985, CYTOGENET CELL GENET, V40, P67, DOI 10.1159/000132170; RAY K, 1988, NUCLEIC ACIDS RES, V16, P2361, DOI 10.1093/nar/16.5.2361; SHERMAN SL, 1984, ANN HUM GENET, V48, P243, DOI 10.1111/j.1469-1809.1984.tb01021.x; SHOWS TB, 1987, DIABETES, V36, P546, DOI 10.2337/diabetes.36.4.546; WEDD N, 1984, ANN HUM GENET, V48, P333, DOI 10.1111/j.1469-1809.1984.tb00847.x; WHITE R, 1986, COLD SPRING HARB SYM, V51, P29, DOI 10.1101/SQB.1986.051.01.005; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180	30	75	75	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					462	470						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902785				2022-12-18	WOS:A1988Q473600013
J	HARIHARA, S; SAITOU, N; HIRAI, M; GOJOBORI, T; PARK, KS; MISAWA, S; ELLEPOLA, SB; ISHIDA, T; OMOTO, K				HARIHARA, S; SAITOU, N; HIRAI, M; GOJOBORI, T; PARK, KS; MISAWA, S; ELLEPOLA, SB; ISHIDA, T; OMOTO, K			MITOCHONDRIAL-DNA POLYMORPHISM AMONG 5 ASIAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,BUNKYO KU,TOKYO 113,JAPAN; NATL INST GENET,MISHIMA,SHIZUOKA 411,JAPAN; UNIV PERPIGNAN,FAC MED,DEPT MED,F-66025 PERPIGNAN,FRANCE; KYOTO UNIV,PRIMATE RES INST,INUYAMA,AICHI,JAPAN	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Universite Perpignan Via Domitia; Kyoto University	HARIHARA, S (corresponding author), UNIV TSUKUBA,INST COMMUNITY MED,DEPT LEGAL MED,SAKURA,IBARAKI 305,JAPAN.		ISHIDA, TAKAFUMI/G-4924-2014					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], [No title captured]; BLANC H, 1983, AM J HUM GENET, V35, P167; BOTCHAN M, 1976, CELL, V9, P269, DOI 10.1016/0092-8674(76)90118-5; BREGA A, 1986, AM J HUM GENET, V39, P502; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; ELLEPOLA SB, 1986, CEYLON J MED SCI, V29, P1; HADLER HI, 1983, P NATL ACAD SCI-BIOL, V80, P6495, DOI 10.1073/pnas.80.21.6495; HARIHARA S, 1986, JPN J HUM GENET, V31, P73, DOI 10.1007/BF01871401; HORAI S, 1986, JPN J GENET, V61, P271, DOI 10.1266/jjg.61.271; HORAI S, 1981, TISSUE ANTIGENS, V17, P343; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; HUTCHINSON SA, 1974, NATURE, V251, P536; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KIRK RL, 1964, ACTA GENET STAT MED, V14, P41; MATSUMOTO H, 1979, AM J HUM GENET, V31, P70; MISAWA S, 1968, P JPN ACAD, V44, P83, DOI 10.2183/pjab1945.44.83; NEI M, 1983, GENETICS, V105, P207; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; OMOTO K, 1978, AM J HUM GENET, V30, P190; OMOTO K, 1984, Acta Anthropogenetica, V8, P137; OMOTO K, 1972, Human Biology in Oceania, V1, P278; OMOTO K, 1981, CURR ANTHROPOL, V22, P421, DOI 10.1086/202696; RIBGY PWJ, 1977, J MOL BIOL, V113, P237; SAITOU N, 1987, NATURE, V327, P288, DOI 10.1038/327288a0; SINGH G, 1987, NATURE, V329, P270, DOI 10.1038/329270a0; Sokal R, 1963, PRINCIPLES NUMERICAL; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202	34	75	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1988	43	2					134	143						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P6084	2840820				2022-12-18	WOS:A1988P608400005
J	WEIR, BS; HILL, WG				WEIR, BS; HILL, WG			NONUNIFORM RECOMBINATION WITHIN THE HUMAN BETA-GLOBIN GENE-CLUSTER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV EDINBURGH, DEPT GENET, EDINBURGH EH9 3JN, MIDLOTHIAN, SCOTLAND	University of Edinburgh	WEIR, BS (corresponding author), N CAROLINA STATE UNIV, DEPT STAT, BOX 8203, RALEIGH, NC 27695 USA.							CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HILL WG, 1977, THEOR POPUL BIOL, V11, P239, DOI 10.1016/0040-5809(77)90026-0; OHTA T, 1969, GENETICS, V63, P229; OHTA T, 1969, GENET RES, V13, P47, DOI 10.1017/S001667230000272X; SVED J A, 1971, Theoretical Population Biology, V2, P125; WEIR BS, 1980, GENETICS, V95, P477	8	75	75	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					776	778						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3013006				2022-12-18	WOS:A1986C973000018
J	MATTISON, DR; EVANS, MI; SCHWIMMER, WB; WHITE, BJ; JENSEN, B; SCHULMAN, JD				MATTISON, DR; EVANS, MI; SCHWIMMER, WB; WHITE, BJ; JENSEN, B; SCHULMAN, JD			FAMILIAL PREMATURE OVARIAN FAILURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NICHHD,PREGNANCY RES BRANCH,REPROD TOXICOL SECT,BETHESDA,MD 20205; NIH,WARREN G MAGNUSON CLIN CTR,MED GENET PROGRAM,BETHESDA,MD 20205; GEORGE WASHINGTON UNIV,DEPT OBSTET & GYNECOL,WASHINGTON,DC 20052; KAISER FDN HOSP BELLFLOWER,DEPT OBSTET & GYNECOL,BELLFLOWER,CA; NIADDKD,CELLULAR BIOL & GENET LAB,CYTOGENET SECT,BETHESDA,MD 20205; GEORGETOWN UNIV HOSP,DEPT PATHOL,WASHINGTON,DC 20007; FAIRFAX HOSP,DEPT OBSTET & GYNECOL,FALLS CHURCH,VA 22046	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; George Washington University; Georgetown University; Inova Fairfax Hospital			Mattison, Donald R/C-2015-2009; Mattison, Donald/L-4661-2013	Mattison, Donald/0000-0001-5623-0874				ASH P, 1980, BRIT J RADIOL, V53, P271, DOI 10.1259/0007-1285-53-628-271; BENGTSSON C, 1979, MATURITAS, V1, P159, DOI 10.1016/0378-5122(79)90003-3; CHAPMAN RM, 1983, REPROD TOXICOL, P149; CHEN YT, 1981, SCIENCE, V214, P1145, DOI 10.1126/science.7302587; COULAM CB, 1983, FERTIL STERIL, V40, P693; COULAM CB, 1983, SEMIN REPROD ENDOCR, V1, P161, DOI 10.1055/s-2007-1022586; DEMORAESRUEHSEN M, 1967, FERTIL STERIL, V18, P440; DEWALD GW, 1983, SEMIN REPROD ENDOCR, V1, P79, DOI 10.1055/s-2007-1022578; DOBERSEN MJ, 1979, LANCET, V2, P1078; EVANS MI, 1983, FAMILIAL PREMATURE O; FITCH N, 1982, AM J OBSTET GYNECOL, V142, P968, DOI 10.1016/0002-9378(82)90776-1; FROMMER DJ, 1964, BMJ-BRIT MED J, V2, P349, DOI 10.1136/bmj.2.5405.349; GOODMAN AL, 1977, ENDOCRINOLOGY, V100, P155, DOI 10.1210/endo-100-1-155; JASZMANN LJB, 1976, MANAGEMENT MENOPAUSE, P12; JONES EC, 1961, J ENDOCRINOL, V21, P469, DOI 10.1677/joe.0.0210469; JONES GS, 1969, AM J OBSTET GYNECOL, V104, P597, DOI 10.1016/S0002-9378(16)34255-7; KAUFMAN FR, 1981, NEW ENGL J MED, V304, P994, DOI 10.1056/NEJM198104233041702; KINCH RAH, 1965, AM J OBSTET GYNECOL, V91, P630; MACMAHON B, 1966, US VITAL HLTH STA 11, V19; MATTISON DR, 1982, ENVIRON RES, V28, P410, DOI 10.1016/0013-9351(82)90139-6; MATTISON DR, 1984, TARGET ORGAN TOXICIT; MAXSON WS, 1983, SEMIN REPROD ENDOCR, V1, P147, DOI 10.1055/s-2007-1022585; MCKINLAY S, 1972, J BIOSOC SCI, V4, P161, DOI 10.1017/S0021932000008464; McKusick V.A., 1983, MENDELIAN INHERITANC; MCNATTY KP, 1975, CLIN EXP IMMUNOL, V22, P378; MORRISON JC, 1975, FERTIL STERIL, V26, P655; REBAR RW, 1982, FERTIL STERIL, V37, P35; REBAR RW, 1983, SEMIN REPROD ENDOCR, V1, P169, DOI 10.1055/s-2007-1022587; REBAR RW, 1982, J REPROD MED, V27, P179; SCHWIMMER W, 1981, FAMILIAL PREMATURE M; SIMPSON JL, 1983, SEMIN REPROD ENDOCR, V1, P93, DOI 10.1055/s-2007-1022579; SMITH A, 1979, FERTIL STERIL, V32, P528; TAKIZAWA K, 1984, CANCER RES, V44, P2571; Tanner J. M., 1962, GROWTH ADOLESCENCE, V2nd; Tulandi T, 1981, Obstet Gynecol Surv, V36, P521, DOI 10.1097/00006254-198109000-00026; VERP MS, 1983, SEMIN REPROD ENDOCR, V1, P101, DOI 10.1055/s-2007-1022580; WALFISH PG, 1983, TISSUE ANTIGENS, V21, P168	37	75	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1341	1348						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517055				2022-12-18	WOS:A1984TZ59000015
J	KHOURY, MJ; ERICKSON, JD; JAMES, LM				KHOURY, MJ; ERICKSON, JD; JAMES, LM			ETIOLOGIC HETEROGENEITY OF NEURAL-TUBE DEFECTS .2. CLUES FROM FAMILY STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205	Johns Hopkins University	KHOURY, MJ (corresponding author), CTR DIS CONTROL,CTR ENVIRONM HLTH,DIV CHRON DIS,BIRTH DEFECTS BRANCH,ATLANTA,GA 30333, USA.							CARTER C O, 1968, Journal of Medical Genetics, V5, P81, DOI 10.1136/jmg.5.2.81; CARTER CO, 1973, J MED GENET, V10, P209, DOI 10.1136/jmg.10.3.209; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; DAVID TJ, 1975, J MED GENET, V12, P1, DOI 10.1136/jmg.12.1.1; EDMONDS LD, 1981, INT J EPIDEMIOL, V10, P247, DOI 10.1093/ije/10.3.247; ELWOOD JM, 1980, EPIDEMIOLOGY ANENCEP, P85; ELWOOD JM, 1980, EPIDEMIOLOGY ANENCEP, P225; EMBURY S, 1979, PROC R SOC SER B-BIO, V206, P85, DOI 10.1098/rspb.1979.0092; ERICKSON JD, 1976, ANN HUM GENET, V39, P315, DOI 10.1111/j.1469-1809.1976.tb00135.x; FRASER FC, 1980, LANCET, V2, P807; HARRIS H, 1977, N ENGL J MED, V25, P1399; HOLMES LB, 1976, NEW ENGL J MED, V294, P365, DOI 10.1056/NEJM197602122940704; JANERICH DT, 1978, J MED GENET, V15, P101, DOI 10.1136/jmg.15.2.101; KHOURY MJ, 1982, AM J EPIDEMIOL, V115, P538, DOI 10.1093/oxfordjournals.aje.a113335; MCBRIDE ML, 1979, AM J MED GENET, V3, P377, DOI 10.1002/ajmg.1320030409; NEVIN NC, 1980, J MED GENET, V17, P203, DOI 10.1136/jmg.17.3.203; SELLER MJ, 1979, PROC R SOC SER B-BIO, V206, P95, DOI 10.1098/rspb.1979.0093; YEN S, 1968, LANCET, V2, P623	18	75	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					980	987						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180852				2022-12-18	WOS:A1982PU21100016
J	WOOLF, CM; GIANAS, AD				WOOLF, CM; GIANAS, AD			CONGENITAL CLEFT-LIP AND FLUCTUATING DERMATOGLYPHIC ASYMMETRY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ARIZONA STATE UNIV,DEPT ZOOL,TEMPE,AZ 85281	Arizona State University; Arizona State University-Tempe								AASE JM, 1971, LANCET, V1, P432; ADAMS MS, 1967, GENET RES, V10, P313, DOI 10.1017/S0016672300011071; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CURTIS EJ, 1961, AM J DIS CHILD, V102, P853, DOI 10.1001/archpedi.1961.02080010855007; Fogh-Anderson P., 1942, INHERITANCE HARELIP; GORLIN RJ, 1964, SYNDROMES HEAD NECK; Lerner M., 1954, GENETIC HOMEOSTASIS; LUBS HA, 1961, LANCET, V2, P1001; NEEL JV, 1958, AM J HUM GENET, V10, P398; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244; Waddington C.H., 1957, STRATEGY GENES; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65; WOOLF CM, 1969, PLAST RECONSTR SURG, V44, P436, DOI 10.1097/00006534-196944050-00003; WOOLF CM, 1963, AM J HUM GENET, V15, P209	14	75	76	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					400	403						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BX345	941907				2022-12-18	WOS:A1976BX34500010
J	RAO, DC; MACLEAN, CJ; MORTON, NE; YEE, S				RAO, DC; MACLEAN, CJ; MORTON, NE; YEE, S			ANALYSIS OF FAMILY RESEMBLANCE .5. HEIGHT AND WEIGHT IN NORTHEASTERN BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,POPULATION GENET LAB,HONOLULU,HI 96822	University of Hawaii System								CAWLEY RH, 1954, AM J HUM GENET, V6, P448; ELSTON RC, IN PRESS; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Hastings C., 1955, APPROXIMATIONS DIGIT, DOI 10.1515/9781400875597; Hogben Lancelot, 1933, NATURE NURTURE; HOTELLING H, 1953, J R STAT SOC B, V15, P193; LEWONTIN RC, 1974, AM J HUM GENET, V26, P400; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; Mather K, 1971, BIOMETRICAL GENETICS; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1955, ANN HUM GENET, V20, P125; MORTON NE, 1974, AM J HUM GENET, V26, P318; RAO DC, 1974, AM J HUM GENET, V26, P331; SHREFFLER DC, 1959, J DAIRY SCI, V42, P607, DOI 10.3168/jds.S0022-0302(59)90626-5; TANNER JM, 1963, 2ND P INT C HUM GEN, V1, P460; VANDENBERG SG, 1962, GROWTH INCLUDING REP, P110; Woolf B., 1952, Quantitative inheritance. Papers read at a colloquium held at the Institute of Animal Genetics Edinburgh University under the auspices of the Agricultural Research Council April 4th to 6th, 1950., P81; Wright S, 1931, J AM STAT ASSOC, V26, P155	19	75	76	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	4					509	520						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM544	1155459				2022-12-18	WOS:A1975AM54400009
J	SILVESTRONI, E; BIANCO, I				SILVESTRONI, E; BIANCO, I			SCREENING FOR MICROCYTEMIA IN ITALY - ANALYSIS OF DATA COLLECTED IN PAST 30 YEARS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ROME, INST HYG, CTR MICROCYTEMIA, 00100 ROME, ITALY	Sapienza University Rome								BANK A, 1966, NATURE, V212, P1198, DOI 10.1038/2121198a0; BERTHIER J, 1948, CR SOC BIOL, V142, P417, DOI 10.1002/hlca.19480310218; BIANCO I, 1973, HUM HERED, V23, P454; BIANCO I, 1972, NOUV REV FR HEMATOL, V12, P191; BIANCO I, 1975, 5 C SULL MICR COS; BIANCO I, 1967, CLIN EUR           S, V6, P5; BRANCATI C, 1962, ATTI GIORNATE STUDIO, V1, P64; CARCASSI U, 1963, ASPETTI MEDICO SOCIA, P33; Dameshek W, 1943, AM J MED SCI, V205, P643, DOI 10.1097/00000441-194305000-00003; POLLI E, 1966, ATTI GIORNATE STUDIO, V1, P81; QUATTRIN N, 1963, ATTI GIORNATE STUDIO, P49; RADICI M, 1968, MICROCITEMIA ATTI GI, P522; SANSONE G, 1966, ATTI GIORNATE STUDIO, V1, P97; SCANDURA S, 1966, ATTI GIORNATE STUDIO, V1, P235; SILVESTRONI E., 1960, Nuovi Annali d'Igiene e Microbiologia, V11, P339; SILVESTRONI E, 1957, Prog Med (Napoli), V13, P409; SILVESTRONI E, 1952, Prog Med (Napoli), V8, P760; SILVESTRONI E, 1959, Nuovi Ann Ig Microbiol, V10, P335; SILVESTRONI E., 1959, Igiene e Sanita Pubblica, V15, P121; SILVESTRONI E., 1957, Igiene e Sanita Pubblica, V13, P3; SILVESTRONI E, 1947, Policlinico Prat, V54, P1147; SILVESTRONI E, 1949, Policlinico Prat, V56, P602; SILVESTRONI E, 1947, Policlinico Prat, V54, P1359; SILVESTRONI E, 1952, Prog Med (Napoli), V8, P757; SILVESTRONI E, 1948, Haematologica, V31, P135; SILVESTRONI E, 1948, B ATTI ACCAD MED ROM, V74, P28; SILVESTRONI E, 1967, CLIN EUR           S, V6, P10; SILVESTRONI E, 1945, B ACCAD MED ROMA, V71, P7; SILVESTRONI E, 1946, B ACCAD MED ROMA, V72, P49; SILVESTRONI E, 1953, RIV PED SICILIANA, V8, P421; SILVESTRONI E, 1947, MINERVA MED, V38, P587; SILVESTRONI E, 1943, BOLL ATTI ACCAD MED, V69, P293; SILVESTRONI E, 1962, ATTI GIORNATE STUDIO, V1, P51; SILVESTRONI E, 1946, B ACCAD MED ROMA, V72, P32; SILVESTRONI E, 1948, B ATTI ACCAD MED ROM, V74, P30; SILVESTRONI E, 1953, PROGR MED, V9, P713; SILVESTRONI E, 1962, ATTI GIORNATE STUDIO, V2, P5; SILVESTRONI E, 1949, POLICLINICO SEZ PRAT, V56, P906; SILVESTRONI E, 1953, ANN SANIT PUB, V8, P1439; SILVESTRONI E, 1961, 2 P INT C HUM GEN RO, V3, P1992; SILVESTRONI E, 1968, MICROCITEMIA ATTI GI, P139; SILVESTRONI E, 1959, CIOMS S ABNORMAL HAE, P242; SILVESTRONI E, 1968, 5 ATTT C INT IG M 2A, V1, P478; Silvestroni E, 1945, POLICLINICO PRAT, V51, P153; SINGER K, 1951, BLOOD, V6, P429, DOI 10.1182/blood.V6.5.429.429; Smith CH, 1943, AM J DIS CHILD, V65, P681; Valentine WN, 1944, ARCH INTERN MED, V74, P185, DOI 10.1001/archinte.1944.00210210032005; WASI P, 1964, NATURE, V204, P907, DOI 10.1038/204907a0; 1966, ATTI GIORNATE STUDIO; 1962, ATTI GIORNATE STUDIO; 1968, ATTI GIORNATE STUDIO; 1967, GAZZETTA UFFICIALE R, P3219; 1975, 5 C SULL MICR COS; 1963, ATTI GIORNATE STUDIO	54	75	89	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	2					198	212						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V9467	1124764				2022-12-18	WOS:A1975V946700006
J	COHEN, MM; SYBERT, V; LIN, CC; ORECCHIO, EJ				COHEN, MM; SYBERT, V; LIN, CC; ORECCHIO, EJ			2 HUMAN X-AUTOSOME TRANSLOCATIONS IDENTIFIED BY AUTORADIOGRAPHY AND FLUORESCENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLDERDICE PW, 1971, 4 P INT C HUM GEN PA; ATKINS L, 1965, ANN HUM GENET, V29, P89, DOI 10.1111/j.1469-1809.1965.tb00503.x; BUCKTON KE, 1971, ANN HUM GENET, V35, P171, DOI 10.1111/j.1469-1809.1956.tb01390.x; CASPERSSON T, 1970, EXP CELL RES, V62, P490, DOI 10.1016/0014-4827(70)90586-0; CATTANACH BM, 1970, GENET RES, V16, P293, DOI 10.1017/S001667230000255X; CATTANACH BM, 1961, Z VEREBUNGSL, V92, P165, DOI 10.1007/BF00890283; COHEN MM, 1971, P NATL ACAD SCI USA, V68, P544, DOI 10.1073/pnas.68.3.544; COHEN MM, 1964, J CELL BIOL, V23, P386, DOI 10.1083/jcb.23.2.386; COURTBROWN WM, 1967, HUMAN POPULATION CYT; ENGEL W, 1971, CYTOGENETICS, V10, P87, DOI 10.1159/000130131; GERALD PS, 1970, HUMAN POPULATION CYT; GERMAN J, 1969, TEX REP BIOL MED, V27, P409; GERMAN J, 1967, 3 P INT C HUM GEN, P123; GIANNELLI F, 1971, NATURE, V232, P315, DOI 10.1038/232315a0; GUSTAVSSON I, 1968, NATURE, V218, P183, DOI 10.1038/218183a0; HAMERTON JL, 1971, NATURE, V232, P312, DOI 10.1038/232312a0; HSU LYF, 1970, PEDIATRICS, V45, P656; HUGHJONES K, 1965, ARCH DIS CHILD, V40, P274, DOI 10.1136/adc.40.211.274; KISTENMACHER ML, 1970, AM J HUM GENET, V22, P304; LIE GW, 1964, CYTOGENETICS, V3, P427, DOI 10.1159/000129831; LIN CC, 1971, CAN J GENET CYTOL, V13, P361, DOI 10.1139/g71-055; LINDSTEN J, 1962, LANCET, V1, P593; LUBS HA, 1970, HUMAN POPULATION CYT; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; MANN JD, 1965, AM J HUM GENET, V17, P377; MILLER OJ, 1963, NATURE, V200, P918, DOI 10.1038/200918a0; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MUKERJEE D, 1966, NATURE, V212, P153, DOI 10.1038/212153a0; MULDAL S, 1963, LANCET, V1, P861; NEUHAUSER G, 1967, HUMANGENETIK, V3, P300; NOWELL PC, 1964, EXP CELL RES, V33, P445, DOI 10.1016/0014-4827(64)90008-4; OHNO S, 1965, CHROMOSOMA, V16, P90, DOI 10.1007/BF00320564; RATTAZZI MC, IN PRESS; ROWLEY J, 1964, P NATL ACAD SCI USA, V51, P779, DOI 10.1073/pnas.51.5.779; RUSSELL LB, 1964, T NEW YORK ACAD SCI, V26, P726, DOI 10.1111/j.2164-0947.1964.tb01939.x; RUSSELL LB, 1969, GENETICS, V63, P103; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; SHAW MW, 1965, GENETICS, V51, P181; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; TAFT PD, 1963, LANCET, V2, P1069; THELEN TH, 1971, AM J HUM GENET, V23, P410; THORBURN M J, 1967, Journal of Medical Genetics, V4, P283, DOI 10.1136/jmg.4.4.283; THORBURN M J, 1970, Journal of Medical Genetics, V7, P402, DOI 10.1136/jmg.7.4.402	44	75	75	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	5					583	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N4590	5054227				2022-12-18	WOS:A1972N459000009
J	AZEVEDO, E; MORTON, NE; MIKI, C; YEE, S				AZEVEDO, E; MORTON, NE; MIKI, C; YEE, S			DISTANCE AND KINSHIP IN NORTHEASTERN BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALSTROM CH, 1958, ACTA GENET BASEL, V8, P295; CAVALLISFORZA LL, 1966, GENETICS, V54, P37; CAVALLISFORZA LL, 1962, USE VITAL HEALTH STA; COCKERHAM CC, 1967, GENETICS, V56, P89; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; CROW JF, 1955, EVOLUTION, V9, P202, DOI 10.2307/2405589; CROW JF, 1967, 3 P INT C HUM GEN ED, P249; Darwin G., 1875, J STAT SOC, V38, P153; FALCONER DS, 1964, QUANTITATIVE GENETIC; FREIREMAIA N, 1968, EUGEN QUART, V15, P22, DOI 10.1080/19485565.1968.9987749; FROTAPESSOA O, 1963, THESIS U SAO PAULO; HAJNAL J, 1963, PROC R SOC SER B-BIO, V159, P125, DOI 10.1098/rspb.1963.0071; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; KEMPTHORNE O, 1957, INTRODUCTION GENETIC; KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x; KRIEGER H, 1966, THESIS U HAWAII; Lasker GW, 1954, SOUTHWEST J ANTHROP, V10, P353, DOI 10.1086/soutjanth.10.4.3628832; LECAM L, 1967, 5 P BERK S MATH S ED, V4, P317; LUUMAUTHANH, 1962, DEPLACEMENTS HUMAINS; MALECOT G, 1967, 36 SESS INT STAT I S; Malecot G, 1948, MATH HEREDITE; MALECOT G, 1967, 5 P BERK S MATH STAT, V4, P317; MENCKEN HL, 1936, AMERICAN LANGUAGE; MORTON NE, 1968, AM J PHYS ANTHROPOL, V28, P191, DOI 10.1002/ajpa.1330280216; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; MORTON NE, 1968, AM J HUM GENET, V20, P411; MORTON NE, 1966, AM J HUM GENET, V18, P153; MORTON NE, 1968, AM J HUM GENET, V20, P420; MORTON NE, 1955, ANN HUM GENET, V20, P116; MORTON NE, 1967, GENETICS INTERRACIAL; MORTON NE, 1962, DEPLACEMENTS HUMAINS; MORTON NEWTON E., 1967, CIENC CULT [SAO PAULO], V19, P14; Moser GM., 1960, NAMES, V8, P30; PAP L, 1949, PORTUGUESEAMERICAN S; SPUHLER JN, 1961, 10 PAC SCIENC C HON; SUTTER J, 1962, DEPLACEMENTS HUMA ED; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1921, GENETICS, V6, P111; Wright S, 1943, GENETICS, V28, P114; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; YASUDA N, 1968, AM J HUM GENET, V20, P1; YASUDA N, 1966, THESIS U HAWAII; YASUDA N, 1967, 3RD P INT C HUM GEN, P249	44	75	75	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	1					1	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D0848	5763605				2022-12-18	WOS:A1969D084800001
J	MORTON, NE				MORTON, NE			EMPIRICAL RISKS IN CONSANGUINEOUS MARRIAGES - BIRTH WEIGHT, GESTATION TIME, AND MEASUREMENTS OF INFANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Crow J. F., 1952, Heterosis., P282; DAHLBERG G, 1948, MATH METHODS POPULAT; DICKERSON GE, 1954, 551 U MISS RES B; East Edward M., 1919, INBREEDING OUTBREEDI; Hogben Lancelot, 1933, NATURE NURTURE; IKUCHI K, 1927, JIKAZASSHI, V329, P50; MORTON NE, 1955, ANN HUM GENET, V20, P125; NEEL JV, 1949, AM J HUM GENET, V1, P156; NEEL JV, 1956, 461 NAT AC SCI NAT R; Schull WJ, 1953, AM ANTHROPOL, V55, P74, DOI 10.1525/aa.1953.55.1.02a00060; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; TAKAHASHI K, 1938, SANKA TO FUJINKA, V6, P617; TYLER WJ, 1949, J DAIRY SCI, V32, P247, DOI 10.3168/jds.S0022-0302(49)92035-4; Wright S, 1921, GENETICS, V6, P124; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414	16	75	75	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	3					344	349						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA220	13571222				2022-12-18	WOS:A1958WA22000006
J	STEINBERG, AG; WILDER, RM				STEINBERG, AG; WILDER, RM			A STUDY OF THE GENETICS OF DIABETES MELLITUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allan W, 1933, ANN INTERN MED, V6, P1272, DOI 10.7326/0003-4819-6-10-1272; BARNS HHF, 1948, J OBSTET GYN BRIT EM, V55, P449; Bell J, 1940, ANN EUGENIC, V10, P370; BERKSON J, 1947, P AM DIABETES ASSOC, V7, P131; BURNSTEIN N, 1949, South Med J, V42, P119, DOI 10.1097/00007611-194902000-00008; Cammidge PJ, 1928, BMJ-BRIT MED J, V1928, P738, DOI 10.1136/bmj.2.3538.738; Cammidge PJ, 1934, LANCET, V1, P393; DAHLBERG G, 1927, ARCH RASSEN GESELLSC, V19, P129; DAHLBERG G, 1947, ACTA MED SCAND S, V188; HANHART E, 1950, ARCH KLAUS STIFT VER, V25, P586; HARRIS H, 1950, ANN EUGENIC, V15, P95; HARRIS H, 1949, ANN EUGENIC, V14, P293; Joslin Elliott P., 1946, TREATMENT DIABETES M; LEVIT SG, 1934, P MAXIM GORKY MED BI, V3, P132; MILLER HC, 1946, J PEDIATR, V29, P455, DOI 10.1016/S0022-3476(46)80164-1; PENROSE LS, 1945, P AM DIABETES ASSOC, V5, P163; Pincus G, 1933, AM J MED SCI, V186, P1; Pipkin AC, 1942, J HERED, V33, P419, DOI 10.1093/oxfordjournals.jhered.a105109; STEINBERG AG, 1950, P STAFF M MAYO CLIN, V25, P625; STEINBERG AG, 1952, ANN INTERN MED, V36, P1285, DOI 10.7326/0003-4819-36-5-1285; Wilder RM, 1940, ARCH INTERN MED, V65, P390, DOI 10.1001/archinte.1940.00190080172011; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	22	75	75	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1952	4	2					113	135						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS397	14943712				2022-12-18	WOS:A1952XS39700005
J	Mighell, TL; Evans-Dutson, S; O'Roak, BJ				Mighell, Taylor L.; Evans-Dutson, Sara; O'Roak, Brian J.			A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDERS; TUMOR-SUPPRESSOR; COWDEN-DISEASE; GERMLINE MUTATIONS; FUNCTIONAL ASSAYS; PROTEIN; ACID; INDIVIDUALS; VARIANTS; GENES	Phosphatase and tensin homolog (PTEN) is a tumor suppressor frequently mutated in diverse cancers. Germline PTEN mutations are also associated with a range of clinical outcomes, including PTEN hamartoma tumor syndrome (PHTS) and autism spectrum disorder (ASD). To empower new insights into PTEN function and clinically relevant genotype-phenotype relationships, we systematically evaluated the effect of PTEN mutations on lipid phosphatase activity in vivo. Using a massively parallel approach that leverages an artificial humanized yeast model, we derived high-confidence estimates of functional impact for 7,244 single amino acid PTEN variants (86% of possible). We identified 2,273 mutations with reduced cellular lipid phosphatase activity, which includes 1,789 missense mutations. These data recapitulated known functional findings but also uncovered new insights into PTEN protein structure, biochemistry, and mutation tolerance. Several residues in the catalytic pocket showed surprising mutational tolerance. We identified that the solvent exposure of wild-type residues is a critical determinant of mutational tolerance. Further, we created a comprehensive functional map by leveraging correlations between amino acid substitutions to impute functional scores for all variants, including those not present in the assay. Variant functional scores can reliably discriminate likely pathogenic from benign alleles. Further, 32% of ClinVar unclassified missense variants are phosphatase deficient in our assay, supporting their reclassification. ASD-associated mutations generally had less severe fitness scores relative to PHTS-associated mutations (p = 7.16 x 10(-5)) and a higher fraction of hypomorphic mutations, arguing for continued genotype-phenotype studies in larger clinical datasets that can further leverage these rich functional data.	[Mighell, Taylor L.] Oregon Hlth & Sci Univ, Neurosci Grad Program, Portland, OR 97239 USA; [Mighell, Taylor L.; Evans-Dutson, Sara; O'Roak, Brian J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	O'Roak, BJ (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.	oroak@ohsu.edu			Martha Atherton and the Atherton Foundation; NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation through the NARSAD-Atherton Foundation [22935]; Sloan Research Fellowship in Neurosciences (Alfred P. Sloan Foundation) [FG-2015-65608]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [T32DK007680]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD095571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER	Martha Atherton and the Atherton Foundation; NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation through the NARSAD-Atherton Foundation(NARSAD); Sloan Research Fellowship in Neurosciences (Alfred P. Sloan Foundation); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Pulido for providing yeast expression constructs and YPH-499 yeast strain and Y. Zhang for providing E. coli strain used for generating the SLiCE reagent. We thank Y. Jia and the Oregon National Primate Research Center Molecular & Cell Biology Core for technical assistance. We thank A.C. Adey, E. Fombonne, D.M. Fowler, A.F. Rubin, J. Mester, J. Weile, J. Savage, U. Shinde, J. Zonana, G. Mandel, P.J. Stork, and K.M. Wright for helpful discussions. We thank Martha Atherton and the Atherton Foundation for their support of the NARSAD awards. This work was supported by a NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation through the NARSAD-Atherton Foundation Young Investigator Award (22935 to B.J.O.), a Sloan Research Fellowship in Neurosciences (Alfred P. Sloan Foundation, FG-2015-65608 to B.J.O.), and internal funds (B.J.O.). T.L.M received support through a training grant supported by National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number T32DK007680. T.L.M. is an ARCS scholar (Achievement Rewards for College Scientists Foundation, Inc., Oregon Chapter) and B.J.O. is a Klingenstein-Simons Fellow (Esther A. & Joseph Klingenstein Fund, Simons Foundation).	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Brenan L, 2016, CELL REP, V17, P1171, DOI 10.1016/j.celrep.2016.09.061; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chen ZH, 2014, CELL REP, V8, P2003, DOI 10.1016/j.celrep.2014.08.008; Chia JYC, 2010, BBA-PROTEINS PROTEOM, V1804, P1785, DOI 10.1016/j.bbapap.2010.05.009; Cid VJ, 2008, ONCOGENE, V27, P5431, DOI 10.1038/onc.2008.240; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Feliciano P, 2018, NEURON, V97, P488, DOI 10.1016/j.neuron.2018.01.015; Fernandez-Acero T, 2012, J BIOMOL SCREEN, V17, P1018, DOI 10.1177/1087057112450051; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fricano-Kugler CJ, 2018, BIOL PSYCHIAT, V84, P265, DOI 10.1016/j.biopsych.2017.11.025; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gil A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119287; Gray VE, 2018, CELL SYST, V6, P116, DOI 10.1016/j.cels.2017.11.003; Gray VE, 2017, GENETICS, V207, P53, DOI 10.1534/genetics.117.300064; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Johnston SB, 2015, BIOCHEMISTRY-US, V54, P1576, DOI 10.1021/acs.biochem.5b00028; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kitzman JO, 2015, NAT METHODS, V12, P203, DOI [10.1038/NMETH.3223, 10.1038/nmeth.3223]; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leslie NR, 2016, SEMIN CELL DEV BIOL, V52, P30, DOI 10.1016/j.semcdb.2016.01.030; Liang H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14771; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Majithia AR, 2016, NAT GENET, V48, P1570, DOI 10.1038/ng.3700; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Matreyek KA, 2018, BIORXIV, DOI [10. 1101/211011, DOI 10.1101/211011]; McBride KL, 2010, AUTISM RES, V3, P137, DOI 10.1002/aur.132; Melamed D, 2013, RNA, V19, P1537, DOI 10.1261/rna.040709.113; Melnikov A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku511; Mester JL, 2011, EUR J HUM GENET, V19, P763, DOI 10.1038/ejhg.2011.20; Morris C.A., 1993, GENEREVIEWS; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Oliver M. D., 2017, BIOSCIENCE REP, V37, P37; PADBERG GW, 1991, ANN NEUROL, V29, P517, DOI 10.1002/ana.410290511; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Redfern RE, 2010, PROTEIN SCI, V19, P1948, DOI 10.1002/pro.483; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rodri I., 2007, CANCER RES, V67, P9731; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Rodriguez-Escudero I, 2009, J BIOL CHEM, V284, P13373, DOI 10.1074/jbc.M807867200; Rubin AF, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1272-5; Shendure J, 2016, GENETICS, V203, P617, DOI 10.1534/genetics.115.180562; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Spinelli L, 2015, J MED GENET, V52, P128, DOI 10.1136/jmedgenet-2014-102803; Starita LM, 2017, AM J HUM GENET, V101, P315, DOI 10.1016/j.ajhg.2017.07.014; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Sun S, 2016, GENOME RES, V26, P670, DOI 10.1101/gr.192526.115; Tan MH, 2012, CLIN CANCER RES, V18, P400, DOI 10.1158/1078-0432.CCR-11-2283; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vogt D, 2015, CELL REP, V11, P944, DOI 10.1016/j.celrep.2015.04.019; Wei Y., 2014, J BIOL CHEM, V290, P1592; Weile J, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177908; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xiao Y, 2007, CELL SIGNAL, V19, P1434, DOI 10.1016/j.cellsig.2007.01.021; Yang M, 2017, ONCOGENE, V36, P3673, DOI 10.1038/onc.2016.493; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang YW, 2014, METHODS MOL BIOL, V1116, P235, DOI 10.1007/978-1-62703-764-8_16; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	79	74	74	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					943	955		10.1016/j.ajhg.2018.03.018	http://dx.doi.org/10.1016/j.ajhg.2018.03.018			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29706350	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000432440100016
J	Dannemann, M; Kelso, J				Dannemann, Michael; Kelso, Janet			The Contribution of Neanderthals to Phenotypic Variation in Modern Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							1 RECEPTOR MC1R; HUMAN PIGMENTATION; RED HAIR; FAIR SKIN; INTROGRESSION; ADAPTATION; GENE; ASSOCIATION; ADMIXTURE; VARIANTS	Assessing the genetic contribution of Neanderthals to non-disease phenotypes in modern humans has been difficult because of the absence of large cohorts for which common phenotype information is available. Using baseline phenotypes collected for 112,000 individuals by the UK Biobank, we can now elaborate on previous findings that identified associations between signatures of positive selection on Neanderthal DNA and various modern human traits but not any specific phenotypic consequences. Here, we show that Neanderthal DNA affects skin tone and hair color, height, sleeping patterns, mood, and smoking status in present-day Europeans. Interestingly, multiple Neanderthal alleles at different loci contribute to skin and hair color in present-day Europeans, and these Neanderthal alleles contribute to both lighter and darker skin tones and hair color, suggesting that Neanderthals themselves were most likely variable in these traits.	[Dannemann, Michael; Kelso, Janet] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany	Max Planck Society	Kelso, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	kelso@eva.mpg.de	Kelso, Janet/N-1812-2019	Kelso, Janet/0000-0002-3618-322X	Max Planck Society	Max Planck Society(Max Planck Society)	This research was conducted with the UK Biobank Resource. We thank Aida Andres, Hernan Burbano, Roger Mundry, Svante Paabo, Martin Petr, Kay Prufer, David Reich, Sriram Sankararaman, Joshua Schmidt, and Benjamin Vernot for useful discussions and the multimedia department of the Max Planck Institute for Evolutionary Anthropology for help with figure preparation. Financial support for this study was provided by the Max Planck Society.	Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Dannemann M, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1181-7; Dannemann M, 2016, AM J HUM GENET, V98, P22, DOI 10.1016/j.ajhg.2015.11.015; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Harris K, 2016, GENETICS, V203, P881, DOI 10.1534/genetics.116.186890; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Jacobs LC, 2013, HUM GENET, V132, P147, DOI 10.1007/s00439-012-1232-9; Juric I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006340; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lane JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10889; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Sams AJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1098-6; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Simonti CN, 2016, SCIENCE, V351, P737, DOI 10.1126/science.aad2149; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457	38	74	75	3	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					578	589		10.1016/j.ajhg.2017.09.010	http://dx.doi.org/10.1016/j.ajhg.2017.09.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28985494	Green Published, hybrid			2022-12-18	WOS:000412277300008
J	Manousaki, D; Dudding, T; Haworth, S; Hsu, YH; Liu, CT; Medina-Gomez, C; Voortman, T; van der Velde, N; Melhus, H; Robinson-Cohen, C; Cousminer, DL; Nethander, M; Vandenput, L; Noordam, R; Forgetta, V; Greenwood, CMT; Biggs, ML; Psaty, BM; Rotter, JI; Zemel, BS; Mitchell, JA; Taylor, B; Lorentzon, M; Karlsson, M; Jaddoe, VVW; Tiemeier, H; Campos-Obando, N; Franco, OH; Utterlinden, AG; Broer, L; van Schoor, NM; Ham, AC; Ikram, MA; Karasik, D; de Mutsert, R; Rosendaal, FR; den Heijer, M; Wang, TJ; Lind, L; Orwoll, ES; Mook-Kanamori, DO; Michaelsson, K; Kestenbaum, B; Ohlsson, C; Mellstrom, D; de Groot, LCPGM; Grant, SFA; Kiel, DP; Zillikens, MC; Rivadeneira, F; Sawcer, S; Timpson, NJ; Richards, JB				Manousaki, Despoina; Dudding, Tom; Haworth, Simon; Hsu, Yi-Hsiang; Liu, Ching-Ti; Medina-Gomez, Carolina; Voortman, Trudy; van der Velde, Nathalie; Melhus, Hakan; Robinson-Cohen, Cassianne; Cousminer, Diana L.; Nethander, Maria; Vandenput, Liesbeth; Noordam, Raymond; Forgetta, Vincenzo; Greenwood, Celia M. T.; Biggs, Mary L.; Psaty, Bruce M.; Rotter, Jerome I.; Zemel, Babette S.; Mitchell, Jonathan A.; Taylor, Bruce; Lorentzon, Mattias; Karlsson, Magnus; Jaddoe, Vincent V. W.; Tiemeier, Henning; Campos-Obando, Natalia; Franco, Oscar H.; Utterlinden, Andre G.; Broer, Linda; van Schoor, Natasja M.; Ham, Annelies C.; Ikram, M. Arfan; Karasik, David; de Mutsert, Renee; Rosendaal, Frits R.; den Heijer, Martin; Wang, Thomas J.; Lind, Lars; Orwoll, Eric S.; Mook-Kanamori, Dennis O.; Michaelsson, Karl; Kestenbaum, Bryan; Ohlsson, Claes; Mellstrom, Dan K; de Groot, Lisette C. P. G. M.; Grant, Struan F. A.; Kiel, Douglas P.; Zillikens, M. Carola; Rivadeneira, Fernando; Sawcer, Stephen; Timpson, Nicholas J.; Richards, J. Brent			Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SEQUENCING DATA; REFERENCE PANEL; RARE VARIANTS; PLASMA-LEVELS; IMPUTATION; DISCOVERY; FRAMEWORK; ALLELES	Vitamin D insufficiency is common, correctable, and influenced by genetic factors, and it has been associated with risk of several diseases. We sought to identify low-frequency genetic variants that strongly increase the risk of vitamin D insufficiency and tested their effect on risk of multiple sclerosis, a disease influenced by low vitamin D concentrations. We used whole-genome sequencing data from 2,619 individuals through the UK10K program and deep-imputation data from 39,655 individuals genotyped genome-wide. Meta-analysis of the summary statistics from 19 cohorts identified in CYP2R1 the low-frequency (minor allele frequency = 2.5%) synonymous coding variant g.14900931G>A (p.Asp120Asp) (rs117913124[A]), which conferred a large effect on 25-hydroxyvitamin D (25OHD) levels (-0.43 SD of standardized natural log-transformed 25OHD per A allele; p value = 1.5 x 10(-88)). The effect on 25OHD was four times larger and independent of the effect of a previously described common variant near CYP2R1. By analyzing 8,711 individuals, we showed that heterozygote carriers of this low-frequency variant have an increased risk of vitamin D insufficiency (odds ratio [OR] = 2.2, 95% confidence interval [CI] = 1.78-2.78, p = 1.26 3 10 x(-12)). Individuals carrying one copy of this variant also had increased odds of multiple sclerosis (OR = 1.4, 95% CI = 1.19-1.64, p = 2.63 3 10 x(-5)) in a sample of 5,927 case and 5,599 control subjects. In conclusion, we describe a low-frequency CYP2R1 coding variant that exerts the largest effect upon 25OHD levels identified to date in the general European population and implicates vitamin D in the etiology of multiple sclerosis.	[Manousaki, Despoina; Forgetta, Vincenzo; Greenwood, Celia M. T.; Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Manousaki, Despoina; Forgetta, Vincenzo; Greenwood, Celia M. T.; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Dudding, Tom; Haworth, Simon; Timpson, Nicholas J.] Univ Bristol, Med Res Council, Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Hsu, Yi-Hsiang; Karasik, David; Kiel, Douglas P.] Hebrew SeniorLife, Inst Aging Res, Boston, MA 02131 USA; [Hsu, Yi-Hsiang; Kiel, Douglas P.] Harvard Med Sch, Boston, MA 02115 USA; [Hsu, Yi-Hsiang; Kiel, Douglas P.] Broad Inst MIT & Harvard, Boston, MA 02142 USA; [Liu, Ching-Ti] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Medina-Gomez, Carolina; van der Velde, Nathalie; Campos-Obando, Natalia; Utterlinden, Andre G.; Broer, Linda; Ham, Annelies C.; Zillikens, M. Carola; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Medina-Gomez, Carolina; Voortman, Trudy; Jaddoe, Vincent V. W.; Tiemeier, Henning; Utterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Generat R Study Grp, NL-3015 GE Rotterdam, Netherlands; [Medina-Gomez, Carolina; Voortman, Trudy; Jaddoe, Vincent V. W.; Tiemeier, Henning; Franco, Oscar H.; Utterlinden, Andre G.; Ikram, M. Arfan; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [van der Velde, Nathalie] Acad Med Ctr, Dept Internal Med, Sect Geriatr, NL-1105 AZ Amsterdam, Netherlands; [Melhus, Hakan; Lind, Lars] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Robinson-Cohen, Cassianne; Kestenbaum, Bryan] Univ Washington, Div Nephrol, Kidney Res Inst, Seattle, WA 98195 USA; [Cousminer, Diana L.; Grant, Struan F. A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Cousminer, Diana L.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Nethander, Maria; Vandenput, Liesbeth; Lorentzon, Mattias; Ohlsson, Claes; Mellstrom, Dan K] Univ Gothenburg, Sahlgrenska Acad, Inst Med,Ctr Bone & Arthrit, Dept Internal Med & Clin Nutr, S-40530 Gothenburg, Sweden; [Nethander, Maria] Univ Gothenburg, Sahlgrenska Acad, Bioinformat Core Facil, S-41390 Gothenburg, Sweden; [Noordam, Raymond] Leiden Univ, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, NL-2333 ZA Leiden, Netherlands; [Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Oncol, Montreal, PQ H4A 3T2, Canada; [Biggs, Mary L.] Univ Washington, Dept Med & Biostat, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Med Epidemiol & Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Unit, Seattle, WA 98101 USA; [Rotter, Jerome I.] Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Zemel, Babette S.; Mitchell, Jonathan A.; Grant, Struan F. A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Zemel, Babette S.; Mitchell, Jonathan A.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Taylor, Bruce] Univ Tasmania, Menzies Inst Med Res, Locked Bag 23, Hobart, Tas 7000, Australia; [Lorentzon, Mattias; Mellstrom, Dan K] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Geriatr Med, S-43180 Molndal, Sweden; [Lorentzon, Mattias] Sahlgrens Univ Hosp, Geriatr Med, S-43180 Molndal, Sweden; [Karlsson, Magnus] Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, S-22241 Malmo, Sweden; [Karlsson, Magnus] Skane Univ Hosp, Dept Orthopaed, S-22241 Malmo, Sweden; [Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat Psychol, NL-3015 GE Rotterdam, Netherlands; [van Schoor, Natasja M.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands; [van Schoor, Natasja M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 HV Amsterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Radiol & Nucl Med, NL-3015 GE Rotterdam, Netherlands; [de Mutsert, Renee; Rosendaal, Frits R.; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands; [den Heijer, Martin] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, NL-1081 HV Amsterdam, Netherlands; [Wang, Thomas J.] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37232 USA; [Orwoll, Eric S.] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97239 USA; [Orwoll, Eric S.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2333 ZA Leiden, Netherlands; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, S-75105 Uppsala, Sweden; [de Groot, Lisette C. P. G. M.] Wageningen Univ, Div Human Nutr, NL-6708 WE Wageningen, Netherlands; [Grant, Struan F. A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Kiel, Douglas P.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Sawcer, Stephen] Univ Cambridge, Dept Clin Neurosci, Box 165,Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0QQ, England; [Richards, J. Brent] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Richards, J. Brent] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	McGill University; Lady Davis Institute; McGill University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Uppsala University; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Gothenburg; University of Gothenburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; McGill University; McGill University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Tasmania; Menzies Institute for Medical Research; University of Gothenburg; Sahlgrenska University Hospital; Lund University; Lund University; Skane University Hospital; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Vanderbilt University; Oregon Health & Science University; Oregon Health & Science University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Uppsala University; Wageningen University & Research; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Beth Israel Deaconess Medical Center; University of Cambridge; University of London; King's College London; McGill University	Richards, JB (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada.; Richards, JB (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Richards, JB (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.; Richards, JB (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada.	brent.richards@mcgill.ca	Attrill, Lauren/V-1688-2018; Michaelsson, Karl/AAM-9094-2021; Rivadeneira, Fernando/O-5385-2015; Zemel, Babette S./D-1117-2009; Timpson, Nicholas John/O-7548-2015; Medina-Gomez, Carolina/I-1725-2019; Richards, J Brent/AAF-4225-2019; Ikram, M. Arfan/AAM-5225-2021; Robinson-Cohen, Cassianne/ABB-4985-2021; Rotter, Jerome/AAY-6598-2021; Lorentzon, Mattias/W-7878-2019; Tiemeier, Henning/H-6534-2019; Ohlsson, Claes/AGP-3544-2022; Vandenput, Liesbeth/AAP-3655-2020; Vandenput, Liesbeth/AAI-4100-2021; Fox, Laura J/C-6249-2016; Haworth, Simon/AAR-7586-2020; Voortman, Trudy/C-2963-2015; Rosendaal, Frits/Q-3842-2017; Franco, Óscar H/ABE-2305-2020; den Heijer, Martin/J-8036-2015	Rivadeneira, Fernando/0000-0001-9435-9441; Zemel, Babette S./0000-0002-6164-7348; Timpson, Nicholas John/0000-0002-7141-9189; Medina-Gomez, Carolina/0000-0001-7999-5538; Richards, J Brent/0000-0002-3746-9086; Lorentzon, Mattias/0000-0003-0749-1431; Tiemeier, Henning/0000-0002-4395-1397; Ohlsson, Claes/0000-0002-9633-2805; Vandenput, Liesbeth/0000-0002-1712-6131; Vandenput, Liesbeth/0000-0002-1712-6131; Haworth, Simon/0000-0001-7793-7326; Voortman, Trudy/0000-0003-2830-6813; Rosendaal, Frits/0000-0003-2558-7496; Franco, Óscar H/0000-0002-4606-4929; Dudding, Tom/0000-0003-3756-040X; Liu, Ching-Ti/0000-0002-0703-0742; de Groot, Lisette/0000-0003-2778-2789; Wang, Thomas/0000-0003-4063-6508; den Heijer, Martin/0000-0003-3620-5617; Greenwood, Celia/0000-0002-2427-5696; Mitchell, Jonathan/0000-0003-3765-2419; van der Velde, Nathalie/0000-0002-6477-6209; Grant, Struan/0000-0003-2025-5302; Robinson-Cohen, Cassianne/0000-0003-4783-7046; Nethander, Maria/0000-0003-3688-906X; van Schoor, Natasja/0000-0002-0870-0795; Broer, Linda/0000-0003-0011-123X; Michaelsson, Karl/0000-0003-2815-1217; Noordam, Raymond/0000-0001-7801-809X	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002369, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130114, R01HL105756] Funding Source: NIH RePORTER; MRC [G0701603, MC_UU_12013/3] Funding Source: UKRI; Cancer Research UK [19169] Funding Source: researchfish; Medical Research Council [MC_UU_12013/3, G0701603] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016220, NNF14OC0010513, NNF13OC0004839, NNF13OC0005785, NNF14OC0009883] Funding Source: researchfish	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)		Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; [Anonymous], 2017, EPITOOLS EPIDEMIOLOG; Barresi C, 2011, J INVEST DERMATOL, V131, P188, DOI 10.1038/jid.2010.231; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; CASELLA SJ, 1994, J PEDIATR-US, V124, P929, DOI 10.1016/S0022-3476(05)83184-1; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Livshits G, 1999, ANN HUM GENET, V63, P429, DOI 10.1046/j.1469-1809.1999.6350429.x; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Team, 2022, R LANG ENV STAT COMP; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; SUCHI M, 1995, GENOMICS, V29, P98, DOI 10.1006/geno.1995.1219; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; The Australia and New Zealand Multiple Sclerosis Genetics Consortium, 2009, Nature Genetics, V41, P824, DOI 10.1038/ng.396; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878	36	74	76	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					227	238		10.1016/j.ajhg.2017.06.014	http://dx.doi.org/10.1016/j.ajhg.2017.06.014			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28757204	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000406854800007
J	Shah, S; Bonder, MJ; Marioni, RE; Zhu, ZH; McRae, AF; Zhernakova, A; Harris, SE; Liewald, D; Henders, AK; Mendelson, MM; Liu, CY; Joehanes, R; Liang, LM; Levy, D; Martin, NG; Starr, JM; Wijmenga, C; Wray, NR; Yang, J; Montgomery, GW; Franke, L; Deary, IJ; Visscher, PM				Shah, Sonia; Bonder, Marc J.; Marioni, Riccardo E.; Zhu, Zhihong; McRae, Allan F.; Zhernakova, Alexandra; Harris, Sarah E.; Liewald, Dave; Henders, Anjali K.; Mendelson, Michael M.; Liu, Chunyu; Joehanes, Roby; Liang, Liming; Levy, Daniel; Martin, Nicholas G.; Starr, John M.; Wijmenga, Cisca; Wray, Naomi R.; Yang, Jian; Montgomery, Grant W.; Franke, Lude; Deary, Ian J.; Visscher, Peter M.		BIOS Consortium	Improving Phenotypic Prediction by Combining Genetic and Epigenetic Associations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; DNA METHYLATION; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; GENOTYPE IMPUTATION; WIDE ASSOCIATION; GENOME; OBESITY; HEIGHT; POPULATION	We tested whether DNA-methylation profiles account for inter-individual variation in body mass index (BMI) and height and whether they predict these phenotypes over and above genetic factors. Genetic predictors were derived from published summary results from the largest genome-wide association studies on BMI (n similar to 350,000) and height (n similar to 250,000) to date. We derived methylation predictors by estimating probe-trait effects in discovery samples and tested them in external samples. Methylation profiles associated with BMI in older individuals from the Lothian Birth Cohorts (LBCs, n = 1,366) explained 4.9% of the variation in BMI in Dutch adults from the Life Lines DEEP study (n = 750) but did not account for any BMI variation in adolescents from the Brisbane Systems Genetic Study (BSGS, n = 403). Methylation profiles based on the Dutch sample explained 4.9% and 3.6% of the variation in BMI in the LBCs and BSGS, respectively. Methylation profiles predicted BMI independently of genetic profiles in an additive manner: 7%, 8%, and 140/0 of variance of BMI in the LBCs were explained by the methylation predictor, the genetic predictor, and a model containing both, respectively. The corresponding percentages for Life Lines DEEP were 5%, 9%, and 13%, respectively, suggesting that the methylation profiles represent environmental effects. The differential effects of the BM! methylation profiles by age support previous observations of age modulation of genetic contributions. In contrast, methylation profiles accounted for almost no variation in height, consistent with a mainly genetic contribution to inter-individual variation. The BMI results suggest that combining genetic and epigenetic information might have greater utility for complex-trait prediction.	[Shah, Sonia; Marioni, Riccardo E.; Zhu, Zhihong; McRae, Allan F.; Wray, Naomi R.; Yang, Jian; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Shah, Sonia; McRae, Allan F.; Visscher, Peter M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4072, Australia; [Bonder, Marc J.; Zhernakova, Alexandra; Wijmenga, Cisca; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Marioni, Riccardo E.; Harris, Sarah E.; Liewald, Dave; Starr, John M.; Deary, Ian J.; Visscher, Peter M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Marioni, Riccardo E.; Harris, Sarah E.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Henders, Anjali K.; Martin, Nicholas G.; Montgomery, Grant W.] Berghofer Med Res Inst, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Mendelson, Michael M.] Framingham Heart Dis Epidemiol Study, Boston, MA 01702 USA; [Mendelson, Michael M.] Boston Univ, Sch Med, Boston, MA 01702 USA; [Mendelson, Michael M.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Mendelson, Michael M.; Levy, Daniel] NHLBI, Populat Studies Branch, NIH, Bethesda, MD 20892 USA; [Liu, Chunyu] Boston Univ, Dept Biostat, Boston, MA 02118 USA; [Joehanes, Roby] Harvard Univ, Sch Med, Hebrew Senior Life, Boston, MA 02131 USA; [Liang, Liming] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Starr, John M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Queensland; University of Queensland; University of Groningen; University of Edinburgh; University of Edinburgh; QIMR Berghofer Medical Research Institute; Framingham Heart Study; Boston University; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Harvard Medical School; Hebrew SeniorLife; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Edinburgh	Visscher, PM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	peter.visscher@uq.edu.au	Mendelson, Michael/I-2874-2014; Yang, Jian/A-5852-2010; Slagboom, P. Eline/R-4790-2016; Levy, Daniel/ABB-2752-2021; Kiełbasa, Szymon/G-1636-2018; Wray, Naomi/C-8639-2015; Wijmenga, Cisca/AAE-7719-2019; Pool, René/AFO-8147-2022; Suchiman, H. Eka D./F-5024-2017; Beekman, Marian/L-3004-2019; Montgomery, Grant W/B-7148-2008; Shah, Sonia/N-7547-2013; Pool, René/B-3652-2009; Deary, Ian J/C-6297-2009; Franke, Lude/P-7036-2016; McRae, Allan F/J-2644-2014; Levy, Daniel/ABF-6873-2021; Zhu, Zhihong/F-8720-2015; Visscher, Peter/ABB-6151-2020; Zhernakova, Alexandra/ABA-9372-2020; Deelen, Patrick/B-3566-2013; Henders, Anjali/E-3126-2017	Mendelson, Michael/0000-0001-7590-3958; Yang, Jian/0000-0003-2001-2474; Slagboom, P. Eline/0000-0002-2875-4723; Kiełbasa, Szymon/0000-0003-2805-6535; Wray, Naomi/0000-0001-7421-3357; Wijmenga, Cisca/0000-0002-5635-1614; Pool, René/0000-0001-5579-0933; Suchiman, H. Eka D./0000-0002-7168-5516; Beekman, Marian/0000-0003-0585-6206; Montgomery, Grant W/0000-0002-4140-8139; Shah, Sonia/0000-0001-5860-4526; Pool, René/0000-0001-5579-0933; Deary, Ian J/0000-0002-1733-263X; Franke, Lude/0000-0002-5159-8802; McRae, Allan F/0000-0001-5286-5485; Levy, Daniel/0000-0003-1843-8724; Zhu, Zhihong/0000-0002-6783-3037; Visscher, Peter/0000-0002-2143-8760; Deelen, Patrick/0000-0002-5654-3966; Marioni, Riccardo/0000-0003-4430-4260; van Dongen, Jenny/0000-0003-2063-8741; Zhernakova, Alexandra/0000-0002-4574-0841; Henders, Anjali/0000-0003-3672-1451; Bonder, Marc Jan/0000-0002-8431-3180; Van Duijn, Cornelia/0000-0002-2374-9204; van Meurs, Joyce/0000-0001-6245-2123; Veldink, Jan/0000-0001-5572-9657	BBSRC [BB/F019394/1] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: Medline; Medical Research Council [MR/K026992/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Delano D., 2010, ARRAY DIFFERENCES GE; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dixon JB, 2006, OBES SURG, V16, P251, DOI 10.1381/096089206776116453; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huynh JL, 2014, NAT NEUROSCI, V17, P121, DOI 10.1038/nn.3588; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Ong ML, 2014, AGING CELL, V13, P142, DOI 10.1111/acel.12159; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Shah S, 2014, GENOME RES, V24, P1725, DOI 10.1101/gr.176933.114; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tigchelaar E. F., 2014, INTRO LIFELINES DEEP; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zaitlen N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003032	43	74	75	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					75	85		10.1016/j.ajhg.2015.05.014	http://dx.doi.org/10.1016/j.ajhg.2015.05.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26119815	Green Published, hybrid			2022-12-18	WOS:000358189500007
J	Wang, CL; Zhan, XW; Liang, LM; Abecasis, GR; Lin, XH				Wang, Chaolong; Zhan, Xiaowei; Liang, Liming; Abecasis, Goncalo R.; Lin, Xihong			Improved Ancestry Estimation for both Genotyping and Sequencing Data using Projection Procrustes Analysis and Genotype Imputation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; RARE VARIANTS; POPULATION STRATIFICATION; LOCI; SUSCEPTIBILITY; DISEASES; FARMERS; EUROPE	Accurate estimation of individual ancestry is important in genetic association studies, especially when a large number of samples are collected from multiple sources. However, existing approaches developed for genome-wide SNP data do not work well with modest amounts of genetic data, such as in targeted sequencing or exome chip genotyping experiments. We propose a statistical framework to estimate individual ancestry in a principal component ancestry map generated by a reference set of individuals. This framework extends and improves upon our previous method for estimating ancestry using low-coverage sequence reads (LASER 1.0) to analyze either genotyping or sequencing data. In particular, we introduce a projection Procrustes analysis approach that uses high-dimensional principal components to estimate ancestry in a low-dimensional reference space. Using extensive simulations and empirical data examples, we show that our new method (LASER 2.0), combined with genotype imputation on the reference individuals, can substantially outperform LASER 1.0 in estimating fine-scale genetic ancestry. Specifically, LASER 2.0 can accurately estimate fine-scale ancestry within Europe using either exome chip genotypes or targeted sequencing data with off-target coverage as low as 0.05x. Under the framework of LASER 2.0, we can estimate individual ancestry in a shared reference space for samples assayed at different loci or by different techniques. Therefore, our ancestry estimation method will accelerate discovery in disease association studies not only by helping model ancestry within individual studies but also by facilitating combined analysis of genetic data from multiple sources.	[Wang, Chaolong] Genome Inst Singapore, Dept Computat & Syst Biol, Singapore 138672, Singapore; [Zhan, Xiaowei] UT Southwestern Med Ctr, Quantitat Biomed Res Ctr, Dept Clin Sci, Ctr Genet Host Def, Dallas, TX 75235 USA; [Liang, Liming; Lin, Xihong] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, CL (corresponding author), Genome Inst Singapore, Dept Computat & Syst Biol, Singapore 138672, Singapore.	wangcl@gis.a-star.edu.sg		Wang, Chaolong/0000-0003-3945-1012	NIH [P01 CA134294, R01 CA092824, P42 ES016454]; NATIONAL CANCER INSTITUTE [R01CA092824, R35CA197449, P01CA134294] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES016454, P30ES000002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank Dr. Noah Rosenberg and two anonymous reviewers for their valuable comments, which substantially improved this manuscript, and Dr. Jun Li for using the unpublished HGDP exome chip data. This work is supported by grants from the NIH (P01 CA134294, R01 CA092824, and P42 ES016454).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Fumagalli M, 2013, GENETICS, V195, P979, DOI 10.1534/genetics.113.154740; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Gower J. C., 2004, PROCRUSTES PROBLEMS; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Lee S, 2010, ANN STAT, V38, P3605, DOI 10.1214/10-AOS821; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Malaspinas AS, 2014, BIOINFORMATICS, V30, P2962, DOI 10.1093/bioinformatics/btu410; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; SCHONEMANN PH, 1970, PSYCHOMETRIKA, V35, P245, DOI 10.1007/BF02291266; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Wang CL, 2014, NAT GENET, V46, P409, DOI 10.1038/ng.2924; Wang CL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002886; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758	39	74	74	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					926	937		10.1016/j.ajhg.2015.04.018	http://dx.doi.org/10.1016/j.ajhg.2015.04.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26027497	Green Published, Bronze			2022-12-18	WOS:000355931200006
J	Simons, C; Griffin, LB; Helman, G; Golas, G; Pizzino, A; Bloom, M; Murphy, JLP; Crawford, J; Evans, SH; Topper, S; Whitehead, MT; Schreiber, JM; Chapman, KA; Tifft, C; Lu, KB; Gamper, H; Shigematsu, M; Taft, RJ; Antonellis, A; Hou, YM; Vanderver, A				Simons, Cas; Griffin, Laurie B.; Helman, Guy; Golas, Gretchen; Pizzino, Amy; Bloom, Miriam; Murphy, Jennifer L. P.; Crawford, Joanna; Evans, Sarah H.; Topper, Scott; Whitehead, Matthew T.; Schreiber, John M.; Chapman, Kimberly A.; Tifft, Cyndi; Lu, Katrina B.; Gamper, Howard; Shigematsu, Megumi; Taft, Ryan J.; Antonellis, Anthony; Hou, Ya-Ming; Vanderver, Adeline			Loss-of-Function Alanyl-tRNA Synthetase Mutations Cause an Autosomal-Recessive Early-Onset Epileptic Encephalopathy with Persistent Myelination Defect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL-CORD INVOLVEMENT; MARIE-TOOTH DISEASE; BRAIN-STEM; CAUSE HYPOMYELINATION; HOMOZYGOUS MUTATION; PERRAULT SYNDROME; HEARING-LOSS; LEUKOENCEPHALOPATHY; IDENTIFICATION; AMINOACYLATION	Mutations in genes encoding aminoacyl-tRNA synthetases are known to cause leukodystrophies and genetic leukoencephalopathies-heritable disorders that result in white matter abnormalities in the central nervous system. Here we report three individuals (two siblings and an unrelated individual) with severe infantile epileptic encephalopathy, clubfoot, absent deep tendon reflexes, extrapyramidal symptoms, and persistently deficient myelination on MRI. Analysis by whole exome sequencing identified mutations in the nuclear-encoded alanyl-tRNA synthetase (AARS) in these two unrelated families: the two affected siblings are compound heterozygous for p.Lys81Thr and p.Arg751Gly AARS, and the single affected child is homozygous for p.Arg751Gly AARS. The two identified mutations were found to result in a significant reduction in function. Mutations in AARS were previously associated with an autosomal-dominant inherited form of axonal neuropathy, Charcot-Marie-Tooth disease type 2N (CMT2N). The autosomal-recessive AARS mutations identified in the individuals described here, however, cause a severe infantile epileptic encephalopathy with a central myelin defect and peripheral neuropathy, demonstrating that defects of alanyl-tRNA charging can result in a wide spectrum of disease manifestations.	[Simons, Cas; Crawford, Joanna; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Griffin, Laurie B.; Antonellis, Anthony] Univ Michigan, Cellular & Mol Biol Program, Sch Med, Ann Arbor, MI 48109 USA; [Griffin, Laurie B.; Vanderver, Adeline] Univ Michigan, Sch Med, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Helman, Guy; Pizzino, Amy; Murphy, Jennifer L. P.; Schreiber, John M.] Childrens Natl Hlth Syst, Dept Neurol, Washington, DC 20010 USA; [Golas, Gretchen] NHGRI, Undiagnosed Dis Program, NIH, Bethesda, MD 20894 USA; [Bloom, Miriam] Childrens Natl Hlth Syst, Dept Hospitalist Med, Washington, DC 20010 USA; [Evans, Sarah H.] Childrens Natl Hlth Syst, Dept Phys Med & Rehabil, Washington, DC 20010 USA; [Topper, Scott] Invitae, San Francisco, CA 94107 USA; [Whitehead, Matthew T.] Childrens Natl Hlth Syst, Dept Neuroradiol, Washington, DC 20010 USA; [Chapman, Kimberly A.] Childrens Natl Hlth Syst, Dept Genet, Washington, DC 20010 USA; [Chapman, Kimberly A.; Vanderver, Adeline] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC 20010 USA; [Lu, Katrina B.; Gamper, Howard; Shigematsu, Megumi; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Taft, Ryan J.] Illumina Inc, San Diego, CA 92122 USA; [Taft, Ryan J.; Vanderver, Adeline] George Washington Univ, Dept Integrated Syst Biol, Washington, DC 20052 USA; [Taft, Ryan J.; Vanderver, Adeline] George Washington Univ, Dept Pediat, Washington, DC 20052 USA; [Antonellis, Anthony] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA; [Antonellis, Anthony] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI 48109 USA	University of Queensland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; Children's National Health System; Children's National Health System; Children's National Health System; Children's National Health System; Jefferson University; Illumina; George Washington University; George Washington University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Vanderver, A (corresponding author), Univ Michigan, Sch Med, Med Scientist Training Program, Ann Arbor, MI 48109 USA.	avanderv@childrensnational.org	Griffin, Laurie/ABE-4525-2021; Vanderver, Adeline/CAG-5072-2022; Crawford, Joanna/F-9135-2013; Helman, Guy T/C-7935-2017; Simons, Cas/A-7905-2011	Crawford, Joanna/0000-0003-0786-6889; Helman, Guy T/0000-0002-4784-7423; Simons, Cas/0000-0003-3147-8042; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; Hou, Ya-Ming/0000-0001-6546-2597; Schreiber, John/0000-0003-0615-2497	Myelin Disorders Bioregistry Project; Delman Fund for Pediatric Neurology Education; NIH National Center for Advancing Translational Sciences [UL1TR000075]; National Institute of General Medical Sciences [GM110184]; NIH Cellular and Molecular Biology Training Grant [T32 GM007315]; Tolz Foundation for Research; Keystone Innovation Network; NIH Medical Scientist Training Grant [T32 GM007863]; NIH [F30 NS092238]; Australian Research Council; National Health and Medical Research Council, Australia [APP1068278]; University of Queensland Foundation Research Excellence Award; NIH Undiagnosed Diseases Program [LD_0115.0A, LD_0115.0B]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007315, R21GM110184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS092238] Funding Source: NIH RePORTER	Myelin Disorders Bioregistry Project; Delman Fund for Pediatric Neurology Education; NIH National Center for Advancing Translational Sciences; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Cellular and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tolz Foundation for Research; Keystone Innovation Network; NIH Medical Scientist Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Foundation Research Excellence Award(University of Queensland); NIH Undiagnosed Diseases Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals described in this manuscript and their families. The participation of G.H. and A.V. was supported by the Myelin Disorders Bioregistry Project. G.H. is also supported by the Delman Fund for Pediatric Neurology Education. This publication was supported by Award Number UL1TR000075 from the NIH National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the NIH. This work was also supported by the National Institute of General Medical Sciences (GM110184 to A. A.), the NIH Cellular and Molecular Biology Training Grant (T32 GM007315 to L.B.G.), the Tolz Foundation for Research and the Keystone Innovation Network award (to Y.M.H.), the NIH Medical Scientist Training Grant (T32 GM007863 to L.B.G.), and other NIH grants (F30 NS092238 to L.B.G.). The NIH Undiagnosed Diseases Program evaluated LD_0115.0A and LD_0115.0B. We thank the QCMG and IMB sequencing facility teams for their assistance with this project. Computational support was provided by the NeCTAR Genomics Virtual Laboratory and QRIScloud programs. R.J.T. was supported by an Australian Research Council Discovery Early Career Research Award. This work was supported by National Health and Medical Research Council, Australia Grant (APP1068278), and a University of Queensland Foundation Research Excellence Award. We also thank Marjo van der Knaap for her manuscript revision.	Almalki A, 2014, BBA-MOL BASIS DIS, V1842, P56, DOI 10.1016/j.bbadis.2013.10.008; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cleary JG, 2014, J COMPUT BIOL, V21, P405, DOI 10.1089/cmb.2014.0029; Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36; Naganuma M, 2014, NATURE, V510, P507, DOI 10.1038/nature13440; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Vanderver A., 2015, MOL GENET METAB; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Yamashita S, 2013, BRAIN DEV-JPN, V35, P312, DOI 10.1016/j.braindev.2012.05.007; Yao P, 2014, TOP CURR CHEM, V344, P167, DOI 10.1007/128_2013_422; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003	25	74	78	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					675	681		10.1016/j.ajhg.2015.02.012	http://dx.doi.org/10.1016/j.ajhg.2015.02.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25817015	Green Published, Bronze			2022-12-18	WOS:000352212600015
J	Grozeva, D; Carss, K; Spasic-Boskovic, O; Parker, MJ; Archer, H; Firth, HV; Park, SM; Canham, N; Holder, SE; Wilson, M; Hackett, A; Field, M; Floyd, JAB; Hurles, M; Raymond, FL				Grozeva, Detelina; Carss, Keren; Spasic-Boskovic, Olivera; Parker, Michael J.; Archer, Hayley; Firth, Helen V.; Park, Soo-Mi; Canham, Natalie; Holder, Susan E.; Wilson, Meredith; Hackett, Anna; Field, Michael; Floyd, James A. B.; Hurles, Matthew; Raymond, F. Lucy		UK10K Consortium	De Novo Loss-of-Function Mutations in SETD5, Encoding a Methyltransferase in a 3p25 Microdeletion Syndrome Critical Region, Cause Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KABUKI SYNDROME; DELETION SYNDROME; PATIENT; SPECTRUM; FEATURES; GENES; MLL2; HAPLOINSUFFICIENCY; 3P25.3-P26.1; DISEASE	To identify further Mendelian causes of intellectual disability (ID), we screened a cohort of 996 individuals with ID for variants in 565 known or candidate genes by using a targeted next-generation sequencing approach. Seven loss-of-function (LoF) mutations-four nonsense (c.1195A>T [p. Lys399*], c.1333C>T [p.Arg445*], c.1866C>G [p.Tyr622*], and c.3001C>T [p.Arg1001*]) and three frameshift (c.2177_2178del [p.Thr726Asnfs*39], c.3771dup [p.Ser1258Glufs*65], and c.3856del [p.Ser1286Leufs*84])-were identified in SETD5, a gene predicted to encode a methyltransferase. All mutations were compatible with de novo dominant inheritance. The affected individuals had moderate to severe ID with additional variable features of brachycephaly; a prominent high forehead with synophrys or striking full and broad eyebrows; a long, thin, and tubular nose; long, narrow upslanting palpebral fissures; and large, fleshy low-set ears. Skeletal anomalies, including significant leg-length discrepancy, were a frequent finding in two individuals. Congenital heart defects, inguinal hernia, or hypospadias were also reported. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, were prominent features. SETD5 lies within the critical interval for 3p25 microdeletion syndrome. The individuals with SETD5 mutations showed phenotypic similarity to those previously reported with a deletion in 3p25, and thus loss of SETD5 might be sufficient to account for many of the clinical features observed in this condition. Our findings add to the growing evidence that mutations in genes encoding methyltransferases regulating histone modification are important causes of ID. This analysis provides sufficient evidence that rare de novo LoF mutations in SETD5 are a relatively frequent (0.7%) cause of ID.	[Grozeva, Detelina; Spasic-Boskovic, Olivera; Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Carss, Keren; Floyd, James A. B.; Hurles, Matthew; UK10K Consortium] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Parker, Michael J.] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Archer, Hayley] Univ Hosp Wales, Inst Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Firth, Helen V.; Park, Soo-Mi] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Treatment Ctr, Cambridge CB2 0QQ, England; [Canham, Natalie; Holder, Susan E.] North West London Hosp NHS Trust, Kennedy Galton Ctr, North West Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Wilson, Meredith] Childrens Hosp Westmead, Dept Clin Genet, Westmead, NSW 2145, Australia; [Hackett, Anna] Hunter Genet, Genet Learning Disabil Serv, Waratah, NSW 2298, Australia; [Field, Michael] Royal N Shore Hosp, Dept Med Genet, St Leonards, NSW 2298, Australia; [Floyd, James A. B.] Queen Mary Univ London, John Vane Sci Ctr, Genome Ctr, London EC1M 6BQ, England	University of Cambridge; Wellcome Trust Sanger Institute; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Cardiff University; University of Cambridge; University of Sydney; Royal North Shore Hospital; University of London; Queen Mary University London	Raymond, FL (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England.	flr24@cam.ac.uk		Carss, Keren/0000-0003-4939-156X; Grozeva, Detelina/0000-0003-3239-8415; Kelly, Kirsten/0000-0003-4234-543X	Wellcome Trust [WT091310]; Action Medical Research; Birth Defect Foundation; Cambridge National Institute for Health Research Biomedical Research Centre; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; Birth Defect Foundation; Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We are indebted to all individuals who participated in the study. This study made use of data generated by the UK10K Project. Funding for the UK10K Project was provided by the Wellcome Trust under award WT091310. A full list of consortium members can be found at the UK10K Project website. This study was supported by grants from Action Medical Research, the Birth Defect Foundation, and the Cambridge National Institute for Health Research Biomedical Research Centre.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Berdasco M, 2013, HUM GENET, V132, P359, DOI 10.1007/s00439-013-1271-x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gunnarsson C, 2010, AM J MED GENET A, V152A, P3110, DOI 10.1002/ajmg.a.33353; Hannibal MC, 2011, AM J MED GENET A, V155A, P1511, DOI 10.1002/ajmg.a.34074; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kellogg G, 2013, AM J MED GENET A, V161A, P1405, DOI 10.1002/ajmg.a.35876; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nagase T, 2000, DNA RES, V7, P347, DOI 10.1093/dnares/7.6.347; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Peltekova IT, 2012, AM J MED GENET A, V158A, P2583, DOI 10.1002/ajmg.a.35559; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Riess A, 2012, AM J MED GENET A, V158A, P2587, DOI 10.1002/ajmg.a.35562; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shuib S, 2009, AM J MED GENET A, V149A, P2099, DOI 10.1002/ajmg.a.32824; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	29	74	77	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					618	624		10.1016/j.ajhg.2014.03.006	http://dx.doi.org/10.1016/j.ajhg.2014.03.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24680889	Green Published, hybrid			2022-12-18	WOS:000333765300012
J	Ko, WY; Rajan, P; Gomez, F; Scheinfeldt, L; An, P; Winkler, CA; Froment, A; Nyambo, TB; Omar, SA; Wambebe, C; Ranciaro, A; Hirbo, JB; Tishkoff, SA				Ko, Wen-Ya; Rajan, Prianka; Gomez, Felicia; Scheinfeldt, Laura; An, Ping; Winkler, Cheryl A.; Froment, Alain; Nyambo, Thomas B.; Omar, Sabah A.; Wambebe, Charles; Ranciaro, Alessia; Hirbo, Jibril B.; Tishkoff, Sarah A.			Identifying Darwinian Selection Acting on Different Human APOL1 Variants among Diverse African Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIV-ASSOCIATED NEPHROPATHY; CHRONIC KIDNEY-DISEASE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; STAGE RENAL-DISEASE; HAPLOTYPE RECONSTRUCTION; GENOMEWIDE ASSOCIATION; TRYPANOLYTIC FACTOR; POSITIVE SELECTION; UNITED-STATES; GENOTYPE DATA	Disease susceptibility can arise as a consequence of adaptation to infectious disease. Recent findings have suggested that higher rates of chronic kidney disease (CKD) in individuals with recent African ancestry might be attributed to two risk alleles (G1 and G2) at the serum-resistance-associated (SRA)-interacting-domain-encoding region of APOL1. These two alleles appear to have arisen adaptively, possibly as a result of their protective effects against human African trypanosomiasis (HAT), or African sleeping sickness. In order to explore the distribution of potential functional variation at APOL1, we studied nucleotide variation in 187 individuals across ten geographically and genetically diverse African ethnic groups with exposure to two Trypanosoma brucei subspecies that cause HAT. We observed unusually high levels of nonsynonymous polymorphism in the regions encoding the functional domains that are required for lysing parasites. Whereas allele frequencies of G2 were similar across all populations (3%-8%), the G1 allele was only common in the Yoruba (39%). Additionally, we identified a haplo type (termed G3) that contains a nonsynonymous change at the membrane-addressing-domain-encoding region of APOL1 and is present in all populations except for the Yoruba. Analyses of long-range patterns of linkage disequilibrium indicate evidence of recent selection acting on the G3 haplotype in Fulani from Cameroon. Our results indicate that the G1 and G2 variants in APOL1 are geographically restricted and that there might be other functional variants that could play a role in HAT resistance and CKD risk in African populations.	[Ko, Wen-Ya; Rajan, Prianka; Gomez, Felicia; Scheinfeldt, Laura; Ranciaro, Alessia; Hirbo, Jibril B.; Tishkoff, Sarah A.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Ko, Wen-Ya] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, P-4485661 Vairao, Portugal; [Gomez, Felicia] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [An, Ping; Winkler, Cheryl A.] NCI, Basic Res Lab, Ctr Canc Res, Frederick Natl Lab,Sci Applicat Int Corp, Frederick, MD 21702 USA; [Froment, Alain] Musee Homme Paris, Unite Mixte Rech 208, Inst Rech Dev, Museum Natl Hist Nat, F-75116 Paris, France; [Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Omar, Sabah A.] Kenya Govt Med Res Ctr, Ctr Biotechnol Res & Dev, Nairobi 5484000200, Kenya; [Wambebe, Charles] Int Biomed Res Africa, Kampala, Uganda; [Tishkoff, Sarah A.] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Universidade do Porto; George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Muhimbili University of Health & Allied Sciences; Kenya Medical Research Institute; University of Pennsylvania	Tishkoff, SA (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	tishkoff@mail.med.upenn.edu		Hirbo, Jibril/0000-0002-8932-7311; Scheinfeldt, Laura/0000-0001-6529-6701; An, Ping/0000-0002-5322-3510	National Science Foundation [BCS-0196183, BCS-0827436]; National Institutes of Health (NIH) [5-R01-GM076637-05, 8DP1ES022577-04]; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Laboratory for Cancer Research, NIH; Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Joseph Lachance and two anonymous reviewers for their valuable comments on the manuscript. We are grateful to Char la Lambert for her assistance with the analyses of extended haplotype homozygosity and integrated haplotype scores. We thank Bill Beggs for his technical assistance. This research was funded by National Science Foundation grants BCS-0196183 and BCS-0827436 and National Institutes of Health (NIH) grants 5-R01-GM076637-05 and 8DP1ES022577-04 to S.A.T. This project was funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. This research was supported (in part) by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research.	Akashi H, 1999, GENETICS, V151, P221; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; [Anonymous], J STAT SOFTW; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Behar DM, 2011, AM J NEPHROL, V34, P452, DOI 10.1159/000332378; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Cagliani R, 2013, MOL BIOL EVOL, V30, P1077, DOI 10.1093/molbev/mst020; Cambien F, 2011, CLIN CHEM, V57, P1263, DOI 10.1373/clinchem.2010.155655; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Fernandez M, 2007, ARTHRIT RHEUM-ARTHR, V57, P576, DOI 10.1002/art.22672; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; GILLES HM, 1967, LANCET, V1, P138; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Haldane J. B., 1990, CAUSES EVOLUTION; Haldane J. B. S., 1949, P 8 INT C GEN, P267; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hartl D., 2007, PRINCIPLES POPULATIO; Hartl D. L., 1997, PRINCIPLES POPULATIO; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HUDSON RR, 2001, HDB STAT GENETICS, P309; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Juran BD, 2011, SEMIN LIVER DIS, V31, P215, DOI 10.1055/s-0031-1276641; Kiberd BA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014251.87778.01; Kieft R, 2010, P NATL ACAD SCI USA, V107, P16137, DOI 10.1073/pnas.1007074107; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Ko WY, 2012, RAPIDLY EVOLVING GENES AND GENETIC SYSTEMS, P223; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kopp JB, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.63.s83.39.x; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lundkvist GB, 2004, PHYSIOLOGY, V19, P198, DOI 10.1152/physiol.00006.2004; LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Tareen N, 2005, KIDNEY INT, V68, pS137, DOI 10.1111/j.1523-1755.2005.09723.x; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Toto RD, 2004, KIDNEY INT, V66, pS102, DOI 10.1111/j.1523-1755.2004.09224.x; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; United State Renal Data System USRD, 2011, ANN DAT REP ATL CHRO; Vanhollebeke B, 2010, MOL MICROBIOL, V76, P806, DOI 10.1111/j.1365-2958.2010.07156.x; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wasser WG, 2012, J NEPHROL, V25, P603, DOI 10.5301/jn.5000179; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wheeler RJ, 2010, TRENDS PARASITOL, V26, P457, DOI 10.1016/j.pt.2010.05.005; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; World Health Organization, 2000, WHO REP GLOB SURV EP	60	74	76	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					54	66		10.1016/j.ajhg.2013.05.014	http://dx.doi.org/10.1016/j.ajhg.2013.05.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23768513	Bronze, Green Published			2022-12-18	WOS:000321804500005
J	Raj, T; Kuchroo, M; Replogle, JM; Raychaudhuri, S; Stranger, BE; De Jager, PL				Raj, Towfique; Kuchroo, Manik; Replogle, Joseph M.; Raychaudhuri, Soumya; Stranger, Barbara E.; De Jager, Philip L.			Common Risk Alleles for Inflammatory Diseases Are Targets of Recent Positive Selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HOST-DEFENSE; POPULATION DIFFERENTIATION; NATURAL-SELECTION; TH17 CELLS; PATHOGENESIS; METAANALYSIS; NETWORK; LOCI; REPLICATION	Genome-wide association studies (GWASs) have identified hundreds of loci harboring genetic variation influencing inflammatory-disease susceptibility in humans. It has been hypothesized that present day inflammatory diseases may have arisen, in part, due to pleiotropic effects of host resistance to pathogens over the course of human history, with significant selective pressures acting to increase host resistance to pathogens. The extent to which genetic factors underlying inflammatory-disease susceptibility has been influenced by selective processes can now be quantified more comprehensively than previously possible. To understand the evolutionary forces that have shaped inflammatory-disease susceptibility and to elucidate functional pathways affected by selection, we performed a systems-based analysis to integrate (1) published GWASs for inflammatory diseases, (2) a genome-wide scan for signatures of positive selection in a population of European ancestry, (3) functional genomics data comprised of protein-protein interaction networks, and (4) a genome-wide expression quantitative trait locus (eQTL) mapping study in peripheral blood mononuclear cells (PBMCs). We demonstrate that loci for inflammatory-disease susceptibility are enriched for genomic signatures of recent positive natural selection, with selected loci forming a highly interconnected protein-protein interaction network. Further, we identify 21 loci for inflammatory-disease susceptibility that display signatures of recent positive selection, of which 13 also show evidence of cis-regulatory effects on genes within the associated locus. Thus, our integrated analyses highlight a set of susceptibility loci that might subserve a shared molecular function and has experienced selective pressure over the course of human history; today, these loci play a key role in influencing susceptibility to multiple different inflammatory diseases, in part through alterations of gene expression in immune cells.	[Raj, Towfique; Kuchroo, Manik; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Raj, Towfique; Replogle, Joseph M.; Raychaudhuri, Soumya; Stranger, Barbara E.; De Jager, Philip L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Raj, Towfique; Raychaudhuri, Soumya; Stranger, Barbara E.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Raj, Towfique; Kuchroo, Manik; Replogle, Joseph M.; Raychaudhuri, Soumya; Stranger, Barbara E.; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy,Dept Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Stranger, Barbara E.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Chicago	Stranger, BE (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA.	bstranger@medicine.bsd.uchicago.edu; pdejager@rics.bwh.harvard.edu	Raj, Towfique/ABD-7620-2021	Replogle, Joseph/0000-0003-1832-919X; Kuchroo, Manik/0000-0001-7512-9739; Raychaudhuri, Soumya/0000-0002-1901-8265; Stranger, Barbara/0000-0001-9021-7331	National Institutes of Health (NIH) [RC2 GM093080, R01 NS067305, F32 AG043267]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG043267] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Christophe Benoist for his leadership on RC2 GM093080. We thank Michelle Lee for sample collection and Katherine Rothamel for data generation. The authors are grateful to Vijay Kuchroo, Eli Stahl, and Chris Cotsapas for comments on a previous version of the manuscript. This work is supported by the National Institutes of Health (NIH) (RC2 GM093080, R01 NS067305, and F32 AG043267). P.L.D. is a Harry Weaver Neuroscience Scholar of the National Multiple Sclerosis Society (JF2138A1).	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Casto AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001266; Cooke Anne, 2006, Review of Diabetic Studies, V3, P72, DOI 10.1900/RDS.2006.3.72; Corona E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012236; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Derbise A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001528; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Fumagalli M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000849; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Mueller JC, 2004, BIOINFORMATICS, V20, P786, DOI 10.1093/bioinformatics/btg481; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qutob N, 2012, IMMUNOGENETICS, V64, P165, DOI 10.1007/s00251-011-0576-y; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	60	74	76	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					517	529		10.1016/j.ajhg.2013.03.001	http://dx.doi.org/10.1016/j.ajhg.2013.03.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23522783	Green Published, Bronze			2022-12-18	WOS:000317449700004
J	Diogo, D; Kurreeman, F; Stahl, EA; Liao, KP; Gupta, N; Greenberg, JD; Rivas, MA; Hickey, B; Flannick, J; Thomson, B; Guiducci, C; Ripke, S; Adzhubey, I; Barton, A; Kremer, JM; Alfredsson, L; Sunyaev, S; Martin, J; Zhernakova, A; Bowes, J; Eyre, S; Siminovitch, KA; Gregersen, PK; Worthington, J; Klareskog, L; Padyukov, L; Raychaudhuri, S; Plenge, RM				Diogo, Dorothee; Kurreeman, Fina; Stahl, Eli A.; Liao, Katherine P.; Gupta, Namrata; Greenberg, Jeffrey D.; Rivas, Manuel A.; Hickey, Brendan; Flannick, Jason; Thomson, Brian; Guiducci, Candace; Ripke, Stephan; Adzhubey, Ivan; Barton, Anne; Kremer, Joel M.; Alfredsson, Lars; Sunyaev, Shamil; Martin, Javier; Zhernakova, Alexandra; Bowes, John; Eyre, Steve; Siminovitch, Katherine A.; Gregersen, Peter K.; Worthington, Jane; Klareskog, Lars; Padyukov, Leonid; Raychaudhuri, Soumya; Plenge, Robert M.		Consortium Rheumatology; Rheumatoid Arthrit Consortium Int	Rare, Low-Frequency, and Common Variants in the Protein-Coding Sequence of Biological Candidate Genes from GWASs Contribute to Risk of Rheumatoid Arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LOCUS; HERITABILITY; AUTOIMMUNITY; METAANALYSIS; CORRECTS; LINKAGE; DISEASE	The extent to which variants in the protein-coding sequence of genes contribute to risk of rheumatoid arthritis (RA) is unknown. In this study, we addressed this issue by deep exon sequencing and large-scale genotyping of 25 biological candidate genes located within RA risk loci discovered by genome-wide association studies (GWASs). First, we assessed the contribution of rare coding variants in the 25 genes to the risk of RA in a pooled sequencing study of 500 RA cases and 650 controls of European ancestry. We observed an accumulation of rare nonsynonymous variants exclusive to RA cases in IL2RA and IL2RB (burden test: p = 0.007 and p = 0.018, respectively). Next, we assessed the aggregate contribution of low-frequency and common coding variants to the risk of RA by dense genotyping of the 25 gene loci in 10,609 RA cases and 35,605 controls. We observed a strong enrichment of coding variants with a nominal signal of association with RA (p < 0.05) after adjusting for the best signal of association at the loci (P-enrichment = 6.4 x 10(-4)). For one locus containing CD2, we found that a missense variant, rs699738 (c.798C>A [p.His266Gln]), and a noncoding variant, rs624988, reside on distinct haplotypes and independently contribute to the risk of RA (p = 4.6 x 10(-6)). Overall, our results indicate that variants (distributed across the allele-frequency spectrum) within the protein-coding portion of a subset of biological candidate genes identified by GWASs contribute to the risk of RA. Further, we have demonstrated that very large sample sizes will be required for comprehensively identifying the independent alleles contributing to the missing heritability of RA.	[Diogo, Dorothee; Kurreeman, Fina; Stahl, Eli A.; Liao, Katherine P.; Hickey, Brendan; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Diogo, Dorothee; Kurreeman, Fina; Stahl, Eli A.; Adzhubey, Ivan; Sunyaev, Shamil; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Diogo, Dorothee; Kurreeman, Fina; Stahl, Eli A.; Rivas, Manuel A.; Flannick, Jason; Thomson, Brian; Guiducci, Candace; Ripke, Stephan; Sunyaev, Shamil; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Gupta, Namrata] Gen Platform Broad Inst, Cambridge, MA 02142 USA; [Greenberg, Jeffrey D.] NYU, Hosp Joint Dis, New York, NY 10003 USA; [Flannick, Jason] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Flannick, Jason] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ripke, Stephan] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Barton, Anne; Bowes, John; Eyre, Steve; Worthington, Jane; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY 12206 USA; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Kurreeman, Fina; Zhernakova, Alexandra] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Zhernakova, Alexandra] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Siminovitch, Katherine A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON M5G 1X5, Canada; [Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Klareskog, Lars; Padyukov, Leonid] Karolinska Univ Hosp Solna, S-17176 Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; Karolinska Institutet; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Northwell Health; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Plenge, RM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	rplenge@partners.org	Zhernakova, Alexandra/ABA-9372-2020; Rivas, Manuel/ABE-8173-2020; eyre, stephen/K-3776-2017; Bowes, John/B-3472-2015; Barton, Anne/N-2053-2014; Martín, Javier/AAV-5209-2021; Siminovitch, Katherine/K-1475-2013; Martin, Javier/B-8141-2008; Worthington, Jane/M-9770-2014; Alfredsson, Lars/AAC-9007-2019; Martín, María/HDL-9512-2022; Ripke, Stephan/AAK-5486-2021; Padyukov, Leonid/A-4890-2009	Rivas, Manuel/0000-0003-1457-9925; eyre, stephen/0000-0002-1251-6974; Bowes, John/0000-0003-4659-031X; Barton, Anne/0000-0003-3316-2527; Martin, Javier/0000-0002-2202-0622; Worthington, Jane/0000-0003-0544-042X; Alfredsson, Lars/0000-0003-1688-6697; Zhernakova, Alexandra/0000-0002-4574-0841; Raychaudhuri, Soumya/0000-0002-1901-8265; Klareskog, Lars/0000-0001-9601-6186; DIOGO, DOROTHEE/0000-0003-2913-5913; ripke, stephan/0000-0003-3622-835X; Padyukov, Leonid/0000-0003-2950-5670	National Institutes of Health (NTH) [R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; Burroughs Wellcome Fund; European Union; NIH [K08AR060257, U54-LM008748]; European Research Council; Swedish Research Council [521-2009-3185]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056768, R01AR057108, R01AR059648, K08AR060257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	National Institutes of Health (NTH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	R.M.P. is supported by National Institutes of Health (NTH) grants R01-AR057108, R01-AR056768, U01-GM092691, and R01-AR059648 and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. F.K. was supported by a European Union international outgoing fellowship. K.P.L. is supported by NIH K08AR060257 Immunochip genotype data from the i2b2 samples and electronic-medical-record dataset were funded in part by NIH grant U54-LM008748. K.A.S. holds the Sherman Family Chair in Genomic Medicine and a Tier 1 Canada Research Chair. L.K. is supported by a grant from the European Research Council. L.P. is supported by Swedish Research Council grant 521-2009-3185.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Baecher-Allan CM, 2011, J IMMUNOL, V186, P3317, DOI 10.4049/jimmunol.1002502; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Garg G, 2012, J IMMUNOL, V188, P4644, DOI 10.4049/jimmunol.1100272; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kremer J, 2005, ANN RHEUM DIS, V64, P37, DOI 10.1136/ard.2005.043497; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Orozco G, 2009, HUM MOL GENET, V18, P2693, DOI 10.1093/hmg/ddp193; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904	56	74	75	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					15	27		10.1016/j.ajhg.2012.11.012	http://dx.doi.org/10.1016/j.ajhg.2012.11.012			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23261300	Green Published, Bronze			2022-12-18	WOS:000313759000002
J	Ackerman, C; Locke, AE; Feingold, E; Reshey, B; Espana, K; Thusberg, J; Mooney, S; Bean, LJH; Dooley, KJ; Cua, CL; Reeves, RH; Sherman, SL; Maslen, CL				Ackerman, Christine; Locke, Adam E.; Feingold, Eleanor; Reshey, Benjamin; Espana, Karma; Thusberg, Janita; Mooney, Sean; Bean, Lora J. H.; Dooley, Kenneth J.; Cua, Clifford L.; Reeves, Roger H.; Sherman, Stephanie L.; Maslen, Cheryl L.			An Excess of Deleterious Variants in VEGF-A Pathway Genes in Down-Syndrome-Associated Atrioventricular Septal Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DEFECTS; ENDOTHELIAL GROWTH-FACTOR; SOMATIC NKX2-5 MUTATIONS; CARDIAC DEVELOPMENT; CANDIDATE GENE; DISEASE; CRELD1; GATA4; MALFORMATIONS; TRISOMY-21	About half of people with trisomy 21 have a congenital heart defect (CHD), whereas the remainder have a structurally normal heart, demonstrating that trisomy 21 is a significant risk factor but is not causal for abnormal heart development. Atrioventricular septal defects (AVSD) are the most commonly occurring heart defects in Down syndrome (DS), and similar to 65% of all AVSD is associated with DS. We used a candidate-gene approach among individuals with DS and complete AVSD (cases = 141) and DS with no CHD (controls = 141) to determine whether rare genetic variants in genes involved in atrioventricular valvuloseptal morphogenesis contribute to AVSD in this sensitized population. We found a significant excess (p < 0.0001) of variants predicted to be deleterious in cases compared to controls. At the most stringent level of filtering, we found potentially damaging variants in nearly 20% of cases but fewer than 3% of controls. The variants with the highest probability of being damaging in cases only were found in six genes: COL6A1, COL6A2, CRELD1, FBLN2, FRZB, and GATA5. Several of the case-specific variants were recurrent in unrelated individuals, occurring in 10% of cases studied. No variants with an equal probability of being damaging were found in controls, demonstrating a highly specific association with AVSD. Of note, all of these genes are in the VEGF-A pathway, even though the candidate genes analyzed in this study represented numerous biochemical and developmental pathways, suggesting that rare variants in the VEGF-A pathway might contribute to the genetic underpinnings of AVSD in humans.	[Ackerman, Christine; Reshey, Benjamin; Espana, Karma; Maslen, Cheryl L.] Oregon Hlth & Sci Univ, Div Cardiovasc Med, Portland, OR 97239 USA; [Ackerman, Christine; Reshey, Benjamin; Espana, Karma; Maslen, Cheryl L.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97239 USA; [Locke, Adam E.; Bean, Lora J. H.; Sherman, Stephanie L.] Emory Univ, Dept Human Genet, Atlanta, GA 30033 USA; [Feingold, Eleanor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Thusberg, Janita; Mooney, Sean] Buck Inst Res Aging, Novato, CA 94945 USA; [Dooley, Kenneth J.] Emory Univ, Dept Pediat, Childrens Healthcare Atlanta, Div Pediat Cardiol, Atlanta, GA 30033 USA; [Dooley, Kenneth J.] Emory Univ, Sibley Heart Ctr Cardiol, Atlanta, GA 30033 USA; [Cua, Clifford L.] Nationwide Childrens Hosp, Ctr Heart, Columbus, OH 43205 USA; [Reeves, Roger H.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Reeves, Roger H.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA	Oregon Health & Science University; Oregon Health & Science University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Buck Institute for Research on Aging; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Johns Hopkins University; Johns Hopkins University	Maslen, CL (corresponding author), Oregon Hlth & Sci Univ, Div Cardiovasc Med, Portland, OR 97239 USA.	maslenc@ohsu.edu	Cua, Clifford/E-2934-2011; Locke, Adam/K-2000-2019	Locke, Adam/0000-0001-6227-198X; MOONEY, SEAN D/0000-0003-2654-0833; Cua, Clifford/0000-0002-9172-3874; Feingold, Eleanor/0000-0003-2898-6484	NHLBI [R01HD083300, T32 HL094294, N01-HV-48194]; American Heart Association; National Institute for Child Health and Development [F32 HD046337]; Western Undergraduate Exchange Program; Portland State University; Rose Tucker Charitable Trust; Throckmorton Scholarship Fund; Children's Healthcare of Atlanta Cardiac Research Committee; National Center for Research Resources (NCRR) [UL1RR024140]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD046337] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039, UL1RR025008, UL1RR024140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094294] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Institute for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Western Undergraduate Exchange Program; Portland State University; Rose Tucker Charitable Trust; Throckmorton Scholarship Fund; Children's Healthcare of Atlanta Cardiac Research Committee; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by NHLBI, R01HD083300 (R.H.R., S.L.S., and C.L.M.), T32 HL094294 (C.A.), the American Heart Association Predoctoral Fellowship Program (A.E.L.), the National Institute for Child Health and Development, F32 HD046337 (L.J.H.B.), the Western Undergraduate Exchange Program, the Portland State University Laurels Scholarship, the Rose Tucker Charitable Trust, the Throckmorton Scholarship Fund (K.E), Children's Healthcare of Atlanta Cardiac Research Committee, the National Center for Research Resources (NCRR), UL1RR024140 (OCTRI), and the technical assistance of the General Clinical Research Center at Emory University (National Institutes of Health/NCRR M01 RR00039). Resequencing services were provided by the University of Washington Department of Genome Sciences under U.S. Federal Government contract number N01-HV-48194 from the NHLBI. The authors thank Robert Glanville for critical reading of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Baptista MJ, 2000, HUM GENET, V107, P476, DOI 10.1007/s004390000395; Benson DW, 2010, CARDIOVASC RES, V88, P205, DOI 10.1093/cvr/cvq302; Benson DW, 2010, CIRCULATION, V121, P1277, DOI 10.1161/CIR.0b013e3181d98516; Berg C, 2009, ULTRASCHALL MED, V30, P25, DOI 10.1055/s-2008-1027438; Borozdin W, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9396; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; DAVIES GE, 1995, ANN HUM GENET, V59, P253, DOI 10.1111/j.1469-1809.1995.tb00746.x; DAVIES GE, 1994, HUM GENET, V93, P443; DAVIES GE, 1993, HUM GENET, V90, P521; Dor Y, 2001, DEVELOPMENT, V128, P1531; Draus JM, 2009, J MED GENET, V46, P115, DOI 10.1136/jmg.2008.060277; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Esposito G, 2011, AM J MED GENET A, V155A, P2416, DOI 10.1002/ajmg.a.34187; FERENCZ C, 1989, J PEDIATR-US, V114, P79, DOI 10.1016/S0022-3476(89)80605-5; Finsterer J, 2008, SCAND CARDIOVASC J, V42, P9, DOI 10.1080/14017430701854953; Freeman SB, 2009, CLIN GENET, V75, P180, DOI 10.1111/j.1399-0004.2008.01110.x; Freeman SB, 2008, GENET MED, V10, P173, DOI 10.1097/GIM.0b013e3181634867; Friedberg Mark K, 2007, Congenit Heart Dis, V2, P110, DOI 10.1111/j.1747-0803.2007.00082.x; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gittenberger-De Grot AC, 2003, ANAT REC PART A, V275A, P1109, DOI 10.1002/ar.a.10126; Grossman TR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002344; Guo Y, 2010, WORLD J PEDIATR, V6, P348, DOI 10.1007/s12519-010-0235-7; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; Hartman RJ, 2011, AM J MED GENET A, V155A, P555, DOI 10.1002/ajmg.a.33874; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Joziasse IC, 2011, EUR J HUM GENET, V19, P389, DOI 10.1038/ejhg.2010.224; Kumar SD, 2008, EXP BIOL MED, V233, P1421, DOI 10.3181/0806-RM-186; Kusuma L, 2011, GENET TEST MOL BIOMA, V15, P483, DOI 10.1089/gtmb.2010.0246; Lagendijk AK, 2010, TRENDS CARDIOVAS MED, V20, P124, DOI 10.1016/j.tcm.2010.10.003; Lambrechts D, 2004, CELL, V118, P532, DOI 10.1016/j.cell.2004.08.022; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li HQ, 2012, CIRC-CARDIOVASC GENE, V5, P301, DOI 10.1161/CIRCGENETICS.111.960872; Liu HM, 2012, DNA CELL BIOL, V31, P88, DOI 10.1089/dna.2011.1286; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Mahle WT, 2006, CARDIOL YOUNG, V16, P43, DOI 10.1017/S1047951106000758; Maslen CL, 2006, AM J MED GENET A, V140A, P2501, DOI 10.1002/ajmg.a.31494; Montano MM, 2008, CIRC RES, V102, P415, DOI 10.1161/CIRCRESAHA.107.157859; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Reamon-Buettner SM, 2004, AM J PATHOL, V164, P2117, DOI 10.1016/S0002-9440(10)63770-4; Reamon-Buettner SM, 2004, J MED GENET, V41, P684, DOI 10.1136/jmg.2003.017483; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Robinson SW, 2003, AM J HUM GENET, V72, P1047, DOI 10.1086/374319; Salazar M, 2011, EUR J MED GENET, V54, P306, DOI 10.1016/j.ejmg.2011.01.004; Sarkozy A, 2005, AM J MED GENET A, V139A, P236, DOI 10.1002/ajmg.a.31018; Sheffield VC, 1997, HUM MOL GENET, V6, P117, DOI 10.1093/hmg/6.1.117; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Weston GC, 2002, MOL HUM REPROD, V8, P855, DOI 10.1093/molehr/8.9.855; Zatyka M, 2005, CLIN GENET, V67, P526, DOI 10.1111/j.1399-0004.2005.00435.x; Zhao YQ, 2011, HUM MUTAT, V32, P1183, DOI 10.1002/humu.21559	60	74	76	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					646	659		10.1016/j.ajhg.2012.08.017	http://dx.doi.org/10.1016/j.ajhg.2012.08.017			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23040494	Green Published, Bronze			2022-12-18	WOS:000309568500007
J	Kirwan, M; Walne, AJ; Plagnol, V; Velangi, M; Ho, A; Hossain, U; Vulliamy, T; Dokal, I				Kirwan, Michael; Walne, Amanda J.; Plagnol, Vincent; Velangi, Mark; Ho, Aloysius; Hossain, Upal; Vulliamy, Tom; Dokal, Inderjeet			Exome Sequencing Identifies Autosomal-Dominant SRP72 Mutations Associated with Familial Aplasia and Myelodysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIGNAL RECOGNITION PARTICLE; ACUTE MYELOID-LEUKEMIA; RNA; BINDING; DOMAIN	Aplastic anemia (AA) and myelodysplasia (MDS) are forms of bone marrow failure that are often part of the same progressive underlying disorder. While most cases are simplex and idiopathic, some show a clear pattern of inheritance; therefore, elucidating the underlying genetic cause could lead to a greater understanding of this spectrum of disorders. We used a combination of exome sequencing and SNP haplotype analysis to identify causative mutations in a family with a history of autosomal-dominant AA/MDS. We identified a heterozygous mutation in SRP72, a component of the signal recognition particle (SRP) that is responsible for the translocation of nascent membrane-bound and excreted proteins to the endoplasmic reticulum. A subsequent screen revealed another autosomal-dominant family with an inherited heterozygous SRP72 mutation. Transfection of these sequences into mammalian cells suggested that these proteins localize incorrectly within the cell. Furthermore, coimmunoprecipitation of epitope-tagged SRP72 indicated that the essential RNA component of the SRP did not fully associate with one of the SRP72 variants. These results suggest that inherited mutations in a component of the SRP have a role in the pathophysiology of AA/MDS, identifying a third pathway for developing these disorders alongside transcription factor and telomerase mutations.	[Kirwan, Michael; Walne, Amanda J.; Hossain, Upal; Vulliamy, Tom; Dokal, Inderjeet] Univ London, Barts & London Sch Med & Dent, London E1 2AT, England; [Kirwan, Michael; Walne, Amanda J.; Hossain, Upal; Vulliamy, Tom; Dokal, Inderjeet] Royal London Hosp, Barts & London Childrens Hosp, London E1 1BB, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Velangi, Mark] Birmingham Childrens Hosp, Dept Clin & Lab Haematol, Birmingham B4 6NH, W Midlands, England; [Ho, Aloysius] Singapore Gen Hosp, Dept Haematol, Singapore 169608, Singapore	University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; University College London; University of Birmingham; Singapore General Hospital	Kirwan, M (corresponding author), Univ London, Barts & London Sch Med & Dent, London E1 2AT, England.	m.j.kirwan@qmul.ac.uk	Plagnol, Vincent/A-5667-2011	Plagnol, Vincent/0000-0002-5597-9215; Dokal, Inderjeet/0000-0003-4462-4782; Ho, Aloysius/0000-0003-1299-8560	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank the families and clinicians who contributed to this research. This work was funded by the Wellcome Trust.	Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Iakhiaeva E, 2005, J MOL BIOL, V345, P659, DOI 10.1016/j.jmb.2004.10.087; Iakhiaeva E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-83; Iakhiaeva E, 2009, PROTEIN SCI, V18, P2183, DOI 10.1002/pro.232; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; LUTCKE H, 1993, J CELL BIOL, V121, P977, DOI 10.1083/jcb.121.5.977; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.e04-03-0184; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470	19	74	78	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					888	892		10.1016/j.ajhg.2012.03.020	http://dx.doi.org/10.1016/j.ajhg.2012.03.020			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22541560	Bronze, Green Published			2022-12-18	WOS:000303907500013
J	Hu, H; Eggers, K; Chen, W; Garshasbi, M; Motazacker, MM; Wrogemann, K; Kahrizi, K; Tzschach, A; Hosseini, M; Bahman, I; Hucho, T; Muhlenhoff, M; Gerardy-Schahn, R; Najmabadi, H; Ropers, HH; Kuss, AW				Hu, Hao; Eggers, Katinka; Chen, Wei; Garshasbi, Masoud; Motazacker, M. Mandi; Wrogemann, Klaus; Kahrizi, Kimia; Tzschach, Andreas; Hosseini, Masoumeh; Bahman, Ideh; Hucho, Tim; Muehlenhoff, Martina; Gerardy-Schahn, Rita; Najmabadi, Hossein; Ropers, H. Hilger; Kuss, Andreas W.			ST3GAL3 Mutations Impair the Development of Higher Cognitive Functions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE MENTAL-RETARDATION; CONGENITAL DISORDERS; GLYCOSYLATION; EXPRESSION; GOLGI; SIALYLTRANSFERASE; LOCALIZATION; GENETICS; CLONING; ALPHA-2,3-SIALYLTRANSFERASE	The genetic variants leading to impairment of intellectual performance are highly diverse and are still poorly understood. ST3GAL3 encodes the Golgi enzyme beta-galactoside-alpha 2,3-sialyltransferase-III that in humans predominantly forms the sialyl Lewis a epitope on proteins. ST3GAL3 resides on chromosome 1 within the MRT4 locus previously identified to associate with nonsyndromic autosomal recessive intellectual disability. We searched for the disease-causing mutations in the MRT4 family and a second independent consanguineous Iranian family by using a combination of chromosome sorting and next-generation sequencing. Two different missense changes in ST3GAL3 cosegregate with the disease but were absent in more than 1000 control chromosomes. In cellular and biochemical test systems, these mutations were shown to cause ER retention of the Golgi enzyme and drastically impair ST3Gal-III functionality. Our data provide conclusive evidence that glycotopes formed by ST3Gal-III are prerequisite for attaining and/or maintaining higher cognitive functions.	[Eggers, Katinka; Muehlenhoff, Martina; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Wrogemann, Klaus] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E OJ9, Canada; [Kahrizi, Kimia; Hosseini, Masoumeh; Bahman, Ideh; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 1985713834, Iran; [Hu, Hao; Chen, Wei; Garshasbi, Masoud; Motazacker, M. Mandi; Tzschach, Andreas; Hucho, Tim; Ropers, H. Hilger; Kuss, Andreas W.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany	Hannover Medical School; University of Manitoba; Max Planck Society	Kuss, AW (corresponding author), Univ Med Greifswald, Inst Human Genet, D-17475 Greifswald, Germany.	kuss_a@molgen.mpg.de	Tzschach, Andreas/I-2648-2019; Kahrizi, Kimia/D-7989-2017; Najmabadi, Hossein/P-8182-2017; Chen, Wei/C-1273-2011; Hucho, Tim/Q-5218-2018	Tzschach, Andreas/0000-0002-6840-965X; Hucho, Tim/0000-0002-4147-9308; Kuss, Andreas/0000-0002-9401-4627; Najmabadi, Hossein/0000-0002-6084-7778; Garshasbi, Masoud/0000-0002-5508-7903; Chen, Wei/0000-0003-3263-1627	Iranian National Science Foundation; Max Planck Innovation Fund; German Federal Ministry of Education and Research [MRNET 01GS08161-2]; German Research Foundation [GE 801/10-1]	Iranian National Science Foundation(Iran National Science Foundation (INSF)); Max Planck Innovation Fund; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	We are grateful to the patients and their families for their participation in the study. We thank Herbert Hildebrandt for helpful discussion and Corinna Jensen, Marianne Schlicht, Anna-Maria Baumann, and Maike Hartmann for expert technical assistance. This work was supported financially by a grant from the Iranian National Science Foundation. Support was also received from the Max Planck Innovation Fund, a grant from the German Federal Ministry of Education and Research to H.H.R. (MRNET 01GS08161-2), and a grant from the German Research Foundation to R.G.-S. (GE 801/10-1). H.H.R., H.N., and K.K. participate in the GENCODYS Consortium.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Burger PC, 1998, GLYCOBIOLOGY, V8, P245, DOI 10.1093/glycob/8.3.245; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; Dhamija R, 2011, PEDIATR NEUROL, V44, P275, DOI 10.1016/j.pediatrneurol.2010.10.015; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Grahn A, 2002, GLYCOCONJUGATE J, V19, P197, DOI 10.1023/A:1024253808424; Grunewald S, 2002, PEDIATR RES, V52, P618, DOI 10.1203/01.PDR.0000031921.02259.35; Guo JP, 2011, AM J RESP CELL MOL, V44, P238, DOI 10.1165/rcmb.2010-0007OC; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Jarosch E, 2003, INT REV CYTOL, V223, P39; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; Kitten S, 2011, BIOL PSYCHIAT, V70, pE15, DOI 10.1016/j.biopsych.2011.03.016; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Krasnewich D, 2007, AM J MED GENET C, V145C, P302, DOI 10.1002/ajmg.c.30143; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuss AW, 2011, HUM GENET, V129, P141, DOI 10.1007/s00439-010-0907-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Parthasarathi UD, 2006, BRIT J PSYCHIAT, V189, P182, DOI 10.1192/bjp.bp.105.012864; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; ROTH J, 1991, J ELECTRON MICR TECH, V17, P121, DOI 10.1002/jemt.1060170202; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Varki A., 1999, ESSENTIALS GLYCOBIOL; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845	49	74	75	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					407	414		10.1016/j.ajhg.2011.08.008	http://dx.doi.org/10.1016/j.ajhg.2011.08.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21907012	Bronze, Green Published			2022-12-18	WOS:000294939800005
J	Mordechai, S; Gradstein, L; Pasanen, A; Ofir, R; El Amour, K; Levy, J; Belfair, N; Lifshitz, T; Joshua, S; Narkis, G; Elbedour, K; Myllyharju, J; Birk, OS				Mordechai, Shikma; Gradstein, Libe; Pasanen, Annika; Ofir, Riyka; El Amour, Khalil; Levy, Jaime; Belfair, Nadav; Lifshitz, Tova; Joshua, Sara; Narkis, Ginat; Elbedour, Khalil; Myllyharju, Johanna; Birk, Ohad S.			High Myopia Caused by a Mutation in LEPREL1, Encoding Prolyl 3-Hydroxylase 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; OSTEOGENESIS IMPERFECTA; SUSCEPTIBILITY LOCUS; BASEMENT-MEMBRANE; CHINESE FAMILY; COLLAGEN-IV; LINKAGE; GENES; DEFICIENCY; EXPRESSION	Autosomal-recessive high-grade axial myopia was diagnosed in Bedouin Israeli consanguineous kindred. Some affected individuals also had variable expressivity of early-onset cataracts, peripheral vitreo-retinal degeneration, and secondary sight loss due to severe retinal detachments. Through genome-wide linkage analysis, the disease-associated gene was mapped to -1.7 Mb on chromosome 3q28 (the maximum LOD score was 11.5 at theta = 0 for marker D3S1314). Sequencing of the entire coding regions and intron-exon boundaries of the six genes within the defined locus identified a single mutation (c.1523G>T) in exon 10 of LEPREL1, encoding prolyl 3-hydroxylase 2 (P3H2), a 2-oxoglutarate-dependent dioxygenase that hydroxylates collagens. The mutation affects a glycine that is conserved within P3H isozymes. Analysis of wild-type and p.Gly508Val (c.1523G>T) mutant recombinant P3H2 polypeptides expressed in insect cells showed that the mutation led to complete inactivation of P3H2.	[Mordechai, Shikma; Ofir, Riyka; Joshua, Sara; Narkis, Ginat; Birk, Ohad S.] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84105 Beer Sheva, Israel; [Gradstein, Libe; Levy, Jaime; Belfair, Nadav; Lifshitz, Tova] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Ophthalmol, IL-84101 Beer Sheva, Israel; [Gradstein, Libe; Levy, Jaime; Belfair, Nadav; Lifshitz, Tova] Ben Gurion Univ Negev, Fac Hlth Sci, Clalit Hlth Serv, IL-84101 Beer Sheva, Israel; [Pasanen, Annika; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Pasanen, Annika; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [El Amour, Khalil; Narkis, Ginat; Elbedour, Khalil; Birk, Ohad S.] Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Clalit Health Services; University of Oulu; University of Oulu; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84105 Beer Sheva, Israel.	obirk@bgu.ac.il	Gradstein, Libe/AAC-5189-2022	Birk, Ohad/0000-0003-1430-1296	Academy of Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	We deeply thank the Morris Kahn Family Foundation for making this study possible. J.M. was supported by the Academy of Finland and the Sigrid Juselius Foundation.	Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; CROSSEN R, 1998, BACULOVIRUS EXPRESSI; Feldkamper M, 2003, DEV OPHTHALMOL, V37, P34; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480; Hornbeak DM, 2009, CURR OPIN OPHTHALMOL, V20, P356, DOI 10.1097/ICU.0b013e32832f8040; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Los LI, 2004, J HISTOCHEM CYTOCHEM, V52, P789, DOI 10.1369/jhc.4A6267.2004; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Morgan Ian G, 2003, Clin Exp Optom, V86, P276; Saika S, 1998, EXP EYE RES, V66, P283, DOI 10.1006/exer.1997.0434; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; Shi Y, 2011, AM J HUM GENET, V88, P805, DOI 10.1016/j.ajhg.2011.04.022; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Tano Y, 2002, AM J OPHTHALMOL, V134, P645, DOI 10.1016/S0002-9394(02)01883-4; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Yang ZK, 2009, MOL VIS, V15, P312; Zhang QJ, 2004, MOL VIS, V10, P890	28	74	76	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					438	445		10.1016/j.ajhg.2011.08.003	http://dx.doi.org/10.1016/j.ajhg.2011.08.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21885030	Green Published, Bronze			2022-12-18	WOS:000294939800009
J	Bandah-Rozenfeld, D; Mizrahi-Meissonnier, L; Farhy, C; Obolensky, A; Chowers, I; Pe'er, J; Merin, S; Ben-Yosef, T; Ashery-Padan, R; Banin, E; Sharon, D				Bandah-Rozenfeld, Dikla; Mizrahi-Meissonnier, Liliana; Farhy, Chen; Obolensky, Alexey; Chowers, Itay; Pe'er, Jacob; Merin, Saul; Ben-Yosef, Tamar; Ashery-Padan, Ruth; Banin, Eyal; Sharon, Dror			Homozygosity Mapping Reveals Null Mutations in FAM161A as a Cause of Autosomal-Recessive Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; EXPRESSION; IDENTIFICATION; DISORDERS; ORTHOLOG; DISEASES; ISRAELI; LOCUS; EYS; CRX	Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal degenerations caused by mutations in at least 45 genes. Using homozygosity mapping, we identified a -4 Mb homozygous region on chromosome 2p15 in patients with autosomal-recessive RP (arRP). This region partially overlaps with RP28, a previously identified arRP locus. Sequence analysis of 12 candidate genes revealed three null mutations in FAM161A in 20 families. RT-PCR analysis in 21 human tissues revealed high levels of FAM161A expression in the retina and lower levels in the brain and testis. In the human retina, we identified two alternatively spliced transcripts with an intact open reading frame, the major one lacking a highly conserved exon. During mouse embryonic development, low levels of Fam161a transcripts were detected throughout the optic cup. After birth, Fam161a expression was elevated and confined to the photoreceptor layer. FAM161A encodes a protein of unknown function that is moderately conserved in mammals. Clinical manifestations of patients with FAM161A mutations varied but were largely within the spectrum associated with arRP. On funduscopy, pallor of the optic discs and attenuation of blood vessels were common, but bone-spicule-like pigmentation was often mild or lacking. Most patients had nonrecordable electroretinographic responses and constriction of visual fields upon diagnosis. Our data suggest a pivotal role for FAM161A in photoreceptors and reveal that FAM161A loss-of-function mutations are a major cause of arRP, accounting for -12% of arRP families in our cohort of patients from Israel and the Palestinian territories.	[Bandah-Rozenfeld, Dikla; Mizrahi-Meissonnier, Liliana; Obolensky, Alexey; Chowers, Itay; Pe'er, Jacob; Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Farhy, Chen; Ashery-Padan, Ruth] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Merin, Saul] St John Eye Hosp, IL-97200 Jerusalem, Israel; [Ben-Yosef, Tamar] Technion Israel Inst Technol, Dept Genet, Rappaport Fac Med, IL-31096 Haifa, Israel	Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Banin, E (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel.	banine@cc.huji.ac.il; dror.sharon1@gmail.com	Sharon, Dror/P-4539-2015	Sharon, Dror/0000-0002-1789-5811	Foundation Fighting Blindness USA [BR-GE-0607-0395-HUJ]; Israeli Science Foundation [612/09]; Yedidut; Israel Ministry of Science; Ziegler Foundation	Foundation Fighting Blindness USA; Israeli Science Foundation(Israel Science Foundation); Yedidut; Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Ziegler Foundation	This study was financially supported mainly by the Foundation Fighting Blindness USA (grant BR-GE-0607-0395-HUJ to D.S.), as well as by the Legacy Heritage Biomedical Program of the Israeli Science Foundation (grant 612/09 to D.S. and T.B.Y.), a Yedidut 1 research grant (to E.B.), the Israel Science Foundation (to RAP.), the Israel Ministry of Science (to RAP), and the Ziegler Foundation (to R.A.P.). We thank the patients and their families for their participation in the study. The authors thank Inbar Erdinest, Devora Marks-Ohana, Malka Sela, and Israel Barzel for excellent technical and imaging assistance.	Abd El-Aziz MM, 2010, INVEST OPHTH VIS SCI, V51, P4266, DOI 10.1167/iovs.09-5109; Audo I, 2008, INVEST OPHTH VIS SCI, V49, P2082, DOI 10.1167/iovs.05-1629; Audo I, 2010, HUM MUTAT, V31, pE1406, DOI 10.1002/humu.21249; Auslender N, 2007, INVEST OPHTH VIS SCI, V48, P5431, DOI 10.1167/iovs.07-0736; Bandah D, 2009, ARCH OPHTHALMOL-CHIC, V127, P297, DOI 10.1001/archophthalmol.2008.615; BANDAHROZENFELD D, 2010, INVEST OPHT IN PRESS; Beit-Ya'acov A, 2007, INVEST OPHTH VIS SCI, V48, P4308, DOI 10.1167/iovs.07-0244; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; BUNDEY S, 1984, J MED GENET, V21, P421, DOI 10.1136/jmg.21.6.421; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Collin RWJ, 2010, AM J HUM GENET, V86, P783, DOI 10.1016/j.ajhg.2010.03.016; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Frio TR, 2009, MOL VIS, V15, P2627; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gu SM, 1999, J MED GENET, V36, P705; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jensen AM, 1997, DEVELOPMENT, V124, P363; Kumar A, 2004, MOL VIS, V10, P399; Ness SL, 2003, J MED GENET, V40, P767, DOI 10.1136/jmg.40.10.767; Rosenberg T, 2003, DEV OPHTHALMOL, V37, P16; Rozen S, 2000, Methods Mol Biol, V132, P365; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Wang H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/j.ajhg.2009.02.005; Zlotogora J, 2000, MOL GENET METAB, V69, P169, DOI 10.1006/mgme.2000.2969; Zlotogora J, 1997, J MED GENET, V34, P765, DOI 10.1136/jmg.34.9.765; Zlotogora J, 2007, HUM MUTAT, V28, P944, DOI 10.1002/humu.20551	30	74	78	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					382	391		10.1016/j.ajhg.2010.07.022	http://dx.doi.org/10.1016/j.ajhg.2010.07.022			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20705279	Bronze, Green Published			2022-12-18	WOS:000281923500008
J	Thienpont, B; Zhang, LT; Postma, AV; Breckpot, J; Tranchevent, LC; Van Loo, P; Mollgard, K; Tommerup, N; Bache, I; Tumer, Z; van Engelen, K; Menten, B; Mortier, G; Waggoner, D; Gewillig, M; Moreau, Y; Devriendt, K; Larsen, LA				Thienpont, Bernard; Zhang, Litu; Postma, Alex V.; Breckpot, Jeroen; Tranchevent, Leon-Charles; Van Loo, Peter; Mollgard, Kjeld; Tommerup, Niels; Bache, Iben; Tumer, Zeynep; van Engelen, Klaartje; Menten, Bjorn; Mortier, Geert; Waggoner, Darrel; Gewillig, Marc; Moreau, Yves; Devriendt, Koen; Larsen, Lars Allan			Haploinsufficiency of TAB2 Causes Congenital Heart Defects in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; MENTAL-RETARDATION; CLINICAL-FEATURES; CURRENT KNOWLEDGE; GROWTH FAILURE; IDENTIFICATION; MUTATIONS; DELETION; TAK1	Congenital heart defects (CHDs) are the most common major developmental anomalies and the most frequent cause for perinatal mortality, but their etiology remains often obscure. We identified a locus for CHDs on 6q24-q25. Genotype-phenotype correlations in 12 patients carrying a chromosomal deletion on 6q delineated a critical 850 kb region on 6q25.1 harboring five genes. Bioinformatics prioritization of candidate genes in this locus for a role in CHDs identified the TGF-beta-activated kinase 1/MAP3K7 binding protein 2 gene (TAB2) as the top-ranking candidate gene. A role for this candidate gene in cardiac development was further supported by its conserved expression in the developing human and zebrafish heart. Moreover, a critical, dosage-sensitive role during development was demonstrated by the cardiac defects observed upon titrated knockdown of tab2 expression in zebrafish embryos. To definitively confirm the role of this candidate gene in CHDs, we performed mutation analysis of TAB2 in 402 patients with a CHD, which revealed two evolutionarily conserved missense mutations. Finally, a balanced translocation was identified, cosegregating with familial CL-ID. Mapping of the breakpoints demonstrated that this translocation disrupts TAB2. Taken together, these data clearly demonstrate a role for TAR2 in human cardiac development.	[Zhang, Litu; Tommerup, Niels; Bache, Iben; Tumer, Zeynep; Larsen, Lars Allan] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen, Denmark; [Thienpont, Bernard; Breckpot, Jeroen; Devriendt, Koen] Univ Louvain, Dept Human Genet, Lab Genet Human Dev, B-3000 Louvain, Belgium; [Postma, Alex V.] Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Tranchevent, Leon-Charles; Moreau, Yves] Univ Louvain, Dept Elect Engn ESAT SCD, B-3000 Louvain, Belgium; [Van Loo, Peter] Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Van Loo, Peter] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Mollgard, Kjeld] Univ Copenhagen, Dept Cellular & Mol Med, Dev Biol Unit, DK-2200 Copenhagen, Denmark; [Tumer, Zeynep] Kennedy Ctr, DK-2600 Glostrup, Denmark; [van Engelen, Klaartje] Univ Amsterdam, Acad Med Ctr, Dept Cardiol & Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Menten, Bjorn; Mortier, Geert] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Mortier, Geert] Univ Antwerp, Dept Med Genet, B-2160 Antwerp, Belgium; [Mortier, Geert] Univ Antwerp Hosp, B-2160 Antwerp, Belgium; [Waggoner, Darrel] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Waggoner, Darrel] Univ Chicago, Dept Genet, Chicago, IL 60637 USA; [Gewillig, Marc] Univ Hosp Leuven, Paediat Cardiol Unit, B-3000 Louvain, Belgium	University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; Flanders Institute for Biotechnology (VIB); University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; Ghent University; Ghent University Hospital; University of Antwerp; University of Antwerp; University of Chicago; University of Chicago; KU Leuven; University Hospital Leuven	Larsen, LA (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen, Denmark.	larsal@sund.ku.dk	Tommerup, Niels/T-8776-2017; ZHANG, LITU/AAI-1671-2019; Thienpont, Bernard/AAG-5423-2019; Mortier, Geert/D-2542-2012; Tumer, Zeynep/AAF-8501-2019; Menten, Björn/B-3072-2013; Tümer, Zeynep/C-4235-2014; Van Loo, Peter/A-3287-2012; Postma, Alex V/H-4806-2019	Tommerup, Niels/0000-0003-2304-0112; ZHANG, LITU/0000-0002-3305-3294; Mortier, Geert/0000-0001-9871-4578; Tumer, Zeynep/0000-0002-4777-5802; Postma, Alex V/0000-0003-4874-2487; Larsen, Lars Allan/0000-0002-7536-1172; Van Loo, Peter/0000-0003-0292-1949; Menten, Bjorn/0000-0001-8182-659X; Moreau, Yves/0000-0002-4647-6560; Bache, Iben/0000-0001-7562-8546; Thienpont, Bernard/0000-0002-8772-6845; Gewillig, Marc/0000-0002-4595-5922; Tranchevent, Leon-Charles/0000-0002-1257-4824	Agentschap voor Innovatie door Wetenschap en Technologie (IWT); The Danish Heart Foundation; The Novo Nordisk Foundation; University of Leuven [OT/O2/40, GOA/2006/12, EF/05/007]; Belgian program of Interuniversity Poles of Attraction (IUAP); ProMeta; GOA Ambiorics; GOA MaNet; START 1; FWO [G.0318.05, G.0254.05, G.0553.06, G.0302.07, ICCoS, ANMMM, MLDM, G.0733.09, G.082409]; IWT; IUAP P6/25 BioMaGNet; ERNSI; Lundbeck Foundation [R13-2007-1172] Funding Source: researchfish	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); The Danish Heart Foundation; The Novo Nordisk Foundation(Novo Nordisk Foundation); University of Leuven(KU Leuven); Belgian program of Interuniversity Poles of Attraction (IUAP); ProMeta; GOA Ambiorics; GOA MaNet; START 1; FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IUAP P6/25 BioMaGNet; ERNSI; Lundbeck Foundation(Lundbeckfonden)	B.T. is supported by a Ph.D. fellowship from the Agentschap voor Innovatie door Wetenschap en Technologie (IWT). P.V.L. is a post-doctoral researcher, K.D. a senior clinical investigator, and J.B. an aspirant investigator of the Research Foundation-Flanders (FWO). L.A.L. is supported by The Danish Heart Foundation and The Novo Nordisk Foundation. This work was supported by OT/O2/40, GOA/2006/12, Centre of Excellence SymBioSys (EF/05/007) from the University of Leuven and from the Belgian program of Interuniversity Poles of Attraction (IUAP), ProMeta, GOA Ambiorics, GOA MaNet, START 1, FWO (G.0318.05, G.0254.05, G.0553.06, G.0302.07, ICCoS, ANMMM, MLDM, G.0733.09, G.082409), IWT (Silicos, SBO-Biarame, SBO-MoKa, TBM-IOTA3), IUAP P6/25 BioMaGNet, ERNSI (FP7-HEALTH CHeartED). The Wilhelm Johannsen Centre for Functional Genome Research is established by the Danish National Research Foundation. We thank D. Stainier for sharing the transgenic flk-GFP zebrafish, S. Forschhammer and A. Ilgun for technical assistance, and the Leuven Aquatic Facility for excellent fish care.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Bache I, 2006, EUR J HUM GENET, V14, P410, DOI 10.1038/sj.ejhg.5201592; Battaglia A, 2008, AM J MED GENET C, V148C, P246, DOI 10.1002/ajmg.c.30187; Bera TK, 2002, P NATL ACAD SCI USA, V99, P16975, DOI 10.1073/pnas.262655399; Bisgaard AM, 2006, AM J MED GENET A, V140A, P2180, DOI 10.1002/ajmg.a.31425; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Calcagni G, 2007, EUR J PEDIATR, V166, P111, DOI 10.1007/s00431-006-0295-9; Caselli R, 2007, EUR J MED GENET, V50, P315, DOI 10.1016/j.ejmg.2007.03.003; Erdogan F, 2008, J MED GENET, V45, P704, DOI 10.1136/jmg.2008.058776; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kirby M. L., 2007, CARDIAC DEV; Manning N, 2006, PRENATAL DIAG, V26, P1062, DOI 10.1002/pd.1556; McElhinney DB, 2002, CIRCULATION, V106, P2567, DOI 10.1161/01.CIR.0000037221.45902.69; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nowaczyk MJM, 2008, AM J MED GENET A, V146A, P354, DOI 10.1002/ajmg.a.32144; Orelio C, 2003, BLOOD, V101, P2246, DOI 10.1182/blood-2002-07-2260; Osoegawa K, 2008, J MED GENET, V45, P81, DOI 10.1136/jmg.2007.052191; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pirola B, 1998, J MED GENET, V35, P1031, DOI 10.1136/jmg.35.12.1031; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Roessler E, 2008, AM J HUM GENET, V83, P18, DOI 10.1016/j.ajhg.2008.05.012; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Van der Velde ET, 2005, EUR J EPIDEMIOL, V20, P549, DOI 10.1007/s10654-005-4264-9; WHITTEMORE R, 1994, J AM COLL CARDIOL, V23, P1459, DOI 10.1016/0735-1097(94)90392-1; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	38	74	77	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					839	849		10.1016/j.ajhg.2010.04.011	http://dx.doi.org/10.1016/j.ajhg.2010.04.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20493459	Green Published, Bronze			2022-12-18	WOS:000278948900002
J	Dougherty, MJ				Dougherty, Michael J.			Closing the Gap: Inverting the Genetics Curriculum to Ensure an Informed Public	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							COPY-NUMBER VARIATION; EXPRESSION PHENOTYPES; PRION PROTEIN; MUTATIONS; DISEASE; ALKAPTONURIA; POLYMORPHISM; SPECTRUM; BIOLOGY; TRAITS	Over the past 20 years, the focus of national efforts to improve K-12 science education has ranged from curriculum and professional development of teachers to the adoption of science standards and high-stakes testing. In spite of this work, students in the United States continue to lag behind their peers in other countries. This underperformance is true for genetics, as well as for science and math in general, and is particularly worrisome given the accelerating need for scientists and engineers in our increasingly technology-driven economy. A scientifically literate public is essential if citizens are to engage effectively with policymakers on issues of scientific importance. Perhaps nowhere is this conjunction more personally meaningful than in human genetics and medicine. Rapid changes in our field have the potential to revolutionize healthcare, but the public is ill prepared to participate in this transformation. One potential solution is to modernize the genetics curriculum so that it matches the science of the 21(st) century. This paper highlights changes in human genetics that support a curricular reorganization, outlines the problems with current genetics instruction, and proposes a new genetics curriculum.	ASHG, Bethesda, MD 20814 USA		Dougherty, MJ (corresponding author), ASHG, 9650 Rockville Pike, Bethesda, MD 20814 USA.	mdougherty@ashg.org						*BATT BIO BIOT I, 2009, TAK PULS BIOSC ED AM; Bercovich D, 2008, J HUM GENET, V53, P407, DOI 10.1007/s10038-008-0264-4; Bloom MV, 2000, GENES ENV HUMAN BEHA; David JR, 2002, P ROY SOC B-BIOL SCI, V269, P127, DOI 10.1098/rspb.2001.1872; de Bernabe DBV, 1998, AM J HUM GENET, V62, P776, DOI 10.1086/301805; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Garrod AE, 1902, LANCET, V2, P1616; Grant E, 1996, Aust J Adv Nurs, V14, P24; Harder A, 1999, AM J MED GENET, V87, P311, DOI 10.1002/(SICI)1096-8628(19991203)87:4<311::AID-AJMG6>3.0.CO;2-5; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hott AM, 2002, BIOSCIENCE, V52, P1024, DOI 10.1641/0006-3568(2002)052[1024:GCIIBC]2.0.CO;2; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Liu L, 2008, CURR ISSUES MOL BIOL, V10, P25, DOI 10.21775/cimb.010.025; McCabe ERB, 2007, MOL CELL ENDOCRINOL, V265, P179, DOI 10.1016/j.mce.2006.12.017; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; NILSSONEHLE H, 1914, Z PLANZENZUCTUNG, V2, P153; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; POPHAM WJ, 2004, AM SCH BOARD J, V191, P30; Porteous John W, 2004, Theor Biol Med Model, V1, P6, DOI 10.1186/1742-4682-1-6; Shaw KRM, 2008, GENETICS, V178, P1157, DOI 10.1534/genetics.107.084194; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; SWANSON CB, 2006, MAKING CONNECTION DE; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; Wang S S, 2001, Community Genet, V4, P18, DOI 10.1159/000051152; Zhang YH, 2006, PEDIATR RES, V59, P590, DOI 10.1203/01.pdr.0000203092.83074.eb	28	74	75	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					6	12		10.1016/j.ajhg.2009.05.010	http://dx.doi.org/10.1016/j.ajhg.2009.05.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19559400	Green Published, Bronze			2022-12-18	WOS:000267997600003
J	Schultz, JM; Khan, SN; Ahmed, ZM; Riazuddin, S; Waryah, AM; Chhatre, D; Starost, MF; Ploplis, B; Buckley, S; Velasquez, D; Kabra, M; Lee, K; Hassan, MJ; Ali, G; Ansar, M; Ghosh, M; Wilcox, ER; Ahmad, W; Merlino, G; Leal, SM; Riazuddin, S; Friedman, TB; Morell, RJ				Schultz, Julie M.; Khan, Shaheen N.; Ahmed, Zubair M.; Riazuddin, Saima; Waryah, Ali M.; Chhatre, Dhananjay; Starost, Matthew F.; Ploplis, Barbara; Buckley, Stephanie; Velasquez, David; Kabra, Madhulika; Lee, Kwanghyuk; Hassan, Muhammad J.; Ali, Ghazanfar; Ansar, Muhammad; Ghosh, Manju; Wilcox, Edward R.; Ahmad, Wasim; Merlino, Glenn; Leal, Suzanne M.; Riazuddin, Sheikh; Friedman, Thomas B.; Morell, Robert J.			Noncoding Mutations of HGF Are Associated with Nonsyndromic Hearing Loss, DFNB39	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR-SCATTER FACTOR; AUTOSOMAL-RECESSIVE DEAFNESS; AUDITORY SENSORY EPITHELIUM; DELAYED NEURONAL DEATH; HEPARIN-BINDING SITE; FACTOR/SCATTER FACTOR; C-MET; INNER-EAR; IN-VIVO	A gene causing autosomal-recessive, nonsyndromic hearing loss, DFNB39, was previously mapped to an 18 Mb interval on chromosome 7q11.22-q21.12. We mapped an additional 40 consanguineous families segregating nonsyndromic hearing loss to the DFNB39 locus and refined the obligate interval to 1.2 Mb. The coding regions of all genes in this interval were sequenced, and no missense, nonsense, or frameshift mutations were found. We sequenced the noncoding sequences of genes, as well as noncoding genes, and found three mutations Clustered in intron 4 and exon 5 in the hepatocyte growth factor gene (HGF). Two intron 4 deletions occur in a highly conserved sequence that is part of the 3' Untranslated region of a previously undescribed short isoform of HGF The third mutation is a silent substitution, and we demonstrate that it affects splicing in vitro. HGF is involved in a wide variety of signaling pathways in many different tissues, yet these putative regulatory mutations cause a surprisingly specific phenotype, which is nonsydromic hearing loss. Two mouse models of Hgf dysregulation, one in which an Hgf transgene is ubiquitously overexpressed and the other a conditional knockout that deletes Hgf from a limited number of tissues, including the cochlea, result in deafness. Overexpression of HGF is associated with progressive degeneration of outer hair cells in the cochlea, whereas cochlear deletion of Hgf is associated with more general dysplasia.	[Schultz, Julie M.; Ahmed, Zubair M.; Riazuddin, Saima; Chhatre, Dhananjay; Ploplis, Barbara; Buckley, Stephanie; Velasquez, David; Wilcox, Edward R.; Friedman, Thomas B.; Morell, Robert J.] NIH, Mol Genet Lab, Natl Inst Deafness & Other Commun Disorders, Rockville, MD 20850 USA; [Khan, Shaheen N.; Waryah, Ali M.; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Starost, Matthew F.] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Kabra, Madhulika; Ghosh, Manju] All India Inst Med Sci, Dept Pediat, Genet Unit, New Delhi 110029, India; [Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Hassan, Muhammad J.; Ali, Ghazanfar; Ansar, Muhammad; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 45320, Pakistan; [Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; All India Institute of Medical Sciences (AIIMS) New Delhi; Baylor College of Medicine; Quaid I Azam University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Morell, RJ (corresponding author), NIH, Mol Genet Lab, Natl Inst Deafness & Other Commun Disorders, Rockville, MD 20850 USA.	morellr@nidcd.nih.gov	Ali, Ghazanfar/L-9277-2019; Waryah, Ali Muhammad/A-5003-2018; Ahmad, Wasim/GSD-8904-2022; Hassan, Muhammad Jawad/CAG-6580-2022; Ansar, Muhammad/F-4808-2015; Ali, Ghazanfar/J-9971-2012; Nasim Khan, Shaheen/F-2135-2015; Ansar, Muhammad/H-5967-2011; Ahmad, Wasim/E-9713-2015; Morell, Robert James/Q-2042-2019	Ali, Ghazanfar/0000-0002-6172-9503; Waryah, Ali Muhammad/0000-0002-2596-9032; Ansar, Muhammad/0000-0001-5891-7063; Lee, Kwanghyuk/0000-0003-1389-1220; Morell, Robert/0000-0003-1537-7356; Lee, Kwanghyuk/0000-0001-7781-9696	NATIONAL CANCER INSTITUTE [ZIABC008756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003594, Z01DC000039, ZIADC000039, R01DC011651] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DC000039] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIDCD NIH HHS [R01 DC03594, 1 Z01 DC000039-11, R01 DC003594, R01 DC011651] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arnold JS, 2006, HUM MOL GENET, V15, P1629, DOI 10.1093/hmg/ddl084; Barrionuevo F, 2008, DEV BIOL, V317, P213, DOI 10.1016/j.ydbio.2008.02.011; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHAN AML, 1991, SCIENCE, V254, P1382, DOI 10.1126/science.1720571; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Cioce V, 1996, J BIOL CHEM, V271, P13110, DOI 10.1074/jbc.271.22.13110; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; Eisen MD, 2007, CELL MOL LIFE SCI, V64, P566, DOI 10.1007/s00018-007-6417-3; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Friedman TB, 2003, EAR HEARING, V24, P289, DOI 10.1097/01.AUD.0000079804.00047.CE; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Hayashi K, 2001, GENE THER, V8, P1167, DOI 10.1038/sj.gt.3301498; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hordichok AJ, 2007, HEARING RES, V232, P1, DOI 10.1016/j.heares.2007.06.011; Jakubczak JL, 1998, MOL CELL BIOL, V18, P1275, DOI 10.1128/MCB.18.3.1275; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; KMIECIK TE, 1992, BLOOD, V80, P2454; Lai LJ, 2001, J IMMUNOL, V167, P3550, DOI 10.4049/jimmunol.167.7.3550; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lyon M, 2004, J BIOL CHEM, V279, P43560, DOI 10.1074/jbc.M408510200; Miyazawa K, 1996, J BIOL CHEM, V271, P3615; MIYAZAWA K, 1991, EUR J BIOCHEM, V197, P15, DOI 10.1111/j.1432-1033.1991.tb15876.x; Miyazawa T, 1998, J CEREBR BLOOD F MET, V18, P345, DOI 10.1097/00004647-199804000-00001; NAKA D, 1992, J BIOL CHEM, V267, P20114; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Oshima K, 2004, FASEB J, V18, P212, DOI 10.1096/fj.03-0567fje; Otsuka T, 2000, MOL CELL BIOL, V20, P2055, DOI 10.1128/MCB.20.6.2055-2065.2000; Petersen MB, 2008, CLIN GENET, V73, P14, DOI 10.1111/j.1399-0004.2007.00913.x; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Phaneuf D, 2004, DNA CELL BIOL, V23, P592, DOI 10.1089/dna.2004.23.592; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; Sakata H, 1996, CELL GROWTH DIFFER, V7, P1513; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schrijver I, 2006, EXPERT REV MOL DIAGN, V6, P375, DOI 10.1586/14737159.6.3.375; SEKI T, 1991, GENE, V102, P213; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; SHIMA N, 1991, BIOCHEM BIOPH RES CO, V180, P1151, DOI 10.1016/S0006-291X(05)81187-8; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; Sobel E, 1996, AM J HUM GENET, V58, P1323; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Takayama H, 1996, P NATL ACAD SCI USA, V93, P5866, DOI 10.1073/pnas.93.12.5866; Takayama H, 2001, LAB INVEST, V81, P297, DOI 10.1038/labinvest.3780238; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Taylor RR, 2008, JARO-J ASSOC RES OTO, V9, P44, DOI 10.1007/s10162-007-0105-8; Tolbert WD, 2007, P NATL ACAD SCI USA, V104, P14592, DOI 10.1073/pnas.0704290104; Tornabene SV, 2006, HEARING RES, V222, P115, DOI 10.1016/j.heares.2006.09.004; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Wajid M, 2003, EUR J HUM GENET, V11, P812, DOI 10.1038/sj.ejhg.5201041; WEEKS DE, 1995, HUM HERED, V45, P13, DOI 10.1159/000154250; Yan D, 2008, FRONT BIOSCI-LANDMRK, V13, P4972, DOI 10.2741/3056; Yu Yiling, 2009, V493, P87, DOI 10.1007/978-1-59745-523-7_6; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358; Zhou HJ, 1999, BIOCHEMISTRY-US, V38, P14793, DOI 10.1021/bi9908641; Zhou HJ, 1998, STRUCTURE, V6, P109, DOI 10.1016/S0969-2126(98)00012-4; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	81	74	77	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					25	39		10.1016/j.ajhg.2009.06.003	http://dx.doi.org/10.1016/j.ajhg.2009.06.003			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19576567	Green Published, Bronze			2022-12-18	WOS:000267997600005
J	Saccone, SF; Pergadia, ML; Loukola, A; Broms, U; Montgomery, GW; Wang, JC; Agrawal, A; Dick, DM; Heath, AC; Todorov, AA; Maunu, H; Heikkila, K; Morley, KI; Rice, JP; Todd, RD; Kaprio, J; Peltonen, L; Martin, NG; Goate, AM; Madden, PAF				Saccone, Scott F.; Pergadia, Michele L.; Loukola, Anu; Broms, Ulla; Montgomery, Grant W.; Wang, Jen C.; Agrawal, Arpana; Dick, Danielle M.; Heath, Andrew C.; Todorov, Alexandre A.; Maunu, Heidi; Heikkila, Kauko; Morley, Katherine I.; Rice, John P.; Todd, Richard D.; Kaprio, Jaakko; Peltonen, Leena; Martin, Nicholas G.; Goate, Alison M.; Madden, Pamela A. F.			Genetic linkage to chromosome 22q12 for a heavy-smoking quantitative trait in two independent samples	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EMPIRICAL P-VALUES; NICOTINE DEPENDENCE; SUSCEPTIBILITY LOCI; SCAN; RISK; BEHAVIOR; SCREEN; IDENTIFICATION; MORTALITY; REGIONS	We conducted a genomewide linkage screen of a simple heavy-smoking quantitative trait, the maximum number of cigarettes smoked in a 24-h period, using two independent samples: 289 Australian and 155 Finnish nuclear multiplex families, all of which were of European ancestry and were targeted for DNA analysis by use of probands with a heavy-smoking phenotype. We analyzed the trait, using a regression of identity-by-descent allele sharing on the sum and difference of the trait values for relative pairs. Suggestive linkage was detected on chromosome 22 at 27 - 29 cM in each sample, with a LOD score of 5.98 at 26.96 cM in the combined sample. After additional markers were used to localize the signal, the LOD score was 5.21 at 25.46 cM. To assess the statistical significance of the LOD score in the combined sample, 1,000 simulated genomewide screens were conducted, resulting in an empirical P value of .006 for the LOD score of 5.21. This linkage signal is driven mainly by the microsatellite marker D22S315 (22.59 cM), which had a single-point LOD score of 5.41 in the combined sample and an empirical P value <. 001 from 1,000 simulated genomewide screens. This marker is located within an intron of the gene ADRBK2, encoding the beta-adrenergic receptor kinase 2. Fine mapping of this linkage region may reveal variants contributing to heaviness of smoking, which will lead to a better understanding of the genetic mechanisms underlying nicotine dependence.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; Univ Helsinki, Finnish Genome Ctr, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Washington University (WUSTL); Washington University (WUSTL); Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Saccone, SF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, Box 8134,660 S Euclid Ave, St Louis, MO 63110 USA.	saccones@msnotes.wustl.edu	Montgomery, Grant W/B-7148-2008; Kaprio, Jaakko/A-1820-2008; Morley, Katherine I/A-2986-2011; Heikkilä, Kauko/E-5578-2019	Montgomery, Grant W/0000-0002-4140-8139; Kaprio, Jaakko/0000-0002-3716-2455; Morley, Katherine I/0000-0002-2725-5535; Heikkilä, Kauko/0000-0002-9256-8028; Loukola, Anu-Maria/0000-0003-0542-5967; Goate, Alison/0000-0002-0576-2472; Martin, Nicholas/0000-0003-4069-8020	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, T32AA007580, R37AA007728, R01AA013321, R01AA007728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, K08DA019951, R01DA012854] Funding Source: NIH RePORTER; NIAAA NIH HHS [R37 AA007728, R01 AA013320, AA07580, R01 AA007728, T32 AA007580, AA13321, AA13320, AA07728, R01 AA013321] Funding Source: Medline; NIDA NIH HHS [R56 DA012854, DA019951, K08 DA019951-02, R01 DA012854, DA12854, K08 DA019951] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Bergen AW, 1999, GENET EPIDEMIOL, V17, pS55; Bergen AW, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S101; Bierut LJ, 2004, AM J MED GENET A, V124A, P19, DOI 10.1002/ajmg.a.20329; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; *CDC, 2004, 2004 SURG GEN REP HL; COSTA PT, 1992, REVISED NEO PERONALI; COTTLER LB, 1991, BRIT J PSYCHIAT, V159, P653, DOI 10.1192/bjp.159.5.653; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; Duggirala R, 1999, GENET EPIDEMIOL, V17, pS139; Ehlers CL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-9; Farrelly MC, 1999, TOB CONTROL, V8, P272, DOI 10.1136/tc.8.3.272; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Gelernter J, 2004, AM J MED GENET B, V128B, P94, DOI 10.1002/ajmg.b.30019; Gelernter J, 2007, BIOL PSYCHIAT, V61, P119, DOI 10.1016/j.biopsych.2006.08.023; GILPIN EA, 2002, NICOTINE TOB RES S, V24, pS157; Goode EL, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S102; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HEATH AC, 1993, ADDICT BEHAV, V18, P19, DOI 10.1016/0306-4603(93)90005-T; Heath AC, 1995, BEHAV GENETIC APPROA, P45; HEATHERTON HF, 1991, BR J ADDICT, V9, P1119; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; KAPRIO J, 1988, J CLIN EPIDEMIOL, V41, P139, DOI 10.1016/0895-4356(88)90088-1; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Li MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S103; Li MD, 2006, AM J HUM GENET, V79, P745, DOI 10.1086/508208; Madden PAF, 1999, BEHAV GENET, V29, P423, DOI 10.1023/A:1021674804714; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Medlund P, 1976, Acta Med Scand Suppl, V600, P1; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Morley KI, 2006, BEHAV GENET, V36, P87, DOI 10.1007/s10519-005-9004-0; North BV, 2003, AM J HUM GENET, V72, P498, DOI 10.1086/346173; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; RISCH HA, 1993, AM J EPIDEMIOL, V138, P281, DOI 10.1093/oxfordjournals.aje.a116857; ROSENBERG L, 1985, JAMA-J AM MED ASSOC, V253, P2965, DOI 10.1001/jama.253.20.2965; Saccone NL, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S105; Shafey O, 2003, TOBACCO CONTROL COUN; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Shiffman S, 2004, NICOTINE TOB RES, V6, P327, DOI 10.1080/1462220042000202481; Straub RE, 1999, MOL PSYCHIATR, V4, P129, DOI 10.1038/sj.mp.4000518; Swan GE, 2006, AM J MED GENET B, V141B, P354, DOI 10.1002/ajmg.b.30315; Teli T, 2005, MOL ENDOCRINOL, V19, P474, DOI 10.1210/me.2004-0275; Terman GW, 2004, BRIT J PHARMACOL, V141, P55, DOI 10.1038/sj.bjp.0705595; True WR, 1997, ADDICTION, V92, P1277, DOI 10.1111/j.1360-0443.1997.tb02847.x; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Vink JM, 2004, PHARMACOGENOMICS J, V4, P274, DOI 10.1038/sj.tpj.6500255; Wang D, 2005, PHARMACOGENOMICS J, V5, P166, DOI 10.1038/sj.tpj.6500304; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529	56	74	74	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					856	866		10.1086/513703	http://dx.doi.org/10.1086/513703			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436240	Bronze, Green Published			2022-12-18	WOS:000245973200004
J	Gargiulo, A; Auricchio, R; Barone, MV; Cotugno, G; Reardon, W; Milla, PJ; Ballabio, A; Ciccodicola, A; Auricchio, A				Gargiulo, Annagiusi; Auricchio, Renata; Barone, Maria Vittoria; Cotugno, Gabriella; Reardon, William; Milla, Peter J.; Ballabio, Andrea; Ciccodicola, Alfredo; Auricchio, Alberto			Filamin A is mutated in X-linked chronic idiopathic intestinal pseudo-obstruction with central nervous system involvement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIVENTRICULAR HETEROTOPIA; MUTATIONS; GENE; NEURONS; MALFORMATIONS; LOCUS; XQ28	We have previously reported that an X-linked recessive form of chronic idiopathic intestinal pseudo-obstruction (CIIPX) maps to Xq28. To select candidate genes for the disease, we analyzed the expression in murine fetal brain and intestine of 56 genes from the critical region. We selected and sequenced seven genes and found that one affected male from a large CIIPX-affected kindred bears a 2-bp deletion in exon 2 of the FLNA gene that is present at the heterozygous state in the carrier females of the family. The frameshift mutation is located between two close methionines at the filamin N terminus and is predicted to produce a protein truncated shortly after the first predicted methionine. Loss-of-function FLNA mutations have been associated with X-linked dominant nodular ventricular heterotopia (PVNH), a central nervous system (CNS) migration defect that presents with seizures in females and lethality in males. Notably, the affected male bearing the FLNA deletion had signs of CNS involvement and potentially has PVNH. To understand how the severe frameshift mutation we found can explain the CIIPX phenotype and its X-linked recessive inheritance, we transiently expressed both the wild-type and mutant filamin in cell culture and found that filamin translation can start from either of the two initial methionines in these conditions. Therefore, translation of a normal shorter filamin can occur in vitro from the second methionine downstream of the 2-bp insertion we found. We confirmed this, demonstrating that the filamin protein is present in the patient's lymphoblastoid cell line that shows abnormal cytoskeletal actin organization compared with normal lymphoblasts. We conclude that the filamin N terminal region between the initial two methionines is crucial for proper enteric neuron development.	Hosp Children, Gastroenterol Unit, London, England; Inst Child Hlth, London, England; Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland; European Sch Mol Med, Naples, Italy; European Lab Invest Food Induced Dis, Naples, Italy; Univ Naples Federico II, Dept Pediat, Naples, Italy; Inst Genet & Biophys, Naples, Italy; Telethon Inst Genet & Med, Naples, Italy	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Our Ladys Children Hospital Crumlin; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Auricchio, A (corresponding author), Via P Castellino 111, I-80131 Naples, Italy.	auricchio@tigem.it	Cotugno, Gabriella/GYA-2858-2022; AURICCHIO, RENATA/AAC-7718-2022; AURICCHIO, Alberto/AHE-7979-2022; BALLABIO, Andrea/AAL-2672-2020	AURICCHIO, Alberto/0000-0002-0832-2472; BALLABIO, Andrea/0000-0003-1381-4604; Reardon, Willie/0000-0001-7329-9179; Ciccodicola, Alfredo/0000-0002-9924-1482; BARONE, Maria Vittoria/0000-0001-6190-4917	NEI NIH HHS [1R01EY015136-01, R01 EY015136] Funding Source: Medline; Telethon [TGM06S01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015136] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Telethon(Fondazione Telethon); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Auricchio A, 1996, AM J HUM GENET, V58, P743; BADNER JA, 1990, AM J HUM GENET, V46, P568; BORNENS M, 1989, J CELL BIOL, V109, P1071, DOI 10.1083/jcb.109.3.1071; Brown BJ, 1996, BBA-BIOMEMBRANES, V1283, P10, DOI 10.1016/0005-2736(96)00108-3; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; FitzPatrick DR, 1997, J MED GENET, V34, P666, DOI 10.1136/jmg.34.8.666; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Hehr U, 2006, J MED GENET, V43, P541, DOI 10.1136/jmg.2005.038505; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Mallon AM, 2000, GENOME RES, V10, P758, DOI 10.1101/gr.10.6.758; MILLA PJ, 1994, INTESTINAL PSEUDO OB; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; SARDE CO, 1994, GENOMICS, V22, P13, DOI 10.1006/geno.1994.1339; STAIANO A, 1996, CHRONIC CONSTIPATION, P153; TANNER MS, 1976, ARCH DIS CHILD, V51, P837, DOI 10.1136/adc.51.11.837	23	74	78	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					751	758		10.1086/513321	http://dx.doi.org/10.1086/513321			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357080	Green Published, Bronze			2022-12-18	WOS:000245465200015
J	Bergmann, C; Senderek, J; Anhuf, D; Thiel, CT; Ekici, AB; Poblete-Gutierrez, P; van Steensel, M; Seelow, D; Nurnberg, G; Schild, HH; Nurnberg, P; Reis, A; Frank, J; Zerres, K				Bergmann, C.; Senderek, J.; Anhuf, D.; Thiel, C. T.; Ekici, A. B.; Poblete-Gutierrez, P.; van Steensel, M.; Seelow, D.; Nuernberg, G.; Schild, H. H.; Nuernberg, P.; Reis, A.; Frank, J.; Zerres, K.			Mutations in the gene encoding the Wnt-signaling component R-spondin 4 (RSPO4) cause autosomal recessive anonychia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NAIL-PATELLA SYNDROME; EXPRESSION; FAMILY; LMX1B; RECEPTORS; PROTEINS	Anonychia is an autosomal recessive disorder characterized by the congenital absence of finger- and toenails. In a large German nonconsanguineous family with four affected and five unaffected siblings with isolated total congenital anonychia, we performed genomewide mapping and showed linkage to 20p13. Analysis of the RSPO4 gene within this interval revealed a frameshift and a nonconservative missense mutation in exon 2 affecting the highly conserved first furin-like cysteine-rich domain. Both mutations were not present among controls and were shown to segregate with the disease phenotype. RSPO4 is a member of the recently described R-spondin family of secreted proteins that play a major role in activating the Wnt/beta-catenin signaling pathway. Wnt signaling is evolutionarily conserved and plays a pivotal role in embryonic development, growth regulation of multiple tissues, and cancer development. Our findings add to the increasing body of evidence indicating that mesenchymal-epithelial interactions are crucial in nail development and put anonychia on the growing list of congenital malformation syndromes caused by Wnt-signaling-pathway defects. To the best of our knowledge, this is the first gene known to be responsible for an isolated, nonsyndromic nail disorder.	Univ Aachen, Dept Human Genet, D-52074 Aachen, Germany; Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; Univ Hosp Maastricht, Dept Dermatol, Maastricht, Netherlands; Maastricht Univ, Univ Hosp Maastricht, Ctr Mol Dermatol, Maastricht, Netherlands; Univ Cologne, Cologne Ctr Genom, D-5000 Cologne, Germany; Univ Bonn, Dept Radiol, D-5300 Bonn, Germany	RWTH Aachen University; University of Erlangen Nuremberg; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Cologne; University of Bonn	Bergmann, C (corresponding author), Univ Aachen, Dept Human Genet, Pauwelsstr 30, D-52074 Aachen, Germany.	cbergmann@ukaachen.de	Thiel, Christian T/H-8964-2012; Senderek, Jan/F-8405-2015; Seelow, Dominik/HGB-3124-2022; Ekici, Arif B/C-3971-2013; Reis, André/D-2309-2009; van Steensel, Maurice A.M./V-3852-2019	Thiel, Christian T/0000-0003-3817-7277; Senderek, Jan/0000-0002-8263-1783; Seelow, Dominik/0000-0002-9746-4412; Ekici, Arif B/0000-0001-6099-7066; Reis, André/0000-0002-6301-6363; van Steensel, Maurice/0000-0002-7507-2442				Chen HX, 2002, INT J DEV BIOL, V46, P937; DERKALOUSTIAN VM, 1979, GENETIC DIS SKIN, P196; Dreyer SD, 2000, HUM MOL GENET, V9, P1067, DOI 10.1093/hmg/9.7.1067; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Katoh M, 2005, INT J MOL MED, V16, P1103; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; KELSELL DP, 2005, 14 C EUR AC DERM VEN; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Kraus P, 2001, DERMATOLOGY ONLINE J, V7, p23D; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; LITTMAN A, 1964, J INVEST DERMATOL, V42, P177, DOI 10.1038/jid.1964.37; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; ROEBROEK AJM, 1994, BIOCHIMIE, V76, P210, DOI 10.1016/0300-9084(94)90148-1; Seitz CS, 2005, BRIT J DERMATOL, V152, P1339, DOI 10.1111/j.1365-2133.2005.06509.x; Strandskov HH, 1939, J HERED, V30, P53, DOI 10.1093/oxfordjournals.jhered.a104670; ZAIAS N, 1963, ARCH DERMATOL, V87, P37, DOI 10.1001/archderm.1963.01590130043010	19	74	85	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1105	1109		10.1086/509789	http://dx.doi.org/10.1086/509789			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186469	Green Published, Bronze			2022-12-18	WOS:000242131600012
J	Zaykin, DV; Meng, ZL; Ehm, MG				Zaykin, DV; Meng, ZL; Ehm, MG			Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE DATA; GAMETIC DISEQUILIBRIUM; HAPLOTYPES; TESTS; INFERENCES; SELECTION; TRAITS; BOUNDS; PHASE	Identification and description of genetic variation underlying disease susceptibility, efficacy, and adverse reactions to drugs remains a difficult problem. One of the important steps in the analysis of variation in a candidate region is the characterization of linkage disequilibrium (LD). In a region of genetic association, the extent of LD varies between the case and the control groups. Separate plots of pairwise standardized measures of LD (e.g.,) for cases and controls are often presented for a candidate region, to graphically convey case-control differences in LD. However, the observed graphic differences lack statistical support. Therefore, we suggest the "LD contrast" test to compare whole matrices of disequilibrium between two samples. A common technique of assessing LD when the haplotype phase is unobserved is the expectation-maximization algorithm, with the likelihood incorporating the assumption of Hardy-Weinberg equilibrium (HWE). This approach presents a potential problem in that, in the region of genetic association, the HWE assumption may not hold when samples are selected on the basis of phenotypes. Here, we present a computationally feasible approach that does not assume HWE, along with graphic displays and a statistical comparison of pairwise matrices of LD between case and control samples. LD-contrast tests provide a useful addition to existing tools of finding and characterizing genetic associations. Although haplotype association tests are expected to provide superior power when susceptibilities are primarily determined by haplotypes, the LD-contrast tests demonstrate substantially higher power under certain haplotype-driven disease models.	NIEHS, NIH, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Dept Genet Res, Res Triangle Pk, NC USA; Sanofi Aventis, Dept Biostat & Programming, Bridgewater, NJ USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); GlaxoSmithKline; Sanofi-Aventis	Zaykin, DV (corresponding author), NIEHS, NIH, Mail Drop A3-03,S Bldg 101,B356B,POB 12233, Res Triangle Pk, NC 27709 USA.	zaykind@niehs.nih.gov	Zaykin, Dmitri/C-3752-2019	Zaykin, Dmitri/0000-0002-9444-2859	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101866] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES101866-03] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Almasy L, 2001, GENET EPIDEMIOL, V21, pS332, DOI 10.1002/gepi.2001.21.s1.s332; Boos DD, 2004, STAT SCI, V19, P571, DOI 10.1214/088342304000000503; BOX GEP, 1953, BIOMETRIKA, V40, P318, DOI 10.1093/biomet/40.3-4.318; CHURCHILL GA, 1994, GENETICS, V138, P963; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Hamilton DC, 2004, ANN HUM GENET, V68, P234, DOI 10.1046/j.1529-8817.2004.00056.x; HAYES MG, 2004, AM J HUM GENET S, V54, pA146; HEDRICK PW, 1987, GENETICS, V117, P331; Hosking L. K., 2002, Pharmacogenomics Journal, V2, P165, DOI 10.1038/sj.tpj.6500096; Huttley GA, 2000, GENETICS, V156, P2127; KRZANOWSKI WJ, 1993, STAT COMPUT, V3, P37, DOI 10.1007/BF00146952; KRZANOWSKI WJ, 1979, J AM STAT ASSOC, V74, P703, DOI 10.2307/2286995; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin DY, 2004, GENET EPIDEMIOL, V26, P255, DOI 10.1002/gepi.10317; Meng ZL, 2003, AM J HUM GENET, V73, P115, DOI 10.1086/376561; Morris AP, 2005, GENET EPIDEMIOL, V29, P91, DOI 10.1002/gepi.20080; Murdoch DJ, 1996, AM STAT, V50, P178, DOI 10.2307/2684435; Nielsen DM, 2004, GENETICS, V168, P1029, DOI 10.1534/genetics.103.022335; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; PEDUZZI PN, 1983, J CHRON DIS, V36, P491, DOI 10.1016/0021-9681(83)90124-8; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Schaid DJ, 2004, GENETICS, V166, P505, DOI 10.1534/genetics.166.1.505; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shibata K, 2004, GENETICS, V168, P525, DOI 10.1534/genetics.104.029751; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; SUAREZ BK, 1994, GENOMICS, V19, P12, DOI 10.1006/geno.1994.1005; van Buuren S, 2000, MULTIVARIATE IMPUTAT; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Yule GU, 1912, J R STAT SOC, V75, P579, DOI 10.2307/2340126; Zapata C, 1997, EVOLUTION, V51, P606, DOI [10.2307/2411132, 10.1111/j.1558-5646.1997.tb02447.x]; Zaykin DV, 2004, GENET EPIDEMIOL, V27, P252, DOI 10.1002/gepi.20015; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	43	74	74	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					737	746		10.1086/503710	http://dx.doi.org/10.1086/503710			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642430	Green Published, Bronze			2022-12-18	WOS:000236756200001
J	Del Campo, M; Antonell, A; Magano, LF; Munoz, FJ; Flores, R; Bayes, M; Jurado, LAP				Del Campo, M; Antonell, A; Magano, LF; Munoz, FJ; Flores, R; Bayes, M; Jurado, LAP			Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC GRANULOMATOUS-DISEASE; VASCULAR OXIDATIVE STRESS; P47-PHOX PSEUDOGENE; DELETION REGION; ANGIOTENSIN-II; NADPH OXIDASE; HUMAN 7Q11.23; TFII-I; MECHANISMS; PREVALENCE	Williams-Beuren syndrome ( WBS), caused by a heterozygous deletion at 7q11.23, represents a model for studying hypertension, the leading risk factor for mortality worldwide, in a genetically determined disorder. Haploinsufficiency at the elastin gene is known to lead to the vascular stenoses in WBS and is also thought to predispose to hypertension, present in similar to 50% of patients. Detailed clinical and molecular characterization of 96 patients with WBS was performed to explore clinical-molecular correlations. Deletion breakpoints were precisely defined and were found to result in variability at two genes, NCF1 and GTF2IRD2. Hypertension was significantly less prevalent in patients with WBS who had the deletion that included NCF1 ( P = .02), a gene coding for the p47(phox) subunit of the NADPH oxidase. Decreased p47(phox) protein levels, decreased superoxide anion production, and lower protein nitrotyrosination were all observed in cell lines from patients hemizygous at NCF1. Our results indicate that the loss of a functional copy of NCF1 protects a proportion of patients with WBS against hypertension, likely through a lifelong reduced angiotensin II-mediated oxidative stress. Therefore, antioxidant therapy that reduces NADPH oxidase activity might have a potential benefit in identifiable patients with WBS in whom serious complications related to hypertension have been reported, as well as in forms of essential hypertension mediated by a similar pathogenic mechanism.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Unitat Genet, Barcelona 08003, Spain; Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Unitat Senyalitzac Cellular, Barcelona 08003, Spain	Pompeu Fabra University; Pompeu Fabra University	Jurado, LAP (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Unitat Genet, Dr Aiguader 80, Barcelona 08003, Spain.	luis.perez@upf.edu	Antonell, Anna/B-2555-2019; Pérez Jurado, Luis Alberto/M-7706-2015; Muñoz, F/E-6751-2014	Antonell, Anna/0000-0002-3286-8459; Muñoz, F/0000-0002-1343-3599; Flores Peirats, Raquel/0000-0002-5844-470X				[Anonymous], 1987, PEDIATRICS, V79, P1; Antonell A, 2005, GENOME RES, V15, P1179, DOI 10.1101/gr.3944605; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bird LM, 1996, J PEDIATR-US, V129, P926, DOI 10.1016/S0022-3476(96)70042-2; Chabrashvili T, 2002, HYPERTENSION, V39, P269, DOI 10.1161/hy0202.103264; Cherniske EM, 2004, AM J MED GENET A, V131A, P255, DOI 10.1002/ajmg.a.30400; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gorlach A, 1997, J CLIN INVEST, V100, P1907, DOI 10.1172/JCI119721; GREENBERG F, 1990, AM J MED GENET, P85; Hall JG, 1989, HDB PHYS MEASUREMENT; Heyworth PG, 2002, BLOOD, V100, P1845, DOI 10.1182/blood-2002-03-0861; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; HOWALD C, 2005, J MED GENET; Jurado LAP, 2003, HORM RES, V59, P106, DOI 10.1159/000067836; Jurado LAP, 1996, AM J HUM GENET, V59, P781; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Masia R, 1998, J EPIDEMIOL COMMUN H, V52, P707, DOI 10.1136/jech.52.11.707; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Partsch CJ, 1999, J PEDIATR-US, V134, P82, DOI 10.1016/S0022-3476(99)70376-8; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Sadler LS, 2001, J PEDIATR-US, V139, P849, DOI 10.1067/mpd.2001.118889; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tipney HJ, 2004, EUR J HUM GENET, V12, P551, DOI 10.1038/sj.ejhg.5201174; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Ungvari Z, 2003, CIRCULATION, V108, P1253, DOI 10.1161/01.CIR.0000079165.84309.4D; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; Wang MS, 1999, AM J MED GENET, V86, P34, DOI 10.1002/(SICI)1096-8628(19990903)86:1<34::AID-AJMG7>3.3.CO;2-W; Wollack JB, 1996, STROKE, V27, P143, DOI 10.1161/01.STR.27.1.143	36	74	77	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					533	542		10.1086/501073	http://dx.doi.org/10.1086/501073			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532385	Bronze, Green Published			2022-12-18	WOS:000236755900001
J	Arinami, T; Arinami, T; Ohtsuki, T; Ishiguro, H; Ujike, H; Tanaka, Y; Morita, Y; Mineta, M; Takeichi, M; Yamada, S; Imamura, A; Ohara, K; Shibuya, H; Ohara, K; Suzuki, Y; Muratake, T; Kaneko, N; Someya, T; Inada, T; Yoshikawa, T; Toyota, T; Yamada, K; Kojima, T; Takahashi, S; Osamu, O; Shinkai, T; Nakamura, M; Fukuzako, H; Hashiguchi, T; Niwa, S; Ueno, T; Tachikawa, H; Hori, T; Asada, T; Nanko, S; Kunugi, H; Hashimoto, R; Ozaki, N; Iwata, N; Harano, M; Arai, H; Ohnuma, T; Kusumi, I; Koyama, T; Yoneda, H; Fukumaki, Y; Shibata, H; Kaneko, S; Higuchi, H; Yasui-Furukori, N; Numachi, Y; Itokawa, M; Okazaki, Y				Arinami, T; Arinami, T; Ohtsuki, T; Ishiguro, H; Ujike, H; Tanaka, Y; Morita, Y; Mineta, M; Takeichi, M; Yamada, S; Imamura, A; Ohara, K; Shibuya, H; Ohara, K; Suzuki, Y; Muratake, T; Kaneko, N; Someya, T; Inada, T; Yoshikawa, T; Toyota, T; Yamada, K; Kojima, T; Takahashi, S; Osamu, O; Shinkai, T; Nakamura, M; Fukuzako, H; Hashiguchi, T; Niwa, S; Ueno, T; Tachikawa, H; Hori, T; Asada, T; Nanko, S; Kunugi, H; Hashimoto, R; Ozaki, N; Iwata, N; Harano, M; Arai, H; Ohnuma, T; Kusumi, I; Koyama, T; Yoneda, H; Fukumaki, Y; Shibata, H; Kaneko, S; Higuchi, H; Yasui-Furukori, N; Numachi, Y; Itokawa, M; Okazaki, Y		Japanese Schizophrenia Sib-Pair L	Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR DISORDER; WIDE SCAN; GENETIC-HETEROGENEITY; VULNERABILITY LOCUS; GENOTYPING ERRORS; SIBLING PAIRS; METAANALYSIS; ASSOCIATION; REGIONS; IRISH	The Japanese Schizophrenia Sib-Pair Linkage Group (JSSLG) is a multisite collaborative study group that was organized to create a national resource for affected sib pair (ASP) studies of schizophrenia in Japan. We used a high-density single-nucleotide-polymorphism (SNP) genotyping assay, the Illumina BeadArray linkage mapping panel (version 4) comprising 5,861 SNPs, to perform a genomewide linkage analysis of JSSLG samples comprising 236 Japanese families with 268 nonindependent ASPs with schizophrenia. All subjects were Japanese. Among these families, 122 families comprised the same subjects analyzed with short tandem repeat markers. All the probands and their siblings, with the exception of seven siblings with schizoaffective disorder, had schizophrenia. After excluding SNPs with high linkage disequilibrium, we found significant evidence of linkage of schizophrenia to chromosome 1p21.2-1p13.2 (LOD = 3.39) and suggestive evidence of linkage to 14q11.2 (LOD = 2.87), 14q11.2- q13.2 (LOD = 2.33), and 20p12.1-p11.2 (LOD = 2.33). Although linkage to these regions has received little x attention, these regions are included in or partially overlap the 10 regions reported by Lewis et al. that passed the two aggregate criteria of a meta-analysis. Results of the present study-which, to our knowledge, is the first genomewide analysis of schizophrenia in ASPs of a single Asian ethnicity that is comparable to the analyses done of ASPs of European descent-indicate the existence of schizophrenia susceptibility loci that are common to different ethnic groups but that likely have different ethnicity-specific effects.	Univ Tsukuba, Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba	Arinami, T (corresponding author), Univ Tsukuba, Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki 3058577, Japan.	tarinami@md.tsukuba.ac.jp	Ozaki, Norio/M-8908-2014; Ishiguro, Hiroki/Q-7532-2019; Ohnuma, Tohru/AAN-2363-2020; Kunugi, Hiroshi/ABC-5260-2021; Imamura, Akira/AAA-9481-2021; Ohtsuki, Tomoaki/D-7179-2014; Kusumi, Ichiro/A-4067-2012; Someya, Toshiyuki/ABD-1878-2021	Ozaki, Norio/0000-0002-7360-4898; Inada, Toshiya/0000-0002-8427-5639; Ohnuma, Tohru/0000-0003-1522-3832; Kunugi, Hiroshi/0000-0002-7209-3790; Imamura, Akira/0000-0002-6373-7160				Abdolmaleky HM, 2004, SCHIZOPHR RES, V67, P53, DOI 10.1016/S0920-9964(03)00183-X; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; BASSETT AS, 1988, LANCET, V1, P799; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Chiu YF, 2002, MOL PSYCHIATR, V7, P658, DOI 10.1038/sj.mp.4001045; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Ginot F, 1996, NUCLEIC ACIDS RES, V24, P540, DOI 10.1093/nar/24.3.540; Glidden DV, 2003, GENET EPIDEMIOL, V24, P107, DOI 10.1002/gepi.10215; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; *JSSLG, 2003, AM J MED GENET B, V120, P22; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Levinson D.F., 2000, GENETIC INFLUENCES N, P47; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Liang KY, 2000, HUM HERED, V51, P64; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; Mowry BJ, 2004, MOL PSYCHIATR, V9, P784, DOI 10.1038/sj.mp.4001481; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Pickard BS, 2005, AM J MED GENET B, V136B, P26, DOI 10.1002/ajmg.b.30204; Pulver AE, 2000, MOL PSYCHIATR, V5, P650, DOI 10.1038/sj.mp.4000814; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Radhakrishna U, 2001, EUR J HUM GENET, V9, P39, DOI 10.1038/sj.ejhg.5200584; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Webb EL, 2005, BIOINFORMATICS, V21, P3060, DOI 10.1093/bioinformatics/bti449; Weeks DE, 2002, GENOME RES, V12, P430, DOI 10.1101/gr.211502; Williams NM, 2003, AM J HUM GENET, V73, P1355, DOI 10.1086/380206	47	74	78	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					937	944		10.1086/498122	http://dx.doi.org/10.1086/498122			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380906	Bronze, Green Published			2022-12-18	WOS:000233241200004
J	Slater, HR; Bailey, DK; Ren, H; Cao, MQ; Bell, K; Nasioulas, S; Henke, R; Choo, KHA; Kennedy, GC				Slater, HR; Bailey, DK; Ren, H; Cao, MQ; Bell, K; Nasioulas, S; Henke, R; Choo, KHA; Kennedy, GC			High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE POLYMORPHISM ARRAYS; DEPENDENT PROBE AMPLIFICATION; GENOME-WIDE DETECTION; COPY NUMBER; HETEROZYGOSITY ANALYSIS; BLADDER-CANCER; DNA; MICROARRAYS; GENE; MLPA	Mutation of the human genome ranges from single base-pair changes to whole-chromosome aneuploidy. Karyotyping, fluorescence in situ hybridization, and comparative genome hybridization are currently used to detect chromosome abnormalities of clinical significance. These methods, although powerful, suffer from limitations in speed, ease of use, and resolution, and they do not detect copy-neutral chromosomal aberrations-for example, uniparental disomy (UPD). We have developed a high-through-put approach for assessment of DNA copy-number changes, through use of high-density synthetic oligonucleotide arrays containing 116,204 single-nucleotide polymorphisms, spaced at an average distance of 23.6 kb across the genome. Using this approach, we analyzed samples that failed conventional karyotypic analysis, and we detected amplifications and deletions across a wide range of sizes (1.3-145.9 Mb), identified chromosomes containing anonymous chromatin, and used genotype data to determine the molecular origin of two cases of UPD. Furthermore, our data provided independent confirmation for a case that had been misinterpreted by karyotype analysis. The high resolution of our approach provides more-precise breakpoint mapping, which allows subtle phenotypic heterogeneity to be distinguished at a molecular level. The accurate genotype information provided on these arrays enables the identification of copy-neutral loss-of-heterozygosity events, and the minimal requirement of DNA (250 ng per array) allows rapid analysis of samples without the need for cell culture. This technology overcomes many limitations currently encountered in routine clinical diagnostic laboratories tasked with accurate and rapid diagnosis of chromosomal abnormalities.	Royal Childrens Hosp, Genet Hlth Serv, Victoria Cytogenet Lab, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Genet Hlth Cytogenet Lab, Melbourne, Vic, Australia; Millennium Biosci, Box Hill, Vic, Australia; Affymetrix, Santa Clara, CA USA	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Affymetrix	Slater, HR (corresponding author), Royal Childrens Hosp, Genet Hlth Serv, Victoria Cytogenet Lab, 10th Floor, Parkville, Vic 3052, Australia.	howard.slater@ghsv.org.au	Nasioulas, Steven/K-7891-2012; Nasioulas, Steven/AAK-6485-2020					Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Carter NP, 2004, NAT GENET, V36, P931, DOI 10.1038/ng0904-931; Dumur CI, 2003, GENOMICS, V81, P260, DOI 10.1016/S0888-7543(03)00020-X; Fiegler H, 2003, J MED GENET, V40, P664, DOI 10.1136/jmg.40.9.664; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Hoque MO, 2003, CANCER RES, V63, P2216; Huang Jing, 2004, Human Genomics, V1, P287; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Janne PA, 2004, ONCOGENE, V23, P2716, DOI 10.1038/sj.onc.1207329; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kapronov Philipp, 2003, Briefings in Functional Genomics & Proteomics, V2, P47, DOI 10.1093/bfgp/2.1.47; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; LICHTER P, 1992, HUMAN CYTOGENETICS P, P157; Lieberfarb ME, 2003, CANCER RES, V63, P4781; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; MANDAHL N, 1992, HUMAN CYTOGENETICS M, P165; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Primdahl H, 2002, J NATL CANCER I, V94, P216; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Ren H, 2005, HUM MUTAT, V25, P476, DOI 10.1002/humu.20164; Rooms L, 2004, HUM MUTAT, V23, P17, DOI 10.1002/humu.10300; Rourke B. P, 1995, SYNDROME NONVERBAL L, P1; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schubert EL, 2002, AM J PATHOL, V160, P73, DOI 10.1016/S0002-9440(10)64351-9; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sellner LN, 2004, HUM MUTAT, V23, P413, DOI 10.1002/humu.20035; Slater HR, 1997, PRENATAL DIAG, V17, P109; Slater HR, 2003, J MED GENET, V40, P907, DOI 10.1136/jmg.40.12.907; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; Steele DL, 2005, AM J MED GENET B, V134B, P104, DOI 10.1002/ajmg.b.30156; WANG ZC, 1960, CANCER RES, V64, P64; Warrington JA, 2002, HUM MUTAT, V19, P402, DOI 10.1002/humu.10075; Wong KK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh072; Woodward K, 2001, PHARMACOGENOMICS, V2, P263, DOI 10.1517/14622416.2.3.263; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhou XF, 2004, HUM GENET, V115, P327, DOI 10.1007/s00439-004-1163-1; Zhou XF, 2004, CANCER GENET CYTOGEN, V151, P82, DOI 10.1016/j.cancergencyto.2003.11.010	49	74	102	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					709	726		10.1086/497343	http://dx.doi.org/10.1086/497343			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252233	Green Published, Bronze			2022-12-18	WOS:000232569600003
J	Nyholt, DR; Morley, KI; Ferreira, MAR; Medland, SE; Boomsma, DI; Heath, AC; Merikangas, KR; Montgomery, GW; Martin, NG				Nyholt, DR; Morley, KI; Ferreira, MAR; Medland, SE; Boomsma, DI; Heath, AC; Merikangas, KR; Montgomery, GW; Martin, NG			Genomewide significant linkage to migrainous headache on chromosome 5q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; SEROTONIN TRANSPORTER GENE; CA2+ CHANNEL GENE; SUSCEPTIBILITY LOCUS; QUANTITATIVE-TRAIT; TYPICAL MIGRAINE; DIAGNOSTIC-CRITERIA; RECEPTOR GENES; COMPLEX TRAITS; LATENT CLASS	Familial typical migraine is a common, complex disorder that shows strong familial aggregation. Using latent-class analysis (LCA), we identified subgroups of people with migraine/severe headache in a community sample of 12,245 Australian twins (60% female), drawn from two cohorts of individuals aged 23-90 years who completed an interview based on International Headache Society criteria. We report results from genomewide linkage analyses involving 756 twin families containing a total of 790 independent sib pairs ( 130 affected concordant, 324 discordant, and 336 unaffected concordant for LCA-derived migraine). Quantitative-trait linkage analysis produced evidence of significant linkage on chromosome 5q21 and suggestive linkage on chromosomes 8, 10, and 13. In addition, we replicated previously reported typical-migraine susceptibility loci on chromosomes 6p12.2-p21.1 and 1q21-q23, the latter being within 3 cM of the rare autosomal dominant familial hemiplegic migraine gene (ATP1A2), a finding which potentially implicates ATP1A2 in familial typical migraine for the first time. Linkage analyses of individual migraine symptoms for our six most interesting chromosomes provide tantalizing hints of the phenotypic and genetic complexity of migraine. Specifically, the chromosome 1 locus is most associated with phonophobia; the chromosome 5 peak is predominantly associated with pulsating headache; the chromosome 6 locus is associated with activity-prohibiting headache and photophobia; the chromosome 8 locus is associated with nausea/vomiting and moderate/severe headache; the chromosome 10 peak is most associated with phonophobia and photophobia; and the chromosome 13 peak is completely due to association with photophobia. These results will prove to be invaluable in the design and analysis of future linkage and linkage disequilibrium studies of migraine.	Queensland Inst Med Res, PO Off Royal Brisbane Hosp, Brisbane, Qld 4029, Australia; Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4067, Australia; Univ Queensland, Dept Psychol, St Lucia, Qld 4067, Australia; Free Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO USA; NIMH, Sect Dev Genet Epidemiol, Intramural Res Program, NIH, Bethesda, MD 20892 USA	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland; Vrije Universiteit Amsterdam; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Nyholt, DR (corresponding author), Queensland Inst Med Res, PO Off Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.	daleN@qimr.edu.au	Morley, Katherine I/A-2986-2011; Ferreira, Manuel A R/D-3609-2013; Boomsma, Dorret I/AAX-4470-2020; Medland, Sarah/AAT-7595-2020; Nyholt, Dale Robert/J-3174-2017; Montgomery, Grant W/B-7148-2008; Medland, Sarah E/C-7630-2013	Morley, Katherine I/0000-0002-2725-5535; Ferreira, Manuel A R/0000-0001-9059-1825; Medland, Sarah/0000-0003-1382-380X; Nyholt, Dale Robert/0000-0001-7159-3040; Montgomery, Grant W/0000-0002-4140-8139; Medland, Sarah E/0000-0003-1382-380X; Merikangas, Kathkeen/0000-0002-4667-2414; Martin, Nicholas/0000-0003-4069-8020	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, R01AA007535, P50AA011998, R37AA007728, P60AA011998, R01AA010249, R01AA007728, R01AA013326, R01AA014041] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA07728, R01 AA007728, P50 AA011998, R01 AA007535, R01 AA013320, AA013320, R01 AA013326, AA013326, R37 AA007728, AA11998, R01 AA014041, R01 AA010249, AA014041] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Bjornsson A, 2003, AM J HUM GENET, V73, P986, DOI 10.1086/378417; Cader ZM, 2003, HUM MOL GENET, V12, P2511, DOI 10.1093/hmg/ddg252; Carlsson A, 2002, NEUROLOGY, V59, P1804, DOI 10.1212/01.WNL.0000036617.04943.96; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Colson NJ, 2005, NEUROGENETICS, V6, P17, DOI 10.1007/s10048-004-0205-0; Colson NJ, 2004, NEUROGENETICS, V5, P129, DOI 10.1007/s10048-004-0181-4; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Del Zompo M, 1998, NEUROLOGY, V51, P781, DOI 10.1212/WNL.51.3.781; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; DUFFY DL, 2002, SIB PAIR VERSION 0 9; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; DUREN WL, 2003, RELPAIR PROGRAM INFE; Elston RC, 2005, AM J HUM GENET, V76, P152, DOI 10.1086/426872; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Heath A C, 2001, Twin Res, V4, P73, DOI 10.1375/1369052012182; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; HOVATTA I, 1994, GENOMICS, V23, P707, DOI 10.1006/geno.1994.1563; Jones KW, 2001, GENOMICS, V78, P150, DOI 10.1006/geno.2001.6665; JOUTEL A, 1994, AM J HUM GENET, V55, P1166; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Kallela M, 2001, EUR J NEUROL, V8, P441, DOI 10.1046/j.1468-1331.2001.00260.x; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P905; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Kowa H, 2000, AM J MED GENET, V96, P762, DOI 10.1002/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-X; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kusumi M, 2003, EUR NEUROL, V49, P218, DOI 10.1159/000070187; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lea RA, 2002, NEUROGENETICS, V4, P17, DOI 10.1007/s10048-001-0125-1; Lea RA, 2000, NEUROGENETICS, V3, P35; MAY A, 1995, HUM GENET, V96, P604, DOI 10.1007/BF00197420; McCarthy LC, 2001, GENOMICS, V78, P135, DOI 10.1006/geno.2001.6647; MERIKANGAS KR, 1994, NEUROLOGY, V44, P11; MERIKANGAS KR, 1993, CEPHALALGIA, V13, P47, DOI 10.1177/0333102493013S1210; Mochi M, 2003, NEUROL SCI, V23, P301, DOI 10.1007/s100720300005; MOCHI M, 1993, CEPHALALGIA, V13, P389, DOI 10.1046/j.1468-2982.1993.1306389.x; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, NEUROLOGY, V50, P1428, DOI 10.1212/WNL.50.5.1428; Nyholt DR, 2004, GENET EPIDEMIOL, V26, P231, DOI 10.1002/gepi.10311; Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogilvie A, 1998, CEPHALALGIA, V18, P23, DOI 10.1046/j.1468-2982.1998.1801023.x; OPHOFF RA, 1994, GENOMICS, V22, P21, DOI 10.1006/geno.1994.1340; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Ophoff RA, 1997, HEADACHE, V37, P479, DOI 10.1046/j.1526-4610.1997.3708479.x; OTERINO A, 2001, CEPHALALGIA, V21, P346; PARDO J, 1995, CEPHALALGIA, V15, P200, DOI 10.1046/j.1468-2982.1995.015003200.x; Paterna S, 2000, EUR NEUROL, V43, P133, DOI 10.1159/000008151; Peroutka SJ, 1997, NEUROLOGY, V49, P201, DOI 10.1212/WNL.49.1.201; Rainero I, 2002, HEADACHE, V42, P337, DOI 10.1046/j.1526-4610.2002.02103.x; RINDSKOPF D, 1986, STAT MED, V5, P21, DOI 10.1002/sim.4780050105; Russo L, 2005, AM J HUM GENET, V76, P327, DOI 10.1086/427521; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Soragna D, 2003, AM J HUM GENET, V72, P161, DOI 10.1086/345298; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; SUAREZ BK, 1979, CLIN GENET, V15, P126; Terwindt GM, 2001, NEUROLOGY, V56, P1028, DOI 10.1212/WNL.56.8.1028; Trabace S, 2002, HEADACHE, V42, P341, DOI 10.1046/j.1526-4610.2002.02104.x; Tzourio C, 2001, NEUROLOGY, V56, P1273, DOI 10.1212/WNL.56.10.1273; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; Wang JJ, 1997, OPHTHALMOLOGY, V104, P1714, DOI 10.1016/S0161-6420(97)30075-X; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Yilmaz M, 2001, J NEUROL SCI, V186, P27, DOI 10.1016/S0022-510X(01)00491-9; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186	77	74	75	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					500	512		10.1086/444510	http://dx.doi.org/10.1086/444510			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080125	Green Published, Bronze			2022-12-18	WOS:000231314100016
J	Thorgeirsson, TE; Oskarsson, H; Desnica, N; Kostic, JP; Stefansson, JG; Kolbeinsson, H; Lindal, E; Gagunashvili, N; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR				Thorgeirsson, TE; Oskarsson, H; Desnica, N; Kostic, JP; Stefansson, JG; Kolbeinsson, H; Lindal, E; Gagunashvili, N; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR			Anxiety with panic disorder linked to chromosome 9q in Iceland	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC EPIDEMIOLOGY; LINKAGE; COMORBIDITY; SENSITIVITY; POLYMORPHISM; ASSOCIATION; PREVALENCE; DEPRESSION; SYMPTOMS; VALIDITY	The results of a genomewide scan for genes conferring susceptibility to anxiety disorders in the Icelandic population are described. The aim of the study was to locate genes that predispose to anxiety by utilizing the extensive genealogical records and the relative homogeneity of the Icelandic population. Participants were recruited in two stages: (1) Initial case-identification by a population screening for anxiety disorders, using the Stamm Screening Questionnaire, was followed by aggregation into extended families, with the help of our genealogy database; and (2) those who fulfilled the diagnostic and family aggregation criteria underwent a more detailed diagnostic workup based on the Composite International Diagnostic Interview. Screening for anxiety in close relatives also identified additional affected members within the families. After genotyping was performed with 976 microsatellite markers, affected-only linkage analysis was done, and allele-sharing LOD scores were calculated using the program Allegro. Linkage analysis of 25 extended families, in each of which at least one affected individual had panic disorder (PD), resulted in a LOD score of 4.18 at D9S271, on chromosome 9q31. The intermarker distance was 4.4 cM on average, whereas it was 1.5 cM in the linked region as additional markers were added to increase the information content. The linkage results may be relevant not only to PD but also to anxiety in general, since our linkage study included patients with other forms of anxiety.	DeCode Genet, IS-101 Reykjavik, Iceland; Therapeia, Reykjavik, Iceland; Landspitalinn Univ Hosp, Reykjavik, Iceland	Landspitali National University Hospital	Thorgeirsson, TE (corresponding author), DeCode Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	thorgeir@decode.is; jgulcher@decode.is	Stefansson, Kari/AAE-7187-2019	Stefansson, Jon/0000-0001-7293-0969; Thorgeirsson, Thorgeir/0000-0002-5149-7040				Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eley TC, 1999, J CHILD PSYCHOL PSYC, V40, P1273, DOI 10.1017/S0021963099004734; Finn C T, 2001, Curr Psychiatry Rep, V3, P131, DOI 10.1007/s11920-001-0010-5; FJALLDAL JB, 2001, P INT JOINT C NEUR N, pA1; Gelernter J, 2001, AM J MED GENET, V105, P548, DOI 10.1002/ajmg.1496; GEORGE DT, 1990, ACTA PSYCHIAT SCAND, V81, P97, DOI 10.1111/j.1600-0447.1990.tb06460.x; Goldenberg IM, 1996, J CLIN PSYCHIAT, V57, P528, DOI 10.4088/JCP.v57n1105; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Hamilton SP, 2002, BIOL PSYCHIAT, V51, P591, DOI 10.1016/S0006-3223(01)01322-1; Hattori E, 2001, MOL PSYCHIATR, V6, P465, DOI 10.1038/sj.mp.4000875; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Hunt C, 1995, J PSYCHIAT RES, V29, P467, DOI 10.1016/0022-3956(95)00014-3; Hunt CJ, 2002, CURR OPIN PSYCHIATR, V15, P157, DOI 10.1097/00001504-200203000-00006; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P257, DOI 10.1001/archpsyc.58.3.257; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P374; KENDLER KS, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2000, ACTA PSYCHIAT SCAND, V102, P7, DOI 10.1111/j.0065-1591.2000.acp29[dash]02.x; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LINDAL E, 1993, ACTA PSYCHIAT SCAND, V88, P29, DOI 10.1111/j.1600-0447.1993.tb03410.x; Lindal E, 1991, Int J Soc Psychiatry, V37, P233, DOI 10.1177/002076409103700402; Mazzanti CM, 1998, ARCH GEN PSYCHIAT, V55, P936, DOI 10.1001/archpsyc.55.10.936; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Muris P, 2001, BEHAV RES THER, V39, P1357, DOI 10.1016/S0005-7967(01)00018-3; Muris P, 2001, BEHAV RES THER, V39, P89, DOI 10.1016/S0005-7967(99)00179-5; Nakamura M, 1999, MOL PSYCHIATR, V4, P155, DOI 10.1038/sj.mp.4000515; NICOLAE CL, 1999, THESIS U CHICAGO CHI; Ohara K, 1998, PSYCHIAT RES, V81, P277, DOI 10.1016/S0165-1781(98)00100-0; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; PETERS L, 1995, PSYCHOL MED, V25, P1269, DOI 10.1017/S0033291700033237; Rice DP, 1998, BRIT J PSYCHIAT, V173, P4, DOI 10.1192/S0007125000293458; Sand PG, 2000, PSYCHIATR GENET, V10, P191, DOI 10.1097/00041444-200010040-00007; SKAER T, 2000, CLIN DRUG INVEST, V20, P870; SKRE I, 1993, ACTA PSYCHIAT SCAND, V88, P85, DOI 10.1111/j.1600-0447.1993.tb03419.x; Stewart SH, 2001, BEHAV RES THER, V39, P443, DOI 10.1016/S0005-7967(00)00023-1; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WITTCHEN HU, 1996, DIAX SSQ	50	74	80	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1221	1230		10.1086/375141	http://dx.doi.org/10.1086/375141			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	671PZ	12679899	Green Published, Bronze			2022-12-18	WOS:000182474400014
J	Brown, DJ; Kim, TB; Petty, EM; Downs, CA; Martin, DM; Strouse, PJ; Moroi, SE; Milunsky, JM; Lesperance, MM				Brown, DJ; Kim, TB; Petty, EM; Downs, CA; Martin, DM; Strouse, PJ; Moroi, SE; Milunsky, JM; Lesperance, MM			Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPEMANN ORGANIZER; EXPRESSION; XENOPUS; MORPHOGENESIS; BINDING; RETINA; BMP4	Although fixation of the stapes is usually progressive and secondary to otosclerosis, it may present congenitally, with other skeletal manifestations, as an autosomal dominant syndrome-such as proximal symphalangism (SYM1) or multiple-synostoses syndrome (SYNS1), both of which are caused by mutations in NOG, the gene encoding noggin. We describe a family that was ascertained to have nonsyndromic otosclerosis but was subsequently found to have a congenital stapes ankylosis syndrome that included hyperopia, a hemicylindrical nose, broad thumbs and great toes, and other minor skeletal anomalies but lacked symphalangism. A heterozygous nonsense NOG mutation-c. 328C-->T (Q110X), predicted to truncate the latter half of the protein- was identified, and a heterozygous insertion in NOG-c. 252-253insC, in which the frameshift is predicted to result in 96 novel amino acids before premature truncation-was identified in a previously described second family with a similar phenotype. In contrast to most NOG mutations that have been reported in kindreds with SYM1 and SYNS1, the mutations observed in these families with stapes ankylosis without symphalangism are predicted to disrupt the cysteine-rich C-terminal domain. These clinical and molecular findings suggest that (1) a broader range of conductive hearing-loss phenotypes are associated with NOG mutations than had previously been recognized, (2) patients with sporadic or familial nonsyndromic otosclerosis should be evaluated for mild features of this syndrome, and (3) NOG alterations should be considered in conductive hearing loss with subtle clinical and skeletal features, even in the absence of symphalangism.	Univ Michigan Hlth Syst, Dept Otolaryngol Head & Neck Surg, Div Pediat Otolaryngol, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI 48109 USA; Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston University; Boston University	Lesperance, MM (corresponding author), Univ Michigan Hlth Syst, Dept Otolaryngol Head & Neck Surg, Div Pediat Otolaryngol, F6905 Mott,Box 0241,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.			Martin, Donna/0000-0002-8070-2007; Moroi, Sayoko E/0000-0002-0418-0657	NCRR NIH HHS [M01 RR00042, M01 RR000042] Funding Source: Medline; NIDCD NIH HHS [K23 DC000161, T32 DC00024, T32 DC000024, K23 DC00161] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000024, K23DC000161] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Belecky-Adams T, 2001, J COMP NEUROL, V430, P562, DOI 10.1002/1096-9861(20010219)430:4<562::AID-CNE1050>3.0.CO;2-S; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; HilhorstHofstee Y, 1997, CLIN DYSMORPHOL, V6, P195; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Mangino M, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9016.abs; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Milunsky J, 1999, AM J MED GENET, V82, P404, DOI 10.1002/(SICI)1096-8628(19990219)82:5<404::AID-AJMG9>3.3.CO;2-9; Moore KB, 1999, DEV BIOL, V212, P25, DOI 10.1006/dbio.1999.9338; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Takahashi T, 2001, CLIN GENET, V60, P447, DOI 10.1034/j.1399-0004.2001.600607.x; TEUNISSEN B, 1990, LARYNGOSCOPE, V100, P380; Trousse F, 2001, J NEUROSCI, V21, P1292; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	20	74	81	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					618	624		10.1086/342067	http://dx.doi.org/10.1086/342067			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12089654	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000177489600015
J	Silva, WA; Bonatto, SL; Holanda, AJ; Ribeiro-dos-Santos, AK; Paixao, BM; Goldman, GH; Abe-Sandes, K; Rodriguez-Delfin, L; Barbosa, M; Paco-Larson, ML; Petzl-Erler, ML; Valente, V; Santos, SEB; Zago, MA				Silva, WA; Bonatto, SL; Holanda, AJ; Ribeiro-dos-Santos, AK; Paixao, BM; Goldman, GH; Abe-Sandes, K; Rodriguez-Delfin, L; Barbosa, M; Paco-Larson, ML; Petzl-Erler, ML; Valente, V; Santos, SEB; Zago, MA			Mitochondrial genome diversity of Native Americans supports a single early entry of founder populations into America	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA HAPLOGROUPS; DNA ANALYSIS; ORIGIN; SEQUENCE; SUBSTITUTIONS; HAPLOTYPES; MIGRATION; EVOLUTION	There is general agreement that the Native American founder populations migrated from Asia into America through Beringia sometime during the Pleistocene, but the hypotheses concerning the ages and the number of these migrations and the size of the ancestral populations are surrounded by controversy. DNA sequence variations of several regions of the genome of Native Americans, especially in the mitochondrial DNA (mtDNA) control region, have been studied as a tool to help answer these questions. However, the small number of nucleotides studied and the nonclocklike rate of mtDNA control-region evolution impose several limitations to these results. Here we provide the sequence analysis of a continuous region of 8.8 kb of the mtDNA outside the D-loop for 40 individuals, 30 of whom are Native Americans whose mtDNA belongs to the four founder haplogroups. Haplogroups A, B, and C form monophyletic clades, but the five haplogroup D sequences have unstable positions and usually do not group together. The high degree of similarity in the nucleotide diversity and time of differentiation (i.e., similar to21,000 years before present) of these four haplogroups support a common origin for these sequences and suggest that the populations who harbor them may also have a common history. Additional evidence supports the idea that this age of differentiation coincides with the process of colonization of the New World and supports the hypothesis of a single and early entry of the ancestral Asian population into the Americas.	Univ Sao Paulo, Dept Clin Med, Sch Med, Fac Med, BR-14049900 Ribeirao Preto, Brazil; Univ Sao Paulo, Dept Cell & Mol Biol & Pathogen Agents, Fac Med, BR-14049900 Ribeirao Preto, Brazil; Univ Sao Paulo, Fac Ciencias Farmaceut, Fac Med, BR-14049900 Ribeirao Preto, Brazil; Univ Sao Paulo, Ctr Cell Therapy & Reg Blood Ctr, Fac Med, BR-14049900 Ribeirao Preto, Brazil; Fed Univ Para, Dept Genet, Santarem, Brazil; Pontificia Univ Catolica Rio Grande do Sul, Ctr Biol Genom & Mol, Porto Alegre, RS, Brazil; Univ Para, Lab Human & Med Genet, Belem, Para, Brazil; Univ Nacl Trujillo, Fac Med, Unidad Biol Mol, Trujillo, Peru; Univ Fed Parana, Dept Genet, Lab Human Mol Genet, BR-80060000 Curitiba, Parana, Brazil; Univ Estadual Sudoeste Bahia, Jequie, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Para; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidad Nacional de Trujillo; Universidade Federal do Parana; Universidade Estadual do Sudoeste da Bahia	Zago, MA (corresponding author), Univ Sao Paulo, Dept Clin Med, Sch Med, Fac Med, BR-14049900 Ribeirao Preto, Brazil.	marazago@usp.br	ZAGO, MARCO A/E-9442-2017; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Petzl-Erler, Maria Luiza/H-8221-2012; Bonatto, Sandro L/A-1240-2010; Santos, Ândrea Ribeiro dos/B-6061-2013; Valente, Valeria/F-1301-2014; Silva Jr, Wilson Araújo/E-9487-2011; Goldman, Gustavo Henrique/F-1848-2013; Paço-Larson, Maria L/I-8613-2012; de Jesus Holanda, Adriano/E-2133-2012	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Bonatto, Sandro L/0000-0002-0064-467X; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Valente, Valeria/0000-0002-3942-7744; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Goldman, Gustavo Henrique/0000-0002-2986-350X; de Jesus Holanda, Adriano/0000-0002-5409-6568				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BANDELT HJ, 1995, GENETICS, V141, P743; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CAVALLISFORZA LL, 1998, HIST GEOGRAPHY HUMAN; Derenko M, 2000, AM J HUM GENET, V67, P215; Forster P, 1996, AM J HUM GENET, V59, P935; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kolman CJ, 1996, GENETICS, V142, P1321; Kumar S., 2001, MEGA2 MOL EVOLUTIONA; Lorenz JG, 1997, HUM BIOL, V69, P749; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; SWOFFORD DL, 1998, PAUPSTAR PHYLOGENETI; TORRONI A, 1995, AM J HUM GENET, V56, P1234; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563	29	74	80	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					187	192		10.1086/341358	http://dx.doi.org/10.1086/341358			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12022039	Green Published, Bronze			2022-12-18	WOS:000176307700021
J	Mount, SM				Mount, SM			Genomic sequence, splicing, and gene annotation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							PRE-MESSENGER-RNA; SITE SELECTION; INTRON; EXONS; DROSOPHILA; EXPRESSION; JUNCTIONS; FEATURES		Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Mount, SM (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, H J Patterson Hall, College Pk, MD 20742 USA.	sm193@umail.umd.edu		Mount, Steve/0000-0003-2748-8205	NIGMS NIH HHS [GM3799111] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; Bagnall RD, 1999, BRIT J HAEMATOL, V107, P766, DOI 10.1046/j.1365-2141.1999.01767.x; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; COLEMAN KG, 1987, GENE DEV, V1, P19, DOI 10.1101/gad.1.1.19; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Dietrich RC, 1997, MOL CELL, V1, P151, DOI 10.1016/S1097-2765(00)80016-7; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GUO M, 1995, J MOL BIOL, V253, P426, DOI 10.1006/jmbi.1995.0564; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Maroni G, 1996, EVOL BIOL, V29, P1; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Reese MG, 2000, GENOME RES, V10, P483, DOI 10.1101/gr.10.4.483; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Roller AB, 2000, GENETICS, V154, P1169; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Shukla GC, 1999, RNA, V5, P525, DOI 10.1017/S1355838299982213; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; Wu Q, 1999, MOL CELL BIOL, V19, P3225; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	37	74	80	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					788	792		10.1086/303098	http://dx.doi.org/10.1086/303098			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986039	Green Published, Bronze			2022-12-18	WOS:000089651100002
J	Correa, CL; Brems, H; Lazaro, C; Marynen, P; Legius, E				Correa, CL; Brems, H; Lazaro, C; Marynen, P; Legius, E			Unequal meiotic crossover: A frequent cause of NF1 microdeletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1; GENE DELETIONS; RECOMBINATION; PHENOTYPE; ORIGIN; REARRANGEMENTS; IDENTIFICATION; MANIFESTATIONS; MECHANISMS; 15Q11-Q13	Neurofibromatosis type 1 is a common autosomal dominant disorder caused by mutations of the NF1 gene on chromosome 17. In only 5%-10% of cases, a microdeletion including the NF1 gene is found. We analyzed a set of polymorphic dinucleotide-repeat markers flanking the microdeletion on chromosome 17 in a group of seven unrelated families with a de novo NF1 microdeletion. Six of seven microdeletions were of maternal origin. The breakpoints of the microdeletions of maternal origin were localized in flanking paralogous sequences, called "NF1-REPs." The single deletion of paternal origin was shorter, and no crossover occurred on the paternal chromosome 17 during transmission. Five of the six cases of maternal origin were informative, and all five showed a crossover, between the flanking markers, after maternal transmission. The observed crossovers flanking the NF1 region suggest that these NF1 microdeletions result from an unequal crossover in maternal meiosis I, mediated by a misalignment of the flanking NF1-REPs.	Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, Ctr Human Genet, Louvain, Belgium; Hosp Duran & Reynals, IRO, Med & Mol Genet Ctr, Barcelona, Spain	KU Leuven; University Hospital Leuven; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals	Legius, E (corresponding author), Catholic Univ Louvain, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium.	Eric.Legius@med.kuleuven.ac.be	GARCIA, CONXI LAZARO/Q-2410-2016; Brems, Hilde/AAN-4075-2020; Legius, Eric/H-1735-2011	GARCIA, CONXI LAZARO/0000-0002-7198-5906; Legius, Eric/0000-0003-2410-6996				Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Carrozzo R, 1997, AM J HUM GENET, V61, P228, DOI 10.1086/513907; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Clementi M, 1996, ANN GENET-PARIS, V39, P92; Cnossen MH, 1997, HUM MUTAT, V9, P458, DOI 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1; Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO;2-4; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; HUSON SM, 1989, J MED GENET, V26, P712, DOI 10.1136/jmg.26.11.712; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; KAYES LM, 1994, AM J HUM GENET, V54, P424; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; Leppig KA, 1996, CYTOGENET CELL GENET, V72, P95, DOI 10.1159/000134171; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Lopes J, 1996, AM J HUM GENET, V58, P1223; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; Lopez-Correa C, 1999, AM J HUM GENET, V65, pA8; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Rasmussen SA, 1998, J MED GENET, V35, P468, DOI 10.1136/jmg.35.6.468; Riva P, 2000, AM J HUM GENET, V66, P100, DOI 10.1086/302709; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; Valero MC, 1997, HUM GENET, V99, P720, DOI 10.1007/s004390050438; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; Wu BL, 1997, AM J MED GENET, V69, P98, DOI 10.1002/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J; Wu RN, 1999, GENE CHROMOSOME CANC, V26, P376, DOI 10.1002/(SICI)1098-2264(199912)26:4<376::AID-GCC13>3.3.CO;2-F	30	74	77	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1969	1974		10.1086/302920	http://dx.doi.org/10.1086/302920			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775528	Green Published, Bronze			2022-12-18	WOS:000088373800025
J	Riva, P; Corrado, L; Natacci, F; Castorina, P; Wu, BL; Schneider, GH; Clementi, M; Tenconi, R; Korf, BR; Larizza, L				Riva, P; Corrado, L; Natacci, F; Castorina, P; Wu, BL; Schneider, GH; Clementi, M; Tenconi, R; Korf, BR; Larizza, L			NF1 microdeletion syndrome: Refined FISH characterization of sporadic and familial deletions with locus-specific probes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYPE-1 NEUROFIBROMATOSIS; DEVELOPMENTAL DELAY; SOMATIC MOSAICISM; GENE DELETIONS; YAC CONTIG; IDENTIFICATION; MANIFESTATIONS; PHENOTYPE; FEATURES; DISEASE	Two familial and seven sporadic patients with neurofibromatosis 1-who showed dysmorphism, learning disabilities/mental retardation, and additional signs and carried deletions of the NF1 gene-were investigated by use of a two-step FISH approach to characterize the deletions. With FISH of YAC clones belonging to a 7-Mb 17q11.2 contig, we estimated the extension of all of the deletions and identified the genomic regions harboring the breakpoints. Mosaicism accounted for the mild phenotype in two patients. In subsequent FISH experiments, performed with locus-specific probes generated from the same YACs by means of a novel procedure, we identified the smallest region of overlapping (SRO), mapped the deletion breakpoints, and identified the genes that map to each deletion interval. From centromere to telomere, the similar to 0.8-Mb SRO includes sequence-tagged site 64381, the SUPT6H gene (encoding a transcription factor involved in chromatin structure), and NF1. Extending telomerically from the SRO, two additional genes-BLMH, encoding a hydrolase involved in bleomycin resistance, and ACCN1, encoding an amiloride-sensitive cation channel expressed in the CNS-were located in the deleted intervals of seven and three patients, respectively. An apparently common centromeric deletion breakpoint was shared by all of the patients, whereas a different telomeric breakpoint defined a deletion interval of 0.8-3 Mb. There was no apparent correlation between the extent of the deletion and the phenotype. This characterization of gross NF1 deletions provides the premise for addressing correctly any genotype-phenotype correlation in the subset of patients with NF1 deletions.	Univ Milan, Fac Med, Dept Biol & Genet, I-20133 Milan, Italy; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; Univ Padua, Dept Pediat, Padua, Italy	University of Milan; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Padua	Larizza, L (corresponding author), Univ Milan, Fac Med, Dept Biol & Genet, Via Viotti 3-5, I-20133 Milan, Italy.		Riva, Paola/K-7871-2016; Korf, Bruce R/H-4882-2012	Riva, Paola/0000-0001-6481-8467; 	Telethon [E.0780] Funding Source: Medline	Telethon(Fondazione Telethon)		Ainsworth PJ, 1997, HUM MUTAT, V9, P452, DOI 10.1002/(SICI)1098-1004(1997)9:5<452::AID-HUMU12>3.3.CO;2-V; BREEN M, 1992, GENOMICS, V13, P726, DOI 10.1016/0888-7543(92)90148-L; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chiang PW, 1996, GENOMICS, V34, P328, DOI 10.1006/geno.1996.0294; CHUMAKOV IM, 1995, NATURE, V377, P175; Corrado L, 1999, MOL CELL PROBE, V13, P199, DOI 10.1006/mcpr.1999.0237; Ferner R. E., 1994, P233; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; KAYES LM, 1994, AM J HUM GENET, V54, P424; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; LAZO JS, 1983, P NATL ACAD SCI-BIOL, V80, P3064, DOI 10.1073/pnas.80.10.3064; Leppig KA, 1996, CYTOGENET CELL GENET, V72, P95, DOI 10.1159/000134171; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; LICHTER P, 1992, HUMAN CYTOGENETICS P, P157; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Montoya SE, 1998, NAT GENET, V18, P211, DOI 10.1038/ng0398-211; Naruse K, 1996, GENOMICS, V34, P236, DOI 10.1006/geno.1996.0274; Riva P, 1996, HUM GENET, V98, P646, DOI 10.1007/s004390050277; STEVENSON AC, 1967, MUTAT RES, V4, P339, DOI 10.1016/0027-5107(67)90029-2; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; Upadhyaya M, 1996, J MED GENET, V33, P148, DOI 10.1136/jmg.33.2.148; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; Van Roy N, 1997, EUR J CANCER, V33, P1974, DOI 10.1016/S0959-8049(97)00319-5; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Vogel F., 1997, HUMAN GENETICS PROBL; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; Wu BL, 1997, AM J MED GENET, V69, P98, DOI 10.1002/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J; Wu BL, 1997, HUM GENET, V99, P209, DOI 10.1007/s004390050341	30	74	78	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					100	109		10.1086/302709	http://dx.doi.org/10.1086/302709			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631140	Green Published, Bronze			2022-12-18	WOS:000085033600011
J	Christ, LA; Crowe, CA; Micale, MA; Conroy, JM; Schwartz, S				Christ, LA; Crowe, CA; Micale, MA; Conroy, JM; Schwartz, S			Chromosome breakage hotspots and delineation of the critical region for the 9p-deletion syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR CYTOGENETIC ANALYSIS; PRADER-WILLI SYNDROMES; UNIPARENTAL DISOMY; HIGH-RESOLUTION; DELETION 9P; DEFINITION; HYBRIDIZATION; ANGELMAN; PATIENT; REPEAT	The clinical features of the 9p-deletion syndrome include dysmorphic facial features (trigonocephaly, midface hypoplasia, upward-slanting palpebral fissures, and a long philtrum) and mental retardation. The majority of these patients appear to have similar cytogenetic breakpoints in 9p22, but some cases show phenotypic heterogeneity. To define the breakpoints of the deleted chromosomes, we studied 24 patients with a deletion of 9p, by high-resolution cytogenetics, FISH with 19 YACs, and PCR using 25 different sequence-tagged sites. Of 10 different breakpoints identified, 9 were localized within an similar to 5-Mb region, in 9p22-p23, that encompasses the interval between D9S1869 (telomeric) and D9S162 (centromeric). Eight unrelated patients had a breakpoint (group 1) in the same interval, between D9S274 (948h1) and D9S285 (767f2), suggesting a chromosome-breakage hotspot. Among 12 patients, seven different breakpoints (groups 3-9) were localized to a 2-Mb genomic region between D9S1709 and D9S162, which identified a breakpoint-cluster region. The critical region for the 9p-deletion syndrome maps to a 4-6-Mb region in 9p22-p23. The results from this study have provided insight into both the heterogeneous nature of the breakage in this deletion syndrome and the resultant phenotype-karyotype correlations.	Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Metrohlth Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; MetroHealth System	Schwartz, S (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Human Genet, 10524 Euclid Ave,6th Floor, Cleveland, OH 44106 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD036252] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36252] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALFI O, 1973, ANN GENET-PARIS, V16, P17; Amos-Landgraf J., 1994, American Journal of Human Genetics, V55, pA38; BENNETT CP, 1993, J MED GENET, V30, P518, DOI 10.1136/jmg.30.6.518; BREG WR, 1976, CYTOGENET CELL GENET, V17, P296, DOI 10.1159/000130726; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; BROWN S, 1995, AM J HUM GENET, V57, P859; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; BURTON BK, 1989, AM J MED GENET, V32, P504, DOI 10.1002/ajmg.1320320416; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; CHURCH DM, 1995, AM J HUM GENET, V56, P1162; DESMAZE C, 1993, AM J HUM GENET, V53, P1239; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; ESTABROOKS LL, 1995, AM J MED GENET, V55, P453, DOI 10.1002/ajmg.1320550412; HURET JL, 1988, J MED GENET, V25, P741, DOI 10.1136/jmg.25.11.741; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; Juyal RC, 1996, AM J HUM GENET, V58, P998; Kiyosawa H, 1996, HUM MOL GENET, V5, P745, DOI 10.1093/hmg/5.6.745; LEANACOX J, 1994, AM J HUM GENET, V54, P748; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; Lupski JR, 1996, AM J HUM GENET, V58, P21; MICALE MA, 1995, AM J MED GENET, V57, P79, DOI 10.1002/ajmg.1320570118; NICHOLLS RD, 1993, AM J MED GENET, V46, P16, DOI 10.1002/ajmg.1320460106; PENNY LA, 1995, AM J HUM GENET, V56, P676; PILZ DT, 1995, J MED GENET, V32, P275, DOI 10.1136/jmg.32.4.275; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; SEABRIGH.M, 1971, LANCET, V2, P971; SHASHI V, 1994, AM J MED GENET, V49, P88, DOI 10.1002/ajmg.1320490116; Sullivan BA, 1996, AM J HUM GENET, V59, P167; TAYLOR LD, 1991, NEUROLOGY, V41, P1513, DOI 10.1212/WNL.41.9.1513; TEEBI AS, 1993, AM J MED GENET, V46, P288, DOI 10.1002/ajmg.1320460310; WAGSTAFF J, 1995, AM J HUM GENET, V56, P302; Wolff DJ, 1996, AM J HUM GENET, V58, P154; WOLFF DJ, 1994, AM J HUM GENET, V55, P87; Young-Brockopp D, 1982, Oncol Nurs Forum, V9, P31; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	39	74	76	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1387	1395		10.1086/302606	http://dx.doi.org/10.1086/302606			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521304	Green Published, Bronze			2022-12-18	WOS:000083531000020
J	Latronico, AC; Segaloff, DL				Latronico, AC; Segaloff, DL			Naturally occurring mutations of the luteinizing-hormone receptor: Lessons learned about reproductive physiology and G protein-coupled receptors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIMITED PRECOCIOUS PUBERTY; LEYDIG-CELL HYPOPLASIA; CONSTITUTIVELY ACTIVATING MUTATION; CHORIOGONADOTROPIN RECEPTOR; LUTROPIN/CHORIOGONADOTROPIN RECEPTOR; MALE PSEUDOHERMAPHRODITISM; OVARIAN RESISTANCE; POINT MUTATION; TRANSMEMBRANE DOMAIN; MISSENSE MUTATION		Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Sao Paulo, Sch Med, Hosp Clin, Dev Endocrinol Unit, Sao Paulo, Brazil	University of Iowa; Universidade de Sao Paulo	Segaloff, DL (corresponding author), Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	deborah-segaloff@uiowa.edu	Latronico, Ana Claudia/AAC-5112-2019; Latronico, Ana Claudia/E-1198-2012	Latronico, Ana Claudia/0000-0001-6782-693X; Latronico, Ana Claudia/0000-0001-6782-693X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD022196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD022196, R37 HD022196, HD22196] Funding Source: Medline; NIDDK NIH HHS [DK 25295] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abell AN, 1997, J BIOL CHEM, V272, P14586, DOI 10.1074/jbc.272.23.14586; Abell AN, 1998, MOL ENDOCRINOL, V12, P1857, DOI 10.1210/me.12.12.1857; Arnhold IJP, 1997, FERTIL STERIL, V67, P394; Arnhold IJP, 1999, FERTIL STERIL, V71, P597, DOI 10.1016/S0015-0282(98)00517-2; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; BERTHEZENE F, 1976, NEW ENGL J MED, V295, P969, DOI 10.1056/NEJM197610282951801; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; EHRMANN DA, 1995, ENDOCR REV, V16, P322, DOI 10.1210/er.16.3.322; Epstein FH, 1997, NEW ENGL J MED, V337, P1675; Evans BAJ, 1996, J MED GENET, V33, P143, DOI 10.1136/jmg.33.2.143; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Gromoll J, 1996, J CLIN ENDOCR METAB, V81, P1367, DOI 10.1210/jc.81.4.1367; Gromoll J, 1998, J CLIN ENDOCR METAB, V83, P476, DOI 10.1210/jc.83.2.476; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; KAWATE N, 1995, J MED GENET, V32, P553, DOI 10.1136/jmg.32.7.553; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; Kosugi S, 1998, MOL PHARMACOL, V53, P894; Kosugi S, 1996, J BIOL CHEM, V271, P31813, DOI 10.1074/jbc.271.50.31813; KOSUGI S, 1995, HUM MOL GENET, V4, P183, DOI 10.1093/hmg/4.2.183; KOSUGI S, 1997, EVIDENCE INTERHELICA; KRAAIJ R, 1995, J CLIN ENDOCR METAB, V80, P3168, DOI 10.1210/jc.80.11.3168; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; KREMER H, 1993, HUM MOL GENET, V2, P1779, DOI 10.1093/hmg/2.11.1779; Kudo M, 1996, J BIOL CHEM, V271, P22470, DOI 10.1074/jbc.271.37.22470; Latronico AC, 1998, MOL ENDOCRINOL, V12, P442, DOI 10.1210/me.12.3.442; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Latronico AC, 1998, J CLIN ENDOCR METAB, V83, P2435, DOI 10.1210/jc.83.7.2435; LATRONICO AC, 1995, J CLIN ENDOCR METAB, V80, P2490, DOI 10.1210/jc.80.8.2490; LAUE L, 1995, HUM MOL GENET, V4, P1429, DOI 10.1093/hmg/4.8.1429; LAUE L, 1995, P NATL ACAD SCI USA, V92, P1906, DOI 10.1073/pnas.92.6.1906; Laue LL, 1996, MOL ENDOCRINOL, V10, P987, DOI 10.1210/me.10.8.987; Martens JWM, 1998, MOL ENDOCRINOL, V12, P775, DOI 10.1210/me.12.6.775; Misrahi M, 1997, J CLIN ENDOCR METAB, V82, P2159, DOI 10.1210/jcem.82.7.4039; Risma KA, 1997, ENDOCRINOLOGY, V138, P3540, DOI 10.1210/en.138.8.3540; Roberts LM, 1999, AM J HUM GENET, V65, P933, DOI 10.1086/302601; Rosenthal IM, 1996, J CLIN ENDOCR METAB, V81, P3802, DOI 10.1210/jc.81.10.3802; ROUSSEAUMERCK MF, 1990, CYTOGENET CELL GENET, V54, P77, DOI 10.1159/000132962; ROZELL TG, 1995, MOL ENDOCRINOL, V9, P1727; SALDANHA PH, 1987, AM J MED GENET, V26, P337, DOI 10.1002/ajmg.1320260212; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHWARTZ M, 1981, J CLIN ENDOCR METAB, V53, P123, DOI 10.1210/jcem-53-1-123; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; Stavrou SS, 1998, J CLIN ENDOCR METAB, V83, P2091, DOI 10.1210/jc.83.6.2091; Toledo SPA, 1996, J CLIN ENDOCR METAB, V81, P3850, DOI 10.1210/jc.81.11.3850; Wu SM, 1998, MOL ENDOCRINOL, V12, P1651, DOI 10.1210/me.12.11.1651; Yano K, 1996, BIOCHEM BIOPH RES CO, V220, P1036, DOI 10.1006/bbrc.1996.0528; YANO K, 1994, J CLIN ENDOCR METAB, V79, P1818, DOI 10.1210/jc.79.6.1818	49	74	81	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					949	958		10.1086/302602	http://dx.doi.org/10.1086/302602			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486313	Green Published, Bronze			2022-12-18	WOS:000082910000003
J	Forestier, L; Jean, G; Attard, M; Cherqui, S; Lewis, C; van't Hoff, W; Broyer, M; Town, M; Antignac, C				Forestier, L; Jean, G; Attard, M; Cherqui, S; Lewis, C; van't Hoff, W; Broyer, M; Town, M; Antignac, C			Molecular characterization of CTNS deletions in nephropathic cystinosis: Development of a PCR-based detection assay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; POPULATION; MAP	Nephropathic cystinosis is an autosomal recessive disorder that is characterized by accumulation of intralysosomal cystine and is caused by a defect in the transport of cystine across the lysosomal membrane. Using a positional cloning strategy, we recently cloned the causative gene, CTNS, and identified pathogenic mutations, including deletions, that span the cystinosis locus. Two types of deletions were detected-one of 9.5-16 kb, which was seen in a single family, and one of similar to 65 kb, which is the most frequent mutation found in the homozygous state in nearly one-third of cystinotic individuals. We present here characterization of the deletion breakpoints and demonstrate that, although both deletions occur in regions of repetitive sequences, they are the result of nonhomologous recombination. This type of mechanism suggests that the similar to 65-kb deletion is not a recurrent mutation, and our results confirm that it is identical in all patients. Haplotype analysis shows that this large deletion is due to a founder effect that occurred in a white individual and that probably arose in the middle of the first millenium. We also describe a rapid PCR-based assay that will accurately detect both homozygous and heterozygous deletions, and we use it to show that the similar to 65-kb deletion is present in either the homozygous or the heterozygous state in 76% of cystinotic patients of European origin.	Univ Paris 05, Hop Necker Enfants Malad, INSERM, U423, F-75015 Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Dept Pediat Nephrol, F-75015 Paris, France; UCL, Sch Med, Inst Child Hlth, Nephrourol Unit, London WC1E 6BT, England; Kings Coll London, Guys Kings & St Thomas Sch Med, London WC2R 2LS, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; UCL Medical School; University of London; King's College London	Antignac, C (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U423, Tour Lavoisier 6e Etage,149 Rue de Sevres, F-75015 Paris, France.	antignac@necker.fr	ANTIGNAC, Corinne/H-8945-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Cherqui, Stephanie/0000-0003-1240-5219				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anikster Y, 1999, MOL GENET METAB, V66, P111, DOI 10.1006/mgme.1998.2790; ANTIGNAC C, 1992, KIDNEY INT, V42, P1178, DOI 10.1038/ki.1992.402; COX DW, 1995, METABOLIC MOL BASES, P4125; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; Jean G, 1996, AM J HUM GENET, V58, P535; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; McDowell G, 1996, BIOCHEM MOL MED, V58, P135, DOI 10.1006/bmme.1996.0041; MCDOWELL GA, 1995, NAT GENET, V10, P246, DOI 10.1038/ng0695-246; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Shotelersuk V, 1998, AM J HUM GENET, V63, P1352, DOI 10.1086/302118; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; WOODSSAMUELS P, 1991, GENOMICS, V10, P91	18	74	76	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					353	359		10.1086/302509	http://dx.doi.org/10.1086/302509			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417278	Green Published, Bronze			2022-12-18	WOS:000081836900011
J	Scolari, F; Puzzer, D; Amoroso, A; Caridi, G; Ghiggeri, GM; Maiorca, R; Aridon, P; De Fusco, M; Ballabio, A; Casari, G				Scolari, F; Puzzer, D; Amoroso, A; Caridi, G; Ghiggeri, GM; Maiorca, R; Aridon, P; De Fusco, M; Ballabio, A; Casari, G			Identification of a new locus for medullary cystic disease, on chromosome 16p12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KIDNEY-DISEASE; NEPHRONOPHTHISIS TYPE-1; SODIUM-CHANNEL; BETA-SUBUNIT; GENE; LOCALIZATION; PROTEIN; LINKAGE; GLYCOPROTEIN; UROMODULIN	Autosomal dominant medullary cystic disease (ADMCKD) is an interstitial nephropathy that has morphologic and clinical features similar to autosomal recessive nephronophthisis. The typical renal dysfunction associated with ADMCKD results mainly from a defect in urinary concentration ability, although results of urinalysis are normal. Recently, a locus on chromosome 1 was associated with ADMCKD, in DNA from two large Cypriot families, and genetic heterogeneity was inferred. We describe the genomewide linkage mapping of a new locus for medullary cystic disease, ADMCKD2, on chromosome 16p12 in a four-generation Italian pedigree. The family with ADMCKD2 fulfills the typical diagnostic criteria of ADMCKD, complicated by hyperuricemia and gouty arthritis. Marker D16S3036 shows a maximum two-point LOD score of 3.68, and the defined critical region spans 10.5 cM, between D16S500 and SCNN1B1-2. Candidate genes included in the critical region are discussed.	Telethon Inst Genet & Med, I-20132 Milan, Italy; Univ Vita Salute, Milan, Italy; Spedali Civili, Div & Chair Nephrol, I-25125 Brescia, Italy; Univ Brescia, Brescia, Italy; Ist Infanzia Burlo Garofolo, Genet Serv, Trieste, Italy; Univ Trieste, Trieste, Italy; G Gaslini Inst, Lab Nephrol, Genoa, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Vita-Salute San Raffaele University; Hospital Spedali Civili Brescia; University of Brescia; IRCCS Burlo Garofolo; University of Trieste; University of Genoa; IRCCS Istituto Giannina Gaslini	Casari, G (corresponding author), Telethon Inst Genet & Med, San Raffaele Biomed Sci Pk,Via Olgettina 58, I-20132 Milan, Italy.		AMOROSO, ANTONIO/AAN-3884-2020; scolari, francesco/AAC-5957-2022; Casari, Giorgio/J-3070-2018; Ghiggeri, Gian Marco/N-4712-2015; De Fusco, Maurizio/AAN-7358-2020; amoroso, antonio/AAL-1475-2020; Caridi, Gianluca/F-7052-2010; BALLABIO, Andrea/AAL-2672-2020	Casari, Giorgio/0000-0002-0115-8980; Ghiggeri, Gian Marco/0000-0003-3659-9062; amoroso, antonio/0000-0002-9437-9407; Caridi, Gianluca/0000-0001-6700-3001; BALLABIO, Andrea/0000-0003-1381-4604; Aridon, Paolo/0000-0002-7424-9533; Scolari, Francesco/0000-0003-0233-9705	Telethon [TGM06S01, TGM97000] Funding Source: Medline	Telethon(Fondazione Telethon)		ALLEN F, 1976, KIDNEY INT, V9, P8, DOI 10.1038/ki.1976.2; BOLGER G, 1993, MOL CELL BIOL, V13, P6558, DOI 10.1128/MCB.13.10.6558; Christodoulou K, 1998, HUM MOL GENET, V7, P905, DOI 10.1093/hmg/7.5.905; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FATHALLAHSHAYKH H, 1991, P NATL ACAD SCI USA, V88, P3451, DOI 10.1073/pnas.88.8.3451; Fuchshuber A, 1998, NEPHROL DIAL TRANSPL, V13, P1955, DOI 10.1093/ndt/13.8.1955; GARDNER KD, 1971, ANN INTERN MED, V74, P47, DOI 10.7326/0003-4819-74-1-47; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HILDEBRANDT F, 1992, CLIN INVESTIGATOR, V70, P802; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; HOSOKAWA Y, 1989, J BIOL CHEM, V264, P13483; KIM RY, 1992, P NATL ACAD SCI USA, V89, P9292, DOI 10.1073/pnas.89.19.9292; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MURRAY T, 1975, ANN INTERN MED, V82, P453, DOI 10.7326/0003-4819-82-4-453; Neumann HPH, 1997, NEPHROL DIAL TRANSPL, V12, P1242, DOI 10.1093/ndt/12.6.1242; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; POOK MA, 1993, ANN HUM GENET, V57, P285, DOI 10.1111/j.1469-1809.1993.tb00902.x; RESNICK JS, 1978, LAB INVEST, V38, P550; Sambrook J, 1989, MOL CLONING LAB MANU; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Scolari F, 1998, NEPHROL DIAL TRANSPL, V13, P2536, DOI 10.1093/ndt/13.10.2536; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SIKRI KL, 1979, BIOCHEM J, V181, P525, DOI 10.1042/bj1810525; Sohocki MM, 1997, GENOMICS, V40, P247, DOI 10.1006/geno.1996.4604; Stavrou C, 1998, AM J MED GENET, V77, P149, DOI 10.1002/(SICI)1096-8628(19980501)77:2<149::AID-AJMG8>3.0.CO;2-N; VOILLEY N, 1995, GENOMICS, V28, P560, DOI 10.1006/geno.1995.1188; Weeks DE., 1990, AM J HUM GENET, V47, pA203; ZANGER RA, 1978, LAB INVEST, V38, P52	29	74	78	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1655	1660		10.1086/302414	http://dx.doi.org/10.1086/302414			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330352	Green Published, Bronze			2022-12-18	WOS:000080696200017
J	Rose, VM; Au, KS; Pollom, G; Roach, ES; Prashner, HR; Northrup, H				Rose, VM; Au, KS; Pollom, G; Roach, ES; Prashner, HR; Northrup, H			Germ-line mosaicism in tuberous sclerosis: How common?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAGNOSTIC-CRITERIA; SOMATIC MOSAICISM; COMPLEX; GENE; MUTATIONS	Two-thirds of cases of tuberous sclerosis complex (TSC) are sporadic and usually are attributed to new mutations, but unaffected parents sometimes have more than one affected child. We sought to determine how many of these cases represent germ-line mosaicism, as has been reported for other genetic diseases. In our sample of 120 families with TSC, 7 families had two affected children and clinically unaffected parents. These families were tested for mutations in the TSC1 and TSC2 genes, by Southern blotting and by single-strand conformational analysis. Unique variants were detected in six families. Each variant was present and identical in both affected children of a family but was absent in both parents and the unaffected siblings. Sequencing of the variants yielded two frameshift mutations, one missense mutation, and two nonsense mutations in TSC2 and one nonsense mutation in TSC1. To determine which parent contributed the affected gametes, the families were analyzed for linkage to TSC1 and TSC2, by construction of haplotypes with markers nanking the two genes. Linkage analysis and loss-of-heterozygosity studies indicated maternal origin in three families, paternal origin in one family, and either being possible in two families. To evaluate the possibility bf,low-level somatic mosaicism for TSC, DNA from lymphocytes of members of the six families were tested by allele-specific PCR. In all the families, the mutant allele was detected only in the known affected individuals. We conclude that germ-line mosaicism was present in five families with mutations in the TSC2 gene and in one family with the causative mutation in the TSC1 gene. The results have implications for genetic counseling of families with seemingly sporadic TSC.	Univ Texas, Sch Med, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; Univ Texas, SW Med Sch, Div Pediat Neurol, Dallas, TX 75230 USA; Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA	University of Texas System; University of Texas System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children	Northrup, H (corresponding author), Univ Texas, Sch Med, Dept Pediat, Div Med Genet, 6431 Fannin St, Houston, TX 77030 USA.	hnorthru@ped1.med.uth.tmc.edu	Roach, Ewell/E-3958-2011	Au, Kit Sing/0000-0002-2694-5833	NINDS NIH HHS [NS32300-02] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Au KS, 1997, HUM MUTAT, V9, P23, DOI 10.1002/(SICI)1098-1004(1997)9:1<23::AID-HUMU4>3.0.CO;2-Q; Au KS, 1997, AM J HUM GENET, V61, pA325; BYERS PH, 1988, AM J HUM GENET, V42, P237; EDWARDS JH, 1986, J MED GENET, V23, P521, DOI 10.1136/jmg.23.6.521; HALL JG, 1988, AM J HUM GENET, V43, P355; Kaltenbock B, 1998, BIOTECHNIQUES, V24, P202, DOI 10.2144/98242bm06; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; LOWRY RB, 1979, LANCET, V1, P216; Murgia Alessandra, 1997, American Journal of Human Genetics, V61, pA75; NELLIST M, 1993, CELL, V75, P1305; NORTHRUP H, 1993, J MED GENET, V30, P41, DOI 10.1136/jmg.30.1.41; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; ROACH ES, 1992, J CHILD NEUROL, V7, P221, DOI 10.1177/088307389200700219; Ruggieri M, 1997, J MED GENET, V34, P256, DOI 10.1136/jmg.34.3.256; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; Sippel KC, 1997, AM J HUM GENET, V61, pA16; VANDERMEULEN MA, 1995, J MED GENET, V32, P102, DOI 10.1136/jmg.32.2.102; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; VERHOEF S, 1995, LANCET, V345, P202, DOI 10.1016/S0140-6736(95)90213-9; Yates JRW, 1997, HUM MOL GENET, V6, P2265, DOI 10.1093/hmg/6.13.2265; [No title captured]	22	74	75	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					986	992		10.1086/302322	http://dx.doi.org/10.1086/302322			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090883	Green Published, Bronze			2022-12-18	WOS:000079632900009
J	Daw, EW; Heath, SC; Wijsman, EM				Daw, EW; Heath, SC; Wijsman, EM			Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAIN MONTE-CARLO; LINKAGE ANALYSIS; QUANTITATIVE TRAIT; GENETIC-LINKAGE; MISSENSE MUTATIONS; SINGLE-LOCUS; MODELS; CHROMOSOME-14; SEGREGATION; FAMILIES	It is usually difficult to localize genes that cause diseases with late ages at onset. These diseases frequently exhibit complex modes of inheritance, and only recent generations are available to be genotyped and phenotyped. In this situation, multipoint analysis using traditional exact linkage analysis methods, with many markers and full pedigree information, is a computationally intractable problem. Fortunately, Monte Carlo Markov chain sampling provides a tool to address this issue. By treating age at onset as a right-censored quantitative trait, we expand the methods used by Heath (1997) and illustrate them using an Alzheimer disease (AD) data set. This approach estimates the number, sizes, allele frequencies, and positions of quantitative trait loci (QTLs). In this simultaneous multipoint linkage and segregation analysis method, the QTLs are assumed to be diallelic and to interact additively. In the AD data set, we were able to localize correctly, quickly, and accurately two known genes, despite the existence of substantial genetic heterogeneity, thus demonstrating the great promise of these methods for the dissection of late-onset oligogenic diseases.	Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Daw, EW (corresponding author), Univ Washington, Dept Med, Div Med Genet, Box 357720, Seattle, WA 98195 USA.	warwickd@u.washington.edu	Heath, Simon C/J-4138-2012	Heath, Simon C/0000-0002-9550-0897	NIA NIH HHS [U24 AG021886, AG05136] Funding Source: Medline; NIGMS NIH HHS [GM11762, GM46255] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046255, R01GM046255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P50AG005136] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMOS CI, 1994, AM J HUM GENET, V54, P535; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Greenberg DA, 1996, AM J HUM GENET, V58, P892; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GUO SW, 1992, AM J HUM GENET, V51, P1111; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Heath SC, 1997, GENET EPIDEMIOL, V14, P1011, DOI 10.1002/(SICI)1098-2272(1997)14:6<1011::AID-GEPI75>3.3.CO;2-E; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; HEATH SC, 1995, THESIS; HOESCHELE I, 1994, P 5 WORLD C GEN APPL, V21, P241; Ikeda M, 1996, ANN NEUROL, V40, P912, DOI 10.1002/ana.410400614; JARVIK GP, 1994, GENET EPIDEMIOL, V11, P375, DOI 10.1002/gepi.1370110407; KNAPP M, 1994, AM J HUM GENET, V55, P1030; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OLSON JM, 1993, GENET EPIDEMIOL, V10, P87, DOI 10.1002/gepi.1370100202; OTT J, 1979, TRANSPLANT P, V11, P1689; Phillips DV, 1996, MARKOV CHAIN MONTE C, P215; Poorkaj P, 1998, HUM MUTAT, V11, P216, DOI 10.1002/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.3.CO;2-O; RICE JP, 1993, AM J HUM GENET, V53, pA66; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Satagopan JM, 1996, GENETICS, V144, P805; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; STEPHENS DA, 1993, ANN HUM GENET, V57, P65, DOI 10.1111/j.1469-1809.1993.tb00887.x; THOMPSON EA, 1994, PHILOS T ROY SOC B, V344, P345, DOI 10.1098/rstb.1994.0073; THOMPSON EA, 1994, STAT SCI, V9, P355, DOI 10.1214/ss/1177010381; VIELAND V, 1992, CYTOGENET CELL GENET, V59, P145, DOI 10.1159/000133229; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S	40	74	77	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					839	851		10.1086/302276	http://dx.doi.org/10.1086/302276			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053019	Green Published, Bronze			2022-12-18	WOS:000079204700022
J	Hedera, P; Rainier, S; Alvarado, D; Zhao, XP; Williamson, J; Otterud, B; Leppert, M; Fink, JK				Hedera, P; Rainier, S; Alvarado, D; Zhao, XP; Williamson, J; Otterud, B; Leppert, M; Fink, JK			Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; LARGE PEDIGREE; HETEROGENEITY; PARAPARESIS; REGION; FAMILY; 2P	Hereditary spastic paraplegia (HSP) is a clinically and genetically heterogeneous group of disorders characterized by insidiously progressive spastic weakness in the legs. Genetic loci for autosomal dominant HSP exist on chromosomes 2p, 14q, and 15q. These loci are excluded in 45% of autosomal dominant HSP kindreds, indicating the presence of additional loci for autosomal dominant HSP. We analyzed a Caucasian kindred with autosomal dominant HSP and identified tight linkage between the disorder and microsatellite markers on chromosome 8q (maximum two-point LOD score 5.51 at recombination fraction 0). Our results clearly establish the existence of a locus for autosomal dominant HSP on chromosome 8q23-24. Currently this locus spans 6.2 cM between D8S1804 and D8S1774 and includes several potential candidate genes. Identifying this novel HSP locus on chromosome 8q23-24 will facilitate discovery of this HSP gene, improve genetic counseling for families with linkage to this locus, and extend our ability to correlate clinical features with different HSP loci.	Univ Michigan, Dept Neurol, Ann Arbor, MI USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA	University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Fink, JK (corresponding author), 5214 CCGCB,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jkfink@umich.edu		Hedera, Peter/0000-0003-2699-4085	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036177, T32NS007222, R01NS033645] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS33645, R01NS36177, T32NS07222] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARAITSER M, 1990, GENETICS NEUROLOGICA, P275; BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOUSTANY RMN, 1987, NEUROLOGY, V37, P910, DOI 10.1212/WNL.37.6.910; CAMBI F, 1995, ARCH NEUROL-CHICAGO, V52, P665, DOI 10.1001/archneur.1995.00540310035013; CARTLIDGE NE, 1973, NEUROLOGY, V23, P1160, DOI 10.1212/WNL.23.11.1160; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930; Dube MP, 1997, AM J HUM GENET, V61, pA169; Figlewicz D. A., 1994, American Journal of Human Genetics, V55, pA185; FINK JK, 1995, NEUROLOGY, V45, P325, DOI 10.1212/WNL.45.2.325; Fink JK, 1997, CURR OPIN NEUROL, V10, P313, DOI 10.1097/00019052-199708000-00006; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; GISPERT S, 1995, AM J HUM GENET, V56, P183; GUYER M, 1992, SCIENCE, V258, P67; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; HENTATI A, 1994, HUM MOL GENET, V3, P1867, DOI 10.1093/hmg/3.10.1867; HOLMES GL, 1977, J NEUROL NEUROSUR PS, V40, P1003, DOI 10.1136/jnnp.40.10.1003; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lennon F., 1995, American Journal of Human Genetics, V57, pA217; MCKUSICK VA, 1988, MENDELIAN INHERITANC, P1189; Nance MA, 1998, HUM HERED, V48, P169, DOI 10.1159/000022798; Nielsen JE, 1998, J NEUROL NEUROSUR PS, V64, P61, DOI 10.1136/jnnp.64.1.61; Nielsen JE, 1997, HUM MOL GENET, V6, P1811, DOI 10.1093/hmg/6.11.1811; PHILIPP E, 1949, N Z Med J, V48, P22; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; RHEIN J, 1914, J NERV MENT DIS, V44, P115; ROE PF, 1963, J NEUROL NEUROSUR PS, V26, P516, DOI 10.1136/jnnp.26.6.516; SCHELTENS P, 1990, ACTA NEUROL SCAND, V82, P169, DOI 10.1111/j.1600-0404.1990.tb04484.x; SCHWARZ GA, 1956, ARCH NEURO PSYCHIATR, V75, P144, DOI 10.1001/archneurpsyc.1956.02330200038005; SKRE H, 1974, CLIN GENET, V6, P165; SUTHERLAND JM, 1975, HDB CLIN NEUROLOGY, V22, P420; ZATZ M, 1976, J MED GENET, V13, P217, DOI 10.1136/jmg.13.3.217	38	74	80	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					563	569		10.1086/302258	http://dx.doi.org/10.1086/302258			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973294	Green Published, Bronze			2022-12-18	WOS:000078740600026
J	Catalan, J; Autio, K; Kuosma, E; Norppa, H				Catalan, J; Autio, K; Kuosma, E; Norppa, H			Age-dependent inclusion of sex chromosomes in lymphocyte micronuclei of man	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; BLOCKED HUMAN-LYMPHOCYTES; X-CHROMOSOME; ANEUPLOIDY; FREQUENCY; WOMEN; CENTROMERES; INDIVIDUALS; SAMPLE; DAMAGE	Two-color centromeric FISH was used to study the inclusion of the X and Y chromosomes in micronuclei of cultured lymphocytes from 10 men representing two age groups (21-29 years and 51-55 years). In addition, pan-centromeric FISH was separately performed to identify any human chromosomes in micronuclei. One hundred micronuclei per probe were examined from each donor. A higher mean frequency of Y-positive micronuclei was observed in the older men than in the younger men. In both age groups, the X chromosome was micronucleated clearly more often than expected by chance, and the Y chromosome was overrepresented in micronuclei among the older men but not among the younger men. In lymphocytes of four women, X-positive micronuclei were more frequent than they were in men, even after the fact that women have two X chromosomes was taken into account. Similar results were obtained in first-division lymphocytes identified by cytochalasin-B-induced cytokinesis block. In comparison with normal cells, these binucleate cells showed a higher frequency (per 1,000 nuclei) of X-positive micronuclei (in the older men) but a lower frequency of micronuclei harboring autosomes or acentric fragments. In conclusion, the results show that both the X chromosome and the Y chromosome are preferentially micronucleated in male lymphocytes, the Y chromosome only in older subjects. Although the X chromosome has a general tendency to be included in micronuclei, it is micronucleated much more often in women than in men, which is probably the main reason for the high micronucleus frequency in women that has been documented in many previous studies.	Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, FIN-00250 Helsinki, Finland; Finnish Inst Occupat Hlth, Dept Epidemiol & Biostat, FIN-00250 Helsinki, Finland; Univ Zaragoza, Dept Anat Embryol & Genet, Zaragoza, Spain	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Zaragoza	Norppa, H (corresponding author), Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Topeliuksenkatu 41 A A, FIN-00250 Helsinki, Finland.	hannu.norppa@occuphealth.fi		Catalan Rodriguez, Julia/0000-0003-2936-242X; Norppa, Hannu/0000-0001-6637-904X				ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; BONASSI S, 1995, CANCER EPIDEM BIOMAR, V4, P671; CATALAN J, 1995, CYTOGENET CELL GENET, V68, P11, DOI 10.1159/000133879; Falck G, 1997, MUTAT RES-GEN TOX EN, V392, P71, DOI 10.1016/S0165-1218(97)00046-3; FENECH M, 1986, MUTAT RES, V161, P193, DOI 10.1016/0027-5107(86)90010-2; FENECH M, 1994, MUTAT RES-ENVIR MUTA, V313, P203, DOI 10.1016/0165-1161(94)90050-7; FENECH M, 1989, MUTAGENESIS, V4, P98, DOI 10.1093/mutage/4.2.98; FITZGERALD PH, 1975, HUMANGENETIK, V28, P153, DOI 10.1007/BF00735748; FITZGERALD PH, 1977, HUM GENET, V39, P329, DOI 10.1007/BF00295428; FORD JH, 1988, AM J HUM GENET, V43, P733; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; GANGULY BB, 1993, MUTAT RES, V295, P135; GUTTENBACH M, 1994, HUM GENET, V94, P295; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; Hando JC, 1997, HUM GENET, V100, P624, DOI 10.1007/s004390050564; HANDO JC, 1994, CHROMOSOMA, V103, P186, DOI 10.1007/s004120050023; HOGSTEDT B, 1983, SCAND J WORK ENV HEA, V9, P241, DOI 10.5271/sjweh.2414; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1046/j.1469-1809.1997.6160471.x; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; NAKAGOME Y, 1984, AM J HUM GENET, V36, P398; NAROD SA, 1988, AM J IND MED, V14, P449, DOI 10.1002/ajim.4700140408; NATH J, 1995, CHROMOSOMA, V103, P725, DOI 10.1007/s004120050085; NORPPA H, 1993, MUTAGENESIS, V8, P519, DOI 10.1093/mutage/8.6.519; RICHARD F, 1993, MUTAT RES, V295, P71, DOI 10.1016/0921-8734(93)90003-L; RICHARD F, 1994, MUTAT RES, V316, P1, DOI 10.1016/0921-8734(94)90002-7; *SAS I, 1989, SAS STAT US GUID VER, V2; Scarpato R, 1996, MUTAT RES-FUND MOL M, V372, P195, DOI 10.1016/S0027-5107(96)00139-X; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Steel R.G.D., 1980, PRINCIPLES STAT; STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y; Surralles J, 1996, AM J HUM GENET, V59, P1091; Surralles J, 1996, CYTOGENET CELL GENET, V75, P151, DOI 10.1159/000134467; Tucker JD, 1996, HUM GENET, V97, P471; Zijno A, 1996, MUTAT RES-FUND MOL M, V372, P211, DOI 10.1016/S0027-5107(96)00141-8; [No title captured]	35	74	75	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1464	1472		10.1086/302092	http://dx.doi.org/10.1086/302092			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792875	Bronze, Green Published			2022-12-18	WOS:000076985200024
J	Weiler, T; Greenberg, CR; Nylen, E; Halliday, W; Morgan, K; Eggertson, D; Wrogemann, K				Weiler, T; Greenberg, CR; Nylen, E; Halliday, W; Morgan, K; Eggertson, D; Wrogemann, K			Limb-girdle muscular dystrophy and Miyoshi myopathy in an aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; GENETIC-HETEROGENEITY; FRIEDREICH ATAXIA; BETA-SARCOGLYCAN; DISTAL MYOPATHY; DOMINANT FORM; LOCUS; MUTATIONS; DISEQUILIBRIUM; LOCALIZATION	We report the results of our investigations of a large, inbred, aboriginal Canadian kindred with nine muscular dystrophy patients. The ancestry of all but two of the carrier parents could be traced to a founder couple, seven generations back. Seven patients presented with proximal myopathy consistent with limb girdle-type muscular dystrophy (LGMD), whereas two patients manifested predominantly distal wasting and weakness consistent with Miyoshi myopathy (distal autosomal recessive muscular dystrophy) (MM). Age at onset of symptoms, degree of creatine kinase elevation, and muscle histology were similar in both phenotypes. Segregation of LGMD/MM is consistent with autosomal recessive inheritance, and the putative locus is significantly linked (LOD scores >3.0) to six marker loci that span the region of the LGMD2B locus on chromosome 2p. Our initial hypothesis that the affected patients would all be homozygous by descent for microsatellite markers surrounding the disease locus was rejected. Rather, two different core haplotypes, encompassing a 4-cM region spanned by D2S291-D2S145-D2S286, segregated with the disease, indicating that there are two mutant alleles of independent origin in this kindred. There was no association, however, between the two different haplotypes and clinical variability; they do not distinguish between the LGMD and MM phenotypes. Thus, we conclude that LGMD and MM in our population are caused by the same mutation in LGMD2B and that additional factors, both genetic and nongenetic, must contribute to the clinical phenotype.	UNIV MANITOBA,DEPT BIOCHEM & MOL BIOL,WINNIPEG,MB R3E 0W3,CANADA; UNIV MANITOBA,DEPT HUMAN GENET,WINNIPEG,MB R3E 0W3,CANADA; UNIV MANITOBA,DEPT PATHOL,WINNIPEG,MB R3E 0W3,CANADA; UNIV MANITOBA,DEPT PEDIAT & CHILD HLTH,WINNIPEG,MB R3E 0W3,CANADA; ST BONIFACE GEN HOSP,DEPT INTERNAL MED,WINNIPEG,MB R2H 2A6,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MONTREAL GEN HOSP,RES INST,MONTREAL,PQ H3G 1A4,CANADA	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; McGill University; McGill University; McGill University			Weiler, Tracey A/D-6646-2017	Weiler, Tracey A/0000-0003-4662-4495				ALLAMAND V, 1995, AM J HUM GENET, V56, P1417; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BENOTHMANE K, 1995, AM J HUM GENET, V57, P732; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BROOKE MH, 1986, CLIN VIEW NEUROMUSCU; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P71, DOI 10.1016/0960-8966(93)E0006-G; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; GREENBERG CR, 1987, AM J HUM GENET, V41, P128; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; LAING NG, 1995, AM J HUM GENET, V56, P422; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; PASSOSBUENO MR, 1995, GENOMICS, V27, P192, DOI 10.1006/geno.1995.1024; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; RODIUS F, 1994, AM J HUM GENET, V54, P1050; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SPEER MC, 1992, AM J HUM GENET, V50, P1211; SPEER MC, 1995, AM J HUM GENET, V57, P1371; SPEER MC, 1993, AM J HUM GENET, V53, P1082; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TODA T, 1994, AM J HUM GENET, V55, P946; UDD B, 1992, J MED GENET, V29, P383, DOI 10.1136/jmg.29.6.383; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; YAMANOUCHI Y, 1995, J NEUROL SCI, V129, P15, DOI 10.1016/0022-510X(94)00231-C; YAMAOKA LH, 1994, NEUROMUSCULAR DISORD, V4, P471, DOI 10.1016/0960-8966(94)90086-8	37	74	79	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					872	878						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808603				2022-12-18	WOS:A1996VL28300017
J	Barrat, FJ; Auloge, L; Pastural, E; Lagelouse, RD; Vilmer, E; Cant, AJ; Weissenbach, J; LePaslier, D; Fischer, A; desaintBasile, G				Barrat, FJ; Auloge, L; Pastural, E; Lagelouse, RD; Vilmer, E; Cant, AJ; Weissenbach, J; LePaslier, D; Fischer, A; desaintBasile, G			Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MARROW TRANSPLANTATION; BEIGE BG; NIDOGEN; DEFECT; MOUSE; END	The Chediak-Higashi syndrome (CHS) is a severe autosomal recessive condition, features of which are partial oculocutaneous albinism, increased susceptibility to infections, deficient natural killer cell activity, and the presence of large intracytoplasmic granulations in various cell types. Similar genetic disorders have been described in other species, including the beige mouse. On the basis of the hypothesis that the murine chromosome 13 region containing the beige locus was homologous to human chromosome 1, we have mapped the CHS locus to a 5-cM interval in chromosome segment 1q42.1-q42.2. The highest LOD score was obtained with the marker D1S235 (Z(max) = 5.38; theta = 0). Haplotype analysis enabled us to establish D1S2680 and D1S163, respectively, as the telomeric and the centromeric flanking markers. Multipoint linkage analysis confirms the localization of the CHS locus in this interval. Three YAC clones were found to cover the entire region in a contig established by YAC end-sequence characterization and sequence-tagged site mapping. The YAC contig contains all genetic markers that are nonrecombinant for the disease in the nine CHS families studied. This mapping confirms the previous hypothesis that the same gene defect causes CHS in human and beige phenotype in mice and provides a genetic framework for the identification of candidate genes.	HOP ROBERT DEBRE,PARIS,FRANCE; CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE; NEWCASTLE GEN HOSP,DEPT PAEDIAT IMMUNOL & INFECT DIS,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND; GENETHON,EVRY,FRANCE; CNRS URA 1922,EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Newcastle General Hospital; Centre National de la Recherche Scientifique (CNRS)	Barrat, FJ (corresponding author), HOP NECKER ENFANTS MALAD,INSERM U429,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269; Le Paslier, Denis/0000-0003-4335-9956				BAETZ K, 1995, J IMMUNOL, V154, P6122; BASILE GD, 1987, P NATL ACAD SCI USA, V84, P7576; BEGUEZCESAR A, 1943, SOC CUBANA PEDIAT B, V15, P900; BEJAOUI M, 1989, ARCH FR PEDIATR, V46, P733; BLUME RS, 1972, MEDICINE, V51, P247, DOI 10.1097/00005792-197207000-00001; BURKHARDT JK, 1993, J EXP MED, V178, P1845, DOI 10.1084/jem.178.6.1845; Burkhardt JK, 1996, TRENDS CELL BIOL, V6, P127, DOI 10.1016/0962-8924(96)20002-9; CLARK RA, 1971, J CLIN INVEST, V50, P2645, DOI 10.1172/JCI106765; CLAWSON C, 1991, BLOOD, V38, P814; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FISCHER A, 1994, BLOOD, V83, P1149; HADDAD E, 1995, BLOOD, V85, P3328, DOI 10.1182/blood.V85.11.3328.bloodjournal85113328; HALIOTIS T, 1980, J EXP MED, V151, P1039, DOI 10.1084/jem.151.5.1039; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; Holcombe R F, 1994, Immunodeficiency, V5, P131; HOLCOMBE R F, 1987, Genomics, V1, P287, DOI 10.1016/0888-7543(87)90058-9; JENKINS NA, 1991, GENOMICS, V9, P401, DOI 10.1016/0888-7543(91)90275-J; JUSTICE MJ, 1990, GENOMICS, V6, P341, DOI 10.1016/0888-7543(90)90575-F; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; OLSEN DR, 1989, AM J HUM GENET, V44, P876; OWEN FL, 1986, J IMMUNOL, V137, P1044; PEROU CM, 1993, SOMAT CELL MOLEC GEN, V19, P459, DOI 10.1007/BF01233251; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; ROOT RK, 1972, J CLIN INVEST, V51, P649, DOI 10.1172/JCI106854; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SATO A, 1955, Tohoku J Exp Med, V61, P201; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; TARGAN SR, 1983, J IMMUNOL, V130, P2671; WHITE JG, 1966, BLOOD-J HEMATOL, V28, P143, DOI 10.1182/blood.V28.2.143.143; WHITEHEART SW, 1995, TRENDS CELL BIOL, V5, P64, DOI 10.1016/S0962-8924(00)88948-5; WINDHORST DB, 1973, J INVEST DERMATOL, V60, P529, DOI 10.1111/1523-1747.ep12703609; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	36	74	77	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					625	632						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751864				2022-12-18	WOS:A1996VN62500017
J	Gardella, R; Belletti, L; Zoppi, N; Marini, D; Barlati, S; Colombi, M				Gardella, R; Belletti, L; Zoppi, N; Marini, D; Barlati, S; Colombi, M			Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the Localisata variant of recessive dystrophic epidermolysis bullosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREMATURE TERMINATION CODONS; ANCHORING FIBRILS; NONSENSE MUTATIONS; POINT MUTATION; EXPRESSION; LINKAGE; ORGANIZATION; JUNCTIONS; SEQUENCE; DOMAIN	Collagen type VII gene (COL7A1) has been demonstrated to be altered in several variants of dystrophic epidermolysis bullosa (DEB), with either recessive or dominant mode of inheritance. We have identified two mutations in a patient affected by a localisata variant of recessive DEB (L-RDEB), which is characterized by the less severe phenotype of the syndrome. These mutations are the first splicing mutations so far described for COL7A1 in DEB. One mutation is a paternally inherited A-->G transition at position -2 of the donor splicing site of intron 3, which results in three aberrant mRNAs, depending on the skipping of exon 3, the usage of a cryptic donor site inside exon 3, or the maintenance of intron 3. The second mutation is a maternally inherited G-->A transition at position -1 of the donor splicing site of intron 95, which induces the activation of a cryptic donor site 7 nt upstream the normal site and gives rise to a deleted mRNA, in addition to the normal one. All aberrant mRNAs show a shift of the reading frame, thus generating premature termination codons of translation. Allele-specific analysis of the transcripts has shown that the maternal mutation does nor completely abolish the correct splicing of COLVII pre-mRNA, thus allowing, in the patient, the synthesis of a certain lever of a functional protein. This result is compatible with the mild clinical L-RDEB phenotype observed in our patient.	UNIV BRESCIA,DIV BIOL & GENET,DEPT BIOMED SCI & BIOTECHNOL,I-25123 BRESCIA,ITALY; UNIV BRESCIA,INST CLIN DERMATOL,I-25123 BRESCIA,ITALY	University of Brescia; University of Brescia			Barlati, Sergio/A-2666-2010; Marini, Danyelle/AHA-6693-2022	Marini, Danyelle/0000-0003-0700-7603; ZOPPI, Nicoletta/0000-0003-0197-8927; Colombi, Marina/0000-0002-3105-5990				Bruckner-Tuderman Leena, 1993, P507; BRUCKNERTUDERMAN L, 1988, DERMATOLOGICA, V176, P57, DOI 10.1159/000248673; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1995, J CLIN INVEST, V95, P1328, DOI 10.1172/JCI117783; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; CHRISTIANO AM, 1992, HUM MOL GENET, V1, P475, DOI 10.1093/hmg/1.7.475; CHRISTIANO AM, 1994, CHRON DERMATOL, V4, P1; COOPER TW, 1987, DERMATOLOGY GENERAL, P610; DUNNILL MGS, 1994, HUM MOL GENET, V3, P1693, DOI 10.1093/hmg/3.9.1693; GRANDCHAMP B, 1989, NUCLEIC ACIDS RES, V17, P6637, DOI 10.1093/nar/17.16.6637; GREENSPAN DS, 1993, HUM MOL GENET, V2, P273, DOI 10.1093/hmg/2.3.273; HILAL L, 1993, NAT GENET, V5, P287, DOI 10.1038/ng1193-287; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; HOVNANIAN A, 1994, AM J HUM GENET, V55, P289; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEMMINK HH, 1994, HUM MOL GENET, V3, P317, DOI 10.1093/hmg/3.2.317; MCGRATH JA, 1993, J INVEST DERMATOL, V100, P366, DOI 10.1111/1523-1747.ep12471830; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; WEIL D, 1989, J BIOL CHEM, V264, P16804	30	74	75	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					292	300						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755915				2022-12-18	WOS:A1996VM28800004
J	Noorani, HZ; Khan, HN; Gallie, BL; Detsky, AS				Noorani, HZ; Khan, HN; Gallie, BL; Detsky, AS			Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY RETINOBLASTOMA; RB1 GENE; GERMLINE MUTATIONS; PENETRANCE; SPECTRUM	To compare costs of molecular and conventional screening of retinoblastoma relatives, we evaluated the direct health care costs. With variables set at the most likely values (baseline), the expected cost (in 1934 Canadian dollars) of conventional screening was $31,430 for a prototype family consisting of seven at-risk relatives (three clinic exams and eight examinations under anaesthetic over the first 3 years of life for each relative). For the molecular strategy that involves looking for the RB1 gene mutation in the proband, testing the relatives for that mutation, and clinical follow-up similar to conventional strategy for relatives with mutation, the expected cost was $8,674, using baseline variables. Sensitivity analysis over the range of values for each variable revealed a significant saving of health care dollars by the molecular route, indicating the benefit of redirecting economic resources to molecular diagnosis in retinoblastoma.	TORONTO HOSP,DIV GEN INTERNAL MED & CLIN EPIDEMIOL,TORONTO,ON M5S 2C4,CANADA; UNIV TORONTO,JOINT CTR BIOETH,TORONTO,ON,CANADA; UNIV TORONTO,SCH CONTINUING STUDIES,TORONTO,ON,CANADA; UNIV TORONTO,DEPT OPHTHALMOL,TORONTO,ON M5S 1A1,CANADA; UNIV TORONTO,DEPT MOL & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT HLTH ADM & MED,TORONTO,ON,CANADA; HOSP SICK CHILDREN,DEPT OPHTHALMOL,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,DIV IMMUNOL & CANC RES,TORONTO,ON M5G 1X8,CANADA; EYE RES INST CANADA,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)				Gallie, Brenda/0000-0002-9697-9211				BARR FG, 1995, JAMA-J AM MED ASSOC, V273, P553, DOI 10.1001/jama.273.7.553; BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; BONAITIPELLIE C, 1981, HUM GENET, V57, P411, DOI 10.1007/BF00281695; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CLEVERLEY WO, 1989, HDB HLTH CARE ACCOUN, P285; COMINGS DE, 1973, P NATL ACAD SCI USA, V70, P3324, DOI 10.1073/pnas.70.12.3324; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; DUNN JM, 1989, MOL CELL BIOL, V9, P4594; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GALLIE BL, 1991, PEDIATR CLIN N AM, V38, P299; GILL RM, 1994, CELL GROWTH DIFFER, V5, P467; HOLLENBERG J, 1989, SMLTREE VERSION 2 9; KASSIRER JP, 1987, ANN INTERN MED, V106, P275, DOI 10.7326/0003-4819-106-2-275; Keeney R., 1976, DECISIONS MULTIPLE O; KRAHN M, 1993, MED CARE, V31, P403, DOI 10.1097/00005650-199305000-00003; LOHMANN D, 1992, HUM GENET, V89, P49, DOI 10.1007/BF00207041; LOHMANN DR, 1994, HUM GENET, V94, P349; LOHMANN DR, 1994, HUM MOL GENET, V3, P2187, DOI 10.1093/hmg/3.12.2187; MATSUNAGA E, 1976, HUM GENET, V33, P1, DOI 10.1007/BF00447281; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; Musarella M A, 1987, J Pediatr Ophthalmol Strabismus, V24, P124; Noorani H. Z., 1995, American Journal of Human Genetics, V57, pA297; *ONT MIN HLTH, 1992, SCHED BEN PHYS SERV; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Sox HC, 1988, MED DECISION MAKING; TAMBOLI A, 1990, ARCH OPHTHALMOL-CHIC, V108, P128, DOI 10.1001/archopht.1990.01070030134045; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1	28	74	79	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					301	307						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755916				2022-12-18	WOS:A1996VM28800005
J	Easton, RD; Merriwether, DA; Crews, DE; Ferrell, RE				Easton, RD; Merriwether, DA; Crews, DE; Ferrell, RE			mtDNA variation in the Yanomami: Evidence for additional New World founding lineages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; NATIVE-AMERICANS; AFRICAN POPULATIONS; ANCIENT; HAPLOGROUPS; SEQUENCES; REVEALS; ORIGIN; POLYMORPHISMS; AFFINITIES	Native Americans have been classified into four founding haplogroups with as many as seven founding lineages based on mtDNA RFLPs and DNA sequence data. mtDNA analysis was completed for 83 Yanomami from eight villages in the Surucucu and Catrimani Plateau regions of Roraima in northwestern Brazil. Samples were typed for 15 polymorphic mtDNA sites (14 RFLP sites and 1 deletion site), and a subset was sequenced for both hypervariable regions of the mitochondrial D-loop. Substantial mitochondrial diversity was detected among the Yanomami, five of seven accepted founding haplotypes and three others were observed. Of the 83 samples, 4 (4.8%) were lineage B1, 1 (1.2%) was lineage B2, 31 (37.4%) were lineage C1, 29 (34.9%) were lineage C2, 2 (2.4%) were lineage D1, 6 (7.2%) were lineage D2, 7 (8.4%) were a haplotype we designated ''X6,'' and 3 (3.6%) were a haplotype we designated ''X7.'' Sequence analysis found 43 haplotypes in 50 samples. B2, X6, and X7 are previously unrecognized mitochondrial founding lineage types of Native Americans. The widespread distribution of these haplotypes in the New World and Asia provides support for declaring these lineages to be New World founding types.	UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT HUMAN GENET, PITTSBURGH, PA 15261 USA; OHIO STATE UNIV, DEPT ANTHROPOL, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, SCH PUBL HLTH, COLUMBUS, OH 43210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University			Crews, Douglas E./A-7078-2008		NCRR NIH HHS [P41 RR06009] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BALLINGER SW, 1992, GENETICS, V130, P139; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANN RL, 1994, AM J HUM GENET, V55, P7; Chagnon N.A., 1977, YANOMAMO FIERCE PEOP; Chagnon Napoleon., 1992, YANOMAMO LAST DAYS E; CHEN YS, 1995, AM J HUM GENET, V57, P133; CREWS DE, 1993, HUM BIOL, V65, P211; Crews Douglas E., 1993, Ethnicity and Disease, V3, P362; Dillehay T.D., 1989, PALEOENVIRONMENT SIT, V1; DORAN GH, 1986, NATURE, V323, P803, DOI 10.1038/323803a0; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GINTHER C, 1993, EXS, V67, P211; GOOD K, 1991, INTO HEART ONE MANS; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Hauswirth William W., 1994, P104; HORAI S, 1993, MOL BIOL EVOL, V10, P23; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lynch T., 1991, 1 AM SEARCH RES, P267; MADDISON WP, 1992, MACCLADE 301 ANAL PH; MARSHALL E, 1990, SCIENCE, V249, P738, DOI 10.1126/science.249.4970.738; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1994, EXPERIENTIA, V50, P592, DOI 10.1007/BF01921730; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; MERRIWETHER DA, 1993, AM J HUM GENET, V53, P833; MONSALVE MV, 1994, ANN HUM GENET, V58, P265, DOI 10.1111/j.1469-1809.1994.tb01890.x; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; ROTHHAMMER F, 1995, AM J HUM GENET, V56, P1247; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzano FM, 1988, S AM INDIANS CASE ST; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; STONEKING M, 1990, GENETICS, V124, P717; Swofford D.L., 1989, PAUP PHYLOGENETIC AN; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1995, AM J HUM GENET, V56, P1234; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; TURNER CG, 1989, SCI AM, V260, P88, DOI 10.1038/scientificamerican0289-88; Turner II C. G., 1985, J PAC HIST, P31; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIGILANT L, 1990, THESIS U CALIFORNIA; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1992, HUM BIOL, V64, P403; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WORMINGTON HM, 1970, EARLY MAN NEW WORLD, P191; Zegura S. L., 1985, J PACIFIC HIST CANBE, P1	58	74	76	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					213	225						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659527				2022-12-18	WOS:A1996VL45500028
J	Peoples, R; PerezJurado, L; Wang, YK; Kaplan, P; Francke, U				Peoples, R; PerezJurado, L; Wang, YK; Kaplan, P; Francke, U			The gene for replication factor C subunit 2 (RFC2) is within the 7q11.23 Williams syndrome deletion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ELASTIN GENE; TRANSLOCATION; POLYMORPHISM		STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,BECKMAN CTR,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT PEDIAT,STANFORD,CA 94305; CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Pennsylvania; Childrens Hospital of Philadelphia			Pérez Jurado, Luis Alberto/M-7706-2015		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000298] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG-00298] Funding Source: Medline; NIGMS NIH HHS [GM-08404] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN M, 1992, P NATL ACAD SCI USA, V89, P2516, DOI 10.1073/pnas.89.7.2516; COLLEY A, 1992, J MED GENET, V29, P63, DOI 10.1136/jmg.29.1.63; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; JURADO LAP, 1995, CYTOGENET CELL GENET, V70, P246; LUCKOW B, 1994, MOL CELL BIOL, V14, P1626, DOI 10.1128/MCB.14.3.1626; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; OKUMURA K, 1995, GENOMICS, V25, P274, DOI 10.1016/0888-7543(95)80135-9; PAN ZQ, 1993, P NATL ACAD SCI USA, V90, P6, DOI 10.1073/pnas.90.1.6; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a	14	74	76	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1370	1373						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651315				2022-12-18	WOS:A1996UM27100031
J	FENG, Y; LAKKIS, L; DEVYS, D; WARREN, ST				FENG, Y; LAKKIS, L; DEVYS, D; WARREN, ST			QUANTITATIVE COMPARISON OF FMRI GENE-EXPRESSION IN NORMAL AND PREMUTATION ALLELES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; CGG-REPEAT; METHYLATION ANALYSIS; FULL MUTATION; RNA-BINDING; CPG ISLAND; I LOCUS; PHENOTYPE; DNA; INSTABILITY	We report studies on FMR1 gene expression in cells derived from male premutation carriers. Transcription of FMR1 genes with CGG-repeat lengths within the premutation range was demonstrated to be normal. Repeat lengths are faithfully transcribed into FMR1 mRNAs, which have steady-state levels, as measured by RNase protection, similar to those of normal cells. Premutation transcripts also are shown to have normal turnover, with the FMR1 mRNA half-life estimated to be 12 h. Measurement of FMR1 protein was also found to be in similar abundance in normal and premutation cell lines. These data support the nonpenetrant status of premutation carriers of fragile X syndrome and suggest that the occasional case reports to the contrary may reflect either other causes, including low-level mosaicism for larger, methylated FMR1 alleles, or simply coincidence.	EMORY UNIV,SCH MED,ROLLINS RES CTR,HOWARD HUGHES MED INST,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; INSERM,U184,CNRS,GENET MOLEC EUCARYOTES LAB,STRASBOURG,FRANCE	Emory University; Howard Hughes Medical Institute; Emory University; Emory University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Warren, Stephen T/A-2498-2012	Feng, Yue/0000-0002-7905-2182; Devys, Didier/0000-0001-9655-3512	NICHD NIH HHS [HD20521] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, R01HD020521] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DORN MB, 1994, J AM ACAD CHILD PSY, V33, P256, DOI 10.1097/00004583-199402000-00015; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; FENG Y, 1991, DEV BIOL, V146, P451, DOI 10.1016/0012-1606(91)90246-Y; FENG Y, 1991, MOL CELL BIOL, V11, P2149, DOI 10.1128/MCB.11.4.2149; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HARLOW E, 1988, ANTIBODIES LABORATOR; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; HULL C, 1993, AM J DIS CHILD, V147, P1236, DOI 10.1001/archpedi.1993.02160350110017; JOSHI HC, 1989, J CELL BIOL, V109, P663, DOI 10.1083/jcb.109.2.663; KRASNEY PA, 1990, MOL BIOL EVOL, V7, P155; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KROWCZYNSKA A, 1985, J MOL BIOL, V181, P231, DOI 10.1016/0022-2836(85)90087-7; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LITT M, 1993, BIOTECHNIQUES, V15, P280; LOESCH DZ, 1993, AM J HUM GENET, V53, P1064; MAZZOCCO MMM, 1993, J DEV BEHAV PEDIATR, V14, P328; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; MEIJER H, 1994, HUM MOL GENET, V3, P615; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1993, AM J HUM GENET, V52, P884; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; ROUSSEAU F, 1993, AM J HUM GENET, V53, P3; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SMITS APT, 1993, J MED GENET, V30, P94, DOI 10.1136/jmg.30.2.94; SNOW K, 1993, AM J HUM GENET, V53, P1217; SOBESKY WE, 1994, J AM ACAD CHILD PSY, V33, P247, DOI 10.1097/00004583-199402000-00014; STEINBACH P, 1993, HUM GENET, V92, P491, DOI 10.1007/BF00216457; STEYAERT J, 1992, AM J MED GENET, V43, P116, DOI 10.1002/ajmg.1320430117; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TAYLOR AK, 1994, JAMA-J AM MED ASSOC, V271, P507, DOI 10.1001/jama.271.7.507; TORRES W, 1993, AM J HUM GENET, V53, P1241; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1995, ANNU REV NEUROSCI, V18, P77, DOI 10.1146/annurev.neuro.18.1.77; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	54	74	76	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					106	113						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825564				2022-12-18	WOS:A1995QC10100014
J	HIRST, M; GREWAL, P; FLANNERY, A; SLATTER, R; MAHER, E; BARTON, D; FRYNS, JP; DAVIES, K				HIRST, M; GREWAL, P; FLANNERY, A; SLATTER, R; MAHER, E; BARTON, D; FRYNS, JP; DAVIES, K			2 NEW CASES OF FMRI DELETION ASSOCIATED WITH MENTAL IMPAIRMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; CGG-REPEAT; GENE; DNA; METHYLATION; EXPRESSION; REGION; SITE; INSTABILITY; MUTATION	Screening of families clinically ascertained for the fragile X syndrome phenotype revealed two mentally impaired males who were cytogenetically negative for the fragile X chromosome. In both cases, screening for the FMR1 trinucleotide expansion mutation revealed a rearrangement within the FMR1 gene. In the first case, a 660-bp deletion is present in 40% of peripheral lymphocytes. PCR and sequence analysis revealed it to include the CpG island and the CGG trinucleotide repeat, thus removing the FMR1 promoter region and putative mRNA start site. In the second case, PCR analysis demonstrated that a deletion extended from a point proximal to FMR1 to 25 kb into the gene, removing all the region 5' to exon II. The distal breakpoint was confirmed by Southern blot analysis and localized to a 600-bp region, and FMR1-mRNA analysis in a cell line established from this individual confirmed the lack of a transcript. These deletion patients provide further confirmatory evidence that loss of FMR1 gene expression is indeed responsible for mental retardation. Additionally, these cases highlight the need for the careful examination of the FMR1 gene, even in the absence of cytogenetic expression, particularly when several fragile X-like clinical features are present.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC GENET GRP,OXFORD OX3 9DU,ENGLAND; ADDENBROOKES HOSP,GENET MOLEC LAB,E ANGLIAN REG GENET SERV,CAMBRIDGE,ENGLAND; UNIV HOSP GASTHUISBERG,DIV HUMAN GENET,B-3000 LOUVAIN,BELGIUM	University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; KU Leuven; University Hospital Leuven			Barton, David E/I-1795-2019; Barton, David E/B-9460-2008	Barton, David E/0000-0002-2031-9719; Hirst, Mark/0000-0003-3851-9740	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; FU YH, 1991, CELL, V67, P1; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GIBSON TJ, 1993, TRENDS BIOCHEM SCI, V18, P331, DOI 10.1016/0968-0004(93)90068-X; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; HIRST MC, 1991, NUCLEIC ACIDS RES, V19, P3283, DOI 10.1093/nar/19.12.3283; HIRST MC, 1993, J MED GENET, V30, P647, DOI 10.1136/jmg.30.8.647; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; HIRST MC, 1991, J MED GENET, V28, P824, DOI 10.1136/jmg.28.12.824; HWU WL, 1993, BIOCHEM BIOPH RES CO, V193, P324, DOI 10.1006/bbrc.1993.1627; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; MEIJER H, 1994, HUM MOL GENET, V3, P615; MORNET E, 1993, HUM GENET, V92, P373, DOI 10.1007/BF01247338; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V329, P624; WEBER C, 1993, HUM MOL GENET, V2, P612; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	31	74	77	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					67	74						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825604				2022-12-18	WOS:A1995QC10100009
J	MUNTONI, F; MELIS, MA; GANAU, A; DUBOWITZ, V				MUNTONI, F; MELIS, MA; GANAU, A; DUBOWITZ, V			TRANSCRIPTION OF THE DYSTROPHIN GENE IN NORMAL-TISSUES AND IN SKELETAL-MUSCLE OF A FAMILY WITH X-LINKED DILATED CARDIOMYOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BECKER MUSCULAR-DYSTROPHY; DIFFERENT PROMOTERS; DUCHENNE; BRAIN; EXPRESSION; DELETIONS; ENHANCER; ISOFORMS; ELEMENTS; BINDING	We recently described a family where a deletion of the dystrophin gene was associated with a severe dilated cardiomyopathy without skeletal muscle weakness. The deletion removed the muscle promoter region and the first muscle exon, but not the brain or Purkinje-cell promoters. Dystrophin was detected immunocytochemically in the skeletal muscle from this family, despite the fact that the deletion eliminated the transcriptional start site of the muscle isoform. In order to determine which promoter was driving dystrophin transcription in skeletal muscle of these individuals, we first evaluated the expression of the exon 1 of muscle, brain, and Purkinje-cell isoforms in normal human skeletal and cardiac muscles and in mouse brain and cerebellum. Our data indicate that, with the exception of minimal expression of the brain isoform, only the muscle isoform is significantly transcribed in skeletal muscle, whereas both the exon 1 muscle and brain isoforms are highly expressed in cardiac muscle. In contrast to what is observed in normal muscle, the skeletal muscle of our patients showed expression of both the brain and the Purkinje-cell isoforms. The overexpression, in skeletal muscle, of these two isoforms thus appears to be of crucial importance in preventing a myopathy in these affected males. The reason for the severe cardiomyopathy remains speculative, in the absence of dystrophin data on their heart. However, we have found in the 5' end of intron 1, a region deleted in our cases, regulatory sequences that might be of importance for dystrophin expression in various tissues. It is also possible that the deletion present in this family affects specifically one of the two dystrophin actin-binding domains.	IST CLIN & BIOL EVOLUT,CAGLIARI,ITALY; IST CLIN MED GEN & TERAPIA MED,SASSARI,ITALY		MUNTONI, F (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT PAEDIAT & NEONATAL MED,DU CANE RD,LONDON W12 0NN,ENGLAND.		Ganau, Antonello/D-6899-2012	GANAU, Antonello/0000-0002-7053-293X				AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; BARNEA E, 1990, NEURON, V5, P881, DOI 10.1016/0896-6273(90)90348-J; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; BULMAN DE, 1991, AM J HUM GENET, V48, P295; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; CHELLY J, 1990, NATURE, V344, P64, DOI 10.1038/344064a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; den Dunnen J T, 1991, Neuromuscul Disord, V1, P327, DOI 10.1016/0960-8966(91)90118-C; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GENG Y, 1991, NEUROMUSCULAR DISORD, V1, P123; GILGENKRANTZ H, 1992, J BIOL CHEM, V267, P10823; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; LEVINE BA, 1990, FEBS LETT, V263, P159, DOI 10.1016/0014-5793(90)80728-2; LEVINE BA, 1991, FEBS LETT, V298, P4; Makover A, 1991, Neuromuscul Disord, V1, P39, DOI 10.1016/0960-8966(91)90041-P; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MINTY A, 1966, MOL CELL BIOL, V6, P2125; MUNTONI F, 1989, FEBS LETT, V252, P95, DOI 10.1016/0014-5793(89)80896-8; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; MUNTONI F, 1994, NEW ENGL J MED, V330, P370; MUNTONI F, IN PRESS J MED GENET; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; RAPAPORT D, 1992, NEUROMUSCULAR DISORD, V2, P117, DOI 10.1016/0960-8966(92)90043-6; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; TAMURA T, 1993, J NEUROL SCI, V115, P214, DOI 10.1016/0022-510X(93)90227-P; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; WALSH K, 1989, MOL CELL BIOL, V9, P2191, DOI 10.1128/MCB.9.5.2191; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YOSHIDA K, 1993, MUSCLE NERVE, V16, P1161, DOI 10.1002/mus.880161104	35	74	75	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					151	157						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825571				2022-12-18	WOS:A1995QC10100019
J	STEICHENGERSDORF, E; GALLION, HH; FORD, D; GIRODET, C; EASTON, DF; DICIOCCIO, RA; EVANS, G; PONDER, MA; PYE, C; MAZOYER, S; NOGUCHI, T; KARENGUEVEN, F; SOBOL, H; HARDOUIN, A; BIGNON, YJ; PIVER, MS; SMITH, SA; PONDER, BAJ				STEICHENGERSDORF, E; GALLION, HH; FORD, D; GIRODET, C; EASTON, DF; DICIOCCIO, RA; EVANS, G; PONDER, MA; PYE, C; MAZOYER, S; NOGUCHI, T; KARENGUEVEN, F; SOBOL, H; HARDOUIN, A; BIGNON, YJ; PIVER, MS; SMITH, SA; PONDER, BAJ			FAMILIAL SITE-SPECIFIC OVARIAN-CANCER IS LINKED TO BRCA1 ON 17Q12-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLORECTAL-CANCER; LINKAGE ANALYSIS; BREAST; MUTATIONS; REGION; LOCUS	In a study of nine families with ''site-specific'' ovarian cancer (criterion: three or more cases of epithelial ovarian cancer and no cases of breast cancer diagnosed at age <50 years) we have obtained evidence of linkage to the breast-ovarian cancer susceptibility gene, BRCA1 on 17q12-21. If the risk of cancer in these families is assumed to be restricted to the ovary, the best estimate of the proportion of families linked to BRCA1 is .78 (95% confidence interval .32-1.0). If predisposition to both breast and ovarian cancer is assumed, the proportion linked is 1.0 (95% confidence interval .46-1.0). The linkage of familial site-specific ovarian cancer to BRCA1 indicates the possibility of predictive testing in such families; however, this is only appropriate in families where the evidence for linkage to BRCA1 is conclusive.	UNIV CAMBRIDGE,DEPT PATHOL,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE,ENGLAND; INST CANC RES,EPIDEMIOL SECT,SUTTON,SURREY,ENGLAND; CTR JEAN PERRIN,CLERMONT FERRAND,FRANCE; ROSWELL PK CANC INST,DEPT GYNECOL ONCOL,BUFFALO,NY 14263; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; INST J PAOLI I CALMETTES,DEPT ONCOL GENET,F-13009 MARSEILLE,FRANCE; CTR FRANCOIS BACLESSE,F-14021 CAEN,FRANCE	University of Cambridge; University of London; Institute of Cancer Research - UK; UNICANCER; Centre Jean Perrin; Roswell Park Cancer Institute; University of Manchester; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Francois Baclesse			, bignon/Y-3243-2019; Evans, D Gareth/AAB-4308-2022; Mazoyer, Sylvie/N-7559-2017	Evans, D Gareth/0000-0002-8482-5784; Mazoyer, Sylvie/0000-0002-2135-0160				EASTON DF, 1993, AM J HUM GENET, V52, P678; EASTON DF, IN PRESS CANCER SURV; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LYNCH HT, 1986, AM J MED, V81, P1073, DOI 10.1016/0002-9343(86)90411-0; MUIR C, 1987, CANCER INCIDENCE 5 C, V5; NAROD SA, 1991, LANCET, V338, P82; OTT J, 1985, ANAL HUMAN GENETIC L; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; SMITH SA, 1994, GENE CHROMOSOME CANC, V10, P71, DOI 10.1002/gcc.2870100112; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122	17	74	74	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					870	875						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977348				2022-12-18	WOS:A1994QB68200004
J	SHIANG, R; LIDRAL, AC; ARDINGER, HH; BUETOW, KH; ROMITTI, PA; MUNGER, RG; MURRAY, JC				SHIANG, R; LIDRAL, AC; ARDINGER, HH; BUETOW, KH; ROMITTI, PA; MUNGER, RG; MURRAY, JC			ASSOCIATION OF TRANSFORMING GROWTH-FACTOR ALPHA-GENE POLYMORPHISMS WITH NONSYNDROMIC CLEFT-PALATE ONLY (CPO)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGREGATION ANALYSIS; UNWINDING ACTIVITY; NO EVIDENCE; FACTOR EGF; LIP; LINKAGE; RNA; CONSTRUCTION; SEQUENCES; RECEPTOR	Genetic analysis and tissue-specific expression studies support a role for transforming growth-factor alpha (TGFA) in craniofacial development. Previous studies have confirmed an association of alleles for TGFA with nonsyndromic cleft lip with or without cleft palate (CL/P) in humans. We carried out a retrospective association study to determine whether specific allelic variants of the TGFA gene are also associated with cleft palate only (CPO). The PCR products from 12 overlapping sets of primers to the TGFA cDNA were examined by using single-strand conformational polymorphism analysis. Four DNA polymorphic sites for TGFA were identified in the 3' untranslated region of the TGFA gene. These variants, as well as previously identified RFLPs for TGFA, were characterized in case and control populations for CPO by using chi2 analysis. A significant association between alleles of TGFA and CPO was identified which further supports a role for this gene as one of the genetic determinants of craniofacial development. Sequence analysis of the variants disclosed a cluster of three variable sites within 30 bp of each other in the 3' untranslated region previously associated with an antisense transcript. These studies extend the role for TGFA in craniofacial morphogenesis and support an interrelated mechanism underlying nonsyndromic forms of CL/P.	UNIV IOWA HOSP & CLIN,DEPT PEDIAT,2613 JCP,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT PREVENT MED,IOWA CITY,IA 52242; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717; UNIV IOWA,COLL DENT,DEPT ORTHODONT,IOWA CITY,IA 52242; UNIV KANSAS,MED CTR,DEPT PEDIAT,KANSAS CITY,KS 66103; FOX CHASE CANC CTR,PHILADELPHIA,PA 19111	University of Iowa; University of Iowa; University of California System; University of California Irvine; University of Iowa; University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center					NIDCR NIH HHS [DE09170, DE08559, K16DE00175] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009170, R01DE008559, K16DE000175] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BLASBAND AJ, 1990, MOL CELL BIOL, V10, P2111, DOI 10.1128/MCB.10.5.2111; BURDICK AB, 1985, J CRANIOFAC GENET DE, V5, P18; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; CHUNG CS, 1989, GENET EPIDEMIOL, V6, P625, DOI 10.1002/gepi.1370060507; CHUNG CS, 1986, AM J HUM GENET, V39, P603; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1985, CANCER CELL, V3, P79; Dixon Michael J., 1992, Human Molecular Genetics, V1, P249, DOI 10.1093/hmg/1.4.249; DIXON MJ, 1991, ANAT EMBRYOL, V184, P83, DOI 10.1007/BF01744264; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; FARRALL M, 1992, AM J HUM GENET, V50, P270; FARRALL M, 1993, AM J HUM GENET, V52, P434; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSON MWJ, 1987, IRISH J MED SCI, V156, P309, DOI 10.1007/BF02951261; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; FRASER FC, 1970, AM J HUM GENET, V22, P336; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; HECHT JT, 1993, AM J HUM GENET, V52, P436; HOLDER SE, 1992, J MED GENET, V29, P390, DOI 10.1136/jmg.29.6.390; JAKOBOVITS EB, 1988, MOL CELL BIOL, V8, P5549, DOI 10.1128/MCB.8.12.5549; JAKOWLEW SB, 1988, MOL ENDOCRINOL, V2, P1056, DOI 10.1210/mend-2-11-1056; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MELNICK M, 1992, AM J MED GENET, V42, P10, DOI 10.1002/ajmg.1320420104; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P5117, DOI 10.1093/nar/14.12.5117; MURRAY JC, 1990, AM J HUM GENET, V46, P486; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; Pratt R., 1980, CURRENT RES TRENDS P, P235; SASSANI R, 1993, AM J MED GENET, V45, P565, DOI 10.1002/ajmg.1320450508; SHEFFIELD VC, 1992, AM J HUM GENET, V50, P567; STOLL C, 1992, AM J HUM GENET, V50, P870; VINTINER GM, 1992, J MED GENET, V29, P393, DOI 10.1136/jmg.29.6.393; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; WILLING MC, 1992, AM J HUM GENET, V51, P508	46	74	79	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					836	843						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8105683				2022-12-18	WOS:A1993LY62700007
J	VILAIN, E; MCELREAVEY, K; JAUBERT, F; RAYMOND, JP; RICHAUD, F; FELLOUS, M				VILAIN, E; MCELREAVEY, K; JAUBERT, F; RAYMOND, JP; RICHAUD, F; FELLOUS, M			FAMILIAL CASE WITH SEQUENCE VARIANT IN THE TESTIS-DETERMINING REGION ASSOCIATED WITH 2 SEX PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-BINDING MOTIF; GENE; HOMOLOGY; PROTEIN; SRY	The human Y chromosome encodes a testis-determining factor (TDF) which is responsible for initiating male sex determination. Recently a region of the Y chromosome (SRY) was identified as part of the TDF gene. We have identified a three-generation family (N) in which all XY individuals have a single base-pair substitution resulting in a conservative amino acid change in the conserved domain of the SRY open reading frame. Three individuals are XY sex-reversed females, and two are XY males. Several models are proposed to explain association between a sequence variant in SRY and two sex phenotypes.	HOP NECKER ENFANTS MALAD,F-75730 PARIS 15,FRANCE; HOP BICHAT,F-75877 PARIS 18,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	VILAIN, E (corresponding author), UNIV PARIS 07,INSERM,UNITE 276,INST PASTEUR,IMMUNOGENET HUMAINE LAB,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE.							BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; DAMIANI D, 1990, HUM GENET, V85, P85; EICHER EM, 1986, ANNU REV GENET, V20, P327, DOI 10.1146/annurev.ge.20.120186.001551; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; SIMPSON JL, 1981, HUM GENET, V58, P91; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WACHTEL S, 1983, H Y ANTIGEN BIOL SEX, P210; WRIGHT JM, 1988, BIOCHEMISTRY-US, V27, P576, DOI 10.1021/bi00402a012	12	74	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1008	1011						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570829				2022-12-18	WOS:A1992HR47300014
J	NOER, AS; SUDOYO, H; LERTRIT, P; THYAGARAJAN, D; UTTHANAPHOL, P; KAPSA, R; BYRNE, E; MARZUKI, S				NOER, AS; SUDOYO, H; LERTRIT, P; THYAGARAJAN, D; UTTHANAPHOL, P; KAPSA, R; BYRNE, E; MARZUKI, S			A TRANSFER RNALYS MUTATION IN THE MTDNA IS THE CAUSAL GENETIC LESION UNDERLYING MYOCLONIC EPILEPSY AND RAGGED-RED FIBER (MERRF) SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL TRANSLATION PRODUCTS; DNA; DISEASE; MUSCLE; GELS	Skeletal muscle mtDNA of three patients with mitochondrial encephalomyopathy, characterized clinically by myoclonic epilepsy and ragged-red fiber (MERRF) syndrome, has been sequenced to determine the underlying molecular defect(s). An A-to-G substitution of nt 8344 in the tRNA(Lys) gene, a substitution suggested to be associated with MERRF encephalomyopathy, was detected in these patients. Abnormal patterns of mitochondrial translation products were observed in the skeletal muscle of patients, consistent with the expected consequential defect in protein synthesis. The genealogical studies of the three patients, as well as mtDNA from one published MERRF patient and from nine other normal and disease controls, revealed that the tRNA(Lys) mutations in the MERRF patients have arisen independently. These observations provided evidence that the base substitution is a causal mutation for MERRF.	MONASH UNIV,DEPT BIOCHEM,CLAYTON,VIC 3168,AUSTRALIA; MONASH UNIV,CTR MOLEC BIOL & MED,CLAYTON,VIC 3168,AUSTRALIA; ST VINCENTS HOSP,DEPT NEUROL,FITZROY,VIC 3065,AUSTRALIA	Monash University; Monash University; St Vincent's Hospital Melbourne			Kapsa, Robert/H-8916-2013; Thyagarajan, Dominic E S/H-6633-2014	Thyagarajan, Dominic E S/0000-0002-7766-4003; Kapsa, Robert/0000-0002-6113-5174				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI G, 1987, HUM GENET, P165; BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802; BRYNE E, 1991, ACTA NEUROPATHOL, V81, P318; BRYNE E, 1985, J NEUROL SCI, V9, P319; BYRNE E, 1988, MED J AUSTRALIA, V149, P30, DOI 10.5694/j.1326-5377.1988.tb120480.x; BYRNE E, 1985, J NEUROL SCI, V71, P273, DOI 10.1016/0022-510X(85)90065-6; BYRNE E, 1988, J NEUROL SCI, V88, P327, DOI 10.1016/0022-510X(88)90229-8; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHING E, 1982, BIOCHEMISTRY-US, V21, P3188, DOI 10.1021/bi00256a024; DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; KADENBACK B, 1984, ANAL BIOCHEM, V129, P517; MARZUKI S, 1988, J NEUROL SCI, V87, P211, DOI 10.1016/0022-510X(88)90246-8; MARZUKI S, UNPUB NORMAL VARIANT; MARZUKI S, IN PRESS PROGR NEURO, V7; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; Sokal R. R., 1963, NUMERICAL TAXONOMY; WALLACE DC, 1986, AM J HUM GENET, V38, P461; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; YONEDA M, IN PRESS PROGR NEURO, V7	25	74	76	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					715	722						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1910259				2022-12-18	WOS:A1991GG66500003
J	LANDER, ES				LANDER, ES			RESEARCH ON DNA TYPING CATCHING UP WITH COURTROOM APPLICATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	LANDER, ES (corresponding author), WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.							BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1991, AM J HUM GENET, V48, P824; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; MALCOLM A, 1989, NY TIMES        0612; NORMAN C, 1989, SCIENCE, V246, P1556, DOI 10.1126/science.2688090	9	74	75	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					819	823						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1760000				2022-12-18	WOS:A1991FK89700001
J	FRANCKE, U; HSIEH, CL; FOELLMER, BE; LOMAX, KJ; MALECH, HL; LETO, TL				FRANCKE, U; HSIEH, CL; FOELLMER, BE; LOMAX, KJ; MALECH, HL; LETO, TL			GENES FOR 2 AUTOSOMAL RECESSIVE FORMS OF CHRONIC GRANULOMATOUS-DISEASE ASSIGNED TO 1Q25 (NCF2) AND 7Q11.23 (NCF1)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; NIAID,CLIN INVEST LAB,BACTERIAL DIS SECT,BETHESDA,MD 20205	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	FRANCKE, U (corresponding author), STANFORD UNIV,MED CTR,BECKMAN CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305, USA.			Malech, Harry/0000-0001-5874-5775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATTAT L, 1989, NUCLEIC ACIDS RES, V17, P3619, DOI 10.1093/nar/17.9.3619; BOLSCHER BGJM, 1989, J CLIN INVEST, V83, P757, DOI 10.1172/JCI113954; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; CIRNUTTE JT, 1989, P NATL ACAD SCI USA, V86, P825; CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; CURNUTTE JT, 1988, HEMATOL ONCOL CLIN N, V2, P241, DOI 10.1016/S0889-8588(18)30618-X; DINAUER MC, 1989, J CLIN INVEST, V84, P2012, DOI 10.1172/JCI114393; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; DINAUER MC, 1989, BLOOD, V74, pA107; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FRANCKE U, 1990, BLOOD, V76, P1; FRANKEL WN, 1989, J VIROL, V63, P1763, DOI 10.1128/JVI.63.4.1763-1774.1989; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P579, DOI 10.1007/BF01534919; HSIEH CL, 1989, CYTOGENET CELL GENET, V51, P1015; HSIEH CL, 1990, GENOMICS, V6, P666, DOI 10.1016/0888-7543(90)90502-L; JOYNER AL, 1985, NATURE, V314, P173, DOI 10.1038/314173a0; KENNEY RT, 1990, CLIN RES, V38, pA434; Klebanoff S.J., 1978, NEUTROPHIL FUNCTION; KRAMER IM, 1988, BIOCHIM BIOPHYS ACTA, V971, P189; KRUH GD, 1986, SCIENCE, V234, P1545, DOI 10.1126/science.3787260; LALLEY PA, 1989, CYTOGENET CELL GENET, V51, P503, DOI 10.1159/000132806; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LETO TL, 1988, MOL CELL BIOL, V8, P1; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MUNKE M, 1986, CYTOGENET CELL GENET, V42, P236, DOI 10.1159/000132284; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; ORKIN SH, 1989, ANNU REV IMMUNOL, V7, P277; PARKOS CA, 1989, BLOOD, V73, P1416; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SECHLER JMG, 1988, P NATL ACAD SCI USA, V85, P4874, DOI 10.1073/pnas.85.13.4874; SEGAL AW, 1988, HEMATOL ONCOL CLIN N, V2, P213, DOI 10.1016/S0889-8588(18)30616-6; SEGAL AW, 1983, NEW ENGL J MED, V308, P245, DOI 10.1056/NEJM198302033080503; SELDIN MF, 1989, GENOMICS, V4, P221, DOI 10.1016/0888-7543(89)90305-4; SHEPHARD EA, 1989, ANN HUM GENET, V53, P291, DOI 10.1111/j.1469-1809.1989.tb01798.x; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; WEENING RS, 1985, J CLIN INVEST, V75, P915, DOI 10.1172/JCI111792	43	74	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					483	492						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393022				2022-12-18	WOS:A1990DX22300013
J	RISCH, NJ; BRESSMAN, SB; DELEON, D; BRIN, MF; BURKE, RE; GREENE, PE; SHALE, H; CLAUS, EB; CUPPLES, LA; FAHN, S				RISCH, NJ; BRESSMAN, SB; DELEON, D; BRIN, MF; BURKE, RE; GREENE, PE; SHALE, H; CLAUS, EB; CUPPLES, LA; FAHN, S			SEGREGATION ANALYSIS OF IDIOPATHIC TORSION DYSTONIA IN ASHKENAZI JEWS SUGGESTS AUTOSOMAL DOMINANT INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; COLUMBIA PRESBYTERIAN MED CTR,INST NEUROL,DYSTONIA CLIN RES CTR,NEW YORK,NY 10032; BOSTON UNIV,SCH PUBL HLTH,BOSTON,MA 02215	Yale University; Columbia University; NewYork-Presbyterian Hospital; Boston University	RISCH, NJ (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.		Burke, Robert/B-7226-2011	Burke, Robert/0000-0002-4760-8553	NIGMS NIH HHS [GM39812] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMSON I, 1920, J NERV MENT DIS, V51, P451; BERNSTEIN S, 1912, WIEN KLIN WCHNSCHR, V25, P1567; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; BUNDEY S, 1975, J MED GENET, V12, P12, DOI 10.1136/jmg.12.1.12; ELDRIDGE R, 1970, NEUROLOGY, V20, P1; FAHN S, 1986, CLIN NEUROPHARMAC S2, V9, P537; Goodman R. M., 1979, GENETIC DISORDERS JE; HOEFNAGEL D, 1970, J CLIN GENET, V1, P258; JOHNSON W, 1962, ARCH NEUROL-CHICAGO, V7, P301, DOI 10.1001/archneur.1962.04210040053005; KORCZYN AD, 1981, ANN NEUROL, V10, P204, DOI 10.1002/ana.410100218; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LARSSON T, 1966, ACTA NEUROL SCAND S, V17, P1; Lee L V, 1976, Adv Neurol, V14, P137; Mankowsky BN, 1929, MON PSYCHIATR NEUROL, V72, P165; MCKUSICK VA, 1988, MENDELIAN INHERITANC; REGENSBURG I, 1930, MONATSCHR PSYCHIAT N, V75, P323; Schwalbe W, 1908, EIGENTUMLICHE TONISC; Wechsler IS, 1922, ARCH NEURO PSYCHIATR, V8, P538, DOI 10.1001/archneurpsyc.1922.02190170085005; ZEMAN W, 1959, AM J HUM GENET, V11, P188; ZEMAN W, 1967, PSYCHIATR NEUROL NEU, P77; ZILBER N, 1984, J MED GENET, V21, P13, DOI 10.1136/jmg.21.1.13	22	74	76	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					533	538						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309703				2022-12-18	WOS:A1990CT66800016
J	TANAKA, A; OHNO, K; SANDHOFF, K; MAIRE, I; KOLODNY, EH; BROWN, A; SUZUKI, K				TANAKA, A; OHNO, K; SANDHOFF, K; MAIRE, I; KOLODNY, EH; BROWN, A; SUZUKI, K			GM2-GANGLIOSIDOSIS-B1 VARIANT - ANALYSIS OF BETA-HEXOSAMINIDASE ALPHA-GENE ABNORMALITIES IN 7 PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,SCH MED,BIOL SCI RES CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,SCH MED,DEPT NEUROL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,SCH MED,DEPT PSYCHIAT,CHAPEL HILL,NC 27599; UNIV BONN,INST ORGAN CHEM,W-5300 BONN,GERMANY; HOP DEBROUSSE,DEPT METAB DIS,F-69005 LYONS,FRANCE; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,WALTHAM,MA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Bonn; CHU Lyon					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD005515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024289] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD-03110, HD-05515] Funding Source: Medline; NINDS NIH HHS [R01 NS-24289] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; Ausubel F.M., 1989, SHORT PROTOCOLS MOL; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; CONZELMANN E, 1985, PEDIATR RES, V19, P1220, DOI 10.1203/00006450-198511000-00022; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; GOLDMAN JE, 1980, ACTA NEUROPATHOL, V52, P189, DOI 10.1007/BF00705807; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KYTZIA HJ, 1983, EMBO J, V2, P1201, DOI 10.1002/j.1460-2075.1983.tb01567.x; KYTZIA HJ, 1985, J BIOL CHEM, V260, P7568; LI YT, 1981, BIOCHEM BIOPH RES CO, V101, P479; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; NAKANO K, 1988, J NEUROCHEM, V51, P984; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; OHNO K, 1988, J NEUROCHEM, V50, P316, DOI 10.1111/j.1471-4159.1988.tb13266.x; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; OHNO K, 1988, J BIOL CHEM, V263, P18563; OSTE C, 1988, BIOTECHNIQUES, V6, P162; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PROIA RL, 1982, P NATL ACAD SCI-BIOL, V79, P6360, DOI 10.1073/pnas.79.20.6360; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR G, 1988, NUCLEIC ACIDS RES, V16, P5197, DOI 10.1093/nar/16.11.5197; SONDERFELD S, 1985, HUM GENET, V71, P196, DOI 10.1007/BF00284572; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; SUZUKI K, 1987, METHOD ENZYMOL, V138, P727; SUZUKI K, 1970, NEUROLOGY, V20, P190, DOI 10.1212/WNL.20.2.190; SUZUKI Y, 1970, NEUROLOGY, V20, P848, DOI 10.1212/WNL.20.9.848; TANAKA A, 1988, BIOCHEM BIOPH RES CO, V156, P1015, DOI 10.1016/S0006-291X(88)80945-8; TANAKA A, 1989, J NEUROCHEM S, V52, pS186D; WONG C, 1987, NATURE, V330, P348; ZERFOWSKI J, 1974, ACTA NEUROPATHOL, V27, P225, DOI 10.1007/BF00687632	37	74	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					329	339						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2137287				2022-12-18	WOS:A1990CM93800014
J	SAVTCHENKO, ES; SCHIFF, TA; JIANG, CK; FREEDBERG, IM; BLUMENBERG, M				SAVTCHENKO, ES; SCHIFF, TA; JIANG, CK; FREEDBERG, IM; BLUMENBERG, M			EMBRYONIC EXPRESSION OF THE HUMAN 40-KD KERATIN - EVIDENCE FROM A PROCESSED PSEUDOGENE SEQUENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NYU MED CTR,DEPT DERMATOL,550 1ST AVE,NEW YORK,NY 10016; NYU MED CTR,DEPT BIOCHEM,NEW YORK,NY 10016	New York University; New York University				Blumenberg, Miroslav/0000-0002-8672-7774	NCRR NIH HHS [RR05399] Funding Source: Medline; NIADDK NIH HHS [AM35290, AM30682] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM030682] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; BLUMENBERG M, 1988, J MOL EVOL, V27, P203, DOI 10.1007/BF02100075; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; BRULET P, 1982, P NATL ACAD SCI-BIOL, V79, P2328, DOI 10.1073/pnas.79.7.2328; BRULET P, 1987, COLD SPRING HARBOR S, V52, P52; COOPER D, 1986, J BIOL CHEM, V261, P4646; DALE BA, 1985, J CELL BIOL, V101, P1257, DOI 10.1083/jcb.101.4.1257; DAMJANOV I, 1985, INTERMEDIATE FILAMEN, V455, P732; DARMON M, 1985, DEV BIOL, V110, P47, DOI 10.1016/0012-1606(85)90062-4; DUPREY P, 1985, P NATL ACAD SCI USA, V82, P8535, DOI 10.1073/pnas.82.24.8535; GLASSER SR, 1985, ANN NY ACAD SCI, V455, P755, DOI 10.1111/j.1749-6632.1985.tb50467.x; GROVER A, 1983, J CELL BIOL, V96, P1690, DOI 10.1083/jcb.96.6.1690; JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x; KEMLER R, 1981, J EMBRYOL EXP MORPH, V64, P45; MANIATIS T, 1982, MOL CLONING LABORATO; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4; OSHIMA RG, 1982, J BIOL CHEM, V257, P3414; OSHIMA RG, 1986, DIFFERENTIATION, V33, P61, DOI 10.1111/j.1432-0436.1986.tb00411.x; PUSTELL J, 1984, NUCLEIC ACIDS RES, V12, P643, DOI 10.1093/nar/12.1Part2.643; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVTCHENKO ES, 1988, MOL BIOL EVOL, V5, P97; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SINGER PA, 1986, J BIOL CHEM, V261, P538; STASIAK PC, 1987, NUCLEIC ACIDS RES, V15, P10058, DOI 10.1093/nar/15.23.10058; STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41; Sun TT, 1984, CANCER CELLS, V1, P169; SWOFFORD DL, 1985, PAUP PHYLOGENETIC AN; TREVOR K, 1985, J BIOL CHEM, V260, P5885; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; VASSEUR M, 1985, P NATL ACAD SCI USA, V82, P1155, DOI 10.1073/pnas.82.4.1155; WEBER K, 1985, ANN NY ACAD SCI, V455, P126, DOI 10.1111/j.1749-6632.1985.tb50408.x; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WU YJ, 1981, CELL, V25, P627, DOI 10.1016/0092-8674(81)90170-7; [No title captured]	36	74	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					630	637						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2461075				2022-12-18	WOS:A1988Q933600009
J	BEATY, TH; KWITEROVICH, PO; KHOURY, MJ; WHITE, S; BACHORIK, PS; SMITH, HH; TENG, B; SNIDERMAN, A				BEATY, TH; KWITEROVICH, PO; KHOURY, MJ; WHITE, S; BACHORIK, PS; SMITH, HH; TENG, B; SNIDERMAN, A			GENETIC-ANALYSIS OF PLASMA SITOSTEROL, APOPROTEIN-B, AND LIPOPROTEINS IN A LARGE AMISH PEDIGREE WITH SITOSTEROLEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS MED INST,LIPID RES ATHEROSCLEROSIS UNIT,DEPT PEDIAT,BALTIMORE,MD 21205; MCGILL UNIV,ROYAL VICTORIA HOSP,CARDIOVASC RES UNIT,MONTREAL H3G 1Y6,QUEBEC,CANADA	Johns Hopkins University; Johns Hopkins Medicine; McGill University; Royal Victoria Hospital	BEATY, TH (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205, USA.		Beaty, Terri/A-6032-2008		NHLBI NIH HHS [R0-1-HL-31497, N01-HV-2158L] Funding Source: Medline; NIGMS NIH HHS [R0-1-GM-32502] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032502] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; BRUNZELL JD, 1984, ARTERIOSCLEROSIS, V4, P79, DOI 10.1161/01.ATV.4.2.79; CAMPEAU L, 1984, NEW ENGL J MED, V311, P1329, DOI 10.1056/NEJM198411223112101; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; FALCONER DS, 1961, INTRO QUANTITATIVE G, P268; Goldstein JL, 1983, METABOLIC BASIS INHE, P672; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; ISHIKAWA TT, 1974, J LIPID RES, V15, P286; KHOURY MJ, 1985, THESIS J HOPKINS U B; KWITEROVICH PO, 1981, LANCET, V1, P466; KWITEROVICH PO, UNPUB PHENOTYPIC EXP; LIN HJ, 1983, METABOLISM, V32, P126, DOI 10.1016/0026-0495(83)90216-0; MELLIES M, 1976, PEDIATRICS, V57, P60; MELLIES MJ, 1976, J LAB CLIN MED, V88, P914; MIETTINEN TA, 1980, EUR J CLIN INVEST, V10, P27, DOI 10.1111/j.1365-2362.1980.tb00006.x; SALEN G, 1970, J CLIN INVEST, V49, P952, DOI 10.1172/JCI106315; SALEN G, 1985, J LIPID RES, V26, P203; SALEN G, 1983, METABOLIC BASIS INHE, P713; SHULMAN RS, 1976, NEW ENGL J MED, V294, P482, DOI 10.1056/NEJM197602262940907; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; SNIDERMAN A, 1975, J LIPID RES, V16, P465; SNIDERMAN AD, 1982, ANN INTERN MED, V97, P833, DOI 10.7326/0003-4819-97-6-833; TENG B, 1983, P NATL ACAD SCI USA, V80, P662; WHITINGTON GL, 1979, CIRCULATION, V60, P33; 1974, DHEW75628 PUBL	26	74	75	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					492	504						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3706300				2022-12-18	WOS:A1986C489300008
J	GONZALEZ, IL; SCHMICKEL, RD				GONZALEZ, IL; SCHMICKEL, RD			THE HUMAN 18S RIBOSOMAL-RNA GENE - EVOLUTION AND STABILITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											GONZALEZ, IL (corresponding author), UNIV PENN, DEPT HUMAN GENET, PHILADELPHIA, PA 19104 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016930] Funding Source: NIH RePORTER; NICHD NIH HHS [HD16930] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATMADJA J, 1984, NUCLEIC ACIDS RES, V12, P2649, DOI 10.1093/nar/12.6.2649; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; CARBON P, 1979, EUR J BIOCHEM, V100, P399, DOI 10.1111/j.1432-1033.1979.tb04183.x; CHAN YL, 1984, J BIOL CHEM, V259, P224; CONNAUGHTON JF, 1984, NUCLEIC ACIDS RES, V12, P4731, DOI 10.1093/nar/12.11.4731; EPERON IC, 1980, NATURE, V286, P460, DOI 10.1038/286460a0; ERICKSON JM, 1981, GENE, V16, P1, DOI 10.1016/0378-1119(81)90055-X; GOMER R, 1985, BRL FOCUS, V7, P6; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; GORSKI JL, UNPUB; HOGAN JJ, 1984, BIOCHEMISTRY-US, V23, P3322, DOI 10.1021/bi00309a032; MANKIN AS, 1981, FEBS LETT, V134, P11, DOI 10.1016/0014-5793(81)80539-X; MESSING J, 1984, DNA-J MOLEC CELL BIO, V3, P31, DOI 10.1089/dna.1.1984.3.31; NELLES L, 1984, NUCLEIC ACIDS RES, V12, P8749, DOI 10.1093/nar/12.23.8749; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; OLSEN GJ, 1983, NUCLEIC ACIDS RES, V11, P8037, DOI 10.1093/nar/11.22.8037; RAYNAL F, 1984, FEBS LETT, V167, P263, DOI 10.1016/0014-5793(84)80139-8; RUBTSOV PM, 1980, NUCLEIC ACIDS RES, V8, P5779, DOI 10.1093/nar/8.23.5779; SALIM M, 1981, NATURE, V291, P205, DOI 10.1038/291205a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAKAIWA F, 1984, NUCLEIC ACIDS RES, V12, P5441, DOI 10.1093/nar/12.13.5441; TORCZYNSKI R, 1983, NUCLEIC ACIDS RES, V11, P4879, DOI 10.1093/nar/11.14.4879; WILSON GN, 1982, AM J HUM GENET, V34, P32; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983	25	74	76	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					419	427						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	2422931				2022-12-18	WOS:A1986C489300002
J	KUBILUS, J; TARASCIO, AJ; BADEN, HP				KUBILUS, J; TARASCIO, AJ; BADEN, HP			STEROID-SULFATASE DEFICIENCY IN SEX-LINKED ICHTHYOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											KUBILUS, J (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT DERMATOL,BOSTON,MA 02114, USA.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; EBLING FJ, 1972, TXB DERMATOLOGY, V2, P1150; KERR CB, 1965, ANN HUM GENET, V29, P33, DOI 10.1111/j.1469-1809.1965.tb00499.x; KUBILUS J, UNPUBLISHED; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; SHAPIRO LJ, 1977, PEDIATR RES, V11, P894, DOI 10.1203/00006450-197708000-00008; SHAPIRO LJ, 1978, LANCET, V1, P70; WELLS RS, 1966, J INVEST DERMATOL, V46, P530, DOI 10.1038/jid.1966.80; WELLS RS, 1967, J AMER MED ASSOC, V202, P485, DOI 10.1001/jama.202.6.485	9	74	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					50	53						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	155398				2022-12-18	WOS:A1979GR11500006
J	KENDALL, AG; OJWANG, PJ; SCHROEDER, WA; HUISMAN, THJ				KENDALL, AG; OJWANG, PJ; SCHROEDER, WA; HUISMAN, THJ			HEMOGLOBIN-KENYA, PRODUCT OF A GAMMA-BETA FUSION GENE - STUDIES OF FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KENYATTA NATL HOSP, NAIROBI, KENYA; MCGILL UNIV, FAC MED, MONTREAL 112, QUEBEC, CANADA; CALTECH, DIV CHEM & CHEM ENGN, PASADENA, CA 91109 USA; VET ADMIN HOSP, AUGUSTA, GA 30902 USA; ROY VICTORIA HOSP, MONTREAL 112, QUEBEC, CANADA; MED COLL GEORGIA, LAB PROT CHEM, AUGUSTA, GA 30902 USA; MED COLL GEORGIA, SICKLE CELL CTR, AUGUSTA, GA 30902 USA	Kenyatta National Hospital; McGill University; California Institute of Technology; McGill University; Royal Victoria Hospital; University System of Georgia; Augusta University; University System of Georgia; Augusta University								AHERN EJ, 1972, BLOOD-J HEMATOL, V40, P246, DOI 10.1182/blood.V40.2.246.246; BAGLIONI C, 1962, P NATL ACAD SCI USA, V48, P1880, DOI 10.1073/pnas.48.11.1880; BALL EW, 1966, NATURE, V209, P1217, DOI 10.1038/2091217a0; BARNABAS J., 1962, NATURE, V194, P931, DOI 10.1038/194931a0; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; CLEGG JB, 1968, NATURE, V219, P69, DOI 10.1038/219069a0; DOZY AM, 1968, J CHROMATOGR, V32, P723, DOI 10.1016/S0021-9673(01)80551-3; EFREMOV GD, 1969, J BIOL CHEM, V244, P6105; Hirs CHW, 1967, METHOD ENZYMOL, P59, DOI [10.1016/S0076-6879(67)11008-2, DOI 10.1016/S0076-6879(67)11008-2]; Huisman T H, 1970, CRC Crit Rev Clin Lab Sci, V1, P471, DOI 10.3109/10408367009027952; HUISMAN THJ, 1972, CLIN CHIM ACTA, V40, P159, DOI 10.1016/0009-8981(72)90264-1; HUISMAN THJ, 1965, J CHROMATOGR, V19, P160, DOI 10.1016/S0021-9673(01)99434-8; HUISMAN THJ, 1969, ANN NY ACAD SCI, V165, P320, DOI 10.1111/j.1749-6632.1969.tb27802.x; HUISMAN THJ, 1972, ARCH BIOCHEM BIOPHYS, V153, P850, DOI 10.1016/0003-9861(72)90408-0; HUISMAN THJ, 1972, CLIN CHIM ACTA, V38, P5, DOI 10.1016/0009-8981(72)90201-X; HUISMAN THJ, 1972, BIOCHEM GENET, V7, P131, DOI 10.1007/BF00486084; HUISMAN THJ, 1972, ADV CLIN CHEM, V15, P150; JONES RT, 1967, J BIOL CHEM, V242, P5141; KLEIHAUER E, 1966, FETALES HAMOGLOBIN F; OSTERTAG W, 1969, EUR J BIOCHEM, V10, P371, DOI 10.1111/j.1432-1033.1969.tb00700.x; RAFTERY MA, 1966, J BIOL CHEM, V241, P3457; SCHROEDER WA, 1963, BIOCHEMISTRY-US, V2, P992, DOI 10.1021/bi00905a016; SCHROEDER WA, 1965, ANAL CHEM, V37, P1583, DOI 10.1021/ac60231a036; SCHROEDER WA, 1970, ANAL BIOCHEM, V35, P235, DOI 10.1016/0003-2697(70)90030-8; SCHROEDER WA, 1970, AM J HUM GENET, V22, P505; SCHROEDER WA, 1968, P NATL ACAD SCI USA, V60, P537, DOI 10.1073/pnas.60.2.537; WINTROBE MM, 1962, CLINICAL HEMATOLOGY; WRIGHTSTONE RN, 1968, CLIN CHIM ACTA, V22, P593, DOI 10.1016/0009-8981(68)90108-3	28	74	74	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	5					548	563						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q7858	4741849				2022-12-18	WOS:A1973Q785800007
J	VIDGOFF, J; BUIST, NRM; OBRIEN, JS				VIDGOFF, J; BUIST, NRM; OBRIEN, JS			ABSENCE OF BETA-N-ACETYL-D-HEXOSAMINIDASE-A ACTIVITY IN A HEALTHY WOMAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OREGON,MED SCH,DEPT MED GENET,PORTLAND,OR 97201; UNIV OREGON,MED SCH,DEPT PEDIAT,PORTLAND,OR 97201; UNIV CALIF,SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92037	University of Oregon; University of Oregon; University of California System; University of California San Diego								CAYGILL JC, 1966, BIOCHEM J, V98, P405, DOI 10.1042/bj0980405; CLAUSEN J, 1972, EUR NEUROL, V7, P56, DOI 10.1159/000114412; DANCE N, 1969, CLIN CHIM ACTA, V24, P189, DOI 10.1016/0009-8981(69)90311-8; DANCE N, 1970, BIOCHIM BIOPHYS ACTA, V222, P662, DOI 10.1016/0304-4165(70)90193-5; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DELVIN EE, 1972, UNION MED CAN, V101, P683; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIEDLAN.J, 1970, CLIN CHIM ACTA, V28, P397, DOI 10.1016/0009-8981(70)90064-1; HOOGHWIN.GJ, 1972, H-S Z PHYSIOL CHEM, V353, P839; HULTBERG B, 1969, LANCET, V2, P1195; KABACK MM, 1972, PEDIATR RES, V6, P261; KAMPINE JP, 1967, SCIENCE, V155, P86, DOI 10.1126/science.155.3758.86; KOLODNY EH, 1969, BIOCHEM BIOPH RES CO, V37, P526, DOI 10.1016/0006-291X(69)90947-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MURPHY JV, 1972, CLIN CHIM ACTA, V42, P267, DOI 10.1016/0009-8981(72)90089-7; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OBRIEN JS, 1971, SCIENCE, V172, P61, DOI 10.1126/science.172.3978.61; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; ROBINSON D, 1972, Journal of Neurochemistry, V19, P1975, DOI 10.1111/j.1471-4159.1972.tb01487.x; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; Sandhoff K, 1970, FEBS Lett, V11, P342, DOI 10.1016/0014-5793(70)80564-6; SANDHOFF K, 1971, H-S Z PHYSIOL CHEM, V352, P1119, DOI 10.1515/bchm2.1971.352.2.1119; SANDHOFF K, 1968, Pathologia Europaea, V3, P278; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; TALLMAN JF, 1972, J CLIN INVEST, V51, P2339, DOI 10.1172/JCI107045; YOSHIKAWA J, 1972, BIOCHEM BIOPH RES CO, V46, P11, DOI 10.1016/0006-291X(72)90622-5	27	74	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	4					372	381						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q0158	4716656				2022-12-18	WOS:A1973Q015800003
J	Guo, MH; Plummer, L; Chan, YM; Hirschhorn, JN; Lippincott, MF				Guo, Michael H.; Plummer, Lacey; Chan, Yee-Ming; Hirschhorn, Joel N.; Lippincott, Margaret F.			Burden Testing of Rare Variants Identified through Exome Sequencing via Publicly Available Control Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOGONADOTROPIC HYPOGONADISM; GENETIC-VARIATION; KALLMANN-SYNDROME; NEUROKININ B; NULL MICE; MUTATIONS; ASSOCIATION; FRAMEWORK; REPRODUCTION; DEFICIENCY	The genetic causes of many Mendelian disorders remain undefined. Factors such as lack of large multiplex families, locus heterogeneity, and incomplete penetrance hamper these efforts for many disorders. Previous work suggests that gene-based burden testing-where the aggregate burden of rare, protein-altering variants in each gene is compared between case and control subjects-might overcome some of these limitations. The increasing availability of large-scale public sequencing databases such as Genome Aggregation Database (gnomAD) can enable burden testing using these databases as controls, obviating the need for additional control sequencing for each study. However, there exist various challenges with using public databases as controls, including lack of individual-level data, differences in ancestry, and differences in sequencing platforms and data processing. To illustrate the approach of using public data as controls, we analyzed whole-exome sequencing data from 393 individuals with idiopathic hypogonadotropic hypogonadism (IHH), a rare disorder with significant locus heterogeneity and incomplete penetrance against control subjects from gnomAD (n = 123,136). We leveraged presumably benign synonymous variants to calibrate our approach. Through iterative analyses, we systematically addressed and overcame various sources of artifact that can arise when using public control data. In particular, we introduce an approach for highly adaptable variant quality filtering that leads to well-calibrated results. Our approach "re-discovered" genes previously implicated in IHH (FGFR1, TACR3, GNRHR). Furthermore, we identified a significant burden in TYRO3, a gene implicated in hypogonadotropic hypogonadism in mice. Finally, we developed a user-friendly software package TRAPD (Test Rare vAriants with Public Data) for performing gene-based burden testing against public databases.	[Guo, Michael H.; Chan, Yee-Ming; Hirschhorn, Joel N.] Boston Childrens Hosp, Dept Pediat, Div Endocrinol, Boston, MA 02115 USA; [Guo, Michael H.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Guo, Michael H.; Hirschhorn, Joel N.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Plummer, Lacey; Lippincott, Margaret F.] Massachusetts Gen Hosp, Div Endocrinol, Reprod Endocrine Unit, Boston, MA 02114 USA; [Guo, Michael H.] Univ North Carolina Hosp, Dept Med, Chapel Hill, NC 25779 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University North Carolina Hospital; University of North Carolina; University of North Carolina School of Medicine	Lippincott, MF (corresponding author), Massachusetts Gen Hosp, Div Endocrinol, Reprod Endocrine Unit, Boston, MA 02114 USA.	mlippincott@mgh.harvard.edu		Lippincott, Margaret/0000-0002-3533-1999	Eunice K. Shriver National Institute for Child Health and Human Development (NICHD) [P50 HD28138]; NIH [R01 HD090071, R01DK075787]; Harvard Catalyst\The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH) [UL 1TR002541]; Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD090071, P50HD028138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787] Funding Source: NIH RePORTER	Eunice K. Shriver National Institute for Child Health and Human Development (NICHD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst\The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH); Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant P50 HD28138 from the Eunice K. Shriver National Institute for Child Health and Human Development (NICHD). Y.-M.C. was supported by NIH R01 HD090071. J.N.H. was supported by NIH R01DK075787. M.F.L. was supported by a Catalyst Medical Research Investigator Training Award from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH award UL 1TR002541), and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Balasubramanian R, 2011, MOL CELL ENDOCRINOL, V346, P4, DOI 10.1016/j.mce.2011.07.012; Beranova M, 2001, J CLIN ENDOCR METAB, V86, P1580, DOI 10.1210/jc.86.4.1580; Boehm U, 2015, NAT REV ENDOCRINOL, V11, P547, DOI 10.1038/nrendo.2015.112; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Guo MH, 2016, AM J HUM GENET, V99, P527, DOI 10.1016/j.ajhg.2016.06.031; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laitinen EM, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-41; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Moutsianas L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005165; O'Connor TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065834; Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169; Pierce A, 2011, MOL CELL ENDOCRINOL, V339, P151, DOI 10.1016/j.mce.2011.04.007; Pitteloud N, 2006, MOL CELL ENDOCRINOL, V254, P60, DOI 10.1016/j.mce.2006.04.021; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raghavan NS, 2018, ANN CLIN TRANSL NEUR, V5, P832, DOI 10.1002/acn3.582; Salian-Mehta S, 2014, J CLIN ENDOCR METAB, V99, P1452, DOI 10.1210/jc.2013-3426; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Stamou MI, 2016, ENDOCR REV, V2016, P4, DOI [10.1210/er.2015-1045.2016.1.test, DOI 10.1210/ER.2015-1045.2016.1.TEST]; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Yang JJ, 2012, ENDOCRINOLOGY, V153, P1498, DOI 10.1210/en.2011-1949	43	73	73	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					522	534		10.1016/j.ajhg.2018.08.016	http://dx.doi.org/10.1016/j.ajhg.2018.08.016			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30269813	Green Published, Bronze			2022-12-18	WOS:000446312200006
J	Chen, BB; Zhang, ZH; Sun, XX; Kuang, YP; Mao, XY; Wang, XQ; Yan, Z; Li, B; Xu, Y; Yu, M; Fu, J; Mu, J; Zhou, Z; Li, QL; Jin, L; He, L; Sang, Q; Wang, L				Chen, Biaobang; Zhang, Zhihua; Sun, Xiaoxi; Kuang, Yanping; Mao, Xiaoyan; Wang, Xueqian; Yan, Zheng; Li, Bin; Xu, Yao; Yu, Min; Fu, Jing; Mu, Jian; Zhou, Zhou; Li, Qiaoli; Jin, Li; He, Lin; Sang, Qing; Wang, Lei			Biallelic Mutations in PATL2 Cause Female Infertility Characterized by Oocyte Maturation Arrest	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCING DATA; MEIOTIC ARREST; TUBB8; FERTILIZATION; NUCLEAR; XENOPUS; WOMEN	Oocyte maturation arrest results in female infertility, but the genetic determinants of human oocyte maturation arrest remain largely unknown. Previously, we identified TUBB8 mutations responsible for human oocyte maturation arrest, indicating the important role of genetic factors in the disorder. However, TUBB8 mutations account for only around 30% of individuals with oocyte maturation arrest; thus, the disorder is likely to involve other genetic factors that are as yet unknown. Here, we initially identified a homozygous nonsense mutation of PATL2 (c.784C>T [p. Arg262*]) in a consanguineous family with a phenotype characterized by human oocyte germinal vesicle (GV) arrest. Subsequent mutation screening of PATL2 in a cohort of 179 individuals identified four additional independent individuals with compound-heterozygous PATL2 mutations with slight phenotypic variability. A genetic burden test further confirmed the genetic contribution of PATL2 to human oocyte maturation arrest. By western blot in HeLa cells, identification of splicing events in affected individuals' granulosa cells, and immunostaining in affected individuals' oocytes, we provide evidence that mutations in PATL2 lead to decreased amounts of protein. These findings suggest an important role for PATL2 mutations in oocyte maturation arrest and expand our understanding of the genetic basis of female infertility.	[Chen, Biaobang; Zhang, Zhihua; Wang, Xueqian; Xu, Yao; Mu, Jian; Zhou, Zhou; Li, Qiaoli; Jin, Li; Sang, Qing; Wang, Lei] Fudan Univ, State Key Lab Genet Engn, Zhongshan Hosp, Inst Biomed Sci,Sch Life Sci, Shanghai 200032, Peoples R China; [Chen, Biaobang; Sang, Qing; Wang, Lei] Guangzhou Med Univ, Guangzhou Med Univ & Guangzhou Inst Biomed & Hlth, Guangzhou 511436, Guangdong, Peoples R China; [Sun, Xiaoxi; Yu, Min; Fu, Jing] Fudan Univ, Shanghai Ji Ai Genet & IVF Inst, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Kuang, Yanping; Mao, Xiaoyan; Yan, Zheng; Li, Bin] Shanghai Jiao Tong Univ, Shanghai Hosp 9, Reprod Med Ctr, Shanghai 200011, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Ctr, Minist Educ, Shanghai 200030, Peoples R China; [He, Lin] Guangzhou Med Univ, Affiliated Hosp 3, Lin Hes Acad Workstn New Med & Clin Translat, Guangzhou 510150, Guangdong, Peoples R China	Fudan University; Guangzhou Medical University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangzhou Medical University	Sang, Q; Wang, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Zhongshan Hosp, Inst Biomed Sci,Sch Life Sci, Shanghai 200032, Peoples R China.; Sang, Q; Wang, L (corresponding author), Guangzhou Med Univ, Guangzhou Med Univ & Guangzhou Inst Biomed & Hlth, Guangzhou 511436, Guangdong, Peoples R China.	sangqing@fudan.edu.cn; wangleiwanglei@fudan.edu.cn	zhang, zh/GWV-4677-2022; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Kuang, Yanping/T-4070-2019; Xu, Yao/AFL-6014-2022	Jin, Li/0000-0002-4546-2415; Xu, Yao/0000-0002-0792-1158; Chen, Biaobang/0000-0002-9921-2155	National Key Research and Development Program of China [2017YFC1001500, 2016YFC1000600]; National Basic Research Program of China [2015CB943300]; National Natural Science Foundation of China [81771581, 81571501, 81571397, 81571506, 81300550]; Shanghai Rising Star Program [17QA1400200]	National Key Research and Development Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising Star Program	This work was supported by the National Key Research and Development Program of China (2017YFC1001500 and 2016YFC1000600), the National Basic Research Program of China (2015CB943300), the National Natural Science Foundation of China (81771581, 81571501, 81571397, 81571506, and 81300550), and Shanghai Rising Star Program (17QA1400200).	Alazami AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0792-0; Bergere M, 2001, HUM REPROD, V16, P2136, DOI 10.1093/humrep/16.10.2136; Chen BB, 2017, HUM REPROD, V32, P457, DOI 10.1093/humrep/dew322; Dean J, 2016, NEW ENGL J MED, V374, P279, DOI 10.1056/NEJMe1515512; EICHENLAUBRITTER U, 1995, HUM REPROD, V10, P2343; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Feng RZ, 2016, J MED GENET, V53, P662, DOI 10.1136/jmedgenet-2016-103891; Feng RZ, 2016, NEW ENGL J MED, V374, P223, DOI 10.1056/NEJMoa1510791; Hartshorne G, 1999, FERTIL STERIL, V71, P567, DOI 10.1016/S0015-0282(98)00505-6; Huang LL, 2017, REPROD BIOMED ONLINE, V35, P305, DOI 10.1016/j.rbmo.2017.05.017; Levran D, 2002, HUM REPROD, V17, P1604, DOI 10.1093/humrep/17.6.1604; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Nakamura Y, 2010, DEV BIOL, V344, P272, DOI 10.1016/j.ydbio.2010.05.006; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; RUDAK E, 1990, FERTIL STERIL, V54, P292; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu Y, 2016, AM J HUM GENET, V99, P744, DOI 10.1016/j.ajhg.2016.06.024	21	73	78	3	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					609	615		10.1016/j.ajhg.2017.08.018	http://dx.doi.org/10.1016/j.ajhg.2017.08.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28965849	Bronze, Green Published			2022-12-18	WOS:000412277300011
J	Zhu, FX; Wang, FS; Yang, XY; Zhang, JJ; Wu, H; Zhang, Z; Zhang, ZG; He, XJ; Zhou, P; Wei, ZL; Gecz, J; Cao, YX				Zhu, Fuxi; Wang, Fengsong; Yang, Xiaoyu; Zhang, Jingjing; Wu, Huan; Zhang, Zhou; Zhang, Zhiguo; He, Xiaojin; Zhou, Ping; Wei, Zhaolian; Gecz, Jozef; Cao, Yunxia			Biallelic SUN5 Mutations Cause Autosomal-Recessive Acephalic Spermatozoa Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEAD-TO-TAIL; DECAPITATED SPERMATOZOA; NUCLEAR-ENVELOPE; INFERTILE MAN; SPERM DEFECT; 2 BROTHERS; SPERMIOGENESIS; MORPHOGENESIS; ODF1/HSPB10; PROTEINS	Acephalic spermatozoa syndrome is a rare and severe form of teratozoospermia characterized by a predominance of headless spermatozoa in the ejaculate. Family clustering and consanguinity suggest a genetic origin; however, causative mutations have yet to be identified. We performed whole-exome sequencing in two unrelated infertile men and subsequent variant filtering identified one homozygous (c.824C>T [p.Thr275Met]) and one compound heterozygous (c.1006C>T [p.Arg356Cys] and c.485T>A [p.Met162Lys]) SUN5 (also named TSARG4) variants. Sanger sequencing of SUN5 in 15 additional unrelated infertile men revealed four compound heterozygous (c.381delA [p.Val128Serfs*7] and c.824C>T [p.Thr275Met]; c.381delA [p.Val128Serfs*7] and c.781G>A [p.Val261Met]; c.216G>A [p.Trp72*] and c.1043A>T [p.Asn348Ile]; c.425+1G>A/c.1043A>T [p.Asn348Ile]) and two homozygous (c.851C>G [p.Ser284*]; c.350G>A [p.Gly114Arg]) variants in six individuals. These 10 SUN5 variants were found in 8 of 17 unrelated men, explaining the genetic defect in 47.06% of the affected individuals in our cohort. These variants were absent in 100 fertile population-matched control individuals. SUN5 variants lead to absent, significantly reduced, or truncated SUN5, and certain variants altered SUN5 distribution in the head-tail junction of the sperm. In summary, these results demonstrate that biallelic SUN5 mutations cause male infertility due to autosomal-recessive acephalic spermatozoa syndrome.	[Zhu, Fuxi; Zhang, Jingjing; Wu, Huan; Zhang, Zhou; Zhang, Zhiguo; He, Xiaojin; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Peoples R China; [Zhu, Fuxi; Zhang, Jingjing; Wu, Huan; Zhang, Zhou; Zhang, Zhiguo; He, Xiaojin; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, Inst Reprod Genet, Hefei 230022, Peoples R China; [Zhu, Fuxi; Wang, Fengsong] Anhui Med Univ, Sch Life Sci, Hefei 230022, Peoples R China; [Yang, Xiaoyu] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Zhiguo; He, Xiaojin; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Peoples R China; [Gecz, Jozef] Univ Adelaide, Robinson Res Inst, Sch Med, Adelaide, SA 5006, Australia; [Gecz, Jozef] South Australian Hlth & Med Res Inst, Adelaide, SA 5006, Australia	Anhui Medical University; Anhui Medical University; Anhui Medical University; Nanjing Medical University; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Zhu, FX; Cao, YX (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Peoples R China.; Zhu, FX; Cao, YX (corresponding author), Anhui Med Univ, Inst Reprod Genet, Hefei 230022, Peoples R China.; Zhu, FX (corresponding author), Anhui Med Univ, Sch Life Sci, Hefei 230022, Peoples R China.; Cao, YX (corresponding author), Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Peoples R China.	fxzhu@ahmu.edu.cn; caoyunxia6@126.com	杨, 玉/W-7221-2019; Gecz, Jozef/X-3469-2019; Wu, Huan/AAL-7095-2021	Gecz, Jozef/0000-0002-7884-6861; 	National Natural Science Foundation of China [81401251]; Key Program in the Youth Elite Support Plan in Universities of Anhui Province [gxyqZD2016050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program in the Youth Elite Support Plan in Universities of Anhui Province	We would like to thank all families for participating in this study. We are thankful to Jianzhong Wang from the Department of Urology at the First Affiliated Hospital of Anhui Medical University for providing a testis sample and to Wen Hu from Anhui Provincial Hospital and Qin Wang from Anhui Agricultural University for electron microscopy techniques. This study was supported by the National Natural Science Foundation of China (81401251 to F.Z.) and by The Key Program in the Youth Elite Support Plan in Universities of Anhui Province (gxyqZD2016050 to F.Z.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BACCETTI B, 1989, GAMETE RES, V23, P181, DOI 10.1002/mrd.1120230205; BACCETTI B, 1984, J REPROD FERTIL, V70, P395; BREUCKER H, 1985, CELL TISSUE RES, V240, P303; Calvi A, 2015, DEV BIOL, V407, P321, DOI 10.1016/j.ydbio.2015.09.010; Chemes HE, 1999, HUM REPROD, V14, P1811, DOI 10.1093/humrep/14.7.1811; CHEMES HE, 1987, FERTIL STERIL, V47, P310; Frohnert C, 2011, MOL HUM REPROD, V17, P207, DOI 10.1093/molehr/gaq099; Gambera L, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2008.12.087; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Jiang XZ, 2011, DNA CELL BIOL, V30, P875, DOI 10.1089/dna.2010.1161; Kamal A, 1999, HUM REPROD, V14, P2791, DOI 10.1093/humrep/14.11.2791; Kierszenbaum AL, 2011, DEV DYNAM, V240, P723, DOI 10.1002/dvdy.22563; Kracklauer MP, 2013, CURR TOP DEV BIOL, V102, P127, DOI 10.1016/B978-0-12-416024-8.00005-2; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liska F, 2009, BIOL REPROD, V81, P1196, DOI 10.1095/biolreprod.109.078980; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Moretti E, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.11.027; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pasch E, 2015, BIOL OPEN, V4, P1792, DOI 10.1242/bio.015768; PEROTTI ME, 1981, J REPROD FERTIL, V63, P543; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Porcu G, 2003, HUM REPROD, V18, P562, DOI 10.1093/humrep/deg121; Ray PF, 2016, BIOL OPEN, V5, P535, DOI 10.1242/bio.016626; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rondanino C, 2015, REPROD BIOMED ONLINE, V31, P89, DOI 10.1016/j.rbmo.2015.04.002; Saias-Magnan J, 1999, HUM REPROD, V14, P1989, DOI 10.1093/humrep/14.8.1989; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; TOYAMA Y, 1995, ANDROLOGIA, V27, P165; Toyama Y, 2000, INT J ANDROL, V23, P109, DOI 10.1046/j.1365-2605.2000.t01-1-00217.x; Vogt PH, 2004, CURR PHARM DESIGN, V10, P471, DOI 10.2174/1381612043453261; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang KF, 2014, REPRODUCTION, V148, P499, DOI 10.1530/REP-14-0370; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Yassine S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118698; Yuan SQ, 2015, P NATL ACAD SCI USA, V112, pE430, DOI 10.1073/pnas.1424648112	41	73	83	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					942	949		10.1016/j.ajhg.2016.08.004	http://dx.doi.org/10.1016/j.ajhg.2016.08.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27640305	Bronze, Green Published			2022-12-18	WOS:000385333700015
J	Gan-Or, Z; Bouslam, N; Birouk, N; Lissouba, A; Chambers, DB; Veriepe, J; Androschuk, A; Laurent, SB; Rochefort, D; Spiegelman, D; Dionne-Laporte, A; Szuto, A; Liao, MJ; Figlewicz, DA; Bouhouche, A; Benomar, A; Yahyaoui, M; Ouazzani, R; Yoon, G; Dupre, N; Suchowersky, O; Bolduc, FV; Parker, JA; Dion, PA; Drapeau, P; Rouleau, GA; Bencheikh, BOA				Gan-Or, Ziv; Bouslam, Naima; Birouk, Nazha; Lissouba, Alexandra; Chambers, Daniel B.; Veriepe, Julie; Androschuk, Alaura; Laurent, Sandra B.; Rochefort, Daniel; Spiegelman, Dan; Dionne-Laporte, Alexandre; Szuto, Anna; Liao, Meijiang; Figlewicz, Denise A.; Bouhouche, Ahmed; Benomar, Ali; Yahyaoui, Mohamed; Ouazzani, Reda; Yoon, Grace; Dupre, Nicolas; Suchowersky, Oksana; Bolduc, Francois V.; Parker, J. Alex; Dion, Patrick A.; Drapeau, Pierre; Rouleau, Guy A.; Bencheikh, Bouchra Ouled Amar			Mutations in CAPN1 Cause Autosomal-Recessive Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MISSENSE MUTATIONS; SEQUENCING DATA; CALPAIN SYSTEM; ZEBRAFISH; PROTEIN; DISEASE; BRAIN; DISRUPTION	Hereditary spastic paraplegia (HSP) is a genetically and clinically heterogeneous disease characterized by spasticity and weakness of the lower limbs with or without additional neurological symptoms. Although more than 70 genes and genetic loci have been implicated in HSP, many families remain genetically undiagnosed, suggesting that other genetic causes of HSP are still to be identified. HSP can be inherited in an autosomal-dominant, autosomal-recessive, or X-linked manner. In the current study, we performed whole-exome sequencing to analyze a total of nine affected individuals in three families with autosomal-recessive HSP. Rare homozygous and compound-heterozygous nonsense, missense, frameshift, and splice-site mutations in CAPN1 were identified in all affected individuals, and sequencing in additional family members confirmed the segregation of these mutations with the disease (spastic paraplegia 76 [SPG76]). CAPN1 encodes calpain 1, a protease that is widely present in the CNS. Calpain 1 is involved in synaptic plasticity, synaptic restructuring, and axon maturation and maintenance. Three models of calpain 1 deficiency were further studied. In Caenorhabditis elegans, loss of calpain 1 function resulted in neuronal and axonal dysfunction and degeneration. Similarly, loss-of-function of the Drosophila melanogaster ortholog calpain B caused locomotor defects and axonal anomalies. Knockdown of calpain 1a, a CAPN1 ortholog in Danio rerio, resulted in abnormal branchiomotor neuron migration and disorganized acetylated-tubulin axonal networks in the brain. The identification of mutations in CAPN1 in HSP expands our understanding of the disease causes and potential mechanisms.	[Gan-Or, Ziv; Laurent, Sandra B.; Rochefort, Daniel; Spiegelman, Dan; Dionne-Laporte, Alexandre; Szuto, Anna; Dion, Patrick A.; Rouleau, Guy A.; Bencheikh, Bouchra Ouled Amar] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Gan-Or, Ziv; Rouleau, Guy A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada; [Gan-Or, Ziv; Laurent, Sandra B.; Rochefort, Daniel; Spiegelman, Dan; Dionne-Laporte, Alexandre; Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 0G4, Canada; [Bouslam, Naima; Bouhouche, Ahmed; Benomar, Ali; Yahyaoui, Mohamed] Mohammed V Univ, Med Sch & Pharm, Equipe Rech Malad Neurodegenerat, BP 6527, Rabat, Morocco; [Birouk, Nazha; Ouazzani, Reda] Univ Mohammed V Souissi, Ctr Hosp Ibn Sina, Serv Neurophysiol Clin, BP 6527, Rabat, Morocco; [Lissouba, Alexandra; Veriepe, Julie; Liao, Meijiang; Parker, J. Alex; Drapeau, Pierre; Bencheikh, Bouchra Ouled Amar] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Lissouba, Alexandra; Veriepe, Julie; Liao, Meijiang; Drapeau, Pierre] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; [Chambers, Daniel B.; Androschuk, Alaura; Bolduc, Francois V.] Univ Alberta, Dept Pediat, Neurosci & Mental Hlth Inst, Edmonton, AB T6G 2R3, Canada; [Parker, J. Alex] Univ Montreal, Dept Neurosci, Montreal, PQ H3C 3J7, Canada; [Figlewicz, Denise A.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Yoon, Grace] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Neurol, Toronto, ON M5G 1X8, Canada; [Yoon, Grace] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Dupre, Nicolas] Ctr Hosp Univ Quebec, Div Neurol, Quebec City, PQ G1V 0A6, Canada; [Dupre, Nicolas] Univ Laval, Fac Med, Quebec City, PQ G1V 0A6, Canada; [Suchowersky, Oksana] Univ Alberta, Div Neurol, Edmonton, AB T6G 2R3, Canada	McGill University; McGill University; McGill University; Mohammed V University in Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Universite de Montreal; Universite de Montreal; University of Alberta; Universite de Montreal; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Laval University; Laval University; University of Alberta	Rouleau, GA (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada.; Rouleau, GA (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada.; Rouleau, GA (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 0G4, Canada.	guy.rouleau@mcgill.ca	Dupre, Nicolas/Y-1828-2019; Veriepe-Salerno, Julie/GPK-4682-2022; Parker, Alex/F-4953-2014	Parker, Alex/0000-0002-3333-2445; Bouhouche, Ahmed/0000-0001-5279-8649; Gan-Or, Ziv/0000-0003-0332-234X; spiegelman, dan/0000-0003-4971-8868	Canadian Institutes for Health Research (CIHR) [RN127580-260005]; Canadian Organization for Rare Disorders; CIHR; CIHR ALS Canada Doctoral Research Award	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Organization for Rare Disorders; CIHR(Canadian Institutes of Health Research (CIHR)); CIHR ALS Canada Doctoral Research Award	We thank the families for their participation. This study was funded by an Emerging Team Grant (RN127580-260005) from the Canadian Institutes for Health Research (CIHR) in collaboration with the Canadian Organization for Rare Disorders. This work was done as a part of a Canadian collaboration to study hereditary spastic paraplegia (CanHSP). Z.G.-O. is supported by a postdoctoral fellowship from the CIHR. P.D. holds a Canada Research Chair in Neuroscience, and A.L. is the recipient of a CIHR ALS Canada Doctoral Research Award. G.A.R. holds a Canada Research Chair in Genetics of the Nervous System and the Wilder Penfield Chair in Neurosciences. We thank Dr. Hitoshi Okamoto for the zebrafish Islet-1 transgenic line. We thank Helene Catoire, Pascale Hince, Cynthia Bourassa, Amirthagowri Ambalavanan, and Cathy Mirarchi for their assistance.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21; Casari G., 1993, GENEREVIEWS, V7; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Coutinho P, 1999, ARCH NEUROL-CHICAGO, V56, P943, DOI 10.1001/archneur.56.8.943; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DeLuca GC, 2004, NEUROPATH APPL NEURO, V30, P576, DOI 10.1111/j.1365-2990.2004.00587.x; DENNY JB, 1990, BRAIN RES, V534, P317, DOI 10.1016/0006-8993(90)90148-5; Denton KR, 2014, STEM CELLS, V32, P414, DOI 10.1002/stem.1569; Forman OP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064627; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanington PC, 2008, DEV BIOL, V314, P250, DOI 10.1016/j.ydbio.2007.10.012; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klebe S, 2006, BRAIN, V129, P1456, DOI 10.1093/brain/awl012; Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lepage SE, 2008, DEV DYNAM, V237, P819, DOI 10.1002/dvdy.21459; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Noreau A, 2014, EXP CELL RES, V325, P18, DOI 10.1016/j.yexcr.2014.02.021; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; O'Hanlon GM, 2003, BRAIN, V126, P2497, DOI 10.1093/brain/awg254; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Vanderklish P, 1996, LEARN MEMORY, V3, P209, DOI 10.1101/lm.3.2-3.209; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	44	73	76	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					1038	1046		10.1016/j.ajhg.2016.04.002	http://dx.doi.org/10.1016/j.ajhg.2016.04.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27153400	Green Published, Bronze			2022-12-18	WOS:000375869300021
J	Olbrich, H; Cremes, C; Loges, NT; Werner, C; Nielsen, KG; Marthin, JK; Philipsen, M; Wallmeier, J; Pennekamp, P; Menchen, T; Edelbusch, C; Dougherty, GW; Schwartz, O; Thiele, H; Altmuller, J; Rommelmann, F; Omran, H				Olbrich, Heike; Cremes, Carolin; Loges, Niki T.; Werner, Claudius; Nielsen, Kim G.; Marthin, June K.; Philipsen, Maria; Wallmeier, Julia; Pennekamp, Petra; Menchen, Tabea; Edelbusch, Christine; Dougherty, Gerard W.; Schwartz, Oliver; Thiele, Holger; Altmueller, Janine; Rommelmann, Frank; Omran, Heymut			Loss-of-Function GAS8 Mutations Cause Primary Ciliary Dyskinesia and Disrupt the Nexin-Dynein Regulatory Complex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OUTER; CHLAMYDOMONAS; INNER; DEFECTS; PROTEIN; RANDOMIZATION; MOTILITY; SUBUNIT; ARMS; INTERACTS	Multiciliated epithelial cells protect the upper and lower airways from chronic bacterial infections by moving mucus and debris outward. Congenital disorders of ciliary beating, referred to as primary ciliary dyskinesia (PCD), are characterized by deficient mucociliary clearance and severe, recurrent respiratory infections. Numerous genetic defects, most of which can be detected by transmission electron microscopy (TEM), are so far known to cause different abnormalities of the ciliary axoneme. However, some defects are not regularly discernable by TEM because the ciliary architecture of the axoneme remains preserved. This applies in particular to isolated defects of the nexin links, also known as the nexin-dynein regulatory complex (N-DRC), connecting the peripheral outer microtubular doublets. Immunofluorescence analyses of respiratory cells from PCD-affected individuals detected a N-DRC defect. Genome-wide exome sequence analyses identified recessive loss-of-function mutations in GAS8 encoding DRC4 in three independent PCD-affected families.	[Olbrich, Heike; Cremes, Carolin; Loges, Niki T.; Werner, Claudius; Wallmeier, Julia; Pennekamp, Petra; Menchen, Tabea; Edelbusch, Christine; Dougherty, Gerard W.; Schwartz, Oliver; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Nielsen, Kim G.; Marthin, June K.; Philipsen, Maria] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp,Dept Pediat & Adolescent Med, Danish PCD Ctr,Pediat Pulm Serv, DK-2100 Copenhagen, Denmark; [Thiele, Holger; Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Altmueller, Janine] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Rommelmann, Frank] Pulm Specialist Practice, D-40217 Dusseldorf, Germany	University of Munster; Rigshospitalet; University of Copenhagen; University of Cologne; University of Cologne	Olbrich, H (corresponding author), Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany.	heike.olbrich@ukmuenster.de; heymut.omran@ultmuenster.de	Thiele, Holger/ABE-6792-2020; Noethe-Menchen, Tabea/AAW-1667-2021; Nielsen, KG/AAE-6575-2020	Thiele, Holger/0000-0002-0169-998X; Noethe-Menchen, Tabea/0000-0002-0571-6767; Nielsen, KG/0000-0001-5906-9449; Omran, Heymut/0000-0003-0282-6765; Wallmeier, Julia/0000-0002-3958-9065; Altmuller, Janine/0000-0003-4372-1521	Nordrhein-Westfalen (NRW) Research School, "Cell Dynamics and Disease, CEDAD"; Deutsche Forschungsgemeinschaft [OM 6/4, OM 6/7, OM6/8, OL450/1]; Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Muenster [Om2/009/12]; European Commission [262055]; European Union [241955, 305404]	Nordrhein-Westfalen (NRW) Research School, "Cell Dynamics and Disease, CEDAD"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Muenster; European Commission(European CommissionEuropean Commission Joint Research Centre); European Union(European Commission)	We are grateful to the PCD-affected individuals and their family members whose cooperation made this study possible, and we thank all referring physicians. We thank Prof. J. Neesen (Medical University of Vienna) for providing us anti-DNALI1 antibodies. We thank A. Wolter for help in immunofluorescence analysis. We thank D. Ernst, M. Herting, B. Lechtape, L. Overkamp, F.J. Seesing, and C. Westermann for excellent technical work. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. This work was supported by a fellowship of the Nordrhein-Westfalen (NRW) Research School, "Cell Dynamics and Disease, CEDAD," to H. Oman, by the Deutsche Forschungsgemeinschaft grants OM 6/4, OM 6/7, and OM6/8 to H. Omran and OL450/1 to H. Olbrich, by the Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Muenster grant to H. Omran (Om2/009/12), by the European Commission (Seventh Framework Programme [FP7] 2007-2013) grant agreement no. 262055 (H. Omran) as a Transnational Access project of the European Sequencing and Genotyping Infrastructure (ESGI), and by the European Union seventh FP under grant agreement no. 241955, project SYSCILIA (H. Omran) and grant agreement no. 305404, project BESTCILIA (K.G.N. and H. Omran).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bower R, 2013, MOL BIOL CELL, V24, P1134, DOI 10.1091/mbc.E12-11-0801; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Collins SA, 2014, EUR RESPIR J, V44, P1589, DOI 10.1183/09031936.00088614; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Jeanson L, 2015, AM J HUM GENET, V97, P153, DOI 10.1016/j.ajhg.2015.05.004; Kabututu ZP, 2010, J CELL SCI, V123, P3587, DOI 10.1242/jcs.073817; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Oda T, 2015, MOL BIOL CELL, V26, P294, DOI 10.1091/mbc.E14-09-1367; Oda T, 2014, SCIENCE, V346, P857, DOI 10.1126/science.1260214; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Song KK, 2015, J BIOL CHEM, V290, P5341, DOI 10.1074/jbc.M114.626556; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Werner Claudius, 2015, Cilia, V4, P2, DOI 10.1186/s13630-014-0011-8; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007	50	73	79	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					546	554		10.1016/j.ajhg.2015.08.012	http://dx.doi.org/10.1016/j.ajhg.2015.08.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26387594	Green Published, Bronze			2022-12-18	WOS:000362617300005
J	Ratbi, I; Falkenberg, KD; Sommen, M; Al-Sheqaih, N; Guaoua, S; Vandeweyer, G; Urquhart, JE; Chandler, KE; Williams, SG; Roberts, NA; El Alloussi, M; Black, GC; Ferdinandusse, S; Ramdi, H; Heimler, A; Fryer, A; Lynch, SA; Cooper, N; Ong, KR; Smith, CEL; Inglehearn, CF; Mighell, AJ; Ecock, C; Poulter, JA; Tischkowitz, M; Davies, SJ; Sefiani, A; Mironov, AA; Newman, WG; Waterham, HR; Van Camp, G				Ratbi, Ilham; Falkenberg, Kim D.; Sommen, Manou; Al-Sheqaih, Nada; Guaoua, Soukaina; Vandeweyer, Geert; Urquhart, Jill E.; Chandler, Kate E.; Williams, Simon G.; Roberts, Neil A.; El Alloussi, Mustapha; Black, Graeme C.; Ferdinandusse, Sacha; Ramdi, Hind; Heimler, Audrey; Fryer, Alan; Lynch, Sally-Ann; Cooper, Nicola; Ong, Kai Ren; Smith, Claire E. L.; Inglehearn, Christopher F.; Mighell, Alan J.; Ecock, Claire; Poulter, James A.; Tischkowitz, Marc; Davies, Sally J.; Sefiani, Abdelaziz; Mironov, Aleksandr A.; Newman, William G.; Waterham, Hans R.; Van Camp, Guy			Heimler Syndrome Is Caused by Hypomorphic Mutations in the Peroxisome-Biogenesis Genes PEX1 and PEX6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ZELLWEGER-SYNDROME SPECTRUM; SENSORINEURAL HEARING-LOSS; HUMAN SKIN FIBROBLASTS; CHAIN FATTY-ACIDS; GAS-CHROMATOGRAPHY; NAIL ABNORMALITIES; ENAMEL HYPOPLASIA; MOLECULAR-BASIS; PRISTANIC ACID; AAA PEROXINS	Heimler syndrome (HS) is a rare recessive disorder characterized by sensorineural hearing loss (SNHL), amelogenesis imperfecta, nail abnormalities, and occasional or late-onset retinal pigmentation. We ascertained eight families affected by HS and, by using a whole-exome sequencing approach, identified biallelic mutations in PEX1 or PEX6 in six of them. Loss-of-function mutations in both genes are known causes of a spectrum of autosomal-recessive peroxisome-biogenesis disorders (PBDs), including Zellweger syndrome. PBDs are characterized by leukodystrophy, hypotonia, SNHL, retinopathy, and skeletal, craniofacial, and liver abnormalities. We demonstrate that each HS-affected family has at least one hypomorphic allele that results in extremely mild peroxisomal dysfunction. Although individuals with HS share some subtle clinical features found in PBDs, the diagnosis was not suggested by routine blood and skin fibroblast analyses used to detect PBDs. In conclusion, our findings define HS as a mild PBD, expanding the pleiotropy of mutations in PEX1 and PEX6.	[Ratbi, Ilham; Guaoua, Soukaina; Sefiani, Abdelaziz] Univ Mohammed 5, Fac Med & Pharm, Ctr Genom Humaine, Rabat 10100, Morocco; [Falkenberg, Kim D.; Ferdinandusse, Sacha; Waterham, Hans R.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Sommen, Manou; Vandeweyer, Geert; Van Camp, Guy] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Al-Sheqaih, Nada; Urquhart, Jill E.; Chandler, Kate E.; Williams, Simon G.; Roberts, Neil A.; Black, Graeme C.; Newman, William G.] Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Al-Sheqaih, Nada; Urquhart, Jill E.; Chandler, Kate E.; Williams, Simon G.; Roberts, Neil A.; Black, Graeme C.; Newman, William G.] Univ Manchester, Inst Human Dev, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [El Alloussi, Mustapha; Ramdi, Hind] Univ Mohammed 5, Fac Med Dent, Dept PedodontiePrevent, Rabat 10100, Morocco; [El Alloussi, Mustapha] Hop Mil Instruct Mohamed V, Serv Odontol, Rabat 10100, Morocco; [Heimler, Audrey] Schneider Childrens Hosp, Long Isl Jewish Med Ctr, Div Human Genet, New Hyde Pk, NY 11042 USA; [Fryer, Alan] Liverpool Womens NHS Fdn Trust, Dept Clin Genet, Liverpool L8 7SS, Merseyside, England; [Davies, Sally J.] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Davies, Sally J.] Childrens Univ Hosp, Dept Genet, Dublin 12, Ireland; [Cooper, Nicola] Birmingham Womens Hosp NHS Trust, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Smith, Claire E. L.; Inglehearn, Christopher F.; Mighell, Alan J.; Poulter, James A.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Biomed & Clin Sci, Leeds LS9 7TF, W Yorkshire, England; [Mighell, Alan J.] Univ Leeds, Sch Dent, Leeds LS2 9JT, W Yorkshire, England; [Ecock, Claire] Univ Sheffield, Sch Clin Dent, Acad Unit Oral Hlth & Dev, Sheffield S10 2TA, S Yorkshire, England; [Tischkowitz, Marc] Univ Cambridge, Dept Med Genet, Cambridge CB2 0QQ, England; [Tischkowitz, Marc] Univ Cambridge, Natl Inst Hlth Res Cambridge, Biomed Res Ctr, Cambridge CB2 0QQ, England; [Tischkowitz, Marc] Addenbrookes Hosp, East Anglian Reg Genet Serv, Dept Clin Genet, Cambridge CB2 0QQ, England; [Davies, Sally J.] Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Sefiani, Abdelaziz] Natl Inst Hyg, Dept Med Genet, Rabat 10090, Morocco; [Mironov, Aleksandr A.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; University of Amsterdam; Academic Medical Center Amsterdam; University of Antwerp; University of Manchester; University of Manchester; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Childrens University Hospital - Temple Street; Birmingham Women's Hospital; Saint James's University Hospital; University of Leeds; University of Leeds; University of Sheffield; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University; University of Manchester	Waterham, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Kruislaan 403, NL-1105 AZ Amsterdam, Netherlands.	h.r.waterham@amc.uva.nl; guy.vancamp@uantwerpen.be	Tischkowitz, Marc/O-4452-2018; Van Camp, Guy/F-3386-2013; Poulter, James A/A-8190-2013; Roberts, Neil A/H-6773-2014; GUAOUA, Soukaina/ABB-3342-2021	Tischkowitz, Marc/0000-0002-7880-0628; Van Camp, Guy/0000-0001-5105-9000; Poulter, James A/0000-0003-2048-5693; Falkenberg, Kim/0000-0002-6882-5231; Mironov, Aleksandr/0000-0002-1497-328X; Guaoua, Soukaina/0000-0003-3238-7388; Newman, William/0000-0002-6382-4678; Roberts, Neil/0000-0002-6955-5536; Williams, Simon/0000-0001-7396-4108; Lynch, Sally Ann/0000-0003-3540-1333; Ferdinandusse, Sacha/0000-0002-7738-5709; Smith, Claire/0000-0001-8320-5105; Vandeweyer, Geert/0000-0002-6262-6522	Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program [TAP P7/43-BeMGI]; Marie Curie Initial Training Networks action [FP-2012-PERFUME-316723]; Manchester Biomedical Research Centre; Wellcome Trust [093113]; RP Fighting Blindness; Fight For Sight [GR586]; National Institute for Health Research [NF-SI-0509-10185] Funding Source: researchfish; Fight for Sight [1801/02] Funding Source: researchfish	Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program; Marie Curie Initial Training Networks action; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); RP Fighting Blindness; Fight For Sight; National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	We thank the families for their participation in this study. We acknowledge Dr. Nawfal Fejjal for his participation in the clinical investigations of the Moroccan family. This study was supported by funding from the Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program (project TAP P7/43-BeMGI to G.V.C.) and funding from the Marie Curie Initial Training Networks action (FP-2012-PERFUME-316723 to K.D.F. and H.R.W.). We acknowledge support from the Manchester Biomedical Research Centre. This study was supported by funding from the Wellcome Trust (grant no. 093113 to C.F.I. and A.J.M.). C.F.I., G.C.B., and J.A.P. are members of the UK Inherited Retinal Disease Consortium, supported by RP Fighting Blindness and Fight For Sight (RP Genome Project GR586). The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.	Acharya BS, 2012, SPEC CARE DENT, V32, P112, DOI 10.1111/j.1754-4505.2012.00248.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aubourg P, 2013, HAND CLINIC, V113, P1593, DOI 10.1016/B978-0-444-59565-2.00028-9; Bader PI, 2000, AM J MED GENET, V90, P110, DOI 10.1002/(SICI)1096-8628(20000117)90:2<110::AID-AJMG4>3.0.CO;2-#; Braverman NE, 2013, DEV DISABIL RES REV, V17, P187, DOI 10.1002/ddrr.1113; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collins CS, 1999, HUM MUTAT, V14, P45, DOI 10.1002/(SICI)1098-1004(1999)14:1<45::AID-HUMU6>3.3.CO;2-A; Dacremont G, 1995, J INHERIT METAB DIS, V18, P76, DOI 10.1007/BF00711430; Dacremont G, 1995, J INHERIT METAB DIS, V18, P84, DOI 10.1007/BF00711431; Dursun A, 2009, J INHERIT METAB DIS, V32, pS345, DOI 10.1007/s10545-009-9010-0; Ebberink MS, 2012, J MED GENET, V49, P307, DOI 10.1136/jmedgenet-2012-100778; Ebberink MS, 2011, HUM MUTAT, V32, P59, DOI 10.1002/humu.21388; Ebberink MS, 2010, HUM MUTAT, V31, pE1058, DOI 10.1002/humu.21153; Fujiki Y, 2012, BBA-MOL CELL RES, V1823, P145, DOI 10.1016/j.bbamcr.2011.10.012; Gootjes J, 2004, HUM MUTAT, V24, P130, DOI 10.1002/humu.20062; HEIMLER A, 1991, AM J MED GENET, V39, P192, DOI 10.1002/ajmg.1320390214; Imamura A, 2000, BRAIN DEV-JPN, V22, P8, DOI 10.1016/S0387-7604(99)00072-8; Kocarnik JM, 2014, JAMA-J AM MED ASSOC, V311, P795, DOI 10.1001/jama.2014.369; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lima LH, 2011, OPHTHALMIC GENET, V32, P97, DOI 10.3109/13816810.2010.551797; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Majewski J, 2011, J MED GENET, V48, P593, DOI 10.1136/jmedgenet-2011-100288; Maxwell MA, 2002, HUM MUTAT, V20, P342, DOI 10.1002/humu.10128; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OFMAN R, 1994, BBA-PROTEIN STRUCT M, V1206, P27, DOI 10.1016/0167-4838(94)90068-X; Ong KR, 2006, EUR J MED GENET, V49, P187, DOI 10.1016/j.ejmg.2005.07.003; Poll-The BT, 2004, AM J MED GENET A, V126A, P333, DOI 10.1002/ajmg.a.20664; Poll-The BT, 2012, BBA-MOL BASIS DIS, V1822, P1421, DOI 10.1016/j.bbadis.2012.03.011; Pollak C, 2003, CLIN DYSMORPHOL, V12, P55, DOI 10.1097/00019605-200301000-00010; Raas-Rothschild A, 2002, AM J HUM GENET, V70, P1062, DOI 10.1086/339766; Regal L, 2010, ANN NEUROL, V68, P259, DOI 10.1002/ana.22035; Steinberg S, 2004, MOL GENET METAB, V83, P252, DOI 10.1016/j.ymgme.2004.08.008; Tamura S, 2014, J BIOL CHEM, V289, P24336, DOI 10.1074/jbc.M114.588038; Tischkowitz M, 1999, J MED GENET, V36, P941; Tran D, 2011, PEDIATR DENT, V33, P270; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; Vreken P, 1998, J CHROMATOGR B, V713, P281, DOI 10.1016/S0378-4347(98)00186-8; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P345, DOI 10.1016/0005-2760(93)90239-6; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006; Yik WY, 2009, HUM MUTAT, V30, pE467, DOI 10.1002/humu.20932; Zeharia A, 2007, J HUM GENET, V52, P599, DOI 10.1007/s10038-007-0157-y	45	73	76	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					535	545		10.1016/j.ajhg.2015.08.011	http://dx.doi.org/10.1016/j.ajhg.2015.08.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26387595	hybrid, Green Published			2022-12-18	WOS:000362617300004
J	Couto, JA; Vivero, MP; Kozakewich, HPW; Taghinia, AH; Mulliken, JB; Warman, ML; Greene, AK				Couto, Javier A.; Vivero, Matthew P.; Kozakewich, Harry P. W.; Taghinia, Amir H.; Mulliken, John B.; Warman, Matthew L.; Greene, Arin K.			A Somatic MAP3K3 Mutation Is Associated with Verrucous Venous Malformation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VASCULAR MALFORMATIONS; GENETIC-VARIATION; SEQUENCING DATA; HEMANGIOMA; GENOMES; MEKK3	Verrucous venous malformation (VVM), also called "verrucous hemangioma,'' is a non-hereditary, congenital, vascular anomaly comprised of aberrant clusters of malformed dermal venule-like channels underlying hyperkeratotic skin. We tested the hypothesis that VVM lesions arise as a consequence of a somatic mutation. We performed whole-exome sequencing (WES) on VVM tissue from six unrelated individuals and looked for somatic mutations affecting the same gene in specimens from multiple persons. We observed mosaicism for a missense mutation (NM_002401.3, c.1323C>G; NP_002392, p.Iso441Met) in mitogen-activated protein kinase kinase kinase 3 (MAP3K3) in three of six individuals. We confirmed the presence of this mutation via droplet digital PCR (ddPCR) in the three subjects and found the mutation in three additional specimens from another four participants. Mutant allele frequencies ranged from 6% to 19% in affected tissue. We did not observe this mutant allele in unaffected tissue or in affected tissue from individuals with other types of vascular anomalies. Studies using global and conditional Map3k3 knockout mice have previously implicated MAP3K3 in vascular development. MAP3K3 dysfunction probably causes VVM in humans.	[Couto, Javier A.; Vivero, Matthew P.; Taghinia, Amir H.; Mulliken, John B.; Greene, Arin K.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Kozakewich, Harry P. W.; Taghinia, Amir H.; Mulliken, John B.; Warman, Matthew L.; Greene, Arin K.] Boston Childrens Hosp, Vasc Anomalies Ctr, Boston, MA 02115 USA; [Kozakewich, Harry P. W.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Warman, Matthew L.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Greene, AK (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA.	arin.greene@childrens.harvard.edu			NIH [R01-AR064231, R21-HD081004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD081004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank their participants for contributing in this study. This work was supported by NIH grants R01-AR064231 (to M.L.W.) and R21-HD081004 (to A.K.G.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Blatt J, 2014, J PEDIAT HEMATOL ONC, V36, P587, DOI 10.1097/MPH.0000000000000260; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Boyden ED, 2011, AM J HUM GENET, V89, P767, DOI 10.1016/j.ajhg.2011.10.016; Chan J. K. C., 1995, INT J SURG PATHOL, V2, P171; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Deng Y, 2007, AM J PHYSIOL-CELL PH, V293, pC1404, DOI 10.1152/ajpcell.00058.2007; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Greene A. K., 2013, VENOUS MALFORMATION; Greene A. K., 2013, VASCULAR ANOMALIES; HAPPLE R, 1986, HUM GENET, V72, P280, DOI 10.1007/BF00291899; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; IMPERIAL R, 1967, ARCH DERMATOL, V96, P247, DOI 10.1001/archderm.96.3.247; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Mankani MH, 2000, ANN PLAS SURG, V45, P31, DOI 10.1097/00000637-200045010-00006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mulliken, 2013, CLASSIFICATION VASCU; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tennant LB, 2006, PEDIATR DERMATOL, V23, P208, DOI 10.1111/j.1525-1470.2006.00219.x; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang L, 2014, J CUTAN PATHOL, V41, P823, DOI 10.1111/cup.12385; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550	29	73	77	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					480	486		10.1016/j.ajhg.2015.01.007	http://dx.doi.org/10.1016/j.ajhg.2015.01.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25728774	Green Published, Bronze			2022-12-18	WOS:000350747800021
J	Tham, E; Lindstrand, A; Santani, A; Malmgren, H; Nesbitt, A; Dubbs, HA; Zackai, EH; Parker, MJ; Millan, F; Rosenbaum, K; Wilson, GN; Nordgren, A				Tham, Emma; Lindstrand, Anna; Santani, Avni; Malmgren, Helena; Nesbitt, Addie; Dubbs, Holly A.; Zackai, Elaine H.; Parker, Michael J.; Millan, Francisca; Rosenbaum, Kenneth; Wilson, Golder N.; Nordgren, Ann			Dominant Mutations in KAT6A Cause Intellectual Disability with Recognizable Syndromic Features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSE GENITOPATELLAR SYNDROME; HEMATOPOIETIC STEM-CELLS; ZINC-FINGER PROTEIN; HISTONE ACETYLTRANSFERASE; HOX EXPRESSION; MOZ; IDENTITY	Through a multi-center collaboration study, we here report six individuals from five unrelated families, with mutations in KAT6A/MOZ detected by whole-exome sequencing. All five different de novo heterozygous truncating mutations were located in the C-terminal transactivation domain of KAT6A: NM_001099412.1: c.3116_3117 delCT, p.(Ser1039*); c.3830_3831insTT, p.(Arg1278Serfs*17); c.3879 dupA, p.(Glu1294Argfs*19); c.4108G>T p.(Glu1370*) and c.4292 dupT, p.(Leu1431Phefs*8). An additional subject with a 0.23 MB microdeletion including the entire KAT6A reading frame was identified with genome-wide array comparative genomic hybridization. Finally, by detailed clinical characterization we provide evidence that heterozygous mutations in KAT6A cause a distinct intellectual disability syndrome. The common phenotype includes hypotonia, intellectual disability, early feeding and oromotor difficulties, microcephaly and/or craniosynostosis, and cardiac defects in combination with subtle facial features such as bitemporal narrowing, broad nasal tip, thin upper lip, posteriorly rotated or low-set ears, and microretrognathia. The identification of human subjects complements previous work from mice and zebrafish where knockouts of Kat6a/kat6a lead to developmental defects.	[Tham, Emma; Lindstrand, Anna; Malmgren, Helena; Nordgren, Ann] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Tham, Emma; Lindstrand, Anna; Malmgren, Helena; Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Santani, Avni; Nesbitt, Addie] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA 19104 USA; [Santani, Avni] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Dubbs, Holly A.; Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Parker, Michael J.] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Millan, Francisca] GeneDx Lab, Gaithersburg, MD 20877 USA; [Rosenbaum, Kenneth] Childrens Natl Med Ctr, Div Genet & Metab, Washington, DC 20010 USA; [Wilson, Golder N.] Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, Lubbock, TX 79106 USA; [Wilson, Golder N.] Med City Hosp, Dallas, TX 75230 USA; [Wilson, Golder N.] Med City Hosp, KinderGenome Pediat Genet, Dallas, TX 75230 USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Children's National Health System; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Medical City Dallas Hospital; Medical City Dallas Hospital	Tham, E (corresponding author), Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden.	emma.tham@karolinska.se	Nordgren, Ann/AAQ-9142-2021; Lindstrand, Anna M/J-3566-2012; Lindstrand, Anna/AAT-9969-2021; Nordgren, Ann C/N-4057-2013	Nordgren, Ann/0000-0003-3285-4281; Lindstrand, Anna M/0000-0003-0806-5602; Lindstrand, Anna/0000-0003-0806-5602; Nordgren, Ann C/0000-0003-3285-4281; Tham, Emma/0000-0001-6079-164X	Stockholm County Council; Karolinska Institutet; Kronprinsessan Lovisa; Frimurare Barnhuset i Stockholm; Cancer Research Foundations of Radiumhemmet; Swedish Childhood Cancer Foundation; Harald och Greta Jeanssons Foundation; Nilsson-Ehle Foundation; Erik Ronnberg Foundation; Swedish Research Council; Swedish Brain Foundation (Hjarnfonden); Karolinska Institutet research funds	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Kronprinsessan Lovisa; Frimurare Barnhuset i Stockholm; Cancer Research Foundations of Radiumhemmet; Swedish Childhood Cancer Foundation(European Commission); Harald och Greta Jeanssons Foundation; Nilsson-Ehle Foundation; Erik Ronnberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation (Hjarnfonden); Karolinska Institutet research funds	We would like to thank all the individuals and their families for participating in this study and especially acknowledge the diligence and persistence of subject 4's mother whose relentless pursuit of a diagnosis for her son included a Facebook page that brought other children with KAT6A mutations to our attention. There is also a patient organization for individuals with KAT6A mutations: http://www.chloekat6a.org. This work was supported through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, by grants from Kronprinsessan Lovisa, Frimurare Barnhuset i Stockholm, Karolinska Institutet, The Cancer Research Foundations of Radiumhemmet, The Swedish Childhood Cancer Foundation, the Harald och Greta Jeanssons Foundation, the Nilsson-Ehle Foundation, the Erik Ronnberg Foundation, the Swedish Research Council, The Swedish Brain Foundation (Hjarnfonden), and the Karolinska Institutet research funds.	Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Champagne N, 2001, ONCOGENE, V20, P404, DOI 10.1038/sj.onc.1204114; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Crump JG, 2006, DEVELOPMENT, V133, P2661, DOI 10.1242/dev.02435; Fahrner JA, 2014, ANNU REV GENOM HUM G, V15, P269, DOI 10.1146/annurev-genom-090613-094245; Gannon T., 2014, EUR J HUM GENET; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Klein BJ, 2014, EPIGENETICS-US, V9, P186, DOI 10.4161/epi.26792; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Moeschler JB, 2014, PEDIATRICS, V134, pE903, DOI 10.1542/peds.2014-1839; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Voss AK, 2012, DEV CELL, V23, P652, DOI 10.1016/j.devcel.2012.07.010; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006	17	73	74	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					507	513		10.1016/j.ajhg.2015.01.016	http://dx.doi.org/10.1016/j.ajhg.2015.01.016			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25728777	Green Published, Bronze			2022-12-18	WOS:000350747800024
J	Pu, XY; Xiao, QZ; Kiechl, S; Chan, K; Ng, FL; Gor, S; Poston, RN; Fang, CC; Patel, A; Senver, EC; Shaw-Hawkins, S; Willeit, J; Liu, CJ; Zhu, JH; Tucker, AT; Xu, QB; Caulfield, MJ; Ye, S				Pu, Xiangyuan; Xiao, Qingzhong; Kiechl, Stefan; Chan, Kenneth; Ng, Fu Liang; Gor, Shivani; Poston, Robin N.; Fang, Changcun; Patel, Ashish; Senver, Ece C.; Shaw-Hawkins, Sue; Willeit, Johann; Liu, Chuanju; Zhu, Jianhua; Tucker, Arthur T.; Xu, Qingbo; Caulfield, Mark J.; Ye, Shu			ADAMTS7 Cleavage and Vascular Smooth Muscle Cell Migration Is Affected by a Coronary-Artery-Disease-Associated Variant	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL COURSE; ATHEROSCLEROSIS	Recent genome-wide association studies have revealed an association between variation at the ADAMTS7 locus and susceptibility to coronary artery disease (CAD). Furthermore, in a population-based study cohort, we observed an inverse association between atherosclerosis prevalence and rs3825807, a nonsynonymous SNP (A to G) leading to a Ser-to-Pro substitution in the prodomain of the protease ADAMTS7. In light of these data, we sought a mechanistic explanation for this association. We found that ADAMTS7 accumulated in smooth muscle cells in coronary and carotid atherosclerotic plaques. Vascular smooth muscle cells (VSMCs) of the GIG genotype for rs3825807 had reduced migratory ability, and conditioned media of VSMCs of the GIG genotype contained less of the cleaved form of thrombospondin-5, an ADAMTS7 substrate that had been shown to be produced by VSMCs and inhibit VSMC migration. Furthermore, we found that there was a reduction in the amount of cleaved ADAMTS7 prodomain in media conditioned by VSMCs of the GIG genotype and that the Ser-to-Pro substitution affected ADAMTS7 prodomain cleavage. The results of our study indicate that rs3825807 has an effect on ADAMTS7 maturation, thrombospondin-5 cleavage, and VSMC migration, with the variant associated with protection from atherosclerosis and CAD rendering a reduction in ADAMTS7 function.	[Pu, Xiangyuan; Xiao, Qingzhong; Chan, Kenneth; Ng, Fu Liang; Gor, Shivani; Poston, Robin N.; Fang, Changcun; Patel, Ashish; Senver, Ece C.; Shaw-Hawkins, Sue; Tucker, Arthur T.; Caulfield, Mark J.; Ye, Shu] Queen Mary Univ London, William Harvey Res Inst, London EC1M 6BQ, England; [Pu, Xiangyuan; Zhu, Jianhua] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Kiechl, Stefan; Willeit, Johann] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Liu, Chuanju] NYU, Sch Med, Musculoskeletal Res Ctr, New York, NY 10003 USA; [Xu, Qingbo] Kings Coll London, Dept Cardiol, London SE5 9NU, England	University of London; Queen Mary University London; Zhejiang University; Medical University of Innsbruck; New York University; University of London; King's College London	Ye, S (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London EC1M 6BQ, England.	s.ye@qmul.ac.uk	Ye, Shu/R-6384-2017; Liu, Chuan-ju/AAT-8165-2021; Pu, Xiangyuan/AHA-2782-2022; Hemingway, Harry/C-1219-2009	Ye, Shu/0000-0002-4126-4278; Caulfield, Mark/0000-0001-9295-3594; liu, chuanju/0000-0002-7181-8032; Chan, Kenneth/0000-0002-5571-7549; Pu, Xiangyuan/0000-0003-4776-3315; Hemingway, Harry/0000-0003-2279-0624	British Heart Foundation; William Harvey Research Foundation; Chinese Scholarship Council; British Heart Foundation Intermediate Basic Science Research Fellowship [FS/09/044/28007]; National Institute for Health Research; MRC [G9521010, G0600237] Funding Source: UKRI; British Heart Foundation [PG/11/40/28891, FS/12/82/29736, FS/11/28/28758, FS/09/044/28007] Funding Source: researchfish; Medical Research Council [G0600237, MR/K006584/1, G9521010] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10113] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); William Harvey Research Foundation; Chinese Scholarship Council(China Scholarship Council); British Heart Foundation Intermediate Basic Science Research Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the British Heart Foundation and the William Harvey Research Foundation for support. X.P. and C.F. are recipients of scholarships from the Chinese Scholarship Council. Q.X. is the recipient of a British Heart Foundation Intermediate Basic Science Research Fellowship (FS/09/044/28007). The work forms part of the research themes contributing to the translational research portfolio of Barts Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute for Health Research.	Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1491, DOI 10.1161/01.ATV.19.6.1491; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Riessen R, 2001, ARTERIOSCL THROM VAS, V21, P47, DOI 10.1161/01.ATV.21.1.47; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425; Willeit J, 2000, ARTERIOSCL THROM VAS, V20, P529, DOI 10.1161/01.ATV.20.2.529; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	20	73	78	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					366	374		10.1016/j.ajhg.2013.01.012	http://dx.doi.org/10.1016/j.ajhg.2013.01.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23415669	Bronze, Green Published			2022-12-18	WOS:000316161700009
J	Williams, SR; Zies, D; Mullegama, SV; Grotewiel, MS; Elsea, SH				Williams, Stephen R.; Zies, Deborah; Mullegama, Sureni V.; Grotewiel, Michael S.; Elsea, Sarah H.			Smith-Magenis Syndrome Results in Disruption of CLOCK Gene Transcription and Reveals an Integral Role for RAI1 in the Maintenance of Circadian Rhythmicity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MELATONIN SECRETION; MOUSE MODELS; DISORDER; SLEEP; MICE; HAPLOINSUFFICIENCY; ABNORMALITIES; INVERSION; OBESITY	Haploinsufficiency of RAI1 results in Smith-Magenis syndrome (SMS), a disorder characterized by intellectual disability, multiple congenital anomalies, obesity, neurobehavioral abnormalities, and a disrupted circadian sleep-wake pattern. An inverted melatonin rhythm (i.e., melatonin peaks during the day instead of at night) and associated sleep-phase disturbances in individuals with SMS, as well as a short-period circadian rhythm in mice with a chromosomal deletion of Rai1, support SMS as a circadian-rhythm-dysfunction disorder. However, the molecular cause of the circadian defect in SMS has not been described. The circadian oscillator temporally orchestrates metabolism, physiology, and behavior largely through transcriptional modulation. Data support RAI1 as a transcriptional regulator, but the genes it might regulate are largely unknown. Investigation into the role that RAI1 plays in the regulation of gene transcription and circadian maintenance revealed that RAI1 regulates the transcription of circadian locomotor output cycles kaput (CLOCK), a key component of the mammalian circadian oscillator that transcriptionally regulates many critical circadian genes. Data further show that haploinsufficiency of RAI1 and Rai1 in SMS fibroblasts and the mouse hypothalamus, respectively, results in the transcriptional dysregulation of the circadian clock and causes altered expression and regulation of multiple circadian genes, including PER2, PER3, CRY1, BMAL1 and others. These data suggest that heterozygous mutation of RAI1 and Rai1 leads to a disrupted circadian rhythm and thus results in an abnormal sleep-wake cycle, which can contribute to an abnormal feeding pattern and dependent cognitive performance. Finally, we conclude that RAI1 is a positive transcriptional regulator of CLOCK, pinpointing a novel and important role for this gene in the circadian oscillator.	[Williams, Stephen R.; Mullegama, Sureni V.; Grotewiel, Michael S.; Elsea, Sarah H.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23298 USA; [Williams, Stephen R.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Zies, Deborah] Univ Mary Washington, Dept Biol, Fredericksburg, VA 22401 USA; [Elsea, Sarah H.] Virginia Commonwealth Univ, Dept Pediat, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Salk Institute; Virginia Commonwealth University	Elsea, SH (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, 1101 E Marshall St, Richmond, VA 23298 USA.	selsea@vcu.edu	Grotewiel, Mike/AAX-4094-2020	Grotewiel, Mike/0000-0001-7302-3252; Williams, Stephen/0000-0003-2108-2757; Elsea, Sarah/0000-0002-1400-8519	Virginia Commonwealth University; PRISMS (Parents and Researchers Interested in Smith-Magenis Syndrome)	Virginia Commonwealth University; PRISMS (Parents and Researchers Interested in Smith-Magenis Syndrome)	We thank Ann C. M. Smith and the National Institutes of Health Smith-Magenis syndrome (SMS) Natural History Study for SMS fibroblasts, Kristie Schmidt and Brooke Burns for assistance with the collection of mouse tissue, Christine Bax and Karen Strat for assistance with Clock<SUP>del</SUP> constructs, and patients, parents, and families for continued support of our research. We also thank Satchin Panda, Christopher Vollmers, and Luchiano DiTacchio for assistance with real-time bioluminescence measurement of circadian rhythm. This study was supported, in part, by funds from Virginia Commonwealth University and by PRISMS (Parents and Researchers Interested in Smith-Magenis Syndrome).	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bhandari P, 2012, GENES BRAIN BEHAV, V11, P387, DOI 10.1111/j.1601-183X.2012.00765.x; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Boone PM, 2011, AM J MED GENET A, V155A, P2024, DOI 10.1002/ajmg.a.34098; Boudreau EA, 2009, AM J MED GENET A, V149A, P1382, DOI 10.1002/ajmg.a.32846; Burns B, 2010, HUM MOL GENET, V19, P4026, DOI 10.1093/hmg/ddq317; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; De Leersnyder H, 2001, J PEDIATR-US, V139, P111, DOI 10.1067/mpd.2001.115018; De Leersnyder H, 2003, REV NEUROL-FRANCE, V159, pS21; De Leersnyder H, 2003, J MED GENET, V40, P74, DOI 10.1136/jmg.40.1.74; De Leersnyder H, 2006, MOL CELL ENDOCRINOL, V252, P88, DOI 10.1016/j.mce.2006.03.043; De Leersnyder H, 2006, TRENDS ENDOCRIN MET, V17, P291, DOI 10.1016/j.tem.2006.07.007; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Elsea SH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001827; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2009, CLIN GENET, V75, P364, DOI 10.1111/j.1399-0004.2008.01135.x; Girirajan S, 2009, EUR J MED GENET, V52, P224, DOI 10.1016/j.ejmg.2008.12.002; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Gropman AL, 2007, CURR OPIN NEUROL, V20, P125, DOI 10.1097/WCO.0b013e3280895dba; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Juyal RC, 1996, AM J MED GENET, V66, P193, DOI 10.1002/(SICI)1096-8628(19961211)66:2<193::AID-AJMG13>3.3.CO;2-9; Lamont EW, 2010, ISR J PSYCHIATR REL, V47, P27; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Mendlewicz J, 2009, CNS DRUGS, V23, P15, DOI 10.2165/11318630-000000000-00000; Novakova M, 2012, J CLIN ENDOCR METAB, V97, pE312, DOI 10.1210/jc.2011-2750; OSHIMA RG, 1977, J CELL PHYSIOL, V93, P129, DOI 10.1002/jcp.1040930116; Potocki L, 2000, J MED GENET, V37, P428, DOI 10.1136/jmg.37.6.428; Salvatore P, 2008, BIPOLAR DISORD, V10, P256, DOI 10.1111/j.1399-5618.2007.00505.x; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Smith ACM, 1998, AM J MED GENET, V81, P186, DOI 10.1002/(SICI)1096-8628(19980328)81:2<186::AID-AJMG11>3.3.CO;2-A; Straume M, 2004, METHOD ENZYMOL, V383, P149; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vlangos CN, 2003, MOL GENET METAB, V79, P134, DOI 10.1016/S1096-7192(03)00048-9; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; Walz K, 2004, HUM MOL GENET, V13, P367, DOI 10.1093/hmg/ddh044; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	42	73	77	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					941	949		10.1016/j.ajhg.2012.04.013	http://dx.doi.org/10.1016/j.ajhg.2012.04.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22578325	Bronze, Green Published			2022-12-18	WOS:000305262600001
J	Heinz-Erian, P; Muller, T; Krabichler, B; Schranz, M; Becker, C; Ruschendorf, F; Nurnberg, P; Rossier, B; Vujic, M; Booth, IW; Holmberg, C; Wijmenga, C; Grigelioniene, G; Kneepkens, CMF; Rosipal, S; Mistrik, M; Kappler, M; Michaud, L; Doczy, LC; Siu, VM; Krantz, M; Zoller, H; Utermann, G; Janecke, AR				Heinz-Erian, Peter; Mueller, Thomas; Krabichler, Birgit; Schranz, Melanie; Becker, Christian; Rueschendorf, Franz; Nuernberg, Peter; Rossier, Bernard; Vujic, Mihailo; Booth, Ian W.; Holmberg, Christer; Wijmenga, Cisca; Grigelioniene, Giedre; Kneepkens, C. M. Frank; Rosipal, Stefan; Mistrik, Martin; Kappler, Matthias; Michaud, Laurent; Doczy, Ludwig-Christoph; Siu, Victoria Mok; Krantz, Marie; Zoller, Heinz; Utermann, Gerd; Janecke, Andreas R.			Mutations in SPINT2 Cause a Syndromic Form of Congenital Sodium Diarrhea	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERINE-PROTEASE INHIBITOR; SECRETORY DIARRHEA; CYSTIC-FIBROSIS; NA+ TRANSPORT; EXCHANGE; GENE; IDENTIFICATION; ASSOCIATION; CHANNEL; DISEASE	Autosomal-recessive congenital sodium diarrhea (CSD) is characterized by perinatal onset of a persistent watery diarrhea with nonproportionally high fecal sodium excretion. Defective jejunal brush-border Na+/H+ exchange has been reported in three sporadic patients, but the molecular basis of the disease has not been elucidated. We reviewed data from a large cohort of CSD patients (n = 24) and distinguished CSD associated with choanal or anal atresia, hypertelorism, and corneal erosions-i.e., a syndromic form of CSD-occurring in ten families from an isolated form-i.e., classic M-presenting in seven families. Patients from both groups have a high risk of mortality due to immediate electrolyte imbalances and complications from long-term parenteral nutrition in the first years of life, but survivors can eventually adapt to partial or complete enteral nutrition. A genome-wide SNP scan was applied and identified a homozygous c.593-1G -> A splicing mutation in SPINT2, encoding a Kunitz-type serine-protease inhibitor, in one extended kindred with syndromic CSD. The same mutation and four distinct, homozygous or compound heterozygous mutations (p.Y163C, c.1A -> T, c.337+2T -> C, c.553+2T -> A) were identified in all syndromic patients. No SPINT2 mutations were found in classic-CSD patients. SPINT2 mutations were associated with loss of protein synthesis or failure to inhibit the serine protease trypsin in vitro. We delineate syndromic CSD as a distinct disease entity caused by SPINT2 loss-of-function mutations. SPINT2 mutations might lead to an excess of yet unknown serine protease activity in affected tissues.	[Krabichler, Birgit; Utermann, Gerd; Janecke, Andreas R.] Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria; [Heinz-Erian, Peter; Mueller, Thomas; Doczy, Ludwig-Christoph] Innsbruck Med Univ, Dept Pediat 2, A-6020 Innsbruck, Austria; [Schranz, Melanie; Zoller, Heinz] Innsbruck Med Univ, Dept Gastroenterol, A-6020 Innsbruck, Austria; [Becker, Christian; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Becker, Christian; Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Rueschendorf, Franz] Max Delbruck Ctr, D-13092 Berlin, Germany; [Rossier, Bernard] Univ Lausanne, Dept Pharmacol, CH-1005 Lausanne, Switzerland; [Vujic, Mihailo] Univ Gothenburg, Div Clin Genet, S-41345 Gothenburg, Sweden; [Booth, Ian W.] Dept Pediat Gastroenterol, Birmingham B15 2TT, W Midlands, England; [Holmberg, Christer] Univ Helsinki, Dept Pediat, Helsinki 00014, Finland; [Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Grigelioniene, Giedre] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Kneepkens, C. M. Frank] Univ Amsterdam, Dept Pediat, NL-1081 HV Amsterdam, Netherlands; [Rosipal, Stefan] Pediat Ctr Prevent Cardiovasc Med, SK-05801 Poprad Velka, Slovakia; [Mistrik, Martin] Gen Hosp, Dept Med Genet, SK-05201 Spisska Nova Ves, Slovakia; [Kappler, Matthias] Univ Munich, Dept Pediat, D-80337 Munich, Germany; [Michaud, Laurent] Univ Lille, Dept Pediat Gastroenterol Hepatol & Nutr, F-59037 Lille, France; [Siu, Victoria Mok] Univ Western Ontario, Dept Pediat, London, ON N6C 2V5, Canada; [Krantz, Marie] Univ Gothenburg, Dept Pediat, S-41345 Gothenburg, Sweden	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; University of Cologne; University of Cologne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Lausanne; University of Gothenburg; University of Helsinki; University of Groningen; University of Groningen; Karolinska Institutet; Karolinska University Hospital; University of Amsterdam; University of Munich; Universite de Lille - ISITE; Universite de Lille; Western University (University of Western Ontario); University of Gothenburg	Janecke, AR (corresponding author), Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria.	andreas.janecke@i-med.ac.at	Grigelioniene, Giedre/AAH-8408-2020; Janecke, Andreas/AAA-5227-2019; Michaud, Laurent/S-2041-2018; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Zoller, Heinz/AAD-7225-2019; Grigelioniene, Giedre/N-6599-2013	Grigelioniene, Giedre/0000-0001-9601-3137; Michaud, Laurent/0000-0002-5020-1367; Wijmenga, Cisca/0000-0002-5635-1614; Grigelioniene, Giedre/0000-0001-9601-3137; Janecke, Andreas/0000-0001-7155-0315; Kneepkens, C M Frank/0000-0001-5415-7319	Tiroler Medizinischer Forschungsfond [99]; Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich (FWF) [P18470, P19579]; Tiroler Wasserkraft AG (TIWAG)	Tiroler Medizinischer Forschungsfond; Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich (FWF)(Austrian Science Fund (FWF)); Tiroler Wasserkraft AG (TIWAG)	We thank Gabriele Rammesmayer and Silvia Lechner for technical assistance. This work was supported by grant no. 99 from Tiroler Medizinischer Forschungsfond to A.R.J.; grants P18470 to A.R.J. and P19579 to H.Z., from the Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich (FWF); and a grant from Tiroler Wasserkraft AG (TIWAG) to T.M.	BOOTH IW, 1985, LANCET, V1, P1066; Bridges RJ, 2001, AM J PHYSIOL-LUNG C, V281, pL16, DOI 10.1152/ajplung.2001.281.1.L16; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; FELL JM, 1992, J PEDIATR GASTR NUTR, V15, P112, DOI 10.1097/00005176-199208000-00002; Ganapathy V, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1667; Girardi ACC, 2001, J BIOL CHEM, V276, P46671, DOI 10.1074/jbc.M106897200; Greig ER, 2003, GUT, V52, P1607, DOI 10.1136/gut.52.11.1607; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; HOLMBERG C, 1985, J PEDIATR-US, V106, P56, DOI 10.1016/S0022-3476(85)80465-0; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; KELLER KM, 1990, GUT, V31, P1156, DOI 10.1136/gut.31.10.1156; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Muller T, 2000, GASTROENTEROLOGY, V119, P1506, DOI 10.1053/gast.2000.20514; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Shin D, 1997, J UROLOGY, V158, P1794, DOI 10.1016/S0022-5347(01)64131-4; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Wright EM, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1653; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	31	73	75	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					188	196		10.1016/j.ajhg.2009.01.004	http://dx.doi.org/10.1016/j.ajhg.2009.01.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19185281	Green Published, Bronze			2022-12-18	WOS:000263799700009
J	Lugassy, J; Itin, P; Ishida-Yamamoto, A; Holland, K; Huson, S; Geiger, D; Hennies, HC; Indelman, M; Bercovich, D; Uitto, J; Bergman, R; McGrath, JA; Richard, G; Sprecher, E				Lugassy, Jennie; Itin, Peter; Ishida-Yamamoto, Akemi; Holland, Kristen; Huson, Susan; Geiger, Dan; Hennies, Hans Christian; Indelman, Margarita; Bercovich, Dani; Uitto, Jouni; Bergman, Reuven; McGrath, John A.; Richard, Gabriele; Sprecher, Eli			Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: Two allelic ectodermal dysplasias caused by dominant mutations in KRT14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KERATIN INTERMEDIATE-FILAMENTS; EPIDERMOLYSIS-BULLOSA SIMPLEX; MOTTLED PIGMENTATION; PALMOPLANTAR KERATODERMA; ICHTHYOSIS HYSTRIX; PROTEIN; FAMILY; GENE; DISORDERS; ENVELOPE	Naegeli-Franceschetti-Jadassohn syndrome (NFJS) and dermatopathia pigmentosa reticularis (DPR) are two closely related autosomal dominant ectodermal dysplasia syndromes that clinically share complete absence of dermatoglyphics ( fingerprint lines), a reticulate pattern of skin hyperpigmentation, thickening of the palms and soles (palmoplantar keratoderma), abnormal sweating, and other subtle developmental anomalies of the teeth, hair, and skin. To decipher the molecular basis of these disorders, we studied one family with DPR and four families with NFJS. We initially reassessed linkage of NFJS/DPR to a previously established locus on 17q11.2-q21. Combined multipoint analysis generated a maximal LOD score of 8.3 at marker D17S800 at a recombination fraction of 0. The disease interval was found to harbor 230 genes, including a large cluster of keratin genes. Heterozygous nonsense or frameshift mutations in KRT14 were found to segregate with the disease trait in all five families. In contrast with KRT14 mutations affecting the central alpha-helical rod domain of keratin 14, which are known to cause epidermolysis bullosa simplex, NFJS/DPR-associated mutations were found in a region of the gene encoding the nonhelical head (E1/V1) domain and are predicted to result in very early termination of translation. These data suggest that KRT14 plays an important role during ontogenesis of dermatoglyphics and sweat glands. Among other functions, the N-terminal part of keratin molecules has been shown to confer protection against proapoptotic signals. Ultrastructural examination of patient skin biopsy specimens provided evidence for increased apoptotic activity in the basal cell layer where KRT14 is expressed, suggesting that apoptosis is an important mechanism in the pathogenesis of NFJS/DPR.	Rambam Med Ctr, Dept Dermatol, Lab Mol Dermatol, IL-31096 Haifa, Israel; Technion Israel Inst Med, Fac Med, Haifa, Israel; Technion Israel Inst Med, Fac Comp Sci, Haifa, Israel; Technion Israel Inst Med, Rappaport Inst Res Med Sci, Haifa, Israel; Univ Basel, Hosp Aarau, Dept Dermatol, Basel, Switzerland; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 078, Japan; Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; St Marys Hosp, Reg Genet Serv, Manchester, NH USA; St Marys Hosp, Acad Unit Med Genet, Manchester, NH USA; Univ Cologne, Ctr Genom, Div Dermatogenet, Cologne, Germany; Migal Galilee Technol Ctr, Kiryat Shmona, Israel; Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Guys Kings Coll & St Thomas Sch Med, St Johns Inst Dermatol, Genet Skin Dis Grp, London, England; GeneDx, Gaithersburg, MD USA	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Basel; Asahikawa Medical College; Medical College of Wisconsin; University of Cologne; Jefferson University; University of London; King's College London	Sprecher, E (corresponding author), Rambam Med Ctr, Dept Dermatol, Lab Mol Dermatol, POB 9602, IL-31096 Haifa, Israel.	e_sprecher@rambam.health.gov.il	McGrath, John/N-3529-2019; Hennies, Hans C/G-9424-2014; McGrath, John/D-6824-2012	Hennies, Hans C/0000-0001-7210-2389; McGrath, John/0000-0002-3708-9964	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002141, P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08 AR002141, P01 AR038923, K08-AR02141, AR38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Babler William J., 1991, DERMATOGLYPHICS SCI, V27, P95; BAIRD HW, 1964, J PEDIATR-US, V64, P621, DOI 10.1016/S0022-3476(64)80610-7; Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Courtois G, 2005, CELL MOL LIFE SCI, V62, P1682, DOI 10.1007/s00018-005-5031-5; DODINVAL P, 1972, HUMANGENETIK, V15, P20, DOI 10.1007/BF00273427; FRANCESCHETTI A., 1954, DERMATOLOGICA [BASEL], V108, P1; FRENK E, 1993, DERMATOLOGY, V187, P169, DOI 10.1159/000247236; Harel A, 2006, J INVEST DERMATOL, V126, P1654, DOI 10.1038/sj.jid.5700296; Has C, 2006, J INVEST DERMATOL, V126, P1912, DOI 10.1038/sj.jid.5700312; HEIMER WL, 1992, J AM ACAD DERMATOL, V26, P298, DOI 10.1016/0190-9622(92)70039-I; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Irvine AD, 2005, CLIN DERMATOL, V23, P6, DOI 10.1016/j.clindermatol.2004.09.014; ITIN PH, 1993, J AM ACAD DERMATOL, V28, P942, DOI 10.1016/0190-9622(93)70135-G; Itin PH, 1998, DERMATOLOGY, V197, P281, DOI 10.1159/000018015; KLIMONIS V, 1994, J INVEST DERMATOL, V103, P764; Langbein L, 2005, J INVEST DERMATOL, V125, P428, DOI 10.1111/j.0022-202X.2005.23860.x; Lunny DP, 2005, J INVEST DERMATOL, V124, P615, DOI 10.1111/j.0022-202X.2005.23623.x; McLean WHI, 2003, HUM MOL GENET, V12, P2395, DOI 10.1093/hmg/ddg234; MERRIL CR, 1984, METHOD ENZYMOL, V104, P441; Naegeli O, 1927, SCHWEIZ MED WOCHENSC, V8, P48; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paulsen M, 2006, AM J HUM GENET, V79, P214, DOI 10.1086/505407; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Richardson ES, 2006, J INVEST DERMATOL, V126, P79, DOI 10.1038/sj.jid.5700025; Rugg EL, 2004, AM J MED GENET C, V131C, P4, DOI 10.1002/ajmg.c.30029; Shurman D, 2006, EUR J DERMATOL, V16, P132; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Smith FJD, 2005, J INVEST DERM SYMP P, V10, P21, DOI 10.1111/j.1087-0024.2005.10204.x; SPARROW GP, 1976, CLIN EXP DERMATOL, V1, P127, DOI 10.1111/j.1365-2230.1976.tb01408.x; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Sprecher E, 2002, J INVEST DERMATOL, V119, P692, DOI 10.1046/j.1523-1747.2002.01855.x; Sprecher E, 2001, J INVEST DERMATOL, V116, P511, DOI 10.1046/j.1523-1747.2001.01292.x; vanEngeland M, 1997, EXP CELL RES, V235, P421, DOI 10.1006/excr.1997.3738; Whittock NV, 2000, J INVEST DERMATOL, V115, P694, DOI 10.1046/j.1523-1747.2000.00097.x; Yoneda K, 2004, J BIOL CHEM, V279, P7296, DOI 10.1074/jbc.M307242200; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	40	73	77	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					724	730		10.1086/507792	http://dx.doi.org/10.1086/507792			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960809	Green Published, Bronze			2022-12-18	WOS:000240855900014
J	Weber, F; Shen, L; Fukino, K; Patocs, A; Mutter, GL; Caldes, T; Eng, C				Weber, Frank; Shen, Lei; Fukino, Koichi; Patocs, Attila; Mutter, George L.; Caldes, Trinidad; Eng, Charis			Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-FUSION; CANCER; HETEROZYGOSITY; BRCA1; EPITHELIUM; GROWTH; MODEL; RISK; MICROENVIRONMENT; HYBRIDIZATION	We have shown that the tumor microenvironment of sporadic breast cancer is diverse in genetic alterations and contributes to the cancer phenotype. The dynamic morphology of the mammary gland might be of special interest in hereditary breast/ovarian cancer syndrome ( HBOC). We hypothesized that hotspots of loss of heterozygosity or allelic imbalance (LOH/AI) within the tumor stroma of BRCA1/2-related breast cancers provide an impaired mammary stroma that could facilitate later malignant transformation of the breast epithelium. We conducted a total genome LOH/AI scan of DNA derived from the epithelium and stroma of 51 BRCA1/2- related breast cancers, using 372 microsatellite markers. We compared these data with those from a set of 134 sporadic breast cancers. HBOC-related breast cancers accumulated significantly more genetic alterations than did sporadic breast cancers. BRCA1/2- related breast cancer stroma showed LOH/AI at 59.7% of all loci analyzed, similar to the average frequency of LOH/AI observed in the epithelium (66.2%). This is remarkably different from sporadic breast cancers, for which the average epithelial LOH/AI frequency (36.7%) far exceeds the average stromal LOH/AI frequency (28.4%) (P = .03). We identified 11 hotspot loci of LOH/AI in the BRCA1/2 stroma, encompassing genes such as POLD1, which functions in DNA replication, and SDHB. In a subset of samples, enriched for BRCA1 cases, we found 45.0% overall LOH/AI in the stroma, which was significantly higher than the 41.8% LOH/AI observed in corresponding epithelium (P = .04). Together, our data indicate that, in HBOC-related breast cancers, the accumulation of genomic instability in the cancer stroma coincides with that in the neoplastic epithelium, and we postulate that such a genetically unstable stroma might facilitate a microenvironment that functions as a landscaper that promotes genomic instability in the epithelium and, subsequently, neoplastic transformation.	Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA; Ohio State Univ, Sch Publ Hlth, Div Biometr, Columbus, OH 43210 USA; Nippon Med Coll, Dept Neurosurg, Tokyo 113, Japan; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; San Carlos Univ Hosp, Mol Oncol Lab, Madrid, Spain; Univ Cambridge, Canc Res UK, Human Canc Genet Res Grp, Cambridge, England	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Ohio State University; Nippon Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hospital Clinico San Carlos; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave,NE 50, Cleveland, OH 44195 USA.	engc@ccf.org	Mutter, George L/C-5819-2009; Weber, Frank/A-1883-2012	Weber, Frank/0000-0002-0995-667X; Eng, Charis/0000-0002-3693-5145; Patocs, Attila/0000-0001-7506-674X	NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA113001, P01 CA097189, P01CA97189, P50CA113001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; American Cancer Society, 2005, BREAST CANC FACTS FI; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Barcellos-Hoff MH, 2005, BREAST CANCER RES, V7, P33, DOI 10.1186/bcr972; Cavalli LR, 2004, CANCER GENET CYTOGEN, V149, P38, DOI 10.1016/S0165-4608(03)00282-6; Colditz GA, 1996, J NATL CANCER I, V88, P365, DOI 10.1093/jnci/88.6.365; Dacic S, 2005, AM J SURG PATHOL, V29, P897, DOI 10.1097/01.pas.0000164367.96379.66; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Honrado E, 2005, MODERN PATHOL, V18, P1305, DOI 10.1038/modpathol.3800453; Jernstrom H, 2005, BRIT J CANCER, V92, P857, DOI 10.1038/sj.bjc.6602389; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Larson PS, 2005, J CLIN ONCOL, V23, P8613, DOI 10.1200/JCO.2005.02.1451; Maffini MV, 2005, AM J PATHOL, V167, P1405, DOI 10.1016/S0002-9440(10)61227-8; Marsh DJ, 1997, CANCER RES, V57, P500; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Moinfar F, 2000, CANCER RES, V60, P2562; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; *NCCN, 2004, GEN FAM HIGH RISK AS; Nelson HH, 2005, CARCINOGENESIS, V26, P1770, DOI 10.1093/carcin/bgi125; Parris GE, 2006, MED HYPOTHESES, V66, P76, DOI 10.1016/j.mehy.2005.08.009; Parris GE, 2005, MED HYPOTHESES, V65, P846, DOI 10.1016/j.mehy.2005.05.036; Roy SK, 2001, J EXP CLIN CANC RES, V20, P103; Russo J, 2001, Breast J, V7, P278, DOI 10.1046/j.1524-4741.2001.21033.x; Shekhar MPV, 2001, CANCER RES, V61, P1320; Sigurdson AJ, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-9; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Weber F, 2005, BRIT J CANCER, V92, P1922, DOI 10.1038/sj.bjc.6602557; Wessels LFA, 2002, CANCER RES, V62, P7110; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754	35	73	77	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					961	972		10.1086/504090	http://dx.doi.org/10.1086/504090			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685647	Bronze, Green Published			2022-12-18	WOS:000237553800006
J	Randolph, AG; Lange, C; Silverman, EK; Lazarus, R; Silverman, ES; Raby, B; Brown, A; Ozonoff, A; Richter, B; Weiss, ST				Randolph, AG; Lange, C; Silverman, EK; Lazarus, R; Silverman, ES; Raby, B; Brown, A; Ozonoff, A; Richter, B; Weiss, ST			The IL12B gene is associated with asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IFN-GAMMA PRODUCTION; PROMOTER POLYMORPHISM; FAMILY; CELLS; IDENTIFICATION; INTERLEUKIN-12; POWERFUL; LINKAGE; MARKERS; TESTS	The IL12B gene on chromosome 5q31-33 encodes the p40 subunit of interleukin 12, an immunomodulatory cytokine. To test the hypothesis that the IL12B gene contains polymorphisms associated with asthma, we genotyped six haplotype-tagging polymorphisms in the IL12B gene, both in 708 children enrolled in the Childhood Asthma Management Program (CAMP) and in their parents. Using the family-based association test (FBAT) program and its haplotype (HBAT) and phenotype (PBAT) options, we tested each polymorphism and haplotype for association with asthma and asthma-related phenotypes. We tested positive associations for replication in a case-control study comparing 177 adult moderate-to-severe asthmatics with 177 nonasthmatic controls. In whites in the CAMP cohort, the A allele of the IL12B G4237A polymorphism was undertransmitted to asthmatic children (P = .0008, recessive model), the global test for haplotypes for affection status was positive (P = .009 multiallelic chi(2)), and two polyP morphisms were associated with different atopy phenotypes. In addition, we found a strong association between the IL12B_4237 and IL12B_6402 polymorphisms and an asthma-severity phenotype in whites, which we also found in the independent population of white adult asthmatics. IL12B may be an important asthma gene.	Childrens Hosp, Dept Anesthesia, Med Surg Intens Care Unit, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Partners Ctr Genet & Genom, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Randolph, AG (corresponding author), Childrens Hosp, Dept Anesthesia, Med Surg Intens Care Unit, FA-108,300 Longwood Ave, Boston, MA 02115 USA.	adrienne.randolph@tch.harvard.edu	Raby, Benjamin/AAK-3866-2021	Ozonoff, Al/0000-0003-4233-5899; lazarus, ross/0000-0003-3939-1961; Randolph, Adrienne/0000-0002-3084-3071	DIVISION OF LUNG DISEASES [N01HR016049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066795, P01HL067664, K23HL004278] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL66795, U01 HL066795, N01HR16049, P01 HL067664, K23 HL04278, N01-HR-16049, K23HL04278, K23 HL004278, P01 HL67664] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Huang D, 2000, GENES IMMUN, V1, P515, DOI 10.1038/sj.gene.6363720; Khoo SK, 2004, J ALLERGY CLIN IMMUN, V113, P475, DOI 10.1016/j.jaci.2003.10.043; Lange C, 2003, HUM HERED, V56, P10, DOI 10.1159/000073728; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Muller-Berghaus J, 2004, GENES IMMUN, V5, P431, DOI 10.1038/sj.gene.6364102; Noguchi E, 2001, GENES IMMUN, V2, P401, DOI 10.1038/sj.gene.6363790; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Shikano H, 2001, CLIN EXP ALLERGY, V31, P1263, DOI 10.1046/j.1365-2222.2001.01141.x; SONNA LA, 2000, ENV MED GEN BANK CUR; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TRINCHIERI G, 1994, IMMUNOL TODAY, V15, P460, DOI 10.1016/0167-5699(94)90189-9; Walley AJ, 2001, GENOMICS, V72, P15, DOI 10.1006/geno.2000.6435; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628	26	73	77	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					709	715		10.1086/424886	http://dx.doi.org/10.1086/424886			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15322986	Green Published, Bronze			2022-12-18	WOS:000223634100018
J	Shoichet, SA; Hoffmann, K; Menzel, C; Trautmann, U; Moser, B; Hoeltzenbein, M; Echenne, B; Partington, M; van Bokhoven, H; Moraine, C; Fryns, JP; Chelly, J; Rott, HD; Ropers, HH; Kalscheuer, VM				Shoichet, SA; Hoffmann, K; Menzel, C; Trautmann, U; Moser, B; Hoeltzenbein, M; Echenne, B; Partington, M; van Bokhoven, H; Moraine, C; Fryns, JP; Chelly, J; Rott, HD; Ropers, HH; Kalscheuer, VM			Mutations in the ZNF41 gene are associated with cognitive deficits: Identification of a new candidate for X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BALANCED CHROMOSOME REARRANGEMENTS; COMPLICATED SPASTIC PARAPLEGIA; ZINC-FINGER PROTEINS; MASA-SYNDROME; TRANSCRIPTIONAL REPRESSION; PRENATAL-DIAGNOSIS; SPLICING MUTATION; DOMAIN; EXPRESSION; MECP2	Nonsyndromic X-linked mental retardation (MRX) is defined by an X-linked inheritance pattern of low IQ, problems with adaptive behavior, and the absence of additional specific clinical features. The 13 MRX genes identified to date account for less than one-fifth of all MRX, suggesting that numerous gene defects cause the disorder in other families. In a female patient with severe nonsyndromic mental retardation And a de novo balanced translocation t(X;7)(p11.3;q11.21), we have cloned the DNA fragment that contains the X-chromosomal and the autosomal breakpoint. In silico sequence analysis provided no indication of a causative role for the chromosome 7 breakpoint in mental retardation (MR), whereas, on the X chromosome, a zinc-finger gene, ZNF41, was found to be disrupted. Expression studies indicated that ZNF41 transcripts are absent in the patient cell line, suggesting that the mental disorder in this patient results from loss of functional ZNF41. Moreover, screening of a panel of patients with MRX led to the identification of two other ZNF41 mutations that were not found in healthy control individuals. A proline-to-leucine amino acid exchange is present in affected members of one family with MRX. A second family carries an intronic splice-site mutation that results in loss of specific ZNF41 splice variants. Wild-type ZNF41 contains a highly conserved transcriptional repressor domain that is linked to mechanisms of chromatin remodeling, a process that is defective in various other forms of MR. Our results suggest that ZNF41 is critical for cognitive development; further studies aim to elucidate the specific mechanisms by which ZNF41 alterations lead to MR.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; Hop St Eloi, Ctr Hosp Univ Montpellier, Montpellier, France; Hunter Genet, Waratah, Australia; Univ Newcastle, Waratah, Australia; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; CHU Bretonneau, INSERM, U316, Serv Genet, F-37044 Tours, France; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium; CHU Cochin, INSERM, Ctr Natl Rech Sci, Inst Cochin Genet Mol, Paris, France	Max Planck Society; University of Erlangen Nuremberg; Universite de Montpellier; CHU de Montpellier; University of Newcastle; Radboud University Nijmegen; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kalscheu@molgen.mpg.de	Chelly, Jamel/J-7528-2015; van Bokhoven, Hans/D-8764-2012; Bokhoven, J.H.L.M. van van/H-8015-2014; Hoeltzenbein, Maria/AAP-4145-2020	Chelly, Jamel/0000-0002-0939-8719; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Hoeltzenbein, Maria/0000-0002-2451-4247; Kalscheuer, Vera/0000-0001-6898-3259				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Brewer CM, 1996, DEV MED CHILD NEUROL, V38, P359; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; Delaunoy JP, 2001, HUM MUTAT, V17, P103, DOI 10.1002/1098-1004(200102)17:2<103::AID-HUMU2>3.0.CO;2-N; Fichera M, 2001, PRENATAL DIAG, V21, P747, DOI 10.1002/pd.142; Finckh U, 2000, AM J MED GENET, V92, P40, DOI 10.1002/(SICI)1096-8628(20000501)92:1<40::AID-AJMG7>3.0.CO;2-R; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frints SGM, 2002, CLIN GENET, V62, P423, DOI 10.1034/j.1399-0004.2002.620601.x; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GESSLER M, 1992, GENOMICS, V12, P807, DOI 10.1016/0888-7543(92)90313-H; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Hendrich B, 2001, HUM MOL GENET, V10, P2233, DOI 10.1093/hmg/10.20.2233; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Ladomery M, 2002, ANN HUM GENET, V66, P331, DOI 10.1017/S0003480002001215; Lebel RR, 2002, CLIN GENET, V61, P139, DOI 10.1034/j.1399-0004.2002.610209.x; Lossi AM, 2002, J MED GENET, V39, P113, DOI 10.1136/jmg.39.2.113; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; PASTERIS NG, 1994, CELL, V79, P669; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; RUIZ JC, 1995, J MED GENET, V32, P549, DOI 10.1136/jmg.32.7.549; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Simensen RJ, 2002, CLIN GENET, V61, P299, DOI 10.1034/j.1399-0004.2002.610410.x; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Vervoort VS, 2002, SCIENCE, V296, P2401; Villard L, 1996, AM J HUM GENET, V58, P499; Villard L, 1996, NAT GENET, V12, P359, DOI 10.1038/ng0496-359; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Wirth J, 1999, J MED GENET, V36, P271; Yntema HG, 2002, AM J MED GENET, V107, P81, DOI 10.1002/ajmg.10085	50	73	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1341	1354		10.1086/380309	http://dx.doi.org/10.1086/380309			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14628291	Green Published, Bronze			2022-12-18	WOS:000187491100011
J	Martin, ER; Bass, MP; Hauser, ER; Kaplan, NL				Martin, ER; Bass, MP; Hauser, ER; Kaplan, NL			Accounting for linkage in family-based tests of association with missing parental genotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE DISEQUILIBRIUM TEST; TRANSMISSION/DISEQUILIBRIUM TEST; PARKINSON-DISEASE; TAU-GENE; HAPLOTYPE; TRANSMISSION; POPULATION	In studies of complex diseases, a common paradigm is to conduct association analysis at markers in regions identified by linkage analysis, to attempt to narrow the region of interest. Family-based tests for association based on parental transmissions to affected offspring are often used in fine-mapping studies. However, for diseases with late onset, parental genotypes are often missing. Without parental genotypes, family-based tests either compare allele frequencies in affected individuals with those in their unaffected siblings or use siblings to infer missing parental genotypes. An example of the latter approach is the score test implemented in the computer program TRANSMIT. The inference of missing parental genotypes in TRANSMIT assumes that transmissions from parents to affected siblings are independent, which is appropriate when there is no linkage. However, using computer simulations, we show that, when the marker and disease locus are linked and the data set consists of families with multiple affected siblings, this assumption leads to a bias in the score statistic under the null hypothesis of no association between the marker and disease alleles. This bias leads to an inflated type I error rate for the score test in regions of linkage. We present a novel test for association in the presence of linkage (APL) that correctly infers missing parental genotypes in regions of linkage by estimating identity-by-descent parameters, to adjust for correlation between parental transmissions to affected siblings. In simulated data, we demonstrate the validity of the APL test under the null hypothesis of no association and show that the test can be more powerful than the pedigree disequilibrium test and family-based association test. As an example, we compare the performance of the tests in a candidate-gene study in families with Parkinson disease.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Martin, ER (corresponding author), Duke Univ, Med Ctr, Dept Med, 595 LaSalle St,Box 3468, Durham, NC 27710 USA.			Hauser, Elizabeth/0000-0003-0367-9189	NIA NIH HHS [R01 AG20135, R01 AG020135] Funding Source: Medline; NIMH NIH HHS [R01 MH59528, R01 MH059528] Funding Source: Medline; NINDS NIH HHS [P50 NS039764, 5 P50 NS39764-03] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Bass MP, 2002, AM J HUM GENET, V71, P569; Casci T, 2002, NAT REV GENET, V3, P573, DOI 10.1038/nrg867; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Farrer M, 2002, NEUROSCI LETT, V322, P83, DOI 10.1016/S0304-3940(02)00106-4; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Shih MC, 2002, GENET EPIDEMIOL, V22, P128, DOI 10.1002/gepi.0151; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	25	73	73	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1016	1026		10.1086/378779	http://dx.doi.org/10.1086/378779			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14551902	Bronze, Green Published			2022-12-18	WOS:000186493400004
J	Scott, WK; Hauser, ER; Schmechel, DE; Welsh-Bohmer, KA; Small, GW; Roses, AD; Saunders, AM; Gilbert, JR; Vance, JM; Haines, JL; Pericak-Vance, MA				Scott, WK; Hauser, ER; Schmechel, DE; Welsh-Bohmer, KA; Small, GW; Roses, AD; Saunders, AM; Gilbert, JR; Vance, JM; Haines, JL; Pericak-Vance, MA			Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E; GENOME SCAN; TYPE-4 ALLELE; ONSET; GENE; PROTEIN; FAMILIES; SCREEN; IDENTIFICATION; FREQUENCY	Alzheimer disease (AD) is a complex disorder characterized by a wide range, within and between families, of ages at onset of symptoms. Consideration of age at onset as a covariate in genetic-linkage studies may reduce genetic heterogeneity and increase statistical power. Ordered-subsets analysis includes continuous covariates in linkage analysis by rank ordering families by a covariate and summing LOD scores to find a subset giving a significantly increased LOD score relative to the overall sample. We have analyzed data from 336 markers in 437 multiplex (greater than or equal to2 sampled individuals with AD) families included in a recent genomic screen for AD loci. To identify genetic heterogeneity by age at onset, families were ordered by increasing and decreasing mean and minimum ages at onset. Chromosomewide significance of increases in the LOD score in subsets relative to the overall sample was assessed by permutation. A statistically significant increase in the nonparametric multipoint LOD score was observed on chromosome 2q34, with a peak LOD score of 3.2 at D2S2944 (P=.008) in 31 families with a minimum age at onset between 50 and 60 years. The LOD score in the chromosome 9p region previously linked to AD increased to 4.6 at D9S741 (P=.01) in 334 families with minimum age at onset between 60 and 75 years. LOD scores were also significantly increased on chromosome 15q22: a peak LOD score of 2.8 (P=.0004) was detected at D15S1507 (60 cM) in 38 families with minimum age at onset greater than or equal to79 years, and a peak LOD score of 3.1 (P=.0006) was obtained at D15S153 (62 cM) in 43 families with mean age at onset >80 years. Thirty-one families were contained in both 15q22 subsets, indicating that these results are likely detecting the same locus. There is little overlap in these subsets, underscoring the utility of age at onset as a marker of genetic heterogeneity. These results indicate that linkage to chromosome 9p is strongest in late-onset AD and that regions on chromosome 2q34 and 15q22 are linked to early-onset AD and very-late-onset AD, respectively.	Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Dept Physiol & Biophys, Nashville, TN USA	Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; GlaxoSmithKline; Vanderbilt University	Scott, WK (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci, 595 LaSalle St,Box 3445, Durham, NC 27710 USA.	bill.scott@duke.edu	Haines, Jonathan/C-3374-2012; Scott, William/A-7593-2009; Welsh-Bohmer, Kathleen/AAA-3178-2020	Haines, Jonathan/0000-0002-4351-4728; Hauser, Elizabeth/0000-0003-0367-9189; Vance, Jeffery/0000-0003-3815-8199; Scott, William/0000-0001-9336-6404	NCRR NIH HHS [RR00856] Funding Source: Medline; NIA NIH HHS [AG019726, AG11268, AG09029, R01 AG019726, R01 AG009029, P50 AG005128, U24 AG021886, P30 AG010123, AG05128, P60 AG011268] Funding Source: Medline; NIMH NIH HHS [U01 MH046373, MH52453, U01 MH046281, MH59528, U01 MH046290, R01 MH059528, R01 MH052453] Funding Source: Medline; NINDS NIH HHS [NS31153, R01 NS031153] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052453, R01MH059528, U01MH046373, U01MH046281, U01MH046290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P50AG005128, P30AG010123, R01AG009029, P60AG011268, R01AG019726] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Farrer LA, 1997, NEUROLOGIST, V3, P13, DOI 10.1097/00127893-199701000-00003; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; HAUSER ER, IN PRESS GENET EPIDE; HAUSER ER, 1998, AM J HUM GENET S, V63, pA45; Hiltunen M, 2001, NEUROLOGY, V57, P1663, DOI 10.1212/WNL.57.9.1663; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Olson JM, 2002, AM J HUM GENET, V71, P154, DOI 10.1086/341034; Olson JM, 2001, AM J HUM GENET, V69, P895, DOI 10.1086/323472; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; PericakVance MA, 1996, ANN NEUROL, V39, P700, DOI 10.1002/ana.410390605; RIMMLER J, 1998, AM J HUM GENET S, V63, pA240; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sherrington R, 1996, HUM MOL GENET, V5, P985, DOI 10.1093/hmg/5.7.985; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Vance Jeffery M., 1998, P213; Xu PT, 2002, AM J HUM GENET, V71, P490; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	40	73	77	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1041	1051		10.1086/379083	http://dx.doi.org/10.1086/379083			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14564669	Green Published, Bronze			2022-12-18	WOS:000186493400006
J	Jaeger, EEM; Woodford-Richens, KL; Lockett, M; Rowan, AJ; Sawyer, EJ; Heinimann, K; Rozen, P; Murday, VA; Whitelaw, SC; Ginsberg, A; Atkin, WS; Lynch, HT; Southey, MC; Debinski, H; Eng, C; Bodmer, WF; Talbot, IC; Hodgson, SV; Thomas, HJW; Tomlinson, IPM				Jaeger, EEM; Woodford-Richens, KL; Lockett, M; Rowan, AJ; Sawyer, EJ; Heinimann, K; Rozen, P; Murday, VA; Whitelaw, SC; Ginsberg, A; Atkin, WS; Lynch, HT; Southey, MC; Debinski, H; Eng, C; Bodmer, WF; Talbot, IC; Hodgson, SV; Thomas, HJW; Tomlinson, IPM			An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; PEUTZ-JEGHERS-SYNDROME	The putative locus for hereditary mixed polyposis syndrome (HMPS) in a large family of Ashkenazi descent (SM96) was previously reported to map to chromosome sub-bands 6q16-q21. However, new clinical data, together with molecular data from additional family members, have shown 6q linkage to be incorrect. A high-density genomewide screen for the HMPS gene was therefore performed on SM96, using stringent criteria for assignment of affection status to minimize phenocopy rates. Significant evidence of linkage was found only on a region on chromosome 15q13-q14. Since this region encompassed CRAC1, a locus involved in inherited susceptibility to colorectal adenomas and carcinomas in another Ashkenazi family (SM1311), we determined whether HMPS and CRAC1 might be the same. We found that affected individuals from both families shared a haplotype between D15S1031 and D15S118; the haplotype was rare in the general Ashkenazi population. A third informative family, SM2952, showed linkage of disease to HMPS/CRAC1 and shared the putative ancestral haplotype, as did a further two families, SMU and RF. Although there are probably multiple causes of the multiple colorectal adenoma and cancer phenotype in Ashkenazim, an important one is the HMPS/CRAC1 locus on 15q13-q14.	Imperial Canc Res Fund, Mol & Populat Genet Lab, London WC2A 3PX, England; Guys Hosp, Dept Clin Genet, London SE1 9RT, England; Yorkhill NHS Trust, Inst Med Genet, Glasgow, Lanark, Scotland; St Marks Hosp, Canc Res UK Colorectal Unit, Harrow, Middx, England; Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Tel Aviv, Israel; Tel Aviv Univ, IL-69978 Tel Aviv, Israel; Dumfries & Galloway Royal Infirm, Dumfries, Scotland; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; Peter MacCallum Canc Inst, Dept Pathol, Melbourne, Vic 3000, Australia; Cabrini Med Ctr, Isabella St Malvern, Vic, Australia; Ohio State Univ, Ctr Comprehens Canc, Clin Canc Genet & Human Canc Genet Programs, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; John Radcliffe Hosp, Inst Mol Med, Canc & Immunogenet Lab, Canc Res UK, Oxford OX3 9DU, England	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of Glasgow; Imperial College London; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Creighton University; Peter Maccallum Cancer Center; Cabrini Health; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cancer Research UK; University of Oxford	Jaeger, EEM (corresponding author), Imperial Canc Res Fund, Mol & Populat Genet Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.			Atkin, Wendy/0000-0001-9073-9658; Bodmer, Walter/0000-0001-6244-9792; Southey, Melissa/0000-0002-6313-9005; Eng, Charis/0000-0002-3693-5145	NCI NIH HHS [P30 CA016058, P30CA16058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Gruber SB, 1998, CANCER RES, V58, P5267; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Thomas HJW, 1996, AM J HUM GENET, V58, P770; Tomlinson I, 1999, GASTROENTEROLOGY, V116, P789, DOI 10.1016/S0016-5085(99)70061-2; Wang ZJ, 1999, J PATHOL, V188, P9, DOI 10.1002/(SICI)1096-9896(199905)188:1<9::AID-PATH326>3.0.CO;2-E; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; Woodford-Richens K, 2000, GUT, V46, P656, DOI 10.1136/gut.46.5.656	10	73	77	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1261	1267		10.1086/375144	http://dx.doi.org/10.1086/375144			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12696020	Green Published, Bronze			2022-12-18	WOS:000182474400017
J	Pajukanta, P; Allayee, H; Krass, KL; Kuraishy, A; Soro, A; Lilja, HE; Mar, R; Taskinen, MR; Nuotio, I; Laakso, M; Rotter, JI; de Bruin, TWA; Cantor, RM; Lusis, AJ; Peltonen, L				Pajukanta, P; Allayee, H; Krass, KL; Kuraishy, A; Soro, A; Lilja, HE; Mar, R; Taskinen, MR; Nuotio, I; Laakso, M; Rotter, JI; de Bruin, TWA; Cantor, RM; Lusis, AJ; Peltonen, L			Combined analysis of genome scans of Dutch and Finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; MELLITUS GENETICS FUSION; CORONARY HEART-DISEASE; COMBINED HYPERLIPIDEMIA; LINKAGE ANALYSIS; COMPLEX TRAITS; DIABETES-MELLITUS; APOLIPOPROTEIN-B; INDEPENDENT REPLICATION; INSULIN-RESISTANCE	Several genomewide screens have been performed to identify novel loci predisposing to unfavorable serum lipid levels and coronary heart disease (CHD). We hypothesized that the accumulating data of these screens in different study populations could be combined to verify which of the identified loci truly harbor susceptibility genes. The power of this strategy has recently been demonstrated with other complex diseases, such as inflammatory bowel disease and asthma. We assessed the largely unknown genetic background of CHD by investigating the most common dyslipidemia predisposing to CHD, familial combined hyperlipidemia (FCHL), affecting 1%-2% of Western populations and 10%-20% of families with premature CHD. To be able to perform a combined data analysis, we unified the diagnostic criteria for FCHL and its component traits and combined the data from two genomewide scans performed in two populations, the Finns and the Dutch. As a result of our pooled data analysis, we identified three chromosomal regions, on chromosomes 2p25.1, 9p23, and 16q24.1, exceeding the statistical significance level of a LOD score >2.0. The 2p25.1 region was detected for the FCHL trait, and the 9p23 and 16q24.1 regions were detected for the low high-density lipoprotein cholesterol (HDL-C) trait. In addition, the previously recognized 1q21 region also obtained additional support in the other study sample, when the triglyceride trait was used. Analysis of the 16q24.1 region resulted in a statistically significant LOD score of 3.6 when the data from Finnish families with low HDL-C were included in the analysis. To search for the underlying gene in the 16q24.1 region, we investigated a novel functional and positional candidate gene, helix/forkhead transcription factor (FOXC2), by sequencing and by genotyping of two single-nucleotide polymorphisms in the families.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol & Mol Genet, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA USA; Steven Spielberg Pediat Res Ctr, Div Med Genet, Los Angeles, CA USA; Cedars Sinai Res Inst, Los Angeles, CA USA; Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Turku Univ, Cent Hosp, Dept Med, Turku, Finland; Univ Kuopio, Cent Hosp, Dept Med, SF-70210 Kuopio, Finland; Acad Hosp Maastricht, Dept Med, Maastricht, Netherlands; Acad Hosp Maastricht, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Turku; Kuopio University Hospital; University of Eastern Finland; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Pajukanta, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	Leena.Peltonen@ktl.fi	Taskinen, Marja-Riitta/AAN-5432-2020	Taskinen, Marja-Riitta/0000-0002-6229-3588	NHLBI NIH HHS [P01 HL028481, HL-28481] Funding Source: Medline; NIGMS NIH HHS [T32 GM008243, 5-T32-GM08243-15] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allayee H, 2002, CIRC RES, V90, P926, DOI 10.1161/01.RES.0000015885.27134.F0; Aouizerat BE, 1999, ARTERIOSCL THROM VAS, V19, P2730, DOI 10.1161/01.ATV.19.11.2730; Aouizerat BE, 1999, AM J HUM GENET, V65, P397, DOI 10.1086/302490; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; BRUNZELL JD, 1983, J LIPID RES, V24, P147; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; CHIANO MN, 1995, ANN HUM GENET, V59, P83, DOI 10.1111/j.1469-1809.1995.tb01607.x; Coon H, 2000, ARTERIOSCL THROM VAS, V20, P2275, DOI 10.1161/01.ATV.20.10.2275; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox NJ, 2001, AM J HUM GENET, V69, P820, DOI 10.1086/323501; CUTHBERT JA, 1986, NEW ENGL J MED, V314, P879, DOI 10.1056/NEJM198604033141404; DallingaThie GM, 1996, J LIPID RES, V37, P136; DallingaThie GM, 1997, J CLIN INVEST, V99, P953, DOI 10.1172/JCI119260; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Eurlings PMH, 2001, MOL GENET METAB, V74, P98, DOI 10.1006/mgme.2001.3232; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lija HE, 2002, ATHEROSCLEROSIS, V164, P103, DOI 10.1016/S0021-9150(02)00040-0; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; NIKKILA EA, 1973, LANCET, V1, P954; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ott J., 1991, ANAL HUMAN GENETIC L; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Pei WD, 2000, CLIN GENET, V57, P29, DOI 10.1034/j.1399-0004.2000.570105.x; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Pielberg G, 2002, GENETICS, V160, P305; PORKKA KVK, 1994, ACTA PAEDIATR, V83, P838, DOI 10.1111/j.1651-2227.1994.tb13155.x; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sinsheimer JS, 2000, AM J HUM GENET, V66, P1168, DOI 10.1086/302826; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soro A, 2002, AM J HUM GENET, V70, P1333, DOI 10.1086/339988; Terwilliger JD, 2000, HUM BIOL, V72, P63; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Wu XD, 2002, AM J HUM GENET, V70, P1247, DOI 10.1086/340362	69	73	78	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					903	917		10.1086/374177	http://dx.doi.org/10.1086/374177			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12638083	Green Published, Bronze			2022-12-18	WOS:000181972600011
J	Berry, R; Schaid, DJ; Smith, JR; French, AJ; Schroeder, JJ; McDonnell, SK; Peterson, BJ; Wang, ZY; Carpten, JD; Roberts, SG; Tester, DJ; Blute, ML; Trent, JM; Thibodeau, SN				Berry, R; Schaid, DJ; Smith, JR; French, AJ; Schroeder, JJ; McDonnell, SK; Peterson, BJ; Wang, ZY; Carpten, JD; Roberts, SG; Tester, DJ; Blute, ML; Trent, JM; Thibodeau, SN			Linkage analyses at the chromosome 1 Loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; HIGH-RISK; INHERITANCE; HISTORY; GENE	Recent studies suggest that hereditary prostate cancer (PRCA) is a complex disease, involving multiple susceptibility genes and variable phenotypic expression. Through linkage analysis, potential prostate cancer susceptibility loci have been mapped to 3 regions on chromosome 1. To investigate the reported linkage to these regions, we conducted linkage studies on 144 PRCA families by using microsatellite markers in regions 1q24-25 (HPC1) and 1q42.2-43 (PCAP). We also examined the 1p36 (CAPB) region in 13 PRCA families with at least one case of brain cancer. No significant evidence of linkage to the HPC1 or PCAP region was found when the entire data set was analyzed. However, weak evidence for linkage to HPC1 was observed in the subset of families with male-to-male transmission (n = 102; maximum multipoint nonparametric linkage [NPL] 1.99, P = .03). Weak evidence for linkage with heterogeneity within this subset was also observed (HLOD 1.21, P = .02), with similar to 20% of families linked. Although not statistically significant, suggestive evidence for linkage to PCAP was observed for the families (n = 21) that met the three criteria of male-to-male transmission, average age of diagnosis <66 years, and greater than or equal to 5 affected individuals (maximum multipoint NPL 1.45, P = .08). There was no evidence for linkage to CAPB in the brain cancer-prostate cancer subset. These results strengthen the argument that prostate cancer is a heterogeneous disease and that multiple genetic and environmental factors may be important for its etiology.	Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Lab Genet HI 970, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA; Natl Human Genome Res Inst, Prostate Canc Invest Grp, NIH, Bethesda, MD USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Thibodeau, SN (corresponding author), Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Lab Genet HI 970, 200 1st St SW, Rochester, MN 55905 USA.		Smith, Jeff/C-3484-2012	McDonnell, Shannon/0000-0001-6201-369X; Smith, Jeffrey/0000-0001-8424-910X	NCI NIH HHS [CA 72818, R01CA72818, R01 CA072818] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Cannon L., 1982, CANCER SURV, V1, P47; CARTER BS, 1990, PROSTATE, V16, P187, DOI 10.1002/pros.2990160302; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1997, JAMA-J AM MED ASSOC, V278, P1251, DOI 10.1001/jama.278.15.1251; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; KOSARY CL, 1995, NIH PUBL; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MEIKLE AW, 1982, J CLIN ENDOCR METAB, V54, P1104, DOI 10.1210/jcem-54-6-1104; Ott J, 1996, NATURE, V379, P772, DOI 10.1038/379772a0; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; XU J, IN PRESS AM J HUM GE; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	26	73	73	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					539	546		10.1086/302771	http://dx.doi.org/10.1086/302771			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677314	Green Published, Bronze			2022-12-18	WOS:000088373100021
J	Hundscheid, RDL; Sistermans, EA; Thomas, CMG; Braat, DDM; Straatman, H; Kiemeney, LALM; Oostra, BA; Smits, APT				Hundscheid, RDL; Sistermans, EA; Thomas, CMG; Braat, DDM; Straatman, H; Kiemeney, LALM; Oostra, BA; Smits, APT			Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EARLY MENOPAUSE; EXPRESSION; WOMEN; GENE; IDENTIFICATION; CHROMOSOME; DIAGNOSIS; CARRIERS; FMR1; POF	Fragile X premutations are considered to be a risk factor for premature ovarian failure (POF), which is usually defined as menopause at age <40 years. Since premutations may be inherited from either the mother or the father, we evaluated the influence of the inheritance pattern on the duration of reproductive life in female carriers. The occurrence of POF and age at menopause in women with a paternally inherited fragile X premutation (PIP) were compared to those in women with a maternally inherited fragile X premutation (MIP). We identified 148 women in whom the parental origin of the premutation could be determined. In 109 of these women we were able to establish whether POF had occurred: 82 women had a PIP, and 27 had a MIP Twenty-three of the women (28%) with a PIP had POF, versus only 1 (3.7%) with a MIP (two -tailed Fisher's exact test; P = .007). Kaplan-Meier analysis of all 148 premutations showed that the age at menopause was significantly lower in the women with a PIP than in the woman with a MIP (Breslow test in Kaplan-Meier analysis; P = .003). Our data strongly suggest that, when POF occurs in fragile X premutation carriers, a considerable proportion of the premutations are inherited paternally (parent-of-origin effect). We hypothesize that this map be owing to a paternal genomic imprinting effect.	Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Chem Endocrinol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Epidemiol, NL-6500 HB Nijmegen, Netherlands; Erasmus Univ, Dept Clin Genet, CBG, NL-3000 DR Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam	Smits, APT (corresponding author), Univ Nijmegen Hosp, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	a.smits@antrg.azn.nl	Thomas, C.M.G./L-4687-2015; Braat, D.D.M./H-8017-2014; Sistermans, Erik/B-1109-2009; Kiemeney, Lambertus A./D-3357-2009	Sistermans, Erik/0000-0001-7187-4563; Kiemeney, Lambertus A./0000-0002-2368-1326				Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; BAKKER CE, 1994, CELL, V78, P23; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; COOPER DW, 1971, NATURE, V230, P292, DOI 10.1038/230292a0; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Dorland M, 1998, MATURITAS, V30, P113, DOI 10.1016/S0378-5122(98)00066-8; Eichenlaub-Ritter U, 1998, MATURITAS, V30, P143, DOI 10.1016/S0378-5122(98)00070-X; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Faddy MJ, 1996, HUM REPROD, V11, P1484; FENG Y, 1995, AM J HUM GENET, V56, P106; GINSBURG J, 1991, BMJ-BRIT MED J, V302, P1288, DOI 10.1136/bmj.302.6788.1288; Gosden RG, 1998, REPROD FERT DEVELOP, V10, P73, DOI 10.1071/R98043; Imbert G, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P27; Kenneson A, 1997, AM J HUM GENET, V61, P1362, DOI 10.1086/301647; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Monesi V., 1978, Current Topics in Developmental Biology, V12, P11, DOI 10.1016/S0070-2153(08)60592-X; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; Partington MW, 1996, AM J MED GENET, V64, P370, DOI 10.1002/(SICI)1096-8628(19960809)64:2<370::AID-AJMG27>3.0.CO;2-B; SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; THOMAS CMG, 1977, ACTA ENDOCRINOL-COP, V86, P405, DOI 10.1530/acta.0.0860405; Uzielli MLG, 1999, AM J MED GENET, V84, P300, DOI 10.1002/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.3.CO;2-X; van Kasteren YM, 1999, HUM REPROD, V14, P2455, DOI 10.1093/humrep/14.10.2455; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Willemsen R, 1996, LANCET, V348, P967, DOI 10.1016/S0140-6736(05)65388-3	28	73	75	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					413	418		10.1086/302774	http://dx.doi.org/10.1086/302774			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677300	Green Published, Bronze			2022-12-18	WOS:000088373100007
J	Feldman, G; Li, M; Martin, S; Urbanek, M; Urtizberea, JA; Fardeau, M; LeMerrer, M; Connor, JM; Triffitt, J; Smith, R; Muenke, M; Kaplan, FS; Shore, EM				Feldman, G; Li, M; Martin, S; Urbanek, M; Urtizberea, JA; Fardeau, M; LeMerrer, M; Connor, JM; Triffitt, J; Smith, R; Muenke, M; Kaplan, FS; Shore, EM			Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; REGULATORS; CBFA1; GENE; INTERLEUKIN-15; TRANSCRIPTION; LOCALIZATION	Fibrodysplasia ossificans progressiva (FOP) is a severely disabling, autosomal-dominant disorder of connective tissue and is characterized by postnatal progressive heterotopic ossification of muscle, tendon, ligament, and fascia and by congenital malformation of the great toes. To identify the chromosomal location of the FOP gene, we conducted a genomewide linkage analysis, using four affected families with a total of 14 informative meioses. Male-to-male transmission of the FOP phenotype excluded X-linked inheritance. Highly polymorphic microsatellite markers covering all human autosomes were amplified by use of PCR. The FOP phenotype is linked to markers located in the 4q27-31 region (LOD score 3.10 at recombination fraction 0). Crossover events localize the putative FOP gene within a 36-cM interval bordered proximally by D4S1625 and distally by D4S2417. This interval contains at least one gene involved in the bone morphogenetic protein-signaling pathway.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Assoc Francaise Contre Myopathies, Inst Myol, Paris, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Univ Glasgow, Sch Med, Inst Med Genet, Yorkhill Hosp, Glasgow, Lanark, Scotland; Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Bone Res Lab, Oxford OX1 2JD, England; Natl Human Genet Res Inst, Med Genet Branch, NIH, Bethesda, MD USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Glasgow; Nuffield Orthopaedic Centre; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Shore, EM (corresponding author), Univ Penn, Dept Orthopaed, 424 Stemmler Hall,36th & Hamilton Walk, Philadelphia, PA 19104 USA.	shore@mail.med.upenn.edu	Shore, Eileen/D-2593-2009	Muenke, Maximilian/0000-0002-7719-6545; Urbanek, Margrit/0000-0001-6994-7110	NIAMS NIH HHS [2R01-AR41916-04, R01 AR041916] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; CONNOR JM, 1982, J MED GENET, V19, P35, DOI 10.1136/jmg.19.1.35; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; CONNOR JM, 1993, J MED GENET, V30, P687, DOI 10.1136/jmg.30.8.687; Delatycki M, 1998, CLIN ORTHOP RELAT R, P15; Duax WL, 1997, STEROIDS, V62, P95, DOI 10.1016/S0039-128X(96)00166-3; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gannon FH, 1998, CLIN ORTHOP RELAT R, P19; Gannon FH, 1997, HUM PATHOL, V28, P339, DOI 10.1016/S0046-8177(97)90133-7; GLASER DL, 1998, CLIN ORTHOP RELAT R, V346, P110; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; JANOFF HB, 1995, J RHEUMATOL, V22, P976; Janoff HB, 1996, OTOLARYNG HEAD NECK, V114, P599, DOI 10.1016/S0194-5998(96)70253-X; KAPLAN FS, 1990, CALCIFIED TISSUE INT, V47, P117, DOI 10.1007/BF02555995; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P220, DOI 10.2106/00004623-199302000-00009; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P1214, DOI 10.2106/00004623-199308000-00011; Kaplan FS, 1998, NEUROMUSCULAR DISORD, P289; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kirman I, 1998, INFLAMM RES, V47, P285, DOI 10.1007/s000110050331; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kussmaul WG, 1998, CLIN ORTHOP RELAT R, P104; LANCHONEY TF, 1998, CLIN ORTHOP RELAT R, V346, P38; Lechleider RJ, 1996, J BIOL CHEM, V271, P17617, DOI 10.1074/jbc.271.30.17617; Levitz CL, 1992, CALCIFIED TISSUE INT, V50, P387; Luchetti W, 1996, ORAL SURG ORAL MED O, V81, P21, DOI 10.1016/S1079-2104(96)80141-7; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Olmsted EA, 1996, J BONE MINER RES, V11, pP294; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pichaud F, 1997, HUM GENET, V99, P279, DOI 10.1007/s004390050354; Pichaud F, 1997, ADV EXP MED BIOL, V433, P399; ROCKE DM, 1994, CLIN ORTHOP RELAT R, P243; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHROEDER HW, 1980, JOHNS HOPKINS MED J, V147, P73; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; SHAH PB, 1994, J BONE JOINT SURG AM, V76A, P1442, DOI 10.2106/00004623-199410000-00002; SMITH R, 1998, CLIN ORTHOP RELAT R, V346, P7; Virdi AS, 1999, CALCIFIED TISSUE INT, V65, P250, DOI 10.1007/s002239900693; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; XU M, 1998, CLIN ORTHOP RELAT R, V346, P53	46	73	79	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					128	135		10.1086/302724	http://dx.doi.org/10.1086/302724			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631143	Green Published, Bronze			2022-12-18	WOS:000085033600014
J	Omran, H; Fernandez, C; Jung, M; Haffner, K; Fargier, B; Villaquiran, A; Waldherr, R; Gretz, N; Brandis, M; Ruschendorf, F; Reis, A; Hildebrandt, F				Omran, H; Fernandez, C; Jung, M; Haffner, K; Fargier, B; Villaquiran, A; Waldherr, R; Gretz, N; Brandis, M; Ruschendorf, F; Reis, A; Hildebrandt, F			Identification of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 in a large Venezuelan pedigree	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL JUVENILE NEPHRONOPHTHISIS; PROTEIN-TYROSINE KINASES; LINKAGE ANALYSIS; RENAL-FAILURE; DISEASE; KIDNEY; MAP; CHILDREN; LOCALIZATION; PROGRESSION	Nephronophthisis, an autosomal-recessive cystic kidney disease, is the most frequent monogenic cause for renal failure in childhood. Infantile and juvenile forms of nephronophthisis are known to originate from separate gene loci. We describe here a new disease form, adolescent nephronophthisis, that is clearly distinct by clinical and genetic findings. In a large, 340-member consanguineous Venezuelan kindred, clinical symptoms and renal pathology were evaluated. Onset of terminal renal failure was compared with that in a historical sample of juvenile nephronophthisis. Onset of terminal renal failure in adolescent nephronophthisis occurred significantly later (median age 19 years, quartile borders 16.0 and 25.0 years) than in juvenile nephronophthisis (median age 13.1 years, quartile borders 11.3 and 17.3 years; Wilcoxon test P = .0069). A total-genome scan of linkage analysis was conducted and evaluated by LOD score and total-genome haplotype analyses. A gene locus for adolescent nephronophthisis was localized to a region of homozygosity by descent, on chromosome 3q22, within a critical genetic interval of 2.4 cM between flanking markers D3S1292 and D3S1238. The maximum LOD score for D3S1273 was 5.90 (maximum recombination fraction .035). This locus is different than that identified for juvenile nephronophthisis. These findings will have implications for diagnosis and genetic counseling in hereditary chronic renal failure and provide the basis for identification of the responsible gene.	Univ Hosp Los Andes, Merida, Venezuela; Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany; Max Delbruck Ctr Mol Med, Microsatellite Ctr, Berlin, Germany; Humboldt Univ, Charite, Inst Human Genet, Berlin, Germany; Univ Heidelberg, Med Res Ctr, Heidelberg, Germany; Univ Heidelberg, Inst Pathol, Heidelberg, Germany	University of Los Andes Venezuela; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Omran, H (corresponding author), Univ Freiburg, Childrens Hosp, Mathildenstr 1, D-79106 Freiburg, Germany.		Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; ANTIGNAC C, 1988, TXB CLIN NEPHROLOGY, P2417; Blowey DL, 1996, PEDIATR NEPHROL, V10, P22, DOI 10.1007/BF00863431; BODAGHI E, 1987, INT J PED NEPHROL, V8, P207; BOICHIS H, 1973, Q J MED, V42, P221; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Christodoulou K, 1998, HUM MOL GENET, V7, P905, DOI 10.1093/hmg/7.5.905; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Fillastre J P, 1976, Clin Nephrol, V5, P14; Fivush BA, 1998, PEDIATR NEPHROL, V12, P328, DOI 10.1007/s004670050462; GAGNADOUX MF, 1989, PEDIATR NEPHROL, V3, P50, DOI 10.1007/BF00859626; GARDNER KD, 1971, ANN INTERN MED, V74, P47, DOI 10.7326/0003-4819-74-1-47; GOLDMAN SH, 1966, NEW ENGL J MED, V274, P984, DOI 10.1056/NEJM196605052741802; GRATEAU G, 1986, NEPHROLOGIE, V7, P104; GRETZ NM, 1994, PEDIATR NEPHROL, V8, P499, DOI 10.1007/BF00856550; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; HILDEBRANDT F, 1993, AM J HUM GENET, V53, P1256; Hildebrandt F, 1997, KIDNEY INT, V51, P261, DOI 10.1038/ki.1997.31; HILDEBRANDT F, 1993, COMPUT BIOMED RES, V26, P592, DOI 10.1006/cbmr.1993.1042; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 1998, NEPHROL DIAL TRANSPL, V13, P1334, DOI 10.1093/ndt/13.6.1334; HILDEBRANDT F, 1999, PEDIAT NEPHROLOGY, P453; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kee NJ, 1997, KIDNEY INT, V52, P309, DOI 10.1038/ki.1997.336; Konrad M, 1996, HUM MOL GENET, V5, P367, DOI 10.1093/hmg/5.3.367; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; MAINZER F, 1970, AM J MED, V49, P556, DOI 10.1016/S0002-9343(70)80051-1; MEIER DA, 1965, AM J MED, V39, P58, DOI 10.1016/0002-9343(65)90245-7; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Saar K, 1997, AM J HUM GENET, V60, P605; Sambrook J, 1989, MOL CLONING LAB MANU; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Scolari F, 1999, AM J HUM GENET, V64, P1655, DOI 10.1086/302414; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; SMITH CH, 1945, AM J DIS CHILD, V69, P369; STACKER SA, 1993, ONCOGENE, V8, P1347; STEEL CM, 1977, NATURE, V270, P729, DOI 10.1038/270729a0; STEELE BT, 1980, AM J MED, V68, P531, DOI 10.1016/0002-9343(80)90299-5; STRAUSS MB, 1967, NEW ENGL J MED, V277, P863, DOI 10.1056/NEJM196710192771606; TAKAHASHI T, 1995, BIOCHEM BIOPH RES CO, V209, P218, DOI 10.1006/bbrc.1995.1492; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; ZOLLINGER HU, 1980, HELV PAEDIATR ACTA, V35, P509	48	73	81	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					118	127		10.1086/302705	http://dx.doi.org/10.1086/302705			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631142	Bronze, Green Published			2022-12-18	WOS:000085033600013
J	Ober, C; Hyslop, T; Hauck, WW				Ober, C; Hyslop, T; Hauck, WW			Inbreeding effects on fertility in humans: Evidence for reproductive compensation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREREPRODUCTIVE MORTALITY; HLA	The effects of inbreeding on prereproductive mortality have been demonstrated in many natural populations, including humans. However, little is known about the effects in inbred individuals who survive to adulthood. We have investigated the effects of inbreeding on fertility among inbred adult Hutterites and demonstrate significantly reduced fecundity among the most inbred Hutterite women, as evidenced by longer interbirth intervals (P =.024) and longer intervals to a recognized pregnancy (P =.010) but not by increased rates of fetal loss (P >.50). These data suggest the presence of recessive alleles that adversely affect fecundity among the population. In contrast, completed family sizes do not differ among the more and the less-inbred Hutterite women who were born after 1920, suggesting that reproductive compensation is occurring among the more-inbred and less-fecund women. This recent reproductive strategy would facilitate the maintenance of recessive alleles and contribute to an overall decline in fertility in the population.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; Thomas Jefferson Univ, Div Clin Pharmacol, Biostat Sect, Philadelphia, PA 19107 USA	University of Chicago; University of Chicago; Jefferson University	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 924 E 57th St, Chicago, IL 60637 USA.				NICHD NIH HHS [HD 21244] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Bleibtreu H., 1964, THESIS HARVARD U CAM; BOYCE AJ, 1983, J HERED, V74, P400, DOI 10.1093/oxfordjournals.jhered.a109825; Cox D.R., 1984, ANAL SURVIVAL DATA; HARPER PS, 1988, PRACTICAL GENETIC CO; HAUCK WW, 1991, GENET EPIDEMIOL, V8, P187, DOI 10.1002/gepi.1370080305; Hostetler J, 1974, HUTTERITE SOC; KHOURY MJ, 1987, AM J EPIDEMIOL, V125, P453, DOI 10.1093/oxfordjournals.aje.a114551; KHOURY MJ, 1987, AM J EPIDEMIOL, V125, P251, DOI 10.1093/oxfordjournals.aje.a114524; MANGE AP, 1964, HUM BIOL, V36, P104; MARGULIS SW, 1996, THESIS U CHICAGO CHI; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; MORTON NE, 1958, AM J HUM GENET, V10, P344; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; Ober C, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.1.33; OBER C, 1992, AM J HUM GENET, V50, P6; OBER C, 1995, PLACENTA, V16, P569, DOI 10.1016/0143-4004(95)90026-8; REED TE, 1971, AM J HUM GENET, V23, P215; SCHULL WJ, 1972, AM J HUM GENET, V24, P425; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; SHEPS MC, 1965, POP STUD-J DEMOG, V19, P65, DOI 10.2307/2173165; STEINBERG ARTHUR G., 1967, P267; Thornhill N.W., 1993, NATURAL HIST INBREED; Vogel F., 1997, HUMAN GENETICS; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; [No title captured]	26	73	74	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					225	231		10.1086/302198	http://dx.doi.org/10.1086/302198			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915962	Bronze, Green Published			2022-12-18	WOS:000078477400028
J	Poulton, J; Macaulay, V; Marchington, DR				Poulton, J; Macaulay, V; Marchington, DR			Is the bottleneck cracked?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; RED FIBERS MERRF; MITOCHONDRIAL-DNA; A->G(8344) MUTATION; POINT MUTATION; SEGREGATION; REPLICATION; ADVANTAGE; DIAGNOSIS; EPILEPSY		Univ Oxford, Dept Paediat, Oxford OX1 2JD, England; Univ Oxford, Dept Cellular Genet, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Poulton, J (corresponding author), John Radcliffe Hosp, Dept Paediat, Level 4, Oxford OX3 9DU, England.			Poulton, Joanna/0000-0002-2460-5587	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bartley J., 1996, American Journal of Human Genetics, V59, pA316; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; CHEN X, 1995, AM J HUM GENET, V57, P239; Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; HARDING AE, 1992, AM J HUM GENET, V50, P629; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HAUSWIRTH WW, 1985, ACHIEVEMENTS PERSPEC, V2; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251; HOWELL N, 1992, HUM GENET, V90, P117; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Laipis P J, 1996, Methods Enzymol, V264, P345, DOI 10.1016/S0076-6879(96)64033-6; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; Marchington DR, 1997, AM J HUM GENET, V60, P408; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; Meirelles FV, 1997, GENETICS, V145, P445; POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; TOURTE M, 1984, EUR J CELL BIOL, V34, P171; Weber K, 1997, AM J HUM GENET, V60, P373; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	29	73	78	0	7	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					752	757		10.1086/301811	http://dx.doi.org/10.1086/301811			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529369	Green Published, Bronze			2022-12-18	WOS:000073514400002
J	Zhang, YH; Guo, WW; Wagner, RL; Huang, BL; McCabe, L; Vilain, E; Burris, TP; Anyane-Yeboa, K; Burghes, AHM; Chitayat, D; Chudley, AE; Genel, M; Gertner, JM; Klingensmith, GJ; Levine, SN; Nakamoto, J; New, MI; Pagon, RA; Pappas, LC; Quigley, CA; Rosenthal, IM; Baxter, JD; Fetterick, RJ; McCabe, ERB				Zhang, YH; Guo, WW; Wagner, RL; Huang, BL; McCabe, L; Vilain, E; Burris, TP; Anyane-Yeboa, K; Burghes, AHM; Chitayat, D; Chudley, AE; Genel, M; Gertner, JM; Klingensmith, GJ; Levine, SN; Nakamoto, J; New, MI; Pagon, RA; Pappas, LC; Quigley, CA; Rosenthal, IM; Baxter, JD; Fetterick, RJ; McCabe, ERB			DAX1 mutations map to putative structural domains in a deduced three-dimensional model	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL HYPOPLASIA; NUCLEAR HORMONE-RECEPTOR; GONADOTROPIN-RELEASING HORMONE; LIGAND-BINDING DOMAIN; HYPOGONADOTROPIC HYPOGONADISM; GENE; DEFICIENCY; SUPERFAMILY; PROTEIN; DNA	The DAX1 protein is an orphan nuclear hormone receptor based on sequence similarity in the putative ligand-binding domain (LBD). DAX1 mutations result in X-linked adrenal hypoplasia congenita (AHC). Our objective was to identify DAX1 mutations in a series of families, to determine the types of mutations resulting in AHC and to locate single-amino-acid changes in a DAX1 structural model. The 14 new mutations identified among our 17 families with AHC brought the total number of families with AHC to 48 and the number of reported mutations to 42; 1 family showed gonadal mosaicism. These mutations included 23 frameshift, 12 nonsense, and six missense mutations and one single-codon deletion. We mapped the seven single-amino-acid changes to a homology model constructed by use of the three-dimensional crystal structures of the thyroid-hormone receptor and retinoid X receptor alpha. All single-amino-acid changes mapped to the C-terminal half of the DAX1 protein, in the conserved hydrophobic core of the putative LED, and none affected residues expected to interact directly with a ligand. We conclude that most genetic alterations in DAX1 are frameshift or nonsense mutations and speculate that the codon deletion and missense mutations give insight into the structure and function of DAX1.	Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Columbia Presbyterian Med Ctr, New York, NY 10032 USA; Cornell Univ, Ithaca, NY 14853 USA; Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; Ohio State Univ, Columbus, OH 43210 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Manitoba, Winnipeg, MB R3T 2N2, Canada; Yale Univ, Sch Med, New Haven, CT 06520 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Louisiana State Univ, Med Ctr, Shreveport, LA USA; Childrens Hosp & Med Ctr, Seattle, WA 98105 USA; Indiana Univ, Indianapolis, IN 46204 USA; Univ Chicago, Chicago, IL 60637 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; Columbia University; NewYork-Presbyterian Hospital; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; University System of Ohio; Ohio State University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Manitoba; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Seattle Children's Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; University of Chicago	McCabe, ERB (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pediat, MDCC 22-412,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	emccabe@pediatrics.medsch.ucla.edu	Pappas, John/Q-6683-2019; Burris, Thomas P/B-3886-2016; Pappas, John G./K-6530-2012; Burris, Thomas/H-5078-2011	Pappas, John/0000-0001-5625-2598; Burris, Thomas P/0000-0003-2922-4449; Pappas, John G./0000-0001-5625-2598; Anyane-Yeboa, Kwame/0000-0002-4977-9719; Burghes, Arthur/0000-0001-9031-1555	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022563] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD-22563] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BOVET P, 1988, J ENDOCRINOL INVEST, V11, P201, DOI 10.1007/BF03350135; Burris TP, 1996, RECENT PROG HORM RES, V51, P241; BURRIS TP, 1995, BIOCHEM BIOPH RES CO, V214, P576, DOI 10.1006/bbrc.1995.2324; EPSTEIN CJ, 1995, P NATL ACAD SCI USA, V92, P8566, DOI 10.1073/pnas.92.19.8566; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; GOLDEN MP, 1977, AM J DIS CHILD, V131, P1117, DOI 10.1001/archpedi.1977.02120230063010; GORDON D, 1984, CLIN ENDOCRINOL, V21, P597, DOI 10.1111/j.1365-2265.1984.tb01401.x; Guo WW, 1996, J CLIN ENDOCR METAB, V81, P2481, DOI 10.1210/jc.81.7.2481; GUO WW, 1995, BIOCHEM MOL MED, V56, P8, DOI 10.1006/bmme.1995.1049; GUO WW, 1995, JAMA-J AM MED ASSOC, V274, P324, DOI 10.1001/jama.274.4.324; Guo WW, 1996, GENE, V178, P31, DOI 10.1016/0378-1119(96)00320-4; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; HAY ID, 1981, ARCH DIS CHILD, V56, P715, DOI 10.1136/adc.56.9.715; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; KIKUCHI K, 1987, ACTA ENDOCRINOL-COP, V114, P153, DOI 10.1530/acta.0.1140153; KLETTER GB, 1991, TRENDS ENDOCRIN MET, V2, P123, DOI 10.1016/1043-2760(91)90001-4; KRUSE K, 1984, J CLIN ENDOCR METAB, V58, P12, DOI 10.1210/jcem-58-1-12; MARSDEN HB, 1978, VIRCHOWS ARCH A, V378, P105, DOI 10.1007/BF00432354; Martin M.M., 1985, INT J ADOLESC MED HL, V1, P119; McCabe ER, 1995, METABOLIC BASIS INHE, P1631; McCabe ERB, 1996, J CLIN INVEST, V98, P881, DOI 10.1172/JCI118868; Mumm S, 1997, AM J HUM GENET, V60, P153; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nakae J, 1996, J CLIN ENDOCR METAB, V81, P3680, DOI 10.1210/jc.81.10.3680; ODONNELL AL, 1991, MOL ENDOCRINOL, V5, P94, DOI 10.1210/mend-5-1-94; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PARTSCH CJ, 1989, HORM METAB RES, V21, P623, DOI 10.1055/s-2007-1009303; PRADER A, 1975, J PEDIATR-US, V86, P421, DOI 10.1016/S0022-3476(75)80978-4; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwartz M, 1997, HUM GENET, V99, P83; SELTZER WK, 1985, BIOCHEM MED METAB B, V33, P189, DOI 10.1016/0006-2944(85)90027-4; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Takahashi T, 1997, J PEDIATR-US, V130, P485, DOI 10.1016/S0022-3476(97)70217-8; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Vilain E, 1997, BIOCHEM MOL MED, V61, P1, DOI 10.1006/bmme.1997.2601; VIRDIS R, 1983, J ENDOCRINOL INVEST, V6, P51, DOI 10.1007/BF03350561; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yanase T, 1996, J CLIN ENDOCR METAB, V81, P530, DOI 10.1210/jc.81.2.530; YU RN, 1996, 10 INT C END SAN FRA; ZACHMANN M, 1980, J PEDIATR-US, V97, P255, DOI 10.1016/S0022-3476(80)80486-0; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	47	73	77	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					855	864		10.1086/301782	http://dx.doi.org/10.1086/301782			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529340	hybrid, Green Published			2022-12-18	WOS:000073514400017
J	Rannala, B; Slatkin, M				Rannala, B; Slatkin, M			Likelihood analysis of disequilibrium mapping, and related problems	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DIASTROPHIC DYSPLASIA; POPULATIONS; LOCUS; HUMANS	In this paper a theory is developed that provides the sampling distribution of alleles at a diallelic marker locus closely linked to a low-frequency allele that arose as a single mutant. The sampling distribution provides a basis for maximum-likelihood estimation of either the recombination rate, the mutation rate, or the age of the allele, provided that the two other parameters are known. This theory is applied to (1) the data of Hastbacka et al., to estimate the recombination rate between a locus associated with diastrophic dysplasia and a linked RFLP marker; (2) the data of Risch et al., to estimate the age of a presumptive allele causing idiopathic distortion dystonia in Ashkenazi jews; and (3) the data of Tishkoff et al., to estimate the date at which, at the CD4 locus, non-African lineages diverged from African lineages. We conclude that the extent of linkage disequilibrium can lead to relatively accurate estimates of recombination and mutation rates and that those estimates are not very sensitive to parameters, such as the population age, whose values are not known with certainty. In contrast, we also conclude that, in many cases, linkage disequilibrium may not lead to useful estimates of allele age, because of the relatively large degree of uncertainly in those estimates.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Slatkin, M (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, VLSB 3060, Berkeley, CA 94720 USA.		Rannala, Bruce/M-3188-2014	Rannala, Bruce/0000-0002-8355-9955	NIGMS NIH HHS [GM-40282] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CASELLA G, 1990, STAT INTERFERENCE; Guo SW, 1997, HUM HERED, V47, P315, DOI 10.1159/000154431; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KAPLAN NL, 1995, AM J HUM GENET, V57, P1486; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Pritchard JK, 1996, SCIENCE, V274, P1548, DOI 10.1126/science.274.5292.1548; Rannala B, 1997, HEREDITY, V78, P417, DOI 10.1038/hdy.1997.65; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SERRE JL, 1990, HUM GENET, V84, P449; Slatkin M, 1997, AM J HUM GENET, V60, P447; SLATKIN M, 1991, GENETICS, V129, P555; Thompson EA, 1997, AM J HUM GENET, V60, P197; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475	18	73	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					459	473		10.1086/301709	http://dx.doi.org/10.1086/301709			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463316	Green Published, Bronze			2022-12-18	WOS:000072416000029
J	Davis, S; Weeks, DE				Davis, S; Weeks, DE			Comparison of nonparametric statistics for detection of linkage in nuclear families: Single-marker evaluation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; PEDIGREE-MEMBER METHOD; SIB-PAIR LINKAGE; SUSCEPTIBILITY GENES; MULTIPLE-SCLEROSIS; POLYGENIC DISEASE; COMPLEX; TRAITS; LOCUS; TESTS	We have evaluated 23 different statistics, from a total of 10 popular software packages for model-free linkage analysis of nuclear-family data, by applying them to single-marker data simulated under several two-locus disease models. The statistics that we examined fall into two broad categories: (1) those that test directly for increased identity-by-state or identity-by-descent sharing (by use of the programs APM, Genetic Analysis System [GAS] SIBSTATE and SIBDES, SAGE SIBPAL, ERPA, SimIBD, and Genehunter NPL) and (2) those that are based on likelihood-ratio tests and that report LOD scores (by use of the programs Splink, SIBPAIR, Mapmaker/Sibs, ASPEX, and GAS SIBMLS). For each of eight two-locus disease models, we analyzed six data sets; the first three data sets consisted of two-child families with both sibs affected and zero, one, or both parents typed, whereas the other three data sets consisted of four-child families with at least two affected sibs and zero, one, or both parents typed. We report false-positive rates, overall rank by power, and the power for each statistic. We give rough recommendations regarding which programs provide the most powerful tests for linkage, as well as the programs to be avoided under certain conditions. For the likelihood-ratio-based statistics, we examined the effects of various treatments of sibships with multiple affected individuals. Finally we explored the use of some simple two-of-three composite statistics and found that such tests are of only marginal benefit over the most powerful single statistic.	Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Wellcome Centre for Human Genetics	Weeks, DE (corresponding author), Univ Pittsburgh, Dept Human Genet, Crabtree Hall,Room A310,130 DeSoto St, Pittsburgh, PA 15261 USA.		Weeks, Daniel E/B-2995-2012; Davis, Sean/AAD-1801-2021	Weeks, Daniel E/0000-0001-9410-7228; Davis, Sean/0000-0002-8991-6458	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000719] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NHGRI NIH HHS [HG00719] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Davis S, 1996, AM J HUM GENET, V58, P867; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Feingold E, 1997, AM J HUM GENET, V60, P965; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hinds DA, 1996, ASPEX PACKAGE AFFECT; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; HYER RN, 1991, AM J HUM GENET, V48, P243; KNAPP M, 1994, HUM HERED, V44, P37, DOI 10.1159/000154187; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; PENROSE LS, 1953, ANN EUGENIC, V18, P120; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1992, AM J HUM GENET, V51, P673; *SAGE, 1994, STAT AN GEN EP REL 2; SCHROEDER M, 1994, GENET EPIDEMIOL, V11, P69, DOI 10.1002/gepi.1370110107; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; STINE OC, 1995, AM J HUM GENET, V57, P1384; TERWILLIGER J, 1996, PROGRAM SIBPAIR SIBP; WARD PJ, 1993, AM J HUM GENET, V52, P1200; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; YOUNG A, 1995, GAS GENETIC ANAL SYS	35	73	74	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1431	1444		10.1086/301635	http://dx.doi.org/10.1086/301635			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399893	Bronze, Green Published			2022-12-18	WOS:000071555900028
J	Palmer, LJ; Pare, PD; Faux, JA; Moffatt, MF; Daniels, SE; LeSouef, PN; Bremner, PR; Mockford, E; Gracey, M; Spargo, R; Musk, AW; Cookson, WOCM				Palmer, LJ; Pare, PD; Faux, JA; Moffatt, MF; Daniels, SE; LeSouef, PN; Bremner, PR; Mockford, E; Gracey, M; Spargo, R; Musk, AW; Cookson, WOCM			Fc(epsilon)R1-beta polymorphism and total serum IgE levels in endemically parasitized Australian aborigines	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FC-EPSILON-RI; HELMINTHIC INFECTION; ALLERGIC REACTIVITY; CHROMOSOME 11Q13; BETA-SUBUNIT; ATOPY; ASTHMA; ASSOCIATION; PREVALENCE; CHILDREN	Endemic helminthic infection is a major public-health problem and affects a large proportion of the world's population. In Australia, helminthic infection is endemic in Aboriginal communities living in tropical northern regions of the continent. Such infection is associated with nonspecific (polyclonal) stimulation of IgE synthesis and highly elevated total serum IgE levels. There is evidence that worm-infection variance (i.e., human capacity of resistance) and total serum IgE levels may be related to the presence of a major codominant gene. The beta chain of the high-affinity IgE receptor, Fc(epsilon)R1-beta, has been previously identified as a candidate for the close genetic linkage of the 11q13 region to IgE responses in several populations. We show a biallelic RsaI polymorphism in Fc(epsilon)R1-beta to be associated with total serum IgE levels (P =.0001) in a tropical population of endemically parasitized Australian Aborigines (n = 234 subjects). The polymorphism explained 12.4% of the total residual variation in serum total IgE and showed a significant (P =.0000) additive relationship with total serum IgE levels, across the three genotypes. These associations were independent of familial correlations, age, gender, racial admixture, or smoking status. Alleles of a microsatellite repeat in intron 5 of the same gene showed similar associations. The results suggest that variation in Fc(epsilon)R1-beta may regulate IgE-mediated immune responses in this population.	JOHN RADCLIFFE HOSP, NUFFIELD DEPT CLIN MED, OXFORD OX3 9DU, ENGLAND; UNIV WESTERN AUSTRALIA, DEPT PAEDIAT, PERTH, WA 6009, AUSTRALIA; SIR CHARLES GAIRDINER HOSP, DEPT RESP MED, PERTH, WA 6000, AUSTRALIA; HLTH DEPT WESTERN AUSTRALIA, PERTH, AUSTRALIA	University of Oxford; University of Western Australia; University of Western Australia			Le Souef, Peter N/H-5256-2014; Pare, Peter D/C-7425-2011; Palmer, Lyle John/N-1948-2019; Cookson, William/HHC-1790-2022; Palmer, Lyle John/K-3196-2014	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Le Souef, Peter/0000-0003-0930-1654	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akaike H., 1977, J R STAT SOC C-APPL, P27; [Anonymous], 1965, LANCET, V1, P775; Boguniewicz M, 1996, THORAX, V51, pS55, DOI 10.1136/thx.51.Suppl_2.S55; COLLEE JM, 1993, LANCET, V342, P936, DOI 10.1016/0140-6736(93)91988-X; COOKSON WOCM, 1989, LANCET, V1, P1292; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DANIELS SE, 1994, HUM MOL GENET, V3, P213, DOI 10.1093/hmg/3.1.213; DEPONCE DP, 1991, INVEST CLIN, V32, P77; DESSEIN AJ, 1992, IMMUNOL INVEST, V21, P423, DOI 10.3109/08820139209069383; DIZIER MH, 1995, GENET EPIDEMIOL, V12, P93, DOI 10.1002/gepi.1370120109; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; GRACEY M, 1992, AUST J PUBLIC HEALTH, V16, P216; GROVE D, 1991, DIARRHEA, P93; HAGEL I, 1993, PARASITE IMMUNOL, V15, P311, DOI 10.1111/j.1365-3024.1993.tb00615.x; Hill MR, 1996, HUM MOL GENET, V5, P959, DOI 10.1093/hmg/5.7.959; HILL MR, 1995, BRIT MED J, V311, P776, DOI 10.1136/bmj.311.7008.776; HIZAWA N, 1995, J MED GENET, V32, P363, DOI 10.1136/jmg.32.5.363; HOPKINS R, IN PRESS MED J AUST; Khoury M, 1993, FUNDAMENTALS GENETIC; KING CL, 1993, J IMMUNOL, V150, P1873; LYNCH NR, 1983, INT ARCH ALLER A IMM, V72, P369, DOI 10.1159/000234899; LYNCH NR, 1992, PARASITOL TODAY, V8, P166, DOI 10.1016/0169-4758(92)90011-P; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; MARTINEZ FD, 1994, AM J HUM GENET, V55, P555; MELONI BP, 1993, MED J AUSTRALIA, V158, P157, DOI 10.5694/j.1326-5377.1993.tb121692.x; MEYERS DA, 1982, HUM HERED, V32, P15, DOI 10.1159/000153262; National Health and Medical Research Council Medical Research Ethics Committee, 1991, GUID ETH MATT AB TOR; NINAN TK, 1992, BRIT MED J, V304, P873, DOI 10.1136/bmj.304.6831.873; PEAT JK, 1994, BMJ-BRIT MED J, V308, P1591, DOI 10.1136/bmj.308.6944.1591; PRITCHARD DI, 1995, PARASITE IMMUNOL, V17, P71, DOI 10.1111/j.1365-3024.1995.tb00968.x; RAVETCH JV, 1994, NAT GENET, V7, P117, DOI 10.1038/ng0694-117; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Rodrigues V, 1996, AM J HUM GENET, V59, P453; SAGE, 1994, STAT AN GEN EP REL 2; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; SEARS MR, 1993, CLIN EXP ALLERGY, V23, P941, DOI 10.1111/j.1365-2222.1993.tb00279.x; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; SHIRAKAWA T, 1994, CLIN GENET, V46, P228; Shirakawa T, 1996, LANCET, V347, P394, DOI 10.1016/S0140-6736(96)90570-X; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; SUNYER J, 1995, J ALLERGY CLIN IMMUN, V95, P699, DOI 10.1016/S0091-6749(95)70175-3; WATANABE N, 1993, PARASITOL RES, V79, P431, DOI 10.1007/BF00931835; YOUNG RP, 1992, J MED GENET, V29, P236, DOI 10.1136/jmg.29.4.236	43	73	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					182	188		10.1086/513888	http://dx.doi.org/10.1086/513888			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245999	Bronze, Green Published			2022-12-18	WOS:A1997XM72800026
J	Bapat, B; Xia, L; Madlensky, L; Mitri, A; Tonin, P; Narod, SA; Gallinger, S				Bapat, B; Xia, L; Madlensky, L; Mitri, A; Tonin, P; Narod, SA; Gallinger, S			The genetic basis of Muir-Torre syndrome includes the hMLH1 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NONPOLYPOSIS COLON-CANCER; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; HEREDITARY; MUTATIONS; HOMOLOG; ASSOCIATION; FAMILIES; TUMORS; MSH2		UNIV TORONTO, MT SINAI HOSP, DEPT SURG, TORONTO, ON M5G 1X5, CANADA; UNIV TORONTO, MT SINAI HOSP, STEVE ATANAS STAVRO FAMILIAL GI CANC REGISTRY, TORONTO, ON M5G 1X5, CANADA; UNIV TORONTO, MT SINAI HOSP, SAMUEL LUNENFELD RES INST, TORONTO, ON M5G 1X5, CANADA; MCGILL UNIV, DIV MED GENET, MONTREAL, PQ H3A 2T5, CANADA; UNIV TORONTO, WOMENS COLL HOSP, TORONTO, ON, CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital	Bapat, B (corresponding author), UNIV TORONTO, MT SINAI HOSP, DEPT PATHOL & LAB MED, 600 UNIV AVE, TORONTO, ON M5G 1X5, CANADA.		Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014; Narod, Steven A/AAA-6112-2022					AALTONEN LA, 1994, CANCER RES, V54, P1645; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CHARBONNIER F, 1995, CANCER RES, V55, P1839; COHEN PR, 1991, AM J MED, V90, P606; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GREEN RC, 1994, AM J HUM GENET, V54, P1067; HALL NR, 1994, EUR J CANCER, V30A, P180, DOI 10.1016/0959-8049(94)90083-3; HONCHEL R, 1994, CANCER RES, V54, P1159; KOLODNER RD, 1994, GENOMICS, V24, P516, DOI 10.1006/geno.1994.1661; KOLODNER RD, 1995, CANCER RES, V55, P242; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LUCE MC, 1995, GASTROENTEROLOGY, V109, P1368, DOI 10.1016/0016-5085(95)90600-2; LYNCH HT, 1985, BRIT J DERMATOL, V113, P295, DOI 10.1111/j.1365-2133.1985.tb02081.x; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; MUIR EG, 1967, BRIT J SURG, V54, P191, DOI 10.1002/bjs.1800540309; NAN HJ, 1995, HUM MOL GENET, V4, P237, DOI 10.1093/hmg/4.2.237; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARAF F, 1995, HUM PATHOL, V26, P422, DOI 10.1016/0046-8177(95)90144-2; TANNERGARD P, 1995, CANCER RES, V55, P6092; TORRE D, 1968, ARCH DERMATOL, V98, P549, DOI 10.1001/archderm.98.5.549	24	73	76	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					736	739						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751876				2022-12-18	WOS:A1996VN62500029
J	Guldberg, P; Levy, HL; Hanley, WB; Koch, R; Matalon, R; Rouse, BM; Trefz, F; delaCruz, F; Henriksen, KF; Guttler, F				Guldberg, P; Levy, HL; Hanley, WB; Koch, R; Matalon, R; Rouse, BM; Trefz, F; delaCruz, F; Henriksen, KF; Guttler, F			Phenylalanine hydroxylase gene mutations in the United States: Report from the maternal PKU collaborative study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA SPLICE JUNCTIONS; MOLECULAR ANALYSIS; SOUTHERN EUROPE; MESSENGER-RNA; PHENYLKETONURIA; DNA; SPECTRUM; SEQUENCE; REGIONS; ALLELES	The major cause of hyperphenylalaninemia is mutations in the gene encoding phenylalanine hydroxylase (PAH). The lino,vn mutations have been identified primarily in European patients. The purpose of this study was to determine the spectrum of mutations responsible for PAH deficiency in the United States. One hundred forty-nine patients enrolled in the Maternal PKU Collaborative Study were subjects for clinical and molecular investigations. PAH gene mutations associated with phenylketonuria (PKU) or mild hyperphenylalaninemia (MHP) were identified on 279 of 294 independent mutant chromosomes, a diagnostic efficiency of 95%. The spectrum is composed of 71 different mutations, including 47 missense mutations, 11 splice mutations, 5 nonsense mutations, and 8 microdeletions. Sixteen previously unreported mutations were identified. Among the novel mutations, five were found in patients with MHP, and the remainder were found in patients with PKU. The most common mutations were R408W, IVS12nt1g-->a, and Y414C, accounting for 18.7%, 7.8%, and 5.4% of the mutant chromosomes, respectively. Thirteen mutations had relative frequencies of 1%-5%, and 55 mutations each had frequencies less than or equal to 1%. The mutational spectrum corresponded to that observed for the European ancestry of the U.S. population. To evaluate the extent of allelic variation at the PAH locus within the United States in comparison with other populations, we used allele frequencies to calculate the homozygosity for 11 populations where >90% ascertainment of mutations has been obtained. The United States was shown to contain one of the most heterogeneous populations, with homozygosity values similar to Sicily and ethnically mixed sample populations in Europe. The extent of allelic heterogeneity must be a major determining factor in the choice of mutation-detection methodology for molecular diagnosis in PAH deficiency.	NICHHD, BETHESDA, MD 20892 USA; JOHN F KENNEDY INST, DANISH CTR HUMAN GENOME RES, DK-2600 GLOSTRUP, DENMARK; HARVARD UNIV, CHILDRENS HOSP, SCH MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; HOSP SICK CHILDREN, TORONTO, ON M5G 1X8, CANADA; UNIV SO CALIF, LOS ANGELES, CA 90089 USA; CHILDRENS HOSP, DIV MED GENET, LOS ANGELES, CA 90027 USA; UNIV TEXAS, MED BRANCH, CHILDRENS HOSP, GALVESTON, TX 77550 USA; CHILDRENS HOSP, RES INST, MIAMI, FL USA; UNIV TUBINGEN, REUTLINGEN, GERMANY	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Aarhus University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Southern California; Children's Hospital Los Angeles; University of Texas System; University of Texas Medical Branch Galveston; Eberhard Karls University of Tubingen					NICHD NIH HHS [N01-HD-Z-3155] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; BICKEL H, 1981, EUR J PEDIATR, V137, P133; BYCK S, 1994, HUM MOL GENET, V3, P1675, DOI 10.1093/hmg/3.9.1675; *COMM DEP, 1992, GERM IR ENGL AFR AM; DWORNICZAK B, 1991, GENOMICS, V11, P242, DOI 10.1016/0888-7543(91)90129-3; EIKEN HG, IN PRESS HUM MUTAT; EISENSMITH RC, 1995, ADV GENET, V32, P199; EISENSMITH RC, 1995, AM J HUM GENET, V56, P278; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1355; FORREST S, 1995, HUM MUTAT, V10, P375; GOLTSOV AA, 1992, AM J HUM GENET, V51, P627; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; GULDBERG P, 1993, HUM MOL GENET, V2, P1703, DOI 10.1093/hmg/2.10.1703; GULDBERG P, 1994, NUCLEIC ACIDS RES, V22, P880, DOI 10.1093/nar/22.5.880; GULDBERG P, 1994, GENOMICS, V21, P453, DOI 10.1006/geno.1994.1296; GULDBERG P, 1994, ACTA PAEDIATR, V83, P27, DOI 10.1111/j.1651-2227.1994.tb13443.x; GULDBERG P, 1995, EUR J PEDIATR, V154, P551, DOI 10.1007/BF02074833; GULDBERG P, IN PRESS HUM MUTAT; GUTHRIE R, 1963, PEDIATRICS, V32, P338; GUTTLER F, 1980, ACTA PAEDIATR SCAND, P1; GUTTLER F, 1994, ACTA PAEDIATR, V83, P49, DOI 10.1111/j.1651-2227.1994.tb13451.x; Hoang L, 1996, NUCLEIC ACIDS RES, V24, P127, DOI 10.1093/nar/24.1.127; HOFMAN KJ, 1991, AM J HUM GENET, V48, P791; KALAYDJIEVA L, 1991, J MED GENET, V28, P686, DOI 10.1136/jmg.28.10.686; KOCH R, 1994, ACTA PAEDIATR, V83, P111, DOI 10.1111/j.1651-2227.1994.tb13468.x; KONECKI DS, 1992, BIOCHEMISTRY-US, V31, P8363, DOI 10.1021/bi00150a033; KRAWCZAK M, 1992, HUM GENET, V90, P41; KUZMIN AI, 1995, EUR J HUM GENET, V3, P246; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LICHTERKONECKI U, 1994, HUM GENET, V94, P307; MCCAMAN MW, 1962, J LAB CLIN MED, V59, P885; OKANO Y, 1991, GENOMICS, V9, P96, DOI 10.1016/0888-7543(91)90225-4; ONEILL CA, 1994, ACTA PAEDIATR, V83, P43, DOI 10.1111/j.1651-2227.1994.tb13448.x; RAMUS SJ, 1995, AM J HUM GENET, V56, P1034; Romano Valentino, 1993, Developmental Brain Dysfunction, V6, P83; Scriver C.R., 1995, METABOLIC MOL BASIS, V7th ed, P1015; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SVENSSON E, 1993, EUR J PEDIATR, V152, P132, DOI 10.1007/BF02072490; Treacy Eileen, 1993, European Journal of Human Genetics, V1, P220; TREFZ FK, 1993, CLIN CHIM ACTA, V217, P15, DOI 10.1016/0009-8981(93)90233-T; Tyfield L. A., 1993, Developmental Brain Dysfunction, V6, P60; TYFIELD LA, 1994, ACTA PAEDIATR, V83, P47, DOI 10.1111/j.1651-2227.1994.tb13450.x; VANDERSIJSBOS CJM, 1996, IN PRESS HUM HERED; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; ZSCHOCKE J, 1995, AM J HUM GENET, V57, P1311; ZYGULSKA M, 1994, HUM MUTAT, V4, P297, DOI 10.1002/humu.1380040412	47	73	81	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					84	94						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659548				2022-12-18	WOS:A1996VL45500013
J	Bartsch, O; Wuyts, W; VanHul, W; Hecht, JT; Meinecke, P; Hogue, D; Werner, W; Zabel, B; Hinkel, GK; Powell, CM; Shaffer, LG; Willems, PJ				Bartsch, O; Wuyts, W; VanHul, W; Hecht, JT; Meinecke, P; Hogue, D; Werner, W; Zabel, B; Hinkel, GK; Powell, CM; Shaffer, LG; Willems, PJ			Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions on the short arm of chromosome 11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAETHRE-CHOTZEN SYNDROME	A contiguous gene syndrome due to deletions of the proximal short arm of chromosome 11 is described in eight patients belonging to four families. The main clinical features are multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation. The patients have cytogenetic and/or molecular deletions of chromosome 11p11-p13. These deletions are located between the centromere and D11S914 in a region of similar to 20 cM. The present study confirms the presence of a multiple exostoses gene on chromosome 11p. Furthermore, it suggests that the gene for isolated foramina parietalia permagna and genes associated with craniofacial dysostosis and mental retardation reside in the same chromosomal region.	UNIV ANTWERP, DEPT MED GENET, B-2610 ANTWERP, BELGIUM; UNIV HOSP DRESDEN, DEPT CLIN GENET, DRESDEN, GERMANY; UNIV TEXAS, HLTH SCI CTR, DEPT PEDIAT, HOUSTON, TX 77225 USA; BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, HOUSTON, TX 77030 USA; ALTONAER KINDERKRANKENHAUS, DIV MED GENET, HAMBURG, GERMANY; UNIV MAINZ, DEPT PEDIAT, W-6500 MAINZ, GERMANY; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27515 USA	University of Antwerp; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; University of North Carolina; University of North Carolina Chapel Hill			Bartsch, Oliver/ABE-2681-2020; wuyts, wim/B-1346-2012	wuyts, wim/0000-0002-4349-9038; Van Hul, Wim/0000-0002-5065-7858				COOK A, 1993, AM J HUM GENET, V53, P71; CURRARINO G, 1976, AM J ROENTGENOL, V127, P487, DOI 10.2214/ajr.127.3.487; DUNN FH, 1960, AMER J ROENTGENOL RA, V84, P472; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; FRIEDMAN JM, 1977, J PEDIATR-US, V91, P929, DOI 10.1016/S0022-3476(77)80892-5; Goldsmith WM, 1922, J HERED, V13, P69, DOI 10.1093/oxfordjournals.jhered.a102158; GUSTAVSON KH, 1984, CLIN GENET, V26, P247; HECHT JT, 1995, AM J HUM GENET, V56, P1125; HERRMANN J, 1969, Birth Defects Original Article Series, V5, P39; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; LEHRER HZ, 1969, RADIOLOGY, V92, P127, DOI 10.1148/92.1.127; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LITTLE BB, 1990, AM J MED GENET, V35, P453, DOI 10.1002/ajmg.1320350402; LORENZ P, 1990, AM J MED GENET, V36, P265, DOI 10.1002/ajmg.1320360302; LOTHER K, 1959, Arch Kinderheilkd, V160, P156; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; MCGAUGHRAN JM, 1995, J MED GENET, V32, P823, DOI 10.1136/jmg.32.10.823; MURPHY J, 1970, RADIOLOGY, V97, P391, DOI 10.1148/97.2.391; Pendergrass EP, 1939, AM J ROENTGENOL RADI, V41, P343; PIERSOL GA, 1902, U PENNA MED B, V15, P203; POTOCKI L, 1995, AM J HUM GENET, V57, P688; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; RASORE-QUARTINO A, 1985, Pathologica (Genoa), V77, P449; SCHMIDTWITTKAMP E, 1970, ROFO-FORTSCHR RONTG, V113, P29; SHAFFER LG, 1993, AM J MED GENET, V45, P581, DOI 10.1002/ajmg.1320450512; SOLOMON L, 1961, J BONE JOINT SURG BR, V43, P700, DOI 10.1302/0301-620X.43B4.700; THOMPSON EM, 1984, J MED GENET, V21, P369, DOI 10.1136/jmg.21.5.369; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; WUYTS W, 1995, AM J HUM GENET, V57, P382; YOUNG ID, 1985, J MED GENET, V22, P413, DOI 10.1136/jmg.22.5.413-a; ZABEK M, 1987, NEUROCHIRURGIA, V30, P25	31	73	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					734	742						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	UA380	8644736				2022-12-18	WOS:A1996UA38000010
J	Casaubon, LK; Melanson, M; LopesCendes, I; Marineau, C; Andermann, E; Andermann, F; Weissenbach, J; Prevost, C; Bouchard, JP; Mathieu, J; Rouleau, GA				Casaubon, LK; Melanson, M; LopesCendes, I; Marineau, C; Andermann, E; Andermann, F; Weissenbach, J; Prevost, C; Bouchard, JP; Mathieu, J; Rouleau, GA			The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANDERMANN SYNDROME; NEURONOPATHY	Peripheral neuropathy with or without agenesis of the corpus callosum (ACCPN) is a devastating neurodegenerative disorder that is transmitted as an autosomal recessive trait. Genealogical studies in a large number of affected French Canadian individuals suggest that ACCPN results from a single founder mutation, A genomewide search using 120 microsatellite DNA markers in 14 French Canadian families allowed the mapping of the ACCPN gene to a 5-cM region on chromosome 15q13-q15 that is flanked by markers D15S1040 and D15S118. A maximum two-point LOD score of 11.1 was obtained with the marker D15S971 at a recombination fraction of 0. Haplotype analysis and linkage disequilibrium support a founder effect. These findings are the first step in the identification of the gene responsible for ACCPN, which may shed some light on the numerous conditions associated with progressive peripheral neuropathy or agenesis of the corpus callosum.	MONTREAL GEN HOSP, CTR RES NEUROSCI, RES INST, MONTREAL, PQ H3G 1A4, CANADA; MCGILL UNIV, CTR RES NEUROSCI, MONTREAL, PQ H3A 2T5, CANADA; MCGILL UNIV, MONTREAL NEUROL HOSP & INST, MONTREAL, PQ H3A 2T5, CANADA; HOTEL DIEU CHICOUTIMI, CHICOUTIMI, PQ, CANADA; GENETHON, CNRS, URA 1922, EVRY, FRANCE; HOP ENFANTS JESUS, DEPT NEUROL, QUEBEC CITY, PQ, CANADA	McGill University; McGill University; McGill University; University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); Laval University			Lopes-Cendes, Iscia/B-9416-2013	Lopes-Cendes, Iscia/0000-0002-6221-6822				ANDERMANN E, 1979, CAN J NEUROL SCI, V6, P400; ANDERMANN E, 1994, ADV BEHAV BIOL, V42, P31; Andermann E., 1981, HDB CLIN NEUROLOGY, P100; ANDERMANN F, 1994, ADV BEHAV BIOL, V42, P19; Andermann F., 1972, T AM NEUROL ASS, V97, P242; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BATTISTELLA PS, 1986, 12TH NATL C NEUR CHI; BENOTHMANE K, 1993, GENOMICS, V2, P1625; CARPENTER S, 1994, ADV BEHAV BIOL, V42, P27; CHANCE PF, 1994, HUM MOL GENET, V3, P1503, DOI 10.1093/hmg/3.suppl_1.1503; DEBRAEKELEER M, 1993, HUM GENET, V91, P223, DOI 10.1007/BF00218260; DONNENFELD AE, 1990, AM J MED GENET, V37, P182, DOI 10.1002/ajmg.1320370205; FILTEAU MJ, 1991, ARCH NEUROL-CHICAGO, V48, P1275, DOI 10.1001/archneur.1991.00530240079027; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAUSER E, 1993, NEUROPEDIATRICS, V24, P107, DOI 10.1055/s-2008-1071524; JETTE R., 1991, HIST GENOME POPULATI, P76; KWON JM, 1995, AM J HUM GENET, V57, P853; LARBRISSEAU A, 1984, CAN J NEUROL SCI, V11, P257, DOI 10.1017/S0317167100045509; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; MALCOLM S, 1994, CYTOGENET CELL GENET, V67, P2; Maniatis T., 1982, MOL CLONING; MATHIEU J, 1990, CAN J NEUROL SCI, V17, P103, DOI 10.1017/S0317167100030298; MENKES JH, 1990, TXB CHILD NEUROLOGY, P209; OTT J, 1991, ANAL HUMAM GENETIC L, P238; RENAULT F, 1991, AUG IBRO SAT S CALL; RINCHIK EM, 1992, MAMM GENOME, V3, pS104, DOI 10.1007/BF00648425; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P126	29	73	75	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					28	34						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554065				2022-12-18	WOS:A1996TL69700006
J	ZLOTOGORA, J; LERER, I; BARDAVID, S; ERGAZ, Z; ABELIOVICH, D				ZLOTOGORA, J; LERER, I; BARDAVID, S; ERGAZ, Z; ABELIOVICH, D			HOMOZYGOSITY FOR WAARDENBURG SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAIRED DOMAIN; PAX3 GENE; DOMINANT INHERITANCE; MUTATIONS; CHROMOSOME-2	In a large kindred including many individuals affected with Waardenburg (WS) type 1 (WS1) syndrome, a child affected with a very severe form of WS type 3 was born. This child presented with dystopia canthorum, partial albinism, and very severe upper-limb defects. His parents were first cousins, both affected with a mild form of WSI. Molecular analysis of PAX3, the gene that was determined by linkage to cause the disorder in the family, demonstrated a novel missense mutation (S84F) in exon 2 of PAX3 within the paired box. While individuals affected with WS1 were heterozygous for the mutation, the child with WS3 was homozygous for S84F. The observation that the PAX3 homozygote in humans may allow life at least in early infancy and does not cause neural tube defects was unexpected, since, in all the mutations known in mice (splotch), homozygosity has led to severe neural tube defects and intrauterine or neonatal death.	MISGAV LADACH HOSP, DEPT NEONATOL, JERUSALEM, ISRAEL		ZLOTOGORA, J (corresponding author), HEBREW UNIV JERUSALEM, HADASSAH UNIV HOSP, SCH MED, DEPT HUMAN GENET, POB 12000, IL-91120 JERUSALEM, ISRAEL.		BAR-DAVID, SHIRLI/F-1512-2012	BAR-DAVID, SHIRLI/0000-0001-8103-041X; Zlotogora, Joel/0000-0001-6293-2979				BALDWIN CT, 1994, HUM MUTAT, V3, P205, DOI 10.1002/humu.1380030306; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; FARRER LA, 1994, AM J HUM GENET, V55, P728; FARRER LA, 1992, AM J HUM GENET, V50, P902; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GOULDING M, 1993, GENOMICS, V17, P355, DOI 10.1006/geno.1993.1332; HOTH CF, 1993, AM J HUM GENET, V52, P455; KLEIN D, 1983, AM J MED GENET, V14, P231, DOI 10.1002/ajmg.1320140205; Klein D, 1950, HELV PAEDIATR ACTA, V5, P38; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LERER I, 1994, AM J MED GENET, V52, P79, DOI 10.1002/ajmg.1320520116; SHEFFER R, 1992, AM J MED GENET, V42, P320, DOI 10.1002/ajmg.1320420312; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; TASSABEHJI M, 1994, HUM MOL GENET, V3, P1069, DOI 10.1093/hmg/3.7.1069; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WILCOX ER, 1992, HUM MOL GENET, V1, P215, DOI 10.1093/hmg/1.3.215-a; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	20	73	77	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1173	1178						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726174				2022-12-18	WOS:A1995QU58600021
J	EGGERDING, FA; SCHONBERG, SA; CHEHAB, FF; NORTON, ME; COX, VA; EPSTEIN, CJ				EGGERDING, FA; SCHONBERG, SA; CHEHAB, FF; NORTON, ME; COX, VA; EPSTEIN, CJ			UNIPARENTAL ISODISOMY FOR PATERNAL 7P AND MATERNAL 7Q IN A CHILD WITH GROWTH-RETARDATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; HUMAN-X-ISOCHROMOSOMES; ALPHA-SATELLITE DNA; CYSTIC-FIBROSIS; HUMAN CHROMOSOME-7; PARENTAL ORIGIN; HIGH-RESOLUTION; DISOMY; GENE; IDENTIFICATION	Uniparental isodisomy resulting from the simultaneous presence of isochromosomes of the p and q arms of a chromosome and absence of a normal homologue is an exceptionally rare event. We have observed a growth-retarded female infant in whom the normal chromosome 7 homologues were replaced by what appeared cytogenetically to be isochromosomes of 7p and 7q. Polymorphic microsatellite loci spanning the length of 7p and 7q were analyzed in the proband and her parents to ascertain the parental origin and extent of heterozygosity of the proband's rearranged chromosomes. These studies demonstrated that the 7p alleles of the proband were derived only from the father, the 7q alleles were derived only from the mother, and there was homozygosity for all chromosome 7 loci analyzed. The mechanisms leading to the formation of the proband's isochromosomes could reflect abnormalities of cell division occurring at meiosis, postfertilization mitosis, or both. We believe that the present case may result from incomplete mitotic interchange in the pericentromeric regions of chromosome 7 homologues, with resolution by sister-chromatid reunion in an early, if not first, zygotic division. Phenotypically, our proband resembled three previously reported cases of maternal isodisomy for chromosome 7, suggesting that lack of paternal genes from 7q may result in a phenotype of short stature and growth retardation.	UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT OBSTET GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	EGGERDING, FA (corresponding author), PERKIN ELMER CORP,DIV APPL BIOSYST,850 LINCOLN CTR DR,BLDG 200,FOSTER CITY,CA 94404, USA.				NIGMS NIH HHS [GM-07085] Funding Source: Medline; PHS HHS [MCJ-445] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007085] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDALLA JA, 1992, AM J HUM GENET, V51, P579; ANTONARAKIS SE, 1990, AM J HUM GENET, V47, P968; ANTONARAKIS SE, 1993, AM J HUM GENET, V52, P1145; BARON B, 1992, NUCLEIC ACIDS RES, V20, P3665, DOI 10.1093/nar/20.14.3665; BELDJORD C, 1992, BLOOD, V80, P287; BLOUIN JL, 1993, AM J HUM GENET, V53, P1074; CALLEN DF, 1987, HUM GENET, V77, P236, DOI 10.1007/BF00284476; CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; CATTANACH BM, 1990, DEVELOPMENT, P63; CHEHAB FF, 1992, HUM GENET, V89, P163; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; Chi D. D., 1992, Human Molecular Genetics, V1, P135, DOI 10.1093/hmg/1.2.135; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; FELDMAN GL, 1988, LANCET, V2, P102; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GREGG RG, 1992, HUM MOL GENET, V1, P659, DOI 10.1093/hmg/1.8.659; GURRIERI F, 1993, NAT GENET, V3, P247, DOI 10.1038/ng0393-247; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALL JG, 1990, AM J HUM GENET, V46, P857; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; HARBISON M, 1988, CYTOGENET CELL GENET, V47, P217, DOI 10.1159/000132553; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KRUGER G, 1987, CLIN GENET, V32, P249; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LARSON LM, 1978, J MED GENET, P73; LITT M, 1989, AM J HUM GENET, V44, P397; LORDASANCHEZ I, 1991, AM J HUM GENET, V49, P1034; LUTY JA, 1990, AM J HUM GENET, V46, P776; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIIKAWA N, 1983, HUM GENET, V63, P85, DOI 10.1007/BF00285407; OHAMA K, 1978, HUM GENET, V40, P221, DOI 10.1007/BF00272305; PALMER CG, 1980, CLIN GENET, V17, P418; PENTAO L, 1992, AM J HUM GENET, V50, P690; PHELAN MC, 1988, HUM GENET, V80, P81, DOI 10.1007/BF00451462; PRIEST JH, 1988, HUM GENET, V81, P1, DOI 10.1007/BF00283718; REYNOLDS JF, 1987, AM J MED GENET, V27, P257, DOI 10.1002/ajmg.1320270204; ROSENBLOOM CL, 1989, NUCLEIC ACIDS RES, V17, P7117, DOI 10.1093/nar/17.17.7117; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANDIG KR, 1979, HUM GENET, V52, P175; SCHINZEL AA, 1994, AM J HUM GENET, V54, P21; SCHMUTZ SM, 1986, HUM GENET, V72, P253, DOI 10.1007/BF00291889; SHAFFER LG, 1991, HUM GENET, V86, P375; SHAPIRO SD, 1985, AM J MED GENET, V20, P271, DOI 10.1002/ajmg.1320200210; SHARP CB, 1990, HUM GENET, V85, P330; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; VOSS R, 1989, AM J HUM GENET, V45, P373; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WANG JCC, 1991, AM J HUM GENET, V48, P1069; WARBURTON D, 1987, AM J MED GENET, V27, P275, DOI 10.1002/ajmg.1320270205; WAYE JS, 1987, MOL CELL BIOL, V7, P349, DOI 10.1128/MCB.7.1.349; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4039, DOI 10.1093/nar/18.13.4039; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295; WEVRICK R, 1992, GENOMICS, V14, P912, DOI 10.1016/S0888-7543(05)80112-0; WULFSBERG EA, 1984, J MED GENET, V21, P151, DOI 10.1136/jmg.21.2.151; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	76	73	73	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					253	265						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	7913578				2022-12-18	WOS:A1994NZ33600005
J	JORDE, LB; WATKINS, WS; VISKOCHIL, D; OCONNELL, P; WARD, K				JORDE, LB; WATKINS, WS; VISKOCHIL, D; OCONNELL, P; WARD, K			LINKAGE DISEQUILIBRIUM IN THE NEUROFIBROMATOSIS-I (NFI) REGION - IMPLICATIONS FOR GENE-MAPPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA HAPLOTYPES; FRAGMENT LENGTH POLYMORPHISMS; HUMAN INSULIN GENE; NONUNIFORM RECOMBINATION; GAMETIC DISEQUILIBRIUM; FRIEDREICH ATAXIA; GENOMIC STRUCTURE; RECEPTOR LOCUS; LINKED MARKERS; DISEASE GENE	To test the usefulness of linkage disequilibrium for gene mapping, we compared physical distances and linkage disequilibrium among eight RFLPs in the neurofibromatosis 1 (NF1) region. Seven of the polymorphisms span most of the NF1 gene, while the remaining polymorphism lies approximately 70 kb 3' to a stop codon in exon 49. By using Centre d'Etude du Polymorphisme Humain (CEPH) kindreds, 91-110 unrelated parents were genotyped. A high degree of disequilibrium is maintained among the seven intragenic polymorphisms (r > .82, P < 10(-7)), even though they are separated by as much as 340 kb. The 3' polymorphism is only 68 kb distal to the next polymorphism, but disequilibrium between the 3' polymorphism and all others is comparatively low (Absolute value of r < .33, P values .27-.001). This result was replicated in three sets of unrelated kindreds: the Utah CEPH families, the non-Utah CEPH families, and an independent set of NF1 families. Trigenic, quadrigenic, three-locus, and four-locus disequilibrium measures were also estimated. There was little evidence of higher-order linkage disequilibrium. As expected for a disease with multiple mutations, no disequilibrium was observed between the disease gene and any of the RFLPs. The observed pattern of high disequilibrium within the gene and a loss of disequilibrium 3' to the stop codon could have implications for gene mapping studies. These are discussed, and guidelines for linkage disequilibrium studies are suggested.	UNIV UTAH, HLTH SCI CTR, DEPT PEDIAT, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, HLTH SCI CTR, DEPT OBSTET & GYNECOL, SALT LAKE CITY, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	JORDE, LB (corresponding author), UNIV UTAH, HLTH SCI CTR, DEPT HUMAN GENET, 2100 ECCLES INST HUMAN GENET, SALT LAKE CITY, UT 84112 USA.				NHGRI NIH HHS [HG-00347, HG-00367, HG-00470] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000347, P01HG000470, R01HG000367] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ASCHBACHER A, 1985, American Journal of Human Genetics, V37, pA186; BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENLIAN P, 1991, AM J HUM GENET, V48, P903; BORRESEN AL, 1988, HUM GENET, V78, P216, DOI 10.1007/BF00291664; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; CAROTHERS AD, 1992, ANN HUM GENET, V56, P155, DOI 10.1111/j.1469-1809.1992.tb01141.x; CAWTHON RM, 1990, GENOMICS, V7, P555, DOI 10.1016/0888-7543(90)90199-5; CAWTHON RM, 1991, GENOMICS, V9, P446, DOI 10.1016/0888-7543(91)90410-G; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P177; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DAIGER SP, 1989, AM J HUM GENET, V45, P310; ELBEIN SC, 1992, AM J HUM GENET, V51, P1103; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; HEDRICK PW, 1988, HEREDITY, V60, P435, DOI 10.1038/hdy.1988.61; HEDRICK PW, 1987, GENETICS, V117, P331; HEGELE RA, 1990, GENET EPIDEMIOL, V7, P69, DOI 10.1002/gepi.1370070114; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HUDSON RR, 1985, GENETICS, V109, P611; KAPLAN N, 1992, AM J HUM GENET, V51, P333; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KUPKE KG, 1992, AM J HUM GENET, V50, P808; LALOUEL JM, 1988, ANN NY ACAD SCI, V526, P34, DOI 10.1111/j.1749-6632.1988.tb55490.x; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V49, P49; LITT M, 1986, AM J HUM GENET, V39, P166; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MANTEL N, 1967, CANCER RES, V27, P209; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MESSIAEN L, 1993, HUM MOL GENET, V2, P485, DOI 10.1093/hmg/2.4.485; MIGONE N, 1985, AM J HUM GENET, V37, P1146; MISEREZ AR, 1993, AM J HUM GENET, V52, P808; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; MURRAY JC, 1987, AM J HUM GENET, V40, P338; OCONNELL P, 1990, GENOMICS, V7, P547, DOI 10.1016/0888-7543(90)90198-4; OCONNELL P, 1989, AM J HUM GENET, V44, P51; OCONNELL P, 1989, SCIENCE, V244, P1087, DOI 10.1126/science.2543077; OCONNELL P, 1993, GENOMICS, V15, P38, DOI 10.1006/geno.1993.1007; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; POUND SE, 1992, J MED GENET, V29, P247, DOI 10.1136/jmg.29.4.247; SKRAASTAD MI, 1992, AM J HUM GENET, V51, P730; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; STEINMETZ M, 1987, TRENDS GENET, V3, P7, DOI 10.1016/0168-9525(87)90154-5; SVED J A, 1971, Theoretical Population Biology, V2, P125; TEMPLETON AR, 1987, GENETICS, V117, P343; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; TZALL S, 1989, AM J HUM GENET, V44, P864; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; VISKOCHIL D, 1993, ANNU REV NEUROSCI, V16, P183, DOI 10.1146/annurev.ne.16.030193.001151; VNENCAKJONES CL, 1990, SCIENCE, V250, P1745, DOI 10.1126/science.1980158; WALTER MA, 1991, AM J HUM GENET, V49, P917; WARD K, 1990, AM J HUM GENET, V46, P943; WATKINS WS, 1991, NUCLEIC ACIDS RES, V19, P6662, DOI 10.1093/nar/19.23.6662; WEIR BS, 1992, CYTOGENET CELL GENET, V59, P128, DOI 10.1159/000133223; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1986, AM J HUM GENET, V38, P776; Weir BS, 1990, GENETIC DATA ANAL; WEIR BS, 1989, MULTIPOINT MAPPING L, V6, P81; WERI BS, 1989, MATH EVOLUTIONARY TH, P86; ZERBA KE, 1991, GENETICS, V129, P525	80	73	74	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1038	1050						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8105688				2022-12-18	WOS:A1993MC33300008
J	RICHARD, CW; WITHERS, DA; MEEKER, TC; MAURER, S; EVANS, GA; MYERS, RM; COX, DR				RICHARD, CW; WITHERS, DA; MEEKER, TC; MAURER, S; EVANS, GA; MYERS, RM; COX, DR			A RADIATION HYBRID MAP OF THE PROXIMAL LONG ARM OF HUMAN CHROMOSOME-II CONTAINING THE MULTIPLE ENDOCRINE NEOPLASIA TYPE-I (MEN-I) AND BCL-I DISEASE LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ESOPHAGEAL CARCINOMAS; GLUTATHIONE S-TRANSFERASES; T(11-14)(Q13-Q32) TRANSLOCATION; SMALL REGION; GENE MAPS; INT2 GENE; AMPLIFICATION; LOCALIZATION; 11Q13; HST1	We describe a high-resolution radiation hybrid map of the proximal long arm of human chromosome 11 containing the bcl-1 and multiple endocrine neoplasia type 1 (MEN-1) disease gene loci. We used X-ray irradiation and cell fusion to generate a panel of 102 hamster-human somatic cell hybrids containing fragments of human chromosome 11. Sixteen human loci in the 11q12-13 region were mapped by statistical analysis of the cosegregation of markers in these radiation hybrids. The most likely order for these loci is C1NH-OSBP-(CDS/CD20)-PGA-FTH1-COX8-PYGM-SEA-KRN1-(MTC/P11EH/HSTF1/INT2)-GST3-PPP1A. Our localization of the human protooncogene SEA between PYGM and INT2, two markers that flank MEN-1, suggests SEA as a potential candidate for the MEN-1 locus. We map two mitogenic fibroblast growth factor genes, HSTF1 and INT2, close to bcl-1, a mapping that is consistent with previously published data. Our map places the human leukocyte antigen genes CD5 and CD20 far from the bcl-1 locus, indicating that CD5 and CD20 expression is unlikely to be altered by bcl-1 rearrangements. PPP1A, which has been postulated as a MEN-1 candidate tumor suppressor gene, and GST3, a gene transcriptionally active in many human cancers, both map distal to the bcl-1 translocation duster and the region containing MEN-1, and therefore are unlikely to be directly involved in bcl-1 or MEN-1.	UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; SALK INST BIOL STUDIES,MOLEC GENET LAB,LA JOLLA,CA 92037	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Salk Institute	RICHARD, CW (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,BOX 0554,HSE 1556,SAN FRANCISCO,CA 94143, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [K11MH000802] Funding Source: NIH RePORTER; NIMH NIH HHS [MH00802] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BALE AE, 1990, AM J HUM GENET, V47, pA1; BALE SJ, 1989, GENOMICS, V4, P320, DOI 10.1016/0888-7543(89)90336-4; BARKER HM, 1990, GENOMICS, V7, P159, DOI 10.1016/0888-7543(90)90536-4; BERENSON JR, 1989, ONCOGENE, V4, P1111; BOYER TD, 1989, HEPATOLOGY, V9, P486, DOI 10.1002/hep.1840090324; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; COX DR, 1989, GENOMICS, V4, P397, DOI 10.1016/0888-7543(89)90347-9; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; HECHT BK, 1989, CYTOGENET CELL GENET, V51, P1012; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; JUNIEN C, 1989, CYTOGENET CELL GENET, V51, P226, DOI 10.1159/000132793; KAO FT, 1976, P NATL ACAD SCI USA, V73, P193, DOI 10.1073/pnas.73.1.193; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LARSSON C, 1989, CYTOGENET CELL GENET, V51, P1029; LEVANON D, 1990, GENOMICS, V7, P65, DOI 10.1016/0888-7543(90)90519-Z; MEEKER TC, 1989, BLOOD, V74, P1801; MORROW CS, 1990, CANCER CELL-MON REV, V2, P15; NADEAU JH, 1990, LINKAGE SYNTENY HOMO; NAKAMURA Y, 1989, AM J HUM GENET, V44, P751; NGUYEN C, 1988, ONCOGENE, V3, P703; RABBITTS PH, 1988, ONCOGENE, V3, P99; SAINTRUF C, 1991, ONCOGENE, V6, P403; TEDDER TF, 1989, J IMMUNOL, V142, P2555; THEILLET C, 1990, ONCOGENE, V5, P147; THEILLET C, 1989, ONCOGENE, V4, P915; TSUDA T, 1989, JPN J CLIN ONCOL, V19, P26; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; TSUDA T, 1989, CANCER RES, V49, P5505; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; WADA A, 1988, BIOCHEM BIOPH RES CO, V157, P828, DOI 10.1016/S0006-291X(88)80324-3; WITHERS DA, 1991, MOL CELL BIOL, V11, P4846, DOI 10.1128/MCB.11.10.4846; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861	34	73	73	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1189	1196						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1684084				2022-12-18	WOS:A1991GU67200006
J	BAKKER, E; VAN BROECKHOVEN, C; HAAN, J; VOORHOEVE, E; VANHUL, W; LEVY, E; LIEBERBURG, I; CARMAN, MD; VANOMMEN, GJB; FRANGIONE, B; ROOS, RAC				BAKKER, E; VAN BROECKHOVEN, C; HAAN, J; VOORHOEVE, E; VANHUL, W; LEVY, E; LIEBERBURG, I; CARMAN, MD; VANOMMEN, GJB; FRANGIONE, B; ROOS, RAC			DNA DIAGNOSIS FOR HEREDITARY CEREBRAL-HEMORRHAGE WITH AMYLOIDOSIS (DUTCH TYPE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-PROTEIN-PRECURSOR; FAMILIAL ALZHEIMERS-DISEASE; GENE; ANGIOPATHY; CDNA	Hereditary cerebral hemorrhage with amyloidosis of the Dutch type (HCHWA-D) is tightly linked to the Alzheimer amyloid precursor protein gene on chromosome 21, which codes for the amyloid beta-protein. A point mutation detected at position 1852 of the amyloid precursor protein gene in four HCHWA-D patients was hypothesized to be the basic defect. This study proves that 22 HCHWA-D patients from three pedigrees all carry this point mutation, whereas the mutation is absent in escapees from the HCHWA-D families as well as in randomly selected Dutch individuals. A mutation-specific oligonucleotide is now available for the confirmation of the HCHWA-D diagnosis. Therefore, presymptomatic testing and prenatal evaluation of individuals at risk in the HCHWA-D families is now feasible.	LEIDEN UNIV HOSP, CTR CLIN GENET, 2333 AA LEIDEN, NETHERLANDS; LEIDEN UNIV HOSP, DEPT NEUROL, 2333 AA LEIDEN, NETHERLANDS; BORN BUNGE FDN, NEUROGENET LAB, ANTWERP, BELGIUM; UNIV INSTELLING ANTWERP, DEPT BIOCHEM, B-2610 WILRIJK, BELGIUM; NYU MED CTR, DEPT PATHOL, NEW YORK, NY 10016 USA; ATHENA NEUROSCI, S SAN FRANCISCO, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Antwerp; New York University	BAKKER, E (corresponding author), LEIDEN UNIV, DEPT HUMAN GENET, SYLVIUS LAB, POB 9503, 2300 RA LEIDEN, NETHERLANDS.		Van Broeckhoven, Christine/M-7853-2019; Bakker, Egbert/D-3525-2009	Van Broeckhoven, Christine/0000-0003-0183-7665; Bakker, Egbert/0000-0002-2843-7357; Van Hul, Wim/0000-0002-5065-7858				ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HAAN J, 1990, ARCH NEUROL-CHICAGO, V47, P649, DOI 10.1001/archneur.1990.00530060059018; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LEMAIRE HG, 1989, NUCLEIC ACIDS RES, V17, P517, DOI 10.1093/nar/17.2.517; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LUYENDIJK W, 1988, J NEUROL SCI, V85, P267, DOI 10.1016/0022-510X(88)90186-4; PRELLI F, 1988, BIOCHEM BIOPH RES CO, V151, P1150, DOI 10.1016/S0006-291X(88)80486-8; PRELLI F, 1990, BIOCHEM BIOPH RES CO, V170, P301, DOI 10.1016/0006-291X(90)91274-V; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; WATTENDORFF AR, 1982, J NEUROL SCI, V55, P121, DOI 10.1016/0022-510X(82)90094-6; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N	21	73	74	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					518	521						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1679289				2022-12-18	WOS:A1991GE36700003
J	LIVSHITS, G; SOKAL, RR; KOBYLIANSKY, E				LIVSHITS, G; SOKAL, RR; KOBYLIANSKY, E			GENETIC AFFINITIES OF JEWISH POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ORIGIN; DIVERSITY; DISTANCE; PATTERNS; JEWS	Genetic relations between various Jewish (J) and non-Jewish (NJ) populations were assessed using two sets of data. The first set contained 12 pairs of matched J and NJ populations from Europe, the Middle East, and North Africa, for which 10 common polymorphic genetic systems (13 loci) were available. The second set included 22 polymorphic genetic systems (26 loci) with various numbers of populations (ranging from 21 to 51) for each system. Therefore, each system was studied separately. Nei's standard genetic distance (D) matrices obtained for these two sets of data were tested against design matrices specifying hypotheses concerning the affiliations of the tested populations. The tests against single designs were carried out by means of Mantel tests. Our results consistently show lower distances among J populations than with their NJ neighbors, most simply explained by the common origin of the former. Yet, there is evidence also of genetic similarity between J and corresponding NJ populations, suggesting reciprocal gene flow between these populations or convergent selection in a common environment. The results of our study also indicate that stochastic factors are likely to have played a role in masking the descent relationships of the J populations.	SUNY STONY BROOK,DEPT ECOL & EVOLUT,STONY BROOK,NY 11794; TEL AVIV UNIV,SACKLER FAC MED,DIV ANAT & ANTHROPOL,HUMAN POPULAT BIOL RES UNIT,IL-69978 TEL AVIV,ISRAEL	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Tel Aviv University; Sackler Faculty of Medicine			Livshits, Gregory/AAG-7051-2019	Livshits, Gregory/0000-0003-3766-7493	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028262] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28262] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONNETAMIR B, 1985, GENETIC MICRODIFFERE, P153; CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; CARMELLI D, 1979, HUM BIOL, V51, P41; Cavalli-Sforza Luigi., 1979, GENETIC DISEASES ASH, P93; CHAKRABORTY R, 1977, EVOLUTION, V31, P347, DOI 10.1111/j.1558-5646.1977.tb01017.x; COTTERMAN CW, 1953, AM J HUM GENET, V5, P193; DESHEN S, 1982, JEWISH SOC MIDDLE E; FUERST PA, 1985, GENETIC MICRODIFFERE, P15; HEDRICK PW, 1986, EVOLUTIONARY PROCESS, P583; KARLIN S, 1979, AM J HUM GENET, V31, P341; KOBYLIANSKY E, 1982, ANN HUM BIOL, V9, P1, DOI 10.1080/03014468200005461; KOBYLIANSKY E, 1989, ANN HUM BIOL, V16, P237, DOI 10.1080/03014468900000352; KOBYLIANSKY E, 1983, ANN HUM BIOL, V10, P453, DOI 10.1080/03014468300006661; LI WH, 1977, GENETICS, V86, P901; LIVSHITS G, 1990, ANN HUM BIOL, V17, P501, DOI 10.1080/03014469000001272; MANTEL N, 1967, CANCER RES, V27, P209; MAYR ERNST, 1965, SYST ZOOL, V14, P73, DOI 10.2307/2411730; MORTON NE, 1982, CURR ANTHROPOL, V23, P157, DOI 10.1086/202800; MOTULSKY AG, 1980, POPULATION STRUCTURE, P363; Mourant AE, 1978, BLOOD GROUPS DIS; Nei M., 1987, MOL EVOLUTIONARY GEN; Rao C.R., 1984, HUMAN POPULATION GEN, P331; Rohlf F. J., 1987, INTRO BIOSTATISTICS; ROHLF FJ, 1989, NUMERICAL TAXONOMY S; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sokal R.R., 1981, BIOMETRY, V2nd ed.; SOKAL RR, 1987, J ARCHAEOL SCI, V14, P615, DOI 10.1016/0305-4403(87)90080-X; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; SOURDIS J, 1987, MOL BIOL EVOL, V4, P159; TATENO Y, 1982, J MOL EVOL, V18, P397; WIJSMAN EM, 1984, HUM GENET, V67, P441, DOI 10.1007/BF00291407; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	34	73	74	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					131	146						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063865				2022-12-18	WOS:A1991FW51100016
J	SCHELLENBERG, GD; PERICAKVANCE, MA; WIJSMAN, EM; MOORE, DK; GASKELL, PC; YAMAOKA, LA; BEBOUT, JL; ANDERSON, L; WELSH, KA; CLARK, CM; MARTIN, GM; ROSES, AD; BIRD, TD				SCHELLENBERG, GD; PERICAKVANCE, MA; WIJSMAN, EM; MOORE, DK; GASKELL, PC; YAMAOKA, LA; BEBOUT, JL; ANDERSON, L; WELSH, KA; CLARK, CM; MARTIN, GM; ROSES, AD; BIRD, TD			LINKAGE ANALYSIS OF FAMILIAL ALZHEIMER-DISEASE, USING CHROMOSOME-21 MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE; RISK; RELATIVES; DISORDERS; KINDREDS; DEMENTIA; DEFECT	Chromosome 21 markers were tested for linkage to familial Alzheimer disease (FAD) in 48 kindreds. These families had multiple cases of Alzheimer disease (AD) in 2 or more generations with family age-at-onset means (M) ranging from 41 to 83 years. Included in this group are seven Volga German families which are thought to be genetically homogeneous with respect to FAD. Autopsy documentation of AD was available for 32 families. Linkage to the 21 q11-q21 region was tested using D21S16, D21S13, D21S110, D21S1/S11, and the APP gene as genetic markers. When linkage results for all the families were summed, the LOD scores for these markers were consistently negative and the entire region was formally excluded. Linkage results were also summed for the following family groups; late-onset (M > 60), early-onset (M less-than-or-equal-to 60), Volga Germans (M = 56), and early-onset non- Volga Germans (M less-than-or-equal-to 60). For the first three groups, LOD scores were negative for this region. For the early-onset non- Volga German group (six families), small positive LOD scores of Z(max) = 0.78 (recombination fraction theta = .15), Z(max) = 0.27 (theta = .15), and Z(max) = 0.64 (theta = .0), were observed for D21S13, D21S16, and D21S110, respectively. The remainder of the long arm of chromosome 21 was tested for linkage to FAD using seven markers spanning the q22 region. Results for these markers were also predominantly negative. Thus it is highly unlikely that a chromosome 21 gene is responsible for late-onset FAD and at least some forms of early-onset FAD represented by the Volga German kindreds.	UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; VET ADM MED CTR,DIV NEUROL,SEATTLE,WA 98108; DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,DURHAM,NC 27710	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University	SCHELLENBERG, GD (corresponding author), UNIV WASHINGTON,DEPT MED,DIV NEUROL RG27,SEATTLE,WA 98195, USA.				NIA NIH HHS [AG07922, AG05128, AG05136] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005136, R35AG007922] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; BREITNER JCS, 1988, NEUROLOGY, V38, P207; GOATE AM, 1989, LANCET, V1, P352; GOUDSMIT J, 1981, J NEUROL SCI, V49, P79, DOI 10.1016/0022-510X(81)90190-8; HAYNES C S, 1988, American Journal of Human Genetics, V43, pA146; HESTON LL, 1981, ARCH GEN PSYCHIAT, V38, P1085; HESTON LL, 1977, SCIENCE, V196, P322, DOI 10.1126/science.196.4287.322; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; Hodge SE, 1979, AM J HUM GENET, V31, P761; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LARRSON T, 1963, ACTA PSYCHIATR  S167, V39, P1; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; NEE LE, 1987, NEUROLOGY, V37, P359, DOI 10.1212/WNL.37.3.359; NEE LE, 1983, ARCH NEUROL-CHICAGO, V40, P203, DOI 10.1001/archneur.1983.04050040033004; OLIVER C, 1986, PSYCHOL MED, V16, P307, DOI 10.1017/S0033291700009120; OTT J, 1974, AM J HUM GENET, V26, P588; OWEN MJ, 1990, AM J HUM GENET, V46, P316; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PERICAKVANCE MA, 1990, P INT S DEMENTIA MOL, P215; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1990, P INT S DEMENTIA MOL, P245; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6	32	73	76	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					563	583						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FK470	1998342				2022-12-18	WOS:A1991FK47000017
J	PERUSSE, L; RICE, T; BOUCHARD, C; VOGLER, GP; RAO, DC				PERUSSE, L; RICE, T; BOUCHARD, C; VOGLER, GP; RAO, DC			CARDIOVASCULAR RISK-FACTORS IN A FRENCH-CANADIAN POPULATION - RESOLUTION OF GENETIC AND FAMILIAL ENVIRONMENTAL-EFFECTS ON BLOOD-PRESSURE BY USING EXTENSIVE INFORMATION ON ENVIRONMENTAL CORRELATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DIV BIOSTAT,660 S EUCLID,BOX 8067,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104; LAVAL UNIV,PHYS ACTIV SCI LAB,SAINTE FOY,QUEBEC,CANADA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; Laval University			Perusse, Louis/A-3444-2012; Bouchard, Claude/AAE-2035-2019; Rice, Treva K/D-1385-2009; Bouchard, Claude/A-7637-2009	Perusse, Louis/0000-0001-6440-9698; Bouchard, Claude/0000-0002-0048-491X; Rice, Treva/0000-0001-7452-2600	NHLBI NIH HHS [HL33973] Funding Source: Medline; NIGMS NIH HHS [GM28719] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANNEST JL, 1979, AM J EPIDEMIOL, V110, P492, DOI 10.1093/oxfordjournals.aje.a112830; BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; BLISHEN BR, 1970, CAN REV SOCIOL ANTHR, V7, P110; Blom G., 1958, STAT ESTIMATES TRANS; BOUCHARD C, 1985, HUM BIOL, V57, P61; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; BOUCHARD C, 1984, ANN HUM BIOL, V11, P303, DOI 10.1080/03014468400007201; Bouchard C., 1985, BODY COMPOSITION ASS, P9; BURNS TL, 1986, GENETICS CARDIOVASCU, P305; DESPRES JP, 1988, J CLIN EPIDEMIOL, V41, P889, DOI 10.1016/0895-4356(88)90106-0; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; FEINLEIB M, 1979, GENETIC ANAL COMMON, P653; FORTMANN SP, 1983, AM J EPIDEMIOL, V118, P497, DOI 10.1093/oxfordjournals.aje.a113655; HARLAN WR, 1984, AM J EPIDEMIOL, V120, P17, DOI 10.1093/oxfordjournals.aje.a113870; HAVLIK RJ, 1979, AM J EPIDEMIOL, V109, P512, DOI 10.1093/oxfordjournals.aje.a112708; JACKSON R, 1985, AM J EPIDEMIOL, V122, P1037, DOI 10.1093/oxfordjournals.aje.a114185; Kannel WB, 1975, EPIDEMIOLOGY CONTROL, P553; KIRKENDALL WM, 1967, CIRCULATION, V36, P980, DOI 10.1161/01.CIR.36.6.980; KRIEGER H, 1980, HUM GENET, V53, P415, DOI 10.1007/BF00287065; LAPORTE RE, 1984, AM J EPIDEMIOL, V120, P507, DOI 10.1093/oxfordjournals.aje.a113911; LECLERC S, 1985, ATHEROSCLEROSIS, V57, P43, DOI 10.1016/0021-9150(85)90136-4; Li C., 1975, PATH ANAL A PRIMER; LORTIE G, 1982, HUM BIOL, V54, P801; MATTHEWS KA, 1987, AM J EPIDEMIOL, V126, P280, DOI 10.1093/aje/126.2.280; MCGUE M, 1989, GENET EPIDEMIOL, V6, P373, DOI 10.1002/gepi.1370060207; MORTON NE, 1980, HUM GENET, V53, P261; PAN WH, 1986, AM J EPIDEMIOL, V124, P612, DOI 10.1093/oxfordjournals.aje.a114434; PERUSSE L, 1988, AM J CLIN NUTR, V47, P629, DOI 10.1093/ajcn/47.4.629; PERUSSE L, 1987, ANN HUM BIOL, V14, P425, DOI 10.1080/03014468700009241; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1982, AM J HUM GENET, V34, P888; RAO DC, UNPUB ENV INDEX GENE; RAO DC, 1984, HUMAN POPULATION GEN, P35; SOBOLSKI J, 1987, AM J EPIDEMIOL, V125, P601, DOI 10.1093/oxfordjournals.aje.a114573; TREMBLAY A, 1983, NUTR RES, V3, P819, DOI 10.1016/S0271-5317(83)80035-9; 1984, FORTRAN SUBROUTINES	37	73	74	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					240	251						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2757030				2022-12-18	WOS:A1989AK38000006
J	SCOZZARI, R; TORRONI, A; SEMINO, O; SIRUGO, G; BREGA, A; SANTACHIARABENERECETTI, AS				SCOZZARI, R; TORRONI, A; SEMINO, O; SIRUGO, G; BREGA, A; SANTACHIARABENERECETTI, AS			GENETIC-STUDIES ON THE SENEGAL POPULATION .1. MITOCHONDRIAL-DNA POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL A BUZZATITRAVERSO,14 VIA S EPIFANIO,I-27100 PAVIA,ITALY; UNIV ROME LA SAPIENZA,DIPARTIMENTO GENET & BIOL MOLEC,I-00185 ROME,ITALY; CNR,CTR GENET EVOLUZ,ROME,ITALY; UNIV MILAN,DIPARTIMENTO BIOL & GENET SCI MED,I-20122 MILAN,ITALY	University of Pavia; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); University of Milan			Torroni, Antonio/E-1557-2011; Sirugo, Giorgio/L-1628-2016; Sirugo, Giorgio/N-9056-2019	Torroni, Antonio/0000-0002-4163-4478; SEMINO, Ornella/0000-0002-9675-9403				BENERECETTI ASS, 1988, ANN HUM GENET, V52, P39, DOI 10.1111/j.1469-1809.1988.tb01076.x; BLANC H, 1983, AM J HUM GENET, V35, P167; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, EXTRACHROMOSOMAL DNA, P485; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; GILES RE, 1980, SOMAT CELL GENET, V6, P543, DOI 10.1007/BF01539155; HARIHARA S, 1986, JPN J HUM GENET, V31, P73, DOI 10.1007/BF01871401; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; MBOW R, 1983, ATLAS SENEGAL, P20; Murdock G.P., 1959, AFRICA ITS PEOPLES T; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1982, HUM GENET, V61, P145, DOI 10.1007/BF00274205	22	73	73	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					534	544						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902791				2022-12-18	WOS:A1988Q473600022
J	KAMBOH, MI; FERRELL, RE; SEPEHRNIA, B				KAMBOH, MI; FERRELL, RE; SEPEHRNIA, B			GENETIC-STUDIES OF HUMAN APOLIPOPROTEINS .4. STRUCTURAL HETEROGENEITY OF APOLIPOPROTEIN-H (BETA-2-GLYCOPROTEIN-I)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											KAMBOH, MI (corresponding author), UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT BIOSTAT,DIV HUMAN GENET,PITTSBURGH,PA 15261, USA.			Kamboh, M. Ilyas/0000-0002-3453-1438	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039107, R01HL024799] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL24799, HL39107] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BURSTEIN M, 1977, PROTIDES BIOL FLUIDS, P407; CLEVE H, 1968, HUMANGENETIK, V5, P294, DOI 10.1007/BF00291637; FINLAYSO.JS, 1967, BIOCHIM BIOPHYS ACTA, V147, P413, DOI 10.1016/0005-2795(67)90001-3; HAUPT H, 1968, HUMANGENETIK, V5, P291, DOI 10.1007/BF00291636; KAMBOH MI, 1986, BIOCHEM GENET, V24, P273, DOI 10.1007/BF00502794; KOPPE AL, 1970, HUMANGENETIK, V9, P164, DOI 10.1007/BF00278932; LEE NS, 1983, J BIOL CHEM, V258, P4765; LOZIER J, 1984, P NATL ACAD SCI-BIOL, V81, P3640, DOI 10.1073/pnas.81.12.3640; NAKAYA Y, 1980, BIOCHEM BIOPH RES CO, V95, P1168, DOI 10.1016/0006-291X(80)91595-8; POLZ E, 1979, BIOCHEM BIOPH RES CO, V90, P1305, DOI 10.1016/0006-291X(79)91178-1; POLZ E, 1979, FEBS LETT, V102, P183, DOI 10.1016/0014-5793(79)80955-2; PROPERT DN, 1978, HUM GENET, V43, P281, DOI 10.1007/BF00278835; SCHOUSBOE I, 1980, THROMB RES, V19, P225, DOI 10.1016/0049-3848(80)90421-1; SCHULTZE HE, 1961, NATURWISSENSCHAFTEN, V48, P719, DOI 10.1007/BF00620967; SCHWICK HG, 1984, PLASMA PROTEINS, V4, P167; WALTER H, 1979, HUM HERED, V29, P236, DOI 10.1159/000153051; WURM H, 1982, METABOLISM, V31, P484, DOI 10.1016/0026-0495(82)90238-4	17	73	79	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					452	457						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	3348213				2022-12-18	WOS:A1988M620600007
J	SUNDARAM, V; RUMBOLO, P; GRUBB, J; STRISCIUGLIO, P; SLY, WS				SUNDARAM, V; RUMBOLO, P; GRUBB, J; STRISCIUGLIO, P; SLY, WS			CARBONIC ANHYDRASE-II DEFICIENCY - DIAGNOSIS AND CARRIER DETECTION USING DIFFERENTIAL ENZYME-INHIBITION AND INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV NAPLES,CLIN PEDIAT,I-80131 NAPLES,ITALY	University of Naples Federico II	SUNDARAM, V (corresponding author), ST LOUIS UNIV,SCH MED,EDWARD A DOISY DEPT BIOCHEM,ST LOUIS,MO 63104, USA.				NCRR NIH HHS [RR-00036] Funding Source: Medline; NIAID NIH HHS [AI/GM-20610] Funding Source: Medline; NIGMS NIH HHS [GM-31988] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTER ND, 1984, ANN NY ACAD SCI, V429, P284, DOI 10.1111/j.1749-6632.1984.tb12351.x; CONROY CW, 1985, CLIN CHIM ACTA; DESIMONE J, 1973, BIOCHEM GENET, V8, P165, DOI 10.1007/BF00485544; FERRELL RE, 1981, P SOC EXP BIOL MED, V168, P155; GOETHE PO, 1972, FEBS LETT, V21, P159; GUIBAUD P, 1972, ARCH FR PEDIATR, V29, P269; HEATH R, 1982, CLIN CHIM ACTA, V119, P299, DOI 10.1016/0009-8981(82)90343-6; HEATH R, 1983, FED P, V43, P2180; HEWETTEMMETT D, 1982, FED PROC, V41, P1385; KENDALL AG, 1977, SCIENCE, V197, P471, DOI 10.1126/science.406674; LEE B L, 1984, American Journal of Human Genetics, V36, p145S; MAREN TH, 1960, J PHARMACOL EXP THER, V130, P26; MAREN TH, 1979, ARCH BIOCHEM BIOPHYS, V196, P501, DOI 10.1016/0003-9861(79)90302-3; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; MCKINLEY DN, 1976, BIOCHIM BIOPHYS ACTA, V445, P780, DOI 10.1016/0005-2744(76)90128-5; SANYAL G, 1981, BIOCHIM BIOPHYS ACTA, V657, P128, DOI 10.1016/0005-2744(81)90136-4; SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; SLY WS, 1972, AM J HUM GENET, V24, P34; TASHIAN RE, 1984, ANN NY ACAD SCI, V429, P262, DOI 10.1111/j.1749-6632.1984.tb12346.x; TASHIAN RE, 1983, ISOZYMES-CURR T BIOL, V7, P79; Tashian RE, 1976, ADV HUM GENET, P1; VAINSEL M, 1972, ACTA PAEDIATR SCAND, V61, P429, DOI 10.1111/j.1651-2227.1972.tb15859.x; VENTA P J, 1984, American Journal of Human Genetics, V36, p156S; VENTA PJ, 1984, ANN NY ACAD SCI, V429, P309, DOI 10.1111/j.1749-6632.1984.tb12355.x; VENTA PJ, 1983, P NATL ACAD SCI-BIOL, V80, P4437, DOI 10.1073/pnas.80.14.4437; WHITNEY PL, 1982, J BIOL CHEM, V257, P2056; WISTRAND PJ, 1979, UPSALA J MED SCI S, V26, P75	28	73	75	2	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					125	136						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3080873				2022-12-18	WOS:A1986A311100002
J	HENRY, I; UZAN, G; WEIL, D; NICOLAS, H; KAPLAN, JC; MARGUERIE, C; KAHN, A; JUNIEN, C				HENRY, I; UZAN, G; WEIL, D; NICOLAS, H; KAPLAN, JC; MARGUERIE, C; KAHN, A; JUNIEN, C			THE GENES-CODING FOR A-ALPHA-CHAINS, B-BETA-CHAINS, AND GAMMA-CHAINS OF FIBRINOGEN MAP TO 4Q2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INSERM,U143,INST PATHOL CELLULAIRE,F-94270 BICETRE,FRANCE; INSERM,U12,UNITE RECH GENET MED,F-75730 PARIS 15,FRANCE; INSERM,U73,RECH BIOL PRENATALE GRP,F-75016 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	HENRY, I (corresponding author), INST PATHOL & BIOL CELLULAIRES & MOLEC,INSERM,U129,24 RUE FBG ST JACQUES,F-75674 PARIS 14,FRANCE.							BUDZINSKI AZ, 1974, NATURE, V256, P66; CHU ML, 1982, NUCLEIC ACIDS RES, V10, P5925, DOI 10.1093/nar/10.19.5925; CHUNG DW, 1983, BIOCHEMISTRY-US, V22, P3250, DOI 10.1021/bi00282a033; CRABTREE GR, 1981, J BIOL CHEM, V256, P9718; CRABTREE GR, 1982, J BIOL CHEM, V257, P7277; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; FULLER GM, 1981, THROMB HAEMOSTASIS, V46, P252; HENSCHEN A, 1983, THROMB HAEMOST, V45, P103; JUNIEN C, 1982, AM J HUM GENET, V34, P381; JUNIEN C, 1983, AM J HUM GENET, V35, P584; KANT JA, 1983, P NATL ACAD SCI-BIOL, V80, P3953, DOI 10.1073/pnas.80.13.3953; KANT JA, 1983, J BIOL CHEM, V258, P4666; KANT JA, 1983, CYTOGENET CELL GENET, V307, P503; KUDRYK B, 1976, THROMB RES, V9, P25, DOI 10.1016/0049-3848(76)90146-8; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; OLAISEN B, 1982, HUM GENET, V61, P24, DOI 10.1007/BF00291325; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; RAUGEI G, 1983, NUCLEIC ACIDS RES, V11, P5811, DOI 10.1093/nar/11.17.5811; SANDERSHAIGH L, 1980, NATURE, V283, P683, DOI 10.1038/283683a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEINMETZ M, 1982, NATURE, V300, P35, DOI 10.1038/300035a0; UZAN G, 1982, BIOCHEM INT, V4, P271; UZAN G, 1984, BIOCH BIOPHYS RES CO; VIEGASPEQUIGNOT E, 1978, ANN GENET-PARIS, V21, P122; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WEIL D, 1980, ANN HUM GENET, V44, P11, DOI 10.1111/j.1469-1809.1980.tb00941.x; WEIL D, 1979, HUM GENET, V52, P249, DOI 10.1007/BF00271580	28	73	73	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	4					760	768						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TJ077	6089549				2022-12-18	WOS:A1984TJ07700004
J	GOLDIN, LR; GERSHON, ES; TARGUM, SD; SPARKES, RS; MCGINNISS, M				GOLDIN, LR; GERSHON, ES; TARGUM, SD; SPARKES, RS; MCGINNISS, M			SEGREGATION AND LINKAGE ANALYSES IN FAMILIES OF PATIENTS WITH BIPOLAR, UNIPOLAR, AND SCHIZOAFFECTIVE MOOD DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PSYCHIAT INST WASHINGTON DC,WASHINGTON,DC 20006; UNIV CALIF LOS ANGELES,SCH MED,DIV MED GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PSYCHIAT,LOS ANGELES,CA 90024; NIH,BLOOD BANK,CTR CLIN,BETHESDA,MD 20205	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	GOLDIN, LR (corresponding author), NIMH,BIOL PSYCHIAT BRANCH,PSYCHOGENET SECT,9000 ROCKVILLE PIKE,BETHESDA,MD 20205, USA.							AKISKAL HS, 1977, AM J PSYCHIAT, V134, P1227; ASHBY HB, 1978, COMPR PSYCHIAT, V19, P415, DOI 10.1016/0010-440X(78)90070-6; BARON M, 1977, ARCH GEN PSYCHIAT, V24, P721; BUCHER KD, 1981, J PSYCHIAT RES, V16, P65, DOI 10.1016/0022-3956(81)90014-5; BUCHER KD, 1981, J PSYCHIATR RES, V16, P53, DOI 10.1016/0022-3956(81)90013-3; CANNINGS C, 1977, CLIN GENET, V12, P208; CROWE RR, 1981, NEUROPSYCHOBIOLOGY, V7, P20, DOI 10.1159/000117829; DUNNER DL, 1976, BIOL PSYCHIAT, V11, P43; EGELAND J, 1980, DEC ANN M AM COLL NE; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; ELSTON RC, 1979, AM J HUM GENET, V31, P62; ELSTON RC, 1978, NEUROPSYCHOBIOLOGY, V4, P193, DOI 10.1159/000117633; ELSTON RC, 1975, AM J HUM GENET, V27, P31; GERSHON E S, 1979, Psychopharmacology Bulletin, V15, P27; GERSHON ES, 1975, J PSYCHIAT RES, V12, P283, DOI 10.1016/0022-3956(75)90007-2; GERSHON ES, 1975, J PSYCHIATR RES, V12, P301, DOI 10.1016/0022-3956(75)90008-4; GERSHON ES, 1979, ARCH GEN PSYCHIAT, V36, P1423; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; GERSHON ES, 1973, BIOL PSYCHIAT, V7, P63; GERSHON ES, 1976, BEHAV GENET, V6, P227, DOI 10.1007/BF01065722; GERSHON ES, 1981, 3RD WORLD C BIOL PSY; GERSHON ES, 1980, ENZYMES NEUROTRANSMI; Giblett ER., 1969, GENETIC MARKERS HUMA; GOLDIN LR, 1982, PSYCHIAT RES, V7, P29, DOI 10.1016/0165-1781(82)90050-6; GOLDIN LR, 1981, GENETIC RES STRATEGI; Harris, 1976, HDB ENZYME ELECTROPH; KAPLAN EB, 1975, UNPUB GENPED GENERAL; LECKMAN JF, 1979, ARCH GEN PSYCHIAT, V36, P1435; MAZURE C, 1979, ARCH GEN PSYCHIAT, V36, P521; MENDLEWICZ J, 1979, ARCH GEN PSYCHIAT, V36, P1442; MENDLEWICZ J, 1972, J AMER MED ASSOC, V222, P1624, DOI 10.1001/jama.222.13.1624; MENDLEWICZ J, 1980, BRIT J PSYCHIAT, V137, P337, DOI 10.1192/bjp.137.4.337; MENDLEWICZ J, 1974, BIOL PSYCHIAT, V9, P261; MENDLEWICZ J, 1980, J AFFECT DISORDERS, V2, P289, DOI 10.1016/0165-0327(80)90030-0; MERRITT AD, 1973, AM J HUM GENET, V25, P510; MORTON NE, 1956, AM J HUM GENET, V8, P80; NEGRI F, 1981, BRIT J PSYCHIAT, V138, P236, DOI 10.1192/bjp.138.3.236; NURNBERGER JI, 1979, LITHIUM CONTROVERSIA; NURNBERGER JI, 1982, HDB AFFECTIVE DISORD, P126; OTT J, 1974, AM J HUM GENET, V26, P588; RISCH N, 1982, ANN HUM GENET, V46, P153, DOI 10.1111/j.1469-1809.1982.tb00706.x; SMERALDI E, 1981, J AFFECT DISORDERS, V3, P173, DOI 10.1016/0165-0327(81)90042-2; SPITZER RL, 1975, BIOMETRICS RES; TARGUM SD, 1979, BIOL PSYCHIAT, V14, P615; TURNER WJ, 1981, BIOL PSYCHIAT, V16, P417; VANEERDEWEGH MM, 1980, J PSYCHIAT RES, V15, P215; VANPRAAG HM, 1979, PSYCHIAT RES, V1, P219, DOI 10.1016/0165-1781(79)90002-7; WEITKAMP LR, 1980, ARCH GEN PSYCHIAT, V37, P1187; WEITKAMP LR, 1981, NEW ENGL J MED, V305, P1301, DOI 10.1056/NEJM198111263052201; WILLIAMS JBW, 1980, DIAGNOSTIC STATISTIC; WINOKUR G, 1972, COMPR PSYCHIAT, V13, P3, DOI 10.1016/0010-440X(72)90028-4	52	73	73	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					274	287						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6837575				2022-12-18	WOS:A1983QJ26500010
J	SING, CF; ORR, JD				SING, CF; ORR, JD			ANALYSIS OF GENETIC AND ENVIRONMENTAL SOURCES OF VARIATION IN SERUM-CHOLESTEROL IN TECUMSEH, MICHIGAN .4. SEPARATION OF POLYGENE FROM COMMON ENVIRONMENT EFFECTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SING, CF (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.			Sing, Charles/0000-0001-5872-7956				BRUNNER D, 1971, J CHRON DIS, V23, P763, DOI 10.1016/0021-9681(71)90007-5; CHRISTIAN JC, 1977, AM J HUM GENET, V29, P462; ELSTON RC, 1975, BIOMETRIKA, V62, P133, DOI 10.2307/2334495; EPSTEIN FH, 1965, ANN INTERN MED, V62, P1170, DOI 10.7326/0003-4819-62-6-1170; FALCONER DS, 1960, QUANTITATIVE GENETIC; FELDMAN MW, 1975, SCIENCE, V190, P1163, DOI 10.1126/science.1198102; FISHER RA, 1958, STATISTICAL METHODS; JOHNSON BC, 1965, J CHRON DIS, V18, P147, DOI 10.1016/0021-9681(65)90098-6; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; MARTIN AO, 1973, AM J HUM GENET, V25, P581; MORTON NE, 1977, AM J HUM GENET, V29, P52; MORTON NE, 1974, AM J HUM GENET, V26, P318; NAPIER JA, 1962, AM J PUBLIC HEALTH N, V52, P208, DOI 10.2105/AJPH.52.2.208; NAPIER JA, 1971, CASEBOOK COMMUNITY S, P25; NICHOLS AB, 1976, JAMA-J AM MED ASSOC, V236, P1948, DOI 10.1001/jama.236.17.1948; ORR JD, 1975, SOC BIOL, V22, P34, DOI 10.1080/19485565.1975.9988145; RAO DC, 1977, BEHAV GENET, V7, P147, DOI 10.1007/BF01066003; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1976, EXCERPTA MEDICA INT, V397, P192; REED TE, 1968, AM J HUM GENET, V20, P579; SING CF, 1973, AM J HUM GENET, V25, pA72; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1975, AM J HUM GENET, V27, P333; SING CF, 1973, HUMAN POPULATION STR, P217; SWIGER LA, 1964, BIOMETRICS, V20, P818, DOI 10.2307/2528131	26	73	73	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					491	504						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GA288	736039				2022-12-18	WOS:A1978GA28800003
J	LENZ, W				LENZ, W			HALF CHROMATID MUTATIONS MAY EXPLAIN INCONTINENTIA PIGMENTI IN MALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									INST HUMAN GENET,MUNSTER,FED REP GER									GARTLER SM, 1975, AM J HUM GENET, V27, P218	1	73	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					690	691						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	1163541				2022-12-18	WOS:A1975AR23900015
J	NEWCOMBE, HB				NEWCOMBE, HB			RECORD LINKING - DESIGN OF EFFICIENT SYSTEMS FOR LINKING RECORDS INTO INDIVIDUAL AND FAMILY HISTORIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract																		DAVIDSON L, 1962, COMMUN ACM, V5, P169, DOI 10.1145/366862.366913; HOGBEN L, 1948, BRIT MED J, V1, P625; KENNEDY JM, 1964, AECL2078 AT EN CAN L; KENNEDY JM, 1965, AECL2222 AT EN CAN L; NEWCOMBE HB, 1959, SCIENCE, V130, P954, DOI 10.1126/science.130.3381.954; NEWCOMBE HB, 1962, COMMUN ACM, V5, P563, DOI 10.1145/368996.369026; SMITH ME, 1965, AECL2530 AT EN CAN L; 1960, UNIQUE COMPUTABLE NA	8	73	76	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P1					335	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96073	6026587				2022-12-18	WOS:A19679607300011
J	MACKLIN, MT				MACKLIN, MT			A STUDY OF RETINOBLASTOMA IN OHIO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		FALLS HF, 1951, AMA ARCH OPHTHALMOL, V46, P367; NEEL JV, 1951, SCIENCE, V114, P419, DOI 10.1126/science.114.2964.419; REESE AB, 1954, AMA ARCH OPHTHALMOL, V52, P815; REESE AB, 1949, ARCH OPHTHALMOL-CHIC, V42, P119; SOVIK WE, 1952, AM J OPHTHALMOL, V35, P1611, DOI 10.1016/0002-9394(52)91450-5; TUCKER DP, 1957, ARCH OPHTHALMOL-CHIC, V57, P532; VOGEL FRIEDRICH, 1954, ZEITSCHR MENSCHL VERERBUNGS U KONSTITUTIONSLEHRE, V32, P308; WAITZ R, 1946, PRESSE MED, V54, P322	8	73	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1960	12	1					1	43						43	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF077	14419544				2022-12-18	WOS:A1960WF07700001
J	Wallmeier, J; Frank, D; Shoemark, A; Nothe-Menchen, T; Cindric, S; Olbrich, H; Loges, NT; Aprea, I; Dougherty, GW; Pennekamp, P; Kaiser, T; Mitchison, HM; Hogg, C; Carr, SB; Zariwala, MA; Ferkol, T; Leigh, MW; Davis, SD; Atkinson, J; Dutcher, SK; Knowles, MR; Thiele, H; Altmuller, J; Krenz, H; Woste, M; Brentrup, A; Ahrens, F; Vogelberg, C; Morris-Rosendahl, DJ; Omran, H				Wallmeier, Julia; Frank, Diana; Shoemark, Amelia; Noethe-Menchen, Tabea; Cindric, Sandra; Olbrich, Heike; Loges, Niki T.; Aprea, Isabella; Dougherty, Gerard W.; Pennekamp, Petra; Kaiser, Thomas; Mitchison, Hannah M.; Hogg, Claire; Carr, Siobhan B.; Zariwala, Maimoona A.; Ferkol, Thomas; Leigh, Margaret W.; Davis, Stephanie D.; Atkinson, Jeffrey; Dutcher, Susan K.; Knowles, Michael R.; Thiele, Holger; Altmueller, Janine; Krenz, Henrike; Woeste, Marius; Brentrup, Angela; Ahrens, Frank; Vogelberg, Christian; Morris-Rosendahl, Deborah J.; Omran, Heymut			De Novo Mutations in FOXJ1 Result in a Motile Ciliopathy with Hydrocephalus and Randomization of Left/Right Body Asymmetry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CILIARY DYSKINESIA; CONGENITAL HEART-DISEASE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; DEFECTS; CILIOGENESIS; DIAGNOSIS; CCDC39	Hydrocephalus is one of the most prevalent form of developmental central nervous system (CNS) malformations. Cerebrospinal fluid (CSF) flow depends on both heartbeat and body movement. Furthermore, it has been shown that CSF flow within and across brain ventricles depends on cilia motility of the ependymal cells lining the brain ventricles, which play a crucial role to maintain patency of the narrow sites of CSF passage during brain formation in mice. Using whole-exome and whole-genome sequencing, we identified an autosomal-dominant cause of a distinct motile ciliopathy related to defective ciliogenesis of the ependymal cilia in six individuals. Heterozygous de novo mutations in FOXJ1, which encodes a well-known member of the forkhead transcription factors important for ciliogenesis of motile cilia, cause a motile ciliopathy that is characterized by hydrocephalus internus, chronic destructive airway disease, and randomization of left/right body asymmetry. Mutant respiratory epithelial cells are unable to generate a fluid flow and exhibit a reduced number of cilia per cell, as documented by high-speed video microscopy (HVMA), transmission electron microscopy (TEM), and immunofluorescence analysis (IF). TEM and IF demonstrate mislocalized basal bodies. In line with this finding, the focal adhesion protein PTK2 displays aberrant localization in the cytoplasm of the mutant respiratory epithelial cells.	[Wallmeier, Julia; Frank, Diana; Noethe-Menchen, Tabea; Cindric, Sandra; Olbrich, Heike; Loges, Niki T.; Aprea, Isabella; Dougherty, Gerard W.; Pennekamp, Petra; Kaiser, Thomas; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Shoemark, Amelia] Univ Dundee, Mol & Clin Med, Dundee DD1 4HN, Scotland; [Shoemark, Amelia; Hogg, Claire; Carr, Siobhan B.] Royal Brompton & Harefield NHS Trust, Dept Paediat Resp Med, London SW3 6NP, England; [Shoemark, Amelia; Mitchison, Hannah M.; Hogg, Claire; Carr, Siobhan B.] UCL, Genet & Genom Med, Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Zariwala, Maimoona A.] Univ N Carolina, Dept Pathol & Lab Med, Marsico Lung Inst, UNC CF Res Ctr,Sch Med, Chapel Hill, NC 27599 USA; [Ferkol, Thomas] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Leigh, Margaret W.] Univ N Carolina, Dept Pediat, Marsico Lung Inst, UNC CF Res Ctr,Sch Med, Chapel Hill, NC 27599 USA; [Atkinson, Jeffrey] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Dutcher, Susan K.] Washington Univ, McDonnell Genome Inst, Dept Genet, Sch Med, St Louis, MO 63108 USA; [Knowles, Michael R.] Univ N Carolina, Marsico Lung Inst, UNC CF Res Ctr, Dept Med,Sch Med, Chapel Hill, NC 27599 USA; [Thiele, Holger; Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, CMMC, D-50931 Cologne, Germany; [Krenz, Henrike; Woeste, Marius] Univ Munster, Inst Med Informat, D-48149 Munster, Germany; [Brentrup, Angela] Univ Hosp Muenster, Dept Neurosurg, D-48149 Munster, Germany; [Ahrens, Frank] Childrens Hosp Altona, D-22763 Hamburg, Germany; [Vogelberg, Christian] Tech Univ Dresden, Dept Paediat, Univ Hosp Carl Gustav Carus Dresden, D-01307 Dresden, Germany; [Morris-Rosendahl, Deborah J.] Royal Brompton & Harefield NHS Fdn Trust, Clin Genet & Genom, London SW3 6NP, England; [Morris-Rosendahl, Deborah J.] Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England; [Davis, Stephanie D.] Univ N Carolina, Dept Pediat, Sch Med, Chapel Hill, NC 27599 USA	University of Munster; University of Dundee; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Cologne; University of Munster; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Omran, H (corresponding author), Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany.	heymut.omran@ukmuenster.de	Thiele, Holger/ABE-6792-2020; Noethe-Menchen, Tabea/AAW-1667-2021; Shoemark, Amelia/I-4068-2019	Thiele, Holger/0000-0002-0169-998X; Noethe-Menchen, Tabea/0000-0002-0571-6767; Shoemark, Amelia/0000-0001-7360-6060; Wallmeier, Julia/0000-0002-3958-9065; Mitchison, Hannah/0000-0002-3163-6293; Morris-Rosendahl, Deborah/0000-0002-7780-4707; Atkinson, Jeffrey/0000-0001-9125-7968; Omran, Heymut/0000-0003-0282-6765; Altmuller, Janine/0000-0003-4372-1521; Kaiser, Thomas/0000-0002-6699-0014	Deutsche Forschungsgemeinschaft (DFG); National Institutes of Health (US); 100,000 Genomes Project National Institute for Health Research (UK); NHS England (UK); IZKF Muenster; "Innovative Medical Research'' of the University of Muenster Medical School; Great Ormond Street Children's Charity; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006504] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 100,000 Genomes Project National Institute for Health Research (UK); NHS England (UK); IZKF Muenster; "Innovative Medical Research'' of the University of Muenster Medical School; Great Ormond Street Children's Charity; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the PCD-affected individuals and their families for their participation and acknowledge the German PCD support group Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V, UK PCD Family Support Group, and North American PCD Foundation. The University Children's Hospital Muenster and the Royal Brompton and Harefield NHS Trust are part of ERNLung, the European Reference Network for Rare Diseases. We would like to thank K.-P. Schlingmann for the discussion and A. Borgscheiper, A. Dorissen, D. Ernst, S. Helms, M. Herting, J. Quante, A. Robbers, L. Schwiddessen, F.J. Seesing, S. Sivalingam, M. Tekaat, K. Wohlgemuth, C. Westermann, and S. Wilkinson for excellent clinical and technical work. We thank the investigators and coordinators of Genetics Disorders of Mucociliary Clearance Consortium (GDMCC); Drs. J. Stonebraker and H. Dang of UNC for technical and bioinformatics assistance, respectively; Ms. Kimberly Burns of UNC for electron microscopy support; McDonnell Genome Institute (Washington University); and Drs. S. Mane, F. Lopez-Giraldez, and W. Dong from Yale Center for Mendelian Genomics (UM1 HG006504) for providing whole-exome sequencing and bioinformatics support. We thank Sayyid Hasan (RBHT) as WL GMC Validation Coordinator of results from the UK 100K Project, Dr. Anne Schmidt for the clinical workup of subject RBH II-1 as well as Mitali P. Patel for the IF stainings. This work was funded by the Deutsche Forschungsgemeinschaft (DFG), the National Institutes of Health (US), 100,000 Genomes Project National Institute for Health Research and NHS England (UK), IZKF Muenster, "Innovative Medical Research'' of the University of Muenster Medical School, and Great Ormond Street Children's Charity. The authors participate in the COST action BEAT-PCD. The findings in subject RBH II1 were made possible through access to the data and findings generated by the 100,000 Genomes Project. Please find detailed funding information in the Supplemental Data.	Abdi K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03812-w; Altmuller J, 2016, BIOL CHEM, V397, P791, DOI 10.1515/hsz-2015-0300; Amirav I, 2016, HUM MUTAT, V37, P396, DOI 10.1002/humu.22957; Antoniades I, 2014, DEV CELL, V28, P70, DOI 10.1016/j.devcel.2013.12.003; Antony D, 2013, HUM MUTAT, V34, P462, DOI 10.1002/humu.22261; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Beckers A, 2007, P NATL ACAD SCI USA, V104, P15765, DOI 10.1073/pnas.0704344104; Behan L, 2016, EUR RESPIR J, V47, P1103, DOI 10.1183/13993003.01551-2015; Beydon N, 2015, PEDIATR PULM, V50, P1374, DOI 10.1002/ppul.23167; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Boon M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5418; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Frommer A, 2015, AM J RESP CELL MOL, V53, P563, DOI 10.1165/rcmb.2014-0483OC; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Harrison MJ, 2016, PAEDIATR RESPIR REV, V18, P25, DOI 10.1016/j.prrv.2015.09.003; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Leigh Margaret W, 2013, Ann Am Thorac Soc, V10, P574, DOI 10.1513/AnnalsATS.201305-110OC; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mukherjee I, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00023; Munch TN, 2012, BRAIN, V135, P2409, DOI 10.1093/brain/aws158; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olstad EW, 2019, CURR BIOL, V29, P229, DOI 10.1016/j.cub.2018.11.059; Raidt J, 2015, HUM REPROD, V30, P2871, DOI 10.1093/humrep/dev227; Shapiro AJ, 2016, PEDIATR PULM, V51, P115, DOI 10.1002/ppul.23304; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Vanaken GJ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00314-2017; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Wheway G, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00127; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhang M, 2004, BIOCHEM BIOPH RES CO, V324, P1413, DOI 10.1016/j.bbrc.2004.09.207	42	72	75	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2019	105	5					1030	1039		10.1016/j.ajhg.2019.09.022	http://dx.doi.org/10.1016/j.ajhg.2019.09.022			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JL9XL	31630787	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000495878800014
J	Aref-Eshghi, E; Bend, EG; Colaiacovo, S; Caudle, M; Chakrabarti, R; Napier, M; Brick, L; Brady, L; Carere, DA; Levy, MA; Kerkhof, J; Stuart, A; Saleh, M; Beaudet, AL; Li, CM; Kozenko, M; Karp, N; Prasad, C; Siu, VM; Tarnopolsky, MA; Ainsworth, PJ; Lin, HX; Rodenhiser, DI; Krantz, ID; Deardorff, MA; Schwartz, CE; Sadikovic, B				Aref-Eshghi, Erfan; Bend, Eric G.; Colaiacovo, Samantha; Caudle, Michelle; Chakrabarti, Rana; Napier, Melanie; Brick, Lauren; Brady, Lauren; Carere, Deanna Alexis; Levy, Michael A.; Kerkhof, Jennifer; Stuart, Alan; Saleh, Maha; Beaudet, Arthur L.; Li, Chumei; Kozenko, Maryia; Karp, Natalya; Prasad, Chitra; Siu, Victoria Mok; Tarnopolsky, Mark A.; Ainsworth, Peter J.; Lin, Hanxin; Rodenhiser, David I.; Krantz, Ian D.; Deardorff, Matthew A.; Schwartz, Charles E.; Sadikovic, Bekim			Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINICAL VALIDATION; WILLIAMS-SYNDROME; SIGNATURE; GENE; EXPRESSION; MUTATIONS; VARIANTS; IDENTIFICATION; SCHIZOPHRENIA; MECHANISMS	Conventional genetic testing of individuals with neurodevelopmental presentations and congenital anomalies (ND/CAs), i.e., the analysis of sequence and copy number variants, leaves a substantial proportion of them unexplained. Some of these cases have been shown to result from DNA methylation defects at a single locus (epi-variants), while others can exhibit syndrome-specific DNA methylation changes across multiple loci (epi-signatures). Here, we investigate the clinical diagnostic utility of genome-wide DNA methylation analysis of peripheral blood in unresolved ND/CAs. We generate a computational model enabling concurrent detection of 14 syndromes using DNA methylation data with full accuracy. We demonstrate the ability of this model in resolving 67 individuals with uncertain clinical diagnoses, some of whom had variants of unknown clinical significance (VUS) in the related genes. We show that the provisional diagnoses can be ruled out in many of the case subjects, some of whom are shown by our model to have other diseases initially not considered. By applying this model to a cohort of 965 ND/CA-affected subjects without a previous diagnostic assumption and a separate assessment of rare epi-variants in this cohort, we identify 15 case subjects with syndromic Mendelian disorders, 12 case subjects with imprinting and trinucleotide repeat expansion disorders, as well as 106 case subjects with rare epi-variants, a portion of which involved genes clinically or functionally linked to the subjects' phenotypes. This study demonstrates that genomic DNA methylation analysis can facilitate the molecular diagnosis of unresolved clinical cases and highlights the potential value of epigenomic testing in the routine clinical assessment of ND/CAs.	[Aref-Eshghi, Erfan; Levy, Michael A.; Ainsworth, Peter J.; Lin, Hanxin; Sadikovic, Bekim] Western Univ, Dept Pathol & Lab Med, London, ON N6A 3K7, Canada; [Aref-Eshghi, Erfan; Carere, Deanna Alexis; Levy, Michael A.; Kerkhof, Jennifer; Stuart, Alan; Ainsworth, Peter J.; Lin, Hanxin; Sadikovic, Bekim] London Hlth Sci Ctr, Mol Genet Lab, Mol Diagnost Div, London, ON N6A 5W9, Canada; [Bend, Eric G.; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Colaiacovo, Samantha; Caudle, Michelle; Chakrabarti, Rana; Napier, Melanie; Saleh, Maha; Karp, Natalya; Prasad, Chitra; Siu, Victoria Mok] London Hlth Sci Ctr, Med Genet Program Southwestern Ontario, London, ON N6A 5W9, Canada; [Brick, Lauren; Brady, Lauren; Li, Chumei; Kozenko, Maryia; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rodenhiser, David I.] Western Univ, Dept Pediat Biochem & Oncol, London, ON N6A 3K7, Canada; [Krantz, Ian D.; Deardorff, Matthew A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Western University (University of Western Ontario); London Health Sciences Centre; Greenwood Genetic Center; London Health Sciences Centre; McMaster University; Baylor College of Medicine; Western University (University of Western Ontario); University of Pennsylvania	Sadikovic, B (corresponding author), Western Univ, Dept Pathol & Lab Med, London, ON N6A 3K7, Canada.; Sadikovic, B (corresponding author), London Hlth Sci Ctr, Mol Genet Lab, Mol Diagnost Div, London, ON N6A 5W9, Canada.	bekim.sadikovic@lhsc.on.ca	Bend, Eric/AAT-6739-2020	Stuart, Alan/0000-0001-6370-8581	South Carolina Department of Disabilities and Special Needs (SCDDSN); McMaster New Investigator Grant; Children's Health Research Institute Epigenetics and Bioinformatics Trainee Award - Children's Heart Foundation, London, ON, Canada; Illumina Medical Research Grant	South Carolina Department of Disabilities and Special Needs (SCDDSN); McMaster New Investigator Grant; Children's Health Research Institute Epigenetics and Bioinformatics Trainee Award - Children's Heart Foundation, London, ON, Canada; Illumina Medical Research Grant	We thank the staff, molecular geneticists, and clinical geneticists at London Health Science Centre, Greenwood Genetic Center, and Care4Rare Canada Consortium for the identification, evaluations, and diagnosis of the individuals with neurodevelopmental conditions presented in this study. We also thank the families of the affected subjects for providing consent and information. We thank Cindy Skinner and Heather Davis at the Greenwood Genetic Center for assisting with the collection of samples for the study. The study was supported in part by a grant from the South Carolina Department of Disabilities and Special Needs (SCDDSN), as well as Illumina Medical Research Grant and McMaster New Investigator Grant awarded to B.S. E.A.-E. was supported by Children's Health Research Institute Epigenetics and Bioinformatics Trainee Award, funded by the Children's Heart Foundation, London, ON, Canada. Dedicated to the memory of Ethan Francis Schwartz, 1996-1998.	Aref-Eshghi E, 2018, TRANSL EPIGENET SER, V6, P837, DOI 10.1016/B978-0-12-812215-0.00027-3; Aref-Eshghi E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07193-y; Aref-Eshghi E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00100; Aref-Eshghi E, 2018, AM J HUM GENET, V102, P156, DOI 10.1016/j.ajhg.2017.12.008; Aref-Eshghi E, 2017, EPIGENETICS-US, V12, P923, DOI 10.1080/15592294.2017.1381807; Aref-Eshghi E, 2017, J MOL DIAGN, V19, P848, DOI 10.1016/j.jmoldx.2017.07.002; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Azimi T, 2018, MULT SCLER RELAT DIS, V19, P15, DOI 10.1016/j.msard.2017.10.017; Banno K, 2012, INT J ONCOL, V41, P793, DOI 10.3892/ijo.2012.1528; Barbosa M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04540-x; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Bogershausen N, 2016, HUM MUTAT, V37, P847, DOI 10.1002/humu.23026; Butcher DT, 2017, AM J HUM GENET, V100, P773, DOI 10.1016/j.ajhg.2017.04.004; Changela V, 2009, ANN PEDIAT CARDIOL, V2, P165, DOI 10.4103/0974-2069.58322; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Darling AL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122027; Dolan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080491; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Ellingford JM, 2017, EUR J HUM GENET, V25, P719, DOI 10.1038/ejhg.2017.42; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Helbig I, 2013, CURR OPIN NEUROL, V26, P179, DOI 10.1097/WCO.0b013e32835ee6ff; Hood RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38803; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Jarick I, 2014, MOL PSYCHIATR, V19, P115, DOI 10.1038/mp.2012.161; Johansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378; Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Kernohan KD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0254-x; Kular L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04732-5; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Martin CL, 2015, ANNU REV GENOM HUM G, V16, P309, DOI 10.1146/annurev-genom-090413-025346; Metcalfe K, 2000, EUR J HUM GENET, V8, P955, DOI 10.1038/sj.ejhg.5200564; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Monies D, 2017, HUM GENET, V136, P921, DOI 10.1007/s00439-017-1821-8; Muurinen M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16070-5; Nakamoto S, 2003, HEART, V89, DOI 10.1136/heart.89.5.e15; Nevado J, 2014, GENET MOL BIOL, V37, P210, DOI 10.1590/S1415-47572014000200007; Piekutowska-Abramczuk D, 2018, AM J HUM GENET, V102, P460, DOI 10.1016/j.ajhg.2018.01.008; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Platt JC, 2000, ADV NEUR IN, P61; Prickett AR, 2015, HUM GENET, V134, P317, DOI 10.1007/s00439-014-1526-1; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Revenga L, 2007, GENET MED, V9, P600, DOI 10.1097/GIM.0b013e318149e1e3; Schenkel LC, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0453-8; Schenkel LC, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0118-4; Schenkel LC, 2016, J MOL DIAGN, V18, P834, DOI 10.1016/j.jmoldx.2016.06.005; Shi CH, 2014, HUM MOL GENET, V23, P1013, DOI 10.1093/hmg/ddt497; Shi L, 2018, FORENSIC SCI INT-GEN, V33, P1, DOI 10.1016/j.fsigen.2017.11.005; Sobreira N, 2017, EUR J HUM GENET, V25, P1335, DOI 10.1038/s41431-017-0023-0; Strong E, 2015, AM J HUM GENET, V97, P216, DOI 10.1016/j.ajhg.2015.05.019; Su D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166486; Tesli M, 2016, BRIT J PSYCHIAT, V209, P114, DOI 10.1192/bjp.bp.115.161950; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vanzo RJ, 2014, AM J MED GENET A, V164, P554, DOI 10.1002/ajmg.a.36242; Ventham NT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13507; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yuan SM, 2017, TURKISH J PEDIATR, V59, P225, DOI 10.24953/turkjped.2017.03.001	65	72	73	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					685	700		10.1016/j.ajhg.2019.03.008	http://dx.doi.org/10.1016/j.ajhg.2019.03.008			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30929737	Green Published, Bronze			2022-12-18	WOS:000463474700009
J	Riordan, JD; Nadeau, JH				Riordan, Jesse D.; Nadeau, Joseph H.			From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							SICKLE-CELL-DISEASE; DOMINANT RETINITIS-PIGMENTOSA; GENOME-WIDE ASSOCIATION; RETINAL DEGENERATION; SPONTANEOUS MUTATION; SUPPRESSOR SCREEN; KNOCKOUT RESOURCE; CYSTIC-FIBROSIS; COMPLEX TRAITS; RETT-SYNDROME	Phenotypes are rarely consistent across genetic backgrounds and environments, but instead vary in many ways depending on allelic variants, unlinked genes, epigenetic factors, and environmental exposures. In the extreme, individuals carrying the same causal DNA sequence variant but on different backgrounds can be classified as having distinct conditions. Similarly, some individuals that carry disease alleles are nevertheless healthy despite affected family members in the same environment. These genetic background effects often result from the action of so-called "modifier genes'' that modulate the phenotypic manifestation of target genes in an epistatic manner. While complicating the prospects for gene discovery and the feasibility of mechanistic studies, such effects are opportunities to gain a deeper understanding of gene interaction networks that provide organismal form and function as well as resilience to perturbation. Here, we review the principles of modifier genetics and assess progress in studies of modifier genes and their targets in both simple and complex traits. We propose that modifier effects emerge from gene interaction networks whose structure and function vary with genetic background and argue that these effects can be exploited as safe and effective ways to prevent, stabilize, and reverse disease and dysfunction.	[Riordan, Jesse D.; Nadeau, Joseph H.] Pacific Northwest Res Inst, Seattle, WA 98122 USA		Riordan, JD; Nadeau, JH (corresponding author), Pacific Northwest Res Inst, Seattle, WA 98122 USA.	jriordan@pnri.org; jnadeau@pnri.org	Riordan, Jesse/G-3582-2017	Riordan, Jesse/0000-0001-6734-3954				Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Carouge D, 2012, GERM CELL TUMOR, P75; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Crotti L, 2009, CIRCULATION, V120, P1657, DOI 10.1161/CIRCULATIONAHA.109.879643; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Cruz NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087942; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; Dansky HM, 2002, GENETICS, V160, P1599; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; De Castro SCP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003059; East EM, 1916, GENETICS, V1, P311; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Erikson GA, 2016, CELL, V165, P1002, DOI 10.1016/j.cell.2016.03.022; EVANS K, 1995, BRIT J OPHTHALMOL, V79, P841, DOI 10.1136/bjo.79.9.841; Fisher R., 1930, GENETICAL THEORY NAT; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; Gruneberg H., 1943, GENETICS MOUSE; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Haider NB, 2008, MAMM GENOME, V19, P145, DOI 10.1007/s00335-008-9092-2; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Harms DW, 2014, CURR PROTOC HUM GENE, V83, P1; Harper AR, 2015, NAT REV GENET, V16, P689, DOI 10.1038/nrg4017; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Heaney Jason D., 2008, V450, P211, DOI 10.1007/978-1-60327-214-8_15; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Jiang LI, 2001, MAMM GENOME, V12, P89, DOI 10.1007/s003350010257; Keightley PD, 2014, GENETICS, V196, P313, DOI 10.1534/genetics.113.158758; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lanzkron S, 2008, ANN INTERN MED, V148, P939, DOI 10.7326/0003-4819-148-12-200806170-00221; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Levine AJ, 2007, ANN NY ACAD SCI, V1115, P32, DOI 10.1196/annals.1407.018; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Litchfield K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13889; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Lynch M, 2016, GENETICS, V202, P869, DOI 10.1534/genetics.115.180471; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mackay TFC, 2015, METHODS MOL BIOL, V1253, P47, DOI 10.1007/978-1-4939-2155-3_4; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; McGee TL, 1997, AM J HUM GENET, V61, P1059, DOI 10.1086/301614; Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225; Mouton JM, 2016, HUM GENET, V135, P477, DOI 10.1007/s00439-016-1649-7; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nadeau JH, 2006, NAT GENET, V38, P1095, DOI 10.1038/ng1006-1095; Ni HM, 2008, APOPTOSIS, V13, P53, DOI 10.1007/s10495-007-0147-8; Nikonova AS, 2014, P NATL ACAD SCI USA, V111, P12859, DOI 10.1073/pnas.1405362111; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Noebels J, 2015, NAT NEUROSCI, V18, P344, DOI 10.1038/nn.3933; Noguchi M, 1996, DEV GROWTH DIFFER, V38, P59, DOI 10.1046/j.1440-169X.1996.00008.x; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Paaby AB, 2014, NAT REV GENET, V15, P247, DOI 10.1038/nrg3688; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Robinson A, 2013, BIRTH DEFECTS RES A, V97, P398, DOI 10.1002/bdra.23141; Rodriguez JM, 2013, CIRC RES, V113, P1054, DOI 10.1161/CIRCRESAHA.113.302052; Sackton TB, 2016, CELL, V166, P279, DOI 10.1016/j.cell.2016.06.047; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Schell R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2001015; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spiezio SH, 2014, MAMM GENOME, V25, P549, DOI 10.1007/s00335-014-9530-2; Stevens L C, 1981, Prog Clin Biol Res, V45, P93; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Suzuki M, 2014, MOL CELL BIOL, V34, P3560, DOI 10.1128/MCB.00714-14; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Timberlake AT, 2016, ELIFE, V5, DOI 10.7554/eLife.20125; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Uchimura A, 2015, GENOME RES, V25, P1125, DOI 10.1101/gr.186148.114; van Leeuwen J, 2016, SCIENCE, V354, DOI 10.1126/science.aag0839; van Straaten HWM, 2001, ANAT EMBRYOL, V203, P225, DOI 10.1007/s004290100169; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Venturini G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003040; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Wang Z, 2011, METHOD CELL BIOL, V106, P113, DOI 10.1016/B978-0-12-544172-8.00005-0; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Williams EG, 2015, CELL, V162, P23, DOI 10.1016/j.cell.2015.06.024; WRIGHT S, 1988, AM NAT, V131, P115, DOI 10.1086/284777; Wright S, 1931, GENETICS, V16, P0097; Yazbek SN, 2011, GENOME RES, V21, P1065, DOI 10.1101/gr.120741.111; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	101	72	72	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					177	191		10.1016/j.ajhg.2017.06.004	http://dx.doi.org/10.1016/j.ajhg.2017.06.004			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28777930	Green Published, Bronze			2022-12-18	WOS:000406854800003
J	Mencacci, NE; Kamsteeg, EJ; Nakashima, K; R'Bibo, L; Lynch, DS; Balint, B; Willemsen, MAAP; Adams, ME; Wiethoff, S; Suzuki, K; Davies, CH; Ng, J; Meyer, E; Veneziano, L; Giunti, P; Hughes, D; Raymond, FL; Carecchio, M; Zorzi, G; Nardocci, N; Barzaghi, C; Garavaglia, B; Salpietro, V; Hardy, J; Pittman, AM; Houlden, H; Kurian, MA; Kimura, H; Vissers, LELM; Wood, NW; Bhatia, KP				Mencacci, Niccolo E.; Kamsteeg, Erik-Jan; Nakashima, Kosuke; R'Bibo, Lea; Lynch, David S.; Balint, Bettina; Willemsen, Michel A. A. P.; Adams, Matthew E.; Wiethoff, Sarah; Suzuki, Kazunori; Davies, Ceri H.; Ng, Joanne; Meyer, Esther; Veneziano, Liana; Giunti, Paola; Hughes, Deborah; Raymond, F. Lucy; Carecchio, Miryam; Zorzi, Giovanna; Nardocci, Nardo; Barzaghi, Chiara; Garavaglia, Barbara; Salpietro, Vincenzo; Hardy, John; Pittman, Alan M.; Houlden, Henry; Kurian, Manju A.; Kimura, Haruhide; Vissers, Lisenka E. L. M.; Wood, Nicholas W.; Bhatia, Kailash P.			De Novo Mutations in PDE1 0A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHODIESTERASE 10A; FAMILIAL DYSKINESIA; ADCY5 MUTATIONS; CAMP; MECHANISM; FRAMEWORK; DOPAMINE; CYCLASES; LIGAND; DOMAIN	Chorea is a hyperkinetic movement disorder resulting from dysfunction of striatal medium spiny neurons (MSNs), which form the main output projections from the basal ganglia Here, we used whole-exome sequencing to unravel the underlying genetic cause in three unrelated individuals with a very similar and unique clinical presentation of childhood-onset chorea and characteristic brain MRI showing symmetrical bilateral striatal lesions. All individuals were identified to carry a de novo heterozygous mutation in PDE10A (c.898T>C [p.Phe300Leu] in two individuals and c.1000T>C [p.Phe334Leu] in one individual), encoding a phosphodiesterase highly and selectively present in MSNs. PDE10A contributes to the regulation of the intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Both substitutions affect highly conserved amino acids located in the regulatory GAF-B domain, which, by binding to cAMP, stimulates the activity of the PDE10A catalytic domain. In silico modeling showed that the altered residues are located deep in the binding pocket, where they are likely to alter cAMP binding properties. In vitro functional studies showed that neither substitution affects the basal PDE10A activity, but they severely disrupt the stimulatory effect mediated by cAMP binding to the GAF-B domain. The identification of PDE10A mutations as a cause of chorea further motivates the study of cAMP signaling in MSNs and highlights the crucial role of striatal cAMP signaling in the regulation of basal ganglia circuitry. Pharmacological modulation of this pathway could offer promising etiologically targeted treatments for chorea and other hyperkinetic movement disorders.	[Mencacci, Niccolo E.; R'Bibo, Lea; Lynch, David S.; Wiethoff, Sarah; Giunti, Paola; Hughes, Deborah; Salpietro, Vincenzo; Hardy, John; Pittman, Alan M.; Houlden, Henry; Wood, Nicholas W.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Mencacci, Niccolo E.] Univ Milan, Dept Neurol, I-20149 Milan, Italy; [Mencacci, Niccolo E.] Univ Milan, Lab Neurosci, IRCCS Ist Auxol Italiano, Dept Pathophysiol & Transplantat,Ctr Dino Ferrari, I-20149 Milan, Italy; [Kamsteeg, Erik-Jan; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Ctr Brain Cognit & Behav, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands; [Nakashima, Kosuke; Suzuki, Kazunori; Davies, Ceri H.; Kimura, Haruhide] Takeda Pharmaceut Co Ltd, CNS Drug Discovery Unit, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan; [Balint, Bettina; Bhatia, Kailash P.] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Balint, Bettina] Univ Heidelberg Hosp, Dept Neurol, D-69120 Heidelberg, Germany; [Willemsen, Michel A. A. P.] Radboud Univ Nijmegen, Med Ctr, Dept Paediat Neurol, Donders Ctr Brain Cognit & Behav, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands; [Adams, Matthew E.] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, Queen Sq, London WC1N 3BG, England; [Wiethoff, Sarah] Univ Tubingen, Ctr Neurol, D-72076 Tubingen, Germany; [Wiethoff, Sarah] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Ng, Joanne; Meyer, Esther; Kurian, Manju A.] UCL Inst Child Hlth, Dev Neurosci, London WC1N 1EH, England; [Ng, Joanne; Kurian, Manju A.] Great Ormond St Hosp Sick Children, Dept Neurol, London WC1N 3JH, England; [Veneziano, Liana] CNR, Inst Translat Pharmacol, I-00133 Rome, Italy; [Raymond, F. Lucy] Univ Cambridge, Dept Med Genet, Cambridge CB2 0XY, England; [Carecchio, Miryam; Zorzi, Giovanna; Nardocci, Nardo] IRCCS Ist Neurol Carlo Besta, Neuropediat Unit, I-20133 Milan, Italy; [Barzaghi, Chiara; Garavaglia, Barbara] IRCCS Ist Neurol Carlo Besta, Mol Neurogenet Unit, I-20133 Milan, Italy; [Hardy, John; Pittman, Alan M.] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London WC1N 3BG, England	University of London; University College London; University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; Radboud University Nijmegen; Takeda Pharmaceutical Company Ltd; University of London; University College London; Ruprecht Karls University Heidelberg; Radboud University Nijmegen; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Cambridge; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; University of London; University College London	Wood, NW (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.	n.wood@ud.ac.uk	Houlden, Henry J/C-1532-2008; Wood, Nicholas W/C-2505-2009; Giunti, Paola/E-5526-2012; Pittman, Alan/AAP-2534-2020; Vissers, Lisenka ELM/A-2598-2015; Willemsen, Michel A.A.P./H-8119-2014; Barzaghi, Chiara/H-8456-2014; Kamsteeg, Erik-Jan/L-4421-2015; Carecchio, Miryam/AAC-2219-2019; Garavaglia, Barbara/J-5257-2018; Veneziano, Liana/F-7858-2018; Salpietro, Vincenzo/AAA-8706-2020; Hardy, John/C-2451-2009; Zorzi, Giovanna/AAM-4138-2021; Nardocci, Nardo/AAB-9903-2019; Pittman, Alan M/D-6231-2012	Houlden, Henry J/0000-0002-2866-7777; Wood, Nicholas W/0000-0002-9500-3348; Giunti, Paola/0000-0003-3508-4788; Pittman, Alan/0000-0002-8112-2987; Vissers, Lisenka ELM/0000-0001-6470-5497; Garavaglia, Barbara/0000-0003-4323-9145; Veneziano, Liana/0000-0002-9921-8450; Hardy, John/0000-0002-3122-0423; Zorzi, Giovanna/0000-0001-7041-5365; Nardocci, Nardo/0000-0001-5863-5592; Pittman, Alan M/0000-0002-8112-2987; Carecchio, Miryam/0000-0002-0755-5477; Ng, Joanne/0000-0002-7946-9965; Salpietro, Vincenzo/0000-0003-0132-7921; Mencacci, Niccolo Emanuele/0000-0003-3383-9665; R'Bibo, Lea/0000-0001-6773-797X	Medical Research Council and Wellcome Trust [WT089698/Z/09/Z]; Netherlands Organization of Scientific Research (ZonMW) [40-41200-98-9131]; Bachman-Strauss Dystonia Parkinsonism Foundation; National Institute for Health Research (NIHR) Bioresource Rare Diseases; "Cell Lines and DNA Bank of Movement Disorders and Mitochondrial Diseases" of the Telethon Network of Genetic Biobanks [GTB12001J]; NIHR; Reta Lila Weston Trust; Wellcome Intermediate Fellowship;  [UK10K]; Medical Research Council [G108/638, G1001253, MR/J004758/1, G0802760, MR/K02342X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082, NF-SI-0513-10064, NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [G-1107] Funding Source: researchfish; Rosetrees Trust [M576] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1284, ICH1031] Funding Source: researchfish; Action Medical Research [1722] Funding Source: researchfish; MRC [G0802760, MR/K02342X/1, G1001253, MR/J004758/1, G108/638] Funding Source: UKRI	Medical Research Council and Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organization of Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Bachman-Strauss Dystonia Parkinsonism Foundation; National Institute for Health Research (NIHR) Bioresource Rare Diseases(National Institute for Health Research (NIHR)); "Cell Lines and DNA Bank of Movement Disorders and Mitochondrial Diseases" of the Telethon Network of Genetic Biobanks(Fondazione Telethon); NIHR(National Institute for Health Research (NIHR)); Reta Lila Weston Trust; Wellcome Intermediate Fellowship(Wellcome Trust); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Childrens Charity; Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to extend our thanks to the individuals whose participation made this research possible. This work was supported financially by the Medical Research Council and Wellcome Trust (Strategic Award WT089698/Z/09/Z), the Netherlands Organization of Scientific Research (ZonMW grant 40-41200-98-9131), and grants from the Bachman-Strauss Dystonia Parkinsonism Foundation, National Institute for Health Research (NIHR) Bioresource Rare Diseases, and UK10K. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was undertaken at University College London (UCL) Hospitals, Great Ormond Street Hospital for Children NHS Foundation Trust, and UCL, which receive support from the Department of Health's NIHR Biomedical Research Center funding streams. We acknowledge the "Cell Lines and DNA Bank of Movement Disorders and Mitochondrial Diseases" of the Telethon Network of Genetic Biobanks (grant GTB12001J) and the Eurobiobank Network, which provided the Italian samples. N.E.M. is funded by a NIHR funding scheme. A.M.P. is funded by the Reta Lila Weston Trust. M.A.K. is funded by a Wellcome Intermediate Fellowship. Next-generation sequencing was performed at the UCL Institute of Neurology Sequencing Facility and the Genome Technology, Center at the Radboudumc. Expression data were provided by the UK Human Brain Expression Consortium (UKBEC), which comprises John A. Hardy, Mina Ryten, Michael Weale, Daniah Trabzuni, Adaikalavan Ramasamy, Colin Smith, and Robert Walker. UKBEC members are affiliated with the UCL Institute of Neurology (J.H., M.R., and D.T.), King's College London (M.R., M.W., and A.R.), and University of Edinburgh (C.S. and R.W.).	Appenzeller S, 2010, AM J HUM GENET, V86, P83, DOI 10.1016/j.ajhg.2009.12.003; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bollen E, 2012, IUBMB LIFE, V64, P965, DOI 10.1002/iub.1104; Chappie TA, 2012, J MED CHEM, V55, P7299, DOI 10.1021/jm3004976; Chen YZ, 2014, ANN NEUROL, V75, P542, DOI 10.1002/ana.24119; Chen YZ, 2012, ARCH NEUROL-CHICAGO, V69, P630, DOI 10.1001/archneurol.2012.54; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Exome Aggregation Consortium, 2015, BIORXIV; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Gardiner AR, 2015, BRAIN, V138, P3567, DOI 10.1093/brain/awv310; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hermann A, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-014-0514-0; Herve D, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00048; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jager R, 2012, J BIOL CHEM, V287, P1210, DOI 10.1074/jbc.M111.263806; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klein Christine, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS137, DOI 10.1016/S1353-8020(13)70033-6; KOESLING D, 1991, FASEB J, V5, P2785, DOI 10.1096/fasebj.5.13.1680765; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Lee KW, 2002, J NEUROSCI, V22, P7931; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MARSDEN CD, 1984, NEUROL CLIN, V2, P435, DOI 10.1016/S0733-8619(18)31083-1; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; Mencacci NE, 2015, NEUROLOGY, V85, P80, DOI 10.1212/WNL.0000000000001720; Mencacci NE, 2015, AM J HUM GENET, V96, P938, DOI 10.1016/j.ajhg.2015.04.008; Niccolini F, 2015, BRAIN, V138, P3003, DOI 10.1093/brain/awv219; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Peall KJ, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D8RJ4HM5; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Barsottini OGP, 2015, NEUROLOGY, V85, P1816, DOI 10.1212/WNL.0000000000002128; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Russwurm C, 2015, J BIOL CHEM, V290, P11936, DOI 10.1074/jbc.M114.595769; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Spatola M., 2014, PARKINSONISM RELA S1, V20, pS35, DOI DOI 10.1016/S1353-8020(13)70011-7; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Threlfell S, 2013, BASAL GANGLIA, V3, P137, DOI 10.1016/j.baga.2013.08.001; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446	49	72	73	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					763	771		10.1016/j.ajhg.2016.02.015	http://dx.doi.org/10.1016/j.ajhg.2016.02.015			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27058447	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000374203800014
J	Miyake, N; Tsukaguchi, H; Koshimizu, E; Shono, A; Matsunaga, S; Shiina, M; Mimura, Y; Imamura, S; Hirose, T; Okudela, K; Nozu, K; Akioka, Y; Hattori, M; Yoshikawa, N; Kitamura, A; Cheong, HI; Kagami, S; Yamashita, M; Fujita, A; Miyatake, S; Tsurusaki, Y; Nakashima, M; Saitsu, H; Ohashi, K; Imamoto, N; Ryo, A; Ogata, K; Iijima, K; Matsumoto, N				Miyake, Noriko; Tsukaguchi, Hiroyasu; Koshimizu, Eriko; Shono, Akemi; Matsunaga, Satoko; Shiina, Masaaki; Mimura, Yasuhiro; Imamura, Shintaro; Hirose, Tomonori; Okudela, Koji; Nozu, Kandai; Akioka, Yuko; Hattori, Motoshi; Yoshikawa, Norishige; Kitamura, Akiko; Cheong, Hae Il; Kagami, Shoji; Yamashita, Michiaki; Fujita, Atsushi; Miyatake, Satoko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Saitsu, Hirotomo; Ohashi, Kenichi.; Imamoto, Naoko; Ryo, Akihide; Ogata, Kazuhiro; Iijima, Kazumoto; Matsumoto, Naomichi			Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-CYCLE; NUCLEOCYTOPLASMIC TRANSPORT; SINGLE NUCLEOPORIN; IN-VITRO; PODOCYTE; GLOMERULOSCLEROSIS; ORGANIZATION; DEPLETION; PROTEINS; GENETICS	The nuclear pore complex (NPC) is a huge protein complex embedded in the nuclear envelope. It has central functions in nucleocytoplasmic transport, nuclear framework, and gene regulation. Nucleoporin 107 kDa (NUP107) is a component of the NPC central scaffold and is an essential protein in all eukaryotic cells. Here, we report on biallelic NUP107 mutations in nine affected individuals who are from five unrelated families and show early-onset steroid-resistant nephrotic syndrome (SRN). These individuals have pathologically focal segmental glomerulosclerosis, a condition that leads to end-stage renal disease with high frequency. NUP107 is ubiquitously expressed, including in glomerular podocytes. Three of four NUP107 mutations detected in the affected individuals hamper NUP107 binding to NUP133 (nucleoporin 133 kDa) and NUP107 incorporation into NPCs in vitro. Zebrafish with nup107 knockdown generated by morpholino oligonucleotides displayed hypoplastic glomerulus structures and abnormal podocyte foot processes, thereby mimicking the pathological changes seen in the kidneys of the SRNS individuals with NUP107 mutations. Considering the unique properties of the podocyte (highly differentiated foot-process architecture and slit membrane and the inability to regenerate), we propose a "podocyte-injury model" as the pathomechanism for SRNS due to biallelic NUP107 mutations.	[Miyake, Noriko; Koshimizu, Eriko; Fujita, Atsushi; Miyatake, Satoko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Tsukaguchi, Hiroyasu] Kansai Med Univ, Dept Internal Med 2, Osaka 5708507, Japan; [Shono, Akemi; Nozu, Kandai; Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Matsunaga, Satoko; Ryo, Akihide] Yokohama City Univ, Grad Sch Med, Dept Microbiol, Yokohama, Kanagawa 2360004, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Mimura, Yasuhiro; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan; [Imamura, Shintaro; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Hirose, Tomonori] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan; [Okudela, Koji; Ohashi, Kenichi.] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 2360004, Japan; [Akioka, Yuko; Hattori, Motoshi] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo 1628666, Japan; [Yoshikawa, Norishige] Natl Ctr Child Hlth & Dev, Ctr Clin Res & Dev, Tokyo 1578535, Japan; [Kitamura, Akiko] Univ Tokushima, Grad Sch, Dept Immunol & Parasitol, Inst Biomed Sci, Tokushima 7708503, Japan; [Cheong, Hae Il] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul 03080, South Korea; [Cheong, Hae Il] Seoul Natl Univ Hosp, Res Coordinat Ctr Rare Dis, Seoul 03080, South Korea; [Cheong, Hae Il] Seoul Natl Univ, Coll Med, Kidney Res Inst, Med Res Ctr, Seoul 03080, South Korea; [Kagami, Shoji] Univ Tokushima, Grad Sch, Dept Pediat, Tokushima 7708503, Japan	Yokohama City University; Kansai Medical University; Kobe University; Yokohama City University; Yokohama City University; RIKEN; Japan Fisheries Research & Education Agency (FRA); Yokohama City University; Yokohama City University; Tokyo Women's Medical University; National Center for Child Health & Development - Japan; Tokushima University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Tokushima University	Tsukaguchi, H (corresponding author), Kansai Med Univ, Dept Internal Med 2, Osaka 5708507, Japan.	tsukaguh@hirakata.kmu.ac.jp; naomat@yokohama-cu.ac.jp	Saitsu, Hirotomo/AAM-7131-2021; Nozu, Kandai/Q-9383-2019; Hirose, Tomonori/F-6015-2010; Hirose, Tomonori/M-8872-2019	Hirose, Tomonori/0000-0003-2428-0919; Hirose, Tomonori/0000-0003-2428-0919; Saitsu, Hirotomo/0000-0003-0723-0960; Tsurusaki, Yoshinori/0000-0002-7240-6355	Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24118007]; Japan Society for the Promotion of Science; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Takeda Science Foundation; Osaka Kidney Foundation; Korean Health Technology R&D Project, Ministry of Health Welfare [HI12C0014]; Pfizer Japan; Daiichi Sankyo; Japan Blood Product Organization; Miyarisan Pharmaceutical; AbbVie; CSL Behring; JCR Pharmaceuticals; Teijin Pharma; Chugai Pharmaceutical; Astellas Pharma; Novartis Pharma KK; Asahi Kasei Pharma; Grants-in-Aid for Scientific Research [26461549] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Takeda Science Foundation(Takeda Science Foundation (TSF)); Osaka Kidney Foundation; Korean Health Technology R&D Project, Ministry of Health Welfare; Pfizer Japan(Pfizer); Daiichi Sankyo(Daiichi Sankyo Company Limited); Japan Blood Product Organization; Miyarisan Pharmaceutical(Johnson & Johnson); AbbVie(AbbVie); CSL Behring; JCR Pharmaceuticals; Teijin Pharma; Chugai Pharmaceutical; Astellas Pharma(Astellas Pharmaceuticals); Novartis Pharma KK(Novartis); Asahi Kasei Pharma; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to all the affected individuals and their families who participated in this study. We also thank our clinical colleagues who supported the participating families: Dr. Makoto Endo (Laboratory of Fish Health Management, Tokyo University of Marine Science and Technology) for morphological evaluation of zebrafish and Ms. Sugimoto, Ms. Takabe, and Mr. Mitsui for technical assistance. This work was supported in part by a grant for Research on Measures for Intractable Diseases, a grant for Comprehensive Research on Disability Health and Welfare, and the Strategic Research Program for Brain Science from the Japan Agency for Medical Research and Development; a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) (24118007) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research (A, B, and C) and for Challenging Exploratory Research from the Japan Society for the Promotion of Science; the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Project for Developing Innovation Systems from the Japan Science and Technology Agency; the Takeda Science Foundation; the Osaka Kidney Foundation; and grant HI12C0014 from the Korean Health Technology R&D Project, Ministry of Health & Welfare. K.I. also received grants from Pfizer Japan, Daiichi Sankyo, the Japan Blood Product Organization, Miyarisan Pharmaceutical, AbbVie, CSL Behring, JCR Pharmaceuticals, and Teijin Pharma; and consulting fees from Chugai Pharmaceutical and Astellas Pharma. N.Y. received grants from Novartis Pharma KK and Asahi Kasei Pharma.	Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Banerjee HN, 2010, MOL CELL BIOCHEM, V343, P21, DOI 10.1007/s11010-010-0494-6; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Bullich G, 2015, EUR J HUM GENET, V23, P1192, DOI 10.1038/ejhg.2014.252; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Clever M, 2012, NUCLEUS-PHILA, V3, P187, DOI 10.4161/nucl.19595; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gipson DS, 2009, PEDIATRICS, V124, P747, DOI 10.1542/peds.2008-1559; Gonzalez-Aguilera C, 2012, NUCLEUS-PHILA, V3, P340, DOI 10.4161/nucl.21135; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.E04-10-0857; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim JS, 2005, KIDNEY INT, V68, P1275, DOI 10.1111/j.1523-1755.2005.00524.x; Kitamura A, 2006, NEPHROL DIAL TRANSPL, V21, P3133, DOI 10.1093/ndt/gfl347; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lovric S, 2014, CLIN J AM SOC NEPHRO, V9, P1109, DOI 10.2215/CJN.09010813; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; McKinney PA, 2001, PEDIATR NEPHROL, V16, P1040, DOI 10.1007/s004670100021; Mekahli D, 2009, PEDIATR NEPHROL, V24, P1525, DOI 10.1007/s00467-009-1138-5; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; Nagata M, 1998, AM J PATHOL, V153, P1511, DOI 10.1016/S0002-9440(10)65739-2; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Petermann AT, 2002, KIDNEY INT, V61, P40, DOI 10.1046/j.1523-1755.2002.00102.x; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Saleem MA, 2013, PEDIATR NEPHROL, V28, P699, DOI 10.1007/s00467-012-2239-0; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Sawasaki Tatsuya, 2007, V375, P95; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Swift J, 2014, J CELL SCI, V127, P3005, DOI 10.1242/jcs.149203; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; Thong KM, 2013, NEPHRON CLIN PRACT, V124, P31, DOI 10.1159/000354716; Trautmann A, 2015, CLIN J AM SOC NEPHRO, V10, P592, DOI 10.2215/CJN.06260614; Tsurusaki Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5011; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Zagury Alberto, 2013, Braz. J. Nephrol., V35, P191, DOI 10.5935/0101-2800.20130031; Zheng XF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408997	53	72	77	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					555	566		10.1016/j.ajhg.2015.08.013	http://dx.doi.org/10.1016/j.ajhg.2015.08.013			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26411495	Bronze, Green Published			2022-12-18	WOS:000362617300006
J	Esteki, MZ; Dimitriadou, E; Mateiu, L; Melotte, C; Van der Aa, N; Kumar, P; Das, R; Theunis, K; Cheng, JQ; Legius, E; Moreau, Y; Debrock, S; D'Hooghe, T; Verdyck, P; De Rycke, M; Sermon, K; Vermeesch, JR; Voet, T				Esteki, Masoud Zamani; Dimitriadou, Eftychia; Mateiu, Ligia; Melotte, Cindy; Van der Aa, Niels; Kumar, Parveen; Das, Rakhi; Theunis, Koen; Cheng, Jiqiu; Legius, Eric; Moreau, Yves; Debrock, Sophie; D'Hooghe, Thomas; Verdyck, Pieter; De Rycke, Martine; Sermon, Karen; Vermeesch, Joris R.; Voet, Thierry			Concurrent Whole-Genome Haplotyping and Copy-Number Profiling of Single Cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; CLEAVAGE-STAGE EMBRYOS; ESHRE PGD; CHROMOSOME INSTABILITY; MEIOTIC RECOMBINATION; PRACTICE GUIDELINES; MEDIAN FILTERS; SPERM CELLS; SNP ARRAYS; IN-VITRO	Methods for haplotyping and DNA copy-number typing of single cells are paramount for studying genomic heterogeneity and enabling genetic diagnosis. Before analyzing the DNA of a single cell by microarray or next-generation sequencing, a whole-genome amplification (WGA) process is required, but it substantially distorts the frequency and composition of the cell's alleles. As a consequence, haplotyping methods suffer from error-prone discrete SNP genotypes (AA, AB, BB) and DNA copy-number profiling remains difficult because true DNA copy-number aberrations have to be discriminated from WGA artifacts. Here, we developed a single-cell genome analysis method that reconstructs genome-wide haplotype architectures as well as the copy-number and segregational origin of those haplotypes by employing phased parental genotypes and deciphering WGA-distorted SNP B-allele fractions via a process we coin haplarithmisis. We demonstrate that the method can be applied as a generic method for preimplantation genetic diagnosis on single cells biopsied from human embryos, enabling diagnosis of disease alleles genome wide as well as numerical and structural chromosomal anomalies. Moreover, meiotic segregation errors can be distinguished from mitotic ones.	[Esteki, Masoud Zamani; Dimitriadou, Eftychia; Mateiu, Ligia; Melotte, Cindy; Van der Aa, Niels; Kumar, Parveen; Das, Rakhi; Theunis, Koen; Cheng, Jiqiu; Legius, Eric; Vermeesch, Joris R.; Voet, Thierry] Katholieke Univ Leuven, Ctr Human Genet, Univ Hosp Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Cheng, Jiqiu; Moreau, Yves] Katholieke Univ Leuven, Dept Elect Engn, ESAT STADIUS, B-3000 Leuven, Belgium; [Debrock, Sophie; D'Hooghe, Thomas] Univ Hosp Gasthuisberg, Leuven Univ Fertil Ctr, B-3000 Leuven, Belgium; [Verdyck, Pieter; De Rycke, Martine] Univ Ziekenhuis Brussel, Ctr Med Genet, B-1090 Brussels, Belgium; [De Rycke, Martine; Sermon, Karen] Vrije Univ Brussel, Res Grp Reprod & Genet REGE, B-1090 Brussels, Belgium; [Voet, Thierry] Welcome Trust Sanger Inst, Single Cell Genom Ctr, Hinxton CB10 1SA, Cambs, England	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Wellcome Trust Sanger Institute	Vermeesch, JR (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Univ Hosp Leuven, Dept Human Genet, B-3000 Leuven, Belgium.	joris.vermeesch@med.kuleuven.be; thierry.voet@med.kuleuven.be	Melotte, Cindy/GXV-5465-2022; Voet, Thierry/E-8877-2017; Mateiu, Ligia/Z-2118-2019; t, lf/AAJ-4924-2020	Voet, Thierry/0000-0003-1204-9963; Mateiu, Ligia/0000-0002-2655-3581; Zamani Esteki, Masoud/0000-0003-3909-0050; De Rycke, Martine/0000-0001-7861-9426; Verdyck, Pieter/0000-0002-0243-8650; Sermon, Karen/0000-0002-2311-9034; Kumar, Parveen/0000-0003-2739-273X; Vermeesch, Joris/0000-0002-3071-1191; Theunis, Koen/0000-0002-0699-6676; Dimitriadou, Eftychia/0000-0003-2845-0057; Moreau, Yves/0000-0002-4647-6560	Agency for Innovation by Science and Technology (IWT) [TBM-090878]; Research Foundation Flanders (FWO) [G.A093.11N]; European Union [324509]; University of Leuven (KU Leuven); SymBioSys [PFV/10/016]; Auxilio	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); European Union(European Commission); University of Leuven (KU Leuven)(KU Leuven); SymBioSys; Auxilio	We are grateful to all families that participated in this study (families were treated at the Leuven University Fertility center, Leuven University Hospital, Belgium) and the PGD Clinic of the UZ Brussel. We thank S. Jackmaert, Dr. E. Vanneste, and N. Ardeshirdavani for their help with the SNP arrays and initiating the 24 hr protocol. We thank Dr. A. Destouni for critical reading of the manuscript. Funding for this study is provided by the Agency for Innovation by Science and Technology (IWT) (TBM-090878 to J.R.V., T.V., Y.M., and T.D.), the Research Foundation Flanders (FWO) (G.A093.11N to T.V. and J.R.V.), the European Union's Research and Innovation funding programme (FP7-PEOPLE-2012-IAPP SARM: 324509 to J.R.V., T.V., and T.D.), the University of Leuven (KU Leuven), SymBioSys (PFV/10/016 to Y.M., J.R.V., and T.V.), and Auxilio (to T.V.). M.Z.E., J.R.V., and T.V. are co-inventors on patent applications ZL910050-PCT/EP2011/060211-WO/2011/157846 "Methods for haplotyping single cells'' and ZL913096-PCT/EP2014/068315-WO/2015/028576 "Haplotyping and copy-number typing using polymorphic variant allelic frequencies." T.V. and J.R.V. are co-inventors on patent application ZL912076-PCT/EP2013/070858 "High-throughput genotyping by sequencing." J.R.V. and Y.M. are co-founders and stockholders of Cartagenia.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alfarawati S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003025; Altarescu G, 2013, J ASSIST REPROD GEN, V30, P1595, DOI 10.1007/s10815-013-0044-8; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Ben Hamza A, 1999, J MATH IMAGING VIS, V11, P161, DOI 10.1023/A:1008395514426; BOVIK AC, 1987, IEEE T PATTERN ANAL, V9, P181, DOI 10.1109/TPAMI.1987.4767894; Braude P, 2002, NAT REV GENET, V3, P941, DOI 10.1038/nrg953; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; GALLAGHER NC, 1981, IEEE T ACOUST SPEECH, V29, P1136, DOI 10.1109/TASSP.1981.1163708; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Handyside AH, 2013, FERTIL STERIL, V100, P595, DOI 10.1016/j.fertnstert.2013.07.1965; Handyside AH, 2010, J MED GENET, V47, P651, DOI 10.1136/jmg.2009.069971; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Harper JC, 2012, HUM REPROD UPDATE, V18, P234, DOI 10.1093/humupd/dmr052; Harton GL, 2011, HUM REPROD, V26, P33, DOI 10.1093/humrep/deq231; Harton GL, 2011, HUM REPROD, V26, P25, DOI 10.1093/humrep/deq230; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Johnson DS, 2010, HUM REPROD, V25, P1066, DOI 10.1093/humrep/dep452; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Konings P, 2012, NAT PROTOC, V7, P281, DOI 10.1038/nprot.2011.426; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Melotte C, 2004, HUM REPROD, V19, P2777, DOI 10.1093/humrep/deh539; Moller EK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00320; Natesan SA, 2014, GENET MED, V16, P838, DOI 10.1038/gim.2014.45; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Simpson JL, 2010, PRENATAL DIAG, V30, P682, DOI 10.1002/pd.2552; Speicher MR, 2013, GENOME MED, V5, DOI 10.1186/gm478; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Strachan T, 2011, HUMAN MOLECULAR GENETICS 4TH EDITION, P1; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Treff NR, 2011, MOL HUM REPROD, V17, P335, DOI 10.1093/molehr/gaq103; Van der Aa N, 2013, GENOME MED, V5, DOI 10.1186/gm475; Van der Auwera I, 2002, HUM REPROD, V17, P1507, DOI 10.1093/humrep/17.6.1507; van Echten-Arends J, 2011, HUM REPROD UPDATE, V17, P620, DOI 10.1093/humupd/dmr014; Vanneste E, 2009, HUM REPROD, V24, P2679, DOI 10.1093/humrep/dep266; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vattathil S, 2013, GENOME RES, V23, P152, DOI 10.1101/gr.141374.112; Voet T, 2011, CYTOGENET GENOME RES, V133, P160, DOI 10.1159/000324235; Voet T, 2011, HUM MUTAT, V32, P783, DOI 10.1002/humu.21502; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wilton L, 2002, PRENATAL DIAG, V22, P512, DOI 10.1002/pd.388; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	60	72	74	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					894	912		10.1016/j.ajhg.2015.04.011	http://dx.doi.org/10.1016/j.ajhg.2015.04.011			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	25983246	Green Published, Bronze			2022-12-18	WOS:000355931200004
J	Mencacci, NE; Rubio-Agusti, I; Zdebik, A; Asmus, F; Ludtmann, MHR; Ryten, M; Plagnol, V; Hauser, AK; Bandres-Ciga, S; Bettencourt, C; Forabosco, P; Hughes, D; Soutar, MMP; Peall, K; Morris, HR; Trabzuni, D; Tekman, M; Stanescu, HC; Kleta, R; Carecchio, M; Zorzi, G; Nardocci, N; Garavaglia, B; Lohmann, E; Weissbach, A; Klein, C; Hardy, J; Pittman, AM; Foltynie, T; Abramov, AY; Gasser, T; Bhatia, KP; Wood, NW				Mencacci, Niccolo E.; Rubio-Agusti, Ignacio; Zdebik, Anselm; Asmus, Friedrich; Ludtmann, Marthe H. R.; Ryten, Mina; Plagnol, Vincent; Hauser, Ann-Kathrin; Bandres-Ciga, Sara; Bettencourt, Conceicao; Forabosco, Paola; Hughes, Deborah; Soutar, Marc M. P.; Peall, Kathryn; Morris, Huw R.; Trabzuni, Daniah; Tekman, Mehmet; Stanescu, Horia C.; Kleta, Robert; Carecchio, Miryam; Zorzi, Giovanna; Nardocci, Nardo; Garavaglia, Barbara; Lohmann, Ebba; Weissbach, Anne; Klein, Christine; Hardy, John; Pittman, Alan M.; Foltynie, Thomas; Abramov, Andrey Y.; Gasser, Thomas; Bhatia, Kailash P.; Wood, Nicholas W.			A Missense Mutation in KCTD17 Causes Autosomal Dominant Myoclonus-Dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPSILON-SARCOGLYCAN MUTATIONS; CHANNEL-RELATED GENE; COPY NUMBER VARIANT; HUMAN BRAIN; UPDATE; SGCE; PROTEINS; INSIGHTS; EPILEPSY; TRANSCRIPTOME	Myoclonus-dystonia (M-D) is a rare movement disorder characterized by a combination of non-epileptic myoclonic jerks and dystonia. SGCE mutations represent a major cause for familial M-D being responsible for 30%-50% of cases. After excluding SGCE mutations, we identified through a combination of linkage analysis and whole-exome sequencing KCTD17 c. 434 G>A p.(Arg145His) as the only segregating variant in a dominant British pedigree with seven subjects affected by M-D. A subsequent screening in a cohort of M-D cases without mutations in SGCE revealed the same KCTD17 variant in a German family. The clinical presentation of the KCTD17-mutated cases was distinct from the phenotype usually observed in M-D due to SGCE mutations. All cases initially presented with mild myoclonus affecting the upper limbs. Dystonia showed a progressive course, with increasing severity of symptoms and spreading from the cranio-cervical region to other sites. KCTD17 is abundantly expressed in all brain regions with the highest expression in the putamen. Weighted gene co-expression network analysis, based on mRNA expression profile of brain samples from neuropathologically healthy individuals, showed that KCTD17 is part of a putamen gene network, which is significantly enriched for dystonia genes. Functional annotation of the network showed an over-representation of genes involved in post-synaptic dopaminergic transmission. Functional studies in mutation bearing fibroblasts demonstrated abnormalities in endoplasmic reticulum-dependent calcium signaling. In conclusion, we demonstrate that the KCTD17 c. 434 G>A p.(Arg145His) mutation causes autosomal dominant M-D. Further functional studies are warranted to further characterize the nature of KCTD17 contribution to the molecular pathogenesis of M-D.	[Mencacci, Niccolo E.; Ludtmann, Marthe H. R.; Ryten, Mina; Bettencourt, Conceicao; Hughes, Deborah; Soutar, Marc M. P.; Trabzuni, Daniah; Hardy, John; Pittman, Alan M.; Abramov, Andrey Y.; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Mencacci, Niccolo E.] Univ Milan, Dept Neurol, IRCCS Ist Auxol Italiano, I-20149 Milan, Italy; [Mencacci, Niccolo E.] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Lab Neurosci, I-20149 Milan, Italy; [Rubio-Agusti, Ignacio] Hosp Univ La Fe, Unidad Trastornos Movimiento, Valencia 46026, Spain; [Rubio-Agusti, Ignacio; Foltynie, Thomas; Bhatia, Kailash P.] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Zdebik, Anselm] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Zdebik, Anselm; Tekman, Mehmet; Stanescu, Horia C.; Kleta, Robert] UCL, Ctr Nephrol, London NW3 2PF, England; [Asmus, Friedrich; Hauser, Ann-Kathrin; Lohmann, Ebba; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Asmus, Friedrich; Hauser, Ann-Kathrin; Lohmann, Ebba; Gasser, Thomas] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Ryten, Mina] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London SE1 7EH, England; [Plagnol, Vincent] UCL Genet Inst, London WC1E 6BT, England; [Bandres-Ciga, Sara] Univ Granada, Ctr Invest Biomed CIBM, Dept Physiol, E-18071 Granada, Spain; [Bandres-Ciga, Sara] Univ Granada, Ctr Invest Biomed CIBM, Inst Neurosci Federico Oloriz, E-18071 Granada, Spain; [Forabosco, Paola] CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy; [Peall, Kathryn] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, S Glam, Wales; [Morris, Huw R.] UCL Inst Neurol, Dept Clin Neurosci, London WC1N 3BG, England; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Carecchio, Miryam; Zorzi, Giovanna; Nardocci, Nardo] IRCCS Ist Neurol Carlo Besta, Neuropediat Unit, I-20133 Milan, Italy; [Carecchio, Miryam; Garavaglia, Barbara] IRCCS Ist Neurol Carlo Besta, Mol Neurogenet Unit, I-20133 Milan, Italy; [Weissbach, Anne; Klein, Christine] Med Univ Lubeck, Inst Neurogenet, D-23538 Lubeck, Germany; [Hardy, John; Pittman, Alan M.] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London WC1N 3BG, England	University of London; University College London; IRCCS Istituto Auxologico Italiano; University of Milan; University of Milan; Hospital Universitari i Politecnic La Fe; University of London; University College London; University of London; University College London; University of London; University College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of Granada; University of Granada; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Cardiff University; University of London; University College London; King Faisal Specialist Hospital & Research Center; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; University of Lubeck; University of London; University College London	Bhatia, KP (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England.	k.bhatia@ucl.ac.uk; n.wood@ucl.ac.uk	Garavaglia, Barbara/J-5257-2018; Tekman, Mehmet/K-7084-2019; Trabzuni, Daniah M/C-4034-2012; Zorzi, Giovanna/AAM-4138-2021; Soutar, Marc P M/G-3637-2011; Ryten, Mina/Q-8419-2016; Ciga, Sara Bandres/AAA-5036-2020; Forabosco, Paola/AAM-5540-2021; Carecchio, Miryam/AAC-2219-2019; Abramov, Andrey Y/H-9053-2012; Nardocci, Nardo/AAB-9903-2019; Gasser, Thomas/GNH-5293-2022; Hardy, John/C-2451-2009; Klein, Christine/AGK-8003-2022; Pittman, Alan M/D-6231-2012; Abramov, Andrey/AAC-6712-2019; Trabzuni, Daniah/AAI-2037-2021; Morris, Huw R/B-8527-2008; Ludtmann, Marthe H.R./A-1446-2013; Pittman, Alan/AAP-2534-2020; Wood, Nicholas W/C-2505-2009	Garavaglia, Barbara/0000-0003-4323-9145; Tekman, Mehmet/0000-0002-4181-2676; Trabzuni, Daniah M/0000-0003-4826-9570; Zorzi, Giovanna/0000-0001-7041-5365; Soutar, Marc P M/0000-0003-0008-9423; Abramov, Andrey Y/0000-0002-7646-7235; Nardocci, Nardo/0000-0001-5863-5592; Gasser, Thomas/0000-0002-1069-1146; Hardy, John/0000-0002-3122-0423; Pittman, Alan M/0000-0002-8112-2987; Abramov, Andrey/0000-0002-7646-7235; Trabzuni, Daniah/0000-0003-4826-9570; Morris, Huw R/0000-0002-5473-3774; Ludtmann, Marthe H.R./0000-0003-1051-6425; Pittman, Alan/0000-0002-8112-2987; Wood, Nicholas W/0000-0002-9500-3348; Carecchio, Miryam/0000-0002-0755-5477; Bandres Ciga, Sara/0000-0003-0056-1361; Mencacci, Niccolo Emanuele/0000-0003-3383-9665; Bettencourt, Conceicao/0000-0001-9090-7690; FORABOSCO, PAOLA/0000-0002-2006-2693; Klein, Christine/0000-0003-2102-3431; Plagnol, Vincent/0000-0002-5597-9215	Medical Research Council/Wellcome Trust [WT089698/Z/09/Z]; Bachman-Strauss Dystonia Parkinsonism Foundation; Department of Health's NIHR Biomedical Research Center; Dystonia Medical Research Foundation (DMRF); Herman and Lilly Schilling Foundation; Reta Lila Weston Trust; Spanish Ministry of Education and Science; Cei-BioTic; University of Granada; MRC [G0700943, MC_G0901330, MC_PC_09003, MC_G1000735, G1100643] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL11-Peall] Funding Source: researchfish; Medical Research Council [G1100643, MR/L501554/1, MC_PC_09003, G0700943, MC_G1000735, MC_G0901330] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-017, NF-SI-0513-10064, NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [H-1006] Funding Source: researchfish	Medical Research Council/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Bachman-Strauss Dystonia Parkinsonism Foundation; Department of Health's NIHR Biomedical Research Center; Dystonia Medical Research Foundation (DMRF); Herman and Lilly Schilling Foundation; Reta Lila Weston Trust; Spanish Ministry of Education and Science(Spanish Government); Cei-BioTic; University of Granada; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	We would like to extend our thanks to the individuals whose participation made this research possible. This work was supported financially by a Medical Research Council/Wellcome Trust Strategic Award (WT089698/Z/09/Z) and a grant from the Bachman-Strauss Dystonia Parkinsonism Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was undertaken at University College London Hospitals (UCLH) and University College London (UCL), who receive support from the Department of Health's NIHR Biomedical Research Center's funding streams. E.L. and T.G. are supported by a grant from the Dystonia Medical Research Foundation (DMRF). C.K. is the recipient of a career development award from the Herman and Lilly Schilling Foundation. A.M.P. is funded by the Reta Lila Weston Trust. S.B.C. held a FPU fellowship from the Spanish Ministry of Education and Science jointly with a short-term stay grant by Cei-BioTic and University of Granada. Next Generation Sequencing was performed at the UCL Institute of Neurology Sequencing Facility. We thank the UCL-Exomes Consortium for providing the exome sequencing data of UK population controls. Expression data was provided by the UK Human Brain Expression Consortium (UKBEC), which comprises J.H., M.R., Michael Weale, D.T., Adaikalavan Ramasamy, Colin Smith, and Robert Walker. UKBEC members are affiliated with UCL Institute of Neurology (J.H., M.R., D.T.), King's College London (M.R., Adaikalavan Ramasamy, and Michael Weale), and the University of Edinburgh (Colin Smith and Robert Walker). We thank Miss Elisavet Preza for providing help with the skin biopsy preparation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Asmus F, 2002, ANN NEUROL, V52, P489, DOI 10.1002/ana.10325; Asmus Friedrich, 2004, Adv Neurol, V94, P113; Carecchio M, 2013, MOVEMENT DISORD, V28, P787, DOI 10.1002/mds.25506; Charlesworth G, 2015, AM J HUM GENET, V96, P657, DOI 10.1016/j.ajhg.2015.02.007; Charlesworth G, 2013, BRAIN, V136, P2017, DOI 10.1093/brain/awt138; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007598; du Montcel ST, 2006, J MED GENET, V43, P394, DOI 10.1136/jmg.2005.036780; Forabosco P, 2013, NEUROBIOL AGING, V34, P2699, DOI 10.1016/j.neurobiolaging.2013.05.001; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fung VSC, 2013, MOVEMENT DISORD, V28, P889, DOI 10.1002/mds.25549; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Grunewald A, 2008, HUM MUTAT, V29, P331, DOI 10.1002/humu.9521; Hersheson J, 2013, ANN NEUROL, V73, P546, DOI 10.1002/ana.23832; Iwabuchi S, 2013, NEUROSCI LETT, V548, P61, DOI 10.1016/j.neulet.2013.05.047; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kasahara K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6081; Kimmich O, 2014, MOVEMENT DISORD, V29, P804, DOI 10.1002/mds.25822; Kinugawa K, 2009, MOVEMENT DISORD, V24, P479, DOI 10.1002/mds.22425; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kousi M, 2012, J MED GENET, V49, P391, DOI 10.1136/jmedgenet-2012-100859; Krabichler B, 2012, ANN HUM GENET, V76, P326, DOI 10.1111/j.1469-1809.2012.00710.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LeDoux MS, 2013, MOVEMENT DISORD, V28, P968, DOI 10.1002/mds.25547; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Matsui A, 2013, SCIENCE, V342, P1114, DOI 10.1126/science.1244505; Nardocci Nardo, 2011, Handb Clin Neurol, V100, P563, DOI 10.1016/B978-0-444-52014-2.00041-0; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Peall KJ, 2014, J NEUROL, V261, P2296, DOI 10.1007/s00415-014-7488-3; Peall KJ, 2013, BRAIN, V136, P294, DOI 10.1093/brain/aws308; Pfeiffenberger C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003003; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Ritz K, 2011, EUR J HUM GENET, V19, P438, DOI 10.1038/ejhg.2010.206; Schule B, 2004, J NEUROL NEUROSUR PS, V75, P1181, DOI 10.1136/jnnp.2003.027177; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Skoblov M, 2013, BIOESSAYS, V35, P586, DOI 10.1002/bies.201300002; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Stavropoulos N, 2011, NEURON, V72, P964, DOI 10.1016/j.neuron.2011.12.003; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Van Bogaert P, 2007, ANN NEUROL, V61, P579, DOI 10.1002/ana.21121; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhu SJ, 2005, J NEUROSCI, V25, P4189, DOI 10.1523/JNEUROSCI.0149-05.2005; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709	56	72	83	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					938	947		10.1016/j.ajhg.2015.04.008	http://dx.doi.org/10.1016/j.ajhg.2015.04.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	25983243	Green Published, hybrid			2022-12-18	WOS:000355931200007
J	Machiela, MJ; Zhou, WY; Sampson, JN; Dean, MC; Jacobs, KB; Black, A; Brinton, LA; Chang, IS; Chen, C; Chen, C; Chen, KX; Cook, LS; Bou, MC; De Vivo, I; Doherty, J; Friedenreich, CM; Gaudet, MM; Haiman, CA; Hankinson, SE; Hartge, P; Henderson, BE; Hong, YC; Hosgood, HD; Hsiung, CA; Hu, W; Hunter, DJ; Jessop, L; Kim, HN; Kim, YH; Kim, YT; Klein, R; Kraft, P; Lan, Q; Lin, DX; Liu, JJ; Le Marchand, L; Liang, XL; Lissowska, J; Lu, LG; Magliocco, AM; Matsuo, K; Olson, SH; Orlow, I; Park, JY; Pooler, L; Prescott, J; Rastogi, R; Risch, HA; Schumacher, F; Seow, A; Setiawan, VW; Shen, HB; Sheng, X; Shin, MH; Shu, XO; VanDen Berg, D; Wang, JC; Wentzensen, N; Wong, MP; Wu, C; Wu, TC; Wu, YL; Xia, L; Yang, HP; Yang, PC; Zheng, W; Zhou, BS; Abnet, CC; Albanes, D; Aldrich, MC; Amos, C; Amundadottir, LT; Berndt, SI; Blot, WJ; Bock, CH; Bracci, PM; Burdett, L; Buring, JE; Butler, MA; Carreon, T; Chatterjee, N; Chung, CC; Cook, MB; Cullen, M; Davis, FG; Ding, T; Duell, EJ; Epstein, CG; Fan, JH; Figueroa, JD; Fraumeni, JF; Freedman, ND; Fuchs, CS; Gao, YT; Gapstur, SM; Patino-Garcia, A; Garcia-Closas, M; Gaziano, JM; Giles, GG; Gillanders, EM; Giovannucci, EL; Goldin, L; Goldstein, AM; Greene, MH; Hallmans, G; Harris, CC; Henriksson, R; Holly, EA; Hoover, RN; Hu, N; Hutchinson, A; Jenab, M; Johansen, C; Khaw, KT; Koh, WP; Kolonel, LN; Kooperberg, C; Krogh, V; Kurtz, RC; LaCroix, A; Landgren, A; Landi, MT; Li, DH; Liao, LM; Malats, N; McGlynn, KA; McNeill, LH; McWilliams, RR; Melin, BS; Mirabello, L; Peplonska, B; Peters, U; Petersen, GM; Prokunina-Olsson, L; Purdue, M; Qiao, YL; Rabe, KG; Rajaraman, P; Real, FX; Riboli, E; Rodriguez-Santiago, B; Rothman, N; Ruder, AM; Savage, SA; Schwartz, AG; Schwartz, KL; Sesso, HD; Severi, G; Silverman, DT; Spitz, MR; Stevens, VL; Stolzenberg-Solomon, R; Stram, D; Tang, ZZ; Taylor, PR; Teras, LR; Tobias, GS; Viswanathan, K; Wacholder, S; Wang, ZM; Weinstein, SJ; Wheeler, W; White, E; Wiencke, JK; Wolpin, BM; Wu, XF; Wunder, JS; Yu, K; Zanetti, KA; Zeleniuch-Jacquotte, A; Ziegler, RG; De Andrade, M; Barnes, KC; Beaty, TH; Bierut, LJ; Desch, KC; Doheny, KF; Feenstra, B; Ginsburg, D; Heit, JA; Kang, JH; Laurie, CA; Li, JZ; Lowe, WL; Marazita, ML; Melbye, M; Mirel, DB; Murray, JC; Nelson, SC; Pasquale, LR; Rice, K; Wiggs, JL; Wise, A; Tucker, M; Perez-Jurado, LA; Laurie, CC; Caporaso, NE; Yeager, M; Chanock, SJ				Machiela, Mitchell J.; Zhou, Weiyin; Sampson, Joshua N.; Dean, Michael C.; Jacobs, Kevin B.; Black, Amanda; Brinton, Louise A.; Chang, I-Shou; Chen, Chu; Chen, Constance; Chen, Kexin; Cook, Linda S.; Bou, Marta Crous; De Vivo, Immaculata; Doherty, Jennifer; Friedenreich, Christine M.; Gaudet, Mia M.; Haiman, Christopher A.; Hankinson, Susan E.; Hartge, Patricia; Henderson, Brian E.; Hong, Yun-Chul; Hosgood, H. Dean, III; Hsiung, Chao A.; Hu, Wei; Hunter, David J.; Jessop, Lea; Kim, Hee Nam; Kim, Yeul Hong; Kim, Young Tae; Klein, Robert; Kraft, Peter; Lan, Qing; Lin, Dongxin; Liu, Jianjun; Le Marchand, Loic; Liang, Xiaolin; Lissowska, Jolanta; Lu, Lingeng; Magliocco, Anthony M.; Matsuo, Keitaro; Olson, Sara H.; Orlow, Irene; Park, Jae Yong; Pooler, Loreall; Prescott, Jennifer; Rastogi, Radhai; Risch, Harvey A.; Schumacher, Fredrick; Seow, Adeline; Setiawan, Veronica Wendy; Shen, Hongbing; Sheng, Xin; Shin, Min-Ho; Shu, Xiao-Ou; VanDen Berg, David; Wang, Jiu-Cun; Wentzensen, Nicolas; Wong, Maria Pik; Wu, Chen; Wu, Tangchun; Wu, Yi-Long; Xia, Lucy; Yang, Hannah P.; Yang, Pan-Chyr; Zheng, Wei; Zhou, Baosen; Abnet, Christian C.; Albanes, Demetrius; Aldrich, Melinda C.; Amos, Christopher; Amundadottir, Laufey T.; Berndt, Sonja I.; Blot, William J.; Bock, Cathryn H.; Bracci, Paige M.; Burdett, Laurie; Buring, Julie E.; Butler, Mary A.; Carreon, Tania; Chatterjee, Nilanjan; Chung, Charles C.; Cook, Michael B.; Cullen, Michael; Davis, Faith G.; Ding, Ti; Duell, Eric J.; Epstein, Caroline G.; Fan, Jin-Hu; Figueroa, Jonine D.; Fraumeni, Joseph F., Jr.; Freedman, Neal D.; Fuchs, Charles S.; Gao, Yu-Tang; Gapstur, Susan M.; Patino-Garcia, Ana; Garcia-Closas, Montserrat; Gaziano, J. Michael; Giles, Graham G.; Gillanders, Elizabeth M.; Giovannucci, Edward L.; Goldin, Lynn; Goldstein, Alisa M.; Greene, Mark H.; Hallmans, Goran; Harris, Curtis C.; Henriksson, Roger; Holly, Elizabeth A.; Hoover, Robert N.; Hu, Nan; Hutchinson, Amy; Jenab, Mazda; Johansen, Christoffer; Khaw, Kay-Tee; Koh, Woon-Puay; Kolonel, Laurence N.; Kooperberg, Charles; Krogh, Vittorio; Kurtz, Robert C.; LaCroix, Andrea; Landgren, Annelie; Landi, Maria Teresa; Li, Donghui; Liao, Linda M.; Malats, Nuria; McGlynn, Katherine A.; McNeill, Lorna H.; McWilliams, Robert R.; Melin, Beatrice S.; Mirabello, Lisa; Peplonska, Beata; Peters, Ulrike; Petersen, Gloria M.; Prokunina-Olsson, Ludmila; Purdue, Mark; Qiao, You-Lin; Rabe, Kari G.; Rajaraman, Preetha; Real, Francisco X.; Riboli, Elio; Rodriguez-Santiago, Benjamin; Rothman, Nathaniel; Ruder, Avima M.; Savage, Sharon A.; Schwartz, Ann G.; Schwartz, Kendra L.; Sesso, Howard D.; Severi, Gianluca; Silverman, Debra T.; Spitz, Margaret R.; Stevens, Victoria L.; Stolzenberg-Solomon, Rachael; Stram, Daniel; Tang, Ze-Zhong; Taylor, Philip R.; Teras, Lauren R.; Tobias, Geoffrey S.; Viswanathan, Kala; Wacholder, Sholom; Wang, Zhaoming; Weinstein, Stephanie J.; Wheeler, William; White, Emily; Wiencke, John K.; Wolpin, Brian M.; Wu, Xifeng; Wunder, Jay S.; Yu, Kai; Zanetti, Krista A.; Zeleniuch-Jacquotte, Anne; Ziegler, Regina G.; De Andrade, Mariza; Barnes, Kathleen C.; Beaty, Terri H.; Bierut, Laura J.; Desch, Karl C.; Doheny, Kimberly F.; Feenstra, Bjarke; Ginsburg, David; Heit, John A.; Kang, Jae H.; Laurie, Cecilia A.; Li, Jun Z.; Lowe, William L.; Marazita, Mary L.; Melbye, Mads; Mirel, Daniel B.; Murray, Jeffrey C.; Nelson, Sarah C.; Pasquale, Louis R.; Rice, Kenneth; Wiggs, Janey L.; Wise, Anastasia; Tucker, Margaret; Perez-Jurado, Luis A.; Laurie, Cathy C.; Caporaso, Neil E.; Yeager, Meredith; Chanock, Stephen J.			Characterization of Large Structural Genetic Mosaicism in Human Autosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; COPY-NUMBER-VARIATION; SOMATIC MOSAICISM; MAFFUCCI SYNDROME; OLLIER DISEASE; HUMAN GENOME; MUTATIONS; CANCER; CELLS; IDENTIFICATION	Analyses of genome-wide association study (GWAS) data have revealed that detectable genetic mosaicism involving large (>2 Mb) structural autosomal alterations occurs in a fraction of individuals. We present results for a set of 24,849 genotyped individuals (total GWAS set II [TGSII]) in whom 341 large autosomal abnormalities were observed in 168 (0.68%) individuals. Merging data from the new TGSII set with data from two prior reports (the Gene-Environment Association Studies and the total GWAS set I) generated a large dataset of 127,179 individuals; we then conducted a meta-analysis to investigate the patterns of detectable autosomal mosaicism (n = 1,315 events in 925 [0.73%] individuals). Restricting to events >2 Mb in size, we observed an increase in event frequency as event size decreased. The combined results underscore that the rate of detectable mosaicism increases with age (p value = 5.5 x 3 10(-31)) and is higher in men (p value = 0.002) but lower in participants of African ancestry (p value = 0.003). In a subset of 47 individuals from whom serial samples were collected up to 6 years apart, complex changes were noted over time and showed an overall increase in the proportion of mosaic cells as age increased. Our large combined sample allowed for a unique ability to characterize detectable genetic mosaicism involving large structural events and strengthens the emerging evidence of non-random erosion of the genome in the aging population.	[Machiela, Mitchell J.; Zhou, Weiyin; Sampson, Joshua N.; Black, Amanda; Brinton, Louise A.; Hartge, Patricia; Hosgood, H. Dean, III; Hu, Wei; Jessop, Lea; Lan, Qing; Wentzensen, Nicolas; Yang, Hannah P.; Abnet, Christian C.; Albanes, Demetrius; Amundadottir, Laufey T.; Berndt, Sonja I.; Burdett, Laurie; Chatterjee, Nilanjan; Chung, Charles C.; Cook, Michael B.; Cullen, Michael; Epstein, Caroline G.; Figueroa, Jonine D.; Fraumeni, Joseph F., Jr.; Freedman, Neal D.; Goldin, Lynn; Goldstein, Alisa M.; Greene, Mark H.; Hoover, Robert N.; Hu, Nan; Hutchinson, Amy; Landgren, Annelie; Landi, Maria Teresa; Liao, Linda M.; McGlynn, Katherine A.; Mirabello, Lisa; Prokunina-Olsson, Ludmila; Purdue, Mark; Rajaraman, Preetha; Rothman, Nathaniel; Savage, Sharon A.; Silverman, Debra T.; Stolzenberg-Solomon, Rachael; Taylor, Philip R.; Tobias, Geoffrey S.; Wacholder, Sholom; Wang, Zhaoming; Weinstein, Stephanie J.; Yu, Kai; Ziegler, Regina G.; Tucker, Margaret; Caporaso, Neil E.; Yeager, Meredith; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Zhou, Weiyin; Jacobs, Kevin B.; Burdett, Laurie; Chung, Charles C.; Cullen, Michael; Hutchinson, Amy; Wang, Zhaoming; Yeager, Meredith] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, NIH,Leidos Biomed Res Inc, Bethesda, MD 20892 USA; [Dean, Michael C.] NCI, Expt Immunol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Jacobs, Kevin B.] BioInformed LLC, Gaithersburg, MD 20877 USA; [Chang, I-Shou] Natl Inst Canc Res, Natl Hlth Res Inst, Zhunan 35053, Taiwan; [Chen, Chu; Kooperberg, Charles; LaCroix, Andrea; Peters, Ulrike; White, Emily] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Chen, Constance; Bou, Marta Crous; De Vivo, Immaculata; Hunter, David J.; Kraft, Peter; Prescott, Jennifer] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Chen, Kexin] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin 300040, Peoples R China; [Cook, Linda S.] Univ New Mexico, Albuquerque, NM 87131 USA; [Bou, Marta Crous; De Vivo, Immaculata; Hankinson, Susan E.; Hunter, David J.; Prescott, Jennifer; Fuchs, Charles S.; Giovannucci, Edward L.; Wolpin, Brian M.; Kang, Jae H.; Pasquale, Louis R.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Bou, Marta Crous; De Vivo, Immaculata; Hankinson, Susan E.; Hunter, David J.; Prescott, Jennifer; Fuchs, Charles S.; Gaziano, J. Michael; Giovannucci, Edward L.; Wolpin, Brian M.; Kang, Jae H.; Pasquale, Louis R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Doherty, Jennifer] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Friedenreich, Christine M.] Alberta Hlth Serv, CancerControl Alberta, Dept Populat Hlth Res, Calgary, AB T2N 2T9, Canada; [Gaudet, Mia M.; Gapstur, Susan M.; Stevens, Victoria L.; Teras, Lauren R.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA; [Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick; Setiawan, Veronica Wendy; VanDen Berg, David; Stram, Daniel] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hankinson, Susan E.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 151742, South Korea; [Hosgood, H. Dean, III] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Hsiung, Chao A.] Inst Populat Hlth Sci, Natl Hlth Res Inst, Zhunan 35053, Taiwan; [Hunter, David J.; Mirel, Daniel B.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kim, Hee Nam] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Kwangju 500757, South Korea; [Kim, Yeul Hong] Korea Univ, Anam Hosp, Coll Med, Div Oncol Hematol,Dept Internal Med, Seoul 151742, South Korea; [Kim, Young Tae] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Canc Res Inst, Seoul 151742, South Korea; [Klein, Robert] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10065 USA; [Lin, Dongxin; Wu, Chen] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Lin, Dongxin; Wu, Chen] Peking Union Med Coll, Beijing 100730, Peoples R China; [Lin, Dongxin; Wu, Chen] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Liu, Jianjun] Genome Inst Singapore, Dept Human Genet, Singapore 138672, Singapore; [Liu, Jianjun] Anhui Med Univ, Sch Life Sci, Hefei 230032, Peoples R China; [Le Marchand, Loic; Kolonel, Laurence N.] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96813 USA; [Liang, Xiaolin; Olson, Sara H.; Orlow, Irene; Rastogi, Radhai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Lissowska, Jolanta] Maria Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, PL-02781 Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, PL-02781 Warsaw, Poland; [Lu, Lingeng; Risch, Harvey A.] Yale Univ, Sch Publ Hlth, New Haven, CT 06510 USA; [Magliocco, Anthony M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 8190395, Japan; [Park, Jae Yong] Kyungpook Natl Univ, Med Ctr, Lung Canc Ctr, Daegu 101, South Korea; [Pooler, Loreall; Sheng, Xin; Xia, Lucy] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Seow, Adeline; Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 119077, Singapore; [Shen, Hongbing] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 210029, Jiangsu, Peoples R China; [Shen, Hongbing] Nanjing Med Univ, Minist Educ, Key Lab Modern Toxicol, Nanjing 210029, Jiangsu, Peoples R China; [Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Gwanju 501746, South Korea; [Shu, Xiao-Ou] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37232 USA; [Wang, Jiu-Cun] Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wong, Maria Pik] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Inst Occupat Med, Wuhan 430400, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Minist Educ, Key Lab Environm & Hlth, Wuhan 430400, Peoples R China; [Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou 515200, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou 515200, Guangdong, Peoples R China; [Yang, Pan-Chyr] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei 10617, Taiwan; [Zheng, Wei; Aldrich, Melinda C.; Blot, William J.] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37232 USA; [Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Peoples R China; [Aldrich, Melinda C.] Vanderbilt Univ, Sch Med, Dept Thorac Surg, Nashville, TN 37232 USA; [Amos, Christopher] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Blot, William J.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Bracci, Paige M.; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Buring, Julie E.; Sesso, Howard D.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Butler, Mary A.; Carreon, Tania; Ruder, Avima M.] NIOSH, Ctr Dis Control & Prevent, Cincinnati, OH 45226 USA; [Davis, Faith G.] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2R3, Canada; [Ding, Ti; Tang, Ze-Zhong] Shanxi Canc Hosp, Taiyuan 030013, Shanxi, Peoples R China; [Duell, Eric J.] Catalan Inst Oncol, Bellvitge Biomed Res Inst, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona 08908, Spain; [Fan, Jin-Hu] Shanghai Canc Inst, Shanghai 200032, Peoples R China; [Fuchs, Charles S.; Wolpin, Brian M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Gao, Yu-Tang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Epidemiol,Shanghai Canc Inst, Shanghai 200032, Peoples R China; [Patino-Garcia, Ana] Univ Navarra, Univ Navarra Clin, Dept Pediat, E-31080 Pamplona, Spain; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SM2 5NG, Surrey, England; [Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SM2 5NG, Surrey, England; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA 02130 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Cooperat Studies Programs, Boston, MA 02130 USA; [Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3010, Australia; [Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia; [Gillanders, Elizabeth M.; Zanetti, Krista A.] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Nutr Res Unit, S-90187 Umea, Sweden; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Henriksson, Roger; Melin, Beatrice S.] Umea Univ, Dept Radiat Sci, Dept Oncol, S-90187 Umea, Sweden; [Jenab, Mazda] Int Agcy Res Canc, F-69372 Lyon, France; [Johansen, Christoffer] Rigshosp, Finsen Ctr, Dept Oncol, DK-2100 Copenhagen, Denmark; [Johansen, Christoffer] Danish Canc Soc, Res Ctr, Unit Survivorship Res, DK-2100 Copenhagen, Denmark; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Cambridge CB2 1TN, England; [Koh, Woon-Puay] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Krogh, Vittorio] Fdn IRCCS Ist Nazl Tumori, I-20133 Milan, Italy; [Kurtz, Robert C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Malats, Nuria; Real, Francisco X.] Spanish Natl Canc Res Ctr, Madrid 28029, Spain; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Div OVP Canc Prevent & Populat Sci, Houston, TX 77030 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Ctr Community Engaged Translat Res, Duncan Family Inst, Houston, TX 77030 USA; [McWilliams, Robert R.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Peplonska, Beata] Nofer Inst Occupat Med, PL-91348 Lodz, Poland; [Petersen, Gloria M.; Rabe, Kari G.; De Andrade, Mariza] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Qiao, You-Lin] Chinese Acad Med Sci, Inst Canc, Dept Epidemiol, Beijing 100730, Peoples R China; [Real, Francisco X.; Rodriguez-Santiago, Benjamin; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Div Epidemiol & Biostat, London SW7 2AZ, England; [Rodriguez-Santiago, Benjamin; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras, Barcelona 08003, Spain; [Rodriguez-Santiago, Benjamin] QGenomics, Quantitat Genom Med Lab, Barcelona 08003, Spain; [Schwartz, Kendra L.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Schwartz, Kendra L.] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48201 USA; [Severi, Gianluca] Human Genet Fdn, I-10126 Turin, Italy; [Spitz, Margaret R.] Baylor Coll Med, Houston, TX 77030 USA; [Viswanathan, Kala; Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Wheeler, William] Informat Management Serv Inc, Calverton, MD 20904 USA; [Wiencke, John K.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wunder, Jay S.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Zeleniuch-Jacquotte, Anne] NYU, Perlmutter Canc Inst, New York, NY 10016 USA; [Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Bierut, Laura J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Desch, Karl C.] Univ Michigan, Dept Pediat & Communicable Dis, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Doheny, Kimberly F.] Johns Hopkins Univ, Inst Med Genet, Sch Med, Ctr Inherited Dis Res, Baltimore, MD 21218 USA; [Feenstra, Bjarke; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Heit, John A.] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Laurie, Cecilia A.; Nelson, Sarah C.; Rice, Kenneth; Laurie, Cathy C.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Lowe, William L.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Evanston, IL 60208 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA; [Marazita, Mary L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Melbye, Mads] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Pasquale, Louis R.; Wiggs, Janey L.] Harvard Univ, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Wise, Anastasia] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA; [Perez-Jurado, Luis A.] Hosp del Mar, Res Inst, Barcelona 08003, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Health Research Institutes - Taiwan; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Tianjin Medical University; University of New Mexico; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Dartmouth College; Alberta Health Services (AHS); University of Calgary; American Cancer Society; University of Southern California; University of Massachusetts System; University of Massachusetts Amherst; Seoul National University (SNU); Yeshiva University; Albert Einstein College of Medicine; National Health Research Institutes - Taiwan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Chonnam National University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Memorial Sloan Kettering Cancer Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Anhui Medical University; Cancer Research Center of Hawaii; University of Hawaii System; Memorial Sloan Kettering Cancer Center; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Yale University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Kyushu University; Kyungpook National University; University of Southern California; National University of Singapore; Nanjing Medical University; Nanjing Medical University; Chonnam National University; Vanderbilt University; Fudan University; Fudan University; University of Hong Kong; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; National Taiwan University; Vanderbilt University; China Medical University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Alberta; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Shanghai Jiao Tong University; Harvard University; Dana-Farber Cancer Institute; Shanghai Jiao Tong University; University of Navarra; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Cancer Council Victoria; University of Melbourne; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Umea University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Umea University; World Health Organization; International Agency for Research on Cancer (IARC); Rigshospitalet; University of Copenhagen; Danish Cancer Society; University of Cambridge; National University of Singapore; Fondazione IRCCS Istituto Nazionale Tumori Milan; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Nofer Institute of Occupational Medicine; Mayo Clinic; Chinese Academy of Medical Sciences - Peking Union Medical College; Pompeu Fabra University; Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Information Management Services, Inc.; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL); New York University; New York University; Johns Hopkins University; Washington University (WUSTL); University of Michigan System; University of Michigan; Johns Hopkins University; Statens Serum Institut; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Mayo Clinic; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; University of Iowa; Harvard University; Massachusetts Eye & Ear Infirmary; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Pérez Jurado, Luis Alberto/M-7706-2015; wei, hu/GXW-2391-2022; Berndt, Sonja I/J-8423-2016; Liu, Jianjun/AAK-4989-2020; gao, yi/HCI-8298-2022; Prokunina-Olsson, Ludmila/A-8240-2019; Van Den Berg, David J/G-8598-2017; Weinstein, Stephanie J/P-1627-2017; Chang, I-Shou/D-2084-2010; Matsuo, Keitaro/H-6758-2019; Freedman, Neal David/B-9741-2015; Stolzenberg-Solomon, Rachael/Y-9280-2018; Savage, Sharon A/B-9747-2015; Severi, Gianluca/H-3774-2018; Nelson, Sarah Catherine/AAN-9814-2020; Schumacher, Fredrick/R-6043-2019; Wang, Zhaoming/R-5527-2018; Abnet, Christian C/C-4111-2015; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Zheng, Wei/O-3351-2013; Amundadottir, Laufey T/L-7656-2016; Garcia-Closas, Montserrat/F-3871-2015; Brinton, Louise A/G-7486-2015; Gao, Y./GWZ-3665-2022; Krogh, Vittorio/AAA-9171-2019; Mirabello, Lisa/H-5594-2018; Purdue, Mark P/C-9228-2016; Malats, Nuria/H-7041-2015; Yeager, Meredith/AAA-5322-2020; Lissowska, Jolanta/AAH-3252-2020; Machiela, Mitchell J/H-7335-2019; Patiño-Garcia, Ana/I-4299-2012; Khaw, Kay-Tee/AAZ-3209-2021; Figueroa, Jonine/GWD-1322-2022; Henriksson, Roger/AAI-8608-2020; Wu, Yi-Long/AAB-9137-2022; Figueroa, Jonine/AFK-2752-2022; Arribas, Francisco X Real/H-5275-2015; Severi, Gianluca/Q-1824-2019; Wu, Yi-Long/C-3396-2008; Figueroa, Jonine/AAG-1065-2022; Klein, Robert/ABI-7857-2020; Kraft, Peter/GQH-8448-2022; Wu, Yi-Long/AAW-9832-2020; Hsiung, Chao Agnes/E-3994-2010; Qiao, You-Lin/B-4139-2012; zhang, weihua/GXV-1334-2022; Johansen, Christoffer/AAG-7916-2020; Savage, Sharon/AAB-5160-2019; Hong, Yun-Chul/J-5725-2012; Garcia-Closas, Montserrat/AAZ-6930-2021; Wu, Yi-Long/GRJ-9238-2022; Gao, Yu/HGE-1937-2022; Tobias, Geoffrey S/M-4135-2016; Cook, Michael B/A-5641-2009; Crous-Bou, Marta/A-9499-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Krogh, Vittorio/K-2628-2016; Wentzensen, Nicolas/AAG-8522-2019; Bierut, Laura Jean/W-6806-2019; Liao, Linda M/B-3960-2011; Peplonska, Beata/AAO-1265-2020	Liu, Jianjun/0000-0002-3255-3019; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Van Den Berg, David J/0000-0002-5404-5218; Weinstein, Stephanie J/0000-0002-3834-1535; Matsuo, Keitaro/0000-0003-1761-6314; Freedman, Neal David/0000-0003-0074-1098; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Savage, Sharon A/0000-0001-6006-0740; Severi, Gianluca/0000-0001-7157-419X; Nelson, Sarah Catherine/0000-0002-2109-6465; Schumacher, Fredrick/0000-0002-3073-7463; Wang, Zhaoming/0000-0001-7556-3869; Abnet, Christian C/0000-0002-3008-7843; Dean, Michael C/0000-0003-2234-0631; Zheng, Wei/0000-0003-1226-070X; Amundadottir, Laufey T/0000-0003-1859-8971; Garcia-Closas, Montserrat/0000-0003-1033-2650; Brinton, Louise A/0000-0003-3853-8562; Krogh, Vittorio/0000-0003-0122-8624; Purdue, Mark P/0000-0003-1177-3108; Malats, Nuria/0000-0003-2538-3784; Lissowska, Jolanta/0000-0003-2695-5799; Machiela, Mitchell J/0000-0001-6538-9705; Patiño-Garcia, Ana/0000-0002-4066-8203; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Arribas, Francisco X Real/0000-0001-9501-498X; Severi, Gianluca/0000-0001-7157-419X; Wu, Yi-Long/0000-0002-3611-0258; Figueroa, Jonine/0000-0002-5100-623X; Klein, Robert/0000-0003-3539-5391; Qiao, You-Lin/0000-0001-6380-0871; Johansen, Christoffer/0000-0002-4384-206X; Savage, Sharon/0000-0001-6006-0740; Garcia-Closas, Montserrat/0000-0003-1033-2650; Wu, Yi-Long/0000-0002-3611-0258; Tobias, Geoffrey S/0000-0002-2878-8253; Cook, Michael B/0000-0002-0533-7302; Crous-Bou, Marta/0000-0003-1493-4288; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Krogh, Vittorio/0000-0003-0122-8624; Bierut, Laura Jean/0000-0002-9952-4810; Liao, Linda M/0000-0002-1923-5294; Peplonska, Beata/0000-0003-3915-2872; Setiawan, Veronica/0000-0001-9239-5692; Ginsburg, David/0000-0002-6436-8942; Kim, Yeul Hong/0000-0002-2555-2333; Jacobs, Kevin/0000-0002-4657-6473; Chen, Kexin/0000-0003-4248-7681; Riboli, Elio/0000-0001-6795-6080; Shen, Hongbing/0000-0002-2581-5906; Giles, Graham/0000-0003-4946-9099; melbye, mads/0000-0001-8264-6785; fan, jinhu/0000-0003-3159-7893; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Olson, Sara/0000-0003-0182-2754; Lin, Dongxin/0000-0002-8723-8868; YANG, PAN-CHYR/0000-0001-6330-6048; Wu, Chen/0000-0003-4954-1011; Kim, Young Tae/0000-0001-9006-4881; De Vivo, Immaculata/0000-0002-7185-7402; Jenab, Mazda/0000-0002-0573-1852; Feenstra, Bjarke/0000-0003-1478-649X; Friedenreich, Christine/0000-0002-4783-1966; Orlow, Irene/0000-0001-6234-6961; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852; Carreon, Tania/0000-0003-1745-0852	Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA182934, ZIABC011492, P30CA023108, P01CA087969, ZIABC011495, K07CA172294, R25CA174664, ZIACP010201, P30CA008748, K05CA154337, UM1CA182910, R01CA092447, P50CA102701, R01CA124908] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022305, P30EY014104, R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039693, R01HL112642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899, R01DE016148] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ainsworth PJ, 1997, HUM MUTAT, V9, P452, DOI 10.1002/(SICI)1098-1004(1997)9:5<452::AID-HUMU12>3.3.CO;2-V; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Bonnefond A, 2013, NAT GENET, V45, P1040, DOI 10.1038/ng.2700; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; Gottlieb B, 2001, TRENDS GENET, V17, P79, DOI 10.1016/S0168-9525(00)02178-8; Groesser L, 2012, NAT GENET, V44, P783, DOI 10.1038/ng.2316; Hafner C, 2013, CELL CYCLE, V12, P43, DOI 10.4161/cc.23108; HALL JG, 1988, AM J HUM GENET, V43, P355; Heim S., 2009, CANC CYTOGENETICS, P25; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtin PJ, 1996, AM J CLIN PATHOL, V106, P680; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Machiela MJ, 2013, SEMIN HEMATOL, V50, P348, DOI 10.1053/j.seminhematol.2013.09.001; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Papavassiliou P, 2009, AM J MED GENET A, V149A, P573, DOI 10.1002/ajmg.a.32729; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Pique-Regi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-380; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Schick UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059823; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Strachan T, 1999, HUMAN MOL GENETICS; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	35	72	73	3	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					487	497		10.1016/j.ajhg.2015.01.011	http://dx.doi.org/10.1016/j.ajhg.2015.01.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25748358	Green Published, Bronze			2022-12-18	WOS:000350747800022
J	Duan, JB; Shi, JX; Fiorentino, A; Leites, C; Chen, XN; Moy, W; Chen, JC; Alexandrov, BS; Usheva, A; He, DL; Freda, J; O'Brien, NL; McQuillin, A; Sanders, AR; Gershon, ES; DeLisi, LE; Bishop, AR; Gurling, HMD; Pato, MT; Levinson, DF; Kendler, KS; Pato, CN; Gejman, PV				Duan, Jubao; Shi, Jianxin; Fiorentino, Alessia; Leites, Catherine; Chen, Xiangning; Moy, Winton; Chen, Jingchun; Alexandrov, Boian S.; Usheva, Anny; He, Deli; Freda, Jessica; O'Brien, Niamh L.; McQuillin, Andrew; Sanders, Alan R.; Gershon, Elliot S.; DeLisi, Lynn E.; Bishop, Alan R.; Gurling, Hugh M. D.; Pato, Michele T.; Levinson, Douglas F.; Kendler, Kenneth S.; Pato, Carlos N.; Gejman, Pablo V.		MGS; GPC	A Rare Functional Noncoding Variant at the GWAS-Implicated MIR137/MIR2682 Locus Might Confer Risk to Schizophrenia and Bipolar Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; MACULAR DEGENERATION; COMMON VARIANTS; TRANSCRIPTION FACTOR; REGULATORY ELEMENTS; LOW-FREQUENCY; STEM-CELLS; MIR137; GENES	Schizophrenia (SZ) genome-wide association studies (GWASs) have identified common risk variants in >100 susceptibility loci; however, the contribution of rare variants at these loci remains largely unexplored. One of the strongly associated loci spans MIR137 (miR137) and M1R2682 (miR2682), two microRNA genes important for neuronal function. We sequenced -6.9 kb MIR137/MIR2682 and upstream regulatory sequences in 2,610 SZ cases and 2,611 controls of European ancestry. We identified 133 rare variants with minor allele frequency (MAF) <0.5%. The rare variant burden in promoters and enhancers, but not insulators, was associated with SZ (p = 0.021 for MAF < 0.5%, p = 0.003 for MAF < 0.1%). A rare enhancer SNP, 1:g.98515539A>T, presented exclusively in 11 SZ cases (nominal p = 4.8 x 10(-4) ). We further identified its risk allele Tin 2 of 2,434 additional SZ cases, 11 of 4,339 bipolar (BP) cases, and 3 of 3,572 SZ/BP study controls and 1,688 population controls; yielding combined p values of 0.0007, 0.0013, and 0.0001 for SZ, BP, and SZ/BP, respectively. The risk allele T of 1:g.98515539A>T reduced enhancer activity of its flanking sequence by >50% in human neuroblastoma cells, predicting lower expression of MIR137/MIR2682. Both empirical and computational analyses showed weaker transcription factor (YY1) binding by the risk allele. Chromatin conformation capture (3C) assay further indicated that 1:g.98515539A>T influenced MIR137/MIR2682, but not the nearby DPYD or LOC729987. Our results suggest that rare noncoding risk variants are associated with SZ and BP at MIR137/MIR2682 locus, with risk alleles decreasing MIR137/MIR2682 expression.	[Duan, Jubao; Leites, Catherine; Moy, Winton; He, Deli; Freda, Jessica; Sanders, Alan R.; Gejman, Pablo V.] NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, Ctr Psychiat Genet, Evanston, IL 60201 USA; [Duan, Jubao; Sanders, Alan R.; Gershon, Elliot S.; Gejman, Pablo V.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Shi, Jianxin] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Fiorentino, Alessia; O'Brien, Niamh L.; McQuillin, Andrew; Gurling, Hugh M. D.] UCL, Mol Psychiat Lab, Div Psychiat, London WC1E 6JJ, England; [Chen, Xiangning; Chen, Jingchun; Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Alexandrov, Boian S.; Usheva, Anny] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Alexandrov, Boian S.; Bishop, Alan R.] Los Alamos Natl Lab, Los Alamos, NM 87544 USA; [DeLisi, Lynn E.] Harvard Univ, Sch Med, VA Boston Healthcare Syst, Brockton, MA 02301 USA; [Pato, Michele T.; Pato, Carlos N.] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Levinson, Douglas F.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA	NorthShore University Health System; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; University College London; Virginia Commonwealth University; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Los Alamos National Laboratory; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Southern California; Stanford University	Duan, JB (corresponding author), NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, Ctr Psychiat Genet, Evanston, IL 60201 USA.	jduan@uchicago.edu	McQuillin, Andrew/C-1623-2008; Fanous, Ayman H/O-1263-2017; Macciardi, Fabio/N-3768-2014; Kendler, Kenneth/AAF-2876-2019; Fiorentino, Alessia/ABC-3638-2020; Alexandrov, Boian/D-2488-2010; Mowry, Bryan/G-5046-2010	McQuillin, Andrew/0000-0003-1567-2240; Macciardi, Fabio/0000-0003-0537-4266; Nicolini, Humberto/0000-0003-2494-0067; Alexandrov, Boian/0000-0001-8636-4603; Mowry, Bryan/0000-0002-4115-5645; Perkins, Diana/0000-0001-9396-2206; Chen, Jingchun/0000-0001-9408-0117; Fiorentino, Alessia/0000-0002-1403-4581	Wellcome Trust [WT091310]; NIH [R01MH067257, R01MH059588, R01MH059565, R01MH059587, R01MH060870, R01MH059566, R01MH059586, R01MH061675, R01MH060879, U01MH046276, U01MH079470]; MRC [G1000708]; National Nuclear Security Administration of the US Department of Energy; LANL, LDRD [20110516ECR]; National Institutes of Health (NIH) [R21MH102685]; NorthShore University HealthSystem Research Career Development Award;  [R01MH059571];  [R01MH081800];  [U01MH079469];  [MH085548];  [MH085542]; Medical Research Council [G1000708] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046276, R01MH059587, R01MH081800, R01MH060870, R01MH059571, R01MH060879, U01MH079469, R01MH061675, R01MH085542, R01MH059588, R01MH059565, R01MH059566, R21MH102685, R01MH101054, R01MH059586, R01MH067257, U01MH079470, R01MH085548] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Nuclear Security Administration of the US Department of Energy(National Nuclear Security Administration); LANL, LDRD(United States Department of Energy (DOE)Los Alamos National Laboratory); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NorthShore University HealthSystem Research Career Development Award; ; ; ; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the study participants of MGS, CNG, ICCSS, ISHDSF, UCL, GPC, NIME-BP collections. This study also makes use of whole-genome sequencing data (TwinsUK) generated by the UK10K Consortium. A full list of the investigators who contributed to the generation of the data is available from UK10K Project homepage. Wellcome Trust award WT091310 provided funding for UK10K. We also thank K. Fang and N. Park (Illinois Mathematics and Science Academy) for their technical help with the 3C experiment. This work was primarily supported by R01MH059571, R01MH081800, and U01MH079469 (to P.V.G.) and other NIH grants for MGS (R01MH067257 to N.G.B., R01MH059588 to B.J.M., R01MH059565 to R.F., R01MH059587 to F.A., R01MH060870 to W.F.B., R01MH059566 to D.W.B., R01MH059586 to J.M.S., R01MH061675 to D.F.L., R01MH060879 to C.R.C., U01MH046276 to C.R.C., and U01MH079470 to D.F.L). GPC was supported by MH085548 and MH085542 (to C.N.P and M.T.P). UCL genotyping was supported by MRC grant G1000708 (to H.M.D.G. and A.M.). The computational modeling of transcription factor binding at Los Alamos National Laboratory was carried out under the auspices of the National Nuclear Security Administration of the US Department of Energy and was supported by the LANL, LDRD, 20110516ECR grant (to B.S.A.). This work was also partially supported by National Institutes of Health (NIH) grant R21MH102685 and NorthShore University HealthSystem Research Career Development Award (to J.D.).	Alexandrov BS, 2012, NUCLEIC ACIDS RES, V40, P10116, DOI 10.1093/nar/gks758; Alexandrov BS, 2010, NUCLEIC ACIDS RES, V38, P1790, DOI 10.1093/nar/gkp1084; Alexandrov BS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000313; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Blain H, 2010, EXP GERONTOL, V45, P679, DOI 10.1016/j.exger.2010.04.006; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Carter MT, 2011, CLIN GENET, V80, P435, DOI 10.1111/j.1399-0004.2010.01578.x; Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157; Chen X, 2008, BIOL PSYCHIAT, V63, P441, DOI 10.1016/j.biopsych.2007.11.003; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; Collins AL, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.42; Cope N.F., 2009, CHROMOSOME CONFORMAT; Devanna P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03994; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Duan JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01318; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egawa J, 2013, PSYCHIAT CLIN NEUROS, V67, P277, DOI 10.1111/pcn.12047; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gejman PV, 2001, AM J MED GENET, V105, P789, DOI 10.1002/ajmg.1552; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hill MJ, 2014, SCHIZOPHR RES, V153, P225, DOI 10.1016/j.schres.2014.01.034; Hwang YC, 2013, NUCLEIC ACIDS RES, V41, P4835, DOI 10.1093/nar/gkt188; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jablensky A, 2012, MOL PSYCHIATR, V17, P1328, DOI 10.1038/mp.2011.129; Khetarpal SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002393; Kim AH, 2012, SCHIZOPHR RES, V141, P60, DOI 10.1016/j.schres.2012.06.038; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Levinson DF, 2012, AM J PSYCHIAT, V169, P963, DOI 10.1176/appi.ajp.2012.11091423; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu B, 2014, NEUROPSYCHOPHARMACOL, V39, P2153, DOI 10.1038/npp.2014.63; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Muddyman D, 2013, GENOME MED, V5, DOI 10.1186/gm504; Pato MT, 2013, AM J MED GENET B, V162B, P306, DOI 10.1002/ajmg.b.32160; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi S, 2014, J BIOL CHEM, V289, P13434, DOI 10.1074/jbc.M113.535203; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Strazisar M., 2014, MOL PSYCHIAT; Sun E., 2014, EXP NEUROL; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; van Erp TGM, 2014, BIOL PSYCHIAT, V75, P398, DOI 10.1016/j.biopsych.2013.06.016; Volvert ML, 2012, CELL DEATH DIFFER, V19, P1573, DOI 10.1038/cdd.2012.96; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294	76	72	75	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					744	753		10.1016/j.ajhg.2014.11.001	http://dx.doi.org/10.1016/j.ajhg.2014.11.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25434007	Green Published, Bronze			2022-12-18	WOS:000346623100011
J	Herrmann, DN; Horvath, R; Sowden, JE; Gonzales, M; Sanchez-Mejias, A; Guan, Z; Whittaker, RG; Almodovar, JL; Lane, M; Bansagi, B; Pyle, A; Boczonadi, V; Lochmuller, H; Griffin, H; Chinnery, PE; Lloyd, TE; Littleton, JT; Zuchner, S				Herrmann, David N.; Horvath, Rita; Sowden, Janet E.; Gonzales, Michael; Sanchez-Mejias, Avencia; Guan, Zhuo; Whittaker, Roger G.; Almodovar, Jorge L.; Lane, Maria; Bansagi, Boglarka; Pyle, Angela; Boczonadi, Veronika; Lochmueller, Hanns; Griffin, Helen; Chinnery, Patrick E.; Lloyd, Thomas E.; Littleton, J. Troy; Zuchner, Stephan			Synaptotagmin 2 Mutations Cause an Autosomal-Dominant Form of Lambert-Eaton Myasthenic Syndrome and Nonprogressive Motor Neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EVOKED NEUROTRANSMITTER RELEASE; DOMAIN	Synaptotagmin 2 is a synaptic vesicle protein that functions as a calcium sensor for neurotransmission but has not been previously associated with human disease. Via whole-exome sequencing, we identified heterozygous missense mutations in the C2B calcium-binding domain of the gene encoding Synaptotagmin 2 in two multigenerational families presenting with peripheral motor neuron syndromes. An essential calcium-binding aspartate residue, Asp307Ala, was disrupted by a c.920A>C change in one family that presented with an autosomal-dominant presynaptic neuromuscular junction disorder resembling Lambert-Eaton myasthenic syndrome. A c.923C>T variant affecting an adjacent residue (p.Pro308Leu) produced a presynaptic neuromuscular junction defect and a dominant hereditary motor neuropathy in a second family. Characterization of the mutation homologous to the human c.920A>C variant in Drosophila Synaptotagmin revealed a dominant disruption of synaptic vesicle exocytosis using this transgenic model. These findings indicate that Synaptotagmin 2 regulates neurotransmitter release at human peripheral motor nerve terminals. In addition, mutations in the Synaptotagmin 2 C2B domain represent an important cause of presynap tic congenital myasthenic syndromes and link them with hereditary motor axonopathies.	[Herrmann, David N.; Sowden, Janet E.] Univ Rochester, Dept Neurol, Med Ctr, Rochester, NY 14642 USA; [Horvath, Rita; Lane, Maria; Bansagi, Boglarka; Pyle, Angela; Boczonadi, Veronika; Lochmueller, Hanns; Griffin, Helen; Chinnery, Patrick E.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Gonzales, Michael; Sanchez-Mejias, Avencia; Zuchner, Stephan] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Gonzales, Michael; Sanchez-Mejias, Avencia; Zuchner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Guan, Zhuo; Littleton, J. Troy] MIT, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA; [Guan, Zhuo; Littleton, J. Troy] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Whittaker, Roger G.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Almodovar, Jorge L.] Geisel Sch Med, Dartmouth Hitchcock Clin, Dept Neurol, Hanover, NH 03755 USA; [Lloyd, Thomas E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lloyd, Thomas E.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Rochester; Newcastle University - UK; University of Miami; University of Miami; Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Northwell Health; Newcastle University - UK; Dartmouth College; Johns Hopkins University; Johns Hopkins University	Zuchner, S (corresponding author), Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA.	szuchner@med.miami.edu	Horvath, Rita/AAY-7042-2020	Griffin, Helen R/0000-0002-5288-3322; Whittaker, Roger/0000-0002-3403-0182; Horvath, Rita/0000-0002-9841-170X; Chinnery, Patrick/0000-0002-7065-6617; Lloyd, Thomas/0000-0003-4756-3700	Inherited Neuropathies Consortium Rare Disease Clinical Research Network, National Institute of Neurological Disorders and Stroke [1U54NS0657]; NIH [NS40296, NS082563, U54NS0657, R01NS075764, R01NS072248]; Picower Neurological Disease Research Fund; JPB Foundation; MDA; CMT Association; Medical Research Council (UK) [G1000848]; European Research Council [309548]; EPSRC; Wellcome Trust; Medical Research Council Neuromuscular Translational Research Centre; European Union [305444, 305121]; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296, R01NS072248, R01NS082563, R01NS075764, U54NS065712] Funding Source: NIH RePORTER; Medical Research Council [G1000848, G0601943, G1002274, MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1, G0601943, G1002274, G1000848] Funding Source: UKRI	Inherited Neuropathies Consortium Rare Disease Clinical Research Network, National Institute of Neurological Disorders and Stroke; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Neurological Disease Research Fund; JPB Foundation; MDA(Muscular Dystrophy Association); CMT Association; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Neuromuscular Translational Research Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); Medical Research Council (UK) Centre for Translational Muscle Disease research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU FP7 TIRCON; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.N.H. and J.E.S. are supported by the Inherited Neuropathies Consortium Rare Disease Clinical Research Network, National Institute of Neurological Disorders and Stroke (1U54NS0657); J.T.L. and Z.G. are supported by NIH grant NS40296, the Picower Neurological Disease Research Fund, and The JPB Foundation; T.E.L. is supported by NIH grant NS082563; S.Z., A.S.-M., and M.G. are supported by NIH grants U54NS0657, R01NS075764, R01NS072248, the MDA, and the CMT Association; R.H. is supported by the Medical Research Council (UK) (G1000848) and the European Research Council (309548); R.G.W. is supported by the EPSRC and the Wellcome Trust; B.B. is supported by the Medical Research Council Neuromuscular Translational Research Centre; H.L. receives funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 305444 (RD-Connect) and 305121 (Neuromics); and P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science (101876/Z/13/Z) and a UK NIHR Senior Investigator and receives additional support from the Wellcome Trust Centre for Mitochondrial Research (096919Z/11/Z), the Medical Research Council (UK) Centre for Translational Muscle Disease research (G0601943), EU FP7 TIRCON, and the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The authors would like to thank Eric Logigian for electrophysiological advice and Tracy Forrester for administrative assistance with manuscript preparation.	Barwick KES, 2012, AM J HUM GENET, V91, P1103, DOI 10.1016/j.ajhg.2012.09.019; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Jorquera RA, 2012, J NEUROSCI, V32, P18234, DOI 10.1523/JNEUROSCI.3212-12.2012; Lee J, 2013, J NEUROSCI, V33, P187, DOI 10.1523/JNEUROSCI.3214-12.2013; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pfeffer G, 2012, BRAIN, V135, P1695, DOI 10.1093/brain/aws102; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Takamori M, 2000, NEUROSCI RES, V36, P183, DOI 10.1016/S0168-0102(99)00135-2; Titulaer MJ, 2011, LANCET NEUROL, V10, P1098, DOI 10.1016/S1474-4422(11)70245-9; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	16	72	74	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					332	339		10.1016/j.ajhg.2014.08.007	http://dx.doi.org/10.1016/j.ajhg.2014.08.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25192047	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000341404100010
J	Schuurs-Hoeijmakers, JHM; Oh, EC; Vissers, LELM; Swinkels, MEM; Gilissen, C; Willemsen, MA; Holvoet, M; Steehouwer, M; Veltman, JA; de Vries, BBA; van Bokhoven, H; de Brouwer, APM; Katsanis, N; Devriendt, K; Brunner, HG				Schuurs-Hoeijmakers, Janneke H. M.; Oh, Edwin C.; Vissers, Lisenka E. L. M.; Swinkels, Marielle E. M.; Gilissen, Christian; Willemsen, Michel A.; Holvoet, Maureen; Steehouwer, Marloes; Veltman, Joris A.; de Vries, Bert B. A.; van Bokhoven, Hans; de Brouwer, Arjan P. M.; Katsanis, Nicholas; Devriendt, Koenraad; Brunner, Han G.			Recurrent De Novo Mutations in PACS1 Cause Defective Cranial-Neural-Crest Migration and Define a Recognizable Intellectual-Disability Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHORYLATION; PROTEINS	We studied two unrelated boys with intellectual disability (ID) and a striking facial resemblance suggestive of a hitherto unappreciated syndrome. Exome sequencing in both families identified identical de novo mutations in PACS1, suggestive of causality. To support these genetic findings and to understand the pathomechanism of the mutation, we studied the protein in vitro and in vivo. Altered PACS1 forms cytoplasmic aggregates in vitro with concomitant increased protein stability and shows impaired binding to an isoform-specific variant of TRPV4, but not the full-length protein. Furthermore, consistent with the human pathology, expression of mutant PACS, mRNA in zebrafish embryos induces craniofacial defects most likely in a dominant-negative fashion. This phenotype is driven by aberrant specification and migration of SOX10-positive cranial, but not enteric, neural-crest cells. Our findings suggest that PACS1 is necessary for the formation of craniofacial structures and that perturbation of its functions results in a specific syndromic ID phenotype.	[Schuurs-Hoeijmakers, Janneke H. M.; Vissers, Lisenka E. L. M.; Gilissen, Christian; Steehouwer, Marloes; Veltman, Joris A.; de Vries, Bert B. A.; van Bokhoven, Hans; de Brouwer, Arjan P. M.; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 855, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Schuurs-Hoeijmakers, Janneke H. M.; Vissers, Lisenka E. L. M.; Gilissen, Christian; Steehouwer, Marloes; Veltman, Joris A.; de Vries, Bert B. A.; van Bokhoven, Hans; de Brouwer, Arjan P. M.; Brunner, Han G.] Radboud Univ Nijmegen, Inst Genet & Metab Dis, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Swinkels, Marielle E. M.] Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands; [Willemsen, Michel A.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Neurol, NL-6500 HB Nijmegen, Netherlands; [Willemsen, Michel A.; de Vries, Bert B. A.; van Bokhoven, Hans; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands; [Holvoet, Maureen; Devriendt, Koenraad] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27710 USA	Radboud University Nijmegen; Radboud University Nijmegen; Duke University; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Duke University; Duke University	Brunner, HG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 855, Nijmegen Ctr Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.	h.brunner@gen.umcn.nl	Veltman, Joris A/F-5128-2010; van Bokhoven, Hans/D-8764-2012; Gilissen, Christian/E-5246-2012; Bokhoven, J.H.L.M. van van/H-8015-2014; de Brouwer, Arjan PM/P-5949-2015; Willemsen, Michel A.A.P./H-8119-2014; Vissers, Lisenka ELM/A-2598-2015; Brunner, Han/C-9928-2013; Katsanis, Nicholas/E-1837-2012	Veltman, Joris A/0000-0002-3218-8250; Gilissen, Christian/0000-0003-1693-9699; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Vissers, Lisenka ELM/0000-0001-6470-5497; Katsanis, Nicholas/0000-0002-2480-0171	National Institutes of Health [DK072301, MH-084018]; Dutch Organization for Health Research and Development (ZON-MW) [916-86-016, 917-86-319, 911-08-025]; European-Union [Health-F5-2009-223143]; GENCODYS project (EU) [241995]; Dutch Brain Foundation [2010(1)-30, 2009(1)-22]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Organization for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); European-Union(European Commission); GENCODYS project (EU); Dutch Brain Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to individuals 1 and 2 and their families for their support and cooperation. We thank J. de Ligt for bioinformatics support and data analysis. This work was funded in part by National Institutes of Health grants DK072301 and MH-084018 (to N.K.), the Dutch Organization for Health Research and Development (ZON-MW grants 916-86-016 to L.E.L.M.V., 917-86-319 to B.B.A.d.V., and 911-08-025 to J.A.V.), the European-Union-funded TECHGENE project (Health-F5-2009-223143 to J.A.V.), the GENCODYS project (EU-7th-2010-241995 to H.v.B. and B.B.A.d.V.), and the Dutch Brain Foundation (2010(1)-30 to A.P.M.d.B. and 2009(1)-22 to B.B.A.d.V.). N.K. is a Distinguished Brumley Professor.	Ahmed MK, 2009, RHINOLOGY, V47, P242, DOI [10.4193/Rhin.08.155, 10.4193/Rhin08.155]; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Scott GK, 2003, EMBO J, V22, P6234, DOI 10.1093/emboj/cdg596; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Shin SH, 2012, CELL SIGNAL, V24, P641, DOI 10.1016/j.cellsig.2011.11.002; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Vaglia JL, 1999, INT J DEV BIOL, V43, P95; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016	17	72	74	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1122	1127		10.1016/j.ajhg.2012.10.013	http://dx.doi.org/10.1016/j.ajhg.2012.10.013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23159249	Bronze, Green Published			2022-12-18	WOS:000312417400017
J	Bjursell, MK; Blom, HJ; Cayuela, JA; Engvall, ML; Lesko, N; Balasubramaniam, S; Brandberg, G; Halldin, M; Falkenberg, M; Jakobs, C; Smith, D; Struys, E; von Dobeln, U; Gustafsson, CM; Lundeberg, J; Wedell, A				Bjursell, Magnus K.; Blom, Henk J.; Cayuela, Jordi Asin; Engvall, Martin L.; Lesko, Nicole; Balasubramaniam, Shanti; Brandberg, Goran; Halldin, Maria; Falkenberg, Maria; Jakobs, Cornelis; Smith, Desiree; Struys, Eduard; von Dobeln, Ulrika; Gustafsson, Claes M.; Lundeberg, Joakim; Wedell, Anna			Adenosine Kinase Deficiency Disrupts the Methionine Cycle and Causes Hypermethioninemia, Encephalopathy, and Abnormal Liver Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; ENZYMATIC DEFECT; MAMMALIAN-CELLS; HOMOCYSTEINE; METABOLISM	Four inborn errors of metabolism (IEMs) are known to cause hypermethioninemia by directly interfering with the methionine cycle. Hypermethioninemia is occasionally discovered incidentally, but it is often disregarded as an unspecific finding, particularly if liver disease is involved. In many individuals the hypermethioninemia resolves without further deterioration, but it can also represent an early sign of a severe, progressive neurodevelopmental disorder. Further investigation of unclear hypermethioninemia is therefore important. We studied two siblings affected by severe developmental delay and liver dysfunction. Biochemical analysis revealed increased plasma levels of methionine, S-adenosylmethionine (Ado Met), and S-adenosylhomocysteine (AdoHcy) but normal or mildly elevated homocysteine (Hcy) levels, indicating a block in the methionine cycle. We excluded S-adenosylhomocysteine hydrolase (SAHH) deficiency, which causes a similar biochemical phenotype, by using genetic and biochemical techniques and hypothesized that there was a functional block in the SAHH enzyme as a result of a recessive mutation in a different gene. Using exome sequencing, we identified a homozygous c.902C>A (p.Ala301Glu) missense mutation in the adenosine kinase gene (ADK), the function of which fits perfectly with this hypothesis. Increased urinary adenosine excretion confirmed ADK deficiency in the siblings. Four additional individuals from two unrelated families with a similar presentation were identified and shown to have a homozygous c.653A>C (p.Asp218Ala) and c.38G>A (p.Gly13Glu) mutation, respectively, in the same gene. All three missense mutations were deleterious, as shown by activity measurements on recombinant enzymes. ADK deficiency is a previously undescribed, severe IEM shedding light on a functional link between the methionine cycle and adenosine metabolism.	[Bjursell, Magnus K.; Wedell, Anna] Karolinska Inst, Sci Life Lab, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Bjursell, Magnus K.; Engvall, Martin L.; Wedell, Anna] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Blom, Henk J.; Jakobs, Cornelis; Smith, Desiree; Struys, Eduard] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands; [Cayuela, Jordi Asin] Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden; [Engvall, Martin L.] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Engvall, Martin L.; Lesko, Nicole; von Dobeln, Ulrika] Karolinska Univ Hosp, Ctr Inherited Metab Dis, S-14186 Stockholm, Sweden; [Lesko, Nicole; von Dobeln, Ulrika] Karolinska Inst, Dept Lab Med, S-14183 Stockholm, Sweden; [Balasubramaniam, Shanti] Kuala Lumpur Hosp, Dept Genet, Kuala Lumpur 50586, Malaysia; [Brandberg, Goran] Dept Pediat, S-79182 Falu Lasarett, Falun, Sweden; [Halldin, Maria] Akad Univ Hosp, Dept Womens & Childrens Hlth, S-75105 Uppsala, Sweden; [Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Inst Biomed, S-40530 Gothenburg, Sweden; [Lundeberg, Joakim] Royal Inst Technol, Sch Biotechnol, Sci Life Lab, S-17121 Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Sahlgrenska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital; University of Gothenburg; Royal Institute of Technology	Wedell, A (corresponding author), Karolinska Inst, Sci Life Lab, Dept Mol Med & Surg, S-17176 Stockholm, Sweden.	anna.wedell@ki.se		Gustafsson, Claes/0000-0003-3531-8468; Blom, Henk/0000-0001-5202-9241; Engvall, Martin/0000-0002-8339-3545; Smith, Desiree/0000-0003-2053-3392	Swedish Research Council [12198, 2009-4848]; Karolinska Institutet; Stockholm County Council; Swedish Cancer Foundation; Arne and IngaBritt Lundberg Foundation; Swedish federal government	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Swedish Cancer Foundation; Arne and IngaBritt Lundberg Foundation; Swedish federal government	This work was supported by the Swedish Research Council (12198 to A.W; 2009-4848 to C.M.G.), the Karolinska Institutet (to M.K.B and A.W.), the Stockholm County Council (to A.W.), the Swedish Cancer Foundation (to C.M.G.), the Arne and IngaBritt Lundberg Foundation (to C.M.G.), and the Swedish federal government under the agreement concerning research and education of doctors. We thank Daniel Klevebring, Johan Lindberg, and Ellen Sherwood for valuable discussions. The Swedish National Infrastructure for Large-Scale Sequencing (SNISS) is acknowledged, and the computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under project b2010024. Jonas Hagberg and Lennart Karlsson at UPPMAX are acknowledged for assistance concerning technical and implementational aspects of making the code run on the UPPMAX resources. The director general of health, Ministry of Health, Malaysia is acknowledged for allowing the publication of the Malaysian patients.	ANDRES CM, 1979, J BIOL CHEM, V254, P1388; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899; Cui XA, 2009, BIOCHEM BIOPH RES CO, V388, P46, DOI 10.1016/j.bbrc.2009.07.106; DELAHABA G, 1959, J BIOL CHEM, V234, P603; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; FOX IH, 1978, ANNU REV BIOCHEM, V47, P655, DOI 10.1146/annurev.bi.47.070178.003255; GAULL GE, 1974, SCIENCE, V186, P59, DOI 10.1126/science.186.4158.59; GURANOWSKI A, 1981, BIOCHEMISTRY-US, V20, P110, DOI 10.1021/bi00504a019; KORNBERG A, 1951, J BIOL CHEM, V193, P481; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mathews II, 1998, BIOCHEMISTRY-US, V37, P15607, DOI 10.1021/bi9815445; MOHAMEDALI KA, 1993, J BIOL CHEM, V268, P23728; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; MUDD SH, 1964, SCIENCE, V143, P1443, DOI 10.1126/science.143.3613.1443; Mudd SH, 2001, J INHERIT METAB DIS, V24, P448, DOI 10.1023/A:1010577512912; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Struys EA, 2000, CLIN CHEM, V46, P1650; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; YAMADA Y, 1981, BIOCHIM BIOPHYS ACTA, V660, P36, DOI 10.1016/0005-2744(81)90105-4	23	72	76	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					507	515		10.1016/j.ajhg.2011.09.004	http://dx.doi.org/10.1016/j.ajhg.2011.09.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21963049	Green Published, Bronze			2022-12-18	WOS:000295951300005
J	Ballif, BC; Theisen, A; Rosenfeld, JA; Traylor, RN; Gastier-Foster, J; Thrush, DL; Astbury, C; Bartholomew, D; McBride, KL; Pyatt, RE; Shane, K; Smith, WE; Banks, V; Gallentine, WB; Brock, P; Rudd, MK; Adam, MP; Keene, JA; Phillips, JA; Pfotenhauer, JP; Gowans, GC; Stankiewicz, P; Bejjani, BA; Shaffer, LG				Ballif, Blake C.; Theisen, Aaron; Rosenfeld, Jill A.; Traylor, Ryan N.; Gastier-Foster, Julie; Thrush, Devon Lamb; Astbury, Caroline; Bartholomew, Dennis; McBride, Kim L.; Pyatt, Robert E.; Shane, Kate; Smith, Wendy E.; Banks, Valerie; Gallentine, William B.; Brock, Pamela; Rudd, M. Katharine; Adam, Margaret P.; Keene, Julia A.; Phillips, John A., III; Pfotenhauer, Jean P.; Gowans, Gordon C.; Stankiewicz, Pawel; Bejjani, Bassem A.; Shaffer, Lisa G.			Identification of a Recurrent Microdeletion at 17q23.1q23.2 Flanked by Segmental Duplications Associated with Heart Defects and Limb Abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL PATELLA SYNDROME; T-BOX GENES; MULTIPLE-SCLEROSIS LOCUS; CHROMOSOMAL REARRANGEMENTS; HUMAN-GENOME; TBX GENES; IDENTITY; MUTATIONS; ARCHITECTURE; DISORDERS	Segmental duplications, which comprise similar to 5%-10% of the human genome, are known to mediate medically relevant deletions, duplications, and inversions through nonallelic homologous recombination (NAHR) and have been suggested to be hot spots in chromosome evolution and human genomic instability. We report seven individuals with microdeletions at 17q23.1q23.2, identified by microarray-based comparative genomic hybridization (aCGH). Six of the seven deletions are similar to 2.2 Mb in size and flanked by large segmental duplications of >98% sequence identity and in the same orientation. One of the deletions is similar to 2.8 Mb in size and is flanked on the distal side by a segmental duplication, whereas the proximal breakpoint falls between segmental duplications. These characteristics suggest that NAHR mediated six out of seven of these rearrangements. These individuals have common features, including mild to moderate developmental delay (particularly speech delay), microcephaly, postnatal growth retardation, heart defects, and hand, foot, and limb abnormalities. Although all individuals had at least mild dysmorphic facial features, there was no characteristic constellation of features that would elicit clinical Suspicion of a specific disorder. The identification of common clinical features suggests that microdeletions at 17q23.1q23.2 constitute a novel syndrome. Furthermore, the inclusion in the minimal deletion region of TBX2 and TBX4, transcription factors belonging to a family of genes implicated in a variety of developmental pathways including those of heart and limb, suggests that these genes may play an important role in the phenotype of this emerging syndrome.	[Ballif, Blake C.; Theisen, Aaron; Rosenfeld, Jill A.; Traylor, Ryan N.; Bejjani, Bassem A.; Shaffer, Lisa G.] Signature Genom Labs, Spokane, WA 99207 USA; [Gastier-Foster, Julie; Thrush, Devon Lamb; Astbury, Caroline; Pyatt, Robert E.] Nationwide Childrens Hosp, Dept Lab Med, Columbus, OH 43209 USA; [Gastier-Foster, Julie; Pyatt, Robert E.] Ohio State Univ, Dept Pathol, Columbus, OH 43209 USA; [Gastier-Foster, Julie; Thrush, Devon Lamb; Astbury, Caroline; Bartholomew, Dennis; McBride, Kim L.; Shane, Kate] Ohio State Univ, Dept Pediat, Columbus, OH 43209 USA; [Bartholomew, Dennis; Shane, Kate] Nationwide Childrens Hosp, Genet Sect, Columbus, OH 43209 USA; [McBride, Kim L.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43209 USA; [Smith, Wendy E.; Banks, Valerie] Maine Pediat Specialty Grp, Dept Pediat, Portland, ME 04102 USA; [Gallentine, William B.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Brock, Pamela; Gowans, Gordon C.] Univ Louisville, Weisskopf Child Evaluat Ctr, Louisville, KY 40202 USA; [Rudd, M. Katharine; Adam, Margaret P.; Keene, Julia A.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Phillips, John A., III] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Pfotenhauer, Jean P.] Vanderbilt Univ, Med Ctr, Div Genet & Genom Med, Nashville, TN 37232 USA; [Stankiewicz, Pawel] Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; [Stankiewicz, Pawel] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Duke University; University of Louisville; Emory University; Vanderbilt University; Vanderbilt University; Baylor College of Medicine	Ballif, BC (corresponding author), Signature Genom Labs, Spokane, WA 99207 USA.	ballif@signaturegenomics.com	Shane-Carson, Kate/GRY-7595-2022; Astbury, Caroline/E-2665-2011; Gastier-Foster, Julie/E-3105-2011; Stankiewicz, Paweł/AAP-7906-2021; McBride, Kim L/A-5879-2008	Stankiewicz, Paweł/0000-0002-6456-7490; McBride, Kim L/0000-0002-8407-8942				Azouz EM, 1997, PEDIATR RADIOL, V27, P432, DOI 10.1007/s002470050163; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Baldwin EL, 2008, GENET MED, V10, P415, DOI 10.1097/GIM.0b013e318177015c; Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bongers EMHF, 2004, AM J HUM GENET, V74, P1239, DOI 10.1086/421331; Bongers EMHF, 2001, J MED GENET, V38, P209, DOI 10.1136/jmg.38.3.209; Cardone MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r28; Chen DC, 2004, GENOME RES, V14, P1483, DOI 10.1101/gr.2340804; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; El-Hattab AW, 2009, HUM GENET, V126, P589, DOI 10.1007/s00439-009-0706-x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Gibson-Brown JJ, 1998, MECH DEVELOP, V74, P165, DOI 10.1016/S0925-4773(98)00056-2; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Habboub HK, 1997, PEDIATR RADIOL, V27, P430, DOI 10.1007/s002470050162; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Horton A, 2008, DEV GENES EVOL, V218, P613, DOI 10.1007/s00427-008-0249-5; Isaac A, 1998, DEVELOPMENT, V125, P1867; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; KOZLOWSKI K, 1995, AM J MED GENET, V57, P558, DOI 10.1002/ajmg.1320570408; Li QY, 1997, NAT GENET, V15, P21; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Saarela J, 2002, HUM MOL GENET, V11, P2257, DOI 10.1093/hmg/11.19.2257; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	44	72	76	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					454	461		10.1016/j.ajhg.2010.01.038	http://dx.doi.org/10.1016/j.ajhg.2010.01.038			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20206336	Bronze, Green Published			2022-12-18	WOS:000275678800017
J	Alazami, AM; Shaheen, R; Alzahrani, F; Snape, K; Saggar, A; Brinkmann, B; Bavi, P; Al-Gazali, LI; Alkuraya, FS				Alazami, Anas M.; Shaheen, Ranad; Alzahrani, Fatema; Snape, Katie; Saggar, Anand; Brinkmann, Bernd; Bavi, Prashant; Al-Gazali, Lihadh I.; Alkuraya, Fowzan S.			FREM1 Mutations Cause Bifid Nose, Renal Agenesis, and Anorectal Malformations Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE EMBRYONIC-DEVELOPMENT; FRASER-SYNDROME; BASEMENT-MEMBRANE; FRAS1/FREM PROTEINS; DIAGNOSTIC-CRITERIA; BLEBBED PHENOTYPE; LOCALIZATION; CRYPTOPHTHALMOS; IDENTIFICATION; ADHESION	An autosomal-recessive syndrome of bifid nose and anorectal and renal anomalies (BNAR) was previously reported in a consanguineous Egyptian sibship. Here, we report the results of linkage analysis, on this family and on two other families with a similar phenotype, which identified a shared region of homozygosity on chromosome 9p22.2-p23. Candidate-gene analysis revealed homozygous frame-shift and missense mutations in FREM1, which encodes an extracellular matrix component of basement membranes. In situ hybridization experiments demonstrated gene expression of Frem1 in the midline of E11.5 mouse embryos, in agreement with the observed cleft nose phenotype of our patients. FREM1 is part of a ternary complex that includes FRAS1 and FREM2, and mutations of the latter two genes have been reported to cause Fraser syndrome in mice and humans. The phenotypic variability previously reported for different Frem1 mouse mutants suggests that the apparently distinct phenotype of BNAR in humans may represent a previously unrecognized variant of Fraser syndrome.	[Alazami, Anas M.; Shaheen, Ranad; Alzahrani, Fatema; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Dev Genet Unit, Riyadh 11211, Saudi Arabia; [Snape, Katie] Great Ormond St Hosp NHS Trust, Clin Genet Unit, NE Thames Reg Genet Serv, London WC1N 3JH, England; [Saggar, Anand] St Georges Univ London, Clin Genet Unit, London SW17 0RE, England; [Brinkmann, Bernd] Univ Munster, Inst Med Legale, D-48149 Munster, Germany; [Bavi, Prashant] King Faisal Specialist Hosp & Res Ctr, Biol Repository Sect, Riyadh 11211, Saudi Arabia; [Al-Gazali, Lihadh I.] United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates; [Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11411, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11411, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] Childrens Hosp, Dept Med, Div Genet & Metab, Boston, MA 02115 USA; [Alkuraya, Fowzan S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	King Faisal Specialist Hospital & Research Center; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; St Georges University London; University of Munster; King Faisal Specialist Hospital & Research Center; United Arab Emirates University; King Saud University; King Khalid University Hospital; King Saud University; Alfaisal University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Dev Genet Unit, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Bavi, Prashant/B-2123-2009; Alkuraya, Fowzan S./A-1542-2009; Snape, Katie/AAA-8101-2022	Bavi, Prashant/0000-0002-7711-2911; Alkuraya, Fowzan S./0000-0003-4158-341X; SHAHEEN, RANAD/0000-0002-2590-1759	King Faisal Specialist Hospital & Research Centre [2080006]	King Faisal Specialist Hospital & Research Centre	We are grateful to the family members for their enthusiastic and generous participation. We thank Raafat El-Sayed and Catalino Santos for invaluable support with the mouse work, Valerie Atizado and Valorie Balde for their critical help with mouse sections, Mohammad Rajab and Shamsa Al-Enazi for rapid DNA sequencing, Hassan Omirah for whole-mount embryo photography, Brigitte Loddenkotter and Carsten Hohoff for DNA extraction of control samples, Haya Al-Saud for whole-genome amplification of various controls, and Salma Wakil, Batoul Baz, Khushnooda Ramzan, Rana Al-Omar, and Abeer Al-Mostafa for their tremendous help in processing all Affy chips. We are particularly grateful to Irfan Saadi for his critical review of the manuscript. This study was approved and funded by the King Faisal Specialist Hospital & Research Centre (RAC no. 2080006).	Al-Gazali LI, 2002, CLIN DYSMORPHOL, V11, P33, DOI 10.1097/00019605-200201000-00007; Chiotaki R, 2007, GENE EXPR PATTERNS, V7, P381, DOI 10.1016/j.modgep.2006.12.001; FINDLATER GS, 1993, J ANAT, V183, P121; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Kiyozumi D, 2005, EXP CELL RES, V306, P9, DOI 10.1016/j.yexcr.2005.01.020; Kiyozumi D, 2006, P NATL ACAD SCI USA, V103, P11981, DOI 10.1073/pnas.0601011103; MACONNACHIE E, 1979, J EMBRYOL EXP MORPH, V49, P259; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Pavlakis E, 2008, HISTOCHEM CELL BIOL, V130, P785, DOI 10.1007/s00418-008-0453-4; Petrou P, 2008, CONNECT TISSUE RES, V49, P277, DOI 10.1080/03008200802148025; Petrou P, 2007, MATRIX BIOL, V26, P652, DOI 10.1016/j.matbio.2007.05.008; Petrou P, 2007, EXP CELL RES, V313, P910, DOI 10.1016/j.yexcr.2006.12.008; Short K, 2007, IUBMB LIFE, V59, P427, DOI 10.1080/15216540701510581; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Smyth I, 2005, HUM MOL GENET, V14, pR269, DOI 10.1093/hmg/ddi262; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Staub E, 2002, FEBS LETT, V527, P114, DOI 10.1016/S0014-5793(02)03195-2; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Van Haelst MM, 2007, AM J MED GENET A, V143A, P3194, DOI 10.1002/ajmg.a.31951; VARNUM DS, 1981, J HERED, V72, P293, DOI 10.1093/oxfordjournals.jhered.a109505; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168	21	72	77	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					414	418		10.1016/j.ajhg.2009.08.010	http://dx.doi.org/10.1016/j.ajhg.2009.08.010			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19732862	Green Published, Bronze			2022-12-18	WOS:000270104500011
J	Lin, DY; Hu, Y; Huang, B				Lin, D. Y.; Hu, Y.; Huang, Be			Simple and efficient analysis of disease association with missing genotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-ASSOCIATION; HAPLOTYPE INFERENCE; POPULATION; INFORMATION; IMPUTATION; ALLELES	Missing genotype data arise in association studies when the single-nucleotide polymorphisms (SNPs) on the genotying platform are not assayed successfully, when the SNPs of interest are not on the platform, or when total sequence variation is determined only on a small fraction of individuals. We present a simple and flexible likelihood framework to study SNP-disease associations with such missing genotype data. Our likelihood makes full use of all available data in case-control studies and reference panels (e.g., the HapMap), and it properly accounts for the biased nature of the case-control sampling as well as the uncertainty in inferring unknown variants. The corresponding maximum-likelihood estimators for genetic effects and gene-environment interactions are unbiased and statistically efficient. We developed fast and stable numerical algorithms to calculate the maximum-likelihood estimators and their variances, and we implemented these algorithms in a freely available computer program. Simulation studies demonstrated that the new approach is more powerful than existing methods while providing accurate control of the type I error. An application to a case-control study on rheumatoid arthritis revealed several loci that deserve further investigations.	[Lin, D. Y.; Hu, Y.; Huang, Be] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu	Huang, Bevan/A-5949-2009	Huang, Bevan/0000-0002-1981-5838	NATIONAL CANCER INSTITUTE [T32CA106209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA106209] Funding Source: Medline; NIAMS NIH HHS [R01AR44422, N01AR82232, R01 AR044422] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Lin DY, 2007, AM J HUM GENET, V80, P577, DOI 10.1086/512201; Lin DY, 2006, AM J HUM GENET, V78, P505, DOI 10.1086/500812; Lin DY, 2006, J AM STAT ASSOC, V101, P89, DOI 10.1198/016214505000000808; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P703, DOI 10.1002/gepi.20181; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	21	72	74	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					444	452		10.1016/j.ajhg.2007.11.004	http://dx.doi.org/10.1016/j.ajhg.2007.11.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252224	Green Published, Bronze			2022-12-18	WOS:000253223900016
J	Collin, RWJ; Kalay, E; Tariq, M; Peters, T; van der Zwaag, B; Venselaar, H; Oostrik, J; Lee, K; Ahmed, ZM; Caylan, R; Li, Y; Spierenburg, HA; Eyupoglu, E; Heister, A; Riazuddin, S; Bahat, E; Ansar, M; Arslan, S; Wollnik, B; Brunner, HG; Cremers, CWRJ; Karaguzel, A; Ahmad, W; Cremers, FPM; Vriend, G; Friedman, TB; Riazuddin, S; Leal, SM; Kremer, H				Collin, Rob W. J.; Kalay, Ersan; Tariq, Muhammad; Peters, Theo; van der Zwaag, Bert; Venselaar, Hanka; Oostrik, Jaap; Lee, Kwanghyuk; Ahmed, Zubair M.; Caylan, Refik; Li, Yun; Spierenburg, Henk A.; Eyupoglu, Erol; Heister, Angelien; Riazuddin, Saima; Bahat, Elif; Ansar, Muhammad; Arslan, Selcuk; Wollnik, Bernd; Brunner, Han G.; Cremers, Cor W. R. J.; Karaguzel, Ahmet; Ahmad, Wasim; Cremers, Frans P. M.; Vriend, Gert; Friedman, Thomas B.; Riazuddin, Sheikh; Leal, Suzanne M.; Kremer, Hannie			Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THYROID-HORMONE RECEPTORS; DNA-BINDING DOMAIN; INNER-EAR; NUCLEAR RECEPTOR; GENE-EXPRESSION; MOUSE EMBRYOS; ERR-ALPHA; ACTIVATION; CELLS; MATURATION	In a large consanguineous family of Turkish origin, genome-wide homozygosity mapping revealed a locus for recessive nonsyndromic hearing impairment on chromosome 14q24.3-q34.12. Fine mapping with microsatellite markers defined the critical linkage interval to a 18.7 cM region flanked by markers D14S53 and D14S1015. This region partially overlapped with the DFNB35 locus. Mutation analysis of ESRRB, a candidate gene in the overlapping region, revealed a homozygous 7 bp duplication in exon 8 in all affected individuals. This duplication results in a frame shift and premature stop codon. Sequence analysis of the ESRRB gene in the affected individuals of the original DFNB35 family and in three other DFNB35-linked consanguineous families from Pakistan revealed four missense mutations. ESRRB encodes the estrogen-related receptor beta protein, and one of the substitutions (p.A110V) is located in the DNA-binding domain of ESRRB, whereas the other three are substitutions (p.L320P, p.V342L, and p.L347P) located within the ligand-binding domain. Molecular modeling of this nuclear receptor showed that the missense mutations are likely to affect the structure and stability of these domains. RNA in situ hybridization in mice revealed that Esrrb is expressed during inner-ear development, whereas immunohistochemical analysis showed that ESRRB is present postnatally in the cochlea. Our data indicate that ESRRB is essential for inner-ear development and function. To our knowledge, this is the first report of pathogenic mutations of an estrogen-related receptor gene.	[Collin, Rob W. J.; Kalay, Ersan; Peters, Theo; Oostrik, Jaap; Heister, Angelien; Brunner, Han G.; Cremers, Cor W. R. J.; Cremers, Frans P. M.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6525 GA Nijmegen, Netherlands; [Kalay, Ersan; Karaguzel, Ahmet] Karadeniz Tech Univ, Fac Med, Dept Med Biol, TR-61080 Trabzon, Turkey; [Tariq, Muhammad; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [van der Zwaag, Bert; Spierenburg, Henk A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3584 CG Utrecht, Netherlands; [Venselaar, Hanka; Vriend, Gert] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Venselaar, Hanka; Cremers, Frans P. M.; Vriend, Gert; Kremer, Hannie] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ahmed, Zubair M.; Riazuddin, Saima; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Caylan, Refik; Arslan, Selcuk] Karadeniz Tech Univ, Fac Med, Dept Otorhinolaryngol, TR-61080 Trabzon, Turkey; [Li, Yun; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Li, Yun; Wollnik, Bernd] Univ Cologne, Inst Human Genet, D-50674 Cologne, Germany; [Eyupoglu, Erol] Ordu Govt Hosp, Dept Ophthalmol, TR-52200 Ordu, Turkey; [Bahat, Elif] Karadeniz Tech Univ, Fac Med, Dept Pediat Nephrol, TR-61080 Trabzon, Turkey; [Ansar, Muhammad; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 44520, Pakistan; [Wollnik, Bernd] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey	Radboud University Nijmegen; Karadeniz Technical University; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Karadeniz Technical University; University of Cologne; University of Cologne; Ordu State Hospital; Karadeniz Technical University; Quaid I Azam University; Istanbul University	Kremer, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6525 GA Nijmegen, Netherlands.	h.kremer@antrg.umcn.nl	Brunner, Han/C-9928-2013; Vriend, G./H-8112-2014; Collin, Rob/N-3575-2014; Cremers, Frans/A-5625-2014; Peters, T.A./L-4571-2015; Ansar, Muhammad/F-4808-2015; Tariq, Muhammad/ABC-2204-2020; Cremers, C.W.R.J./L-4254-2015; Ansar, Muhammad/H-5967-2011; Kremer, Hannie/F-5126-2010; Venselaar, Hanka/D-2009-2016; Oostrik, Jaap/A-1703-2016; Heister, Angelien/ABC-3651-2020; Bahat Ozdogan, Elif Bahat/AAW-6278-2021; Kalay, Ersan/AAL-2906-2021; Ahmad, Wasim/E-9713-2015; Ahmad, Wasim/GSD-8904-2022; Arslan, Selçuk/AAW-8461-2021; Wollnik, Bernd/GRY-6062-2022; Vriend, Gert/D-6730-2011	Cremers, Frans/0000-0002-4954-5592; Peters, T.A./0000-0001-8443-5500; Tariq, Muhammad/0000-0002-8239-9339; Ansar, Muhammad/0000-0001-5891-7063; Kremer, Hannie/0000-0002-0841-8693; Venselaar, Hanka/0000-0001-9824-6559; Kalay, Ersan/0000-0002-1467-2268; Wollnik, Bernd/0000-0003-2589-0364; Lee, Kwanghyuk/0000-0003-1389-1220; Lee, Kwanghyuk/0000-0001-7781-9696	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIDCD NIH HHS [T32 DC000035, DC03594, 1 Z01 DC000035-10, R29 DC003594, R01 DC003594] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ansar M, 2003, EUR J HUM GENET, V11, P77, DOI 10.1038/sj.ejhg.5200905; Ariazi EA, 2002, CANCER RES, V62, P6510; Bardet PL, 2006, TRENDS ENDOCRIN MET, V17, P166, DOI 10.1016/j.tem.2006.03.005; Bardet PL, 2005, DEV BIOL, V281, P102, DOI 10.1016/j.ydbio.2005.02.018; Bardet PL, 2005, EVOL DEV, V7, P223, DOI 10.1111/j.1525-142X.2005.05025.x; BELSHAM DD, 1995, HUM MUTAT, V5, P28, DOI 10.1002/humu.1380050104; BENOR S, 1983, J STEROID BIOCHEM, V19, P305, DOI 10.1016/S0022-4731(83)80041-7; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chen J, 2007, DEV CELL, V13, P325, DOI 10.1016/j.devcel.2007.07.011; CHINEA G, 1995, PROTEINS, V23, P415, DOI 10.1002/prot.340230315; DEFILIPPIS V, 1994, PROTEIN ENG, V7, P1203, DOI 10.1093/protein/7.10.1203; Eng FCS, 1997, MOL CELL BIOL, V17, P4644, DOI 10.1128/MCB.17.8.4644; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Hawkins RD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000525; Hildebrand MS, 2007, HEARING RES, V225, P1, DOI 10.1016/j.heares.2007.01.015; Holt JA, 2003, MOL ENDOCRINOL, V17, P1704, DOI 10.1210/me.2003-0001; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Jaaskelainen Jarmo, 2006, Hum Mutat, V27, P291, DOI 10.1002/humu.9405; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; KUIJPERS W, 1991, HEARING RES, V52, P133, DOI 10.1016/0378-5955(91)90193-D; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Luijendijk MWJ, 2003, GENOMICS, V82, P480, DOI 10.1016/S0888-7543(03)00150-2; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Morton CC, 2004, AM J MED GENET A, V130A, P26, DOI 10.1002/ajmg.a.30049; Murcia CL, 2001, MECH DEVELOP, V105, P163, DOI 10.1016/S0925-4773(01)00388-4; Oxombre B, 2004, BIOCHEM J, V383, P573, DOI 10.1042/BJ20040473; Peters LM, 2007, GENOMICS, V89, P197, DOI 10.1016/j.ygeno.2006.09.006; PETERS TA, 1995, HEARING RES, V85, P169, DOI 10.1016/0378-5955(95)00043-4; ROCHEFORT H, 1981, NATURE, V292, P257, DOI 10.1038/292257a0; Rusch A, 2001, J NEUROSCI, V21, P9792, DOI 10.1523/JNEUROSCI.21-24-09792.2001; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Sendin G, 2007, J NEUROSCI, V27, P3163, DOI 10.1523/JNEUROSCI.3974-06.2007; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Trapp T, 1996, TRENDS PHARMACOL SCI, V17, P145, DOI 10.1016/0165-6147(96)81590-2; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WINTER H, 2007, CELL BIOL, V128, P65, DOI DOI 10.1007/S00418-007-0294-6; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Zhou W, 2006, J CLIN ENDOCR METAB, V91, P569, DOI 10.1210/jc.2004-1957	55	72	76	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					125	138		10.1016/j.ajhg.2007.09.008	http://dx.doi.org/10.1016/j.ajhg.2007.09.008			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179891	Green Published, Bronze			2022-12-18	WOS:000253223800013
J	Moore, LT; McEvoy, B; Cape, E; Simms, K; Bradley, DG				Moore, LT; McEvoy, B; Cape, E; Simms, K; Bradley, DG			A Y-chromosome signature of hegemony in Gaelic Ireland	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRITISH-ISLES; ORIGINS; TIME; AGE; POPULATIONS; NETWORKS; EUROPE; MARKER; GENE	Seventeen-marker simple tandem repeat genetic analysis of Irish Y chromosomes reveals a previously unnoted modal haplotype that peaks in frequency in the northwestern part of the island. It shows a significant association with surnames purported to have descended from the most important and enduring dynasty of early medieval Ireland, the Ui Neill. This suggests that such phylogenetic predominance is a biological record of past hegemony and supports the veracity of semimythological early genealogies. The fact that about one in five males sampled in northwestern Ireland is likely a patrilineal descendent of a single early medieval ancestor is a powerful illustration of the potential link between prolificacy and power and of how Y-chromosome phylogeography can be influenced by social selection.	Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; Univ Dublin Trinity Coll, Sch Hist & Humanities, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Bradley, DG (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.	dbradley@tcd.ie	Bradley, Daniel G/A-3240-2012	Bradley, Daniel G/0000-0001-7335-7092	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; BETZIG L, 1995, J FAM HIST, V20, P181, DOI 10.1177/036319909602000204; Bosch E, 2002, FORENSIC SCI INT, V125, P42, DOI 10.1016/S0379-0738(01)00627-2; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Connolly S.J., 2002, OXFORD COMPANION IRI; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Ellis N, 2002, GENOME RES, V12, P339; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Jaski B., 2000, EARLY IRISH KINGSHIP; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; LI WH, 1975, AM J HUM GENET, V27, P274; McEvoy B, 2004, AM J HUM GENET, V75, P693, DOI 10.1086/424697; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; O Croinin D., 1995, EARLY MEDIEVAL IRELA; PENDER S, 1951, ANAL HIBERNICA; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	23	72	73	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					334	338		10.1086/500055	http://dx.doi.org/10.1086/500055			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16358217	Bronze, Green Published			2022-12-18	WOS:000236744900013
J	Molitor, J; Marjoram, P; Thomas, D				Molitor, J; Marjoram, P; Thomas, D			Fine-scale mapping of disease genes with multiple mutations via spatial clustering techniques	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; BAYESIAN-ANALYSIS; HISTORY; MODEL; LOCI	We present a method to perform fine mapping by placing haplotypes into clusters on the basis of risk. Each cluster has a haplotype "center." Cluster allocation is defined according to haplotype centers, with each haplotype assigned to the cluster with the "closest" center. The closeness of two haplotypes is determined by a similarity metric that measures the length of the shared segment around the location of a putative functional mutation for the particular cluster. Our method allows for missing marker information but still estimates the risks of complete haplotypes without resorting to a one-marker-at-a-time analysis. The dimensionality issues that can occur in haplotype analyses are removed by sampling over the haplotype space, allowing for estimation of haplotype risks without explicitly assigning a parameter to each haplotype to,be estimated. In this way, we are able to handle haplotypes of arbitrary size., Furthermore, our clustering approach has the potential to allow us to detect the presence of multiple functional mutations.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California	Molitor, J (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St,Suite 220, Los Angeles, CA 90089 USA.	jmolitor@usc.edu	Marjoram, Paul/A-3066-2008		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058897] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58897] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Carlin BP., 2000, C&H TEXT STAT SCI, P419; Cox D. R., 2018, ANAL BINARY DATA; Cressie N., 2011, STAT SPATIO TEMPORAL; Denison D.G.T., 2002, BAYESIAN METHODS NON; Gilks WR, 1996, MARKOV CHAIN MONTE C; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Griffiths R.C., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; GRIFFITHS RC, 1997, PROGR POPULATION GEN, P100; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Molitor J, 2003, GENET EPIDEMIOL, V25, P95, DOI 10.1002/gepi.10251; Morris AP, 2002, AM J HUM GENET, V70, P686, DOI 10.1086/339271; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M., 2001, HDB STAT GENETICS, P179; OKABE A, 1992, SPATIAL TESSELATIONS; Richardson S, 1997, J ROY STAT SOC B MET, V59, P731, DOI 10.1111/1467-9868.00095; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Tavare S, 1997, GENETICS, V145, P505; Thomas DC, 2001, GENET EPIDEMIOL, V21, pS712, DOI 10.1002/gepi.2001.21.s1.s712; Voronoi G, 1908, J REINE ANGEW MATH, V134, P198, DOI 10.1515/crll.1908.134.198; Weiss G, 1998, GENETICS, V149, P1539; Wiuf C, 1999, THEOR POPUL BIOL, V56, P183, DOI 10.1006/tpbi.1998.1411	33	72	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1368	1384		10.1086/380415	http://dx.doi.org/10.1086/380415			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14631555	Bronze, Green Published			2022-12-18	WOS:000187491100013
J	Lange, C; DeMeo, D; Silverman, EK; Weiss, ST; Laird, NM				Lange, C; DeMeo, D; Silverman, EK; Weiss, ST; Laird, NM			Using the noninformative families in family-based association tests: A powerful new testing strategy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENERAL-CLASS; UNIFIED APPROACH; TRAITS	For genetic association studies with multiple phenotypes, we propose a new strategy for multiple testing with family-based association tests (FBATs). The strategy increases the power by both using all available family data and reducing the number of hypotheses tested while being robust against population admixture and stratification. By use of conditional power calculations, the approach screens all possible null hypotheses without biasing the nominal significance level, and it identifies the subset of phenotypes that has optimal power when tested for association by either univariate or multivariate FBATs. An application of our strategy to an asthma study shows the practical relevance of the proposed methodology. In simulation studies, we compare our testing strategy with standard methodology for family studies. Furthermore, the proposed principle of using all data without biasing the nominal significance in an analysis prior to the computation of the test statistic has broad and powerful applications in many areas of family-based association studies.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Lange, C (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.	clange@hsph.harvard.edu			DIVISION OF LUNG DISEASES [N01HR016049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, U01HL066795, R01HL066386, P01HL067664, R03HL067427] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL66386, P01 HL67664, U01 HL066795, T32 HL007427, T32 HL07427, P01 HL067664, N01 HR16049, N01HR16049, HL66795, N01 HLC6795, T32HL67427] Funding Source: Medline; NINR NIH HHS [N01-NR-01648, N01-NR-01647, N01-NR-01650, N01-NR-01651, N01-NR-01646, N01-NR-01645, N01-NR-01652, N01-NR-01649, N01-NR-01644] Funding Source: Medline; PHS HHS [R01 NL66386] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; DeMeo DL, 2002, GENET EPIDEMIOL, V23, P335, DOI 10.1002/gepi.10182; Falconer D.S., 1997, INTRO QUANTITATIVE G, VFourth; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lange C, 2001, GENETICS, V159, P1325; LANGE C, IN PRESS HUM HERED; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMSON G, 1995, AM J HUM GENET, V57, P474; Zhao HY, 2000, STAT METHODS MED RES, V9, P563, DOI 10.1191/096228000668447080	20	72	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					801	811		10.1086/378591	http://dx.doi.org/10.1086/378591			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14502464	Green Published, Bronze			2022-12-18	WOS:000185676100008
J	Valente, EM; Salpietro, DC; Brancati, F; Bertini, E; Galluccio, T; Tortorella, G; Briuglia, S; Dallapiccola, B				Valente, EM; Salpietro, DC; Brancati, F; Bertini, E; Galluccio, T; Tortorella, G; Briuglia, S; Dallapiccola, B			Description, nomenclature, and mapping of a novel cerebello-renal syndrome with the molar tooth malformation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JOUBERT-SYNDROME; JUVENILE NEPHRONOPHTHISIS; SENIOR-LOKEN; FOLLOW-UP; PROTEIN; LOCUS; DELETIONS; CHILDREN; LINKAGE; ENCODES	Cerebello-oculo-renal syndromes (CORSs) and Joubert syndrome (JS) are clinically and genetically heterogeneous autosomal recessive syndromes that share a complex neuroradiological malformation resembling a molar tooth on brain axial images, a condition referred to as "molar tooth on imaging" (MTI) or the "molar tooth sign." The current literature on these syndromes is complex, with overlapping and incomplete phenotypes that complicate the selection of clinically homogeneous cases for genetic purposes. So far, only one locus (JBTS1 on 9q34) has been mapped, in two families with JS. Here, we describe a large consanguineous family with JS and nephronophthisis, representing a novel cerebello-renal phenotype. We have mapped this condition to the pericentromeric region of chromosome 11 and have named the locus "CORS2." The acronym "CORS" is proposed for all loci associated with JS, CORSs, and related phenotypes sharing the MTI, because this neuroradiological sign seems to be the unifying feature of these clinically heterogeneous syndromes.	CSS Mendel Inst, I-00198 Rome, Italy; IRCCS CSS, San Giovanni Rotondo, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Rome, Italy; Osped Pediat Bambin Gesu, Unita Med Mol, Rome, Italy; Univ Messina, Dipartimento Sci Pediat, Unita Operat Genet & Immunol Pediat, Messina, Italy; Univ Messina, Dipartimento Sci Pediat, Unita Operat Neuropsichiatria Infantile, Messina, Italy	IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; IRCCS Bambino Gesu; University of Messina; University of Messina	Valente, EM (corresponding author), CSS Mendel Inst, Viale Regina Margherita 261, I-00198 Rome, Italy.		Briuglia, Silvana/J-9621-2019; Valente, Enza Maria/G-2942-2017; Bertini, Enrico/A-2284-2014; Tortorella, Gaetano/C-9333-2011; Bertini, Enrico/ABG-1278-2020; Dallapiccola, Bruno/K-8692-2016	Valente, Enza Maria/0000-0002-0600-6820; Bertini, Enrico/0000-0001-9276-4590; BRIUGLIA, Silvana/0000-0002-5213-441X; Dallapiccola, Bruno/0000-0002-5031-1013; Brancati, Francesco/0000-0003-3624-2354				Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; Blair IP, 2002, AM J MED GENET, V107, P190, DOI 10.1002/ajmg.10145; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; Chance PF, 1999, J CHILD NEUROL, V14, P660, DOI 10.1177/088307389901401007; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Hildebrandt F, 2000, J AM SOC NEPHROL, V11, P1753, DOI 10.1681/ASN.V1191753; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Maria BL, 1999, J CHILD NEUROL, V14, P368, DOI 10.1177/088307389901400605; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Pellegrino JE, 1997, AM J MED GENET, V72, P59, DOI 10.1002/(SICI)1096-8628(19971003)72:1<59::AID-AJMG12>3.0.CO;2-T; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; Satran D, 1999, AM J MED GENET, V86, P459; Saunier S, 1997, AM J HUM GENET, V61, pA346; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; Spinella GM, 1999, J CHILD NEUROL, V14, P667, DOI 10.1177/088307389901401008; Steinlin M, 1997, NEUROPEDIATRICS, V28, P204, DOI 10.1055/s-2007-973701; Sztriha L, 1999, PEDIATR NEUROL, V20, P274, DOI 10.1016/S0887-8994(98)00154-4	25	72	73	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					663	670		10.1086/378241	http://dx.doi.org/10.1086/378241			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12908130	Bronze, Green Published			2022-12-18	WOS:000185134000020
J	Housworth, EA; Stahl, FW				Housworth, EA; Stahl, FW			Crossover interference in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAENORHABDITIS-ELEGANS; MEIOTIC RECOMBINATION; CROSSING-OVER; RECIPROCAL RECOMBINATION; MULTILOCUS RECOMBINATION; DROSOPHILA-MELANOGASTER; RELATIVE EFFICIENCIES; STATISTICAL-ANALYSIS; CHROMOSOME SYNAPSIS; MEIOSIS	Crossing-over between homologous chromosomes facilitates proper disjunction of chromosomes during meiosis I. In many organisms, gene functions that are essential to crossing-over also facilitate the intimate chromosome pairing called "synapsis." Many organisms - including budding yeast, humans, zebrafish, Drosophila, and Arabidopsis regulate the distribution of crossovers, so that, most of the time, each chromosome bundle gets at least one crossover while the mean number of crossovers per chromosome remains modest. This regulation is obtained through crossover interference. Recent evidence suggests that the organisms that use recombination functions to achieve synapsis have two classes of crossovers, only one of which is subject to interference. We statistically test this two-pathway hypothesis in the CEPH data and find evidence to support the two-pathway hypothesis in humans.	Indiana Univ, Dept Math, Bloomington, IN 47405 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Oregon	Housworth, EA (corresponding author), Indiana Univ, Dept Math, Bloomington, IN 47405 USA.	ehouswor@indiana.edu						Bailey NTJ., 1961, INTRO MATH THEORY GE; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Copenhaver GP, 2002, GENETICS, V160, P1631; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; FOSS E, 1993, GENETICS, V133, P681; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; GOLDGAR DE, 1988, AM J HUM GENET, V43, P38; GOLDGAR DE, 1989, GENOMICS, V5, P283, DOI 10.1016/0888-7543(89)90059-1; GOLDSTEIN DR, 1995, GENOMICS, V27, P265, DOI 10.1006/geno.1995.1041; HAWLEY RS, 1980, GENETICS, V94, P625; Kaback DB, 1999, GENETICS, V152, P1475; Lin S, 1999, ANN HUM GENET, V63, P81, DOI 10.1046/j.1469-1809.1999.6310081.x; Liu H, 2002, GENETICS, V162, P245; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; MCKIM KS, 1993, GENETICS, V134, P749; MCPEEK MS, 1995, GENETICS, V139, P1031; Moens PB, 2002, J CELL SCI, V115, P1611; Mortimer R.R., 1974, MECH RECOMBINATION, P263, DOI [10.1007/978-1-4684-2133-0_23, DOI 10.1007/978-1-4684-2133-0_23]; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; PRESS WH, 1986, NUMERICAL RECIPES FO; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SINGLETON JR, 1953, AM J BOT, V40, P124, DOI 10.2307/2438770; Takanami T, 2000, NUCLEIC ACIDS RES, V28, P4232, DOI 10.1093/nar/28.21.4232; VILLENEUVE AM, 1994, GENETICS, V136, P887; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407; WEEKS DE, 1993, HUM HERED, V43, P86, DOI 10.1159/000154123; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Zalevsky J, 1999, GENETICS, V153, P1271; ZHAO HY, 1995, GENETICS, V139, P1057; ZHAO HY, 1995, GENETICS, V139, P1045; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	34	72	72	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					188	197		10.1086/376610	http://dx.doi.org/10.1086/376610			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12772089	Bronze, Green Published			2022-12-18	WOS:000183904900016
J	Hallmayer, J; Glasson, EJ; Bower, C; Petterson, B; Croen, L; Grether, J; Risch, N				Hallmayer, J; Glasson, EJ; Bower, C; Petterson, B; Croen, L; Grether, J; Risch, N			On the twin risk in autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFFECTED SIBLING PAIRS; GENOMIC SCREEN; SUSCEPTIBILITY GENE; POPULATION; ETIOLOGY; CHILDREN	Autism is considered by many to be the most strongly genetically influenced multifactorial childhood psychiatric disorder. In the absence of any known gene or genes, the main support for this is derived from family and twin studies. Two recent studies (Greenberg et al. 2001; Betancur et al. 2002) suggested that the twinning process itself is an important risk factor in the development of autism. If true, this would have major consequences for the interpretation of twin studies. Both studies compared the number of affected twin pairs among affected sib pairs to expected values in two separate samples of multiplex families and reported a substantial and significant excess of twin pairs. Using data from our epidemiological study in Western Australia, we investigated the possibility of an increased rate of autism in twins. All children born between 1980 and 1995 with autism, Asperger syndrome, or pervasive developmental disorder not otherwise specified (PDD-NOS) were ascertained. Of the 465 children with a diagnosis, 14 were twin births (rate 30.0/1,000) compared to 9,640 children of multiple births out of a total of 386,637 births in Western Australia between 1980 and 1995 (twin rate weighted to number of children with autism or PDD per year 26.3/1,000). These data clearly do not support twinning as a substantial risk factor in the etiology of autism. We demonstrate that the high proportion of twins found in affected-sib-pair studies can be adequately explained by the high ratio of concordance rates in monozygotic (MZ) twins versus siblings and the distribution of family size in the population studied. Our results are in agreement with those of two similar studies by Croen et al. (2002) in California and Hultman et al. (2002) in Sweden.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA; Univ Western Australia, Dept Psychiat & Behav Sci, Perth, WA 6009, Australia; Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Edith Cowan Univ, Ctr Hlth & Ageing, Perth, WA, Australia; Disabil Serv Commiss, Perth, WA, Australia; Kaiser Permanente Div Res, Oakland, CA USA; Dept Hlth Serv State Calif, Oakland, CA USA	Stanford University; Stanford University; University of Western Australia; Telethon Kids Institute; University of Western Australia; Edith Cowan University; Kaiser Permanente	Hallmayer, J (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 1201 Welch Rd,Room P112, Palo Alto, CA 94304 USA.	joachimh@stanford.edu	Glasson, Emma/H-5339-2013	Glasson, Emma/0000-0003-3996-9049; Croen, Lisa/0000-0001-7849-9428; , Emma/0000-0001-5547-8595				AUGUST GJ, 1981, BRIT J PSYCHIAT, V138, P416, DOI 10.1192/bjp.138.5.416; Auranen M, 2000, MOL PSYCHIATR, V5, P320, DOI 10.1038/sj.mp.4000708; Bailey A, 1998, HUM MOL GENET, V7, P571; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAIRD TD, 1985, J AUTISM DEV DISORD, V15, P315, DOI 10.1007/BF01531501; Barrett S, 1999, AM J MED GENET, V88, P609; Betancur C, 2002, AM J HUM GENET, V70, P1381, DOI 10.1086/340364; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; CARREY NJ, 1995, J AM ACAD CHILD PSY, V34, P1655, DOI 10.1097/00004583-199512000-00016; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; GILLBERG C, 1992, DEV MED CHILD NEUROL, V34, P389; Greenberg DA, 2001, AM J HUM GENET, V69, P1062, DOI 10.1086/324191; Hallmayer J, 1996, ARCH GEN PSYCHIAT, V53, P985; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Kanner L, 1943, NERV CHILD, V2, P217; Korvatska E, 2002, NEUROBIOL DIS, V9, P107, DOI 10.1006/nbdi.2002.0479; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; STANLEY FJ, 1994, PAEDIATR PERINAT EP, V8, P433, DOI 10.1111/j.1365-3016.1994.tb00482.x; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; SZATMARI P, 1993, J AM ACAD CHILD PSY, V32, P1264, DOI 10.1097/00004583-199311000-00022; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; TSAI L, 1981, J AUTISM DEV DISORD, V11, P165, DOI 10.1007/BF01531682; Wolff S, 1996, EUR CHILD ADOLES PSY, V5, P119, DOI 10.1007/BF00571671	36	72	74	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					941	946		10.1086/342990	http://dx.doi.org/10.1086/342990			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	604HT	12297988	Green Published, Bronze			2022-12-18	WOS:000178613800020
J	Walter, C; Gootjes, J; Mooijer, PA; Portsteffen, H; Klein, C; Waterham, HR; Barth, PG; Epplen, JT; Kunau, WH; Wanders, RJA; Dodt, G				Walter, C; Gootjes, J; Mooijer, PA; Portsteffen, H; Klein, C; Waterham, HR; Barth, PG; Epplen, JT; Kunau, WH; Wanders, RJA; Dodt, G			Disorders of peroxisome biogenesis due to mutations in PEX1: Phenotypes and PEX1 protein levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAIN FATTY-ACIDS; ZELLWEGER-SYNDROME; PHENYLALANINE-HYDROXYLASE; COMPLEMENTATION GROUP; PTS1 RECEPTOR; COMMON-CAUSE; DEFICIENCY; IMPORT; IDENTIFICATION; CELLS	Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD) are clinically overlapping syndromes, collectively called "peroxisome biogenesis disorders" (PBDs), with clinical features being most severe in ZS and least pronounced in IRD. Inheritance of these disorders is autosomal recessive. The peroxisome biogenesis disorders are genetically heterogeneous, having at least 12 different complementation groups (CGs). The gene affected in CG1 is PEX1. Approximately 65% of the patients with PBD harbor mutations in PEX1. In the present study, we used SSCP analysis to evaluate a series of patients belonging to CG1 for mutations in PEX1 and studied phenotype-genotype correlations. A complete lack of PEX1 protein was found to be associated with severe ZS; however, residual amounts of PEX1 protein were found in patients with the milder phenotypes, NALD and IRD. The majority of these latter patients carried at least one copy of the common G843D allele. When patient fibroblasts harboring this allele were grown at 30 degreesC, a two- to threefold increase in PEX1 protein levels was observed, associated with a recovery of peroxisomal function. This suggests that the G843D missense mutation results in a misfolded protein, which is more stable at lower temperatures. We conclude that the search for the factors and/or mechanisms that determine the stability of mutant PEX1 protein by high-throughput procedures will be a first step in the development of therapeutic strategies for patients with mild PBDs.	Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, D-44801 Bochum, Germany; Ruhr Univ Bochum, Inst Physiol Chem, Abt Zellbiochem, D-44801 Bochum, Germany; Ruhr Univ Bochum, Inst Mol Humangenet, D-44801 Bochum, Germany; Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Dodt, G (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, Univ Str 150, D-44801 Bochum, Germany.	Gabriele.Dodt@ruhr-uni-bochum.de		Epplen, Joerg T./0000-0002-6087-3327				Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; BUDDEN SS, 1986, J PEDIATR-US, V108, P33, DOI 10.1016/S0022-3476(86)80765-X; Collins CS, 1999, HUM MUTAT, V14, P45, DOI 10.1002/(SICI)1098-1004(1999)14:1<45::AID-HUMU6>3.3.CO;2-A; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Gartner J, 1999, J INHERIT METAB DIS, V22, P311, DOI 10.1023/A:1005599903632; Geisbrecht BV, 1998, P NATL ACAD SCI USA, V95, P8630, DOI 10.1073/pnas.95.15.8630; HEYMANS HSA, 1984, EUR J PEDIATR, V142, P10, DOI 10.1007/BF00442582; Imamura A, 1998, HUM MOL GENET, V7, P2089, DOI 10.1093/hmg/7.13.2089; Imamura A, 1998, AM J HUM GENET, V62, P1539, DOI 10.1086/301881; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LAZAROW PB, 1982, ANN NY ACAD SCI, V386, P285, DOI 10.1111/j.1749-6632.1982.tb21423.x; MAQUAT LE, 1995, RNA, V1, P453; Maxwell MA, 1999, HUM GENET, V105, P38, DOI 10.1007/s004390051061; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Porter TL, 1997, RRD POLYM SCI, V1, P1; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Singh I, 1997, BIOCHEM MOL MED, V61, P198, DOI 10.1006/bmme.1997.2593; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SMEITINK JAM, 1992, J INHERIT METAB DIS, V15, P377, DOI 10.1007/BF02435981; Tamura S, 1998, BIOCHEM BIOPH RES CO, V245, P883, DOI 10.1006/bbrc.1998.8522; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Vreken P, 1998, J CHROMATOGR B, V713, P281, DOI 10.1016/S0378-4347(98)00186-8; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Wanders RJA, 1999, NEUROCHEM RES, V24, P565, DOI 10.1023/A:1022592014988; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P314, DOI 10.1023/A:1005504104541; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P90, DOI 10.1007/BF00711432; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; Waters PJ, 1998, HUM MUTAT, V12, P344, DOI 10.1002/(SICI)1098-1004(1998)12:5<344::AID-HUMU8>3.0.CO;2-D; Waters PJ, 1998, HUM MUTAT, V11, P4; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; Wei HM, 2000, ANN NEUROL, V47, P286, DOI 10.1002/1531-8249(200003)47:3<286::AID-ANA3>3.3.CO;2-2; WIEMER EAC, 1991, BIOCHIM BIOPHYS ACTA, V1097, P232, DOI 10.1016/0925-4439(91)90041-7	39	72	73	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					35	48		10.1086/321265	http://dx.doi.org/10.1086/321265			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11389485	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000170108100004
J	Abecasis, GR; Cookson, WOC; Cardon, LR				Abecasis, GR; Cookson, WOC; Cardon, LR			The power to detect linkage disequilibrium with quantitative traits in selected samples	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISCORDANT SIB PAIRS; TRANSMISSION-DISEQUILIBRIUM; NUCLEAR FAMILIES; SNP MAP; LOCI; ASSOCIATION; TESTS; DISEASES; HUMANS; GENES	Results from power studies for linkage detection have led to many ongoing and planned collections of phenotypically extreme nuclear families. Given the great expense of collecting these families and the imminent availability of a dense diallelic marker map, the families are likely to be used in allelic-association as well as linkage studies. However, optimal selection strategies for linkage may not be equally powerful for association. We examine the power to detect linkage disequilibrium for quantitative traits after phenotypic selection. The results encompass six selection strategies that are in widespread use, including single selection (two designs), affected sib pairs, concordant and discordant pairs, and the extreme-concordant and -discordant design. Selection of sibships on the basis of one extreme proband with high or low trait scores provides as much power as discordant sib pairs but requires the screening and phenotyping of substantially fewer initial families from which to select. Analysis of the role of allele frequencies within each selection design indicates that common trait alleles generally offer the most power, but similarities between the marker- and trait-allele frequencies are much more important than the trait-locus frequency alone. Some of the most widespread selection designs, such as single selection, yield power gains only when both the marker and quantitative trait loci (QTL) are relatively rare in the population. In contrast, discordant pairs and the extreme-proband design provide power for the broadest range of QTL-marker-allele frequency differences. Overall, proband selection from either tail provides the best balance of power, robustness, and simplicity of ascertainment for family-based association analysis.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk	Abecasis, Goncalo R/B-7840-2010; Cookson, William/HHC-1790-2022	Abecasis, Goncalo/0000-0003-1509-1825	NEI NIH HHS [R01 EY012562, EY-12562] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott A, 2000, NATURE, V406, P340, DOI 10.1038/35019167; Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Allison DB, 1997, AM J HUM GENET, V60, P676; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Cardon LR, 2000, BEHAV GENET, V30, P235, DOI 10.1023/A:1001970425822; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CARDON LR, 1994, AM J HUM GENET, V55, P825; CAREY G, 1991, AM J HUM GENET, V49, P786; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Falconer D. S., 1981, INTRO QUANTITATIVE G; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gu C, 1996, GENET EPIDEMIOL, V13, P513, DOI 10.1002/(SICI)1098-2272(1996)13:6<513::AID-GEPI1>3.0.CO;2-1; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER ES, 1989, GENETICS, V121, P185; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; Lynch M, 1998, GENETICS ANAL QUANTI; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Martin N, 2000, Twin Res, V3, P310, DOI 10.1375/twin.3.4.310; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Page GP, 1999, AM J HUM GENET, V64, P1194, DOI 10.1086/302331; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1996, AM J HUM GENET, V58, P836; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roberts L, 2000, SCIENCE, V287, P1898, DOI 10.1126/science.287.5460.1898; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schork NJ, 2000, AM J HUM GENET, V67, P1208, DOI 10.1086/321201; Searle S., 1992, WILEY SERIES PROBABI; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Slatkin M, 1999, AM J HUM GENET, V64, P1765, DOI 10.1086/302413; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tu IP, 1999, AM J HUM GENET, V64, P641, DOI 10.1086/302253; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Zhang HP, 1996, AM J HUM GENET, V59, P951	48	72	78	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1463	1474		10.1086/320590	http://dx.doi.org/10.1086/320590			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349228	Bronze, Green Published			2022-12-18	WOS:000169094600017
J	Yamada, R; Tanaka, T; Unoki, M; Nagai, T; Sawada, T; Ohnishi, Y; Tsunoda, T; Yukioka, M; Maeda, A; Suzuki, K; Tateishi, H; Ochi, T; Nakamura, Y; Yamamoto, K				Yamada, R; Tanaka, T; Unoki, M; Nagai, T; Sawada, T; Ohnishi, Y; Tsunoda, T; Yukioka, M; Maeda, A; Suzuki, K; Tateishi, H; Ochi, T; Nakamura, Y; Yamamoto, K			Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; LINKAGE	Genetic variants of interleukin-3 (IL-3), a well-studied cytokine, may have a role in the pathophysiology of rheumatoid arthritis (RA); but reports on this association sometimes conflict. A case-control study was designed to investigate association between RA and a single-nucleotide polymorphism (SNP) in the IL-3 promoter region. Comparison of cases of RA versus control individuals yielded a chi (2) value of 14.28 (P = .0002), with a genotype odds ratio of 2.24 (95% confidence interval [95% CI] 1.44-3.49). When female cases with earlier onset were compared with female control individuals, the SNP revealed an even more significant correlation, with chi (2) = 21.75 (P = .000004) and a genotype odds ratio of 7.27 (95% CI 2.80-18.89). The stronger association that we observed in this clinically distinct subgroup (females with early onset), within a region where linkage disequilibrium was not significantly extended, suggested that the genuine RA locus should locate either within or close to the IL-3 gene. Combined genotype data on SNPs on eight other candidate genes were combined with our IL-3 results, to estimate relationships between pairs of loci and RA, by maximum-likelihood analysis. The utility of combining the genotype data in this way to identify possible contributions of various genes to this disease is discussed.	Univ Tokyo, Inst Med Sci, Ctr Human Genome,Lab Mol Med, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Rheumat Dis Lab, Tokyo 1088639, Japan; Univ Tokyo, Cardiovasc Dis Lab, Tokyo 1088639, Japan; Univ Tokyo, Med Informat Lab, SNP Res Ctr, Inst Phys & Chem Res, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1088639, Japan; Yukioka Hosp, Dept Orthoped Surg, Osaka, Japan; Osaka Univ, Sch Med, Dept Orthoped, Osaka, Japan; Hyogo Coll Med, Sasayama Hosp, Sasayama, Hyogo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; RIKEN; University of Tokyo; University of Tokyo; Osaka University; Hyogo College of Medicine	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome,Lab Mol Med, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Sawed, Tetsuji/GRX-6582-2022; Tsunoda, Tatsuhiko/K-2061-2014; Tanaka, Toshihiro/J-9310-2014; Unoki, Motoko/X-3285-2019; Yamamoto, Kazuhiko/N-5096-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tanaka, Toshihiro/0000-0001-6201-9784; Unoki, Motoko/0000-0002-9629-3818; Yamada, Ryo/0000-0002-1587-630X				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; DEAL CL, 1985, ARTHRITIS RHEUM, V28, P987, DOI 10.1002/art.1780280905; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EHRLICH GE, 1970, GERIATRICS, V25, P103; FIRESTEIN GS, 1988, J EXP MED, V168, P1573, DOI 10.1084/jem.168.5.1573; GORDON DA, 1994, RHEUMATOLOGY; Hara M., 1998, Research Reports on Information Science and Electrical Engineering of Kyushu University, V3, P35; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Jeong MC, 1998, MOL CELL PROBE, V12, P49, DOI 10.1006/mcpr.1997.0148; Levesque MC, 1997, J IMMUNOL, V159, P6184; Levesque MC, 1998, ARTHRITIS RHEUM, V41, P2221, DOI 10.1002/1529-0131(199812)41:12<2221::AID-ART18>3.0.CO;2-I; Nepom GT, 1998, ADV IMMUNOL, V68, P315, DOI 10.1016/S0065-2776(08)60563-5; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WAALEN K, 1992, SCAND J IMMUNOL, V36, P865, DOI 10.1111/j.1365-3083.1992.tb03148.x; Wakitani S, 1997, BRIT J RHEUMATOL, V36, P630; Yamada R, 2000, HUM GENET, V106, P293; YANG YC, 1988, BLOOD, V71, P958	23	72	78	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					674	685		10.1086/318789	http://dx.doi.org/10.1086/318789			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179015	Green Published, Bronze			2022-12-18	WOS:000166994200012
J	Parkes, M; Barmada, MM; Satsangi, J; Weeks, DE; Jewell, DP; Duerr, RH				Parkes, M; Barmada, MM; Satsangi, J; Weeks, DE; Jewell, DP; Duerr, RH			The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; LARGE EUROPEAN COHORT; GENOME-WIDE SEARCH; SUSCEPTIBILITY LOCI; PROVIDES EVIDENCE; SUPPORTS LINKAGE; GENETIC-ANALYSIS; COMPLEX TRAITS; CHROMOSOME-16; IDENTIFICATION	The IBD2 locus on chromosome 12 has been Linked to both Crohn disease (CD) and ulcerative colitis (UC) but has not been detected in some CD-dominated data sets. In the present study, we genotyped 581 relative pairs with inflammatory bowel disease (252 from CD-only families, 138 from UC-only families, and 191 from mixed families containing cases of both CD and UC), using 12 markers spanning the IBD2 locus. A GENEHUNTER-PLUS multipoint LOD score of 3.91 was detected for pairs from UC-only families, compared with 1.66 for CD-only and 1.29 for mixed families. The difference between the LOD scores for UC and CD was significant in two different tests for heterogeneity (P =.0057 for one test and P =.0375 for the other). IBD2 thus appears to make a major contribution to UC susceptibility but to have only a relatively minor effect with regard to CD, for which there may be substantially more locus heterogeneity.	Univ Oxford, Radcliffe Infirm, Nuffield Dept Med, Gastroenterol Unit, Oxford OX2 6HE, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX2 6HE, England; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Genom Sci, Pittsburgh, PA 15261 USA	Radcliffe Infirmary; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Duerr, RH (corresponding author), 565 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	duerr@msx.dept-med.pitt.edu	Duerr, Richard H/B-4188-2009; Weeks, Daniel E/B-2995-2012	Duerr, Richard H/0000-0001-6586-3905; Weeks, Daniel E/0000-0001-9410-7228; Parkes, Miles/0000-0002-6467-0631; Barmada, M Michael/0000-0002-3604-6460	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050993] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-50993] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKOLKAR P, 1998, AM J HUM GENET, V63, pA279; Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cavanaugh JA, 2000, GASTROENTEROLOGY, V118, pA708, DOI 10.1016/S0016-5085(00)84961-6; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Duerr RH, 1998, AM J HUM GENET, V63, P95, DOI 10.1086/301929; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; KIRSNER JB, 1973, CLIN GASTROENTEROL, V2, P557; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1996, AM J HUM GENET, V58, P1092; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mandal DM, 1999, GENET EPIDEMIOL, V17, pS643; MORTON NE, 1956, AM J HUM GENET, V8, P80; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parkes M, 1996, LANCET, V348, P1588, DOI 10.1016/S0140-6736(05)66204-6; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; PROBERT CSJ, 1993, GUT, V34, P1547, DOI 10.1136/gut.34.11.1547; Rioux JD, 1998, GASTROENTEROLOGY, V115, P1062, DOI 10.1016/S0016-5085(98)70074-5; SATSANGI J, 1994, EUR J GASTROEN HEPAT, V6, P413; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Subhani J, 1998, GASTROENTEROLOGY, V114, pA1093; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Vermeire S, 2000, INFLAMM BOWEL DIS, V6, P165, DOI 10.1097/00054725-200008000-00002	31	72	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1605	1610		10.1086/316905	http://dx.doi.org/10.1086/316905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078482	Green Published, Bronze			2022-12-18	WOS:000165607600028
J	Tishkoff, SA; Pakstis, AJ; Stoneking, M; Kidd, JR; Destro-Bisol, G; Sanjantila, A; Lu, RB; Deinard, AS; Sirugo, G; Jenkins, T; Kidd, KK; Clark, AG				Tishkoff, SA; Pakstis, AJ; Stoneking, M; Kidd, JR; Destro-Bisol, G; Sanjantila, A; Lu, RB; Deinard, AS; Sirugo, G; Jenkins, T; Kidd, KK; Clark, AG			Short tandem-repeat polymorphism/Alu haplotype variation at the PLAT locus: Implications for modern human origins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							PLASMINOGEN-ACTIVATOR GENE; HUMAN MITOCHONDRIAL-DNA; Y-CHROMOSOME POLYMORPHISMS; STEPWISE MUTATION MODEL; RECENT AFRICAN ORIGIN; LINKAGE DISEQUILIBRIUM; HUMAN-POPULATIONS; HUMAN-EVOLUTION; MICROSATELLITE LOCI; ALU INSERTIONS	Two dinucleotide short tandem-repeat polymorphisms (STRPs) and a polymorphic Alu element spanning a 22-kb region of the FLAT locus on chromosome 8p12-q11.2 were typed in 1,287-1,420 individuals originating from 30 geographically diverse human populations, as well as in 29 great apes. These data were analyzed as haplotypes consisting of each of the dinucleotide repeats and the flanking Alu insertion/deletion polymorphism. The global pattern of STRP/Alu haplotype variation and linkage disequilibrium (LD) is informative for the reconstruction of human evolutionary history. Sub-Saharan African populations have high levels of haplotype diversity within and between populations, relative to non-Africans, and have highly divergent patterns of LD. Non-African populations have both a subset of the haplotype diversity present in Africa and a distinct pattern of LD. The pattern of haplotype variation and LD observed at the FLAT locus suggests a recent common ancestry of non-African populations, from a small population originating in eastern Africa. These data indicate that, throughout much of modern human history, sub-Saharan Africa has maintained both a large effective population size and a high level of population substructure. Additionally, Papua New Guinean and Micronesian populations have rare haplotypes observed otherwise only in African populations, suggesting ancient gene flow from Africa into Papua New Guinea, as well as gene flow between Melanesian and Micronesian populations.	Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; Univ La Sapienza, Dept Anim & Human Biol, Rome, Italy; Univ Helsinki, Dept Forens Med, SF-00300 Helsinki, Finland; Triserv Gen Hosp, Dept Psychiat, Natl Def Med Ctr, Taipei, Taiwan; Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; MRC, Human Mol Genet Lab, Fajara, Senegal; Univ Witwatersrand, Sch Pathol, S African Inst Med Res, Dept Human Genet, Johannesburg, South Africa	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yale University; Max Planck Society; Sapienza University Rome; University of Helsinki; National Defense Medical Center; Tri-Service General Hospital; University of California System; University of California Davis; University of Witwatersrand	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.		Sirugo, Giorgio/L-1628-2016; Sirugo, Giorgio/N-9056-2019	Destro Bisol, Giovanni/0000-0002-4232-9715; Clark, Andrew/0000-0001-7159-8511	NIGMS NIH HHS [GM57672] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; BARR CL, 1993, BIOL PSYCHIAT, V34, P204, DOI 10.1016/0006-3223(93)90073-M; BATZER MA, 1991, NUCLEIC ACIDS RES, V19, P3619, DOI 10.1093/nar/19.13.3619; Batzer MA, 1996, J MOL EVOL, V42, P22, DOI 10.1007/BF00163207; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bellwood P., 1995, AUSTRONESIANS HIST C, P96; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Belwood P, 1985, PREHISTORY INDOMALAY; Bertranpetit J, 1996, CIBA F SYMP, V197, P97; Birdsell, 1967, ARCH PHYS ANTHR OCEA, V2, P102; BIRDSELL J, 1993, MICROEVOLUTIONARY PA; BLANQUERMAUMONT A, 1995, J MOL EVOL, V41, P492, DOI 10.1007/BF00160321; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Calafell F, 1999, AM J PHYS ANTHROPOL, V108, P137, DOI 10.1002/(SICI)1096-8644(199902)108:2<137::AID-AJPA1>3.0.CO;2-K; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; CLARK DJ, 1959, PREHISTORY SO AFRICA; DEGEN SJF, 1986, J BIOL CHEM, V261, P6972; Deinard A, 1999, J HUM EVOL, V36, P687, DOI 10.1006/jhev.1999.0298; DESTROBISOL G, 1994, AM J HUM GENET, V55, P168; Di Rienzo A, 1998, GENETICS, V148, P1269; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Garza JC, 1996, GENOME RES, V6, P211, DOI 10.1101/gr.6.3.211; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GREENBERG JH, 1963, LANGUAGES AFRICA; Grimaldi MC, 1997, J MOL EVOL, V44, P336, DOI 10.1007/PL00006151; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; GUTHRIE M, 1962, J AFR HIST, V3, P273, DOI 10.1017/S002185370000311X; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HARPENDING HC, 1996, MOL BIOL HUMAN DIVER, P288; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Howells W.W., 1989, SKULL SHAPES MAP CRA; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; JONES R, 1995, ANNU REV ANTHROPOL, V24, P423; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; KIDD JR, 1991, HUM BIOL, V63, P775; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KIDD KK, 1996, MOL BIOL HUMAN DIVER, P242; Kimmel M, 1998, GENETICS, V148, P1921; KOFLER A, 1995, VOX SANG, V68, P50, DOI 10.1111/j.1423-0410.1995.tb02545.x; Kolman CJ, 1996, GENETICS, V142, P1321; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; LEWONTIN RC, 1964, GENETICS, V49, P49; LEWONTIN RC, 1995, GENETICS, V140, P377; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; Lum JK, 1998, AM J PHYS ANTHROPOL, V105, P109, DOI 10.1002/(SICI)1096-8644(199802)105:2<109::AID-AJPA1>3.0.CO;2-Q; LUM JK, 1994, HUM BIOL, V66, P567; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; MARTINSON JJ, 1996, MOL BIOL HUMAN DIVER, P171; MELTON T, 1995, AM J HUM GENET, V57, P403; Melton T, 1998, AM J HUM GENET, V63, P1807, DOI 10.1086/302131; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; NEI M, 1995, P NATL ACAD SCI USA, V92, P6720, DOI 10.1073/pnas.92.15.6720; NEI M, 1993, MOL BIOL EVOL, V10, P927; Novick GE, 1998, HUM BIOL, V70, P23; Nurse GT., 1985, PEOPLES SO AFRICA TH; O'Connell JF, 1998, EVOL ANTHROPOL, V6, P132, DOI 10.1002/(SICI)1520-6505(1998)6:4<132::AID-EVAN3>3.0.CO;2-F; OSHAUGHNESSY DF, 1990, AM J HUM GENET, V46, P144; Paetkau D, 1997, GENETICS, V147, P1943; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; PENNY D, 1995, MOL BIOL EVOL, V12, P863; PERNA NT, 1992, HUM BIOL, V64, P641; Peterson RJ, 1999, GENOME RES, V9, P844, DOI 10.1101/gr.9.9.844; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P249; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Relethford John H., 1995, Evolutionary Anthropology, V4, P53, DOI 10.1002/evan.1360040207; Ridker PM, 1997, ARTERIOSCL THROM VAS, V17, P1687; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; RITTE U, 1993, J MOL EVOL, V37, P435; Roberts RG, 1994, AUSTR ABORIGINAL STU, V2, P2; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; ROGERS AR, 1995, HUM BIOL, V67, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenbaum Howard C., 1998, P87; Rousset F, 1996, GENETICS, V142, P1357; ROUSSET F, 1995, GENETICS, V140, P1413; SADLER LA, 1991, NUCLEIC ACIDS RES, V19, P6058, DOI 10.1093/nar/19.21.6058-a; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SERJEANTSON SW, 1985, J PAC HIST, P133; SERRE JL, 1990, HUM GENET, V84, P449; Sherry ST, 1997, GENETICS, V147, P1977; SHERRY ST, 1994, HUM BIOL, V66, P761; SHRIVER MD, 1993, GENETICS, V134, P983; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Shriver MD, 1997, GENOME RES, V7, P586, DOI 10.1101/gr.7.6.586; Sokal R. R., 1995, BIOMETRY; Soodyall H, 1996, AM J HUM GENET, V58, P595; Spedini G, 1999, AM J PHYS ANTHROPOL, V110, P143, DOI 10.1002/(SICI)1096-8644(199910)110:2<143::AID-AJPA3>3.3.CO;2-A; SPURDLE A, 1992, AM J HUM GENET, V50, P107; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Steeds R, 1998, THROMB HAEMOSTASIS, V79, P980; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STONEKING M, 1990, GENETICS, V124, P717; STRINGER CB, 1993, ORIGIN AND EVOLUTION OF HUMANS AND HUMANNESS, P75; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; SYKES B, 1995, AM J HUM GENET, V57, P1463; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; TERRELL J, 1988, ANTIQUITY, V62, P642, DOI 10.1017/S0003598X00075049; Thomas W., 1992, Human Molecular Genetics, V1, P138, DOI 10.1093/hmg/1.2.138-a; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Tishkoff SA, 1996, HUM GENET, V97, P759; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TISHKOFF SA, 1998, P TRIN WORKSH MOL EV, P181; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VALDES AM, 1993, GENETICS, V133, P737; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILSON AC, 1969, P NATL ACAD SCI USA, V63, P1088, DOI 10.1073/pnas.63.4.1088; Wright S, 1931, GENETICS, V16, P0097; Zietkiewicz E, 1997, GENE, V205, P161; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	146	72	73	0	18	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					901	925		10.1086/303068	http://dx.doi.org/10.1086/303068			25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	360DL	10986042	Green Published, Bronze			2022-12-18	WOS:000089651100013
J	Reid, E; Dearlove, AM; Rhodes, M; Rubinsztein, DC				Reid, E; Dearlove, AM; Rhodes, M; Rubinsztein, DC			A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANDIDATE REGION; HUMAN GENOME; LINKAGE MAP; 2P; FAMILIES; ANTICIPATION; IMPAIRMENT; MUTATIONS; PHENOTYPE; REDUCTION	Autosomal dominant pure hereditary spastic paraplegia (ADPHSP) is clinically characterized by slowly progressive lower-limb spasticity. The condition is genetically heterogeneous, and loci have been mapped at chromosomes 2p, 8q, 14q, and 15q. We have performed a genome-wide linkage screen on a large family with ADPHSP, in which linkage to all four previously known loci was excluded. Analysis of markers on chromosome 12q gave a peak pairwise LOD score of 3.61 at D12S1691, allowing us to assign a new locus for ADPHSP (a locus that we have designated "SPG10") to this region. Haplotype construction and analysis of recombination events narrowed the SPG10 locus to a 9.2-cM region between markers D12S368 and D12S83. In addition, our data strongly suggest that there are at least six ADPHSP loci, since we describe a further family in which linkage to all five known ADPHSP loci has been excluded.	Univ Cambridge, Dept Med Genet, Cambridge, England; MRC, Human Genome Mapping Project Resource Ctr, Cambridge, England	University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Hills Rd,Level 4,Wellcome MRC Bldg, Cambridge CB2 2XY, England.		Reid, Evan/F-3250-2010; Rubinsztein, David C/C-3472-2011	Reid, Evan/0000-0003-1623-7304; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Burger J, 1996, HUM GENET, V98, P371, DOI 10.1007/s004390050223; Cambi F, 1996, NEUROLOGY, V46, P1112, DOI 10.1212/WNL.46.4.1112; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; De Jonghe P, 1996, EUR J HUM GENET, V4, P260; De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURR A, 1994, NEUROLOGY, V44, P1274, DOI 10.1212/WNL.44.7.1274; Durr A, 1996, BRAIN, V119, P1487, DOI 10.1093/brain/119.5.1487; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; GISPERT S, 1995, AM J HUM GENET, V56, P183; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING A, 1984, HEREDITARY ATAXIAS R; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; Hedera P, 1999, AM J HUM GENET, V64, P563, DOI 10.1086/302258; Heinzlef O, 1998, J MED GENET, V35, P89, DOI 10.1136/jmg.35.2.89; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; HENTATI A, 1994, HUM MOL GENET, V3, P1867, DOI 10.1093/hmg/3.10.1867; Huang SZ, 1997, HUM GENET, V100, P620, DOI 10.1007/s004390050563; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Kobayashi H, 1996, J NEUROL SCI, V137, P131, DOI 10.1016/0022-510X(95)00349-7; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Nielsen JE, 1998, J NEUROL NEUROSUR PS, V64, P61, DOI 10.1136/jnnp.64.1.61; Paternotte C, 1998, GENOME RES, V8, P1216, DOI 10.1101/gr.8.11.1216; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; Reid E, 1997, J MED GENET, V34, P499, DOI 10.1136/jmg.34.6.499; REID E, IN PRESS BRAIN; REID E, IN PRESS NEUROLOGY; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHADY W, 1990, BRAIN, V113, P709, DOI 10.1093/brain/113.3.709; Scott WK, 1997, NEUROGENETICS, V1, P95, DOI 10.1007/s100480050014; Seri M, 1999, AM J HUM GENET, V64, P586, DOI 10.1086/302241; TEDESCHI G, 1991, J NEUROL SCI, V103, P55, DOI 10.1016/0022-510X(91)90284-E; Webb S, 1998, BRAIN, V121, P923, DOI 10.1093/brain/121.5.923; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	38	72	74	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					757	763		10.1086/302555	http://dx.doi.org/10.1086/302555			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441583	Bronze, Green Published			2022-12-18	WOS:000082426400021
J	Nellissery, MJ; Padalecki, SS; Brkanac, Z; Singer, FR; Roodman, GD; Unni, KK; Leach, RJ; Hansen, MF				Nellissery, MJ; Padalecki, SS; Brkanac, Z; Singer, FR; Roodman, GD; Unni, KK; Leach, RJ; Hansen, MF			Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL EXPANSILE OSTEOLYSIS; BECKWITH-WIEDEMANN-SYNDROME; OSTEOGENIC-SARCOMA; P53 GENE; RETINOBLASTOMA; IDENTIFICATION; LINKAGE; DNA; NEUROFIBROMATOSIS; LOCALIZATION	Paget disease of bone, or "osteitis deformans," is a bone disorder characterized by rapid bone remodeling resulting in abnormal bone formation. It is the second most common metabolic bone disease after osteoporosis, affecting 3%-5% of subjects aged >40 years. Recent evidence suggests that predisposition to Paget disease may have a genetic component. Genetic linkage analysis of families with multigenerational Paget disease shows linkage to a region of chromosome 18q near the polymorphic locus D18S42. Approximately 1% of Paget patients develop osteosarcoma, which represents an increase in risk that is several thousandfold over that of the general population. Osteosarcoma in Paget patients is the underlying basis for a significant fraction of osteosarcomas occurring after age 60 years. Our analysis of tumor-specific loss of constitutional heterozygosity (LOH) in 96 sporadic osteosarcomas has identified a putative tumor-suppressor locus that maps to chromosome 18q. We have localized this tumor-suppressor locus between D18S60 and D18S42, a region tightly linked to familial Paget disease. Analysis of osteosarcomas from patients with Paget disease revealed that these tumors also undergo LOH in this region. These findings suggest that the association between Paget disease and osteosarcoma is the result of a single gene or two tightly linked genes on chromosome 18.	Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; Audie L Murphy Mem Vet Adm Med Ctr, Dept Med, San Antonio, TX 78284 USA; St Johns Hosp, John Wayne Canc Inst, Santa Monica, CA USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; John Wayne Cancer Institute; Mayo Clinic	Hansen, MF (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, 3307 N Broad St, Philadelphia, PA 19140 USA.	mfh@sgi1.fels.temple.edu		Leach, Robin/0000-0002-3201-5579	NCI NIH HHS [CA 53318] Funding Source: Medline; NIAMS NIH HHS [AR 44904, AR44919] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA053318, R01CA053318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044919, R01AR044904] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAIRD PN, 1992, ONCOGENE, V7, P2141; BRENTON DP, 1980, POSTGRAD MED J, V56, P238, DOI 10.1136/pgmj.56.654.238; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Cody JD, 1997, AM J HUM GENET, V61, P1117, DOI 10.1086/301601; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FREYDINGER JE, 1963, ARCH PATHOL, V75, P496; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GREDITZER HG, 1983, RADIOLOGY, V146, P327, DOI 10.1148/radiology.146.2.6571760; Green E D, 1991, PCR Methods Appl, V1, P77; HADJIPAVLOU A, 1992, CANCER-AM CANCER SOC, V70, P2802, DOI 10.1002/1097-0142(19921215)70:12<2802::AID-CNCR2820701213>3.0.CO;2-N; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HANSEN MF, 1988, CELL, V53, P172, DOI 10.1016/0092-8674(88)90376-5; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; HARTLEY AL, 1990, CANCER GENET CYTOGEN, V45, P245, DOI 10.1016/0165-4608(90)90089-S; HARTLEY AL, 1988, PEDIATR HEMAT ONCOL, V5, P7, DOI 10.3109/08880018809031246; Haslam SI, 1998, J BONE MINER RES, V13, P911, DOI 10.1359/jbmr.1998.13.6.911; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; HUGHES AE, 1996, MOL BIOL PAGETS DIS, P179; HUVOS AG, 1983, CANCER, V52, P1489, DOI 10.1002/1097-0142(19831015)52:8<1489::AID-CNCR2820520826>3.0.CO;2-X; HUVOS AG, 1986, CANCER, V57, P1442, DOI 10.1002/1097-0142(19860401)57:7<1442::AID-CNCR2820570734>3.0.CO;2-3; JACOBS TP, 1979, CANCER-AM CANCER SOC, V44, P742, DOI 10.1002/1097-0142(197908)44:2<742::AID-CNCR2820440247>3.0.CO;2-U; KLEIN RM, 1995, ENDOCRIN METAB CLIN, V24, P437, DOI 10.1016/S0889-8529(18)30048-3; KOENIG M, 1989, AM J HUM GENET, V45, P498; Kruzelock RP, 1997, CANCER RES, V57, P106; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOORE TE, 1991, AM J ROENTGENOL, V156, P1199, DOI 10.2214/ajr.156.6.2028867; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; NASSAR VH, 1981, AM J CLIN PATHOL, V76, P235; Ooi CG, 1997, POSTGRAD MED J, V73, P69, DOI 10.1136/pgmj.73.856.69; OSTERBERG PH, 1988, J BONE JOINT SURG BR, V70, P255, DOI 10.1302/0301-620X.70B2.3346299; Paget J., 1889, ILLUS MED NEWS, V2, P181; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PONDER BAJ, 1994, ANN MED, V26, P199, DOI 10.3109/07853899409147890; SCHAJOWICZ F, 1983, J BONE JOINT SURG BR, V65, P299, DOI 10.1302/0301-620X.65B3.6573330; Schneid H, 1997, MED PEDIATR ONCOL, V28, P411, DOI 10.1002/(SICI)1096-911X(199706)28:6<411::AID-MPO3>3.3.CO;2-X; SCHUBERT EL, 1993, HUM MUTAT, V2, P123, DOI 10.1002/humu.1380020211; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SERET P, 1987, J CANCER RES CLIN, V113, P392, DOI 10.1007/BF00397726; SIRIS ES, 1994, SEMIN ARTHRITIS RHEU, V23, P222, DOI 10.1016/0049-0172(94)90037-X; SOFAER JA, 1983, J EPIDEMIOL COMMUN H, V37, P226, DOI 10.1136/jech.37.3.226; SOTELOAVILA C, 1980, J PEDIATR-US, V96, P47, DOI 10.1016/S0022-3476(80)80322-2; SWEETNAM R, 1982, BRIT J HOSP MED, V28, P112; THOMAS DW, 1994, J ORAL PATHOL MED, V23, P12, DOI 10.1111/j.1600-0714.1994.tb00247.x; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WALLACE RGH, 1989, CLIN ORTHOP RELAT R, P265; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WICK MR, 1981, AM J SURG PATHOL, V5, P47, DOI 10.1097/00000478-198101000-00008; WU RK, 1991, CLIN ORTHOP RELAT R, P306; YAMAGUCHI T, 1992, CANCER RES, V52, P2419	52	72	76	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					817	824		10.1086/302019	http://dx.doi.org/10.1086/302019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718349	Bronze, Green Published			2022-12-18	WOS:000075919000020
J	Li, A; Tedde, R; Krozowski, ZS; Pala, A; Li, KXZ; Shackleton, CHL; Mantero, F; Palermo, M; Stewart, PM				Li, A; Tedde, R; Krozowski, ZS; Pala, A; Li, KXZ; Shackleton, CHL; Mantero, F; Palermo, M; Stewart, PM			Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; TISSUE DISTRIBUTION; DEFICIENCY; GENE; CORTISOL; ENZYME; MUTATIONS; LOCALIZATION; SPECIFICITY; METABOLISM	The syndrome of apparent mineralocorticoid excess (AME) is a heritable form of hypertension in which cortisol acts as a potent mineralocorticoid. The type I variant results in a severe clinical and biochemical phenotype and arises because of mutations in the gene encoding the type 2 isozyme of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD2), an enzyme responsible for the peripheral inactivation of cortisol to cortisone. Only mild abnormalities of cortisol metabolism have been found in the type II variant of AME, suggesting that it may be a separate gene defect. In an extensive consanguineous Sardinian pedigree affected with "type II" AME, a novel homozygous point mutation (C945T) was found in the human 11 beta-HSD2 gene in four affected individuals. Thirteen family members were heterozygous for the resultant R279C amino acid substitution. The LOD score of linkage of the mutation to the disease was 3.23. Expression of the 11 beta-HSD2 mutant cDNA resulted in an enzyme with reduced maximum velocity, but similar substrate affinity, compared with activity of the wild-type cDNA. Affected individuals were >30 years of age and had both mineralocorticoid hypertension and evidence of impaired metabolism of cortisol to cortisone. The heterozygote state was phenotypically normal but was associated with subtle defects in cortisol metabolism. AME represents a spectrum of mineralocorticoid hypertension with severity reflecting the underlying genetic defect in the 11 beta-HSD2 gene; classification into distinct subtypes is inappropriate. Hypertensive populations should be screened to identify the prevalence of milder defects in 11 beta-HSD2 in patients currently labeled as having "essential" hypertension.	Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England; Univ Sassari, Inst Clin Med, I-07100 Sassari, Italy; Univ Sassari, Inst Endocrinol, I-07100 Sassari, Italy; Baker Med Res Inst, Melbourne, Vic, Australia; Childrens Hosp, Med Ctr, Steroid Lab, Oakland, CA 94609 USA; Univ Ancona, Clin Endocrinol, Ancona, Italy	University of Birmingham; University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Sassari; Baker Heart and Diabetes Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Marche Polytechnic University	Stewart, PM (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England.	p.m.stewart@bham.ac.uk						ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; DIMARTINONARDI J, 1987, CLIN ENDOCRINOL, V27, P49, DOI 10.1111/j.1365-2265.1987.tb00838.x; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; FARESE RV, 1991, NEW ENGL J MED, V325, P1223, DOI 10.1056/NEJM199110243251706; Ferrari P, 1996, MOL CELL ENDOCRINOL, V119, P21, DOI 10.1016/0303-7207(96)03787-2; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GORDON RD, 1995, NAT GENET, V11, P6, DOI 10.1038/ng0995-6; KROZOWSKI ZS, 1983, P NATL ACAD SCI-BIOL, V80, P6056, DOI 10.1073/pnas.80.19.6056; Li AR, 1997, J HYPERTENS, V15, P1397, DOI 10.1097/00004872-199715120-00005; MANTERO F, 1994, STEROIDS, V59, P80, DOI 10.1016/0039-128X(94)90080-9; Mantero F, 1996, STEROIDS, V61, P193, DOI 10.1016/0039-128X(96)00012-8; MONDER C, 1986, J CLIN ENDOCR METAB, V63, P550, DOI 10.1210/jcem-63-3-550; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; Mune T, 1996, HYPERTENSION, V27, P1193, DOI 10.1161/01.HYP.27.6.1193; NIKKILA H, 1993, J CLIN ENDOCR METAB, V77, P687, DOI 10.1210/jc.77.3.687; OBERFIELD SE, 1983, J CLIN ENDOCR METAB, V56, P332, DOI 10.1210/jcem-56-2-332; OBEYESEKERE VR, 1995, J CLIN ENDOCR METAB, V80, P3381, DOI 10.1210/jc.80.11.3381; Palermo M, 1996, CLIN ENDOCRINOL, V45, P605, DOI 10.1046/j.1365-2265.1996.00853.x; PHILLIPOU G, 1982, CLIN ENDOCRINOL, V16, P433, DOI 10.1111/j.1365-2265.1982.tb02757.x; SHACKLETON CHL, 1985, CLIN ENDOCRINOL, V22, P701, DOI 10.1111/j.1365-2265.1985.tb00160.x; SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G; SHACKLETON CHL, 1990, ENDOCRINE HYPERTENSI, P155; SHIMOJO M, 1995, J ENDOCRINOL INVEST, V18, P518, DOI 10.1007/BF03349763; Shimojo M, 1997, ENDOCRINOLOGY, V138, P1305, DOI 10.1210/en.138.3.1305; SIMARD J, 1995, J STEROID BIOCHEM, V53, P127, DOI 10.1016/0960-0760(95)00043-Y; SORO A, 1995, HYPERTENSION, V25, P67, DOI 10.1161/01.HYP.25.1.67; Stewart PM, 1996, LANCET, V347, P88, DOI 10.1016/S0140-6736(96)90211-1; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; STEWART PM, 1994, J CLIN ENDOCR METAB, V78, P1529, DOI 10.1210/jc.78.6.1529; STEWART PM, 1987, LANCET, V2, P821; STEWART PM, 1994, J CLIN ENDOCR METAB, V79, P480, DOI 10.1210/jc.79.2.480; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; TEDDE R, 1992, J ENDOCRINOL INVEST, V15, P471, DOI 10.1007/BF03348778; ULICK S, 1979, J CLIN ENDOCR METAB, V49, P757, DOI 10.1210/jcem-49-5-757; ULICK S, 1990, J CLIN ENDOCR METAB, V70, P200, DOI 10.1210/jcem-70-1-200; ULICK S, 1992, J CLIN ENDOCR METAB, V74, P593, DOI 10.1210/jc.74.3.593; WERDER E, 1974, RES STEROIDS, V6, P385; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; WHORWOOD CB, 1995, MOL CELL ENDOCRINOL, V110, pR7, DOI 10.1016/0303-7207(95)03546-J; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P2263, DOI 10.1210/jc.80.7.2263; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P3145, DOI 10.1210/jc.80.11.3145; WILSON RC, 1997, P 79 ANN M END SOC	43	72	76	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					370	379		10.1086/301955	http://dx.doi.org/10.1086/301955			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683587	Green Published, Bronze			2022-12-18	WOS:000075360800012
J	Greer, WL; Riddell, DC; Gillan, TL; Girouard, GS; Sparrow, SM; Byers, DM; Dobson, MJ; Neumann, PE				Greer, WL; Riddell, DC; Gillan, TL; Girouard, GS; Sparrow, SM; Byers, DM; Dobson, MJ; Neumann, PE			The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G(3097)-> T transversion in NPC1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D FIBROBLASTS; CHOLESTEROL; ESTERIFICATION; LINKAGE	Niemann-Pick type D (NPD) disease is a progressive neurodegenerative disorder characterized by the accumulation of tissue cholesterol and sphingomyelin. This disorder is relatively common in southwestern Nova Scotia, because of a founder effect. Our previous studies, using classic linkage analysis of this large extended kindred, defined the critical gene region to a 13-cM chromosome segment between D18S40 and D18S66. A recently isolated gene from this region, NPC1, is mutated in the majority of patients with Niemann-Pick type C disease. We have identified a point mutation within this gene (G3097-->T; Gly992-->Trp) that shows complete linkage disequilibrium with NPD, confirming that NPD is an allelic variant of NPC1.	Dalhousie Univ, Fac Med, Dept Pathol, Div Mol Pathol & Mol Genet, Halifax, NS, Canada; Dalhousie Univ, Fac Med, Dept Biochem, Halifax, NS, Canada; Dalhousie Univ, Fac Med, Dept Paediat, Halifax, NS, Canada; Dalhousie Univ, Fac Med, Dept Anat & Neurobiol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Greer, WL (corresponding author), Queen Elizabeth II Hlth Sci Ctr, DNA Lab, VG Site,Hematol Room 223B,Mackenzie Bldg,5788 Uni, Halifax, NS B3H 1V8, Canada.			Neumann, Paul/0000-0002-8480-4799; Dobson, Melanie/0000-0001-9291-7200				BYERS DM, 1989, BIOCHEM J, V262, P713, DOI 10.1042/bj2620713; CARSTEA ED, 1993, P NATL ACAD SCI USA, V90, P2002, DOI 10.1073/pnas.90.5.2002; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Greer WL, 1997, AM J HUM GENET, V61, P139, DOI 10.1086/513899; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; MAURER J, 1990, DIS MARKERS, V8, P211; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1986, J BIOL CHEM, V261, P6775; SIDHU HS, 1993, BIOCHEM CELL BIOL, V71, P467, DOI 10.1139/o93-069; SPENCE MW, 1989, METABOLIC BASIS INHE, P1655; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; Vanier MT, 1996, AM J HUM GENET, V58, P118; WINSOR EJT, 1978, AM J HUM GENET, V30, P530	14	72	80	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					52	54		10.1086/301931	http://dx.doi.org/10.1086/301931			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634529	Green Published, Bronze			2022-12-18	WOS:000074761000009
J	Effros, RB				Effros, RB			Replicative senescence in the immune system: Impact of the hayflick limit on T-cell function in the elderly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-VIVO; LYMPHOCYTES-T; POPULATIONS; PROLIFERATION; ACTIVATION; INDUCTION; TELOMERES; DISTINCT; VIRUSES		Univ Calif Los Angeles, Dept Pathol & Lab Med, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Effros, RB (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Sch Med, Los Angeles, CA 90095 USA.	reffros@pathology.medsch.ucla.edu			NIA NIH HHS [AG10415] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P60AG010415] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adibzadeh M, 1996, MECH AGEING DEV, V91, P145, DOI 10.1016/0047-6374(96)01783-6; AZUMA M, 1993, J IMMUNOL, V150, P1147; Berube NG, 1998, AM J HUM GENET, V62, P1015, DOI 10.1086/301848; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; Campisi Judith, 1996, P121; Cuadrado E, 1996, CLIN IMMUNOL IMMUNOP, V78, P209, DOI 10.1006/clin.1996.0031; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; EFFROS RB, 1994, J GERONTOL, V49, pB65, DOI 10.1093/geronj/49.2.B65; ENGERS HD, 1980, J IMMUNOL, V125, P1481; GRUBECKLOEBENSTEIN B, 1994, INT ARCH ALLERGY IMM, V104, P232, DOI 10.1159/000236671; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Janeway CA., 2021, IMMUNOBIOLOGY IMMUNE; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Levine BL, 1997, J IMMUNOL, V159, P5921; MILLER RA, 1994, EXP GERONTOL, V29, P21, DOI 10.1016/0531-5565(94)90060-4; Monteiro J, 1996, J IMMUNOL, V156, P3587; MURASKO D M, 1988, Aging Immunology and Infectious Disease, V1, P1; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; SHIMIZU Y, 1992, J EXP MED, V175, P577, DOI 10.1084/jem.175.2.577; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; TRIPP RA, 1995, J IMMUNOL, V154, P6013; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471	31	72	77	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1003	1007		10.1086/301845	http://dx.doi.org/10.1086/301845			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545415	Bronze, Green Published			2022-12-18	WOS:000073487000001
J	Barbujani, G; Bertorelle, G; Chikhi, L				Barbujani, G; Bertorelle, G; Chikhi, L			Evidence for paleolithic and neolithic gene flow in Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DEMIC DIFFUSION; POPULATIONS; FREQUENCIES; ORIGIN; SIMULATION; LANGUAGES; DNA		Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy; Univ Padua, Dept Biol, Padua, Italy	University of Ferrara; University of Padua	Barbujani, G (corresponding author), Univ Ferrara, Dipartimento Biol, Via L Borsari 46, I-44100 Ferrara, Italy.		Mackey, David A/H-5340-2014; Bertorelle, Giorgio/AAE-9078-2022; Barbujani, Guido/ABE-9998-2020	Mackey, David A/0000-0001-7914-4709; Barbujani, Guido/0000-0001-7854-6669; Bertorelle, Giorgio/0000-0002-2498-2702; Chikhi, Lounes/0000-0002-1140-0718; Oostra, Roelof-Jan/0000-0002-2452-8307				Ammerman A.J., 1984, NEOLITHIC TRANSITION; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; BANDELT HJ, 1995, GENETICS, V141, P743; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; BARBUJANI G, 1993, P NATL ACAD SCI USA, V90, P4670, DOI 10.1073/pnas.90.10.4670; BARBUJANI G, 1995, AM J PHYS ANTHROPOL, V96, P109, DOI 10.1002/ajpa.1330960202; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; CHIKHI L, IN PRESS HUM BIOL; COLEMAN R, 1988, CURR ANTHROPOL, V29, P449; Fix AG, 1996, J ROY ANTHROPOL INST, V2, P625, DOI 10.2307/3034300; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Lahermo P, 1996, AM J HUM GENET, V58, P1309; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; PIAZZA A, 1995, P NATL ACAD SCI USA, V92, P5836, DOI 10.1073/pnas.92.13.5836; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 1997, AM J HUM GENET, V61, P251; Richards M, 1996, AM J HUM GENET, V59, P185; Semino O, 1996, AM J HUM GENET, V59, P964; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; STENICO M, 1998, P R SOC LOND B BIOL, V265, P1; TAJIMA F, 1983, GENETICS, V105, P437	28	72	72	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					488	491		10.1086/301719	http://dx.doi.org/10.1086/301719			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ZA927	9463326	Green Published, Bronze			2022-12-18	WOS:000072416000035
J	Ostrander, EA; Giniger, E				Ostrander, EA; Giniger, E			Semper Fidelis: What man's best friend can teach us about human biology and disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINAL DEGENERATION; MUTATION; DOGS; DROSOPHILA; DEFICIENCY; PHENOTYPE; KINASE; LOCUS		FRED HUTCHINSON CANC RES CTR,DIV BASIC SCI,SEATTLE,WA 98104	Fred Hutchinson Cancer Center	Ostrander, EA (corresponding author), FRED HUTCHINSON CANC RES CTR,DIV CLIN RES M318,1124 COLUMBIA ST,SEATTLE,WA 98104, USA.		Giniger, Edward/C-1764-2015; Fiumefreddo, Andrea/T-2977-2019	Giniger, Edward/0000-0002-8340-6158; Ostrander, Elaine/0000-0001-6075-9738				ACLAND GM, 1994, AM J MED GENET, V52, P27, DOI 10.1002/ajmg.1320520106; ACLAND GM, 1989, EXP EYE RES, V49, P983, DOI 10.1016/S0014-4835(89)80021-1; AGUIRRE GD, 1988, EXP EYE RES, V46, P663, DOI 10.1016/S0014-4835(88)80055-1; BARKER E, 1974, ARISTOTLE POLITICS; Bartlett RJ, 1996, AM J VET RES, V57, P650; Brooks M, 1996, J AM VET MED ASSOC, V209, P926; CLEMENTS PJM, 1993, CURR EYE RES, V9, P861; DARWIN C, 1983, ORIGIN SPECIES; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; GRAPHODATSKY AS, 1995, CYTOGENET CELL GENET, V69, P226, DOI 10.1159/000133970; Langford CF, 1995, CHROMOSOME RES, V3, P1; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LINGAAS F, 1997, MAMM GENOME, V8, P2178; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; Mauser AE, 1996, BLOOD, V88, P3451, DOI 10.1182/blood.V88.9.3451.bloodjournal8893451; MURPHREE OD, 1971, COND REFLEX, V6, P129; MURPHY KA, 1973, PHYS REV B, V7, P23, DOI 10.1103/PhysRevB.7.23; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OSTRANDER EA, 1995, MAMM GENOME, V6, P192, DOI 10.1007/BF00293011; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Smith BF, 1996, J BIOL CHEM, V271, P20070, DOI 10.1074/jbc.271.33.20070; SOMBERG RL, 1995, VET IMMUNOL IMMUNOP, V47, P203, DOI 10.1016/0165-2427(94)05400-M; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; SWITONSKI M, 1995, 2 INT DOGMAP M CAMBR; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Werner P, 1997, GENOMICS, V42, P74, DOI 10.1006/geno.1997.4723; WHITNEY KM, 1995, J AM VET MED ASSOC, V207, P918; Willis M.B., 1989, GENETICS DOG; Woolf Virginia, 2002, FLUSH BIOGRAPHY; YuzbasiyanGurkan V, 1997, AM J VET RES, V58, P23; Zajc I, 1997, MAMM GENOME, V8, P182, DOI 10.1007/s003359900386	32	72	73	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					475	480		10.1086/515522	http://dx.doi.org/10.1086/515522			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326310	Green Published, Bronze			2022-12-18	WOS:A1997XY52300002
J	Moisio, AL; Sistonen, P; Weissenbach, J; delaChapelle, A; Peltomaki, P				Moisio, AL; Sistonen, P; Weissenbach, J; delaChapelle, A; Peltomaki, P			Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; CYSTIC-FIBROSIS GENE; LINKAGE DISEQUILIBRIUM; TORSION DYSTONIA; ASHKENAZI JEWS; POPULATIONS; FINLAND; CHROMOSOMES; FREQUENT; LOCUS	Two mutations in the DNA mismatch repair gene MLH1, referred to as mutations 1 and 2, are frequent among Finnish kindreds with hereditary nonpolyposis colorectal cancer (HNPCC). In order to assess the ages and origins of these mutations, we constructed a map of 15 microsatellite markers around MLH1 and used this information in haplotype analyses of 19 kindreds with mutation 1 and 6 kindreds with mutation 2. All kindreds with mutation 1 showed a single allele for the intragenic marker D3S1611 that was not observed on any unaffected chromosome. They also shared portions of a haplotype of 4-15 markers encompassing 2.0-19.0 cM around MLH1. All kindreds with mutation 2 shared another allele for D3S1611 and a conserved haplotype of 5-14 markers spanning 2.0-15.0 cM around MLH1. The degree of haplotype conservation was used to estimate the ages of these two mutations. While some recessive disease genes have been estimated to have existed and spread for as long as thousands of generations worldwide and hundreds of generations in the Finnish population, our analyses suggest that the spread of mutation 1 started 16-43 generations (400-1,075 years) ago and that of mutation 2 some 5-21 generations (125-525 years) ago. These datings are compatible with our genealogical results identifying a common ancestor born in the 16th and 18th century, respectively. Overall, our results indicate that all Finnish kindreds studied to date showing either mutation 1 or mutation 2 are due to single ancestral founding mutations relatively recent in origin in the population. Alternatively, the mutations arose elsewhere earlier and were introduced in Finland more recently.	UNIV HELSINKI,HAARTMAN INST,DEPT MED GENET,FIN-00014 HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,CTR BLOOD TRANSFUS,HELSINKI,FINLAND; GENETHON,EVRY,FRANCE; CNRS,URA 1922,EVRY,FRANCE	University of Helsinki; Centre National de la Recherche Scientifique (CNRS)				Peltomaki, Paivi/0000-0001-8819-2980				AALTONEN LA, 1994, CANCER DETECT PREV, V18, P57; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; delaChapelle A, 1995, ANNU REV GENET, V29, P329, DOI 10.1146/annurev.ge.29.120195.001553; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FROGGATT NJ, 1995, LANCET, V345, P727, DOI 10.1016/S0140-6736(95)90900-1; HALILA A, 1985, SUOMEN HIST 3, P335; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; HOGLUND P, 1995, AM J HUM GENET, V57, P95; JUTIKKALA E, 1984, SUOMEN VAESTON ESIHI, P365; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIUASMAA K, 1985, SUOMEN HIST 2, P335; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; MECKLIN JP, 1995, DIS COLON RECTUM, V38, P588, DOI 10.1007/BF02054116; Meinander C.F., 1984, SUOMEN VAESTON ESIHI, P21; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PAPADOPOULOS N, 1994, SCIENCE, V263, P1825; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PIRASTU M, 1987, P NATL ACAD SCI USA, V84, P2882, DOI 10.1073/pnas.84.9.2882; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SUVANTO S, 1985, SUOMEN HIST 2, P217; Varilo T, 1996, AM J HUM GENET, V58, P506; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; VOGEL F, 1986, HUM GENET, P509	39	72	73	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1243	1251						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940269				2022-12-18	WOS:A1996VV31500010
J	WILDENBERG, SC; OETTING, WS; ALMODOVAR, C; KRUMWIEDE, M; WHITE, JG; KING, RA				WILDENBERG, SC; OETTING, WS; ALMODOVAR, C; KRUMWIEDE, M; WHITE, JG; KING, RA			A GENE CAUSING HERMANSKY-PUDLAK SYNDROME IN A PUERTO-RICAN POPULATION MAPS TO CHROMOSOME 10Q2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; STORAGE POOL DEFICIENCY; HUMAN TYROSINASE GENE; OCULOCUTANEOUS ALBINISM; SYNDROME HPS; POLYMORPHISMS; MUTATIONS; LOCI; DNA	Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disorder that affects pigment production and platelet function and causes the deposition of a ceroid-like material in various tissues. Variability in the phenotype and the presence of several potential mouse models suggest that HPS may be a heterogeneous disorder. In order to identify a gene responsible for HPS, we collected blood samples from a relatively homogeneous population in Puerto Rico where the HPS carrier frequency is estimated to be 1 in 21. Analysis of pooled DNA samples allowed us to rapidly screen the genome for candidate loci, and significant evidence for linkage was detected for a marker on chromosome 10q. This region of the human genome is conserved syntenically with the region on mouse chromosome 19 where two possible mouse models for HPS, pale ear and ruby eye, are located. This linkage result was verified with additional markers, and a maximum LOD score of 5.07 at theta = .001 was calculated for marker D10S198. Haplotype analysis places the HPS gene in a region of similar to 14 cM that contains the markers D10S198 and D10S1239.	UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED,MINNEAPOLIS,MN 55455; HPS,ARECIBO,PR	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					PHS HHS [22167] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; GARAY SM, 1979, AM J MED, V66, P737, DOI 10.1016/0002-9343(79)91111-2; HARMON KR, 1994, J LAB CLIN MED, V123, P617; HAUGE XY, 1993, HUM MOL GENET, V2, P411, DOI 10.1093/hmg/2.4.411; HELLENS RP, 1993, PLANT MOL BIOL, V22, P153, DOI 10.1007/BF00039003; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; MORRIS SW, 1991, NUCLEIC ACIDS RES, V19, P6968, DOI 10.1093/nar/19.24.6968; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; NOVAK EK, 1984, BLOOD, V63, P536; NOVAK EK, 1981, BLOOD, V57, P38; OBRIEN EP, 1994, MAMM GENOME, V5, P356, DOI 10.1007/BF00356554; OETTING WS, 1993, AM J HUM GENET, V52, P17; OETTING WS, 1993, HUM MUTAT, V2, P1, DOI 10.1002/humu.1380020102; PALMER DJ, 1983, OPHTHALMIC PAED GEN, V3, P147, DOI 10.3109/13816818309007832; RAO GHR, 1974, J LAB CLIN MED, V84, P839; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHALLREUTER KU, 1993, DERMATOLOGY, V187, P248, DOI 10.1159/000247258; SCHINELLA RA, 1980, ANN INTERN MED, V92, P20, DOI 10.7326/0003-4819-92-1-20; SCHINELLA RA, 1985, HUM PATHOL, V16, P366, DOI 10.1016/S0046-8177(85)80230-6; SHANAHAN F, 1988, AM J MED, V85, P823; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; SIMON JW, 1982, AM J OPHTHALMOL, V93, P71, DOI 10.1016/0002-9394(82)90701-2; STEFFENS DL, 1993, BIOTECHNIQUES, V15, P580; SUMMERS CG, 1988, OPHTHALMOLOGY, V95, P545; TAYLOR BA, 1994, GENOMICS, V21, P626, DOI 10.1006/geno.1994.1323; Theuring F, 1973, Dtsch Stomatol, V23, P52; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; Witkop C J Jr, 1987, Am J Med, V82, P463; WITKOP CJ, 1990, OPHTHALMIC PAED GEN, V11, P245, DOI 10.3109/13816819009020986; WITKOP CJ, 1973, ORAL SURG ORAL MED O, V35, P790, DOI 10.1016/0030-4220(73)90118-7; WITKOP CJ, 1987, AM J HEMATOL, V26, P305, DOI 10.1002/ajh.2830260403; WITKOP CJ, 1989, ADV EXP MED BIOL, V266, P283; Witkop CK, 1974, HERITABLE DISORDERS, P177; ZAITLIN D, 1993, GENOME, V36, P555, DOI 10.1139/g93-076	41	72	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					755	765						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573033				2022-12-18	WOS:A1995RV79300003
J	LANGE, E; BORRESEN, AL; CHEN, XG; CHESSA, L; CHIPLUNKAR, S; CONCANNON, P; DANDEKAR, S; GERKEN, S; LANGE, K; LIANG, T; MCCONVILLE, C; POLAKOW, J; PORRAS, O; ROTMAN, G; SANAL, O; SHEIKHAVANDI, S; SHILOH, Y; SOBEL, E; TAYLOR, M; TELATAR, M; TERAOKA, S; TOLUN, A; UDAR, N; UHRHAMMER, N; VANAGAITE, L; WANG, ZJ; WAPELHORST, B; WRIGHT, J; YANG, HM; YANG, L; ZIV, Y; GATTI, RA				LANGE, E; BORRESEN, AL; CHEN, XG; CHESSA, L; CHIPLUNKAR, S; CONCANNON, P; DANDEKAR, S; GERKEN, S; LANGE, K; LIANG, T; MCCONVILLE, C; POLAKOW, J; PORRAS, O; ROTMAN, G; SANAL, O; SHEIKHAVANDI, S; SHILOH, Y; SOBEL, E; TAYLOR, M; TELATAR, M; TERAOKA, S; TOLUN, A; UDAR, N; UHRHAMMER, N; VANAGAITE, L; WANG, ZJ; WAPELHORST, B; WRIGHT, J; YANG, HM; YANG, L; ZIV, Y; GATTI, RA			LOCATION OF AN ATAXIA-TELANGIECTASIA GENE TO AN SIMILAR-TO-500-KB INTERVAL ON CHROMOSOME 11Q23.1 - LINKAGE ANALYSIS OF 176 FAMILIES BY AN INTERNATIONAL CONSORTIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS; MAP; LOCALIZATION; POLYMORPHISM; MARKERS; REGION	We describe a 20-point linkage analysis map of chromosome 11q22-23 that is based on genotyping 249 families (59 CEPH and 190 A-T). Monte Carlo linkage analyses of 176 ataxia-telangiectasia (A-T) families localizes the major A-T locus to the region between S1819(A4) and S1818(A2). When seven nonlinking families were excluded from subsequent analyses, a 2-lod support interval of similar to 500 kb was identified between S1819(A4) and S1294. No recombinants were observed between A-T and markers S384, B7, S535, or S1294. Only 17 of the international consortium families have been assigned to complementation groups, The available evidence favors either a cluster of A-T genes on chromosome 11 or intragenic defects in a single gene.	UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOMATH, LOS ANGELES, CA 90024 USA; NORWEGIAN RADIUM HOSP, DEPT GENET, OSLO, NORWAY; UNIV ROMA LA SAPIENZA, DEPT EXPTL MED, I-00185 ROME, ITALY; VIRGINIA MASON RES CTR, SEATTLE, WA 98101 USA; UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT USA; UNIV BIRMINGHAM, CANC RES CAMPAIGN LABS, BIRMINGHAM, ENGLAND; NATL CHILDRENS HOSP, DEPT IMMUNOL, SAN JOSE, COSTA RICA; TEL AVIV UNIV, DEPT HUMAN GENET, IL-69978 TEL AVIV, ISRAEL; HACETTEPE UNIV, SCH MED, DEPT PEDIAT, ANKARA, TURKEY; BOGAZICI UNIV, DEPT BIOL, ISTANBUL, TURKEY	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oslo; Sapienza University Rome; Virginia Mason Medical Center; Utah System of Higher Education; University of Utah; University of Birmingham; Tel Aviv University; Hacettepe University; Bogazici University			Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; tolun, aslihan/0000-0002-0328-6046; Concannon, Patrick/0000-0002-5801-1859; Sobel, Eric/0000-0002-1718-0031	NCI NIH HHS [CA16042, CA57569] Funding Source: Medline; NIGMS NIH HHS [GM07104] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042, R01CA057569] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMBROSE HJ, 1994, GENOMICS, V21, P612, DOI 10.1006/geno.1994.1321; CHARMLEY P, 1990, GENOMICS, V6, P316, DOI 10.1016/0888-7543(90)90572-C; CORNELIS F, 1993, NATO ASI SER, V77, P23; FOROUD T, 1991, AM J HUM GENET, V49, P1263; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1994, CANCER RES, V54, P6007; GATTI RA, 1994, INT J RADIAT BIOL, V66, pS57, DOI 10.1080/09553009414551861; HAUGE XY, 1991, GENOMICS, V10, P527, DOI 10.1016/0888-7543(91)90431-D; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANGE E, 1993, NATO ASI SERIES H, V77, P37; LANGE K, 1991, AM J HUM GENET, V49, P1320; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P5921, DOI 10.1093/nar/18.19.5921-a; LITT M, 1993, HUM MOL GENET, V2, P909, DOI 10.1093/hmg/2.7.909; MCCONVILLE CM, 1993, HUM MOL GENET, V2, P969; MEYN MS, 1993, SCIENCE, V260, P1327, DOI 10.1126/science.8493577; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OSKATO R, 1993, AM J HUM GENET, V53, P1055; ROTMAN G, 1994, INT J RADIAT BIOL, V66, pS63, DOI 10.1080/09553009414551871; SANAL O, 1990, AM J HUM GENET, V47, P860; SANAL O, 1992, FASEB J, V6, P2848, DOI 10.1096/fasebj.6.10.1634048; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Sobel E, 1993, Stat Methods Med Res, V2, P263, DOI 10.1177/096228029300200305; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TELATAR M, 1994, HUM MOL GENET, V3, P842, DOI 10.1093/hmg/3.5.842; UHRHAMMER N, 1994, GENOMICS, V20, P278, DOI 10.1006/geno.1994.1165; UHRHAMMER N, 1995, AM J HUM GENET, V57, P103; VANAGAITE L, 1994, GENOMICS, V22, P231, DOI 10.1006/geno.1994.1370; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; XUE YH, 1991, NUCLEIC ACIDS RES, V19, P1964; ZIV Y, 1991, GENOMICS, V9, P373, DOI 10.1016/0888-7543(91)90268-J	35	72	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					112	119						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611279				2022-12-18	WOS:A1995RE62900014
J	CARINCI, F; PEZZETTI, F; SCAPOLI, L; PADULA, E; BACILIERO, U; CURIONI, C; TOGNON, M				CARINCI, F; PEZZETTI, F; SCAPOLI, L; PADULA, E; BACILIERO, U; CURIONI, C; TOGNON, M			NONSYNDROMIC CLEFT-LIP AND PALATE - EVIDENCE OF LINKAGE TO A MICROSATELLITE MARKER ON 6P23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DINUCLEOTIDE REPEAT POLYMORPHISM; GROWTH FACTOR-ALPHA; SEGREGATION ANALYSIS; NO EVIDENCE; LOCUS; GENETICS; DANISH		UNIV FERRARA, SCH MED, INST HISTOL & GEN EMBRYOL, FERRARA, ITALY; SAN BORTOLO HOSP, DEPT MAXILLOFACIAL SURG, VICENZA, ITALY	University of Ferrara; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	CARINCI, F (corresponding author), UNIV FERRARA, SCH MED, DEPT MAXILLOFACIAL SURG, FERRARA, ITALY.		Scapoli, Luca/C-6152-2008; Scapoli, Luca/I-7609-2019	Scapoli, Luca/0000-0003-4006-9910; Scapoli, Luca/0000-0003-4006-9910				BONAITIPELLIE C, 1982, J MED GENET, V11, P374; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; CHUNG CS, 1986, AM J HUM GENET, V39, P603; EIBERG H, 1987, CLIN GENET, V32, P129; FRASER FC, 1970, AM J HUM GENET, V22, P336; HECHT JT, 1993, AM J HUM GENET, V52, P1230; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; PAGES JC, 1993, HUM MOL GENET, V2, P90, DOI 10.1093/hmg/2.1.90; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4306, DOI 10.1093/nar/19.15.4306-a; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; TEMPLE K, 1989, J MED GENET, V26, P386, DOI 10.1136/jmg.26.6.386; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968	19	72	75	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					337	339						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825597				2022-12-18	WOS:A1995QC10100046
J	BRIGGS, MD; CHOI, HC; WARMAN, ML; LOUGHLIN, JA; WORDSWORTH, P; SYKES, BC; IRVEN, CMM; SMITH, M; WYNNEDAVIES, R; LIPSON, MH; BIESECKER, LG; GARBER, AP; LACHMAN, R; OLSEN, BR; RIMOIN, DL; COHN, DH				BRIGGS, MD; CHOI, HC; WARMAN, ML; LOUGHLIN, JA; WORDSWORTH, P; SYKES, BC; IRVEN, CMM; SMITH, M; WYNNEDAVIES, R; LIPSON, MH; BIESECKER, LG; GARBER, AP; LACHMAN, R; OLSEN, BR; RIMOIN, DL; COHN, DH			GENETIC-MAPPING OF A LOCUS FOR MULTIPLE EPIPHYSEAL DYSPLASIA (EDM2) TO A REGION OF CHROMOSOME-I CONTAINING A TYPE IX COLLAGEN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE MAP; L-MYC; CARTILAGE; PSEUDOACHONDROPLASIA; RECOMBINATION; LOCALIZATION; PROTEOGLYCAN; AGGRECAN; CLONING	Multiple epiphyseal dysplasia (MED) is a dominantly inherited chondrodysplasia characterized by mild short stature and early-onset osteoarthrosis. Some forms of MED clinically resemble another chondrodysplasia phenotype, the mild form of pseudoachondroplasia (PSACH). On the basis of their clinical similarities as well as similar ultrastructural and biochemical features in cartilage from some patients, it has been proposed that MED and PSACH belong to a single bone-dysplasia family. Recently, both mild and severe PSACH as well as a form of MED have been linked to the same interval on chromosome 19, suggesting that they may be allelic disorders. Linkage studies with the chromosome 19 markers were carried out in a large family with MED and excluded the previously identified interval. Using this family, we have identified an MED locus on the short arm of chromosome 1, in a region containing the gene (COL9A2) that encodes the alpha 2 chain of type IX collagen, a structural component of the cartilage extracellular matrix.	CEDARS SINAI MED CTR,DEPT OBSTET & GYNECOL,LOS ANGELES,CA 90048; STEVEN SPIELBERG PEDIAT RES CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; UNIV OXFORD,INST MOLEC MED,OXFORD,ENGLAND; JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,OXFORD OX3 9DU,ENGLAND; ST THOMAS HOSP,DEPT ORTHOPAED SURG,LONDON,ENGLAND; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; PERMANENTE MED GRP INC,SACRAMENTO,CA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; University of Oxford; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Permanente Medical Groups			Biesecker, Leslie/AAG-2526-2021	Loughlin, John/0000-0003-2018-3361	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036820, R37AR036820, R37AR036819, R01AR036819] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR36820, AR36819] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		APTE S, 1991, FEBS LETT, V282, P393, DOI 10.1016/0014-5793(91)80521-4; BARRIE H, 1958, BRIT MED J, V2, P133, DOI 10.1136/bmj.2.5089.133; BRIGGS MD, 1993, GENOMICS, V18, P656, DOI 10.1016/S0888-7543(05)80369-6; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; COLLINS A, 1992, P NATL ACAD SCI USA, V89, P4598, DOI 10.1073/pnas.89.10.4598; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; FASSLER R, IN PRESS P NATL ACAD; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HENRY I, 1988, Genomics, V3, P87, DOI 10.1016/0888-7543(88)90165-6; JENKINS RN, 1990, J BIOL CHEM, V265, P19624; KIMURA T, 1989, EUR J BIOCHEM, V179, P71, DOI 10.1111/j.1432-1033.1989.tb14522.x; KORENBERG JR, 1993, GENOMICS, V16, P546, DOI 10.1006/geno.1993.1228; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOUGHLIN J, IN PRESS HUM GENET; MAKELA TP, 1992, HUM MOL GENET, V1, P217, DOI 10.1093/hmg/1.3.217-a; MAROTEAUX P, 1980, EUR J PEDIATR, V133, P227, DOI 10.1007/BF00496081; MAYNARD JA, 1972, LAB INVEST, V26, P40; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; Ribbing S, 1937, ACTA RADIOL S, V34, P1; RIMOIN DL, 1994, HUM GENET, V93, P236, DOI 10.1007/BF00212015; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1982, EUR J PEDIATR, V138, P221, DOI 10.1007/BF00441206; STANESCU V, 1977, ARCH FR PEDIATR   S3, V34, P1; Taybi H, 1990, RADIOLOGY SYNDROMES; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VANDERREST M, 1985, J BIOL CHEM, V260, P220; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WARMAN ML, 1993, GENOMICS, V17, P694, DOI 10.1006/geno.1993.1391; WARMAN ML, IN PRESS GENOMICS; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WORDSWORTH P, 1988, J MED GENET, V25, P5201; WU JJ, 1992, J BIOL CHEM, V267, P23007; 1992, AM J MED GENET, V44, P223	39	72	74	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					678	684						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942845				2022-12-18	WOS:A1994PJ02700010
J	HOVNANIAN, A; HILAL, L; BLANCHETBARDON, C; DEPROST, Y; CHRISTIANO, AM; UITTO, J; GOOSSENS, M				HOVNANIAN, A; HILAL, L; BLANCHETBARDON, C; DEPROST, Y; CHRISTIANO, AM; UITTO, J; GOOSSENS, M			RECURRENT NONSENSE MUTATIONS WITHIN THE TYPE-VII COLLAGEN GENE IN PATIENTS WITH SEVERE RECESSIVE DYSTROPHIC EPIDERMOLYSIS-BULLOSA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMAL BASEMENT-MEMBRANE; POLYMERASE CHAIN-REACTION; ANCHORING FIBRILS; MESSENGER-RNA; HEMOPHILIA-A; COL7A1 GENE; GENOMIC DNA; LINKAGE; DOMAIN; IDENTIFICATION	The generalized mutilating form of recessive dystrophic epidermolysis bullosa (i.e., the Hallopeau-Siemens type; HS-RDEB) is a life-threatening disease characterized by extreme mucocutaneous fragility associated with absent or markedly altered anchoring fibrils (AF). Recently, we reported linkage between HS-RDEB and the type VII collagen gene (COL7A1), which encodes the major component of AF. In this study, we investigated 52 unrelated HS-RDEB patients and 2 patients with RDEB inversa for the presence, at CpG dinucleotides, of mutations changing CGA arginine codons to premature stop codons TGA within the COL7A1 gene. Eight exons containing 10 CGA codons located in the amino-terminal domain of the COL7A1 gene were studied. Mutation analysis was performed using denaturing gradient gel electrophoresis of PCR-amplified genomic fragments. Direct sequencing of PCR-amplified products with altered electrophoretic mobility led to the characterization of three premature stop codons, each in a single COL7A1 allele, in four patients. Two patients (one affected with HS-RDEB and the other with RDEB inversa) have the same C-to-T transition at arginine codon 109. Two other HS-RDEB patients have a C-to-T transition at arginine 1213 and 1216, respectively. These nonsense mutations predict the truncation of similar to 56%-32% of the polypeptide, including the collagenous and the noncollagenous NC-2 domains. On the basis of linkage analysis, which showed no evidence for locus heterogeneity in RDEB, it is expected that these patients are compound heterozygotes and have additional mutations on the other COL7A1 allele, leading to impaired AF formation. These results indicate that stop mutations within the COL7A1 gene can underlie both HS-RDEB and RDEB inversa, thus providing further evidence for the implication of this gene in RDEB.	HOP HENRI MONDOR,INSERM,U91,MOLEC GENET LAB,F-94010 CRETEIL,FRANCE; HOP ST LOUIS,MALAD CUTANEES CLIN,PARIS,FRANCE; HOP NECKER ENFANTS MALAD,SERV DERMATOL,F-75730 PARIS,FRANCE; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM,PHILADELPHIA,PA 19107	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Jefferson University; Jefferson University; Jefferson University			Hovnanian, Alain/I-4711-2017	Hovnanian, Alain/0000-0003-3412-7512	NIAMS NIH HHS [P01-AR38923, T32-AR07561] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923, T32AR007561] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALIMARA L, 1992, J MED GENET, V29, P381, DOI 10.1136/jmg.29.6.381; AMSELEM S, 1991, J CLIN INVEST, V87, P1098, DOI 10.1172/JCI115071; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BRIGGAMAN RA, 1992, EPIDERMOLYSIS BULLOS, P135; BRUCKNERTUDERMA.L, 1992, J INVEST DERMATOL, V92, P550; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; BRUCKNERTUDERMAN L, 1988, DERMATOLOGICA, V176, P57, DOI 10.1159/000248673; BURGESON RE, 1990, ANN NY ACAD SCI, V580, P32, DOI 10.1111/j.1749-6632.1990.tb17915.x; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; CHRISTIANO AM, 1992, HUM MOL GENET, V1, P475, DOI 10.1093/hmg/1.7.475; CHRISTIANO AM, 1992, GENOMICS, V14, P827, DOI 10.1016/S0888-7543(05)80204-6; Christiano Angela M., 1992, American Journal of Human Genetics, V51, pA125; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GAMMON WR, 1992, J INVEST DERMATOL, V99, P691, DOI 10.1111/1523-1747.ep12614080; GREENSPAN DS, 1993, HUM MOL GENET, V2, P273, DOI 10.1093/hmg/2.3.273; GRUIS NA, 1992, J INVEST DERMATOL, V99, P528, DOI 10.1111/1523-1747.ep12658066; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HASHIMOTO I, 1976, ARCH DERMATOL RES, V256, P137, DOI 10.1007/BF00567360; HEAGERTY AHM, 1986, BRIT J DERMATOL, V115, P125, DOI 10.1111/j.1365-2133.1986.tb05707.x; HILAL L, 1993, NAT GENET, V5, P287, DOI 10.1038/ng1193-287; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; KADOWAKI T, 1990, P NATL ACAD SCI USA, V87, P658, DOI 10.1073/pnas.87.2.658; LEIGH IM, 1988, J INVEST DERMATOL, V90, P639, DOI 10.1111/1523-1747.ep12560795; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LIN AN, 1992, EPIDERMOLYSIS BULLOS, P152; MADDALENA A, 1988, J CLIN INVEST, V82, P1353, DOI 10.1172/JCI113738; MCGRATH JA, 1992, J CUTAN PATHOL, V19, P116, DOI 10.1111/j.1600-0560.1992.tb01352.x; MCGRATH JA, 1993, J INVEST DERMATOL, V100, P366, DOI 10.1111/1523-1747.ep12471830; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; PARENTE MG, 1991, P NATL ACAD SCI USA, V88, P6931, DOI 10.1073/pnas.88.16.6931; REINER AP, 1992, HUM GENET, V89, P88, DOI 10.1007/BF00207049; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SYBERT VP, 1992, EPIDERMOLYSIS BULLOS, P235; TIDMAN MJ, 1985, J INVEST DERMATOL, V84, P374, DOI 10.1111/1523-1747.ep12265460	46	72	73	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					289	296						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037207				2022-12-18	WOS:A1994NZ33600009
J	BRZUSTOWICZ, LM; MERETTE, C; XIE, X; TOWNSEND, L; GILLIAM, TC; OTT, J				BRZUSTOWICZ, LM; MERETTE, C; XIE, X; TOWNSEND, L; GILLIAM, TC; OTT, J			MOLECULAR AND STATISTICAL APPROACHES TO THE DETECTION AND CORRECTION OF ERRORS IN GENOTYPE DATABASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; HUMANS; LOCUS; GENE; MAP	Errors in genotyping data have been shown to have a significant effect on the estimation of recombination fractions in high-resolution genetic maps. Previous estimates of errors in existing databases have been limited to the analysis of relatively few markers and have suggested rates in the range 0.5%-1.5%. The present study capitalizes on the fact that within the Centre d'Etude du Polymorphisme Humain (CEPH) collection of reference families, 21 individuals are members of more than one family, with separate DNA samples provided by CEPH for each appearance of these individuals. By comparing the genotypes of these individuals in each of the families in which they occur, an estimated error rate of 1.4% was calculated for all loci in the version 4.0 CEPH database. Removing those individuals who were clearly identified by CEPH as appearing in more than one family resulted in a 3.0% error rate for the remaining samples, suggesting that some error checking of the identified repeated individuals may occur prior to data submission. An error rate of 3.0% for version 4.0 data was also obtained for four chromosome 5 markers that were retyped through the entire CEPH collection. The effects of these errors on a multipoint map were significant, with a total sex-averaged length of 36.09 cM with the errors, and 19.47 cM with the errors corrected. Several statistical approaches to detect and allow for errors during linkage analysis are presented. One method, which identified families containing possible errors on the basis of the impact on the maximum lod score, showed particular promise, especially when combined with the limited retyping of the identified families. The impact of the demonstrated error rate in an established genotype database on high-resolution mapping is significant, raising the question of the overall value of incorporating such existing data into new genetic maps.	COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032	Columbia University; New York State Psychiatry Institute	BRZUSTOWICZ, LM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,722 W 168TH ST,UNIT 58,NEW YORK,NY 10032, USA.				NHGRI NIH HHS [HG00008, HG00424] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG000424] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BRZUSTOWICZ LM, 1992, GENOMICS, V13, P91; BUETOW KH, 1991, AM J HUM GENET, V49, P985; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; KEATS BJB, 1990, CYTOGENET CELL GENET, V55, P387, DOI 10.1159/000133023; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LASHER L, 1991, AM J HUM GENET S, V49, pA369; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1983, AM J HUM GENET, V35, P241; LIEN LL, 1991, P NATL ACAD SCI USA, V88, P7873, DOI 10.1073/pnas.88.17.7873; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109; OTT J, 1993, CLIN GENET, V43, P25; SHERRINGTON R, 1991, AM J HUM GENET, V49, P966; WEIFFENBACH B, 1991, GENOMICS, V10, P173, DOI 10.1016/0888-7543(91)90498-4	16	72	75	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1137	1145						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213837				2022-12-18	WOS:A1993MC33300018
J	MORIN, C; MITCHELL, G; LAROCHELLE, J; LAMBERT, M; OGIER, H; ROBINSON, BH; DEBRAEKELEER, M				MORIN, C; MITCHELL, G; LAROCHELLE, J; LAMBERT, M; OGIER, H; ROBINSON, BH; DEBRAEKELEER, M			CLINICAL, METABOLIC, AND GENETIC-ASPECTS OF CYTOCHROME-C-OXIDASE DEFICIENCY IN SAGUENAY-LAC-SAINT-JEAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEIGH SYNDROME; 2 SIBLINGS; ENCEPHALOMYELOPATHY; QUEBEC; DISEASE; PATIENT	Thirty-four children with lactic acidosis and Leigh encephalopathy due to cytochrome C oxidase (COX) deficiency distributed in 28 families have recently been identified an northeastern Quebec, particularly in the Saguenay-Lac-Saint-Jean (SLSJ) region. The segregation analysis was consistent with an autosomal recessive mode of inheritance. The incidence was estimated at 1/2,063 live births between 1979 and 1990, and the carrier rate was estimated at 1/23 inhabitants in SLSJ. In SLSJ, the places of origin of the COX-deficient children and their parents did not show a clustered nonuniform distribution. The genealogical reconstruction of 54 obligate carriers identified 26 ancestors common to all of them. Twenty-two were 17th-century Europeans, suggesting that the COX-deficient gene was introduced in the French-Canadian population by early settlers. These results support the hypothesis of a founder effect for COX deficiency in northeastern Quebec. Clinical findings are reported for 15 of these COX-deficient patients, age 6 mo to 11 years. Moderate developmental delay, hypotonia, ataxia, strabismus, and mild facial dysmorphism were frequent. Eleven children died in episodes of fulminant metabolic acidosis. The patients had elevated blood and cerebrospinal fluid lactate levels, decreased blood bicarbonate levels, and normal blood pH. Leigh disease and microvesicular steatosis of the liver were present in all affected patients for whom postmortem examination was performed. This biochemically uniform group of patients showed a wide range of clinical severity.	HOP CHICOUTIMI, UNITE RECH CLIN, CHICOUTIMI, PQ, CANADA; HOSP SICK CHILDREN, RES INST, CANADIAN NETWORK CTR EXCELLENCE HUMAN GENET, TORONTO M5G 1X8, ONTARIO, CANADA; HOP ST JUSTINE, SERV GENET MED, MONTREAL H3T 1C5, QUEBEC, CANADA; UNIV TORONTO, DEPT PEDIAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV QUEBEC, DEPT SCI HUMAINES, CHICOUTIMI G7H 2P9, QUEBEC, CANADA; HOP CHICOUTIMI, UNITE RECH CLIN, CHICOUTIMI, PQ, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; University of Toronto; University of Quebec; University of Quebec Chicoutimi								DEBRAEKELEER M, 1991, ANN HUM GENET, V55, P283; DEBRAEKELEER M, 1991, HUM HERED, V41, P168, DOI 10.1159/000153996; DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P302; DIMAURO S, 1985, BIOCHEM SOC T, V13, P651, DOI 10.1042/bst0130651; DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; DIMAURO S, 1987, ANN NY ACAD SCI, V484, P19; DIROCCO M, 1988, J INHERIT METAB DIS, V11, P189, DOI 10.1007/BF01804232; ESHEL G, 1991, AM J DIS CHILD, V145, P661, DOI 10.1001/archpedi.1991.02160060079025; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; FRERMAN FE, 1989, METABOLIC BASIS INHE, P915; GOODMAN SI, 1989, METABOLIC BASIS INHE, P845; GREENE CL, 1988, J PEDIATR-US, V113, P156, DOI 10.1016/S0022-3476(88)80551-1; HAYASAKA K, 1989, J INHERIT METAB DIS, V12, P247, DOI 10.1007/BF01799214; HOGANSON GE, 1984, PEDIATR RES, V18, pA22; KOGA Y, 1990, J NEUROL SCI, V95, P63, DOI 10.1016/0022-510X(90)90117-6; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; MERANTE F, 1993, AM J HUM GENET, V53, P481; MIYABAYASHI S, 1983, J INHERIT METAB DIS, V6, P121, DOI 10.1007/BF01800742; MIYABAYASHI S, 1984, BRAIN DEV-JPN, V6, P362, DOI 10.1016/S0387-7604(84)80112-6; Nyhan W.L., 1989, METABOLIC BASIS INHE, P743; OGIER H, 1988, J PEDIATR-US, V112, P734, DOI 10.1016/S0022-3476(88)80690-5; Robinson B.H., 1989, METABOLIC BASIS INHE, P869; ROBINSON BH, 1987, J PEDIATR-US, V110, P216, DOI 10.1016/S0022-3476(87)80157-9; ROBINSON BH, 1987, J PEDIATR-US, V111, P525, DOI 10.1016/S0022-3476(87)80112-9; ROSENBERG LE, 1989, METABOLIC BASIS INHE, P821; SHERWOOD G, 1984, Pediatric Research, V18, p300A; SWEETMAN L, 1989, METABOLIC BASIS INHE, P791; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TRIJBELS F, 1983, J INHERIT METAB DIS, V6, P127, DOI 10.1007/BF01810360; VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S; VANERVEN PMM, 1987, CLIN NEUROL NEUROSUR, V89, P217, DOI 10.1016/S0303-8467(87)80020-3; WILLEMS JL, 1977, PEDIATRICS, V60, P850	33	72	73	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					488	496						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8392291				2022-12-18	WOS:A1993LN82000021
J	TASSABEHJI, M; STRACHAN, T; SHARLAND, M; COLLEY, A; DONNAI, D; HARRIS, R; THAKKER, N				TASSABEHJI, M; STRACHAN, T; SHARLAND, M; COLLEY, A; DONNAI, D; HARRIS, R; THAKKER, N			TANDEM DUPLICATION WITHIN A NEUROFIBROMATOSIS TYPE-I (NF1) GENE EXON IN A FAMILY WITH FEATURES OF WATSON SYNDROME AND NOONAN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VONRECKLINGHAUSEN NEUROFIBROMATOSIS; POINT MUTATIONS; TRANSLOCATION; SEQUENCE; DELETION; ENCODES; REGION; LOCUS; GAP	Type 1 neurofibromatosis (NF1), Watson syndrome (WS), and Noonan syndrome (NS) show some overlap in clinical manifestations. In addition, WS has been shown to be linked to markers flanking the NF1 locus and a deletion at the NF1 locus demonstrated in a WS patient. This suggests either that WS and NF1 are allelic or that phenotypes arise from mutations in very closely linked genes. Here we provide evidence for the former by demonstrating a mutation in the NF1 gene in a family with features of both WS and NS. The mutation is an almost perfect in-frame tandem duplication of 42 bases in exon 28 of the NF1 gene. Unlike the mutations previously described in classical NF1, which show a preponderance of null alleles, the mutation in this family would be expected to result in a mutant neurofibromin product.	UNIV MANCHESTER,ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; ST GEORGE HOSP,SCH MED,DEPT CLIN GENET,LONDON,ENGLAND	University of Manchester; St Georges University London				sharland, mike/0000-0001-8626-8291	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABUELO DN, 1988, AM J MED GENET, V29, P937, DOI 10.1002/ajmg.1320290426; ALLANSON JE, 1991, J MED GENET, V28, P752, DOI 10.1136/jmg.28.11.752; ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; ALLANSON JE, 1985, AM J MED GENET, V21, P457, DOI 10.1002/ajmg.1320210307; ALLANSON JE, 1987, P GREENWOOD GENET CE, V6, P173; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; HALL JG, 1983, P GREENWOOD GENET CT, V2, P114; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MEINECKE P, 1987, AM J MED GENET, V26, P711; MENDEZ HMM, 1985, AM J MED GENET, V21, P477; MENON AG, 1989, GENOMICS, V5, P245, DOI 10.1016/0888-7543(89)90053-0; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PARTINGTON MW, 1985, P GREENWOOD GENET CT, V4, P105; QUATTRIN T, 1987, AM J MED GENET, V26, P645, DOI 10.1002/ajmg.1320260320; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; STARK M, 1991, HUM GENET, V87, P685; STERN HJ, 1992, J MED GENET, V29, P184, DOI 10.1136/jmg.29.3.184; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; Upadhyaya M., 1992, Human Molecular Genetics, V1, P735; UPADHYAYA M, 1990, J MED GENET, V27, P738, DOI 10.1136/jmg.27.12.738; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WATSON GH, 1967, ARCH DIS CHILD, V42, P303, DOI 10.1136/adc.42.223.303; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	31	72	78	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					90	95						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317503				2022-12-18	WOS:A1993LJ38500012
J	HEARING, VJ				HEARING, VJ			UNRAVELING THE MELANOCYTE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							NEGATIVE OCULOCUTANEOUS ALBINISM; TYROSINASE-RELATED PROTEIN; SINGLE BASE INSERTION; COAT COLOR LOCUS; MOUSE CHROMOSOME-10; GENE; MUTATIONS; MAPS; EXPRESSION; PIGMENTATION				HEARING, VJ (corresponding author), NCI,CELL BIOL LAB,BLDG 37,ROOM 1B22,BETHESDA,MD 20892, USA.							BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; BENNETT DC, IN PRESS INT REC CYT; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; BRILLIANT MH, IN PRESS MAMMAL GENO; BULTMAN SJ, 1991, P NATL ACAD SCI USA, V88, P8062, DOI 10.1073/pnas.88.18.8062; CHAJLANI V, 1992, FEBS LETT, V309, P417; CHAKRABORTY AK, 1992, PIGM CELL RES, V5, P84; CHINTAMANENI CD, 1991, P NATL ACAD SCI USA, V88, P5272, DOI 10.1073/pnas.88.12.5272; CHINTAMANENI CD, 1991, BIOCHEM BIOPH RES CO, V178, P227, DOI 10.1016/0006-291X(91)91803-K; COHEN T, 1990, NUCLEIC ACIDS RES, V18, P2807, DOI 10.1093/nar/18.9.2807; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GIEBEL LB, 1991, AM J HUM GENET, V48, P1159; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JACKSON IJ, 1992, EMBO J, V11, P527, DOI 10.1002/j.1460-2075.1992.tb05083.x; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; KING RA, 1991, J CLIN INVEST, V87, P1046, DOI 10.1172/JCI115064; KING RA, 1991, MOL BIOL MED, V8, P19; KWON BS, 1989, J INVEST DERMATOL, V93, P589, DOI 10.1111/1523-1747.ep12319693; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; KWON BS, 1987, MOL BIOL MED, V4, P339; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; OETTING WS, 1993, AM J HUM GENET, V52, P17; OETTING WS, 1991, J INVEST DERMATOL, V97, P15, DOI 10.1111/1523-1747.ep12477808; OETTING WS, IN PRESS PIGMENT CEL; QUEVEDO WC, 1987, DERMATOLOGY GENERAL, P224; RAMSAY M, 1992, AM J HUM GENET, V51, P879; SHIBAHARA S, 1986, NUCLEIC ACIDS RES, V14, P2413, DOI 10.1093/nar/14.6.2413; SHIBAHARA S, 1991, J BIOL CHEM, V266, P15895; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; STEEL KP, 1992, DEVELOPMENT, V115, P1111; TAKEDA A, 1990, J BIOL CHEM, V265, P17792; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; TRIPATHI RK, IN PRESS J BIOL CHEM; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; WICK MM, 1987, DERMATOLOGY GENERAL, P251; WITKOP CJ, 1987, METABOLIC BASIS INHE, P2905; ZHAO H, 1992, MOL BIOL CELL, V3, pA85	48	72	73	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					1	7						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434579				2022-12-18	WOS:A1993KK90800001
J	LI, Y; MULLER, B; FUHRMANN, C; VANNOUHUYS, CE; LAQUA, H; HUMPHRIES, P; SCHWINGER, E; GAL, A				LI, Y; MULLER, B; FUHRMANN, C; VANNOUHUYS, CE; LAQUA, H; HUMPHRIES, P; SCHWINGER, E; GAL, A			THE AUTOSOMAL DOMINANT FAMILIAL EXUDATIVE VITREORETINOPATHY LOCUS MAPS ON 11Q AND IS CLOSELY LINKED TO D11S533	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-11	Autosomal dominant familial exudative vitreoretinopathy (adFEVR) is a hereditary disorder characterized by the incomplete vascularization of the peripheral retina. The primary biochemical defect in adFEVR is unknown. The adFEVR locus has tentatively been assigned to 11q by linkage studies. We report the results of an extended multipoint linkage analysis of two families with adFEVR by using five markers (INT2, D11S533, D11S527, D11S35, and CD3D) from 11q13-q23. Pairwise linkage data obtained in the two families were rather similar and hence have not provided evidence for genetic heterogeneity. The highest compiled two-point lod score (3.67, at a recombination fraction of .07) was obtained for the disease locus versus D11S533. Multipoint analyses showed that the adFEVR locus maps most likely, with a maximum location score of over 20, between D11S533/D11S527 and D11S35, at recombination rates of .147 and .104, respectively. Close linkage without recombination (maximum lod score 11.26) has been found between D11S533 and D11S527.	MED UNIV LUBECK,INST HUMANGENET,RATZEBURGER ALLEE 160,W-2400 LUBECK 1,GERMANY; MED UNIV LUBECK,AUGENKLIN,LUBECK,GERMANY; UNIV MUNICH,KINDERPOLIKLIN,PADIATR GENET ABT,W-8000 MUNICH 2,GERMANY; CANISIUS WIHELMINA HOSP,DEPT OPHTHALMOL,NIJMEGEN,NETHERLANDS; UNIV DUBLIN TRINITY COLL,DEPT GENET,DUBLIN 2,IRELAND	University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Munich; Trinity College Dublin			Müller-Myhsok, Bertram/A-3289-2013					BROWNE DL, 1990, NUCLEIC ACIDS RES, V19, P4790; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; EUBANKS JH, 1991, GENOMICS, V11, P720, DOI 10.1016/0888-7543(91)90080-X; FULLWOOD P, 1991, INVEST OPHTH VIS SCI, V32, P1138; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; JUNIEN C, 1991, CYTOGENET CELL GENET, V58, P459, DOI 10.1159/000133171; LAQUA H, 1980, A GRAEF ARCH KLIN EX, V213, P121, DOI 10.1007/BF00413539; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LI Y, 1992, AM J OPHTHALMOL, V113, P712, DOI 10.1016/S0002-9394(14)74800-7; LITT M, 1990, NUCLEIC ACIDS RES, V18, P590; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; TRESE MT, 1991, INVEST OPHTH VIS SCI, V32, P692; VANNOUHUYS CE, 1982, DOC OPHTHALMOL, V54, P1; VANNOUHUYS CE, 1991, AM J OPHTHALMOL, V111, P34, DOI 10.1016/S0002-9394(14)76893-X; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4036, DOI 10.1093/nar/18.13.4036	16	72	76	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					749	754						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415220				2022-12-18	WOS:A1992JQ66700008
J	HAINES, JL; SHORT, MP; KWIATKOWSKI, DJ; JEWELL, A; ANDERMANN, E; BEJJANI, B; YANG, CH; GUSELLA, JF; AMOS, JA				HAINES, JL; SHORT, MP; KWIATKOWSKI, DJ; JEWELL, A; ANDERMANN, E; BEJJANI, B; YANG, CH; GUSELLA, JF; AMOS, JA			LOCALIZATION OF ONE GENE FOR TUBEROUS SCLEROSIS WITHIN 9Q32-9Q34, AND FURTHER EVIDENCE FOR HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; LOCUS	Tuberous sclerosis (TSC) is an autosomal dominant disorder with both neurological and cutaneous manifestations often resulting in significant disability. Although it has been studied clinically and biochemically for many years, the underlying pathophysiology remains unknown. Genetic linkage analysis provides an alternative strategy for understanding the genetic etiology of this disease. Genetic linkage of a gene for TSC to loci in 9q32-9q34 has been reported but has not been a universal finding, since absence of linkage to 9q loci, as well as linkage to loci on 11q, have also been reported. We present here data on 22 families (21 previously unreported) segregating TSC. Our results strongly support a TSC locus in the 9q32-34 region for approximately one-third of families and provide significant evidence for genetic heterogeneity. Application of newly described highly polymorphic dinucleotide repeat marker loci in TSC greatly enhanced the informativeness of our pedigrees and was vital for detecting the heterogeneity. No clear evidence of linkage to chromosome 11q22 markers was found, suggesting that a still unidentified TSC locus elsewhere in the genome may account for the majority of TSC families.	MASSACHUSETTS GEN HOSP, HEMATOL ONCOL UNIT, BOSTON, MA 02114 USA; BOSTON UNIV, MED CTR, CTR HUMAN GENET, BOSTON, MA 02215 USA; MONTREAL NEUROL HOSP & INST, DEPT NEUROGENET, MONTREAL H3A 2B4, QUEBEC, CANADA	Harvard University; Massachusetts General Hospital; Boston University; McGill University	HAINES, JL (corresponding author), MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET LAB, BLDG 149, 6TH FLOOR, 13TH ST, BOSTON, MA 02129 USA.		Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00324] Funding Source: Medline; NINDS NIH HHS [NS24279] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; CONNOR JM, 1987, J MED GENET, V24, P544, DOI 10.1136/jmg.24.9.544; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRYER AE, 1987, LANCET, V1, P659; Gomez MR, 1988, TUBEROUS SCLEROSIS; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HUNT A, 1987, DEV MED CHILD NEUROL, V29, P190; JANSSEN LAJ, 1990, GENOMICS, V8, P237, DOI 10.1016/0888-7543(90)90277-2; JANSSEN LAJ, 1991, ANN NY ACAD SCI, V615, P306; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KANDT RS, 1989, EXP NEUROL, V104, P223, DOI 10.1016/0014-4886(89)90033-2; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; NORTHRUP H, 1987, LANCET, V2, P804; OTT J, 1985, ANAL HUMAN GENETIC L, P111; OZELIUS LJ, UNPUB GENETIC LINKAG; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SMITH M, 1987, American Journal of Human Genetics, V41, pA186; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; TROFATTER JA, 1986, AM J HUM GENET, V39, P147; WEBER JL, 1989, AM J HUM GENET, V44, P388; WIEDERHOLT WC, 1985, NEUROLOGY, V35, P600, DOI 10.1212/WNL.35.4.600; 1989, CYTOGENET CELL GENET, V51; [No title captured]; [No title captured]	28	72	74	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					764	772						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897523				2022-12-18	WOS:A1991GG66500008
J	ANDERSON, IJ; GOLDBERG, RB; MARION, RW; UPHOLT, WB; TSIPOURAS, P				ANDERSON, IJ; GOLDBERG, RB; MARION, RW; UPHOLT, WB; TSIPOURAS, P			SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA - GENETIC-LINKAGE TO TYPE-II COLLAGEN (COL2AI)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06032; UNIV CONNECTICUT,CTR HLTH,DEPT BIOSTRUCT & FUNCT,FARMINGTON,CT 06032; MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,CTR CONGENITAL DISORDERS,BRONX,NY 10467	University of Connecticut; University of Connecticut; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine					NICHD NIH HHS [P01-HD22610] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022610] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALAZS I, 1989, AM J HUM GENET, V44, P182; BYERS PH, 1984, AM J MED GENET, V17, P429, DOI 10.1002/ajmg.1320170206; DAUSSET J, 1986, PRESSE MED, V15, P1801; EYRE DR, 1986, AM J HUM GENET, V39, P52; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; FRASER GR, 1969, ARCH DIS CHILD, V44, P490, DOI 10.1136/adc.44.236.490; GODFREY M, 1988, AM J HUM GENET, V43, P894; GODFREY M, 1988, AM J HUM GENET, V43, P904; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LANGER LO, 1964, RADIOLOGY, V82, P833, DOI 10.1148/82.5.833; LAW ML, 1986, ANN HUM GENET, V50, P131, DOI 10.1111/j.1469-1809.1986.tb01031.x; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; McKusick V.A., 1972, HERITABLE DISORDERS, P61; MURRAY LW, 1989, AM J HUM GENET, V45, P5; MURRAY TG, 1985, ARCH OPHTHALMOL-CHIC, V103, P407, DOI 10.1001/archopht.1985.01050030103032; OTT J, 1974, AM J HUM GENET, V26, P588; POOLE AR, 1988, J CLIN INVEST, V81, P579, DOI 10.1172/JCI113356; RAMIREZ F, 1989, COLLAGEN MOL BIOL, V4, P21; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROAF R, 1967, DEV MED CHILD NEUROL, V9, P464; SPRANGER J, 1966, LANCET, V2, P642; SPRANGER J, 1966, HELV PAEDIATR ACTA, V21, P598; SPRANGER J, 1985, ENDOCRINE GENETICS G, P315; SPRANGER JW, 1970, RADIOLOGY, V94, P313, DOI 10.1148/94.2.313; STROM CM, 1988, NUCLEIC ACIDS RES, V16, P9077, DOI 10.1093/nar/16.18.9077; SYKES B, 1985, J MED GENET, V22, P187, DOI 10.1136/jmg.22.3.187; SYKES B, 1983, DIS MARKERS, V1, P141	28	72	75	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					896	901						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	1971141				2022-12-18	WOS:A1990DD89600005
J	MAY, KM; JACOBS, PA; LEE, M; RATCLIFFE, S; ROBINSON, A; NIELSEN, J; HASSOLD, TJ				MAY, KM; JACOBS, PA; LEE, M; RATCLIFFE, S; ROBINSON, A; NIELSEN, J; HASSOLD, TJ			THE PARENTAL ORIGIN OF THE EXTRA X-CHROMOSOME IN 47,XXX FEMALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WESSEX REG CYTOGENET UNIT,SALISBURY,ENGLAND; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; NATL JEWISH HOSP NATL ASTHMA CTR,DENVER,CO 80206; CYTOGENET LAB,RISSKOV,DENMARK	University of Edinburgh; National Jewish Health	MAY, KM (corresponding author), EMORY UNIV,DIV MED GENET,2040 RIDGEWOOD DR,ATLANTA,GA 30322, USA.				NICHD NIH HHS [HD 21341, HD 25509] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341, R01HD025509] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bridges CB, 1916, GENETICS, V1, P1; Bridges CB, 1916, GENETICS, V1, P107; BURACZYNSKA M, 1989, MOL CYTOGENETIC STUD, P101; CAROTHERS AD, 1987, AM J HUM GENET, V40, P147; CAROTHERS AD, 1978, ANN HUM GENET, V41, P277, DOI 10.1111/j.1469-1809.1978.tb01895.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; HASSOLD T, 1985, ANEUPLOIDY ETIOLOGY, P103; HASSOLD TJ, 1986, TRENDS GENET, V2, P105, DOI 10.1016/0168-9525(86)90194-0; HASSOLD TJ, 1989, MOL CYTOGENETIC STUD, P115; Hook EB, 1977, POPULATION CYTOGENET, P63; JACOBS P, 1989, MOL CYTOGENETIC STUD, P135; JACOBS PA, 1988, ANN HUM GENET, V52, P93, DOI 10.1111/j.1469-1809.1988.tb01084.x; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KUPKE KG, 1989, AM J HUM GENET, V45, P599; Maniatis T., 1982, MOL CLONING; MERRIAM JR, 1964, GENETICS, V49, P109; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SANDLER L, 1981, TRISOMY 21 DOWN SYND, P181; SANGER R, 1971, J MED GENET, V8, P417, DOI 10.1136/jmg.8.4.417; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART GD, 1988, AM J HUM GENET, V42, P227; SUROSKY RT, 1988, GENETICS, V119, P273; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611	29	72	73	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					754	761						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2316522				2022-12-18	WOS:A1990CW54900013
J	WERTZ, DC; FLETCHER, JC				WERTZ, DC; FLETCHER, JC			ATTITUDES OF GENETIC COUNSELORS - A MULTINATIONAL SURVEY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV VIRGINIA,MED CTR,SCH MED,CHARLOTTESVILLE,VA 22901	University of Virginia	WERTZ, DC (corresponding author), BOSTON UNIV,SCH PUBL HLTH,HLTH SERV SECT,80 E CONCORD ST,BOSTON,MA 02118, USA.							CAPRON AM, 1979, BIRTH DEFECTS, V15; CZEIZEL A, 1981, J MED GENET, V8, P91; FLETCHER JC, 1985, CLIN GENET, V27, P199; FLETCHER JC, 1987, HUM GENET, P655; FRASER FC, 1974, AM J HUM GENET, V26, P636; IVEY AE, 1977, PERS GUID J, V55, P296, DOI 10.1002/j.2164-4918.1977.tb04992.x; PALAFOX N, 1980, CROSS CULTURAL CARIN; PEDERSON PB, 1976, COUNSELING CULTURES; Rothman B.K., 1986, TENTATIVE PREGNANCY; SORENSON JR, 1981, REPRODUCTIVE PASTS R; Sue D. W., 1981, COUNSELING CULTURALL; WERTZ DC, 1986, AM J HUM GENET, V39, P253; WERTZ DC, IN PRESS INFORMATION, V2; YUEN J, 1987, OAS, V23; ZARE N, 1984, SOC SCI MED, V19, P671, DOI 10.1016/0277-9536(84)90238-7	15	72	73	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1988	42	4					592	600						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	M6316	3348219				2022-12-18	WOS:A1988M631600010
J	BOARD, PG				BOARD, PG			GENETIC-POLYMORPHISM OF THE B-SUBUNIT OF HUMAN COAGULATION FACTOR-XIII	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BOARD, PG (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DEPT HUMAN BIOL,CANBERRA,ACT 2601,AUSTRALIA.							ASHTON GC, 1961, AUST J BIOL SCI, V14, P248, DOI 10.1071/BI9610248; BARBUI T, 1978, BRIT J HAEMATOL, V38, P267, DOI 10.1111/j.1365-2141.1978.tb01042.x; BARBUI T, 1974, THROMB DIATH HAEMOST, V32, P124; BOARD PG, 1979, AM J HUM GENET, V31, P116; CREDO RB, 1977, FED PROC, V36, P316; GIROLAMI A, 1978, Folia Haematologica (Leipzig), V105, P131; HAMPTON JW, 1966, J LAB CLIN MED, V67, P914; ISRAELS ED, 1973, J CLIN INVEST, V52, P2398, DOI 10.1172/JCI107429; LORAND L, 1970, AM J HUM GENET, V22, P89; LORAND L, 1974, BIOCHEM BIOPH RES CO, V56, P914, DOI 10.1016/S0006-291X(74)80275-5; LOSOWSKY MS, 1977, BRIT J HAEMATOL, V37, P1; MCDONAGH J, 1971, ANN HUM GENET, V35, P197, DOI 10.1111/j.1469-1809.1956.tb01392.x; RATNOFF OD, 1968, LANCET, V1, P25; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395	14	72	73	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					348	353						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	7386462				2022-12-18	WOS:A1980JX05900005
J	BEUTLER, E; KUHL, W; COMINGS, D				BEUTLER, E; KUHL, W; COMINGS, D			HEXOSAMINIDASE ISOENZYME IN TYPE-O GM2 GANGLIOSIDOSIS (SANDHOFF-JATZKEWITZ DISEASE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE MED CTR,DIV MED,1500 E DUARTE RD,DUARTE,CA 91010	City of Hope								BEUTLER E, 1973, AM J HUM GENET, V25, P42; BEUTLER E, 1974, INT RES COMMUN SYST, V2, P1090; BEUTLER E, IN PRESS; BRAIDMAN I, 1974, FEBS LETT, V41, P181, DOI 10.1016/0014-5793(74)81206-8; CARMODY PJ, 1974, BIOCHIM BIOPHYS ACTA, V371, P117, DOI 10.1016/0005-2795(74)90160-3; CARROLL M, 1972, BIOCHEM J, V126, pP17; CARROLL M, 1973, BIOCHEM J, V131, P91, DOI 10.1042/bj1310091; EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432; FROHWEIN YZ, 1967, BIOCHEMISTRY-US, V6, P2775, DOI 10.1021/bi00861a018; GILBERT F, 1975, P NATL ACAD SCI USA, V72, P263, DOI 10.1073/pnas.72.1.263; GRZESCHIK KH, 1972, NATURE-NEW BIOL, V240, P48, DOI 10.1038/newbio240048a0; IKONNE JU, 1975, AM J HUM GENET, V27, P639; LALLEY PA, 1974, P NATL ACAD SCI USA, V71, P1569, DOI 10.1073/pnas.71.4.1569; MURPHY JV, 1972, CLIN CHIM ACTA, V42, P267, DOI 10.1016/0009-8981(72)90089-7; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; POENARU L, 1973, CLIN CHIM ACTA, V43, P439; POENARU L, 1973, BIOMED EXPRESS, V19, P538; RATTAZZI MC, 1974, AM J HUM GENET, V26, pA71; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1973, LYSOSOMES STORAGE DI, P345; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2043; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2049; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; SRIVASTAVA SK, 1972, BIOCHEM BIOPH RES CO, V47, P753, DOI 10.1016/0006-291X(72)90556-6; SWALLOW DM, 1974, ANN HUM GENET, V37, P287, DOI 10.1111/j.1469-1809.1974.tb01836.x; TALLMAN JF, 1974, J BIOL CHEM, V249, P3489; TEDESCO TA, 1973, AM J HUM GENET, V25, pA78; THOMAS GH, 1974, NATURE, V250, P580, DOI 10.1038/250580a0; VANSOMEREN H, 1973, HUMANGENETIK, V1, P1	30	72	73	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					628	638						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	808963				2022-12-18	WOS:A1975AR23900006
J	HO, MW; TENNANT, L; BEUTLER, S; OBRIEN, JS				HO, MW; TENNANT, L; BEUTLER, S; OBRIEN, JS			FABRYS-DISEASE - EVIDENCE FOR A PHYSICALLY ALTERED ALPHA-GALACTOSIDASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1972, AM J HUM GENET, V24, P237; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; GOLDSTON.A, 1971, FEBS LETT, V13, P68, DOI 10.1016/0014-5793(71)80667-1; HAKOMORI SI, 1971, J BIOL CHEM, V246, P2271; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; HO MW, 1972, AM J HUM GENET, V24, P37; HO MW, 1971, CLIN CHIM ACTA, V32, P443; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; ROMEO G, 1970, SCIENCE, V170, P180, DOI 10.1126/science.170.3954.180; SCHIBANOFF JM, 1969, J LIPID RES, V10, P515; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148	12	72	71	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					256	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5028966				2022-12-18	WOS:A1972M694800003
J	LEWONTIN, RC				LEWONTIN, RC			AN ESTIMATE OF AVERAGE HETEROZYGOSITY IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HUBBY JL, 1966, GENETICS, V54, P577; LEWONTIN RC, 1966, GENETICS, V54, P595; RACE RR, 1962, BLOOD GROUPS MAN	4	72	72	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	5					681	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	99950	6050739				2022-12-18	WOS:A19679995000007
J	SCHULL, WJ; NEEL, JV; HASHIZUME, A				SCHULL, WJ; NEEL, JV; HASHIZUME, A			SOME FURTHER OBSERVATIONS ON SEX RATIO AMONG INFANTS BORN TO SURVIVORS OF ATOMIC BOMBINGS OF HIROSHIMA AND NAGASAKI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEEBE GW, 1962, RADIAT RES, V16, P253, DOI 10.2307/3571157; Cochran WG, 1940, ANN MATH STAT, V11, P335, DOI 10.1214/aoms/1177731871; COX DW, 1964, AM J HUM GENET, V16, P214; EISENHART C, 1947, TECHNIQUES STATIS ED, P249; KATO H, 1966, AM J HUM GENET, V18, P339; MULLER C, 1962, ZBL GYNAKOL, V84, P561; MUSIL J, 1962, ROZHL TUBERK, V22, P164; NEEL JV, 1956, 461 NAT AC SCIENC NA, P241; NEEL JV, 1963, CHANGING PERSPECTIVE, P97; NOVITSKI E, 1958, AM J HUM GENET, V10, P268; NOVITSKI E, 1956, ANN HUM GENET, V21, P123, DOI 10.1111/j.1469-1809.1971.tb00271.x; PAULSON E, 1947, TECHNIQUES STATISTIC, P249; RUSSELL WL, 1965, P NATL ACAD SCI USA, V54, P1552, DOI 10.1073/pnas.54.6.1552; SCHULL WJ, 1959, AM J PUBLIC HEALTH N, V49, P1621, DOI 10.2105/AJPH.49.12.1621; SCHULL WJ, 1958, SCIENCE, V128, P343, DOI 10.1126/science.128.3320.343; SCHULL WJ, 1963, NUCLEONICS, V21, P54	16	72	74	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	4					328	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	81309	5945952				2022-12-18	WOS:A19668130900002
J	NANCE, WE; UCHIDA, I				NANCE, WE; UCHIDA, I			TURNERS SYNDROME TWINNING + UNUSUAL VARIANT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; BOYER SH, 1961, ANN HUM GENET, V25, P215; CARR DH, 1963, LANCET, V2, P603; CHILDS B, 1958, B JOHNS HOPKINS HOSP, V102, P21; DENT T, 1963, 11 P INT C GEN HAG, V1, P304; FRASER GR, 1963, ANN HUM GENET, V26, P297, DOI 10.1111/j.1469-1809.1963.tb01325.x; GARTLER S. M., 1962, CYTOGENETICS, V1, P1, DOI 10.1159/000129708; JEANNERET O, 1962, AM J HUM GENET, V14, P410; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; LEJEUNE J, 1961, CR HEBD ACAD SCI, V252, P3148; LEMLI L, 1963, J PEDIATR-US, V63, P577, DOI 10.1016/S0022-3476(63)80368-6; LINDSTEN J, 1963, LANCET, V1, P558; Lindsten j, 1963, NATURE ORIGIN X CHRO; NANCE WE, 1959, MEDICINE, V38, P403, DOI 10.1097/00005792-195912000-00003; NANCE WE, 1963, SCIENCE, V142, P1075, DOI 10.1126/science.142.3595.1075; OSTER J, 1956, Dan Med Bull, V3, P158; RESSLER H, 1963, J LAB CLIN MED, V62, P571; RESSLER H, 1963, NATURE, V198, P888; RUSSELL LIANE BRAUCH, 1962, PROGR MED GENET, V2, P230; STEINBERG AG, 1962, PROGRESS MEDICAL  ED, V2, P230; THERMAN E, 1961, AM J HUM GENET, V13, P193; TURNER HH, 1962, J CLIN ENDOCR METAB, V22, P660, DOI 10.1210/jcem-22-6-660; ZELLWEGER H, 1961, HELV PAEDIATR ACTA, V16, P670	23	72	72	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	3					380	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2973A	14207553				2022-12-18	WOS:A19642973A00003
J	HERSH, AH; STECHER, RM; SOLOMON, WM; WOLPAW, R; HAUSER, H				HERSH, AH; STECHER, RM; SOLOMON, WM; WOLPAW, R; HAUSER, H			HEREDITY IN ANKYLOSING SPONDYLITIS - A STUDY OF 50 FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BUCKLEY CW, 1945, LANCET, V2, P862; CAMPBELL AMG, 1947, LANCET, V252, P406; CLAUSSEN F, 1937, ZBL INN MED, V58, P897; CLAUSSEN F, 1937, ZBL INN MED, V58, P913; CRANG CL, COMMUNICATION; DE BLECOURT J J, 1949, Ned Tijdschr Geneeskd, V93, P3814; DIJKGRAAF S, 1947, EXPERIENTIA, V3, P493, DOI 10.1007/BF02154563; EHRLICH C, 1930, SOGENANNTE BECHTEREW, P58; FISCHER A, 1930, MITT GRENZGEB MED CH, V42, P586; Fletcher E, 1944, LANCET, V1, P754; FRASER TN, 1950, ANN RHEUM DIS, V9, P231, DOI 10.1136/ard.9.3.231; GEILINGER W, 1918, Z ORTHOP CHIR, V38, P183; GOLDSCHMIDT RB, 1948, EXPERIENTIA, V4, P465, DOI 10.1007/BF02164501; HOGBEN L, 1939, NATURE NURTURE, P143; KUHNS J, COMMUNICATION; MASON RM, 1950, ANN REP W LONDON HOS; PAFF GH, 1950, ANAT REC, V106, P229; POLLEY HF, 1947, ANN INTERN MED, V26, P240, DOI 10.7326/0003-4819-26-2-240; Ray M B, 1932, Proc R Soc Med, V25, P325; REYNOLDS LJ, COMMUNICATION; RIECKER HH, 1950, ANN INTERN MED, V33, P1254, DOI 10.7326/0003-4819-33-5-1254; ROGOFF B, 1948, ANN RHEUM DIS, V7, P40; ROSENBERG EF, 1948, ANN RHEUMAT DIS LOND, V7, P41; SCOTT SG, 1942, ADOLESCENT SPONDYLIT, P132; SHIFRIN NE, 1950, ANAT REC, V106, P247; SIMPSON NRW, 1949, BRIT MED J, V1, P214, DOI 10.1136/bmj.1.4596.214; SMYTH CJ, 1948, J CLIN INVEST, V27, P749, DOI 10.1172/JCI102025; STAUFFER J, 1946, J HERED, V37, P287, DOI 10.1093/oxfordjournals.jhered.a105640; STECHER RM, 1949, ANN INTERN MED, V31, P595, DOI 10.7326/0003-4819-31-4-595; STECHER RM, 1946, AM J ROENTGENOL, V56, P601; TALKOV RH, 1948, ANN RHEUM DIS, V7, P40; TEGNER W, 1949, LANCET, V257, P196; WEIL AJ, 1930, DEUT MED WOCHENSCHR, V56, P2038; WEST HF, 1948, THESIS BRISTOL; WRIGHT, CITED INDIRECTLY	35	72	74	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1950	2	4					391	408						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS391	14837909				2022-12-18	WOS:A1950XS39100007
J	Shah, N; Hou, YCC; Yu, HC; Sainger, R; Caskey, CT; Venter, JC; Telenti, A				Shah, Naisha; Hou, Ying-Chen Claire; Yu, Hung-Chun; Sainger, Rachana; Caskey, C. Thomas; Venter, J. Craig; Telenti, Amalio			Identification of Misclassified ClinVar Variants via Disease Population Prevalence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALIGNANT HYPERTHERMIA; INCIDENTAL FINDINGS; GENOMIC VARIATION; MEDICAL GENETICS; AMERICAN-COLLEGE; CLINICAL EXOME; INDIVIDUALS; FREQUENCIES; HEMOCHROMATOSIS; RECOMMENDATIONS	There is a significant interest in the standardized classification of human genetic variants. We used whole-genome sequence data from 10,495 unrelated individuals to contrast population frequency of pathogenic variants to the expected population prevalence of the disease. Analyses included the ACMG-recommended 59 gene-condition sets for incidental findings and 463 genes associated with 265 OrphaNet conditions. A total of 25,505 variants were used to identify patterns of inflation (i.e., excess genetic risk and misclassification). Inflation increases as the level of evidence supporting the pathogenic nature of the variant decreases. We observed up to 11.5% of genetic disorders with inflation in pathogenic variant sets and up to 92.3% for the variant set with conflicting interpretations. This improved to 7.7% and 57.7%, respectively, after filtering for disease-specific allele frequency. The patterns of inflation were replicated using public data from more than 138,000 genomes. The burden of rare variants was a main contributing factor of the observed inflation, indicating collective misclassified rare variants. We also analyzed the dynamics of re-classification of variant pathogenicity in ClinVar over time, which indicates progressive improvement in variant classification. The study shows that databases include a significant proportion of wrongly ascertained variants; however, it underscores the critical role of ClinVar to contrast claims and foster validation across submitters.	[Shah, Naisha; Hou, Ying-Chen Claire; Yu, Hung-Chun; Sainger, Rachana; Venter, J. Craig] Human Longev Inc, San Diego, CA 92121 USA; [Caskey, C. Thomas] Baylor Coll Med, Houston, TX 77030 USA; [Caskey, C. Thomas; Telenti, Amalio] J Craig Venter Inst, La Jolla, CA 92037 USA	Baylor College of Medicine; J. Craig Venter Institute	Venter, JC (corresponding author), Human Longev Inc, San Diego, CA 92121 USA.; Telenti, A (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.	jcventer@jcvi.org; atelenti@jcvi.org	Telenti, Amalio/AAY-1674-2021	Yu, Hung-Chun/0000-0002-4980-8508				Adams MC, 2016, GENET MED, V18, P593, DOI 10.1038/gim.2015.136; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Asselta R, 2009, SEMIN THROMB HEMOST, V35, P382, DOI 10.1055/s-0029-1225760; Bennett CA, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000163; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ding LE, 2015, GENET MED, V17, P197, DOI 10.1038/gim.2014.94; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Goldfeder RL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0269-0; Gonsalves SG, 2013, ANESTHESIOLOGY, V119, P1043, DOI 10.1097/ALN.0b013e3182a8a8e7; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hunter JE, 2016, GENET MED, V18, P1258, DOI 10.1038/gim.2016.40; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056; Kobayashi Y, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0403-7; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lincoln S.E., 2017, JCO PRECIS ONCOL, V1, P1, DOI [DOI 10.1200/P0.16.00020, 10. 1200/PO. 16. 00020]; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Manrai AK, 2016, JAMA-J AM MED ASSOC, V315, P1233, DOI 10.1001/jama.2016.1519; Merritt A, 2017, BRIT J ANAESTH, V118, P533, DOI 10.1093/bja/aex042; Nelson HD., 2013, RISK ASSESSMENT GENE; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Rehm HL, 2017, GENET MED, V19, P1092, DOI 10.1038/gim.2017.90; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rossi E, 1999, J GASTROEN HEPATOL, V14, P427, DOI 10.1046/j.1440-1746.1999.01884.x; Rossi E, 2008, EXPERT REV HEMATOL, V1, P205, DOI 10.1586/17474086.1.2.205; Song W, 2016, GENET MED, V18, P850, DOI 10.1038/gim.2015.180; Tarailo-Graovac M, 2017, GENET MED, V19, P1300, DOI 10.1038/gim.2017.50; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Whiffin N, 2017, GENET MED, V19, P1151, DOI 10.1038/gim.2017.26; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yang S, 2017, GENET MED, V19, P1118, DOI 10.1038/gim.2017.60; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	38	71	72	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					609	619		10.1016/j.ajhg.2018.02.019	http://dx.doi.org/10.1016/j.ajhg.2018.02.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29625023	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000429340800008
J	Do, C; Lang, CF; Lin, J; Darbary, H; Krupska, I; Gaba, A; Petukhova, L; Vonsattel, JP; Gallagher, MP; Goland, RS; Clynes, RA; Dwork, A; Kral, JG; Monk, C; Christiano, AM; Tycko, B				Do, Catherine; Lang, Charles F.; Lin, John; Darbary, Huferesh; Krupska, Izabela; Gaba, Aulona; Petukhova, Lynn; Vonsattel, Jean-Paul; Gallagher, Mary P.; Goland, Robin S.; Clynes, Raphael A.; Dwork, Andrew; Kral, John G.; Monk, Catherine; Christiano, Angela M.; Tycko, Benjamin			Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC ARCHITECTURE; TRANSCRIPTION FACTOR; ALZHEIMERS-DISEASE; TARGET GENES; ZFP57; METAANALYSIS; BINDING; PROTEIN	Haplotype-dependent allele-specific methylation (hap-ASM) can impact disease susceptibility, but maps of this phenomenon using stringent criteria in disease-relevant tissues remain sparse. Here we apply array-based and Methyl-Seq approaches to multiple human tissues and cell types, including brain, purified neurons and glia, T lymphocytes, and placenta, and identify 795 hap-ASM differentially methylated regions (DMRs) and 3,082 strong methylation quantitative trait loci (mQTLs), most not previously reported. More than half of these DMRs have cell type-restricted ASM, and among them are 188 hap-ASM DMRs and 933 mQTLs located near GWAS signals for immune and neurological disorders. Targeted bis-seq confirmed hap-ASM in 12/13 loci tested, including CCDC155, CD69, FRMD1, IRF1, KBTBD11, and S100A*-ILF2, associated with immune phenotypes, MYT1L, PTPRN2, CMTM8 and CELF2, associated with neurological disorders, NGFR and HLA-DRB6, associated with both immunological and brain disorders, and ZFP57, a trans-acting regulator of genomic imprinting. Polymorphic CTCF and transcription factor (TF) binding sites were over-represented among hap-ASM DMRs and mQTLs, and analysis of the human data, supplemented by cross-species comparisons to macaques, indicated that CTCF and TF binding likelihood predicts the strength and direction of the allelic methylation asymmetry. These results show that hap-ASM is highly tissue specific; an important trans-acting regulator of genomic imprinting is regulated by this phenomenon; and variation in CTCF and TF binding sites is an underlying mechanism, and maps of hap-ASM and mQTLs reveal regulatory sequences underlying supra-and sub-threshold GWAS peaks in immunological and neurological disorders.	[Do, Catherine; Lang, Charles F.; Lin, John; Darbary, Huferesh; Krupska, Izabela; Gaba, Aulona; Tycko, Benjamin] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Gaba, Aulona] Vienna Med Univ, Dept Obstet & Gynecol, A-1090 Vienna, Austria; [Petukhova, Lynn] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; [Petukhova, Lynn; Clynes, Raphael A.; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Vonsattel, Jean-Paul; Clynes, Raphael A.; Tycko, Benjamin] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Vonsattel, Jean-Paul; Tycko, Benjamin] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Gallagher, Mary P.] Columbia Univ, Div Pediat Endocrinol Diabet & Metab, New York, NY 10032 USA; [Goland, Robin S.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Clynes, Raphael A.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA; [Kral, John G.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Kral, John G.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Monk, Catherine] Columbia Univ, Dept Psychiat & Behav Med, New York, NY 10032 USA; [Monk, Catherine] Columbia Univ, Dept Obstet & Gynecol, New York, NY 10032 USA; [Christiano, Angela M.] Columbia Univ, Dept Genet, New York, NY 10032 USA; [Christiano, Angela M.] Columbia Univ, Dept Dev, New York, NY 10032 USA	Columbia University; Medical University of Vienna; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; Columbia University; Columbia University; Columbia University	Do, C; Tycko, B (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.; Tycko, B (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.; Tycko, B (corresponding author), Columbia Univ, Dept Cell Biol, New York, NY 10032 USA.	cd2695@columbia.edu; bt12@columbia.edu	Gaba, Aulona/R-2633-2019; Monk, Catherine/X-2277-2019; Darbary, Huferesh/GRX-2935-2022; Petukhova, Lynn/W-6858-2019; Gaba, Aulona/Q-7871-2018	Gaba, Aulona/0000-0003-1305-764X; Monk, Catherine/0000-0001-7827-2602; Gaba, Aulona/0000-0003-1305-764X; do, catherine/0000-0002-9796-4345; , Huferesh/0000-0002-3986-2359; Lang, Charles/0000-0001-6428-3941; Lin, John/0000-0003-1783-8152; Gallagher, Mary/0000-0002-5844-2309	NIH [1R01 MH092580-01, 1R01AG036040-01, 1R01AG035020-01, DP3 DK094400-01]; National Cancer Institute (NCI) [P30CA016056]; NCI [P30CA013696]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035020, R01AG036040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants 1R01 MH092580-01, 1R01AG036040-01, 1R01AG035020-01, and DP3 DK094400-01. SNP genotyping and methylation Beadchip assays were performed by the Genomics Shared Resource of Roswell Park Cancer Institute, supported by National Cancer Institute (NCI) grant P30CA016056. Targeted Nextgen bisulfite sequencing and FANS were performed by the Epigenetics and Flow Cytometry Shared Resources of the Herbert Irving Comprehensive Cancer Center, supported by NCI grant P30CA013696.	Adkins DE, 2011, MOL PSYCHIATR, V16, P321, DOI 10.1038/mp.2010.14; Baglivo I, 2013, FEBS LETT, V587, P1474, DOI 10.1016/j.febslet.2013.02.045; Bakulski KM, 2012, J ALZHEIMERS DIS, V29, P571, DOI 10.3233/JAD-2012-111223; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Boonen SE, 2013, DIABETES CARE, V36, P505, DOI 10.2337/dc12-0700; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butter F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002982; Curtis D, 2011, PSYCHIAT GENET, V21, P1, DOI 10.1097/YPG.0b013e3283413382; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; De Rocker N, 2015, GENET MED, V17, P460, DOI 10.1038/gim.2014.124; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Fanous AH, 2012, AM J PSYCHIAT, V169, P1309, DOI 10.1176/appi.ajp.2012.12020218; Feldmann A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003994; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hachwell E, 2007, TRENDS GENET, V23, P588, DOI 10.1016/j.tig.2007.08.010; Hagarman JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053880; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Hellman A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-11; Hutchinson JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098464; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kennedy RB, 2012, HUM GENET, V131, P1403, DOI 10.1007/s00439-012-1174-2; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Mann IK, 2013, GENOME RES, V23, P988, DOI 10.1101/gr.146654.112; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matevossian Anouch, 2008, J Vis Exp, DOI 10.3791/914; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Mendioroz M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0827-6; Mero IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058352; Michels KB, 2013, NAT METHODS, V10, P949, DOI 10.1038/nmeth.2632; Miura K, 2014, J MED VIROL, V86, P1153, DOI 10.1002/jmv.23943; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pacini A, 2005, MOL BRAIN RES, V140, P34, DOI 10.1016/j.molbrainres.2005.07.006; Paliwal A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003622; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Plongthongkum N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099313; Popadin KY, 2014, AM J HUM GENET, V95, P660, DOI 10.1016/j.ajhg.2014.11.003; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Raychaudhuri SP, 2011, ARTHRITIS RHEUM-US, V63, P3243, DOI 10.1002/art.30564; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Shamis Y, 2015, P NATL ACAD SCI USA, V112, pE2020, DOI 10.1073/pnas.1415541112; Shi JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4365; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Takikawa S, 2013, EPIGENETICS-US, V8, P1268, DOI 10.4161/epi.26544; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; Tycko B, 2010, AM J HUM GENET, V86, P109, DOI 10.1016/j.ajhg.2010.01.021; Uhm TG, 2012, EXP MOL MED, V44, P268, DOI 10.3858/emm.2012.44.4.022; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Yang BZ, 2011, NEUROPSYCHOPHARMACOL, V36, P2422, DOI 10.1038/npp.2011.122; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang X, 2014, HUM MOL GENET, V23, P5893, DOI 10.1093/hmg/ddu313; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	93	71	72	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					934	955		10.1016/j.ajhg.2016.03.027	http://dx.doi.org/10.1016/j.ajhg.2016.03.027			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27153397	Green Published, Bronze			2022-12-18	WOS:000375869300011
J	Haack, TB; Staufner, C; Kopke, MG; Straub, BK; Kolker, S; Thiel, C; Freisinger, P; Baric, I; McKiernan, PJ; Dikow, N; Harting, I; Beisse, F; Burgard, P; Kotzaeridou, U; Kuhr, J; Himbert, U; Taylor, RW; Distelmaier, F; Vockley, J; Ghaloul-Gonzalez, L; Zschocke, J; Kremer, LS; Graf, E; Schwarzmayr, T; Bader, DM; Gagneur, J; Wieland, T; Terrile, C; Strom, TM; Meitinger, T; Hoffmann, GF; Prokisch, H				Haack, Tobias B.; Staufner, Christian; Koepke, Marlies G.; Straub, Beate K.; Koelker, Stefan; Thiel, Christian; Freisinger, Peter; Baric, Ivo; McKiernan, Patrick J.; Dikow, Nicola; Harting, Inga; Beisse, Flemming; Burgard, Peter; Kotzaeridou, Urania; Kuehr, Joachim; Himbert, Urban; Taylor, Robert W.; Distelmaier, Felix; Vockley, Jerry; Ghaloul-Gonzalez, Lina; Zschocke, Johannes; Kremer, Laura S.; Graf, Elisabeth; Schwarzmayr, Thomas; Bader, Daniel M.; Gagneur, Julien; Wieland, Thomas; Terrile, Caterina; Strom, Tim M.; Meitinger, Thomas; Hoffmann, Georg F.; Prokisch, Holger			Biallelic Mutations in NBAS Cause Recurrent Acute Liver Failure with Onset in Infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; DEFICIENCY	Acute liver failure (ALF) in infancy and childhood is a life-threatening emergency. Few conditions are known to cause recurrent acute liver failure (RALF), and in about 50% of cases, the underlying molecular cause remains unresolved. Exome sequencing in five unrelated individuals with fever-dependent RALF revealed biallelic mutations in NBAS. Subsequent Sanger sequencing of NBAS in 15 additional unrelated individuals with RALF or ALF identified compound heterozygous mutations in an additional six individuals from five families. Immunoblot analysis of mutant fibroblasts showed reduced protein levels of NBAS and its proposed interaction partner p31, both involved in retrograde transport between endoplasmic reticulum and Golgi. We recommend NBAS analysis in individuals with acute infantile liver failure, especially if triggered by fever.	[Haack, Tobias B.; Koepke, Marlies G.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Koepke, Marlies G.; Kremer, Laura S.; Graf, Elisabeth; Schwarzmayr, Thomas; Wieland, Thomas; Terrile, Caterina; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Staufner, Christian; Koelker, Stefan; Thiel, Christian; Burgard, Peter; Kotzaeridou, Urania; Hoffmann, Georg F.] Univ Heidelberg Hosp, Dept Gen Pediat, Div Neuropediat & Metab Med, D-69120 Heidelberg, Germany; [Straub, Beate K.] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Freisinger, Peter] Childrens Hosp Reutlingen, D-72764 Reutlingen, Germany; [Baric, Ivo] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb 10000, Croatia; [Baric, Ivo] Univ Zagreb, Sch Med, Zagreb 10000, Croatia; [McKiernan, Patrick J.] Birmingham Childrens Hosp, Liver Unit, Birmingham B4 6NH, W Midlands, England; [Dikow, Nicola] Univ Heidelberg Hosp, Inst Human Genet, D-69120 Heidelberg, Germany; [Harting, Inga] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Beisse, Flemming] Univ Heidelberg Hosp, Dept Ophthalmol, D-69120 Heidelberg, Germany; [Kuehr, Joachim] Childrens Hosp Karlsruhe, D-76133 Karlsruhe, Germany; [Himbert, Urban] Childrens Hosp St Elisabeth, D-56564 Neuwied, Germany; [Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Distelmaier, Felix] Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Vockley, Jerry; Ghaloul-Gonzalez, Lina] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA 15224 USA; [Zschocke, Johannes] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Bader, Daniel M.; Gagneur, Julien] Univ Munich, Gene Ctr, Computat Genom, D-81377 Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Zagreb; University of Zagreb; University of Birmingham; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Newcastle University - UK; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Innsbruck; University of Munich	Prokisch, H (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.	prokisch@helmholtz-muenchen.de	Vockley, Jerry/AAF-8523-2020; Meitinger, Thomas/O-1318-2015; Vockley, Jerry/B-5210-2016; Zschocke, Johannes/C-5885-2013	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Zschocke, Johannes/0000-0002-0046-8274; Kremer, Laura/0000-0002-1647-7538; Gagneur, Julien/0000-0002-8924-8365; Straub, Beate/0000-0002-4857-1561; Bader, Daniel Magnus/0000-0003-1875-6044; Meitinger, Thomas/0000-0002-8838-8403; Thiel, Christian/0000-0001-6419-8747; Vornhuelz, Marlies Gwendolyn/0000-0003-1197-0419; Prokisch, Holger/0000-0003-2379-6286	German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET) [01GM1113C]; German Bundesministerium fur Bildung und Forschung (BMBF) through E-Rare project GENOMIT [01GM1207]; BMBF through the Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C, 01ZX1405A]; Wellcome Trust Strategic Award [096919/Z/11/Z]; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; DFG [STR 1160/1-1, 1-2]; DFG Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM); Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET)(Federal Ministry of Education & Research (BMBF)); German Bundesministerium fur Bildung und Forschung (BMBF) through E-Rare project GENOMIT(Federal Ministry of Education & Research (BMBF)); BMBF through the Juniorverbund in der Systemmedizin "mitOmics"(Federal Ministry of Education & Research (BMBF)); Wellcome Trust Strategic Award(Wellcome Trust); UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; DFG(German Research Foundation (DFG)); DFG Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Lena Pawella, Elisabeth Specht-Delius, Eva Eiteneuer, Marion Hahne, Zlata Antoni, Lena Protzmann, and Sabine Schafer for excellent technical assistance. Human control tissues were provided by the Tissue Bank of the National Center for Tumor Diseases (NCT, Heidelberg, Germany) in accordance with the ethics committee of the University of Heidelberg. We thank Dr. Ronald J.A. Wanders, Department of Medical Biochemistry, Academic Medical Centre, University of Amsterdam, the Netherlands, who excluded fatty acid oxidation disorders in individuals from families 1, 2, 3, 5, and 7. This study was supported by the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET, 01GM1113C to T.M. and H.P.) and through the E-Rare project GENOMIT (01GM1207 for T.M. and H.P.). T.B.H. and J.G. were supported by the BMBF through the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C and 01ZX1405A). R.W.T was supported by a Wellcome Trust Strategic Award (096919/Z/11/Z) and the UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service. B.K.S. was supported by grants of the DFG (STR 1160/1-1 and 1-2). D.M.B. was supported by a DFG Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM).	Al Odaib A, 1998, NEW ENGL J MED, V339, P1752, DOI 10.1056/NEJM199812103392405; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoki T, 2009, MOL BIOL CELL, V20, P2639, DOI 10.1091/mbc.E08-11-1104; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brassier A, 2013, MOL GENET METAB, V109, P28, DOI 10.1016/j.ymgme.2013.01.017; Engelmann G, 2008, J INHERIT METAB DIS, V31, P540, DOI 10.1007/s10545-008-0867-0; Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hong WJ, 2014, TRENDS CELL BIOL, V24, P35, DOI 10.1016/j.tcb.2013.09.006; Jacob DA, 2006, CLIN TRANSPLANT, V20, P211, DOI 10.1111/j.1399-0012.2005.00471.x; Lin XQ, 2007, MOL CELL BIOL, V27, P4905, DOI 10.1128/MCB.02396-06; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maksimova N, 2010, J MED GENET, V47, P538, DOI 10.1136/jmg.2009.074815; Narkewicz MR, 2009, J PEDIATR-US, V155, P801, DOI 10.1016/j.jpeds.2009.06.005; Rinaldo P, 2001, SEMIN LIVER DIS, V21, P489, DOI 10.1055/s-2001-19037; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Uemura T, 2009, MOL CELL BIOL, V29, P1869, DOI 10.1128/MCB.01089-08	19	71	83	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					163	169		10.1016/j.ajhg.2015.05.009	http://dx.doi.org/10.1016/j.ajhg.2015.05.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26073778	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000358189500014
J	Skibola, CF; Berndt, SI; Vijai, J; Conde, L; Wang, ZM; Yeager, M; de Bakker, PIW; Birmann, BM; Vajdic, CM; Foo, JN; Bracci, PM; Vermeulen, RCH; Slager, SL; de Sanjose, S; Wang, SS; Linet, MS; Salles, G; Lan, Q; Severi, G; Hjalgrim, H; Lightfoot, T; Melbye, M; Gu, J; Ghesquieres, H; Link, BK; Morton, LM; Holly, EA; Smith, A; Tinker, LF; Teras, LR; Kricker, A; Becker, N; Purdue, MP; Spinelli, JJ; Zhang, YW; Giles, GG; Vineis, P; Monnereau, A; Bertrand, KA; Albanes, D; Zeleniuch-Jacquotte, A; Gabbas, A; Chung, CC; Burdett, L; Hutchinson, A; Lawrence, C; Montalvan, R; Liang, LM; Huang, JY; Ma, BS; Liu, JJ; Adami, HO; Glimelius, B; Ye, YQ; Nowakowski, GS; Dogan, A; Thompson, CA; Habermann, TM; Novak, AJ; Liebow, M; Witzig, TE; Weiner, GJ; Schenk, M; Hartge, P; De Roos, AJ; Cozen, W; Zhi, DG; Akers, NK; Riby, J; Smith, MT; Lacher, M; Villano, DJ; Maria, A; Roman, E; Kane, E; Jackson, RD; North, KE; Diver, WR; Turner, J; Armstrong, BK; Benavente, Y; Boffetta, P; Brennan, P; Foretova, L; Maynadie, M; Staines, A; McKay, J; Brooks-Wilson, AR; Zheng, TZ; Holford, TR; Chamosa, S; Kaaks, R; Kelly, RS; Ohlsson, B; Travis, RC; Weiderpass, E; Clave, J; Giovannucci, E; Kraft, P; Virtamo, J; Mazza, P; Cocco, P; Ennas, MG; Chiu, BCH; Fraumeni, JR; Nieters, A; Offit, K; Wu, XF; Cerhan, JR; Smedby, KE; Chanock, SJ; Rothman, N				Skibola, Christine F.; Berndt, Sonja I.; Vijai, Joseph; Conde, Lucia; Wang, Zhaoming; Yeager, Meredith; de Bakker, Paul I. W.; Birmann, Brenda M.; Vajdic, Claire M.; Foo, Jia-Nee; Bracci, Paige M.; Vermeulen, Roel C. H.; Slager, Susan L.; de Sanjose, Silvia; Wang, Sophia S.; Linet, Martha S.; Salles, Gilles; Lan, Qing; Severi, Gianluca; Hjalgrim, Henrik; Lightfoot, Tracy; Melbye, Mads; Gu, Jian; Ghesquieres, Herve; Link, Brian K.; Morton, Lindsay M.; Holly, Elizabeth A.; Smith, Alex; Tinker, Lesley F.; Teras, Lauren R.; Kricker, Anne; Becker, Nikolaus; Purdue, Mark P.; Spinelli, John J.; Zhang, Yawei; Giles, Graham G.; Vineis, Paolo; Monnereau, Alain; Bertrand, Kimberly A.; Albanes, Demetrius; Zeleniuch-Jacquotte, Anne; Gabbas, Attilio; Chung, Charles C.; Burdett, Laurie; Hutchinson, Amy; Lawrence, Charles; Montalvan, Rebecca; Liang, Liming; Huang, Jinyan; Ma, Baoshan; Liu, Jianjun; Adami, Hans-Olov; Glimelius, Bengt; Ye, Yuanqing; Nowakowski, Grzegorz S.; Dogan, Ahmet; Thompson, Carrie A.; Habermann, Thomas M.; Novak, Anne J.; Liebow, Mark; Witzig, Thomas E.; Weiner, George J.; Schenk, Maryjean; Hartge, Patricia; De Roos, Anneclaire J.; Cozen, Wendy; Zhi, Degui; Akers, Nicholas K.; Riby, Jacques; Smith, Martyn T.; Lacher, Mortimer; Villano, Danylo J.; Maria, Ann; Roman, Eve; Kane, Eleanor; Jackson, Rebecca D.; North, Kari E.; Diver, W. Ryan; Turner, Jenny; Armstrong, Bruce K.; Benavente, Yolanda; Boffetta, Paolo; Brennan, Paul; Foretova, Lenka; Maynadie, Marc; Staines, Anthony; McKay, James; Brooks-Wilson, Angela R.; Zheng, Tongzhang; Holford, Theodore R.; Chamosa, Saioa; Kaaks, Rudolph; Kelly, Rachel S.; Ohlsson, Bodil; Travis, Ruth C.; Weiderpass, Elisabete; Clave, Jacqueline; Giovannucci, Edward; Kraft, Peter; Virtamo, Jarmo; Mazza, Patrizio; Cocco, Pierluigi; Ennas, Maria Grazia; Chiu, Brian C. H.; Fraumeni, Joseph R., Jr.; Nieters, Alexandra; Offit, Kenneth; Wu, Xifeng; Cerhan, James R.; Smedby, Karin E.; Chanock, Stephen J.; Rothman, Nathaniel			Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-I; VARIANTS; EXPRESSION; UNIVERSITY; RESOURCE; PEPTIDE; RISK; SNPS; TOOL; SET	Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human leukocyte antigen (HLA) gene variants. To identify additional FL susceptibility loci, we conducted a large-scale two-stage GWAS in 4,523 case subjects and 13,344 control subjects of European ancestry. Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 x 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 x 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 x 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 x 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 x 10(-8)) near PVT1. In an analysis of the HLA region, we identified four linked HLA-DR beta 1 multiallelic amino acids at positions 11, 13, 28, and 30 that were associated with FL risk (P-omnibus = 4.20 x 10(-67) to 2.67 x 10(-70)). Additional independent signals included rs17203612 in HLA class II (odds ratio [ORper-allele] = 1.44; p = 4.59 x 10(-16)) and rs3130437 in HLA class I (ORper-allele = 1.23; p = 8.23 x 10(-9)). Our findings further expand the number of loci associated with FL and provide evidence that multiple common variants outside the HLA region make a significant contribution to FL risk.	[Skibola, Christine F.; Conde, Lucia; Riby, Jacques] Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35233 USA; [Skibola, Christine F.; Conde, Lucia; Riby, Jacques] Ctr Comprehens Canc, Birmingham, AL 35233 USA; [Skibola, Christine F.; Conde, Lucia; Akers, Nicholas K.; Riby, Jacques; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Berndt, Sonja I.; Linet, Martha S.; Lan, Qing; Morton, Lindsay M.; Purdue, Mark P.; Albanes, Demetrius; Chung, Charles C.; Hartge, Patricia; Fraumeni, Joseph R., Jr.; Chanock, Stephen J.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Vijai, Joseph; Lacher, Mortimer; Villano, Danylo J.; Maria, Ann; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Wang, Zhaoming; Yeager, Meredith; Burdett, Laurie; Hutchinson, Amy] NCI, Cancer Genom Res Lab, Div Canc Epidemiol & Genet, NIH, Gaithersburg, MD 20877 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet & Epidemiol, NL-3584 CG Utrecht, Netherlands; [de Bakker, Paul I. W.; Vermeulen, Roel C. H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Birmann, Brenda M.; Bertrand, Kimberly A.; Giovannucci, Edward] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Birmann, Brenda M.; Bertrand, Kimberly A.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Vajdic, Claire M.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Foo, Jia-Nee; Liu, Jianjun] Genome Inst Singapore, Singapore 138672, Singapore; [Bracci, Paige M.; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94118 USA; [Vermeulen, Roel C. H.] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands; [Slager, Susan L.; Nowakowski, Grzegorz S.; Cerhan, James R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [de Sanjose, Silvia; Benavente, Yolanda] Inst Catala Oncol, Unit Infect & Canc UNIC, Canc Epidemiol Res Programme, IDIBELL, Barcelona 8907, Spain; [de Sanjose, Silvia; Benavente, Yolanda] CIBERESP, Barcelona 8036, Spain; [Wang, Sophia S.] City Hope Beckman Res Inst, Dept Canc Etiol, Duarte, CA 91030 USA; [Salles, Gilles] Hosp Civils Lyon, Dept Hematol, F-69495 Pierre Benite, France; [Salles, Gilles] Univ Lyon 1, Dept Hematol, F-69495 Pierre Benite, France; [Salles, Gilles; Ghesquieres, Herve] CNRS, UMR 5239, Lab Biol Mol Cellule, F-69495 Pierre Benite, France; [Severi, Gianluca; Vineis, Paolo] Human Genet Fdn, I-10126 Turin, Italy; [Severi, Gianluca; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3053, Australia; [Severi, Gianluca; Giles, Graham G.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Carlton, Vic 3010, Australia; [Hjalgrim, Henrik; Melbye, Mads] Statens Serum Inst, Div Hlth Surveillance & Res, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Lightfoot, Tracy; Smith, Alex; Roman, Eve; Kane, Eleanor] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Melbye, Mads] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Gu, Jian; Ye, Yuanqing; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Ghesquieres, Herve] Ctr Leon Berard, Dept Hematol, F-69008 Lyon, France; [Link, Brian K.; Weiner, George J.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Tinker, Lesley F.; De Roos, Anneclaire J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98117 USA; [Teras, Lauren R.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA; [Kricker, Anne; Armstrong, Bruce K.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Becker, Nikolaus; Kaaks, Rudolph] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Baden Wurttembe, Germany; [Spinelli, John J.] British Columbia Canc Agcy, Canc Control Res, Vancouver, BC V5Z 1L3, Canada; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Zhang, Yawei; Zheng, Tongzhang] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Vineis, Paolo; Kelly, Rachel S.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London W2 1PG, England; [Monnereau, Alain; Clave, Jacqueline] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, Environm Epidemiol Canc Grp, F-94807 Villejuif, France; [Monnereau, Alain; Clave, Jacqueline] Univ Paris Sud, UMRS 1018, F-94807 Villejuif, France; [Monnereau, Alain] Inst Bergonie, Registre Hemopathies Malignes Gironde, F-33076 Bordeaux, France; [Bertrand, Kimberly A.; Liang, Liming; Huang, Jinyan; Ma, Baoshan; Adami, Hans-Olov; Kelly, Rachel S.; Giovannucci, Edward; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Zeleniuch-Jacquotte, Anne] NYU, Inst Canc, Sch Med, New York, NY 10016 USA; [Gabbas, Attilio; Ma, Baoshan; Cocco, Pierluigi] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, I-09042 Cagliari, Italy; [Lawrence, Charles; Montalvan, Rebecca] Westat Corp, Health Studies Sect, Rockville, MD 20850 USA; [Liang, Liming; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Dalian Maritime Univ, Coll Informat Sci & Technol, Dalian 116026, Liaoning, Peoples R China; [Adami, Hans-Olov; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Glimelius, Bengt] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Oncol & Pathol, S-17176 Stockholm, Sweden; [Glimelius, Bengt] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, S-75105 Uppsala, Sweden; [Dogan, Ahmet] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10065 USA; [Dogan, Ahmet] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Thompson, Carrie A.; Habermann, Thomas M.; Novak, Anne J.; Liebow, Mark; Witzig, Thomas E.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Schenk, Maryjean] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI 48201 USA; [De Roos, Anneclaire J.] Drexel Univ, Dept Environm & Occupat Hlth, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Cozen, Wendy] Univ So Calif, USC Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Cozen, Wendy] Univ So Calif, USC Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Zhi, Degui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35233 USA; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Turner, Jenny] Macquarie Univ, Australian Sch Adv Med, Dept Anat Pathol, Sydney, NSW 2109, Australia; [Turner, Jenny] Douglass Hanly Moir Pathol, Dept Histopathol, Macquarie Pk, NSW 2113, Australia; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Brennan, Paul] Int Agcy Res Canc, Genet Sect, Grp Genet Epidemiol, F-69372 Lyon, France; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno 65653, Czech Republic; [Foretova, Lenka] MF MU, Brno 65653, Czech Republic; [Maynadie, Marc] Univ Burgundy, EA 4184, Registre Hemopathies Malignes Cote Or, F-21070 Dijon, France; [Maynadie, Marc] Dijon Univ Hosp, F-21070 Dijon, France; [Staines, Anthony] Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland; [McKay, James] Int Agcy Res Canc, Genet Sect, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Brooks-Wilson, Angela R.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Holford, Theodore R.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Chamosa, Saioa] BioDonostia Res Inst, Dept Hlth, Basque Region 20014, Spain; [Ohlsson, Bodil] Lund Univ, Skane Univ Hosp, Div Internal Med, Dept Clin Sci, S-20502 Malmo, Sweden; [Travis, Ruth C.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Fac Hlth Sci, N-9037 Breivika, Norway; [Weiderpass, Elisabete] Canc Registry Norway, N-0304 Oslo, Norway; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Dept Genet Epidemiol, Helsinki 00250, Finland; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki 00271, Finland; [Mazza, Patrizio] Osped Nord, Dept Hematol, I-74100 Taranto, Italy; [Ennas, Maria Grazia] Univ Cagliari, Dept Biomed Sci, I-09042 Cagliari, Italy; [Chiu, Brian C. H.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Nieters, Alexandra] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79108 Freiburg, Baden Wurttembe, Germany; [Smedby, Karin E.] Karolinska Inst, Dept Med Solna, S-17176 Stockholm, Sweden	University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of New South Wales Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Francisco; Utrecht University; Mayo Clinic; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; City of Hope; Beckman Research Institute of City of Hope; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Cancer Council Victoria; University of Melbourne; Statens Serum Institut; University of York - UK; Stanford University; University of Texas System; UTMD Anderson Cancer Center; UNICANCER; Centre Leon Berard; University of Iowa; Fred Hutchinson Cancer Center; American Cancer Society; University of Sydney; Helmholtz Association; German Cancer Research Center (DKFZ); British Columbia Cancer Agency; University of British Columbia; Yale University; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Institut Bergonie; Harvard University; Harvard T.H. Chan School of Public Health; New York University; New York University; University of Cagliari; Westat; Harvard University; Harvard T.H. Chan School of Public Health; Dalian Maritime University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Wayne State University; Drexel University; University of Southern California; University of Southern California; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Macquarie University; Icahn School of Medicine at Mount Sinai; World Health Organization; International Agency for Research on Cancer (IARC); Masaryk Memorial Cancer Institute; Masaryk University Brno; Universite de Bourgogne; CHU Dijon Bourgogne; Dublin City University; World Health Organization; International Agency for Research on Cancer (IARC); British Columbia Cancer Agency; Simon Fraser University; Yale University; Lund University; Skane University Hospital; University of Oxford; UiT The Arctic University of Tromso; University of Oslo; Folkhalsan Research Center; Harvard University; Harvard T.H. Chan School of Public Health; Finland National Institute for Health & Welfare; University of Cagliari; University of Chicago; University of Freiburg; Karolinska Institutet	Skibola, CF (corresponding author), Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35233 USA.	cskibola@uab.edu	Weiderpass, Elisabete/AAP-2747-2021; Morton, Lindsay M/B-5234-2015; de Bakker, Paul IW/B-8730-2009; Yeager, Meredith/AAA-5322-2020; Albanes, Demetrius/B-9749-2015; Morton, Lindsay/AAE-7495-2022; Spinelli, John J./B-6210-2013; Vajdic, Claire/AAP-5940-2020; Staines, Anthony/AFQ-7565-2022; Foo, Jia Nee/D-6069-2014; Severi, Gianluca/H-3774-2018; Purdue, Mark P/C-9228-2016; Severi, Gianluca/Q-1824-2019; Brooks-Wilson, Angela/E-9399-2012; Conde, Lucia/D-9295-2011; Berndt, Sonja I/J-8423-2016; Vermeulen, Roel/F-8037-2011; Hjalgrim, Henrik/AAG-4973-2021; de Sanjosé Llongueras, Silvia/H-6339-2014; Boffetta, Paolo/AAI-7767-2021; Liu, Jianjun/AAK-4989-2020; Weiderpass, Elisabete/M-4029-2016; Clavel, Jacqueline/Q-2750-2016; kelly, rachel/H-4505-2017; Armstrong, Bruce K/K-9464-2015; Wang, Zhaoming/R-5527-2018; Cocco, Pierluigi/AAM-7474-2021; Monnereau, Alain/L-1249-2014; Diver, Ryan/AAG-3469-2019; Salles, Gilles/Z-2336-2019; Joseph, Vijai/J-9158-2013	Weiderpass, Elisabete/0000-0003-2237-0128; Morton, Lindsay M/0000-0001-9767-2310; de Bakker, Paul IW/0000-0001-7735-7858; Morton, Lindsay/0000-0001-9767-2310; Spinelli, John J./0000-0002-9119-3287; Staines, Anthony/0000-0001-9161-1357; Foo, Jia Nee/0000-0001-9899-2308; Severi, Gianluca/0000-0001-7157-419X; Purdue, Mark P/0000-0003-1177-3108; Severi, Gianluca/0000-0001-7157-419X; Brooks-Wilson, Angela/0000-0003-1009-6408; Vermeulen, Roel/0000-0003-4082-8163; Boffetta, Paolo/0000-0002-3811-2791; Liu, Jianjun/0000-0002-3255-3019; Weiderpass, Elisabete/0000-0003-2237-0128; Clavel, Jacqueline/0000-0002-3616-7676; kelly, rachel/0000-0003-3023-1822; Armstrong, Bruce K/0000-0001-8940-7525; Wang, Zhaoming/0000-0001-7556-3869; Monnereau, Alain/0000-0002-5056-1397; Diver, Ryan/0000-0002-5418-9000; Salles, Gilles/0000-0002-9541-8666; Bertrand, Kimberly/0000-0002-4565-7618; Kane, Eleanor/0000-0002-7438-9982; Turner, Jennifer/0000-0001-5550-3375; melbye, mads/0000-0001-8264-6785; Link, Brian/0000-0001-5084-0698; Chamosa, Saioa/0000-0002-8321-4404; Ennas, Maria Grazia/0000-0002-9448-715X; Conde, Lucia/0000-0001-5180-543X; weiner, george/0000-0003-3427-0562; Vajdic, Claire/0000-0002-3612-8298; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Giles, Graham/0000-0003-4946-9099; Birmann, Brenda/0000-0002-7550-5498; Joseph, Vijai/0000-0002-7933-151X; Roman, Eve/0000-0001-7603-3704; Foretova, Lenka/0000-0003-0494-2620; WANG, SOPHIA/0000-0003-2597-9393	Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH; Cancer Research UK [16491] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA154643, R01CA149445, P30CA016672, ZIACP010170, P30CA015083, P30CA033572, P30CA016359, P30CA086862, P50CA097274] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142, UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705, P30ES010126] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The overall FL GWAS project was supported by the intramural program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH. A full list of Supplemental Acknowledgements is provided online.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barenboim M, 2013, BIOINFORMATICS, V29, P2197, DOI 10.1093/bioinformatics/btt356; Conde L, 2013, AM J HUM GENET, V92, P126, DOI 10.1016/j.ajhg.2012.11.009; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Link BK, 2013, J CLIN ONCOL, V31, P3272, DOI 10.1200/JCO.2012.48.3990; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rapin Nicolas, 2010, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1817s88; Sille FCM, 2014, GENES IMMUN, V15, P133, DOI 10.1038/gene.2013.64; Skibola CF, 2012, TISSUE ANTIGENS, V79, P279, DOI 10.1111/j.1399-0039.2012.01845.x; Skibola CF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-516; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Tan D, 2013, BLOOD, V122, P981, DOI 10.1182/blood-2013-03-491514; Taylor GM, 1999, BRIT J CANCER, V80, P1405, DOI 10.1038/sj.bjc.6690536; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wang SS, 2010, BLOOD, V115, P4820, DOI 10.1182/blood-2010-01-266775; Wang ZM, 2012, NAT GENET, V44, P6, DOI 10.1038/ng.1044; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	25	71	71	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					462	471		10.1016/j.ajhg.2014.09.004	http://dx.doi.org/10.1016/j.ajhg.2014.09.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25279986	Bronze, Green Published			2022-12-18	WOS:000342654300011
J	Cushion, TD; Paciorkowski, AR; Pilz, DT; Mullins, JGL; Seltzer, LE; Marion, RW; Tuttle, E; Ghoneim, D; Christian, SL; Chung, SK; Rees, MI; Dobyns, WB				Cushion, Thomas D.; Paciorkowski, Alex R.; Pilz, Daniela T.; Mullins, Jonathan G. L.; Seltzer, Laurie E.; Marion, Robert W.; Tuttle, Emily; Ghoneim, Dalia; Christian, Susan L.; Chung, Seo-Kyung; Rees, Mark I.; Dobyns, William B.			De Novo Mutations in the Beta-Tubulin Gene TUBB2A Cause Simplified Gyral Patterning and Infantile-Onset Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORTICAL DEVELOPMENT; NEURONAL MIGRATION; MICROTUBULE; ALPHA; MALFORMATIONS; TUBA1A; BRAIN; POLYMICROGYRIA; CLASSIFICATION; RESOLUTION	Tubulins, and microtubule polymers into which they incorporate, play critical mechanical roles in neuronal function during cell proliferation, neuronal migration, and postmigrational development: the three major overlapping events of mammalian cerebral cortex development. A number of neuronally expressed tubulin genes are associated with a spectrum of disorders affecting cerebral cortex formation. Such "tubulinopathies" include lissencephaly/pachygyria, polymicrogyria-like malformations, and simplified gyral patterns, in addition to characteristic extracortical features, such as corpus callosal, basal ganglia, and cerebellar abnormalities. Epilepsy is a common finding in these related disorders. Here we describe two unrelated individuals with infantile-onset epilepsy and abnormalities of brain morphology, harboring de novo variants that affect adjacent amino acids in a beta-tubulin gene TUBB2A. Located in a highly conserved loop, we demonstrate impaired tubulin and microtubule function resulting from each variant in vitro and by using in silico predictive modeling. We propose that the affected functional loop directly associates with the alpha-tubulin-bound guanosine triphosphate (GTP) molecule, impairing the intradimer interface and correct formation of the alpha/beta-tubulin heterodimer. This study associates mutations in TUBB2A with the spectrum of "tubulinopathy" phenotypes. As a consequence, genetic variations affecting all beta-tubulin genes expressed at high levels in the brain (TUBB2B, TUBB3, TUBB, TUBB4A, and TUBB2A) have been linked with malformations of cortical development.	[Cushion, Thomas D.; Mullins, Jonathan G. L.; Chung, Seo-Kyung; Rees, Mark I.] Swansea Univ, Coll Med, Inst Life Sci, Neurol & Mol Neurosci Res Grp, Swansea SA2 8PP, W Glam, Wales; [Paciorkowski, Alex R.; Seltzer, Laurie E.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14641 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14641 USA; [Paciorkowski, Alex R.; Tuttle, Emily; Ghoneim, Dalia] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Pilz, Daniela T.; Chung, Seo-Kyung; Rees, Mark I.] Swansea Univ, Coll Med, WERN, Swansea SA2 8PP, W Glam, Wales; [Marion, Robert W.] Childrens Hosp Montefiore, Bronx, NY 10467 USA; [Christian, Susan L.; Dobyns, William B.] Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Swansea University; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Cardiff University; Swansea University; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rees, MI (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Neurol & Mol Neurosci Res Grp, Swansea SA2 8PP, W Glam, Wales.	m.i.rees@swansea.ac.uk; wbd@u.washington.edu	Chung, Seo-Kyung/AAT-4693-2021; Rees, Mark I/J-3129-2012; Chung, Seo-Kyung/I-3329-2017; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020; Cushion, Thomas D/O-3986-2017	Chung, Seo-Kyung/0000-0002-5008-8384; Rees, Mark I/0000-0003-3570-5986; Chung, Seo-Kyung/0000-0002-5008-8384; Dobyns, William/0000-0002-7681-2844; Cushion, Thomas D/0000-0002-0040-0069; Mullins, Jonathan/0000-0003-0144-2962	(UK) National Institute of Social Care and Health Research; Wales Epilepsy Research Network (WERN); Waterloo Foundation; (USA) National Institute for Neurological Disorders and Stroke (NINDS) of the National Institutes of Health [K08NS078054, K12NS066098, R01NS050375, R01NS058721]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058721, R01NS050375, K08NS078054, K12NS066098] Funding Source: NIH RePORTER	(UK) National Institute of Social Care and Health Research; Wales Epilepsy Research Network (WERN); Waterloo Foundation; (USA) National Institute for Neurological Disorders and Stroke (NINDS) of the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank the affected individuals and their families for participation in this study. We would also like to thank Owain Howell for providing immunofluorescent antibodies to perform the in vitro functional analysis. Research reported in this publication was supported by the (UK) National Institute of Social Care and Health Research (M.I.R., D.T.P.), the Wales Epilepsy Research Network (WERN - M.I.R., S.-K.C., D.T.P.) and Waterloo Foundation (M.I.R.), and by the (USA) National Institute for Neurological Disorders and Stroke (NINDS) of the National Institutes of Health under award numbers K08NS078054 (to A.R.P.), K12NS066098 (to L.E.S.), and R01NS050375 and R01NS058721 (to W.B.D.).	Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; Amrom D, 2014, CLIN GENET, V85, P178, DOI 10.1111/cge.12141; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Cushion TD, 2013, BRAIN, V136, P536, DOI 10.1093/brain/aws338; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Leandro-Garcia LJ, 2012, CLIN CANCER RES, V18, P4441, DOI 10.1158/1078-0432.CCR-12-1221; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mullins JGL, 2010, ADV PROTEIN CHEM STR, V80, P117, DOI [10.1016/S1876-1623(10)80004-5, 10.1016/B978-0-12-381264-3.00004-7]; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Simons C, 2013, AM J HUM GENET, V92, P767, DOI 10.1016/j.ajhg.2013.03.018; Stottmann RW, 2013, HUM MOL GENET, V22, P4053, DOI 10.1093/hmg/ddt255; Tischfield MA, 2010, BIOSCIENCE REP, V30, P319, DOI 10.1042/BSR20100025; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Yoshida K, 2009, BIOCHEM BIOPH RES CO, V389, P506, DOI 10.1016/j.bbrc.2009.09.011	29	71	75	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					634	641		10.1016/j.ajhg.2014.03.009	http://dx.doi.org/10.1016/j.ajhg.2014.03.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24702957	Bronze, Green Published			2022-12-18	WOS:000333765300014
J	Schmidts, M; Vodopiutz, J; Christou-Savina, S; Cortes, CR; McInerney-Leo, AM; Emes, RD; Arts, HH; Tuysuz, B; D'Silva, J; Leo, PJ; Giles, TC; Oud, MM; Harris, JA; Koopmans, M; Marshall, M; Elcioglu, N; Kuechler, A; Bockenhauer, D; Moore, AT; Wilson, LC; Janecke, AR; Hurles, ME; Emmet, W; Gardiner, B; Streubel, B; Dopita, B; Zankl, A; Kayserili, H; Scambler, PJ; Brown, MA; Beales, PL; Wicking, C; Duncan, EL; Mitchison, HM				Schmidts, Miriam; Vodopiutz, Julia; Christou-Savina, Sonia; Cortes, Claudio R.; McInerney-Leo, Aideen M.; Emes, Richard D.; Arts, Heleen H.; Tuysuz, Beyhan; D'Silva, Jason; Leo, Paul J.; Giles, Tom C.; Oud, Machteld M.; Harris, Jessica A.; Koopmans, Marije; Marshall, Mhairi; Elcioglu, Nursel; Kuechler, Alma; Bockenhauer, Detlef; Moore, Anthony T.; Wilson, Louise C.; Janecke, Andreas R.; Hurles, Matthew E.; Emmet, Warren; Gardiner, Brooke; Streubel, Berthold; Dopita, Belinda; Zankl, Andreas; Kayserili, Hulya; Scambler, Peter J.; Brown, Matthew A.; Beales, Philip L.; Wicking, Carol; Duncan, Emma L.; Mitchison, Hannah M.		UK10K	Mutations in the Gene Encoding IFT Dynein Complex Component WDR34 Cause Jeune Asphyxiating Thoracic Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETROGRADE INTRAFLAGELLAR TRANSPORT; RIB-POLYDACTYLY SYNDROME; DNA-SEQUENCING DATA; VERTEBRATE PHOTORECEPTORS; CYTOPLASMIC DYNEIN-2; DYNC2H1 MUTATIONS; OUTER SEGMENT; PRIMARY CILIA; PROTEIN; CILIOPATHIES	Bidirectional (anterograde and retrograde) motor-based intraflagellar transport (IFT) governs cargo transport and delivery processes that are essential for primary cilia growth and maintenance and for hedgehog signaling functions. The IFT dynein-2 motor complex that regulates ciliary retrograde protein transport contains a heavy chain dynein ATPase/motor subunit, DYNC2H1, along with other less well functionally defined subunits. Deficiency of IFT proteins, including DYNC2H1, underlies a spectrum of skeletal ciliopathies. Here, by using exome sequencing and a targeted next-generation sequencing panel, we identified a total of 11 mutations in WDR34 in 9 families with the clinical diagnosis of Jeune syndrome (asphyxiating thoracic dystrophy). WDR34 encodes a WD40 repeat-containing protein orthologous to Chlamydomonas FAP133, a dynein intermediate chain associated with the retrograde intraflagellar transport motor. Three-dimensional protein modeling suggests that the identified mutations all affect residues critical for WDR34 protein-protein interactions. We find that WDR34 concentrates around the centrioles and basal bodies in mammalian cells, also showing axonemal staining. WDR34 coimmunoprecipitates with the dynein-1 light chain DYNLL1 in vitro, and mining of proteomics data suggests that WDR34 could represent a previously unrecognized link between the cytoplasmic dynein-1 and IFT dynein-2 motors. Together, these data show that WDR34 is critical for ciliary functions essential to normal development and survival, most probably as a previously unrecognized component of the mammalian dynein-IFT machinery.	[Schmidts, Miriam; Christou-Savina, Sonia; D'Silva, Jason; Scambler, Peter J.; Beales, Philip L.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Schmidts, Miriam; Christou-Savina, Sonia; D'Silva, Jason; Scambler, Peter J.; Beales, Philip L.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Birth Defect Res Ctr, London WC1N 1EH, England; [Vodopiutz, Julia] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria; [Cortes, Claudio R.; Wicking, Carol] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [McInerney-Leo, Aideen M.; Leo, Paul J.; Harris, Jessica A.; Marshall, Mhairi; Gardiner, Brooke; Brown, Matthew A.; Duncan, Emma L.] Univ Queensland, Princess Alexandra Hosp, Translat Res Inst, Diamantina Inst, Woolloongabba, Qld 4102, Australia; [Emes, Richard D.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Emes, Richard D.; Giles, Tom C.] Univ Nottingham, Adv Data Anal Ctr, Loughborough LE12 5RD, Leics, England; [Arts, Heleen H.; Oud, Machteld M.] Radboud Univ Nijmegen, Radboud Univ Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Arts, Heleen H.; Oud, Machteld M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Arts, Heleen H.; Oud, Machteld M.] Radboud Univ Nijmegen, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Med Fac, Dept Pediat, Div Pediat Genet, TR-34303 Istanbul, Turkey; [Koopmans, Marije] Leiden Univ Med Ctr, Ctr Human & Clin Genet, Dept Clin Genet, NL-2333 AL Leiden, Netherlands; [Elcioglu, Nursel] Marmara Univ Hosp, Dept Pediat, TR-34716 Istanbul, Turkey; [Kuechler, Alma] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Bockenhauer, Detlef] UCL, Great Ormond St Hosp, London WC1N 1EH, England; [Bockenhauer, Detlef] UCL, Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England; [Moore, Anthony T.] Moorfields Eye Hosp, London EC1V 2PH, England; [Moore, Anthony T.] UCL Inst Ophthalmol, London EC1V 2PH, England; [Wilson, Louise C.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London WC1N 3JH, England; [Janecke, Andreas R.] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria; [Janecke, Andreas R.] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1RQ, England; [Emmet, Warren] UCL, UCL Genet Inst, Dept Genet Environm & Evol, London WC1E 6BT, England; [Streubel, Berthold] Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria; [Dopita, Belinda] Canberra Hosp, Dept Genet, Woden, ACT 2606, Australia; [Zankl, Andreas] Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Dept Endocrinol, Herston, Qld 4029, Australia	University of London; University College London; University of London; University College London; Medical University of Vienna; University of Queensland; University of Queensland; University of Nottingham; University of Nottingham; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Istanbul University; Istanbul University - Cerrahpasa; Leiden University; Leiden University Medical Center (LUMC); Marmara University; University of Duisburg Essen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Medical University of Innsbruck; Medical University of Innsbruck; Wellcome Trust Sanger Institute; University of London; University College London; Medical University of Vienna; Australian National University; Canberra Hospital; University of Queensland; Istanbul University; Royal Brisbane & Women's Hospital	Schmidts, M (corresponding author), UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England.	miriam.schmidts.10@ucl.ac.uk; h.mitchison@ucl.ac.uk	McInerney-Leo, Aideen M/E-1788-2018; Brown, Matthew A/E-5749-2010; Vodopiutz, Julia/AAR-4425-2020; Leo, Paul/R-4464-2019; Leo, Paul J/B-3470-2011; Tüysüz, Beyhan/AAN-4858-2020; Schmidts, Miriam/A-3777-2012; McInerney-Leo, Aideen M/D-8302-2016; Scambler, Peter/AAZ-6026-2020; Emes, Richard D/C-5341-2008; Cortes, Claudio/AAM-3948-2020; Oud, Machteld/S-9062-2019; Gardiner, Brooke B/C-7773-2011; Janecke, Andreas/AAA-5227-2019; Beales, Philip L/C-7367-2009; Bockenhauer, Detlef/AAF-6495-2020; Oud, Machteld/P-6939-2015; Duncan, Emma L/L-1224-2013; Kayserili, Hülya/AAA-5593-2021; arts, heleen/ACL-6040-2022; Wicking, Carol/J-1814-2014	Brown, Matthew A/0000-0003-0538-8211; Leo, Paul J/0000-0001-8325-4134; Schmidts, Miriam/0000-0002-1714-6749; McInerney-Leo, Aideen M/0000-0002-0059-5732; Scambler, Peter/0000-0002-1487-4628; Emes, Richard D/0000-0001-6855-5481; Cortes, Claudio/0000-0003-2255-7806; Gardiner, Brooke B/0000-0003-3740-3244; Bockenhauer, Detlef/0000-0001-5878-941X; Oud, Machteld/0000-0003-4864-9346; Duncan, Emma L/0000-0002-8143-4403; Kayserili, Hülya/0000-0003-0376-499X; Arts, Heleen/0000-0002-9860-3744; Wicking, Carol/0000-0002-7225-3803; Janecke, Andreas/0000-0001-7155-0315; Mitchison, Hannah/0000-0002-3163-6293; Tuysuz, Beyhan/0000-0002-9620-5021; Vodopiutz, Julia/0000-0002-8087-7026	Wellcome Trust [WT091310]; Dutch Kidney Foundation [CP11.18, IP11.58]; European Community [241955]; Netherlands Organization for Scientific Research NWO [Veni-91613008]; NIHR (Moorfields Eye Hospital BRC); British Heart Foundation; UQ International PhD Scholarship; University of Queensland postgraduate scholarship; NHMRC; Action Medical Research UK [RTF-1411]; Newlife Foundation for Disabled Children; National Institute for Health Research [NF-SI-0507-10204, NF-SI-0510-10268] Funding Source: researchfish; Action Medical Research [1794, 2101] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Dutch Kidney Foundation; European Community(European Commission); Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); NIHR (Moorfields Eye Hospital BRC); British Heart Foundation(British Heart Foundation); UQ International PhD Scholarship; University of Queensland postgraduate scholarship(University of Queensland); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Action Medical Research UK; Newlife Foundation for Disabled Children; National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research; Great Ormond Street Hospital Childrens Charity	We are very grateful to the families for their participation in this study and to all participating physicians. We thank Sharon Song and Lisa Anderson for technical support (exome capture, sequencing) and Ideke J.C. Lamers (cell biology). We thank ESDN, Andrea Superti-Furga, and Sheila Unger (University of Lausanne) in supporting diagnoses of individual SKDP-78.3. We thank Lotte Bang Pedersen (University of Copenhagen) and Dominic Norris (MRC Harwell, UK) for very helpful discussions and Hamsa Puthalakath (La Trobe University, Australia) for the kind gift of pEF-Flag-DYNLL1. This study makes use of data generated by the UK10K Consortium who we thank, in particular Matthew Hurles and participants of the UK10K RARE group. Funding for UK10K was provided by the Wellcome Trust under award WT091310. A full list of investigators who contributed to the generation of the data is available from http://www.uk10k.org/publications.html. This study was supported by Dutch Kidney Foundation grants CP11.18 (M.S., P.L.B., H.H.A.) and IP11.58 (H.H.A.), the European Community's Seventh Framework Programme FP7/2009; 241955, SYSCILIA (P.L.B.), the Netherlands Organization for Scientific Research NWO Veni-91613008 (H.H.A.), and NIHR (Moorfields Eye Hospital BRC) (A.T.M.). Confocal microscopy at UQ was carried out at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, developed with the generous support of the Australian Cancer Research Foundation. P.J.S. is supported by the British Heart Foundation, P.L.B. is a Wellcome Trust Senior Fellow, C.W. is a University of Queensland (UQ) Vice-Chancellor's Senior Research Fellow, C.R.C. is supported by a UQ International PhD Scholarship, A.M.M.-L. is supported by a University of Queensland postgraduate scholarship, M.A.B. is supported by an NHMRC senior fellowship, and M.S. is supported by an Action Medical Research UK Clinical Training Fellowship (RTF-1411). H.M.M. is supported by Action Medical Research UK and the Newlife Foundation for Disabled Children.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baujat G, 2013, J MED GENET, V50, P91, DOI 10.1136/jmedgenet-2012-101282; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; de Vries J, 2010, EUR J PEDIATR, V169, P77, DOI 10.1007/s00431-009-0991-3; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; El Hokayem J, 2012, J MED GENET, V49, P227, DOI 10.1136/jmedgenet-2011-100717; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gao D, 2009, CELL MOL LIFE SCI, V66, P2573, DOI 10.1007/s00018-009-0059-6; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Jonassen JA, 2012, J AM SOC NEPHROL, V23, P641, DOI 10.1681/ASN.2011080829; Krock BL, 2009, INVEST OPHTH VIS SCI, V50, P5463, DOI 10.1167/iovs.09-3828; Li AQ, 2011, NAT CELL BIOL, V13, P402, DOI 10.1038/ncb2218; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; McInerney-Leo AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/j.ajhg.2013.06.022; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Patel-King RS, 2013, MOL BIOL CELL, V24, P2668, DOI 10.1091/mbc.E13-05-0266; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rix S, 2011, HUM MOL GENET, V20, P1306, DOI 10.1093/hmg/ddr013; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Tuysuz B, 2009, AM J MED GENET A, V149A, P1727, DOI 10.1002/ajmg.a.32962; Wu VM, 2012, P NATL ACAD SCI USA, V109, P13644, DOI 10.1073/pnas.1207170109; Yerian LM, 2003, SEMIN LIVER DIS, V23, P195	48	71	78	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					932	944		10.1016/j.ajhg.2013.10.003	http://dx.doi.org/10.1016/j.ajhg.2013.10.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24183451	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000326996600014
J	Gronskov, K; Dooley, CM; Ostergaard, E; Kelsh, RN; Hansen, L; Levesque, MP; Vilhelmsen, K; Mollgard, K; Stemple, DL; Rosenberg, T				Gronskov, Karen; Dooley, Christopher M.; Ostergaard, Elsebet; Kelsh, Robert N.; Hansen, Lars; Levesque, Mitchell P.; Vilhelmsen, Kaj; Mollgard, Kjeld; Stemple, Derek L.; Rosenberg, Thomas			Mutations in C10orf11, a Melanocyte-Differentiation Gene, Cause Autosomal-Recessive Albinism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURAL-CREST; PIGMENT-CELLS; BETA-CATENIN; ZEBRAFISH; MITF; EXPRESSION; PATHWAY; NACRE; WNT	Autosomal-recessive albinism is a hypopigmentation disorder with a broad phenotypic range. A substantial fraction of individuals with albinism remain genetically unresolved, and it has been hypothesized that more genes are to be identified. By using homozygosity mapping of an inbred Faroese family, we identified a 3.5 Mb homozygous region (10q22.2-q22.3) on chromosome 10. The region contains five protein-coding genes, and sequencing of one of these, C10orf11, revealed a nonsense mutation that segregated with the disease and showed a recessive inheritance pattern. Investigation of additional albinism-affected individuals from the Fame Islands revealed that five out of eight unrelated affected persons had the nonsense mutation in C10orf11. Screening of a cohort of autosomal-recessive-albinism-affected individuals residing in Denmark showed a homozygous 1 bp duplication in C10orf11 in an individual originating from Lithuania. Immunohistochemistry showed localization of C10orf11 in melanoblasts and melanocytes in human fetal tissue, but no localization was seen in retinal pigment epithelial cells. Knockdown of the zebrafish (Danio rerio) homolog with the use of morpholinos resulted in substantially decreased pigmentation and a reduction of the apparent number of pigmented melanocytes. The morphant phenotype was rescued by wild-type C10orf11, but not by mutant C10orf11. In conclusion, we have identified a melanocyte-differentiation gene, C10orf11, which when mutated causes autosomal-recessive albinism in humans.	[Gronskov, Karen] Rigshosp, Kennedy Ctr, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Dooley, Christopher M.; Stemple, Derek L.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Ostergaard, Elsebet] Rigshosp, Dept Clin Genet 4062, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Kelsh, Robert N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Gronskov, Karen; Hansen, Lars; Mollgard, Kjeld] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Levesque, Mitchell P.] Univ Zurich Hosp, Dept Dermatol, CH-8006 Zurich, Switzerland; [Rosenberg, Thomas] Rigshosp, Natl Eye Clin Visually Impaired, Kennedy Ctr, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Rosenberg, Thomas] Gordon Norrie Ctr Genet Eye Dis, DK-2400 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Wellcome Trust Sanger Institute; Rigshospitalet; University of Copenhagen; University of Bath; University of Bath; University of Copenhagen; University of Zurich; University Zurich Hospital; Rigshospitalet; University of Copenhagen	Gronskov, K (corresponding author), Rigshosp, Kennedy Ctr, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark.	karen.groenskov@regionh.dk	Kelsh, Robert/B-6445-2008	Kelsh, Robert/0000-0002-9381-0066; Gronskov, Karen/0000-0002-2341-1326	Danish Association of the Blind	Danish Association of the Blind	The study was supported by a grant from The Danish Association of the Blind. We thank Soren Petersen, Alma Dedic, Pia Skovgaard, and Jette Bune Rasmussen (Kennedy Center, Copenhagen University Hospital, Rigshospitalet) for technical assistance. We would also like to thank Hans-Martian Maischein of the Nuesslein-Volhard lab for sending us mitfaw2 embryos. The expert technical assistance of Hanne Hadberg and Pernille S. Froh (Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen) is gratefully acknowledged.	Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Dorsky RI, 2000, GENE DEV, V14, P158; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Dupin E, 2010, CELL CYCLE, V9, P238, DOI 10.4161/cc.9.2.10491; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Greenhill ER, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002265; Gronskov K, 2009, INVEST OPHTH VIS SCI, V50, P1058, DOI 10.1167/iovs.08-2639; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379; Lister JA, 1999, DEVELOPMENT, V126, P3757; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P611, DOI 10.1111/j.1755-148X.2009.00584.x; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Murisier F, 2006, HISTOL HISTOPATHOL, V21, P567, DOI 10.14670/HH-21.567; Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/j.devcel.2007.07.017; Ostergaard E, 2010, J MED GENET, V47, P665, DOI 10.1136/jmg.2009.069120; Schiaffino MV, 2010, INT J BIOCHEM CELL B, V42, P1094, DOI 10.1016/j.biocel.2010.03.023; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Tomita Y, 2004, AM J MED GENET C, V131C, P75, DOI 10.1002/ajmg.c.30036; Wada S, 2008, DEV GROWTH DIFFER, V50, P215, DOI [10.1111/j.1440-169x.2008.01012.x, 10.1111/j.1440-169X.2008.01012.x]; Wan P, 2011, MOL CELL BIOCHEM, V354, P241, DOI 10.1007/s11010-011-0823-4; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049	27	71	75	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					415	421		10.1016/j.ajhg.2013.01.006	http://dx.doi.org/10.1016/j.ajhg.2013.01.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23395477	Green Published, Bronze			2022-12-18	WOS:000316161700015
J	Radmanesh, F; Caglayan, AO; Silhavy, JL; Yilmaz, C; Cantagrel, V; Omar, T; Rosti, B; Kaymakcalan, H; Gabriel, S; Li, MF; Sestan, N; Bilguvar, K; Dobyns, WB; Zaki, MS; Gunel, M; Gleeson, JG				Radmanesh, Farid; Caglayan, Ahmet Okay; Silhavy, Jennifer L.; Yilmaz, Cahide; Cantagrel, Vincent; Omar, Tarek; Rosti, Basak; Kaymakcalan, Hande; Gabriel, Stacey; Li, Mingfeng; Sestan, Nenad; Bilguvar, Kaya; Dobyns, William B.; Zaki, Maha S.; Gunel, Murat; Gleeson, Joseph G.			Mutations in LAMB1 Cause Cobblestone Brain Malformation without Muscular or Ocular Abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORTICAL DEVELOPMENT; NEURONAL MIGRATION; RADIAL GLIA; DEFICIENCY; LAMINATION; GENES; DYSTROGLYCANOPATHIES; DYSTROPHIES; POPULATION; EXPRESSION	Cobblestone brain malformation (COB) is a neuronal migration disorder characterized by protrusions of neurons beyond the first cortical layer at the pial surface of the brain. It is usually seen in association with dystroglycanopathy types of congenital muscular dystrophies (CMDs) and ocular abnormalities termed muscle-eye-brain disease. Here we report homozygous deleterious mutations in LAMB1, encoding laminin subunit beta-1, in two families with autosomal-recessive COB. Affected individuals displayed a constellation of brain malformations including cortical gyral and white-matter signal abnormalities, severe cerebellar dysplasia, brainstem hypoplasia, and occipital encephalocele, but they had less apparent ocular or muscular abnormalities than are typically observed in COB. LAMB1 is localized to the pial basement membrane, suggesting that defective connection between radial glial cells and the pial surface mediated by LAMB1 leads to this malformation.	[Radmanesh, Farid; Silhavy, Jennifer L.; Cantagrel, Vincent; Rosti, Basak; Gleeson, Joseph G.] Univ Calif San Diego, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA; [Radmanesh, Farid; Silhavy, Jennifer L.; Cantagrel, Vincent; Rosti, Basak; Gleeson, Joseph G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Neurosurg, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Neurobiol, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Genet, New Haven, CT 06510 USA; [Yilmaz, Cahide] Mustafa Kemal Univ, Sch Med, Div Pediat Neurol, Dept Pediat, TR-31000 Antakya, Turkey; [Omar, Tarek] Univ Alexandria, Dept Pediat & Pediat Neurol, Sch Med, Alexandria 21558, Egypt; [Kaymakcalan, Hande] Bahcesehir Univ, Dept Genet & Bioinformat, TR-34353 Istanbul, Turkey; [Gabriel, Stacey] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Li, Mingfeng; Sestan, Nenad] Yale Univ, Kavli Inst Neurosci, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo 12311, Egypt	University of California System; University of California San Diego; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Mustafa Kemal University; Egyptian Knowledge Bank (EKB); Alexandria University; Bahcesehir University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Gunel, M (corresponding author), Yale Univ, Sch Med, Yale Program Neurogenet, Dept Neurosurg, New Haven, CT 06510 USA.	murat.gunel@yale.edu; jogleeson@ucsd.edu	Zaki, Maha S/B-9361-2013; Vincent, Cantagrel/H-8698-2017; Radmanesh, Farid/AAN-3362-2021; Kaymakcalan, Hande/AAO-4208-2021; Kaymakcalan, Hande/AFP-2191-2022; Wang, Guilin/G-8794-2018; Caglayan, Ahmet O/D-1066-2012; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Vincent, Cantagrel/0000-0002-5180-4848; Radmanesh, Farid/0000-0001-5431-0176; Kaymakcalan, Hande/0000-0001-7736-7634; Caglayan, Ahmet O/0000-0002-2332-322X; Dobyns, William/0000-0002-7681-2844; Zaki, Maha/0000-0001-7840-0002	US National Human Genome Research Institute [U54HG003067]; Yale Center for Mendelian Disorders [U54HG006504]; US National Institutes of Health (NIH) [RC2NS070477]; Gregory M. Kiez and Mehmet Kutman Foundation; NIH [U01MH081896, R01NS048453, R01NS052455, P01HD070494]; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070477, P30NS047101, R01NS048453, R01NS052455] Funding Source: NIH RePORTER	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Yale Center for Mendelian Disorders; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gregory M. Kiez and Mehmet Kutman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the families for their participation in the study. We thank the Broad Institute (supported by the US National Human Genome Research Institute; grant U54HG003067 to E. Lander), the Yale Center for Mendelian Disorders; (grant U54HG006504 to R. Lifton, M. Gunel, M. Gerstein, and S. Mane) for sequencing support and analysis, J. Santini at the UCSD Microscopy Core for imaging (P30NS047101), the Yale Biomedical High Performance Computing Center for data analysis and storage, the Yale Program on Neurogenetics, the Yale Center for Human Genetics and Genomics, and Carsten G. Bonnemann (National Institute of Neurological Disorders and Stroke) for discussions. This work was supported by US National Institutes of Health (NIH) grant RC2NS070477 and the Gregory M. Kiez and Mehmet Kutman Foundation (M.G.), NIH grants U01MH081896 (to N.S.), R01NS048453, R01NS052455, and P01HD070494, the Simons Foundation Autism Research Initiative, and the Howard Hughes Medical Institute (to J.G.G.).	Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259; Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836; Barkovich AJ, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00007; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bouchet C, 2007, HUM MUTAT, V28, P1020, DOI 10.1002/humu.20561; Brasseur-Daudruy M, 2012, PEDIATR RADIOL, V42, P488, DOI 10.1007/s00247-011-2242-9; Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357; Dobyns WB, 1996, NEUROPEDIATRICS, V27, P70, DOI 10.1055/s-2007-973752; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Jeong SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029767; Jissendi-Tchofo P, 2009, NEUROLOGY, V72, P410, DOI 10.1212/01.wnl.0000333256.74903.94; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062; Lee J, 2007, INVEST OPHTH VIS SCI, V48, P2483, DOI 10.1167/iovs.06-1211; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Martin Paul T, 2005, Semin Pediatr Neurol, V12, P152, DOI 10.1016/j.spen.2005.10.003; Mercuri E, 2009, NEUROLOGY, V72, P1802, DOI 10.1212/01.wnl.0000346518.68110.60; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Okanishi T, 2010, BRAIN DEV-JPN, V32, P342, DOI 10.1016/j.braindev.2009.11.006; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; Radner S, 2013, DEV NEUROBIOL, V73, P209, DOI 10.1002/dneu.22057; Roediger M, 2010, J MOL HISTOL, V41, P177, DOI 10.1007/s10735-010-9275-5; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Sharif KA, 2004, NEUROSCIENCE, V126, P967, DOI 10.1016/j.neuroscience.2004.03.064; Sharif KA, 2001, MECH DEVELOP, V103, P13, DOI 10.1016/S0925-4773(01)00326-4; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284	43	71	74	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					468	474		10.1016/j.ajhg.2013.02.005	http://dx.doi.org/10.1016/j.ajhg.2013.02.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23472759	Green Published, Bronze			2022-12-18	WOS:000316161700022
J	Schrauwen, I; Helfmann, S; Inagaki, A; Predoehl, F; Tabatabaiefar, MA; Picher, MM; Sommen, M; Seco, CZ; Oostrik, J; Kremer, H; Dheedene, A; Claes, C; Fransen, E; Chaleshtori, MH; Coucke, P; Lee, A; Moser, T; Van Camp, G				Schrauwen, Isabelle; Helfmann, Sarah; Inagaki, Akira; Predoehl, Friederike; Tabatabaiefar, Mohammad Amin; Picher, Maria Magdalena; Sommen, Manou; Seco, Celia Zazo; Oostrik, Jaap; Kremer, Hannie; Dheedene, Annelies; Claes, Charlotte; Fransen, Erik; Chaleshtori, Morteza Hashemzadeh; Coucke, Paul; Lee, Amy; Moser, Tobias; Van Camp, Guy			A Mutation in CABP2, Expressed in Cochlear Hair Cells, Causes Autosomal-Recessive Hearing Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CALCIUM-BINDING PROTEINS; CA(V)1.3 CHANNELS; CA2+-BINDING PROTEINS; GENE; CALMODULIN; IDENTIFICATION; REGULATOR; SENSORS	CaBPs are a family of Ca2+-binding proteins related to calmodulin and are localized in the brain and sensory organs, including the retina and cochlea. Although their physiological roles are not yet fully elucidated, CaBPs modulate Ca2+ signaling through effectors such as voltage-gated Ca-v Ca2+ channels. In this study, we identified a splice-site mutation (c.637+1G>T) in Ca2+-binding protein 2 (CABP2) in three consanguineous Iranian families affected by moderate-to-severe hearing loss. This mutation, most likely a founder mutation, probably leads to skipping of exon 6 and premature truncation of the protein (p.Phe164Serfs(star)4). Compared with wild-type CaBP2, the truncated CaBP2 showed altered Ca2+ binding in isothermal titration calorimetry and less potent regulation of Ca(v)1.3 Ca2+ channels. We show that genetic defects in CABP2 cause moderate-to-severe sensorineural hearing impairment. The mutation might cause a hypofunctional CaBP2 defective in Ca2+ sensing and effector regulation in the inner ear.	[Helfmann, Sarah; Predoehl, Friederike; Picher, Maria Magdalena; Moser, Tobias] Univ Gottingen, Sch Med, Dept Otolaryngol, Collaborat Res Ctr 889,InnerEar Lab, D-37075 Gottingen, Germany; [Schrauwen, Isabelle; Sommen, Manou; Claes, Charlotte; Fransen, Erik; Van Camp, Guy] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Inagaki, Akira; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Inagaki, Akira; Lee, Amy] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Inagaki, Akira; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Tabatabaiefar, Mohammad Amin] Ahvaz Jundishapour Univ Med Sci, Sch Med, Dept Med Genet, Ahvaz 6135733118, Iran; [Tabatabaiefar, Mohammad Amin; Chaleshtori, Morteza Hashemzadeh] Shahrekord Univ Med Sci, Sch Med, Cellular & Mol Res Ctr, Shahrekord 88155137, Iran; [Seco, Celia Zazo; Oostrik, Jaap; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Seco, Celia Zazo; Oostrik, Jaap; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Seco, Celia Zazo; Oostrik, Jaap; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Dheedene, Annelies; Coucke, Paul] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium	University of Gottingen; University of Antwerp; University of Iowa; University of Iowa; University of Iowa; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Shahrekord University Medical Sciences; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Ghent University	Moser, T (corresponding author), Univ Gottingen, Sch Med, Dept Otolaryngol, Collaborat Res Ctr 889,InnerEar Lab, Robert Koch Str 40, D-37075 Gottingen, Germany.	tmoser@gwdg.de; guy.vancamp@ua.ac.be	Coucke, Paul J/AAO-2954-2020; Kremer, Hannie/F-5126-2010; Schrauwen, Isabelle/H-5908-2019; Seco, Celia Zazo/AAB-7636-2020; Moser, Tobias/L-5068-2014; Fransen, Erik/C-4102-2015; Van Camp, Guy/F-3386-2013; Oostrik, Jaap/A-1703-2016; Zeinalian, Mehrdad/M-8515-2017; hashemzadeh Chaleshtori, morteza/V-6011-2017	Coucke, Paul J/0000-0001-7119-586X; Kremer, Hannie/0000-0002-0841-8693; Schrauwen, Isabelle/0000-0001-7310-6082; Seco, Celia Zazo/0000-0003-3506-7611; Moser, Tobias/0000-0001-7145-0533; Fransen, Erik/0000-0001-7785-4790; Van Camp, Guy/0000-0001-5105-9000; Zeinalian, Mehrdad/0000-0003-1381-0582; Lee, Amy/0000-0001-8021-0443; Inagaki, Akira/0000-0001-5560-9321; hashemzadeh Chaleshtori, morteza/0000-0002-8700-5554	University of Antwerp; State of Lower Saxony through the "Audiologie Initiative Niedersachsen" program; Federal Ministry for Research and Technology through the Bernstein Center for Computational Neuroscience Gottingen [01GQ1005A]; German Research Foundation [MO896/3-1]; Shahrekord University of Medical Sciences; National Institutes of Health [R01 DC009433, R01 HL087120, R01 EY020850]; Carver Research Program of Excellence; Oticon Foundation [09-3742]; ZonMW [40-00812-98-09047]; NATIONAL EYE INSTITUTE [R01EY020850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009433] Funding Source: NIH RePORTER	University of Antwerp; State of Lower Saxony through the "Audiologie Initiative Niedersachsen" program; Federal Ministry for Research and Technology through the Bernstein Center for Computational Neuroscience Gottingen; German Research Foundation(German Research Foundation (DFG)); Shahrekord University of Medical Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence; Oticon Foundation; ZonMW(Netherlands Organization for Health Research and Development); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the University of Antwerp to G.V.C.; grants from the State of Lower Saxony through the "Audiologie Initiative Niedersachsen" program, from the Federal Ministry for Research and Technology through the Bernstein Center for Computational Neuroscience Gottingen (01GQ1005A), and from the German Research Foundation (through the Priority Program 1608, MO896/3-1) to T.M.; a Shahrekord University of Medical Sciences grant to M.H.C.; National Institutes of Health grants (R01 DC009433, R01 HL087120, and R01 EY020850) and a Carver Research Program of Excellence to A.L.; and grants from the Oticon Foundation (09-3742) and ZonMW (40-00812-98-09047 to H.K. I.S. is a postdoctoral fellow of the Fonds Wetenschappelijk Onderzoek-Vlaanderen. We would like to thank Maarten Vanwesemael for assistance with the exon-trapping experiments; the NXTGNT sequencing centre at Ghent University for support with next-generation sequencing; Kai Tittmann for advice on the isothermal titration calorimetry; and Mercedes Suske, Christiane Senger-Freitag, and Sandra Gerke for excellent technical assistance.	Alasti F, 2008, INT J PEDIATR OTORHI, V72, P249, DOI 10.1016/j.ijporl.2007.09.023; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Brandt A, 2003, J NEUROSCI, V23, P10832; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; Francey LJ, 2012, AM J MED GENET A, V158A, P298, DOI 10.1002/ajmg.a.34391; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Helfmann S, 2011, J MOL BIOL, V406, P479, DOI 10.1016/j.jmb.2010.12.031; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Meyer NC, 2007, AM J MED GENET A, V143A, P1623, DOI 10.1002/ajmg.a.31718; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rozen S, 2000, Methods Mol Biol, V132, P365; Tabatabaiefar MA, 2011, CLIN GENET, V79, P594, DOI 10.1111/j.1399-0004.2010.01593.x; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	33	71	74	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					636	645		10.1016/j.ajhg.2012.08.018	http://dx.doi.org/10.1016/j.ajhg.2012.08.018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	22981119	Bronze, Green Published			2022-12-18	WOS:000309568500006
J	Cullinane, AR; Curry, JA; Carmona-Rivera, C; Summers, CG; Ciccone, C; Cardillo, ND; Dorward, H; Hess, RA; White, JG; Adams, D; Huizing, M; Gahl, WA				Cullinane, Andrew R.; Curry, James A.; Carmona-Rivera, Carmelo; Summers, C. Gail; Ciccone, Carla; Cardillo, Nicholas D.; Dorward, Heidi; Hess, Richard A.; White, James G.; Adams, David; Huizing, Marjan; Gahl, William A.			RETRACTED: A BLOC-1 Mutation Screen Reveals that PLDN Is Mutated in Hermansky-Pudlak Syndrome Type 9 (Retracted article. See vol. 100, pg. 837, 2017)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Retracted Publication							LYSOSOME-RELATED ORGANELLES; PROTEIN TRAFFICKING; COMPLEX; GENE; BIOGENESIS; MELANOSOMES; ENDOSOMES; DYSBINDIN; NONSENSE; PALLIDIN	Hermansky-Pudlak Syndrome (HPS) is an autosomal-recessive condition characterized by oculocutaneous albinism and a bleeding diathesis due to absent platelet delta granules. HPS is a genetically heterogeneous disorder of intracellular vesicle biogenesis. We first screened all our patients with HPS-like symptoms for mutations in the genes responsible for HPS-1 through HPS-6 and found no functional mutations in 38 individuals. We then examined all eight genes encoding the biogenesis of lysosome-related organelles complex-1, or BLOC-1, proteins in these individuals. This identified a homozygous nonsense mutation in PLDN in a boy with characteristic features of HPS. PLDN is mutated in the HPS mouse model pallid and encodes the protein pallidin, which interacts with the early endosomal t-SNARE syntaxin-13. We could not detect any full-length pallidin in our patient's cells despite normal mRNA expression of the mutant transcript. We could detect an alternative transcript that would skip the exon that harbored the mutation, but we demonstrate that if this transcript is translated into protein, although it correctly localizes to early endosomes, it does not interact with syntaxin-13. In our patient's melanocytes, the melanogenic protein TYRP1 showed aberrant localization, an increase in plasma-membrane trafficking, and a failure to reach melanosomes, explaining the boy's severe albinism and establishing his diagnosis as HPS-9.	[Cullinane, Andrew R.; Curry, James A.; Carmona-Rivera, Carmelo; Ciccone, Carla; Cardillo, Nicholas D.; Dorward, Heidi; Hess, Richard A.; Adams, David; Huizing, Marjan; Gahl, William A.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Summers, C. Gail] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; [Summers, C. Gail] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [White, James G.] Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA; [Adams, David; Gahl, William A.] NIH, Intramural Off Rare Dis Res, Off Director, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA	Cullinane, AR (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	andrew.cullinane@nih.gov	Huizing, Marjan/AAR-8860-2020		National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322, ZIAHG000215] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We appreciate the excellent technical assistance of Roxanne Fischer. We thank Thomas Markello and Hannah Carlson-Donohoe for assistance with SNP arrays and E. Dell'Angelica for supplying the pallidin antibody. This study was supported by the Intramural Research Programs of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. All authors declare no conflicts of interest.	Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Li Wei, 2007, Journal of Genetics and Genomics, V34, P669, DOI 10.1016/S1673-8527(07)60076-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Yuzaki M, 2010, NEURON, V68, P4, DOI 10.1016/j.neuron.2010.09.036; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087	23	71	72	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					778	787		10.1016/j.ajhg.2011.05.009	http://dx.doi.org/10.1016/j.ajhg.2011.05.009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21665000	Bronze, Green Published			2022-12-18	WOS:000291768500009
J	Schraders, M; Haas, SA; Weegerink, NJD; Oostrik, J; Hu, H; Hoefsloot, LH; Kannan, S; Huygen, PLM; Pennings, RJE; Admiraal, RJC; Kalscheuer, VM; Kunst, HPM; Kremer, H				Schraders, Margit; Haas, Stefan A.; Weegerink, Nicole J. D.; Oostrik, Jaap; Hu, Hao; Hoefsloot, Lies H.; Kannan, Sriram; Huygen, Patrick L. M.; Pennings, Ronald J. E.; Admiraal, Ronald J. C.; Kalscheuer, Vera M.; Kunst, Henricus P. M.; Kremer, Hannie			Next-Generation Sequencing Identifies Mutations of SMPX, which Encodes the Small Muscle Protein, X-Linked, as a Cause of Progressive Hearing Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE SMPX; INNER-EAR; DEAFNESS; LOCUS; DFNA20/26; MAPS; MICE; FORM	In a Dutch family with an X-linked postlingual progressive hearing impairment, a critical linkage interval was determined to span a region of 12.9 Mb flanked by the markers DXS7108 and DXS7110. This interval overlaps with the previously described DFNX4 locus and contains 75 annotated genes. Subsequent next-generation sequencing (NGS) detected one variant within the linkage interval, a nonsense mutation in SMPX. SMPX encodes the small muscle protein, X-linked (SMPX). Further screening was performed on 26 index patients from small families for which X-linked inheritance of nonsyndromic hearing impairment (NSHI) was not excluded. We detected a frameshift mutation in SMPX in one of the patients. Segregation analysis of both mutations in the families in whom they were found revealed that the mutations cosegregated with hearing impairment. Although we show that SMPX is expressed in many different organs, including the human inner ear, no obvious symptoms other than hearing impairment were observed in the patients. SMPX had previously been demonstrated to be specifically expressed in striated muscle and, therefore, seemed an unlikely candidate gene for hearing impairment. We hypothesize that SMPX functions in inner ear development and/or maintenance in the IGF-1 pathway, the integrin pathway through Rac1, or both.	[Schraders, Margit; Weegerink, Nicole J. D.; Oostrik, Jaap; Huygen, Patrick L. M.; Pennings, Ronald J. E.; Admiraal, Ronald J. C.; Kunst, Henricus P. M.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, NL-6500 HB Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Kannan, Sriram; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Schraders, Margit; Weegerink, Nicole J. D.; Oostrik, Jaap; Pennings, Ronald J. E.; Admiraal, Ronald J. C.; Kunst, Henricus P. M.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Hoefsloot, Lies H.; Kannan, Sriram; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Max Planck Society; Radboud University Nijmegen; Max Planck Society	Kremer, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, NL-6500 HB Nijmegen, Netherlands.	h.kremer@antrg.umcn.nl	Pennings, Ronald JE/J-6651-2012; Kremer, Hannie/F-5126-2010; Schraders, Margit/A-1607-2016; Kunst, Henricus P.M./J-6456-2012; Oostrik, Jaap/A-1703-2016; Huygen, P.L.M./L-4401-2015; Admiraal, R.J.C./L-4171-2015; kannan, sriram/U-3451-2019; kannan, sriram/N-1076-2014	Pennings, Ronald JE/0000-0001-5517-9683; Kremer, Hannie/0000-0002-0841-8693; Kunst, Henricus P.M./0000-0003-1162-6394; Kalscheuer, Vera/0000-0001-6898-3259; Haas, Stefan/0000-0003-3418-3688; kannan, sriram/0000-0002-2504-7177	Heinsius Houbolt Foundation; INTERREG IV A-program Germany-the Netherlands; Oticon Foundation [09-3742]; Netherlands Genomics Initiative [40-41009-98-9073]; ZonMW [40-00812-98-09047]	Heinsius Houbolt Foundation; INTERREG IV A-program Germany-the Netherlands; Oticon Foundation; Netherlands Genomics Initiative; ZonMW(Netherlands Organization for Health Research and Development)	We thank the families for their participation in this study. We would like to thank Suzanne Granneman for her contribution to the linkage analysis; Anne-Katrin Emde, Sean O'Keeffe, and Wei Chen for their help with establishing the bioinformatic tools; Claudia Langnick for construction of the single-end Illumina sequencing library; and Corinna Jensen and Melanie Bienek for NGS. The work was financially supported by the Heinsius Houbolt Foundation, the INTERREG IV A-program Germany-the Netherlands, The Oticon Foundation (09-3742), the Netherlands Genomics Initiative (40-41009-98-9073), and ZonMW (40-00812-98-09047).	Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; delCastillo I, 1996, HUM MOL GENET, V5, P1383, DOI 10.1093/hmg/5.9.1383; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Fishelson M., 2002, BIOINFORMATICS, V18, pS189, DOI [10.1093/bioinformatics/18.suppl_1.S189, DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S189]; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Kee AJ, 2009, J MUSCLE RES CELL M, V30, P187, DOI 10.1007/s10974-009-9193-x; Kemp TJ, 2001, GENOMICS, V72, P260, DOI 10.1006/geno.2000.6461; Kemperman MH, 2004, ARCH OTOLARYNGOL, V130, P281, DOI 10.1001/archotol.130.3.281; LALWANI AK, 1994, AM J HUM GENET, V55, P685; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Liu XZ, 2009, HUM GENET, V125, P53, DOI 10.1007/s00439-008-0602-9; Oti M, 2009, AM J HUM GENET, V85, P801, DOI 10.1016/j.ajhg.2009.10.026; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; Patzak D, 1999, HUM GENET, V105, P506, DOI 10.1007/s004390051138; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Schindeler A, 2005, EXP CELL RES, V307, P367, DOI 10.1016/j.yexcr.2005.04.006; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Tyson J, 1996, HUM MOL GENET, V5, P2055, DOI 10.1093/hmg/5.12.2055; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang QJ, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037929; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	35	71	85	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					628	634		10.1016/j.ajhg.2011.04.012	http://dx.doi.org/10.1016/j.ajhg.2011.04.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549342	Bronze, Green Published			2022-12-18	WOS:000290832100011
J	Collin, RWJ; Safieh, C; Littink, KW; Shalev, SA; Garzozi, HJ; Rizel, L; Abbasi, AH; Cremers, FPM; den Hollander, AI; Klevering, BJ; Ben-Yosef, T				Collin, Rob W. J.; Safieh, Christine; Littink, Karin W.; Shalev, Stavit A.; Garzozi, Hanna J.; Rizel, Leah; Abbasi, Anan H.; Cremers, Frans P. M.; den Hollander, Anneke I.; Klevering, B. Jeroen; Ben-Yosef, Tamar			Mutations in C2ORF71 Cause Autosomal-Recessive Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNDERLIES; DEGENERATION	With a worldwide prevalence of I in 4,000, retinitis pigmentosa (RP) is the most common form of hereditary retinal degeneration. More than 30 genes and loci have been implicated in nonsyndromic autosomal-recessive (ar) RP. Genome-wide homozygosity mapping was conducted in one Dutch and one Israeli family affected by arRP. The families were found to share a 5.9 Mb homozygous region on chromosome 2p23.1-p23.3. A missense variant in one of the genes residing in this interval, C2ORF71, has recently been reported to be associated with RP. C2ORF71, encoding a putative protein of 1,288 amino acids, was found to be specifically expressed in human retina. Furthermore, RT-PCR analysis revealed that in the mouse eye, C2orf71 is expressed as early as embryonic day 14. Mutation analysis detected a I bp deletion (c.946 del; p.Asn237MetfsX5) segregating with RP in the Dutch family, whereas a nonsense mutation (c.556C > T; p.Gln186X) was identified in the Israeli family. Microsatellite-marker analysis in additional Israeli families revealed cosegregation of a C2ORF71-linked haplotype in one other family, in which a 13 bp deletion (c.2756_2768 del; plys919ThrfsX) was identified. Clinically, patients with mutations in C2ORF71 show signs of typical RP; these signs include poor night vision and peripheral field loss, typical retinal bone-spicule-type pigment deposits, pale appearance of the optic disk, and markedly reduced or completely extinguished electroretinograms. In conclusion, truncating mutations in C2ORE71 were identified in three unrelated families, thereby confirming the involvement of this gene in the etiology of arRP.	[Safieh, Christine; Shalev, Stavit A.; Rizel, Leah; Ben-Yosef, Tamar] Technion Israel Inst Technol, Dept Genet, Haifa, Israel; [Collin, Rob W. J.; Littink, Karin W.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; den Hollander, Anneke I.; Klevering, B. Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Safieh, Christine; Rizel, Leah; Ben-Yosef, Tamar] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Fac Med, IL-31096 Haifa, Israel; [Littink, Karin W.] Rotterdam Eye Hosp, Rotterdam, Netherlands; [Shalev, Stavit A.] HaEmek Med Ctr, Genet Inst, Afula, Israel; [Garzozi, Hanna J.; Abbasi, Anan H.] Bnai Zion Med Ctr, Dept Ophthalmol, Haifa, Israel	Technion Israel Institute of Technology; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rotterdam Eye Hospital; Emek Medical Center; Bnai Zion Medical Center	Ben-Yosef, T (corresponding author), Technion Israel Inst Technol, Dept Genet, Haifa, Israel.	benyosef@tx.technion.ac.il	Hollander, Anneke den/N-4911-2014; Klevering, B.J./L-4434-2015; Collin, Rob/N-3575-2014; Cremers, Frans/A-5625-2014	Cremers, Frans/0000-0002-4954-5592; Abbasi, Anan/0000-0002-3466-0854	Israel Science Foundation; Foundation Fighting Blindness USA [BR-GE-0507-0381-RAD]; Stichting Wetenschappelijk Onderzoek Oogziekenhuis Prof. Dr. H.J. Fheringa Foundation; The Rotterdam Eye Hospital [2005-13]	Israel Science Foundation(Israel Science Foundation); Foundation Fighting Blindness USA; Stichting Wetenschappelijk Onderzoek Oogziekenhuis Prof. Dr. H.J. Fheringa Foundation; The Rotterdam Eye Hospital	We would like to thank Saskia van der Velde-Visser, Christel Beumer, and Angeline Hoffman for their excellent technical assistance, and we are grateful to all the patients and their relatives for their participation in this study. This work was supported by a grant from the Legacy Heritage Bio-Medical program of the Israel Science Foundation (to TB.), from the Foundation Fighting Blindness USA (grant BR-GE-0507-0381-RAD [to A.I.d.H.]), and from the Stichting Wetenschappelijk Onderzoek Oogziekenhuis Prof. Dr. H.J. Fheringa Foundation, The Rotterdam Eye Hospital (2005-13; to F.P.M.C. and A.I.d.H.).	Abbasi AH, 2008, MOL VIS, V14, P675; Auslender N, 2007, INVEST OPHTH VIS SCI, V48, P5431, DOI 10.1167/iovs.07-0736; CHANG JC, 1979, NATURE, V281, P602, DOI 10.1038/281602a0; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; PINCKERS A, 1973, ACTA OPHTHALMOL, V51, P445; Rozen S, 2000, Methods Mol Biol, V132, P365	8	71	77	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					783	788		10.1016/j.ajhg.2010.03.016	http://dx.doi.org/10.1016/j.ajhg.2010.03.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20398884	Green Published, Bronze			2022-12-18	WOS:000278045300014
J	de Brouwer, APM; van Bokhoven, H; Nabuurs, SB; Arts, WF; Christodoulou, J; Duley, J				de Brouwer, Arjan P. M.; van Bokhoven, Hans; Nabuurs, Sander B.; Arts, Willem Frans; Christodoulou, John; Duley, John			PRPS1 Mutations: Four Distinct Syndromes and Potential Treatment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							HUMAN PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE; LINKED MENTAL-RETARDATION; RUBINSTEIN-TAYBI-SYNDROME; URIC-ACID OVERPRODUCTION; PYROPHOSPHATE SYNTHETASE; PURINE METABOLISM; GENETIC-HETEROGENEITY; ENZYMATIC SYNTHESIS; ADENOSINE KINASE; HEARING-LOSS	Phosphoribosylpyrophosphate synthetases (PRSs) catalyze the first step of nucleotide synthesis. Nucleotides are central to cell function, being the building blocks of nucleic acids and serving as cofactors in cellular signaling and metabolism. With this in mind, it is remarkable that mutations in phosphoribosylpyrophosphate synthetase 1 (PRPS1), which is the most ubiquitously expressed gene of the three PRS genes, are compatible with life. Mutations described thus far in PRPS1 are all missense mutations that result in PRS-I superactivity or in variable levels of decreased activity, resulting in X-linked Charcot-Marie-Tooth disease-5 (CMTX5), Arts syndrome, and X-linked nonsyndromic sensorineural deafness (DFN2). Patients with PRS-I superactivity primarily present with uric acid overproduction, mental retardation, ataxia, hypotonia, and hearing impairment. Post lingual progressive hearing loss is found as an isolated feature in DFN2 patients. Patients with CMTX5 and Arts syndrome have peripheral neuropathy, including hearing impairment and optic atrophy. However, patients with Arts syndrome are more severely affected because they also have central neuropathy and an impaired immune system. The neurological phenotype in all four PRPS1-related disorders seems to result primarily from reduced levels of GTP and possibly other purine nucleotides including ATP, suggesting that these disorders belong to the same disease spectrum. Preliminary results of S-adenosylmethionine (SAM) supplementation in two Arts syndrome patients show improvement of their condition, indicating that SAM supplementation in the diet could alleviate some of the symptoms of patients with PRPS1 spectrum diseases by replenishing purine nucleotides (J.C., unpublished data).	[de Brouwer, Arjan P. M.; van Bokhoven, Hans] Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [de Brouwer, Arjan P. M.; van Bokhoven, Hans] Radboud Univ Nijmegen, Inst Genet & Metab Dis, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [van Bokhoven, Hans] Radboud Univ Nijmegen, Dept Cognit Neurosci, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Nabuurs, Sander B.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Arts, Willem Frans] Sophia Childrens Univ Hosp, Dept Paediat Neurol, Erasmus Med Ctr, NL-3000 CB Rotterdam, Netherlands; [Christodoulou, John] Childrens Hosp Westmead, Western Sydney Genet Program, Sydney, NSW 2145, Australia; [Christodoulou, John] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Duley, John] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Duley, John] Mater Hosp, Dept Pathol, Brisbane, Qld 4101, Australia	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Sydney; University of Sydney; University of Queensland	de Brouwer, APM (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6500 HB Nijmegen, Netherlands.	a.debrouwer@antrg.umcn.nl	Christodoulou, John/E-5866-2015; van Bokhoven, Hans/D-8764-2012; Duley, John/B-1806-2013; Christodoulou, John/M-3628-2019; Bokhoven, J.H.L.M. van van/H-8015-2014; de Brouwer, Arjan PM/P-5949-2015	Christodoulou, John/0000-0002-8431-0641; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; 	Netherlands Organization for Scientific Research [700.58.410]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We are grateful to Christian Gilissen (Department of Human Genetics, Radboud University Nijmegen Medical Centre, The Netherlands) for the expression profiling data analysis. S.B.N. is supported by VENI grant 700.58.410 from the Netherlands Organization for Scientific Research.	Ahmed M, 1999, J BIOL CHEM, V274, P7482, DOI 10.1074/jbc.274.11.7482; AKAOKA I, 1981, J RHEUMATOL, V8, P563; ARTS WFM, 1993, ANN NEUROL, V33, P535, DOI 10.1002/ana.410330519; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Bartholdi D, 2007, J MED GENET, V44, P327, DOI 10.1136/jmg.2006.046698; BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; BECKER MA, 1976, J CLIN INVEST, V57, P308, DOI 10.1172/JCI108282; BECKER MA, 1980, J CLIN INVEST, V65, P109, DOI 10.1172/JCI109640; BECKER MA, 1986, BIOCHIM BIOPHYS ACTA, V882, P168, DOI 10.1016/0304-4165(86)90151-0; BECKER MA, 1982, J LAB CLIN MED, V99, P495; Becker MA, 2000, ADV EXP MED BIOL, V486, P5; BECKER MA, 1975, J BIOL CHEM, V250, P6822; Becker MA, 2001, PROG NUCLEIC ACID RE, V69, P115, DOI 10.1016/S0079-6603(01)69046-9; BECKER MA, 1986, ARTHRITIS RHEUM, V29, P880, DOI 10.1002/art.1780290710; Becker MA, 1996, J BIOL CHEM, V271, P19894, DOI 10.1074/jbc.271.33.19894; BECKER MA, 1988, AM J MED, V85, P383, DOI 10.1016/0002-9343(88)90591-8; BECKER MA, 2008, ONLINE METABOLIC MOL, pCH205; BECROFT DMO, 1969, J PEDIATR, V75, P885; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Bottiglieri T, 2002, AM J CLIN NUTR, V76, p1151S, DOI 10.1093/ajcn/76.5.1151S; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; CHRISTEN HJ, 1992, LANCET, V340, P1167, DOI 10.1016/0140-6736(92)93202-X; Cui B, 2004, J GENET, V83, P35, DOI 10.1007/BF02715827; de Brouwer APM, 2007, AM J HUM GENET, V81, P507, DOI 10.1086/520706; EELLS JT, 1983, NEUROCHEM RES, V8, P1451; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Ernst M, 1996, NEW ENGL J MED, V334, P1568, DOI 10.1056/NEJM199606133342403; Fairbanks LD, 2002, BIOCHEM J, V366, P265, DOI 10.1042/bj20020148; FOX IH, 1971, J BIOL CHEM, V246, P5739; Garcia-Pavia P, 2003, ARTHRITIS RHEUM, V48, P2036, DOI 10.1002/art.11058; GIBLETT ER, 1975, LANCET, V1, P1010, DOI 10.1016/S0140-6736(75)91950-9; GIROT R, 1983, NEW ENGL J MED, V308, P700, DOI 10.1056/NEJM198303243081207; Glick N, 2006, J INHERIT METAB DIS, V29, P687, DOI 10.1007/s10545-006-0229-8; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARTMAN SC, 1958, J BIOL CHEM, V233, P451; Kaida A, 2005, BIOCHEM J, V391, P239, DOI 10.1042/BJ20041308; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KELLEY WN, 1968, J CLIN INVEST, V47, P2281, DOI 10.1172/JCI105913; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; Kim HJ, 2005, NEUROLOGY, V64, P1964, DOI 10.1212/01.WNL.0000163768.58168.3A; KITA K, 1994, J BIOL CHEM, V269, P8334; KORNBERG A, 1955, J BIOL CHEM, V215, P389; Kremer H, 1996, HUM GENET, V98, P513, DOI 10.1007/s004390050250; LEHNINGER A, 1978, BIOCHEMISTRY-US, P729; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; LIEBERMAN I, 1955, J BIOL CHEM, V215, P403; LLOYD KG, 1981, NEW ENGL J MED, V305, P1106, DOI 10.1056/NEJM198111053051902; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; LUI X, 2009, AM J HUM GENET, V86, P65; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Manolis EN, 1999, AM J OTOL, V20, P621; MOORE EC, 1966, J BIOL CHEM, V241, P4802; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; NYHAN WL, 1969, J PEDIATR, V74, P20, DOI 10.1016/S0022-3476(69)80004-1; PALELLA TD, 1980, J BIOL CHEM, V255, P5264; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; PREISS J, 1958, J BIOL CHEM, V233, P493; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reichard P, 1972, Adv Enzyme Regul, V10, P3, DOI 10.1016/0065-2571(72)90003-9; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; ROESSLER BJ, 1991, ADV EXP MED BIOL, V309, P125; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; ROSENBER.RN, 1967, NEUROLOGY, V17, P827, DOI 10.1212/WNL.17.9.827; Ross BM, 1997, LIPIDS, V32, P351, DOI 10.1007/s11745-997-0044-x; ROTH DG, 1974, J BIOL CHEM, V249, P291; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; SIDI Y, 1989, ADV EXP MED BIOL, V253, P67; SIMMONDS HA, 1985, NEUROPEDIATRICS, V16, P106, DOI 10.1055/s-2008-1052552; Skaper SD, 2001, PROG NEUROBIOL, V65, P593, DOI 10.1016/S0301-0082(01)00017-X; SMOLENSKI RT, 1992, BIOCHEM PHARMACOL, V43, P2053, DOI 10.1016/0006-2952(92)90161-B; SPERLING O, 1972, REV EUR ETUD CL BIOL, V17, P703; SPERLING O, 1972, BIOCHEM MED METAB B, V6, P310, DOI 10.1016/0006-2944(72)90017-8; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; STOW RA, 1993, J PHYSIOL-LONDON, V468, P311, DOI 10.1113/jphysiol.1993.sp019773; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; SWITZER RL, 1973, J BIOL CHEM, V248, P1063; Tang WY, 2006, ACTA CRYSTALLOGR F, V62, P432, DOI 10.1107/S1744309106009067; TATIBANA M, 1995, ADV ENZYME REGUL, V35, P229, DOI 10.1016/0065-2571(94)00017-W; Tyson J, 1996, HUM MOL GENET, V5, P2055, DOI 10.1093/hmg/5.12.2055; Van de Wiele CJ, 2002, J CLIN INVEST, V110, P395, DOI 10.1172/JCI200215683; WINN HR, 1980, AM J PHYSIOL, V239, pH212, DOI 10.1152/ajpheart.1980.239.2.H212; Wong DF, 1996, P NATL ACAD SCI USA, V93, P5539, DOI 10.1073/pnas.93.11.5539; WORTMANN RL, 2010, HARRISONS PRINCIPL E, V17, pCH353; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; YEN RCK, 1981, J BIOL CHEM, V256, P1839; ZOREF E, 1975, J CLIN INVEST, V56, P1093, DOI 10.1172/JCI108183	94	71	73	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					506	518		10.1016/j.ajhg.2010.02.024	http://dx.doi.org/10.1016/j.ajhg.2010.02.024			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20380929	Bronze, Green Published			2022-12-18	WOS:000276716800001
J	Hanson, D; Murray, PG; Sud, A; Remtamy, SA; Aglan, M; Superti-Furga, A; Holder, SE; Urquhart, J; Hilton, E; Manson, FDC; Scambler, P; Black, GCM; Clayton, PE				Hanson, Dan; Murray, Philip G.; Sud, Amit; Remtamy, Samia A.; Aglan, Mona; Superti-Furga, Andrea; Holder, Sue E.; Urquhart, Jill; Hilton, Emma; Manson, Forbes D. C.; Scambler, Peter; Black, Graeme C. M.; Clayton, Peter E.			The Primordial Growth Disorder 3-M Syndrome Connects Ubiquitination to the Cytoskeletal Adaptor OBSL1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CUL7; OBSCURIN-LIKE-1; MUTATIONS; CULLIN-7; BINDS; P53	3-M syndrome is an autosomal-recessive primordial growth disorder characterized by significant intrauterine and postnatal growth restriction. Mutations in the CUL7 gene are known to cause 3-M syndrome. In 3-M syndrome patients that do not carry CUL7 mutations, we performed high-density genome-wide SNP mapping to identify a second locus at 2q35-c36.1. Further haplotype analysis revealed a 1.29 Mb interval in which the underlying gene is located and we subsequently discovered seven distinct null mutations from 10 families within the gene OBSL1. OBSL1 is a putative cytoskeletal adaptor protein that localizes to the nuclear envelope. We were also able to demonstrate that loss of OBSL1 leads to downregulation of CUL7, implying a role for OBSL1 in the maintenance of CUL7 protein levels and suggesting that both proteins are involved within the same molecular pathway.	[Hanson, Dan; Murray, Philip G.; Sud, Amit; Urquhart, Jill; Hilton, Emma; Manson, Forbes D. C.; Black, Graeme C. M.] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Hanson, Dan; Murray, Philip G.; Sud, Amit; Clayton, Peter E.] Univ Manchester, Fac Med & Human Sci, Manchester M13 9NT, Lancs, England; [Murray, Philip G.; Urquhart, Jill; Black, Graeme C. M.; Clayton, Peter E.] Cent Manchester Univ Hosp Fdn Trust, Manchester M13 0JH, Lancs, England; [Remtamy, Samia A.; Aglan, Mona] Natl Res Ctr, Dept Clin Genet, Div Human Genet & Human Genome Res, Cairo 12311, Egypt; [Superti-Furga, Andrea] Univ Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Holder, Sue E.] NW London Hosp NHS Trust, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Scambler, Peter] Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England	University of Manchester; University of Manchester; University of Manchester; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Freiburg; University of London; University College London	Black, GCM (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England.	gblack@manchester.ac.uk	Scambler, Peter/AAZ-6026-2020; Urquhart, Jill/G-2282-2015; Black, Graeme/K-7374-2015; Manson, Forbes/G-2222-2015	Scambler, Peter/0000-0002-1487-4628; Urquhart, Jill/0000-0002-5788-5511; Black, Graeme/0000-0001-8727-6592; Hilton, Emma/0000-0002-3750-577X; Murray, Philip/0000-0002-1480-1576; Manson, Forbes/0000-0002-8342-660X; aglan, mona/0000-0002-0908-0639; temtamy, samia/0000-0002-6452-823X; Clayton, Peter/0000-0003-1225-4537; Sud, Amit/0000-0002-6133-0164	Pfizer; Newlife Foundation; National Institute of Health Research Manchester Biomedical Research Centre; MRC [G9901217, G0700541] Funding Source: UKRI; Medical Research Council [G0700541, G9901217] Funding Source: researchfish	Pfizer(Pfizer); Newlife Foundation; National Institute of Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Luisa Bonaf for collaboration. G.C.M.B. is a Wellcome Trust Senior Clinical Research Fellow. P.G.M. is a Medical Research Council (UK) Clinical Research Fellow. Part of this work was supported by a grant to D.H. and P.E.C. from Pfizer and a grant to P.S. from the Newlife Foundation. Support from the National Institute of Health Research Manchester Biomedical Research Centre is acknowledged.	Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Geisler SB, 2007, GENOMICS, V89, P521, DOI 10.1016/j.ygeno.2006.12.004; Huber C, 2005, NAT GENET, V37, P1119, DOI 10.1038/ng1628; Jung P, 2007, P NATL ACAD SCI USA, V104, P11388, DOI 10.1073/pnas.0609467104; Kasper JS, 2006, BIOCHEM BIOPH RES CO, V348, P132, DOI 10.1016/j.bbrc.2006.07.013; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Maksimova N, 2007, J MED GENET, V44, P772, DOI 10.1136/jmg.2007.051979; Miller J D, 1975, Birth Defects Orig Artic Ser, V11, P39; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rozen S, 2000, Methods Mol Biol, V132, P365; Temtamy SA, 2006, CLIN DYSMORPHOL, V15, P55, DOI 10.1097/01.mcd.0000198926.01706.33; Tsutsumi T, 2008, MOL CELL BIOL, V28, P743, DOI 10.1128/MCB.01665-07; van der Wall G, 2001, CLIN DYSMORPHOL, V10, P241, DOI 10.1097/00019605-200110000-00002; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009	19	71	77	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					801	806		10.1016/j.ajhg.2009.04.021	http://dx.doi.org/10.1016/j.ajhg.2009.04.021			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19481195	Bronze, Green Published			2022-12-18	WOS:000267042800010
J	Lou, XY; Chen, GB; Yan, L; Ma, JZ; Mangold, JE; Zhu, J; Elston, RC; Li, MD				Lou, Xiang-Yang; Chen, Guo-Bo; Yan, Lei; Ma, Jennie Z.; Mangold, Jamie E.; Zhu, Jun; Elston, Robert C.; Li, Ming D.			A Combinatorial Approach to Detecting Gene-Gene and Gene-Environment Interactions in Family Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NICOTINE DEPENDENCE; EPISTASIS; POLYMORPHISMS; POPULATION; REVEALS; DISEASE; MODELS	Widespread multifactor interactions present a significant challenge in determining risk factors of complex diseases. Several combinatorial approaches, such as the multifactor dimensionality reduction (MDR) method, have emerged as a promising tool for better detecting gene-gene (G x G) and gene-environment (G x E) interactions. We recently developed a general combinatorial approach, namely the generalized multifactor dimensionality reduction (GMDR) method, which can entertain both qualitative and quantitative phenotypes and allows for both discrete and continuous covariates to detect G x G and G X E interactions in a sample of unrelated individuals. In this article, we report the development of an algorithm that can be used to study G x G and G x E interactions for family-based designs, called pedigree-based GMDR (PGMDR). Compared to the available method, our proposed method has several major improvements, including allowing for covariate adjustments and being applicable to arbitrary phenotypes, arbitrary pedigree structures, and arbitrary patterns of missing marker genotypes. Our Monte Carlo simulations provide evidence that the PGMDR method is superior in performance to identify epistatic loci compared to the MDR-pedigree disequilibriurn test (PDT). Finally, we applied Our proposed approach to a genetic data set on tobacco dependence and found a significant interaction between two taste receptor genes (i.e., TAS2R16 and TAS2R38) in affecting nicotine dependence.	[Lou, Xiang-Yang; Chen, Guo-Bo; Mangold, Jamie E.; Li, Ming D.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22911 USA; [Chen, Guo-Bo; Yan, Lei; Zhu, Jun] Zhejiang Univ, Inst Bioinformat, Hangzhou 310029, Zhejiang, Peoples R China; [Ma, Jennie Z.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Elston, Robert C.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA	University of Virginia; Zhejiang University; University of Virginia; Case Western Reserve University	Li, MD (corresponding author), Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22911 USA.	ming_li@virginia.edu	Zhu, Jun/B-9945-2009; Lou, Xiang-Yang/B-6291-2013; Chen, Guo-Bo/C-2435-2009	Chen, Guo-Bo/0000-0001-5475-8237	National Institutes of Health [GM28356, DA025095, DA12844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844, R01DA025095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The original MDR Java source code was downloaded from http:// www.epistasis.org/open-source-mdr-project.html and the MDR-PDT software was downloaded from http://chgr.mc.vanderbilt. edu/ritchielab/MDRPDT.html. We greatly appreciate Jason Moore and his colleagues at the Dartmouth Medical School for making their MDR Java source code available to this project. We also highly appreciate Dr. Ritchie and her colleagues at Vanderbilt University for providing the MDR-PDT software and technical help for running the MDR-PDT software. This project was supported in part by National Institutes of Health Grants GM28356 to R.C.E., DA025095 to X.-Y.L., and DA12844 to M.D.L. All authors declare no conflict of interest on this work.	Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li MD, 2006, AM J HUM GENET, V79, P745, DOI 10.1086/508208; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Mangold JE, 2008, J MED GENET, V45, P578, DOI 10.1136/jmg.2008.057844; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; MCCULLAGH P, 1983, ANN STAT, V11, P59, DOI 10.1214/aos/1176346056; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Reed DR, 2006, PHYSIOL BEHAV, V88, P215, DOI 10.1016/j.physbeh.2006.05.033; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; Williams SM, 2004, BIOESSAYS, V26, P170, DOI 10.1002/bies.10401	31	71	72	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					457	467		10.1016/j.ajhg.2008.09.001	http://dx.doi.org/10.1016/j.ajhg.2008.09.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18834969	Green Published, Bronze			2022-12-18	WOS:000260239200003
J	Rajasimha, HK; Chinnery, PF; Samuels, DC				Rajasimha, Harsha Karur; Chinnery, Patrick F.; Samuels, David C.			Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A -> G mutation in blood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATIONS; RAGGED-RED FIBERS; STROKE-LIKE EPISODES; RANDOM GENETIC DRIFT; DIABETES-MELLITUS; A3243G MUTATION; TISSUE DISTRIBUTION; MYOCLONUS EPILEPSY; LACTIC-ACIDOSIS; POINT MUTATION	The mutation 3243A -> G is the most common heteroplasmic pathogenic mitochondrial DNA (mtDNA) mutation in humans, but it is not understood why the proportion of this mution decreases in blood during life. Changing levels of mtDNA heteroplasmy are fundamentally related to the pathophysiology of the mitochondrial disease and correlate with clinical progression. To understand this process, we simulated the segregation of mtDNA in hematopoietic stem cells and leukocyte precursors. Our observations show that the percentage of mutant mtDNA in blood decreases exponentially over time. This is consistent with the existence of a selective process acting at the stem cell level and explains why the level of mutant mtDNA in blood is almost invariably lower than in nondividing (postmitotic) tissues such as skeletal muscle. By using this approach, we derived a formula from human data to correct for the change in heteroplasmy over time. A comparison of age-corrected blood heteroplasmy levels with skeletal muscle, an embryologically distinct postmitotic tissue, provides independent confirmation of the model. These findings indicate that selection against pathogenic mtDNA mutations occurs in a stem cell population.	[Rajasimha, Harsha Karur; Samuels, David C.] Virginia Polytech Inst & State Univ, Virgina Bioinformat Inst, Blacksburg, VA 24061 USA; [Chinnery, Patrick F.] Univ Newcastle, Sch Med, Mitochondria Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chinnery, Patrick F.] Univ Newcastle, Sch Med, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Virginia Polytechnic Institute & State University; Newcastle University - UK; Newcastle University - UK	Samuels, DC (corresponding author), Virginia Polytech Inst & State Univ, Virgina Bioinformat Inst, Blacksburg, VA 24061 USA.	dsamuels@vbi.vt.edu	Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Samuels, David/C-1365-2012	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617				Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; AVISE JC, 1984, J MOL EVOL, V20, P99, DOI 10.1007/BF02257369; Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018; Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293; Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Canter JA, 2005, FREE RADICAL BIO MED, V38, P678, DOI 10.1016/j.freeradbiomed.2004.11.031; Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G; Chinnery PF, 1997, LANCET, V350, P1402, DOI 10.1016/S0140-6736(05)65183-5; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Chinnery PF, 1999, AM J MED GENET, V85, P498; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033; Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X; DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0; Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012; El Meziane A, 1998, NAT GENET, V18, P350; Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0; Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339; Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; Ho AD, 2005, EXP HEMATOL, V33, P1, DOI 10.1016/j.exphem.2004.09.004; Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x; Howell N, 2000, J NEUROL SCI, V172, P1, DOI 10.1016/S0022-510X(99)00207-5; HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Jacobi FK, 2001, INVEST OPHTH VIS SCI, V42, P1208; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kato Y, 2002, DIABETIC MED, V19, P784, DOI 10.1046/j.1464-5491.2002.00777.x; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Lien LM, 2001, ACTA NEUROL SCAND, V103, P159, DOI 10.1034/j.1600-0404.2001.103003159.x; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Lu JX, 2006, BIOCHEM BIOPH RES CO, V348, P115, DOI 10.1016/j.bbrc.2006.07.010; Mackey MC, 2001, CELL PROLIFERAT, V34, P71, DOI 10.1046/j.1365-2184.2001.00195.x; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12; MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O; MATTHEWS PM, 1995, HUM GENET, V96, P261; McDonald SAC, 2006, CELL CYCLE, V5, P808, DOI 10.4161/cc.5.8.2641; MOSEWICH RK, 1993, ARCH NEUROL-CHICAGO, V50, P275, DOI 10.1001/archneur.1993.00540030041012; Ng MCY, 2000, CLIN ENDOCRINOL, V52, P557, DOI 10.1046/j.1365-2265.2000.00989.x; OBERMAIERKUSSER B, 1991, FEBS LETT, V286, P67, DOI 10.1016/0014-5793(91)80942-V; OGAWA M, 1993, BLOOD, V81, P2844; Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742; Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K; PICCOLO G, 1993, ACTA NEUROL SCAND, V88, P406, DOI 10.1111/j.1600-0404.1993.tb05368.x; Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010; Saitoh S, 1999, J INHERIT METAB DIS, V22, P608, DOI 10.1023/A:1005569711521; Sciacco M, 2001, NEUROLOGY, V56, P1070, DOI 10.1212/WNL.56.8.1070; Shepherd BE, 2004, EXP HEMATOL, V32, P1040, DOI 10.1016/j.exphem.2004.07.023; SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101; Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; tHart LM, 1996, HUM MUTAT, V7, P193; TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394; van Essen EHR, 2000, DIABETIC MED, V17, P841, DOI 10.1046/j.1464-5491.2000.00379.x; Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607; Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9; Zhong S, 2000, J CLIN PATHOL, V53, P466, DOI 10.1136/jcp.53.6.466	73	71	72	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					333	343		10.1016/j.ajhg.2007.10.007	http://dx.doi.org/10.1016/j.ajhg.2007.10.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252214	Green Published, Bronze			2022-12-18	WOS:000253223900006
J	Kranz, C; Jungeblut, C; Denecke, J; Erlekotte, A; Sohlbach, C; Debus, V; Kehl, HG; Harms, E; Reith, A; Reichel, S; Grobe, H; Hammersen, G; Schwarzer, U; Marquardt, T				Kranz, Christian; Jungeblut, Christoph; Denecke, Jonas; Erlekotte, Anne; Sohlbach, Christina; Debus, Volker; Kehl, Hans Gerd; Harms, Erik; Reith, Anna; Reichel, Sonja; Grobe, Helfried; Hammersen, Gerhard; Schwarzer, Ulrich; Marquardt, Thorsten			A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; RAT-LIVER; PYROPHOSPHATE PHOSPHATASE; ENZYMATIC PHOSPHORYLATION; LINKED OLIGOSACCHARIDES; KINASE-ACTIVITY; GLYCOSYLATION; PROTEIN; MEMBRANE	The following study describes the discovery of a new inherited metabolic disorder, dolichol kinase (DK1) deficiency. DK1 is responsible for the final step of the de novo biosynthesis of dolichol phosphate. Dolichol phosphate is involved in several glycosylation reactions, such as N-glycosylation, glycosylphosphatidylinositol (GPI)-anchor biosynthesis, and C-and O-mannosylation. We identified four patients who were homozygous for one of two mutations (c.295T -> A[99Cys -> Ser] or c.1322A -> C [441Tyr -> Ser]) in the corresponding hDK1 gene. The residual activity of mutant DK1 was 2%-4% when compared with control cells. The mutated alleles failed to complement the temperature-sensitive phenotype of DK1-deficient yeast cells, whereas the wild-type allele restored the normal growth phenotype. Affected patients present with a very severe clinical phenotype, with death in early infancy. Two of the patients died from dilative cardiomyopathy.	Univ Klinikum Munster, Klin Kinder & Jugendmed, D-48149 Munster, Germany; Klinikum Stadt Nurnberg, Kinderklin, Nurnberg, Germany; Cnopfsche Kinderklin, Nurnberg, Germany	University of Munster	Marquardt, T (corresponding author), Univ Klinikum Munster, Klin Kinder & Jugendmed, Albert Schweitzer Str 33, D-48149 Munster, Germany.	marquat@uni-muenster.de	Kehl, Hans Gerd/A-1624-2012	Kehl, Hans Gerd/0000-0002-6555-8174				ALLEN CM, 1978, BIOCHEMISTRY-US, V17, P5020, DOI 10.1021/bi00616a025; BERNSTEIN M, 1989, MOL CELL BIOL, V9, P1191, DOI 10.1128/MCB.9.3.1191; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; BURTON WA, 1979, J BIOL CHEM, V254, P7129; CRICK DC, 1991, J NEUROCHEM, V57, P1354, DOI 10.1111/j.1471-4159.1991.tb08301.x; Doucey MA, 1998, MOL BIOL CELL, V9, P291, DOI 10.1091/mbc.9.2.291; Fernandez F, 2002, GLYCOBIOLOGY, V12, P555, DOI 10.1093/glycob/cwf068; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; FERRONOVICK S, 1984, J CELL BIOL, V98, P35, DOI 10.1083/jcb.98.1.35; Gao NG, 2002, J BIOL CHEM, V277, P39425, DOI 10.1074/jbc.M205195200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HELLER L, 1992, P NATL ACAD SCI USA, V89, P7013, DOI 10.1073/pnas.89.15.7013; HUBBARD SC, 1980, J BIOL CHEM, V255, P1782; KATO S, 1980, BIOCHEM BIOPH RES CO, V95, P770, DOI 10.1016/0006-291X(80)90853-0; KELLER RK, 1982, BIOCHIM BIOPHYS ACTA, V719, P118; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Kranz C, 2001, J CLIN INVEST, V108, P1613, DOI 10.1172/JCI200113635; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; LECHNER J, 1985, J BIOL CHEM, V260, P860; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Quellhorst GJ, 1998, BIOCHEM BIOPH RES CO, V244, P546, DOI 10.1006/bbrc.1998.8098; RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6; ROSENWALD AG, 1990, J BIOL CHEM, V265, P14544; SAGAMI H, 1993, J BIOL CHEM, V268, P10109; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; SCHER MG, 1984, J BIOL CHEM, V259, P4580; SPIRO MJ, 1986, J BIOL CHEM, V261, P4725; TAKEDA J, 1995, TRENDS BIOCHEM SCI, V20, P367, DOI 10.1016/S0968-0004(00)89078-7; TROY FA, 1979, ANNU REV MICROBIOL, V33, P519, DOI 10.1146/annurev.mi.33.100179.002511; VALTERSSON C, 1985, J BIOL CHEM, V260, P2742; VANDUIJN G, 1986, BIOCHIM BIOPHYS ACTA, V861, P211; WOLF M J, 1991, Glycobiology, V1, P405, DOI 10.1093/glycob/1.4.405	35	71	73	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					433	440		10.1086/512130	http://dx.doi.org/10.1086/512130			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273964	Bronze, Green Published			2022-12-18	WOS:000244403300004
J	Puel, A; Reichenbach, J; Bustamante, J; Ku, CL; Feinberg, J; Doffinger, R; Bonnet, M; Filipe-Santos, O; de Beaucoudrey, L; Durandy, A; Horneff, G; Novelli, F; Wahn, V; Smahi, A; Israel, A; Niehues, T; Casanova, JL				Puel, A; Reichenbach, J; Bustamante, J; Ku, CL; Feinberg, J; Doffinger, R; Bonnet, M; Filipe-Santos, O; de Beaucoudrey, L; Durandy, A; Horneff, G; Novelli, F; Wahn, V; Smahi, A; Israel, A; Niehues, T; Casanova, JL			The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; INCONTINENTIA PIGMENTI; INHERITED DISORDERS; IMMUNE-DEFICIENCY; IMMUNODEFICIENCY; INITIATION; INFECTIONS; ACTIVATION; DISEASE	Amorphic mutations in the NF-kappa B essential modulator ( NEMO) cause X-dominant incontinentia pigmenti, which is lethal in males in utero, whereas hypomorphic mutations cause X-recessive anhidrotic ectodermal dysplasia with immunodeficiency, a complex developmental disorder and life-threatening primary immunodeficiency. We characterized the NEMO mutation 110_111insC, which creates the most-upstream premature translation termination codon ( at codon position 49) of any known NEMO mutation. Surprisingly, this mutation is associated with a pure immunodeficiency. We solve this paradox by showing that a Kozakian methionine codon located immediately downstream from the insertion allows the reinitiation of translation. The residual production of an NH2-truncated NEMO protein was sufficient for normal fetal development and for the subsequent normal development of skin appendages but was insufficient for the development of protective immune responses.	Hop Necker Enfants Malad, Lab Genet Humaine Malad Infect, INSERM U550, Fac Med Necker Enfants Malades, Paris, France; Hop Necker Enfants Malad, INSERM U429, Paris, France; Hop Necker Enfants Malad, Unite Rech Handicaps Genet & Enfant, INSERM U393, Paris, France; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, Paris, France; Inst Pasteur, Unite Signalisat Mol & Activat Cellulaire, URA 2582, CNRS, Paris, France; Univ Dusseldorf, Zentrum Kinderheilkunde, D-4000 Dusseldorf, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Heinrich Heine University Dusseldorf	Casanova, JL (corresponding author), Univ Paris 05, INSERM U550, Fac Med Necker Enfants Malades, Lab Genet Humaine Malad Infect, 156 Rue Vaugirard, F-75015 Paris, France.	casanova@necker.fr	Smahi, Asma/J-4184-2017; Reichenbach, Janine/U-2171-2018; Bonnet, Marion C/C-5612-2014; KU, Cheng-Lung/AAT-1033-2020; Durandy, Anne/H-7475-2017; Novelli, Francesco/Z-5990-2019; KU, Cheng-Lung/L-6073-2015; Puel, Anne/H-7305-2017; Casanova, Jean-Laurent/I-3418-2017; Bustamante, Jacinta/H-7877-2017	Smahi, Asma/0000-0002-6002-0981; Reichenbach, Janine/0000-0002-9008-1312; Bonnet, Marion C/0000-0002-7559-2413; KU, Cheng-Lung/0000-0002-0643-2256; Durandy, Anne/0000-0001-7706-8466; KU, Cheng-Lung/0000-0002-0643-2256; Puel, Anne/0000-0003-2603-0323; Bustamante, Jacinta/0000-0002-3439-2482; NOVELLI, FRANCESCO/0000-0002-6259-5666; Casanova, Jean-Laurent/0000-0002-7782-4169				Abinun M, 1996, EUR J PEDIATR, V155, P146, DOI 10.1007/s004310050395; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Aradhya S, 2001, AM J HUM GENET, V68, P765, DOI 10.1086/318806; Aradhya S, 2001, HUM MOL GENET, V10, P2171, DOI 10.1093/hmg/10.19.2171; Carrol ED, 2003, ARCH DIS CHILD, V88, P340, DOI 10.1136/adc.88.4.340; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chitnis S, 2000, ARTHRITIS RES, V2, P399, DOI 10.1186/ar118; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis-Girod S, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e97; Fusco F, 2004, HUM MOL GENET, V13, P1763, DOI 10.1093/hmg/ddh192; Jain A, 2004, J CLIN INVEST, V114, P1593, DOI 10.1172/JCI200421345; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Kosaki K, 2001, AM J HUM GENET, V69, P664, DOI 10.1086/323003; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 2002, MAMM GENOME, V13, P401, DOI 10.1007/s00335-002-4002-5; Kozak M, 2000, GENOMICS, V70, P396, DOI 10.1006/geno.2000.6412; Ku CL, 2005, PEDIATRICS, V115, pE615, DOI 10.1542/peds.2004-1754; Ku CL, 2005, IMMUNOL REV, V203, P10, DOI 10.1111/j.0105-2896.2005.00235.x; Mansour S, 2001, AM J MED GENET, V99, P172, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1155>3.0.CO;2-Y; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Niehues T, 2004, J ALLERGY CLIN IMMUN, V114, P1456, DOI 10.1016/j.jaci.2004.08.047; Nishikomori R, 2004, BLOOD, V103, P4565, DOI 10.1182/blood-2003-10-3655; Orange JS, 2004, J ALLERGY CLIN IMMUN, V114, P650, DOI 10.1016/j.jaci.2004.06.052; Orange JS, 2004, J ALLERGY CLIN IMMUN, V113, P725, DOI 10.1016/j.jaci.2004.01.762; Orange JS, 2002, J CLIN INVEST, V109, P1501, DOI 10.1172/JCI200214858; Ozisik G, 2003, J CLIN ENDOCR METAB, V88, P417, DOI 10.1210/jc.2002-021034; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pittis M G, 2004, Hum Mutat, V24, P186, DOI 10.1002/humu.9263; Priolo M, 2001, J MED GENET, V38, P579, DOI 10.1136/jmg.38.9.579; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Santagata S, 2000, P NATL ACAD SCI USA, V97, P14572, DOI 10.1073/pnas.97.26.14572; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Smahi A, 2000, NATURE, V405, P466; Yamashita T, 1996, BLOOD, V87, P4424, DOI 10.1182/blood.V87.10.4424.bloodjournal87104424; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	37	71	71	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					691	701		10.1086/501532	http://dx.doi.org/10.1086/501532			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532398	Green Published, Bronze			2022-12-18	WOS:000236755900014
J							GOPEC Consortium	Disentangling fetal and maternal susceptibility for pre-eclampsia: A British multicenter candidate-gene study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE; TRANSMISSION/DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; COMMON MUTATION; RISK-FACTOR; TRANSMISSION; POLYMORPHISM; PROBABILITY; ASSOCIATION; EXCLUSION	The Genetics of Pre- Eclampsia ( GOPEC) collaboration aims to identify genetic factors in U. K. families affected by pre- eclampsia. A number of genetic studies have reported associations with pre- eclampsia, but attempts to replicate these findings have yielded inconsistent results. We describe the results of extensive genotyping of seven candidate genes previously reported as conferring susceptibility to pre- eclampsia. Six hundred fifty- seven women affected by pre- eclampsia and their families were genotyped at 28 single- nucleotide polymorphisms in the genes encoding angiotensinogen, the angiotensin receptors, factor V Leiden variant, methylene tetrahydrofolate reductase, nitric oxide synthase, and TNF alpha. Genotypes were analyzed by the transmission/ disequilibrium test. Genotype risk ratios ( GRRs) associated with maternal genotypes had a range of 0.70 - 1.16; GRRs associated with fetal genotypes had a range of 0.72 - 1.11. No GRR achieved the prespecified criteria for statistical significance ( posterior probability >.05). We conclude that none of the genetic variants tested in this large study of strictly defined pre- eclamptic pregnancies confers a high risk of disease. The results emphasize the importance of conducting rigorously designed studies of adequate size to provide precise genetic risks with narrow confidence intervals, if overreporting of false-positive results is to be avoided.	Queens Med Ctr, Div Clin Chem, Inst Genet, Nottingham NG14 7GZ, England	University of Nottingham	Queens Med Ctr, Div Clin Chem, Inst Genet, Nottingham NG14 7GZ, England.			Williamson, Catherine/0000-0002-6226-7611; Symonds, Ian/0000-0002-0746-5674; Caulfield, Mark/0000-0001-9295-3594	NIAID NIH HHS [U19 AI111224] Funding Source: Medline; NIAMS NIH HHS [UH2 AR067677] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chakraborty R, 1996, J FORENSIC SCI, V41, P671; Chen G, 1996, CLIN EXP IMMUNOL, V104, P154, DOI 10.1046/j.1365-2249.1996.d01-647.x; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; DizonTownson DS, 1996, AM J OBSTET GYNECOL, V175, P902, DOI 10.1016/S0002-9378(96)80022-6; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gordon D, 1999, GENET EPIDEMIOL, V17, pS587; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Mitchell LE, 1997, AM J HUM GENET, V60, P1006; Morgan L, 1998, J MED GENET, V35, P632, DOI 10.1136/jmg.35.8.632; Nakajima T, 2002, AM J HUM GENET, V70, P108, DOI 10.1086/338454; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Plummer S, 2004, HUM MUTAT, V24, P14, DOI 10.1002/humu.20050; Sohda S, 1997, J MED GENET, V34, P525, DOI 10.1136/jmg.34.6.525; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; Yoshimura T, 2000, J SOC GYNECOL INVEST, V7, P238, DOI 10.1016/S1071-5576(00)00060-5	23	71	74	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					127	131						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15889386				2022-12-18	WOS:000229794500012
J	Fox, CS; Cupples, LA; Chazaro, I; Polak, JF; Wolf, PA; D'Agostino, RB; Ordovas, JM; O'Donnell, CJ				Fox, CS; Cupples, LA; Chazaro, I; Polak, JF; Wolf, PA; D'Agostino, RB; Ordovas, JM; O'Donnell, CJ			Genomewide linkage analysis for internal carotid artery intimal medial thickness: Evidence for linkage to chromosome 12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; DENSITY-LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR; SR-BI; MYOCARDIAL-INFARCTION; RISK-FACTORS; GENE LOCUS; DEFICIENT MICE; WIDE SCAN; I GENE	Carotid intimal medial thickness (IMT) is a heritable quantitative measure of atherosclerosis. A genomewide linkage analysis was conducted to localize a quantitative-trait locus (QTL) influencing carotid IMT. Carotid IMT was measured in 596 men and 629 women from 311 extended families (1,242 sib pairs) in the Framingham Heart Study Offspring cohort. B-mode carotid ultrasonography was used to define mean IMT of the carotid artery segments. Multipoint variance-component linkage analysis was performed. Evidence for significant linkage to internal carotid artery (ICA) IMT (two-point log odds [LOD] score 4.1, multipoint LOD score 3.4) was found 161 cM from the tip of the short arm of chromosome 12; these results were confirmed using the GENEHUNTER package ( multipoint LOD score 4.3). No LOD scores >2.0 were observed for common carotid artery (CCA) IMT. Association analysis of a single-nucleotide-polymorphism variant of SCARB1 (minor allele frequency 0.13), a gene in close proximity to the region of peak linkage, revealed a protective association of the missense variant allele in exon 1 of SCARB1, with decreased ICA IMT compared with subjects homozygous for the common allele. Although the exon 1 variant contributed 2% to overall variation in ICA IMT, there was no significant change in the peak LOD score after adjustment in the linkage analyses. These data provide substantial evidence for a QTL on chromosome 12 influencing ICA IMT and for association of a rare variant of SCARB1, or a nearby locus, with ICA IMT. Because this rare SCARB1 variant does not account for our observed linkage, further investigations are warranted to identify additional candidate-gene variants on chromosome 12 predisposing to atherosclerosis phenotypes and clinical vascular disease.	NHLBIs Framingham Heart Study, Framingham, MA USA; Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Cambridge, MA 02138 USA; Boston Univ, Sch Med, Dept Neurol & Prevent Med, Boston, MA 02215 USA; Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02215 USA; Boston Univ, Dept Biostat & Stat, Boston, MA 02215 USA; Boston Univ, Dept Math, Stat & Consulting Unit, Boston, MA 02215 USA; Tufts Univ, USDA, Human Nutr Res Ctr, Medford, MA 02155 USA; NHLBI, Natl Inst Hlth, Bethesda, MD 20892 USA	Framingham Heart Study; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Boston University; Boston University; Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	O'Donnell, CJ (corresponding author), 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	chris@fram.nhlbi.nih.gov	; Ordovas, Jose/B-8727-2013	Cupples, L. Adrienne/0000-0003-0273-7965; Ordovas, Jose/0000-0002-7581-5680; Wolf, Philip/0000-0002-3628-301X	NHLBI NIH HHS [N01-HC-25195, N01HC25195, HL54776, R01 HL054776] Funding Source: Medline; NINDS NIH HHS [R501-NS17950-20, R01 NS017950] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; *AM HEART ASS, 2002, 2003 HEART STROK STA; [Anonymous], 2000, SAS STAT US GUID VER; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Crouse JR, 1996, STROKE, V27, P69, DOI 10.1161/01.STR.27.1.69; CUPPLES LA, 1987, NIH PUBLICATION; Davis PH, 1999, CIRCULATION, V100, P838, DOI 10.1161/01.CIR.100.8.838; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Ekstrom CT, 2001, GENET EPIDEMIOL, V21, P285, DOI 10.1002/gepi.1035; Espeland MA, 1999, STROKE, V30, P1047, DOI 10.1161/01.STR.30.5.1047; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Frayling TM, 2002, DIABETES, V51, P2313, DOI 10.2337/diabetes.51.7.2313; Gnasso A, 1996, CIRCULATION, V94, P3257, DOI 10.1161/01.CIR.94.12.3257; GRABOWSKI EF, 1995, THROMB HAEMOSTASIS, V74, P123; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; Immervoll T, 2001, HUM MUTAT, V18, P327, DOI 10.1002/humu.1194; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lange LA, 2002, ARTERIOSCL THROM VAS, V22, P418, DOI 10.1161/hq0302.105721; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLeary DH, 1996, STROKE, V27, P224, DOI 10.1161/01.STR.27.2.224; Osgood D, 2003, J CLIN ENDOCR METAB, V88, P2869, DOI 10.1210/jc.2002-021664; Osgood-McWeeney D, 2000, CLIN CHEM, V46, P118; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Silver DL, 2000, ANN NY ACAD SCI, V902, P103; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Weichert W, 2001, AM J PHYSIOL-RENAL, V280, pF706, DOI 10.1152/ajprenal.2001.280.4.F706; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zhang F, 2000, J BIOL CHEM, V275, P23287, DOI 10.1074/jbc.M001819200	44	71	72	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					253	261		10.1086/381559	http://dx.doi.org/10.1086/381559			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14730480	Green Published, Bronze			2022-12-18	WOS:000188860000006
J	Fan, RZ; Knapp, M				Fan, RZ; Knapp, M			Genome association studies of complex diseases by case-control designs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM TESTS; GENETIC-MARKERS; SUSCEPTIBILITY; RECOMBINATION; PARENTS; BLOCKS; LOCUS	One way to perform linkage-disequilibrium (LD) mapping of genetic traits is to use single markers. Since dense marker maps-such as single- nucleotide polymorphism and high-resolution microsatellite maps-are available, it is natural and practical to generalize single- marker LD mapping to high-resolution haplotype or multiple-marker LD mapping. This article investigates high-resolution LD-mapping methods, for complex diseases, based on haplotype maps or microsatellite marker maps. The objective is to explore test statistics that combine information from haplotype blocks or multiple markers. Based on two coding methods, genotype coding and haplotype coding, Hotelling's T-2 statistics T-G and T-H are proposed to test the association between a disease locus and two haplotype blocks or two markers. The validity of the two T-2 statistics is proved by theoretical calculations. A statistic T-C, an extension of the traditional method of comparing haplotype frequencies, is introduced by simply adding the chi(2) test statistics of the two haplotype blocks together. The merit of the three methods is explored by calculation and comparison of power and of type I errors. In the presence of LD between the two blocks, the type I error of T-C is higher than that of T-H and T-G, since T-C ignores the correlation between the two blocks. For each of the three statistics, the power of using two haplotype blocks is higher than that of using only one haplotype block. By power comparison, we notice that T-C has higher power than that of T-H, and T-H has higher power than that of T-G. In the absence of LD between the two blocks, the power of is similar to that of T-H and higher than that of T-G. Hence, we advocate use of T-H in the data analysis. In the presence of LD between the two blocks, takes into account the correlation between the two haplotype blocks and has a lower type I error and higher power than T-G. Besides, the feasibility of the methods is shown by sample-size calculation.	Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany	Texas A&M University System; Texas A&M University College Station; University of Bonn	Fan, RZ (corresponding author), Texas A&M Univ, Dept Stat, 447 Blocker Bldg, College Stn, TX 77843 USA.							Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Anderson T. W, 1984, INTRO MULTIVARIATE S; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Falconer D., INTRO QUANTITATIVE G, V4th; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Iles MM, 2002, HUM HERED, V53, P153, DOI 10.1159/000064977; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; OLSON JM, 1994, AM J HUM GENET, V55, P574; Ott J, 1999, ANAL HUMAN GENETIC L; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392	26	71	73	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					850	868		10.1086/373966	http://dx.doi.org/10.1086/373966			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12647259	Green Published, Bronze			2022-12-18	WOS:000181972600007
J	Herzing, LBK; Kim, SJ; Cook, EH; Ledbetter, DH				Herzing, LBK; Kim, SJ; Cook, EH; Ledbetter, DH			The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANGELMAN-SYNDROME; AUTISTIC DISORDER; CANDIDATE GENE; PROXIMAL 15Q; UBE3A/E6-AP; CHROMOSOME-15; MUTATIONS	Maternal duplications of the imprinted 15q11-13 domain result in an estimated 1%-2% of autism-spectrum disorders, and linkage to autism has been identified within 15q12-13. UBE3A, the Angelman syndrome gene, has, to date, been the only maternally expressed, imprinted gene identified within this region, but mutations have not been found in autistic patients. Here we describe the characterization of ATP10C, a new human imprinted gene, which encodes a putative protein homologous to the mouse aminophospholipid-transporting ATPase Atp10c. ATP10C maps within 200 kb distal to UBE3A and, like UBE3A, also demonstrates imprinted, preferential maternal expression in human brain. The location and imprinted expression of ATP10C thus make it a candidate for chromosome 15-associated autism and suggest that it may contribute to the Angelman syndrome phenotype.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Psychiat, Lab Dev Neurosci, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Ledbetter, DH (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.			Cook, Edwin/0000-0002-5848-5114	NICHD NIH HHS [R01 HD36111, N0I-HD-8-3284] Funding Source: Medline; NIMH NIH HHS [K02 MH01389, R01 MH52223] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036111, N01HD083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052223, K02MH001389] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Bass MP, 2000, NEUROGENETICS, V2, P219, DOI 10.1007/s100489900081; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; Cassidy SB, 2000, AM J MED GENET, V97, P136, DOI 10.1002/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V; Christian SL, 1998, GENOME RES, V8, P146, DOI 10.1101/gr.8.2.146; Cook EH, 1997, AM J HUM GENET, V60, P928; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Dhar M, 2000, PHYSIOL GENOMICS, V4, P93, DOI 10.1152/physiolgenomics.2000.4.1.93; DiDonato M, 1997, BBA-MOL BASIS DIS, V1360, P3, DOI 10.1016/S0925-4439(96)00064-6; Halleck MS, 1998, GENOME RES, V8, P354, DOI 10.1101/gr.8.4.354; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; Veenstra-VanderWeele J, 1999, MOL PSYCHIATR, V4, P64, DOI 10.1038/sj.mp.4000472; Wolpert CM, 2000, AM J MED GENET, V96, P365, DOI 10.1002/1096-8628(20000612)96:3<365::AID-AJMG25>3.0.CO;2-X	20	71	76	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1501	1505		10.1086/320616	http://dx.doi.org/10.1086/320616			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11353404	Green Published, Bronze			2022-12-18	WOS:000169094600021
J	Cui, JS; Staples, MP; Hopper, JL; English, DR; McCredie, MRE; Giles, GG				Cui, JS; Staples, MP; Hopper, JL; English, DR; McCredie, MRE; Giles, GG			Segregation analyses of 1,476 population-based Australian families affected by prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; BREAST-CANCER; CHROMOSOME 1Q; RISK; HISTORY; SWEDEN; LINKAGE; BRCA1; MEN; ASSOCIATION	Segregation analyses aim to detect genetic factors that have a major effect on an individual's risk of disease and to describe them in terms of mode of inheritance, age-specific cumulative risk (penetrance), and allele frequency. We conducted single- and two-locus segregation analyses of data from 1,476 men with prostate cancer diagnosed at age <70 years and ascertained through population registries in Melbourne, Sydney, and Perth, Australia, and from their brothers, fathers, and both maternal and paternal lineal uncles. Estimation and model selection were based on asymptotic likelihood theory and were performed through use of the software MENDEL. All two-locus models gave better fits than did single- locus models, even if lineal uncles were excluded or if we censored data (age and disease status) for relatives at 1992, when prostate-specific-antigen testing started to have a major impact on the incidence of prostate cancer in Australia. Among the genetic models that we considered, the best-fitting ones included a dominantly inherited increased risk that was greater, in multiplicative terms, at younger ages, as well as a recessively inherited or X-linked increased risk that was greater, in multiplicative terms, at older ages. The recessive and X-linked effects were strongly confounded, and it was not possible to fit them together. Penetrance to age 80 years was <similar to>70% (95% confidence interval [CI] 57%-85%) for the dominant effect and virtually 100% for the recessive and X-linked effects. Approximately 1/30 (95% CI 1/80-1/12) men would carry the dominant risk, and 1/140 (95% CI 1/220-1/90) would carry the recessive risk or 1/200 (95% CI 1/380-1/100) would carry the X-linked risk. Within discussed limitations, these analyses confirm the genetic heterogeneity, of prostate cancer susceptibility, that is becoming evident from linkage analyses, and they may aid future efforts in gene discovery.	Univ Melbourne, Ctr Genet Epidemiol, Carlton, Vic 3053, Australia; Anticanc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; New S Wales Canc Council, Canc Epidemiol Res Unit, Woolloomooloo, NSW, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	University of Melbourne; Cancer Council New South Wales; University of Otago	Hopper, JL (corresponding author), Univ Melbourne, Ctr Genet Epidemiol, 200 Berkeley St, Carlton, Vic 3053, Australia.	j.hopper@unimelb.edu.au	English, Dallas/AAH-5005-2019	English, Dallas/0000-0001-7828-8188; Giles, Graham/0000-0003-4946-9099	NATIONAL CANCER INSTITUTE [U01CA069638] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA069638, CA 69638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BENICHOU J, 1997, ENCY BIOSTATISTICS, P11; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; Bishop DT, 1997, SEMIN CANCER BIOL, V8, P45, DOI 10.1006/scbi.1997.0053; Bratt O, 1997, EUR J CANCER, V33, P2237, DOI 10.1016/S0959-8049(97)00320-1; Bratt O, 1999, EUR J CANCER, V35, P272, DOI 10.1016/S0959-8049(98)00358-X; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cerhan JR, 1999, CANCER EPIDEM BIOMAR, V8, P53; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Cui JS, 2000, CANCER EPIDEM BIOMAR, V9, P805; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; Etzioni R, 1998, AM J EPIDEMIOL, V148, P775; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Ghadirian P, 1997, INT J CANCER, V70, P679, DOI 10.1002/(SICI)1097-0215(19970317)70:6<679::AID-IJC9>3.3.CO;2-3; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; GILES G, 1998, CANC VICTORIA; GILES G, 1992, CANC VICTORIA; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; Harrap SB, 2000, AM J EPIDEMIOL, V152, P704, DOI 10.1093/aje/152.8.704; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lesko SM, 1996, AM J EPIDEMIOL, V144, P1041, DOI 10.1093/oxfordjournals.aje.a008876; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MCCREDIE M, 1996, J EPIDEMIOL BIOSTAT, V1, P99; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Page WF, 1997, PROSTATE, V33, P240; Paris PL, 2000, CANCER RES, V60, P3645; Pearson JD, 1996, UROLOGY, V48, P4, DOI 10.1016/S0090-4295(96)00603-6; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Schleutker J, 1999, AM J HUM GENET, V65, pA86; Schuurman AG, 1999, EPIDEMIOLOGY, V10, P192, DOI 10.1097/00001648-199903000-00020; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Tavtigian SV, 2000, AM J HUM GENET, V67, P11; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807	52	71	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1207	1218		10.1086/320114	http://dx.doi.org/10.1086/320114			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309686	Bronze, Green Published			2022-12-18	WOS:000168171200014
J	Wang, K; Pugh, EW; Griffen, S; Doheny, KF; Mostafa, WZ; al-Aboosi, MM; el-Shanti, H; Gitschier, J				Wang, K; Pugh, EW; Griffen, S; Doheny, KF; Mostafa, WZ; al-Aboosi, MM; el-Shanti, H; Gitschier, J			Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ZINC-DEFICIENCY; GROWTH-RETARDATION; HUMAN FIBROBLASTS; RECESSIVE TRAITS; LINKAGE ANALYSIS; RAT INTESTINE; CHILDREN; ABSORPTION; DIARRHEA	Acrodermatitis enteropathica (AE) is a rare autosomal recessive pediatric disease characterized by dermatitis, diarrhea, alopecia, and growth failure. The disease results from insufficient uptake of zinc by the intestine and can be fatal unless the diet is supplemented with zinc. To map the gene responsible for AE, a genomewide screen was performed on 17 individuals, including 4 affected individuals, in a consanguineous Jordanian family. Three markers-D8S373, D10S212, and D6S1021-had a pattern consistent with tight linkage to a recessive disease: one allele in the affected sibs and multiple alleles in unaffected sibs and parents. Two-point parametric linkage analysis using FASTLINK identified one region, D8S373, with a maximum LOD score >1.5 (1.94 at D8S373: recombination fraction .001). Twelve additional markers flanking D8S373 were used to genotype the extended family, to fine-map the AE gene. All five affected individuals-including one who was not genotyped in the genomewide screen-were found to be homozygous for a common haplotype, spanning similar to3.5 cM, defined by markers D8S1713 and D8S2334 on chromosomal region 8q24.3. To support these mapping data, seven consanguineous Egyptian families with eight patients with AE were genotyped using these markers, and six patients from five families were found to be homozygous in this region. Multipoint analysis with all consanguineous families, by Mapmaker/Homoz, resulted in a maximum LOD score of 3.89 between D8S1713 and D8S373. Sliding three-point analysis resulted in a maximum LOD score of 5.16 between markers D8S1727 and D8S1744.	Univ Calif San Francisco, Sch Med, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt; Jordan Univ Sci & Technol, Dept Dermatol, Irbid, Jordan; Jordan Univ Sci & Technol, Dept Pediat, Irbid, Jordan; Jordan Univ Sci & Technol, Dept Med Genet, Irbid, Jordan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Egyptian Knowledge Bank (EKB); Cairo University; Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology	Gitschier, J (corresponding author), Univ Calif San Francisco, Sch Med, Howard Hughes Med Inst, U-286,Box 0794,3rd & Parnassus Ave, San Francisco, CA 94143 USA.		Mostafa, Wedad Z/H-6786-2017; EL-SHANTI, HATEM/Q-4932-2016; El-Shanti, Hatem/O-5990-2014	Mostafa, Wedad Z/0000-0001-8464-8549; EL-SHANTI, HATEM/0000-0001-6230-8316; El-Shanti, Hatem/0000-0001-6230-8316	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NHGRI NIH HHS [N01HG65403] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ATHERTON DJ, 1979, CLIN SCI, V56, P505, DOI 10.1042/cs0560505; BARNES PM, 1973, P ROY SOC MED, V66, P327, DOI 10.1177/003591577306600411; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIES NT, 1980, BRIT J NUTR, V43, P189, DOI 10.1079/BJN19800078; DILLAHA CJ, 1953, JAMA-J AM MED ASSOC, V152, P509, DOI 10.1001/jama.1953.03690060025009; Duffy DL, 1997, AM J HUM GENET, V61, pA197; Grider A, 1998, J NUTR, V128, P1311, DOI 10.1093/jn/128.8.1311; Grider A, 1996, J NUTR, V126, P219, DOI 10.1093/jn/126.1.219; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KRIEGER I, 1982, MINERAL DEFICIENCIES; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOMBECK I, 1975, LANCET, V1, P855; Muga SJ, 1999, BIOL TRACE ELEM RES, V68, P1, DOI 10.1007/BF02784392; NAVEH Y, 1982, J PEDIATR-US, V101, P730, DOI 10.1016/S0022-3476(82)80303-X; NISHI Y, 1980, AM J CLIN NUTR, V33, P2613, DOI 10.1093/ajcn/33.12.2613; RODRIGUEZ A, 1985, ACTA PAEDIATR SCAND, V74, P770, DOI 10.1111/j.1651-2227.1985.tb10029.x; STEEL L, 1985, AM J PHYSIOL, V248, pG46; TERWILLIGER JD, 1994, HDB GENETIC LINKAGE; VANDENHAMER CJA, 1985, TRACE ELEMENTS MAN A, V5, P689; VANWOUWE JP, 1989, EUR J PEDIATR, V149, P2, DOI 10.1007/BF02024322; VANWOUWE JP, 1988, TRACE ELEM MED, V5, P90; WEISMANN K, 1979, BRIT J DERMATOL, V101, P573, DOI 10.1111/j.1365-2133.1979.tb11889.x	24	71	80	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1055	1060		10.1086/319514	http://dx.doi.org/10.1086/319514			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254458	Green Published, Bronze			2022-12-18	WOS:000167666000026
J	Goodship, J; Gill, H; Carter, J; Jackson, A; Splitt, M; Wright, M				Goodship, J; Gill, H; Carter, J; Jackson, A; Splitt, M; Wright, M			Autozygosity mapping of a Seckel syndrome locus to chromosome 3q22.1-q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NIJMEGEN BREAKAGE SYNDROME; INTRAUTERINE GROWTH-RETARDATION; CEPHALIC PRIMORDIAL DWARFISM; MITOMYCIN-C SENSITIVITY; DNA-DAMAGE RESPONSE; PROTEIN; CLONING; GENE; LINKAGE; REPAIR	Seckel syndrome (MIM 210600) is an autosomal recessive disorder of low birth weight, severe microcephaly, and dysmorphic facial appearance with receding forehead, prominent nose, and micrognathia. We have performed a genomic screen in two consanguineous families of Pakistani origin and found that the disorder segregates with markers between loci D3S1316 and D3S3710, which map to chromosome 3q22.1-q24. Analysis using HOMOZ/ MAPMAKER gave a maximum LOD score of 8.72. All five affected individuals were homozygous for the same allele, for two adjacent polymorphic markers within the region segregating with the disease, narrowing the region to 12 cM.	Univ Newcastle Upon Tyne, Sch Biochem & Genet, Human Genet Unit, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds, W Yorkshire, England	Newcastle University - UK; Saint James's University Hospital; University of Leeds	Goodship, J (corresponding author), Univ Newcastle Upon Tyne, Sch Biochem & Genet, Human Genet Unit, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.		Jackson, Andrew/D-3442-2009	Jackson, Andrew/0000-0002-8739-2646				Bass H, 1975, SYNDROME IDENT J, V3, P12; Brown KD, 1999, AM J HUM GENET, V64, P46, DOI 10.1086/302223; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; DERKALOUSTIAN VM, 1995, J MED GENET, V32, P998, DOI 10.1136/jmg.32.12.998; DerKaloustian VM, 1996, AM J MED GENET, V65, P21, DOI 10.1002/(SICI)1096-8628(19961002)65:1<21::AID-AJMG3>3.0.CO;2-0; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; HERSH JH, 1994, AM J MED GENET, V51, P194, DOI 10.1002/ajmg.1320510304; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; MAJEWSKI F, 1982, AM J MED GENET, V12, P37, DOI 10.1002/ajmg.1320120105; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; MAJEWSKI F, 1982, AM J MED GENET, V12, P23, DOI 10.1002/ajmg.1320120104; MAJEWSKI F, 1976, MONATSSCHR KINDERH, V124, P499; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; SHERIDAN PL, 1995, J BIOL CHEM, V270, P4575, DOI 10.1074/jbc.270.9.4575; Smith L, 1998, NAT GENET, V19, P39, DOI 10.1038/ng0598-39; Syrrou M., 1995, Genetic Counseling, V6, P37; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; WOODS CG, 1995, J MED GENET, V32, P301, DOI 10.1136/jmg.32.4.301	20	71	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					498	503		10.1086/303023	http://dx.doi.org/10.1086/303023			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10889046	Bronze, Green Published			2022-12-18	WOS:000089357800025
J	Del Campo, M; Jones, MC; Veraksa, AN; Curry, CJ; Jones, KL; Mascarello, JT; Ali-Kahn-Catts, Z; Drumheller, T; McGinnis, W				Del Campo, M; Jones, MC; Veraksa, AN; Curry, CJ; Jones, KL; Mascarello, JT; Ali-Kahn-Catts, Z; Drumheller, T; McGinnis, W			Monodactylous limbs and abnormal genitalia are associated with hemizygosity for the human 2q31 region that includes the HOXD cluster	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; SONIC-HEDGEHOG; VERTEBRATE LIMB; COMPLEX; MUTATION; MICE; CHROMOSOME-2; DELETION; ULNALESS; MOUSE	Vertebrates have four clusters of Hox genes (HoxA, HoxB, HoxC, and HoxD). A variety of expression and mutation studies indicate that posterior members of the HoxA and HoxD clusters play an important role in vertebrate limb development. In humans, mutations in HOXD13 have been associated with type II syndactyly or synpolydactyly, and, in HOXA13, with hand-foot-genital syndrome. We have investigated two unrelated children with a previously unreported pattern of severe developmental defects on the anterior-posterior (a-p) limb axis and in the genitalia, consisting of a single bone in the zeugopod, either monodactyly or oligodactyly ill the autopod of all four limbs, and penoscrotal hypoplasia. Both children are heterozygous for a deletion that eliminates at least eight (HOXD3-HOXD13) of the nine genes in the HOXD cluster. We propose that the patients' phenotypes are due in part to haploinsufficiency for HOXD-cluster genes. This hypothesis is supported by the expression patterns of these genes in early vertebrate embryos. However, the involvement of additional genes in the region could explain the discordance, in severity, between these human phenotypes and the milder, nonpolarized phenotypes present in mice hemizygous for HoxD cluster genes. These cases represent the first reported examples of deficiencies for an entire Hox cluster in vertebrates and suggest that the diploid dose of human HOXD genes is crucial for normal growth and patterning of the limbs along the anterior-posterior axis.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Dysmorphol, Dept Pediat, La Jolla, CA 92093 USA; Childrens Hosp, Div Dysmorphol & Genet, San Diego, CA USA; UCSF, Valley Childrens Hosp, Madera, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Hospital Los Angeles; University of California System; University of California San Francisco	McGinnis, W (corresponding author), Univ Calif San Diego, Dept Biol, 0349,9500 Gilman Dr, La Jolla, CA 92093 USA.			Veraksa, Alexey/0000-0003-2920-080X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER; NICHD NIH HHS [HD28315] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOLES RG, 1995, AM J MED GENET, V55, P155, DOI 10.1002/ajmg.1320550204; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Davis AP, 1996, DEVELOPMENT, V122, P1175; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DAVISSON MT, 1990, J HERED, V81, P151; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1994, SCIENCE, V266, P575, DOI 10.1126/science.7939709; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; FAVIER B, 1995, P NATL ACAD SCI USA, V92, P310, DOI 10.1073/pnas.92.1.310; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Fujimoto M, 1998, J HUM GENET, V43, P32, DOI 10.1007/s100380050033; Herault Y, 1997, DEVELOPMENT, V124, P3493; Herault Y, 1996, EMBO J, V15, P6727, DOI 10.1002/j.1460-2075.1996.tb01062.x; ISPIZUABELMONTE JC, 1991, NATURE, V350, P585; KAUFMAN TC, 1980, GENETICS, V94, P115; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; MUGAAKI Y, 1995, SCIENCE, V272, P548; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Nixon J, 1997, AM J MED GENET, V70, P324; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Ramenofsky A.F., 1990, COLUMBIAN CONSEQUENC, V2, P31; RAMER JC, 1989, AM J MED GENET, V32, P359, DOI 10.1002/ajmg.1320320318; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sambrook J, 1989, MOL CLONING LAB MANU; SHABTAI F, 1982, ANN GENET-PARIS, V25, P156; SHUBIN NH, 1986, EVOL BIOL, V20, P319; STUART JJ, 1991, NATURE, V350, P72, DOI 10.1038/350072a0; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zeltser L, 1996, DEVELOPMENT, V122, P2475	39	71	72	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					104	110		10.1086/302467	http://dx.doi.org/10.1086/302467			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364522	Green Published, Bronze			2022-12-18	WOS:000081224300014
J	Seri, M; Cusano, R; Forabosco, P; Cinti, R; Caroli, F; Picco, P; Bini, R; Morra, VB; De Michele, G; Lerone, M; Silengo, M; Pela, I; Borrone, C; Romeo, G; Devoto, M				Seri, M; Cusano, R; Forabosco, P; Cinti, R; Caroli, F; Picco, P; Bini, R; Morra, VB; De Michele, G; Lerone, M; Silengo, M; Pela, I; Borrone, C; Romeo, G; Devoto, M			Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; MITOCHONDRIAL-DNA; TRINUCLEOTIDE REPEATS; CHROMOSOME 10Q23-Q24; MULTIPLE DELETIONS; POLAR CATARACT; HUMAN GENOME; LOCUS; PARAPLEGIA; LINKAGE	We have recently observed a large pedigree with a new rare autosomal dominant spastic paraparesis. In three subsequent generations, 13 affected individuals presented with bilateral cataracts, gastroesophageal reflux with persistent vomiting, and spastic paraparesis with amyotrophy. Bilateral cataracts occurred in all affected individuals, with the exception of one patient who presented with a chorioretinal dystrophy, whereas clinical signs of spastic paraparesis showed a variable expressivity. Using a genomewide mapping approach, we mapped the disorder to the long arm of chromosome 10 on band q23.3-q24.2, in a 12-cM chromosomal region where additional neurologic disorders have been localized. The spectrum of phenotypic manifestations in this family is reminiscent of a smaller pedigree, reported recently, confirming the possibility of a new syndrome. Finally, the anticipation of symptoms suggests that an unstable trinucleotide repeat may be responsible for the condition.	Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; Ist Giannina Gaslini, Div Pediat 2, I-16148 Genoa, Italy; Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy; Univ Florence, Osped Pediat Meyer, Florence, Italy; Univ Naples Federico II, Dipartimento Sci Neurol, Naples, Italy; Univ Turin, Ist Discipline Pediat, Turin, Italy; IARC, Lyon, France	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Naples Federico II; University of Turin; World Health Organization; International Agency for Research on Cancer (IARC)	Seri, M (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Largo G Gaslini 5, I-16148 Genoa, Italy.		Forabosco, Paola/AAM-5540-2021; Devoto, Marcella/AAP-7595-2021; lerone, margherita/AAC-1583-2021; Caroli, Francesco/ABF-6080-2020; Seri, Marco/A-4339-2014	lerone, margherita/0000-0003-0666-4740; Caroli, Francesco/0000-0003-1828-6900; Seri, Marco/0000-0003-2425-2176; DEVOTO, MARCELLA/0000-0002-4431-5114; Silengo, Margherita/0000-0002-6255-1532; Cusano, Roberto/0000-0001-5543-7881; FORABOSCO, PAOLA/0000-0002-2006-2693; Picco, Paolo/0000-0003-0686-0725	Telethon [E.0440] Funding Source: Medline	Telethon(Fondazione Telethon)		ABBOTT C, 1994, ANN HUM GENET, V58, P87, DOI 10.1111/j.1469-1809.1994.tb01878.x; ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; Behnke H, 1965, Klin Monbl Augenheilkd, V147, P662; Berry V, 1996, HUM MOL GENET, V5, P415, DOI 10.1093/hmg/5.3.415; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Bundey S, 1992, GENETICS NEUROLOGY; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; CORMIER V, 1991, AM J HUM GENET, V48, P643; De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930; EIBERG H, 1988, CLIN GENET, V34, P272; EIBERG H, 1995, HUM GENET, V96, P33, DOI 10.1007/BF00214183; ELEJALDE BR, 1979, AM J MED GENET, V3, P97, DOI 10.1002/ajmg.1320030114; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; FINK JK, 1995, AM J HUM GENET, V56, P188; GIGLI GL, 1993, AM J MED GENET, V45, P711, DOI 10.1002/ajmg.1320450610; Gray IC, 1997, GENOMICS, V43, P85, DOI 10.1006/geno.1997.4809; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; Hejtmancik JF, 1998, AM J HUM GENET, V62, P520, DOI 10.1086/301774; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; HENTATI A, 1994, HUM MOL GENET, V3, P1867, DOI 10.1093/hmg/3.10.1867; Ionides ACW, 1997, HUM MOL GENET, V6, P47, DOI 10.1093/hmg/6.1.47; Kramer P, 1996, GENOMICS, V35, P539, DOI 10.1006/geno.1996.0395; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Mackay D, 1997, AM J HUM GENET, V60, P1474, DOI 10.1086/515468; MAUMENEE IH, 1979, OPHTHALMOLOGY, V86, P1554; Merin S., 1991, INHERITED EYE DIS, P86; Neri C, 1996, HUM MOL GENET, V5, P1001, DOI 10.1093/hmg/5.7.1001; Nielsen JE, 1997, HUM MOL GENET, V6, P1811, DOI 10.1093/hmg/6.11.1811; NIKALI K, 1995, AM J HUM GENET, V56, P1088; Nikali K, 1997, GENOMICS, V39, P185, DOI 10.1006/geno.1996.4465; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; PADMA T, 1995, AM J HUM GENET, V57, P840; Reid E, 1997, J MED GENET, V34, P499, DOI 10.1136/jmg.34.6.499; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Slavotinek AM, 1996, AM J MED GENET, V62, P42, DOI 10.1002/(SICI)1096-8628(19960301)62:1<42::AID-AJMG9>3.0.CO;2-Y; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; WILDENBERG SC, 1995, AM J HUM GENET, V57, P755; Yee RW, 1997, GENOMICS, V46, P152, DOI 10.1006/geno.1997.5028; ZEVIANI M, 1990, AM J HUM GENET, V47, P904; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	48	71	74	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					586	593		10.1086/302241	http://dx.doi.org/10.1086/302241			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973297	Green Published, Bronze			2022-12-18	WOS:000078740600029
J	Blanco, J; Gabau, E; Gomez, D; Baena, N; Guitart, M; Egozcue, J; Vidal, F				Blanco, J; Gabau, E; Gomez, D; Baena, N; Guitart, M; Egozcue, J; Vidal, F			Chromosome 21 disomy in the spermatozoa of the fathers of children with trisomy 21, in a population with a high prevalence of Down syndrome: Increased incidence in cases of paternal origin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; REDUCED RECOMBINATION; SPERM NUCLEI; 3-COLOR FISH; NONDISJUNCTION; ANEUPLOIDY; MEN; INFERTILE; OOCYTES; MEIOSIS	Between April 1991 and December 1994, epidemiological studies detected a population with a high prevalence of Down syndrome in El Valles, Spain. Parallel double studies were carried out to determine the parental and the meiotic origins of the trisomy 21, by use of DNA polymorphisms, and to establish the incidence of disomy 21 in the spermatozoa of the fathers of affected children, by use of multicolor FISH. Results show that the overall incidence of chromosome 21 disomy in the fathers of affected children was not significantly different from that in the control population (0.31% vs. 0.37%). However, analysis of individual data demonstrates that two cases (DP-4 and DP-5) with significant increases of disomy 21 (0.75% and 0.78% vs. 0.37%) correspond to the fathers of the two individuals with Down syndrome of paternal origin. DP-5 also had a significant increase of sex-chromosome disomies (0.69% vs. 0.37%) and of diploid spermatozoa (1.13% vs. 0.24%).	Univ Autonoma Barcelona, Unitat Biol Cellular, Bellaterra 08193, Barcelona, Spain; Corp Sanitaria, Genet Lab, Sabadell, Spain	Autonomous University of Barcelona	Vidal, F (corresponding author), Univ Autonoma Barcelona, Unitat Biol Cellular, Edifici C, Bellaterra 08193, Barcelona, Spain.	IBCE1@cc.uab.es	Rodríguez, Joan Blanco/I-1633-2015; Dominguez, Francesca Vidal/I-5946-2016; VIDAL, Francesca/Z-5021-2019	Rodríguez, Joan Blanco/0000-0003-0647-3856; Dominguez, Francesca Vidal/0000-0002-0985-7348; VIDAL, Francesca/0000-0002-0985-7348; Baena, Neus/0000-0003-0677-240X				ANTONARAKIS SE, 1993, TRENDS GENET, V9, P142, DOI 10.1016/0168-9525(93)90210-9; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; Benkhalifa M, 1996, J ASSIST REPROD GEN, V13, P140, DOI 10.1007/BF02072536; Bernardini L, 1997, MOL HUM REPROD, V3, P431, DOI 10.1093/molehr/3.5.431; Blanco J, 1996, HUM REPROD, V11, P722; Blanco J, 1997, HUM GENET, V99, P413, DOI 10.1007/s004390050381; Chevret E, 1996, HUM GENET, V97, P171, DOI 10.1007/BF02265260; Chevret E, 1997, HUM GENET, V99, P407, DOI 10.1007/s004390050380; Downie SE, 1997, MOL HUM REPROD, V3, P585, DOI 10.1093/molehr/3.7.585; Egozcue J, 1997, HUM REPROD UPDATE, V3, P441, DOI 10.1093/humupd/3.5.441; EGOZCUE J, 1983, HUM GENET, V65, P185, DOI 10.1007/BF00286660; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lange R, 1997, HUM REPROD, V12, P2154, DOI 10.1093/humrep/12.10.2154; Liebaers I, 1995, FERTILITY AND STERILITY, P409; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; Martin RH, 1996, BIOL REPROD, V54, P394, DOI 10.1095/biolreprod54.2.394; PANG MG, 1995, J ASSIST REPROD GE S, V12, P53; PELLESTOR F, 1991, HUM GENET, V86, P283; Pieters MHEC, 1998, LANCET, V351, P957; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SPEED RM, 1990, HUM GENET, V84, P547; Spriggs E. L., 1995, American Journal of Human Genetics, V57, pA127; TEMPLADO C, 1981, HUM GENET, V59, P345, DOI 10.1007/BF00295469; VanHummelen P, 1997, AM J HUM GENET, V61, P651; Veld PAI, 1997, HUM REPROD, V12, P752; VELD PI, 1995, LANCET, V346, P773, DOI 10.1016/S0140-6736(95)91531-1; VIDAL F, 1993, HUM REPROD, V8, P1740, DOI 10.1093/oxfordjournals.humrep.a137926; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WILLIAMS BJ, 1993, HUM MOL GENET, V2, P1929, DOI 10.1093/hmg/2.11.1929	31	71	75	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1067	1072		10.1086/302058	http://dx.doi.org/10.1086/302058			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758616	Green Published, Bronze			2022-12-18	WOS:000076577800019
J	Neufeld, EJ; Mandel, H; Raz, T; Szargel, R; Yandava, CN; Stagg, A; Faure, S; Barrett, T; Buist, N; Cohen, N				Neufeld, EJ; Mandel, H; Raz, T; Szargel, R; Yandava, CN; Stagg, A; Faure, S; Barrett, T; Buist, N; Cohen, N			Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSORINEURAL DEAFNESS; DIABETES-MELLITUS; WOLFRAM-SYNDROME; LINKAGE; FAMILIES; ATAXIA; DNA; MAP	Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment. On the basis of a linkage analysis of affected families of Alaskan and of Italian origin, we found, using homozygosity mapping, that the TRMA-syndrome gene maps to a region on chromosome 1q23.2-23.3 (maximum LOD score of 3.7 for D1S1679). By use of additional consanguineous kindreds of Israeli-Arab origin, the putative disease-gene interval also has been confirmed and narrowed, suggesting genetic homogeneity. Linkage analysis generated the highest combined LOD-score value, 8.1 at a recombination fraction of 0, with marker D1S2799. Haplotype analysis and recombination events narrowed the TRMA locus to a 16-cM region between markers D1S194 and D1S2786. Several heterozygote parents had diabetes mellitus, deafness, or megaloblastic anemia, which raised the possibility that mutations at this locus predispose carriers in general to these manifestations. Characterization of the metabolic defect of TRMA may shed light on the role of thiamine deficiency in such common diseases.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Tamkin Human Mol Genet Res Facil, Dept Genet, IL-31096 Haifa, Israel; Dana Farber Canc Inst, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Div Pulm Med, Boston, MA 02115 USA; Rambam Med Ctr, Dept Pediat, Haifa, Israel; Genethon, CNRS, URA 1922, Evry, France; Univ Birmingham, Dept Pediat & Child Hlth, Birmingham, W Midlands, England; Oregon Hlth Sci Univ, Portland, OR 97201 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Rambam Health Care Campus; Technion Israel Institute of Technology; Centre National de la Recherche Scientifique (CNRS); University of Birmingham; Oregon Health & Science University	Cohen, N (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Tamkin Human Mol Genet Res Facil, Dept Genet, POB 9649, IL-31096 Haifa, Israel.		Barrett, Timothy/F-1682-2010; Neufeld, Ellis J./F-9331-2011	Barrett, Timothy/0000-0002-6873-0750; Neufeld, Ellis J./0000-0001-8092-6281	NHLBI NIH HHS [HL075Z4] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOUD MR, 1985, J PEDIATR-US, V107, P537, DOI 10.1016/S0022-3476(85)80011-1; Akinci Aysehan, 1993, Acta Paediatrica Japonica, V35, P262; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581; BORGNAPIGNATTI C, 1989, J PEDIATR-US, V114, P405, DOI 10.1016/S0022-3476(89)80558-X; BORGNAPIGNATTI C, 1989, J PEDIATR, V114, P834; CAGIANUT B, 1977, SCHWEIZ MED WSCHR, V107, P446; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GRILL J, 1991, NOUV REV FR HEMATOL, V33, P543; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWORTH C, 1982, BRIT J HAEMATOL, V50, P549, DOI 10.1111/j.1365-2141.1982.tb01955.x; LAGRUTTA A, 1980, RIV ITAL PED, V6, P65; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MANDEL H, 1984, NEW ENGL J MED, V311, P836, DOI 10.1056/NEJM198409273111307; Mandel H., 1993, Pediatric Research, V33, p193A; MORIMOTO A, 1992, J JPN PEDIAT SOC, V96, P2137; POGGI V, 1989, EUR J PEDIATR, V148, P307, DOI 10.1007/BF00444120; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; RINDI G, 1994, J INHERIT METAB DIS, V17, P667, DOI 10.1007/BF00712009; ROGERS LE, 1969, J PEDIATR-US, V74, P494, DOI 10.1016/S0022-3476(69)80031-4; ROSSKAMP R, 1985, KLIN PADIATR, V197, P315, DOI 10.1055/s-2008-1033992; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; Schorderet D. F., 1994, American Journal of Human Genetics, V55, pA92; SCHWINGSHANDL J, 1989, J PEDIATR, V114, P834; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; VIANA MB, 1978, J PEDIATR-US, V93, P235, DOI 10.1016/S0022-3476(78)80503-4; VIGNAL A, 1993, METHODS MOL GENET, V1, P212	29	71	73	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1335	1341		10.1086/301642	http://dx.doi.org/10.1086/301642			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399900	Green Published, Bronze			2022-12-18	WOS:000071555900017
J	XU, J; LEVITT, RC; PANHUYSEN, CIM; POSTMA, DS; TAYLOR, EW; AMELUNG, PJ; HOLROYD, KJ; BLEECKER, ER; MEYERS, DA				XU, J; LEVITT, RC; PANHUYSEN, CIM; POSTMA, DS; TAYLOR, EW; AMELUNG, PJ; HOLROYD, KJ; BLEECKER, ER; MEYERS, DA			EVIDENCE FOR 2 UNLINKED LOCI REGULATING TOTAL SERUM IGE LEVELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SKIN-TEST REACTIVITY; IMMUNOGLOBULIN-E; SEGREGATION ANALYSIS; BRONCHIAL RESPONSE; LINKAGE ANALYSIS; LUNG-FUNCTION; ASTHMA; CHILDREN; METHACHOLINE	Studies investigating the genetic control of total serum IgE levels are of major importance in understanding basic pathophysiologic mechanisms in atopy and asthma, since IgE levels predict onset and correlate with the clinical expression of these disorders. Previous analysis of data from 92 families, ascertained through a parent with asthma, showed evidence for recessive inheritance of high IgE levels with linkage to chromosome 5q. Since there was significant residual familial correlation in the one-locus segregation analysis, two-locus segregation and linkage analyses were performed. Segregation analyses provided evidence for a second major locus unlinked to the locus on 5q. Utilization of this two-locus model corroborates the previous evidence for linkage between this trait and markers on 5q(31)-q(33) The LODs for the most informative marker D5S436 increased from 3.00 at 10% recombination to 4.67 at 9% recombination, when the two-locus model was used. Additional linkage studies are needed to map this second locus. These results demonstrate the importance of performing multilocus segregation and linkage analyses for quantitative traits that are related to the phenotype of a complex disorder. This approach has given further insight into the genetics of allergy and asthma by providing evidence for a two-locus model.	JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD; UNIV MARYLAND,SCH MED,BALTIMORE,MD; BEATRIXOORD,CTR ASTHMA,HAREN,NETHERLANDS; UNIV GRONINGEN HOSP,GRONINGEN,NETHERLANDS	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Groningen; University of Groningen				Holroyd, Kenneth/0000-0001-6050-3935	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048341] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL48341] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akaike H, 1974, IEEE T AUTOMAT CONTR, V19, P719; AMELUNG PJ, 1992, CLIN EXP ALLERGY, V22, P1077, DOI 10.1111/j.1365-2222.1992.tb00133.x; BLUMENTHAL MN, 1981, AM J MED GENET, V10, P219, DOI 10.1002/ajmg.1320100304; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; BURROWS B, 1992, J ALLERGY CLIN IMMUN, V90, P376, DOI 10.1016/S0091-6749(05)80018-1; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; CLIFFORD RD, 1987, ARCH DIS CHILD, V62, P66, DOI 10.1136/adc.62.1.66; COGSWELL JJ, 1982, BRIT MED J, V284, P1011, DOI 10.1136/bmj.284.6321.1011; DEVRIES K, 1962, INT ARCH ALLER A IMM, V20, P93, DOI 10.1159/000229248; GERGEN PJ, 1991, ARCH INTERN MED, V151, P487, DOI 10.1001/archinte.151.3.487; GERRARD JW, 1978, AM J HUM GENET, V30, P46; HALONEN M, 1992, AM REV RESPIR DIS, V146, P666; HASSTEDT SJ, 1983, AM J MED GENET, V14, P61, DOI 10.1002/ajmg.1320140110; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; HOPP RJ, 1990, AM REV RESPIR DIS, V141, P2, DOI 10.1164/ajrccm/141.1.2; JOHANSSON SGO, 1972, PROG CLIN IMMUNOL, V1, P1; MACCLUER JW, IN PRESS GENET EPIDE; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MARSH DG, 1982, NEW ENGL J MED, V305, P1551; MARSH DG, 1994, SCIENCE, V264, P1162; MARTINEZ FD, 1994, AM J HUM GENET, V55, P555; MEYERS DA, 1987, AM J HUM GENET, V41, P51; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; MEYERS DA, 1991, GENET EPIDEMIOL, V8, P351, DOI 10.1002/gepi.1370080507; MEYERS DA, 1982, HUM HERED, V32, P15, DOI 10.1159/000153262; OCONNOR GT, 1989, AM REV RESPIR DIS, V140, P225, DOI 10.1164/ajrccm/140.1.225; POSTMA DS, 1986, AM REV RESPIR DIS, V134, P276; POSTMA DS, 1989, AM REV RESPIR DIS, V140, pS100, DOI 10.1164/ajrccm/140.3_Pt_2.S100; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; TOWNLEY RG, 1986, J ALLERGY CLIN IMMUN, V77, P101, DOI 10.1016/0091-6749(86)90330-1; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; XU J, IN PRESS GENET EPIDE	34	71	75	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					425	430						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668269				2022-12-18	WOS:A1995RL77100026
J	DAHL, N; HU, LJ; CHERY, M; FARDEAU, M; GILGENKRANTZ, S; NIVELONCHEVALLIER, A; SIDANERNOISETTE, I; MUGNERET, F; GOUYON, JB; GAL, A; KIOSCHIS, P; DURSO, M; MANDEL, JL				DAHL, N; HU, LJ; CHERY, M; FARDEAU, M; GILGENKRANTZ, S; NIVELONCHEVALLIER, A; SIDANERNOISETTE, I; MUGNERET, F; GOUYON, JB; GAL, A; KIOSCHIS, P; DURSO, M; MANDEL, JL			MYOTUBULAR MYOPATHY IN A GIRL WITH A DELETION AT XQ27-Q28 AND UNBALANCED X-INACTIVATION ASSIGNS THE MTM1 GENE TO A 600-KB REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-II; MENTAL-RETARDATION; DNA MARKERS; CHROMOSOME INACTIVATION; FRAGILE SITE; LINKAGE; XQ28; LOCALIZATION; PATIENT; FEMALE	A young girl with a clinically moderate form of myotubular myopathy was found to carry a cytogenetically detectable deletion in Xq27-q28. The deletion had occurred de novo on the paternal X chromosome. It encompasses the fragile X (FRAXA) and Hunter syndrome (IDS) loci, and the DXS304 and DXS455 markers, in Xq27.3 and proximal Xq28., Other loci from the proximal half of Xq28 (DXS49, DXS256, DXS258, DXS305, and DXS497) were found intact. As the X-linked myotubular myopathy locus (MTM1) was previously mapped to Xq28 by linkage analysis, the present observation suggested that MTM1 is included in the deletion. However, a significant clinical phenotype is unexpected in a female MTM1 carrier. Analysis of inactive X-specific methylation at the androgen receptor gene showed that the deleted X chromosome was active in similar to 80% of leukocytes. Such unbalanced inactivation may account for the moderate MTM1 phenotype and for the mental retardation that later developed in the patient. This observation is discussed in relation to the hypothesis that a locus modulating X inactivation may lie in the region. Comparison of this deletion with that carried by a male patient with a severe Hunter syndrome phenotype but no myotubular myopathy, in light of recent linkage data on recombinant MTM1 families, led to a considerable refinement of the position of the MTM1 locus, to a region of similar to 600 kb, between DXS304 and DXS497.	INSERM,U184,CNRS,GENET MOLEC EUCARYOTES LAB,STRASBOURG,FRANCE; CHRU,GENET LAB,NANCY,FRANCE; INSERM,U153,PARIS,FRANCE; CHRU,CTR GENET,DIJON,FRANCE; CHRU,CYTOGENET LAB,DIJON,FRANCE; CHRU,SERV PEDIAT,DIJON,FRANCE; INST HUMAN GENET & ANTHROPOL,LUBECK,GERMANY; DKFZ,HEIDELBERG,GERMANY; IIGB,NAPLES,ITALY	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Helmholtz Association; German Cancer Research Center (DKFZ)								ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ASKANAS V, 1979, ARCH NEUROL-CHICAGO, V36, P604, DOI 10.1001/archneur.1979.00500460038003; BARKER DF, 1989, CYTOGENET CELL GENET, V51, P958; BECK M, 1992, AM J MED GENET, V44, P100, DOI 10.1002/ajmg.1320440123; BOYD Y, 1990, GENOMICS, V7, P182, DOI 10.1016/0888-7543(90)90539-7; BROADHEAD DM, 1986, CLIN GENET, V30, P392; CLARKE JTR, 1991, AM J HUM GENET, V49, P289; CLARKE JTR, 1992, AM J HUM GENET, V51, P316; CONSALEZ GG, 1992, GENOMICS, V12, P710, DOI 10.1016/0888-7543(92)90299-8; DAHL N, 1989, AM J HUM GENET, V45, P304; DAHL N, 1994, J MED GENET, V31, P922, DOI 10.1136/jmg.31.12.922; DARNFORS C, 1990, CLIN GENET, V37, P335; FARDEAU M, 1992, SKELETAL MUSCLE PATH, P237; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GILGENKRANTZ S, 1986, HUM GENET, V72, P157; Hall C W, 1978, Methods Enzymol, V50, P439; HAMERTON JL, 1984, CYTOGENET CELL GENET, V37, P486; HIRST MC, 1991, GENOMICS, V10, P243, DOI 10.1016/0888-7543(91)90506-A; LEHESJOKI AE, 1990, J MED GENET, V27, P288, DOI 10.1136/jmg.27.5.288; MIGEON BR, 1993, AM J HUM GENET, V52, P431; NISEN P, 1986, NEW ENGL J MED, V315, P1139, DOI 10.1056/NEJM198610303151806; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; PALMIERI G, 1993, GENOMICS, V16, P586, DOI 10.1006/geno.1993.1234; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P503; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; ROGNER UC, 1994, HUM MOL GENET, V3, P2137, DOI 10.1093/hmg/3.12.2137; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SARNAT HB, 1992, NEUROLOGY, V42, P1616, DOI 10.1212/WNL.42.8.1616; SCHLESSINGER D, 1993, CYTOGENET CELL GENET, V64, P148; SCHMIDT M, 1990, HUM GENET, V84, P347, DOI 10.1007/BF00196232; SCHMIDT M, 1992, AM J MED GENET, V43, P279, DOI 10.1002/ajmg.1320430143; STARR J, 1990, J MED GENET, V27, P281, DOI 10.1136/jmg.27.5.281; TARLETON J, 1993, HUM MOL GENET, V2, P1973, DOI 10.1093/hmg/2.11.1973; THOMAS NST, 1990, J MED GENET, V27, P284, DOI 10.1136/jmg.27.5.284; THOMAS NST, 1987, CYTOGENET CELL GENET, V46, P704; TOMMERUP N, 1993, J MED GENET, V30, P7132; VINCENT A, 1989, HUM GENET, V82, P85, DOI 10.1007/BF00288280; WALLGRENPETTERS.C, IN PRESS NEUROMUSCUL; WALLGRENPETTERS.C, 1994, NEUROMUSCULAR DISORD, V4, P71; WATSON A, 1982, METHOD ENZYMOL, V83, P573; WEBER C, 1993, HUM MOL GENET, V2, P612; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531	46	71	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1108	1115						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726166				2022-12-18	WOS:A1995QU58600013
J	DEMEESTER, CA; BU, XD; GRAY, RJ; LUSIS, AJ; ROTTER, JI				DEMEESTER, CA; BU, XD; GRAY, RJ; LUSIS, AJ; ROTTER, JI			GENETIC-VARIATION IN LIPOPROTEIN (A) LEVELS IN FAMILIES ENRICHED FOR CORONARY-ARTERY DISEASE IS DETERMINED ALMOST ENTIRELY BY THE APOLIPOPROTEIN (A) GENE LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LP(A) GLYCOPROTEIN PHENOTYPES; EPSTEIN-BARR-VIRUS; APO(A) MESSENGER-RNA; HEART-DISEASE; HUMAN-PLASMA; RISK FACTOR; MYOCARDIAL-INFARCTION; HYPERVARIABLE REGION; PLASMINOGEN GENE; SERUM-LIPIDS	Lipoprotein (a) (Lp[a]) is a cholesterol-rich lipoprotein resembling LDL but also containing a large polypeptide designated apolipoprotein (a) (apo[a]). Its levels are highly variable among individuals and, in a number of studies, are strongly correlated with the risk of coronary artery disease (CAD). In an effort to determine which genes control Lp(a) levels, we have studied 25 multiplex families (comprising 298 members) enriched for CAD. The apo(a) gene was genotyped among the families, using a highly informative pulse-field gel electrophoresis procedure. In addition, polymorphisms of the gene for the other major protein of Lp(a), apolipoprotein B (apoB), were examined. Quantitative sib-pair linkage analysis indicates that apo(a) is the major gene controlling Lp(a) levels in this CAD population (P = .001; 99 sib pairs), whereas the apoB gene demonstrated no significant quantitative linkage effect. We estimate that the apo(a) locus accounts for less than or equal to 98% of variance of Lp(a) serum levels. Approximately 43% of this variation is explained by size polymorphisms within the apo(a) gene. These results indicate that the apo(a) gene is the major determinant of Lp(a) serum levels not only in the general population but also in a high-risk CAD population.	UNIV CALIF LOS ANGELES, DEPT MED, DIV CARDIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT MICROBIOL & MOLEC GENET, LOS ANGELES, CA USA; UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA; CEDARS SINAI MED CTR, DEPT MED, DIV MED GENET, LOS ANGELES, CA 90048 USA; CEDARS SINAI MED CTR, DEPT PEDIAT, DIV CARDIOL, LOS ANGELES, CA 90048 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Cedars Sinai Medical Center					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007426] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28481] Funding Source: Medline; NIDDK NIH HHS [DK07426] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERS JJ, 1974, BIOCHEM GENET, V11, P475, DOI 10.1007/BF00486079; AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ARMSTRONG VW, 1986, ATHEROSCLEROSIS, V62, P249, DOI 10.1016/0021-9150(86)90099-7; AUSTIN MA, 1992, AM J HUM GENET, V51, P829; AZROLAN N, 1991, J BIOL CHEM, V266, P13866; BERG K, 1974, CLIN GENET, V6, P230; BERG K, 1979, BIOCH ATHEROSCLEROSI, P419; BERG K, 1992, MONOGR HUM GENET, P189; BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brewer Jr HB, 1990, LIPOPROTEIN A, P211; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; CORESH J, 1992, AM J HUM GENET, V50, P1038; DAHLEN G, 1976, CLIN GENET, V9, P558; Dahlen GH, 1990, LIPOPROTEIN A, P151; DRAYNA DT, 1988, GENOMICS, V3, P230, DOI 10.1016/0888-7543(88)90084-5; ETINGIN OR, 1991, J BIOL CHEM, V266, P2459; FLESS GM, 1984, J BIOL CHEM, V259, P1470; FRANK SL, 1988, HUM GENET, V79, P352; FRICK MH, 1978, CHEST, V73, P62, DOI 10.1378/chest.73.1.62; GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582; HARPEL PC, 1992, P NATL ACAD SCI USA, V89, P10193, DOI 10.1073/pnas.89.21.10193; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HIXSON JE, 1989, J BIOL CHEM, V264, P6013; KAMBOH MI, 1991, AM J HUM GENET, V49, P1063; KONDO I, 1990, CLIN GENET, V37, P132; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; KRAFT HG, 1992, HUM GENET, V90, P220; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LAWN RM, 1992, SCI AM, V266, P54, DOI 10.1038/scientificamerican0692-54; LINDAHL G, 1989, HUM GENET, V81, P149, DOI 10.1007/BF00293891; LINDAHL G, 1990, HUM GENET, V84, P563; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P672, DOI 10.1161/01.ATV.10.5.672; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MILES LA, 1990, THROMB HAEMOSTASIS, V63, P331; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; PEROMBELON YFN, 1994, J CLIN INVEST, V93, P1481, DOI 10.1172/JCI117126; PLOW EF, 1990, LIPOPROTEIN A, P117; PRESSMAN S, 1991, AM J HUM GENET, V49, P467; RADER DJ, 1993, J CLIN INVEST, V91, P443, DOI 10.1172/JCI116221; RAINWATER DL, 1989, J LIPID RES, V30, P549; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; SANDHOLZER C, 1992, ARTERIOSCLER THROMB, V12, P1214, DOI 10.1161/01.ATV.12.10.1214; SANDHOLZER C, 1992, J CLIN INVEST, V89, P1040, DOI 10.1172/JCI115645; Sandkamp M, 1990, LIPOPROTEIN A, P205; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SCANU AM, 1992, JAMA-J AM MED ASSOC, V267, P3326, DOI 10.1001/jama.267.24.3326; SCHRIEWER H, 1984, J CLIN CHEM CLIN BIO, V22, P591; UTERMANN G, 1983, FEBS LETT, V154, P357, DOI 10.1016/0014-5793(83)80182-3; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; UTERMANN G, 1988, HUM GENET, V78, P47, DOI 10.1007/BF00291233; UTERMANN G, 1988, HUM GENET, V78, P41, DOI 10.1007/BF00291232; WADE DP, 1993, P NATL ACAD SCI USA, V90, P1369, DOI 10.1073/pnas.90.4.1369; 1992, STATISTICAL ANAL GEN	59	71	71	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					287	293						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825589				2022-12-18	WOS:A1995QC10100037
J	GANDELMAN, KY; GIBSON, L; MEYN, MS; YANGFENG, TL				GANDELMAN, KY; GIBSON, L; MEYN, MS; YANGFENG, TL			MOLECULAR DEFINITION OF THE SMALLEST REGION OF DELETION OVERLAP IN THE WOLF-HIRSCHHORN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTON DISEASE GENE; COSMID CLONES; CHROMOSOME-4; TELOMERE; DEL(4P); LOCUS	Wolf-Hirschhorn syndrome (WHS), associated with a deletion of chromosome 4p, is characterized by mental and growth retardation and typical facial dysmorphism. A girl with clinical features of WHS was found to carry a subtle deletion of chromosome 4p. Initially suggested by high-resolution chromosome analysis, her deletion was confirmed by fluorescence in situ hybridization (FISH) with cosmid probes, E13 and Y2, of D4S113. To delineate this 4p deletion, we performed a series of FISH and pulsed-field gel electrophoresis analyses by using probes from 4p16.3. A deletion of approximately 2.5 Mb with the breakpoint at approximately 80 kb distal to D4S43 was defined in this patient and appears to be the smallest WHS deletion so far identified. To further refine the WHS critical region, we have studied three unrelated patients with presumptive 4p deletions, two resulting from unbalanced segregations of parental chromosomal translocations and one resulting from an apparently de novo unbalanced translocation. Larger deletions were identified in two patients with WHS. One patient who did not clinically present with WHS had a smaller deletion that thus eliminates the distal 100-300 kb from the telomere as being part of the WHS region. This study has localized the WHS region to approximately 2 Mb between D4S43 and D4S142.	YALE UNIV,DEPT GENET,BOX 3333,333 CEDAR ST,NEW HAVEN,CT 06520	Yale University								ALTHERR MR, 1991, AM J HUM GENET, V49, P1235; ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; ANVRET M, 1991, HUM GENET, V86, P481; BARTSCH O, 1990, AM J MED GENET, V37, P254, DOI 10.1002/ajmg.1320370218; BATES GP, 1990, AM J HUM GENET, V46, P762; BATES GP, 1991, AM J HUM GENET, V49, P7; BUCAN M, 1990, GENOMICS, V6, P1; BURGESS WH, 1989, ANN REV BIOCH, V58, P557; CARPENTER NJ, 1987, J MED GENET, V24, P706, DOI 10.1136/jmg.24.11.706; CURRY CJR, 1982, BIRTH DEFECTS-ORIG, V18, P275; CURTIS A, 1991, AM J HUM GENET S, V49, pA299; DRISCOLL DA, 1989, PEDIATR RES, V25, pA140; FRANCKE U, 1977, J PEDIATR-US, V90, P250, DOI 10.1016/S0022-3476(77)80642-2; GANDELMAN K, 1991, AM J HUM GENET S, V49, pA310; GREENBERG F, 1989, PEDIATR RES, V25, pA76; HARNDEN DG, 1985, ISCN 1985 INT SYSTEM; HIRSCHHORN K, 1965, HUMANGENETIK, V1, P479; JACKSON LG, 1977, CYTOGENET CELL GENET, V19, P50, DOI 10.1159/000130795; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; LAZJUK GI, 1980, CLIN GENET, V18, P6; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; LURIE IW, 1980, CLIN GENET, V17, P375; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; MACDONALD ME, 1991, SOMAT CELL MOLEC GEN, V17, P421, DOI 10.1007/BF01233067; MACLAREN L, 1991, AM J HUM GENET S, V49, pA270; MCKEOWN C, 1987, J MED GENET, V24, P410, DOI 10.1136/jmg.24.7.410; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; PREUS M, 1985, AM J MED GENET, V21, P337, DOI 10.1002/ajmg.1320210216; SCHMUTZ SM, 1983, HUM GENET, V64, P134, DOI 10.1007/BF00327109; SPIEGEL R, 1991, AM J HUM GENET S, V49, pA307; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; WILSON MG, 1981, HUM GENET, V59, P297, DOI 10.1007/BF00295461; WOLF U, 1965, HUMANGENETIK, V1, P397; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516	37	71	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					571	578						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1379774				2022-12-18	WOS:A1992JJ82800014
J	MARAZITA, ML; HU, DN; SPENCE, MA; LIU, YE; MELNICK, M				MARAZITA, ML; HU, DN; SPENCE, MA; LIU, YE; MELNICK, M			CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE IN SHANGHAI, CHINA - EVIDENCE FOR AN AUTOSOMAL MAJOR LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; GROWTH-FACTOR-ALPHA; GENETIC-VARIATION; ASSOCIATION; LINKAGE; DANISH; FAMILY; MODEL	Orientals are at higher risk for cleft lip with or without cleft palate (CL +/- P) than Caucasians or blacks. We collected demographic and family data to study factors contributing to the etiology of CL +/- P in Shanghai. The birth incidence of nonsyndromic CL +/- P (Shanghai 1980-87) was 1.11/1,000, with a male/female ratio of 1.42. Almost 2,000 nonsyndromic CL +/- P probands were ascertained from individuals operated on during the years 1956-83 at surgical hospitals in Shanghai. Detailed family histories and medical examinations were obtained for thc probands and all available family members. Genetic analyses of the probands' families were performed under the mixed model with major locus (ML) and multifactorial (MFT) components. The hypotheses of no familial transmission and of MFT alone could be rejected. Of the ML models, the autosomal recessive was significantly most likely and was assumed for testing three complex hypotheses: (1) ML and sporadics; (2) ML and MFT; (3) ML, MFT, and sporadics. None of the complex models were more likely than the ML alone model. In conclusion, the best-fitting, most parsimonious model for CL +/- P in Shanghai was that of an autosomal recessive major locus.	ZHABEI EYE INST, SHANGHAI, PEOPLES R CHINA; UNIV CALIF LOS ANGELES, LOS ANGELES, CA 90024 USA; UNIV SO CALIF, LOS ANGELES, CA 90089 USA	University of California System; University of California Los Angeles; University of Southern California	MARAZITA, ML (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT HUMAN GENET, BOX 3, MCV STN, RICHMOND, VA 23298 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009886] Funding Source: NIH RePORTER; NCRR NIH HHS [1-P41-RR03655] Funding Source: Medline; NIDCR NIH HHS [DE09886] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ARDINGER H H, 1988, American Journal of Human Genetics, V43, pA77; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; CARTER CO, 1982, J MED GENET, V19, P416; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHUNG CS, 1974, AM J HUM GENET, V26, P177; CHUNG CS, 1986, AM J HUM GENET, V39, P603; DEMENAIS F, 1984, J MED GENET, V21, P436, DOI 10.1136/jmg.21.6.436; EIBERG H, 1987, CLIN GENET, V32, P129; Fogh-Andersen P., 1968, CRANIOFACIAL ANOMALI, P27; FOGHANDERSEN P, 1971, BIRTH DEFECTS, V70, P50; GLADSTIEN K, 1978, AM J MED GENET, V2, P7, DOI 10.1002/ajmg.1320020103; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; HU DN, 1982, AM J HUM GENET, V34, P999; ISELIUS L, 1991, AM J HUM GENET, V49, P459; KHOO BC, 1966, PLAST RECONSTR SURG, V38, P89; KOGUCHI H, 1975, JPN J HUM GENET, V20, P207; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MARAZITA ML, 1986, GENET EPIDEMIOL, V3, P335, DOI 10.1002/gepi.1370030506; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; Melnick M, 1986, Am J Med Genet Suppl, V2, P183; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; MYRIANTHOPOULOS N C, 1974, Birth Defects Original Article Series, V10, P1; NEMANA LJ, 1992, AM J MED GENET, V42, P5, DOI 10.1002/ajmg.1320420103; Pratt R., 1980, CURRENT RES TRENDS P, P235; QIAN JF, 1991, AM J HUM GENET, V49, P397; Ross RB., 1972, CLEFT LIP PALATE; SHIANG R, 1991, AM J HUM GENET, V49, P418; SORANT AJM, 1989, STATISTICAL ANAL GEN; TANAKA K, 1969, JPN J HUM GENET, V14, P1; VINTINER J, 1991, AM J HUM GENET, V49, P190	37	71	71	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					648	653						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1307687				2022-12-18	WOS:A1992JJ82800021
J	FREIJE, D; SCHLESSINGER, D				FREIJE, D; SCHLESSINGER, D			A 1.6-MB CONTIG OF YEAST ARTIFICIAL CHROMOSOMES AROUND THE HUMAN FACTOR-VIII GENE REVEALS 3 REGIONS HOMOLOGOUS TO PROBES FOR THE DXS115 LOCUS AND 2 FOR THE DXYS64 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUMAN X-CHROMOSOME; HUMAN XQ24-XQ28; LARGE SEGMENTS; PHYSICAL MAP; HUMAN GENOME; DNA; SEQUENCES; XQ28; CLONES	Two yeast artificial chromosome (YAC) libraries were screened for probes in Xq28, around the gene for coagulation factor VIII (F8). A set of 30 YACs were recovered and assembled into a contig spanning at least 1.6 Mb from the DXYS64 locus to the glucose 6-phosphate dehydrogenase gene (G6PD). Overlaps among the YACs were determined by several fingerprinting techniques and by additional probes generated from YAC inserts by using Alu-vector or ligation-mediated PCR. Analysis of more than 30 probes and sequence-tagged sites (STSs) made from the region revealed the presence of several homologous genomic segments. For example, a probe for the DXYS64 locus, which maps less than 500 kb 5' of F8, detects a similar but not identical locus between F8 and G6PD. Also, a probe for the DXS115 locus detects at least three identical copies in this region, one in intron 22 of F8 and at least two more, which are upstream of the 5' end of the gene. Comparisons of genomic and YAC DNA suggest that the multiple loci are not created artifactually during cloning but reflect the structure of uncloned human DNA. On the basis of these data, the most likely order for the loci analyzed is tel-DXYS61-DXYS64-(DXS115-3-DXS115-2)-5'F8-(DXS115-1)-3'F8-G6PD.	WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,660 S EUCLID AVE,ST LOUIS,MO 63110	Washington University (WUSTL)					NIGMS NIH HHS [GM00247] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABIDI FE, 1990, GENOMICS, V7, P363, DOI 10.1016/0888-7543(90)90170-Y; ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; AUBOURG PR, 1987, ANN NEUROL, V21, P349, DOI 10.1002/ana.410210406; BARDONI B, 1988, Genomics, V3, P32, DOI 10.1016/0888-7543(88)90155-3; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CONSALEZ GG, 1991, AM J HUM GENET, V48, P468; COOKE HJ, 1984, NATURE, V311, P259, DOI 10.1038/311259a0; DILELLA AG, 1987, METHOD ENZYMOL, V152, P199; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; KENWRICK S, 1989, AM J HUM GENET, V45, P873; KNOWLTON RG, 1989, NUCLEIC ACIDS RES, V17, P423, DOI 10.1093/nar/17.1.423; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; LITTLE RD, 1992, P NATL ACAD SCI USA, V89, P177, DOI 10.1073/pnas.89.1.177; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P385; MERMER B, 1987, P NATL ACAD SCI USA, V84, P3320, DOI 10.1073/pnas.84.10.3320; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NUSSBAUM RL, 1986, AM J MED GENET, V23, P4457; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PATTERSON M, 1989, AM J HUM GENET, V44, P679; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROUYER F, 1990, EMBO J, V9, P505, DOI 10.1002/j.1460-2075.1990.tb08137.x; SAMBROOK J, 1986, MOL CLONING LABORATO; SCHLESSINGER D, 1991, GENOMICS, V11, P783, DOI 10.1016/0888-7543(91)90001-U; SHERMAN F, 1986, LABORATORY COURSE MA; TRASK BJ, 1991, AM J HUM GENET, V48, P1; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WADA M, 1990, AM J HUM GENET, V46, P95; WILSON RK, 1990, BIOTECHNIQUES, V8, P184	38	71	71	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					66	80						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609806				2022-12-18	WOS:A1992JA46700008
J	BARTELS, CF; JAMES, K; LADU, BN				BARTELS, CF; JAMES, K; LADU, BN			DNA MUTATIONS ASSOCIATED WITH THE HUMAN BUTYRYLCHOLINESTERASE J-VARIANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SERUM CHOLINESTERASE; AMINO-ACID-SEQUENCE; PLASMA CHOLINESTERASE; QUANTITATIVE VARIANT; MOLECULAR-CLONING; ACETYLCHOLINESTERASE; GENE; LOCUS-1; IDENTIFICATION; REGIONS	The J-variant of human serum butyrylcholinesterase (BChE) causes both an approximately two-thirds reduction of circulating enzyme molecules and a corresponding decrease in the level of BChE activity present in serum. Since the level of serum BChE activity and the duration of succinylcholine apnea are inversely correlated, this marked decrease in activity makes individuals with the J-variant more susceptible than usual subjects to prolonged apnea from succinylcholine. We reinvestigated the same family in which Garry et al. identified the J-variant phenotype. The atypical, fluoride, and K-variant mutations were also identified in members of the 47-person pedigree. DNA amplification by PCR, followed by direct sequencing of the amplified DNA, led to the finding that the J-variant phenotype of human serum BChE was associated with two DNA point mutations in the coding region. One of these was the mutation previously identified with the K-variant phenotype (GCA --> ACA; Ala539 --> Thr). The other was an adenine-to-thymine transversion at nucleotide 1490, which changed amino acid 497 from glutamic acid to valine (GAA --> GTA; Glu497 --> Val). This latter point mutation was named the J-variant mutation (formal name BCHE*497V). The J-variant mutation has not been identified without the K-variant mutation. The J-variant mutation created an RsaI-enzyme RFLP. Two additional point mutations, located in the noncoding regions of the gene, were also found to be linked with the J-variant and K-variant point mutations on the same allele. These noncoding polymorphic mutations had previously been found linked to the atypical and K-variant point mutations. A summary table shows dibucaine, fluoride, and Hoffmann-La Roche compound Ro 2-0683 inhibition numbers for 119 samples whose DNA has been sequenced. Eighteen BChE genotypes are represented.	UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48104; CENT DUPAGE HOSP,WINFIELD,IL	University of Michigan System; University of Michigan					NIGMS NIH HHS [GM 44887, GM27028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM027028, R01GM044887] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; BARTELS CF, 1990, NUCLEIC ACIDS RES, V18, P6171, DOI 10.1093/nar/18.20.6171-a; BARTELS CF, 1992, AM J HUM GENET, V50, P1086; BARTELS CF, 1991, CHOLINESTERASES; DOCTOR BP, 1990, FEBS LETT, V266, P123, DOI 10.1016/0014-5793(90)81522-P; EVANS RT, 1984, J MED GENET, V21, P99, DOI 10.1136/jmg.21.2.99; EVANS RT, 1980, J MED GENET, V17, P464, DOI 10.1136/jmg.17.6.464; GARRY PJ, 1976, J MED GENET, V13, P38, DOI 10.1136/jmg.13.1.38; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; JBILO O, 1990, NUCLEIC ACIDS RES, V18, P3990, DOI 10.1093/nar/18.13.3990; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; LADU BN, 1991, CELL MOL NEUROBIOL, V11, P79, DOI 10.1007/BF00712801; LIDDELL J, 1963, ACTA GENET STAT MED, V13, P95; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; MASSON P, 1990, FEBS LETT, V262, P115, DOI 10.1016/0014-5793(90)80167-H; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; NOGUEIRA CP, UNPUB IDENTIFICATION; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RUBINSTEIN HM, 1976, J MED GENET, V13, P43, DOI 10.1136/jmg.13.1.43; RUBINSTEIN HM, 1978, J MED GENET, V15, P27, DOI 10.1136/jmg.15.1.27; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; VIBYMOGENSEN J, 1980, ANESTHESIOLOGY, V53, P517, DOI 10.1097/00000542-198012000-00017; WHITTAKER M, 1989, HUM HERED, V39, P1, DOI 10.1159/000153823; WHITTAKER M, 1986, MONOGRAPHS HUMAN GEN, V11	27	71	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1104	1114						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1349196				2022-12-18	WOS:A1992HR47300026
J	MATHUR, A; STEKOL, L; SCHATZ, D; MACLAREN, NK; SCOTT, ML; LIPPE, B				MATHUR, A; STEKOL, L; SCHATZ, D; MACLAREN, NK; SCOTT, ML; LIPPE, B			THE PARENTAL ORIGIN OF THE SINGLE X-CHROMOSOME IN TURNER SYNDROME - LACK OF CORRELATION WITH PARENTAL AGE OR CLINICAL PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THYROID ABNORMALITIES; MATERNAL AGE; MONOSOMY-X; MOSAICISM; POLYMORPHISMS	We have used X- and Y-linked RFLPs to determine the origin of the single X chromosome in 25 live-born individuals with Turner syndrome. We determined that 18 individuals retained a maternal X (X(m)) and that seven retained the paternal X (X(p)). No occult mosaicism was detected. We found no differences in either maternal or paternal ages for the two groups. The ratio of maternal X to paternal X is just over 2:1, which is consistent with the expected proportion of meiotic or mitotic products, with equal loss at each step, given the nonviability of 45, Y. Six phenotypic or physiologic characteristics were assessed: (1) birth weight, (2) height percentile at time of testing, (3) presence of a webbed neck, (4) cardiovascular abnormalities, (5) renal abnormalities, and (6) thyroid autoimmunity. There were no significant differences in birth weights or heights between the girls who retained the maternal X or the paternal X. In addition, no differences between the groups could be appreciated in the incidence of the physical, anatomic, or physiologic parameters assessed.	UNIV CALIF LOS ANGELES,MED CTR,SCH MED,DEPT PEDIAT,DIV ENDOCRINOL,10833 LE CONTE AVE,LOS ANGELES,CA 90024; UNIV FLORIDA,COLL MED,DEPT PEDIAT,GAINESVILLE,FL 32611; UNIV FLORIDA,COLL MED,DEPT PATHOL,GAINESVILLE,FL 32611	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Florida; State University System of Florida; University of Florida								BURNS JL, 1979, CLIN GENET, V15, P22; CAROTHERS AD, 1980, ANN HUM GENET, V43, P355, DOI 10.1111/j.1469-1809.1980.tb01570.x; CONNOR JM, 1989, ACTA PAEDIATR SC   S, V356, P77; FIALKOW PJ, 1968, ANN NY ACAD SCI, V155, P759, DOI 10.1111/j.1749-6632.1968.tb55062.x; GERMAIN EL, 1986, ACTA PAEDIATR SCAND, V75, P750, DOI 10.1111/j.1651-2227.1986.tb10285.x; HALL JG, 1988, AM J HUM GENET, V43, P355; HALL JG, 1990, AM J HUM GENET, V46, P857; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HASSOLD T, 1985, AM J HUM GENET, V37, P965; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; KAJII T, 1979, HUM GENET, V51, P147, DOI 10.1007/BF00287168; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LYON AJ, 1985, ARCH DIS CHILD, V60, P932, DOI 10.1136/adc.60.10.932; Maniatis T., 1982, MOL CLONING; MAY KM, 1990, AM J HUM GENET, V46, P754; PAI GS, 1977, J PEDIATR-US, V91, P267, DOI 10.1016/S0022-3476(77)80827-5; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RILEY WJ, 1981, J PEDIATR-US, V99, P350, DOI 10.1016/S0022-3476(81)80316-2; SANGER R, 1977, J MED GENET, V14, P210, DOI 10.1136/jmg.14.3.210; SCHATZ DA, 1989, TURNER SYNDROME, P205; STAGNAROGREEN A, 1990, JAMA-J AM MED ASSOC, V264, P1422, DOI 10.1001/jama.264.11.1422; THO SPT, AM J OBSTET GYNECOL, V162, P59; TORFS CP, 1990, AM J HUM GENET, V47, P727; VANDERPUTTE SCJ, 1977, VIRCHOWS ARCH A, V376, P233; VANHEIM CM, 1986, NEW ENGL J MED, V315, P1314; WARBURTON D, 1980, LANCET, V1, P167	27	71	73	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					682	686						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	1673045				2022-12-18	WOS:A1991FK47800006
J	CREMERS, FPM; SANKILA, EM; BRUNSMANN, F; JAY, M; JAY, B; WRIGHT, A; PINCKERS, AJLG; SCHWARTZ, M; VANDEPOL, DJR; WIERINGA, B; DELACHAPELLE, A; PAWLOWITZKI, IH; ROPERS, HH				CREMERS, FPM; SANKILA, EM; BRUNSMANN, F; JAY, M; JAY, B; WRIGHT, A; PINCKERS, AJLG; SCHWARTZ, M; VANDEPOL, DJR; WIERINGA, B; DELACHAPELLE, A; PAWLOWITZKI, IH; ROPERS, HH			DELETIONS IN PATIENTS WITH CLASSICAL CHOROIDEREMIA VARY IN SIZE FROM 45 KB TO SEVERAL MEGABASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									RADBOUD HOSP, DEPT OPHTHALMOL, NIJMEGEN, NETHERLANDS; UNIV HELSINKI, DEPT MED GENET, SF-00100 HELSINKI 10, FINLAND; UNIV MUNSTER, INST HUMAN GENET, W-4400 MUNSTER, GERMANY; MOORFIELDS EYE HOSP, INST OPHTHALMOL, LONDON WC1V 7AN, ENGLAND; WESTERN GEN HOSP, MRC, CLIN & POPULAT CYTOGENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; RIGSHOSP, DEPT PEDIAT, CLIN GENET SECT, DK-2100 COPENHAGEN, DENMARK	Radboud University Nijmegen; University of Helsinki; University of Munster; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Edinburgh; Rigshospitalet; University of Copenhagen	CREMERS, FPM (corresponding author), CATHOLIC UNIV NIJMEGEN, RADBOUD HOSP, DEPT HUMAN GENET, POB 9101, 6500 HB NIJMEGEN, NETHERLANDS.		Cremers, Frans/A-5625-2014; Wieringa, Berend/A-5346-2011	Cremers, Frans/0000-0002-4954-5592; Wieringa, Berend/0000-0001-9192-8020				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CREMERS FPM, 1989, P NATL ACAD SCI USA, V86, P7510, DOI 10.1073/pnas.86.19.7510; CREMERS FPM, 1987, HUM GENET, V77, P23, DOI 10.1007/BF00284707; CREMERS FPM, 1987, CLIN GENET, V32, P421; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; CREMERS FPM, IN PRESS HUM GENET; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DIEKSTALL F, 1988, PAKISTAN J OPHTHALMO, V4, P51; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANCKE U, 1985, AM J HUM GENET, V37, P250; Goedbloed J., 1942, OPHTHALMOLOGICA, V104, P308; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; HAMMERSTEIN W, 1985, OPHTHALMOLOGISCHE GE, P300; HODGSON SV, 1987, HUM GENET, V75, P286, DOI 10.1007/BF00281076; JAY M, 1986, OPHTHALMIC PAED GEN, V7, P201, DOI 10.3109/13816818609004139; KAPLAN J, 1989, CYTOGENET CELL GENET, V51, P1022; KARNA J, 1986, ACTA OPHTHALMOL, V64, P1; KURSTJENS JH, 1965, DOC OPHTHALMOL, V19, P1; LESKO JG, 1987, AM J HUM GENET, V40, P303; LEWIS RA, 1985, OPHTHALMOLOGY, V92, P800; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MACDONALD IM, 1987, HUM GENET, V77, P233, DOI 10.1007/BF00284475; Maniatis T., 1982, MOL CLONING; McCULLOCH C, 1948, Trans Am Acad Ophthalmol Otolaryngol, V52, P160; MERRY DE, 1990, GENOMICS, V6, P609, DOI 10.1016/0888-7543(90)90494-F; MERRY DE, 1989, AM J HUM GENET, V45, P530; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P473; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; PILLERS D M, 1988, American Journal of Human Genetics, V43, pA65; ROSENBERG T, 1986, OPHTHALMIC PAED GEN, V7, P205, DOI 10.3109/13816818609004140; SAITO F, 1986, CLIN GENET, V29, P92; SANKILA EM, 1987, CLIN GENET, V31, P315; SANKILA EM, 1989, HUM GENET, V84, P66, DOI 10.1007/BF00210674; SANKILA EM, 1990, HUM GENET, V85, P117, DOI 10.1007/BF00276335; SCHWARTZ M, 1986, HUM GENET, V74, P449, DOI 10.1007/BF00280505; SCHWARTZ M, 1988, HUM GENET, V78, P156, DOI 10.1007/BF00278188; SIU VM, 1990, HUM GENET, V84, P459; SORSBY A, 1952, BRIT J OPHTHALMOL, V36, P547, DOI 10.1136/bjo.36.10.547; VANDEPOL TJR, 1990, NUCLEIC ACIDS RES, V18, P725, DOI 10.1093/nar/18.4.725; VANOMMEN GJB, 1986, HUMAN GENETIC DISEAS, P113; WAARDENBURG PJ, 1942, ACTA OPHTHALMOL, V20, P235; WIERINGA B, 1985, CLIN GENET, V27, P522	46	71	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					622	628						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2220804				2022-12-18	WOS:A1990EB31900006
J	LANGLOIS, S; KASTELEIN, JJP; HAYDEN, MR				LANGLOIS, S; KASTELEIN, JJP; HAYDEN, MR			CHARACTERIZATION OF 6 PARTIAL DELETIONS IN THE LOW-DENSITY-LIPOPROTEIN (LDL) RECEPTOR GENE CAUSING FAMILIAL HYPERCHOLESTEROLEMIA (FH)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA, DEPT MED GENET, VANCOUVER V6T 1W5, BC, CANADA; UNIV BRITISH COLUMBIA, DEPT INTERNAL MED, VANCOUVER V6T 1W5, BC, CANADA	University of British Columbia; University of British Columbia			Kastelein, John/AAF-7950-2020; Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				ALLAIN CC, 1974, CLIN CHEM, V20, P470; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BUCOLO G, 1973, CLIN CHEM, V19, P476; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; HAYDEN MR, 1986, MED N AM, V4, P2; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HOBBS HH, 1985, P NATL ACAD SCI USA, V82, P7651, DOI 10.1073/pnas.82.22.7651; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HORSTHEMKE B, 1985, HUM GENET, V71, P75, DOI 10.1007/BF00295672; HORSTHEMKE B, 1987, J MED GENET, V24, P144, DOI 10.1136/jmg.24.3.144; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; RUSSELL DW, 1983, P NATL ACAD SCI-BIOL, V80, P7501, DOI 10.1073/pnas.80.24.7501; SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664; SHAPIRO L J, 1987, American Journal of Human Genetics, V41, pA238; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WARNICK GR, 1978, J LIPID RES, V19, P65; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	27	71	71	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					60	68						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	2837085				2022-12-18	WOS:A1988N986300009
J	JASPERS, NGJ; TAALMAN, RDFM; BAAN, C				JASPERS, NGJ; TAALMAN, RDFM; BAAN, C			PATIENTS WITH AN INHERITED SYNDROME CHARACTERIZED BY IMMUNODEFICIENCY, MICROCEPHALY, AND CHROMOSOMAL INSTABILITY - GENETIC-RELATIONSHIP TO ATAXIA TELANGIECTASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS	Radboud University Nijmegen	JASPERS, NGJ (corresponding author), ERASMUS UNIV,CELL BIOL & GENET LAB,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.			Baan, Carla/0000-0003-2274-2788				BRIDGES BA, 1982, ATAXIA TELANGIECTASI; BYRNE E, 1984, J NEUROL SCI, V66, P307, DOI 10.1016/0022-510X(84)90019-4; CONLEY ME, 1986, BLOOD, V67, P1251; CRAMER P, 1981, NATURE, V291, P671, DOI 10.1038/291671a0; DANESHBODSKIBBA G, 1980, AM J MED GENET, V5, P315, DOI 10.1002/ajmg.1320050315; GATTI RA, 1982, CLIN IMMUNOL IMMUNOP, V23, P501, DOI 10.1016/0090-1229(82)90134-9; GATTI RA, 1985, KROC F SERIES, V19; HELMERHORST FM, 1984, HUM GENET, V65, P252, DOI 10.1007/BF00286512; JASPERS NG, 1985, KROC F SERIES, P147; JASPERS NGJ, 1982, CANCER RES, V42, P335; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; MARASCHIO P, 1986, CLIN GENET, V30, P353; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; PAINTER RB, 1981, MUTAT RES, V84, P183, DOI 10.1016/0027-5107(81)90061-0; Sedgewick RP, 1972, HDB CLINICAL NEUROLO, V14, P267; SEEMANOVA E, 1985, AM J MED GENET, V20, P639, DOI 10.1002/ajmg.1320200410; SHILOH Y, 1983, CARCINOGENESIS, V4, P1317, DOI 10.1093/carcin/4.10.1317; SHILOH Y, 1982, CARCINOGENESIS, V3, P815, DOI 10.1093/carcin/3.7.815; SPERLING K, 1983, PROSPETTIVE PEDIAT, V49, P53; TAALMAN RDFM, 1983, MUTAT RES, V112, P23, DOI 10.1016/0167-8817(83)90021-4; TAYLOR AMR, 1978, MUTAT RES, V50, P407, DOI 10.1016/0027-5107(78)90045-3; TEEBI AS, 1987, AM J MED GENET, V26, P355, DOI 10.1002/ajmg.1320260214; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x	23	71	73	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					66	73						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3337113				2022-12-18	WOS:A1988L869700009
J	BLANC, H; CHEN, KH; DAMORE, MA; WALLACE, DC				BLANC, H; CHEN, KH; DAMORE, MA; WALLACE, DC			AMINO-ACID CHANGE ASSOCIATED WITH THE MAJOR POLYMORPHIC HINC-II SITE OF ORIENTAL AND CAUCASIAN MITOCHONDRIAL DNAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305	Stanford University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-28428, GM-24285] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BLANC H, 1981, P NATL ACAD SCI-BIOL, V78, P3789, DOI 10.1073/pnas.78.6.3789; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BROWN WM, 1979, EXTRACHROMOSOMAL DNA, P485; CASTORA FJ, 1980, P NATL ACAD SCI-BIOL, V77, P6415, DOI 10.1073/pnas.77.11.6415; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; GILES RE, 1980, SOMAT CELL GENET, V6, P543, DOI 10.1007/BF01539155; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; JOHNSON MJ, UNPUB RAD HUMAN MITO; Maxam A M, 1980, Methods Enzymol, V65, P499; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; POTTER SS, 1975, P NATL ACAD SCI USA, V72, P4496, DOI 10.1073/pnas.72.11.4496; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0	18	71	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					167	176						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6301266				2022-12-18	WOS:A1983QJ26500001
J	AYME, S; LIPPMANHAND, A				AYME, S; LIPPMANHAND, A			MATERNAL-AGE EFFECT IN ANEUPLOIDY - DOES ALTERED EMBRYONIC SELECTION PLAY A ROLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,DEPT EPIDEMIOL & HLTH,MONTREAL H3A 2B4,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2B4,QUEBEC,CANADA	McGill University; McGill University	AYME, S (corresponding author), HOP ENFANTS TIMONE,CTR GENET MED,F-13385 MARSEILLE 4,FRANCE.		Ayme, Segolene/ABE-2545-2020					BUCKTON KE, 1980, ANN HUM GENET, V43, P227, DOI 10.1111/j.1469-1809.1980.tb01556.x; CAROTHERS AD, 1978, ANN HUM GENET, V41, P277, DOI 10.1111/j.1469-1809.1978.tb01895.x; FRIEDRICH U, 1973, CLIN GENET, V4, P333; GOAD WB, 1976, AM J HUM GENET, V28, P62; HAMERTON JL, 1975, CLIN GENET, V8, P223; HANSSON A, 1978, CYTOGENET CELL GENET, V20, P194, DOI 10.1159/000130851; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; Hook E B, 1979, Birth Defects Orig Artic Ser, V15, P81; HOOK EB, 1978, TERATOLOGY, V17, P223, DOI 10.1002/tera.1420170303; HOOK EB, 1980, AM J HUM GENET, V32, P849; HOOK EB, 1978, AM J HUM GENET, V30, P19; Hook EB, 1981, TRISOMY 21 DOWN SYND, P3; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; KUSHNICK T, 1975, PERSPECT BIOL MED, V18, P292; LERIDON H, 1976, POP STUD-J DEMOG, V30, P319, DOI 10.1080/00324728.1976.10412738; LUBS HA, 1970, SCIENCE, V169, P495, DOI 10.1126/science.169.3944.495; MAGENIS RE, 1977, HUM GENET, V37, P7, DOI 10.1007/BF00293766; MATTEI JF, 1979, HUM GENET, V46, P107, DOI 10.1007/BF00278908; MATTEI JF, 1980, J MED GENET, V17, P368, DOI 10.1136/jmg.17.5.368; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; MILLER JF, 1980, LANCET, V2, P554; NAYLOR AF, 1974, SOC BIOL, V21, P195, DOI 10.1080/19485565.1974.9988106; NIELSEN J, 1975, HUMANGENETIK, V30, P1, DOI 10.1007/BF00273626; POLANI PE, 1966, DEV MED CHILD NEUROL, V8, P67; ROBERTS DF, 1980, J MED GENET, V17, P363, DOI 10.1136/jmg.17.5.363; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; STEIN Z, 1975, AM J EPIDEMIOL, V102, P275, DOI 10.1093/oxfordjournals.aje.a112163; STEIN ZA, 1977, POPULATION CYTOGENET, P257; SVED JA, 1981, TRISOMY 21 DOWN SYND, P95; TRIMBLE BK, 1978, AM J MED GENET, V2, P1, DOI 10.1002/ajmg.1320020102; TURNER JH, 1970, HUMAN POPULATION CYT, P143; WAGENBICHLER P, 1976, HUM GENET, V32, P13, DOI 10.1007/BF00569971; WARBURTON D, 1964, AM J HUM GENET, V16, P1	33	71	74	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	4					558	565						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NY863	6213153				2022-12-18	WOS:A1982NY86300003
J	ROSENFELD, RG; LUZZATTI, L; HINTZ, RL; MILLER, OJ; KOO, GC; WACHTEL, SS				ROSENFELD, RG; LUZZATTI, L; HINTZ, RL; MILLER, OJ; KOO, GC; WACHTEL, SS			SEXUAL AND SOMATIC DETERMINANTS OF THE HUMAN Y-CHROMOSOME - STUDIES IN A 46,XYP- PHENOTYPIC FEMALE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV COLL PHYS & SURG, DEPT HUMAN GENET & DEV, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT OBSTET & GYNECOL, NEW YORK, NY 10032 USA; MEM SLOAN KETTERING CANC CTR, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, NEW YORK HOSP, DEPT PEDIAT, NEW YORK, NY 10021 USA	Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital	ROSENFELD, RG (corresponding author), STANFORD UNIV, MED CTR, DEPT PEDIAT, STANFORD, CA 94305 USA.							ANGELL R, 1970, ANN HUM GENET, V34, P39, DOI 10.1111/j.1469-1809.1970.tb00218.x; ARMENDARES S, 1972, J MED GENET, V9, P96, DOI 10.1136/jmg.9.1.96; BOBROW M, 1971, CYTOGENETICS, V10, P190, DOI 10.1159/000130138; BOOK JA, 1973, CLIN GENET, V4, P410; CARR BR, 1971, J CLIN ENDOCR METAB, V33, P358, DOI 10.1210/jcem-33-2-358; CHAPELLE ADL, 1978, CELL, V15, P837, DOI 10.1016/0092-8674(78)90268-4; COHEN MM, 1973, J MED GENET, V10, P74, DOI 10.1136/jmg.10.1.74; FEDERMAN DANIEL D., 1967, J MED GENET, V4, P36, DOI 10.1136/jmg.4.1.36; FEDERMAN DD, 1968, ABNORMAL SEXUAL DEV, P82; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FERGUSON-SMITH M A, 1969, Journal of Medical Genetics, V6, P422, DOI 10.1136/jmg.6.4.422; FERRIER PE, 1968, HUMANGENETIK, V6, P131, DOI 10.1007/BF00297721; Gasser D L, 1972, Adv Immunol, V15, P215, DOI 10.1016/S0065-2776(08)60686-0; GERMAN J, 1973, ANN GENET-PARIS, V16, P225; GODING JW, 1976, J IMMUNOL METHODS, V10, P61, DOI 10.1016/0022-1759(76)90007-7; GOLDBERG EH, 1971, NATURE, V232, P478, DOI 10.1038/232478a0; GORLIN RJ, 1977, CLASSICAL CHROMOSOME, P98; GRANT DB, 1976, ARCH DIS CHILD, V51, P596, DOI 10.1136/adc.51.8.596; HAMMERLING U, 1973, METHOD CANCER RES, V9, P255; JACOBS PA, 1966, NATURE, V210, P352, DOI 10.1038/210352a0; JOST A, 1957, HERMAPHRODITISM GENI, P14; KOO GC, 1977, SCIENCE, V198, P940, DOI 10.1126/science.929180; KOO GC, 1973, P NATL ACAD SCI USA, V70, P1502, DOI 10.1073/pnas.70.5.1502; KOO GC, J IMMUNOL METHODS; KRMPOTIC E, 1972, CLIN GENET, V3, P381; LANGMAID H, 1974, J MED GENET, V11, P208, DOI 10.1136/jmg.11.2.208; MCILREE ME, 1966, LANCET, V2, P69; MEISNER LF, 1972, J MED GENET, V9, P373, DOI 10.1136/jmg.9.3.373; NAKAGOME Y, 1965, J PEDIATR-US, V67, P1163, DOI 10.1016/S0022-3476(65)80220-7; NOEL B, 1971, Clinical Genetics, V2, P1; OHNO S, 1976, CELL, V7, P315, DOI 10.1016/0092-8674(76)90160-4; PEARSON PL, 1970, NATURE, V226, P959, DOI 10.1038/226959a0; PENNY R, 1970, J CLIN INVEST, V49, P1847, DOI 10.1172/JCI106402; ROBINSON JA, 1971, CHROMOSOMA, V35, P342, DOI 10.1007/BF00326283; SIEBERS JW, 1973, HUMANGENETIK, V19, P57, DOI 10.1007/BF00295235; SIMPSON J L, 1975, Birth Defects Original Article Series, V11, P23; SOLARI AJ, 1970, J CELL BIOL, V45, P43, DOI 10.1083/jcb.45.1.43; TELFER M, 1973, LANCET, V1, P608; TISHLER PV, 1972, CLIN GENET, V3, P116; TUNCBILEK E, 1976, CLIN GENET, V9, P365; WACHTEL SS, 1976, NEW ENGL J MED, V295, P750, DOI 10.1056/NEJM197609302951403; WACHTEL SS, 1975, NEW ENGL J MED, V293, P1070, DOI 10.1056/NEJM197511202932105; WACHTEL SS, 1975, NATURE, V257, P235, DOI 10.1038/257235a0; WACHTEL SS, 1975, NATURE, V254, P270, DOI 10.1038/254270a0; WACHTEL SS, 1977, IMMUNOL REV, V33, P33, DOI 10.1111/j.1600-065X.1977.tb00361.x; WACHTEL SS, PROG MED GENET; WACHTEL SS, CELL; WEINSTEIN RL, 1974, J CLIN INVEST, V53, P408, DOI 10.1172/JCI107574; WINTER JSD, 1972, J CLIN ENDOCR METAB, V34, P348, DOI 10.1210/jcem-34-2-348; WINTER JSD, 1972, J CLIN ENDOCR METAB, V35, P561, DOI 10.1210/jcem-35-4-561; WU C, 1971, STEROIDS, V18, P91, DOI 10.1016/S0039-128X(71)80174-5	51	71	71	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1979	31	4					458	468						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HM222	573550				2022-12-18	WOS:A1979HM22200007
J	FREZAL, J; GUILLEMOT, ML; KELLEY, J; LAMY, M				FREZAL, J; GUILLEMOT, ML; KELLEY, J; LAMY, M			ANENCEPHALY IN FRANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALISON F., 1959, BULL INST NATL HYG [PARIS], V14, P1195; BOOK JA, 1950, AM J HUM GENET, V2, P61; BROWNLEE KA, 1953, INDUSTRIAL EXPERIMEN; COFFEY V P, 1957, Br J Prev Soc Med, V11, P174; EDWARDS J H, 1958, Br J Prev Soc Med, V12, P115; EDWARDS JH, 1961, ANN HUM GENET, V25, P83, DOI 10.1111/j.1469-1809.1961.tb01501.x; GIROUD A, 1962, Pathol Biol, V10, P119; GITTELSOHN AM, 1962, BRIT J PREV SOC MED, V16, P153; HEWITT D, 1963, BRIT J PREV SOC MED, V17, P13; Ingalls TH, 1954, BRIT J PREV SOC MED, V8, P17; LAMY M, 1960, 1 INT C CONG MALF, P345; LAMY M, 1959, 10 P INT C GEN MONTR, P89; MacMahon B, 1953, BRIT J PREV SOC MED, V7, P211; MASTERSON JG, 1962, ACTA GENET STAT MED, V12, P219; MCKEOWN T, 1960, CIBA F S CONGENITAL, P2; MCKEOWN T, 1960, 1 INT C CONG MALF, P45; NEEL JV, 1958, AM J HUM GENET, V10, P398; NELSON MM, 1960, CIBA F S CONGENITAL, P134; PENROSE LS, 1957, J MENT DEFIC RES, V1, P4; PENROSE LS, 1946, ANN EUGENIC, V13, P73, DOI 10.1111/j.1469-1809.1946.tb02344.x; POLMAN A., 1950, GENETICA, V25, P29; RECORD RG, 1951, ANN EUGENIC, V15, P285; RECORD RG, 1961, BRIT J PREV SOC MED, V15, P93; SEARLE AG, 1959, ANN HUM GENET, V23, P279, DOI 10.1111/j.1469-1809.1959.tb01471.x; SUTTER J, 1962, POPULATION, V17, P683, DOI 10.2307/1526249; WARKANY J, 1959, AMA J DIS CHILD, V97, P274, DOI 10.1001/archpedi.1959.02070010276003; 1945, STATISTIQUE MOUVEMEN	27	71	71	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1964	16	3					336	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2973A	14207549				2022-12-18	WOS:A19642973A00001
J	KRAUS, BS				KRAUS, BS			CARABELLI ANOMALY OF THE MAXILLARY MOLAR TEETH - OBSERVATIONS ON MEXICANS AND PAPAGO INDIANS AND AN INTERPRETATION OF THE INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Bachrach F. H., 1927, BR DENT J, V48, P1293; Dahlberg AA, 1950, AM J PHYS ANTHROP-NE, V8, P15, DOI 10.1002/ajpa.1330080110; Dietz V. H., 1944, JOUR AMER DENTAL ASSOC, V31, P784; HIRAKAWA W, 1940, REV ZBL ZAHN MUND KI, V5, P262; KORKHAUS G, 1930, Z ANAT ENTWICKLUNGS, V91, P594; KORKHAUS G, 1930, DEUT MSCHR ZAHNH, V48, P593; KORKHAUS G, 1930, INT J ORTHODONT, V16, P640; MONTAGU MFA, 1933, HUM BIOL, V5, P628; Nelson CT, 1938, AM J PHYS ANTHROPOL, V23, P261, DOI 10.1002/ajpa.1330230303; NEWMAN HH, 1940, MULTIPLE HUMAN BIRTH; OSHIMA S, 1938, REV ZAHNARZTL RUNDSC, V47, P1149; Pedersen P. O, 1949, E GREENLAND ESKIMO D; SHAPIRO MMJ, 1949, OFFICIAL J DENT ASS, V4, P355; VONEICKSTEDT E, 1942, RASSENKUNDE RASSENGE	14	71	72	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1951	3	4					348	355						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS395	14933364				2022-12-18	WOS:A1951XS39500006
J	O'Rawe, JA; Wu, YY; Dorfel, MJ; Rope, AF; Au, PYB; Parboosingh, JS; Moon, S; Kousi, M; Kosma, K; Smith, CS; Tzetis, M; Schuette, JL; Hufnagel, RB; Prada, CE; Martinez, F; Orellana, C; Crain, J; Caro-Llopis, A; Oltra, S; Monfort, S; Jimenez-Barron, LT; Swensen, J; Ellingwood, S; Smith, R; Fang, H; Ospina, S; Stegmann, S; Den Hollander, N; Mittelman, D; Highnam, G; Robison, R; Yang, E; Faivre, L; Roubertie, A; Riviere, JB; Monaghan, KG; Wang, K; Davis, EE; Katsanis, N; Kalscheuer, VM; Wang, EH; Metcalfe, K; Kleefstra, T; Innes, AM; Kitsiou-Tzeli, S; Rosello, M; Keegan, CE; Lyon, GJ				O'Rawe, Jason A.; Wu, Yiyang; Doerfel, Max J.; Rope, Alan F.; Au, P. Y. Billie; Parboosingh, Jillian S.; Moon, Sungjin; Kousi, Maria; Kosma, Konstantina; Smith, Christopher S.; Tzetis, Maria; Schuette, Jane L.; Hufnagel, Robert B.; Prada, Carlos E.; Martinez, Francisco; Orellana, Carmen; Crain, Jonathan; Caro-Llopis, Alfonso; Oltra, Silvestre; Monfort, Sandra; Jimenez-Barron, Laura T.; Swensen, Jeffrey; Ellingwood, Sara; Smith, Rosemarie; Fang, Han; Ospina, Sandra; Stegmann, Sander; Den Hollander, Nicolette; Mittelman, David; Highnam, Gareth; Robison, Reid; Yang, Edward; Faivre, Laurence; Roubertie, Agathe; Riviere, Jean-Baptiste; Monaghan, Kristin G.; Wang, Kai; Davis, Erica E.; Katsanis, Nicholas; Kalscheuer, Vera M.; Wang, Edith H.; Metcalfe, Kay; Kleefstra, Tjitske; Innes, A. Micheil; Kitsiou-Tzeli, Sophia; Rosello, Monica; Keegan, Catherine E.; Lyon, Gholson J.			TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURON-SPECIFIC ISOFORM; DE-LANGE-SYNDROME; TRANSCRIPTION; GENE; EXPRESSION; CORNELIA; COMPLEX; MUTATIONS; PHENOTYPE; BINDING	We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals. Simultaneous studies using diverse strategies led to the identification of nine families with overlapping clinical presentations and affected by de novo or maternally inherited single-nucleotide changes. Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes, but they also demonstrated a severe neurodegeneration phenotype. Functional analysis with RNA-seq for one of the families suggested that the phenotype is associated with downregulation of a set of genes notably enriched with genes regulated by E-box proteins. In addition, knockdown and mutant studies of this gene in zebrafish have shown a quantifiable, albeit small, effect on a neuronal phenotype. Our results suggest that mutations in TAF1 play a critical role in the development of this X-linked ID syndrome.	[O'Rawe, Jason A.; Wu, Yiyang; Doerfel, Max J.; Crain, Jonathan; Jimenez-Barron, Laura T.; Fang, Han; Lyon, Gholson J.] Cold Spring Harbor Lab, Stanley Inst Cognit Genom, POB 100, Cold Spring Harbor, NY 11724 USA; [O'Rawe, Jason A.; Wu, Yiyang; Lyon, Gholson J.] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Rope, Alan F.] Northwest Kaiser Permanente, Dept Med Genet, Portland, OR 97227 USA; [Au, P. Y. Billie; Parboosingh, Jillian S.; Smith, Christopher S.; Innes, A. Micheil] Univ Calgary, Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Au, P. Y. Billie; Parboosingh, Jillian S.; Smith, Christopher S.; Innes, A. Micheil] Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med, Calgary, AB T3B 6A8, Canada; [Moon, Sungjin; Kousi, Maria; Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27708 USA; [Kosma, Konstantina; Tzetis, Maria; Kitsiou-Tzeli, Sophia] Univ Athens, Sch Med, Dept Med Genet, Athens 11527, Greece; [Kosma, Konstantina; Tzetis, Maria] Childrens Hosp, Res Inst Study Genet & Malignant Disorders Childh, Aghia Sophia, Athens 11527, Greece; [Schuette, Jane L.] Univ Michigan, Dept Pediat, Div Genet, Ann Arbor, MI 48109 USA; [Schuette, Jane L.; Keegan, Catherine E.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Hufnagel, Robert B.; Prada, Carlos E.] Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH 45229 USA; [Hufnagel, Robert B.] NEI, Unit Pediat Dev & Genet Ophthalmol, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Prada, Carlos E.] Fdn Cardiovasc Colombia, Ctr Med Genom & Metab, Santander 681004, Colombia; [Martinez, Francisco; Orellana, Carmen; Caro-Llopis, Alfonso; Oltra, Silvestre; Monfort, Sandra; Rosello, Monica] Hosp Univ & Politecn La Fe, Unidad Genet, Valencia 46026, Spain; [Jimenez-Barron, Laura T.] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico; [Swensen, Jeffrey] Caris Life Sci, Phoenix, AZ 85040 USA; [Ellingwood, Sara] Maine Med Partners, Pediat Specialty Care, Div Genet, Portland, ME 04102 USA; [Smith, Rosemarie] Barbara Bush Childrens Hosp, Maine Med Ctr, Dept Pediat, Div Genet, Portland, ME 04102 USA; [Ospina, Sandra] Fdn Cardioinfantil, Bogota 681004, Colombia; [Ospina, Sandra] Univ Rosario, Bogota 681004, Colombia; [Stegmann, Sander] Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Den Hollander, Nicolette] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Mittelman, David; Highnam, Gareth] Gene Gene Ltd, Houston, TX 77008 USA; [Robison, Reid; Lyon, Gholson J.] Utah Fdn Biomed Res, Salt Lake City, UT 84107 USA; [Robison, Reid] Tute Genom, Provo, UT 84601 USA; [Yang, Edward] Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Faivre, Laurence; Riviere, Jean-Baptiste] Univ Bourgogne Franche Comte, Genet Anomalies Dev EA4271, F-21000 Dijon, France; [Faivre, Laurence] CHU Dijon, Ctr Reference Malad Rares Anomalies Dev & Syndrom, Ctr Genet, F-21000 Dijon, France; [Roubertie, Agathe] Univ Montpellier, Inst Neurosci Montpellier, F-34950 Montpellier 5, France; [Roubertie, Agathe] CHU Gui de Chauliac, Serv Neuropediat, F-34000 Montpellier, France; [Monaghan, Kristin G.] GeneDx, Gaithersburg, MD 20877 USA; [Wang, Kai] Univ So Calif, Zilkha Neurogenet Inst, Dept Psychiat & Prevent Med, Los Angeles, CA 90089 USA; [Kalscheuer, Vera M.] Max Planck Inst Mol Genet, Res Grp Dev & Dis, D-14195 Berlin, Germany; [Wang, Edith H.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Metcalfe, Kay] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Clin Genet Serv, Manchester M13 9WL, Lancs, England; [Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Kaiser Permanente; University of Calgary; Alberta Childrens Hospital; University of Calgary; Duke University; Athens Medical School; National & Kapodistrian University of Athens; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Hospital Universitari i Politecnic La Fe; Universidad Nacional Autonoma de Mexico; Maine Medical Center; Fundacion Cardioinfantil - Instituto de Cardiologia; Universidad del Rosario; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Boston Children's Hospital; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Southern California; Max Planck Society; University of Washington; University of Washington Seattle; University of Manchester; Radboud University Nijmegen	Lyon, GJ (corresponding author), Cold Spring Harbor Lab, Stanley Inst Cognit Genom, POB 100, Cold Spring Harbor, NY 11724 USA.	gholsonjlyon@gmail.com	Wu, Yiyang/ABB-9162-2020; Monfort, Sandra/B-2860-2009; Monfort, Sandra/D-8801-2019; Caro-Llopis, Alfonso/D-7865-2019; fang, han/GSN-6404-2022; innes, allan micheil/A-9955-2017; Rosello, Monica/B-2319-2009; Martinez, Francisco/A-2543-2009; Tzetis, Maria/K-5220-2012; Kleefstra, Tjitske/G-2619-2012; Orellana, Carmen/B-1925-2009; Yang, Edward/Q-8175-2019; Oltra, Silvestre/A-2697-2009; Lyon, Gholson/D-2765-2014	Wu, Yiyang/0000-0002-9231-7093; Monfort, Sandra/0000-0003-2016-1410; Monfort, Sandra/0000-0003-2016-1410; Rosello, Monica/0000-0001-9234-2953; Martinez, Francisco/0000-0002-0589-2584; Tzetis, Maria/0000-0002-6810-2922; Orellana, Carmen/0000-0003-4271-5859; Oltra, Silvestre/0000-0001-6863-4382; Lyon, Gholson/0000-0002-5869-0716; Prada, Carlos/0000-0003-3348-3531; Innes, Micheil/0000-0001-9881-5467; Fang, Han/0000-0002-4010-2525; Davis, Erica/0000-0002-2412-8397; Kalscheuer, Vera/0000-0001-6898-3259; Caro-Llopis, Alfonso/0000-0003-4187-2748; , Tushar/0000-0002-8527-8719; Stegmann, Alexander/0000-0002-9736-7137	Stanley Institute for Cognitive Genomics at Cold Spring Harbor Laboratory; NIH [HG006465]; Alberta Children's Hospital Foundation; Instituto de Salud Carlos III Accion Estrategica en Salud [PI14/00350]; Netherlands Organization for Health Research and Development, ZonMw [907-00-365]; Cincinnati Children's Hospital; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006465] Funding Source: NIH RePORTER	Stanley Institute for Cognitive Genomics at Cold Spring Harbor Laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Children's Hospital Foundation; Instituto de Salud Carlos III Accion Estrategica en Salud; Netherlands Organization for Health Research and Development, ZonMw(Netherlands Organization for Health Research and Development); Cincinnati Children's Hospital; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	G.J.L. is supported by funds from the Stanley Institute for Cognitive Genomics at Cold Spring Harbor Laboratory. K.W. is supported by NIH grant HG006465. The sequencing by Complete Genomics was provided by a data-analysis grant to K.W. We would like to thank Megan Cho for facilitating discovery of affected individuals through GeneDx. Margaret Yoon and David Tegay assisted with Human Phenotype Ontology annotation. A.M.I. and J.S.P. were supported by a grant from the Alberta Children's Hospital Foundation and would like to thank Francois Bernier and Ryan Lamont for helpful discussions and contributions. F.M., M.R., and colleagues are supported by grant PI14/00350 (Instituto de Salud Carlos III Accion Estrategica en Salud 2013-2016; Fondo Europeo de Desarrollo Regional). This work was supported in part by funding from grants from the Netherlands Organization for Health Research and Development, ZonMw (grant 907-00-365 to T.K.), and an institutional award from Cincinnati Children's Hospital (R.B.H.). N.K. is a distinguished George W. Brumley Professor. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.	Abu-Amero KK, 2010, OPHTHALMIC GENET, V31, P1, DOI 10.3109/13816810903312535; Bhattacharya S, 2014, P NATL ACAD SCI USA, V111, P9103, DOI 10.1073/pnas.1408293111; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Carayol J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00033; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Cucala L, 2008, BIOMETRICAL J, V50, P299, DOI 10.1002/bimj.200710412; Deardorff M. A., 2008, INBORN ERRORS DEV, P1020; Dikstein R, 1996, CELL, V84, P781, DOI 10.1016/S0092-8674(00)81055-7; Domingo A, 2015, EUR J HUM GENET, V23, P1334, DOI 10.1038/ejhg.2014.292; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Gegonne A, 2001, P NATL ACAD SCI USA, V98, P12432, DOI 10.1073/pnas.211444798; Gil-Rodriguez MC, 2015, HUM MUTAT, V36, P454, DOI 10.1002/humu.22761; Goff LA, 2013, CUMMERBUND ANAL EXPL; Hellman-Aharony S, 2013, PEDIATR NEUROL, V49, P411, DOI 10.1016/j.pediatrneurol.2013.07.017; Herzfeld T, 2013, HUM MOL GENET, V22, P941, DOI 10.1093/hmg/dds499; Hogben L., 1933, NATURE AND NURTURE; Hu H., 2015, MOL PSYCHIAT; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Izumi K, 2015, NAT GENET, V47, P338, DOI 10.1038/ng.3229; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jambaldorj J, 2012, BIOCHEM BIOPH RES CO, V425, P273, DOI 10.1016/j.bbrc.2012.07.081; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kline AD, 2014, AM J MED GENET A, V164, P1384, DOI 10.1002/ajmg.a.36417; Kloet SL, 2012, MOL CELL BIOL, V32, P3358, DOI 10.1128/MCB.00416-12; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kotani T, 1998, J BIOL CHEM, V273, P32254, DOI 10.1074/jbc.273.48.32254; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lyon GJ, 2015, GENETICS OF NEURODEVELOPMENTAL DISORDERS, P289; Mackay TFC, 2014, GENOME MED, V6, DOI 10.1186/gm561; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Mannini L, 2013, HUM MUTAT, V34, P1589, DOI 10.1002/humu.22430; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; O'Rawe J., 2015, VARIANT TAF1 IS ASS; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Pennington KL, 2013, P NATL ACAD SCI USA, V110, P7678, DOI 10.1073/pnas.1221712110; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Rooms L, 2006, EUR J HUM GENET, V14, P1090, DOI 10.1038/sj.ejhg.5201674; RUPPERT S, 1995, GENE DEV, V9, P2747, DOI 10.1101/gad.9.22.2747; Sako W, 2011, NEUROSCIENCE, V189, P100, DOI 10.1016/j.neuroscience.2011.05.031; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang H, 2014, CELL RES, V24, P1433, DOI 10.1038/cr.2014.148; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Weldon WFR, 1901, BIOMETRIKA, V1, P228; Yuan B, 2015, J CLIN INVEST, V125, P636, DOI 10.1172/JCI77435	56	70	72	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					922	932		10.1016/j.ajhg.2015.11.005	http://dx.doi.org/10.1016/j.ajhg.2015.11.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26637982	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000368437900015
J	Ravenscroft, G; Nolent, F; Rajagopalan, S; Meireles, AM; Paavola, KJ; Gaillard, D; Alanio, E; Buckland, M; Arbuckle, S; Krivanek, M; Maluenda, J; Pannell, S; Gooding, R; Ong, RW; Allcock, RJ; Carvalho, EDF; Carvalho, MDF; Kok, F; Talbot, WS; Melki, J; Laing, NG				Ravenscroft, Gianina; Nolent, Flora; Rajagopalan, Sulekha; Meireles, Ana M.; Paavola, Kevin J.; Gaillard, Dominique; Alanio, Elisabeth; Buckland, Michael; Arbuckle, Susan; Krivanek, Michael; Maluenda, Jerome; Pannell, Stephen; Gooding, Rebecca; Ong, Royston W.; Allcock, Richard J.; Carvalho, Ellaine D. F.; Carvalho, Maria D. F.; Kok, Fernando; Talbot, William S.; Melki, Judith; Laing, Nigel G.			Mutations of GPR126 Are Responsible for Severe Arthrogryposis Multiplex Congenita	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; PROTEIN-COUPLED RECEPTORS; GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; SCHWANN-CELLS; MYELINATION; DEFINES; HEIGHT; IV	Arthrogryposis multiplex congenita is defined by the presence of contractures across two or more major joints and results from reduced or absent fetal movement. Here, we present three consanguineous families affected by lethal arthrogryposis multiplex congenita. By whole-exome or targeted exome sequencing, it was shown that the probands each harbored a different homozygous mutation (one missense, one nonsense, and one frameshift mutation) in GPR126. GPR126 encodes G-protein-coupled receptor 126, which has been shown to be essential for myelination of axons in the peripheral nervous system in fish and mice. A previous study reported that Gpr126(-/-) mice have a lethal arthrogryposis phenotype. We have shown that the peripheral nerves in affected individuals from one family lack myelin basic protein, suggesting that this disease in affected individuals is due to defective myelination of the peripheral axons during fetal development. Previous work has suggested that autoproteolytic cleavage is important for activating GPR126 signaling, and our biochemical assays indicated that the missense substitution (p.Val769Glu [c.2306T>A]) impairs autoproteolytic cleavage of GPR126. Our data indicate that GPR126 is critical for myelination of peripheral nerves in humans. This study adds to the literature implicating defective axoglial function as a key cause of severe arthrogryposis multiplex congenita and suggests that GPR126 mutations should be investigated in individuals affected by this disorder.	[Ravenscroft, Gianina; Pannell, Stephen; Ong, Royston W.; Laing, Nigel G.] Univ Western Australia, Harry Perkins Inst Med Res, Med Res Ctr, Nedlands, WA 6009, Australia; [Nolent, Flora; Maluenda, Jerome; Melki, Judith] INSERM, Unite Mixte Rech 1169, F-94276 Le Kremlin Bicetre, France; [Nolent, Flora; Maluenda, Jerome; Melki, Judith] Univ Paris 11, F-94276 Le Kremlin Bicetre, France; [Rajagopalan, Sulekha] Liverpool Hosp, Dept Clin Genet, Liverpool, NSW 1871, Australia; [Meireles, Ana M.; Paavola, Kevin J.; Talbot, William S.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Gaillard, Dominique] Ctr Hosp Univ Reims, Dept Genet, Maison Blanche Hosp, F-51092 Reims, France; [Alanio, Elisabeth] Univ Hosp, Pol Bouin Lab, F-51092 Reims, France; [Buckland, Michael] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Buckland, Michael] Royal Prince Alfred Hosp, Dept Neuropathol, Camperdown, NSW 2050, Australia; [Arbuckle, Susan; Krivanek, Michael] Childrens Hosp Westmead, Dept Pathol, Westmead, NSW 2145, Australia; [Gooding, Rebecca] PathWest Lab Med, Dept Diagnost Genom, Nedlands, WA 6009, Australia; [Allcock, Richard J.] Univ Western Australia, Sch Pathol & Lab Med, Lotterywest State Biomed Facil Genom, Nedlands, WA 6009, Australia; [Carvalho, Ellaine D. F.; Carvalho, Maria D. F.] Christus Univ Ctr, BR-04013000 Fortaleza, CE, Brazil; [Carvalho, Ellaine D. F.; Carvalho, Maria D. F.] Genpharma Consultoria Farmaceut & Genet Ltda, BR-60160230 Fortaleza, CE, Brazil; [Carvalho, Maria D. F.] Univ Estadual Ceara, BR-04013000 Fortaleza, CE, Brazil; [Kok, Fernando] Mendel Genom Anal, BR-04013000 Sao Paulo, SP, Brazil	Harry Perkins Institute of Medical Research; University of Western Australia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Liverpool Hospital; Stanford University; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; University of Sydney; University of Sydney; University of Sydney; University of Western Australia; University of Western Australia; Universidade Estadual do Ceara	Melki, J (corresponding author), INSERM, Unite Mixte Rech 1169, F-94276 Le Kremlin Bicetre, France.	judith.melki@inserm.fr; nigel.laing@perkins.uwa.edu.au	Ravenscroft, Gina/H-5695-2014; Kok, Fernando/E-7865-2016	Ravenscroft, Gina/0000-0003-3634-211X; , William/0000-0002-2048-7472; Nolent, Flora/0000-0002-3623-690X; Laing, Nigel/0000-0001-5111-3732; Maluenda, Jerome/0000-0002-6653-1336	National Health and Medical Research Council of Australia [1035955, APP1002147, APP1022707]; French Ministry of Health [AOM10181]; Association Francaise contre les Myopathies [DAJ1891]; INSERM; University Paris-Sud; NIH [NS050223]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050223, R56NS050223] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); French Ministry of Health; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris-Sud; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Health and Medical Research Council of Australia (Early Career Researcher Fellowship 1035955 to G.R. and Research Fellowship APP1002147 and Project Grant APP1022707 to N.G.L.). This work was also supported by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2010, AOM10181), the Association Francaise contre les Myopathies (DAJ1891), and INSERM and University Paris-Sud (ERM2013) to J.M. Work in the W.S.T. lab was supported by NIH grant NS050223. The authors would like to thank the Exome Aggregation Consortium (a full list of contributing groups can be found at http://exac.broadinstitute.org/about) and the groups that provided exome variant data for comparison: the Clinical Research Unit of Bicetre Hospital, the Department of Clinical Research and Development of the Assistance Publique - Hopitaux de Paris, and the NHLBI Grand Opportunity Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; EDELHOFF S, 1995, MAMM GENOME, V6, P111, DOI 10.1007/BF00303253; Glenn TD, 2013, DEVELOPMENT, V140, P3167, DOI 10.1242/dev.093401; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Haliloglu G, 2013, HAND CLINIC, V113, P1311, DOI 10.1016/B978-0-444-59565-2.00003-4; HALL JG, 1985, CLIN ORTHOP RELAT R, P44; Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Laquerriere A, 2014, HUM MOL GENET, V23, P2279, DOI 10.1093/hmg/ddt618; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Lyons DA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020586; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Patel N, 2014, HUM MOL GENET, V23, P6584, DOI 10.1093/hmg/ddu384; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu JF, 2015, GENOMICS, V105, P101, DOI 10.1016/j.ygeno.2014.11.009; Yau K, 2014, NEUROMUSCULAR DISORD, V24, P799, DOI 10.1016/j.nmd.2014.06.032; Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96	26	70	72	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					955	961		10.1016/j.ajhg.2015.04.014	http://dx.doi.org/10.1016/j.ajhg.2015.04.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26004201	Green Published, Bronze			2022-12-18	WOS:000355931200009
J	Wortmann, SB; Zietkiewicz, S; Kousi, M; Szklarczyk, R; Haack, TB; Gersting, SW; Muntau, AC; Rakovic, A; Renkema, GH; Rodenburg, RJ; Strom, TM; Meitinger, T; Rubio-Gozalbo, ME; Chrusciel, E; Distelmaier, F; Golzio, C; Jansen, JH; van Karnebeek, C; Lillquist, Y; Lucke, T; Ounap, K; Zordania, R; Yaplito-Lee, J; van Bokhoven, H; Spelbrink, JN; Vaz, FM; Pras-Raves, M; Ploski, R; Pronicka, E; Klein, C; Willemsen, MAAP; de Brouwer, APM; Prokisch, H; Katsanis, N; Wevers, RA				Wortmann, Saskia B.; Zietkiewicz, Szymon; Kousi, Maria; Szklarczyk, Radek; Haack, Tobias B.; Gersting, Soren W.; Muntau, Ania C.; Rakovic, Aleksandar; Renkema, G. Herma; Rodenburg, Richard J.; Strom, Tim M.; Meitinger, Thomas; Rubio-Gozalbo, M. Estela; Chrusciel, Elzbieta; Distelmaier, Felix; Golzio, Christelle; Jansen, Joop H.; van Karnebeek, Clara; Lillquist, Yolanda; Luecke, Thomas; Ounap, Katrin; Zordania, Riina; Yaplito-Lee, Joy; van Bokhoven, Hans; Spelbrink, Johannes N.; Vaz, Frederic M.; Pras-Raves, Mia; Ploski, Rafal; Pronicka, Ewa; Klein, Christine; Willemsen, Michel A. A. P.; de Brouwer, Arjan P. M.; Prokisch, Holger; Katsanis, Nicholas; Wevers, Ron A.			CLPB Mutations Cause 3-Methylglutaconic Aciduria, Progressive Brain Atrophy, Intellectual Disability, Congenital Neutropenia, Cataracts, Movement Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANKYRIN REPEAT; PROTEINS; PATIENT	We studied a group of individuals with elevated urinary excretion of 3-methylglutaconic acid, neutropenia that can develop into leukemia, a neurological phenotype ranging from nonprogressive intellectual disability to a prenatal encephalopathy with progressive brain atrophy, movement disorder, cataracts, and early death. Exome sequencing of two unrelated individuals and subsequent Sanger sequencing of 16 individuals with an overlapping phenotype identified a total of 14 rare, predicted deleterious alleles in CLPB in 14 individuals from 9 unrelated families. CLPB encodes caseinolytic peptidase B homolog ClpB, a member of the AAA+ protein family. To evaluate the relevance of CLPB in the pathogenesis of this syndrome, we developed a zebrafish model and an in vitro assay to measure ATPase activity. Suppression of clpb in zebrafish embryos induced a central nervous system phenotype that was consistent with cerebellar and cerebral atrophy that could be rescued by wild-type, but not mutant, human CLPB mRNA. Consistent with these data, the loss-of-function effect of one of the identified variants (c.1222A>G [p.Arg408Gly]) was supported further by in vitro evidence with the mutant peptides abolishing ATPase function. Additionally, we show that CLPB interacts biochemically with ATP2A2, known to be involved in apoptotic processes in severe congenital neutropenia (SCN) 3 (Kostmann disease [caused by HAX1 mutations]). Taken together, mutations in CLPB define a syndrome with intellectual disability, congenital neutropenia, progressive brain atrophy, movement disorder, cataracts, and 3-methylglutaconic aciduria.	[Wortmann, Saskia B.; Renkema, G. Herma; Rodenburg, Richard J.; Spelbrink, Johannes N.] Amalia Childrens Hosp, Nijmegen Ctr Mitochondrial Disorders NCMD, NL-6500 HB Nijmegen, Netherlands; [Zietkiewicz, Szymon; Chrusciel, Elzbieta] Univ Gdansk, Intercoll Fac Biotechnol, Dept Mol & Cellular Biol, PL-80822 Gdansk, Poland; [Kousi, Maria; Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Med Ctr, Durham, NC 27710 USA; [Szklarczyk, Radek] Maastricht UMC, Clin Genom, NL-6200 MD Maastricht, Netherlands; [Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Gersting, Soren W.] Univ Munich, Dr von Hauner Childrens Hosp, Dept Mol Pediat, D-80337 Munich, Germany; [Muntau, Ania C.] Univ Childrens Hosp, Univ Med Ctr Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Rakovic, Aleksandar; Klein, Christine] Med Univ Lubeck, Inst Neurogenet, D-23562 Lubeck, Germany; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Pediat, NL-6202 AZ Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Lab Genet Metab Dis, NL-6202 AZ Maastricht, Netherlands; [Distelmaier, Felix] Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Jansen, Joop H.] Radboudumc, Dept Lab Med, Hematol Lab, NL-6525 GA Nijmegen, Netherlands; [van Karnebeek, Clara; Lillquist, Yolanda] BC Childrens Hosp, Div Biochem Dis, Dept Pediat, Treatable Intellectual Disabil Endeavour, Vancouver, BC V6H 3N4, Canada; [van Karnebeek, Clara] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Luecke, Thomas] Ruhr Univ Bochum, Univ Childrens Hosp, Dept Neuropediat, D-44791 Bochum, Germany; [Ounap, Katrin; Zordania, Riina] Tartu Univ Hosp, Dept Genet, United Labs, EE-51014 Tartu, Estonia; [Yaplito-Lee, Joy] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [van Bokhoven, Hans; de Brouwer, Arjan P. M.] Radboudumc, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Spelbrink, Johannes N.] Univ Tampere, BioMediTech, Tampere 33014, Finland; [Vaz, Frederic M.; Pras-Raves, Mia] Acad Med Ctr, Lab Genet Metab Dis, Dept Clin Chem & Pediat, NL-1100 AZ Amsterdam, Netherlands; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland; [Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, Dept Pediat Nutr & Metab Dis, PL-04730 Warsaw, Poland; [Willemsen, Michel A. A. P.] Radboudumc, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Wevers, Ron A.] Radboudumc, Dept Lab Med, Translat Metab Lab, NL-6525 GA Nijmegen, Netherlands	Fahrenheit Universities; University of Gdansk; Duke University; Maastricht University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Maastricht University; Maastricht University; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen; BC Childrens Hospital; University of British Columbia; Child & Family Research Institute; University of British Columbia; Ruhr University Bochum; University of Hamburg; University Medical Center Hamburg-Eppendorf; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Radboud University Nijmegen; Tampere University; University of Amsterdam; Academic Medical Center Amsterdam; Medical University of Warsaw; Children's Memorial Health Institute; Radboud University Nijmegen; Radboud University Nijmegen	Wortmann, SB (corresponding author), Amalia Childrens Hosp, Nijmegen Ctr Mitochondrial Disorders NCMD, NL-6500 HB Nijmegen, Netherlands.	saskia-wortmann@gmx.de	Wevers, Ron A./H-8116-2014; Meitinger, Thomas/O-1318-2015; de Brouwer, Arjan PM/P-5949-2015; Ziętkiewicz, Szymon/L-5259-2014; Rodenburg, Richard/N-3579-2014; Spelbrink, Johannes N/L-4661-2015; Klein, Christine/AGK-8003-2022; Ounap, Katrin/Q-1103-2016; Rubio-Gozalbo, M Estela/H-1833-2011; Bokhoven, J.H.L.M. van van/H-8015-2014; Jansen, J.H./H-8054-2014; Willemsen, Michel A.A.P./H-8119-2014; Renkema, Herma/L-1489-2015; Gersting, Soeren/D-4612-2011	Wevers, Ron A./0000-0003-2278-9746; Rodenburg, Richard/0000-0001-5227-3527; Spelbrink, Johannes N/0000-0002-9756-2602; Ounap, Katrin/0000-0002-4594-6364; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Jansen, J.H./0000-0001-9459-568X; Renkema, Herma/0000-0002-8174-6538; Meitinger, Thomas/0000-0002-8838-8403; Ploski, Rafal/0000-0001-6286-5526; Katsanis, Nicholas/0000-0002-2480-0171; Golzio, Christelle/0000-0002-4420-3921; Zietkiewicz, Szymon/0000-0002-3435-4603; Prokisch, Holger/0000-0003-2379-6286; Klein, Christine/0000-0003-2102-3431; Chrusciel, Elzbieta/0000-0001-9621-2013; Vaz, Frederic/0000-0002-9048-1041; Pronicka, Ewa/0000-0002-5705-4814; Gersting, Soeren/0000-0001-7482-4748	Van Leersumfonds, Koninklijke Nederlandse Akademie van Wetenschappen [VLF2013277]; Dutch society; NARSAD from BBRF; Canadian Institutes of Health Research [301221]; NIH [P50MH094268]; German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET) [01GM1113C]; German Bundesministerium fur Bildung und Forschung (BMBF) through the E-Rare project GENOMIT [01GM1207]; Hermann and Lilly Schilling Foundation; Deutsche Forschungsgemeinschaft (DFG); Michael Smith Foundation for Health Research; Metakids Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Van Leersumfonds, Koninklijke Nederlandse Akademie van Wetenschappen; Dutch society; NARSAD from BBRF; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET)(Federal Ministry of Education & Research (BMBF)); German Bundesministerium fur Bildung und Forschung (BMBF) through the E-Rare project GENOMIT(Federal Ministry of Education & Research (BMBF)); Hermann and Lilly Schilling Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Metakids Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the individuals and their parents for participation in this study. The study was financially supported by Van Leersumfonds, Koninklijke Nederlandse Akademie van Wetenschappen (project VLF2013277 to S.B.W.), by the Dutch society for the study of inborn errors of metabolism (ESN stimulatie beurs to S.B.W.), the NARSAD Young Investigator Grant from BBRF (to C.G.), the Canadian Institutes of Health Research (#301221 grant to C.v.K.), NIH P50MH094268 (to N.K.), the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET; 01GM1113C to T.M. and H.P.), and through the E-Rare project GENOMIT (01GM1207 for T.M. and H.P.). N.K. is a Distinguished George W. Brumley Professor. C.K. is the recipient of a career development award from the Hermann and Lilly Schilling Foundation and is supported by a grant from the Deutsche Forschungsgemeinschaft (DFG). C.v.K. is the recipient of a scholar award from the Michael Smith Foundation for Health Research. R.S. is financially supported by the Metakids Foundation. We thank Edwin van Kaauwen and Liesbeth Wintjes (Radboudumc. Nijmegen) for excellent technical assistance, Dr. Graham Sinclair (University of British Columbia) for providing biochemical data, and Dirk Klee (Heinrich-Heine University) for the MRI images of individual #8. We thank Han Brunner (Radboudumc Nijmegen), K. Liberek (Department of Molecular and Cellular Biology, University of Gdansk, Poland), Angela Luyf and Antoine van Kampen (AMC, Amsterdam), and Mathias Woidy and Philipp Guder (Ludwig-Maximilians-University, Munich, Germany), as well as Harry Kampinga (University Medical Center Groningen, Groningen, Germany) for fruitful discussions.	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Donadieu J, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-26; Germeshausen M, 2008, BLOOD, V111, P4954, DOI 10.1182/blood-2007-11-120667; Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Leidhold C, 2006, J STRUCT BIOL, V156, P149, DOI 10.1016/j.jsb.2006.04.007; Letunic I, 2014, NUCL ACIDS RES; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Matsui H, 2014, P NATL ACAD SCI USA, V111, P11846, DOI 10.1073/pnas.1403105111; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Neuwald AF, 1999, GENOME RES, V9, P27; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0; Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6; Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325; WORTMANN SB, 2014, J INHERIT METAB DIS; Yetgin S, 2008, LEUKEMIA, V22, P1797, DOI 10.1038/leu.2008.64; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	32	70	73	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					245	257		10.1016/j.ajhg.2014.12.013	http://dx.doi.org/10.1016/j.ajhg.2014.12.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25597510	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000349276700006
J	Williamson, KA; Rainger, J; Floyd, JAB; Ansari, M; Meynert, A; Aldridge, KV; Rainger, JK; Anderson, CA; Moore, AT; Hurles, ME; Clarke, A; van Heyningen, V; Verloes, A; Taylor, MS; Wilkie, AOM; FitzPatrick, DR				Williamson, Kathleen A.; Rainger, Joe; Floyd, James A. B.; Ansari, Morad; Meynert, Alison; Aldridge, Kishan V.; Rainger, Jacqueline K.; Anderson, Carl A.; Moore, Anthony T.; Hurles, Matthew E.; Clarke, Angus; van Heyningen, Veronica; Verloes, Alain; Taylor, Martin S.; Wilkie, Andrew O. M.; FitzPatrick, David R.		UK10K Consortium	Heterozygous Loss-of-Function Mutations in YAP1 Cause Both Isolated and Syndromic Optic Fissure Closure Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCULAR COLOBOMA; SONIC HEDGEHOG; MICROPHTHALMIA; GENE; ANOMALIES; FAMILY; ANOPHTHALMIA; PATHWAYS; ISOFORMS; DOMAIN	Exome sequence analysis of affected individuals from two families with autosomal-dominant inheritance of coloboma identified two different cosegregating heterozygous nonsense mutations (c.370C>T [p.Arg124*] and c. 1066G>T [p.Glu356*]) in YAP1. The phenotypes of the affected families differed in that one included no extraocular features and the other manifested with highly variable multisystem involvement, including hearing loss, intellectual disability, hematuria, and orofacial clefting. A combined LOD score of 4.2 was obtained for the association between YAP1 loss-of-function mutations and the phenotype in these families. YAP1 encodes an effector of the HIPPO-pathway-induced growth response, and whole-mount in situ hybridization in mouse embryos has shown that Yap/ is strongly expressed in the eye, brain, and fusing facial processes. RT-PCR showed that an alternative transcription start site (TSS) in intron 1 of YAP1 and Yap1 is widely used in human and mouse development, respectively. Transcripts from the alternative TSS are predicted to initiate at codon Met179 relative to the canonical transcript (RefSeq NM_001130145). In these alternative transcripts, the c.370C>T mutation in family 1305 is within the 5' UTR and cannot result in nonsense-mediated decay (NMD). The c. 1066G>T mutation in family 132 should result in NMD in transcripts from either TSS. Amelioration of the phenotype by the alternative transcripts provides a plausible explanation for the phenotypic differences between the families.	[Williamson, Kathleen A.; Rainger, Joe; Ansari, Morad; Meynert, Alison; Aldridge, Kishan V.; Rainger, Jacqueline K.; van Heyningen, Veronica; Taylor, Martin S.; FitzPatrick, David R.] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Floyd, James A. B.; Anderson, Carl A.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Moore, Anthony T.] Moorfields Eye Hosp NHS Fdn Trust, London EC1V 2PD, England; [Clarke, Angus] Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Verloes, Alain] Hop Robert Debre, Dept Genet, F-75019 Paris, France; [Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Moore, Anthony T.] UCL, Inst Ophthalmol, London EC1V 9EL, England	University of Edinburgh; Wellcome Trust Sanger Institute; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of London; University College London	FitzPatrick, DR (corresponding author), Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@igmm.ed.ac.uk	VAN HEYNINGEN, Veronica/GYE-0531-2022; Wilkie, Andrew/AAC-3820-2020; /AAK-8500-2021; van Heyningen, Veronica/B-8039-2008; Schmidts, Miriam/A-3777-2012; Taylor, Martin S/C-3825-2009; Scambler, Peter/C-4998-2008	Wilkie, Andrew/0000-0002-2972-5481; van Heyningen, Veronica/0000-0003-0359-0141; Schmidts, Miriam/0000-0002-1714-6749; Taylor, Martin S/0000-0001-7656-330X; Mitchison, Hannah/0000-0002-3163-6293; Scambler, Peter/0000-0002-1487-4628; Kelly, Kirsten/0000-0003-4234-543X; Ansari, Morad/0000-0002-8905-5379; Anderson, Carl/0000-0003-1719-7009; Rainger, Joe/0000-0003-1091-5100; Walter, Klaudia/0000-0003-4448-0301; Semple, Robert Kenneth/0000-0001-6539-3069; Futema, Marta/0000-0002-2120-2088; Plagnol, Vincent/0000-0002-5597-9215; FitzPatrick, David R./0000-0003-4861-969X	Medical Research Council (MRC) program; Wellcome Trust [WT091310]; National Institute of Health Research (Moorfields Eye Hospital Biomedical Research Centre); Medical Research Council [MC_U127561093, MC_U127527199, MC_PC_U127527199, MC_PC_U127597124, MC_PC_U127561093] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268, NF-SI-0507-10204] Funding Source: researchfish; MRC [MC_U127561093, MC_PC_U127561093, MC_PC_U127597124, MC_U127527199, MC_PC_U127527199] Funding Source: UKRI	Medical Research Council (MRC) program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research (Moorfields Eye Hospital Biomedical Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Michael Oldridge, Nicola Ragge, and David Ravine for their assistance with previous analyses of family 132. K.A.W., J.R., M.A., A.M., J.K.R., V.v.H., and D.R.F. are all supported by Medical Research Council (MRC) program grants awarded to the MRC Human Genetics Unit. Funding for UK10K was provided by the Wellcome Trust under award WT091310. We also acknowledge funding from the National Institute of Health Research (Moorfields Eye Hospital Biomedical Research Centre).	Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Azuma N, 2003, AM J HUM GENET, V72, P1565, DOI 10.1086/375555; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; Chang L, 2006, CURR OPIN OPHTHALMOL, V17, P447, DOI 10.1097/01.icu.0000243020.82380.f6; Daufenbach DR, 1998, OPHTHALMOLOGY, V105, P1455, DOI 10.1016/S0161-6420(98)98028-9; Di Donato N., 2013, EUR J HUM GENET; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Gerth-Kahlert C, 2013, MOL GENET GENOM MED, V1, P15, DOI 10.1002/mgg3.2; Hornby SJ, 2000, OPHTHALMOLOGY, V107, P511, DOI 10.1016/S0161-6420(99)00140-2; KINGSTON HM, 1982, J MED GENET, V19, P444, DOI 10.1136/jmg.19.6.444; Kondo Y, 2013, AM J MED GENET A, V161A, P1543, DOI 10.1002/ajmg.a.35983; Kumar K, 2011, MOL VIS, V17, P1414; Mihelec M, 2009, EUR J HUM GENET, V17, P1417, DOI 10.1038/ejhg.2009.79; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Rainger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002114; Ravine D, 1997, AM J MED GENET, V72, P227, DOI 10.1002/(SICI)1096-8628(19971017)72:2<227::AID-AJMG19>3.0.CO;2-P; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schimmenti LA, 2003, AM J MED GENET A, V116A, P215, DOI 10.1002/ajmg.a.10884; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sudol M, 2013, ONCOGENE, V32, P3922, DOI 10.1038/onc.2012.520; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Wang PF, 2008, ARCH OPHTHALMOL-CHIC, V126, P709, DOI 10.1001/archopht.126.5.709; Wyatt AW, 2010, HUM MUTAT, V31, P781, DOI 10.1002/humu.21280; Zhang R, 2013, J BIOL CHEM, V288, P10275, DOI 10.1074/jbc.M112.416719	32	70	72	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					295	302		10.1016/j.ajhg.2014.01.001	http://dx.doi.org/10.1016/j.ajhg.2014.01.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24462371	Green Published, Bronze			2022-12-18	WOS:000331419500013
J	Krumm, N; O'Roak, BJ; Karakoc, E; Mohajeri, K; Nelson, B; Vives, L; Jacquemont, S; Munson, J; Bernier, R; Eichler, EE				Krumm, Niklas; O'Roak, Brian J.; Karakoc, Emre; Mohajeri, Kiana; Nelson, Ben; Vives, Laura; Jacquemont, Sebastien; Munson, Jeff; Bernier, Raphe; Eichler, Evan E.			Transmission Disequilibrium of Small CNVs in Simplex Autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; DE-NOVO MUTATIONS; SPECTRUM DISORDERS; GENE; ALGORITHM; UBIQUITIN; VARIANTS; RESOURCE; DELETION; ORIGIN	We searched for disruptive, genic rare copy-number variants (CNVs) among 411 families affected by sporadic autism spectrum disorder (ASD) from the Simons Simplex Collection by using available exome sequence data and CoNIFER (Copy Number Inference from Exome Reads). Compared to high-density SNP microarrays, our approach yielded similar to 2x more smaller genic rare CNVs. We found that affected probands inherited more CNVs than did their siblings (453 versus 394, p = 0.004; odds ratio [OR] = 1.19) and that the probands' CNVs affected more genes (921 versus 726, p = 0.02; OR = 1.30). These smaller CNVs (median size 18 kb) were transmitted preferentially from the mother (136 maternal versus 100 paternal, p = 0.02), although this bias occurred irrespective of affected status. The excess burden of inherited CNVs among probands was driven primarily by sibling pairs with discordant social-behavior phenotypes (p < 0.0002, measured by Social Responsiveness Scale [SRS] score), which contrasts with families where the phenotypes were more closely matched or less extreme (p > 0.5). Finally, we found enrichment of brain-expressed genes unique to probands, especially in the SRS-discordant group (p = 0.0035). In a combined model, our inherited CNVs, de novo CNVs, and de novo single-nucleotide variants all independently contributed to the risk of autism (p < 0.05). Taken together, these results suggest that small transmitted rare CNVs play a role in the etiology of simplex autism. Importantly, the small size of these variants aids in the identification of specific genes as additional risk factors associated with ASD.	[Krumm, Niklas; O'Roak, Brian J.; Karakoc, Emre; Mohajeri, Kiana; Nelson, Ben; Vives, Laura; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Jacquemont, Sebastien] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Vaud, Switzerland; [Munson, Jeff; Bernier, Raphe] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Washington; University of Washington Seattle; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Jacquemont, Sebastien/AAS-5060-2021	Jacquemont, Sebastien/0000-0001-6838-8767; O'Roak, Brian/0000-0002-4141-0095	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]; Simons Foundation Autism Research Initiative [SFARI 137578, 191889]; NIH [HD065285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, UC2HL102923, RC2HL102923, UC2HL102925, UC2HL102924, RC2HL102926, RC2HL103010, UC2HL102926, RC2HL102925, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). We thank all the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R.B., J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, S. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We also acknowledge M. State and the SSC Genetics Consortium for providing Illumina genotyping data and T. Lehner and the Autism Sequencing Consortium for data exchange among the participating groups. We are grateful for helpful discussion and manuscript preparation from T. Brown, P. Sudmant, and all members of the Eichler lab. This work was supported by the Simons Foundation Autism Research Initiative (SFARI 137578 and 191889 to E.E.E., J.S., and R.B.) and NIH HD065285 (E.E.E. and J.S.). E.B. is an Alfred P. Sloan Research Fellow. E.E.E. is an Investigator of the Howard Hughes Medical Institute and is on the scientific advisory boards for Pacific Biosciences, Inc., SynapDx Corp., and DNAnexus, Inc.	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Davidson J., 2012, J AUTISM DEV DISORD; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Holder JL, 2012, AM J MED GENET A, V158A, P1962, DOI 10.1002/ajmg.a.35289; Huang Z, 2005, J CELL BIOL, V170, P527, DOI 10.1083/jcb.200505075; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lorenz P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-206; Losh M, 2008, AM J MED GENET B, V147B, P424, DOI 10.1002/ajmg.b.30612; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wali A, 2007, ANN HUM GENET, V71, P570, DOI 10.1111/j.1469-1809.2007.00362.x; Wobst H, 2012, FEBS J, V279, P4398, DOI 10.1111/febs.12029	34	70	71	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					595	606		10.1016/j.ajhg.2013.07.024	http://dx.doi.org/10.1016/j.ajhg.2013.07.024			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24035194	Green Published, Bronze			2022-12-18	WOS:000326305600002
J	Dirami, T; Rode, B; Jollivet, M; Da Silva, N; Escalier, D; Gaitch, N; Norez, C; Tuffery, P; Wolf, JP; Becq, F; Ray, PF; Dulioust, E; Gacon, G; Bienvenu, T; Toure, A				Dirami, Thassadite; Rode, Baptiste; Jollivet, Mathilde; Da Silva, Nathalie; Escalier, Denise; Gaitch, Natacha; Norez, Caroline; Tuffery, Pierre; Wolf, Jean-Philippe; Becq, Frederic; Ray, Pierre F.; Dulioust, Emmanuel; Gacon, Gerard; Bienvenu, Thierry; Toure, Aminata			Missense Mutations in SLC26A8, Encoding a Sperm-Specific Activator of CFTR, Are Associated with Human Asthenozoospermia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SOLUBLE ADENYLYL-CYCLASE; TERMINAL DIFFERENTIATION; ORGANIZATION; INVOLVEMENT; CHANNEL; FAMILY; TAT1	The cystic fibrosis transmembrane conductance regulator (CFTR) is present in mature sperm and is required for sperm motility and capacitation. Both these processes are controlled by ions fluxes and are essential for fertilization. We have shown that SLC26A8, a sperm-specific member of the SLC26 family of anion exchangers, associates with the CFTR channel and strongly stimulates its activity. This suggests that the two proteins cooperate to regulate the anion fluxes required for correct sperm motility and capacitation. Here, we report on three heterozygous SLC26A8 missense mutations identified in a cohort of 146 men presenting with asthenozoospermia: c.260G>A (p.Arg87Gln), c.2434G>A (p.Glu812Lys), and c.2860C>T (p.Arg954Cys). These mutations were not present in 121 controls matched for ethnicity, and statistical analysis on a control population of 8,600 individuals (from dbSNP and 1000 Genomes) showed them to be associated with asthenozoospermia with a power > 95%. By cotransfecting Chinese hamster ovary (CHO)-K1 cells with SLC26A8 variants and CFTR, we showed that the physical interaction between the two proteins was partly conserved but that the capacity to activate CFTR-dependent anion transport was completely abolished for all mutants. Biochemical studies revealed the presence of much smaller amounts of protein for all variants, but these amounts were restored to wild-type levels upon treatment with the proteasome inhibitor MG132. Immunocytochemistry also showed the amounts of SLC26A8 in sperm to be abnormally small in individuals carrying the mutations. These mutations might therefore impair formation of the SLC26A8-CFTR complex, principally by affecting SLC26A8 stability, consistent with an impairment of CFTR-dependent sperm-activation events in affected individuals.	[Dirami, Thassadite; Rode, Baptiste; Da Silva, Nathalie; Wolf, Jean-Philippe; Gacon, Gerard; Bienvenu, Thierry; Toure, Aminata] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Dirami, Thassadite; Rode, Baptiste; Da Silva, Nathalie; Wolf, Jean-Philippe; Gacon, Gerard; Bienvenu, Thierry; Toure, Aminata] CNRS, UMR 8104, F-75014 Paris, France; [Dirami, Thassadite; Rode, Baptiste; Da Silva, Nathalie; Wolf, Jean-Philippe; Gacon, Gerard; Bienvenu, Thierry; Toure, Aminata] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Jollivet, Mathilde; Norez, Caroline; Becq, Frederic] Univ Poitiers, Inst Physiol & Biol Cellulaires, CNRS, FEE 3511, F-86022 Poitiers, France; [Escalier, Denise] Hop Armand Trousseau, INSERM, UMR S933, F-75012 Paris, France; [Gaitch, Natacha; Bienvenu, Thierry] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Lab Biochim & Genet Mol, F-75014 Paris, France; [Tuffery, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMR S973, F-75205 Paris 13, France; [Wolf, Jean-Philippe; Dulioust, Emmanuel] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Serv Histol Embryol & Biol Reprod, F-75014 Paris, France; [Ray, Pierre F.] Univ Grenoble 1, Lab Androl Gerontechnol Inflammat & Modelisat, Equipe Genet Infertil & Therapeut, CNRS,FRE 3405, F-38043 Grenoble, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Toure, A (corresponding author), INSERM, Inst Cochin, U1016, F-75014 Paris, France.	aminata.toure@inserm.fr	TOURE, Aminata/B-3236-2018; Ray, Pierre F/D-7315-2019; Norez, Caroline/P-9567-2016; Becq, Frederic/P-9233-2016; Tuffery, Pierre/L-6953-2017	TOURE, Aminata/0000-0001-5629-849X; Ray, Pierre F/0000-0003-1544-7449; Becq, Frederic/0000-0003-3915-0973; Tuffery, Pierre/0000-0003-1033-9895	Ministere de l'Education Nationale et de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite Paris Descartes; Agence Nationale de la Recherche [ANR-07-JCJC-0099, ANR-12-BSV1-0011-01 MUCOFERTIL]; Association Vaincre la Mucoviscidose [RF20110600465]	Ministere de l'Education Nationale et de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Vaincre la Mucoviscidose	We thank the Cellular Imaging Facility of Institut Cochin (Institut National de la Sante et de la Recherche Medicale U1016, Centre National de la Recherche Scientifique UMR 8104, Universite Paris Descartes): Jean Marc Masse and Alain Schmitt for electron microscopy and Beatrice Durel and Pierre Bourdoncle for light microscopy. This work was supported by the Ministere de l'Education Nationale et de la Recherche Scientifique (graduate fellowships to B.R. and T.D.), Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite Paris Descartes, Agence Nationale de la Recherche (ANR-07-JCJC-0099; ANR-12-BSV1-0011-01 MUCOFERTIL), and Association Vaincre la Mucoviscidose (RF20110600465).	Avella M, 2011, J CELL PHYSIOL, V226, P212, DOI 10.1002/jcp.22328; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Dawson PA, 2005, CURR MED CHEM, V12, P385, DOI 10.2174/0929867053363144; Everett LA, 1999, HUM MOL GENET, V8, P1883, DOI 10.1093/hmg/8.10.1883; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Lhuillier P, 2009, HUM REPROD, V24, P1296, DOI 10.1093/humrep/dep020; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Norez Caroline, 2004, J Cyst Fibros, V3 Suppl 2, P119, DOI 10.1016/j.jcf.2004.05.025; Rode B, 2012, HUM MOL GENET, V21, P1287, DOI 10.1093/hmg/ddr558; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; Singh AK, 2010, AM J PHYSIOL-CELL PH, V298, pC1057, DOI 10.1152/ajpcell.00454.2009; Sugino Y, 2008, J UROLOGY, V180, P2706, DOI 10.1016/j.juro.2008.08.005; Sun L, 2012, NAT GENET, V44, P562, DOI 10.1038/ng.2221; Toure A, 2001, J BIOL CHEM, V276, P20309, DOI 10.1074/jbc.M011740200; Toure A, 2007, HUM MOL GENET, V16, P1783, DOI 10.1093/hmg/ddm117; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104	29	70	75	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					760	766		10.1016/j.ajhg.2013.03.016	http://dx.doi.org/10.1016/j.ajhg.2013.03.016			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23582645	Green Published, Bronze			2022-12-18	WOS:000318582800010
J	Vulto-van Silfhout, AT; de Vries, BBA; van Bon, BWM; Hoischen, A; Ruiterkamp-Versteeg, M; Gilissen, C; Gao, FJ; van Zwam, M; Harteveld, CL; van Essen, AJ; Hamel, BCJ; Kleefstra, T; Willemsen, MAAP; Yntema, HG; van Bokhoven, H; Brunner, HG; Boyer, TG; de Brouwer, APM				Vulto-van Silfhout, Anneke T.; de Vries, Bert B. A.; van Bon, Bregje W. M.; Hoischen, Alexander; Ruiterkamp-Versteeg, Martina; Gilissen, Christian; Gao, Fangjian; van Zwam, Marloes; Harteveld, Cornelis L.; van Essen, Anthonie J.; Hamel, Ben C. J.; Kleefstra, Tjitske; Willemsen, Michel A. A. P.; Yntema, Helger G.; van Bokhoven, Hans; Brunner, Han G.; Boyer, Thomas G.; de Brouwer, Arjan P. M.			Mutations in MED12 Cause X-Linked Ohdo Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPITZ-KAVEGGIA-SYNDROME; MENTAL-RETARDATION; MEDIATOR COMPLEX; FG SYNDROME; BLEPHAROPHIMOSIS; YEAST; GENE; COACTIVATOR; PROTEINS; DISEASE	Ohdo syndrome comprises a heterogeneous group of disorders characterized by intellectual disability (ID) and typical facial features, including blepharophimosis. Clinically, these blepharophimosis-ID syndromes have been classified in five distinct subgroups, including the Maat-Kievit-Brunner (MKB) type, which, in contrast to the others, is characterized by X-linked inheritance and facial coarsening at older age. We performed exome sequencing in two families, each with two affected males with Ohdo syndrome MKB type. In the two families, MED12 missense mutations (c.3443G>A [p.Arg1148His] or c.3493T>C [p.Ser1165Pro]) segregating with the phenotype were identified. Upon subsequent analysis of an additional cohort of nine simplex male individuals with Ohdo syndrome, one additional de novo missense change (c.5185C>A [p.His1729Asn]) in MED12 was detected. The occurrence of three different hemizygous missense mutations in three unrelated families affected by Ohdo syndrome MKB type shows that mutations in MED12 are the underlying cause of this X-linked form of Ohdo syndrome. Together with the recently described KAT6B mutations resulting in Ohdo syndrome Say/Barber/Biesecker/Young/Simpson type, our findings point to aberrant chromatin modification as being central to the pathogenesis of Ohdo syndrome.	[Vulto-van Silfhout, Anneke T.; de Vries, Bert B. A.; van Bon, Bregje W. M.; Hoischen, Alexander; Ruiterkamp-Versteeg, Martina; Gilissen, Christian; Hamel, Ben C. J.; Kleefstra, Tjitske; Yntema, Helger G.; van Bokhoven, Hans; Brunner, Han G.; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Vulto-van Silfhout, Anneke T.; de Vries, Bert B. A.; van Bon, Bregje W. M.; Hoischen, Alexander; Gilissen, Christian; Kleefstra, Tjitske; Brunner, Han G.] Radboud Univ Nijmegen, Inst Genet & Metab Dis, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Hoischen, Alexander; Gilissen, Christian; Brunner, Han G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Gao, Fangjian; Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78229 USA; [van Zwam, Marloes] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Harteveld, Cornelis L.] Leiden Univ, Hemoglobinopathies Lab, Dept Human & Clin Genet, Med Ctr, NL-2300 RC Leiden, Netherlands; [van Essen, Anthonie J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Willemsen, Michel A. A. P.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Willemsen, Michel A. A. P.; van Bokhoven, Hans; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [van Bokhoven, Hans; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Texas System; University of Texas Health San Antonio; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Brunner, HG (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands.	h.brunner@gen.umcn.nl	AT, Vulto-van Silfhout/H-4199-2015; van Bon, Bregje/Q-2445-2015; Kleefstra, Tjitske/G-2619-2012; Hoischen, Alexander/AGF-7293-2022; Willemsen, Michel A.A.P./H-8119-2014; Hoischen, Alexander/D-1282-2013; van Bon, Bregje/D-3720-2013; Gilissen, Christian/E-5246-2012; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013; de Brouwer, Arjan PM/P-5949-2015; van Bokhoven, Hans/D-8764-2012; gao, fangjian/AAA-2717-2020; Yntema, H.G./L-4771-2015	van Bon, Bregje/0000-0003-2234-0105; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Gilissen, Christian/0000-0003-1693-9699; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; 	European Commission [037627, 241995]; Netherlands Organisation for Health Research and Development (ZON-MW) [917-86-319, 917-66-363]; National Institutes of Health (National Institute of Mental Health) [R01MH085320]; Hersenstichting Nederland [2010(1)-30]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085320] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organisation for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); National Institutes of Health (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hersenstichting Nederland; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the families for their participation. We thank the Genomic Disorders Group Nijmegen for the technical support in performing the exome-sequencing experiments. This work was supported by the European Commission (AnEUploidy Project grant 037627 under FP6 to A.T.V.v.S., B.B.A.d.V., H.G.B., and A.H. and GENCODYS grant 241995 under FP7 to A.T.V.v.S. and B.B.A.d.V.), the Netherlands Organisation for Health Research and Development (ZON-MW grant 917-86-319 to B.B.A.d.V. and ZON-MW grant 917-66-363 to A.H.), the National Institutes of Health (National Institute of Mental Health grant R01MH085320 to T.G.B.), and Hersenstichting Nederland (2010(1)-30 to A.d.B.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Clark RD, 2009, GENET MED, V11, P769, DOI 10.1097/GIM.0b013e3181bd3d90; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Dacie J., 1991, PRACTICAL HEMATOLOGY, V7th; Day R, 2008, CLIN GENET, V74, P434, DOI 10.1111/j.1399-0004.2008.01087.x; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Hennekam R.C., 2010, MANAGEMENT GENETIC S, V3rd ed., P705; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; MAATKIEVIT A, 1993, AM J MED GENET, V47, P901, DOI 10.1002/ajmg.1320470618; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; OHDO S, 1986, J MED GENET, V23, P242, DOI 10.1136/jmg.23.3.242; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; OZISIK YY, 1993, CANCER GENET CYTOGEN, V69, P132, DOI 10.1016/0165-4608(93)90089-5; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Spath MA, 2010, AM J MED GENET A, V152A, P387, DOI 10.1002/ajmg.a.33243; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Van Delft P, 2009, INT J LAB HEMATOL, V31, P484, DOI 10.1111/j.1751-553X.2009.01158.x; Verloes A, 2006, AM J MED GENET A, V140A, P1285, DOI 10.1002/ajmg.a.31270; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19763, DOI 10.1073/pnas.1121120109	36	70	71	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					401	406		10.1016/j.ajhg.2013.01.007	http://dx.doi.org/10.1016/j.ajhg.2013.01.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23395478	Green Published, Bronze			2022-12-18	WOS:000316161700013
J	Fares-Taie, L; Gerber, S; Chassaing, N; Clayton-Smith, J; Hanein, S; Silva, E; Serey, M; Serre, V; Gerard, X; Baumann, C; Plessis, G; Demeer, B; Bretillon, L; Bole, C; Nitschke, P; Munnich, A; Lyonnet, S; Calvas, P; Kaplan, J; Ragge, N; Rozet, JM				Fares-Taie, Lucas; Gerber, Sylvie; Chassaing, Nicolas; Clayton-Smith, Jill; Hanein, Sylvain; Silva, Eduardo; Serey, Margaux; Serre, Valerie; Gerard, Xavier; Baumann, Clarisse; Plessis, Ghislaine; Demeer, Benedicte; Bretillon, Lionel; Bole, Christine; Nitschke, Patrick; Munnich, Arnold; Lyonnet, Stanislas; Calvas, Patrick; Kaplan, Josseline; Ragge, Nicola; Rozet, Jean-Michel			ALDH1A3 Mutations Cause Recessive Anophthalmia and Microphthalmia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EYE	Anophthalmia and microphthalmia (A/M) are early-eye-development anomalies resulting in absent or small ocular globes, respectively. A/M anomalies occur in syndromic or nonsyndromic forms. They are genetically heterogeneous, some mutations in some genes being responsible for both anophthalmia and microphthalmia. Using a combination of homozygosity mapping, exome sequencing, and Sanger sequencing, we identified homozygosity for one splice-site and two missense mutations in the gene encoding the A3 isoform of the aldehyde dehydrogenase 1 (ALDH1A3) in three consanguineous families segregating A/M with occasional orbital cystic, neurological, and cardiac anomalies. ALDH1A3 is a key enzyme in the formation of a retinoic acid gradient along the dorso-ventral axis during early eye development. Transitory expression of mutant ALDH1A3 open reading frames showed that both missense mutations reduce the accumulation of the enzyme, potentially leading to altered retinoic acid synthesis. Although the role of retinoic acid signaling in eye development is well established, our findings provide genetic evidence of a direct link between retinoic-acid-synthesis dysfunction and early-eye-development anomalies in humans.	[Fares-Taie, Lucas; Gerber, Sylvie; Hanein, Sylvain; Serey, Margaux; Serre, Valerie; Gerard, Xavier; Munnich, Arnold; Lyonnet, Stanislas; Kaplan, Josseline; Rozet, Jean-Michel] Paris Descartes Univ, INSERM U781, F-75015 Paris, France; [Fares-Taie, Lucas; Gerber, Sylvie; Hanein, Sylvain; Serey, Margaux; Serre, Valerie; Gerard, Xavier; Munnich, Arnold; Lyonnet, Stanislas; Kaplan, Josseline; Rozet, Jean-Michel] Paris Descartes Univ, Dept Genet, F-75015 Paris, France; [Chassaing, Nicolas] Hop Purpan, CHU Toulouse, Serv Genet Med, F-31059 Toulouse, France; [Chassaing, Nicolas; Calvas, Patrick] Univ Toulouse 3, EA 4555, F-31000 Toulouse, France; [Clayton-Smith, Jill; Ragge, Nicola] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Silva, Eduardo] Univ Coimbra, Dept Ophthalmol, Ctr Hosp Univ Coimbra, IBILI,Fac Med, P-3000548 Coimbra, Portugal; [Serre, Valerie] Univ Paris Diderot, F-75205 Paris 13, France; [Baumann, Clarisse] CHU Robert Debre, Dept Genet, F-75019 Paris, France; [Plessis, Ghislaine] Hop Cote de Nacre, CHU Caen, Dept Med Genet, F-14033 Caen 9, France; [Demeer, Benedicte] Hop Nord Amiens, CHU Amiens, Dept Pediat, F-80054 Amiens 1, France; [Bretillon, Lionel] Univ Bourgogne, INRA UMR1324, F-21065 Dijon, France; [Bretillon, Lionel] Univ Bourgogne, CNRS UMR6265, Ctr Sci Gout & Alimentat, F-21065 Dijon, France; [Bole, Christine] IMAGINE Fdn, F-75015 Paris, France; [Bole, Christine; Nitschke, Patrick] Paris Descartes Univ, F-75015 Paris, France; [Ragge, Nicola] Southampton Univ Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Ragge, Nicola] Oxford Brookes Univ, Oxford OX1 3QX, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Manchester; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Southampton; Oxford Brookes University	Kaplan, J (corresponding author), Paris Descartes Univ, INSERM U781, F-75015 Paris, France.	josseline.kaplan@inserm.fr; jean-michel.rozet@inserm.fr	hanein, sylvain/AAG-4933-2019; ROZET, Jean-Michel/E-5737-2016; GERARD, Xavier/H-6039-2017; Lyonnet, Stanislas/H-5483-2017; FARES TAIE, Lucas/H-2940-2017; KAPLAN, Josseline/I-2622-2017	hanein, sylvain/0000-0001-5817-6330; ROZET, Jean-Michel/0000-0001-7951-7886; GERARD, Xavier/0000-0003-0586-4820; Lyonnet, Stanislas/0000-0001-5426-9417; GERBER, Sylvie/0000-0002-6827-1769; Silva, Eduardo/0000-0002-2739-9854; Bretillon, Lionel/0000-0002-6957-100X; FARES TAIE, Lucas/0000-0002-4613-0711; KAPLAN, Josseline/0000-0002-1849-8658	Retina France; Clinical Research Hospital Program of the French Ministry of Health [PHRC 09 109 01]; Academy of Medical Sciences/Health Foundation; VICTA (Visually Impaired Children Taking Action); MACS (Microphthalmia and Anophthalmia Children's Society); Hampshire and Isle of Wight Comprehensive Local Research Network	Retina France; Clinical Research Hospital Program of the French Ministry of Health; Academy of Medical Sciences/Health Foundation; VICTA (Visually Impaired Children Taking Action); MACS (Microphthalmia and Anophthalmia Children's Society); Hampshire and Isle of Wight Comprehensive Local Research Network	We are grateful to the families for their participation in the study. We thank A. Martin and L. Harrison for research co-ordination, A. Salt and R. Collin (Moorfields Eye Hospital, London) for clinical support, and D. Robinson (Wessex Regional Genetics Laboratory Salisbury), N. Graham (Southampton University Hospitals Trust, Southampton), E. Leclerc and B. Leloire (CRB-CHU Biobanque de Picardie, Amiens), and Soraya Sin (Laboratoire d'Oncogenetique, Hopital Rene Huguenin-Institut Curie, St Cloud) for technical assistance. This work was supported by grants from Retina France, the Clinical Research Hospital Program of the French Ministry of Health (PHRC 09 109 01), the Academy of Medical Sciences/Health Foundation (NR), VICTA (Visually Impaired Children Taking Action), MACS (Microphthalmia and Anophthalmia Children's Society), and the Hampshire and Isle of Wight Comprehensive Local Research Network.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bakrania P, 2007, BRIT J OPHTHALMOL, V91, P1471, DOI 10.1136/bjo.2007.117929; Bardakjian TM, 2011, CURR OPIN OPHTHALMOL, V22, P309, DOI 10.1097/ICU.0b013e328349b004; Chassaing N., 2012, CLIN GENET, V9999; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Graham CE, 2006, BIOCHEM J, V394, P67, DOI 10.1042/BJ20050918; Grun F, 2000, J BIOL CHEM, V275, P41210, DOI 10.1074/jbc.M007376200; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Slavotinek AM, 2011, MOL GENET METAB, V104, P448, DOI 10.1016/j.ymgme.2011.09.029; Tucker S, 1996, EYE, V10, P310, DOI 10.1038/eye.1996.65; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064	23	70	73	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					265	270		10.1016/j.ajhg.2012.12.003	http://dx.doi.org/10.1016/j.ajhg.2012.12.003			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23312594	Green Published, Bronze			2022-12-18	WOS:000315179600011
J	Tang, WH; Schwienbacher, C; Lopez, LM; Ben-Shlomo, Y; Oudot-Mellakh, T; Johnson, AD; Samani, NJ; Basu, S; Gogele, M; Davies, G; Lowe, GDO; Tregouet, DA; Tan, A; Pankow, JS; Tenesa, A; Levy, D; Volpato, CB; Rumley, A; Gow, AJ; Minelli, C; Yarnell, JWG; Porteous, DJ; Starr, JM; Gallacher, J; Boerwinkle, E; Visscher, PM; Pramstaller, PP; Cushman, M; Emilsson, V; Plump, AS; Matijevic, N; Morange, PE; Deary, IJ; Hicks, AA; Folsom, AR				Tang, Weihong; Schwienbacher, Christine; Lopez, Lorna M.; Ben-Shlomo, Yoav; Oudot-Mellakh, Tiphaine; Johnson, Andrew D.; Samani, Nilesh J.; Basu, Saonli; Goegele, Martin; Davies, Gail; Lowe, Gordon D. O.; Tregouet, David-Alexandre; Tan, Adrian; Pankow, James S.; Tenesa, Albert; Levy, Daniel; Volpato, Claudia B.; Rumley, Ann; Gow, Alan J.; Minelli, Cosetta; Yarnell, John W. G.; Porteous, David J.; Starr, John M.; Gallacher, John; Boerwinkle, Eric; Visscher, Peter M.; Pramstaller, Peter P.; Cushman, Mary; Emilsson, Valur; Plump, Andrew S.; Matijevic, Nena; Morange, Pierre-Emmanuel; Deary, Ian J.; Hicks, Andrew A.; Folsom, Aaron R.			Genetic Associations for Activated Partial Thromboplastin Time and Prothrombin Time, their Gene Expression Profiles, and Risk of Coronary Artery Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HISTIDINE-RICH GLYCOPROTEIN; GENOME-WIDE ASSOCIATION; VON-WILLEBRAND-FACTOR; DEEP-VEIN THROMBOSIS; ABO BLOOD-GROUP; PROTEIN-C; PLASMA-LEVELS; CELLULAR CHARACTERIZATION; VENOUS THROMBOEMBOLISM; HEMOSTASIS PHENOTYPES	Activated partial thromboplastin time (aPTT) and prothrombin time (PT) are clinical tests commonly used to screen for coagulation-factor deficiencies. One genome-wide association study (GWAS) has been reported previously for aPTT, but no GWAS has been reported for PT. We conducted a GWAS and meta-analysis to identify genetic loci for aPTT and PT. The GWAS for aPTT was conducted in 9,240 individuals of European ancestry from the Atherosclerosis Risk in Communities (ARIC) study, and the GWAS for PT was conducted in 2,583 participants from the Genetic Study of Three Population Microisolates in South Tyrol (MICROS) and the Lothian Birth Cohorts (LBC) of 1921 and 1936. Replication was assessed in 1,041 to 3,467 individuals. For aPTT, previously reported associations with KNG1, HRG, F11, F12, and ABO were confirmed. A second independent association in ABO was identified and replicated (rs8176704, p = 4.26 x 10(-24)). Pooling the ARIC and replication data yielded two additional loci in F5 (rs6028, p = 3.22 x 10(-9)) and AGBL1 (rs2469184, p = 3.61 x 10(-8)). For PT, significant associations were identified and confirmed in F7 (rs561241, p = 3.71 x 10(-56)) and PROCR/EDEM2 (rs2295888, p = 5.25 x 10(-13)). Assessment of existing gene expression and coronary artery disease (CAD) databases identified associations of five of the GWAS loci with altered gene expression and two with CAD. In summary, eight genetic loci that account for similar to 29% of the variance in aPTT and two loci that account for similar to 14% of the variance in PT were detected and supported by functional data.	[Tang, Weihong; Pankow, James S.; Folsom, Aaron R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Schwienbacher, Christine; Goegele, Martin; Volpato, Claudia B.; Minelli, Cosetta; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy; [Schwienbacher, Christine] Univ Ferrara, Dept Expt & Diagnost Med, I-44121 Ferrara, Italy; [Lopez, Lorna M.; Gow, Alan J.; Porteous, David J.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Gow, Alan J.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Oudot-Mellakh, Tiphaine; Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMR S 937, Inst Cardiometab & Nutr ICAN, F-75013 Paris, France; [Johnson, Andrew D.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Johnson, Andrew D.; Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20824 USA; [Johnson, Andrew D.] NHLBI, Div Intramural Res, Bethesda, MD 20824 USA; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Samani, Nilesh J.] Leicester Cardiovasc Biomed Res Unit, Glenfield Hosp, Natl Inst Hlth Res, Leicester LE3 9QP, Leics, England; [Basu, Saonli; Tan, Adrian] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [Lowe, Gordon D. O.; Rumley, Ann] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Tenesa, Albert] Inst Genet & Mol Med, Med Res Council MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Yarnell, John W. G.] Queens Univ Belfast, Epidemiol Res Grp, Belfast BT12 6BJ, Antrim, North Ireland; [Porteous, David J.] Univ Edinburgh, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Gallacher, John] Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Cushman, Mary] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Cushman, Mary] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Emilsson, Valur] Merck & Co Inc, Mol Programming & Res Informat, Rahway, NJ 07065 USA; [Plump, Andrew S.] Merck Res Lab, Dept Cardiovasc Dis, Rahway, NJ 07065 USA; [Matijevic, Nena] Univ Texas Hlth Sci Ctr Houston, Hemostasis Lab, Houston, TX 77030 USA; Aix Marseille Univ, INSERM, UMR S 1062, F-13385 Marseille, France	University of Minnesota System; University of Minnesota Twin Cities; European Academy of Bozen-Bolzano; University of Ferrara; University of Edinburgh; University of Edinburgh; University of Bristol; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Glasgow; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Queens University Belfast; University of Edinburgh; University of Edinburgh; Cardiff University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; QIMR Berghofer Medical Research Institute; Krankenhaus Bozen; University of Lubeck; University of Vermont; University of Vermont; Merck & Company; Merck & Company; University of Texas System; University of Texas Health Science Center Houston; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Tang, WH (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.	tang0097@umn.edu	Porteous, David/AAA-3446-2021; Lopez, Lorna M/F-7265-2010; Levy, Daniel/ABF-6873-2021; Tregouet, David-Alexandre/E-3961-2016; Porteous, David J/C-7289-2013; Levy, Daniel/ABB-2752-2021; Pramstaller, Peter P/C-2357-2008; Johnson, Andrew D/G-6520-2013; Visscher, Peter/ABB-6151-2020; Hicks, Andrew Anthony/E-9518-2017; Cushman, Mary/K-1157-2019; Trégouët, David-Alexandre/P-9210-2019; Lopez, Lorna/AAR-4912-2020; Gow, Alan J/A-6070-2009; Morange, Pierre/T-9070-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Deary, Ian J/C-6297-2009	Porteous, David/0000-0003-1249-6106; Levy, Daniel/0000-0003-1843-8724; Porteous, David J/0000-0003-1249-6106; Johnson, Andrew D/0000-0001-6369-5178; Visscher, Peter/0000-0002-2143-8760; Hicks, Andrew Anthony/0000-0001-6320-0411; Cushman, Mary/0000-0002-7871-6143; Trégouët, David-Alexandre/0000-0001-9084-7800; Lopez, Lorna/0000-0002-0241-9783; Gow, Alan J/0000-0002-3320-4531; Morange, Pierre/0000-0002-9065-722X; Ben-Shlomo, Yoav/0000-0001-6648-3007; Deary, Ian J/0000-0002-1733-263X; Pramstaller, Peter P/0000-0002-9831-8302; Pankow, James/0000-0001-7076-483X; Emilsson, Valur/0000-0001-9982-0524; Tenesa, Albert/0000-0003-4884-4475; Gogele, Martin/0000-0003-4785-4348; Basu, Saonli/0000-0003-1200-4546	National Institutes of Health (NIH) [R01-HL095603]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, ZIAHL006170, R01HL095603, ZIAHL006001] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; British Heart Foundation [PG/09/002/26056] Funding Source: researchfish; Medical Research Council [G0700704, G0700704B] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We warmly thank all staff and participants. The individual studies were supported by the National Institutes of Health (NIH) or other funding sources. W.T. is partially supported by NIH grant R01-HL095603. We would like to thank the University of Minnesota Supercomputing Institute for use of the Blade and Calhoun super-computers. Additional acknowledgments for each study and conflict-of-interest disclosures are listed in the Supplemental Data.	[Anonymous], AM J EPIDEMIOL, V129, P687; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; EWALD GA, 1995, CIRCULATION, V91, P28, DOI 10.1161/01.CIR.91.1.28; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; FOUREL V, 1993, HAEMOSTASIS, V23, P321; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Greenwell P, 1997, GLYCOCONJUGATE J, V14, P159, DOI 10.1023/A:1018581503164; Hosoi E, 2008, J MED INVESTIG, V55, P174, DOI 10.2152/jmi.55.174; Houlihan LM, 2010, AM J HUM GENET, V86, P626, DOI 10.1016/j.ajhg.2010.02.016; Hron G, 2006, J THROMB HAEMOST, V4, P752, DOI 10.1111/j.1538-7836.2006.01868.x; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Ireland H, 2005, ATHEROSCLEROSIS, V183, P283, DOI 10.1016/j.atherosclerosis.2005.02.028; Ireland HA, 2009, ARTERIOSCL THROM VAS, V29, P1968, DOI 10.1161/ATVBAHA.109.191551; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Jacobs DS, 1991, LAB TEST HDB; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Kitchen S., 2010, DIAGNOSIS HEMOPHILIA; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lopez-Sagaseta J, 2007, J THROMB HAEMOST, V5, P1817, DOI 10.1111/j.1538-7836.2007.02648.x; Morange PE, 2011, BLOOD, V117, P3692, DOI 10.1182/blood-2010-11-319053; Morelli VM, 2007, THROMB HAEMOSTASIS, V97, P534, DOI 10.1160/TH06-09-0549; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Owens AP, 2010, THROMB HAEMOSTASIS, V104, P432, DOI 10.1160/TH09-11-0771; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Scanavini D, 2004, ARTERIOSCL THROM VAS, V24, P200, DOI 10.1161/01.ATV.0000109750.34073.f6; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shigekiyo T, 1998, BLOOD, V91, P128, DOI 10.1182/blood.V91.1.128.128_128_133; Shigekiyo T, 2000, THROMB HAEMOSTASIS, V84, P675; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Souto JC, 2000, ARTERIOSCL THROM VAS, V20, P2024, DOI 10.1161/01.ATV.20.8.2024; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x; Warrew DM, 2005, HUM BIOL, V77, P1, DOI 10.1353/hub.2005.0034; White GC, 2003, J THROMB HAEMOST, V1, P2267, DOI 10.1046/j.1538-7836.2003.00459.x; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yarnell JWG, 2001, BLOOD COAGUL FIBRIN, V12, P721, DOI 10.1097/00001721-200112000-00015; Zakai NA, 2008, AM J MED, V121, P231, DOI 10.1016/j.amjmed.2007.10.025; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	57	70	70	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					152	162		10.1016/j.ajhg.2012.05.009	http://dx.doi.org/10.1016/j.ajhg.2012.05.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22703881	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000306445000013
J	Spiegel, K; Pines, O; Ta-Shma, A; Burak, E; Shaag, A; Halvardson, J; Edvardson, S; Mahajna, M; Zenvirt, S; Saada, A; Shalev, S; Feuk, L; Elpeleg, O				Spiegel, Konen; Pines, Ophry; Ta-Shma, Asaf; Burak, Efrat; Shaag, Avraham; Halvardson, Jonatan; Edvardson, Shimon; Mahajna, Muhammad; Zenvirt, Shamir; Saada, Ann; Shalev, Stavit; Feuk, Lars; Elpeleg, Orly			Infantile Cerebellar-Retinal Degeneration Associated with a Mutation in Mitochondrial Aconitase, ACO2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OXIDATIVE STRESS; DNA DEPLETION; DEFICIENCY; GENE; NEURODEGENERATION; DEFECTS; SUBUNIT; CANCER	Degeneration of the cerebrum, cerebellum, and retina in infancy is part of the clinical spectrum of lysosomal storage disorders, mitochondrial respiratory chain defects, carbohydrate glycosylation defects, and infantile neuroaxonal dystrophy. We studied eight individuals from two unrelated families who presented at 2-6 months of age with truncal hypotonia and athetosis, seizure disorder, and ophthalmologic abnormalities. Their course was characterized by failure to acquire developmental milestones and culminated in profound psychomotor retardation and progressive visual loss, including optic nerve and retinal atrophy. Despite their debilitating state, the disease was compatible with survival of up to 18 years. Laboratory investigations were normal, but the oxidation of glutamate by muscle mitochondria was slightly reduced. Serial brain MRI displayed progressive, prominent cerebellar atrophy accompanied by thinning of the corpus callosum, dysmyelination, and frontal and temporal cortical atrophy. Homozygosity mapping followed by whole-exome sequencing disclosed a Ser112Arg mutation in ACO2, encoding mitochondrial aconitase, a component of the Krebs cycle. Specific aconitase activity in the individuals' lymphoblasts was severely reduced. Under restrictive conditions, the mutant human ACO2 failed to complement a yeast ACO1 deletion strain, whereas the wild-type human ACO2 succeeded, indicating that this mutation is pathogenic. Thus, a defect in mitochondrial aconitase is associated with an infantile neurodegenerative disorder affecting mainly the cerebellum and retina. In the absence of noninvasive biomarkers, determination of the ACO2 sequence or of aconitase activity in lymphoblasts are warranted in similarly affected individuals, based on clinical and neuroradiologic grounds.	[Pines, Ophry; Burak, Efrat] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada, Fac Med, IL-91120 Jerusalem, Israel; [Spiegel, Konen; Shalev, Stavit] HaEmek Med Ctr, Dept Pediat A, IL-18101 Afula, Israel; [Spiegel, Konen; Shalev, Stavit] HaEmek Med Ctr, Genet Inst, IL-18101 Afula, Israel; [Spiegel, Konen; Shalev, Stavit] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Ta-Shma, Asaf; Shaag, Avraham; Edvardson, Shimon; Zenvirt, Shamir; Saada, Ann; Elpeleg, Orly] Hebrew Univ Med Ctr, Moniques & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Halvardson, Jonatan; Feuk, Lars] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Halvardson, Jonatan; Feuk, Lars] Uppsala Univ, Sci Life Lab, Rudbeck Lab, S-75185 Uppsala, Sweden; [Mahajna, Muhammad] Hillel Yaffe Med Ctr, Child Dev & Pediat Neurol Unit, IL-38101 Hadera, Israel	Hebrew University of Jerusalem; Emek Medical Center; Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Uppsala University; Uppsala University	Pines, O (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada, Fac Med, IL-91120 Jerusalem, Israel.	ophryp@ekmd.huji.ac.il; elpeleg@hadassah.org.il	Saada, Ann/J-6864-2017; pines, ophry/C-4086-2011	Saada, Ann/0000-0003-2951-0656; Edvardson, Simon/0000-0003-2878-1278; pines, ophry/0000-0001-7126-2575				Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; NARDOCCI N, 1995, AM J MED GENET, V57, P137, DOI 10.1002/ajmg.1320570205; Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222; Ottolenghi C, 2011, HUM MUTAT, V32, P1046, DOI 10.1002/humu.21534; Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021; Prensner JR, 2011, NAT MED, V17, P291, DOI 10.1038/nm0311-291; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.E04-11-1028; Regev-Rudzki N, 2008, J CELL SCI, V121, P2423, DOI 10.1242/jcs.029207; SLAUGHTER CA, 1977, ANN HUM GENET, V40, P385; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16	22	70	72	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					518	523		10.1016/j.ajhg.2012.01.009	http://dx.doi.org/10.1016/j.ajhg.2012.01.009			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22405087	Green Published, Bronze			2022-12-18	WOS:000301762800018
J	Glessner, JT; Bradfield, JP; Wang, K; Takahashi, N; Zhang, HT; Sleiman, PM; Mentch, FD; Kim, CE; Hou, CP; Thomas, KA; Garris, ML; Deliard, S; Frackelton, EC; Otieno, FG; Zhao, JH; Chiavacci, RM; Li, MY; Buxbaum, JD; Berkowitz, RI; Hakonarson, H; Grant, SFA				Glessner, Joseph T.; Bradfield, Jonathan P.; Wang, Kai; Takahashi, Nagahide; Zhang, Haitao; Sleiman, Patrick M.; Mentch, Frank D.; Kim, Cecilia E.; Hou, Cuiping; Thomas, Kelly A.; Garris, Maria L.; Deliard, Sandra; Frackelton, Edward C.; Otieno, F. George; Zhao, Jianhua; Chiavacci, Rosetta M.; Li, Mingyao; Buxbaum, Joseph D.; Berkowitz, Robert I.; Hakonarson, Hakon; Grant, Struan F. A.			A Genome-wide Study Reveals Copy Number Variants Exclusive to Childhood Obesity Cases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LANGUAGE CHARACTERISTICS; FTO GENE; ADULT; CHILDREN; OVERWEIGHT; DELETIONS; SPEECH; IMPACT; LOCI; MASS	The prevalence of obesity in children and adults in the United States has increased dramatically over the past decade Genomic copy number variations (CNVs) have been strongly implicated in subjects with extreme obesity and coexisting developmental delay To complement these previous studies, we addressed CNVs in common childhood obesity by examining children with a BMI in the upper 5(th) percentile but excluding any subject greater than three standard deviations from the mean in order to reduce severe cases in the cohort We performed a whole genome CNV survey of our cohort of 1080 defined European American (EA) childhood obesity cases and 2500 lean controls (<50(th) percentile BMI) who were genotyped with 550,000 SNP markers Positive findings were evaluated in an independent African American (AA) cohort of 1479 childhood obesity cases and 1575 lean controls We identified 17 CNV loci that were unique to at least three EA cases and were both previously unreported in the public domain and validated via quantitative PCR Eight of these loci (47 1%) also replicated exclusively in AA cases (six deletions and two duplications) Replicated deletion loci consisted of EDIL3, S1PR5, FOXP2, TBCA ABCB5, and ZPLD1, whereas replicated duplication loci consisted of KIF2B and ARL15 We also observed evidence for a deletion at the 1 PHA6 UNQ6114 locus when the AA cohort was investigated as a discovery set Although these variants may be individually rare our results indicate that CNVs contribute to the genetic susceptibility of common childhood obesity in subjects of both European and African ancestry	[Glessner, Joseph T.; Bradfield, Jonathan P.; Wang, Kai; Zhang, Haitao; Sleiman, Patrick M.; Mentch, Frank D.; Kim, Cecilia E.; Hou, Cuiping; Thomas, Kelly A.; Garris, Maria L.; Frackelton, Edward C.; Otieno, F. George; Chiavacci, Rosetta M.; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Takahashi, Nagahide; Buxbaum, Joseph D.; Hakonarson, Hakon; Grant, Struan F. A.] Mt Sinai Sch Med, Lab Mol Neuropsychiat, Dept Psychiat, New York, NY 10029 USA; [Deliard, Sandra; Zhao, Jianhua] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Berkowitz, Robert I.] Childrens Hosp Philadelphia, Ctr Behav Hlth, Philadelphia, PA 19104 USA; [Berkowitz, Robert I.] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat, Philadelphia, PA 19104 USA; [Berkowitz, Robert I.] Univ Penn, Ctr Weight & Eating Disorders, Dept Psychiat, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; Grant, Struan F. A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA.		Deliard, Sandra/L-9356-2019; Buxbaum, Joseph D/G-6001-2010; Takahashi, Nagahide/AAR-6268-2020	Deliard, Sandra/0000-0003-0030-0989; Takahashi, Nagahide/0000-0002-7711-0297; Buxbaum, Joseph/0000-0001-8898-8313; Glessner, Joseph/0000-0001-5131-2811	Cotswold Foundation; NIH [1R01HD056465 01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056465] Funding Source: NIH RePORTER	Cotswold Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank all participating subjects and families We also thank Hope Thomas, Kisha Harden, Andrew Hill, Kenya Fain, Crystal Johnson Honesty, Alex Moy, Cynthia Drummond, Shanell Harrison, and Sarah Wildrick for their expert assistance with data collection and management Special thanks to Sman Kristinsson, Larus Arm Hermannsson and Asbjorn Krisbjornsson of Raforninn Ehf for their extensive software design and contribution This research was financially supported by the Children s Hospital of Philadelphia The study is supported in part by a Research Development Award from the Cotswold Foundation and NIH grant 1R01HD056465 01A1	Akefeldt A, 1997, J INTELL DISABIL RES, V41, P302, DOI 10.1111/j.1365-2788.1997.tb00713.x; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Farooqi IS, 2005, INT J OBESITY, V29, P1149, DOI 10.1038/sj.ijo.0803056; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Hebebrand J, 2003, Obes Rev, V4, P139; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; KLEPPE SA, 1990, J SPEECH HEAR DISORD, V55, P300, DOI 10.1044/jshd.5502.300; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyon HN, 2005, AM J CLIN NUTR, V82, p215S, DOI 10.1093/ajcn/82.1.215S; Must A, 2003, NUTR REV, V61, P139, DOI 10.1301/nr.2003.apr.139-142; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Troiano RP, 1998, PEDIATRICS, V101, P497; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2010, DIABETES, V59, P751, DOI 10.2337/db09-0972	30	70	72	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					661	666		10.1016/j.ajhg.2010.09.014	http://dx.doi.org/10.1016/j.ajhg.2010.09.014			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	20950786	Green Published, Bronze			2022-12-18	WOS:000284668400011
J	Medland, SE; Zayats, T; Glaser, B; Nyholt, DR; Gordon, SD; Wright, MJ; Montgomery, GW; Campbell, MJ; Henders, AK; Timpson, NJ; Peltonen, L; Wolke, D; Ring, SM; Deloukas, P; Martin, NG; Smith, GD; Evans, DM				Medland, Sarah E.; Zayats, Tetyana; Glaser, Beate; Nyholt, Dale R.; Gordon, Scott D.; Wright, Margaret J.; Montgomery, Grant W.; Campbell, Megan J.; Henders, Anjali K.; Timpson, Nicholas J.; Peltonen, Leena; Wolke, Dieter; Ring, Susan M.; Deloukas, Panos; Martin, Nicholas G.; Smith, George Davey; Evans, David M.			A Variant in LIN288 Is Associated with 2D:4D Finger-Length Ratio, a Putative Retrospective Biomarker of Prenatal Testosterone Exposure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							4TH DIGIT RATIO; GENOME-WIDE ASSOCIATION; SEXUAL ORIENTATION; 2ND; MENARCHE; 2D-4D; 2D/4D; AGE; HERITABILITY; POPULATION	The ratio of the lengths of an individual's second to fourth digit (2D:4D) is commonly used as a noninvasive retrospective biomarker for prenatal androgen exposure. In order to identify the genetic determinants of 20:40, we applied a genome-wide association approach to 1507 11-year-old children from the Avon Longitudinal Study of Parents and Children (ALSPAC) in whom 2D:4D ratio had been measured, as well as a sample of 1382 12- to 16-year-olds from the Brisbane Adolescent Twin Study. A meta-analysis of the two scans identified a single variant in the LIN28B gene that was strongly associated with 2D:4D (rs314277: p = 4.1 x 10(-8)) and was subsequently independently replicated in an additional 3659 children from the ALSPAC cohort (p = 1.53 x 10(-6)). The minor allele of the rs314277 variant has previously been linked to increased height and delayed age at menarche, but in our study it was associated with increased 20:4D in the direction opposite to that of previous reports on the correlation between 2D:4D and age at menarche. Our findings call into question the validity of 2D:4D as a simplistic retrospective biomarker for prenatal testosterone exposure.	[Zayats, Tetyana; Glaser, Beate; Timpson, Nicholas J.; Smith, George Davey; Evans, David M.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS82BN, Avon, England; [Medland, Sarah E.; Nyholt, Dale R.; Gordon, Scott D.; Wright, Margaret J.; Montgomery, Grant W.; Campbell, Megan J.; Henders, Anjali K.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Zayats, Tetyana; Glaser, Beate; Timpson, Nicholas J.; Ring, Susan M.; Smith, George Davey; Evans, David M.] Univ Bristol, Dept Social Med, Bristol BS82PS, Avon, England; [Peltonen, Leena; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Peltonen, Leena] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Med, FI-00290 Helsinki, Finland; [Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, FI-00271 Helsinki, Finland; [Peltonen, Leena] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Wolke, Dieter] Univ Warwick, Dept Psychol & Hlth Sci, Coventry CV4 7AL, W Midlands, England	University of Bristol; QIMR Berghofer Medical Research Institute; University of Bristol; Wellcome Trust Sanger Institute; University of Helsinki; Finland National Institute for Health & Welfare; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Warwick	Evans, DM (corresponding author), Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS82BN, Avon, England.	dave.evans@bristol.ac.uk	St Pourcain, Beate/K-8004-2017; Wright, Margaret Jane/A-4560-2016; Nyholt, Dale Robert/J-3174-2017; Medland, Sarah/AAT-7595-2020; Davey Smith, George/A-7407-2013; Medland, Sarah E/C-7630-2013; Fox, Laura J/C-6249-2016; Wolke, Dieter/C-5372-2008; Wright, Margaret J/H-3308-2014; Deloukas, Panos/B-2922-2013; Montgomery, Grant W/B-7148-2008; Attrill, Lauren/V-1688-2018; Evans, David M/H-6325-2013; Timpson, Nicholas John/O-7548-2015; Henders, Anjali/E-3126-2017	St Pourcain, Beate/0000-0002-4680-3517; Wright, Margaret Jane/0000-0001-7133-4970; Nyholt, Dale Robert/0000-0001-7159-3040; Medland, Sarah/0000-0003-1382-380X; Davey Smith, George/0000-0002-1407-8314; Medland, Sarah E/0000-0003-1382-380X; Wolke, Dieter/0000-0003-0304-268X; Deloukas, Panos/0000-0001-9251-070X; Montgomery, Grant W/0000-0002-4140-8139; Evans, David M/0000-0003-0663-4621; Timpson, Nicholas John/0000-0002-7141-9189; Henders, Anjali/0000-0003-3672-1451; s, hema/0000-0002-3440-9475; Campbell, Megan/0000-0002-6056-6140; Martin, Nicholas/0000-0003-4069-8020; Gordon, Scott/0000-0001-7623-328X; Venkatasubramanian, Siddharth/0000-0002-5860-0768	UK Medical Research Council; Wellcome Trust; University of Bristol; MRC [MRC 90600705, MRC G0800582]; Australian National Health and Medical Research Council (NHMRC) [241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, 552498]; Australian Research Council [A7960034, A79906588, A79801419, DP0212016, DP0343921]; Netherlands Scientific Organization (NWO) [480-05-003]; Medical Research Council [G0800582, G0600705, G9815508] Funding Source: researchfish; MRC [G0600705, G0800582] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are extremely grateful to all of the families who took part in the ALSPAC study, the midwives for their help in recruiting them, and the whole ALSPAC team. We thank John Manning for advice with the set up of the 2D:4D measurement, and we thank Jeremy Horwood and Andrea Waylen for help with implementation in the assessment clinics. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC and the MRC CAiTE (MRC 90600705). We thank the Sample Logistics and Genotyping facilities at the Wellcome Trust Sanger Institute for generating the ALSPAC genome-wide association data. D.M.E. and this work were supported by a Medical Research Council New Investigator Award (MRC G0800582 to D.M.E). We thank the twins and their families from the QIMR Brisbane Adolescent Twin Study for their participation; Dixie Statham, Ann Eldridge, Marlene Grace, and Kerrie McAloney for sample collection; Lisa Bowdler, Sara Smith, and Steven Crooks for DNA processing; and David Smyth, Harry Beeby, and Daniel Park for IT support.; We thank the Australian National Health and Medical Research Council (NHMRC; grants 241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, and 552498) and the Australian Research Council (A7960034, A79906588, A79801419, DP0212016, and DP0343921) for funding the QIMR Brisbane Adolescent Twin Study. Statistical analyses were carried out on the Genetic Cluster Computer, which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). S.E.M., D.R.N., and G.W.M. are supported by the NHMRC Fellowship Scheme.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bang AK, 2005, HUM REPROD, V20, P3109, DOI 10.1093/humrep/dei170; Collaer ML, 2007, ARCH SEX BEHAV, V36, P177, DOI 10.1007/s10508-006-9152-1; Ecker A, 1875, ARCH ANTHR, V8, P67; Gobrogge KL, 2008, ARCH SEX BEHAV, V37, P112, DOI 10.1007/s10508-007-9272-2; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Manning JT, 2003, MED HYPOTHESES, V61, P303, DOI 10.1016/S0306-9877(03)00184-1; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2000, MED HYPOTHESES, V54, P855, DOI 10.1054/mehy.1999.1150; Manning JT., 2002, DIGIT RATIO POINTER; Matchock RL, 2008, AM J HUM BIOL, V20, P487, DOI 10.1002/ajhb.20763; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; McIntyre MH, 2005, P ROY SOC B-BIOL SCI, V272, P1473, DOI 10.1098/rspb.2005.3100; MEDLAND S, AM J HUM GENET, V85, P750; Medland SE, 2008, TWIN RES HUM GENET, V11, P335, DOI 10.1375/twin.11.3.335; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahman Q, 2003, PSYCHONEUROENDOCRINO, V28, P288, DOI 10.1016/S0306-4530(02)00022-7; Stevenson JC, 2007, AM J HUM BIOL, V19, P41, DOI 10.1002/ajhb.20571; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Voracek M, 2007, PSYCHOL REP, V100, P115, DOI 10.2466/PR0.100.1.115-126; Voracek M, 2009, PSYCHOL REP, V104, P922, DOI 10.2466/PR0.104.3.922-956; WILSON GD, 1983, PERS INDIV DIFFER, V4, P111, DOI 10.1016/0191-8869(83)90061-2; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865	39	70	75	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					519	525		10.1016/j.ajhg.2010.02.017	http://dx.doi.org/10.1016/j.ajhg.2010.02.017			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20303062	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000276716800002
J	Iqbal, Z; Cejudo-Martin, P; de Brouwer, A; van der Zwaag, B; Ruiz-Lozano, P; Scimia, MC; Lindsey, JD; Weinreb, R; Albrecht, B; Megarbane, A; Alanay, Y; Ben-Neriah, Z; Amenduni, M; Artuso, R; Veltman, JA; van Beusekom, E; Oudakker, A; Millan, JL; Hennekam, R; Hamel, B; Courtneidge, SA; van Bokhoven, H				Iqbal, Zafar; Cejudo-Martin, Pilar; de Brouwer, Arjan; van der Zwaag, Bert; Ruiz-Lozano, Pilar; Scimia, M. Cecilia; Lindsey, James D.; Weinreb, Robert; Albrecht, Beate; Megarbane, Andre; Alanay, Yasemin; Ben-Neriah, Ziva; Amenduni, Mariangela; Artuso, Rosangela; Veltman, Joris A.; van Beusekom, Ellen; Oudakker, Astrid; Millan, Jose Luis; Hennekam, Raoul; Hamel, Ben; Courtneidge, Sara A.; van Bokhoven, Hans			Disruption of the Podosome Adaptor Protein TKS4 (SH3PXD2B) Causes the Skeletal Dysplasia, Eye, and Cardiac Abnormalities of Frank-Ter Haar Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MELNICK-NEEDLES SYNDROME; MOUSE; DELINEATION; ANOMALIES; INVASION	Frank-Ter Haar syndrome (FTHS), also known as Ter Haar syndrome, is an autosomal-recessive disorder characterized by skeletal, cardiovascular, and eye abnormalities, such as increased intraocular pressure, prominent eyes, and hypertelorism. We have conducted homozygosity mapping on patients representing 12 FTHS families. A locus on chromosome 5q35.1 was identified for which patients from nine families shared homozygosity. For one family, a homozygous deletion mapped exactly to the smallest region of overlapping homozygosity, which contains a single gene, SH3PXD2B. This gene encodes the TKS4 protein, a phox homology (PX) and Src homology 3 (SH3) domain-containing adaptor protein and Src substrate. This protein was recently shown to be involved in the formation of actin-rich membrane protrusions called podosomes or invadopodia, which coordinate pericellular proteolysis with cell migration. Mice lacking Tks4 also showed pronounced skeletal, eye, and cardiac abnormalities and phenocopied the majority of the defects associated with FTHS. These findings establish a role for TKS4 in FTHS and embryonic development. Mutation analysis revealed five different homozygous mutations in SH3PXD2B in seven FTHS families. No SH3PXD2B mutations were detected in six other FTHS families, demonstrating the genetic heterogeneity of this condition. Interestingly however, dermal fibroblasts from one of the individuals without all SH3PXD2B mutation nevertheless expressed lower levels of the TKS4 protein, Suggesting a common mechanism underlying disease causation.	[Cejudo-Martin, Pilar; Ruiz-Lozano, Pilar; Scimia, M. Cecilia; Millan, Jose Luis; Courtneidge, Sara A.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Iqbal, Zafar; de Brouwer, Arjan; Veltman, Joris A.; van Beusekom, Ellen; Oudakker, Astrid; Hamel, Ben; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet 855, NL-6500 HB Nijmegen, Netherlands; [Oudakker, Astrid; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci 126, NL-6500 HB Nijmegen, Netherlands; [van der Zwaag, Bert] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, NL-3584 EA Utrecht, Netherlands; [Lindsey, James D.; Weinreb, Robert] Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Albrecht, Beate] Univ Duisburg Essen, Univ Klinikum, Inst Humangenet, D-45122 Essen, Germany; [Megarbane, Andre] St Joseph Univ, Med Genet Unit, Beirut 11072180, Lebanon; [Alanay, Yasemin] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Genet Unit, TR-06100 Ankara, Turkey; [Ben-Neriah, Ziva] Hebrew Univ Jerusalem, Hadassah Med Ctr, Ctr Human Genet, IL-91120 Jerusalem, Israel; [Amenduni, Mariangela; Artuso, Rosangela] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Hennekam, Raoul] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Hennekam, Raoul] UCL, Great Ormond St Hosp Children, Inst Child Hlth, London WC1N 1EH, England	Sanford Burnham Prebys Medical Discovery Institute; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Diego; University of Duisburg Essen; Hacettepe University; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Siena; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Courtneidge, SA (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	courtneidge@burnham.org	Bokhoven, J.H.L.M. van van/H-8015-2014; de Brouwer, Arjan PM/P-5949-2015; Megarbane, Andre/ABD-5574-2021; Alanay, Yasemin/A-1516-2016; Veltman, Joris A/F-5128-2010; Iqbal, Zafar/J-8700-2015; van Bokhoven, Hans/D-8764-2012; van Beusekom, Ellen/AAF-2687-2019; Oudakker, Astrid/AAB-7890-2019; Artuso, Rosangela/AAB-9701-2019	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Alanay, Yasemin/0000-0003-0683-9731; Veltman, Joris A/0000-0002-3218-8250; Iqbal, Zafar/0000-0002-6387-8019; Artuso, Rosangela/0000-0001-9330-1360; Iqbal, Zafar/0000-0002-1334-6372	National Cancer Institute [CA098383]; Mathers Foundation; Comissionat per a Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa de la Generalitat de Catalunya; National Institutes of Health; California Institute of Regenerative Medicine; Higher Education Commission (HEC) of Pakistan; NATIONAL CANCER INSTITUTE [R01CA098383] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mathers Foundation; Comissionat per a Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa de la Generalitat de Catalunya(Generalitat de Catalunya); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the families for their cooperation in this study; Hulya Kayserili (Istanbul), Helen Stewart (London), Emma Wakeling (London), Valerie Cormier-Daire (Paris), and Charles Scott Jr. (Wilmington) for providing patient material; Ehud Banne for clinical investigations in family 13; Karen X. Duong-Polk for assistance with the experiments on the mouse eyes; Saskia van der Velde-Vissers and Christel Beumer for fibroblast culture; Irene Janssen for carrying out the SNP microarray analysis; and Jeroen Bakkers and Evelyn Kouwenhoven for animal studies and scientific discussion. This research in the Courtneidge laboratory was funded by the National Cancer Institute (CA098383) and the Mathers Foundation, and by Beatriu de Pinos fellowship support (Comissionat per a Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa de la Generalitat de Catalunya) to P.C.-M. P.R.-L. and J.L.M. are supported by the National Institutes of Health, and M.C.S. is a fellow of the California Institute of Regenerative Medicine. Z.I. was supported by a fellowship from the Higher Education Commission (HEC) of Pakistan. The authors declare no conflicting financial interests.	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P4314, DOI 10.1167/iovs.03-0137; Aihara M, 2002, INVEST OPHTH VIS SCI, V43, P146; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Dundar M, 2009, EUR J MED GENET, V52, P247, DOI 10.1016/j.ejmg.2009.03.005; FRANK Y, 1973, J GENET HUM, V21, P67; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; HAMEL BCJ, 1995, AM J MED GENET, V56, P312, DOI 10.1002/ajmg.1320560320; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Lindsey JD, 2002, INVEST OPHTH VIS SCI, V43, P2201; Maas SM, 2004, AM J MED GENET A, V131A, P127, DOI 10.1002/ajmg.a.30244; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Megarbane A, 1997, AM J MED GENET, V73, P67, DOI 10.1002/(SICI)1096-8628(19971128)73:1<67::AID-AJMG13>3.0.CO;2-P; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Rosser EM, 1996, CLIN DYSMORPHOL, V5, P105, DOI 10.1097/00019605-199604000-00002; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; Tello Celso, 2002, Semin Ophthalmol, V17, P69, DOI 10.1076/soph.17.2.69.14722; TERHAAR B, 1982, AM J MED GENET, V13, P469, DOI 10.1002/ajmg.1320130418; Wallerstein R, 1997, AM J MED GENET, V70, P267, DOI 10.1002/(SICI)1096-8628(19970613)70:3<267::AID-AJMG10>3.0.CO;2-J; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7	25	70	72	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					254	261		10.1016/j.ajhg.2010.01.009	http://dx.doi.org/10.1016/j.ajhg.2010.01.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137777	Bronze, Green Published			2022-12-18	WOS:000274637200015
J	Naumann, A; Hochstein, N; Weber, S; Fanning, E; Doerfler, W				Naumann, Anja; Hochstein, Norbert; Weber, Stefanie; Fanning, Ellen; Doerfler, Walter			A Distinct DNA-Methylation Boundary in the 5 '- Upstream Sequence of the FMR1 Promoter Binds Nuclear Proteins and Is Lost in Fragile X Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CGG REPEAT; GENE; CPG; REPLICATION; INSTABILITY; EXPRESSION; REGION; REVEALS; ORIGIN; LENGTH	We have discovered a distinct DNA-methylation boundary at a site between 650 and 800 nucleotides upstream of the CGG repeat in the first exon of the human FMR1 gene. This boundary, identified by bisulfite sequencing, is present in all human cell lines and cell types, irrespective of age, gender, and developmental stage. The same boundary is found also in different mouse tissues, although sequence homology between human and mouse in this region is only 46.7%. This boundary sequence, in both the unmethylated and the CpG-methylated modes, binds specifically to nuclear proteins from human cells. We interpret this boundary as carrying a specific chromatin structure that delineates a hypermethylated area in the genome from the unmethylated FMR1 promoter and protecting it from the spreading of DNA methylation. In individuals with the fragile X syndrome (FRAXA), the methylation boundary is lost; methylation has penetrated into the FMR1 promoter and inactivated the FMR1 gene. In one FRAXA genome, the upstream terminus of the methylation boundary region exhibits decreased methylation as compared to that of healthy individuals. This finding suggests changes in nucleotide sequence and chromatin structure in the boundary region of this FRAXA individual. In the completely de novo methylated FMR1 promoter, there are isolated unmethylated CpG dinucleotides that are, however, not found when the FMR1 promoter and upstream sequences are methylated in vitro with the bacterial M-SssI DNA methyltransferase. They may arise during de novo methylation only in DNA that is organized in chromatin and be due to the binding of specific proteins.	[Naumann, Anja; Hochstein, Norbert; Weber, Stefanie; Doerfler, Walter] Univ Erlangen Nurnberg, Sch Med, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Fanning, Ellen] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Doerfler, Walter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Erlangen Nuremberg; Vanderbilt University; Vanderbilt University; University of Cologne	Doerfler, W (corresponding author), Univ Erlangen Nurnberg, Sch Med, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.	walter.doerfler@viro.med.uni-erlangen.de			Fritz Thyssen Foundation; amaxa/LONZA GmbH; U.S. National Institutes of Health [GM52948]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948] Funding Source: NIH RePORTER	Fritz Thyssen Foundation; amaxa/LONZA GmbH; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the Institute for Virology of Erlangen University Medical School (EUMS) for their hospitality extended to W.D.'s Senior Research Group. We thank Cornelia Kraus, Institute of Human Genetics, EUMS, for PBMC DNA (14,451) from a FRAXA individual and the Department of Pediatrics, EUMS, for providing the human foreskin fibroblasts. This project was supported by the Fritz Thyssen Foundation and by amaxa/LONZA GmbH, both in Koln, Germany (to W.D.), and by U.S. National Institutes of Health grant GM52948 (to E.F.). The project was initiated during W.D.'s sabbatical stay (Deutscher Akademischer Austauschdienst) in E.F.'s laboratory at Vanderbilt University, Nashville, TN, USA.	ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Brylawski BP, 2007, EXP MOL PATHOL, V82, P190, DOI 10.1016/j.yexmp.2006.10.004; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cleaver JE, 2002, DNA REPAIR, V1, P41, DOI 10.1016/S1568-7864(01)00004-0; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; Doerfler W, 2008, EPIGENETICS-US, V3, P125, DOI 10.4161/epi.3.3.6249; Drouin R, 1997, HUM MOL GENET, V6, P2051, DOI 10.1093/hmg/6.12.2051; Edamura KN, 2005, AM J HUM GENET, V76, P302, DOI 10.1086/427928; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Fan SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001184; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Genc B, 2000, NUCLEIC ACIDS RES, V28, P2141, DOI 10.1093/nar/28.10.2141; Gray SJ, 2007, MOL CELL BIOL, V27, P426, DOI 10.1128/MCB.01382-06; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; Hochstein N, 2007, J VIROL, V81, P5349, DOI 10.1128/JVI.02624-06; HWU WL, 1993, BIOCHEM BIOPH RES CO, V193, P324, DOI 10.1006/bbrc.1993.1627; JOHNS MB, 1989, ANAL BIOCHEM, V180, P276, DOI 10.1016/0003-2697(89)90430-2; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; KOCHANEK S, 1990, P NATL ACAD SCI USA, V87, P8830, DOI 10.1073/pnas.87.22.8830; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; Munnes M, 1998, ONCOGENE, V17, P2573, DOI 10.1038/sj.onc.1202165; Naumann F, 2004, GENOMICS, V83, P106, DOI 10.1016/S0888-7543(03)00212-X; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pietrobono R, 2002, NUCLEIC ACIDS RES, V30, P3278, DOI 10.1093/nar/gkf434; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Razin A, 2005, PROG MOLEC, V38, P151; Remus R, 2005, INT J HEMATOL, V81, P385, DOI 10.1532/IJH97.04171; Schwemmle S, 1997, AM J HUM GENET, V60, P1354, DOI 10.1086/515456; SMEETS HJM, 1995, HUM MOL GENET, V4, P2103, DOI 10.1093/hmg/4.11.2103; SUTTER D, 1980, P NATL ACAD SCI-BIOL, V77, P253, DOI 10.1073/pnas.77.1.253; Tabolacci E, 2008, EUR J HUM GENET, V16, P1487, DOI 10.1038/ejhg.2008.130; Terracciano A, 2005, AM J MED GENET C, V137C, P32, DOI 10.1002/ajmg.c.30062; TOTH M, 1990, J MOL BIOL, V214, P673, DOI 10.1016/0022-2836(90)90285-T; VARDIMON L, 1980, NUCLEIC ACIDS RES, V8, P2461, DOI 10.1093/nar/8.11.2461; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; WOODCOCK DM, 1988, GENE, V74, P151, DOI 10.1016/0378-1119(88)90273-9	44	70	73	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					606	616		10.1016/j.ajhg.2009.09.018	http://dx.doi.org/10.1016/j.ajhg.2009.09.018			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19853235	Green Published, Bronze			2022-12-18	WOS:000271916500008
J	Crisponi, L; Crisponi, G; Meloni, A; Toliat, MR; Nurnberg, G; Usala, G; Uda, M; Masala, M; Hohne, W; Becker, C; Marongiu, M; Chiappe, F; Kleta, R; Rauch, A; Wollnik, B; Strasser, F; Reese, T; Jakobs, C; Kurlemann, G; Cao, A; Nurnberg, P; Rutsch, F				Crisponi, Laura; Crisponi, Giangiorgio; Meloni, Alessandra; Toliat, Mohammad Reza; Nuernberg, Gudrun; Usala, Gianluca; Uda, Manuela; Masala, Marco; Hoehne, Wolfgang; Becker, Christian; Marongiu, Mara; Chiappe, Francesca; Kleta, Robert; Rauch, Anita; Wollnik, Bernd; Strasser, Friedrich; Reese, Thomas; Jakobs, Cornelis; Kurlemann, Gerd; Cao, Antonio; Nuernberg, Peter; Rutsch, Frank			Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic to cold-induced sweating syndrome type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STUVE-WIEDEMANN-SYNDROME; MULTIPOINT LINKAGE ANALYSIS; SYMPATHETIC NEURONS; FACTOR-RECEPTOR; CNTF RECEPTOR; MICE LACKING; CYTOKINE; DISORDER; COMPLEX; PATIENT	Crisponi syndrome is a severe autosomal recessive condition that is phenotypically characterized by abnormal, paroxysmal muscular contractions resembling neonatal tetanus, large face, broad nose, anteverted nares, camptodactyly, hyperthermia, and sudden death in most cases. We performed homozygosity mapping in five Sardinian and three Turkish families with Crisponi syndrome, using high-density single-nucleotide polymorphism arrays, and identified a critical region on chromosome 19p12-13.1. The most prominent candidate gene was CRLF1, recently found to be involved in the pathogenesis of cold-induced sweating syndrome type 1 (CISS1). CISS1 belongs to a group of conditions with overlapping phenotypes, also including cold-induced sweating syndrome type 2 and Stuve-Wiedemann syndrome. All these syndromes are caused by mutations of genes of the ciliary neurotrophic factor ( CNTF) - receptor pathway. Here, we describe the identification of four different CRLF1 mutations in eight different Crisponi-affected families, including a missense mutation, a single-nucleotide insertion, and a nonsense and an insertion/deletion (indel) mutation, all segregating with the disease trait in the families. Comparison of the mutation spectra of Crisponi syndrome and CISS1 suggests that neither the type nor the location of the CRLF1 mutations points to a phenotype/genotype correlation that would account for the most severe phenotype in Crisponi syndrome. Other, still-unknown molecular factors may be responsible for the variable phenotypic expression of the CRLF1 mutations. We suggest that the syndromes can comprise a family of "CNTF-receptor - related disorders," of which Crisponi syndrome would be the newest member and allelic to CISS1.	Citta Univ Monserrato, CNR, Ist Neurogenet & Neurofarmacol, I-09042 Monserrato, Cagliari, Italy; Casa Cura SantAnna, Cagliari, Italy; Univ Cagliari, I-09124 Cagliari, Italy; Univ Cologne, Cologne Ctr Genom, D-5000 Cologne 41, Germany; Univ Cologne, Genet Inst, D-5000 Cologne 41, Germany; Univ Cologne, Ctr Mol Med Cologne, D-5000 Cologne 41, Germany; Univ Cologne, Inst Human Genet, D-5000 Cologne 41, Germany; Univ Med Berlin, Charite, RZPD Deutsch Ressourcenzentrum Genomforsch, Berlin, Germany; Univ Med Berlin, Charite, Inst Biochem, Berlin, Germany; Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; UCL, Royal Free Hosp, Ctr Nephrol, London, England; Mathias Spital, Klin Kinder & Jugendmed, Rheine, Germany; Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem & Pediat, Amsterdam, Netherlands; Univ Munster, Childrens Hosp, Dept Pediat Neurol, D-4400 Munster, Germany; Univ Munster, Childrens Hosp, Dept Gen Pediat, D-4400 Munster, Germany	Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Vrije Universiteit Amsterdam; University of Munster; University of Munster	Crisponi, L (corresponding author), Citta Univ Monserrato, CNR, Ist Neurogenet & Neurofarmacol, Str Statale 554 Bivio Sestu Km 4500, I-09042 Monserrato, Cagliari, Italy.	laura.crisponi@inn.cnr.it	Uda, Manuela/AAC-2645-2019; Rauch, Anita/C-5568-2014; Masala, Marco/Q-2748-2018; Crisponi, Laura/AAC-2642-2019; Wollnik, Bernd/GRY-6062-2022; Marongiu, Mara/H-9437-2019	Uda, Manuela/0000-0002-4890-6456; Rauch, Anita/0000-0003-2930-3163; Masala, Marco/0000-0001-5556-9964; Crisponi, Laura/0000-0001-9128-8537; Wollnik, Bernd/0000-0003-2589-0364; Marongiu, Mara/0000-0002-7321-2384				Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Accorsi P, 2003, AM J MED GENET A, V123A, P183, DOI 10.1002/ajmg.a.20292; Al-Gazali LI, 2003, CLIN DYSMORPHOL, V12, P1, DOI 10.1097/00019605-200301000-00001; Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Asmus SE, 2001, DEV BIOL, V235, P1, DOI 10.1006/dbio.2001.0282; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Cormier-Daire V, 1998, AM J MED GENET, V78, P146, DOI 10.1002/(SICI)1096-8628(19980630)78:2<146::AID-AJMG9>3.0.CO;2-M; Crisponi G, 1996, AM J MED GENET, V62, P365, DOI 10.1002/(SICI)1096-8628(19960424)62:4<365::AID-AJMG8>3.0.CO;2-Q; Dagoneau N, 2007, AM J HUM GENET, V80, P966, DOI 10.1086/513608; Dagoneau N, 2004, AM J HUM GENET, V74, P298, DOI 10.1086/381715; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Di Rocco M, 2003, AM J MED GENET A, V118A, P362, DOI 10.1002/ajmg.a.10242; Elson GCA, 1998, J IMMUNOL, V161, P1371; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hahn AF, 2006, J NEUROL SCI, V250, P62, DOI 10.1016/j.jns.2006.07.001; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; JENKINS D, IN PRESS AM J HUM GE; Knappskog PM, 2003, AM J HUM GENET, V72, P375, DOI 10.1086/346120; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Nannenberg EA, 2005, AM J MED GENET A, V133A, P90, DOI 10.1002/ajmg.a.30536; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; RUTSCH F, 2006, EUR J HUM GEN S, V14, P119; SOHAR E, 1978, LANCET, V2, P1073; Stanke M, 2006, DEVELOPMENT, V133, P141, DOI 10.1242/dev.02189; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488	32	70	72	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					971	981		10.1086/516843	http://dx.doi.org/10.1086/516843			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436252	Bronze, Green Published			2022-12-18	WOS:000245973200016
J	Valleix, S; Niel, F; Nedelec, B; Algros, MP; Schwartz, C; Delbosc, B; Delpech, M; Kantelip, B				Valleix, Sophie; Niel, Florence; Nedelec, Brigitte; Algros, Marie-Paule; Schwartz, Claire; Delbosc, Bernard; Delpech, Marc; Kantelip, Bernadette			Homozygous nonsense mutation in the FOXE3 gene as a cause of congenital primary aphakia in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANTERIOR SEGMENT; LENS DEVELOPMENT; HOMEOBOX GENE; FORKHEAD GENE; PAX6; EYE; DIFFERENTIATION; MICE; PROLIFERATION; EXPRESSION	Congenital primary aphakia (CPA) is a rare developmental disorder characterized by the absence of lens, the development of which is normally induced during the 4th-5th wk of human embryogenesis. This original failure leads, in turn, to complete aplasia of the anterior segment of the eye, which is the diagnostic histological criterion for CPA. So far, the genetic basis for this human condition has remained unclear. Here, we present the analysis of a consanguineous family with three siblings who had bilateral aphakia, microphthalmia, and complete agenesis of the ocular anterior segment. We show that a null mutation in the FOXE3 gene segregates and, in the homozygous state, produces the mutant phenotype in this family. Therefore, this study identifies-to our knowledge, for the first time-a causative gene for CPA in humans. Furthermore, it indicates a possible critical role for FOXE3 very early in the lens developmental program, perhaps earlier than any role recognized elsewhere for this gene.	Univ Paris 05, Fac Med Rene Descartes, Lab Biochim & Genet Mol, AP HP, Paris, France; INSERM, U567, Paris, France; Inst Cochin Genet Mol, Dept Genet & Dev, Paris, France; Ctr Hosp Univ Jean Minjoz, Anat Pathol Lab, Besancon, France; Ctr Hosp Univ Jean Minjoz, Serv Pediat 2, Besancon, France; Ctr Hosp Univ Jean Minjoz, Serv Ophtalmol, Besancon, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon	Valleix, S (corresponding author), Hop Cochin, Lab Biochim & Genet Mol, 123 Blvd Port Royal, F-75014 Paris, France.	sophie.valleix@cch.ap-hop-paris.fr	VALLEIX, Sophie/H-5048-2017; nedelec, brigitte/H-3002-2017	VALLEIX, Sophie/0000-0002-4812-7102; nedelec, brigitte/0000-0002-4487-9438				Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Barishak Y R, 1992, Dev Ophthalmol, V24, P1; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Blixt A, 2000, GENE DEV, V14, P245; Brownell I, 2000, GENESIS, V27, P81, DOI 10.1002/1526-968X(200006)27:2<81::AID-GENE50>3.0.CO;2-N; Dimanlig PV, 2001, DEVELOPMENT, V128, P4415; FitzPatrick DR, 2005, CURR OPIN GENET DEV, V15, P348, DOI 10.1016/j.gde.2005.04.013; Goudreau G, 2002, P NATL ACAD SCI USA, V99, P8719, DOI 10.1073/pnas.132195699; Gould DB, 2004, INT J DEV BIOL, V48, P1015, DOI 10.1387/ijdb.041865dg; GRAINGER RM, 1992, TRENDS GENET, V8, P349, DOI 10.1016/0168-9525(92)90280-H; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Graw J, 1999, PROG RETIN EYE RES, V18, P235, DOI 10.1016/S1350-9462(98)00018-4; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Honkanen RA, 2003, AM J OPHTHALMOL, V135, P368, DOI 10.1016/S0002-9394(02)02061-5; Hsieh YW, 2002, DEV BIOL, V248, P265, DOI 10.1006/dbio.2002.0732; Hyer J, 2003, DEV BIOL, V259, P351, DOI 10.1016/S0012-1606(03)00205-7; Kamachi Y, 2001, GENE DEV, V15, P1272, DOI 10.1101/gad.887101; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Lehmann OJ, 2003, INVEST OPHTH VIS SCI, V44, P2627, DOI 10.1167/iovs.02-0609; MANSCHOT W, 1963, ARCH OPHTHALMOL-CHIC, V69, P551; Medina-Martinez O, 2005, MOL CELL BIOL, V25, P8854, DOI 10.1128/MCB.25.20.8854-8863.2005; Ormestad M, 2002, INVEST OPHTH VIS SCI, V43, P1350; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Semina EV, 2001, HUM MOL GENET, V10, P231, DOI 10.1093/hmg/10.3.231; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4	29	70	71	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					358	364		10.1086/505654	http://dx.doi.org/10.1086/505654			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826526	Green Published, Bronze			2022-12-18	WOS:000239040400017
J	Dawson, K; Seeman, P; Sebald, E; King, L; Edwards, M; Williams, J; Mundlos, S; Krakow, D				Dawson, K; Seeman, P; Sebald, E; King, L; Edwards, M; Williams, J; Mundlos, S; Krakow, D			GDF5 is a second locus for multiple-synostosis syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRACHYDACTYLY TYPE-C; GENE-ENCODING NOGGIN; TGF-BETA-SUPERFAMILY; MISSENSE MUTATION; JOINT FORMATION; CDMP1; MORPHOGENESIS; BONE; CHONDRODYSPLASIA; SYMPHALANGISM	Multiple-synostosis syndrome is an autosomal dominant disorder characterized by progressive symphalangism, carpal/tarsal fusions, deafness, and mild facial dysmorphism. Heterozygosity for functional null mutations in the NOGGIN gene has been shown to be responsible for the disorder. However, in a cohort of six probands with multiple-synostosis syndrome, only one was found to be heterozygous for a NOGGIN mutation ( W205X). Linkage studies involving the four-generation family of one of the mutation-negative patients excluded the NOGGIN locus, providing genetic evidence of locus heterogeneity. In this family, polymorphic markers flanking the GDF5 locus were found to cosegregate with the disease, and sequence analysis demonstrated that affected individuals in the family were heterozygous for a novel missense mutation that predicts an R438L substitution in the GDF5 protein. Unlike mutations that lead to haploinsufficiency for GDF5 and produce brachydactyly C, the protein encoded by the multiple-synostosis-syndrome allele was secreted as a mature GDF5 dimer. These data establish locus heterogeneity in multiple-synostosis syndrome and demonstrate that the disorder can result from mutations in either the NOGGIN or the GDF5 gene.	Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; Calif State Univ Los Angeles, David Geffen Sch Med, Los Angeles, CA 90032 USA; Univ Newcastle, Hunter Area Hlth Serv, Waratah, Australia; Kaiser Permanente, Oakland, CA USA; Univ Med Berlin, Charite, Inst Med Genet, Berlin, Germany; Max Planck Inst Mol Genet, Berlin, Germany	Cedars Sinai Medical Center; Cedars Sinai Medical Center; California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Newcastle; Kaiser Permanente; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Krakow, D (corresponding author), Cedars Sinai Med Ctr, Dept Obstet & Gynecol, 8700 Beverly Blvd,SSB 369, Los Angeles, CA 90048 USA.	Deborah.krakow@cshs.org	Mundlos, Stefan/ABH-9585-2020; Seemann, Petra/G-3606-2011; Edwards, Matthew/A-7560-2011; Edwards, Matthew/L-8698-2019	Seemann, Petra/0000-0002-6056-6669; Edwards, Matthew/0000-0001-8437-8120; Edwards, Matthew/0000-0001-8437-8120; Mundlos, Stefan/0000-0002-9788-3166	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000425, M01-RR00425] Funding Source: Medline; NICHD NIH HHS [HD22657, P01 HD022657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akarsu AN, 1999, AM J HUM GENET, V65, pA281; Brown DJ, 2002, AM J HUM GENET, V71, P618, DOI 10.1086/342067; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Everman DB, 2002, AM J MED GENET, V112, P291, DOI 10.1002/ajmg.10777; Faiyaz-Ul-Haque M, 2002, AM J MED GENET, V111, P31, DOI 10.1002/ajmg.10501; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; KJAER KW, 2005, J MED GENET; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Mangino M, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9016.abs; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Schwabe GC, 2004, AM J MED GENET A, V124A, P356, DOI 10.1002/ajmg.a.20349; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Takahashi T, 2001, CLIN GENET, V60, P447, DOI 10.1034/j.1399-0004.2001.600607.x; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Wang Wanshan, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P212; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	23	70	77	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					708	712		10.1086/503204	http://dx.doi.org/10.1086/503204			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532400	Green Published, Bronze			2022-12-18	WOS:000236755900016
J	Greenberg, DA; Cayanis, E; Strug, L; Marathe, S; Durner, M; Pal, DK; Alvin, GB; Klotz, I; Dicker, E; Shinnar, S; Bromfield, EB; Resor, S; Cohen, J; Moshe, SL; Harden, C; Kang, H				Greenberg, DA; Cayanis, E; Strug, L; Marathe, S; Durner, M; Pal, DK; Alvin, GB; Klotz, I; Dicker, E; Shinnar, S; Bromfield, EB; Resor, S; Cohen, J; Moshe, SL; Harden, C; Kang, H			Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE MYOCLONIC EPILEPSY; PYRUVATE CARBOXYLATION; GENE; MUTATION; LINKAGE; CHANNEL; HETEROGENEITY; INHERITANCE; FAMILIES; LOCUS	Idiopathic generalized epilepsy (IGE) is a class of genetically determined, phenotypically related epilepsy syndromes. Linkage analysis identified a chromosome 18 locus predisposing to a number of adolescent-onset IGEs. We report a single-nucleotide polymorphism ( SNP) association analysis of the region around the marker locus with the high LOD score. This analysis, which used both case-control and family-based association methods, yielded strong evidence that malic enzyme 2 (ME2) is the gene predisposing to IGE. We also observed association among subgroups of IGE syndromes. An ME2-centered nine-SNP haplotype, when present homozygously, increases the risk for IGE ( odds ratio 6.1; 95% confidence interval 2.9 - 12.7) compared with any other genotype. Both the linkage analysis and the association analysis support recessive inheritance for the locus, which is compatible with the fact that ME2 is an enzyme. ME2 is a genome-coded mitochondrial enzyme that converts malate to pyruvate and is involved in neuronal synthesis of the neurotransmitter gamma-aminobutyric acid (GABA). The results suggest that GABA synthesis disruption predisposes to common IGE and that clinical seizures are triggered when mutations at other genes, or perhaps other insults, are present.	Columbia Univ, Genome Ctr, Div Stat Genet, New York, NY USA; Columbia Univ, Genome Ctr, Dept Psychiat, New York, NY USA; Columbia Univ, Genome Ctr, Dept Neurol, New York, NY USA; Monash Med Ctr, Dept Neurol, Clayton, Vic, Australia; Monash Med Ctr, Dept Pediat, Clayton, Vic, Australia; Albert Einstein Coll Med, Dept Neurol, Bronx, NY USA; Beth Israel Deaconess Med Ctr, Dept Neurol, New York, NY 10003 USA; NY Hosp Cornell, Dept Neurol, New York, NY USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Columbia University; Columbia University; Columbia University; Monash University; Monash University; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Greenberg, DA (corresponding author), Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Biostat,Div Stat Genet, 6th Floor,722 W 168th St, New York, NY 10032 USA.	dag2005@columbia.edu		Moshe, Solomon/0000-0001-9427-9476; Strug, Lisa/0000-0003-0503-9740	NIDDK NIH HHS [R01 DK031775, DK 31775] Funding Source: Medline; NIMH NIH HHS [R01 MH048858, MH 48858] Funding Source: Medline; NINDS NIH HHS [R01 NS027941, NS 279841, R01 NS037466, NS 37466] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037466] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; ANNEGERS JF, 1994, NEUROL CLIN, V12, P15, DOI 10.1016/S0733-8619(18)30108-7; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BECKMANNAGETTA G, 1991, EPILEPSY RES, P105; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Durner M, 1999, AM J HUM GENET, V64, P1411, DOI 10.1086/302371; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; Durner M, 2001, ANN NEUROL, V49, P328, DOI 10.1002/ana.69.abs; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; GREENBERG DA, 1994, AM J HUM GENET, V55, P834; GREENBERG DA, 1988, GENET EPIDEMIOL, V5, P81, DOI 10.1002/gepi.1370050204; GREENBERG DA, 1992, NEUROLOGY, V42, P56; GREENBERG DA, 1995, NEUROLOGY, V45, P942, DOI 10.1212/WNL.45.5.942; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Hassel B, 2001, J NEUROSCI RES, V66, P755, DOI 10.1002/jnr.10044; Hassel B, 2000, J NEUROSCI, V20, P1342; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; McKenna MC, 2000, NEUROCHEM INT, V36, P451, DOI 10.1016/S0197-0186(99)00148-5; MELDRUM B, 1982, CLIN NEUROPHARMACOL, V5, P293, DOI 10.1097/00002826-198205030-00004; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109	29	70	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					139	146		10.1086/426735	http://dx.doi.org/10.1086/426735			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15532013	Green Published, Bronze			2022-12-18	WOS:000225643600012
J	Seielstad, M; Yuldasheva, N; Singh, N; Underhill, P; Oefner, P; Shen, PD; Wells, RS				Seielstad, M; Yuldasheva, N; Singh, N; Underhill, P; Oefner, P; Shen, PD; Wells, RS			A novel Y-chromosome variant puts an upper limit on the timing of first entry into the Americas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MUTATIONS; HISTORY; AGE		Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Headington, England; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Wellcome Centre for Human Genetics; Stanford University; Stanford University	Seielstad, M (corresponding author), Genome Inst Singapore, 1 Sci Pk Rd,05-01 Capricorn, Singapore 117528, Singapore.		Seielstad, Mark/T-7841-2019; Yuldasheva, Nadira Yusupovna/GXM-9013-2022	Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Seielstad, Mark/0000-0001-5783-1401				Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Dillehay T., 2000, SETTLEMENT AM NEW PR; Ellis N, 2002, GENOME RES, V12, P339; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098	16	70	78	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					700	705		10.1086/377589	http://dx.doi.org/10.1086/377589			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12929085	Green Published, Bronze			2022-12-18	WOS:000185134000026
J	Olson, JM; Goddard, KAB; Dudek, DM				Olson, JM; Goddard, KAB; Dudek, DM			A second locus for very-late-onset Alzheimer disease: A genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTATIN-C GENE; HEREDITARY CEREBRAL-HEMORRHAGE; DUTCH TYPE; BETA-PROTEIN; CATHEPSIN-S; HCHWA-D; ASSOCIATION; POLYMORPHISM; BRAIN; CHROMOSOME-10	We used a covariate-based linkage method to reanalyze genome scan data from affected sibships collected by the Alzheimer Disease (AD) Genetics Initiative of the National Institute of Mental Health. As reported in an earlier article, the amyloid-beta precursor protein (APP) region is strongly linked to affected sib pairs of the oldest current age (i.e., age either at last exam or at death) who lack E4 alleles at the apolipoprotein E (ApoE) locus. We now report that a region on 20p shows the same pattern. A model that includes current age and the number of E2 alleles as covariates gives a LOD score of 4.1. The signal on 20p is near the location of the gene coding for cystatin-C, previously shown to be associated with late-onset AD and to codeposit with APP in the brains of patients with AD. Two-locus analysis provides evidence of strong epistasis between 20p and the APP region, limited to the oldest age group and to those lacking ApoE4 alleles. We speculate that high-risk polymorphisms in both regions produce a biological interaction between these two proteins that increases susceptibility to a very-late-onset form of AD.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Olson, JM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, 2500 MetroHlth Drive,R258,MetroHlth Campus, Cleveland, OH 44109 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001577, R01HG001577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046373, U01MH046281, U01MH046290] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHGRI NIH HHS [HG01577, R01 HG001577, R29 HG001577] Funding Source: Medline; NIMH NIH HHS [U01 MH046373, U01 MH046290, U01 MH046281] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Beyer K, 2001, NEUROSCI LETT, V315, P17, DOI 10.1016/S0304-3940(01)02307-2; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Bornebroek M, 1996, BRAIN PATHOL, V6, P111, DOI 10.1111/j.1750-3639.1996.tb00793.x; Collins JS, 2000, AM J MED GENET, V96, P823, DOI 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO;2-I; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford FC, 2000, NEUROLOGY, V55, P763, DOI 10.1212/WNL.55.6.763; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; LEMERE CA, 1995, AM J PATHOL, V146, P848; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MaatSchieman MLC, 1996, BRAIN PATHOL, V6, P115, DOI 10.1111/j.1750-3639.1996.tb00794.x; Maruyama H, 2001, NEUROLOGY, V57, P337, DOI 10.1212/WNL.57.2.337; MUNGER JS, 1995, BIOCHEM J, V311, P299, DOI 10.1042/bj3110299; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Olson JM, 2001, AM J HUM GENET, V69, P895, DOI 10.1086/323472; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; PARFITT M, 1993, NEUROSCI LETT, V154, P81, DOI 10.1016/0304-3940(93)90176-L; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; PRELLI F, 1988, BIOCHEM BIOPH RES CO, V151, P1150, DOI 10.1016/S0006-291X(88)80486-8; RISCH N, 1990, AM J HUM GENET, V46, P222; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Steinhoff T, 2001, NEUROBIOL DIS, V8, P647, DOI 10.1006/nbdi.2001.0412; VINTERS HV, 1990, AM J PATHOL, V137, P233; Wei LH, 1998, J BIOL CHEM, V273, P11806, DOI 10.1074/jbc.273.19.11806; Whittemore AS, 1998, AM J HUM GENET, V62, P1228, DOI 10.1086/301820	33	70	72	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					154	161		10.1086/341034	http://dx.doi.org/10.1086/341034			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12016588	Green Published, Bronze			2022-12-18	WOS:000176307700015
J	Derbeneva, OA; Starikovskaya, EB; Wallace, DC; Sukernik, RI				Derbeneva, OA; Starikovskaya, EB; Wallace, DC; Sukernik, RI			Traces of early Eurasians in the Mansi of northwest Siberia revealed by mitochondrial DNA analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINEAGES; REGION; EUROPE	The mitochondrial DNA (mtDNA) of 98 Mansi, an ancient group (formerly known as "Vogul") of Uralic-speaking fishers and hunters on the eastern slope of the northern Ural Mountains, were analyzed for sequence variants by restriction fragment-length polymorphism analysis, control-region sequencing, and sequencing of additional informative sites in the coding region. Although 63.3% of the mtDNA detected in the Mansi falls into western Eurasian lineages (e. g., haplogroups UK, TJ, and HV), the remaining 36.7% encompass a subset of eastern Eurasian lineages (e. g., haplogroups A, C, D, F, G, and M). Among the western Eurasian lineages, subhaplogroup U4 was found at a remarkable frequency of 16.3%, along with lineages U5, U7, and J2. This suggests that the aboriginal populations residing immediately to the east of the Ural Mountains may encompass remnants of the early Upper Paleolithic expansion from the Middle East/southeastern Europe. The added presence of eastern Eurasian mtDNA lineages in the Mansi introduces the possibilities that proto-Eurasians encompassed a range of macrohaplogroup M and N lineages that subsequently became geographically distributed and that the Paleolithic expansion may have reached this part of Siberia before it split into western and eastern human groups.	Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Lab Human Mol Genet, Novosibirsk 630090, Russia; Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Emory University	Sukernik, RI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Lab Human Mol Genet, 10 Lavrentev Ave, Novosibirsk 630090, Russia.		Starikovskaya, Elena/N-5636-2015; Sukernik, Rem I/N-6990-2015		FIC NIH HHS [TW 1175] Funding Source: Medline; NHLBI NIH HHS [HL 64017] Funding Source: Medline; NIA NIH HHS [R01 AG013154, AG 13154] Funding Source: Medline; NINDS NIH HHS [R01 NS041850, NS 21328, R01 NS021328, NS 41850] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS041850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; FEDOROVA EG, 1994, ENCY WORLD CULTURES, V6, P252; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malyarchuk B. A., 2001, Genetika, V37, P1411; Meinila M, 2001, HUM HERED, V52, P160, DOI 10.1159/000053372; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485	14	70	72	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1009	1014		10.1086/339524	http://dx.doi.org/10.1086/339524			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11845409	Green Published, Bronze			2022-12-18	WOS:000174252100018
J	Chinnery, PF; Taylor, GA; Howell, N; Brown, DT; Parsons, TJ; Turnbull, DM				Chinnery, PF; Taylor, GA; Howell, N; Brown, DT; Parsons, TJ; Turnbull, DM			Point mutations of the mtDNA control region in normal and neurodegenerative human brains	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; SEQUENCE	Recent observations in cultured human fibroblasts suggest that the accumulation of point mutations in the noncoding control region of mtDNA may be important in human aging. We studied the mtDNA control region in brain tissue from 31 normal elderly individuals, from 35 individuals who had Alzheimer disease, and from 47 individuals who had dementia with Lewy bodies. We found no evidence that these somatic mtDNA point mutations accumulate either in the brains of normal elderly individuals or in the brains of individuals with neurodegenerative disease.	Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; MRC, Dev Ctr Clin Brain Aging, Newcastle Upon Tyne, Tyne & Wear, England; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA; Armed Forces DNA Identificat Lab, Rockville, MD USA	Newcastle University - UK; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@newcastle.ac.uk		Chinnery, Patrick/0000-0002-7065-6617				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Fahy E, 1997, NUCLEIC ACIDS RES, V25, P3102, DOI 10.1093/nar/25.15.3102; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Pennisi E, 1999, SCIENCE, V286, P664, DOI 10.1126/science.286.5440.664; PERRY R, 1996, DEMENTIA LEWY BODIES	11	70	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					529	532		10.1086/318204	http://dx.doi.org/10.1086/318204			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133363	Green Published, Bronze			2022-12-18	WOS:000166524800025
J	Pattison, L; Crow, YJ; Deeble, VJ; Jackson, AP; Jafri, H; Rashid, Y; Roberts, E; Woods, CG				Pattison, L; Crow, YJ; Deeble, VJ; Jackson, AP; Jafri, H; Rashid, Y; Roberts, E; Woods, CG			A fifth locus for primary autosomal recessive microcephaly maps to chromosome 1q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS	Primary microcephaly is a genetic disorder in which an affected individual has a head circumference >3 SDs below the age- and sex-related mean. A small but apparently normally formed brain is the reason for the reduced head circumference, and, probably because of this, all affected individuals are mentally retarded. The condition is genetically heterogeneous, and four loci have already been identified. We now report a fifth locus, MCPH5, which is an 8-cM region mapping to chromosome 1q31, defined by the markers GATA135F02 and D1S1678.	St Jamess Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Genetech Labs, Lahore, Pakistan; Rawalpindi Med Coll, Rawalpindi, Pakistan	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; National University of Sciences & Technology - Pakistan; Rawalpindi Medical College	Woods, CG (corresponding author), St Jamess Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England.		woods, christopher g/A-1361-2010; Jackson, Andrew P/D-3442-2009; Crow, Yanick J/N-6120-2014	Jackson, Andrew P/0000-0002-8739-2646; Crow, Yanick J/0000-0001-7211-7564	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; PEREZCASTILLO A, 1984, HUM GENET, V67, P230, DOI 10.1007/BF00273009; QAZI QH, 1975, CLIN GENET, V7, P85; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Ross JJ, 1977, HDB CLIN NEUROLOGY, V30, P507; SCHINZEL A, 1994, HUMAN CYTOGENETICS D	10	70	71	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1578	1580		10.1086/316910	http://dx.doi.org/10.1086/316910			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078481	Green Published, Bronze			2022-12-18	WOS:000165607600023
J	Xu, X; Weiss, S; Xu, XP; Wei, LJ				Xu, X; Weiss, S; Xu, XP; Wei, LJ			A unified Haseman-Elston method for testing linkage with quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB	The Haseman and Elston (H-E) method uses a simple linear regression to model the squared trait difference of sib pairs with the shared allele identical by descent (IBD) at marker locus for linkage testing. Under this setting, the squared mean-corrected trait sum is also linearly related to the IBD sharing. However, the resulting slope estimate for either model is not efficient. In this report, we propose a simple linkage test that optimally uses information from the estimates of both models. We also demonstrate that the new test is more powerful than both the traditional one and the recently revisited H-E methods.	Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Xu, X (corresponding author), Harvard Univ, Sch Publ Hlth, Program Populat Genet, 665 Huntington Ave,FXB-103, Boston, MA 02115 USA.		Xu, Xin/A-1687-2016; Wei, Lee-Jen/CAI-0175-2022	Xu, Xin/0000-0002-6324-5211; 				Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hettmansperger TP, 1984, STAT INFERENCE BASED; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Rao C.R., 1965, LINEAR STAT INFERENC; WEI LJ, 1985, BIOMETRIKA, V72, P359; Wright FA, 1997, AM J HUM GENET, V60, P740	10	70	71	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1025	1028		10.1086/303081	http://dx.doi.org/10.1086/303081			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10961909	Green Published, Bronze			2022-12-18	WOS:000089651100029
J	Yoshihashi, H; Maeyama, K; Kosaki, R; Ogata, T; Tsukahara, M; Goto, Y; Hata, J; Matsuo, N; Smith, RJ; Kosaki, K				Yoshihashi, H; Maeyama, K; Kosaki, R; Ogata, T; Tsukahara, M; Goto, Y; Hata, J; Matsuo, N; Smith, RJ; Kosaki, K			Imprinting of human GRB10 and its mutations in two patients with Russell-Silver syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHYLATION-SPECIFIC PCR; DISTAL LONG ARM; I RECEPTOR GENE; RING CHROMOSOME-15; UNIPARENTAL DISOMY-7; GROWTH-RETARDATION; HUMAN PEG1/MEST; PROTEIN GRB10; INSULIN; DELETION	Documentation of maternal uniparental disomy of chromosome 7 in 10% of patients with Russell-Silver syndrome (RSS), characterized by prenatal and postnatal growth retardation and dysmorphic features, has suggested the presence of an imprinted gene on chromosome 7 whose mutation is responsible for the RSS phenotype, Human GRB10 on chromosome 7, a homologue of the mouse imprinted gene Grb10, is a candidate, because GRB10 has a suppressive effect on growth, through its interaction with either the IGF-I receptor or the GH receptor, and two patients with RSS were shown to have a maternally derived duplication of 7p11-p13, encompassing GRB10. In the present study, we first demonstrated that the GRB10 gene is also monoallelically expressed in human fetal brain tissues and is transcribed from the maternally derived allele in somatic-cell hybrids. Hence, human GRB10 is imprinted. A mutation analysis of GRB10 in 58 unrelated patients with RSS identified, within the N-terminal domain of the protein, a P95S substitution in two patients with RSS. In these two cases, the mutant allele was inherited from the mother. The fact that monoallelic GRB10 expression was observed from the maternal allele in this study suggests but does not prove that these maternally transmitted mutant alleles contribute to the RSS phenotype.	Keio Univ, Sch Med, Dept Pediat, Div Med Genet,Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Pharmacia Upjohn Fund Growth & Dev Res, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Ctr Hlth, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan; Yamaguchi Univ, Sch Allied Hlth Sci, Ube, Yamaguchi 755, Japan; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	Keio University; Keio University; Keio University; Keio University; National Center for Neurology & Psychiatry - Japan; Yamaguchi University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kosaki, K (corresponding author), Keio Univ, Sch Med, Dept Pediat, Div Med Genet,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.		Kosaki, Kenjiro/K-5350-2013	Ogata, Tsutomu/0000-0001-7178-9991				Angrist M, 1998, ONCOGENE, V17, P3065, DOI 10.1038/sj.onc.1202226; Bernstein BS, 1999, POW ENGN SER, V7, P87; BUTLER MG, 1988, AM J MED GENET, V29, P149, DOI 10.1002/ajmg.1320290119; Cattanach BM, 1998, CYTOGENET CELL GENET, V80, P41, DOI 10.1159/000014955; CHRISTENSEN MF, 1978, ACTA PAEDIATR SCAND, V67, P101, DOI 10.1111/j.1651-2227.1978.tb16284.x; DUNCAN PA, 1990, AM J MED GENET, V35, P245, DOI 10.1002/ajmg.1320350220; Eggermann T, 1998, J MED GENET, V35, P784, DOI 10.1136/jmg.35.9.784; Eggermann T, 1997, HUM GENET, V100, P415, DOI 10.1007/s004390050526; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jerome CA, 1997, GENOMICS, V40, P215, DOI 10.1006/geno.1996.4535; Joyce CA, 1999, HUM GENET, V105, P273, DOI 10.1007/s004390051101; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; Kosaki K, 1997, AM J MED GENET, V73, P308; Kosaki K, 2000, AM J HUM GENET, V66, P309, DOI 10.1086/302712; KOSAKI K, IN PRESS J MED GENET; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; MIDRO AT, 1993, CLIN GENET, V44, P53; Miyoshi N, 1998, P NATL ACAD SCI USA, V95, P1102, DOI 10.1073/pnas.95.3.1102; Monk D, 2000, AM J HUM GENET, V66, P36, DOI 10.1086/302717; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Moutoussamy S, 1998, J BIOL CHEM, V273, P15906, DOI 10.1074/jbc.273.26.15906; ONeill TJ, 1996, J BIOL CHEM, V271, P22506, DOI 10.1074/jbc.271.37.22506; OOI J, 1995, ONCOGENE, V10, P1621; Pan YZ, 1998, AM J HUM GENET, V62, P1551, DOI 10.1086/301857; PEOPLES R, 1995, CYTOGENET CELL GENET, V70, P228, DOI 10.1159/000134040; Preece MA, 1997, J MED GENET, V34, P6, DOI 10.1136/jmg.34.1.6; Price SM, 1999, J MED GENET, V36, P837; RAMIREZDUENAS ML, 1992, CLIN GENET, V41, P51; Riesewijk AM, 1998, EUR J HUM GENET, V6, P114, DOI 10.1038/sj.ejhg.5200164; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; ROBACK EW, 1991, AM J MED GENET, V38, P74, DOI 10.1002/ajmg.1320380117; ROBICHAUX V, 1981, ARCH PATHOL LAB MED, V105, P157; Rogan PK, 1996, AM J MED GENET, V62, P10, DOI 10.1002/(SICI)1096-8628(19960301)62:1<10::AID-AJMG3>3.3.CO;2-5; RUSSELL A, 1954, P ROY SOC MED, V47, P1040; Schinzel A A, 1994, Clin Dysmorphol, V3, P63; SIEBLER T, 1995, J CLIN ENDOCR METAB, V80, P3447, DOI 10.1210/jc.80.12.3447; SILVER H, 1953, PEDIATRICS, V12, P356; Stanhope R, 1998, HORM RES, V49, P37, DOI 10.1159/000053086; Tamura T, 1993, Clin Dysmorphol, V2, P106; Teebi A S, 1992, Clin Dysmorphol, V1, P151; Wagner TMU, 1999, HUM MOL GENET, V8, P413, DOI 10.1093/hmg/8.3.413; Wakeling EL, 1998, HORM RES, V49, P32, DOI 10.1159/000053085; Wang J, 1999, MOL CELL BIOL, V19, P6217; WILSON GN, 1985, J MED GENET, V22, P233, DOI 10.1136/jmg.22.3.233; Wojcik J, 1999, BIOCHEM BIOPH RES CO, V259, P113, DOI 10.1006/bbrc.1999.0727; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805	51	70	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					476	482		10.1086/302997	http://dx.doi.org/10.1086/302997			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10856193	Green Published, Bronze			2022-12-18	WOS:000089357800021
J	Karet, FE; Finberg, KE; Nayir, A; Bakkaloglu, A; Ozen, S; Hulton, SA; Sanjad, SA; Al-Sabban, EA; Medina, JF; Lifton, RP				Karet, FE; Finberg, KE; Nayir, A; Bakkaloglu, A; Ozen, S; Hulton, SA; Sanjad, SA; Al-Sabban, EA; Medina, JF; Lifton, RP			Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VACUOLAR H+-ATPASE; INTERCALATED CELLS; MUTATIONS; EXCHANGER; CHILDREN; ACIDIFICATION; DOMINANT; SUBUNIT; BAND-3; DNA	Failure of distal nephrons to excrete excess acid results in the "distal renal tubular acidoses" (dRTA). Early childhood features of autosomal recessive dRTA include severe metabolic acidosis with inappropriately alkaline urine, poor growth, rickets, and renal calcification. Progressive bilateral sensorineural hearing loss (SNHL) is evident in approximately one-third of patients. We have recently identified mutations in ATP6B1, encoding the B-subunit of the collecting-duct apical proton pump, as a cause of recessive dRTA with SNHL. We now report the results of genetic analysis of 13 kindreds with recessive dRTA and normal hearing. Analysis of linkage and molecular examination of ATP6B1 indicated that mutation in ATP6B1 rarely, if ever, accounts for this phenotype, prompting a genomewide linkage search for loci underlying this trait. The results strongly supported linkage with locus heterogeneity to a segment of 7q33-34, yielding a maximum multipoint LOD score of 8.84 with 68% of kindreds linked. The LOD-3 support interval defines a 14-cM region flanked by D7S500 and D7S688. That 4 of these 13 kindreds do not support linkage to rdRTA2 and ATP6B1 implies the existence of at least one additional dRTA locus. These findings establish that genes causing recessive dRTA with normal and impaired hearing are different, and they identify, at 7q33-34, a new locus, rdRTA2, for recessive dRTA with normal hearing.	Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Univ Istanbul, Dept Pediat Nephrol, Istanbul, Turkey; Hacettepe Univ, Dept Pediat Nephrol, Ankara, Turkey; Birmingham Childrens Hosp, Dept Nephrol, Birmingham, W Midlands, England; Amer Univ Beirut, Med Ctr, Dept Pediat, Beirut, Lebanon; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; Univ Navarra, Dept Med, E-31080 Pamplona, Spain; Univ Navarra, Liver Unit, E-31080 Pamplona, Spain	University of Cambridge; Howard Hughes Medical Institute; Yale University; Yale University; Istanbul University; Hacettepe University; University of Birmingham; American University of Beirut; King Faisal Specialist Hospital & Research Center; University of Navarra; University of Navarra	Karet, FE (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Room 4-2,Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.		NAYIR, AHMET NEVZAT/A-9276-2019; OZEN, SEZA/I-9096-2013	Karet, Fiona/0000-0002-2457-2869	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALPERN RJ, 1996, BRENNER RECTORS KIDN, P408; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; Butler AM, 1936, J PEDIATR-US, V8, P489, DOI 10.1016/S0022-3476(36)80111-5; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; Karet FE, 1998, P NATL ACAD SCI USA, V95, P6337, DOI 10.1073/pnas.95.11.6337; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KURTZMAN NA, 1990, KIDNEY INT, V38, P720, DOI 10.1038/ki.1990.264; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lightwood R., 1935, ARCH DIS CHILD, V10, P205, DOI [10.1136/adc.10.57.205, DOI 10.1136/ADC.10.57.205]; MCSHERRY E, 1978, J CLIN INVEST, V61, P509, DOI 10.1172/JCI108962; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Ott J., 1991, ANAL HUMAN GENETIC L; PALUMBO AP, 1986, AM J HUM GENET, V39, P307; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Silver RB, 1997, J EXP ZOOL, V279, P443; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Tanphaichitr VS, 1998, J CLIN INVEST, V102, P2173, DOI 10.1172/JCI4836; ZAKZOUK SM, 1995, J LARYNGOL OTOL, V109, P930, DOI 10.1017/S0022215100131706	22	70	73	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1656	1665		10.1086/302679	http://dx.doi.org/10.1086/302679			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577919	Green Published, Bronze			2022-12-18	WOS:000084282500020
J	Fitze, G; Schreiber, M; Kuhlisch, E; Schackert, HK; Roesner, D				Fitze, G; Schreiber, M; Kuhlisch, E; Schackert, HK; Roesner, D			Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TYROSINE KINASE DOMAIN; NEOPLASIA TYPE 2B; SPORADIC TUMORS; MUTATIONS; ACTIVATION; RECEPTOR; FMTC; GENE; CANCER; MEN2A		Dresden Univ Technol, Dept Pediat Surg, D-01307 Dresden, Germany; Dresden Univ Technol, Dept Surg Res, D-01307 Dresden, Germany; Dresden Univ Technol, Inst Med Informat & Biometry, D-01307 Dresden, Germany; Univ Erlangen Nurnberg, Dept Pediat Surg, D-8520 Erlangen, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; University of Erlangen Nuremberg	Fitze, G (corresponding author), Dresden Univ Technol, Dept Pediat Surg, Fetscherstr 74, D-01307 Dresden, Germany.							ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; BADNER JA, 1990, AM J HUM GENET, V46, P568; BOLINO A, 1995, ONCOGENE, V10, P2415; Borrego S, 1998, J CLIN ENDOCR METAB, V83, P3361, DOI 10.1210/jc.83.9.3361; Borrello MG, 1995, ONCOGENE, V11, P2419; BUGALHO MJM, 1994, HUM MOL GENET, V3, P2263, DOI 10.1093/hmg/3.12.2263-a; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; CECCHERINI I, 1994, ONCOGENE, V9, P3025; Ceccherini I, 1997, ONCOGENE, V14, P2609, DOI 10.1038/sj.onc.1201079; Chappuis-Flament S, 1998, ONCOGENE, V17, P2851, DOI 10.1038/sj.onc.1202202; Cosma MP, 1998, MOL CELL BIOL, V18, P3321, DOI 10.1128/MCB.18.6.3321; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; EDERY P, 1994, HUM GENET, V94, P579; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; Eng C, 1997, HUM MUTAT, V9, P97, DOI 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.3.CO;2-Q; Gimm O, 1999, ONCOGENE, V18, P1369, DOI 10.1038/sj.onc.1202418; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P407, DOI 10.1093/oxfordjournals.jbchem.a123594; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; MARTUCCIELLO G, 1992, PEDIATR SURG INT, V7, P308; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; Pasini A, 1997, ONCOGENE, V15, P393, DOI 10.1038/sj.onc.1201199; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Seri M, 1997, HUM MUTAT, V9, P243; [No title captured]	30	70	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1469	1473		10.1086/302618	http://dx.doi.org/10.1086/302618			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521317	Green Published, Bronze			2022-12-18	WOS:000083531000033
J	Kniazeva, M; Chiang, MF; Morgan, B; Anduze, AL; Zack, DJ; Han, M; Zhang, K				Kniazeva, M; Chiang, MF; Morgan, B; Anduze, AL; Zack, DJ; Han, M; Zhang, K			A new locus for autosomal dominant Stargardt-like disease maps to chromosome 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONE-ROD DYSTROPHY; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; FUNDUS-FLAVIMACULATUS; GENETIC-LINKAGE; HOMEOBOX GENE; ABCR; PHOTORECEPTOR; MUTATIONS; PROTEINS	Stargardt disease (STGD) is the most common hereditary macular dystrophy and is characterized by decreased central vision, atrophy of the macula and underlying retinal-pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD is most commonly inherited as an autosomal recessive trait, but many families have been described in which features of the disease are transmitted in an autosomal dominant manner. A recessive locus has been identified on chromosome 1p (STGD1), and dominant loci have been mapped to both chromosome 13q (STGD2) and chromosome 6q (STGD3). In this study we describe a kindred with an autosomal dominant Stargardt-like phenotype. A genomewide search demonstrated linkage to a locus on chromosome 4p, with a maximum LOD scare of 5.12 at a recombination fraction of .00, for marker D4S403. Analysis of extended haplotypes localized the disease gene to an similar to 12-cM interval between loci D4S1582 and D4S2397. Therefore, this kindred establishes a new dominant Stargardt-like locus, STGD4.	Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Isl Med Ctr, St Croix, VI USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Kniazeva, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Campus Box 347, Boulder, CO 80309 USA.		Kniazeva, Marina/D-4085-2012; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697; Zack, Don/0000-0002-7966-1973				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; CIBIS GW, 1980, ARCH OPHTHALMOL-CHIC, V98, P1785; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dryja T. P., 1998, SCIENCE, V279; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; FISH G, 1981, BRIT J OPHTHALMOL, V65, P359, DOI 10.1136/bjo.65.5.359; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; HADDEN OB, 1976, AM J OPHTHALMOL, V82, P527, DOI 10.1016/0002-9394(76)90539-0; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; KALVER CCW, 1998, SCIENCE, V279, P1107; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; Kelsell RE, 1997, HUM MOL GENET, V6, P597, DOI 10.1093/hmg/6.4.597; Kojima M, 1996, NEUROSCI LETT, V205, P215, DOI 10.1016/0304-3940(96)12406-X; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOPEZ PF, 1990, OPHTHALMOLOGY, V97, P798; MANSOUR AM, 1992, OPHTHALMOLOGICA, V205, P138, DOI 10.1159/000310329; MORTON NE, 1955, AM J HUM GENET, V7, P277; NOBLE KG, 1979, ARCH OPHTHALMOL-CHIC, V97, P1281; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; REBBE NF, 1989, J BIOL CHEM, V264, P15006; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Small KW, 1996, AM J OPHTHALMOL, V121, P13, DOI 10.1016/S0002-9394(14)70529-X; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; van Driel MA, 1998, OPHTHALMIC GENET, V19, P117, DOI 10.1076/opge.19.3.117.2187; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035	35	70	74	2	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1394	1399		10.1086/302377	http://dx.doi.org/10.1086/302377			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205271	Green Published, Bronze			2022-12-18	WOS:000080093000018
J	Santorelli, FM; Tanji, K; Manta, P; Casali, C; Krishna, S; Hays, AP; Mancini, DM; DiMauro, S; Hirano, M				Santorelli, FM; Tanji, K; Manta, P; Casali, C; Krishna, S; Hays, AP; Mancini, DM; DiMauro, S; Hirano, M			Maternally inherited cardiomyopathy: An atypical presentation of the mtDNA 12S rRNA gene A1555G mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR-BASIS; DISEASE		Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ La Sapienza, Ist Clin Malattie Nervose & Mentali, Rome, Italy; Childrens Hosp, Dept Mol Med, Rome, Italy	Columbia University; Columbia University; Columbia University; Sapienza University Rome	Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.		Santorelli, Filippo M/ABE-5124-2020	Santorelli, Filippo M/0000-0002-1359-9062; Hirano, Michio/0000-0002-7070-7402	Telethon [844] Funding Source: Medline	Telethon(Fondazione Telethon)		AFIFI AK, 1965, NEUROLOGY, V15, P371, DOI 10.1212/WNL.15.4.371; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; DiMauro S, 1997, MOL GENETIC BASIS NE, P201; ENGEL AG, 1971, MAYO CLIN PROC, V46, P666; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; FANANAPAZIR L, 1993, P NATL ACAD SCI USA, V90, P3993, DOI 10.1073/pnas.90.9.3993; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; KELLY DP, 1994, NEW ENGL J MED, V330, P913; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Santorelli FM, 1996, AM J HUM GENET, V58, P933; Shoffner J. M., 1996, Neurology, V46, pA331; SHOFFNER JM, 1995, METABOLIC MOL BASES, P1535	14	70	75	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					295	300		10.1086/302188	http://dx.doi.org/10.1086/302188			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915970	Bronze, Green Published			2022-12-18	WOS:000078477400036
J	Vieland, VJ				Vieland, VJ			Bayesian linkage analysis, or: How I learned to stop worrying and love the posterior probability of linkage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORES; ASCERTAINMENT		Univ Iowa, Coll Med, Dept Prevent Med, Div Biostat & Psychiat, Iowa City, IA 52240 USA; Univ Iowa, Coll Med, Dept Environm Hlth, Div Biostat & Psychiat, Iowa City, IA 52240 USA	University of Iowa; University of Iowa	Vieland, VJ (corresponding author), Univ Iowa, Coll Med, Dept Prevent Med, Div Biostat & Psychiat, Iowa City, IA 52240 USA.	veronica-vieland@uiowa.edu			PHS HHS [KO2 01432, R01 52841] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Edwards A.W.F, 1972, LIKELIHOOD; EDWARDS W, 1963, P 3 BERK S MATH STAT; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; Elston RC, 1997, AM J HUM GENET, V60, P255; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; ELSTON RC, 1994, GENETIC APPROACHES M; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; Feller W., 1968, INTRO PROBABILITY TH, V1; GENIN E, 1995, ANN HUM GENET, V59, P123, DOI 10.1111/j.1469-1809.1995.tb01610.x; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Greenberg DA, 1998, AM J HUM GENET, V62, P202, DOI 10.1086/301690; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hacking I., 1965, LOGIC STAT INFERENCE; HAUSER ER, 1993, AM J HUM GENET, V53, P1012; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; MORTON NE, 1955, AM J HUM GENET, V7, P277; Royall R.M., 1997, STAT EVIDENCE LIKELI; Schaid DJ, 1998, AM J HUM GENET, V63, P935, DOI 10.1086/302077; SMITH CAB, 1976, ANN HUM GENET, V39, P423, DOI 10.1111/j.1469-1809.1976.tb00146.x; SMITH CAB, 1959, AM J HUM GENET, V11, P289; STUART A., 1987, KENDALLS ADV THEORY; SUAREZ BK, 1994, GENETIC APPROACHES M; Thomas DC, 1997, GENET EPIDEMIOL, V14, P903, DOI 10.1002/(SICI)1098-2272(1997)14:6<903::AID-GEPI57>3.0.CO;2-Q; Vieland VJ, 1996, AM J HUM GENET, V58, P1072	27	70	70	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					947	954		10.1086/302076	http://dx.doi.org/10.1086/302076			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758634	Green Published, Bronze			2022-12-18	WOS:000076577800005
J	Webster, AR; Richards, FM; MacRonald, FE; Moore, AT; Maher, ER				Webster, AR; Richards, FM; MacRonald, FE; Moore, AT; Maher, ER			An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: Evidence for modifier effects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; CENTRAL-NERVOUS-SYSTEM; GERMLINE MUTATIONS; RENAL-CARCINOMA; VHL GENE; SOMATIC MUTATIONS; CYP2D6 GENES; LUNG-CANCER; SUSCEPTIBILITY; LOCUS	von Hippel-Lindau disease (VHL) is a dominantly inherited familial cancer syndrome predisposing to ocular and CNS hemangioblastomas, renal-cell carcinoma (RCC), and pheochromocytoma. Both interfamilial and intrafamilial variability in expression is well recognized. Interfamilial differences in pheochromocytoma susceptibility have been attributed to allelic heterogeneity such that specific missense germ-line mutations confer a high risk for this complication. However, in most cases, tumor susceptibility does not appear to be influenced by the type of underlying VHL mutation. To probe the causes of phenotypic variation, we examined 183 individuals with germ-line VHL gene mutations, for the presence and number of ocular tumors. The prevalence of ocular angiomatosis did not increase with age, and the distribution of these tumors in gene carriers was significantly different than the expected stochastic distributions. Individuals with ocular hemangioblastomas had a significantly increased incidence of cerebellar hemangioblastoma and RCC (hazard ratios 2.3 and 4.0, respectively). The number of ocular tumors was significantly correlated in individuals of 1/2 degree relatedness but not in more distantly related individuals. These findings suggest that the development of VHL ocular tumors is determined at an early age and is influenced by genetic and/or environmental modifier effects that act at multiple sites. Functional polymorphisms in the glutathione-S-transferase M1 gene (GSTM1) or the cytochrome P450 2D6 gene (CYP2D6) did not show a significant association with the severity of ocular or renal involvement.	Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Addenbrookes Hosp, Dept Ophthalmol, Cambridge, England	University of Birmingham; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Maher, ER (corresponding author), Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.	ermaher@hgmp.mrc.ac.uk	McRonald, Fiona/B-4005-2009; MAHER, EAMONN R/A-9507-2008	MAHER, EAMONN R/0000-0002-6226-6918; McRonald, Fiona/0000-0001-7226-9461				Agundez JAG, 1996, PHARMACOGENETICS, V6, P501; AGUNDEZ JAG, 1995, LANCET, V345, P830, DOI 10.1016/S0140-6736(95)92965-7; BRAUCH H, 1995, HUM GENET, V95, P551, DOI 10.1007/BF00223868; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; CROSSEY PA, 1994, HUM GENET, V93, P53; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; DALY AK, 1993, BRIT MED J, V307, P481, DOI 10.1136/bmj.307.6902.481; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; EASTON DF, 1993, AM J HUM GENET, V53, P305; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gould KA, 1996, GENETICS, V144, P1769; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HIRVONEN A, 1993, ENVIRON HEALTH PERSP, V101, P109, DOI 10.2307/3431709; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KANNO H, 1994, CANCER RES, V54, P4845; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MAHER ER, 1990, Q J MED, V77, P1151, DOI 10.1093/qjmed/77.2.1151; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maher ER, 1996, J MED GENET, V33, P328, DOI 10.1136/jmg.33.4.328; Oberstrass J, 1996, J PATHOL, V179, P151, DOI 10.1002/(SICI)1096-9896(199606)179:2<151::AID-PATH556>3.0.CO;2-0; Phelan CM, 1996, NAT GENET, V12, P309, DOI 10.1038/ng0396-309; Prowse AH, 1997, AM J HUM GENET, V60, P765; RAUNIO H, 1995, GENE, V159, P113, DOI 10.1016/0378-1119(94)00448-2; RICHARDS FM, 1995, HUM MOL GENET, V4, P2139, DOI 10.1093/hmg/4.11.2139; Richards FM, 1996, HUM MOL GENET, V5, P639, DOI 10.1093/hmg/5.5.639; RICHARDS FM, 1994, HUM MOL GENET, V3, P595, DOI 10.1093/hmg/3.4.595; Sachse C, 1997, AM J HUM GENET, V60, P284; SMITH CAD, 1992, ENVIRON HEALTH PERSP, V98, P107, DOI 10.2307/3431255; WHALEY JM, 1994, AM J HUM GENET, V55, P1092; WOLF CR, 1994, BRIT MED BULL, V50, P718, DOI 10.1093/oxfordjournals.bmb.a072920; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.3.CO;2-9; ZHONG S, 1993, CARCINOGENESIS, V14, P1821, DOI 10.1093/carcin/14.9.1821; ZHONG S, 1991, CARCINOGENESIS, V12, P1533, DOI 10.1093/carcin/12.9.1533	36	70	71	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1025	1035		10.1086/302037	http://dx.doi.org/10.1086/302037			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758595	Bronze, Green Published			2022-12-18	WOS:000076577800015
J	Weiler, T; Greenberg, CR; Zelinski, T; Nylen, E; Coghlan, G; Crumley, MJ; Fujiwara, TM; Morgan, K; Wrogemann, K				Weiler, T; Greenberg, CR; Zelinski, T; Nylen, E; Coghlan, G; Crumley, MJ; Fujiwara, TM; Morgan, K; Wrogemann, K			A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: Evidence for another limb-girdle muscular dystrophy locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; BETA-SARCOGLYCAN; MISSENSE MUTATIONS; FRIEDREICH ATAXIA; DNA; DISEQUILIBRIUM; HETEROGENEITY; COMPUTATIONS; LOCALIZATION; HAPLOTYPES	Characterized by proximal muscle weakness and wasting, limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of clinical disorders. Previous reports have documented either autosomal dominant or autosomal recessive modes of inheritance, with genetic linkage studies providing evidence for the existence of at least 12 distinct loci. Gene products have been identified for five genes responsible for autosomal recessive forms of the disorder. We performed a genome scan using pooled DNA from a large Hutterite kindred in which the affected members display a mild form of autosomal recessive LGMD. A total of 200 markers were used to screen pools of DNA from patients and their siblings. Linkage between the LGMD locus and D9S302 (maximum LOD score 5.99 at recombination fraction .03) was established. Since this marker resides within the chromosomal region known to harbor the gene causing Fukuyama congenital muscular dystrophy (FCMD), we expanded our investigations, to include additional markers in chromosome region 9q31-q34.1. Haplotype analysis revealed five recombinations that place the LGMD locus distal to the FCMD locus. The LGMD locus maps close to D9S934 (maximum multipoint LOD score 7.61) in a region that is estimated to be similar to 4.4 Mb (Genetic Location Database composite map). On the basis of an inferred ancestral recombination, the gene may lie in a 300-kb region between D9S302 and D9S934. Our results provide compelling evidence that yet another gene is involved in LGMD; we suggest that it be named "LGMD2H.".	Univ Manitoba, Dept Biochem & Mol Biol, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Human Genet, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3E 0W3, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Montreal Gen Hosp, Res Inst, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ, Canada	University of Manitoba; University of Manitoba; University of Manitoba; McGill University; McGill University; McGill University; McGill University	Wrogemann, K (corresponding author), Univ Manitoba, Dept Biochem & Mol Biol, 770 Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada.		Weiler, Tracey A/D-6646-2017	Weiler, Tracey A/0000-0003-4662-4495				BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; Bonnemann CG, 1996, HUM MOL GENET, V5, P1953, DOI 10.1093/hmg/5.12.1953; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P71, DOI 10.1016/0960-8966(93)E0006-G; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; FUJIWARA TM, 1989, AM J HUM GENET, V44, P327; GREENBERG CR, 1987, AM J HUM GENET, V41, P128; KondoIida E, 1997, HUM GENET, V99, P427, DOI 10.1007/s004390050384; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MARBOIS BN, 1994, ARCH BIOCHEM BIOPHYS, V313, P83, DOI 10.1006/abbi.1994.1362; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; McNally EM, 1997, AM J HUM GENET, V61, pA29; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Miyake M, 1997, GENOMICS, V40, P284, DOI 10.1006/geno.1996.4584; Moreira ES, 1997, AM J HUM GENET, V61, P151, DOI 10.1086/513889; MULLERSEITZ M, 1993, GENOMICS, V18, P559, DOI 10.1016/S0888-7543(05)80356-8; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PassosBueno MR, 1996, HUM MOL GENET, V5, P815, DOI 10.1093/hmg/5.6.815; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; RODIUS F, 1994, AM J HUM GENET, V54, P1050; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; SHOKEIR MHK, 1976, CLIN GENET, V9, P197; Sirlin J. L., 1956, Journal of Genetics, V54, P42, DOI 10.1007/BF02981700; SIRLIN J. L., 1957, HEREDITY, V11, P259, DOI 10.1038/hdy.1957.21; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SPEER MC, 1992, AM J HUM GENET, V50, P1211; SPEER MC, 1995, AM J HUM GENET, V57, P1371; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; Toda T, 1996, AM J HUM GENET, V59, P1313; TODA T, 1994, AM J HUM GENET, V55, P946; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weiler T, 1997, AM J MED GENET, V72, P363, DOI 10.1002/(SICI)1096-8628(19971031)72:3<363::AID-AJMG22>3.0.CO;2-Q; ZELINSKI T, 1991, TRANSFUSION, V31, P762, DOI 10.1046/j.1537-2995.1991.31892023506.x	50	70	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					140	147		10.1086/301925	http://dx.doi.org/10.1086/301925			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634523	Bronze, Green Published			2022-12-18	WOS:000074761000021
J	Heinecke, JW; Lusis, AJ				Heinecke, JW; Lusis, AJ			Paraoxonase-gene polymorphisms associated with coronary heart disease: Support for the oxidative damage hypothesis?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HUMAN SERUM PARAOXONASE; LOW-DENSITY-LIPOPROTEIN; ARTERY DISEASE; ATHEROGENESIS; ANTIOXIDANTS; HUMPONA; RISK		Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Heinecke, JW (corresponding author), Div Atherosclerosis Nutr & Lipid Res, Box 8046,660 S Euclid Ave, St Louis, MO 63110 USA.	heinecke@im.wustl.edu						AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Antikainen M, 1996, J CLIN INVEST, V98, P883, DOI 10.1172/JCI118869; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; Garin MCB, 1997, J CLIN INVEST, V99, P62, DOI 10.1172/JCI119134; GARIN MCB, 1994, BIOCHEM J, V304, P549, DOI 10.1042/bj3040549; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; Heinecke JW, 1997, CURR OPIN LIPIDOL, V8, P268, DOI 10.1097/00041433-199710000-00005; Herrmann SM, 1996, ATHEROSCLEROSIS, V126, P299, DOI 10.1016/0021-9150(96)05917-5; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Lusis AJ, 1998, TXB CARDIOVASCULAR M, P2389; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; MACKNESS MI, 1991, ATHEROSCLEROSIS, V86, P193, DOI 10.1016/0021-9150(91)90215-O; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Odawara M, 1997, J CLIN ENDOCR METAB, V82, P2257, DOI 10.1210/jc.82.7.2257; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; Serrato M, 1995, J CLIN INVEST, V96, P3005, DOI 10.1172/JCI118373; Shih DM, 1996, J CLIN INVEST, V97, P1630, DOI 10.1172/JCI118589; STEINBERG D, 1995, LANCET, V346, P36, DOI 10.1016/S0140-6736(95)92657-7; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Suehiro T, 1996, INT J CARDIOL, V57, P69, DOI 10.1016/S0167-5273(96)02779-9; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359	26	70	74	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					20	24		10.1086/301691	http://dx.doi.org/10.1086/301691			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443884	Green Published, Bronze			2022-12-18	WOS:000072127900005
J	Fink, JM; Dobyns, WB; Guerrini, R; Hirsch, BA				Fink, JM; Dobyns, WB; Guerrini, R; Hirsch, BA			Identification of a duplication of Xq28 associated with bilateral periventricular nodular heterotopia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOOTH DISEASE TYPE-1A; FLUORESCENCE INSITU HYBRIDIZATION; CORTICAL DEVELOPMENT; NEURONAL MIGRATION; GENE; MALFORMATIONS; MUTATIONS; EPILEPSY; HYDROCEPHALUS; SPECTRUM	Bilateral periventricular nodular heterotopia (BPNH) is a malformation of neuronal migration and is characterized by nodules of heterotopic gray matter lining the lateral ventricles of the brain. The majority of BPNH patients are female and have epilepsy as a sole clinical manifestation of their disease. Familial BPNH has been mapped to Xq28 by linkage analysis. A multiple congenital anomaly-mental retardation syndrome (BPNH/MR) was recently delineated in three unrelated boys with BPNH, cerebellar hypoplasia, severe mental retardation, epilepsy, and syndactyly. High-resolution chromosome analysis revealed a subtle abnormality of Xq28 in one of the boys with BPNH/MR syndrome. FISH with cosmids and YACs from Xq28 further characterized this abnormality as a 2.25-3.25-Mb inverted duplication. No abnormality of Xq28 was detected by G-banding or FISH in the other two boys. These data support the linkage assignment of BPNH to band Xq28 and narrow the critical region to the distal 2.25-3.25 Mb of Xq28.	UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT NEUROL & PEDIAT, MINNEAPOLIS, MN 55455 USA; UNIV PISA, FDN STELLA MARIS, DIV CLIN NEUROPSICHIAT INFANTILE, PISA, ITALY	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; IRCCS Fondazione Stella Maris; University of Pisa			Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; Guerrini, Renzo/0000-0002-7272-7079				Auricchio A, 1996, AM J HUM GENET, V58, P743; BARKOVICH AJ, 1992, RADIOLOGY, V182, P493, DOI 10.1148/radiology.182.2.1732969; Barkovich AJ, 1996, NEUROPEDIATRICS, V27, P59, DOI 10.1055/s-2007-973750; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; DOBYNS WB, IN PRESS NEUROLOGY; DUBEAU F, 1995, BRAIN, V118, P1273, DOI 10.1093/brain/118.5.1273; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Gustashow KM, 1991, ACT CYTOGENETICS LAB, P205; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HUTTENLOCHER PR, 1994, NEUROLOGY, V44, P51, DOI 10.1212/WNL.44.1.51; KAMURO K, 1993, BRAIN DEV-JPN, V15, P237, DOI 10.1016/0387-7604(93)90073-H; KOOB M, 1992, METHOD ENZYMOL, V216, P13; LAHN BT, 1994, NAT GENET, V8, P243, DOI 10.1038/ng1194-243; LAWCE HJ, 1991, ACT CYTOGENETICS LAB, P31; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; NEZELOF C, 1976, ANN ANAT PATHOL, V21, P401; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; RAYMOND AA, 1994, J NEUROL NEUROSUR PS, V57, P1195, DOI 10.1136/jnnp.57.10.1195; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; SCHRANDERSTUMPEL C, 1995, AM J MED GENET, V57, P107, DOI 10.1002/ajmg.1320570122; Sidman R. L., 1982, HISTOL HISTOPATHOL, P3; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TRASK BJ, 1991, AM J HUM GENET, V48, P1; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WARD DC, 1995, HUMAN CHROMOSOMES PR, P184; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; [No title captured]	35	70	70	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					379	387		10.1086/514863	http://dx.doi.org/10.1086/514863			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311743	Green Published, Bronze			2022-12-18	WOS:A1997XX70100016
J	Meyer, JM; Han, JF; Singh, R; Moxley, G				Meyer, JM; Han, JF; Singh, R; Moxley, G			Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMUNOGLOBULIN-KAPPA; OLIGONUCLEOTIDE PROBES; ISRAELI JEWS; CONFERS RISK; MASC METHOD; SUSCEPTIBILITY; ASSOCIATION; HLA-DR4; ALLELES; HYPOTHESIS	The association between rheumatoid arthritis (RA) and HLA DRB1 alleles may arise through linkage disequilibrium with a disease locus or the direct involvement of HLA alleles in RA. In support of the latter possibility, the shared-epitope hypothesis has been postulated, stating that conformationally similar DR beta chains encoded by several DRB1 alleles confer disease susceptibility. To examine these alternative hypotheses of marker-disease association and to investigate gender differences in RA susceptibility, we analyzed the distributions of PCR-based DRB1 genotypes of 309 Caucasian RA patients and 283 Caucasian controls. Initially, the marker-association-segregation chi(2) method was used to evaluate evidence for linkage disequilibrium and the direct involvement of markers DR4 Dw4, DR4 Dw14, and DR1 in RA susceptibility. Additional shared-epitope models that grouped DRB1 alleles into five classes (*0401, *0404/*0102, *0405/*0408/*0101, *1001, and all others) and postulated relationships between genotypes and RA susceptibility were also fitted to observed genotypic distributions by the method of minimal chi(2) For females, a linkage-disequilibrium model provided a good fit to the data, as did a shared-epitope model with RA most penetrant among individuals with the *0401,*0401 genotype. For males, the best model indicated highest RA penetrance among shared-epitope compound heterozygotes. Clinically, male RA patients had more subcutaneous nodules and greater use of slowly acting antirheumatic drugs, while female RA patients had earlier disease onset. This study therefore suggests that sex-related factors influence the RA penetrance associated with DRB1 shared-epitope genotypes and that DRB1 effects on RA prognosis and pathogenesis should be considered separately for men and women.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,DIV RHEUMATOL ALLERGY & IMMUNOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED,DIV RHEUMATOL ALLERGY & IMMUNOL,RICHMOND,VA 23298; MCGUIRE VET AFFAIRS MED CTR,RICHMOND,VA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048148] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-48148] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BIDWELL J, 1988, IMMUNOL TODAY, V9, P18, DOI 10.1016/0167-5699(88)91351-5; BIDWELL JL, 1986, MOL IMMUNOL, V23, P1111, DOI 10.1016/0161-5890(86)90009-X; BOKI KA, 1992, ARTHRITIS RHEUM, V35, P749, DOI 10.1002/art.1780350706; CARTHY D, 1993, EUR J IMMUNOGENET, V20, P391, DOI 10.1111/j.1744-313X.1993.tb00158.x; CLERGETDARPOUX F, 1988, ANN HUM GENET, V52, P247, DOI 10.1111/j.1469-1809.1988.tb01102.x; CUTOLO M, 1991, CLIN EXP RHEUMATOL, V9, P641; DEIGHTON CM, 1989, CLIN GENET, V36, P178; DEIGHTON CM, 1993, ANN RHEUM DIS, V52, P638, DOI 10.1136/ard.52.9.638; DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813; DEVRIES N, 1993, TISSUE ANTIGENS, V41, P26; DIZIER MH, 1993, AM J HUM GENET, V53, P715; EBERHARDT K, 1993, J RHEUMATOL, V20, P1825; GAO XJ, 1991, J RHEUMATOL, V18, P801; GAO XJ, 1990, ARTHRITIS RHEUM, V33, P939, DOI 10.1002/art.1780330704; GO RCP, 1987, ARTHRITIS RHEUM, V30, P1115; Goronzy J J, 1993, Curr Opin Rheumatol, V5, P169; GOUGH A, 1994, ARTHRITIS RHEUM, V37, P1166, DOI 10.1002/art.1780370809; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HASSTEDT SJ, 1994, AM J HUM GENET, V55, P738; HILLARBY MC, 1991, TISSUE ANTIGENS, V37, P39, DOI 10.1111/j.1399-0039.1991.tb01842.x; INOKO H, 1993, HDB HLA TYPING TECHN, P9; JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627, DOI 10.1136/ard.45.8.627; JAWAHEER D, 1993, EUR J IMMUNOGENET, V20, P175, DOI 10.1111/j.1744-313X.1993.tb00108.x; KHAN MA, 1986, DIS MARKERS, V4, P67; KIDD KK, 1993, AM J MED GENET, V48, P71, DOI 10.1002/ajmg.1320480202; KIMURA A, 1992, HLA 1991, P397; LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357, DOI 10.1136/ard.29.4.357; LEGRAND L, 1984, AM J HUM GENET, V36, P690; LEWIS RB, 1980, J RHEUMATOL, V7, P559; Macgregor Alex, 1994, Arthritis and Rheumatism, V37, pS169; MARTENS HF, 1994, J RHEUMATOL, V21, P1427; MOXLEY G, 1989, ARTHRITIS RHEUM, V32, P1365, DOI 10.1002/anr.1780321104; MOXLEY G, 1989, ARTHRITIS RHEUM, V32, P634, DOI 10.1002/anr.1780320518; MOXLEY G, 1992, ARTHRITIS RHEUM, V35, P19, DOI 10.1002/art.1780350104; NELSON JL, 1993, NEW ENGL J MED, V329, P466, DOI 10.1056/NEJM199308123290704; NELSON JL, 1991, TISSUE ANTIGENS, V38, P145, DOI 10.1111/j.1399-0039.1991.tb01888.x; NELSON JL, 1992, HLA 1991, P772; NEPOM BS, 1984, J CLIN INVEST, V74, P287, DOI 10.1172/JCI111413; NEPOM GT, 1989, ARTHRITIS RHEUM, V32, P15, DOI 10.1002/anr.1780320104; Ott J., 1991, ANAL HUMAN GENETIC L; RIGBY AS, 1993, GENET EPIDEMIOL, V10, P311, DOI 10.1002/gepi.1370100504; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; RONNINGEN KS, 1992, TISSUE ANTIGENS, V39, P280, DOI 10.1111/j.1399-0039.1992.tb01949.x; RONNINGEN KS, 1990, TISSUE ANTIGENS, V36, P235; ROSSEN RD, 1980, J CLIN INVEST, V65, P629, DOI 10.1172/JCI109708; SALMON M, 1993, BRIT J RHEUMATOL, V32, P628; SALMON M, 1992, Current Opinion in Rheumatology, V4, P342, DOI 10.1097/00002281-199206000-00011; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903; SILMAN AJ, 1993, EPIDEMIOLOGY RHEUMAT, P7; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; STROTZER M, 1991, ANN RHEUM DIS, V50, P298, DOI 10.1136/ard.50.5.298; TANEJA V, 1992, INDIAN J MED RES-B, V96, P16; THOMSON W, 1993, ANN RHEUM DIS, V52, P539, DOI 10.1136/ard.52.7.539; Tiwari JL, 1985, HLA DISEASE ASS, P18; TODA Y, 1994, ANN RHEUM DIS, V53, P587, DOI 10.1136/ard.53.9.587; TSUJI K, 1992, HLA 1991; WALKER DJ, 1987, ARTHRITIS RHEUM, V30, P31, DOI 10.1002/art.1780300104; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; WINCHESTER R, 1994, ADV IMMUNOL, V56, P389, DOI 10.1016/S0065-2776(08)60456-3; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P178; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585	67	70	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					371	383						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571964				2022-12-18	WOS:A1996TR79100014
J	CHETTOUH, Z; CROQUETTE, MF; DELOBEL, B; GILGENKRANTS, S; LEONARD, C; MAUNOURY, C; PRIEUR, M; RETHORE, MO; SINET, PM; CHERY, M; DELABAR, JM				CHETTOUH, Z; CROQUETTE, MF; DELOBEL, B; GILGENKRANTS, S; LEONARD, C; MAUNOURY, C; PRIEUR, M; RETHORE, MO; SINET, PM; CHERY, M; DELABAR, JM			MOLECULAR MAPPING OF 21 FEATURES ASSOCIATED WITH PARTIAL MONOSOMY-21 - INVOLVEMENT OF THE APP-SOD1 REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOWN-SYNDROME PHENOTYPE; NORMAL SOD-1 ACTIVITY; GENETIC-LINKAGE MAP; HUMAN CHROMOSOME-21; INTERSTITIAL DELETION; SUPEROXIDE-DISMUTASE; INSITU HYBRIDIZATION; DNA-SEQUENCES; CDNA CLONE; LONG ARM	We compared the phenotypes, karyotypes, and molecular data for six cases of partial monosomy 21. Regions of chromosome 21, the deletion of which corresponds to particular features of monosomy 21, were thereby defined. Five such regions were identified for 21 features. Ten of the features could be assigned to the region flanked by genes APP and SOD1: six facial features, transverse palmar crease, arthrogryposis-like symptoms, hypertonia, and contribution to mental retardation. This region, covering the interface of bands 21q21-21q22.1, is 4.7-6.4 Mb long and contains the gene encoding the glutamate receptor subunit GluR5 (GRIK1).	HOP NECKER ENFANTS MALAD, CNRS, URA 1335, F-75743 PARIS, FRANCE; HOP NECKER ENFANTS MALAD, SERV CYTOGENET, F-75743 PARIS, FRANCE; HOP NECKER ENFANTS MALAD, SERV GENET MED, F-75743 PARIS, FRANCE; UNIV CATHOLIQUE LILLE, HOP ST ANTOINE, CYTOGENET LAB, LILLE, FRANCE; CTR REG TRANSFUS SANGUINE & HEMATOL, VANDOEUVRE LES NANCY, FRANCE; CTR HOSP BICETRE, CYTOGENET LAB, LE KREMLIN BICETRE, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Catholique de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP								ACKERMAN AD, 1988, NEW ENGL J MED, V318, P1666, DOI 10.1056/NEJM198806233182506; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BLOUIN JL, 1990, AM J HUM GENET, V46, P518; BOULUKOS KE, 1988, EMBO J, V7, P697, DOI 10.1002/j.1460-2075.1988.tb02865.x; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; BUYSE ML, 1990, BIRTH DEFEDTS ENCY; CARPENTER NJ, 1987, J MED GENET, V24, P706, DOI 10.1136/jmg.24.11.706; CHU ML, 1982, NUCLEIC ACIDS RES, V10, P5925, DOI 10.1093/nar/10.19.5925; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COHEN MM, 1972, AM J DIS CHILD, V124, P908, DOI 10.1001/archpedi.1972.02110180110016; COURTENS W, 1994, AM J MED GENET, V51, P260, DOI 10.1002/ajmg.1320510318; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DAVIS JG, 1976, CYTOGENET CELL GENET, V17, P65, DOI 10.1159/000130691; de Grouchy J., 1984, CLIN ATLAS HUMAN CHR; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; DELABAR JM, 1993, GENOMICS, V18, P735, DOI 10.1016/S0888-7543(05)80390-8; DELABAR JM, 1992, GENOMICS, V13, P887, DOI 10.1016/0888-7543(92)90177-T; DUTRILLAUX B, 1973, ANN GENET-PARIS, V16, P11; DZIUBA P, 1976, HUM GENET, V31, P351, DOI 10.1007/BF00270866; EPSTEIN CJ, 1990, AM J MED GENET, P31; ESTABROOKS LL, 1990, AM J MED GENET, V36, P306, DOI 10.1002/ajmg.1320360312; FRIED K, 1978, J MED GENET, V15, P152, DOI 10.1136/jmg.15.2.152; FRYNS JP, 1977, HUM GENET, V37, P155, DOI 10.1007/BF00393578; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GILL P, 1994, AM J MED GENET, V52, P416, DOI 10.1002/ajmg.1320520405; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GREGOR P, 1993, P NATL ACAD SCI USA, V90, P3053, DOI 10.1073/pnas.90.7.3053; GRIPENBERG U, 1972, J MED GENET, V9, P110, DOI 10.1136/jmg.9.1.110; HALLORAN KH, 1974, J MED GENET, V11, P386, DOI 10.1136/jmg.11.4.386; HERTZ B, 1993, CLIN GENET, V44, P89; HERVA R, 1983, EUR J PEDIATR, V140, P57, DOI 10.1007/BF00661907; HOLBEK S, 1974, HUMANGENETIK, V24, P191; HOUSTON CS, 1981, CAN ASS RADIOL, V32, P220; IKEUCHI T, 1976, HUM GENET, V33, P327, DOI 10.1007/BF00286861; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KLINE AD, 1993, AM J HUM GENET, V52, P895; KORENBERG JR, 1987, AM J HUM GENET, V41, P963; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KORENBERG JR, 1991, HUM GENET, V87, P112, DOI 10.1007/BF00204163; KORENBERG JR, 1991, CYTOGENET CELL GENET, V58, P2037; LAURENT C, 1973, ANN GENET-PARIS, V16, P281; LEVANON D, 1987, BIOCHEM BIOPH RES CO, V147, P1182, DOI 10.1016/S0006-291X(87)80194-8; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; LOPEZPAJARES I, 1993, CLIN GENET, V43, P94, DOI 10.1111/j.1399-0004.1993.tb04457.x; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MCGINNISS MJ, 1992, AM J HUM GENET, V50, P15; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; MODI N, 1982, CLIN GENET, V22, P215; MYERS JC, 1981, P NATL ACAD SCI-BIOL, V78, P3516, DOI 10.1073/pnas.78.6.3516; NIELSEN F, 1984, J MED GENET, V21, P218, DOI 10.1136/jmg.21.3.218; ORTI R, 1994, 5TH INT WORKSH HUM C; OTTO PG, 1978, HUM GENET, V41, P243, DOI 10.1007/BF00284757; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; PANGALOS C, 1992, AM J HUM GENET, V51, P1240; PELLISSIER MC, 1987, HUM GENET, V75, P95; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; PHELAN MC, 1988, AM J HUM GENET, V43, P511; PHILIP N, 1984, EUR J PEDIATR, V142, P61, DOI 10.1007/BF00442594; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; RETHORE MO, 1973, ANN GENET-PARIS, V16, P271; RETHORE MO, 1982, ANN GENET-PARIS, V25, P36; REYNOLDS JF, 1985, AM J MED GENET, V20, P173, DOI 10.1002/ajmg.1320200121; RIVERA H, 1983, ANN GENET-PARIS, V26, P234; ROLAND B, 1990, CLIN GENET, V37, P423; SCHINZEL A, 1976, HUM GENET, V32, P105, DOI 10.1007/BF00569984; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; TANZI RE, 1992, AM J HUM GENET, V50, P551; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VANCAMP G, 1989, NUCLEIC ACIDS RES, V17, P4420; VILJOEN DL, 1992, CLIN GENET, V42, P105; WAHRMAN J, 1974, CHROMOSOMES TODAY, V5, P241; WARREN AC, 1993, HUM GENET, V91, P87; WATKINS PC, 1985, NUCLEIC ACIDS RES, V13, P6075, DOI 10.1093/nar/13.17.6075; WATKINS PC, 1985, CYTOGENET CELL GENET, V40, P773; WISNIEWSKI K, 1983, CLIN GENET, V23, P102; WULFSBERG EA, 1983, HUM GENET, V64, P271, DOI 10.1007/BF00279408; YAMAMOTO Y, 1979, HUM GENET, V48, P321, DOI 10.1007/BF00272832; YAO XL, 1994, AM J MED GENET, V52, P491, DOI 10.1002/ajmg.1320520418; YOSHIMITSU K, 1983, HUM GENET, V64, P200, DOI 10.1007/BF00327128	81	70	70	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					62	71						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611297				2022-12-18	WOS:A1995RE62900008
J	LYNN, AH; KWOH, CK; VENGLISH, CM; ASTON, CE; CHAKRAVARTI, A				LYNN, AH; KWOH, CK; VENGLISH, CM; ASTON, CE; CHAKRAVARTI, A			GENETIC EPIDEMIOLOGY OF RHEUMATOID-ARTHRITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; SHARED-EPITOPE HYPOTHESIS; HLA ASSOCIATED DISEASES; MASC METHOD; PREVALENCE; SUSCEPTIBILITY; INHERITANCE; HAPLOTYPES; COMPONENT; MODELS	We conducted family studies and segregation analyses of rheumatoid arthritis (RA) that were based on consecutive patients with RA ascertained without regard to family history or known risk factors. First-degree relatives from 135 simplex and 30 multiplex families were included in the analyses. A highly penetrant recessive major gene, with a mutant allele frequency of .005, was identified as the most parsimonious genetic risk factor. Significant evidence for heterogeneity in risk for RA was observed for proband gender but not for proband age at onset. Kaplan-Meier risk analysis demonstrated significant evidence for differences in the distribution of risk among first-degree relatives. These analyses demonstrated that both proband gender and age at onset are important risk factors but that proband gender appears to be the more important determinant of risk, with relatives of male probands having the greatest cumulative risk for RA. In addition, log-linear modeling identified proband gender, familiality (multiplex or simplex), and an interaction term between these two variables as being adequate to define the distribution of risk in families. The pattern of risk for RA among susceptible individuals and its inheritance is thus heterogeneous. For future genetic analyses, families with an excess of affected males having a young age at onset may be the most informative in identifying the putative recessive gene and its modifiers.	CASE WESTERN RESERVE UNIV, DEPT GENET, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, DEPT MED, CLEVELAND, OH 44106 USA; UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA USA; UNIV PITTSBURGH, DEPT EPIDEMIOL, PITTSBURGH, PA 15261 USA; ST MARGARETS HOSP, PITTSBURGH, PA 15261 USA	Case Western Reserve University; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NHGRI NIH HHS [HG00344] Funding Source: Medline; NIAMS NIH HHS [AR39366] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR039366] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; CHAKRABORTY R, 1984, Genetic Epidemiology, V1, P229, DOI 10.1002/gepi.1370010303; CHAKRAVARTI A, 1988, American Journal of Human Genetics, V43, pA212; CLERGETDARPOUX F, 1988, ANN HUM GENET, V52, P247, DOI 10.1111/j.1469-1809.1988.tb01102.x; DEIGHTON CM, 1992, J RHEUMATOL, V19, P237; DEIGHTON CM, 1991, ANN RHEUM DIS, V50, P62, DOI 10.1136/ard.50.1.62; DEIGHTON CM, 1993, BRIT J RHEUMATOL, V32, P893; DEIGHTON CM, 1993, BRIT J RHEUMATOL, V32, P857; DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813; DIXON WJ, 1990, BMDP BIOMEDICAL COMP; DIZIER MH, 1993, AM J HUM GENET, V53, P715; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HASSTEDT SJ, 1994, AM J HUM GENET, V55, P738; HASSTEDT SJ, 1981, 13 U UT MED CTR LDS; HOCHBERG MC, 1990, SEMIN ARTHRITIS RHEU, V19, P294, DOI 10.1016/0049-0172(90)90052-H; HOCHBERG MC, 1981, EPIDEMIOL REV, V3, P27, DOI 10.1093/oxfordjournals.epirev.a036238; KELLEY WN, 1989, TXB RHEUMATOLOGY; KHAN MA, 1986, DIS MARKERS, V4, P67; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357, DOI 10.1136/ard.29.4.357; LAWRENCE RC, 1989, J RHEUMATOL, V16, P427; LINOS A, 1980, AM J EPIDEMIOL, V111, P87, DOI 10.1093/oxfordjournals.aje.a112878; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEPOM GT, 1987, J CLIN IMMUNOL, V7, P1, DOI 10.1007/BF00915418; RIGBY AS, 1993, GENET EPIDEMIOL, V10, P311, DOI 10.1002/gepi.1370100504; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; RISCH N, 1990, AM J HUM GENET, V46, P222; SANDERS PA, 1987, J RHEUMATOL, V14, P718; Schumacher H.R., 1988, PRIMER RHEUMATIC DIS; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; WALLIN J, 1991, ARTHRITIS RHEUM, V34, P1416; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; YAMASHITA TS, 1986, DIS MARKERS, V4, P113	36	70	72	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					150	159						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611283				2022-12-18	WOS:A1995RE62900018
J	THOMAS, GR; ROBERTS, EA; WALSHE, JM; COX, DW				THOMAS, GR; ROBERTS, EA; WALSHE, JM; COX, DW			HAPLOTYPES AND MUTATIONS IN WILSON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; LINKAGE; ATPASE; DNA	Wilson disease is a disorder of copper transport, resulting in neurological and hepatic damage due to copper toxicity. We have recently identified >20 mutations in the copper-transporting ATPase defective in this disease. Given the difficulties of searching for mutations in a gene spanning >80 kb of genomic DNA, haplotype data are important as a guide to mutation detection. Here we examine the haplotypes associated with specific mutations. We have extended previous studies of DNA haplotypes of dinucleotide-repeat polymorphisms (CA repeats) in the Wilson disease region to include an additional marker, in 58 families. These haplotypes, combining three markers (D13S314, D13S316, and D13S301), are usually specific for each different mutation, even though highly polymorphic CA repeat markers have been used. Haplotypes, as well as their accompanying mutations, differ between populations, In the patients whom we have studied, the haplotype data indicate that as many as 20 mutations may still be unidentified. The use of the haplotypes that we have identified provides an important guide for the identification of known mutations and can facilitate future mutation searches.	HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO,ON,CANADA; MIDDLESEX HOSP,LONDON,ENGLAND	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of London; University College London								BONNETAMIR B, 1990, ANN HUM GENET, V54, P155, DOI 10.1111/j.1469-1809.1990.tb00372.x; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Danks DM, 1989, METABOLIC BASIS INHE, P1411; HOUWEN RHJ, 1993, J HEPATOL, V17, P269, DOI 10.1016/S0168-8278(05)80204-1; HOUWEN RHJ, 1993, NETH J MED, V43, P26; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OUDET C, 1993, AM J HUM GENET, V52, P297; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; SIRUGO G, 1992, AM J HUM GENET, V50, P559; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; THOMAS GR, 1995, AM J HUM GENET, V56, P1140; THOMAS GR, 1994, AM J HUM GENET, V54, P71	15	70	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1315	1319						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762553				2022-12-18	WOS:A1995RA79400008
J	SCHMITT-NEY, M; THIELE, H; KALTWASSER, P; BARDONI, B; CISTERNINO, M; SCHERER, G				SCHMITT-NEY, M; THIELE, H; KALTWASSER, P; BARDONI, B; CISTERNINO, M; SCHERER, G			2 NOVEL SRY MISSENSE MUTATIONS REDUCING DNA-BINDING IDENTIFIED IN XY FEMALES AND THEIR MOSAIC FATHERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEX-DETERMINING REGION; DETERMINING GENE SRY; HUMAN Y-CHROMOSOME; HMG BOX; DOMAIN; MOTIF; HOMOLOGY; PROTEINS; FAMILY	Two novel mutations in the sex-determining gene SRY were identified by screening DNA from 30 sex-reversed XY females by using the SSCP assay. Both point mutations lead to an amino acid substitution in the DNA-binding high-mobility-group domain of the SRY protein. The first mutation, changing a serine at position 91 to glycine, was found in a sporadic case. The second mutation, leading to replacement of a highly conserved proline at position 125 with leucine, is shared by three members of the same family, two sisters and a half sister having the same father. The mutant SRY proteins showed reduced DNA-binding ability in a gel-shift assay. Analysis of lymphocyte DNA from the respective fathers revealed that they carry both the wild-type and the mutant version of the SRY gene. The fact that both fathers transmitted the mutant SRY copy to their offspring implies that they are mosaic for the SRY gene in testis as well as in blood, as a result of a mutation during early embryonic development.	UNIV FREIBURG, INST HUMANGENET, D-79106 FREIBURG, GERMANY; UNIV HALLE WITTENBERG, INST HUMANGENET, HALLE, GERMANY; UNIV HALLE WITTENBERG, GEBURTSHILFE & REPROD MED KLIN, HALLE, GERMANY; UNIV PAVIA, IST BIOL GEN & GENET MED, I-27100 PAVIA, ITALY; UNIV PAVIA, DEPT PEDIAT, I-27100 PAVIA, ITALY	University of Freiburg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Pavia; University of Pavia			Thiele, Holger/ABE-6792-2020; Bardoni, Barbara/F-9918-2013	Thiele, Holger/0000-0002-0169-998X; Bardoni, Barbara/0000-0001-6411-1517				BEHLKE MA, 1993, GENOMICS, V17, P736, DOI 10.1006/geno.1993.1395; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BRAUN A, 1993, AM J HUM GENET, V52, P578; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1994, P NATL ACAD SCI USA, V91, P3368, DOI 10.1073/pnas.91.8.3368; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; JAGER RJ, 1992, HUM GENET, V90, P350; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; MCELREAVEY K, 1993, EUR J BIOCHEM, V218, P769, DOI 10.1111/j.1432-1033.1993.tb18432.x; NASRIN N, 1991, CURR BIOL, V2, P208; ORITA M, 1989, GENOMICS, V5, P871; POULAT F, 1994, HUM MUTAT, V3, P200, DOI 10.1002/humu.1380030305; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; SAAD FA, 1994, NUCLEIC ACIDS RES, V22, P4352, DOI 10.1093/nar/22.20.4352; Sambrook J., 1989, MOL CLONING LAB MANU; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TAJIMA T, 1994, HUM MOL GENET, V3, P1187, DOI 10.1093/hmg/3.7.1187; VANDEWETERING M, 1992, EMBO J, V11, P3039, DOI 10.1002/j.1460-2075.1992.tb05374.x; VILAIN E, 1992, AM J HUM GENET, V50, P1008; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WOLF U, 1992, REV PHYSIOL BIOCH P, V121, P147, DOI 10.1007/BFb0033195; WRIGHT EM, 1993, NUCLEIC ACIDS RES, V21, P744, DOI 10.1093/nar/21.3.744; ZENG YT, 1993, J MED GENET, V30, P655, DOI 10.1136/jmg.30.8.655	30	70	74	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					862	869						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717397				2022-12-18	WOS:A1995QP66300007
J	THANH, LT; MAN, NT; HELLIWELL, TR; MORRIS, GE				THANH, LT; MAN, NT; HELLIWELL, TR; MORRIS, GE			CHARACTERIZATION OF REVERTANT MUSCLE-FIBERS IN DUCHENNE MUSCULAR-DYSTROPHY, USING EXON-SPECIFIC MONOCLONAL-ANTIBODIES AGAINST DYSTROPHIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; POSITIVE FIBERS; GENE DELETIONS; FRAME; MUTATIONS; TERMINUS; SEVERITY; PROTEIN	Most Duchenne muscular dystrophy (DMD) patients have genetic deletions or point mutations in the dystrophin gene that alter the reading frame of dystrophin mRNA. This causes early termination of translation, and no dystrophin (Or, less commonly, a truncated N-terminal dystrophin fragment) is produced. In many DMD patients, however, a small proportion of muscle fibers show strong dystrophin staining, and these ''revertant fibers'' are thought to arise by a mechanism that restores the reading frame. Exon-specific monoclonal antibodies (mAbs) have now been used to determine, for the first time, which exons are removed, in order to correct the reading frame in individual muscle fibers. Thus, 15 revertant fibers in a DMD patient with a frameshift deletion of exon 45 were shown to correct the frameshift by the additional deletion of exon 44 (or perhaps exon 46 in some fibers) from the dystrophin mRNA, but not by larger deletions. This result was consistent with reverse transciption (RT)-PCR and sequencing of a minor dystrophin mRNA with an exon 43/46 junction in this biopsy. In a DMD patient with a frameshift deletion of exons 42 and 43, however, larger deletions than the minimum necessary were used to correct the frameshift. In this patient, who produces a half-size N-terminal dystrophin fragment in all fibers, we were able to show that the revertant dystrophin replaces the truncated dystrophin in revertant-fiber sarcolemma. The results are consistent with somatic mutations in revertant-fiber nuclei, which result in removal of additional exons from dystrophin mRNA. They do not clearly distinguish between additional somatic deletions and somatic effects on dystrophin mRNA splicing, however, and both mechanisms may be operating.	NE WALES INST,MRIC BIOTECHNOL GRP,DEESIDE CH5 4BR,CLWYD,WALES; UNIV LIVERPOOL,DEPT PATHOL,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND	Glyndwr University; University of Liverpool				Helliwell, Timothy/0000-0003-2112-4128				BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; FANIN M, 1992, NEUROMUSCULAR DISORD, V2, P41, DOI 10.1016/0960-8966(92)90025-2; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; HELLIWELL TR, 1994, NEUROMUSCULAR DISORD, V4, P101, DOI 10.1016/0960-8966(94)90001-9; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MAN NT, 1990, FEBS LETT, V262, P237, DOI 10.1016/0014-5793(90)80199-S; MAN NT, 1993, AM J HUM GENET, V52, P1057; MAN NT, 1992, BIOCHEM J, V288, P663; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; MATSUO M, 1991, J CLIN INVEST, V87, P2127, DOI 10.1172/JCI115244; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P137, DOI 10.1016/0022-510X(89)90224-4; NICHOLSON LVB, 1993, ARCH DIS CHILD, V68, P632, DOI 10.1136/adc.68.5.632; NICHOLSON LVB, 1992, J MED GENET, V29, P892, DOI 10.1136/jmg.29.12.892; ONO T, 1994, FEBS LETT, V337, P18, DOI 10.1016/0014-5793(94)80621-7; ROBERTS RG, 1993, GENOMICS, V16, P536, DOI 10.1006/geno.1993.1225; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; THAHN LT, IN PRESS AM J MED GE; THANH LT, 1993, AM J HUM GENET, V53, P131; WALLGRENPETTERS.C, 1993, J NEUROL SCI, V118, P56; WILTON SD, 1993, AM J MED GENET, V46, P563, DOI 10.1002/ajmg.1320460521; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125	35	70	87	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					725	731						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887428				2022-12-18	WOS:A1995QK91800023
J	REILLY, SL; FERRELL, RE; SING, CF				REILLY, SL; FERRELL, RE; SING, CF			THE GENDER-SPECIFIC APOLIPOPROTEIN-E GENOTYPE INFLUENCE ON THE DISTRIBUTION OF PLASMA-LIPIDS AND APOLIPOPROTEINS IN THE POPULATION OF ROCHESTER, MN .3. CORRELATIONS AND COVARIANCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN RECEPTORS; E POLYMORPHISM; CORONARY ATHEROSCLEROSIS; PHENOTYPIC PLASTICITY; CHOLESTEROL; DISEASE; HYPERCHOLESTEROLEMIA; METABOLISM; GENETICS; LOCUS	The gender-specific influence that the apolipoprotein E (Ape E) polymorphism has on the correlations and covariances between pairs of nine plasma lipid and apolipoprotein traits (total cholesterol; In triglycerides; high-density-lipoprotein cholesterol; apolipoproteins AI, AII, B, CII, InCIII, and InE) was studied in 507 unrelated individuals representative of the adult population of Rochester, MN. Analyses are presented separately for females and males. The Apo E polymorphism had a significant influence on a large number (10 of 36) of correlations and covariances in females and on a small number (3 of 36) in males. The contribution of allelic variation in the Apo E gene to the definition of multivariate measures of the 36-dimensional correlation structure was evaluated. The influence of Apo E genotype on correlation structure was gender dependent. These findings were used to demonstrate how heterogeneity of risk-factor correlations and covariances among genotype-gender subgroups of the population at large may influence the evaluation of risk of coronary artery disease.	UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	REILLY, SL (corresponding author), UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, M4708 MED SCI 2, ANN ARBOR, MI 48109 USA.			Sing, Charles/0000-0001-5872-7956	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039107] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39107] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen TFH, 1992, UNIFIED ECOLOGY; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; BADIMON JJ, 1993, CIRCULATION, V87, P3; BARKER JSF, 1987, GENETIC CONSTRAINTS, P3; BERG K, 1990, FROM PHENOTYPE TO GENE IN COMMON DISORDERS, P77; BERG K, 1988, CLIN GENET, V33, P102; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BOERWINKLE E, 1992, CURR OPIN LIPIDOL, V3, P128; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BRESLOW JL, 1993, CIRCULATION, V87, P16; CARSON ER, 1983, MATH MODELING METABO; CHILDS B, 1977, AM J HUM GENET, V29, P1; Clark A., 1987, GENETIC CONSTRAINTS, P25, DOI DOI 10.1007/978-3-642-72770-2_3; Crawford Michael A., 1993, American Journal of Clinical Nutrition, V57, p703S, DOI 10.1093/ajcn/57.5.703S; CUMMING AM, 1984, CLIN GENET, V25, P310; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Efron B., 1992, EXPLORING LIMITS BOO, P99; Falconer D. S., 1989, Introduction to quantitative genetics.; FERRANNINI E, 1991, HYPERTENSION, V18, P636, DOI 10.1161/01.HYP.18.5.636; Garrod AE, 1908, LANCET, V2, P1; Garrod AE, 1902, LANCET, V2, P1616; GRUMMER RR, 1988, J ANIM SCI, V66, P3160; Hall P., 1992, EXPLORING LIMITS BOO, P127; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; HOBBS HH, 1989, J CLIN INVEST, V84, P656, DOI 10.1172/JCI114212; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; IZZO C, 1981, CLIN CHEM, V27, P371; KAMBOH MI, 1988, J LIPID RES, V29, P1535; KARLIN S, 1983, P NATL ACAD SCI USA, V80, P647, DOI 10.1073/pnas.80.2.647; KAUFFMAN SA, 1993, ORIGINS ORDER SELF O; KOTTKE BA, 1991, MAYO CLIN PROC, V66, P1198, DOI 10.1016/S0025-6196(12)62470-7; LUSIS AJ, 1988, J LIPID RES, V29, P397; MAHLEY RW, 1991, JAMA-J AM MED ASSOC, V265, P78, DOI 10.1001/jama.265.1.78; McKusick VA, 1990, MENDELIAN INHERITANC; MEADE TW, 1987, THROMB DIATH HAEMO, P37; MOLL PP, 1989, AM J HUM GENET, V44, P124; MORRISON DF, 1980, MULTIVARIATE STATIST; MURPHY EA, 1986, AM J MED GENET, V24, P159, DOI 10.1002/ajmg.1320240120; OLIVER M, 1976, BRIT HEART J, V38, P214, DOI 10.1136/hrt.38.3.214; PEARSON K, 1924, TABLES STATISTICIA 2; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; REILLY SL, 1990, J CLIN EPIDEMIOL, V43, P921, DOI 10.1016/0895-4356(90)90076-2; REILLY SL, 1992, AM J HUM GENET, V51, P1311; REILLY SL, 1991, AM J HUM GENET, V49, P1155; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; ROSE MR, 1982, HEREDITY, V48, P63, DOI 10.1038/hdy.1982.7; Rosenman Ray H., 1993, Integrative Physiological and Behavioral Science, V28, P84, DOI 10.1007/BF02691202; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Salthe S. N., 1985, EVOLVING HIERARCHICA; SAVAGEAU M A, 1976, P379; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; SCHLICHTING CD, 1989, BIOSCIENCE, V39, P460, DOI 10.2307/1311138; Simon H.A., 1962, P AM PHILOS SOC, V106, P467, DOI [10.1007/978-1-4899-0718-9_31, DOI 10.1080/14759550302804]; SING CF, 1992, ANN MED, V24, P539, DOI 10.3109/07853899209167008; SING CF, 1990, ANNU REV GENET, V24, P171; SING CF, 1994, CLIN GENET, V46, P6; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1985, AM J HUM GENET, V37, P268; SING CF, 1993, GENETICS CELLULAR IN; Snedecor GW., 1968, STAT METHODS; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; Sokal R.R., 1981, BIOMETRY, V2nd ed.; STROHMAN RC, 1993, PERSPECT BIOL MED, V37, P112; TAUBER AI, 1992, PERSPECT BIOL MED, V35, P220; TURNER ST, 1989, HYPERTENSION, V13, P378, DOI 10.1161/01.HYP.13.4.378; VEGA GL, 1991, ARTERIOSCLER THROMB, V11, P578, DOI 10.1161/01.ATV.11.3.578; Via S., 1987, GENETIC CONSTRAINTS, P47, DOI DOI 10.1007/978-3-642-72770-2_4; WALDROP, 1992, COMPLEXITY EMERGING; Weiss K. M., 1993, GENETIC VARIATION HU; Zerba Kim E., 1993, Current Opinion in Lipidology, V4, P152, DOI 10.1097/00041433-199304000-00011	73	70	70	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					1001	1018						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977338				2022-12-18	WOS:A1994QB68200021
J	CARON, H; VANSLUIS, P; VANROY, N; DEKRAKER, J; SPELEMAN, F; VOUTE, PA; WESTERVELD, A; SLATER, R; VERSTEEG, R				CARON, H; VANSLUIS, P; VANROY, N; DEKRAKER, J; SPELEMAN, F; VOUTE, PA; WESTERVELD, A; SLATER, R; VERSTEEG, R			RECURRENT 1,17 TRANSLOCATIONS IN HUMAN NEUROBLASTOMA REVEAL NONHOMOLOGOUS MITOTIC RECOMBINATION DURING THE S/G2 PHASE AS A NOVEL MECHANISM FOR LOSS OF HETEROZYGOSITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							N-MYC AMPLIFICATION; NEURO-BLASTOMA; WILMS-TUMORS; CELL-LINE; HUMAN CHROMOSOME-1; SHORT ARM; EXPRESSION; DELETION; ALLELES; GENES	Neuroblastomas often show loss of heterozygosity of the chromosomal region 1p36 (LOH 1p), probably reflecting loss of a tumor-suppressor gene. Here we describe three neuroblastoma tumors and two cell lines in which LOH 1p results from an unbalanced translocation between the p arm of chromosome 1 and the q arm of chromosome 17. Southern blot and cytogenetic analyses show that in all cases the chromosome 17 homologue from which the 1;17 translocation was derived is still present and intact. This suggests a model in which a translocation between the short arm of chromosome 1 and the long arm of chromosome 17 takes place in the S/G2 phase of the cell cycle and results in LOH 1p. Nonhomologous mitotic recombination in the S/G2 phase is a novel mechanism of LOH.	UNIV AMSTERDAM, ACAD MED CTR, INST HUMAN GENET, 1105 AZ AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, ACAD MED CTR, EMMA KINDERZIEKENHUIS, DEPT PAEDIAT ONCOL & HAEMATOL, 1105 AZ AMSTERDAM, NETHERLANDS; STATE UNIV GHENT HOSP, DEPT MED GENET, B-9000 GHENT, BELGIUM	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Ghent University; Ghent University Hospital			Versteeg, Rogier/AAQ-1765-2020; speleman, frank/AAR-5184-2020	speleman, frank/0000-0002-6628-8559; Versteeg, Rogier/0000-0001-7172-0388				BRODEUR GM, 1981, CANCER RES, V41, P4678; CARON H, 1993, NAT GENET, V4, P187, DOI 10.1038/ng0693-187; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHENG JM, 1993, NAT GENET, V4, P191, DOI 10.1038/ng0693-191; CHRISTIANSEN H, 1988, BRIT J CANCER, V57, P121, DOI 10.1038/bjc.1988.24; CORNAGLIAFERRARIS P, 1990, PEDIATR RES, V27, P1, DOI 10.1203/00006450-199001000-00001; COWELL JK, 1983, CANCER GENET CYTOGEN, V9, P273, DOI 10.1016/0165-4608(83)90011-0; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; HAYASHI Y, 1989, CANCER, V63, P126, DOI 10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z; LAUTHIER V, 1992, HUM MOL GENET, V1, P63; LITTLE JB, 1989, ENVIRON HEALTH PERSP, V81, P63, DOI 10.2307/3430806; LITTLE MH, 1992, ONCOGENE, V7, P635; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MANUELIDIS L, 1990, CYTOMETRY, V11, P8, DOI 10.1002/cyto.990110104; Mitelman F., 1991, ISCN GUIDELINES CANC; MULLENBACH R, 1989, TRENDS GENET, V5, P391; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; NELSON FK, 1989, MOL CELL BIOL, V9, P1284, DOI 10.1128/MCB.9.3.1284; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; VANROY N, 1994, GENE CHROMOSOME CANC, V10, P103, DOI 10.1002/gcc.2870100205; VANROY N, 1993, GENOMICS, V18, P71, DOI 10.1006/geno.1993.1427; WEITH A, 1989, GENE CHROMOSOME CANC, V1, P159, DOI 10.1002/gcc.2870010209	24	70	70	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					341	347						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037211				2022-12-18	WOS:A1994NZ33600016
J	AITTOMAKI, K				AITTOMAKI, K			THE GENETICS OF XX GONADAL-DYSGENESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREMATURE OVARIAN FAILURE; ENDOCRINE	In a nationwide population-based study of women born between 1950 and 1976, 75 patients with XX gonadal dysgenesis (XXGD) were identified in Finland. Patients were ascertained through hospital records and the registers of chromosome laboratories. In one family 4 daughters were affected; in six families 2 daughters were affected; and 57 cases were isolated. In one additional family the two affected females were in successive generations. Population records were utilized to trace ancestors of patients back to the beginning of the 19th century, in most cases. Consanguinity was detected in 8 (12%) of 66 families. When females only are considered, the segregation analyses yield a proportion of .23 affected, The relatively large number of affected individuals identified (incidence 1 in 8,300 live-born girls) implies a high gene frequency in the Finnish population. The geographic distribution was highly uneven, with most families originating in the sparsely populated north-central part of Finland. These findings support the existence of an autosomal recessive MGD gene (locus designation ''ODG1'') that is highly enriched in Finland. The multiplex families already identified will make it possible to map the ODG1 gene by a random search for linkage by using polymorphic markers. Linkage-disequilibrium analysis in the sporadic patients will then be used to test for genetic homogeneity versus heterogeneity.			AITTOMAKI, K (corresponding author), UNIV HELSINKI,DEPT MED GENET,POB 21,HAARTMANINKATU 3,SF-00014 HELSINKI,FINLAND.							AIMAN J, 1985, OBSTET GYNECOL, V66, P9; ALEEM FA, 1986, FERTIL STERIL, V35, P317; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GRANAT M, 1983, FERTIL STERIL, V40, P215; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Li C, 1961, HUMAN GENETICS PRINC; MALKOVA J, 1974, HUMANGENETIK, V23, P205, DOI 10.1007/BF00285106; MCDONOUGH PG, 1977, FERTIL STERIL, V28, P251; McKusick V.A., 1992, MENDELIAN INHERITANC; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NIELSEN J, 1979, BRIT J OBSTET GYNAEC, V86, P833, DOI 10.1111/j.1471-0528.1979.tb10706.x; NISHI Y, 1988, AM J MED GENET, V31, P623, DOI 10.1002/ajmg.1320310317; NORIO R, 1984, YB POP RES FINLAND, V22, P7; Norio R., 1981, BIOCULTURAL ASPECTS, P359; PORTUONDO JA, 1987, INT J FERTIL, V32, P56; QUAYLE SA, 1991, AM J MED GENET, V40, P75, DOI 10.1002/ajmg.1320400114; REBAR RW, 1982, FERTIL STERIL, V37, P35; REINDOLLAR RH, 1984, J REPROD MED, V29, P391; SIMPSON J L, 1971, Birth Defects Original Article Series, V7, P215; SIMPSON JL, 1980, FERTIL STERIL, V33, P107; SIMPSON JL, 1979, GENETIC MECHANISMS S, P365; SIMPSON JL, 1976, DISORDERS SEXUAL DIF; SMITH A, 1979, FERTIL STERIL, V32, P528; SMITH A, 1989, J MED GENET, V26, P434, DOI 10.1136/jmg.26.7.434; WORTSMAN J, 1983, ARCH INTERN MED, V143, P825, DOI 10.1001/archinte.143.4.825; YOULTON R, 1982, CLIN GENET, V21, P262	27	70	70	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					844	851						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178824				2022-12-18	WOS:A1994NH39400014
J	PETTY, EM; GIBSON, LH; FOUNTAIN, JW; BOLOGNIA, JL; YANGFENG, TL; HOUSMAN, DE; BALE, AE				PETTY, EM; GIBSON, LH; FOUNTAIN, JW; BOLOGNIA, JL; YANGFENG, TL; HOUSMAN, DE; BALE, AE			MOLECULAR DEFINITION OF A CHROMOSOME-9P21 GERM-LINE DELETION IN A WOMAN WITH MULTIPLE MELANOMAS AND A PLEXIFORM NEUROFIBROMA - IMPLICATIONS FOR 9P TUMOR-SUPPRESSOR GENE(S)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-MALIGNANT MELANOMA; DYSPLASTIC NEVUS; CELL-LINES; PROGRESSION; LINKAGE; CANCER; ABNORMALITIES; INTERFERON; EVOLUTION; FAMILIES	Cutaneous malignant melanoma (CMM) is often familial, but the mode of inheritance and the chromosomal location of a melanoma susceptibility locus are controversial. Identification of a 34-year-old woman with eight primary malignant melanomas, multiple atypical moles, and a de novo constitutional cytogenetic rearrangement involving chromosomes 5p and 9p suggested the presence of a melanoma predisposition gene at one of these locations. A high-resolution karyotype showed a partial deletion of a dark-staining Giemsa band, either 5p14 or 9p21. The patient was heterozygous for five 5p14 RFLPs. In situ hybridization with D9S3 indicated that this 9p21 marker was deleted. Gene dosage studies demonstrated the deletion of two more distal 9p21 markers, D9S126 and IFNA. In addition, she was hemizygous for the more proximal 9p21 short tandem-repeat polymorphism at D9S104. D9S18, D9S19, and D9S33 were retained, localizing the deletion to 9p21 between D9S19 on the proximal side and D9S33 on the distal side. Pulsed-field gel electrophoresis with D9S19 and D9S33 did not reveal any junction fragments in the patient's DNA. This germ-line deletion suggests that mutations in a 9p21 gene may initiate melanoma tumorigenesis.	YALE UNIV,SCH MED,DEPT DERMATOL,NEW HAVEN,CT 06510; MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139	Yale University; Massachusetts Institute of Technology (MIT)	PETTY, EM (corresponding author), YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510, USA.				NCI NIH HHS [CA-17575] Funding Source: Medline; NHGRI NIH HHS [HG00297] Funding Source: Medline; NIGMS NIH HHS [NRSA-GM07439] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA017575, R37CA017575] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALABAN GB, 1986, CANCER GENET CYTOGEN, V19, P113, DOI 10.1016/0165-4608(86)90378-X; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CLARK WH, 1978, ARCH DERMATOL, V114, P732, DOI 10.1001/archderm.114.5.732; COWAN JM, 1988, J NATL CANCER I, V80, P1159, DOI 10.1093/jnci/80.14.1159; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; DRACOPOLI NC, 1987, CANCER RES, V47, P3995; DRACOPOLI NC, 1988, SEMIN ONCOL, V15, P541; FALLSTROM SP, 1979, CLIN GENET, V15, P480; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; FRICHOT BC, 1977, LANCET, V1, P864; FRIEDMAN RJ, 1991, CA-CANCER J CLIN, V41, P201, DOI 10.3322/canjclin.41.4.201; GRAMMATICO P, 1990, CANCER GENET CYTOGEN, V48, P237, DOI 10.1016/0165-4608(90)90126-U; GREENE MH, 1985, ANN INTERN MED, V102, P458, DOI 10.7326/0003-4819-102-4-458; JAMES CD, 1991, CANCER RES, V51, P1684; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LUKEIS R, 1990, GENE CHROMOSOME CANC, V2, P116, DOI 10.1002/gcc.2870020207; LYNCH HT, 1978, J MED GENET, V15, P352, DOI 10.1136/jmg.15.5.352; MIYAKOSHI J, 1990, CANCER RES, V50, P278; NANCARROW DJ, 1992, GENOMICS, V12, P18, DOI 10.1016/0888-7543(92)90401-D; OLOPADE OI, 1992, GENOMICS, V14, P437, DOI 10.1016/S0888-7543(05)80238-1; PEDERSEN MI, 1989, CANCER GENET CYTOGEN, V41, P185, DOI 10.1016/0165-4608(89)90245-8; PETTY EM, 1993, AM J MED GENET, V45, P77, DOI 10.1002/ajmg.1320450119; RIGEL DS, 1987, J AM ACAD DERMATOL, V17, P1050, DOI 10.1016/S0190-9622(87)80487-5; RISCH N, 1992, CYTOGENET CELL GENET, V59, P148, DOI 10.1159/000133230; Sambrook J., 1989, MOL CLONING LAB MANU; SILVERBERG E, 1990, CA-CANCER J CLIN, V40, P9, DOI 10.3322/canjclin.40.1.9; SMOLLER BR, 1989, AM J SURG PATHOL, V13, P680, DOI 10.1097/00000478-198908000-00006; TAYEL SM, 1988, AM J MED GENET, V31, P853, DOI 10.1002/ajmg.1320310419; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; 1991, CYTOGENET CELL GENET, V58, P1419; 1984, JAMA-J AM MED ASSOC, V251, P1864; 1991, CYTOGENET CELL GENET, V58, P1341	40	70	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					96	104						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317504				2022-12-18	WOS:A1993LJ38500013
J	GOSTOUT, B; LIU, Q; SOMMER, SS				GOSTOUT, B; LIU, Q; SOMMER, SS			CRYPTIC REPEATING TRIPLETS OF PURINES AND PYRIMIDINES (CRRY(I)) ARE FREQUENT AND POLYMORPHIC - ANALYSIS OF CODING CRRY(I) IN THE PROOPIOMELANOCORTIN (POMC) AND TATA-BINDING PROTEIN (TBP) GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS	Triplets of the form of purine, purine, pyrimidine (RRY(i)) are enhanced in frequency in the genomes of primates, rodents, and bacteria. Some RRY(i) are ''cryptic'' repeats (cRRY(i)) in which no one tandem run of a trinucleotide predominates. A search of human GenBank sequence revealed that the sequences of cRRY(i) are highly nonrandom. Three randomly chosen human cRRY(i) were sequenced in search of polymorphic alleles. Multiple polymorphic alleles were found in cRRY(i) in the coding regions of the genes for proopiomelanocortin (POMC) and TATA-binding protein (TBP). The highly polymorphic TBP cRRY(i) was characterized in detail. Direct sequencing of 157 unrelated human alleles demonstrated the presence of 20 different alleles which resulted in 29-40 consecutive glutamines in the amino-terminal region of TBP. These alleles are differentially distributed among the races. PCR was used to screen 1,846 additional alleles in order to characterize more fully the range of variation in the population. Three additional alleles were discovered, but there was no example of a substantial sequence amplification as is seen in the repeat sequences associated with X-linked spinal and bulbar muscular atrophy, myotonic dystrophy, or the fragile-X syndrome. The structure of the TBP cRRY(i) is conserved in the five monkey species examined. In the chimpanzee, examination of four individuals revealed that the cRRY(i) was highly polymorphic, but the pattern of polymorphism differed from that in humans. The TBP cRRY(i) displays both similarities with and differences from the previously described RRY(i) in the coding sequence of the androgen receptor. Our data suggest how simple tandem repeats could evolve from cryptic repeats.	MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic								CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CHANG ACY, 1980, P NATL ACAD SCI-BIOL, V77, P4890, DOI 10.1073/pnas.77.8.4890; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; GASCH A, 1990, NATURE, V346, P390, DOI 10.1038/346390a0; HAHN S, 1989, CELL, V58, P1173, DOI 10.1016/0092-8674(89)90515-1; JENKINS RN, 1990, J BIOL CHEM, V265, P19624; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LUTY JA, 1990, AM J HUM GENET, V46, P776; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4307, DOI 10.1093/nar/19.15.4307; SARKAR G, 1991, NUCLEIC ACIDS RES, V19, P631, DOI 10.1093/nar/19.3.631; SOMMER SS, 1990, PCR PROTOCOLS GUIDE, P197; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; TAKAHASHI H, 1983, NUCLEIC ACIDS RES, V11, P6847, DOI 10.1093/nar/11.19.6847; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WONG JM, 1992, GENE, V117, P91, DOI 10.1016/0378-1119(92)90494-A	18	70	70	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1182	1190						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503450				2022-12-18	WOS:A1993LG13300020
J	ABEL, L; COT, M; MULDER, L; CARNEVALE, P; FEINGOLD, J				ABEL, L; COT, M; MULDER, L; CARNEVALE, P; FEINGOLD, J			SEGREGATION ANALYSIS DETECTS A MAJOR GENE CONTROLLING BLOOD INFECTION LEVELS IN HUMAN MALARIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The profound influence that the genetic makeup of the host has on resistance to malaria infection has been established in numerous animal studies. This genetic heterogeneity is one of the main causes of the difficulties in developing an effective malaria vaccine. Segregation analysis is the first step in identifying the nature of genetic factors involved in the expression of human complex diseases, as infectious diseases. To assess the role of host genes in human malaria, we performed segregation analysis of blood parasite densities in 42 Cameroonian families by using both the unified mixed model and the class D regressive model of analysis. The results provide clear evidence for the presence of a recessive major gene controlling the degree of infection in human malaria. Parameter estimates show a frequency of .44-.48 for the deleterious allele, indicating that about 21% of the population is predisposed to high levels of infection.	INSERM, U155, UNITE RECH GENET EPIDEMIOL, F-75005 PARIS, FRANCE; ORSTOM, ORG COOPERAT LUTTE ENDEMIES AFRIQUE CENT, YAOUNDE, CAMEROON; CATHOLIC UNIV NIJMEGEN, DEPT PARASITOL, NIJMEGEN, NETHERLANDS; UNIV WAGENINGEN, NIJMEGEN, NETHERLANDS	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Radboud University Nijmegen	ABEL, L (corresponding author), HOP LA PITIE SALPETRIERE, DEPT BIOMATH, INSERM, U194, 91 BLVD HOP, F-75013 PARIS, FRANCE.		Cot, Michel/E-7633-2011; Abel, Laurent/H-8888-2017	Cot, Michel/0000-0003-3014-4294; Abel, Laurent/0000-0001-7016-6493				ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1991, AM J HUM GENET, V48, P959; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; ELSTON RC, 1986, 7TH INT C HUM GEN BE; Gazin P, 1990, Med Trop (Mars), V50, P27; GOOD MF, 1988, SCIENCE, V242, P574, DOI 10.1126/science.2902690; GRAU GE, 1987, PARASITOLOGY, V94, pS123, DOI 10.1017/S0031182000085851; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LONDONO JA, 1990, J IMMUNOL, V145, P1557; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MILLER LH, 1986, SCIENCE, V234, P1349, DOI 10.1126/science.2431481; Morton N.E., 1983, METHODS GENETIC EPID; NAGEL RL, 1989, BLOOD, V74, P1213; OSOBA D, 1979, IMMUNOGENETICS, V8, P323, DOI 10.1007/BF01561443; RICE T, 1990, AM J HUM GENET, V46, P37; SAYLES PC, 1988, J IMMUNOL, V141, P241; SCHURR E, 1989, J IMMUNOL, V142, P4507; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; STEVENSON MM, 1985, INFECT IMMUN, V47, P452, DOI 10.1128/IAI.47.2.452-456.1985; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; WEISS WR, 1989, J IMMUNOL, V143, P4263; WUNDERLICH F, 1988, INFECT IMMUN, V56, P2400, DOI 10.1128/IAI.56.9.2400-2406.1988	28	70	72	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1308	1317						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598911				2022-12-18	WOS:A1992HY65400020
J	LANGE, K; SOBEL, E				LANGE, K; SOBEL, E			A RANDOM-WALK METHOD FOR COMPUTING GENETIC LOCATION SCORES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; RECOMBINATION; INTERFERENCE; CONSTRUCTION; HUMANS; MAPS	Calculation of location scores is one of the most computationally intensive tasks in modem genetics. Since these scores are crucial in placing disease loci on marker maps, there is ample incentive to pursue such calculations with large numbers of markers. However, in contrast to the simple, standardized pedigrees used in making marker maps, disease pedigrees are often graphically complex and sparsely phenotyped. These complications can present insuperable barriers to exact likelihood calculations with more than a few markers simultaneously. To overcome these barriers we introduce in the present paper a random walk method for computing approximate location scores with large numbers of biallelic markers. Sufficient mathematical theory is developed to explain the method. Feasibility is checked by small-scale simulations for two applications permitting exact calculation of location scores.			LANGE, K (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024, USA.			Sobel, Eric/0000-0002-1718-0031	NCI NIH HHS [CA 16042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHARMLEY P, 1990, GENOMICS, V6, P316, DOI 10.1016/0888-7543(90)90572-C; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Edwards A.W.F, 1972, LIKELIHOOD; Feller W., 1968, INTRO PROBABILITY TH, V1; FOROUD T, 1991, AM J HUM GENET, V49, P1263; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; HALMOS PR, 1956, LECTURES ERGODIC THE; Kalos M.H., 1986, MONTE CARLO METHODS, V1; KARLIN S, 1979, ADV APPL PROBAB, V11, P479, DOI 10.2307/1426950; KARLIN S, 1975, 1ST COURSE STOCHASTI; KONG A, 1991, GENET EPIDEMIOL, V8, P81, DOI 10.1002/gepi.1370080203; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1989, AM J HUM GENET, V45, P959; LANGE K, 1989, ANN HUM GENET, V53, P67, DOI 10.1111/j.1469-1809.1989.tb01122.x; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; RISCH N, 1979, ANN HUM GENET, V43, P61, DOI 10.1111/j.1469-1809.1979.tb01549.x; RISCH N, 1983, BIOMETRICS, V39, P949, DOI 10.2307/2531330; Sheehan N, 1989, 176 U WASH DEP STAT; THOMAS DC, IN PRESS HUM HERED	24	70	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1320	1334						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746559				2022-12-18	WOS:A1991GU67200019
J	DIXON, MJ; READ, AP; DONNAI, D; COLLEY, A; DIXON, J; WILLIAMSON, R				DIXON, MJ; READ, AP; DONNAI, D; COLLEY, A; DIXON, J; WILLIAMSON, R			THE GENE FOR TREACHER COLLINS SYNDROME MAPS TO THE LONG ARM OF CHROMOSOME-5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; MANDIBULOFACIAL DYSOSTOSIS; GROWTH-FACTOR; RECEPTOR; DNA; COMMITTEE; HUMANS	Treacher Collins syndrome (TCS) is an autosomal dominant disorder of craniofacial development, the features of which include conductive hearing loss and cleft palate. We have studied 12 unrelated TCS families with multiple affected individuals for linkage to five chromosome 5 markers. There is strong evidence demonstrating linkage to three of these markers. Multipoint linkage analysis places the mutation causing TCS in the interval between the gene for the glucocorticoid receptor and the anonymous marker D5S22, with a maximum multipoint lod score of 9.1.	ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; UNIV MANCHESTER,MANCHESTER M13 9PL,LANCS,ENGLAND; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON,ENGLAND	University of Manchester; University of Manchester; Imperial College London	DIXON, MJ (corresponding author), UNIV MANCHESTER,DEPT CELL & STRUCT BIOL,3RD FLOOR STOPFORD BLDG,OXFORD RD,MANCHESTER M13 9PT,LANCS,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CONNOR JM, 1988, ESSENTIAL MED GENETI; DIXON MJ, 1991, AM J HUM GENET, V48, P274; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FRAZEN LE, 1967, AM J DIS CHILD, V113, P406; GIUFFRA LA, 1988, CYTOGENET CELL GENET, V49, P313, DOI 10.1159/000132686; HERRING SW, 1979, AM J MED GENET, V3, P225, DOI 10.1002/ajmg.1320030303; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KAY ED, 1989, AM J MED GENET, V32, P27, DOI 10.1002/ajmg.1320320107; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; MURRAY JC, 1987, NUCLEIC ACIDS RES, V15, P6765, DOI 10.1093/nar/15.16.6765; NICOLAIDES KH, 1984, PRENATAL DIAG, V4, P201, DOI 10.1002/pd.1970040307; PHELPS PD, 1981, CLIN OTOLARYNGOL, V6, P15, DOI 10.1111/j.1365-2273.1981.tb01782.x; POSWILLO D, 1975, BRIT J ORAL SURG, V13, P1, DOI 10.1016/0007-117X(75)90019-0; ROVIN S, 1964, J PEDIATR-US, V65, P215, DOI 10.1016/S0022-3476(64)80522-9; Sambrook J., 1989, MOL CLONING LAB MANU; Swaroop A, 1988, GENOMICS, V2, P37, DOI 10.1016/0888-7543(88)90107-3; THERIAULT A, 1989, HUM GENET, V83, P289, DOI 10.1007/BF00285175; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YOUNG MF, 1990, CONNECT TISSUE RES, V24, P17, DOI 10.3109/03008209009152419	25	70	72	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					17	22						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1676560				2022-12-18	WOS:A1991FW51100003
J	MODIANO, G; MORPURGO, G; TERRENATO, L; NOVELLETTO, A; DIRIENZO, A; COLOMBO, B; PURPURA, M; MARIANI, M; SANTACHIARABENERECETTI, S; BREGA, A; DIXIT, KA; SHRESTHA, SL; LANIA, A; WANACHIWANAWIN, W; LUZZATTO, L				MODIANO, G; MORPURGO, G; TERRENATO, L; NOVELLETTO, A; DIRIENZO, A; COLOMBO, B; PURPURA, M; MARIANI, M; SANTACHIARABENERECETTI, S; BREGA, A; DIXIT, KA; SHRESTHA, SL; LANIA, A; WANACHIWANAWIN, W; LUZZATTO, L			PROTECTION AGAINST MALARIA MORBIDITY - NEAR-FIXATION OF THE ALPHA-THALASSEMIA GENE IN A NEPALESE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; TRIBAL POPULATIONS; PARASITE GROWTH; GLOBIN GENE; INDIA; SUSCEPTIBILITY; RECEPTORS; MUTATION; KNOWLESI	We have previously reported that the Tharu people of the Terai region in southern Nepal have an incidence of malaria about sevenfold lower than that of synpatric non-Tharu people. In order to find out whether this marked resistance against malaria has a genetic basis, we have now determined in these populations the prevalence of candidate protective genes and have performed in-vitro cultures of Plasmodium falciparum in both Tharu and non-Tharu red cells. We have found significant but relatively low and variable frequencies of beta-thal, beta-s, G6PD (-), and Duffy (a-b-) in different parts of the Terai region. The average in-vitro rate of invasion and of parasite multiplication did not differ significantly in red cells from Tharus versus those from non-Tharu controls. By contrast, the frequency of alpha-thalassemia is uniformly high in Tharus, with the majority of them having the homozygous alpha-/alpha-genotype and an overall alpha-thal gene (alpha-) frequency of .8. We suggest that holoendemic malaria has caused preferential survival of subjects with alpha-thal and that this genetic factor has enabled the Tharus as a population to survive for centuries in a malaria-holoendemic area. From our data we estimate that the alpha-thal homozygous state decreases morbidity from malaria by about 10-fold. This is an example of selection evolution toward fixation of an otherwise abnormal gene.	CNR,INST CELL BIOL,ROME,ITALY; UNIV MILAN,DEPT BIOL & GENET MED SCI,I-20122 MILAN,ITALY; INT INST GENET & BIOPHYS,NAPLES,ITALY; UNIV PERUGIA,DEPT BIOL,I-06100 PERUGIA,ITALY; CTR NAZL TRANSFUS SANGUE,CRI,ROME,ITALY; UNIV CALABRIA,DEPT CELLULAR BIOL,ARCAVACATA,ITALY; NAPAL MALARIA ERADICAT ORG,KATHMANDU,INDIA; UNIV LONDON,RPMS,DEPT HAEMATOL,LONDON,ENGLAND	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Perugia; University of Calabria; Imperial College London; University of London	MODIANO, G (corresponding author), UNIV ROME TOR VERGATA,DEPT BIOL,I-00173 LA ROMANINA,ITALY.		Wanachiwanwin, Wanchai/L-6328-2019	Novelletto, Andrea/0000-0002-1146-7680	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1967, WHO TECH REP SER, V366, P1; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; DIRIENZO A, 1985, HUM GENET, V71, P147, DOI 10.1007/BF00283371; DRYSDALE HC, 1988, BRIT J HAEMATOL, V68, P264, DOI 10.1111/j.1365-2141.1988.tb06201.x; EFREMOV CD, 1974, J LAB CLIN MED, V83, P657; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; FODDE R, 1988, HUM GENET, V80, P157, DOI 10.1007/BF00702860; HIGGS DR, 1984, NUCLEIC ACIDS RES, V12, P6965, DOI 10.1093/nar/12.18.6965; HILL AVS, 1986, COLD SPRING HARB SYM, V51, P480; IFEDIBA TC, 1985, BLOOD, V65, P452; KAR BC, 1986, LANCET, V2, P1198; LABIE D, 1989, HUM BIOL, V61, P479; LIEINJO LE, 1981, NUCLEIC ACIDS RES, V9, P3707, DOI 10.1093/nar/9.15.3707; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; LUZZATTO L, 1979, BLOOD, V54, P961; LUZZI GA, 1989, 10TH C INT SOC HAEM; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1977, J EXP MED, V146, P277, DOI 10.1084/jem.146.1.277; NALBANDIAN RM, 1971, CLIN CHEM, V17, P1033; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; PASVOL G, 1982, BRIT MED BULL, V38, P133, DOI 10.1093/oxfordjournals.bmb.a071749; RICHARDS WHG, 1979, ANN TROP MED PARASIT, V73, P99, DOI 10.1080/00034983.1979.11687236; Shrestha S.L., 1986, Journal of Communicable Diseases, V17, P287; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; TEMPLE R, 1887, TRAVELS NEPAL SIKKIM; TERRENATO L, 1988, ANN TROP MED PARASIT, V82, P1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TUCCI G, 1977, NEPAL ALLE SCOPERTA; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; YUTHAVONG Y, 1988, AM J CLIN PATHOL, V89, P521, DOI 10.1093/ajcp/89.4.521	30	70	71	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					390	397						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990845				2022-12-18	WOS:A1991EV74400024
J	SCOTT, HS; ASHTON, LJ; EYRE, HJ; BAKER, E; BROOKS, DA; CALLEN, DF; SUTHERLAND, GR; MORRIS, CP; HOPWOOD, JJ				SCOTT, HS; ASHTON, LJ; EYRE, HJ; BAKER, E; BROOKS, DA; CALLEN, DF; SUTHERLAND, GR; MORRIS, CP; HOPWOOD, JJ			CHROMOSOMAL LOCALIZATION OF THE HUMAN ALPHA-L-IDURONIDASE GENE (IDUA) TO 4P16.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,72 KING WILLIAM RD,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA				Scott, Hamish/B-2122-2009; Callen, David F/G-1975-2012; Sutherland, Grant Robert/D-2606-2012; Brooks, Doug A/K-6714-2012	Scott, Hamish/0000-0002-5813-631X; Brooks, Doug/0000-0001-9098-3626; Callen, David/0000-0002-6189-9991; Morris, Phillip/0000-0001-8976-619X				ASHTON L, 1990, UNPUB IMMUNOQUANTIFI; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; CALLEN DF, 1989, GENOMICS, V4, P348, DOI 10.1016/0888-7543(89)90341-8; CLEMENTS PR, 1989, BIOCHEM J, V259, P199, DOI 10.1042/bj2590199; CLEMENTS PR, 1985, EUR J BIOCHEM, V152, P21, DOI 10.1111/j.1432-1033.1985.tb09158.x; COX DR, 1989, CYTOGENET CELL GENET, V51, P121, DOI 10.1159/000132788; DEISSEROTH A, 1977, CELL, V12, P205, DOI 10.1016/0092-8674(77)90198-2; HOPWOOD JJ, 1979, CLIN SCI, V57, P265, DOI 10.1042/cs0570265; HOPWOOD JJ, IN PRESS MOL BIOL ME; HOPWOOD JJ, 1989, HEPARIN CHEM BIOL PR, P190; KAMPINE JP, 1967, SCIENCE, V155, P86, DOI 10.1126/science.155.3758.86; MARKWELL MK, 1978, ANAL BIOCHEM, V87, P211; MULLER VJ, 1984, CLIN GENET, V26, P414; MYEROWITZ R, 1981, J BIOL CHEM, V256, P3044; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; ROME LH, 1978, ARCH BIOCHEM BIOPHYS, V189, P344, DOI 10.1016/0003-9861(78)90221-7; SCHUCHMAN EH, 1984, P NATL ACAD SCI-BIOL, V81, P1169, DOI 10.1073/pnas.81.4.1169; SCHUCHMAN EH, 1984, ENZYME, V31, P166, DOI 10.1159/000469519; SCHUCHMAN EH, 1988, J CLIN INVEST, V81, P98, DOI 10.1172/JCI113317; SCHUCHMAN EH, 1984, J BIOL CHEM, V259, P3132; SHAPIRO LJ, 1976, ARCH BIOCHEM BIOPHYS, V172, P156, DOI 10.1016/0003-9861(76)90061-8; SUTHERLAND GR, 1988, AM J HUM GENET, V43, P331; VANKESSEL AHMG, 1983, P NATL ACAD SCI-BIOL, V80, P3748	23	70	76	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					802	807						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220820				2022-12-18	WOS:A1990EE94000006
J	MERRY, DE; LESKO, JG; SOSNOSKI, DM; LEWIS, RA; LUBINSKY, M; TRASK, B; VANDENENGH, G; COLLINS, FS; NUSSBAUM, RL				MERRY, DE; LESKO, JG; SOSNOSKI, DM; LEWIS, RA; LUBINSKY, M; TRASK, B; VANDENENGH, G; COLLINS, FS; NUSSBAUM, RL			CHOROIDEREMIA AND DEAFNESS WITH STAPES FIXATION - A CONTIGUOUS GENE DELETION SYNDROME IN XQ21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,37TH & HAMILTON WALK,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104; UNIV CALIF LAWRENCE LIVERMORE LAB,DIV BIOMED & ENVIRONM HLTH,LIVERMORE,CA 94550; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; BAYLOR UNIV,CULLEN EYE INST,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030; CHILDRENS MEM HOSP,CTR CLIN GENET,OMAHA,NE; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor University; Baylor College of Medicine; Baylor University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17665] Funding Source: Medline; NIGMS NIH HHS [GM34960] Funding Source: Medline; PHS HHS [R01-06566] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; AYAZI S, 1981, AM J OPHTHALMOL, V92, P63, DOI 10.1016/S0002-9394(14)75909-4; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; BRUNNER HG, 1988, HUM GENET, V80, P337, DOI 10.1007/BF00273647; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; CREMERS CWRJ, 1985, ARCH OTOLARYNGOL, V111, P249; CREMERS FPM, 1987, CLIN GENET, V32, P421; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1985, AM J HUM GENET, V37, P250; GAL A, 1986, HUM GENET, V73, P123, DOI 10.1007/BF00291600; HODGSON SV, 1987, HUM GENET, V75, P286, DOI 10.1007/BF00281076; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LESKO JG, 1987, AM J HUM GENET, V40, P303; MACDONALD IM, 1987, HUM GENET, V77, P233, DOI 10.1007/BF00284475; MANDEL J-L, 1988, Cytogenetics and Cell Genetics, V49, P107, DOI 10.1159/000132662; Maniatis T., 1982, MOL CLONING; McCULLOCH C, 1948, Trans Am Acad Ophthalmol Otolaryngol, V52, P160; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; NANCE W E, 1971, Birth Defects Original Article Series, V7, P64; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P473; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; ROSENBERG T, 1986, OPHTHALMIC PAED GEN, V7, P205, DOI 10.3109/13816818609004140; SANKILA EM, 1987, CLIN GENET, V31, P315; SCHNUR RE, 1989, AM J HUM GENET, V44, P248; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SCHWARTZ M, 1986, HUM GENET, V74, P449, DOI 10.1007/BF00280505; SCHWARTZ M, 1988, HUM GENET, V78, P156, DOI 10.1007/BF00278188; SIU V M, 1988, American Journal of Human Genetics, V43, pA96; SORSBY A, 1952, BRIT J OPHTHALMOL, V36, P547, DOI 10.1136/bjo.36.10.547; TABOR A, 1983, HUM GENET, V64, P196, DOI 10.1007/BF00327127; THORPE P, 1974, S AFR MED J, V48, P587; VANDENENGH G, 1988, CYTOMETRY, V9, P266; VANDENENGH GJ, 1985, CYTOMETRY, V6, P92, DOI 10.1002/cyto.990060203; WALLIS C, 1988, GENOMICS, V3, P299, DOI 10.1016/0888-7543(88)90119-X	41	70	70	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					530	540						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2491012				2022-12-18	WOS:A1989AW39500006
J	MISRA, BC; SRIVATSAN, ES				MISRA, BC; SRIVATSAN, ES			LOCALIZATION OF HELA-CELL TUMOR-SUPPRESSOR GENE TO THE LONG ARM OF CHROMOSOME-II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP, DIV HEMATOL ONCOL, 4650 SUNSET BLVD, LOS ANGELES, CA 90027 USA	Children's Hospital Los Angeles					NATIONAL CANCER INSTITUTE [R29CA047206] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47206] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CLEWELL DB, 1969, P NATL ACAD SCI USA, V62, P1159, DOI 10.1073/pnas.62.4.1159; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DER CJ, 1978, CELL, V15, P1241, DOI 10.1016/0092-8674(78)90050-8; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; FEARON ER, 1985, NATURE, V318, P337; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P1922, DOI 10.1093/nar/14.4.1922; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; HARRIS H, 1971, PROC R SOC SER B-BIO, V179, P1, DOI 10.1098/rspb.1971.0078; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; JOLLY DJ, 1982, P NATL ACAD SCI-BIOL, V79, P5038, DOI 10.1073/pnas.79.16.5038; KAELBLING M, 1986, CYTOGENET CELL GENET, V41, P65, DOI 10.1159/000132206; KARATHANASIS SK, 1983, P NATL ACAD SCI-BIOL, V80, P6147, DOI 10.1073/pnas.80.20.6147; KLINGER HP, 1978, CYTOGENET CELL GENET, V22, P245, DOI 10.1159/000130947; KLINGER HP, 1982, CYTOGENET CELL GENET, V32, P68, DOI 10.1159/000131688; KLINGER HP, 1980, CYTOGENET CELL GENET, V27, P254, DOI 10.1159/000131494; KORNELUK RG, 1984, J BIOL CHEM, V259, P3819; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KUCHERLAPATI R, 1979, CELL, V16, P639, DOI 10.1016/0092-8674(79)90037-0; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Maslen CL, 1988, GENOMICS, V2, P66, DOI 10.1016/0888-7543(88)90110-3; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1989, AM J HUM GENET, V44, P751; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PASQUALE SR, 1988, CANCER RES, V48, P2715; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; SAXON PJ, 1985, MOL CELL BIOL, V5, P140, DOI 10.1128/MCB.5.1.140; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SRIVATSAN ES, 1986, CANCER RES, V46, P6174; STANBRIDGE EJ, 1981, SOMAT CELL GENET, V7, P699, DOI 10.1007/BF01538758; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; STARK B, 1989, CANCER-AM CANCER SOC, V63, P117, DOI 10.1002/1097-0142(19890101)63:1<117::AID-CNCR2820630119>3.0.CO;2-7; TANG A, 1989, ONCOGENE, V4, P401; TURCCAREL C, 1984, CANCER GENET CYTOGEN, V12, P1, DOI 10.1016/0165-4608(84)90002-5; WARNICH L, 1986, NUCLEIC ACIDS RES, V14, P1920, DOI 10.1093/nar/14.4.1920; WEISSMAN BE, 1987, SCIENCE, V236, P175, DOI 10.1126/science.3031816; Yunis J J, 1986, Important Adv Oncol, P93	48	70	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					565	577						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2577469				2022-12-18	WOS:A1989AW39500010
J	BUDARF, M; SELLINGER, B; GRIFFIN, C; EMANUEL, BS				BUDARF, M; SELLINGER, B; GRIFFIN, C; EMANUEL, BS			COMPARATIVE MAPPING OF THE CONSTITUTIONAL AND TUMOR-ASSOCIATED 11,22 TRANSLOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP PHILADELPHIA,34TH & CIV CTR BLVD,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania					NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032592] Funding Source: NIH RePORTER; NCI NIH HHS [CA39926] Funding Source: Medline; NIGMS NIH HHS [GM32592] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; ANDERSON MLM, 1985, NUCLEIC ACIDS RES, V13, P2931, DOI 10.1093/nar/13.8.2931; ANDERSON MLM, 1984, NUCLEIC ACIDS RES, V12, P6647, DOI 10.1093/nar/12.17.6647; AURIAS A, 1978, HUM GENET, V45, P259, DOI 10.1007/BF00278725; AURIAS A, 1984, CANCER GENET CYTOGEN, V12, P21, DOI 10.1016/0165-4608(84)90003-7; BAUER SR, 1988, IMMUNOGENETICS, V28, P328, DOI 10.1007/BF00364231; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BUDARF M, 1987, American Journal of Human Genetics, V41, pA114; BUDARF M, 1988, Genomics, V3, P168, DOI 10.1016/0888-7543(88)90149-8; BUDARF M, IN PRESS CYTOGENET C; BUDARF M, 1988, AM J HUM GENET, V42, pA139; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CROCE CM, 1983, P NATL ACAD SCI-BIOL, V80, P6922, DOI 10.1073/pnas.80.22.6922; CROCE CM, 1987, P NATL ACAD SCI USA, V84, P7174, DOI 10.1073/pnas.84.20.7174; DALLAFAVERA R, 1982, SCIENCE, V218, P686, DOI 10.1126/science.6291150; DETAISNE C, 1984, NATURE, V310, P581, DOI 10.1038/310581a0; DIAZ MO, 1986, SCIENCE, V231, P265, DOI 10.1126/science.3455787; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EMANUAL BS, 1984, CYTOGENET CELL GENET, V38, P127, DOI 10.1159/000132044; EMANUEL BS, 1985, NUCLEIC ACIDS RES, V13, P381, DOI 10.1093/nar/13.2.381; ERIKSON J, 1981, NATURE, V294, P173, DOI 10.1038/294173a0; ERIKSON J, 1986, P NATL ACAD SCI USA, V83, P1807, DOI 10.1073/pnas.83.6.1807; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; GATTI RA, 1987, CYTOGENET CELL GENET, V46, P618; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GLASER TM, 1987, CYTOGENET CELL GENET, V46, P621; GRIFFIN CA, 1986, P NATL ACAD SCI USA, V83, P6122, DOI 10.1073/pnas.83.16.6122; HALUSKA FG, 1987, ANNU REV GENET, V21, P321, DOI 10.1146/annurev.ge.21.120187.001541; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; HAMERTON JL, 1975, CLIN GENET, V8, P223; HEDIGER MA, 1989, GENOMICS, V4, P297, DOI 10.1016/0888-7543(89)90333-9; HEIM S, 1987, CANCER CYTOGENETICS; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HOFKER MH, 1985, NUCLEIC ACIDS RES, V13, P7167, DOI 10.1093/nar/13.19.7167; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; KARATHANASIS SK, 1983, P NATL ACAD SCI-BIOL, V80, P6147, DOI 10.1073/pnas.80.20.6147; KARATHANASIS SK, 1983, NATURE, V304, P371, DOI 10.1038/304371a0; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KRAPCHO K, 1988, NUCLEIC ACIDS RES, V16, P5221, DOI 10.1093/nar/16.11.5221; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P648; Maniatis T., 1982, MOL CLONING; Maslen CL, 1988, GENOMICS, V2, P66, DOI 10.1016/0888-7543(88)90110-3; MCDERMID H E, 1987, American Journal of Human Genetics, V41, pA228; MCDERMID HE, 1986, CHROMOSOMA, V94, P228, DOI 10.1007/BF00288497; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; MCKEON C, 1988, CANCER RES, V48, P4307; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P377, DOI 10.1093/nar/16.1.377; NIELSEN J, 1976, CLIN GENET, V10, P161; RAICH N, 1986, NUCLEIC ACIDS RES, V14, P5955, DOI 10.1093/nar/14.15.5955; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; ROULEAU GA, 1988, NUCLEIC ACIDS RES, V16, P1646, DOI 10.1093/nar/16.4.1646; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; Schinzel A, 1983, CATALOGUE UNBALANCED; SEKI T, 1985, P NATL ACAD SCI USA, V82, P6657, DOI 10.1073/pnas.82.19.6657; SELDEN JR, 1983, P NATL ACAD SCI-BIOL, V80, P7289, DOI 10.1073/pnas.80.23.7289; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAM K, 1985, NEW ENGL J MED, V313, P1429, DOI 10.1056/NEJM198512053132301; TRENT J M, 1988, Cytogenetics and Cell Genetics, V49, P236, DOI 10.1159/000132669; TSUJIMOTO Y, 1984, NUCLEIC ACIDS RES, V12, P8407, DOI 10.1093/nar/12.22.8407; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; TURCCAREL C, 1984, CANCER GENET CYTOGEN, V12, P1, DOI 10.1016/0165-4608(84)90002-5; VANDENELSEN P, 1984, NATURE, V312, P413, DOI 10.1038/312413a0; VANKESSEL AG, 1985, MOL CELL BIOL, V5, P427, DOI 10.1128/MCB.5.2.427; VANKEUREN ML, 1987, CYTOGENET CELL GENET, V44, P142, DOI 10.1159/000132358; WANG AL, 1981, P NATL ACAD SCI-BIOL, V78, P5734, DOI 10.1073/pnas.78.9.5734; WARNICH L, 1986, NUCLEIC ACIDS RES, V14, P1920, DOI 10.1093/nar/14.4.1920; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	77	70	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					128	139						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2741943				2022-12-18	WOS:A1989AE77900016
J	MAJUMDER, PP; DAS, SK; LI, CC				MAJUMDER, PP; DAS, SK; LI, CC			A GENETIC MODEL FOR VITILIGO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIAN STAT INST,CALCUTTA 700035,W BENGAL,INDIA	Indian Statistical Institute; Indian Statistical Institute Kolkata	MAJUMDER, PP (corresponding author), UNIV PITTSBURGH,DEPT BIOSTAT,DIV HUMAN GENET,PITTSBURGH,PA 15261, USA.							BEHL P N, 1955, J Indian Med Assoc, V24, P615; CARNEVALE A, 1980, REV INVEST CLIN, V32, P37; Cockayne EA, 1933, INHERITED ABNORMALIT; DAS S K, 1985, Genetic Epidemiology, V2, P255, DOI 10.1002/gepi.1370020303; DAS SK, 1985, GENET EPIDEMIOL, V2, P71; El-Mofty A. M., 1968, VITILIGO PSORALENS; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; GOUDIE RB, 1980, LANCET, V2, P285; HAFEZ M, 1983, ACTA DERM-VENEREOL, V63, P249; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; LERNER AB, 1959, J INVEST DERMATOL, V32, P285, DOI 10.1038/jid.1959.49; LEVAI M, 1958, ARCH DERMATOL, V78, P364, DOI 10.1001/archderm.1958.01560090080017; LI CC, 1987, AM J HUM GENET, V41, P517; MEHTA NR, 1973, INDIAN J MED RES, V61, P145; MERELENDER J, 1940, ACTA DERM-VENEREOL, V21, P583; METZKER A, 1980, DERMATOLOGICA, V160, P100, DOI 10.1159/000250480; MOHR JAN, 1951, ACTA GENET ET STATIST MED, V2, P252; MOSHER DB, 1979, DERMATOLOGY GENERAL, P582; NAUGHTON GK, 1986, J AM ACAD DERMATOL, V15, P978, DOI 10.1016/S0190-9622(86)70260-0; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; QUEVEDO WC, 1987, DERMATOLOGY GENERAL, V1, P224; SIEMENS H W, 1953, Acta Genet Med Gemellol (Roma), V2, P118; WASFI AI, 1980, CLIN GENET, V17, P415; 1984, P NATIONAL S PIGMENT, P1	24	70	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1988	43	2					119	125						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P6084	3400640				2022-12-18	WOS:A1988P608400002
J	ESTIVILL, X; FARRALL, M; WILLIAMSON, R; FERRARI, M; SEIA, M; GIUNTA, AM; NOVELLI, G; POTENZA, L; DALLAPICOLLA, B; BORGO, G; GASPARINI, P; PIGNATTI, PF; DEBENEDETTI, L; VITALE, E; DEVOTO, M; ROMEO, G				ESTIVILL, X; FARRALL, M; WILLIAMSON, R; FERRARI, M; SEIA, M; GIUNTA, AM; NOVELLI, G; POTENZA, L; DALLAPICOLLA, B; BORGO, G; GASPARINI, P; PIGNATTI, PF; DEBENEDETTI, L; VITALE, E; DEVOTO, M; ROMEO, G			LINKAGE DISEQUILIBRIUM BETWEEN CYSTIC-FIBROSIS AND LINKED DNA POLYMORPHISMS IN ITALIAN FAMILIES - A COLLABORATIVE STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LONDON,ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,NORFOLK PL,LONDON W2 1PG,ENGLAND; IST GIANNINA GASLINI,GENET MOLEC LAB,GENOA,ITALY; UNIV VERONA,FAC MED & CHIRURG,IST SCI BIOL,I-37100 VERONA,ITALY; UNIV MILAN,IST CLIN PERDEZIONAMENTO,RIC CLIN LAB,I-20133 MILANO,ITALY; UNIV MILAN,PEDIAT CLIN 1,I-20133 MILANO,ITALY; UNIV URBINO,CATTEDRA GENET,I-61029 URBINO,ITALY; UNIV ROMA 2,DIPARTIMENTO SANITA PUBBL & BIOL CELLULAIRE,ROMA,ITALY; OSPED BORGO TRENTO,CTR REG VENETO FIBROSI CIST,TRENTO,ITALY	Imperial College London; University of London; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; University of Milan; University of Milan; University of Urbino; University of Rome Tor Vergata			Ferrari, Maurizio/D-9107-2013; Estivill, Xavier/A-3125-2013; Gasparini, Paolo/B-6173-2014; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Devoto, Marcella/AAP-7595-2021; Novelli, Giuseppe/A-5195-2013	Estivill, Xavier/0000-0002-0723-2256; Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; DEVOTO, MARCELLA/0000-0002-4431-5114; Potenza, Lucia/0000-0003-3619-9413; Vitale, Emilia/0000-0003-4651-3875				BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CHAKRABORTY R, 1987, HUM GENET, V76, P40; COX DR, 1970, METHUEN STATISTICAL; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FARRALL M, 1987, LANCET, V2, P156; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WAINWRIGHT BJ, IN PRESS EMBO J; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	11	70	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					23	28						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	2897786				2022-12-18	WOS:A1988N986300004
J	LATHROP, GM; FARRALL, M; OCONNELL, P; WAINWRIGHT, B; LEPPERT, M; NAKAMURA, Y; LENCH, N; KRUYER, H; DEAN, M; PARK, M; VANDEWOUDE, G; LALOUEL, JM; WILLIAMSON, R; WHITE, R				LATHROP, GM; FARRALL, M; OCONNELL, P; WAINWRIGHT, B; LEPPERT, M; NAKAMURA, Y; LENCH, N; KRUYER, H; DEAN, M; PARK, M; VANDEWOUDE, G; LALOUEL, JM; WILLIAMSON, R; WHITE, R			REFINED LINKAGE MAP OF CHROMOSOME-7 IN THE REGION OF THE CYSTIC-FIBROSIS GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; ST MARYS HOSP, LONDON, ENGLAND; NCI, LITTON BIONET, FREDERICK, MD 21701 USA	Utah System of Higher Education; University of Utah; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	LATHROP, GM (corresponding author), UNIV UTAH, MED CTR, HOWARD HUGHES MED INST, 603 WINTROBE BLDG, SALT LAKE CITY, UT 84132 USA.		; Dean, Michael/G-8172-2012	Lench, Nicholas/0000-0002-6108-0759; Wainwright, Brandon/0000-0003-0406-2092; Dean, Michael/0000-0003-2234-0631				BEAUDET A, 1986, AM J HUM GENET, V39, P681; BUCHWALD M, 1986, CYTOGENET CELL GENET, V41, P234, DOI 10.1159/000132235; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DONISKELLER H, 1986, COLD SPRING HARB SYM, V51, P317, DOI 10.1101/SQB.1986.051.01.037; EIBERG H, 1985, CLIN GENET, V28, P265; FARRALL M, 1986, AM J HUM GENET, V39, P713; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MORTON C, 1985, CYTOGENET CELL GENET, V40, P703; SCAMBLER PJ, 1985, LANCET, V2, P1241; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; TSUI LC, 1986, AM J HUM GENET, V39, P720; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WAINWRIGHT BJ, 1987, AM J HUM GENET, V41, P944; WHITE R, 1986, AM J HUM GENET, V39, P694; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WHITE R, 1987, ADV HUM GENET, V16, P121	20	70	71	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					38	44						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2892400				2022-12-18	WOS:A1988L869700005
J	MEYERS, DA; BEATY, TH; FREIDHOFF, LR; MARSH, DG				MEYERS, DA; BEATY, TH; FREIDHOFF, LR; MARSH, DG			INHERITANCE OF TOTAL SERUM IGE (BASAL LEVELS) IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH HYG,DEPT EPIDEMIOL,BALTIMORE,MD 21218	Johns Hopkins University	MEYERS, DA (corresponding author), JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,SCH MED,DEPT MED,DIV CLIN IMMUNOL,5601 LOCH RAVEN BLVD,BALTIMORE,MD 21239, USA.				NIAID NIH HHS [AI-20059] Funding Source: Medline; NIGMS NIH HHS [GM-32502] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032502] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P106, DOI 10.1016/0091-6749(81)90167-6; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BLUMENTHAL MN, 1974, SCIENCE, V184, P1301, DOI 10.1126/science.184.4143.1301; BLUMENTHAL MN, 1981, AM J MED GENET, V10, P219, DOI 10.1002/ajmg.1320100304; BORECKI I B, 1985, Genetic Epidemiology, V2, P327, DOI 10.1002/gepi.1370020402; FREIDHOFF LR, 1983, J ALLERGY CLIN IMMUN, V72, P274, DOI 10.1016/0091-6749(83)90032-5; FREIDHOFF LR, 1981, AM J MED GENET, V9, P323, DOI 10.1002/ajmg.1320090409; FREIDHOFF LR, 1986, INT ARCH ALLER A IMM, V79, P188, DOI 10.1159/000233969; FREIDHOFF LR, 1987, IN PRESS GENETIC ENV; GERRARD JW, 1974, J PEDIATR-US, V85, P660, DOI 10.1016/S0022-3476(74)80510-X; GERRARD JW, 1978, AM J HUM GENET, V30, P46; HASSTEDT SJ, 1983, AM J MED GENET, V14, P61, DOI 10.1002/ajmg.1320140110; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603; MEYERS DA, 1981, J ALLERGY CLIN IMMUN, V67, P167, DOI 10.1016/0091-6749(81)90056-7; MEYERS DA, 1983, AM J MED GENET, V16, P575, DOI 10.1002/ajmg.1320160414; MEYERS DA, 1986, J ALLERGY CLIN IMMUN, V77, P608, DOI 10.1016/0091-6749(86)90354-4; MEYERS DA, 1982, HUM HERED, V32, P15, DOI 10.1159/000153262; SCHELLENBERG RR, 1975, J IMMUNOL, V115, P1577; WARREN CPW, 1982, J ALLERGY CLIN IMMUN, V69, P370, DOI 10.1016/0091-6749(82)90148-8; WATANABE N, 1976, J EXP MED, V143, P833, DOI 10.1084/jem.143.4.833; WILLCOX HNA, 1978, IMMUNOGENETICS, V6, P209, DOI 10.1007/BF01563911	25	70	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1987	41	1					51	62						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J0581	3605096				2022-12-18	WOS:A1987J058100005
J	HOOK, EB; CROSS, PK				HOOK, EB; CROSS, PK			EXTRA STRUCTURALLY ABNORMAL CHROMOSOMES (ESAC) DETECTED AT AMNIOCENTESIS - FREQUENCY IN APPROXIMATELY 75,000 PRENATAL CYTOGENETIC DIAGNOSES AND ASSOCIATIONS WITH MATERNAL AND PATERNAL AGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	Albany Medical College	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,BUR ENVIRONM EPIDEMIOL & OCCUPAT HLTH,ALBANY,NY 12237, USA.							BENN PA, 1984, AM J HUM GENET, V36, P1092; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CAROTHERS AD, 1978, ANN HUM GENET, V41, P227; CONNOR JM, 1984, J MED GENET, V21, P213, DOI 10.1136/jmg.21.3.213; HOOK EB, 1983, AM J HUM GENET, V35, P96; HOOK EB, 1984, HUM GENET, V68, P211, DOI 10.1007/BF00418391; HOOK EB, 1981, POPULATION BIOL ASPE, P389; HOOK EB, PERINATAL GENETICS; LIEBER E, 1978, CLIN GENET, V14, P130; SAKAMOTO Y, 1978, ANN I STAT MATH, V30, P185, DOI 10.1007/BF02480213; SCHREINEMACHERS DM, 1982, HUM GENET, V61, P318; SINHA AK, 1985, CYTOBIOS, V43, P49; TOOMEY KE, 1977, CLIN GENET, V12, P275; VOGEL F, 1979, HUMAN GENETICS; WISNIEWSKI L, 1979, HUM GENET, V50, P259, DOI 10.1007/BF00399391; 1985, BIRTH DEFECTS ORIG A, V21, P1	16	70	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1987	40	2					83	101						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G7740	3471088				2022-12-18	WOS:A1987G774000002
J	ERICKSON, JM; SCHMICKEL, RD				ERICKSON, JM; SCHMICKEL, RD			A MOLECULAR-BASIS FOR DISCRETE SIZE VARIATION IN HUMAN RIBOSOMAL DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,DEPT HUMAN GENET,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-13506] Funding Source: Medline; NIGMS NIH HHS [T32-GM-07544] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; DORNEY DJ, 1984, THESIS U MICHIGAN AN; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; ERICKSON JM, 1981, GENE, V16, P1, DOI 10.1016/0378-1119(81)90055-X; FINANCSEK I, 1982, P NATL ACAD SCI-BIOL, V79, P3092, DOI 10.1073/pnas.79.10.3092; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; KABAYASHI I, 1983, GENETICS, V104, P549; KRYSTAL M, 1978, J MOL BIOL, V126, P91, DOI 10.1016/0022-2836(78)90281-4; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; LEDER P, 1977, SCIENCE, V196, P175, DOI 10.1126/science.322278; MANIATIS T, 1982, MOL CLONING LABORATO, P264; MIESFELD R, 1982, NUCLEIC ACIDS RES, V10, P3933, DOI 10.1093/nar/10.13.3933; MILLER DA, 1978, HUM GENET, V43, P289, DOI 10.1007/BF00278836; PETES TD, 1980, CELL, V19, P765, DOI 10.1016/S0092-8674(80)80052-3; RIMM DL, 1980, GENE, V12, P301, DOI 10.1016/0378-1119(80)90113-4; SCHMICKEL RD, 1977, PEDIATR RES, V11, P929, DOI 10.1203/00006450-197708000-00015; SCHMICKEL RD, 1973, PEDIATR RES, V7, P5, DOI 10.1203/00006450-197301000-00002; SCHMICKEL RD, 1980, AM J HUM GENET, V32, P890; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; SMITH HO, 1976, NUCLEIC ACIDS RES, V3, P2387, DOI 10.1093/nar/3.9.2387; SPRITZ RA, 1981, NUCLEIC ACIDS RES, V9, P5037, DOI 10.1093/nar/9.19.5037; STERNBERG N, 1977, GENE, V1, P255, DOI 10.1016/0378-1119(77)90049-X; TARTOF KD, 1973, COLD SPRING HARB SYM, V38, P491, DOI 10.1101/SQB.1974.038.01.053; WELLAUER PK, 1979, J MOL BIOL, V128, P289, DOI 10.1016/0022-2836(79)90089-5; WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367	28	70	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					311	325						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	2984926				2022-12-18	WOS:A1985AGY5900006
J	SUTHERLAND, GR; JACKY, PB; BAKER, EG				SUTHERLAND, GR; JACKY, PB; BAKER, EG			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .11. FACTORS AFFECTING EXPRESSION OF FRAGILE SITES AT 10Q25, 16Q22, AND 17P12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,DEPT HISTOPATHOL,CYTOGENET UNIT,N ADELAIDE,SA 5006,AUSTRALIA.		Baker, Elizabeth/HGC-9161-2022; Sutherland, Grant Robert/D-2606-2012					ASHMAN CR, 1981, MOL CELL BIOL, V1, P254, DOI 10.1128/MCB.1.3.254; COMINGS DE, 1975, CHROMOSOMA, V52, P229, DOI 10.1007/BF00332113; CONNER MK, 1978, CHROMOSOMA, V68, P303, DOI 10.1007/BF00327165; CROCI G, 1983, AM J HUM GENET, V35, P530; HAYMAN D, 1981, CHROMOSOMA, V83, P249, DOI 10.1007/BF00286793; JACKY PB, 1980, HUM GENET, V53, P267; JACKY PB, 1983, ANN GENET; LEDBETTER DH, 1982, AM J HUM GENET, V34, pA132; MAZRIMAS JA, 1978, EXP CELL RES, V117, P23, DOI 10.1016/0014-4827(78)90423-8; PETIT P, 1983, AM J HUM GENET, V35, P126; PIJNACKER LP, 1982, CHROMOSOMA, V85, P67, DOI 10.1007/BF00344594; PRANTERA G, 1979, CYTOGENET CELL GENET, V23, P103, DOI 10.1159/000131310; SCHMID M, 1980, CYTOGENET CELL GENET, V28, P87, DOI 10.1159/000131516; SHABTAI F, 1982, HUM GENET, V61, P177, DOI 10.1007/BF00274215; SUTHERLAND GR, 1983, INT REV CYTOL, V81, P107, DOI 10.1016/S0074-7696(08)62336-0; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERLAND GR, 1980, AM J HUM GENET, V32, P542; SUTHERLAND GR, 1982, AM J HUM GENET, V34, P753; TAYLOR AMR, 1983, AM J HUM GENET, V35, P123; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; ZAKHAROV AF, 1980, HUM GENET, V55, P259, DOI 10.1007/BF00291775; ZIMMER C, 1979, NUCLEIC ACIDS RES, V6, P2831, DOI 10.1093/nar/6.8.2831	23	70	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					110	122						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6198907				2022-12-18	WOS:A1984SC43000010
J	WEISS, KM; FERRELL, RE; HANIS, CL; STYNE, PN				WEISS, KM; FERRELL, RE; HANIS, CL; STYNE, PN			GENETICS AND EPIDEMIOLOGY OF GALLBLADDER-DISEASE IN NEW-WORLD NATIVE PEOPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, SCH MED, DEPT INTERNAL MED, DIV GASTROENTEROL, HOUSTON, TX 77030 USA	University of Texas System	WEISS, KM (corresponding author), UNIV TEXAS, GRAD SCH BIOMED SCI, CTR DEMOG & POPULAT GENET, HOUSTON, TX 77030 USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R23AM032895, R01AM027582] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA019311] Funding Source: NIH RePORTER; NCI NIH HHS [CA-19311] Funding Source: Medline; NIADDK NIH HHS [AM-32895, AM-27582] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMS JS, 1983, DIS COLON RECTUM, V26, P141, DOI 10.1007/BF02560154; Albores-Saavedra J, 1971, Gac Med Mex, V102, P193; ALBORESSAAVEDRA J, 1980, CANCER, V45, P919, DOI 10.1002/1097-0142(19800301)45:5<919::AID-CNCR2820450514>3.0.CO;2-4; [Anonymous], BIOCULTURAL ASPECTS; BAGHERI SA, 1978, GASTROENTEROLOGY, V74, P188; BAINTON D, 1976, NEW ENGL J MED, V294, P1147, DOI 10.1056/NEJM197605202942103; BISMUTH H, 1979, NEW ENGL J MED, V301, P704, DOI 10.1056/NEJM197909273011307; BLACK W, 1981, PROGR SURGICAL PATHO, P207; BLACK WC, 1977, CANCER, V39, P1267, DOI 10.1002/1097-0142(197703)39:3<1267::AID-CNCR2820390338>3.0.CO;2-0; BOSS LP, 1982, JNCI-J NATL CANCER I, V69, P1005; BOSS LP, 1981, THESIS U HAWAII HONO; BROWN JE, 1967, J AMER MED ASSOC, V202, P1050, DOI 10.1001/jama.202.11.1050; BROWN KS, 1958, AM J HUM GENET, V10, P175; BUCHANAN A, 1983, THESIS U TEXAS SCH P; BUCHANAN AV, 1984, COMP BIOMED RES; COMESS LJ, 1967, NEW ENGL J MED, V277, P894, DOI 10.1056/NEJM196710262771702; DANZINGER RG, 1972, MAYO CLIN PROC, V47, P762; Devor E, 1982, EPIDEMIOLOGY CANCER, P197; DEVOR EJ, 1979, CANCER GENET CYTOGEN, V1, P139, DOI 10.1016/0165-4608(79)90019-0; DIEHL AK, 1980, J NATL CANCER I, V65, P1209; DIEHL AK, 1980, SOUTHERN MED J, V73, P438, DOI 10.1097/00007611-198004000-00012; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Elandt-Johnson R C, 1980, SURVIVAL MODELS DATA; Erickson W G, 1972, Rocky Mt Med J, V69, P33; FERRELL R, UNPUB AMERINDIAN ADM; FRIEDMAN GD, 1966, J CHRON DIS, V19, P273, DOI 10.1016/0021-9681(66)90132-9; GEARE R, 1915, MED WORLD, V33, P86; GRACIE WA, 1982, NEW ENGL J MED, V307, P798, DOI 10.1056/NEJM198209233071305; GRUNDY SM, 1972, J CLIN INVEST, V51, P3026, DOI 10.1172/JCI107130; HANCOCK J. C., 1933, Southwestern Medicine, V17, P126; HANIS C, UNPUB GALLBLADDER DI; HANNA BL, 1953, AM J HUM GENET, V5, P377; HEATON KW, 1981, W DISEASES THEIR EME, P47; HENSON DE, 1983, J NATL CANCER I, V70, P979; HESSE FG, 1959, JAMA-J AM MED ASSOC, V170, P1789, DOI 10.1001/jama.1959.03010150033009; HILL MJ, 1983, GUT, V24, P871, DOI 10.1136/gut.24.10.871; HOLMES SL, 1971, SURG GYNECOL OBSTETR, V133, P561; KING H, 1980, JNCI-J NATL CANCER I, V65, P1141; KOLONEL LN, 1980, J NATL CANCER I, V65, P1127; KRAVETZ RE, 1964, GASTROENTEROLOGY, V46, P392; LAM RC, 1954, LANCET, P305; LANIER AP, 1982, J NCI MONOGRAPH, V62, P79; LANLER AP, 1980, J NATL CANCER I, V65, P1157; LOCKE FB, 1980, JNCI-J NATL CANCER I, V65, P1149; LOWENFELS AB, 1982, GASTROENTEROLOGY, V83, P672; LOWENFELS AB, 1980, GUT, V21, P1090, DOI 10.1136/gut.21.12.1090; MACDONALD EJ, 1978, EPIDEMIOLOGY CANCER; MACK T, 1982, EPIDEMIOLOGY CANCER, P227; MCLAUGHLIN CW, 1964, SURGERY, V56, P757; MEDINA E, 1976, B OFICINA SANITA MAR, P220; MORRIS DL, 1978, CANCER, V42, P2472, DOI 10.1002/1097-0142(197811)42:5<2472::AID-CNCR2820420550>3.0.CO;2-A; NAKAYAMA F, 1970, American Journal of Surgery, V120, P794, DOI 10.1016/S0002-9610(70)80052-6; NARISAWA T, 1983, DIS COLON RECTUM, V26, P512, DOI 10.1007/BF02563742; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEEL JV, 1982, GENETICS DIABETES ME, P283; PALMER RH, 1966, J CLIN INVEST, V45, P1255, DOI 10.1172/JCI105432; Puffer RR., 1967, PATTERNS URBAN MORTA, P353; REDDY BS, 1979, CANCER RES, V39, P1521; REED TE, 1974, SCIENCE, V185, P283, DOI 10.1126/science.185.4147.283; REICHENBACH DD, 1967, ARCH PATHOL, V84, P81; RELETHFORD JH, 1983, AM J PHYS ANTHROPOL, V61, P97, DOI 10.1002/ajpa.1330610110; RIOSDALENZ J, 1983, INT J EPIDEMIOL, V12, P156, DOI 10.1093/ije/12.2.156; RIOSDALENZ J, 1981, INT J CANCER, V28, P307, DOI 10.1002/ijc.2910280309; Rudolph R, 1970, Ariz Med, V27, P1; RUIZ PA, 1982, ACTA CYTOL, V26, P144; SALISBURY C, 1937, SW MED, V21, P230; SALISBURY CG, 1947, ARIZ MED, V4, P29; SAMPLINE.JE, 1968, ARCH SURG-CHICAGO, V96, P1; SAMPLINER RE, 1970, NEW ENGL J MED, V283, P1358, DOI 10.1056/NEJM197012172832502; SIEVERS ML, 1966, PUBLIC HEALTH REP, V81, P1075, DOI 10.2307/4592918; SIEVERS ML, 1962, JAMA-J AM MED ASSOC, V182, P570, DOI 10.1001/jama.1962.03050440062021; SILVERMAN SJ, 1977, J NATL CANCER I, V59, P1557, DOI 10.1093/jnci/59.5.1557; SPERLING MJ, 1964, JAMA-J AM MED ASSOC, V190, P944; SZATHMARY EJE, 1983, HUM BIOL, V55, P493; TAKABAYASHI A, 1981, GASTROENTEROLOGY, V80, P1352; THISTLE JL, 1971, NEW ENGL J MED, V284, P177, DOI 10.1056/NEJM197101282840404; THISTLE JL, 1971, MAYO CLIN PROC, V46, P603; Trowell HC, 1981, W DIS THEIR EMERGENC; VERNICK LJ, 1980, CANCER, V45, P392, DOI 10.1002/1097-0142(19800115)45:2<392::AID-CNCR2820450234>3.0.CO;2-9; WATERHOUSE J, 1982, CANCER INCIDENCE 5 C, V4; WEISS K, 1980, BANBURY REPORT, V4, P267; WEISS K, 1984, YB PHYS ANTHR, V27; WEISS KM, 1984, NEW ENGL J MED, V310, P657; WEISS KM, 1985, GENETIC EPIDEMIOLOGY; WEST KM, 1974, DIABETES, V23, P841, DOI 10.2337/diab.23.10.841; WEST KM, 1979, EPIDEMIOLOGY DIABETE; WILLIAMS CN, 1977, CAN MED ASSOC J, V117, P758; YOUNG JL, 1981, NCI MONOGRAPH, V57; YOUNG TK, 1983, AM J PUBLIC HEALTH, V73, P515, DOI 10.2105/AJPH.73.5.515	89	70	71	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1259	1278						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517051				2022-12-18	WOS:A1984TZ59000009
J	ROMEO, G; MENOZZI, P; FERLINI, A; FADDA, S; DIDONATO, S; UZIEL, G; LUCCI, B; CAPODAGLIO, L; FILLA, A; CAMPANELLA, G				ROMEO, G; MENOZZI, P; FERLINI, A; FADDA, S; DIDONATO, S; UZIEL, G; LUCCI, B; CAPODAGLIO, L; FILLA, A; CAMPANELLA, G			INCIDENCE OF FRIEDREICH ATAXIA IN ITALY ESTIMATED FROM CONSANGUINEOUS MARRIAGES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									ARCISPEDALE S MARIA NUOVA,REGGIO EMILIA,ITALY; UNIV NAPOLI,FAC MED 2,NEUROL CLIN,NAPOLI,ITALY; UNIV PARMA,IST ECOL,I-43100 PARMA,ITALY; IST NEUROL C BESTA,I-20133 MILAN,ITALY; UNIV ANCONA,MALATTIE NERVOSE CLIN,I-60100 ANCONA,ITALY	IRCCS Arcispedale S. Maria Nuova; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Parma; IRCCS Istituto Neurologico Besta; Marche Polytechnic University	ROMEO, G (corresponding author), UNIV BOLOGNA,NEUROL CLIN,SERV NEUROGENET,I-40123 BOLOGNA,ITALY.		MENOZZI, PAOLO/A-6234-2012; Di Donato, Stefano/B-9717-2012	MENOZZI, PAOLO/0000-0001-8638-7370; FERLINI, ALESSANDRA/0000-0001-8385-9870				BARBEAU A, 1976, Canadian Journal of Neurological Sciences, V3, P389; BARRAI I, 1965, AM J HUM GENET, V17, P220; BARRAI I, UNPUB INTRO SEGREGAT; CAMPANELLA G, 1980, CAN J NEUROL SCI, V7, P351, DOI 10.1017/S0317167100022873; CARUSO G, 1983, ACTA NEUROL SCAND; Dahlberg G, 1947, MATH METHODS POPULAT, P61; FILLA A, 1981, PHARMACOLOGY, V22, P66; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; MORONI A, 1977, HUMAN ADAPTABILITY, P153; MORONI A, 1964, ATTI A G I, V9, P220; ROMEO G, 1981, RIV ITAL PED, V7, P201; WINTER RM, 1981, CLIN GENET, V20, P419	12	70	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					523	529						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	QS160	6859045				2022-12-18	WOS:A1983QS16000017
J	BARON, M; SHAPIRO, E; SHAPIRO, A; RAINER, JD				BARON, M; SHAPIRO, E; SHAPIRO, A; RAINER, JD			GENETIC-ANALYSIS OF TOURETTE SYNDROME SUGGESTING MAJOR GENE EFFECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE PSYCHIAT INST, DEPT MED GENET, NEW YORK, NY 10032 USA; MT SINAI HOSP & MED CTR, DEPT PSYCHIAT, NEW YORK, NY 10029 USA	New York State Psychiatry Institute; Icahn School of Medicine at Mount Sinai	BARON, M (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PSYCHIAT, NEW YORK, NY 10032 USA.				NIMH NIH HHS [1K01MH00176] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARON M, 1981, ARCH GEN PSYCHIAT, V38, P79; BARON M, UNPUBLISHED; COHEN DJ, 1974, ARCH GEN PSYCHIAT, V31, P845; ELDRIDGE R, 1977, NEUROLOGY, V27, P115, DOI 10.1212/WNL.27.2.115; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; GERSHON ES, 1975, J PSYCHIATR RES, V12, P301, DOI 10.1016/0022-3956(75)90008-4; GOLDEN GS, 1977, AM J DIS CHILD, V131, P531, DOI 10.1001/archpedi.1977.02120180045008; HALDANE JBS, 1949, ANN EUGENIC, V14, P339; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; KIDD KK, 1973, GENETICS, V74, pS137; KIDD KK, 1976, J MED GENET, V13, P290, DOI 10.1136/jmg.13.4.290; LAKE CR, 1977, AM J PSYCHIAT, V134, P257; LARSSON T, 1954, ACTA PSYCHIATRICA S, V89, P40; MATTHYSSE SW, 1976, AM J PSYCHIAT, V133, P185; REICH T, 1979, ANN HUM GENET, V42, P371, DOI 10.1111/j.1469-1809.1979.tb00670.x; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; ROSS MS, 1977, LANCET, V1, P103; Shapiro A. K., 1978, GILLES TOURETTE SYND; SHAPIRO AK, 1973, J AM ACAD CHILD PSY, V12, P702, DOI 10.1016/S0002-7138(09)61277-2; SHAPIRO AK, 1981, MOVEMENT DISORDERS; SWEET RD, 1976, CLIN NEUROPHARMACOL, V1, P81, DOI 10.1097/00002826-197600010-00006; SWEET RD, 1973, J NEUROL NEUROSUR PS, V36, P1, DOI 10.1136/jnnp.36.1.1; VANWOERT MH, 1976, BASAL GANGLIA, P541; WASSMAN ER, 1978, NEUROLOGY, V28, P304, DOI 10.1212/WNL.28.3.304; WAYNE HL, 1972, CLIN ELECTROENCEPHAL, V3, P160; WILSON RS, 1978, BEHAV GENET, V8, P503, DOI 10.1007/BF01067479; 1980, DIAGNOSTIC STATISTIC	28	70	73	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	5					767	775						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ232	6945803				2022-12-18	WOS:A1981MJ23200013
J	LAURELL, CB; SVEGER, T				LAURELL, CB; SVEGER, T			MASS SCREENING OF NEWBORN SWEDISH INFANTS FOR ALPHA1-ANTITRYPSIN DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MALMO GEN HOSP, DEPT CLIN CHEM, MALMO, SWEDEN; MALMO GEN HOSP, DEPT PAEDIAT, MALMO, SWEDEN									ALTAY C, 1973, NEW ENGL J MED, V289, P754; BERG NO, 1972, NEW ENGL J MED, V287, P1264, DOI 10.1056/NEJM197212212872502; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; FAGERHOL MK, 1970, PROG MED GENET, V7, P96; LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P21, DOI 10.3109/00365517209102748; LAURELL CB, 1974, ACTA PAEDIATR SCAND, V63, P855, DOI 10.1111/j.1651-2227.1974.tb04876.x; LAURELL CB, 1973, BIOCHIM BIOPHYS ACTA, V310, P500, DOI 10.1016/0005-2795(73)90135-9; LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P247, DOI 10.3109/00365517209080237; LAURELL CB, 1973, FUNDAMENTAL PROBLEMS, P269; MARTIN JP, 1973, LANCET, V2, P845; MITTMAN C, 1973, ARCH ENVIRON HEALTH, V27, P201, DOI 10.1080/00039896.1973.10666352; PIERCE JM, IN PRESS; SHARP H L, 1971, Hospital Practice, V6, P83; TALAMO RC, 1971, J PEDIATR-US, V79, P20, DOI 10.1016/S0022-3476(71)80053-7; TALAMO RC, 1973, SCIENCE, V181, P70, DOI 10.1126/science.181.4094.70	15	70	72	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	2					213	217						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V9467	1079113				2022-12-18	WOS:A1975V946700007
J	EPSTEIN, CJ; BRADY, RO; SCHNEIDER, EL; BRADLEY, RM; SHAPIRO, D				EPSTEIN, CJ; BRADY, RO; SCHNEIDER, EL; BRADLEY, RM; SHAPIRO, D			IN-UTERO DIAGNOSIS OF NIEMANN-PICK DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BRADY RO, 1967, J BIOL CHEM, V242, P1021; BRADY RO, 1971, SCIENCE, V172, P174, DOI 10.1126/science.172.3979.174; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; BRADY RO, 1965, J BIOL CHEM, V240, P39; FUJIMOTO WY, 1968, LANCET, V2, P511; KANFER JN, 1966, J BIOL CHEM, V241, P1081; NADLER HL, 1970, NEW ENGL J MED, V282, P596, DOI 10.1056/NEJM197003122821105; NADLER HL, 1970, NEW ENGL J MED, V282, P302, DOI 10.1056/NEJM197002052820604; NADLER HL, 1969, LANCET, V2, P1277; SCHNECK L, 1970, LANCET, V1, P582; SLOAN HR, 1969, BIOCHEM BIOPH RES CO, V34, P582, DOI 10.1016/0006-291X(69)90777-3	11	70	70	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	5					533	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4744	4328491				2022-12-18	WOS:A1971K474400010
J	MACMAHON, B; MCKEOWN, T				MACMAHON, B; MCKEOWN, T			THE INCIDENCE OF HARELIP AND CLEFT PALATE RELATED TO BIRTH RANK AND MATERNAL AGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Fogh-Andersen, 1942, INHERITANCE HARELIP; Grace Linwood G., 1943, JOUR DENTAL RES, V22, P495, DOI 10.1177/00220345430220061001; HIXON E H, 1951, Can J Public Health, V42, P508; IVY R, 1951, 9TH AM AC CLEFT PAL; MCKEOWN T, 1951, ANN EUGENIC, V16, P249, DOI 10.1111/j.1469-1809.1951.tb02478.x; MUELLER G, 1946, THESIS U WISCONSIN; Reed SC, 1936, GENETICS, V21, P339; TIEDEMANN G, 1949, Z MENSCHL VERERB KON, V29, P231	8	70	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	2					176	183						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW630	13065265				2022-12-18	WOS:A1953XW63000007
J	Basmanav, FBU; Cau, L; Tafazzoli, A; Mechin, MC; Wolf, S; Romano, MT; Valentin, F; Wiegmann, H; Huchenq, A; Kandil, R; Bartels, NG; Kilic, A; George, S; Ralser, DJ; Bergner, S; Ferguson, DJP; Oprisoreanu, AM; Wehner, M; Thiele, H; Altmuller, J; Nurenberg, P; Swan, D; Houniet, D; Buuchner, A; Weibel, L; Wagner, N; Grimalt, R; Bygum, A; Serre, G; Blume-Peytavi, U; Sprecher, E; Schoch, S; Oji, V; Hamm, H; Farrant, P; Simon, M; Betz, RC				Basmanav, F. Buket U.; Cau, Laura; Tafazzoli, Aylar; Mechin, Marie-Claire; Wolf, Sabrina; Romano, Maria Teresa; Valentin, Frederic; Wiegmann, Henning; Huchenq, Anne; Kandil, Rima; Bartels, Natalie Garcia; Kilic, Arzu; George, Susannah; Ralser, Damian J.; Bergner, Stefan; Ferguson, David J. P.; Oprisoreanu, Ana-Maria; Wehner, Maria; Thiele, Holger; Altmueller, Janine; Nuerenberg, Peter; Swan, Daniel; Houniet, Darren; Buechner, Aline; Weibel, Lisa; Wagner, Nicola; Grimalt, Ramon; Bygum, Anette; Serre, Guy; Blume-Peytavi, Ulrike; Sprecher, Eli; Schoch, Susanne; Oji, Vinzenz; Hamm, Henning; Farrant, Paul; Simon, Michel; Betz, Regina C.			Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SCANNING-ELECTRON-MICROSCOPY; PEPTIDYLARGININE DEIMINASES; ECTODERMAL DYSPLASIA; DOMINANT INHERITANCE; CHEVEUX INCOIFFABLES; PILI-TRIANGULI; ET-CANALICULI; AUTOANTIBODIES; SKIN; TRICHOHYALIN	Uncombable hair syndrome (UHS), also known as "spun glass hair syndrome,'' "pili trianguli et canaliculi,'' or "cheveux incoiffables'' is a rare anomaly of the hair shaft that occurs in children and improves with age. UHS is characterized by dry, frizzy, spangly, and often fair hair that is resistant to being combed flat. Until now, both simplex and familial UHS-affected case subjects with autosomal-dominant as well as - recessive inheritance have been reported. However, none of these case subjects were linked to a molecular genetic cause. Here, we report the identification of UHS-causative mutations located in the three genes PADI3 (peptidylarginine deiminase 3), TGM3 (transglutaminase 3), and TCHH (trichohyalin) in a total of 11 children. All of these individuals carry homozygous or compound heterozygous mutations in one of these three genes, indicating an autosomal-recessive inheritance pattern in the majority of UHS case subjects. The two enzymes PADI3 and TGM3, responsible for posttranslational protein modifications, and their target structural protein TCHH are all involved in hair shaft formation. Elucidation of the molecular outcomes of the disease-causing mutations by cell culture experiments and tridimensional protein models demonstrated clear differences in the structural organization and activity of mutant and wildtype proteins. Scanning electron microscopy observations revealed morphological alterations in hair coat of Padi3 knockout mice. All together, these findings elucidate the molecular genetic causes of UHS and shed light on its pathophysiology and hair physiology in general.	[Basmanav, F. Buket U.; Tafazzoli, Aylar; Wolf, Sabrina; Romano, Maria Teresa; Kandil, Rima; Ralser, Damian J.; Bergner, Stefan; Wehner, Maria; Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Basmanav, F. Buket U.] Univ Med Ctr Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Basmanav, F. Buket U.] Univ Gottingen, Campus Lab Adv Imaging Microscopy & Spect, D-37073 Gottingen, Germany; [Cau, Laura; Mechin, Marie-Claire; Huchenq, Anne; Serre, Guy; Simon, Michel] CNRS, UMR5165, F-31059 Toulouse, France; [Cau, Laura; Mechin, Marie-Claire; Huchenq, Anne; Serre, Guy; Simon, Michel] INSERM, U1056, F-31059 Toulouse, France; [Cau, Laura; Mechin, Marie-Claire; Huchenq, Anne; Serre, Guy; Simon, Michel] Univ Toulouse, F-31059 Toulouse, France; [Valentin, Frederic; Wiegmann, Henning; Oji, Vinzenz] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Bartels, Natalie Garcia; Blume-Peytavi, Ulrike] Charite Univ Med Berlin, Dept Dermatol & Allergy, Clin Res Ctr Hair & Skin Sci, D-10117 Berlin, Germany; [Kilic, Arzu] Balikesir Univ, Sch Med, Dept Dermatol, TR-10100 Balikesir, Turkey; [George, Susannah; Farrant, Paul] Brighton Gen Hosp, Brighton & Sussex Univ Hosp NHS Trust, Dept Dermatol, Brighton BN2 3EW, E Sussex, England; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Oprisoreanu, Ana-Maria; Schoch, Susanne] Univ Bonn, Dept Neuropathol, D-53127 Bonn, Germany; [Oprisoreanu, Ana-Maria; Schoch, Susanne] Univ Bonn, Dept Epileptol, D-53127 Bonn, Germany; [Thiele, Holger; Altmueller, Janine; Nuerenberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Altmueller, Janine] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Nuerenberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuerenberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Swan, Daniel; Houniet, Darren] Oxford Gene Technol, Computat Biol Grp, Oxford OX5 1PF, England; [Buechner, Aline; Weibel, Lisa] Univ Zurich Hosp, Univ Childrens Hosp Zurich, Pediat Dermatol Dept, CH-8032 Zurich, Switzerland; [Weibel, Lisa] Univ Zurich Hosp, Dept Dermatol, CH-8032 Zurich, Switzerland; [Wagner, Nicola] Clin Ctr Darmstadt, D-64297 Darmstadt, Germany; [Grimalt, Ramon] Univ Int Catalunya, Barcelona 08195, Spain; [Bygum, Anette] Odense Univ Hosp, Dept Dermatol, DK-5000 Odense, Denmark; [Bygum, Anette] Odense Univ Hosp, Allergy Ctr, DK-5000 Odense, Denmark; [Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64239 Tel Aviv, Israel; [Hamm, Henning] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, D-97080 Wurzburg, Germany	University of Bonn; University of Gottingen; University of Gottingen; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Balikesir University; Brighton and Sussex University Hospitals NHS Trust; Brighton General Hospital; University of Brighton; University of Oxford; University of Bonn; University of Bonn; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Klinikum Darmstadt; Universitat Internacional de Catalunya (UIC); University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Wurzburg	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany.	regina.betz@uni-bonn.de	Betz, Regina C/E-8591-2011; Thiele, Holger/ABE-6792-2020; /AAG-8046-2020; Simon, Michel/B-7308-2011	Betz, Regina C/0000-0001-5024-3623; Thiele, Holger/0000-0002-0169-998X; Simon, Michel/0000-0003-3655-6329; grimalt, ramon/0000-0001-7204-8626; Swan, Daniel/0000-0001-8978-8129; Oprisoreanu, Ana-Maria/0000-0002-9409-0830; Blume-Peytavi, Ulrike/0000-0003-3528-3752; Bygum, Anette/0000-0002-3004-0180; Altmuller, Janine/0000-0003-4372-1521; Weibel, Lisa/0000-0002-8696-8164; Oji, Vinzenz/0000-0003-1380-4828; Cau, Laura/0000-0002-2480-536X	Deutsche Forschungsgemeinschaft (DFG) [SFB1089]; German Ministry of Research and Education (BMBF) [01GQ0806]; European Union [602102]; German Research Foundation (DFG) [OJ 53/3-1]; University of Toulouse; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Excellence Cluster ImmunoSensation and was a recipient of a Heisenberg Professorship of the DFG [BE 2346/4-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Toulouse; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Excellence Cluster ImmunoSensation and was a recipient of a Heisenberg Professorship of the DFG(German Research Foundation (DFG))	P.N. is a founder, CEO, and shareholder of ATLAS Biolabs GmbH, which is a service provider for genomic analyses. We would like to thank the individuals and their families for participating in this study. We would like to acknowledge Dr. Marianne Chabod, the technical assistance of Carole Pons and Geraldine Offer, the Toulouse Rio Imagerie imaging (INSERM U1043) and electron microscopy (University of Toulouse) facilities, and the TAMM animal facility, in particular Laetitia Trottereau. We would like to thank Dr. Thomas Zillinger for providing us with HEK293T cells. We would like to acknowledge Dr. Thomas Butterbrodt from Bio-Rad Laboratories GmbH and Dr. Kourosh Zolghadr from Leica Biosystems for their technical assistance. S.S. is supported by the Deutsche Forschungsgemeinschaft (DFG, SFB1089), the German Ministry of Research and Education (BMBF, 01GQ0806), and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 602102 (EPITARGET). V.O. is supported by the German Research Foundation (DFG) (OJ 53/3-1). M.S. and G.S. are supported by The University of Toulouse, the Centre National de la Recherche Scientifique, and the Institut National de la Sante et de la Recherche Medicale. This work was further supported by local funding (BONFOR to R.C.B. and S.S.). R.C.B. is a member of the DFG-funded Excellence Cluster ImmunoSensation and was a recipient of a Heisenberg Professorship of the DFG (BE 2346/4-2).	Anquetil F, 2015, J IMMUNOL, V194, P3664, DOI 10.4049/jimmunol.1402334; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Aufenvenne K, 2009, J INVEST DERMATOL, V129, P2068, DOI 10.1038/jid.2009.18; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brennan BM, 2015, MOL GENET METAB, V116, P187, DOI 10.1016/j.ymgme.2015.07.002; Calderon P, 2009, J AM ACAD DERMATOL, V61, P512, DOI 10.1016/j.jaad.2009.01.006; de Luna M M, 1985, Pediatr Dermatol, V2, P324; DUPRE A, 1973, B SOC FR DERMATOL SY, V80, P111; FERRANDO J, 1980, ANN DERMATOL VENER, V107, P243; GARTY B, 1982, ARCH DIS CHILD, V57, P710, DOI 10.1136/adc.57.9.710; HEBERT AA, 1987, AM J MED GENET, V28, P185, DOI 10.1002/ajmg.1320280126; Hicks J, 2001, ULTRASTRUCT PATHOL, V25, P99; John S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034252; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kilic A, 2013, ACTA DERMATOVENER CR, V21, P209; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MALLON E, 1994, BRIT J DERMATOL, V131, P608, DOI 10.1111/j.1365-2133.1994.tb04970.x; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mechin M.-C., 2007, International Journal of Cosmetic Science, V29, P147, DOI 10.1111/j.1467-2494.2007.00377.x; Mechin MC, 2010, CELL MOL LIFE SCI, V67, P1491, DOI 10.1007/s00018-010-0262-5; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Navarini AA, 2010, ARCH PEDIAT ADOL MED, V164, P1165, DOI 10.1001/archpediatrics.2010.228-a; Nissen Christoffer Valdemar, 2013, Ugeskr Laeger, V175, P2878; Novoa A, 2012, AN PEDIATR, V77, P139, DOI 10.1016/j.anpedi.2012.01.014; Posch A, 2013, JOVE-J VIS EXP, V82, P50948, DOI DOI 10.3791/50948; SENSHU T, 1995, J INVEST DERMATOL, V105, P163, DOI 10.1111/1523-1747.ep12317070; SHELLEY WB, 1985, J AM ACAD DERMATOL, V13, P97, DOI 10.1016/S0190-9622(85)70150-8; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Stroud J. D., 1973, 1 HUM HAIR S; Takahara H. S. G., 2014, PROTEIN DEIMINATION, P113; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; TRUEB RM, 1994, HAUTARZT, V45, P372, DOI 10.1007/s001050050086; Vincent C, 2005, AUTOIMMUNITY, V38, P17, DOI 10.1080/08916930400022582; Westgate GE, 2013, INT J COSMETIC SCI, V35, P329, DOI 10.1111/ics.12041	37	69	72	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1292	1304		10.1016/j.ajhg.2016.10.004	http://dx.doi.org/10.1016/j.ajhg.2016.10.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27866708	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-18	WOS:000389148600005
J	Thompson, K; Majd, H; Dallabona, C; Reinson, K; King, MS; Alston, CL; He, LP; Lodi, T; Jones, SA; Fattal-Valevski, A; Fraenkel, ND; Saada, A; Haham, A; Isohanni, P; Vara, R; Barbosa, IA; Simpson, MA; Deshpande, C; Puusepp, S; Bonnen, PE; Rodenburg, RJ; Suomalainen, A; Ounap, K; Elpeleg, O; Ferrero, I; McFarland, R; Kunji, ERS; Taylor, RW				Thompson, Kyle; Majd, Homa; Dallabona, Christina; Reinson, Karit; King, Martin S.; Alston, Charlotte L.; He, Langping; Lodi, Tiziana; Jones, Simon A.; Fattal-Valevski, Aviva; Fraenkel, Nitay D.; Saada, Ann; Haham, Alon; Isohanni, Pirjo; Vara, Roshni; Barbosa, Ines A.; Simpson, Michael A.; Deshpande, Charu; Puusepp, Sanna; Bonnen, Penelope E.; Rodenburg, Richard J.; Suomalainen, Anu; Ounap, Katrin; Elpeleg, Orly; Ferrero, Ileana; McFarland, Robert; Kunji, Edmund R. S.; Taylor, Robert W.			Recurrent De Novo Dominant Mutations in SLC2SA4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SUBSTRATE-BINDING SITE; ADP/ATP CARRIER; SACCHAROMYCES-CEREVISIAE; TRANSPORT MECHANISM; RESPIRATORY-CHAIN; ANT1 GENE; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION	Mutations in SLC25A4 encoding the mitochondrial ADP/ATP carrier AAC1 are well-recognized causes of mitochondrial disease. Several heterozygous SLC25A4 mutations cause adult-onset autosomal-dominant progressive external ophthalmoplegia associated with multiple mitochondrial DNA deletions, whereas recessive SLC25A4 mutations cause childhood-onset mitochondrial myopathy and cardiomyopathy. Here, we describe the identification by whole-exome sequencing of seven probands harboring dominant, de novo SLC25A4 mutations. All affected individuals presented at birth, were ventilator dependent and, where tested, revealed severe combined mitochondria' respiratory chain deficiencies associated with a marked loss of mitochondria' DNA copy number in skeletal muscle. Strikingly, an identical c.239G>A (p.Arg80His) mutation was present in four of the seven subjects, and the other three case subjects harbored the same c.703C>G (p.Arg235Gly) mutation. Analysis of skeletal muscle revealed a marked decrease of AAC1 protein levels and loss of respiratory chain complexes containing mitochondria' DNA-encoded subunits. We show that both recombinant AAC1 mutant proteins are severely impaired in ADP/ATP transport, affecting most likely the substrate binding and mechanics of the carrier, respectively. This highly reduced capacity for transport probably affects mitochondria' DNA maintenance and in turn respiration, causing a severe energy crisis. The confirmation of the pathogenicity of these de novo SLC25A4 mutations highlights a third distinct clinical phenotype associated with mutation of this gene and demonstrates that early-onset mitochondria' disease can be caused by recurrent de novo mutations, which has significant implications for the application and analysis of whole-exome sequencing data in mitochondrial disease.	[Thompson, Kyle; Alston, Charlotte L.; He, Langping; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Majd, Homa; King, Martin S.; Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus,Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England; [Dallabona, Christina; Lodi, Tiziana; Ferrero, Ileana] Univ Parma, Dept Life Sci, Parco Area Sci 11A, I-43124 Parma, Italy; [Reinson, Karit; Puusepp, Sanna; Ounap, Katrin] Univ Tartu, Dept Pediat, Inst Clin Med, EE-51014 Tartu, Estonia; [Reinson, Karit; Puusepp, Sanna; Ounap, Katrin] Tartu Univ Hosp, Dept Genet, United Labs, EE-51014 Tartu, Estonia; [Jones, Simon A.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, St Marys Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England; [Fattal-Valevski, Aviva] Tel Aviv Univ, Sackler Fac Med, Paediat Neurol Unit, Dana Children Hosp,Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; [Fraenkel, Nitay D.] Alyn Hosp, Dept Resp Rehabil, IL-91090 Jerusalem, Israel; [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Metab Lab Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel; [Haham, Alon] Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Neonatal Intens Care Unit, IL-64239 Tel Aviv, Israel; [Isohanni, Pirjo; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Mol Neurol, Res Programs Unit, FIN-00290 Helsinki, Finland; [Isohanni, Pirjo] Helsinki Univ Hosp, Childrens Hosp, Dept Pediat Neurol, Helsinki 00290, Finland; [Isohanni, Pirjo; Suomalainen, Anu] Univ Helsinki, FIN-00290 Helsinki, Finland; [Vara, Roshni] Evelina Childrens Hosp, Dept Paediat Inherited Metab Dis, London SE1 7EH, England; [Barbosa, Ines A.; Simpson, Michael A.] Kings Coll London, Sch Med, Div Genet & Mol Med, London SE1 9RY, England; [Deshpande, Charu] Guys & St Thomas NHS Fdn Trust, Clin Genet Unit, London SE1 9RT, England; [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Radboud Ctr Mitochondrial Med,Dept Paediat, NL-6525 GA Nijmegen, Netherlands; [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland; [Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel	Newcastle University - UK; University of Parma; University of Tartu; University of Manchester; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; ALYN Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Baylor College of Medicine; Radboud University Nijmegen; University of Helsinki; Helsinki University Central Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center	Taylor, RW (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	robert.taylor@ncl.ac.uk	Saada, Ann/J-6864-2017; Ounap, Katrin/Q-1103-2016; King, Martin S/B-6361-2012; Alston, Charlotte/ABG-9602-2020; Rodenburg, Richard/N-3579-2014; Reinson, Karit/AAJ-3939-2021; Kunji, Edmund/AAH-2362-2020; Simpson, Michael/F-4737-2011	Saada, Ann/0000-0003-2951-0656; Ounap, Katrin/0000-0002-4594-6364; Alston, Charlotte/0000-0003-2095-5464; Rodenburg, Richard/0000-0001-5227-3527; Kunji, Edmund/0000-0002-0610-4500; Simpson, Michael/0000-0002-8539-8753; King, Martin/0000-0001-6030-5154; DALLABONA, Cristina/0000-0003-4397-9143; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; jones, simon/0000-0002-5117-0566; Majd, Homa/0000-0002-2048-1839; McFarland, Robert/0000-0002-8833-2688	Wellcome Trust [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne; NIHR/CSO Healthcare Science Research Fellowship from the National Institute for Health Research [NIHR-HCS-D12-03-04]; Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with the King's College London; Medical Research Council UK [MC_U105663139]; Fondazione Telethon (Italy) [GGP15041]; Estonian Science Foundation [8175, PUT355]; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Academy of Finland; Helsinki University Hospital Funds; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS083726]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083726] Funding Source: NIH RePORTER; Medical Research Council [MC_U105663139] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-04] Funding Source: researchfish; MRC [MC_U105663139] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne; NIHR/CSO Healthcare Science Research Fellowship from the National Institute for Health Research; Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with the King's College London; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondazione Telethon (Italy)(Fondazione Telethon); Estonian Science Foundation; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Helsinki University Hospital Funds; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Strategic Award (096919/Z/11/Z), the MRC Centre for Neuromuscular Diseases (G0601943), the Lily Foundation, the UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne, an NIHR/CSO Healthcare Science Research Fellowship from the National Institute for Health Research (NIHR-HCS-D12-03-04 to C.L.A.), the Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with the King's College London, Medical Research Council UK (MC_U105663139) (E.R.S.K., M.S.K., H.M.), Fondazione Telethon (Italy) (grant GGP15041) (C. Dallabona, T.L., I.F.), Estonian Science Foundation (grants 8175 and PUT355) (K.R., K.O.), Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Academy of Finland and Helsinki University Hospital Funds (P.I., A. Suomalainen), and National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01NS083726) (P.E.B.). We would also like to thank the Genome Technology Center at the RadboudUMC and BGI Copenhagen (R.J.R.) and Institute of Molecular Medicine Finland (A. Suomalainen) for technical support of the exome sequencing, together with colleagues at the cell culture, muscle, and DNA laboratories of the Translational Metabolic Laboratory, RadboudUMC Nijmegen for excellent technical assistance (R.J.R.).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375; Clemencon B, 2013, MOL ASPECTS MED, V34, P485, DOI 10.1016/j.mam.2012.05.006; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fischer-Zirnsak B, 2015, AM J HUM GENET, V97, P483, DOI 10.1016/j.ajhg.2015.08.001; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goffrini P, 2009, HUM MOL GENET, V18, P1860, DOI 10.1093/hmg/ddp102; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kearney JA, 2006, PEDIATR NEUROL, V34, P116, DOI 10.1016/j.pediatrneurol.2005.07.009; King MS, 2016, BBA-BIOENERGETICS, V1857, P14, DOI 10.1016/j.bbabio.2015.09.013; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Korver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Kunji ERS, 2016, BBA-MOL CELL RES, V1863, P2379, DOI 10.1016/j.bbamcr.2016.03.015; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Kunji ERS, 2003, J BIOL CHEM, V278, P36985, DOI 10.1074/jbc.C300304200; LI K, 1989, J BIOL CHEM, V264, P13998; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Liu YX, 2015, MOL BIOL CELL, V26, P1985, DOI 10.1091/mbc.E15-01-0030; MAJANDER A, 1995, J NEUROL SCI, V134, P95, DOI 10.1016/0022-510X(95)00225-5; Mandel H., 2016, J MED GENET; Mifsud J, 2013, MOL MEMBR BIOL, V30, P160, DOI 10.3109/09687688.2012.745175; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1122, DOI 10.1016/j.ajhg.2012.10.013; Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Wagnon JL, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00104; Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y; Yang ZQ, 2013, OXID MED CELL LONGEV, V2013, DOI [10.1155/2013/329183, 10.1155/2013/146860]	70	69	71	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					860	876		10.1016/j.ajhg.2016.08.014	http://dx.doi.org/10.1016/j.ajhg.2016.08.014			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27693233	Green Published, hybrid			2022-12-18	WOS:000385333700006
J	Ilumae, AM; Reidla, M; Chukhryaeva, M; Jarve, M; Post, H; Karmin, M; Saag, L; Agdzhoyan, A; Kushniarevich, A; Litvinov, S; Ekomasova, N; Tambets, K; Metspalu, E; Khusainova, R; Yunusbayev, B; Khusnutdinova, EK; Osipova, LP; Fedorova, S; Utevska, O; Koshel, S; Balanovska, E; Behar, DM; Balanovsky, O; Kivisild, T; Underhill, PA; Villems, R; Rootsi, S				Ilumae, Anne-Mai; Reidla, Maere; Chukhryaeva, Marina; Jarve, Mari; Post, Helen; Karmin, Monika; Saag, Lauri; Agdzhoyan, Anastasiya; Kushniarevich, Alena; Litvinov, Sergey; Ekomasova, Natalya; Tambets, Kristiina; Metspalu, Ene; Khusainova, Rita; Yunusbayev, Bayazit; Khusnutdinova, Elza K.; Osipova, Ludmila P.; Fedorova, Sardana; Utevska, Olga; Koshel, Sergey; Balanovska, Elena; Behar, Doron M.; Balanovsky, Oleg; Kivisild, Toomas; Underhill, Peter A.; Villems, Richard; Rootsi, Siiri			Human Y Chromosome Haplogroup N: A Non-trivial Time-Resolved Phylogeography that Cuts across Language Families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTER-GATHERER; MITOCHONDRIAL-DNA; POPULATIONS; SIBERIA; MIGRATION; HOLOCENE; REVEALS; VEGETATION; DIVERSITY; SEQUENCE	The paternal haplogroup (hg) N is distributed from southeast Asia to eastern Europe. The demographic processes that have shaped the vast extent of this major Y chromosome lineage across numerous linguistically and autosomally divergent populations have previously been unresolved. On the basis of 94 high-coverage re-sequenced Y chromosomes, we establish and date a detailed hg N phylogeny. We evaluate geographic structure by using 16 distinguishing binary markers in 1,631 hg N Y chromosomes from a collection of 6,521 samples from 56 populations. The more southerly distributed sub-clade N4 emerged before N2a1 and N3, found mostly in the north, but the latter two display more elaborate branching patterns, indicative of regional contrasts in recent expansions. In particular, a number of prominent and well-defined clades with common N3a3 ' 6 ancestry occur in regionally dissimilar northern Eurasian populations, indicating almost simultaneous regional diversification and expansion within the last 5,000 years. This patrilineal genetic affinity is decoupled from the associated higher degree of language diversity.	[Ilumae, Anne-Mai; Reidla, Maere; Jarve, Mari; Post, Helen; Karmin, Monika; Saag, Lauri; Kushniarevich, Alena; Litvinov, Sergey; Tambets, Kristiina; Metspalu, Ene; Yunusbayev, Bayazit; Behar, Doron M.; Kivisild, Toomas; Villems, Richard; Rootsi, Siiri] Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia; [Ilumae, Anne-Mai; Reidla, Maere; Jarve, Mari; Post, Helen; Karmin, Monika; Saag, Lauri; Kushniarevich, Alena; Litvinov, Sergey; Tambets, Kristiina; Metspalu, Ene; Yunusbayev, Bayazit; Behar, Doron M.; Kivisild, Toomas; Villems, Richard; Rootsi, Siiri] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Chukhryaeva, Marina; Agdzhoyan, Anastasiya; Balanovsky, Oleg] Vavilov Inst Gen Genet, Moscow 119991, Russia; [Kushniarevich, Alena] Natl Acad Sci Belarus, Inst Cytol & Genet, Minsk 220072, BELARUS; [Litvinov, Sergey; Khusainova, Rita; Khusnutdinova, Elza K.] Russian Acad Sci, Inst Biochem & Genet, Ufa Sci Ctr, Ufa 450054, Russia; [Ekomasova, Natalya; Khusnutdinova, Elza K.] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Russia; [Osipova, Ludmila P.] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Osipova, Ludmila P.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Fedorova, Sardana] North Eastern Fed Univ, Yakutsk 677010, Sakha Republic, Russia; [Fedorova, Sardana] Yakut Res Ctr Complex Med Problems, Yakutsk 677010, Sakha Republic, Russia; [Utevska, Olga] Kharkov Natl Univ, UA-61022 Kharkov, Ukraine; [Koshel, Sergey] Lomonosov Moscow State Univ, Fac Geog, Moscow 119991, Russia; [Balanovska, Elena; Balanovsky, Oleg] Med Genet Res Ctr, Moscow 115478, Russia; [Kivisild, Toomas] Univ Cambridge, Cambridge CB2 3QG, England; [Underhill, Peter A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia	Estonian Biocentre; University of Tartu; University of Tartu; Russian Academy of Sciences; Vavilov Institute of General Genetics; National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; North-Eastern Federal University in Yakutsk; Yakut Science Centre of Complex Medical Problems; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; Lomonosov Moscow State University; Research Centre for Medical Genetics; University of Cambridge; Stanford University; Estonian Academy of Sciences	Rootsi, S (corresponding author), Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia.; Rootsi, S (corresponding author), Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia.	sroots@ebc.ee	Tambets, Kristiina/M-2568-2019; Saag, Lauri/H-3312-2012; Koshel, Sergey M/B-2662-2012; Litvinov, Sergey/L-1738-2013; Khusnutdinova, Elza Kamilevna/A-4810-2013; Yunusbaev, Bayazit/T-5444-2019; Ekomasova, Natalia V/Q-1723-2017; Kivisild, Toomas/P-5889-2017; Khusainova, Rita/E-6061-2014; Fedorova, Sardana/K-5445-2017; Agdzhoyan, Anastasia/G-1540-2014	Tambets, Kristiina/0000-0002-8173-6380; Saag, Lauri/0000-0002-0978-7415; Koshel, Sergey M/0000-0002-4540-2922; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Kivisild, Toomas/0000-0002-6297-7808; Khusainova, Rita/0000-0002-8643-850X; Agdzhoyan, Anastasia/0000-0002-8776-2934; Ilumae, Anne-Mai/0000-0001-6920-1335; Yunusbayev, Bayazit/0000-0002-6035-8763; Karmin, Monika/0000-0001-9827-5579; Post, Helen/0000-0002-9112-7589; Fedorova, Sardana/0000-0002-6952-3868	EU European Regional Development Fund through the Centre of Excellence in Genomics to the Estonian Biocentre; Estonian institutional research grant [IUT24-1]; Estonian personal research grant [PUT1217]; European Commission [205419 ECOGENE]; Russian Scientific Foundation [14-1400827]; Ministry of Education and Science of Russia [6.656]; Russian Foundation for Basic Research [14-04-00725-a, 16-06-00303-a, 14-06-00384-a]; Estonian personal grants [PUT-766, PUT1339]; SAP grant SP0 [115016];  [0324-2015-0004]; Russian Science Foundation [14-14-00827] Funding Source: Russian Science Foundation	EU European Regional Development Fund through the Centre of Excellence in Genomics to the Estonian Biocentre; Estonian institutional research grant; Estonian personal research grant; European Commission(European CommissionEuropean Commission Joint Research Centre); Russian Scientific Foundation(Russian Science Foundation (RSF)); Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Estonian personal grants; SAP grant SP0; ; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the EU European Regional Development Fund through the Centre of Excellence in Genomics to the Estonian Biocentre, by Estonian institutional research grant IUT24-1, by Estonian personal research grant PUT1217 to K.T., by European Commission grant 205419 ECOGENE to the Estonian Biocentre, by Russian Scientific Foundation grant 14-1400827 (to O.B., M.C, and A.A), by project no. 6.656 of the Ministry of Education and Science of Russia (to S.F.), and by Russian Foundation for Basic Research grants 14-04-00725-a (to E.K.), 16-06-00303-a (to E.B.), and 14-06-00384-a (to O.B., M.C., and A.A.). L.P.O. was supported by the federal budget under state project no. 0324-2015-0004. M.K. and A.K. acknowledge financial support from Estonian personal grants PUT-766 and PUT1339, respectively. P.A.U. was supported by SAP grant SP0#115016 to Prof. Carlos D. Bustamante.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Anderson PM, 2002, QUATERNARY RES, V57, P325, DOI 10.1006/qres.2002.2321; Andreev AA, 2003, BOREAS, V32, P484, DOI 10.1080/03009480310003388; Andreson R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-172; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Chernykh E, 2008, TRABAJOS PREHIST, V65, P73, DOI 10.3989/tp.2008.08004; Cui YQ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-216; Derenko M, 2007, J HUM GENET, V52, P763, DOI 10.1007/s10038-007-0179-5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gao SZ, 2015, AM J PHYS ANTHROPOL, V157, P71, DOI 10.1002/ajpa.22690; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Monserud RA, 1998, PALAEOGEOGR PALAEOCL, V139, P15, DOI 10.1016/S0031-0182(97)00127-2; Mooder KP, 2006, AM J PHYS ANTHROPOL, V129, P349, DOI 10.1002/ajpa.20247; Nazarova L, 2013, QUATERN INT, V290, P264, DOI 10.1016/j.quaint.2012.11.006; Nei M., 1987, MOL EVOLUTIONARY GEN; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Pimenoff VN, 2008, EUR J HUM GENET, V16, P1254, DOI 10.1038/ejhg.2008.101; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Sarkissian CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003296; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Weber AW, 2002, J ANTHROPOL ARCHAEOL, V21, P230, DOI 10.1006/jaar.2001.0395; Weber AW, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P1; Xue YL, 2005, AM J HUM GENET, V77, P1112, DOI 10.1086/498583; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zerjal T, 1997, AM J HUM GENET, V60, P1174; Zhao YB, 2014, AM J HUM BIOL, V26, P813, DOI 10.1002/ajhb.22604; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	56	69	88	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					163	173		10.1016/j.ajhg.2016.05.025	http://dx.doi.org/10.1016/j.ajhg.2016.05.025			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27392075	Bronze, Green Published			2022-12-18	WOS:000381616600013
J	Aldinger, KA; Mosca, SJ; Tetreault, M; Dempsey, JC; Ishak, GE; Hartley, T; Phelps, IG; Lamont, RE; O'Day, DR; Basel, D; Gripp, KW; Baker, L; Stephan, MJ; Bernier, FP; Boycott, KM; Majewski, J; Parboosingh, JS; Innes, AM; Doherty, D				Aldinger, Kimberly A.; Mosca, Stephen J.; Tetreault, Martine; Dempsey, Jennifer C.; Ishak, Gisele E.; Hartley, Taila; Phelps, Ian G.; Lamont, Ryan E.; O'Day, Diana R.; Basel, Donald; Gripp, Karen W.; Baker, Laura; Stephan, Mark J.; Bernier, Francois P.; Boycott, Kym M.; Majewski, Jacek; Parboosingh, Jillian S.; Innes, A. Micheil; Doherty, Dan		Univ Washington	Mutations in LAMA1 Cause Cerebellar Dysplasia and Cysts with and without Retinal Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LAMININ ALPHA-1; CORTICAL DYSPLASIA; MEMBRANE FORMATION; ABNORMALITIES; MALFORMATION; ZEBRAFISH; CHILDREN; COMPLEX; ATAXIA; GENES	Cerebellar dysplasia with cysts (CDC) is an imaging finding typically seen in combination with cobblestone cortex and congenital muscular dystrophy in individuals with dystroglycanopathies. More recently, CDC was reported in seven children without neuromuscular involvement (Poretti-Boltshauser syndrome). Using a combination of homozygosity mapping and whole-exome sequencing, we identified biallelic mutations in LAM41 as the cause of CDC in seven affected individuals (from five families) independent from those included in the phenotypic description of Poretti-Boltshauser syndrome. Most of these individuals also have high myopia, and some have retinal dystrophy and patchy increased T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) signal in cortical white matter. In one additional family, we identified two siblings who have truncating LAMA1 mutations in combination with retinal dystrophy and mild cerebellar dysplasia without cysts, indicating that cysts are not an obligate feature associated with loss of LAMA1 function. This work expands the phenotypic spectrum associated with the lamininopathy disorders and highlights the tissue-specific roles played by different laminin-encoding genes.	[Aldinger, Kimberly A.; Dempsey, Jennifer C.; Phelps, Ian G.; O'Day, Diana R.; Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Aldinger, Kimberly A.; Doherty, Dan] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Mosca, Stephen J.; Lamont, Ryan E.; Bernier, Francois P.; Parboosingh, Jillian S.; Innes, A. Micheil] Univ Calgary, Dept Med Genet, Res Inst Child & Maternal Hlth, Calgary, AB T3B 6A8, Canada; [Mosca, Stephen J.; Lamont, Ryan E.; Bernier, Francois P.; Parboosingh, Jillian S.; Innes, A. Micheil] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB T3B 6A8, Canada; [Tetreault, Martine] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Tetreault, Martine] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Ishak, Gisele E.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA 98105 USA; [Hartley, Taila; Boycott, Kym M.; Univ Washington] Univ Ottawa, Care4Rare, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Basel, Donald] Med Coll Wisconsin, Dept Pediat, Div Genet, Milwaukee, WI 53201 USA; [Gripp, Karen W.; Baker, Laura] Nemours Alfred I duPont Hosp Children, Div Med Genet, Wilmington, DE 19803 USA; [Stephan, Mark J.] Madigan Army Med Ctr, Dept Pediat, Tacoma, WA 98431 USA; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; McGill University; Seattle Children's Hospital; University of Ottawa; Children's Hospital of Eastern Ontario; Medical College of Wisconsin; Nemours Alfred I. duPont Hospital for Children; Madigan Army Medical Center; McGill University	Innes, AM (corresponding author), Univ Calgary, Dept Med Genet, Res Inst Child & Maternal Hlth, Calgary, AB T3B 6A8, Canada.	micheil.innes@albertahealthservices.ca; ddoher@uw.edu	innes, allan micheil/A-9955-2017; Aldinger, Kimberly/ABB-1561-2020; Bernier, Francois/V-7150-2018; Bernier, Francois/AAP-2174-2020	Aldinger, Kimberly/0000-0002-5406-8911; Bernier, Francois/0000-0001-7063-4269; Innes, Micheil/0000-0001-9881-5467	Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Alberta Children's Hospital Research Institute; Alberta Innovates Health Solutions; University of Washington Center for Mendelian Genomics (National Human Genome Research Institute) [U54HG006493]; Alberta Children's Hospital Foundation; University of Washington School of Medicine Department of Pediatrics; NIH National Institute for Neurological Disorders and Stroke [R01NS050375]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050375] Funding Source: NIH RePORTER	Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Alberta Children's Hospital Research Institute; Alberta Innovates Health Solutions; University of Washington Center for Mendelian Genomics (National Human Genome Research Institute); Alberta Children's Hospital Foundation; University of Washington School of Medicine Department of Pediatrics; NIH National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to all of the families who elected to participate in this study. This work was selected for study by the Care4Rare (Enhanced Care for Rare Genetic Diseases in Canada) Consortium Gene Discovery Steering Committee: Kym Boycott (lead; University of Ottawa), Alex MacKenzie (co-lead; University of Ottawa), Jacek Majewski (McGill University), Michael Brudno (University of Toronto), Dennis Bulman (University of Ottawa), and David Dyment (University of Ottawa). This work was funded in part by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, the Ontario Research Fund, Genome Quebec, the Children's Hospital of Eastern Ontario Foundation, Alberta Children's Hospital Research Institute, and Alberta Innovates Health Solutions. The authors wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre in Montreal. This work was also supported by the University of Washington Center for Mendelian Genomics (National Human Genome Research Institute award number U54HG006493), the Alberta Children's Hospital Foundation, University of Washington School of Medicine Department of Pediatrics funds, private donations from families to the University of Washington Hindbrain Malformation Research Program, and the NIH National Institute for Neurological Disorders and Stroke under award number R01NS050375. The opinions and assertions contained herein are the views of the authors and are not to be construed as official or as reflecting the views of the United States Department of Defense.	Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836; Biehlmaier O, 2007, INVEST OPHTH VIS SCI, V48, P2887, DOI 10.1167/iovs.06-1212; Boddaert N, 2010, J NEURORADIOLOGY, V37, P220, DOI 10.1016/j.neurad.2009.12.009; Darbro BW, 2013, HUM MUTAT, V34, P1075, DOI 10.1002/humu.22351; Demaerel P, 2002, NEURORADIOLOGY, V44, P639, DOI 10.1007/s00234-002-0783-1; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Edwards MM, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-60; Edwards MM, 2010, J BIOL CHEM, V285, P7697, DOI 10.1074/jbc.M109.069575; Heng C, 2011, CELL ADHES MIGR, V5, P480, DOI 10.4161/cam.5.6.19191; Ichikawa-Tomikawa N, 2012, MATRIX BIOL, V31, P17, DOI 10.1016/j.matbio.2011.09.002; Jissendi-Tchofo P, 2011, DEV MED CHILD NEUROL, V53, P1119, DOI 10.1111/j.1469-8749.2011.04117.x; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Poretti A, 2012, CEREBELLAR DISORDERS, P172; Poretti A, 2014, CEREBELLUM, V13, P79, DOI 10.1007/s12311-013-0521-8; Radmanesh F, 2013, AM J HUM GENET, V92, P468, DOI 10.1016/j.ajhg.2013.02.005; Sasaki S, 2007, CLIN OPHTHALMOL, V1, P289; Sasaki T, 2002, EXP CELL RES, V275, P185, DOI 10.1006/excr.2002.5499; Scheele S, 2005, P NATL ACAD SCI USA, V102, P1502, DOI 10.1073/pnas.0405095102; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Semina EV, 2006, DEV BIOL, V299, P63, DOI 10.1016/j.ydbio.2006.07.005; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; Soto-Ares G, 2000, AM J NEURORADIOL, V21, P1511; Srour M., 2014, MUSCLE NERVE; Vigliano P, 2009, EUR J PAEDIATR NEURO, V13, P72, DOI 10.1016/j.ejpn.2008.01.010; Zhao YY, 2011, MOL VIS, V17, P1003	28	69	72	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					227	234		10.1016/j.ajhg.2014.07.007	http://dx.doi.org/10.1016/j.ajhg.2014.07.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25105227	Bronze, Green Published			2022-12-18	WOS:000340076000009
J	Cheng, PH; Li, CL; Chang, YF; Tsai, SJ; Lai, YY; Chan, AWS; Chen, CM; Yang, SH				Cheng, Pei-Hsun; Li, Chia-Ling; Chang, Yu-Fan; Tsai, Shaw-Jeng; Lai, Yen-Yu; Chan, Anthony W. S.; Chen, Chuan-Mu; Yang, Shang-Hsun			miR-196a Ameliorates Phenotypes of Huntington Disease in Cell, Transgenic Mouse, and Induced Pluripotent Stem Cell Models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICRORNA; GENE	Huntington disease.(HD) is a dominantly inherited neurodegenerative disorder characterized by dysregulation of various genes. Recently, microRNAs (miRNAs) have been reported to be involved in this dysregulation, suggesting that manipulation of appropriate miRNA regulation may have a therapeutic benefit. Here, we report the beneficial effects of miR-196a (miR196a) on HD in cell, transgenic mouse models, and human induced pluripotent stem cells derived from one individual with HD (HD-iPSCs). In the in vitro results, a reduction of mutant HTT and pathological aggregates, accompanying the overexpression of miR-196a, was observed in HD models of human embryonic kidney cells and mouse neuroblastoma cells. In the in vivo model, HD transgenic mice overexpressing miR-196a revealed the suppression of mutant HTT in the brain and also showed improvements in neuropathological progression, such as decreases of nuclear, intranuclear, and neuropil aggregates and late-stage behavioral phenotypes. Most importantly, miR-196a also decreased HIT expression and pathological aggregates when HD-iPSCs were differentiated into the neuronal stage. Mechanisms of miR-196a in HD might be through the alteration of ubiquitin-proteasome systems, gliosis, cAMP response element-binding protein pathway, and several neuronal regulatory pathways in vivo. Taken together, these results show that manipulating miR-196a provides beneficial effects in HD, suggesting the potential therapeutical role of miR-196a in HD.	[Cheng, Pei-Hsun; Chang, Yu-Fan; Tsai, Shaw-Jeng; Lai, Yen-Yu; Yang, Shang-Hsun] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Li, Chia-Ling; Tsai, Shaw-Jeng; Yang, Shang-Hsun] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chan, Anthony W. S.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30329 USA; [Chen, Chuan-Mu] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Dept Life Sci, Taichung 40227, Taiwan	National Cheng Kung University; National Cheng Kung University; Emory University; National Chung Hsing University	Yang, SH (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan.	syang@mail.ncku.edu.tw	Chen, Chuan-Mu/K-7049-2013; Yang, Shang-Hsun/AAV-3763-2020; Tsai, Shaw-Jenq/AAG-6569-2019	Chen, Chuan-Mu/0000-0003-2461-9150; TSAI, SHAW-JENQ/0000-0002-3569-5813; Yang, Shang-Hsun/0000-0002-1601-3653	National Science Council [NSC 99-2320-B-006-026-MY3, NSC 101-2627-B-006, NSC 97-3122-B-006-011]; Ministry of Education, Taiwan, Republic of China, under the ATU plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China, under the ATU plan	We thank Jonathan Courtenay for critical reading of the manuscript, Chauying Jen and Pi-Hsueh Shirley Li for providing equipment, and Xiao-Jiang Li for providing mEM48 antibodies. This work was supported by National Science Council grants (NSC 99-2320-B-006-026-MY3 and NSC 101-2627-B-006) and in part by a grant of the Ministry of Education, Taiwan, Republic of China, under the ATU plan. Computational analyses and data mining were done with the system provided by the Bioinformatics Core at National Cheng Kung University, supported by a National Science Council grant (NSC 97-3122-B-006-011).	Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Cheng PH, 2013, BRAIN STRUCT FUNCT, V218, P283, DOI 10.1007/s00429-012-0401-x; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Gaughwin PM, 2011, HUM MOL GENET, V20, P2225, DOI 10.1093/hmg/ddr111; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Li SH, 2004, NEUROSCIENTIST, V10, P467, DOI 10.1177/1073858404266777; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Sinha M, 2011, RNA BIOL, V8, P1005, DOI 10.4161/rna.8.6.16035; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yang SH, 2011, CURR TOP BEHAV NEURO, V7, P61, DOI 10.1007/7854_2010_105; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002	19	69	71	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					306	312		10.1016/j.ajhg.2013.05.025	http://dx.doi.org/10.1016/j.ajhg.2013.05.025			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23810380	Green Published, Bronze			2022-12-18	WOS:000323186200010
J	Campbell, CD; Sampas, N; Tsalenko, A; Sudmant, PH; Kidd, JM; Malig, M; Vu, TH; Vives, L; Tsang, P; Bruhn, L; Eichler, EE				Campbell, Catarina D.; Sampas, Nick; Tsalenko, Anya; Sudmant, Peter H.; Kidd, Jeffrey M.; Malig, Maika; Vu, Tiffany H.; Vives, Laura; Tsang, Peter; Bruhn, Laurakay; Eichler, Evan E.			Population-Genetic Properties of Differentiated Human Copy-Number Polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGMENTAL DUPLICATIONS; LINKAGE DISEQUILIBRIUM; STRUCTURAL VARIATION; FINE-SCALE; DIVERSITY; SNPS; SUSCEPTIBILITY; REARRANGEMENTS; ARCHITECTURE; ASSOCIATION	Copy-number variants (CNVs) can reach appreciable frequencies in the human population, and recent discoveries have shown that several of these copy-number polymorphisms (CNPs) are associated with human diseases, including lupus, psoriasis, Crohn disease, and obesity. Despite new advances, significant biases remain in terms of CNP discovery and genotyping. We developed a method based on single-channel intensity data and benchmarked against copy numbers determined from sequencing read depth to successfully obtain CNP genotypes for 1495 CNPs from 487 human DNA samples of diverse ethnic backgrounds. This microarray contained CNPs in segmental duplication-rich regions and insertions of sequences not represented in the reference genome assembly or on standard SNP microarray platforms. We observe that CNPs in segmental duplications are more likely to be population differentiated than CNPs in unique regions (p = 0.015) and that biallelic CNPs show greater stratification when compared to frequency-matched SNPs (p = 0.0026). Although biallelic CNPs show a strong correlation of copy number with flanking SNP genotypes, the majority of multicopy CNPs do not (40% with r > 0.8). We selected a subset of CNPs for further characterization in 1876 additional samples from 62 populations; this revealed striking population-differentiated structural variants in genes of clinical significance such as OCLN, a tight junction protein involved in hepatitis C viral entry. Our microarray design allows these variants to be rapidly tested for disease association and our results suggest that CNPs (especially those that cannot be imputed from SNP genotypes) might have contributed disproportionately to human diversity and selection.	[Campbell, Catarina D.; Sudmant, Peter H.; Kidd, Jeffrey M.; Malig, Maika; Vu, Tiffany H.; Vives, Laura; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Sampas, Nick; Tsalenko, Anya; Tsang, Peter] Agilent Technol, Santa Clara, CA 95051 USA; [Kidd, Jeffrey M.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Agilent Technologies; Stanford University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu		Sudmant, Peter/0000-0002-9573-8248; Kidd, Jeffrey/0000-0002-9631-1465	Ruth L. Kirschstein National Research Service Award (NRSA) [T32HG00035]; NRSA [F32HG006070]; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health [HG004120]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120, F32HG006070, T32HG000035] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank K. Meltz Steinberg and S. Girirajan for thoughtful discussions. We are grateful to T. Brown for assistance with manuscript preparation and to C. Baker for technical advice. C.D.C. was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington (T32HG00035) and an individual NRSA Fellowship (F32HG006070). P.H.S. was supported by a Natural Sciences and Engineering Research Council of Canada Fellowship. This work was supported by National Institutes of Health Grant HG004120 to E.E.E. E.E.E. is an Investigator of the Howard Hughes Medical Institute. N.S., A.T., P.T., and L.B. are employees and shareholders of Agilent Technologies. E.E.E. is on the scientific advisory board for Pacific Biosciences.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bailey JA, 2008, CYTOGENET GENOME RES, V123, P234, DOI 10.1159/000184713; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Frank B, 2007, CARCINOGENESIS, V28, P1442, DOI 10.1093/carcin/bgm033; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Schrider DR, 2010, MOL BIOL EVOL, V27, P103, DOI 10.1093/molbev/msp210; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WEIR BS, 1996, GENETIC DATA ANAL, pR2; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006	57	69	70	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					317	332		10.1016/j.ajhg.2011.02.004	http://dx.doi.org/10.1016/j.ajhg.2011.02.004			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21397061	Green Published, Bronze			2022-12-18	WOS:000288589000009
J	Lemmers, RJLF; van der Vliet, PJ; van der Gaag, KJ; Zuniga, S; Frants, RR; de Knijff, P; van der Maarel, SM				Lemmers, Richard J. L. F.; van der Vliet, Patrick J.; van der Gaag, Kristiaan J.; Zuniga, Sofia; Frants, Rune R.; de Knijff, Peter; van der Maarel, Silvere M.			Worldwide Population Analysis of the 4q and 10q Subtelomeres Identifies Only Four Discrete Interchromosomal Sequence Transfers in Human Evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DNA REARRANGEMENTS; D4Z4; FSHD; CHROMOSOMES; REGION; KB; POLYMORPHISM; DIVERSITY; PHENOTYPE	Subtelomeres are dynamic structures composed of blocks of homologous DNA sequences. These so-called duplicons are dispersed over many chromosome ends. We studied the human 4q and 10q subtelomeres, which contain the polymorphic macrosatellite repeat D4Z4 and which share high sequence similarity over a region of, on average, >200 kb. Sequence analysis of four polymorphic markers in the African, European, and Asian HAPMAP panels revealed 17 subtelomeric 4q and eight subtelomeric 10qter haplotypes. Haplotypes that are composed of a mixture of 4q and 10q sequences were detected at frequencies >10% in all three populations, seemingly supporting a mechanism of ongoing interchromosomal exchanges between these chromosomes. We constructed an evolutionary network of most haplotypes and identified the 4q haplotype ancestral to all 4q and 10q haplotypes. According to the network, all subtelomeres originate from only four discrete sequence-transfer events during human evolution, and haplotypes with mixtures of 4q- and 10q-specific sequences represent intermediate structures in the transition from 4q to 10q subtelomeres. Haplotype distribution studies on a large number of globally dispersed human DNA samples from the HGDP-CEPH panel supported our findings and show that all haplotypes were present before human migration out of Africa. D4Z4 repeat array contractions on the 4A161 haplotype cause Facioscapulohumeral muscular dystrophy (FSHD), whereas contractions on most other haplotypes; are nonpathogenic. We propose that the limited occurrence of interchromosomal sequence transfers results in an accumulation of haplotype-specific polymorphisms that can explain the unique association of FSHD with D4Z4 contractions in a single 4q subtelomere.	[Lemmers, Richard J. L. F.; van der Vliet, Patrick J.; van der Gaag, Kristiaan J.; Zuniga, Sofia; Frants, Rune R.; de Knijff, Peter; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018; de Knijff, Peter/Y-2519-2018	van der Maarel, Silvere/0000-0001-8103-711X; de Knijff, Peter/0000-0002-0899-771X; van der Gaag, Kristiaan/0000-0001-7976-1977	Leiden University Medical Center; Shaw Family Foundation; Fields Center for FSHD and Neuromuscular Research; Netherlands Organization for Scientific Research [NWO 917.56.338, NWO 93.51.8001]; FSH	Leiden University Medical Center; Shaw Family Foundation; Fields Center for FSHD and Neuromuscular Research; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); FSH	The authors thank Barbara Trask for critical reading and useful comments on the manuscript. This study was financially supported by institutional funds from the Leiden University Medical Center, the Shaw Family Foundation; the Fields Center for FSHD and Neuromuscular Research; the Netherlands Organization for Scientific Research (NWO 917.56.338); a Breakthrough Project Grant from the Netherlands Genomics Initiative (NWO 93.51.8001) to RJ.L.F.L.; and a Muscular Dystrophy Association and Marjorie Bronfman Fellowship grant from the FSH Society to R.J.L.F.L.	Ambrosini A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r151; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BAKKER E, 1995, MUSCLE NERVE       S, V2, P39; Buzhov BT, 2005, HUM GENET, V116, P262, DOI 10.1007/s00439-004-1237-0; Cann HM, 2002, SCIENCE, V296, P261; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Ehrlich M, 2007, CHROMOSOMA, V116, P107, DOI 10.1007/s00412-006-0080-6; Ellis N, 2002, GENOME RES, V12, P339; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2004, AM J HUM GENET, V75, P44, DOI 10.1086/422175; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lernmers RJLF, 2001, ANN NEUROL, V50, P816, DOI 10.1002/ana.10057; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Matsumura T, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-7; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Nei M, 2005, GENETICS, V170, P1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park SDE, 2001, TRYPANOTOLERANCE W A; Rossi M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-8; Rudd MK, 2009, GENOME RES, V19, P33, DOI 10.1101/gr.083170.108; van der Maarel SM, 2000, AM J HUM GENET, V66, P26, DOI 10.1086/302730; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Wu ZY, 2004, NEUROLOGY, V63, P581, DOI 10.1212/01.WNL.0000133210.93075.81	35	69	71	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					364	377		10.1016/j.ajhg.2010.01.035	http://dx.doi.org/10.1016/j.ajhg.2010.01.035			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20206332	Bronze, Green Published			2022-12-18	WOS:000275678800008
J	Huber, C; Oules, B; Bertoli, M; Chami, M; Fradin, M; Alanay, Y; Al-Gazali, LI; Ausems, MGEM; Bitoun, P; Cavalcanti, DP; Krebs, A; Le Merrer, M; Mortier, G; Shafeghati, Y; Superti-Furga, A; Robertson, SP; Le Goff, C; Muda, AO; Paterlini-Brechot, P; Munnich, A; Cormier-Daire, V				Huber, Celine; Oules, Benedicte; Bertoli, Marta; Chami, Mounia; Fradin, Melanie; Alanay, Yasemin; Al-Gazali, Lihadh I.; Ausems, Margreet G. E. M.; Bitoun, Pierre; Cavalcanti, Denise P.; Krebs, Alexander; Le Merrer, Martine; Mortier, Geert; Shafeghati, Yousef; Superti-Furga, Andrea; Robertson, Stephen P.; Le Goff, Carine; Muda, Andrea Onetti; Paterlini-Brechot, Patrizia; Munnich, Arnold; Cormier-Daire, Valerie			Identification of CANT1 Mutations in Desbuquois Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDASE; EXPRESSION	Desbuquois dysplasia is a severe condition characterized by short stature, joint laxity, scoliosis, and advanced carpal ossification with a delta phalanx. Studying nine Desbuquois families, we identified seven distinct mutations in the Calcium-Activated Nucleotidase 1 gene (CANT1), which encodes a soluble UDP-preferring nucleotidase belonging to the apyrase family. Among the seven mutations, four were nonsense mutations (Del 5' UTR and exon 1, p.P24SRfsX3, p.S303AfsX20, and p.W125X), and three were missense mutations (p.R300C, p.R300H, and p.P299L) responsible for the change of conserved amino acids located in the seventh nucleotidase conserved region (NRC). The arginine substitution at position 300 was identified in five out of nine families. The specific function of CANT1 is as yet unknown, but its substrates are involved in several major signaling functions, including Ca2+ release, through activation of pyrimidinergic signaling. Importantly, using RT-PCR analysis, we observed a specific expression in chondrocytes. We also found electron-dense material within distended rough endoplasmic reticulum in the fibroblasts of Desbuquois patients. Our findings demonstrate the specific involvement of a nucleotidase in the endochondral ossification process.	[Huber, Celine; Oules, Benedicte; Bertoli, Marta; Chami, Mounia; Fradin, Melanie; Le Merrer, Martine; Le Goff, Carine; Paterlini-Brechot, Patrizia; Munnich, Arnold; Cormier-Daire, Valerie] Paris Descartes Univ, Dept Genet, F-75015 Paris, France; [Huber, Celine; Oules, Benedicte; Bertoli, Marta; Chami, Mounia; Fradin, Melanie; Le Merrer, Martine; Le Goff, Carine; Paterlini-Brechot, Patrizia; Munnich, Arnold; Cormier-Daire, Valerie] INSERM, U781, F-75015 Paris, France; [Huber, Celine; Oules, Benedicte; Bertoli, Marta; Chami, Mounia; Fradin, Melanie; Le Merrer, Martine; Le Goff, Carine; Paterlini-Brechot, Patrizia; Munnich, Arnold; Cormier-Daire, Valerie] Hop Necker Enfants Malad, U807, F-75015 Paris, France; [Chami, Mounia] Italian Inst Technol, I-16163 Genoa, Italy; [Alanay, Yasemin] Hacettepe Univ, Dept Pediat, Genet Unit, Fac Med, TR-06100 Ankara, Turkey; [Al-Gazali, Lihadh I.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; [Ausems, Margreet G. E. M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Bitoun, Pierre] Hop Jean Verdier, F-93140 Bondy, France; [Cavalcanti, Denise P.] Univ Estadual Campinas, Fac Med Sci, Dept Med Genet, Perinatal Genet Program, BR-13084971 Campinas, Seo Paulo, Brazil; [Krebs, Alexander] Orthoped Hosp Speising, Div Pediat Orthoped, A-1130 Vienna, Austria; [Mortier, Geert] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Shafeghati, Yousef] Sarem Women Hosp, Stem Cell Res & Med Genet Dept, Tehran 13969, Iran; [Superti-Furga, Andrea] Freiburg Univ Hosp, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Paediat & Child Hlth, Dunedin 9054, New Zealand; [Muda, Andrea Onetti] Campus Biomed Univ, Dept Pathol, I-00128 Rome, Italy	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Istituto Italiano di Tecnologia - IIT; Hacettepe University; United Arab Emirates University; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universidade Estadual de Campinas; Ghent University; Ghent University Hospital; University of Freiburg; University of Otago; University Campus Bio-Medico - Rome Italy	Cormier-Daire, V (corresponding author), Paris Descartes Univ, Dept Genet, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Muda, Andrea Onetti/AAA-5105-2020; Onetti Muda, Andrea/G-5384-2012; superti-furga, andrea/E-9162-2015; Cavalcanti, Denise/D-3579-2012; Alanay, Yasemin/A-1516-2016; Chami, Mounia/S-6471-2019; LE GOFF, Carine/AAG-2390-2020; Le Goff, Carine/N-9940-2017; Mortier, Geert/D-2542-2012; cormier-daire, valerie/H-6520-2017	Onetti Muda, Andrea/0000-0002-0274-6178; superti-furga, andrea/0000-0002-3543-7531; Alanay, Yasemin/0000-0003-0683-9731; Chami, Mounia/0000-0003-1498-7187; LE GOFF, Carine/0000-0002-7788-708X; Mortier, Geert/0000-0001-9871-4578; Bitoun, Pierre/0000-0001-6557-6826; Paterlini- Brechot, Patrizia/0000-0001-7981-6325; cormier-daire, valerie/0000-0002-2839-9856; huber, celine/0000-0002-8601-9655; Oules, Benedicte/0000-0001-8269-4306; Robertson, Stephen/0000-0002-5181-7809	MD-PhD program of the Fondation pour la Recherche Medicale (FRM); INSERM young researcher; MD-PhD program of the Ecole de I'INSERM Liliane Bettencourt	MD-PhD program of the Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); INSERM young researcher; MD-PhD program of the Ecole de I'INSERM Liliane Bettencourt	We thank the patients and their families for their participation in this study. C. Huber and M. Fradin are supported by the MD-PhD program of the Fondation pour la Recherche Medicale (FRM). M. Chami was supported by an INSERM young researcher contract. B. Oules was supported by the MD-PhD program of the Ecole de I'INSERM Liliane Bettencourt.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; DESBUQUO.G, 1966, ARCH FR PEDIATR, V23, P573; Faivre L, 2004, AM J MED GENET A, V124A, P54, DOI 10.1002/ajmg.a.20441; Faivre L, 2004, AM J MED GENET A, V124A, P48, DOI 10.1002/ajmg.a.20440; Faivre L, 2003, J MED GENET, V40, P282, DOI 10.1136/jmg.40.4.282; Hermanns P, 2008, AM J HUM GENET, V83, P293, DOI 10.1016/j.ajhg.2008.06.022; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Lecca D, 2008, BIOCHEM PHARMACOL, V75, P1869, DOI 10.1016/j.bcp.2007.12.009; Murphy DM, 2003, BIOCHEMISTRY-US, V42, P2412, DOI 10.1021/bi026763b; SHOHAT M, 1994, AM J MED GENET, V52, P9, DOI 10.1002/ajmg.1320520104; Smith TM, 2002, ARCH BIOCHEM BIOPHYS, V406, P105, DOI 10.1016/S0003-9861(02)00420-4; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Uccelletti D, 2008, MOL BIOL CELL, V19, P1337, DOI 10.1091/mbc.E07-06-0547; Yang MY, 2004, BIOCHEMISTRY-US, V43, P9185, DOI 10.1021/bi049565o	16	69	73	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					706	710		10.1016/j.ajhg.2009.10.001	http://dx.doi.org/10.1016/j.ajhg.2009.10.001			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19853239	Bronze, Green Published			2022-12-18	WOS:000271916500017
J	Hanein, S; Perrault, I; Roche, O; Gerber, S; Khadom, N; Rio, M; Boddaert, N; Jean-Pierre, M; Brahimi, N; Serre, V; Chretien, D; Delphin, N; Fares-Taie, L; Lachheb, S; Rotig, A; Meire, F; Munnich, A; Dufier, JL; Kaplan, J; Rozet, JM				Hanein, Sylvain; Perrault, Isabelle; Roche, Olivier; Gerber, Sylvie; Khadom, Noman; Rio, Marlene; Boddaert, Nathalie; Jean-Pierre, Marc; Brahimi, Nora; Serre, Valerie; Chretien, Dominique; Delphin, Nathalie; Fares-Taie, Lucas; Lachheb, Sahran; Rotig, Agnes; Meire, Francoise; Munnich, Arnold; Dufier, Jean-Louis; Kaplan, Josseline; Rozet, Jean-Michel			TMEM126A, Encoding a Mitochondrial Protein, Is Mutated in Autosomal-Recessive Nonsyndromic Optic Atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNAS; MUTATIONS; OPA1; COLOCALIZATION; NEUROPATHIES; FUSION	Nonsyndromic autosomal-recessive optic neuropathies are rare conditions of unknown genetic and molecular origin. Using an approach of whole-genome homozygosity mapping and positional cloning, we have identified the first gene, to our knowledge, responsible for this condition, TMEM126A, in a large multiplex inbred Algerian family and subsequently in three other families originating from the Maghreb. TMEM126A is conserved in higher eukaryotes and encodes a transmembrane mitochondrial protein of unknown function, Supporting the view that mitochondrial dysfunction may be a hallmark of inherited optic neuropathies including isolated autosomal-recessive forms.	[Hanein, Sylvain; Perrault, Isabelle; Roche, Olivier; Gerber, Sylvie; Khadom, Noman; Rio, Marlene; Boddaert, Nathalie; Brahimi, Nora; Serre, Valerie; Chretien, Dominique; Delphin, Nathalie; Fares-Taie, Lucas; Lachheb, Sahran; Rotig, Agnes; Munnich, Arnold; Dufier, Jean-Louis; Kaplan, Josseline; Rozet, Jean-Michel] Univ Paris 05, Dept Genet, INSERM, Hop Necker Enfants Malad,Unite U781, F-75015 Paris, France; [Jean-Pierre, Marc] Univ Paris 05, CNRS, Inst Cochin,UMR 8104, Hop Cochin,AP HP,Serv Genet,INSERM,Unite U567, F-75014 Paris, France; [Serre, Valerie] Univ Paris Diderot, F-75205 Paris, France; [Meire, Francoise] Hop Univ Enfants Reine Fabiola, Brussels, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rozet, JM (corresponding author), Univ Paris 05, Dept Genet, INSERM, Hop Necker Enfants Malad,Unite U781, F-75015 Paris, France.	jean-michel.rozet@inserm.fr	hanein, sylvain/AAG-4933-2019; Rötig, Agnès/G-9592-2017; boddaert, nathalie/GWV-2865-2022; ROZET, Jean-Michel/E-5737-2016; FARES TAIE, Lucas/H-2940-2017; KAPLAN, Josseline/I-2622-2017; perrault, isabelle/H-3047-2017	hanein, sylvain/0000-0001-5817-6330; Rötig, Agnès/0000-0003-0589-0703; ROZET, Jean-Michel/0000-0001-7951-7886; GERBER, Sylvie/0000-0002-6827-1769; FARES TAIE, Lucas/0000-0002-4613-0711; boddaert, nathalie/0000-0003-0991-7774; Rio, Marlene/0000-0003-2049-5058; KAPLAN, Josseline/0000-0002-1849-8658; perrault, isabelle/0000-0002-8560-1379	Retina France and Federation des Aveugles de France Associations; Foundation Fighting Blindness [FFB-BR-GE-0406-0335-INSERM]; European Community [EC-IP-EVI-Genoret LSHG-07-2005-51236]	Retina France and Federation des Aveugles de France Associations; Foundation Fighting Blindness(European Commission); European Community(European Commission)	We are grateful to the families who participated. We thank E. Martin, V. Dufresne, K. Bigot, and N. Goudin at the IFR94 Imaging Platform for technical assistance and P. Nitschke and J.M. Plaza at the University Paris-Descartes Bioinformatics Platform. This work has been supported by the Retina France and Federation des Aveugles de France Associations, the Foundation Fighting Blindness (Grant FFB-BR-GE-0406-0335-INSERM), and the European Community (EC-IP-EVI-Genoret LSHG-07-2005-51236).	Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Barbet F, 2003, EUR J HUM GENET, V11, P966, DOI 10.1038/sj.ejhg.5201070; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0; Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Garcia M, 2007, MOL BIOL CELL, V18, P362, DOI 10.1091/mbc.E06-09-0827; Hanein S, 2008, EUR J HUM GENET, V16, P115, DOI 10.1038/sj.ejhg.5201905; Heinrich P C, 1982, Prog Clin Biol Res, V102 Pt B, P149; Lev D, 2002, Eur J Paediatr Neurol, V6, P121, DOI 10.1053/ejpn.2001.0558; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; RINGS EHHM, 1992, FEBS LETT, V300, P183, DOI 10.1016/0014-5793(92)80192-J; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Sylvestre J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r44; Vinkler C, 2003, AM J MED GENET A, V121A, P263, DOI 10.1002/ajmg.a.20238; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	21	69	76	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					493	498		10.1016/j.ajhg.2009.03.003	http://dx.doi.org/10.1016/j.ajhg.2009.03.003			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19327736	Green Published, Bronze			2022-12-18	WOS:000265232800008
J	Bargal, R; Cormier-Daire, V; Ben-Neriah, Z; Le Merrer, M; Sosna, J; Melki, J; Zangen, DH; Smithson, SF; Borochowitz, Z; Belostotsky, R; Raas-Rothschild, A				Bargal, Ruth; Cormier-Daire, Valerie; Ben-Neriah, Ziva; Le Merrer, Martine; Sosna, Jacob; Melki, Judith; Zangen, David H.; Smithson, Sarah F.; Borochowitz, Zvi; Belostotsky, Ruth; Raas-Rothschild, Annick			Mutations in DDR2 Gene Cause SMED with Short Limbs and Abnormal Calcifications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							META-EPIPHYSEAL DYSPLASIA; RECEPTOR TYROSINE KINASE; COLLAGEN-BINDING; HOMOZYGOSITY; COMPLEX	The spondylo-meta-epiphyseal dysplasia [SMED] short limb-hand type [SMED-SL] is a rare autosomal-recessive disease, first reported by Borochowitz et al. in 1993.(1) Since then, 14 affected patients have been reported.(2-5) We diagnosed 6 patients from 5 different consanguineous Arab Muslim families from the Jerusalem area with SMED-SL. Additionally, we studied two patients from Algerian and Pakistani ancestry and the parents of the first Jewish patients reported.(1) Using a homozygosity mapping strategy, we located a candidate region on chromosome 1q23 spanning 2.4 Mb. The position of the Discoidin Domain Receptor 2 (DDR2) gene within the candidate region and the similarity of the ddr2 knockout mouse to the SMED patients' phenotype prompted us to study this gene(6). We identified three missense mutations c.2254 C > T [R752C], c. 2177 T > G [1726R], c.2138C > T [T7131] and one splice site mutation [IVS17+1g > a] in the conserved sequence encoding the tyrosine kinase domain of the DDR2 gene. The results of this study will permit an accurate early prenatal diagnosis and carrier screening for families at risk.	[Bargal, Ruth; Ben-Neriah, Ziva; Melki, Judith; Raas-Rothschild, Annick] Hadassah Hebrew Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel; [Sosna, Jacob] Hadassah Hebrew Univ Hosp, Dept Radiol, IL-91120 Jerusalem, Israel; [Cormier-Daire, Valerie; Le Merrer, Martine] Hop Necker Enfants Malad, Dept Human Genet, Paris, France; [Smithson, Sarah F.] St Michaels Hosp, Dept Clin Genet, Bristol BS2 8EG, Avon, England; [Borochowitz, Zvi] Technion Israel Inst Technol, Fac Med, Bnai Zion Med Ctr, Simon Winter Inst Human Genet, IL-31048 Haifa, Israel; [Belostotsky, Ruth] Shaare Zedek Med Ctr, Div Pediat Nephrol, Jerusalem, Israel; [Zangen, David H.] Hadassah Hebrew Univ, Med Ctr, Div Pediat Endocrinol, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Raas-Rothschild, A (corresponding author), Hadassah Hebrew Univ Hosp, Dept Human Genet, POB 12000, IL-91120 Jerusalem, Israel.	annick@hadassah.org.il	cormier-daire, valerie/H-6520-2017	cormier-daire, valerie/0000-0002-2839-9856	Z. family	Z. family	We are grateful to the families for their participation in this study; we wish to thank Professor Orly Elpeleg for her help with computational SNP analysis and Dr. Mira Korner of the National Center of Genomic Technologies at the Hebrew University of Jerusalem for the SNP analysis. We thank Dr. Zeev Paroush for his fruitful comments and support. This research was supported by a grant provided by the Z. family.	AlGazali LI, 1996, CLIN DYSMORPHOL, V5, P197; BOROCHOWITZ Z, 1993, AM J MED GENET, V45, P320, DOI 10.1002/ajmg.1320450308; Cormier-Daire V, 2008, BEST PRACT RES CL RH, V22, P33, DOI 10.1016/j.berh.2007.12.009; Fano V, 2001, PEDIATR RADIOL, V31, P19, DOI 10.1007/s002470000359; Frishberg Y, 2007, GENET MED, V9, P180, DOI 10.1097/GIM.0b013e318031c7de; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; LANGER LO, 1993, AM J MED GENET, V45, P488, DOI 10.1002/ajmg.1320450419; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Till JH, 2001, J BIOL CHEM, V276, P10049, DOI 10.1074/jbc.M010161200; Tuysuz B, 2009, PEDIATR RADIOL, V39, P84, DOI 10.1007/s00247-008-1036-1; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Yang K, 2005, J BIOL CHEM, V280, P39058, DOI 10.1074/jbc.M506921200	17	69	74	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					80	84		10.1016/j.ajhg.2008.12.004	http://dx.doi.org/10.1016/j.ajhg.2008.12.004			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19110212	Green Published, Bronze			2022-12-18	WOS:000262679500010
J	Chen, PL; Avramopoulos, D; Lasseter, VK; McGrath, JA; Fallin, MD; Liang, KY; Nestadt, G; Feng, N; Steel, G; Cutting, AS; Wolyniec, P; Pulver, AE; Valle, D				Chen, Pei-Lung; Avramopoulos, Dimitrios; Lasseter, Virginia K.; McGrath, John A.; Fallin, M. Daniele; Liang, Kung-Yee; Nestadt, Gerald; Feng, Ningping; Steel, Gary; Cutting, Andrew S.; Wolyniec, Paula; Pulver, Ann E.; Valle, David			Fine Mapping on Chromosome 10q22-q23 Implicates Neuregulin 3 in Schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE RARE ALLELES; ASHKENAZI JEWS; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAITS; 1ST-RANK SYMPTOMS; NUCLEAR FAMILIES; BIPOLAR DISORDER; CANDIDATE GENES; SIBLING PAIRS	Linkage studies have implicated 10q22-q23 as a schizophrenia (SZ) susceptibility locus in Ashkenazi Jewish (AJ) and Han Chinese from Taiwan populations. To further explore our previous linkage signal in the AJ population (NPL score: 4.27, empirical p = 2 x 10(-5)), we performed a peakwide association fine mapping study by using 1414 SNPs across similar to 12.5 Mb in 10q22-q23. We genotyped 1515 AJ individuals, including 285 parent-child trios, 173 unrelated cases, and 487 unrelated controls. We analyzed the binary diagnostic phenotype of SZ and 9 heritable quantitative traits derived from a principal components factor analysis of 73 items from our consensus diagnostic ratings and direct assessment interviews. Although no marker withstood multiple test correction for association with the binary SZ phenotype, we found strong evidence of association by using the "delusion" factor as the quantitative trait at three SNPs (rs10883866, rs10748842, and rs6584400) located in a 13 kb interval in intron I of Neuregulin 3 (NRG3). Our best p value from family-based association analysis was 7.26 x 10(-7). We replicated this association in the collection of 173 unrelated AJ cases (p = 1.55 x 10(-2)), with a combined p value of 2.30 x 10(-7). After performing 10,000 permutations of each of the phenotypes, we estimated the empirical study-wide significance across all 9 factors (90,000 permutations) to be p = 2.7 x 10(-3). NRG3 is primarily expressed in the central nervous system and is one of three paralogs of NRG1, a gene strongly implicated in SZ. These biological properties together with our linkage and association results strongly support NRG3 as a gene involved in SZ.	[Chen, Pei-Lung; Avramopoulos, Dimitrios; Feng, Ningping; Steel, Gary; Cutting, Andrew S.; Valle, David] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Chen, Pei-Lung] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Avramopoulos, Dimitrios; Lasseter, Virginia K.; McGrath, John A.; Nestadt, Gerald; Wolyniec, Paula; Pulver, Ann E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Fallin, M. Daniele; Pulver, Ann E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Valle, D (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	dvalle@jhmi.edu	Liang, Kung-Yee/F-8299-2011; Chen, Pei-Lung/A-3520-2010; Avramopoulos, Dimitrios/J-4392-2012	Chen, Pei-Lung/0000-0002-5640-3074; McGrath, John A./0000-0002-9756-7892	National Institutes of Health [NO1-HG-65403]; National Institutes of Mental Health [RO1MH057314, R01MH068406]; Wasie Foundation; National Alliance for Research on Schizophrenia and Depression; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068406, R01MH057314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wasie Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are indebted to all the patients and controls for participation in this research. Genotyping services were provided by the Johns Hopkins Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number NO1-HG-65403. This study was funded by National Institutes of Mental Health grant RO1MH057314 and R01MH068406, and by the Wasie Foundation (A.E.P.). This project also was funded in part by the National Alliance for Research on Schizophrenia and Depression (D.V. and D.A.). None of the authors have;any conflict of interest concerning this manuscript. We also thank Sandy Muscelli for assistance with the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Balciuniene J, 2007, AM J HUM GENET, V80, P938, DOI 10.1086/513607; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Cardno AG, 2002, BRIT J PSYCHIAT, V180, P35, DOI 10.1192/bjp.180.1.35; Cardno AG, 1999, SCHIZOPHRENIA BULL, V25, P841, DOI 10.1093/oxfordjournals.schbul.a033423; Carteron C, 2006, J CELL SCI, V119, P898, DOI 10.1242/jcs.02799; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Childs B, 1976, Adv Hum Genet, V7, P57; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; EATON WW, 1985, EPIDEMIOL REV, V7, P105, DOI 10.1093/oxfordjournals.epirev.a036278; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Fanous AH, 2005, MOL PSYCHIATR, V10, P6, DOI 10.1038/sj.mp.4001571; Fanous AH, 2007, AM J MED GENET B, V144B, P589, DOI 10.1002/ajmg.b.30442; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Freedman R, 2000, AM J MED GENET, V97, P58, DOI 10.1002/(SICI)1096-8628(200021)97:1<58::AID-AJMG8>3.0.CO;2-Y; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GEORGE VT, 1988, COMMUN STAT-THEOR M, V17, P2933, DOI 10.1080/03610928808829781; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guo SZ, 2007, SCHIZOPHR RES, V93, P385, DOI 10.1016/j.schres.2007.03.007; Hall J, 2006, NAT NEUROSCI, V9, P1477, DOI 10.1038/nn1795; Hobbs SS, 2002, ONCOGENE, V21, P8442, DOI 10.1038/sj.onc.1205960; Jablensky A, 2006, MOL PSYCHIATR, V11, P815, DOI 10.1038/sj.mp.4001857; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lakhani VT, 2007, ANNU REV MED, V58, P253, DOI 10.1146/annurev.med.58.100305.115303; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Loftus J, 2000, BRIT J PSYCHIAT, V177, P15, DOI 10.1192/bjp.177.1.15; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; McGrath JA, 2004, SCHIZOPHRENIA BULL, V30, P855, DOI 10.1093/oxfordjournals.schbul.a007138; MCGRATH JA, 2009, ARCH GEN PS IN PRESS; MCGUE M, 1991, EUR ARCH PSY CLIN N, V240, P174, DOI 10.1007/BF02190760; MCKUSICK VA, 1969, PERSPECT BIOL MED, V12, P298; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; Nicodemus KK, 2006, MOL PSYCHIATR, V11, P1062, DOI 10.1038/sj.mp.4001878; Nicodemus KK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S78; Norton N, 2006, CURR OPIN PSYCHIATR, V19, P158, DOI 10.1097/01.yco.0000214341.52249.59; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Tuathaigh CMP, 2007, NEUROSCI BIOBEHAV R, V31, P60, DOI 10.1016/j.neubiorev.2006.04.002; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053; Peralta V, 2001, SCHIZOPHR RES, V49, P269, DOI 10.1016/S0920-9964(00)00071-2; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schneider K., 1959, CLIN PSYCHOPATHOLOGY; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; Serretti A, 2001, AM J MED GENET, V105, P283, DOI 10.1002/ajmg.1321; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Stern HS, 2001, GASTROENTEROLOGY, V120, P392, DOI 10.1053/gast.2001.21170; Sugimura K, 2003, AM J HUM GENET, V72, P509, DOI 10.1086/367848; Tan W, 2007, J BIOL CHEM, V282, P24343, DOI 10.1074/jbc.M702953200; TSUANG MT, 1991, SCHIZOPHR RES, V4, P157, DOI 10.1016/0920-9964(91)90031-L; Wang YC, 2008, BIOL PSYCHIAT, V64, P1093, DOI 10.1016/j.biopsych.2008.07.012; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Wilcox MA, 2002, BIOL PSYCHIAT, V52, P847, DOI 10.1016/S0006-3223(02)01465-8; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; [No title captured]	77	69	73	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					21	34		10.1016/j.ajhg.2008.12.005	http://dx.doi.org/10.1016/j.ajhg.2008.12.005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19118813	Green Published, Bronze			2022-12-18	WOS:000262679500003
J	Andreou, AM; Pauws, E; Jones, MC; Singh, MK; Bussen, M; Doudney, K; Moore, GE; Kispert, A; Brosens, JJ; Stanier, P				Andreou, Artemisia M.; Pauws, Erwin; Jones, Marius C.; Singh, Manvendra K.; Bussen, Markus; Doudney, Kit; Moore, Gudrun E.; Kispert, Andreas; Brosens, Jan J.; Stanier, Philip			TBX22 missense mutations found in patients with x-linked cleft palate affect DNA binding, sumoylation, and transcriptional repression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOLT-ORAM-SYNDROME; T-BOX GENES; SUMO; LIP; NUCLEAR; RISK; MALFORMATION; STRESS; MOTIF; LIMB	The T-box transcription factor TBX22 is essential for normal craniofacial development, as demonstrated by the finding of nonsense, frameshift, splice-site, or missense mutations in patients with X-linked cleft palate (CPX) and ankyloglossia. To better understand the function of TBX22, we studied 10 different naturally occurring missense mutations that are phenotypically equivalent to loss-of-function alleles. Since all missense mutations are located in the DNA-binding T-box domain, we first investigated the preferred recognition sequence for TBX22. Typical of T-box proteins, the resulting sequence is a palindrome based around near-perfect copies of AGGTGTGA. DNA-binding assays indicate that missense mutations at or near predicted contact points with the DNA backbone compromise stable DNA-protein interactions. We show that TBX22 functions as a transcriptional repressor and that TBX22 missense mutations result in impaired repression activity. No effect on nuclear localization of TBX22 was observed. We find that TBX22 is a target for the small ubiquitin-like modifier SUMO-1 and that this modification is required for TBX22 repressor activity. Although the site of SUMO attachment at the lysine at position 63 is upstream of the T-box domain, loss of SUMO-1 modification is consistently found in all pathogenic CPX missense mutations. This implies a general mechanism linking the loss of SUMO conjugation to the loss of TBX22 function. Orofacial clefts are well known for their complex etiology and variable penetrance, involving both genetic and environmental risk factors. The sumoylation process is also subject to and profoundly affected by similar environmental stresses. Thus, we suggest that SUMO modification may represent a common pathway that regulates normal craniofacial development and is involved in the pathogenesis of both Mendelian and idiopathic forms of orofacial clefting.	UCL, Inst Child Hlth, London WC1N 1EH, England; Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; Med Hochschule Hannover, Inst Mol Biol, Hannover, Germany	University of London; University College London; Imperial College London; Hannover Medical School	Stanier, P (corresponding author), UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	p.stanier@ich.ucl.ac.uk	Singh, Manvendra K./AHE-0676-2022; Doudney, Kit/Q-9728-2019; Pauws, Erwin/C-1665-2008; Pauws, Erwin/J-4848-2019; Moore, Gudrun/A-2092-2009; Stanier, Philip/C-1593-2008	Doudney, Kit/0000-0002-0089-1152; Pauws, Erwin/0000-0003-1751-0317; Stanier, Philip/0000-0001-9340-8117; Brosens, Jan/0000-0003-0116-9329; Singh, Manvendra K./0000-0002-2884-0074	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bille C, 2005, EPIDEMIOLOGY, V16, P311, DOI 10.1097/01.ede.0000158745.84019.c2; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brassington AME, 2003, AM J HUM GENET, V73, P74, DOI 10.1086/376436; Braybrook C, 2002, HUM MOL GENET, V11, P2793, DOI 10.1093/hmg/11.22.2793; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Castilla EE, 1999, AM J MED GENET, V86, P9, DOI 10.1002/(SICI)1096-8628(19990903)86:1<9::AID-AJMG3>3.0.CO;2-X; Chaabouni M, 2005, CLIN DYSMORPHOL, V14, P23, DOI 10.1097/00019605-200501000-00005; Chowdhuri SR, 2006, DEV BIOL, V295, P664, DOI 10.1016/j.ydbio.2006.04.001; Collavoli A, 2003, J MOL CELL CARDIOL, V35, P1191, DOI 10.1016/S0022-2828(03)00231-1; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gupta V, 2006, BIOCHEM BIOPH RES CO, V345, P74, DOI 10.1016/j.bbrc.2006.03.232; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; JOHNSTON MC, 1991, J CRAN GENET DEV BIO, V11, P227; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Krapels IPC, 2006, BIRTH DEFECTS RES A, V76, P613, DOI 10.1002/bdra.20285; Li QY, 1997, NAT GENET, V15, P21; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Marcano ACB, 2004, J MED GENET, V41, P68, DOI 10.1136/jmg.2003.010868; MELNICK M, 1992, AM J MED GENET, V42, P10, DOI 10.1002/ajmg.1320420104; MONTENEGRO MA, 1995, ARCH ORAL BIOL, V40, P33; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Muller S, 1999, J VIROL, V73, P5137; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; ROSENZWEIG S, 1966, J DENT RES, V45, P1585, DOI 10.1177/00220345660450060301; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Stanier P, 2004, HUM MOL GENET, V13, pR73, DOI 10.1093/hmg/ddh052; Sun GF, 2004, J CELL BIOCHEM, V92, P189, DOI 10.1002/jcb.20039; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; Takahashi H, 2005, DEV GROWTH DIFFER, V47, P173; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Webster WS, 2006, CURR PHARM DESIGN, V12, P1431, DOI 10.2174/138161206776389868; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597	49	69	71	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					700	712		10.1086/521033	http://dx.doi.org/10.1086/521033			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17846996	Green Published, Bronze			2022-12-18	WOS:000249307600012
J	Maystadt, I; Rezsohazy, R; Barkats, M; Duque, S; Vannuffel, P; Remacle, S; Lambert, B; Najimi, M; Sokal, E; Munnich, A; Viollet, L; Verellen-Dumoulin, C				Maystadt, Isabelle; Rezsohazy, Rene; Barkats, Martine; Duque, Sandra; Vannuffel, Pascal; Remacle, Sophie; Lambert, Barbara; Najimi, Mustapha; Sokal, Etienne; Munnich, Arnold; Viollet, Louis; Verellen-Dumoulin, Christine			The nuclear factor kappa B-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; HEREDITARY SPASTIC PARALYSIS; MARIE-TOOTH-DISEASE; EXCHANGE FACTOR; ALS2 GENE; PROTEIN AGGREGATION; MUTATIONS; NEUROPROTECTION; DOMAIN; PATHWAY	Lower motor neuron diseases (LMNDs) include a large spectrum of clinically and genetically heterogeneous disorders. Studying a large inbred African family, we recently described a novel autosomal recessive LMND variant characterized by childhood onset, generalized muscle involvement, and severe outcome, and we mapped the disease gene to a 3.9-cM interval on chromosome 1p36. We identified a homozygous missense mutation (c. 1940 T -> C [p. 647 Phe -> Ser]) of the Pleckstrin homology domain-containing, family G member 5 gene, PLEKHG5. In transiently transfected HEK293 and MCF10A cell lines, we found that wild-type PLEKHG5 activated the nuclear factor kappa B (NF kappa B) signaling pathway and that both the stability and the intracellular location of mutant PLEKHG5 protein were altered, severely impairing the NFkB transduction pathway. Moreover, aggregates were observed in transiently transfected NSC34 murine motor neurons overexpressing the mutant PLEKHG5 protein. Both loss of PLEKHG5 function and aggregate formation may contribute to neurotoxicity in this novel form of LMND.	Inst Pathol & Genet, Ctr Human Genet, B-6041 Gosselies, Belgium; Catholic Univ Louvain, Ctr Genet Humaine, B-1200 Brussels, Belgium; Catholic Univ Louvain, Unite Genet Med, B-1200 Brussels, Belgium; Catholic Univ Louvain, Dept Pediat, B-1200 Brussels, Belgium; Catholic Univ Louvain, Rech Pediat, B-1200 Brussels, Belgium; Hop Necker Enfants Malad, INSERM U781, Unite Rech Genet & Epigenet Malad Metab Neurosens, F-75730 Paris, France; Catholic Univ Louvain, Inst Sci Vie, Unite Sci Vet, B-3000 Louvain, Belgium; GENETHON, Ctr Rech & Applicat Therapies Gen, CNRS, FRE 3018, Evry, France	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS)	Maystadt, I (corresponding author), Inst Pathol & Genet, Ctr Human Genet, Ave Georges Lemaitre 25, B-6041 Gosselies, Belgium.	isabelle.maystadt@ipg.be	Maystadt, Isabelle/AAH-1483-2021	Sokal, Etienne/0000-0001-5597-4708				Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; Anhuf D, 2003, NEUROMUSCULAR DISORD, V13, P660; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Barger SW, 2005, CURR PHARM DESIGN, V11, P985, DOI 10.2174/1381612053381594; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Devon RS, 2003, CLIN GENET, V64, P210, DOI 10.1034/j.1399-0004.2003.00138.x; Dhandapani KM, 2005, J NEUROCHEM, V95, P9, DOI 10.1111/j.1471-4159.2005.03319.x; Dhib-Jalbut S, 2006, J NEUROIMMUNOL, V176, P198, DOI 10.1016/j.jneuroim.2006.03.027; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Gispert-Sanchez S, 2006, J NEURAL TRANSM-SUPP, P111; Goswami A, 2006, J BIOL CHEM, V281, P37017, DOI 10.1074/jbc.M608095200; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Irobi J, 2006, NEUROMUSCULAR DISORD, V16, P645, DOI 10.1016/j.nmd.2006.05.023; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Irobi J, 2004, HUM MOL GENET, V13, pR195, DOI 10.1093/hmg/ddh226; James PA, 2006, BBA-MOL BASIS DIS, V1762, P986, DOI 10.1016/j.bbadis.2006.04.003; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lesca G, 2003, NEUROLOGY, V60, P674, DOI 10.1212/01.WNL.0000048207.28790.25; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Lin H, 2005, HUM MOL GENET, V14, P3643, DOI 10.1093/hmg/ddi392; Lin H, 2004, J NEUROSCI, V24, P2716, DOI 10.1523/JNEUROSCI.5689-03.2004; Lin H, 2006, ANN NEUROL, V60, P399, DOI 10.1002/ana.20965; Matis C, 2001, FEBS LETT, V499, P92, DOI 10.1016/S0014-5793(01)02532-7; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; May V, 2002, J NEUROSCI, V22, P6980; Maystadt I, 2006, NEUROLOGY, V67, P120, DOI 10.1212/01.wnl.0000223834.55225.2d; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Nahm M, 2006, GENE, V384, P139, DOI 10.1016/j.gene.2006.07.024; Panzeri C, 2006, BRAIN, V129, P1710, DOI 10.1093/brain/awl104; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Tamatani M, 2000, J NEUROCHEM, V75, P683, DOI 10.1046/j.1471-4159.2000.0750683.x; Van den Bosch L, 2006, CURR NEUROL NEUROSCI, V6, P423, DOI 10.1007/s11910-996-0024-9; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yamanaka K, 2003, P NATL ACAD SCI USA, V100, P16041, DOI 10.1073/pnas.2635267100; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	60	69	70	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					67	76		10.1086/518900	http://dx.doi.org/10.1086/518900			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564964	Bronze, Green Published			2022-12-18	WOS:000247039700006
J	Twigg, SRF; Matsumoto, K; Kidd, AMJ; Goriely, A; Taylor, IB; Fisher, RB; Hoogeboom, AJM; Mathijssen, IMJ; Lourenco, MT; Morton, JEV; Sweeney, E; Wilson, LC; Brunner, HG; Mulliken, JB; Wall, SA; Wilkie, AOM				Twigg, Stephen R. F.; Matsumoto, Kazuya; Kidd, Alexa M. J.; Goriely, Anne; Taylor, Indira B.; Fisher, Richard B.; Hoogeboom, A. Jeannette M.; Mathijssen, Irene M. J.; Lourenco, M. Teresa; Morton, Jenny E. V.; Sweeney, Elizabeth; Wilson, Louise C.; Brunner, Han G.; Mulliken, John B.; Wall, Steven A.; Wilkie, Andrew O. M.			The origin of EFNB1 mutations in craniofrontonasal syndrome: Frequent somatic mosaicism and explanation of the paucity of carrier males	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PATERNAL ORIGIN; CRYSTAL-STRUCTURE; EPHRIN-B1; GENE; DYSPLASIA; RETINOBLASTOMA; EXPRESSION; LETHALITY	Craniofrontonasal syndrome (CFNS) is an X-linked disorder that exhibits a paradoxical sex reversal in phenotypic severity: females characteristically have frontonasal dysplasia, craniosynostosis, and additional minor malformations, but males are usually mildly affected with hypertelorism only. Despite this, males appear underrepresented in CFNS pedigrees, with carrier males encountered infrequently compared with affected females. To investigate these unusual genetic features of CFNS, we exploited the recent discovery of causative mutations in the EFNB1 gene, which encodes ephrin-B1, to survey the molecular alterations in 59 families (39 newly investigated and 20 published elsewhere). We identified the first complete deletions of EFNB1, catalogued 27 novel intragenic mutations, and used Pyrosequencing and analysis of nearby polymorphic alleles to quantify mosaic cases and to determine the parental origin of verified germline mutations. Somatic mosaicism was demonstrated in 6 of 53 informative families, and, of 17 germline mutations in individuals for whom the parental origin of mutation could be demonstrated, 15 arose from the father. We conclude that the major factor accounting for the relative scarcity of carrier males is the bias toward mutations in the paternal germline (which present as affected female offspring) combined with reduced reproductive fitness in affected females. Postzygotic mutations also contribute to the female preponderance, whereas true nonpenetrance in males who are hemizygous for an EFNB1 mutation appears unusual. These results highlight the importance of considering possible origins of mutation in the counseling of families with CFNS and provide a generally applicable approach to the combined analysis of mosaic and germline mutations.	Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Radcliffe Infirm, Oxford Craniofacial Unit, Oxford OX2 6HE, England; Univ Tokushima, Sch Med, Dept Plast & Reconstruct Surg, Tokushima 770, Japan; Wellington Hosp, Cent & So Reg Genet Serv, Wellington, New Zealand; St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; Erasmus MC, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands; Hosp Dona Estefania, Serv Genet Med, Lisbon, Portugal; Womens Hosp Med Ctr, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; Womens Hosp Med Ctr, Merseyside & Cheshire Clin Genet Serv, Liverpool, Merseyside, England; Inst Child Hlth, NE Thames Reg Genet Serv, London, England; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Childrens Hosp, Craniofacial Ctr, Boston, MA 02115 USA	University of Oxford; Radcliffe Infirmary; Tokushima University; Saint James's University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Birmingham Women's Hospital; University of London; University College London; Radboud University Nijmegen; Harvard University; Boston Children's Hospital	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	awilkie@hammer.imm.ox.ac.uk	Brunner, Han/C-9928-2013; Mathijssen, Irene M.J./B-1955-2013; Wilkie, Andrew/AAC-3820-2020; Twigg, Stephen/AAU-1135-2021; Goriely, Anne/AAR-1133-2020	Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X; Goriely, Anne/0000-0001-9229-7216				Cohen M. M., 2000, CRANIOSYNOSTOSIS DIA, P380; Cohen M M Jr, 1979, Birth Defects Orig Artic Ser, V15, P85; COHN DH, 1990, AM J HUM GENET, V46, P591; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Dryja TP, 1997, HUM GENET, V100, P446, DOI 10.1007/s004390050531; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; GRUTZNER E, 1988, ORAL SURG ORAL MED O, V65, P436, DOI 10.1016/0030-4220(88)90358-1; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; HURST LD, 2003, NATURE ENCY HUMAN GE, V4, P218; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; Jones AC, 2001, HUM MUTAT, V17, P233, DOI 10.1002/humu.8; KAPUSTA L, 1992, EUR J PEDIATR, V151, P837, DOI 10.1007/BF01957936; KERE J, 1990, CLIN GENET, V38, P441; Ketterling RP, 1999, HUM GENET, V105, P629, DOI 10.1007/s004390051155; Kluwe L, 2003, J MED GENET, V40, P109, DOI 10.1136/jmg.40.2.109; Langaee T, 2005, MUTAT RES-FUND MOL M, V573, P96, DOI 10.1016/j.mrfmmm.2004.07.023; Leuer M, 2001, AM J HUM GENET, V69, P75, DOI 10.1086/321285; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Natarajan U, 1993, Clin Dysmorphol, V2, P360; Nikolov DB, 2005, BIOCHEMISTRY-US, V44, P10947, DOI 10.1021/bi050789w; PRUZANSKY S, 1982, BIRTH DEFECTS-ORIG, V18, P121; Rannan-Eliya SV, 2004, HUM GENET, V115, P200, DOI 10.1007/s00439-004-1151-5; Sado T, 2005, HUM MOL GENET, V14, pR59, DOI 10.1093/hmg/ddi117; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Slover R, 1979, Birth Defects Orig Artic Ser, V15, P75; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Thomas GH, 1996, AM J HUM GENET, V58, P1364; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; VASUDEVAN PC, IN PRESS EUR J HUM G; Verhoef S, 1999, AM J HUM GENET, V64, P1632, DOI 10.1086/302412; Wieacker P, 2005, MOL GENET METAB, V86, P110, DOI 10.1016/j.ymgme.2005.07.017; Wieland I, 2005, HUM MUTAT, V26, P113, DOI 10.1002/humu.20193; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; YOUNG ID, 1984, CLIN GENET, V25, P473	39	69	74	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					999	1010		10.1086/504440	http://dx.doi.org/10.1086/504440			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685650	Green Published, Bronze			2022-12-18	WOS:000237553800009
J	Kaabi, B; Gelernter, J; Woods, SW; Goddard, A; Page, GP; Elston, RC				Kaabi, B; Gelernter, J; Woods, SW; Goddard, A; Page, GP; Elston, RC			Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: Strong evidence for a chromosome 4 risk locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; NATIONAL COMORBIDITY SURVEY; LOD-SCORE ANALYSIS; PANIC DISORDER; COMPLEX TRAITS; GENOTYPING ERRORS; SOCIAL PHOBIA; PAIR LINKAGE; FAMILY DATA; SIB-PAIR	We conducted a 10-centimorgan linkage autosomal genome scan in a set of 19 extended American pedigrees ( 219 subjects) ascertained through probands with panic disorder. Several anxiety disorders-including social phobia, agoraphobia, and simple phobia-in addition to panic disorder segregate in these families. In previous studies of this sample, linkage analyses were based separately on each of the individual categorical affection diagnoses. Given the substantial comorbidity between anxiety disorders and their probable shared genetic liability, it is clear that this method discards a considerable amount of information. In this article, we propose a new approach that considers panic disorder, simple phobia, social phobia, and agoraphobia as expressions of the same multivariate, putatively genetically influenced trait. We applied the most powerful multipoint Haseman-Elston method, using the grade of membership score generated from a fuzzy clustering of these phenotypes as the dependent variable in Haseman-Elston regression. One region on chromosome 4q31-q34, at marker D4S413 ( with multipoint and single-point nominal P values < .00001), showed strong evidence of linkage ( genomewide significance at). The same P < .05 region is known to be the site of a neuropeptide Y receptor gene, NPY1R ( 4q31-q32), that was recently connected to anxiolytic-like effects in rats. Several other regions on four chromosomes ( 4q21.21-22.3, 5q14.2-14.3, 8p23.1, and 14q22.3-23.3) met criteria for suggestive linkage ( multipoint nominal P values < .01). Family-by-family analysis did not show any strong evidence of heterogeneity. Our findings support the notion that the major anxiety disorders, including phobias and panic disorder, are complex traits that share at least one susceptibility locus. This method could be applied to other complex traits for which shared genetic-liability factors are thought to be important, such as substance dependencies.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Cleveland, OH 44106 USA; Inst Pasteur, Lab Epidemiol & Ecol Parasites, Tunis, Tunisia; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; VA Connecticut Healthcare Syst, Dept Psychiat, West Haven, CT USA; Indiana Univ, Sch Med, Indianapolis, IN 46204 USA; Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA	Case Western Reserve University; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Indiana University System; Indiana University-Purdue University Indianapolis; University of Alabama System; University of Alabama Birmingham	Elston, RC (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Wolstein Res Bldg 1304,2103 Cornell Rd, Cleveland, OH 44106 USA.	rce@darwin.case.edu	/AAF-4811-2020	/0000-0002-3103-5228; Page, Grier/0000-0003-2582-3786; Kaabi, Belhassen/0000-0002-5042-6996; Gelernter, Joel/0000-0002-4067-1859	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012849, K24DA015105, R01DA012690] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NIDA NIH HHS [R01 DA012690, DA12690, R01 DA012849, DA12849, K24 DA015105, DA15105] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, GM-28356, R37 GM028356] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; Curtis GC, 1998, BRIT J PSYCHIAT, V173, P212, DOI 10.1192/bjp.173.3.212; Dizier MH, 1996, AM J HUM GENET, V58, P1338; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Douglas JA, 2002, AM J HUM GENET, V70, P487, DOI 10.1086/338919; Dunn J.C, 1977, FUZZY AUTOMATA DECIS, P271; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; First M.B., 2015, SCID 2 PERSONALITY Q; Gelernter J, 2004, AM J PSYCHIAT, V161, P59, DOI 10.1176/appi.ajp.161.1.59; Gelernter J, 2003, MOL PSYCHIATR, V8, P71, DOI 10.1038/sj.mp.4001224; Gelernter J, 2004, AM J MED GENET B, V128B, P94, DOI 10.1002/ajmg.b.30019; Gelernter J, 2001, AM J MED GENET, V105, P548, DOI 10.1002/ajmg.1496; Hamilton SP, 2002, BIOL PSYCHIAT, V51, P591, DOI 10.1016/S0006-3223(01)01322-1; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; HEILIG M, 1989, PSYCHOPHARMACOLOGY, V98, P524, DOI 10.1007/BF00441953; Hettema JM, 2005, ARCH GEN PSYCHIAT, V62, P182, DOI 10.1001/archpsyc.62.2.182; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Insightful Corporation, 2003, S PLUS SOFTW S PLUS; Jeste DV, 2005, BIOL PSYCHIAT, V58, P265, DOI 10.1016/j.biopsych.2005.02.004; Kaabi B, 2003, GENET EPIDEMIOL, V24, P253, DOI 10.1002/gepi.10234; Kaufman L., 1990, FINDING GROUPS DATA; Kendler KS, 1999, PSYCHOL MED, V29, P539, DOI 10.1017/S0033291799008429; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Magee WJ, 1996, ARCH GEN PSYCHIAT, V53, P159; Mazzanti CM, 1998, ARCH GEN PSYCHIAT, V55, P936, DOI 10.1001/archpsyc.55.10.936; Nakamura M, 1999, MOL PSYCHIATR, V4, P155, DOI 10.1038/sj.mp.4000515; Ohara K, 1998, PSYCHIAT RES, V81, P277, DOI 10.1016/S0165-1781(98)00100-0; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Pison G, 1999, COMPUT STAT DATA AN, V30, P381, DOI 10.1016/S0167-9473(98)00102-9; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sand PG, 2000, PSYCHIATR GENET, V10, P191, DOI 10.1097/00041444-200010040-00007; Seaman SR, 2005, HUM HERED, V59, P157, DOI 10.1159/000085939; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Smoller JW, 2001, AM J MED GENET, V105, P195, DOI 10.1002/ajmg.1209; Sorensen G, 2004, J NEUROSCI RES, V77, P723, DOI 10.1002/jnr.20200; Stein MB, 2004, BIOL PSYCHIAT, V56, P217, DOI 10.1016/j.biopsych.2004.05.020; Thorgeirsson TE, 2003, AM J HUM GENET, V72, P1221, DOI 10.1086/375141; van den Heuvel OA, 2000, J CLIN PSYCHIAT, V61, P756, DOI 10.4088/JCP.v61n1008; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976	48	69	70	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					543	553		10.1086/501072	http://dx.doi.org/10.1086/501072			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532386	Green Published, Bronze			2022-12-18	WOS:000236755900002
J	Suresh, R; Ambrose, N; Roe, C; Pluzhnikov, A; Wittke-Thompson, JK; Ng, MCY; Wu, XL; Cook, EH; Lundstrom, C; Garsten, M; Ezrati, R; Yairi, E; Cox, NJ				Suresh, R; Ambrose, N; Roe, C; Pluzhnikov, A; Wittke-Thompson, JK; Ng, MCY; Wu, XL; Cook, EH; Lundstrom, C; Garsten, M; Ezrati, R; Yairi, E; Cox, NJ			New complexities in the genetics of stuttering: Significant sex-specific linkage signals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDER; LANGUAGE DISORDER; GENOME SCAN; CHROMOSOME-2; GUIDELINES; RECOVERY; PROGRAM; SUPPORT; DISEASE; MARKERS	Stuttering is a speech disorder long recognized to have a genetic component. Recent linkage studies mapped a susceptibility locus for stuttering to chromosome 12 in 46 highly inbred families ascertained in Pakistan. We report here on linkage studies in 100 families of European descent ascertained in the United States, Sweden, and Israel. These families included 252 individuals exhibiting persistent stuttering, 45 individuals classified as recovered from stuttering, and 19 individuals too young to classify. Primary analyses identified moderate evidence for linkage of the broader diagnosis of "ever stuttered" ( including both persistent and recovered stuttering) on chromosome 9 ( LOD p 2.3 at 60 cM) and of the narrower diagnosis of persistent stuttering on chromosome 15 ( LOD p 1.95 at 23 cM). In contrast, sex-specific evidence for linkage on chromosome 7 at 153 cM in the male-only data subset ( LOD p 2.99) and on chromosome 21 at 34 cM in the female-only data subset ( LOD p 4.5) met genomewide criteria for significance. Secondary analyses revealed a significant increase in the evidence for linkage on chromosome 12, conditional on the evidence for linkage at chromosome 7, with the location of the increased signal congruent with the previously reported signal in families ascertained in Pakistan. In addition, a region on chromosome 2 ( 193 cM) showed a significant increase in the evidence for linkage conditional on either chromosome 9 ( positive) or chromosome 7 ( negative); this chromosome 2 region has been implicated elsewhere in studies on autism, with increased evidence for linkage observed when the sample is restricted to those with delayed onset of phrase speech. Our results support the hypothesis that the genetic component to stuttering has significant sex effects.	Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Illinois, Dept Speech & Hearing Sci, Urbana, IL 61801 USA; Columbia Univ, Dept Genet & Dev, New York, NY USA; Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60612 USA; Helsingborg Hosp, Helsingborg, Sweden; Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; Columbia University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Helsingborgs Hospital; Tel Aviv University	Cox, NJ (corresponding author), Univ Chicago, Dept Med, Med Genet Sect, 5841 S Maryland Ave,AMB M265, Chicago, IL 60637 USA.	ncox@bsd.uchicago.edu		Cook, Edwin/0000-0002-5848-5114	NIDCD NIH HHS [DC-04415, R01 DC004415] Funding Source: Medline; NIDDK NIH HHS [DK-55889, R01 DK055889] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004415] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alarcon M, 2005, MOL PSYCHIATR, V10, P747, DOI 10.1038/sj.mp.4001666; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; AMBROSE NG, 1993, J SPEECH HEAR RES, V36, P701, DOI 10.1044/jshr.3604.701; Ambrose NG, 1997, J SPEECH LANG HEAR R, V40, P567, DOI 10.1044/jslhr.4003.567; ANDREWS G, 1991, ARCH GEN PSYCHIAT, V48, P1034; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bloodstein O., 1995, HDB STUTTERING; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; COX N J, 1984, Genetic Epidemiology, V1, P245, DOI 10.1002/gepi.1370010304; Douglas JA, 2002, AM J HUM GENET, V70, P487, DOI 10.1086/338919; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Felsenfeld S, 2002, J COMMUN DISORD, V35, P329, DOI 10.1016/S0021-9924(02)00088-6; Felsenfeld S, 2000, BEHAV GENET, V30, P359, DOI 10.1023/A:1002765620208; Fisher SA, 2002, EUR J HUM GENET, V10, P259, DOI 10.1038/sj.ejhg.5200792; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HOWIE PM, 1981, J SPEECH HEAR RES, V24, P317, DOI 10.1044/jshr.2403.317; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Kidd K. K., 1984, NATURE TREATMENT STU, P149; KIDD KK, 1980, J SPEECH HEAR RES, V23, P539, DOI 10.1044/jshr.2303.539; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Riaz N, 2005, AM J HUM GENET, V76, P647, DOI 10.1086/429226; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Shugart YY, 2004, AM J MED GENET A, V124A, P133, DOI 10.1002/ajmg.a.20347; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Viswanath N, 2004, HUM BIOL, V76, P401, DOI 10.1353/hub.2004.0050; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Weiss LA, 2005, HUM GENET, V117, P81, DOI 10.1007/s00439-004-1250-3; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097; Yairi E, 1996, J SPEECH HEAR RES, V39, P771, DOI 10.1044/jshr.3904.771; Yairi E., 2005, EARLY CHILDHOOD STUT, V1st; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	44	69	76	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					554	563		10.1086/501370	http://dx.doi.org/10.1086/501370			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532387	Green Published, Bronze			2022-12-18	WOS:000236755900003
J	Hamet, P; Merlo, E; Seda, O; Broeckel, U; Tremblay, J; Kaldunski, M; Gaudet, D; Bouchard, G; Deslauriers, B; Gagnon, F; Antoniol, G; Pausova, Z; Labuda, M; Jomphe, M; Gossard, F; Tremblay, G; Kirova, R; Tonellato, P; Orlov, SN; Pintos, J; Platko, J; Hudson, TJ; Rioux, JD; Kotchen, TA; Cowley, AW				Hamet, P; Merlo, E; Seda, O; Broeckel, U; Tremblay, J; Kaldunski, M; Gaudet, D; Bouchard, G; Deslauriers, B; Gagnon, F; Antoniol, G; Pausova, Z; Labuda, M; Jomphe, M; Gossard, F; Tremblay, G; Kirova, R; Tonellato, P; Orlov, SN; Pintos, J; Platko, J; Hudson, TJ; Rioux, JD; Kotchen, TA; Cowley, AW			Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTOLIC BLOOD-PRESSURE; WIDE LINKAGE SCAN; GENOME SCAN; INSULIN-RESISTANCE; NATIONAL-HEART; DISEASE; POPULATION; OBESITY; GENES; MODEL	The Saguenay-Lac St-Jean population of Quebec is relatively isolated and has genealogical records dating to the 17th-century French founders. In 120 extended families with at least one sib pair affected with early-onset hypertension and/or dyslipidemia, we analyzed the genetic determinants of hypertension and related cardiovascular and metabolic conditions. Variance-components linkage analysis revealed 46 loci after 100,000 permutations. The most prominent clusters of overlapping quantitative-trait loci were on chromosomes 1 and 3, a finding supported by principal-components and bivariate analyses. These genetic determinants were further tested by classifying families by use of LOD score density analysis for each measured phenotype at every 5 cM. Our study showed the founder effect over several generations and classes of living individuals. This quantitative genealogical approach supports the notion of the ancestral causality of traits uniquely present and inherited in distinct family classes. With the founder effect, traits determined within population subsets are measurably and quantitatively transmitted through generational lineage, with a precise component contributing to phenotypic variance. These methods should accelerate the uncovering of causal haplotypes in complex diseases such as hypertension and metabolic syndrome.	Ctr Hosp Univ Montreal, Montreal, PQ, Canada; Ecole Polytech, Montreal, PQ H3C 3A7, Canada; McGill Univ, Montreal, PQ, Canada; Genome Quebec Innovat Ctr, Montreal, PQ, Canada; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Complexe Hosp Sagamie, Chicoutimi, PQ, Canada; Univ Quebec Chicoutimi, Chicoutimi, PQ, Canada; Univ Ottawa, Ottawa, ON, Canada; Univ Sannio, Benevento, Italy; Broad Inst, Cambridge, MA USA	Universite de Montreal; Universite de Montreal; Polytechnique Montreal; McGill University; Medical College of Wisconsin; University of Quebec; University of Quebec Chicoutimi; University of Ottawa; University of Sannio; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hamet, P (corresponding author), CHUM Hotel Dieu, Ctr Rech, Mol Med Lab, 3850 St Urbain St, Montreal, PQ H2W 1T7, Canada.	pavel.hamet@umontreal.ca	Cossette, Suzanne/I-8008-2016; Seda, Ondrej/A-2058-2008; Yordanova, Roumyana/AAR-2275-2021; ORLOV, SERGEI/I-4071-2013; Rioux, John D/A-9599-2015	Seda, Ondrej/0000-0001-8498-5895; Rioux, John D/0000-0001-7560-8326; Kaldunski, Mary/0000-0003-3645-6803	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064541] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064541] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Atzmon G, 2004, J AM GERIATR SOC, V52, P274, DOI 10.1111/j.1532-5415.2004.52068.x; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Bouchard G, 1989, Hist Mes, V4, P39, DOI 10.3406/hism.1989.874; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Daw EW, 1999, AM J HUM GENET, V64, P839, DOI 10.1086/302276; Doris PA, 2002, HYPERTENSION, V39, P323, DOI 10.1161/hy0202.104087; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Franklin SS, 2004, AM J HYPERTENS, V17, p49S, DOI 10.1016/j.amjhyper.2004.08.020; Gagnon F, 2003, HUM GENET, V113, P522, DOI 10.1007/s00439-003-1006-5; Ghosh S, 2001, ADV GENET, V42, P323, DOI 10.1016/S0065-2660(01)42031-1; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Groop L, 2001, J INTERN MED, V250, P105, DOI 10.1046/j.1365-2796.2001.00864.x; Hamet P, 1998, J HYPERTENS, V16, P397, DOI 10.1097/00004872-199816040-00001; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; HEYER E, 1995, AM J HUM GENET, V56, P970; Jacobs KB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S82; James K, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S83; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Joffres MR, 2001, AM J HYPERTENS, V14, P1099, DOI 10.1016/S0895-7061(01)02211-7; Kotchen TA, 2002, HYPERTENSION, V40, P634, DOI 10.1161/01.HYP.0000036400.79248.22; Kotchen TA, 2000, HYPERTENSION, V36, P7, DOI 10.1161/01.HYP.36.1.7; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Labuda M, 1996, AM J HUM GENET, V59, P633; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Langefeld CD, 2004, DIABETES, V53, P1170, DOI 10.2337/diabetes.53.4.1170; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loos RJF, 2003, J CLIN ENDOCR METAB, V88, P5935, DOI 10.1210/jc.2003-030553; MCADOO WG, 1990, J HYPERTENS, V8, P961, DOI 10.1097/00004872-199010000-00012; Newman DL, 2003, HUM MOL GENET, V12, P137, DOI 10.1093/hmg/ddg012; OBRIEN E, 1994, HUM BIOL, V66, P185; Pausova Z, 1999, Curr Hypertens Rep, V1, P42, DOI 10.1007/s11906-999-0072-z; Pausova Z, 2002, OBES RES, V10, P463, DOI 10.1038/oby.2002.64; Pausova Z, 2000, HYPERTENSION, V36, P14, DOI 10.1161/01.HYP.36.1.14; Pausova Z, 2001, HYPERTENSION, V38, P41, DOI 10.1161/01.HYP.38.1.41; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Province MA, 2003, AM J HYPERTENS, V16, P144, DOI 10.1016/S0895-7061(02)03248-X; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Reaven GM, 2004, DIABETES CARE, V27, P1011, DOI 10.2337/diacare.27.4.1011; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Samani NJ, 2003, AM J HYPERTENS, V16, P167, DOI 10.1016/S0895-7061(02)03244-2; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Siegmund D, 2002, AM J HUM GENET, V71, P1183, DOI 10.1086/343819; STEIL GM, 1993, DIABETES, V42, P250, DOI 10.2337/diabetes.42.2.250; Stein CM, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S99; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Tang WH, 2003, DIABETES, V52, P2840, DOI 10.2337/diabetes.52.11.2840; Turnbull F, 2003, LANCET, V362, P1527; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003; von Wowern F, 2003, HUM MOL GENET, V12, P2077, DOI 10.1093/hmg/ddg206; Wijsman EM, 2002, METH MOL B, V195, P139; Woolley N, 2002, HUM GENET, V111, P40, DOI 10.1007/s00439-002-0745-z	63	69	70	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					815	832		10.1086/430133	http://dx.doi.org/10.1086/430133			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15800845	Green Published, Bronze			2022-12-18	WOS:000228198300009
J	Casper, AM; Durkin, SG; Arlt, MF; Glover, TW				Casper, AM; Durkin, SG; Arlt, MF; Glover, TW			Chromosomal instability at common fragile sites in Seckel syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SISTER CHROMATID EXCHANGES; VIRAL INTEGRATION; MITOMYCIN-C; GENE AMPLIFICATION; ATR; CHECKPOINT; BREAKAGE; DNA; SENSITIVITY; EXPRESSION	Seckel syndrome (SCKL) is a rare, genetically heterogeneous disorder, with dysmorphic facial appearance, growth retardation, microcephaly, mental retardation, variable chromosomal instability, and hematological disorders. To date, three loci have been linked to this syndrome, and recently, the gene encoding ataxia-telangiectasia and Rad3-related protein (ATR) was identified as the gene mutated at the SCKL1 locus. The ATR mutation affects splicing efficiency, resulting in low levels of ATR in affected individuals. Elsewhere, we reported increased instability at common chromosomal fragile sites in cells lacking the replication checkpoint gene ATR. Here, we tested whether cells from patients carrying the SCKL1 mutation would show increased chromosome breakage following replication stress. We found that, compared with controls, there is greater chromosomal instability, particularly at fragile sites, in SCKL1-affected patient cells after treatment with aphidicolin, an inhibitor of DNA polymerase a and other polymerases. The difference in chromosomal instability between control and patient cells increases at higher levels of aphidicolin treatment, suggesting that the low level of ATR present in these patients is not sufficient to respond appropriately to replication stress. This is the first human genetic syndrome associated with increased chromosome instability at fragile sites following replication stress, and these findings may be related to the phenotypic findings in patients with SCKL1.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Glover, TW (corresponding author), Univ Michigan, Dept Human Genet, 4909 Buhl,Box 0618,1241 E Catherine St, Ann Arbor, MI 48109 USA.	glover@umich.edu		Casper, Anne/0000-0003-4975-5749	NCI NIH HHS [R01 CA043222, CA43222] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abou-Zahr F, 1999, AM J MED GENET, V83, P388, DOI 10.1002/(SICI)1096-8628(19990423)83:5<388::AID-AJMG9>3.0.CO;2-1; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bobabilla-Morales L, 2003, AM J MED GENET A, V123A, P148, DOI 10.1002/ajmg.a.20341; Borglum AD, 2001, EUR J HUM GENET, V9, P753, DOI 10.1038/sj.ejhg.5200701; BUTLER MG, 1987, AM J MED GENET, V27, P645, DOI 10.1002/ajmg.1320270318; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; CERVENKA J, 1979, AM J DIS CHILD, V133, P555, DOI 10.1001/archpedi.1979.02130050099023; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Geisel J, 2003, J PERINAT NEONAT NUR, V17, P268, DOI 10.1097/00005237-200310000-00005; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; HAYANI A, 1994, J MED GENET, V31, P148, DOI 10.1136/jmg.31.2.148; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Kilinc MO, 2003, EUR J HUM GENET, V11, P851, DOI 10.1038/sj.ejhg.5201057; Koury MJ, 1997, BLOOD, V90, P4054, DOI 10.1182/blood.V90.10.4054; KUO MT, 1994, MOL CELL BIOL, V14, P5202, DOI 10.1128/MCB.14.8.5202; LILLEYMAN JS, 1984, AM J PEDIAT HEMATOL, V6, P207; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; POPESCU NC, 1989, CANCER GENET CYTOGEN, V42, P157, DOI 10.1016/0165-4608(89)90084-8; RASSOOL FV, 1991, P NATL ACAD SCI USA, V88, P6657, DOI 10.1073/pnas.88.15.6657; Seckel H.P.G., 1960, BIRD HEADED DWARFS S; SMITH PP, 1992, GENE CHROMOSOME CANC, V5, P150, DOI 10.1002/gcc.2870050209; Syrrou M., 1995, Genetic Counseling, V6, P37; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Verhaar MC, 2002, ARTERIOSCL THROM VAS, V22, P6, DOI 10.1161/hq0102.102190; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; WOODS CG, 1995, J MED GENET, V32, P301, DOI 10.1136/jmg.32.4.301	37	69	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					654	660		10.1086/422701	http://dx.doi.org/10.1086/422701			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15309689	Green Published, Bronze			2022-12-18	WOS:000223634100011
J	Arnheim, N; Calabrese, P; Nordborg, M				Arnheim, N; Calabrese, P; Nordborg, M			Hot and cold spots of recombination in the human genome: The reason we should find them and how this can be achieved	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; STRAND-BREAK REPAIR; HUMAN PSEUDOAUTOSOMAL REGION; POLYMERASE CHAIN-REACTION; SINGLE SPERM ANALYSIS; GLOBIN GENE-CLUSTER; HUMAN X-CHROMOSOME; CLASS-II REGION; MEIOTIC RECOMBINATION; LINKAGE DISEQUILIBRIUM		Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Arnheim, N (corresponding author), Univ So Calif, Mol & Computat Biol Program, 835 W 37th St,SHS 172, Los Angeles, CA 90089 USA.	arnheim@usc.edu		Nordborg, Magnus/0000-0001-7178-9748; Arnheim, Norman/0000-0003-1247-1347	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036745] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Badge RM, 2000, HUM MOL GENET, V9, P1239, DOI 10.1093/hmg/9.8.1239; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brown GM, 1998, AM J HUM GENET, V62, P1484, DOI 10.1086/301863; Buard J, 2000, AM J HUM GENET, V67, P333, DOI 10.1086/303015; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Carrington M, 1999, IMMUNOL REV, V167, P245, DOI 10.1111/j.1600-065X.1999.tb01397.x; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Crouau-Roy B, 2002, GENETICA, V114, P17, DOI 10.1023/A:1014665314979; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; CUI XF, 1992, GENOMICS, V13, P713, DOI 10.1016/0888-7543(92)90146-J; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; CULLEN M, 2001, MOL EPIDEMIOLOGY PRA, P145; DA Y, 1995, GENETICS, V139, P1091; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; DAY CE, 1994, IMMUNOGENETICS, V39, P335; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Girardet A, 2000, AM J HUM GENET, V66, P167, DOI 10.1086/302715; Grewal RP, 1999, HUM MOL GENET, V8, P1779, DOI 10.1093/hmg/8.9.1779; GRIMM T, 1989, AM J HUM GENET, V45, P368; Guillon H, 2002, NAT GENET, V32, P296, DOI 10.1038/ng990; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; HOGSTRAND K, 1994, P NATL ACAD SCI USA, V91, P9921, DOI 10.1073/pnas.91.21.9921; Hogstrand K, 1999, IMMUNOL REV, V167, P305, DOI 10.1111/j.1600-065X.1999.tb01400.x; Holbeck SL, 1997, GENETICS, V147, P1017; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; INNAN H, IN PRESS GENOME RES; Isobe T, 2002, GENOMICS, V80, P229, DOI 10.1006/geno.2002.6817; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; KOBORI JA, 1986, SCIENCE, V234, P173, DOI 10.1126/science.3018929; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; Leeflang EP, 1996, AM J HUM GENET, V59, P896; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; LIEN S, 1993, GENOMICS, V16, P41, DOI 10.1006/geno.1993.1137; LIEN S, 2002, CURRENT PROTOCOLS HU; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Martinsohn JT, 1999, IMMUNOGENETICS, V50, P168, DOI 10.1007/s002510050593; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Morris AP, 2002, AM J HUM GENET, V70, P686, DOI 10.1086/339271; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pramanik S, 2002, AM J HUM GENET, V71, P1342, DOI 10.1086/344713; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Rattray AJ, 2001, GENETICS, V158, P109; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Robinson WP, 1996, AM J HUM GENET, V59, P1175; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHMITT K, 1994, AM J HUM GENET, V55, P423; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; Shi QH, 2002, AM J HUM GENET, V71, P254, DOI 10.1086/341559; Shi QH, 2001, AM J MED GENET, V99, P34, DOI 10.1002/1096-8628(20010215)99:1<34::AID-AJMG1106>3.0.CO;2-D; SHIROISHI T, 1990, IMMUNOGENETICS, V31, P79, DOI 10.1007/BF00661217; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; SHIROISHI T, 1995, ADV BIOPHYS, V31, P119, DOI 10.1016/0065-227X(95)99387-5; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; STRATHERN JN, 1995, GENETICS, V140, P965; Takiyama Y, 1999, HUM MOL GENET, V8, P453, DOI 10.1093/hmg/8.3.453; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; Tayebi N, 2003, AM J HUM GENET, V72, P519, DOI 10.1086/367850; TUSIELUNA MT, 1995, P NATL ACAD SCI USA, V92, P10796, DOI 10.1073/pnas.92.23.10796; UGOZZOLI L, 1991, Methods (Orlando), V2, P42, DOI 10.1016/S1046-2023(05)80124-0; Wall JD, 2000, GENETICS, V155, P1865; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; Wall JD, 2002, GENETICS, V162, P203; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Weber JL, 2002, NAT GENET, V31, P225, DOI 10.1038/ng920; WILLIAMS C, 1993, HUM MOL GENET, V2, P445, DOI 10.1093/hmg/2.4.445; Yip SP, 1999, HUM MOL GENET, V8, P1699, DOI 10.1093/hmg/8.9.1699; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Yu J, 1996, AM J HUM GENET, V59, P1186; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	100	69	72	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					5	16		10.1086/376419	http://dx.doi.org/10.1086/376419			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12772086	Green Published, Bronze			2022-12-18	WOS:000183904900002
J	Busfield, F; Duffy, DL; Kesting, JB; Walker, SM; Lovelock, PK; Good, D; Tate, H; Watego, D; Marczak, M; Hayman, N; Shaw, JTE				Busfield, F; Duffy, DL; Kesting, JB; Walker, SM; Lovelock, PK; Good, D; Tate, H; Watego, D; Marczak, M; Hayman, N; Shaw, JTE			A genomewide search for type 2 diabetes-susceptibility genes in indigenous Australians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; AFFECTED SIB PAIRS; BETA-CELL FUNCTION; LATE-ONSET NIDDM; ABORIGINAL COMMUNITY; CHROMOSOME 20Q; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; COMPLEX TRAITS; WIDE SEARCH	The prevalence of type 2 diabetes among Australian residents is 7.5%; however, prevalence rates up to six times higher have been reported for indigenous Australian communities. Epidemiological evidence implicates genetic factors in the susceptibility of indigenous Australians to type 2 diabetes and supports the hypothesis of the "thrifty genotype," but, to date, the nature of the genetic predisposition is unknown. We have ascertained clinical details from a community of indigenous Australian descent in North Stradbroke Island, Queensland. In this population, the phenotype is characterized by severe insulin resistance. We have conducted a genomewide scan, at an average resolution of 10 cM, for type 2 diabetes-susceptibility genes in a large multigeneration pedigree from this community. Parametric linkage analysis undertaken using FASTLINK version 4.1p yielded a maximum two-point LOD score of +2.97 at marker D2S2345. Multipoint analysis yielded a peak LOD score of +3.9 <1 cM from marker D2S2345, with an 18-cM 3-LOD support interval. Secondary peak LOD scores were noted on chromosome 3 (+1.8 at recombination fraction [&theta;] 0.05, at marker D3S1311) and chromosome 8 (+ 1.77 at &theta; = 0.0, at marker D8S549). These chromosomal regions are likely to harbor novel susceptibility genes for type 2 diabetes in the indigenous Australian population.	Princess Alexandra Hosp, Dept Endocrinol & Diabet, Brisbane, Qld 4102, Australia; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Inala Community Hlth Ctr, Brisbane, Qld, Australia; Yulu Burri Ba Aboriginal Corp Community Hlth, N Stradbroke Isl, Qld, Australia; Redland Hlth Serv Ctr, Cleveland, Qld, Australia	QIMR Berghofer Medical Research Institute	Shaw, JTE (corresponding author), Princess Alexandra Hosp, Dept Endocrinol & Diabet, Brisbane, Qld 4102, Australia.		Duffy, David L/B-7392-2013; Hayman, Noel/H-9626-2013	Duffy, David L/0000-0001-7227-632X; 				ALESSI DR, 1993, EUR J BIOCHEM, V213, P1055, DOI 10.1111/j.1432-1033.1993.tb17853.x; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; BASTIAN P, 1979, AUST NZ J MED, V9, P284, DOI 10.1111/j.1445-5994.1979.tb04140.x; Bell GI, 1996, ANNU REV PHYSIOL, V58, P171, DOI 10.1146/annurev.ph.58.030196.001131; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Ebert DH, 1999, DIABETES, V48, P543, DOI 10.2337/diabetes.48.3.543; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Ferrer J, 1996, DIABETES, V45, P262, DOI 10.2337/diabetes.45.2.262; Gault A, 1996, DIABETES CARE, V19, P1269, DOI 10.2337/diacare.19.11.1269; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; GUEST CS, 1993, DIABETES RES CLIN PR, V20, P155, DOI 10.1016/0168-8227(93)90010-3; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hayman N., 1997, ABORIGINAL ISLANDER, V21, P15; Hegele RA, 1999, J HUM GENET, V44, P10, DOI 10.1007/s100380050097; Hemming R, 2001, BIOCHEM CELL BIOL, V79, P21, DOI 10.1139/bcb-79-1-21; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; Kasus-Jacobi A, 1998, J BIOL CHEM, V273, P26026, DOI 10.1074/jbc.273.40.26026; KHAN A, 1995, ENDOCRINOLOGY, V136, P1934, DOI 10.1210/en.136.5.1934; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEVY JC, 1991, DIABETOLOGIA, V34, P488, DOI 10.1007/BF00403285; Maassen JA, 1996, DIABETOLOGIA, V39, P375; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Malecki MT, 1998, DIABETES, V47, P970, DOI 10.2337/diabetes.47.6.970; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'DEA K, 1991, Ethnicity and Disease, V1, P171; ODEA K, 1993, DIABETES CARE, V16, P1004, DOI 10.2337/diacare.16.7.1004; ODEA K, 1992, J INTERN MED, V232, P103, DOI 10.1111/j.1365-2796.1992.tb00559.x; ODEA K, 1990, DIABETES CARE, V13, P830, DOI 10.2337/diacare.13.8.830; Rao DC, 2000, HUM HERED, V50, P34, DOI 10.1159/000022889; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHAW J, 2000, AUSTRALASIAN EPIDEMI, V7, P21; Shaw JTE, 1998, DIABETES, V47, P1793, DOI 10.2337/diabetes.47.11.1793; Steiner D. F., 1995, METABOLIC MOL BASES, P897; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Taylor S. I., 1995, METABOLIC MOL BASES, P843; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Vionnet N, 1997, DIABETES, V46, P1062, DOI 10.2337/diabetes.46.6.1062; WILLIAMS DRR, 1987, DIABETOLOGIA, V30, P72; Yamada T, 1996, POLYM REACT ENG, V4, P1; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang H, 2001, DIABETES, V50, pA27; ZIMMER P, 2001, FINAL REPORT AUSTR D; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401	55	69	70	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					349	357		10.1086/338626	http://dx.doi.org/10.1086/338626			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11742441	Green Published, Bronze			2022-12-18	WOS:000173254300008
J	Vasen, HFA; Morreau, H; Nortier, JWR				Vasen, HFA; Morreau, H; Nortier, JWR			Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Vasen, HFA (corresponding author), Leiden Univ, Med Ctr, Netherlands Fdn Detect Hereditary Tumours, Rijnsburgerweg 10,Poortgebouw Zuid, NL-2333 AA Leiden, Netherlands.			Vasen, Hans/0000-0003-2682-2603				Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L; Boyd J, 1999, BREAST CANCER RES TR, V53, P87, DOI 10.1023/A:1006030116357; Risinger JI, 1996, CANCER, V77, P1836, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#	5	69	71	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1533	1534		10.1086/320610	http://dx.doi.org/10.1086/320610			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11359214	Green Published, Bronze			2022-12-18	WOS:000169094600026
J	Drenth, JPH; Finley, WH; Breedveld, GJ; Testers, L; Michiels, JJ; Guillet, G; Taieb, A; Kirby, RL; Heutink, P				Drenth, JPH; Finley, WH; Breedveld, GJ; Testers, L; Michiels, JJ; Guillet, G; Taieb, A; Kirby, RL; Heutink, P			The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SECONDARY ERYTHERMALGIA; ERYTHROMELALGIA; SKIN	Primary erythermalgia is a rare disorder characterized by recurrent attacks of red, warm, and painful hands and/or feet. The symptoms are generally refractory to treatment and persist throughout life. Five kindreds with multiple cases of primary erythermalgia were identified, and the largest was subjected to a genomewide search. We detected strong evidence for linkage of the primary erythermalgia locus to markers from chromosome 2q. The highest LOD score (Z) was obtained with D2S2330 (Z(max) = 6.51). Analysis of recombination events identified D2S2370 and D2S1776 as flanking markers, on chromosome 2q31-32. This defines a critical interval of 7.94 cM that harbors the primary erythermalgia gene. Affected members within the additional families also shared a common haplotype on chromosome 2q31-32, supporting our linkage results. Identification of the primary erythermalgia gene will allow a better clinical classification of this pleomorphic group of disorders.	Univ Med Ctr St Radboud, Dept Med, Div Gastroenterol, NL-6500 HB Nijmegen, Netherlands; Univ Alabama, Dept Human Genet, Birmingham, AL USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Hemostasis & Thrombosis Goodheart Inst, NL-3000 DR Rotterdam, Netherlands; Univ Antwerp Hosp, Dept Hematol, Antwerp, Belgium; Hop Morvan, Dept Dermatol, Brest, France; Hop Pellegrin Enfants, Pediat Dermatol Unit, Bordeaux, France; Dalhousie Univ, Dept Med, Halifax, NS, Canada	Radboud University Nijmegen; University of Alabama System; University of Alabama Birmingham; Erasmus University Rotterdam; Erasmus University Rotterdam; University of Antwerp; CHU Brest; Universite de Bretagne Occidentale; CHU Bordeaux; Dalhousie University	Drenth, JPH (corresponding author), Univ Med Ctr St Radboud, Dept Med, Div Gastroenterol, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Drenth, Joost/V-7436-2019; Drenth, J.P.H./H-8025-2014	Heutink, Peter/0000-0001-5218-1737				COHEN IJK, 1982, ARCH DERMATOL, V118, P953, DOI 10.1001/archderm.118.11.953; DANGELO R, 1992, ANESTH ANALG, V74, P142; Davis MDP, 2000, ARCH DERMATOL, V136, P330, DOI 10.1001/archderm.136.3.330; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Drenth J P, 1994, Ned Tijdschr Geneeskd, V138, P2231; DRENTH JPH, 1994, INT J DERMATOL, V33, P393, DOI 10.1111/j.1365-4362.1994.tb04037.x; DRENTH JPH, 1992, BRIT J DERMATOL, V127, P292, DOI 10.1111/j.1365-2133.1992.tb00132.x; Drenth JPH, 1996, AM J DERMATOPATH, V18, P30, DOI 10.1097/00000372-199602000-00005; Drenth JPH, 1997, ACTA DERM-VENEREOL, V77, P325; DRENTH JPH, 1990, BRIT MED J, V301, P454, DOI 10.1136/bmj.301.6750.454; FINLEY WH, 1992, AM J MED GENET, V42, P310, DOI 10.1002/ajmg.1320420310; GELEHRTER TD, 1990, PRINCIPLES MED GENET, P27; Guillet MH, 1995, ANN DERMATOL VENER, V122, P777; Hart JJ, 1996, ARTHRITIS RHEUM, V39, P1761, DOI 10.1002/art.1780391022; KIRBY RL, 1987, ARCH PHYS MED REHAB, V68, P389; KREBS A, 1969, SCHWEIZ MED WSCHR, V99, P344; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Littleford RC, 1999, EUR J CLIN INVEST, V29, P588; MARTIN JC, 1994, ANN DERMATOL VENER, V121, P309; MICHIELS JJ, 1989, J AM ACAD DERMATOL, V21, P1128, DOI 10.1016/S0190-9622(89)70313-3; MICHIELS JJ, 1988, NETH J MED, V33, P205; MICHIELS JJ, 1985, ANN INTERN MED, V102, P466, DOI 10.7326/0003-4819-102-4-466; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mork C, 2000, J INVEST DERMATOL, V114, P643, DOI 10.1046/j.1523-1747.2000.00944.x; THOMPSON GH, 1979, CLIN ORTHOP RELAT R, P249; UNO H, 1983, ARCH DERMATOL, V119, P65, DOI 10.1001/archderm.119.1.65; VANCAMP G, 1997, TRENDS GENET, V13, P82	27	69	75	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1277	1282		10.1086/320107	http://dx.doi.org/10.1086/320107			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283792	Green Published, Bronze			2022-12-18	WOS:000168171200021
J	George, V; Tiwari, HK; Zhu, XF; Elston, RC				George, V; Tiwari, HK; Zhu, XF; Elston, RC			A test of transmission disequilibrium for quantitative traits in pedigree data, by multiple regression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION; MARKERS	The transmission/disequilibrium (TD) test (TDT), proposed, by Spielman et al., for binary traits is a powerful method for detection of linkage between a marker locus and a disease locus, in the presence of allelic association. As a test for linkage disequilibrium, the TDT makes the assumption that any allelic association present is due to linkage. Allison proposed a series of TD-type tests for quantitative traits and calculated their power, assuming that the marker locus is the disease locus. All these tests assume that the observations are independent, and therefore they are applicable, as a test for linkage, only for nuclear-family data. In this report, we propose a regression-based TD-type test for linkage between a marker locus and a quantitative trait locus, using information on the parent-to-offspring transmission status of the associated allele at the marker locus. This method does not require independence of observations, thus allowing for analysis of pedigree data as well, and allows adjustment for covariates. We investigate-the statistical power and validity of the test by simulating markers at various recombination fractions from the disease locus.	Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Chicago, IL 60611 USA	Medical College of Wisconsin; Case Western Reserve University; Loyola University Chicago	George, V (corresponding author), Med Coll Wisconsin, Div Biostat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.		Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03655] Funding Source: Medline; NHLBI NIH HHS [HL 55055] Funding Source: Medline; NIGMS NIH HHS [GM 28353] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 1997, AM J HUM GENET, V60, P676; Cleves MA, 1997, GENET EPIDEMIOL, V14, P337, DOI 10.1002/(SICI)1098-2272(1997)14:4<337::AID-GEPI1>3.3.CO;2-S; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1992, HUM HERED, V42, P16, DOI 10.1159/000154043; GEORGE VT, 1988, COMMUN STAT-THEOR M, V17, P2933, DOI 10.1080/03610928808829781; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Lindsey J.K., 1996, PARAMETRIC STAT INFE; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Risch NJ, 1996, AM J HUM GENET, V58, P836; *SAGE, 1998, STAT AN GEN EP REL 3; Shah BV, 1997, SUDAAN USERS MANUAL; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wolfinger, 1996, SAS SYSTEM LINEAR MO; ZHU X, 1999, THESIS CASE W RESERV	16	69	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					236	245		10.1086/302444	http://dx.doi.org/10.1086/302444			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364537	Green Published, Bronze			2022-12-18	WOS:000081224300029
J	Giunti, P; Stevanin, G; Worth, PF; David, G; Brice, A; Wood, NW				Giunti, P; Stevanin, G; Worth, PF; David, G; Brice, A; Wood, NW			Molecular and clinical study of 18 families with ADCA type II: Evidence for genetic heterogeneity and De Novo mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; MACHADO-JOSEPH-DISEASE; NON-MENDELIAN TRANSMISSION; CAG REPEAT EXPANSION; SPINOCEREBELLAR ATAXIA; RETINAL DEGENERATION; TRINUCLEOTIDE REPEAT; MACULAR DYSTROPHY; GERMAN KINDREDS; LOCUS	The SCA7 mutation has: been found in 54 patients and 7 at-risk subjects from 17 families who have autosomal dominant cerebellar ataxia (ADCA) II with progressive pigmentary maculopathy. In one isolated case, haplotype reconstruction through three generations confirmed a de novo mutation owing to paternal meiotic instability. Different disease-associated haplotypes segregated among the SCA7-positive kindreds, which indicated a multiple origin of the mutation. One family with the clinical phenotype of ADCA type II did not have the CAG expansion that indicated locus heterogeneity. The distribution of the repeat size in 944 independent normal chromosomes from controls; unaffected at-risk subjects, and one affected individual fell into two ranges. The majority of the alleles were in the first range of 7-19 CAG repeats. A second range could be. identified with 28-35 repeats, and we provide evidence that these repeats represent intermediate alleles that are prone to further expansion. The repeat size df the pathological allele, the widest reported for all GAG-repeat disorders, ranged from 37 to similar to 220. The repeat size showed significant negative correlation with both. age at onset and age at death. Analysis of the clinical features in the patients with SCA7 confirmed that the most frequently associated features are pigmentary maculopathy, pyramidal tract involvement, and slow saccades. The subjects with <49 repeats tended to have a less complicated neurological phenotype and a longer disease duration, whereas the converse applied to subjects with greater than or equal to 49 repeats. The degree of instability during meiotic transmission was greater than in all other GAG-repeat disorders and was particularly striking in paternal transmission, in which a median increase in repeat size of 6 and an interquartile range of 12 were observed, versus a median increase of 3 and interquartile range of 3.5 in maternal transmission.	Inst Neurol, London WC1N 3BG, England; Hop La Pitie Salpetriere, INSERM, U289, Paris, France; Hop La Pitie Salpetriere, Federat Neurol, Paris, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Wood, NW (corresponding author), Inst Neurol, Queen Sq, London WC1N 3BG, England.		Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; Giunti, Paola/E-5526-2012; Wood, Nicholas W/C-2505-2009; brice, alexis/AAE-8275-2019	Stevanin, Giovanni/0000-0001-9368-8657; Giunti, Paola/0000-0003-3508-4788; Wood, Nicholas W/0000-0002-9500-3348; brice, alexis/0000-0002-0941-3990				BENOMAR A, 1994, ANN NEUROL, V35, P439, DOI 10.1002/ana.410350411; BENOMAR A, 1995, NAT GENET, V10, P89; Burk K, 1997, J NEUROL, V244, P256, DOI 10.1007/s004150050081; David G, 1996, AM J HUM GENET, V59, P1328; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Del-Favero J, 1998, HUM MOL GENET, V7, P177, DOI 10.1093/hmg/7.2.177; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; Flanigan K, 1996, AM J HUM GENET, V59, P392; FROMENT J, 1937, J MED LYON, V22, P153; Giunti P, 1998, BRAIN, V121, P459, DOI 10.1093/brain/121.3.459; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; Ikeuchi T, 1996, AM J HUM GENET, V58, P730; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Jobsis GJ, 1997, J NEUROL NEUROSUR PS, V62, P367, DOI 10.1136/jnnp.62.4.367; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; Johansson J, 1998, HUM MOL GENET, V7, P171, DOI 10.1093/hmg/7.2.171; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOOB MD, 1998, NAT GENET, V99, P225; Krols L, 1997, HUM GENET, V99, P225, DOI 10.1007/s004390050344; OPHOFF RA, 1997, NEUROLOGIA S5, V12, P331; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Sathasivam K, 1997, HUM GENET, V99, P692, DOI 10.1007/s004390050432; Schols L, 1997, ARCH NEUROL-CHICAGO, V54, P1073, DOI 10.1001/archneur.1997.00550210011007; Stevanin G, 1998, HUM MOL GENET, V7, P1809, DOI 10.1093/hmg/7.11.1809; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	34	69	72	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1594	1603		10.1086/302406	http://dx.doi.org/10.1086/302406			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330346	Bronze, Green Published			2022-12-18	WOS:000080696200011
J	Tu, IP; Whittemore, AS				Tu, IP; Whittemore, AS			Power of association and linkage tests when the disease alleles are unobserved	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX DISEASES; GENETIC-ANALYSIS; DISEQUILIBRIUM	Genomewide association studies have been advocated as a promising alternative to genomewide linkage scans for detection of small-effect genes in complex diseases. Comparisons of power and sample size between the two strategies have shown considerable advantages for the association studies. These comparisons assume that the set of markers includes the exact disease-related polymorphism. A concern, however, is that the power of an association study decreases when this is not the case, because of discrepant allele frequencies and less-than-maximum disequilibrium between the disease-related polymorphism and its nearest marker. Here, we quantify this concern by comparing the sample sizes needed by the two strategies when the markers exclude the disease-related polymorphism. For affected sib pairs and their parents, we found that incomplete disequilibrium and differing allele frequencies can have substantial negative impact on the power of association studies, resulting, in some circumstances, in little gain and even in loss of power, compared with linkage analysis. We provide some guidelines for choosing between strategies, for the detection of genes for complex diseases.	Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA	Stanford University	Whittemore, AS (corresponding author), Stanford Univ, Dept Hlth Res & Policy, Sch Med, Redwood Bldg,Room T204, Stanford, CA 94305 USA.	asw@osiris.stanford.edu		Tu, I-Ping/0000-0001-8666-8391	NATIONAL CANCER INSTITUTE [R35CA047448] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA47448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abel L, 1998, AM J HUM GENET, V63, P664, DOI 10.1086/301975; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Risch N, 1997, SCIENCE, V275, P1329; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	14	69	72	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					641	649		10.1086/302253	http://dx.doi.org/10.1086/302253			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973303	Bronze, Green Published			2022-12-18	WOS:000078740600035
J	Burrows, NP; Nicholls, AC; Richards, AJ; Luccarini, C; Harrison, JB; Yates, JRW; Pope, FM				Burrows, NP; Nicholls, AC; Richards, AJ; Luccarini, C; Harrison, JB; Yates, JRW; Pope, FM			A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN GENE COL5A1; NAIL-PATELLA SYNDROME; V COLLAGEN; FIBRILLOGENESIS; CHAIN; ORGANIZATION; SELECTION; SEQUENCE; LINKAGE; REGION	Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective-tissue disorders characterized by skin fragility, joint laxity, and skeletal deformities. Type V collagen appears to have a causal role in EDS types I and II, which show phenotypic overlap and may sometimes be allelic. Type V collagen can exist as a heterotrimer, [alpha 1(V)](2)alpha 2(V), and it both coassembles with and regulates type I collagen-fibril diameter. Using an intragenic COL5A1 polymorphism, we have demonstrated linkage, at zero recombination, to the sane allele in two large British EDS type II families (LOD scores 4.1 and 4.3), Affected members from each family were heterozygous for a point mutation in intron 32 (IVS32:T-25G), causing the 45-bp exon 33 to be lost from the mRNA in similar to 60% of transcripts from the mutant gene. This mutation lies only 2 bp upstream of a highly conserved adenosine in the consensus branch-site sequence, which is required for lariat formation. Although both families shared the same marker allele, we have been unable to identify a common genealogy. This is the first description of a mutation at the lariat branch site, which plays a pivotal role in the splicing mechanism, in a collagen gene. Very probably, the resulting in-frame exon skip has a dominant-negative effect due to incorporation of the mutant pro alpha chain into the triple-helical molecule. These findings further confirm the importance of type V collagen in the causation of EDS type II, and the novel collagen mutation indicates the importance of the lariat branch site in splicing.	Addenbrookes NHS Trust, Dept Dermatol, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Addenbrookes NHS Trust, Dept Med Genet, Cambridge CB2 2QQ, England; Strangeways Res Lab, MRC, Connect Tissue Genet Grp, Cambridge CB1 4RN, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Burrows, NP (corresponding author), Addenbrookes NHS Trust, Dept Dermatol, Box 46,Hills Rd, Cambridge CB2 2QQ, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BIRK DE, 1990, J CELL SCI, V95, P649; Burrows NP, 1996, J INVEST DERMATOL, V106, P1273, DOI 10.1111/1523-1747.ep12348978; DePaepe A, 1997, AM J HUM GENET, V60, P547; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; GREENSPAN DS, 1995, GENOMICS, V25, P737, DOI 10.1016/0888-7543(95)80021-D; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; GREENSPAN DS, 1992, GENOMICS, V12, P836, DOI 10.1016/0888-7543(92)90320-R; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; Kuivenhoven JA, 1996, J CLIN INVEST, V98, P358, DOI 10.1172/JCI118800; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; LOUGHLIN J, 1995, HUM MOL GENET, V4, P1649, DOI 10.1093/hmg/4.9.1649; Maquat LE, 1996, AM J HUM GENET, V59, P279; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; Nicholls A. C., 1994, American Journal of Human Genetics, V55, pA233; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; OTT J, 1974, AM J HUM GENET, V26, P588; Pope FM, 1997, J MED GENET, V34, P400, DOI 10.1136/jmg.34.5.400; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; REED R, 1988, GENE DEV, V2, P1268, DOI 10.1101/gad.2.10.1268; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	29	69	70	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					390	398		10.1086/301948	http://dx.doi.org/10.1086/301948			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683580	Bronze, Green Published			2022-12-18	WOS:000075360800014
J	Bendall, KE; Macaulay, VA; Sykes, BC				Bendall, KE; Macaulay, VA; Sykes, BC			Variable levels of a heteroplasmic point mutation in individual hair roots	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; HUMAN MITOCHONDRIAL GENOME; TISSUE DISTRIBUTION; RAPID SEGREGATION; MTDNA MUTATION; DNA; SEQUENCE; REGION; GENE	During direct sequencing of the first hypervariable segment of the human mitochondrial control region, we identified one individual with a heteroplasmic point mutation at nt 16256. We used primer extension to analyze the proportions of each mitochondrial haplotype in peripheral blood, buccal cells, and single hair roots from this individual and from eight members of his maternal lineage. Significant levels of heteroplasmy were found in only three individuals, and, in these cases, the proportions of each haplotype were similar in both blood and buccal cells. From the changes in mitochondrial haplotypes within mother-offspring pairs, we calculated that the most likely size of a mitochondrial bottleneck during development was 1-27 segregating units. However, highly variable levels of heteroplasmy were found in single hair roots, even among roots from the same individual. We analyzed a large number of hair roots from one individual and found that the proportion of one haplotype was within a range of 9% to >99% in different roots. Roots originating from within a small patch of skin had haplotype proportions as variable as those from different areas of skin.	John Radcliffe Hosp, Inst Mol Med, Dept Cellular Sci, Oxford OX3 9DS, England	University of Oxford	Sykes, BC (corresponding author), John Radcliffe Hosp, Inst Mol Med, Dept Cellular Sci, Oxford OX3 9DS, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Bendall KE, 1996, AM J HUM GENET, V59, P1276; CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Howell N, 1996, AM J HUM GENET, V59, P501; HOWELL N, 1992, HUM GENET, V90, P117; HOWELL N, 1994, AM J HUM GENET, V55, P203; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KOEHLER CM, 1991, GENETICS, V129, P247; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; MONTAGNA W, 1958, BIOL HAIR GROWTH, P39; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PINKUS H., 1958, BIOL HAIR GROWTH, P1; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wilson MR, 1997, HUM GENET, V100, P167, DOI 10.1007/s004390050485; YEN MY, 1992, INVEST OPHTH VIS SCI, V33, P2561	24	69	78	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1303	1308		10.1086/301636	http://dx.doi.org/10.1086/301636			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399894	Bronze, Green Published			2022-12-18	WOS:000071555900013
J	Gasparini, P; delGiudice, EM; Delaunay, J; Totaro, A; Granatiero, M; Melchionda, S; Zelante, L; Iolascon, A				Gasparini, P; delGiudice, EM; Delaunay, J; Totaro, A; Granatiero, M; Melchionda, S; Zelante, L; Iolascon, A			Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-MANNOSIDASE-II; N-GLYCANS; EXPRESSION; GENE; MEMBRANE; PROTEINS; CLONING; DEFECT; BLOOD; MAP	Congenital dyserythropoietic anemias (CDA) are genetic disorders characterized by anemia and ineffective erythropoiesis. Three main types of CDA have been distinguished: CDA I and CDA III, whose loci have been already mapped, and CDA II (MIM 224100), the most frequent among CDAs, which is transmitted as an autosomal recessive trait and is known also as ''HEMPAS'' (hereditary erythroblast multinuclearity with positive acidified serum). We have recruited a panel of well-characterized CDA II families and have used them to search for the CDA II gene by linkage analysis. After the exclusion of three candidate genes, we obtained conclusive evidence for linkage of CDA II to microsatellite markers on the long arm of chromosome 20 (20q11.2). A maximum two-point LOD score of 5.4 at a recombination fraction of .00 was obtained with marker D20S863. Strong evidence of allelic association with the disease was detected with the same marker. Some recombinational events established a maximum candidate interval of similar to 5 cM.	UNIV NAPLES 2,DIPARTIMENTO PEDIAT,NAPLES,ITALY; SERV HEMATOL,U299,LE KREMLIN BICETR,FRANCE; UNIV BARI,DIPARTIMENTO BIOMED ETA EVOLUT,BARI,ITALY	Universita della Campania Vanvitelli; Universita degli Studi di Bari Aldo Moro	Gasparini, P (corresponding author), IRCCS,CSS,SERV GENET MED,SAN GIOVANNI ROTO,FG,ITALY.		Iolascon, Achille/A-4461-2014; Gasparini, Paolo/B-6173-2014					Alloisio N, 1996, BLOOD, V87, P4433, DOI 10.1182/blood.V87.10.4433.bloodjournal87104433; ANSELSTETTER V, 1977, BRIT J HAEMATOL, V35, P209, DOI 10.1111/j.1365-2141.1977.tb00577.x; CROOKSTON JH, 1969, BRIT J HAEMATOL, V17, P11, DOI 10.1111/j.1365-2141.1969.tb05660.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FUKUDA M N, 1990, Glycobiology, V1, P9, DOI 10.1093/glycob/1.1.9; FUKUDA MN, 1990, P NATL ACAD SCI USA, V87, P7443, DOI 10.1073/pnas.87.19.7443; FUKUDA MN, 1987, J BIOL CHEM, V262, P7195; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Iolascon A, 1996, HAEMATOLOGICA, V81, P543; IOLASCON A, IN PRESS BLOOD; LIND L, 1995, HUM MOL GENET, V4, P109, DOI 10.1093/hmg/4.1.109; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; MOREMEN KW, 1991, J CELL BIOL, V115, P1521, DOI 10.1083/jcb.115.6.1521; OTT J, 1992, ANAL HUMAN LINKAGE; Tamary H., 1996, Blood, V88, p144A; TAN J, 1995, EUR J BIOCHEM, V231, P317, DOI 10.1111/j.1432-1033.1995.tb20703.x; WONG KY, 1972, BLOOD-J HEMATOL, V39, P23, DOI 10.1182/blood.V39.1.23.23	17	69	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1112	1116		10.1086/301609	http://dx.doi.org/10.1086/301609			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345103	Green Published, Bronze			2022-12-18	WOS:A1997YH01700016
J	Thomas, PM; Wohllk, N; Huang, E; Kuhnle, U; Rabl, W; Gagel, RF; Cote, GJ				Thomas, PM; Wohllk, N; Huang, E; Kuhnle, U; Rabl, W; Gagel, RF; Cote, GJ			Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATIONS; ATP-BINDING; MULTIDRUG RESISTANCE; GENE; SPECTRUM; HYDROLYSIS; SEQUENCES; CHANNELS; PROTEINS	Familial persistent hyperinsulinemic hypoglycemia of infancy is a disorder of glucose homeostasis and is characterized by unregulated insulin secretion and profound hypoglycemia. Loss-of-function mutations in the second nucleotide-binding fold of the sulfonylurea receptor, a subunit of the pancreatic-islet beta-cell ATP-dependent potassium channel, has been demonstrated to be causative for persistent hyperinsulinemic hypoglycemia of infancy. We now describe three additional mutations in the first nucleotide-binding fold of the sulfonylurea-receptor gene. One point mutation disrupts the highly conserved Walker A motif of the first nucleotide-binding-fold region. The other two mutations occur in noncoding sequences required for RNA processing and are predicted to disrupt the normal splicing pathway of the sulfonylurea-receptor mRNA precursor. These data suggest that both nucleotide-binding-fold regions of the sulfonylurea receptor are required for normal regulation of beta-cell ATP-dependent potassium channel activity and insulin secretion.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED SPECIALTIES,ENDOCRINOL SECT,HOUSTON,TX; UNIV KEBANGSAAN MALAYSIA,KUALA LUMPUR,MALAYSIA; TECH UNIV MUNICH,KINDERKLIN,MUNICH,GERMANY	University of Texas System; UTMD Anderson Cancer Center; Universiti Kebangsaan Malaysia; Technical University of Munich				Wohllk, Nelson/0000-0002-7354-6894	NCI NIH HHS [CA67946] Funding Source: Medline; NIDDK NIH HHS [DK 38146] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA067946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038146] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; AYNSLEYGREEN A, 1981, ARCH DIS CHILD, V56, P496, DOI 10.1136/adc.56.7.496; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BRUINING G J, 1990, Current Opinion in Pediatrics, V2, P758, DOI 10.1097/00008480-199008000-00024; CUPPENS H, 1990, J MED GENET, V27, P717, DOI 10.1136/jmg.27.11.717; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; GLASER B, 1995, HUM MOL GENET, V4, P879, DOI 10.1093/hmg/4.5.879; GLASER B, 1994, NAT GENET, V7, P185, DOI 10.1038/ng0694-185; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; JAFFE R, 1980, LAB INVEST, V42, P356; KHORANA S, 1994, NUCLEIC ACIDS RES, V22, P3425, DOI 10.1093/nar/22.16.3425; KRAWCZAK M, 1992, HUM GENET, V90, P41; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIGTENBERG MJL, 1995, AM J HUM GENET, V56, P44; LOU H, 1994, MOL ENDOCRINOL, V8, P1618, DOI 10.1210/me.8.12.1618; MATHEW PM, 1988, CLIN PEDIATR, V27, P148, DOI 10.1177/000992288802700307; PHILLIPSON LH, 1995, SCIENCE, V17, P1159; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; SMIT LS, 1993, P NATL ACAD SCI USA, V90, P9963, DOI 10.1073/pnas.90.21.9963; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; THOMAS PM, 1995, AM J HUM GENET, V56, P416; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	32	69	71	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					510	518						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751851				2022-12-18	WOS:A1996VN62500004
J	Kurahashi, H; Nakayama, T; Osugi, Y; Tsuda, E; Masuno, M; Imaizumi, K; Kamiya, T; Sano, T; Okada, S; Nishisho, I				Kurahashi, H; Nakayama, T; Osugi, Y; Tsuda, E; Masuno, M; Imaizumi, K; Kamiya, T; Sano, T; Okada, S; Nishisho, I			Deletion mapping of 22q11 in CATCH22 syndrome: Identification of a second critical region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DIGEORGE-SYNDROME		OSAKA UNIV,SCH MED,BIOMED RES CTR,DEPT MED GENET,DIV CLIN GENET,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT PEDIAT,OSAKA 553,JAPAN; NATL CARDIOVASC CTR,DEPT PEDIAT,OSAKA,JAPAN; KANAGAWA CHILDRENS MED CTR,DEPT MED GENET,YOKOHAMA,KANAGAWA,JAPAN	Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan								AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BURN J, 1993, J MED GENET, V30, P822, DOI 10.1136/jmg.30.10.822; DEMCZUK S, 1995, HUM MOL GENET, V4, P551, DOI 10.1093/hmg/4.4.551; FU WN, 1976, CLIN GENET, V10, P329; HALFORD S, 1993, HUM MOL GENET, V2, P1577, DOI 10.1093/hmg/2.10.1577; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; INAZAWA J, 1994, CYTOGENET CELL GENET, V65, P130, DOI 10.1159/000133618; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KURAHASHI H, 1995, HUM MOL GENET, V4, P541, DOI 10.1093/hmg/4.4.541; KURAHASHI H, 1994, HUM GENET, V93, P248, DOI 10.1007/BF00212017; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852	15	69	71	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1377	1381						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651317				2022-12-18	WOS:A1996UM27100033
J	Brune, W; Weber, RG; Saul, B; Doeberitz, MV; GrondGinsbach, C; Kellermann, K; Meinck, HM; Becker, CM				Brune, W; Weber, RG; Saul, B; Doeberitz, MV; GrondGinsbach, C; Kellermann, K; Meinck, HM; Becker, CM			A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAT SPINAL-CORD; INSITU HYBRIDIZATION; DNA; FLUORESCENCE; STRYCHNINE; SUBUNIT	Dominant missense mutations in the human glycine receptor (GlyR) alpha 1 subunit gene (GLRA1) give rise to hereditary hyperekplexia. These mutations impair agonist affinities and change conductance states of expressed mutant channels, resulting in a partial loss of function. In a recessive case of hyperekplexia, we found a deletion of exons 1-6 of the GLRA1 gene. Born to consanguineous parents, the affected child is homozygous for this GLRA1(null) allele consistent with a complete loss of gene function. The child displayed exaggerated startle responses and pronounced head-retraction jerks reflecting a disinhibition of vestigial brain-stem reflexes. In contrast, proprio- and exteroceptive inhibition of muscle activity previously correlated to glycinergic mechanisms were not affected. This case demonstrates that, in contrast to the lethal effect of a null allele in the recessive mouse mutant oscillator (Glra1(spd-ot)), the loss of the GLyR alpha 1 subunit is effectively compensated in man.	UNIV ERLANGEN NURNBERG,INST BIOCHEM,D-91054 ERLANGEN,GERMANY; UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,HEIDELBERG,GERMANY; UNIV HEIDELBERG,NEUROL KLIN,HEIDELBERG,GERMANY; UNIV HEIDELBERG,INST HUMANGENET,HEIDELBERG,GERMANY; UNIV HEIDELBERG,CHIRURG KLIN,HEIDELBERG,GERMANY; STADT KINDERKRANKENHAUS,COLOGNE,GERMANY	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg			Brune, Wolfram/H-5058-2019; Weber, Ruthild/E-2906-2015	Brune, Wolfram/0000-0002-6078-5255; Weber, Ruthild/0000-0001-6610-1080				BAKER E, 1994, GENOMICS, V22, P491, DOI 10.1006/geno.1994.1419; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Becker C. M., 1995, NEUROSCIENTIST, V1, P130; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BECKER CM, 1992, HDB EXPT PHARM, P539; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; CURTIS DR, 1971, EXP BRAIN RES, V12, P547; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HASSFELD S, 1995, J NEUROL SCI, V134, P197; KIMURA J, 1983, ADV NEUROL, P459; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; KRUJEVIC K, 1981, HDB PHYSL, P1078; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LI X, 1994, GENOMICS, V19, P470, DOI 10.1006/geno.1994.1096; LICHTER P, 1992, HUMAN CYTOGENETICS P, V1, P157; MATSUMOTO J, 1992, ANN NEUROL, V32, P41, DOI 10.1002/ana.410320108; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; Milani N, 1996, AM J HUM GENET, V58, P420; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; NAAS E, 1991, BRAIN RES, V561, P139, DOI 10.1016/0006-8993(91)90758-N; Ongerboer de Visser B W, 1983, Adv Neurol, V39, P727; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PROBST A, 1986, NEUROSCIENCE, V17, P11, DOI 10.1016/0306-4522(86)90222-8; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; REES MI, 1994, HUM MOL GENET, V3, P2175, DOI 10.1093/hmg/3.12.2175; RICKER K, 1971, ARCH PSYCHIAT NERVEN, V215, P75, DOI 10.1007/BF00342824; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; RIED T, 1992, GENE CHROMOSOME CANC, V4, P69, DOI 10.1002/gcc.2870040109; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	38	69	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					989	997						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651283				2022-12-18	WOS:A1996UH19200011
J	Rogers, AR; Jorde, LB				Rogers, AR; Jorde, LB			Ascertainment bias in estimates of average heterozygosity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISMS; POPULATIONS; EVOLUTION; LOCUS; RACES	Population geneticists work with a nonrandom sample of the human genome. Conventional practice ensures that unusually variable Loci are most likely to be discovered and thus included in the sample of loci. Consequently, estimates of average heterozygosity are biased upward. In what follows we describe a model of this bias. When the mutation rate varies among loci, bias is increased. This effect is only moderate, however, so that a model of invariant mutation rates provides a reasonable approximation. Bias is pronounced when estimated heterozygosity is < similar to 35%. Consequently, it probably affects estimates from classical. polymorphisms as well as from restriction-site polymorphisms. Estimates from short-tandem-repeat polymorphisms have negligible bias, because of their high heterozygosity. Bias should vary not only among categories of polymorphism but also among populations. It should be largest in European populations, since these are the populations in which most polymorphisms were discovered. As this argument predicts, European estimates exceed those of Africa and Asia at systems with large bias. The magnitude of this European excess is consistent with the version of our model in which mutation rates vary across loci.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah	Rogers, AR (corresponding author), UNIV UTAH,DEPT ANTHROPOL,102 STEWART HALL,SALT LAKE CITY,UT 84112, USA.							Abramowitz M., 1964, HDB MATH FUNCTIONS F; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHAKRABORTY R, 1980, GENETICS, V94, P1039; Ewens W.J., 1979, MATH POPULATION GENE; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; JOHNSON NL, 1970, DISTRIBUTIONS STATIS, V2; JORDE LB, 1995, AM J HUM GENET, V57, P523; JORDE LB, 1995, MED GENETICS; LEWONTIN RC, 1967, AM J HUM GENET, V19, P681; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; MOUNTAIN JL, 1994, THESIS STANFORD U ST; NEI M, 1982, EVOL BIOL, V14, P1; NEI M, 1974, AM J HUM GENET, V26, P421; NEI M, 1976, P NATL ACAD SCI USA, V73, P4164, DOI 10.1073/pnas.73.11.4164; Nei Masatoshi, 1993, P239; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; SHERRY ST, 1994, HUM BIOL, V66, P761; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485; WILKS SS, 1962, MATH STATISTICS	24	69	70	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1033	1041						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651264				2022-12-18	WOS:A1996UH19200016
J	Kunst, CB; Zerylnick, C; Karickhoff, L; Eichler, E; Bullard, J; Chalifoux, M; Holden, JJA; Torroni, A; Nelson, DL; Warren, ST				Kunst, CB; Zerylnick, C; Karickhoff, L; Eichler, E; Bullard, J; Chalifoux, M; Holden, JJA; Torroni, A; Nelson, DL; Warren, ST			FMR1 in global populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; MITOCHONDRIAL-DNA; CGG REPEAT; FOUNDER CHROMOSOMES; RNA-BINDING; INSTABILITY; SITE; GENE; METHYLATION; MIGRATIONS	Fragile X syndrome, a frequent form of inherited mental retardation, results from the unstable expansion of a cryptic CGG repeat within the 5' UTR region of the FMR1 gene. The CGG repeat is normally polymorphic in length, and the content is frequently interrupted by AGG triplets. These interruptions are believed to stabilize the repeat, and their absence, leading to long tracts of perfect CGG repeats, may give rise to predisposed alleles. In order to examine the stability of normal FMR1 alleles, the repeat length of 345 chromosomes from nine global populations was examined with the content also determined from 114 chromosomes as assessed by automated DNA sequencing. The FMR1 alleles, defined by the CGG repeat, as well as by the haplotypes of nearby polymorphic loci, were very heterogeneous, although the level of variation correlated with the age and/or genetic history of a particular population. Native American alleles, interrupted by three AGG repeats, exhibited marked stability over 7,000 years. However, in older African populations, parsimony analysis predicts the occasional loss of an AGG, leading to more perfect CGG repeats. These data therefore support the suggestion that AGG interruptions enhance the stability of the FMR1 repeat and indicate that the rare loss of these interruptions leads to alleles with longer perfect CGG-repeat tracts.	EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PEDIAT,ATLANTA,GA 30322; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; QUEENS UNIV,DEPT PSYCHIAT,KINGSTON,ON K7L 3N6,CANADA; CYTOGENET & DNA RES LAB,KINGSTON,ON,CANADA; UNIV ROMA LA SAPIENZA,DIPARTIMENTO GENET & BIOL MOLEC,I-00185 ROME,ITALY	Emory University; Howard Hughes Medical Institute; Emory University; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Queens University - Canada; Sapienza University Rome			Warren, Stephen T/A-2498-2012; Torroni, Antonio/E-1557-2011; Gunter, Chris/AHA-7271-2022	Torroni, Antonio/0000-0002-4163-4478; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, R01HD029256, R01HD020521] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20521, HD29256] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARINAMI T, 1993, HUM GENET, V92, P431, DOI 10.1007/BF00216445; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BALLINGER SW, 1992, GENETICS, V130, P139; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BURKE AR, 1994, LANCET, V344, P1711, DOI 10.1016/S0140-6736(94)90497-9; BUYLE S, 1993, HUM GENET, V92, P269, DOI 10.1007/BF00244471; CHAKRAVARTI A, 1992, NAT GENET, V1, P237, DOI 10.1038/ng0792-237; CHEN YS, 1995, AM J HUM GENET, V57, P133; CHONG SS, 1994, AM J MED GENET, V51, P522, DOI 10.1002/ajmg.1320510447; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; JACOBS PA, 1993, J MED GENET, V30, P454, DOI 10.1136/jmg.30.6.454; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4214; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Oudet C., 1993, European Journal of Human Genetics, V1, P181; OUDET C, 1993, AM J HUM GENET, V52, P297; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SMITS APT, 1993, J MED GENET, V30, P94, DOI 10.1136/jmg.30.2.94; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Swofford D, 1993, PHYLOGENETIC ANAL US; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WALLACE DC, 1992, HUM BIOL, V64, P403; WARREN ST, 1995, ANNU REV NEUROSCI, V18, P77, DOI 10.1146/annurev.neuro.18.1.77; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; ZERYLNICK C, 1995, AM J HUM GENET, V56, P123	42	69	71	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					513	522						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644711				2022-12-18	WOS:A1996TV56400010
J	CHENG, SD; SPINNER, NB; ZACKAI, EH; KNOLL, JHM				CHENG, SD; SPINNER, NB; ZACKAI, EH; KNOLL, JHM			CYTOGENETIC AND MOLECULAR CHARACTERIZATION OF INVERTED DUPLICATED CHROMOSOMES 15 FROM 11 PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; INV DUP(15); ANGELMAN SYNDROME; UNIPARENTAL DISOMY; PARENTAL ORIGIN; MARKER CHROMOSOME; FOLLOW-UP; DELETION; GENE; RESOLUTION	We have studied the inverted duplicated chromosomes 15 (inv dup(15)) from 11 individuals-7 with severe mental retardation and seizures, 3 with a normal phenotype, and I with Prader-Willi syndrome (PWS). Through a combination of FISH and quantitative DNA analyses, three different molecular sizes of inv dup(15) were identified. The smallest inv dup(15) was positive only for the centromeric locus D15Z1 (type 1); the next size was positive for D15Z1 and D15S18 (type 2); and the largest inv dup(15) was positive for two additional copies of loci extending from D15Z1 and D15S18 through D15S12 (type 3). Type 1 or type 2 was observed in the three normal individuals and the PWS patient. Type 3 was observed in all seven individuals with mental retardation and seizures but without PWS or Angelman Syndrome (AS). The PWS patient, in addition to being mosaic for a small inv dup(15), demonstrated at D15S63 a methylation pattern consistent with maternal uniparental inheritance of the normal chromosomes 15. The results from this study show (a) two additional copies of proximal 15q loci, D15S9 through D15S12, in mentally retarded patients with an inv dup(15) but without AS or PWS and (b) no additional copies of these loci in patients with a normal phenotype or with PWS.	CHILDRENS HOSP,DIV GENET,BOSTON,MA 02115; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT PATHOL,BOSTON,MA; CHILDRENS HOSP,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DEPT GENET,PHILADELPHIA,PA 19104	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia				Knoll, Joan/0000-0001-6691-1710	NICHD NIH HHS [HD18658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; BUTLER MG, 1983, LANCET, V1, P1285; DITTRICH B, 1992, HUM GENET, V90, P313; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; FREEMAN SB, 1993, AM J MED GENET, V45, P625, DOI 10.1002/ajmg.1320450522; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HAMABE J, 1991, AM J MED GENET, V41, P54, DOI 10.1002/ajmg.1320410116; KNIGHT LA, 1984, AM J MED GENET, V17, P649, DOI 10.1002/ajmg.1320170315; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1993, HUM MOL GENET, V2, P183, DOI 10.1093/hmg/2.2.183; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LAWRENCE JB, 1990, SCIENCE, V249, P928, DOI 10.1126/science.2203143; LAZARUS AL, 1991, CLIN GENET, V39, P65; LEANACOX J, 1994, AM J HUM GENET, V54, P748; LEANACOX J, 1993, AM J HUM GENET, V53, P124; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MATTEI MG, 1984, HUM GENET, V66, P313, DOI 10.1007/BF00287636; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROBINSON WP, 1993, J MED GENET, V30, P756, DOI 10.1136/jmg.30.9.756; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; SACHS ES, 1987, PRENATAL DIAG, V7, P81, DOI 10.1002/pd.1970070204; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; SEABRIGH.M, 1971, LANCET, V2, P971; SHIBUYA Y, 1991, CLIN GENET, V40, P233; STETTEN G, 1981, HUM GENET, V57, P357, DOI 10.1007/BF00281684; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WISNIEWSKI L, 1979, HUM GENET, V50, P259, DOI 10.1007/BF00399391; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; [No title captured]	36	69	71	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					753	759						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942854				2022-12-18	WOS:A1994PJ02700019
J	SHIELDS, DC; RATANACHAIYAVONG, S; MCGREGOR, AM; COLLINS, A; MORTON, NE				SHIELDS, DC; RATANACHAIYAVONG, S; MCGREGOR, AM; COLLINS, A; MORTON, NE			COMBINED SEGREGATION AND LINKAGE ANALYSIS OF GRAVES-DISEASE WITH A THYROID AUTOANTIBODY DIATHESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORE; MODELS; HLA; INHERITANCE; ANTIGENS; GENETICS; FAMILIES; TRAITS	Combined segregation and linkage analysis is a powerful technique for modeling linkage to diseases whose etiology is more complex than the effect of a well-described single genetic locus and for investigating the influence of single genes on various aspects of the disease phenotype. Graves disease is familial and is associated with human leukocyte antigen (HLA) allele DR3. Probands with Graves disease, as well as close relatives, have raised levels of thyroid autoantibodies. This phenotypic information additional to affection status may be considered by the computer program COMDS for combined segregation and linkage analysis, when normals are classified into diathesis classes of increasing thyroid autoantibody titer. The ordinal model considers the cumulative odds of lying in successive classes, and a single additional parameter is introduced for each gene modeled. Distributional assumptions are avoided by providing estimates of the population frequencies of each class. Evidence for linkage was increased by considering the thyroid autoantibody diathesis and by testing two-locus models. The analysis revealed evidence for linkage to HLA-DR when the strong coupling of the linked locus to allele DR3 was considered (led score of 6.6). Linkage analysis of the residual variation revealed no evidence of linkage to Gm, but a suggestion of linkage to Km.	UNIV SOUTHAMPTON,PRINCESS ANNE HOSP,DEPT CHILD HLTH,CRC,GENET EPIDEMIOL RES GRP,SOUTHAMPTON,HANTS,ENGLAND; UNIV LONDON KINGS COLL,SCH MED,DEPT MED,LONDON WC2R 2LS,ENGLAND; PRINCE SONGKLA UNIV,DEPT MED & BIOMED SCI,SONGKHLA,THAILAND	University of Southampton; University of London; King's College London; Prince of Songkla University	SHIELDS, DC (corresponding author), UNIV DUBLIN TRINITY COLL,DEPT GENET,DUBLIN 2,IRELAND.		Collins, Andrew/S-2196-2019; Collins, Andrew/A-6595-2010	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Shields, Denis/0000-0003-4015-2474				ALLANNIC H, 1980, J CLIN ENDOCR METAB, V51, P863, DOI 10.1210/jcem-51-4-863; ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; BIDWELL J, 1988, IMMUNOL TODAY, V9, P18, DOI 10.1016/0167-5699(88)91351-5; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1989, GENET EPIDEMIOL, V6, P211, DOI 10.1002/gepi.1370060137; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CURTIS D, 1991, ANN HUM GENET, V55, P321, DOI 10.1111/j.1469-1809.1991.tb00859.x; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; FARID NR, 1979, J CLIN INVEST, V63, P108, DOI 10.1172/JCI109263; FARID NR, 1992, J CLIN ENDOCR METAB, V74, pA495, DOI 10.1210/jcem.74.3.1740482; HARVALD B, 1956, Dan Med Bull, V3, P150; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; MACLEAN CJ, 1984, COMPUT BIOMED RES, V17, P471, DOI 10.1016/0010-4809(84)90013-2; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; MORTON NE, 1974, AM J HUM GENET, V26, P318; PHILLIPS DIW, 1985, CLIN ENDOCRINOL, V23, P283, DOI 10.1111/j.1365-2265.1985.tb00225.x; RATANACHAIYAVON.S, 1992, THESIS KINGS COLLEGE; RATANACHAIYAVONG S, 1990, CLIN ENDOCRINOL, V32, P241, DOI 10.1111/j.1365-2265.1990.tb00860.x; RATANACHAIYAVONG S, 1993, HUM IMMUNOL, V36, P99, DOI 10.1016/0198-8859(93)90112-E; ROMAN SH, 1992, J CLIN ENDOCR METAB, V74, P496, DOI 10.1210/jc.74.3.496; SKOLNICK MH, 1990, SCIENCE, V250, P1715, DOI 10.1126/science.2270486; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VOLPE R, 1972, MAYO CLIN PROC, V47, P824; VOLPE R, 1978, GENETIC CONTROL AUTO, P43; VONVERSCHUER O, 1958, VERH DEUTSCH GES INN, V64, P262; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WILSON AF, 1990, AM J MED GENET, V35, P425, DOI 10.1002/ajmg.1320350321; 1988, SAS STAT USERS GUIDE	32	69	70	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					540	554						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079993				2022-12-18	WOS:A1994PF50900016
J	MEARS, AJ; DUNCAN, AMV; BUDARF, ML; EMANUEL, BS; SELLINGER, B; SIEGELBARTELT, J; GREENBERG, CR; MCDERMID, HE				MEARS, AJ; DUNCAN, AMV; BUDARF, ML; EMANUEL, BS; SELLINGER, B; SIEGELBARTELT, J; GREENBERG, CR; MCDERMID, HE			MOLECULAR CHARACTERIZATION OF THE MARKER CHROMOSOME ASSOCIATED WITH CAT EYE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; ANONYMOUS DNA MARKERS; DIGEORGE SYNDROME; INSITU HYBRIDIZATION; MICRODELETIONS; 22Q11; DELETIONS; ETIOLOGY	Cat eye syndrome (CES) is associated with a supernumerary bisatellited marker chromosome which is derived from duplicated regions of 22pter-22q11.2. In this study we have used dosage and RFLP analyses on 10 CES patients with marker chromosomes, by using probes to five loci mapped to 22q11.2. The sequences recognized by the probes D22S9, D22S43, and D22S57 are in four copies in all patients, but the sequences at the more distal loci, D22S36 and D22S75, are duplicated only in some individuals. D22S36 is present in three copies in some individuals, and D22S75 is present in two copies in the majority of cases. Only three individuals have a duplication of the most distal locus examined (D22S75), and these individuals have the largest marker chromosomes identified in this study. From the dosage analysis it was found that the marker chromosomes are variable in size and can be asymmetric in nature. There is no obvious correlation between the severity of the phenotype and the size of the duplication. The distal boundary of the CES critical region (D22S36) is proximal to that of DiGeorge syndrome, a contiguous-gene-deletion syndrome of 22q11.2.	UNIV ALBERTA, DEPT GENET, EDMONTON T6G 2E9, AB, CANADA; QUEENS UNIV, DEPT PATHOL, KINGSTON K7L 3N6, ON, CANADA; KINGSTON GEN HOSP, KINGSTON K7L 2V7, ON, CANADA; CHILDRENS HOSP, DIV HUMAN GENET & MOLEC BIOL, PHILADELPHIA, PA 19104 USA; HOSP SICK CHILDREN, DEPT CLIN GENET, TORONTO M5G 1X8, ON, CANADA; CHILDRENS HOSP, GENET & METAB SECT, WINNIPEG R3A 1S1, MB, CANADA	University of Alberta; Queens University - Canada; Queens University - Canada; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Manitoba; Children's Hospital Research Institute of Manitoba								BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; BUDARF ML, 1991, GENOMICS, V10, P996, DOI 10.1016/0888-7543(91)90190-P; CAREY AH, 1992, AM J HUM GENET, V51, P964; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; DEPREZ RHL, 1991, NUCLEIC ACIDS RES, V19, P686; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIBISON WJ, 1990, AM J HUM GENET, V47, pA178; FIREMAN P, 1965, J PEDIATR-US, V67, P907; GABARRON J, 1985, CLIN GENET, V28, P509; Geurts van Kessel A. H., 1980, CYTOGENET CELL GENET, V28, P169; GREENBERG F, 1988, AM J HUM GENET, V43, P605; ING P S, 1985, American Journal of Human Genetics, V37, pA98; KELLY D, 1993, AM J MED GENET, V45, P308, DOI 10.1002/ajmg.1320450306; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MAGENIS RE, 1988, AM J MED GENET, V29, P9, DOI 10.1002/ajmg.1320290103; MCDERMID HE, 1989, GENOMICS, V5, P1, DOI 10.1016/0888-7543(89)90079-7; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; NOEL B, 1976, J GENET HUM, V24, P279; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; Robinson H B Jr, 1975, Perspect Pediatr Pathol, V2, P173; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROSENFELD W, 1984, AM J MED GENET, V18, P19, DOI 10.1002/ajmg.1320180105; SCHACHENMANN G, 1965, LANCET, V2, P290; SCHINZEL A, 1981, HUM GENET, V57, P148; SHARKEY AM, 1992, HUM GENET, V89, P73, DOI 10.1007/BF00207046; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPINNER NB, 1989, AM J HUM GENET, V44, P631; SUTHERLAND GR, 1989, LEUKEMIA, V3, P9; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Wilcoxon F, 1964, SOME RAPID APPROXIMA	35	69	70	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					134	142						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7912885				2022-12-18	WOS:A1994NW46100019
J	BORECKI, IB; BONNEY, GE; RICE, T; BOUCHARD, C; RAO, DC				BORECKI, IB; BONNEY, GE; RICE, T; BOUCHARD, C; RAO, DC			INFLUENCE OF GENOTYPE-DEPENDENT EFFECTS OF COVARIATES ON THE OUTCOME OF SEGREGATION ANALYSIS OF THE BODY-MASS INDEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REGIONAL FAT DISTRIBUTION; REGRESSIVE MODELS; GENETIC-ANALYSIS; COMMINGLING ANALYSIS; QUEBEC FAMILY; OBESITY; INHERITANCE; LINKAGE; TRAITS; SAMPLE	Several recent studies of the body mass index (BMI) have provided support for a recessive major gene influencing heaviness in humans. Segregation analysis of the BMI was carried out recently in a series of randomly sampled French-Canadian families to determine whether we could replicate the major gene finding by using a residual phenotype adjusted for the effects of age and sex. The best model included a recessive major effect for high BMI values with residual familial resemblance; however, Mendelian transmission could not be confirmed, and the no-transmission hypothesis (where all the tau's are constrained to be equal) was not rejected. Considering that the BMI is a complex phenotype affected by many factors and that there are known variations in body composition during growth and aging, we undertook a reanalysis of the data, using a model that allowed the estimation of genotype-specific age and gender effects. New tests on the transmission parameters satisfy the criteria for inferring Mendelian segregation. The results suggest that individuals with the ''high'' recessive genotype show the greatest degree of heaviness at birth, with a subsequent trend toward lower values throughout life, while individuals with the dominant ''normal'' genotypes show no appreciable trends with age. In addition, the ''high'' genotype appears to confer a greater degree of heaviness in females as compared with males. These results, along with other observations from the data, suggest that, while a recessive single gene influence may be discernible, the phenotypic expression of the BMI is likely to be complicated by genotype X environment interactions and, possibly, by the action of other loci. Further, the data also are consistent with the hypothesis that modifying factors may include the adoption of a more prudent life-style by individuals genetically predisposed to heaviness and a secular increase in the incidence, prevalence, and potency of environmentally based triggers leading to a higher penetrance of the ''heavy'' genotype in the young.	WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; FOX CHASE CANC CTR,DEPT BIOSTAT,PHILADELPHIA,PA 19111; LAVAL UNIV,PEPS,PHYS ACT SCI LAB,ST FOY,PQ,CANADA	Washington University (WUSTL); Washington University (WUSTL); Fox Chase Cancer Center; Laval University	BORECKI, IB (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,BOX 8067,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.		Rice, Treva K/D-1385-2009; Bouchard, Claude/AAE-2035-2019; Bouchard, Claude/A-7637-2009	Bouchard, Claude/0000-0002-0048-491X; Rice, Treva/0000-0001-7452-2600	NHLBI NIH HHS [HL47317] Funding Source: Medline; NICHD NIH HHS [HD18281] Funding Source: Medline; NIGMS NIH HHS [GM28719] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018281] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLANGERO J, 1990, AM J HUM GENET, V47, P414; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BONNEY GE, 1992, AM J MED GENET, V42, P28; BORECKI IB, 1990, AM J HUM GENET, V47, P542; BORECKI IB, 1991, INT J OBESITY, V15, P763; BORECKI IB, UNPUB SEGREGATION AN; BOUCHARD C, 1991, INT J OBESITY, V15, P9; BOUCHARD C, 1989, METABOLISM, V38, P364, DOI 10.1016/0026-0495(89)90126-1; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; BOUCHARD C, 1988, INT J OBESITY, V12, P205; BOUCHARD C, 1989, MED CLIN N AM, V73, P67, DOI 10.1016/S0025-7125(16)30692-7; BRAY GA, 1985, ANN INTERN MED, V103, P1052, DOI 10.7326/0003-4819-103-6-1052; BURTON BT, 1985, INT J OBESITY, V9, P155; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS F, 1993, AM J HUM GENET, V52, P441; DEMENAIS FM, 1990, GENET EPIDEMIOL, V7, P319, DOI 10.1002/gepi.1370070503; GARN SM, 1986, AM J CLIN NUTR, V44, P996, DOI 10.1093/ajcn/44.6.996; KARLIN S, 1981, AM J EPIDEMIOL, V113, P307, DOI 10.1093/oxfordjournals.aje.a113100; KRAL JG, 1985, ANN INTERN MED, V103, P1043, DOI 10.7326/0003-4819-103-6-1043; MALINA RM, 1988, FAT DISTRIBUTION GRO, P63; MOLL PP, 1991, AM J HUM GENET, V49, P1243; PERUSSE L, 1988, AM J CLIN NUTR, V47, P629, DOI 10.1093/ajcn/47.4.629; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; PERUSSE L, 1991, AM J HUM GENET, V49, P94; Price R. Arlen, 1992, Behavior Genetics, V22, P746; PRICE RA, 1990, HUM BIOL, V62, P747; PROVINCE MA, 1990, AM J HUM GENET S, V47, pA143; RICE T, 1992, INT J OBESITY, V16, P831; Rice T, 1993, Obes Res, V1, P288; RICE T, 1993, AM J HUM GENET, V52, P967; TIRET L, 1992, GENET EPIDEMIOL, V9, P398; VANITALLIE TB, 1985, RECENT ADV OBESITY R, V4, P1; ZONTA LA, 1987, HUM HERED, V37, P129, DOI 10.1159/000153690; 1983, J R COLL PHYS, V17, P5	36	69	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					676	687						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352276				2022-12-18	WOS:A1993LU55900012
J	SHIELDS, GF; HECKER, K; VOEVODA, MI; REED, JK				SHIELDS, GF; HECKER, K; VOEVODA, MI; REED, JK			ABSENCE OF THE ASIAN-SPECIFIC REGION-V MITOCHONDRIAL MARKER IN NATIVE BERINGIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; ALLOTYPES; MUTATIONS; AMERICAS	The Asian-specific 9-bp deletion between the genes for mitochondrial cytochrome oxidase II and lysine transfer RNA has been used to trace aboriginal human movements out of Southeast Asia and into portions of the South Pacific. Although it has been used to estimate the number of independent lineages that occur in the New World, it has not been studied in native peoples of the Beringian region. Thus, we have used PCR to amplify and compare the lengths of DNA segments surrounding this deletion in native peoples of the Beringia and the adjacent regions, as well as natives of the Altai Mountains of Southwestern Siberia. Of the 176 individuals analyzed here, the deletion was found in only 3 of 25 individuals from the Ust-Kan region on the Altai Mountains. We comment on the distribution of this marker and on potential relationships between Beringians and other Native American groups in which this marker has been surveyed. One Chukchi possessed three copies of the 9-bp sequence, which suggests (1) that the number of copies of this sequence in humans may be more variable than had been believed and (2) that a mechanism of replication based on tandem duplication may be a potential explanation for the origin of this length mutation in humans.	BETHANY COLL,BETHANY,WV 26032; ACAD MED SCI USSR,INST INTERNAL MED,NOVOSIBIRSK,USSR	Russian Academy of Medical Sciences	SHIELDS, GF (corresponding author), UNIV ALASKA,INST ARCT BIOL,FAIRBANKS,AK 99775, USA.		Voevoda, Mikhail/N-6713-2015	Voevoda, Mikhail/0000-0001-9425-413X				ADOVASIO JM, 1984, SCI AM, V250, P130, DOI 10.1038/scientificamerican0584-130; BADA JL, 1984, NATURE, V312, P442, DOI 10.1038/312442a0; CANN RL, 1983, GENETICS, V104, P699; CARR SM, 1987, BIOCHEM GENET, V25, P385, DOI 10.1007/BF00554547; Crawford M.H., 1982, CURRENT DEV ANTHR GE, VII; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HESTER JJ, 1962, MUSEUM N MEX PAP ANT, V6; HORAI S, 1986, HUM GENET, V72, P105; IRVING WN, 1985, ANNU REV ANTHROPOL, V14, P529; LAUGHLIN WS, 1979, 1ST AM ORIGINS AFFIN; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Maniatis T., 1982, MOL CLONING; OWEN RC, 1984, ORIGINS MODERN HUMAN, P517; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHANFIELD MS, 1980, HUM HERED, V30, P343, DOI 10.1159/000153155; SCHMIECHEN AM, 1991, THESIS U ALASKA FAIR; SCHMIECHEN AM, 1989, IN PRESS P CIRCUM PA; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Stanford Dennis., 1983, EARLY MAN NEW WORLD, P65; STONEKING M, 1989, COLONIZATION PACIFIC, P215; Szathmary E., 1985, OUT ASIA PEOPLING AM, P79; Szathmary E.J.E., 1981, YEARB PHYS ANTHROPOL, V24, P37; SZATHMARY EJE, IN PRESS GENETICS CE; TORRONI A, 1992, GENETICS, V130, P153; Turner C G 2nd, 1984, Acta Anthropogenet, V8, P23; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	31	69	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					758	765						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550120				2022-12-18	WOS:A1992HL84800011
J	VENTA, PJ; WELTY, RJ; JOHNSON, TM; SLY, WS; TASHIAN, RE				VENTA, PJ; WELTY, RJ; JOHNSON, TM; SLY, WS; TASHIAN, RE			CARBONIC ANHYDRASE-II DEFICIENCY SYNDROME IN A BELGIAN FAMILY IS CAUSED BY A POINT MUTATION AT AN INVARIANT HISTIDINE RESIDUE (107 HIS-]TYR) - COMPLETE STRUCTURE OF THE NORMAL HUMAN CA-II GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL TUBULAR-ACIDOSIS; AUTOSOMAL RECESSIVE SYNDROME; CEREBRAL CALCIFICATION; ESCHERICHIA-COLI; SEQUENCE; OSTEOPETROSIS; EXPRESSION; PROTEIN; CDNA; DNA	Carbonic anhydrase II (CA II), which has the highest turnover number and widest tissue distribution of any of the seven CA isozymes known in humans, is absent from the red blood cells and probably from other tissues of patients with CA II deficiency syndrome. We have sequenced the CA II gene in a patient from a consanguinous marriage in a Belgian family and identified the mutation that is probably the cause of the CA II deficiency in that family. The change is a C-to-T transition which results in the substitution of Tyr (TAT) for His (CAT) at position 107. This histidine is invariant in all amniotic CA isozymes sequenced to date, as well as the CAs from elasmobranch and algal sources and in a viral CA-related protein. His-107 appears to have a stabilizing function in the structure of all CA molecules, and its substitution by Tyr apparently disrupts the critical hydrogen bonding of His-107 to two other similarly invariant residues, Glu-117 and Tyr-194, resulting in an unstable CA II molecule. We have also completed the intron-exon structure of the normal human CA II gene, which has allowed us to prepare PCR primers for all exons. These primers will facilitate the determination of the mutations in other inherited CA II deficiencies.	UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, M4708 MED SCI II, ANN ARBOR, MI 48109 USA; MICHIGAN STATE UNIV, COLL VET MED, E LANSING, MI 48824 USA; ST LOUIS UNIV, SCH MED, DEPT BIOCHEM, ST LOUIS, MO 63104 USA	University of Michigan System; University of Michigan; Michigan State University; Saint Louis University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034182, R01GM034182] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 2235] Funding Source: Medline; NIGMS NIH HHS [GM 24682, GM 34182] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; AMORGUERET M, 1990, NUCLEIC ACIDS RES, V18, P1646, DOI 10.1093/nar/18.6.1646; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BERGENHEM N, 1990, COMP BIOCHEM PHYS B, V95, P205, DOI 10.1016/0305-0491(90)90272-U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY HJM, 1989, FEBS LETT, V257, P451, DOI 10.1016/0014-5793(89)81594-7; COCHAT P, 1987, PEDIATRIE, V42, P121; DODGSON SJ, 1988, J APPL PHYSIOL, V65, P1472, DOI 10.1152/jappl.1988.65.4.1472; ERICKSSON AE, 1988, THESIS U UPPSALA UPP; FORSMAN C, 1988, ACTA CHEM SCAND B, V42, P314, DOI 10.3891/acta.chem.scand.42b-0314; FRASER P, 1989, MOL CELL BIOL, V9, P3308, DOI 10.1128/MCB.9.8.3308; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; FUKUZAWA H, 1990, P NATL ACAD SCI USA, V87, P4383, DOI 10.1073/pnas.87.11.4383; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Hewett-Emmett D., 1991, CARBONIC ANHYDRASES, P15; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KANNAN KK, 1975, P NATL ACAD SCI USA, V72, P51, DOI 10.1073/pnas.72.1.51; KATO K, 1990, FEBS LETT, V271, P137, DOI 10.1016/0014-5793(90)80390-5; KRUPIN T, 1985, AM J OPHTHALMOL, V99, P396, DOI 10.1016/0002-9394(85)90004-2; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LEWIS SE, 1988, P NATL ACAD SCI USA, V85, P1962, DOI 10.1073/pnas.85.6.1962; LLOYD J, 1987, GENE DEV, V1, P594, DOI 10.1101/gad.1.6.594; Maniatis T., 1982, MOL CLONING; MONTGOMERY JC, 1987, NUCLEIC ACIDS RES, V15, P4687, DOI 10.1093/nar/15.11.4687; MONTGOMERY JC, IN PRESS GENOMICS; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MURAKAMI H, 1987, Genomics, V1, P159, DOI 10.1016/0888-7543(87)90008-5; NAKAI H, 1987, CYTOGENET CELL GENET, V44, P234, DOI 10.1159/000132378; NICEWANDER PH, 1990, THESIS U MICHIGAN AN; NILES EG, 1988, J VIROL, V62, P3772, DOI 10.1128/JVI.62.10.3772-3778.1988; NOTSTRAND B, 1974, ISOZYMES, V1, P575; SATO S, 1990, P NATL ACAD SCI USA, V87, P6073, DOI 10.1073/pnas.87.16.6073; SHAPIRO LH, 1989, FEBS LETT, V249, P307, DOI 10.1016/0014-5793(89)80647-7; SHAPIRO LH, 1987, MOL CELL BIOL, V7, P4589, DOI 10.1128/MCB.7.12.4589; SLY WS, 1985, PEDIATR RES, V19, P1033, DOI 10.1203/00006450-198510000-00017; SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; SLY WS, 1989, METABOLIC BASIS INHE, V2, P2857; SPICER SS, 1989, AM J PATHOL, V134, P947; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VAINSEL M, 1972, ACTA PAEDIATR SCAND, V61, P429, DOI 10.1111/j.1651-2227.1972.tb15859.x; VENTA PJ, 1985, BIOCHIM BIOPHYS ACTA, V826, P195, DOI 10.1016/0167-4781(85)90006-5; VENTA PJ, 1985, J BIOL CHEM, V260, P2130; VENTA PJ, IN PRESS NUCLEIC ACI; VENTA PJ, 1987, ISOZYMES-CURR T BIOL, V14, P59; YOSHIHARA CM, 1987, NUCLEIC ACIDS RES, V15, P753, DOI 10.1093/nar/15.2.753; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359	49	69	70	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1082	1090						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928091				2022-12-18	WOS:A1991GM87300019
J	IONASESCU, VV; TROFATTER, J; HAINES, JL; SUMMERS, AM; IONASESCU, R; SEARBY, C				IONASESCU, VV; TROFATTER, J; HAINES, JL; SUMMERS, AM; IONASESCU, R; SEARBY, C			HETEROGENEITY IN X-LINKED RECESSIVE CHARCOT-MARIE-TOOTH NEUROPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA PROBES; LINKAGE; LOCALIZATION; DISEASE; CARRIERS	Three families presenting with X-linked recessive Charcot-Marie-Tooth neuropathies (CMT) were studied both clinically and genetically. The disease phenotype in family 1 was typical of CMT type 1, except for an infantile onset; two of five affected individuals were mentally retarded, and obligate-carrier females were unaffected. Families 2 and 3 showed distal atrophy with weakness, juvenile onset, and normal intelligence. Motor-nerve conduction velocities were significantly slowed, and electromyography data were consistent with denervation in affected CMT males in all three families. Thirty X-linked RFLPs were tested for linkage studies against the CMT disease loci. Family 1 showed tight linkage (recombination fraction [theta] = 0) to Xp22.2 markers DXS16, DXS143, and DXS43, with peak lod scores of 1.75, 1.78, and 2.04, respectively. A maximum lod score of 3.48 at DXS16 (theta = 0) was obtained by multipoint linkage analysis of the map DXS143-DXS16-DXS43. In families 2 and 3 there was suggestion of tight linkage (theta = 0) to Xq26 markers DXS86, DXS144, and DXS105, with peak lod scores of 2.29, 1.33, and 2.32, respectively. The combined maximum multipoint lod score of 1.81 at DXS144 (theta = 0) for these two families occurred in the map DXS10-DXS144-DXS51-DXS105-DXS15-DXS52. A joint homogeneity analysis including both regions (Xp22.2 and Xq26-28) provided evidence against homogeneity (chi-2 = 9.12, P < .005). No linkage to Xp11.12-q22 markers was observed, as was reported for X-linked dominant CMT and the Cowchock CMT variant. Also, the chromosomes 1 and 17 CMT loci were excluded by pairwise linkage analysis in all three families.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,BOSTON,MA 02114; N YORK GEN HOSP,DEPT GENET,N YORK M2K 1E1,ONTARIO,CANADA	Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital	IONASESCU, VV (corresponding author), UNIV IOWA HOSP & CLIN,DEPT PEDIAT,PEDIAT GENET MUSCLE LAB,IOWA CITY,IA 52242, USA.		Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728				ARVEILER B, 1988, AM J MED GENET, V30, P473, DOI 10.1002/ajmg.1320300150; BECKETT J, 1986, J NEUROGENET, V3, P225, DOI 10.3109/01677068609106852; Boeters H, 1938, Z GESAMTE NEUROL PSY, V160, P455, DOI 10.1007/BF02877992; COWCHOCK FS, 1985, AM J MED GENET, V20, P307, DOI 10.1002/ajmg.1320200214; DARRAS BT, 1987, NEW ENGL J MED, V316, P985, DOI 10.1056/NEJM198704163161604; Erwin WG, 1944, J HERED, V35, P24, DOI 10.1093/oxfordjournals.jhered.a105311; FISCHBECK KH, 1987, CYTOGENET CELL GENET, V46, P614; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; FRYNS JP, 1980, HUM GENET, V55, P413, DOI 10.1007/BF00290228; IONASESCU V, 1990, J NEUROL SCI S, V98, P364; IONASESCU VV, 1988, MUSCLE NERVE, V11, P1154, DOI 10.1002/mus.880111108; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBO RV, 1990, CHARCOT MARIE TOOTH, P307; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; SKRE H, 1974, CLIN GENET, V6, P98; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TROFATTER JA, 1986, AM J HUM GENET, V39, P147; Van Bogaert L, 1939, ENCEPHALE, V34, P312; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5	22	69	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1075	1083						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	1674639				2022-12-18	WOS:A1991FP09200008
J	BARBUJANI, G; SOKAL, RR				BARBUJANI, G; SOKAL, RR			GENETIC POPULATION-STRUCTURE OF ITALY .2. PHYSICAL AND CULTURAL BARRIERS TO GENE FLOW	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LANGUAGE FAMILIES; AUTO-CORRELATION; FREQUENCY MAPS; EUROPE; DISTANCES; HLA; SELECTION; MIGRATION; PATTERNS	Three approaches were employed to evaluate the relative importance of geographic and linguistic factors in maintaining genetic differentiation of Italian populations as shown by blood groups and erythrocyte and serum markers. Genetic distances are closer to linguistic than to geographic distances. Gene-frequency change across 12 linguistic boundaries is significantly more rapid than at random locations. The zones of sharp genetic variation correspond to physical barriers to gene flow and to boundaries between dialect families, which overlap widely. However, two linguistically differentiated populations appear genetically differentiated despite the absence of physical obstacles to gene flow around them. The Po River is associated with abrupt genetic change only in the area where it corresponds to a dialect boundary. At most loci the genetic population structure seems affected by linguistic rather than geographic factors; exceptions are the systems that were subject to malarial selection in geographically close but linguistically heterogeneous localities. Gene flow appears to homogenize gene frequencies within regions corresponding to dialect families but not between them, leading to the patchy distributions of allele frequencies that were detected in an earlier study.	SUNY STONY BROOK, DEPT ECOL & EVOLUT, STONY BROOK, NY 11794 USA; UNIV PADUA, DIPARTMENTO BIOL, I-35100 PADUA, ITALY	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Padua			Barbujani, Guido/ABE-9998-2020	Barbujani, Guido/0000-0001-7854-6669	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028262] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28262] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS WY, 1978, ANNU REV ANTHROPOL, V7, P483, DOI 10.1146/annurev.an.07.100178.002411; Ammerman A.J., 1984, NEOLITHIC TRANSITION; BARBUJANI G, 1987, GENETICS, V117, P777; BARBUJANI G, 1988, ANN HUM GENET, V52, P215, DOI 10.1111/j.1469-1809.1988.tb01099.x; BARBUJANI G, 1989, SYST ZOOL, V38, P376, DOI 10.2307/2992403; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; BARBUJANI G, IN PRESS HUM BIOL; Barker G., 1981, LANDSCAPE SOC PREHIS; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BARTON NH, 1990, NATURE, V346, P415, DOI 10.1038/346415a0; BERETTA M, 1986, HUM HERED, V36, P379, DOI 10.1159/000153662; CANELLA R, 1987, ANN HUM GENET, V51, P337, DOI 10.1111/j.1469-1809.1987.tb01068.x; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1984, HUMAN POPULATION GEN, P229; Endler J.A., 1977, Monographs in Population Biology, pi; EXCOFFIER L, IN PRESS HUM BIOL; FELSENSTEIN J, 1982, J THEOR BIOL, V96, P9, DOI 10.1016/0022-5193(82)90152-7; FRIEDLAENDER JS, 1971, AM J HUM GENET, V23, P253; Goebl H., 1981, REV LINGUIST ROMAN, V45, P349; GOEBL H, IN PRESS LANGUAGE CH; HARDING RM, 1988, P NATL ACAD SCI USA, V85, P9370, DOI 10.1073/pnas.85.23.9370; HEDRICK PW, 1983, GENETICS, V104, P449; KLITZ W, 1986, AM J HUM GENET, V39, P340; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; LIVINGSTONE FB, 1963, CURR ANTHROPOL, V4, P541, DOI 10.1086/200427; LIVINGSTONE FB, 1983, DISTRIBUTION EVOLUTI, P15; Livingstone FB, 1967, ABNORMAL HEMOGLOBINS; MANTEL N, 1967, CANCER RES, V27, P209; Matheron G, 1970, CAHIERS CMM FASCICUL; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Mourant AE, 1976, DISTRIBUTION HUMAN B; Pellegrini G. B., 1977, CARTA DIALETTI ITALI; PIAZZA A, 1981, BIOMETRICS, V37, P635, DOI 10.2307/2530147; PIAZZA A, 1987, NATURE, V329, P714, DOI 10.1038/329714a0; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; Piazza A, 1989, Gene Geogr, V3, P69; PIAZZA A, 1982, DISTRIBUZIONE ALCUNI; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Rohlf F. J., 1987, INTRO BIOSTATISTICS; SALZANO FM, 1977, AM J PHYS ANTHROPOL, V47, P337, DOI 10.1002/ajpa.1330470214; SERJEANTSON SW, 1983, J HUM EVOL, V12, P77, DOI 10.1016/S0047-2484(83)80014-1; SLATKIN M, 1989, GENOME, V31, P196, DOI 10.1139/g89-034; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1975, GENETICS, V81, P787; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sokal R.R., 1981, BIOMETRY, V2nd ed.; SOKAL RR, 1990, AM NAT, V135, P157, DOI 10.1086/285037; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V79, P489, DOI 10.1002/ajpa.1330790406; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; SOKAL RR, 1988, AM J PHYS ANTHROPOL, V76, P337, DOI 10.1002/ajpa.1330760308; SOKAL RR, 1982, AM NAT, V119, P1, DOI 10.1086/283886; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1988, P NATL ACAD SCI USA, V85, P1722, DOI 10.1073/pnas.85.5.1722; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; SOKAL RR, 1983, GENETICS, V105, P219; SPUHLER JN, 1972, ASSESSMENT POPULATIO, P72; TILLS D, 1983, DISTRIBUTION HUMAN S, V1; WHITE NG, 1973, AM J PHYS ANTHROPOL, V38, P5, DOI 10.1002/ajpa.1330380106; WIJSMAN EM, 1984, ANNU REV ECOL SYST, V15, P279; WOMBLE WH, 1951, SCIENCE, V114, P315, DOI 10.1126/science.114.2961.315; [No title captured]	65	69	70	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					398	411						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990846				2022-12-18	WOS:A1991EV74400025
J	SUIJKERBUIJK, RF; VANDEVEEN, AY; VANECHTEN, J; BUYS, CHCM; DEJONG, B; OOSTERHUIS, JW; WARBURTON, DA; CASSIMAN, JJ; SCHONK, D; VANKESSEL, AG				SUIJKERBUIJK, RF; VANDEVEEN, AY; VANECHTEN, J; BUYS, CHCM; DEJONG, B; OOSTERHUIS, JW; WARBURTON, DA; CASSIMAN, JJ; SCHONK, D; VANKESSEL, AG			DEMONSTRATION OF THE GENUINE ISO-12P CHARACTER OF THE STANDARD MARKER CHROMOSOME OF TESTICULAR GERM-CELL TUMORS AND IDENTIFICATION OF FURTHER CHROMOSOME-12 ABERRATIONS BY COMPETITIVE INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERATOMA; I(12P); TESTIS	The recently developed competitive in situ hybridization (CISH) strategy was applied to the analysis of chromosome 12 aberrations in testicular germ cell tumors (TGCTs). DNAs from two rodent-human somatic cell hybrids, containing either a normal chromosome 12 or the p arm of chromosome 12 as their unique human material, were used as probes. Our results demonstrate a genuine iso-12p character of the standard marker chromosome in TGCTs. Moreover, variant markers were identified representing translocation products that also involve chromosome 12.	UNIV HOSP NIJMEGEN, DEPT HUMAN GENET, POB 9101, 6500 HB NIJMEGEN, NETHERLANDS; STATE UNIV GRONINGEN, DEPT MED GENET, 9700 AB GRONINGEN, NETHERLANDS; DR DANIEL DENHOED CLIN, ROTTERDAM, NETHERLANDS; CATHOLIC UNIV LEUVEN, CTR HUMAN GENET, B-3000 LOUVAIN, BELGIUM; COLUMBIA UNIV, DEPT GENET & DEV, NEW YORK, NY 10027 USA; COLUMBIA UNIV, DEPT PEDIAT, NEW YORK, NY 10027 USA	Radboud University Nijmegen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; KU Leuven; Columbia University; Columbia University			van Kessel, Ad Geurts/A-2810-2010					ANDREWS PW, 1987, TERATOCARCINOMAS EMB, P207; ATKIN NB, 1987, CANCER GENET CYTOGEN, V26, P355, DOI 10.1016/0165-4608(87)90070-7; ATKIN NB, 1983, CANCER GENET CYTOGEN, V10, P199, DOI 10.1016/0165-4608(83)90125-5; CASTEDO SMMJ, 1988, CANCER GENET CYTOGEN, V35, P171, DOI 10.1016/0165-4608(88)90239-7; CHAGANTI RSK, 1989, GENE CHROMOSOME CANC, V1, P83, DOI 10.1002/gcc.2870010113; COCCIA M, 1989, CANCER GENET CYTOGEN, V41, P240, DOI 10.1016/0165-4608(89)90288-4; GIBAS Z, 1986, CANCER GENET CYTOGEN, V19, P245, DOI 10.1016/0165-4608(86)90053-1; JENKYN DJ, 1987, CANCER GENET CYTOGEN, V26, P327, DOI 10.1016/0165-4608(87)90067-7; KIEVITS T, 1990, CYTOMETRY, V11, P105, DOI 10.1002/cyto.990110112; LOOIJENGA LHJ, 1990, CYTOGENET CELL GENET, V53, P216, DOI 10.1159/000132934; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; THOMPSON S, 1984, J CELL SCI, V72, P37; VANKESSEL AG, 1989, CANCER GENET CYTOGEN, V40, P129, DOI 10.1016/0165-4608(89)90154-4; VANKESSEL AG, IN PRESS RECENT RESU; VOS A, 1990, CANCER GENET CYTOGEN, V46, P75, DOI 10.1016/0165-4608(90)90011-X; WARBURTON D, 1990, GENOMICS, V6, P358, DOI 10.1016/0888-7543(90)90577-H; ZHANG J, 1989, HUM GENET, V83, P359, DOI 10.1007/BF00291381	17	69	69	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					269	273						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1846721				2022-12-18	WOS:A1991EV74400011
J	PAW, BH; TIEU, PT; KABACK, MM; LIM, J; NEUFELD, EF				PAW, BH; TIEU, PT; KABACK, MM; LIM, J; NEUFELD, EF			FREQUENCY OF 3 HEX-A MUTANT ALLELES AMONG JEWISH AND NON-JEWISH CARRIERS IDENTIFIED IN A TAY-SACHS SCREENING-PROGRAM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,BRAIN RES INST,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF SAN DIEGO,SCH MED,DEPT PEDIAT,LA JOLLA,CA 92093	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California San Diego				Paw, Barry/0000-0002-0492-1419	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 08042] Funding Source: Medline; NINDS NIH HHS [NS22376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; ASAKAI R, 1989, P NATL ACAD SCI USA, V86, P7667, DOI 10.1073/pnas.86.20.7667; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; GREENBERG DA, 1982, AM J HUM GENET, V34, P444; HECHTMAN P, 1989, American Journal of Human Genetics, V45, pA193; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KABACK MM, 1972, METHOD ENZYMOL, V28, P862; KAZAZIAN HH, 1988, BLOOD, V72, P1107; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; MYRIANTHOPOULOS NC, 1972, ADV EXP MED BIOL, V19, P561; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NAVON R, 1985, AM J HUM GENET, V37, P1031; NAVON R, 1990, AM J HUM GENET, V46, P817; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; OHNO K, 1988, J BIOL CHEM, V263, P18563; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PETERSEN GM, 1983, AM J HUM GENET, V35, P1258; PETERSEN GM, 1983, CLIN RES, V31, pA111; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SHORE S, 1990, ANAL BIOCHEM, V186, P179, DOI 10.1016/0003-2697(90)90593-X; SUZUKI K, IN PRESS MOL GENETIC; SUZUKI Y, 1971, J PEDIATR-US, V78, P643, DOI 10.1016/S0022-3476(71)80467-5; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TRIGGS-RAINE B L, 1989, American Journal of Human Genetics, V45, pA226; TRIGGSRAINE BL, 1990, AM J HUM GENET, V46, P183; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349	35	69	69	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					698	705						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2220809				2022-12-18	WOS:A1990EB31900015
J	MURRAY, LW; BAUTISTA, J; JAMES, PL; RIMOIN, DL				MURRAY, LW; BAUTISTA, J; JAMES, PL; RIMOIN, DL			TYPE-II COLLAGEN DEFECTS IN THE CHONDRODYSPLASIAS .1. SPONDYLOEPIPHYSEAL DYSPLASIAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SO CALIF,DEPT PHARMACOL,LOS ANGELES,CA 90089; CEDARS SINAI MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90048	University of Southern California; Cedars Sinai Medical Center	MURRAY, LW (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90502, USA.				NICHD NIH HHS [HD 22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON CE, 1982, AM J MED GENET, V13, P243, DOI 10.1002/ajmg.1320130304; BACHINGER HP, 1981, J BIOL CHEM, V256, P3193; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BATEMAN JF, 1987, J BIOL CHEM, V262, P7021; BENTZ H, 1983, P NATL ACAD SCI-BIOL, V80, P3168, DOI 10.1073/pnas.80.11.3168; BLUMENKRANTZ N, 1984, J BIOL CHEM, V257, P854; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BOROCHOWITZ Z, 1985, CLIN RES, V33, pA129; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; BURGESON RE, 1979, BIOCHEM BIOPH RES CO, V87, P1124, DOI 10.1016/S0006-291X(79)80024-8; BUTLER WT, 1976, BIOCHEMISTRY-US, V15, P3000, DOI 10.1021/bi00659a010; BYERS PH, 1988, AM J HUM GENET, V42, P237; BYERS PH, 1984, AM J MED GENET, V17, P429, DOI 10.1002/ajmg.1320170206; COHN DH, 1986, P NATL ACAD SCI USA, V83, P6045, DOI 10.1073/pnas.83.16.6045; HORTON WA, 1982, AM J DIS CHILD, V136, P316, DOI 10.1001/archpedi.1982.03970400034010; KIRSCH E, 1981, EUR J CLIN INVEST, V11, P39, DOI 10.1111/j.1365-2362.1981.tb01763.x; KIRSCH E, 1981, BIOCHEM J, V2211, P599; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Lachman R S, 1975, Birth Defects Orig Artic Ser, V11, P231; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MILLER EJ, 1973, J BIOL CHEM, V248, P1666; MILLER EJ, 1973, BIOCHEMISTRY-US, V12, P3153, DOI 10.1021/bi00741a003; MILLER EJ, 1983, COLLAGEN REL RES, V3, P79; MURRAY L W, 1985, Journal of Cell Biology, V101, p95A; MURRAY L W, 1985, American Journal of Human Genetics, V37, pA13; MURRAY LW, 1988, PATHOL IMMUNOPATH R, V7, P99, DOI 10.1159/000157111; MURRAY LW, UNPUB TYPE 2 COLLAGE; MURRAY LW, 1986, ANN INTERN MED, V105, P740; OAKLEY BR, 1980, ANAL BIOCHEM, V110, P201; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Rimoin D.L., 1983, PRINCIPLES PRACTICE, V2, P703; SILLENCE DO, 1979, AM J PATHOL, V96, P811; Spranger J, 1975, Birth Defects Orig Artic Ser, V11, P177; SPRANGER JW, 1970, RADIOLOGY, V94, P313, DOI 10.1148/94.2.313; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; TRAUB W, 1986, FEBS LETT, V198, P213, DOI 10.1016/0014-5793(86)80407-0; TRELSTAD RL, 1977, LAB INVEST, V36, P501	37	69	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					5	15						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2741952				2022-12-18	WOS:A1989AE77900002
J	WIGDERSON, M; FIRON, N; HOROWITZ, Z; WILDER, S; FRISHBERG, Y; REINER, O; HOROWITZ, M				WIGDERSON, M; FIRON, N; HOROWITZ, Z; WILDER, S; FRISHBERG, Y; REINER, O; HOROWITZ, M			CHARACTERIZATION OF MUTATIONS IN GAUCHER PATIENTS BY CDNA CLONING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science			; Reiner, Orly/E-9455-2010	, Nurit/0000-0002-1096-1425; Reiner, Orly/0000-0001-7560-9599				AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady R. O., 1983, METABOLIC BASIS INHE, P842; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; CHOUDARY PV, 1986, MOL BIOL MED, V3, P293; DAVIS RW, 1980, ADV BACTERIAL GENET, P106; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HIRSCHHORN R, 1976, PROGR MED GENETICS, P49; HOROWITZ M, 1983, Journal of Molecular and Applied Genetics, V2, P147; HOROWITZ M, IN PRESS GENOMICS; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Maxam A M, 1980, Methods Enzymol, V65, P499; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7053; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; REINER O, 1987, DNA-J MOLEC CELL BIO, V6, P101, DOI 10.1089/dna.1987.6.101; REINER O, 1988, DNA-J MOLEC CELL BIO, V7, P107, DOI 10.1089/dna.1988.7.107; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; SORGE J, 1986, COLD SPRING HARB SYM, V51, P1041, DOI 10.1101/SQB.1986.051.01.120; SORGE JA, 1987, AM J HUM GENET, V41, P1016; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1986, J BIOL CHEM, V261, P50; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79	36	69	69	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					365	377						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2464926				2022-12-18	WOS:A1989T353500009
J	CREMERS, FPM; VANDEPOL, TJR; WIERINGA, B; HOFKER, MH; PEARSON, PL; PFEIFFER, RA; MIKKELSEN, M; TABOR, A; ROPERS, HH				CREMERS, FPM; VANDEPOL, TJR; WIERINGA, B; HOFKER, MH; PEARSON, PL; PFEIFFER, RA; MIKKELSEN, M; TABOR, A; ROPERS, HH			MOLECULAR ANALYSIS OF MALE-VIABLE DELETIONS AND DUPLICATIONS ALLOWS ORDERING OF 52 DNA PROBES ON PROXIMAL XQ	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CATHOLIC UNIV NIJMEGEN,RADBOUD HOSP,DEPT HUMAN GENET,POB 9101,6500 HB NIJMEGEN,NETHERLANDS; STATE UNIV LEIDEN,DEPT HUMAN GENET,2312 AV LEIDEN,NETHERLANDS; UNIV ERLANGEN NURNBERG,DEPT HUMAN GENET,D-8520 ERLANGEN,FED REP GER; JOHN F KENNEDY INST,DEPT MED GENET,GLOSTRUP,DENMARK; RIGSHOSP,DEPT PEDIAT,DK-2100 COPENHAGEN O,DENMARK	Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; University of Erlangen Nuremberg; Rigshospitalet			Cremers, Frans/A-5625-2014; Wieringa, Berend/A-5346-2011	Cremers, Frans/0000-0002-4954-5592; Wieringa, Berend/0000-0001-9192-8020; Tabor, Ann/0000-0001-7450-1543				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ARVEILER B, 1987, NUCLEIC ACIDS RES, V15, P5903, DOI 10.1093/nar/15.14.5903; ARVEILER B, 1987, Genomics, V1, P60, DOI 10.1016/0888-7543(87)90105-4; AYAZI S, 1981, AM J OPHTHALMOL, V92, P63, DOI 10.1016/S0002-9394(14)75909-4; BARTLEY JA, 1986, J PEDIATR-US, V108, P189, DOI 10.1016/S0022-3476(86)80980-5; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; CHANCE PF, 1983, AM J HUM GENET, V35, pA187; CREMERS CWRJ, 1985, ARCH OTOLARYNGOL, V111, P249; CREMERS F, 1987, CYTOGENET CELL GENET, V46, P601; CREMERS FPM, 1987, HUM GENET, V77, P23, DOI 10.1007/BF00284707; CREMERS FPM, 1987, CLIN GENET, V32, P421; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; GAL A, 1985, CYTOGENET CELL GENET, V40, P633; GAL A, 1986, CYTOGENET CELL GENET, V42, P219, DOI 10.1159/000132282; GARTLER S, 1985, CYTOGENET CELL GENET, V40, P635; GERALD PS, 1974, CYTOGENET CELL GENET, V13, P29, DOI 10.1159/000130228; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; GRZESCHIK KH, 1976, CYTOGENET CELL GENET, V16, P149, DOI 10.1159/000130577; HODGSON SV, 1987, HUM GENET, V75, P286, DOI 10.1007/BF00281076; HOFKER MH, 1987, AM J HUM GENET, V40, P312; HOFKER MH, 1986, AM J HUM GENET, V39, P438; KURNIT DM, 1979, ANNU REV GENET, V13, P235, DOI 10.1146/annurev.ge.13.120179.001315; LANGE K, 1985, AM J HUM GENET, V37, P853; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MICHELSON AM, 1985, J BIOL CHEM, V260, P6982; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; OLD JM, 1985, LANCET, V1, P73; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; RIDDELL DC, 1986, CYTOGENET CELL GENET, V42, P123, DOI 10.1159/000132264; ROSENBERG T, 1986, OPHTHALMIC PAED GEN, V7, P205, DOI 10.3109/13816818609004140; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCHWARTZ M, 1986, HUM GENET, V74, P449, DOI 10.1007/BF00280505; TABOR A, 1983, HUM GENET, V64, P196, DOI 10.1007/BF00327127; VEJERSLEV LO, 1985, CLIN GENET, V27, P276; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WIERINGA B, 1985, CLIN GENET, V27, P522; WIERINGA B, 1985, CYTOGENET CELL GENET, V40, P777; WILLARD HF, 1985, HUM GENET, V71, P138; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606	46	69	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					452	461						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3177387				2022-12-18	WOS:A1988Q473600012
J	WURSTERHILL, DH; BROWN, F; PARK, JP; GIBSON, SH				WURSTERHILL, DH; BROWN, F; PARK, JP; GIBSON, SH			CYTOGENETIC STUDIES IN DUPUYTREN CONTRACTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT SURG,HANOVER,NH 03756; DARTMOUTH COLL,HITCHCOCK MED CTR,NORRIS COTTON CANC CTR,HANOVER,NH 03756	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	WURSTERHILL, DH (corresponding author), DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT PATHOL,HANOVER,NH 03756, USA.							ADLER D, 1987, IDEOGRAM ALBUM HUMAN; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BERGER R, 1985, CYTOGENET CELL GENET, V40, P490, DOI 10.1159/000132181; BOWSERRILEY S, 1975, LANCET, V2, P1282; BRICKLEYPARSONS D, 1981, J BONE JOINT SURG AM, V63, P787, DOI 10.2106/00004623-198163050-00014; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; Flynn JE, 1982, HAND SURG, P797; GELBERMAN RH, 1980, J BONE JOINT SURG AM, V62, P425, DOI 10.2106/00004623-198062030-00012; HUNTER JAA, 1975, BRIT J PLAST SURG, V28, P10, DOI 10.1016/0007-1226(75)90144-7; MARK J, 1986, ANTICANCER RES, V6, P299; McKusick V. A., 1986, MENDELIAN INHERITANC; OBE G, 1980, MUTAT RES, V73, P377, DOI 10.1016/0027-5107(80)90202-X; SANDBERG AA, 1983, CHROMOSOMES HUMAN CA; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEABRIGH.M, 1971, LANCET, V2, P971; SERGOVICH FR, 1983, NEW ENGL J MED, V308, P162	16	69	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					285	292						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	3414684				2022-12-18	WOS:A1988P884100009
J	HOOK, EB; CROSS, PK; JACKSON, L; PERGAMENT, E; BRAMBATI, B				HOOK, EB; CROSS, PK; JACKSON, L; PERGAMENT, E; BRAMBATI, B			MATERNAL AGE-SPECIFIC RATES OF 47,+21 AND OTHER CYTOGENETIC ABNORMALITIES DIAGNOSED IN THE 1ST TRIMESTER OF PREGNANCY IN CHORIONIC VILLUS BIOPSY SPECIMENS - COMPARISON WITH RATES EXPECTED FROM OBSERVATIONS AT AMNIOCENTESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF BERKELEY,SCH PUBL HLTH,MATERNAL & CHILD HLTH PROGRAM,BERKELEY,CA 94720; UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208; NEW YORK STATE DEPT HLTH,BUR ENVIRONM EPIDEMIOL & OCCUPAT HLTH,REPROD SURVEILLANCE SECT,ALBANY,NY 12201; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PEDIAT & INTERNAL MED,DIV MED GENET,PHILADELPHIA,PA 19107; MICHAEL REESE HOSP & MED CTR,DIV MED GENET,CHICAGO,IL 60616; UNIV MILAN,OBSTET CLIN 1,I-20122 MILAN,ITALY	University of California System; University of California Berkeley; Albany Medical College; State University of New York (SUNY) System; Jefferson University; Michael Reese Hospital & Medical Center; University of Milan	HOOK, EB (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,GENET COUNSELING PROGRAM,BERKELEY,CA 94720, USA.							BRAMBATI B, 1985, 1ST TRIMESTER FETAL, P7; Brambati B, 1987, RES REPROD, V19, P1; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; Hook E B, 1978, Birth Defects Orig Artic Ser, V14, P249; Hook E B, 1985, Basic Life Sci, V36, P7; HOOK EB, 1981, LANCET, V2, P169; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1987, ANN HUM GENET, V51, P27; HOOK EB, 1984, HUM GENET, V68, P211, DOI 10.1007/BF00418391; HOOK EB, 1981, POPULATION BIOL ASPE, P389; KAJII T, 1978, HUM GENET, V43, P247, DOI 10.1007/BF00278831; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; SCHREINEMACHERS DM, 1982, HUM GENET, V61, P318	13	69	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					797	807						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	2967030				2022-12-18	WOS:A1988N519700001
J	KUIVANIEMI, H; PELTONEN, L; KIVIRIKKO, KI				KUIVANIEMI, H; PELTONEN, L; KIVIRIKKO, KI			TYPE-IX EHLERS-DANLOS SYNDROME AND MENKES SYNDROME - THE DECREASE IN LYSYL OXIDASE ACTIVITY IS ASSOCIATED WITH A CORRESPONDING DEFICIENCY IN THE ENZYME PROTEIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OULU,DEPT ANAT,COLLAGEN RES UNIT,SF-90220 OULU,FINLAND	University of Oulu	KUIVANIEMI, H (corresponding author), UNIV OULU,DEPT MED BIOCHEM,COLLAGEN RES UNIT,SF-90220 OULU,FINLAND.		Kuivaniemi, Helena/Q-8178-2019	Kuivaniemi, Helena/0000-0001-5753-8766				BYERS PH, 1980, NEW ENGL J MED, V303, P61, DOI 10.1056/NEJM198007103030201; BYERS PH, 1983, CLIN MED, P1; HARRIS ED, 1981, P SOC EXP BIOL MED, V166, P528; HOLLISTER DW, 1982, AAOS S HERITABLE DIS, P102; HORN N, 1984, METABOLISM TRACE MET, V2, P25; KAITILA II, 1982, SKELETAL DYSPLASIAS, P307; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KIVIRIKKO KI, 1985, DISEASES CONNECTIVE; KUIVANIEMI H, 1982, J CLIN INVEST, V69, P730, DOI 10.1172/JCI110503; KUIVANIEMI H, 1984, J BIOL CHEM, V259, P6996; McKusick V.A., 1983, MENDELIAN INHERITANC; PELTONEN L, 1983, BIOCHEMISTRY-US, V22, P6156, DOI 10.1021/bi00295a018; PICKART L, 1980, NATURE, V288, P715, DOI 10.1038/288715a0; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; ROWE DW, 1977, J BIOL CHEM, V252, P939; ROYCE PM, 1980, BIOCHEM J, V192, P579, DOI 10.1042/bj1920579; ROYCE PM, 1982, BIOCHEM J, V202, P369, DOI 10.1042/bj2020369; SCHMIDT CJ, 1984, SCIENCE, V224, P1104, DOI 10.1126/science.6719135; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; STARCHER B, 1978, J NUTR, V108, P1229, DOI 10.1093/jn/108.8.1229; STENBERG J, 1983, J IMMUNOL METHODS, V64, P39; STERNBERGER LA, 1979, J HISTOCHEM CYTOCHEM, V27, P1657, DOI 10.1177/27.12.392001; SULLIVAN KA, 1982, J BIOL CHEM, V257, P13520; ZELLER R, 1983, CELL, V32, P425, DOI 10.1016/0092-8674(83)90462-2; [No title captured]	26	69	71	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					798	808						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556668				2022-12-18	WOS:A1985APR1800017
J	SCHROEDER, WT; MILLER, MF; WOO, SLC; SAUNDERS, GF				SCHROEDER, WT; MILLER, MF; WOO, SLC; SAUNDERS, GF			CHROMOSOMAL LOCALIZATION OF THE HUMAN ALPHA-1-ANTITRYPSIN GENE (PI) 14Q31-32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT CELL BIOL,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor College of Medicine; Howard Hughes Medical Institute	SCHROEDER, WT (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030, USA.				NATIONAL CANCER INSTITUTE [P01CA034936, R01CA020124] Funding Source: NIH RePORTER; NCI NIH HHS [CA-34936, CA-20124] Funding Source: Medline; NHLBI NIH HHS [HL-L7509] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; COX D W, 1984, American Journal of Human Genetics, V36, p134S; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KUEPPERS F, 1978, LUNG BIOL HLTH DISEA, V2, P23; LAI EC, 1983, AM J HUM GENET, V35, P385; LAI EC, 1979, CELL, V16, P201; LAURELL CB, 1975, PLASMA PROTEINS, P229; LAURELL CB, 1963, SCAND J CLIN LAB INV, V14, P490; LEICHT M, 1982, NATURE, V297, P655, DOI 10.1038/297655a0; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; OHLSSON K, 1975, PROTEASES BIOL CONTR, P591; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267	15	69	70	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					868	872						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	3876766				2022-12-18	WOS:A1985ASD5500003
J	DEVERNEUIL, H; BEAUMONT, C; DEYBACH, JC; NORDMANN, Y; SFAR, Z; KASTALLY, R				DEVERNEUIL, H; BEAUMONT, C; DEYBACH, JC; NORDMANN, Y; SFAR, Z; KASTALLY, R			ENZYMATIC AND IMMUNOLOGICAL STUDIES OF UROPORPHYRINOGEN DECARBOXYLASE IN FAMILIAL PORPHYRIA CUTANEA-TARDA AND HEPATOERYTHROPOIETIC PORPHYRIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP HABIB THAMEUR,TUNIS,TUNISIA	Universite de Tunis-El-Manar; Hopital Habib Thameur	DEVERNEUIL, H (corresponding author), HOP LOUIS MOURIER,FAC MED XAVIER BICHAT,DEPT BIOCHEM,F-92701 COLOMBES,FRANCE.							AGUADE JP, 1969, BRIT J DERMATOL, V81, P270, DOI 10.1111/j.1365-2133.1969.tb13979.x; ANDERSON PM, 1981, J CLIN INVEST, V68, P1, DOI 10.1172/JCI110223; AVRAMEAS S, 1971, IMMUNOCHEMISTRY, V8, P1175, DOI 10.1016/0019-2791(71)90395-8; BENEDETTO AV, 1978, N ENGL J MED, V298, P858; CZARNECKI DB, 1980, ARCH DERMATOL, V116, P307, DOI 10.1001/archderm.116.3.307; DAY RS, 1982, ARCH DERMATOL, V118, P663, DOI 10.1001/archderm.118.9.663; de Verneuil H, 1978, Hum Genet, V44, P145; DEVERNEUIL H, 1983, J BIOL CHEM, V258, P2454; DEVERNEUIL H, 1980, BIOCHIM BIOPHYS ACTA, V611, P174, DOI 10.1016/0005-2744(80)90053-4; DOWDLE E, 1970, CLIN SCI, V39, P147, DOI 10.1042/cs0390147; ELDER GH, 1983, LANCET, V1, P1301; ELDER GH, 1981, LANCET, V1, P916; ELDER GH, 1978, NEW ENGL J MED, V299, P274, DOI 10.1056/NEJM197808102990603; ELDER GH, 1980, CLIN SCI, V58, P477, DOI 10.1042/cs0580477; Engvall E, 1980, Methods Enzymol, V70, P419; ERIKSEN L, 1974, SCAND J CLIN LAB INV, V33, P323, DOI 10.3109/00365517409082502; FELSHER BF, 1982, NEW ENGL J MED, V306, P766, DOI 10.1056/NEJM198204013061302; FELSHER BF, 1978, NEW ENGL J MED, V299, P1095, DOI 10.1056/NEJM197811162992002; GRANDCHAMP B, 1977, LANCET, V2, P1348; KAPPAS A, 1983, METABOLIC BASIS INHE, P1301; KUSHNER JP, 1982, BLOOD, V59, P725; KUSHNER JP, 1976, J CLIN INVEST, V58, P1089, DOI 10.1172/JCI108560; MASTERS BSS, 1971, J BIOL CHEM, V246, P4143; MAUZERALL D, 1956, J BIOL CHEM, V219, P435; NORDMANN Y, 1983, J CLIN INVEST, V72, P1139, DOI 10.1172/JCI111039; SASSA S, 1984, T ASSOC AM PHYSICIAN; SCHWARTZ SAMUEL, 1960, METHODS BIOCHEM ANAL, V8, P221	27	69	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					613	622						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6375356				2022-12-18	WOS:A1984SY11900010
J	PETERSEN, GM; ROTTER, JI; CANTOR, RM; FIELD, LL; GREENWALD, S; LIM, JST; ROY, C; SCHOENFELD, V; LOWDEN, JA; KABACK, MM				PETERSEN, GM; ROTTER, JI; CANTOR, RM; FIELD, LL; GREENWALD, S; LIM, JST; ROY, C; SCHOENFELD, V; LOWDEN, JA; KABACK, MM			THE TAY-SACHS DISEASE GENE IN NORTH-AMERICAN JEWISH POPULATIONS - GEOGRAPHIC VARIATIONS AND ORIGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT MED,TORRANCE,CA 90509; UNIV CALGARY,ALBERTA CHILDRENS HOSP,DEPT PEDIAT,DIV MED GENET,CALGARY T2T 5C7,ALBERTA,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Alberta Childrens Hospital; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	PETERSEN, GM (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509, USA.							Ankori Zvi., 1979, GENETIC DIS ASHKENAZ, P19; ARONSON S M, 1959, AMA J Dis Child, V98, P50; ARONSON SM, 1962, CEREBRAL SPHINGOLIPI, P375; ARONSON SM, 1964, TAYSACHS DISEASE, P118; BARON SW, 1937, SOCIAL RELIG HIST JE, V2; CHAKRAVARTI A, 1978, AM J HUM GENET, V30, P256; CHASE GA, 1972, AM J HUM GENET, V24, P339; DIXON WJ, 1969, INTRO STATISTICAL AN; FISHMAN P, 1973, JEWS US; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; GAY R, 1965, JEWS AM; GOLDSCHMIDT E, 1956, 25TH ANN M GEN SOC A; GOLDSCHMIDT E, 1963, GENETICS MIGRANT ISO, P290; GRAYZEL S, 1963, HIST JEWS; GREENBERG DA, 1982, AM J HUM GENET, V34, P444; Kaback M. M., 1972, SPHINGOLIPIDS SPHING, P613; KABACK MM, 1974, PROG MED GENET, V10, P103; KABACK MM, 1977, TAY SACHS DISEASE SC; KABACK MM, 1973, METHOD ENZYMOL, V28, P862; KABACK MM, 1974, BIRTH DEFECTS, P248; Knudson AG., 1962, CEREBRAL SPHINGOLIPI, P395; Koestler A., 1976, 13 TRIBE; KOZINN PJ, 1957, J PEDIATR-US, V51, P58, DOI 10.1016/S0022-3476(57)80282-0; LOWDEN JA, 1973, CLIN CHEM, V19, P1345; LOWDEN JA, 1977, TAYSACHS DISEASE SCR, P37; MAYO O, 1970, ANN HUM GENET, V33, P307, DOI 10.1111/j.1469-1809.1970.tb01655.x; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; MYRIANTHOPOULOS NC, 1962, CEREBRAL SPHINGOLIPI, P359; MYRIANTHOPOULOS NC, 1972, SPHINGOLIPIDS SPHING, P561; MYRIANTHOPOULOS NC, 1967, INBORN DISORDERS SPH, P431; MYRIANTHOPOULOS NC, 1977, TAYSACHS DIS, P95; Neel JamesV., 1979, GENETIC DISEASES ASH, P285; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PATRICK AD, 1977, TAY SACHS DISEASE SC, P147; Sklare Marshall, 1971, AM JEWS; SPYROPOULOS B, 1981, AM J HUM GENET, V33, P375	38	69	71	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1258	1269						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RU705	6650504				2022-12-18	WOS:A1983RU70500019
J	BLACK, FL; SALZANO, FM				BLACK, FL; SALZANO, FM			EVIDENCE FOR HETEROSIS IN THE HLA SYSTEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV FED RIO GRANDE SUL,INST BIOCIENCIAS,DEPT GENET,PORTO ALEGRE 90000,RS,BRAZIL	Universidade Federal do Rio Grande do Sul	BLACK, FL (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510, USA.		Salzano, Francisco M/L-7916-2015					BLACK FL, 1980, TISSUE ANTIGENS, V16, P368; BLACK FL, 1980, AM J PHYS ANTHROPOL, V52, P119, DOI 10.1002/ajpa.1330520115; BLACK FL, 1978, MED ANTHROPOL, V2, P95; BLANDEN RV, 1980, IMMUNOL TODAY, V1, P33, DOI 10.1016/0167-5699(80)90029-8; CAMPBELL A, 1976, UNPUB; DEGOS L, 1974, NATURE, V249, P62, DOI 10.1038/249062a0; JACQUES SMC, 1979, J HUM EVOL, V8, P513; LAYRISSE Z, 1976, SCIENCE, V194, P1135, DOI 10.1126/science.136748; LEWONTIN RC, 1978, GENETICS, V88, P149; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; POWELL JR, 1979, AM SCI, V67, P590; Riviu┐re P., 1969, MARRIAGE TRIO; SALZANO FM, 1974, HUM BIOL, V46, P81; SALZANO FM, 1972, HUM BIOL, V44, P443; SALZANO FM, 1972, AM J PHYS ANTHROPOL, V36, P417, DOI 10.1002/ajpa.1330360313; SALZANO FM, 1971, SOC BIOL, V18, P148, DOI 10.1080/19485565.1971.9987911; SALZANO FM, 1973, AM J HUM GENET, V25, P167	18	69	69	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					894	899						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199	7325154				2022-12-18	WOS:A1981MV19900006
J	WOOLF, CM; MYRIANTHOPOULOS, NC				WOOLF, CM; MYRIANTHOPOULOS, NC			POLYDACTYLY IN AMERICAN NEGROES AND WHITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ARIZONA STATE UNIV, DEPT ZOOL, TEMPE, AZ 85281 USA; NINDS, BETHESDA, MD 20014 USA	Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)								ALTEMUS LA, 1965, PEDIATRICS, V36, P56; CHUNG CS, 1968, AM J HUM GENET, V20, P44; Cummins H, 1932, AM J ANAT, V51, P381, DOI 10.1002/aja.1000510205; FRAZIER TM, 1960, AM J OBSTET GYNECOL, V80, P184; GITTELSOHN AM, 1965, GENETICS EPIDEMIOLOG; GOODMAN RM, 1965, J HERED, V56, P37, DOI 10.1093/oxfordjournals.jhered.a107368; IVY R H, 1962, Plast Reconstr Surg Transplant Bull, V30, P581, DOI 10.1097/00006534-196211000-00005; Li CC., 1955, POPULATION GENETICS; McClintic BS, 1935, J HERED, V26, P141, DOI 10.1093/oxfordjournals.jhered.a104054; MCKUSICK VA, 1971, MENDELIAN INHERITANC; NEEL JV, 1958, AM J HUM GENET, V10, P398; SALDANHA PH, 1964, 2 P INT C CONG MALF, P323; SMITH DW, 1963, J PEDIATR-US, V2, P326; Sverdrup A, 1922, J GENET, V12, P217, DOI 10.1007/BF02983978; TEMTAMY S, 1969, BIRTH DEFECTS OAS, V5; WALLACE HM, 1953, PEDIATRICS, V12, P525; WOOLF CM, 1970, AM J HUM GENET, V22, P75	17	69	69	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	4					397	404						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q0158	4351996				2022-12-18	WOS:A1973Q015800006
J	WITKOP, CJ; NANCE, WE; RAWLS, RF; WHITE, JG				WITKOP, CJ; NANCE, WE; RAWLS, RF; WHITE, JG			AUTOSOMAL RECESSIVE OCULOCUTANEOUS ALBINISM IN MAN . EVIDENCE FOR GENETICS HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABE K, 1967, J CLIN INVEST, V46, P1609, DOI 10.1172/JCI105653; AMES GF, 1964, ARCH BIOCHEM BIOPHYS, V104, P1, DOI 10.1016/S0003-9861(64)80028-X; AMES GF, 1968, BACTERIOLOGY, V96, P1742; [Anonymous], 1919, S REP NO 66 283, P2; BARNICOT NA, 1952, ANN EUGENIC, V17, P38; Birbeck MCS, 1959, PIGMENT CELL BIOLOGY, P549; Bloch B, 1917, H-S Z PHYSIOL CHEM, V98, P226; CHIAN LTY, 1967, SCIENCE, V155, P198, DOI 10.1126/science.155.3759.198; CHIRIGOS MA, 1960, J BIOL CHEM, V235, P2075; Dahlberg G, 1929, GENETICS, V14, P421; Davenport GC, 1910, AM NAT, V44, P705, DOI 10.1086/279186; DEBUSK BG, 1965, BIOCHIM BIOPHYS ACTA, V104, P139, DOI 10.1016/0304-4165(65)90229-1; DEMOSS JA, 1965, P NATL ACAD SCI USA, V54, P241, DOI 10.1073/pnas.54.1.241; DODINVAL P, 1965, J GENET HUM, V14, P173; DUCHON J, 1968, YEAR BOOK DERMATOLOG; Durham F.M., 1904, P ROY SOC LONDON, V74, P310; FROGGATT P, 1960, ANN HUM GENET, V24, P213, DOI 10.1111/j.1469-1809.1960.tb01734.x; Garrod AE, 1908, LANCET, V2, P73; GATES RR, 1952, HUMAN GENETICS; GORTNER RA, 1910, CITED INDIRECTLY; Hogben L, 1931, J GENET, V25, P97, DOI 10.1007/BF02983936; HOGBEN L, 1946, INTRODUCTION MATHEMA; KPEARSON K, 1911, BIOMETRIC          8; KPEARSON K, 1911, BIOMETRIC          9; KPEARSON K, 1911, BIOMETRIC          6; KUGELMAN TP, 1961, J INVEST DERMATOL, V37, P73, DOI 10.1038/jid.1961.84; Pipkin AC, 1942, J HERED, V33, P419, DOI 10.1093/oxfordjournals.jhered.a105109; Raper HS, 1927, BIOCHEM J, V21, P89, DOI 10.1042/bj0210089; ROBERTS JAF, 1940, INTRODUCTION MEDICAL; ROESS WB, 1968, J GEN MICROBIOL, V52, P421, DOI 10.1099/00221287-52-3-421; Seiji M., 1966, ADVANCES BIOLOGY SKI, VVIII, P189; Stern C., 1960, PRINCIPLES HUMAN GEN; TREVORROPER PD, 1952, BRIT J OPHTHALMOL, V36, P107, DOI 10.1136/bjo.36.2.107; TREVORROPER PD, 1963, P ROY SOC MED, V56, P21; VAN DEN BOSCH J, 1953, Ned Tijdschr Geneeskd, V97, P3300; WAARDENBURG PJ, 1947, NED TIJDSCHR GENEES, V91, P1863; WITKOP C, 1970, ADVANCES HUMAN GENET, V2; Witkop C J Jr, 1966, Ala J Med Sci, V3, P382; WITKOP CJ, 1961, 2ND P INT C HUM GEN, P1064; ZIPKIN I, 1964, SALIVARY GLANDS THEI, V3, P331	40	69	69	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	1					55	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F4294	4983623				2022-12-18	WOS:A1970F429400005
J	MOTULSKY, AG; VANDEPITTE, J; FRASER, GR				MOTULSKY, AG; VANDEPITTE, J; FRASER, GR			POPULATION GENETIC STUDIES IN CONGO .I. GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY HEMOGLOBIN S AND MALARIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; ALLISON AC, 1961, BRIT MED J, V1, P1346, DOI 10.1136/bmj.1.5236.1346; BLUMBERG BS, 1961, P C GENETIC POLYM ED, P159; BOWMAN JE, 1964, BRIT MED J, V1, P1378, DOI 10.1136/bmj.1.5394.1378; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; BREWER GJ, 1965, P NATL ACAD SCI USA, V54, P741, DOI 10.1073/pnas.54.3.741; CAPLAN HI, 1963, ANN INTERN MED, V59, P449, DOI 10.7326/0003-4819-59-4-449; COLBOURNE MJ, 1955, BRIT MED J, V1, P784, DOI 10.1136/bmj.1.4970.784; EDINGTON GM, 1957, BMJ-BRIT MED J, V2, P143, DOI 10.1136/bmj.2.5037.143; EDINGTON GM, 1965, ABNORMAL HAEMOGLOBIN, P393; FESSAS P, 1962, BRIT MED J, P1359, DOI 10.1136/bmj.2.5316.1359; FLATZ G, 1965, ANN HUM GENET, V29, P151, DOI 10.1111/j.1469-1809.1965.tb00511.x; FLATZ G, 1963, LANCET, V2, P1248; FOY H, 1955, BMJ-BRIT MED J, V2, P1116, DOI 10.1136/bmj.2.4948.1116; FRASER GR, 1966, AM J HUM GENET, V18, P546; GARLICK J. P., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P146, DOI 10.1016/0035-9203(60)90051-1; GIBLETT ER, 1966, AM J HUM GENET, V18, P553; GILLES HM, 1960, W AFR MED J, V9, P266; GLOCK GE, 1953, BIOCHEM J, V55, P400, DOI 10.1042/bj0550400; HIERNAUX JEAN, 1962, ANN SOC BEIGE MED TROP, V42, P145; JADIN J, 1963, Ann Soc Belg Med Trop (1920), V43, P437; JONXIS JHP, 1965, ABNORMAL HAEMOGLO ED, P393; JONXIS JHP, 1965, ABNORMAL HAEMOGLO ED, P319; JONXIS JHP, 1965, ABNORMAL HAEMOGLO ED, P143; KELLGREN JH, 1963, EPIDEMIOLOGY CHRO ED, V1, P74; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; MANN GV, 1962, J CHRON DIS, V15, P341, DOI 10.1016/0021-9681(62)90082-6; MOTULSKY AG, 1964, AM J TROP MED HYG, V13, P147, DOI 10.4269/ajtmh.1964.13.147; MOTULSKY AG, 1964, COLD SPRING HARB SYM, V29, P399, DOI 10.1101/SQB.1964.029.01.042; MOTULSKY AG, 1961, LANCET, V1, P1168; MOTULSKY AG, 1965, ABNORMAL HAEMOGLOBIN, P143; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; PORTER IH, 1964, LANCET, V1, P895; POWELL RD, 1965, AM J TROP MED HYG, V14, P358, DOI 10.4269/ajtmh.1965.14.358; RAPER AB, 1955, BRIT MED J, V1, P1186, DOI 10.1136/bmj.1.4923.1186; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; SARTORI E, 1957, ACTA PAEDIATR LAT, V10, P505; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; SINISCALCO M, 1965, SEP UN NAT WORLD POP; SONNET J, 1960, NATURE, V188, P504, DOI 10.1038/188504a0; STAMATOYANNOPOU.G, 1964, BRIT MED J, V1, P875, DOI 10.1136/bmj.1.5387.875; STAMATOYANNOPOU.G, IN PRESS; STAMATOYANNOPOULOS G, 1966, AM J HUM GENET, V18, P296; STAMATOYANNOPOULOS G, 1966, AM J HUM GENET, V18, P253; THOMPSON GR, 1963, BMJ-BRIT MED J, P976, DOI 10.1136/bmj.2.5363.976; THOMPSON GR, 1962, BMJ-BRIT MED J, P682, DOI 10.1136/bmj.1.5279.682; VALKENBURG HA, 1963, EPIDEMIOL CHRON, V1, P74; VANDEPITTE J, 1957, Ann Soc Belg Med Trop (1920), V37, P703; VANDEPITTE J, 1965, ABNORMAL HAEMOGLOBIN, P319; WALTERS JH, 1956, T ROY SOC TROP MED H, V50, P51; WILSON T, 1961, BRIT MED J, V2, P245, DOI 10.1136/bmj.2.5246.245-b; WILSON T, 1961, BRIT MED J, V2, P895, DOI 10.1136/bmj.2.5256.895-e	56	69	69	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	6					514	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	86655	5333143				2022-12-18	WOS:A19668665500002
J	COHEN, MM; CASSADY, G; HANNA, BL				COHEN, MM; CASSADY, G; HANNA, BL			GENETIC STUDY OF HEREDITARY RENAL DYSFUNCTION WITH ASSOCIATED NERVE DEAFNESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Beadle GW, 1935, GENETICS, V20, P0179; Catcheside DG, 1944, ANN BOT-LONDON, V8, P119, DOI 10.1093/oxfordjournals.aob.a088557; FERGUS.MA, 1961, LANCET, V1, P638, DOI 10.1016/S0140-6736(61)91655-5; GOLDBLOOM RB, 1957, PEDIATRICS, V20, P241; GRAHAM JB, 1959, AM J HUM GENET, V11, P385; GRAHAM JB, 1959, AM J HUM GENET, V11, P333; Guthrie LG, 1902, LANCET, V1, P1243; HURST AF, 1923, GUYS HOSP REP, V73, P368; KENDALL G, 1912, GUYS HOSP REP, V66, P137; LONGLEY AE, 1945, GENETICS, V30, P100; Mather K, 1939, GENETICS, V24, P413; Metz CW, 1938, AM NAT, V72, P485, DOI 10.1086/280803; MORTON NE, 1957, AM J HUM GENET, V9, P55; Perkoff G T, 1960, Am J Hum Genet, V12, P381; PERKOFF GT, 1951, ARCH INTERN MED, V88, P191, DOI 10.1001/archinte.1951.03810080059006; PERKOFF GT, 1958, ARCH INTERN MED, V102, P733, DOI 10.1001/archinte.1958.00260220049005; PERKOFF GT, 1961, HFHISBP, P259; POLI M, 1955, Helv Med Acta, V22, P109; Rhoades M. M., 1952, Heterosis., P66; Rhoades MM, 1942, GENETICS, V27, P0395; SEILER J, 1921, TALAEPORIA TUB AR ZE, V15, P249; SHAW RF, 1961, AM J HUM GENET, V13, P89; SOHAR E, 1954, Harefuah, V47, P161; STEPHENS FE, 1951, AM J HUM GENET, V3, P303; Sturtevant AH, 1936, GENETICS, V21, P444	26	69	69	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	4					379	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2962A	13880289				2022-12-18	WOS:A19612962A00003
J	KLOEPFER, HW; KRAFCHUK, J; DERBES, V; BURKS, J				KLOEPFER, HW; KRAFCHUK, J; DERBES, V; BURKS, J			HEREDITARY MULTIPLE LEIOMYOMA OF THE SKIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Toon, Christopher W/G-3610-2012					ELLER JJ, 1951, TUMORS SKIN, P80; GARIBALDI GM, 1925, ARCH ITAL DERM, V1, P213; HAGENA G, 1925, DERM WSCHR, V19, P673; MICHELSON HE, 1957, COMMUNICATION; STOUT AP, 1938, AM J CANCER, V29, P435; SUTTON RL, 1956, DISEASES SKIN; VIRCHOW R, 1854, ARCH PATH ANAT, V6, P553	7	69	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	1					48	52						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA218	13520698				2022-12-18	WOS:A1958WA21800005
J	Amendola, LM; Berg, JS; Horowitz, CR; Angelo, F; Bensen, JT; Biesecker, BB; Biesecker, LG; Cooper, GM; East, K; Filipski, K; Fullerton, SM; Gelb, BD; Goddard, KAB; Hailu, B; Hart, R; Hassmiller-Lich, K; Joseph, G; Kenny, EE; Koenig, BA; Knight, S; Kwok, PY; Lewis, KL; McGuire, AL; Norton, ME; Ou, J; Parsons, DW; Powell, BC; Risch, N; Robinson, M; Rini, C; Scollon, S; Slavotinek, AM; Veenstra, DL; Wasserstein, MP; Wilfond, BS; Hindorff, LA; Plon, SE; Jarvik, GP				Amendola, Laura M.; Berg, Jonathan S.; Horowitz, Carol R.; Angelo, Frank; Bensen, Jeannette T.; Biesecker, Barbara B.; Biesecker, Leslie G.; Cooper, Gregory M.; East, Kelly; Filipski, Kelly; Fullerton, Stephanie M.; Gelb, Bruce D.; Goddard, Katrina A. B.; Hailu, Benyam; Hart, Ragan; Hassmiller-Lich, Kristen; Joseph, Galen; Kenny, Eimear E.; Koenig, Barbara A.; Knight, Sara; Kwok, Pui-Yan; Lewis, Katie L.; McGuire, Amy L.; Norton, Mary E.; Ou, Jeffrey; Parsons, Donald W.; Powell, Bradford C.; Risch, Neil; Robinson, Mimsie; Rini, Christine; Scollon, Sarah; Slavotinek, Anne M.; Veenstra, David L.; Wasserstein, Melissa P.; Wilfond, Benjamin S.; Hindorff, Lucia A.; Plon, Sharon E.; Jarvik, Gail P.		CSER Consortium	The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONGENETIC HEALTH-PROFESSIONALS; DISCRETE-CHOICE EXPERIMENT; CANCER-RISK ASSESSMENT; HIGH DIAGNOSTIC YIELD; WHOLE-EXOME; INCIDENTAL FINDINGS; PATIENT COMMUNICATION; AMERICAN FAMILIES; INFORMED-CONSENT; OVARIAN-CANCER	The Clinical Sequencing Evidence-Generating Research (CSER) consortium, now in its second funding cycle, is investigating the effectiveness of integrating genomic (exome or genome) sequencing into the clinical care of diverse and medically underserved individuals in a variety of healthcare settings and disease states. The consortium comprises a coordinating center, six funded extramural clinical projects, and an ongoing National Human Genome Research Institute (NHGRI) intramural project. Collectively, these projects aim to enroll and sequence over 6,100 participants in four years. At least 60% of participants will be of non-European ancestry or from underserved settings, with the goal of diversifying the populations that are providing an evidence base for genomic medicine. Five of the six clinical projects are enrolling pediatric patients with various phenotypes. One of these five projects is also enrolling couples whose fetus has a structural anomaly, and the sixth project is enrolling adults at risk for hereditary cancer. The ongoing NHGRI intramural project has enrolled primarily healthy adults. Goals of the consortium include assessing the clinical utility of genomic sequencing, exploring medical follow up and cascade testing of relatives, and evaluating patient-provider-laboratory level interactions that influence the use of this technology. The findings from the CSER consortium will offer patients, healthcare systems, and policymakers a clearer understanding of the opportunities and challenges of providing genomic medicine in diverse populations and settings, and contribute evidence toward developing best practices for the delivery of clinically useful and cost-effective genomic sequencing in diverse healthcare settings.	[Amendola, Laura M.; Angelo, Frank; Hart, Ragan; Ou, Jeffrey; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Berg, Jonathan S.; Powell, Bradford C.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Horowitz, Carol R.] Icahn Sch Med Mt Sinai, Ctr Hlth Equ & Community Engaged Res, New York, NY 10029 USA; [Horowitz, Carol R.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Bensen, Jeannette T.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Biesecker, Barbara B.] Res Triangle Inst, Int, Washington, DC 20005 USA; [Biesecker, Leslie G.; Lewis, Katie L.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Cooper, Gregory M.; East, Kelly] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Filipski, Kelly] NCI, NIH, Rockville, MD 20850 USA; [Fullerton, Stephanie M.] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Goddard, Katrina A. B.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97227 USA; [Hailu, Benyam] Natl Inst Minor Hlth & Hlth Dispar, NIH, Bethesda, MD 20892 USA; [Hassmiller-Lich, Kristen] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA; [Joseph, Galen] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom, New York, NY 10029 USA; [Koenig, Barbara A.] Univ Calif San Francisco, Inst Hlth & Aging, Program Bioeth, San Francisco, CA 94118 USA; [Knight, Sara] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35294 USA; [Knight, Sara] Birmingham VA Med Ctr, Birmingham, AL 35294 USA; [Kwok, Pui-Yan; Risch, Neil] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Norton, Mary E.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Parsons, Donald W.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Parsons, Donald W.; Scollon, Sarah; Plon, Sharon E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Robinson, Mimsie] Bethel Gospel Assembly, New York, NY 10035 USA; [Rini, Christine] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Dept Biomed Res, Hackensack, NJ 07601 USA; [Slavotinek, Anne M.] Univ Calif San Francisco, Dept Pediat, Div Genet, San Francisco, CA 94158 USA; [Veenstra, David L.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Wasserstein, Melissa P.] Childrens Hosp Montefiore, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Wilfond, Benjamin S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Wilfond, Benjamin S.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Hindorff, Lucia A.] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); HudsonAlpha Institute for Biotechnology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of California System; University of California San Francisco; Baylor College of Medicine; University of California System; University of California San Francisco; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Hackensack University Medical Center; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle	Jarvik, GP (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.; Jarvik, GP (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	gjarvik@medicine.washington.edu	Kwok, Pui-Yan/F-7725-2014; Facility, Biospecimen Processing/AAC-7837-2022; Slavotinek, Anne/AAK-6794-2020; Fullerton, Stephanie Malia/H-8696-2019; Biesecker, Leslie/AAG-2526-2021; Knight, Sara/AAJ-3818-2020; Cooper, Gregory/D-6914-2011	Kwok, Pui-Yan/0000-0002-5087-3059; Fullerton, Stephanie Malia/0000-0002-0938-6048; Hart, Ragan/0000-0003-3758-8082; Cooper, Gregory/0000-0001-5509-9923; Biesecker, Barbara/0000-0001-9665-8963; Parsons, Donald/0000-0002-8775-3501; Angelo, Frank/0000-0001-7387-7581	ZIA [HG200387, U01 HG006485, U01 HG007301, U01 HG007292, U01 HG006487, U01 HG009610, U01 HG009599, U24 HG007307]; intramural research program of the National Human Genome Research Institute [HG200359 09]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006485, U01HG009610, U01HG009599, U01HG006487, U01HG007292, U24HG007307, U01HG007301, ZIAHG200317, ZIAHG200387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	ZIA; intramural research program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by ZIA HG200387, U01 HG006485, U01 HG007301, U01 HG007292, U01 HG006487, U01 HG009610, U01 HG009599, and U24 HG007307. L.G.B. and K.L.L. were supported by the intramural research program of the National Human Genome Research Institute, grant HG200359 09. The authors thank Melpi Kasapi and Ellen Howerton for logistical support, as well as Kevin Bowling, Tia Kauffman, and Nuriye Sahin-Hodoglugil for their contributions.	Amendola LM, 2018, J GENET COUNS, V27, P1220, DOI 10.1007/s10897-018-0243-7; Amendola LM, 2015, PERS MED, V12, P283, DOI 10.2217/PME.14.89; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; Bennette CS, 2013, GENET MED, V15, P873, DOI 10.1038/gim.2013.63; Bentley AR, 2017, J COMMUN GENET, V8, P255, DOI 10.1007/s12687-017-0316-6; Bernhardt BA, 2015, AM J MED GENET A, V167, P2635, DOI 10.1002/ajmg.a.37256; Bertier G, 2017, CRIT REV CL LAB SCI, V54, P134, DOI 10.1080/10408363.2016.1275516; Bertier G, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0213-6; Christensen KD, 2018, GENET MED, V20, P1186, DOI 10.1038/gim.2017.243; Cohn EG, 2015, J GENET COUNS, V24, P491, DOI 10.1007/s10897-014-9768-6; Douma KFL, 2016, FAM CANCER, V15, P341, DOI 10.1007/s10689-015-9852-6; Fowler SA, 2018, J GENET COUNS, V27, P104, DOI 10.1007/s10897-017-0127-2; GAFF CL, 2017, NPJ GENOM MED, V2, DOI DOI 10.1038/S41525-017-0017-4; Ginsburg GS, 2013, JAMA-J AM MED ASSOC, V309, P1463, DOI 10.1001/jama.2013.1465; Gray SW, 2016, GENET MED, V18, P1011, DOI 10.1038/gim.2015.207; Green RC, 2016, AM J HUM GENET, V98, P1051, DOI 10.1016/j.ajhg.2016.04.011; Guindalini RSC, 2015, GASTROENTEROLOGY, V149, P1446, DOI 10.1053/j.gastro.2015.07.052; Gutierrez AM, 2017, PERS MED, V14, P503, DOI 10.2217/pme-2017-0040; Hall MJ, 2006, J CLIN ONCOL, V24, P2197, DOI 10.1200/JCO.2006.05.5889; Harrison HF, 2008, GENET TEST, V12, P491, DOI 10.1089/gte.2008.0004; Hartzler A, 2013, GENET MED, V15, P792, DOI 10.1038/gim.2013.127; Hindorff LA, 2018, NAT REV GENET, V19, P175, DOI 10.1038/nrg.2017.89; Hitch K, 2014, J GENET COUNS, V23, P539, DOI 10.1007/s10897-014-9687-6; Jamal Leila, 2017, AJOB Empir Bioeth, V8, P82, DOI 10.1080/23294515.2017.1287786; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kaphingst KA, 2018, TRANSL BEHAV MED, V8, P71, DOI 10.1093/tbm/ibx042; Kaplan B, 2017, PROG COMM HLTH PARTN, V11, P161, DOI 10.1353/cpr.2017.0020; Khan CM, 2016, EUR J HUM GENET, V24, P803, DOI 10.1038/ejhg.2015.204; Kohler JN, 2017, CLIN GENET, V92, P290, DOI 10.1111/cge.12998; Komenaka IK, 2016, J COMMUN GENET, V7, P177, DOI 10.1007/s12687-015-0257-x; Lagos VI, 2008, PSYCHO-ONCOLOGY, V17, P774, DOI 10.1002/pon.1358; Lee K, 2015, AM J OPHTHALMOL, V160, P354, DOI 10.1016/j.ajo.2015.04.026; Lewis KL, 2016, GENET MED, V18, P577, DOI 10.1038/gim.2015.133; Lewis MA, 2018, GENET MED, V20, P181, DOI 10.1038/gim.2017.93; Manolio TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0194; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Niemiec E, 2018, J COMMUN GENET, V9, P143, DOI 10.1007/s12687-017-0324-6; Paneque M, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0483-2; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Regier DA, 2015, CAN MED ASSOC J, V187, pE190, DOI 10.1503/cmaj.140697; Ricker CN, 2018, TRANSL BEHAV MED, V8, P85, DOI 10.1093/tbm/ibx010; Rini C, 2017, GENET MED, V20, P769; Skinner D, 2018, GENET MED, V20, P313, DOI 10.1038/gim.2017.135; Staunton C, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0252-y; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Suriadi C, 2004, AUST NZ J OBSTET GYN, V44, P30, DOI 10.1111/j.1479-828X.2004.00171.x; Talwar D, 2017, GENET MED, V19, P725, DOI 10.1038/gim.2016.156; United States Census Bureau, 2013, LANGUAGE USE US 2011; Vadaparampil ST, 2006, CANCER EPIDEM BIOMAR, V15, P618, DOI 10.1158/1055-9965.EPI-05-0378; Walker AP, 2007, GENET MED, V9, P778, DOI 10.1097/GIM.0b013e318159a303; Wolf SM, 2018, GENET MED, V20, P545, DOI 10.1038/gim.2017.137; Wynn J, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0360-z; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0; Yu JH, 2014, AM J MED GENET A, V164, P2153, DOI 10.1002/ajmg.a.36610; Yu JH, 2013, AM J MED GENET A, V161A, P1064, DOI 10.1002/ajmg.a.35914	57	68	68	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					319	327		10.1016/j.ajhg.2018.08.007	http://dx.doi.org/10.1016/j.ajhg.2018.08.007			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30193136	Green Published, Bronze			2022-12-18	WOS:000443819500001
J	Kasak, L; Punab, M; Nagirnaja, L; Grigorova, M; Minajeva, A; Lopes, AM; Punab, AM; Aston, KI; Carvalho, F; Laasik, E; Smith, LB; Conrad, DF; Laan, M				Kasak, Laura; Punab, Margus; Nagirnaja, Liina; Grigorova, Marina; Minajeva, Ave; Lopes, Alexandra M.; Punab, Anna Maria; Aston, Kenneth I.; Carvalho, Filipa; Laasik, Eve; Smith, Lee B.; Conrad, Donald F.; Laan, Maris		GEMINI Consortium	Bi-allelic Recessive Loss-of-Function Variants in FANCM Cause Non-obstructive Azoospermia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALE-INFERTILITY; NONSENSE MUTATION; BREAST-CANCER; HUMAN TESTIS; DNA-DAMAGE; ANEMIA; FAMILY; TEX11; MEN; C.5791C-GREATER-THAN-T	Infertility affects around 7% of men worldwide. Idiopathic non-obstructive azoospermia (NOA) is defined as the absence of spermatozoa in the ejaculate due to failed spermatogenesis. There is a high probability that NOA is caused by rare genetic defects. In this study, whole-exome sequencing (WES) was applied to two Estonian brothers diagnosed with NOA and Sertoli cell-only syndrome (SCOS). Compound heterozygous loss-of-function (LoF) variants in FANCM (Fanconi anemia complementation group M) were detected as the most likely cause for their condition. A rare maternally inherited frameshift variant p.Gln498Thrfs*7 (rs761250416) and a previously undescribed splicing variant (c.4387-10A>G) derived from the father introduce a premature STOP codon leading to a truncated protein. FANCM exhibits enhanced testicular expression. In control subjects, immunohistochemical staining localized FANCM to the Sertoli and spermatogenic cells of seminiferous tubules with increasing intensity through germ cell development. This is consistent with its role in maintaining genomic stability in meiosis and mitosis. In the individual with SCOS carrying bi-allelic FANCM LoF variants, none or only faint expression was detected in the Sertoli cells. As further evidence, we detected two additional NOA-affected case subjects with independent FANCM homozygous nonsense variants, one from Estonia (p.Gln1701*; rs147021911) and another from Portugal (p.Arg1931*; rs144567652). The study convincingly demonstrates that bi-allelic recessive LoF variants in FANCM cause azoospermia. FANCM pathogenic variants have also been linked with doubled risk of familial breast and ovarian cancer, providing an example mechanism for the association between infertility and cancer risk, supported by published data on Fancm mutant mouse models.	[Kasak, Laura; Grigorova, Marina; Minajeva, Ave; Punab, Anna Maria; Laasik, Eve; Laan, Maris] Univ Tartu, Inst Biomed & Translat Med, EE-50411 Tartu, Estonia; [Punab, Margus] Tartu Univ Hosp, Androl Ctr, EE-50406 Tartu, Estonia; [Nagirnaja, Liina; Conrad, Donald F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Lopes, Alexandra M.] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4200135 Porto, Portugal; [Lopes, Alexandra M.; Carvalho, Filipa] Univ Porto, Inst Invest & Inovacao Saude i3S, P-4200135 Porto, Portugal; [Aston, Kenneth I.] Univ Utah, Sch Med, Dept Surg, Div Urol, Salt Lake City, UT 84132 USA; [Carvalho, Filipa] Univ Porto, Fac Med, Dept Patol, Serv Genet, P-4200319 Porto, Portugal; [Smith, Lee B.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Smith, Lee B.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Conrad, Donald F.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Tartu; Washington University (WUSTL); Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Utah System of Higher Education; University of Utah; Universidade do Porto; University of Edinburgh; University of Newcastle; Washington University (WUSTL)	Laan, M (corresponding author), Univ Tartu, Inst Biomed & Translat Med, EE-50411 Tartu, Estonia.	maris.laan@ut.ee	O'Bryan, Moira K/F-8256-2012; Minajeva, Ave/F-6977-2017; Carvalho, Filipa/L-2566-2013; Kasak, Laura/AAD-1742-2020; Laan, Maris/A-4100-2011	O'Bryan, Moira K/0000-0001-7298-4940; Carvalho, Filipa/0000-0001-9546-4614; Kasak, Laura/0000-0003-4182-2396; Laan, Maris/0000-0002-8519-243X; Nagirnaja, Liina/0000-0003-1948-2495; Punab, Margus/0000-0001-9601-6311; Smith, Lee/0000-0002-4103-3074	European Union through the European Regional Development Fund (project HAPPY PREGNANCY) [3.2.0701.12-0047]; Estonian Research Council [IUT34-12, PUT181]; National Institutes of Health of the United States of America [R01HD078641, R01MH101810]; United States Department of State [P000086]; Portuguese Government through FCT [IF/01262/2014]; FCT [POCI-01-0145-FEDER-007274]; MRC (UK) [MR/N002970/1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101810] Funding Source: NIH RePORTER	European Union through the European Regional Development Fund (project HAPPY PREGNANCY); Estonian Research Council(Estonian Research Council); National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of State; Portuguese Government through FCT(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by the European Union through the European Regional Development Fund (project HAPPY PREGNANCY, 3.2.0701.12-0047; for M.L. and M.P.), the Estonian Research Council (grants IUT34-12 for M.L. and PUT181 to M.P.), and the National Institutes of Health of the United States of America (R01HD078641 to D.F.C. and K.I.A. and R01MH101810 to D.F.C.). Some work on this project was conducted while D.F.C. was visiting the University of Tartu under the support of a grant from the United States Department of State (Fulbright Project #P000086). A.M.L. is funded by the Portuguese Government through FCT (IF/01262/2014). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT in the framework of the project "Institute for Research and Innovation in Health Sciences'' (POCI-01-0145-FEDER-007274). L.B.S. is funded by a MRC (UK) Programme Grant number MR/N002970/1.	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0007-2; Amin M. B., 2016, DIAGNOSTIC PATHOLOGY; [Anonymous], 2014, CURR PROTOC HUM GENE; Arafat M, 2017, J MED GENET, V54, P633, DOI 10.1136/jmedgenet-2017-104514; Ayhan O, 2014, J MED GENET, V51, P239, DOI 10.1136/jmedgenet-2013-102102; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Bogliolo M, 2018, GENET MED, V20, P458, DOI 10.1038/gim.2017.124; Bogliolo M, 2015, CURR OPIN GENET DEV, V33, P32, DOI 10.1016/j.gde.2015.07.002; Catucci I, 2018, GENET MED, V20, P452, DOI 10.1038/gim.2017.123; Che R, 2018, TRENDS GENET, V34, P171, DOI 10.1016/j.tig.2017.11.006; Colombo R, 2017, GYNECOL OBSTET INVES, V82, P283, DOI 10.1159/000468934; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Fakhro KA, 2018, GENET MED, V20, P1365, DOI 10.1038/gim.2018.10; Fouquet B, 2017, ELIFE, V6, DOI 10.7554/eLife.30490; Gershoni M, 2017, GENET MED, V19, P998, DOI 10.1038/gim.2016.225; Grigorova M, 2013, ANDROLOGY-US, V1, P293, DOI 10.1111/j.2047-2927.2012.00028.x; Gunes S, 2015, REPROD BIOMED ONLINE, V31, P309, DOI 10.1016/j.rbmo.2015.06.010; Harper JC, 2018, EUR J HUM GENET, V26, P12, DOI 10.1038/s41431-017-0016-z; He WB, 2018, J MED GENET, V55, P198, DOI 10.1136/jmedgenet-2017-104992; Jamsai D., 2014, SPERMATOGENESIS, V5, DOI DOI 10.4161/21565562.2014.979061; Kherraf ZE, 2017, EMBO MOL MED, V9, P1132, DOI 10.15252/emmm.201607461; Kiiski JI, 2017, BREAST CANCER RES TR, V166, P217, DOI 10.1007/s10549-017-4388-0; Kiiski JI, 2014, P NATL ACAD SCI USA, V111, P15172, DOI 10.1073/pnas.1407909111; Kwak SH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.142; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Lopes AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003349; Luo Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004730; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Nagirnaja L, 2018, FERTIL STERIL, V109, P20, DOI 10.1016/j.fertnstert.2017.10.028; Neidhardt G, 2017, JAMA ONCOL, V3, P1245, DOI 10.1001/jamaoncol.2016.5592; Okutman O, 2017, J ASSIST REPROD GEN, V34, P683, DOI 10.1007/s10815-017-0900-z; Okutman O, 2015, HUM MOL GENET, V24, P5581, DOI 10.1093/hmg/ddv290; Peterlongo P, 2015, HUM MOL GENET, V24, P5345, DOI 10.1093/hmg/ddv251; Punab M, 2017, HUM REPROD, V32, P18, DOI 10.1093/humrep/dew284; Ramasamy R, 2015, FERTIL STERIL, V104, P286, DOI 10.1016/j.fertnstert.2015.04.001; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosado IV, 2009, NUCLEIC ACIDS RES, V37, P4360, DOI 10.1093/nar/gkp365; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sha YW, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0570-4; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Sinnwell JP, 2014, HUM HERED, V78, P91, DOI 10.1159/000363105; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Nguyen-Dumont T, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0524-x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang YC, 2013, CELL RES, V23, P1215, DOI 10.1038/cr.2013.124; Wilfert AB, 2016, NAT GENET, V48, P1455, DOI 10.1038/ng.3697; Xue XY, 2015, GENE DEV, V29, P1777, DOI 10.1101/gad.266593.115; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yang F, 2015, EMBO MOL MED, V7, P1198, DOI 10.15252/emmm.201404967; Yatsenko AN, 2015, NEW ENGL J MED, V372, P2097, DOI 10.1056/NEJMoa1406192	57	68	71	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 2	2018	103	2					200	212		10.1016/j.ajhg.2018.07.005	http://dx.doi.org/10.1016/j.ajhg.2018.07.005			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GP1GR	30075111	Green Published, Bronze			2022-12-18	WOS:000440563700003
J	Seixas, AI; Loureiro, JR; Costa, C; Ordonez-Ugalde, A; Marcelino, H; Oliveira, CL; Loureiro, JL; Dhingra, A; Brandao, E; Cruz, VT; Timoteo, A; Quintans, B; Rouleau, GA; Rizzu, P; Carracedo, A; Bessa, J; Heutink, P; Sequeiros, J; Sobrido, MJ; Coutinho, P; Silveira, I				Seixas, Ana I.; Loureiro, Joana R.; Costa, Cristina; Ordonez-Ugalde, Andres; Marcelino, Hugo; Oliveira, Claudia L.; Loureiro, Jose L.; Dhingra, Ashutosh; Brandao, Eva; Cruz, Vitor T.; Timoteo, Angela; Quintans, Beatriz; Rouleau, Guy A.; Rizzu, Patrizia; Carracedo, Angel; Bessa, Jose; Heutink, Peter; Sequeiros, Jorge; Sobrido, Maria J.; Coutinho, Paula; Silveira, Isabel			A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS CAUSE; HUMAN GENOME; EXPANSION; GENE; TRANSLATION; EXPRESSION; REELIN; MOUSE; MICE; DISORDERS	Advances in human genetics in recent years have largely been driven by next-generation sequencing (NGS); however, the discovery of disease-related gene mutations has been biased toward the exome because the large and very repetitive regions that characterize the non-coding genome remain difficult to reach by that technology. For autosomal-dominant spinocerebellar ataxias (SCAs), 28 genes have been identified, but only five SCAs originate from non-coding mutations. Over half of SCA-affected families, however, remain without a genetic diagnosis. We used genome-wide linkage analysis, NGS, and repeat analysis to identify an (ATTTC)(n) insertion in a polymorphic ATTTT repeat in DAB1 in chromosomal region 1p32.2 as the cause of autosomal-dominant SCA; this region has been previously linked to SCA37. The non-pathogenic and pathogenic alleles have the configurations [(ATTTT)(7-400)] and [(ATTTT)(60-79)(ATTTC)(31-75)(ATTTT)(58-90)], respectively. (ATTTC) n insertions are present on a distinct haplotype and show an inverse correlation between size and age of onset. In the DAB1-oriented strand, (ATTTC) n is located in 50 UTR introns of cerebellar-specific transcripts arising mostly during human fetal brain development from the usage of alternative promoters, but it is maintained in the adult cerebellum. Overexpression of the transfected (ATTTC)(58) insertion, but not (ATTTT) n, leads to abnormal nuclear RNA accumulation. Zebrafish embryos injected with RNA of the (AUUUC)(58) insertion, but not (AUUUU)(n), showed lethal developmental malformations. Together, these results establish an unstable repeat insertion in DAB1 as a cause of cerebellar degeneration; on the basis of the genetic and phenotypic evidence, we propose this mutation as the molecular basis for SCA37.	[Seixas, Ana I.; Loureiro, Jose L.; Sequeiros, Jorge; Coutinho, Paula] Univ Porto, Inst Invest & Inovacao Saude, UnIGENe, P-4200135 Oporto, Portugal; [Seixas, Ana I.; Loureiro, Joana R.; Ordonez-Ugalde, Andres; Marcelino, Hugo; Oliveira, Claudia L.; Loureiro, Jose L.; Bessa, Jose; Sequeiros, Jorge; Coutinho, Paula; Silveira, Isabel] Univ Porto, Inst Mol & Cell Biol, P-4200135 Oporto, Portugal; [Loureiro, Joana R.; Ordonez-Ugalde, Andres; Oliveira, Claudia L.; Silveira, Isabel] Univ Porto, Inst Invest & Inovacao Saude, Genet Cognit Dysfunct Lab, P-4200135 Oporto, Portugal; [Loureiro, Joana R.; Sequeiros, Jorge] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal; [Costa, Cristina; Timoteo, Angela] Hosp Prof Doutor Fernando Fonseca EPE, Dept Neurol, P-2720276 Amadora, Portugal; [Ordonez-Ugalde, Andres; Quintans, Beatriz; Carracedo, Angel; Sobrido, Maria J.] Ctr Invest Biomed Red Enfermedades Raras, Inst Invest Sanitaria, Santiago De Compostela 15706, Spain; [Ordonez-Ugalde, Andres; Quintans, Beatriz; Carracedo, Angel; Sobrido, Maria J.] Ctr Invest Biomed Red Enfermedades Raras, Fdn Publ Galega Med Xen, Santiago De Compostela 15706, Spain; [Marcelino, Hugo; Bessa, Jose] Univ Porto, Inst Invest & Inovacao Saude, Vertebrate Dev & Regenerat Lab, P-4200135 Oporto, Portugal; [Loureiro, Jose L.; Brandao, Eva; Cruz, Vitor T.] Hosp Sao Sebastiao, Dept Neurol, P-4520211 Feira, Portugal; [Rizzu, Patrizia; Heutink, Peter] German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Seixas, Ana I.] Univ Porto, Inst Invest & Inovacao Saude, Glial Cell Biol Lab, P-4200135 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Hospital Professor Doutor Fernando Fonseca, EPE; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); McGill University; McGill University; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Silveira, I (corresponding author), Univ Porto, Inst Mol & Cell Biol, P-4200135 Oporto, Portugal.; Silveira, I (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Genet Cognit Dysfunct Lab, P-4200135 Oporto, Portugal.	isilveir@ibmc.up.pt	Carracedo, Angel/D-4257-2012; costa, cristina/P-5924-2014; Silveira, Isabel/D-6881-2012; Cruz, Vítor Tedim/AAM-3014-2020; Loureiro, Joana R./AAF-6044-2021; Bessa, Jose/I-8084-2013	Carracedo, Angel/0000-0003-1085-8986; costa, cristina/0000-0002-6549-4553; Silveira, Isabel/0000-0002-2610-5260; Cruz, Vítor Tedim/0000-0002-5333-4771; Loureiro, Joana R./0000-0002-3890-852X; Oliveira, Claudia/0000-0002-5453-0504; Seixas, Ana Isabel/0000-0003-3237-777X; Bessa, Jose/0000-0002-8591-7138; Heutink, Peter/0000-0001-5218-1737; Sequeiros, Jorge/0000-0002-9846-1037	Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE Operational Program for Competitiveness and Internationalization (POCI) of Portugal; Portuguese funds through the Fundacao para a Ciencia e a Tecnologia (FCT); Ministerio da Ciencia, Tecnologia, e Inovacao [POCI-01-0145-FEDER-007274]; FCT [PTDC/SAU-GMG/098305/2008, SFRH/BD/30702/2006]; European Molecular Biology Organization [ASTF494-2015]; Porto Neurosciences and Neurologic Disease Research Initiative at the Instituto de Investigacao e Inovacao em Saude [Norte-01-0145-FEDER-000008]; Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL Partnership Agreement through FEDER; Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III [PI12/00742];  [PEst-C/SAU/LA0002/2013]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-GMG/098305/2008, PEst-C/SAU/LA0002/2013] Funding Source: FCT	Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE Operational Program for Competitiveness and Internationalization (POCI) of Portugal; Portuguese funds through the Fundacao para a Ciencia e a Tecnologia (FCT); Ministerio da Ciencia, Tecnologia, e Inovacao; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Porto Neurosciences and Neurologic Disease Research Initiative at the Instituto de Investigacao e Inovacao em Saude; Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL Partnership Agreement through FEDER; Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III(Instituto de Salud Carlos III); ; Fundação para a Ciência e a Tecnologia	We thank the families who participated in this study. We are grateful to Goncalo Abecasis, Miguel Costa, Tito Vieira, and Andre Torres for help with MERLIN analysis; Beatriz Sobrino, Jorge Amigo, and Pilar Cacheiro for next-generation sequencing analysis, performed at the Santiago de Compostela node of the Spanish National Genotyping Center; Nuno Santarem and Anabela Cordeiro-da-Silva for assistance with cloning; Antonio Amorim, Laura Vilarinho, and Paula Jorge for samples from the Portuguese population; and Paula Magalhaes from the Institute for Molecular and Cell Biology Cell Culture and Genotyping Core for DNA extraction. This work was financed by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020 Operational Program for Competitiveness and Internationalization (POCI) of Portugal 2020 and by Portuguese funds through the Fundacao para a Ciencia e a Tecnologia (FCT) and Ministerio da Ciencia, Tecnologia, e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274); and by FCT grant PTDC/SAU-GMG/098305/2008 to I.S. A. I.S. was the recipient of an FCT scholarship (SFRH/BD/30702/2006). J.R.L. was supported by scholarships from PEst-C/SAU/LA0002/2013 and the European Molecular Biology Organization (ASTF494-2015). C.L.O. was supported by a scholarship from PEst-C/SAU/LA0002/2013. This work was also financed by the Porto Neurosciences and Neurologic Disease Research Initiative at the Instituto de Investigacao e Inovacao em Saude (Norte-01-0145-FEDER-000008), supported by Norte Portugal Regional Operational Programme (NORTE 2020) under the PORTUGAL 2020 Partnership Agreement through FEDER, and by the Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III (grant PI12/00742).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alonso I, 2006, NEUROLOGY, V66, P1602, DOI 10.1212/01.wnl.0000216266.30177.bb; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001; Bar I, 2003, J BIOL CHEM, V278, P5802, DOI 10.1074/jbc.M207178200; Bosch C, 2016, CEREB CORTEX, V26, P4282, DOI 10.1093/cercor/bhw216; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Carlson KM, 2009, CURR OPIN GENET DEV, V19, P247, DOI 10.1016/j.gde.2009.02.009; Clark RM, 2004, GENOMICS, V83, P373, DOI 10.1016/j.ygeno.2003.09.001; Cleary JD, 2017, CURR OPIN GENET DEV, V44, P125, DOI 10.1016/j.gde.2017.03.006; Coutelier M, 2015, AM J HUM GENET, V97, P726, DOI 10.1016/j.ajhg.2015.09.007; Coutinho P, 2013, JAMA NEUROL, V70, P746, DOI 10.1001/jamaneurol.2013.1707; Di Gregorio E, 2014, AM J HUM GENET, V95, P209, DOI 10.1016/j.ajhg.2014.07.001; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Garcia-Murias M, 2012, BRAIN, V135, P1423, DOI 10.1093/brain/aws069; Goldowitz D, 1997, J NEUROSCI, V17, P8767; Hatanaka Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16102; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ishiguro T, 2017, NEURON, V94, P108, DOI 10.1016/j.neuron.2017.02.046; Kelkar YD, 2011, GENOME RES, V21, P2038, DOI 10.1101/gr.122937.111; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kurosaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038379; Kurosaki T, 2009, MOL BIOL EVOL, V26, P2573, DOI 10.1093/molbev/msp172; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Loureiro JR, 2016, NEUROBIOL AGING, V39, P174, DOI 10.1016/j.neurobiolaging.2015.12.007; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2006, AM J HUM GENET, V78, P125, DOI 10.1086/498654; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seixas AI, 2005, AM J MED GENET A, V136A, P87, DOI 10.1002/ajmg.a.30761; Sequeiros Jorge, 2012, Handb Clin Neurol, V103, P227, DOI 10.1016/B978-0-444-51892-7.00014-0; Serrano-Munuera C, 2013, JAMA NEUROL, V70, P764, DOI 10.1001/jamaneurol.2013.2311; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Silveira I, 2000, AM J HUM GENET, V66, P830, DOI 10.1086/302827; Silveira I, 2002, ARCH NEUROL-CHICAGO, V59, P623, DOI 10.1001/archneur.59.4.623; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	48	68	70	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					87	103		10.1016/j.ajhg.2017.06.007	http://dx.doi.org/10.1016/j.ajhg.2017.06.007			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28686858	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000404886800007
J	Petrovski, S; Kury, S; Myers, CT; Anyane-Yeboa, K; Cogne, B; Bialer, M; Xia, F; Hemati, P; Riviello, J; Mehaffey, M; Besnard, T; Becraft, E; Wadley, A; Politi, AR; Colombo, S; Zhu, XL; Ren, Z; Andrews, I; Dudding-Byth, T; Schneider, AL; Wallace, G; Rosen, ABI; Schelley, S; Enns, GM; Corre, P; Dalton, J; Mercier, S; Latypova, X; Schmitt, S; Guzman, E; Moore, C; Bier, L; Heinzen, EL; Karachunski, P; Shur, N; Grebe, T; Basinger, A; Nguyen, JM; Bezieau, S; Wierenga, K; Bernstein, JA; Scheffer, IE; Rosenfeld, JA; Mefford, HC; Isidor, B; Goldstein, DB				Petrovski, Slave; Kury, Sebastien; Myers, Candace T.; Anyane-Yeboa, Kwame; Cogne, Benjamin; Bialer, Martin; Xia, Fan; Hemati, Parisa; Riviello, James; Mehaffey, Michele; Besnard, Thomas; Becraft, Emily; Wadley, Alexandrea; Politi, Anya Revah; Colombo, Sophie; Zhu, Xiaolin; Ren, Zhong; Andrews, Ian; Dudding-Byth, Tracy; Schneider, Amy L.; Wallace, Geoffrey; Rosen, Aaron B. I.; Schelley, Susan; Enns, Gregory M.; Corre, Pierre; Dalton, Joline; Mercier, Sandra; Latypova, Xenia; Schmitt, Sebastien; Guzman, Edwin; Moore, Christine; Bier, Louise; Heinzen, Erin L.; Karachunski, Peter; Shur, Natasha; Grebe, Theresa; Basinger, Alice; Nguyen, Joanne M.; Bezieau, Stephane; Wierenga, Klaas; Bernstein, Jonathan A.; Scheffer, Ingrid E.; Rosenfeld, Jill A.; Mefford, Heather C.; Isidor, Bertrand; Goldstein, David B.		Univ Washington	Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							G-PROTEIN; EPILEPTIC ENCEPHALOPATHIES; MESSENGER-RNAS; SPECTRUM; DISEASE; AUTISM; GENE; DISORDERS; FRAMEWORK; VARIANTS	Whole-exome sequencing of 13 individuals with developmental delay commonly accompanied by abnormal muscle tone and seizures identified de novo missense mutations enriched within a sub-region of GNB1, a gene encoding the guanine nucleotide-binding protein subunit beta-1, G beta. These 13 individuals were identified among a base of 5,855 individuals recruited for various undiagnosed genetic disorders. The probability of observing 13 or more de novo mutations by chance among 5,855 individuals is very low (p = 7.1 x 10(-21)), implicating GNB1 as a genome-wide-significant disease-associated gene. The majority of these 13 mutations affect known G beta binding sites, which suggests that a likely disease mechanism is through the disruption of the protein interface required for G alpha-G beta gamma interaction (resulting in a constitutively active G beta gamma) or through the disruption of residues relevant for interaction between G beta gamma and certain downstream effectors (resulting in reduced interaction with the effectors). Strikingly, 8 of the 13 individuals recruited here for a neurodevelopmental disorder have a germline de novo GNB1 mutation that overlaps a set of five recurrent somatic tumor mutations for which recent functional studies demonstrated a gain-of-function effect due to constitutive activation of G protein downstream signaling cascades for some of the affected residues.	[Petrovski, Slave; Hemati, Parisa; Riviello, James; Politi, Anya Revah; Colombo, Sophie; Zhu, Xiaolin; Ren, Zhong; Guzman, Edwin; Bier, Louise; Heinzen, Erin L.; Goldstein, David B.] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Petrovski, Slave] Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic 3050, Australia; [Petrovski, Slave] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; [Kury, Sebastien; Cogne, Benjamin; Besnard, Thomas; Mercier, Sandra; Latypova, Xenia; Schmitt, Sebastien; Bezieau, Stephane; Isidor, Bertrand] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Myers, Candace T.; Mehaffey, Michele; Rosen, Aaron B. I.; Mefford, Heather C.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Anyane-Yeboa, Kwame] Columbia Univ, Med Ctr, Dept Pediat, Div Clin Genet, New York, NY 10032 USA; [Bialer, Martin; Moore, Christine] Northwell Hlth, Div Med Genet, Manhasset, NY 11030 USA; [Xia, Fan; Rosenfeld, Jill A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Becraft, Emily; Schelley, Susan; Enns, Gregory M.; Bernstein, Jonathan A.] Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Wadley, Alexandrea; Wierenga, Klaas] Univ Oklahoma, Dept Pediat, Genet Sect, Norman, OK 73019 USA; [Andrews, Ian] Univ New S Wales, Sch Womens & Childrens Hlth, Kensington, NSW 2052, Australia; [Dudding-Byth, Tracy] Hunter Genet, Genet Learning Disabil Serv, Waratah, NSW 2298, Australia; [Dudding-Byth, Tracy] Univ Newcastle, Prior Res Ctr GrowUpWell, Callaghan, NSW 2308, Australia; [Schneider, Amy L.; Scheffer, Ingrid E.] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic 3081, Australia; [Wallace, Geoffrey] Univ Queensland, Herston Sch Med, Dept Neurosci, Royal Childrens Hosp, Brisbane, Qld 4072, Australia; [Corre, Pierre] CHU Nantes, Serv Stomatol, F-44093 Nantes, France; [Dalton, Joline; Karachunski, Peter] Univ Minnesota, Dept Neurol, Minneapolis, MN 55454 USA; [Shur, Natasha] Albany Med Ctr, Dept Pediat, Div Genet, Albany, NY 12208 USA; [Grebe, Theresa] Univ Arizona, Coll Med, Phoenix Childrens Hosp, Phoenix, AZ 85724 USA; [Grebe, Theresa] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85724 USA; [Basinger, Alice] Cook Childrens Phys Network, Ft Worth, TX 76102 USA; [Nguyen, Joanne M.] Univ Texas Hlth Sci Ctr Houston, Div Med Genet, Dept Pediat, Houston, TX 77030 USA; [Scheffer, Ingrid E.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3050, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3050, Australia	Columbia University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Nantes Universite; CHU de Nantes; University of Washington; University of Washington Seattle; Columbia University; Northwell Health; Baylor College of Medicine; Stanford University; University of Oklahoma System; University of Oklahoma - Norman; University of New South Wales Sydney; University of Newcastle; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Brisbane; University of Queensland; Nantes Universite; CHU de Nantes; University of Minnesota System; University of Minnesota Twin Cities; Albany Medical College; Phoenix Children's Hospital; University of Arizona; University of Arizona; Cook Children's Medical Center; University of Texas System; University of Texas Health Science Center Houston; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Petrovski, S; Goldstein, DB (corresponding author), Columbia Univ, Inst Genom Med, New York, NY 10032 USA.; Petrovski, S (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic 3050, Australia.; Petrovski, S (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	slavep@unimelb.edu.au; dg2875@cumc.columbia.edu	Besnard, Thomas/L-2303-2019; Karachunski, Peter/AAU-8861-2021; CORRE, Pierre/P-1307-2014; Colombo, Sophie/AAD-1030-2019; Mercier, Sandra/E-8922-2018; Wallace, Geoff/H-1252-2013; KÜRY, Sébastien/G-5971-2015; BESNARD, Thomas/D-1329-2018; Goldstein, David/AAY-8125-2020; Zhu, Xiaolin/GLV-1533-2022; Isidor, Bertrand/AAJ-3456-2021; Scheffer, Ingrid E/G-1668-2013	Besnard, Thomas/0000-0003-4804-5147; CORRE, Pierre/0000-0003-4587-2163; Colombo, Sophie/0000-0001-8945-5631; Wallace, Geoff/0000-0001-9306-3542; KÜRY, Sébastien/0000-0001-5497-0465; BESNARD, Thomas/0000-0003-4804-5147; Zhu, Xiaolin/0000-0002-3221-595X; Isidor, Bertrand/0000-0001-6480-126X; Scheffer, Ingrid E/0000-0002-2311-2174; Rosen, Aaron BI/0000-0003-4416-1837; Anyane-Yeboa, Kwame/0000-0002-4977-9719; Blue, Elizabeth/0000-0002-0633-0305	NHGRI NIH HHS [UM1 HG006493] Funding Source: Medline; NICHD NIH HHS [U54 HD083091] Funding Source: Medline; NINDS NIH HHS [R01 NS069605] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Champion KJ, 2011, CLIN GENET, V79, P468, DOI 10.1111/j.1399-0004.2010.01495.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Ware J.S., 2015, CURR PROTOC HUM GENE, V87, P1; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yoda A, 2015, NAT MED, V21, P71, DOI 10.1038/nm.3751; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	32	68	74	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					1001	1010		10.1016/j.ajhg.2016.03.011	http://dx.doi.org/10.1016/j.ajhg.2016.03.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27108799	Green Published, Bronze			2022-12-18	WOS:000375869300017
J	Wojtal, D; Kemaladewi, DU; Malam, Z; Abdullah, S; Wong, TWY; Hyatt, E; Baghestani, Z; Pereira, S; Stavropoulos, J; Mouly, V; Mamchaoui, K; Muntoni, F; Voit, T; Gonorazky, HD; Dowling, JJ; Wilson, MD; Mendoza-Londono, R; Ivakine, EA; Cohn, RD				Wojtal, Dania; Kemaladewi, Dwi U.; Malam, Zeenat; Abdullah, Sarah; Wong, Tatianna W. Y.; Hyatt, Elzbieta; Baghestani, Zahra; Pereira, Sergio; Stavropoulos, James; Mouly, Vincent; Mamchaoui, Kamel; Muntoni, Francesco; Voit, Thomas; Gonorazky, Hernan D.; Dowling, James J.; Wilson, Michael D.; Mendoza-Londono, Roberto; Ivakine, Evgueni A.; Cohn, Ronald D.			Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ENDOGENOUS GENES; RNA; TRANSCRIPTION; EXPRESSION; DNA; REPEATS; TARGET; CRISPR-CAS9; SPECIFICITY	Clustered regularly interspaced short palindromic repeat (CRISPR) has arisen as a frontrunner for efficient genome engineering. However, the potentially broad therapeutic implications are largely unexplored. Here, to investigate the therapeutic potential of CRISPR/Cas9 in a diverse set of genetic disorders, we establish a pipeline that uses readily obtainable cells from affected individuals. We show that an adapted version of CRISPR/Cas9 increases the amount of utrophin, a known disease modifier in Duchenne muscular dystrophy (DMD). Furthermore, we demonstrate preferential elimination of the dominant-negative FGFR3 c.1138G>A allele in fibroblasts of an individual affected by achondroplasia. Using a previously undescribed approach involving single guide RNA, we successfully removed large genome rearrangement in primary cells of an individual with an X chromosome duplication including MECP2. Moreover, removal of a duplication of DMD exons 18-30 in myotubes of an individual affected by DMD produced full-length dystrophin. Our findings establish the far-reaching therapeutic utility of CRISPR/Ca59, which can be tailored to target numerous inherited disorders.	[Wojtal, Dania; Kemaladewi, Dwi U.; Malam, Zeenat; Abdullah, Sarah; Wong, Tatianna W. Y.; Hyatt, Elzbieta; Baghestani, Zahra; Pereira, Sergio; Gonorazky, Hernan D.; Dowling, James J.; Wilson, Michael D.; Ivakine, Evgueni A.; Cohn, Ronald D.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Wojtal, Dania; Dowling, James J.; Wilson, Michael D.; Cohn, Ronald D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pereira, Sergio] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 0A4, Canada; [Stavropoulos, James; Gonorazky, Hernan D.; Dowling, James J.; Mendoza-Londono, Roberto; Cohn, Ronald D.] Univ Toronto, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Mouly, Vincent; Mamchaoui, Kamel] Sorbonne Univ, Univ Paris 06, Ctr Res Myol, CNRS FRE3617,INSERM UMRS974, F-75013 Paris, France; [Muntoni, Francesco] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 1EH, England; [Voit, Thomas] UCL, Inst Child Hlth, NIHR Biomed Res Ctr, London WC1N 1EH, England; [Dowling, James J.; Mendoza-Londono, Roberto; Cohn, Ronald D.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Cohn, Ronald D.] Hosp Sick Children, Ctr Genet Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cohn, RD (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada.	ronald.cohn@sickkids.ca	Wilson, Michael D/K-6294-2014; Cohn, Ronald/AAC-5835-2021; Pereira, Sergio L/B-1984-2010	Wilson, Michael D/0000-0002-4015-3066; Pereira, Sergio L/0000-0002-2796-5625; Mamchaoui, kamel/0000-0002-0323-9290; Kemaladewi, Dwi/0000-0002-0747-4589; Mouly, Vincent/0000-0003-3809-4033; Wojtal, Daria/0000-0002-3401-4641; Ivakine, Evgueni/0000-0003-2132-4699	SickKids Restracomp and Eric Hani Fellowship; AFM-Telethon; Cure CMD; Natural Sciences and Engineering Research Council Canada Research Chair [436194-2013]; Duchenne Children's Trust; Women's Auxiliary of the The Hospital for Sick Children (Chair in Clinical and Metabolic Genetics); SickKids Foundation; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10022] Funding Source: researchfish; Muscular Dystrophy UK [RA2/3076] Funding Source: researchfish	SickKids Restracomp and Eric Hani Fellowship; AFM-Telethon(Association Francaise contre les Myopathies); Cure CMD; Natural Sciences and Engineering Research Council Canada Research Chair; Duchenne Children's Trust; Women's Auxiliary of the The Hospital for Sick Children (Chair in Clinical and Metabolic Genetics); SickKids Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Muscular Dystrophy UK	We would like to thank Drs. Jennifer Doudna, Steve Lin, Aravinda Chakravarti, Hal Dietz, and Janet Rossant for critical insights into our studies, as well as Minggao Liang and Wilson Sung for their bioinformatics input. We also thank Drs. Feng Zhang and Rudolf Jaenisch and their laboratories for the CRISPR/Cas9 backbone constructs used in this study. We thank the R.D.C. lab members and The Centre for Applied Genomics staff for excellent technical assistance, as well as the platform for immortalization of human cells of the Institute of Myology in Paris. This work is supported by SickKids Restracomp and Eric Hani Fellowship (to D.W.), AFM-Telethon (to D.U.K), Cure CMD (to D.U.K. and R.D.C.), a tier II Natural Sciences and Engineering Research Council Canada Research Chair (436194-2013 to M.D.W), the Duchenne Children's Trust (to R.D.C.), the Women's Auxiliary of the The Hospital for Sick Children (Chair in Clinical and Metabolic Genetics to R.D.C.), and the SickKids Foundation (to R.D.C.).	Aoki Y, 2012, P NATL ACAD SCI USA, V109, P13763, DOI 10.1073/pnas.1204638109; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Bushby K, 2004, Neuromuscul Disord, V14, P526, DOI 10.1016/j.nmd.2004.05.006; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; de Vrueh R., 2013, UPDATE 2004 BACKGROU; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Jarmin S, 2014, EXPERT OPIN BIOL TH, V14, P209, DOI 10.1517/14712598.2014.866087; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kimura E, 2010, MOL THER, V18, P206, DOI 10.1038/mt.2009.253; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; Memedula S, 2003, CURR BIOL, V13, P241, DOI 10.1016/S0960-9822(03)00048-4; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; NICHOLSON LVB, 1993, J MED GENET, V30, P728, DOI 10.1136/jmg.30.9.728; NICHOLSON LVB, 1993, NEUROPEDIATRICS, V24, P93, DOI 10.1055/s-2008-1071521; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; van Putten M, 2014, J MOL CELL CARDIOL, V69, P17, DOI 10.1016/j.yjmcc.2014.01.009; van Putten M, 2013, FASEB J, V27, P2484, DOI 10.1096/fj.12-224170; van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937; Van Ry PM, 2014, HUM MOL GENET, V23, P383, DOI 10.1093/hmg/ddt428; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Zhang YD, 2012, HUM GENE THER, V23, P98, DOI 10.1089/hum.2011.131	68	68	73	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					90	101		10.1016/j.ajhg.2015.11.012	http://dx.doi.org/10.1016/j.ajhg.2015.11.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26686765	Green Published, Bronze			2022-12-18	WOS:000368050800007
J	Dazzo, E; Fanciulli, M; Serioli, E; Minervini, G; Pulitano, P; Binelli, S; Di Bonaventura, C; Luisi, C; Pasini, E; Striano, S; Striano, P; Coppola, G; Chiavegato, A; Radovic, S; Spadotto, A; Uzzau, S; La Neve, A; Giallonardo, AT; Mecarelli, O; Tosatto, SCE; Ottman, R; Michelucci, R; Nobile, C				Dazzo, Emanuela; Fanciulli, Manuela; Serioli, Elena; Minervini, Giovanni; Pulitano, Patrizia; Binelli, Simona; Di Bonaventura, Carlo; Luisi, Concetta; Pasini, Elena; Striano, Salvatore; Striano, Pasquale; Coppola, Giangennaro; Chiavegato, Angela; Radovic, Slobodanka; Spadotto, Alessandro; Uzzau, Sergio; La Neve, Angela; Giallonardo, Anna Teresa; Mecarelli, Oriano; Tosatto, Silvio C. E.; Ottman, Ruth; Michelucci, Roberto; Nobile, Carlo			Heterozygous Reelin Mutations Cause Autosomal-Dominant Lateral Temporal Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LGI1 MUTATIONS; SYNAPTIC-TRANSMISSION; AUDITORY FEATURES; BRAIN-DEVELOPMENT; SEQUENCING DATA; LOBE EPILEPSY; GENE; RECEPTOR; PHOSPHORYLATION; PLASTICITY	Autosomal-dominant lateral temporal epilepsy (ADLTE) is a genetic epilepsy syndrome clinically characterized by focal seizures with prominent auditory symptoms. ADLTE is genetically heterogeneous, and mutations in LGI1 account for fewer than 50% of affected families. Here, we report the identification of causal mutations in reelin (RELN) in seven ADLTE-affected families without LGI1 mutations. We initially investigated 13 ADLTE-affected families by performing SNP-array linkage analysis and whole-exome sequencing and identified three heterozygous missense mutations co-segregating with the syndrome. Subsequent analysis of 15 small ADLTE-affected families revealed four additional missense mutations. 3D modeling predicted that all mutations have structural effects on protein-domain folding. Overall, RELN mutations occurred in 7/40 (17.5%) ADLTE-affected families. RELN encodes a secreted protein, Reelin, which has important functions in both the developing and adult brain and is also found in the blood serum. We show that ADLTE-related mutations significantly decrease serum levels of Reelin, suggesting an inhibitory effect of mutations on protein secretion. We also show that Reelin and LGI1 co-localize in a subset of rat brain neurons, supporting an involvement of both proteins in a common molecular pathway underlying ADLTE. Homozygous RELN mutations are known to cause lissencephaly with cerebellar hypoplasia. Our findings extend the spectrum of neurological disorders associated with RELN mutations and establish a link between RELN and LGI1, which play key regulatory roles in both the developing and adult brain.	[Dazzo, Emanuela; Serioli, Elena; Chiavegato, Angela; Tosatto, Silvio C. E.] CNR, Inst Neurosci, Sect Padua, I-35121 Padua, Italy; [Fanciulli, Manuela; Uzzau, Sergio] Porto Conte Ric, I-07041 Sassari, Italy; [Minervini, Giovanni; Tosatto, Silvio C. E.; Nobile, Carlo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Pulitano, Patrizia; Di Bonaventura, Carlo; Giallonardo, Anna Teresa; Mecarelli, Oriano] Univ Roma La Sapienza, Dept Neurol & Psychiat, I-00185 Rome, Italy; [Binelli, Simona] Carlo Besta Fdn Neurol Inst, I-20133 Milan, Italy; [Luisi, Concetta; La Neve, Angela] Univ Bari, Neurol Clin, I-70124 Bari, Italy; [Pasini, Elena; Michelucci, Roberto] Bellaria Hosp, IRCCS Inst Neurol Sci, I-40139 Bologna, Italy; [Striano, Salvatore] Univ Naples Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Sch Med, I-80131 Naples, Italy; [Striano, Pasquale] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16148 Genoa, Italy; [Striano, Pasquale] Giannina Gaslini Inst, I-16148 Genoa, Italy; [Coppola, Giangennaro] Univ Salerno, Fac Med & Surg, Child & Adolescent Psychiat, I-84100 Salerno, Italy; [Radovic, Slobodanka; Spadotto, Alessandro] IGA Technol Serv, I-33100 Udine, Italy; [Ottman, Ruth] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; [Ottman, Ruth] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Ottman, Ruth] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Ottman, Ruth] New York State Psychiat Inst & Hosp, Div Epidemiol, New York, NY 10032 USA	Consiglio Nazionale delle Ricerche (CNR); Porto Conte Ricerche; University of Padua; Sapienza University Rome; IRCCS Istituto Neurologico Besta; Universita degli Studi di Bari Aldo Moro; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Naples Federico II; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Salerno; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Nobile, C (corresponding author), CNR, Inst Neurosci, Sect Padua, I-35121 Padua, Italy.	nobile@bio.unipd.it	Michelucci, Roberto/AAB-9074-2020; Di+Bonaventura, Carlo/AAM-7075-2020; Coppola, Giangennaro/AAC-1111-2019; Tosatto, Silvio/B-2840-2009; Striano, Pasquale/F-9117-2014; Minervini, Giovanni/D-1200-2013; Uzzau, Sergio/F-3233-2015; Luisi, Concetta/GZK-6851-2022; Ottman, Ruth/O-2371-2013; Binelli, Simona/AAO-6149-2021; Pasini, Elena/AAB-9576-2022	Coppola, Giangennaro/0000-0002-9574-0081; Tosatto, Silvio/0000-0003-4525-7793; Striano, Pasquale/0000-0002-6065-1476; Minervini, Giovanni/0000-0001-7013-5785; Uzzau, Sergio/0000-0001-6246-2794; Ottman, Ruth/0000-0001-7074-242X; Binelli, Simona/0000-0002-5885-2295; LUISI, CONCETTA/0000-0003-2310-9992; Nobile, Carlo/0000-0002-0634-2218	Telethon-Italy [GGP12078]; Fondazione Cassa di Risparmio di Padova e Rovigo; Genetics Commission of the Italian League against Epilepsy; NIH [R01 NS036319, R01 NS078419]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036319, R01NS078419] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); Genetics Commission of the Italian League against Epilepsy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Chiara Romualdi for statistical analysis of immunoblot data. This work was supported by Telethon-Italy (grant GGP12078 to C.N.), Fondazione Cassa di Risparmio di Padova e Rovigo (grant to C.N.), the Genetics Commission of the Italian League against Epilepsy (funding to R.M and C. N.), and the NIH (grants R01 NS036319 and R01 NS078419 to R.O.). G. M. is an Associazione Italiana per la Ricerca sul Cancro research fellow.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ashkenazy H., 2010, NUCL ACIDS RES, V38; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Berkovic SF, 1996, ANN NEUROL, V40, P227, DOI 10.1002/ana.410400214; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Boillot M, 2014, BRAIN, V137, P2984, DOI 10.1093/brain/awu259; Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; D'Arcangelo G., 2014, ADV NEUROSCI, V2014, P19, DOI [10.1155/2014/597395, DOI 10.1155/2014/597395]; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Nijs L, 2012, HUM MOL GENET, V21, P5106, DOI 10.1093/hmg/dds356; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; GOFFINET AM, 1992, INT J DEV BIOL, V36, P101; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Ichihara H, 2001, MOL BRAIN RES, V97, P190, DOI 10.1016/S0169-328X(01)00307-2; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michelucci R, 2003, EPILEPSIA, V44, P1289, DOI 10.1046/j.1528-1157.2003.20003.x; Michelucci R, 2013, EPILEPSIA, V54, P1288, DOI 10.1111/epi.12194; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; Nogi T, 2006, EMBO J, V25, P3675, DOI 10.1038/sj.emboj.7601240; Ottman R, 2004, NEUROLOGY, V62, P1120, DOI 10.1212/01.WNL.0000120098.39231.6E; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Persico AM, 2006, J NEURAL TRANSM, V113, P1373, DOI 10.1007/s00702-006-0441-6; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos-Moreno T, 2006, EUR J NEUROSCI, V23, P401, DOI 10.1111/j.1460-9568.2005.04567.x; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Stranahan AM, 2013, AGEING RES REV, V12, P815, DOI 10.1016/j.arr.2013.01.005; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Ventruti A, 2011, NEUROSCIENCE, V189, P32, DOI 10.1016/j.neuroscience.2011.05.050; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zaki M, 2007, AM J MED GENET A, V143A, P939, DOI 10.1002/ajmg.a.31667; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	49	68	73	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					992	1000		10.1016/j.ajhg.2015.04.020	http://dx.doi.org/10.1016/j.ajhg.2015.04.020			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26046367	Green Published, Bronze			2022-12-18	WOS:000355931200014
J	Favaro, FP; Alvizi, L; Zechi-Ceide, RM; Bertola, D; Felix, TM; de Souza, J; Raskin, S; Twigg, SRF; Weiner, AMJ; Armas, P; Margarit, E; Calcaterra, NB; Andersen, GR; McGowan, SJ; Wilkie, AOM; Richieri-Costa, A; de Almeida, MLG; Passos-Bueno, MR				Favaro, Francine P.; Alvizi, Lucas; Zechi-Ceide, Roseli M.; Bertola, Debora; Felix, Temis M.; de Souza, Josiane; Raskin, Salmo; Twigg, Stephen R. F.; Weiner, Andrea M. J.; Armas, Pablo; Margarit, Ezequiel; Calcaterra, Nora B.; Andersen, Gregers R.; McGowan, Simon J.; Wilkie, Andrew O. M.; Richieri-Costa, Antonio; de Almeida, Maria L. G.; Passos-Bueno, Maria Rita			A Noncoding Expansion in EIF4A3 Causes Richieri-Costa-Pereira Syndrome, a Craniofacial Disorder Associated with Limb Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; HEXANUCLEOTIDE REPEAT; FRIEDREICHS-ATAXIA; CRYSTAL-STRUCTURE; COMPLEX; RECRUITMENT; EXPRESSION; MUTATIONS; COMPONENT; VARIANTS	Richieri-Costa-Pereira syndrome is an autosomal-recessive acrofacial dysostosis characterized by mandibular median cleft associated with other craniofacial anomalies and severe limb defects. Learning and language disabilities are also prevalent. We mapped the mutated gene to a 122 kb region at 17q25.3 through identity-by-descent analysis in 17 genealogies. Sequencing strategies identified an expansion of a region with several repeats of 18- or 20-nucleotide motifs in the 5' untranslated region (5' UTR) of EIF4A3, which contained from 14 to 16 repeats in the affected individuals and from 3 to 12 repeats in 520 healthy individuals. A missense substitution of a highly conserved residue likely to affect the interaction of eIF4AIII with the UPF3B subunit of the exon junction complex in trans with an expanded allele was found in an unrelated individual with an atypical presentation, thus expanding mutational mechanisms and phenotypic diversity of RCPS. EIF4A3 transcript abundance was reduced in both white blood cells and mesenchymal cells of RCPS-affected individuals as compared to controls. Notably, targeting the orthologous eif4a3 in zebrafish led to underdevelopment of several craniofacial cartilage and bone structures, in agreement with the craniofacial alterations seen in RCPS. Our data thus suggest that RCPS is caused by mutations in EIF4A3 and show that EIF4A3, a gene involved in RNA metabolism, plays a role in mandible, laryngeal, and limb morphogenesis.	[Favaro, Francine P.; Zechi-Ceide, Roseli M.; Richieri-Costa, Antonio; de Almeida, Maria L. G.] Univ Sao Paulo, HRAC, Dept Clin Genet, BR-17012090 Sao Paulo, Brazil; [Alvizi, Lucas; Bertola, Debora; Passos-Bueno, Maria Rita] Univ Sao Paulo, Inst Biociencias, Ctr Estudos Genoma Humano, BR-05508090 Sao Paulo, Brazil; [Felix, Temis M.] Univ Fed Rio Grande do Sul, Dept Genet, Hosp Clin Porto Alegre, BR-90035903 Porto Alegre, RS, Brazil; [de Souza, Josiane] Ctr Atendimento Integral Fissurado Labio Palatal, BR-80150000 Curitiba, Parana, Brazil; [Raskin, Salmo] Pontificia Univ Catolica Parana, Ctr Ciencias Biol & Saude, Nucleo Invest Mol Avancada, BR-80150000 Curitiba, Parana, Brazil; [Twigg, Stephen R. F.; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England; [Weiner, Andrea M. J.; Armas, Pablo; Margarit, Ezequiel; Calcaterra, Nora B.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina; [Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [McGowan, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica do Parana; University of Oxford; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Aarhus University; University of Oxford	Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Inst Biociencias, Ctr Estudos Genoma Humano, BR-05508090 Sao Paulo, Brazil.	passos@ib.usp.br	Wilkie, Andrew/AAC-3820-2020; Calcaterra, Nora/AAP-7469-2021; Bertola, Débora/I-5120-2016; Félix, Têmis/B-8073-2010; Twigg, Stephen/AAU-1135-2021; Raskin, Salmo/C-4155-2013; Richieri-Costa, Antonio/B-2514-2013; Passos-Bueno, Maria Rita/I-6796-2016; Alvizi, Lucas/F-9043-2012	Wilkie, Andrew/0000-0002-2972-5481; Bertola, Débora/0000-0002-4701-6777; Félix, Têmis/0000-0002-8401-6821; Twigg, Stephen/0000-0001-5024-049X; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Margarit, Ezequiel/0000-0003-0031-2779; McGowan, Simon/0000-0001-9720-1914; Armas, Pablo/0000-0002-0454-1424; , Nora/0000-0003-4259-9800; Andersen, Gregers Rom/0000-0001-6292-3319	CEPID/FAPESP; CNPq; INCT/CNPq-FAPESP; Wellcome Trust [093329]; MRC [G0902418] Funding Source: UKRI; Medical Research Council [G0902418] Funding Source: researchfish	CEPID/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT/CNPq-FAPESP; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are thankful to Alessandra Splendore and Gerson S. Kobayashi for critical discussion on the manuscript, to Regina Bueno for art support, and to the Human Genome Research Center sequencing service for technical support. This work was funded by CEPID/FAPESP, CNPq and INCT/CNPq-FAPESP, and by the Wellcome Trust (093329 to A.O.M.W. and S.R.F.T.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alexandrov A, 2011, GENE DEV, V25, P1078, DOI 10.1101/gad.2045411; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Barker-Haliski ML, 2012, NEUROSCIENCE, V226, P51, DOI 10.1016/j.neuroscience.2012.09.003; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Buchwald G, 2010, P NATL ACAD SCI USA, V107, P10050, DOI 10.1073/pnas.1000993107; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; de Lima RLLF, 2003, AM J MED GENET A, V122A, P56, DOI 10.1002/ajmg.a.20270; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; Favaro FP, 2011, AM J MED GENET A, V155A, P322, DOI 10.1002/ajmg.a.33806; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Galloway JN, 2009, FUTUR NEUROL, V4, P785, DOI 10.2217/FNL.09.44; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Haremaki T, 2010, DEV DYNAM, V239, P1977, DOI 10.1002/dvdy.22330; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kobayashi GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065677; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; Martelli A, 2012, DIS MODEL MECH, V5, P165, DOI 10.1242/dmm.008706; Masotti C, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-136; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen LS, 2013, HUM MOL GENET, V22, P1816, DOI 10.1093/hmg/ddt035; Raskin S, 2013, AM J MED GENET A, V161, P1999, DOI 10.1002/ajmg.a.35989; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Scott JE, 2012, EVOLUTION, V66, P2940, DOI 10.1111/j.1558-5646.2012.01639.x; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Solomon KS, 2003, DEVELOPMENT, V130, P929, DOI 10.1242/dev.00308; Souza J, 2011, AM J MED GENET A, V155A, P1173, DOI 10.1002/ajmg.a.33975; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; Twigg SRF, 2012, AM J HUM GENET, V91, P897, DOI 10.1016/j.ajhg.2012.08.027; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	44	68	71	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					120	128		10.1016/j.ajhg.2013.11.020	http://dx.doi.org/10.1016/j.ajhg.2013.11.020			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360810	Green Published, Bronze			2022-12-18	WOS:000329888400013
J	Hemani, G; Yang, J; Vinkhuyzen, A; Powell, JE; Willemsen, G; Hottenga, JJ; Abdellaoui, A; Mangino, M; Valdes, AM; Medland, SE; Madden, PA; Heath, AC; Henders, AK; Nyholt, DR; de Geus, EJC; Magnusson, PKE; Ingelsson, E; Montgomery, GW; Spector, TD; Boomsma, DI; Pedersen, NL; Martin, NG; Visscher, PM				Hemani, Gibran; Yang, Jian; Vinkhuyzen, Anna; Powell, Joseph E.; Willemsen, Gonneke; Hottenga, Jouke-Jan; Abdellaoui, Abdel; Mangino, Massimo; Valdes, Ana M.; Medland, Sarah E.; Madden, Pamela A.; Heath, Andrew C.; Henders, Anjali K.; Nyholt, Dale R.; de Geus, Eco J. C.; Magnusson, Patrik K. E.; Ingelsson, Erik; Montgomery, Grant W.; Spector, Timothy D.; Boomsma, Dorret I.; Pedersen, Nancy L.; Martin, Nicholas G.; Visscher, Peter M.			Inference of the Genetic Architecture Underlying BMI and Height with the Use of 20,240 Sibling Pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MAJOR DEPRESSIVE DISORDER; SWEDISH TWIN REGISTRY; DE-NOVO MUTATIONS; BODY-MASS INDEX; COMPLEX TRAITS; MISSING HERITABILITY; COMMON SNPS; LINKAGE; OBESITY	Evidence that complex traits are highly polygenic has been presented by population-based genome-wide association studies (GWASs) through the identification of many significant variants, as well as by family-based de novo sequencing studies indicating that several traits have a large mutational target size. Here, using a third study design, we show results consistent with extreme polygenicity for body mass index (BMI) and height. On a sample of 20,240 siblings (from 9,570 nuclear families), we used a within-family method to obtain narrow-sense heritability estimates of 0.42 (SE = 0.17, p = 0.01) and 0.69 (SE = 0.14, p = 6 x 10(-7)) for BMI and height, respectively, after adjusting for covariates. The genomic inflation factors from locus-specific-linkage analysis were 1.69 (SE = 0.21, p = 0.04) for BMI and 2.18 (SE = 0.21, p = 2 x 10(-10)) for height. This inflation is free of confounding and congruent with polygenicity, consistent with observations of ever-increasing genomic-inflation factors from GWASs with large sample sizes, implying that those signals are due to true genetic signals across the genome rather than population stratification. We also demonstrate that the distribution of the observed test statistics is consistent with both rare and common variants underlying a polygenic architecture and that previous reports of linkage signals in complex traits are probably a consequence of polygenic architecture rather than the segregation of variants with large effects. The convergent empirical evidence from GWASs, de novo studies, and within-family segregation implies that family-based sequencing studies for complex traits require very large sample sizes because the effects of causal variants are small on average.	[Hemani, Gibran; Yang, Jian; Powell, Joseph E.; Visscher, Peter M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia; [Hemani, Gibran; Yang, Jian; Vinkhuyzen, Anna; Powell, Joseph E.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4027, Australia; [Willemsen, Gonneke; Abdellaoui, Abdel; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Willemsen, Gonneke; Hottenga, Jouke-Jan; de Geus, Eco J. C.; Boomsma, Dorret I.] EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands; [Hottenga, Jouke-Jan; Abdellaoui, Abdel; de Geus, Eco J. C.; Boomsma, Dorret I.] Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Mangino, Massimo; Valdes, Ana M.; Spector, Timothy D.] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Medland, Sarah E.; Henders, Anjali K.; Nyholt, Dale R.; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Madden, Pamela A.; Heath, Andrew C.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Magnusson, Patrik K. E.; Ingelsson, Erik; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, S-751 Uppsala, Sweden	University of Queensland; University of Queensland; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; QIMR Berghofer Medical Research Institute; Washington University (WUSTL); Karolinska Institutet; Uppsala University	Visscher, PM (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia.	peter.visscher@uq.edu.au	Martin, Nicholas/R-9235-2019; Medland, Sarah/AAT-7595-2020; Nyholt, Dale Robert/J-3174-2017; Mangino, Massimo/F-5134-2011; Magnusson, Patrik KE/C-4458-2017; Montgomery, Grant W/B-7148-2008; de Geus, Eco J.C./M-9318-2015; Medland, Sarah E/C-7630-2013; Yang, Jian/A-5852-2010; Powell, Joseph/G-3027-2014; Boomsma, Dorret I/AAX-4470-2020; Visscher, Peter/ABB-6151-2020; Henders, Anjali/E-3126-2017; Vinkhuyzen, Anna/N-8691-2013	Martin, Nicholas/0000-0003-4069-8020; Medland, Sarah/0000-0003-1382-380X; Nyholt, Dale Robert/0000-0001-7159-3040; Mangino, Massimo/0000-0002-2167-7470; Magnusson, Patrik KE/0000-0002-7315-7899; Montgomery, Grant W/0000-0002-4140-8139; de Geus, Eco J.C./0000-0001-6022-2666; Medland, Sarah E/0000-0003-1382-380X; Yang, Jian/0000-0003-2001-2474; Powell, Joseph/0000-0001-9031-6356; Visscher, Peter/0000-0002-2143-8760; Henders, Anjali/0000-0003-3672-1451; Powell, Joseph/0000-0002-5070-4124; Hemani, Gibran/0000-0003-0920-1055; Valdes, Ana M./0000-0003-1141-4471; Willemsen, Gonneke/0000-0003-3755-0236; Vinkhuyzen, Anna/0000-0003-3352-0603	NHLBI NIH HHS [N02‐HL‐64278, N01‐HC‐25195] Funding Source: Medline; NIAAA NIH HHS [AA13320, AA07535, AA13326, AA13321, AA014041, AA10248] Funding Source: Medline; NIDA NIH HHS [DA12854] Funding Source: Medline; NIDDK NIH HHS [DK U01‐066134] Funding Source: Medline; NIGMS NIH HHS [R01 GM075091, GM075091, GM099568] Funding Source: Medline; NIMH NIH HHS [1RC2MH089951‐01, 1RC2 MH089995‐01, U24 MH068457‐06] Funding Source: Medline; PHS HHS [R01D0042157‐01A] Funding Source: Medline; Wellcome Trust Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075091, P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013326, R01AA014041, R01AA013320, R01AA013321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Benyamin B, 2008, EUR J HUM GENET, V16, P516, DOI 10.1038/sj.ejhg.5201992; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/twin.9.6.849; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; CHURCHILL GA, 1994, GENETICS, V138, P963; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Evans DM, 2002, BIOL PSYCHOL, V61, P33, DOI 10.1016/S0301-0511(02)00051-0; Faeh D, 2012, ARCH INTERN MED, V172, P1766, DOI 10.1001/2013.jamainternmed.327; Johnson L, 2005, INT J OBESITY, V29, P413, DOI 10.1038/sj.ijo.0802817; Katz DA, 2000, J GEN INTERN MED, V15, P789, DOI 10.1046/j.1525-1497.2000.90906.x; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kunej T., 2012, J GENOMICS, V1, P44; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Lewis JP, 2010, GENOMICS, V96, P211, DOI 10.1016/j.ygeno.2010.07.006; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lubke GH, 2012, BIOL PSYCHIAT, V72, P707, DOI 10.1016/j.biopsych.2012.03.011; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Puhl RM, 2013, PEDIATRICS, V131, pE1, DOI 10.1542/peds.2012-1106; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schvey NA, 2013, INT J OBESITY, V37, P1275, DOI 10.1038/ijo.2012.211; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tenesa A, 2013, NAT REV GENET, V14, P139, DOI 10.1038/nrg3377; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 1996, THEOR APPL GENET, V93, P691, DOI 10.1007/BF00224064; Visscher PM, 2001, ANN HUM GENET, V65, P583, DOI [10.1046/j.1469-1809.2001.6560583.x, 10.1017/S0003480001008909]; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	52	68	69	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					865	875		10.1016/j.ajhg.2013.10.005	http://dx.doi.org/10.1016/j.ajhg.2013.10.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24183453	Green Published, Bronze			2022-12-18	WOS:000326996600007
J	Aldahmesh, MA; Khan, AO; Alkuraya, H; Adly, N; Anazi, S; Al-Saleh, AA; Mohamed, JY; Hijazi, H; Prabakaran, S; Tacke, M; Al-Khrashi, A; Hashem, M; Reinheckel, T; Assiri, A; Alkuraya, FS				Aldahmesh, Mohammed A.; Khan, Arif O.; Alkuraya, Hisham; Adly, Nouran; Anazi, Shamsa; Al-Saleh, Ahmed A.; Mohamed, Jawahir Y.; Hijazi, Hadia; Prabakaran, Sarita; Tacke, Marlene; Al-Khrashi, Abdullah; Hashem, Mais; Reinheckel, Thomas; Assiri, Abdullah; Alkuraya, Fowzan S.			Mutations in LRPAP1 Are Associated with Severe Myopia in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATHEPSIN-H; REFRACTIVE ERROR; MODEL; EXPRESSION; GENETICS; PROTEIN; FAMILY; GROWTH; PRSS56; GENES	Myopia is an extremely common eye disorder but the pathogenesis of its isolated form, which accounts for the overwhelming majority of cases, remains poorly understood. There is strong evidence for genetic predisposition to myopia, but determining myopia genetic risk factors has been difficult to achieve. We have identified Mendelian forms of myopia in four consanguineous families and implemented exome/autozygome analysis to identify homozygous truncating variants in LRPAP1 and CTSH as the likely causal mutations. LRPAP1 encodes a chaperone of LRP1, which is known to influence TGF-beta activity. Interestingly, we observed marked deficiency of LRP1 and upregulation of TGF-beta in cells from affected individuals, the latter being consistent with available data on the role of TGF-beta in the remodeling of the sclera in myopia and the high frequency of myopia in individuals with Marfan syndrome who characteristically have upregulation of TGF-beta signaling. CTSH, on the other hand, encodes a protease and we show that deficiency of the murine ortholog results in markedly abnormal globes consistent with the observed human phenotype. Our data highlight a role for LRPAP1 and CTSH in myopia genetics and demonstrate the power of Mendelian forms in illuminating new molecular mechanisms that may be relevant to common phenotypes.	[Aldahmesh, Mohammed A.; Khan, Arif O.; Alkuraya, Hisham; Adly, Nouran; Anazi, Shamsa; Mohamed, Jawahir Y.; Hijazi, Hadia; Hashem, Mais; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Khan, Arif O.] King Khalid Eye Specialist Hosp, Dept Pediat Ophthalmol, Riyadh 11462, Saudi Arabia; [Alkuraya, Hisham] Imam Muhammed Bin Saud Islam Univ, Coll Med, Dept Ophthalmol, Riyadh 13318, Saudi Arabia; [Al-Saleh, Ahmed A.] AlHokama Eye Specialist Ctr, Riyadh 12345, Saudi Arabia; [Prabakaran, Sarita] King Faisal Specialist Hosp & Res Ctr, Canc Genet Ctr, Riyadh 11211, Saudi Arabia; [Tacke, Marlene; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79085 Freiburg, Germany; [Tacke, Marlene; Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79085 Freiburg, Germany; [Al-Khrashi, Abdullah] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11411, Saudi Arabia; [Assiri, Abdullah] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Khaled Eye Specialist Hospital; Imam Mohammad Ibn Saud Islamic University (IMSIU); King Faisal Specialist Hospital & Research Center; University of Freiburg; University of Freiburg; King Saud University; King Faisal Specialist Hospital & Research Center; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Assiri, Abdullah/0000-0002-2753-5238; Aldahmesh, Mohammed Abdullah/0000-0003-0130-9029; Hijazi, Hadia/0000-0002-2206-8730	KACST [08MED]; DHFMR Collaborative Research Grant; Deutsche Forschungsgemeinschaft [SFB 850/B7]	KACST; DHFMR Collaborative Research Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the affected individuals and their families for their enthusiastic participation. We are indebted to the Genomic and Sequencing Core Facilities at KFSHRC for their technical help. F.S.A. is supported by KACST grant 08MED and DHFMR Collaborative Research Grant. T.R. is supported by the Deutsche Forschungsgemeinschaft SFB 850/B7.	Abbott D, 2012, MOL VIS, V18, P720; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Alangari A, 2012, J ALLERGY CLIN IMMUN, V130, P481, DOI 10.1016/j.jaci.2012.05.043; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; BAUDYS M, 1991, BIOMED BIOCHIM ACTA, V50, P569; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Buhling F., 2011, PLOS ONE, V6; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; Gal A, 2011, AM J HUM GENET, V88, P382, DOI 10.1016/j.ajhg.2011.02.006; Gocheva V, 2010, BIOL CHEM, V391, P937, DOI 10.1515/BC.2010.080; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Jobling AI, 2004, J BIOL CHEM, V279, P18121, DOI 10.1074/jbc.M400381200; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; KIRSCHKE H, 1977, ACTA BIOL MED GER, V36, P185; Lawrence Matthew S, 2002, Ophthalmol Clin North Am, V15, P127, DOI 10.1016/S0896-1549(01)00002-5; Lin L L, 1988, Acta Ophthalmol Suppl, V185, P29; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Lu WD, 2012, J NEUROCHEM, V122, P512, DOI 10.1111/j.1471-4159.2012.07788.x; Lyhne N, 2001, BRIT J OPHTHALMOL, V85, P1470, DOI 10.1136/bjo.85.12.1470; Medved LV, 1999, J BIOL CHEM, V274, P717, DOI 10.1074/jbc.274.2.717; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Mizuguchi T, 2007, J HUM GENET, V52, P1, DOI 10.1007/s10038-006-0078-1; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nair KS, 2011, NAT GENET, V43, P579, DOI 10.1038/ng.813; Nowilaty SR, 2013, AM J OPHTHALMOL, V155, P361, DOI 10.1016/j.ajo.2012.08.016; RAVIOLA E, 1985, NEW ENGL J MED, V312, P1609, DOI 10.1056/NEJM198506203122505; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Siegwart JT, 2010, EXP EYE RES, V91, P660, DOI 10.1016/j.exer.2010.08.010; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x; Zhao FX, 2013, HUM GENET, V132, P913, DOI 10.1007/s00439-013-1303-6	46	68	74	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					313	320		10.1016/j.ajhg.2013.06.002	http://dx.doi.org/10.1016/j.ajhg.2013.06.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23830514	Bronze, Green Published			2022-12-18	WOS:000323186200011
J	Kidd, JM; Gravel, S; Byrnes, J; Moreno-Estrada, A; Musharoff, S; Bryc, K; Degenhardt, JD; Brisbin, A; Sheth, V; Chen, R; McLaughlin, SF; Peckham, HE; Omberg, L; Chung, CAB; Stanley, S; Pearlstein, K; Levandowsky, E; Acevedo-Acevedo, S; Auton, A; Keinan, A; Acuna-Alonzo, V; Barquera-Lozano, R; Canizales-Quinteros, S; Eng, C; Burchard, EG; Russell, A; Reynolds, A; Clark, AG; Reese, MG; Lincoln, SE; Butte, AT; De La Vega, FM; Bustamante, CD				Kidd, Jeffrey M.; Gravel, Simon; Byrnes, Jake; Moreno-Estrada, Andres; Musharoff, Shaila; Bryc, Katarzyna; Degenhardt, Jeremiah D.; Brisbin, Abra; Sheth, Vrunda; Chen, Rong; McLaughlin, Stephen F.; Peckham, Heather E.; Omberg, Larsson; Chung, Christina A. Bormann; Stanley, Sarah; Pearlstein, Kevin; Levandowsky, Elizabeth; Acevedo-Acevedo, Suehelay; Auton, Adam; Keinan, Alon; Acuna-Alonzo, Victor; Barquera-Lozano, Rodrigo; Canizales-Quinteros, Samuel; Eng, Celeste; Burchard, Esteban G.; Russell, Archie; Reynolds, Andy; Clark, Andrew G.; Reese, Martin G.; Lincoln, Stephen E.; Butte, Atul T.; De La Vega, Francisco M.; Bustamante, Carlos D.			Population Genetic Inference from Personal Genome Data: Impact of Ancestry and Admixture on Human Genomic Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ADMIXED POPULATIONS; AFRICAN-AMERICANS; LOCAL ANCESTRY; WIDE PATTERNS; MAP; ASSOCIATION; SEQUENCE; RARE; CONSTRAINT	Full sequencing of individual human genomes has greatly expanded our understanding of human genetic variation and population history. Here, we present a systematic analysis of 50 human genomes from 11 diverse global populations sequenced at high coverage. Our sample includes 12 individuals who have admixed ancestry and who have varying degrees of recent (within the last 500 years) African, Native American, and European ancestry. We found over 21 million single-nucleotide variants that contribute to a 1.75-fold range in nucleotide heterozygosity across diverse human genomes. This heterozygosity ranged from a high of one heterozygous site per kilobase in west African genomes to a low of 0.57 heterozygous sites per kilobase in segments inferred to have diploid Native American ancestry from the genomes of Mexican and Puerto Rican individuals. We show evidence of all three continental ancestries in the genomes of Mexican, Puerto Rican, and African American populations, and the genome-wide statistics are highly consistent across individuals from a population once ancestry proportions have been accounted for. Using a generalized linear model, we identified subtle variations across populations in the proportion of neutral versus deleterious variation and found that genome-wide statistics vary in admixed populations even once ancestry proportions have been factored in. We further infer that multiple periods of gene flow shaped the diversity of admixed populations in the Americas-70% of the European ancestry in today's African Americans dates back to European gene flow happening only 7-8 generations ago.	[Kidd, Jeffrey M.; Gravel, Simon; Byrnes, Jake; Moreno-Estrada, Andres; Musharoff, Shaila; De La Vega, Francisco M.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Bryc, Katarzyna; Degenhardt, Jeremiah D.; Brisbin, Abra; Omberg, Larsson; Keinan, Alon; Reynolds, Andy; Clark, Andrew G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Sheth, Vrunda; McLaughlin, Stephen F.; Peckham, Heather E.; Chung, Christina A. Bormann; Stanley, Sarah; Pearlstein, Kevin; Levandowsky, Elizabeth] Life Technol, Beverly, MA 01915 USA; [Chen, Rong; Butte, Atul T.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Acevedo-Acevedo, Suehelay] Univ Puerto Rico, Mayaguez, PR 00680 USA; [Auton, Adam] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Acuna-Alonzo, Victor; Barquera-Lozano, Rodrigo] Escuela Nacl Antropol & Hist, Mol Genet Lab, Mexico City 14030, DF, Mexico; [Acuna-Alonzo, Victor; Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unit Mol Biol & Genom Med, Mexico City 14000, DF, Mexico; [Eng, Celeste; Burchard, Esteban G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Russell, Archie; Reese, Martin G.] Omicia, Oakland, CA 94608 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Lincoln, Stephen E.] Complete Genom, Mountain View, CA 94043 USA; [De La Vega, Francisco M.] Life Technol, Foster City, CA 94404 USA	Stanford University; Cornell University; Thermo Fisher Scientific; Stanford University; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Oxford; Wellcome Centre for Human Genetics; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California San Francisco; Cornell University; Thermo Fisher Scientific	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	francisco.dlv@gmail.com; cdbustam@stanford.edu	Acuna Alonzo, Victor/E-2312-2013; Moreno-Estrada, Andres/AAP-4657-2021; Moreno-Estrada, Andres/R-3950-2017	Acuna Alonzo, Victor/0000-0003-2205-7625; Moreno-Estrada, Andres/0000-0001-8329-8292; Moreno-Estrada, Andres/0000-0001-8329-8292; Acevedo-Acevedo, Suehelay/0000-0002-8559-6055; Kidd, Jeffrey/0000-0002-9631-1465; Clark, Andrew/0000-0001-7159-8511; Omberg, Larsson/0000-0002-4719-9120; Keinan, Alon/0000-0002-9760-1122; Barquera, Rodrigo/0000-0003-0518-4518; Bustamante, Carlos D./0000-0002-4187-7920	National Institutes of Health [T32HG000044];  [R01ES015794];  [R01HL088133];  [1R44HG3667]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG003667, T32HG000044, R44HG006579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Melisa Barker, Fiona Hyland, Clarence Lee, Kirk Lohmueller, Kevin McKernan and Koni Wright for advice about this project. J.M.K was supported by National Institutes of Health training grant T32HG000044. Additional support was provided by grants R01ES015794 and R01HL088133 (E.G.B.) and 1R44HG3667 (M.G.R). Vrunda Sheth, Stephen F. McLaughlin, Heather E. Peckham, Christina A. Bormann Chung, Sarah Stanley, Kevin Pearlstein, Elizabeth Levandowsky, and Francisco M. De La Vega are or were employees of Life Technologies during this study. Archie Russell and Martin Reese are employees of Omicia. The Varimed database has been licensed to Persona lis. Awl Butte is a founder and consults for Persona lis. Carlos D. Bustamante also consults for Personalis, as well as Ancestry.com, Locus Development, and the 23andMe.com project "Roots into the Future." Stephen E. Lincoln was an employee of Complete Genomics during this study. Jake Byrnes is an employee of Ancestry.com.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bercovici S, 2009, J COMPUT BIOL, V16, P1141, DOI 10.1089/cmb.2009.0105; Brisbin A, 2010, LINKAGE ANAL CATEGOR; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Falush D, 2003, GENETICS, V164, P1567; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; McVean GAT, 2005, PHILOS T R SOC B, V360, P1387, DOI 10.1098/rstb.2005.1673; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tavare S, 1997, GENETICS, V145, P505; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240	45	68	73	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					660	671		10.1016/j.ajhg.2012.08.025	http://dx.doi.org/10.1016/j.ajhg.2012.08.025			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23040495	Green Published, Bronze			2022-12-18	WOS:000309568500008
J	Gamazon, ER; Ziliak, D; Im, HK; LaCroix, B; Park, DS; Cox, NJ; Huang, RS				Gamazon, Eric R.; Ziliak, Dana; Im, Hae Kyung; LaCroix, Bonnie; Park, Danny S.; Cox, Nancy J.; Huang, R. Stephanie			Genetic Architecture of MicroRNA Expression: Implications for the Transcriptome and Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VITAMIN-C TRANSPORTERS; INDUCED CYTOTOXICITY; KIDNEY-FUNCTION; MESSENGER-RNA; CELL-LINES; I-TO; VARIANTS; TARGETS; CANCER; POPULATION	We sought to comprehensively and systematically characterize the relationship between genetic variation, miRNA expression, and mRNA expression. Genome-wide expression profiling of samples of European and African ancestry identified in each population hundreds of miRNAs whose increased expression is correlated with correspondingly reduced expression of target mRNAs. We scanned 3' UTR SNPs with a potential functional effect on miRNA binding for cis-acting expression quantitative trait loci (eQTLs) for the corresponding proximal target genes. To extend sequence-based, localized analyses of SNP effect on miRNA binding, we proceeded to dissect the genetic basis of miRNA expression variation; we mapped miRNA expression levels as quantitative traits to loci in the genome as miRNA eQTLs, demonstrating that miRNA expression is under significant genetic control. We found that SNPs associated with miRNA expression are significantly enriched with those SNPs already shown to be associated with mRNA. Moreover, we discovered that many of the miRNA-associated genetic variations identified in our study are associated with a broad spectrum of human complex traits from the National Human Genome Research Institute catalog of published genome-wide association studies. Experimentally, we replicated miRNA-induced mRNA expression inhibition and the cis-eQTL relationship to the target gene for several identified relationships among SNPs, miRNAs, and mRNAs in an independent set of samples; furthermore, we conducted miRNA overexpression and inhibition experiments to functionally validate the miRNA-mRNA relationships. This study extends our understanding of the genetic regulation of the transcriptome and suggests that genetic variation might underlie observed relationships between miRNAs and mRNAs more commonly than has previously been appreciated.	[Ziliak, Dana; LaCroix, Bonnie; Huang, R. Stephanie] Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL 60637 USA; [Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Im, Hae Kyung] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Park, Danny S.] Columbia Univ, New York, NY 10027 USA	University of Chicago; University of Chicago; University of Chicago; Columbia University	Huang, RS (corresponding author), Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL 60637 USA.	rhuang@medicine.bsd.uchicago.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Huang, R. Stephanie/0000-0002-9862-0368; Im, Hae Kyung/0000-0003-0333-5685; LaCroix, Bonnie/0000-0002-6833-5267	National Institutes of Health (NIH)-National Cancer Institute [R21 CA139278]; NIH-National Institute of General Medical Sciences (NIGMS) [UO1GM61393, K08GM089941]; University of Chicago Cancer Center [P30 CA14599]; Breast Cancer SPORE (Specialized Program of Research Excellence) Career Development Award; NATIONAL CANCER INSTITUTE [R21CA139278, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, K08GM089941] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Chicago Cancer Center(University of Chicago); Breast Cancer SPORE (Specialized Program of Research Excellence) Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for the excellent technical support provided by Mr. Ken Hecht in maintaining the cell lines, Mr. Wasim Bleibel for isolating RNA from the discovery samples, Mr. Viren Makhijani for assistance in RNA isolation from the replication samples, and M. Eileen Dolan's lab for generating and depositing Exon-array data (Gene Expression Omnibus accession number GSE7761). This study was supported by the National Institutes of Health (NIH)-National Cancer Institute grant R21 CA139278 and by the NIH-National Institute of General Medical Sciences (NIGMS) grant UO1GM61393. R.S.H. received support from NIH-NIGMS grant K08GM089941, University of Chicago Cancer Center Support Grant P30 CA14599, and the Breast Cancer SPORE (Specialized Program of Research Excellence) Career Development Award.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Akech J, 2005, BIOCHEM BIOPH RES CO, V333, P35, DOI 10.1016/j.bbrc.2005.05.071; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anastasiadou E, 2010, ONCOGENE, V29, P1316, DOI 10.1038/onc.2009.439; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Chen AA, 2009, CARCINOGENESIS, V30, P977, DOI 10.1093/carcin/bgp076; Chen SH, 2011, LEUKEMIA, V25, P66, DOI 10.1038/leu.2010.256; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; DeStefano AL, 2002, AM J HUM GENET, V70, P1089, DOI 10.1086/339814; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Erichsen HC, 2008, NUTR CANCER, V60, P652, DOI 10.1080/01635580802033110; Erichsen HC, 2006, AM J EPIDEMIOL, V163, P245, DOI 10.1093/aje/kwj035; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu ZH, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/910769; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2008, CANCER RES, V68, P3161, DOI 10.1158/0008-5472.CAN-07-6381; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Huang RS, 2007, MOL CANCER THER, V6, P31, DOI 10.1158/1535-7163.MCT-06-0591; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Im HK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002525; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jin HW, 2010, J MOL CELL CARDIOL, V48, P1169, DOI 10.1016/j.yjmcc.2009.12.019; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Latourelle JC, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-98; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Stark AL, 2010, PHARMACOGENOMICS J, V10, P505, DOI 10.1038/tpj.2010.3; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stratakis C A, 2000, J Med Genet, V37, pE20, DOI 10.1136/jmg.37.9.e20; Thomas LF, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr414; Wright ME, 2009, EUR J CANCER, V45, P1824, DOI 10.1016/j.ejca.2009.01.027; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	71	68	69	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1046	1063		10.1016/j.ajhg.2012.04.023	http://dx.doi.org/10.1016/j.ajhg.2012.04.023			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22658545	Bronze, Green Published			2022-12-18	WOS:000305262600009
J	Simpson, MA; Deshpande, C; Dafou, D; Vissers, LELM; Woollard, WJ; Holder, SE; Gillessen-Kaesbach, G; Derks, R; White, SM; Cohen-Snuijf, R; Kant, SG; Hoefsloot, LH; Reardon, W; Brunner, HG; Bongers, EMHF; Trembath, RC				Simpson, Michael A.; Deshpande, Charu; Dafou, Dimitra; Vissers, Lisenka E. L. M.; Woollard, Wesley J.; Holder, Susan E.; Gillessen-Kaesbach, Gabriele; Derks, Ronny; White, Susan M.; Cohen-Snuijf, Ruthy; Kant, Sarina G.; Hoefsloot, Lies H.; Reardon, Willie; Brunner, Han G.; Bongers, Ernie M. H. F.; Trembath, Richard C.			De Novo Mutations of the Gene Encoding the Histone Acetyltransferase KAT6B Cause Genitopatellar Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIER-GORLIN SYNDROME; PATELLA SYNDROME; PHENOTYPE	Genitopatellar syndrome (GPS) is a rare disorder in which patellar aplasia or hypoplasia is associated with external genital anomalies and severe intellectual disability. Using an exome-sequencing approach, we identified de novo mutations of KAT6B in five individuals with GPS; a single nonsense variant and three frameshift indels, including a 4 bp deletion observed in two cases. All identified mutations are located within the terminal exon of the gene and are predicted to generate a truncated protein product lacking evolutionarily conserved domains. KAT6B encodes a member of the MYST family of histone acetyltranferases. We demonstrate a reduced level of both histone H3 and H4 acetylation in patient-derived cells suggesting that dysregulation of histone acetylation is a direct functional consequence of GPS alleles. These findings define the genetic basis of GPS and illustrate the complex role of the regulation of histone acetylation during development.	[Vissers, Lisenka E. L. M.; Derks, Ronny; Hoefsloot, Lies H.; Brunner, Han G.; Bongers, Ernie M. H. F.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Simpson, Michael A.; Dafou, Dimitra; Woollard, Wesley J.; Trembath, Richard C.] Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England; [Deshpande, Charu] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Guys Hosp, London SE1 9RT, England; [Holder, Susan E.] N W London Hosp NHS Trust, N W Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Gillessen-Kaesbach, Gabriele] Univ Lubeck, Inst Humangenet, D-23538 Lubeck, Germany; [White, Susan M.] Murdoch Childrens Res Inst, Genet Hlth Serv Victoria, Melbourne, Vic 3052, Australia; [Cohen-Snuijf, Ruthy] Ctr People Intellectual Disabil, NL-2441 CP Ips De Bruggen, Netherlands; [Kant, Sarina G.] Leiden Univ, Med Ctr, Dept Clin Genet, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands; [Reardon, Willie] Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin 12, Ireland; [Trembath, Richard C.] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 2AD, England	Radboud University Nijmegen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Lubeck; Murdoch Children's Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Our Ladys Children Hospital Crumlin; University of London; Queen Mary University London	Bongers, EMHF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	e.bongers@antrg.umcn.nl; richard.trembath@kcl.ac.uk	Brunner, Han/C-9928-2013; Bongers, M.H.F./L-4214-2015; Simpson, Michael/F-4737-2011; Kant, Sarina/F-8596-2010; Dafou, Dimitra/N-6094-2015; Vissers, Lisenka ELM/A-2598-2015	Simpson, Michael/0000-0002-8539-8753; Dafou, Dimitra/0000-0003-4170-0612; Vissers, Lisenka ELM/0000-0001-6470-5497; Trembath, Richard/0000-0003-0550-3400; Reardon, Willie/0000-0001-7329-9179	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London and King's College Hospital NHS Foundation Trust; Netherlands Organisation for Health Research and Development (ZonMW) [916.86.016]; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London and King's College Hospital NHS Foundation Trust; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors express their gratitude to the families for participating in this study. The authors also acknowledge support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust and the Netherlands Organisation for Health Research and Development (ZonMW 916.86.016 to LELMV). The authors declare no conflicts of interest.	Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bongers EMHF, 2004, AM J HUM GENET, V74, P1239, DOI 10.1086/421331; Brugha R, 2011, CLIN DYSMORPHOL, V20, P163, DOI 10.1097/MCD.0b013e328345a1dd; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Cormier-Daire V, 2000, J MED GENET, V37, P520, DOI 10.1136/jmg.37.7.520; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pelletier N, 2002, ONCOGENE, V21, P2729, DOI 10.1038/sj.onc.1205367; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reardon W, 2002, AM J MED GENET, V111, P313, DOI 10.1002/ajmg.10590; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Thomas T, 2000, DEVELOPMENT, V127, P2537; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	19	68	69	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					290	294		10.1016/j.ajhg.2011.11.024	http://dx.doi.org/10.1016/j.ajhg.2011.11.024			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22265017	Green Published, Bronze			2022-12-18	WOS:000300742200009
J	Weraarpachai, W; Sasarman, F; Nishimura, T; Antonicka, H; Aure, K; Rotig, A; Lombes, A; Shoubridge, EA				Weraarpachai, Woranontee; Sasarman, Florin; Nishimura, Tamiko; Antonicka, Hana; Aure, Karine; Roetig, Agnes; Lombes, Anne; Shoubridge, Eric A.			Mutations in C12orf62, a Factor that Couples COX I Synthesis with Cytochrome c Oxidase Assembly, Cause Fatal Neonatal Lactic Acidosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENCY; EXPRESSION; SCO2; GENE; IDENTIFICATION; COMPLEX; SURF1	We investigated a family in which the index subject presented with severe congenital lactic acidosis and dysmorphic features associated with a cytochrome c oxidase (COX)-assembly defect and a specific decrease in the synthesis of COX I, the subunit that nucleates COX assembly. Using a combination of microcell-mediated chromosome transfer, homozygosity mapping, and transcript profiling, we mapped the gene defect to chromosome 12 and identified a homozygous missense mutation (c.88G>A) in C12orf62. C12orf62 was not detectable by immunoblot analysis in subject fibroblasts, and retroviral expression of the wild-type C12orf62 cDNA rescued the biochemical phenotype. Furthermore, siRNA-mediated knockdown of C12orf62 recapitulated the biochemical defect in control cells and exacerbated it in subject cells. C12orf62 is apparently restricted to the vertebrate lineage. It codes for a very small (6 kDa), uncharacterized, single-transmembrane protein that localizes to mitochondria and elutes in a complex of similar to 110 kDa by gel filtration. COX I, II, and IV coimmunoprecipated with an epitope-tagged version of C12orf62, and 2D blue-native-polyacrylamide-gel-electrophoresis analysis of newly synthesized mitochondrial COX subunits in subject fibroblasts showed that COX assembly was impaired and that the nascent enzyme complex was unstable. We conclude that C12orf62 is required for coordination of the early steps of COX assembly with the synthesis of COX I.	[Weraarpachai, Woranontee; Sasarman, Florin; Nishimura, Tamiko; Antonicka, Hana; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; [Weraarpachai, Woranontee; Sasarman, Florin; Nishimura, Tamiko; Antonicka, Hana; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Aure, Karine] Hop Ambroise Pare, AP HP, F-92100 Paris, France; [Aure, Karine] Fac Med Paris Ile De France Ouest, Unite Format & Rech, F-78280 Paris, France; [Aure, Karine; Lombes, Anne] CNRS, INSERM, UMR S 1016, Inst Cochin,UMR 8104, F-75014 Paris, France; [Aure, Karine; Lombes, Anne] Univ Paris 05, F-75014 Paris, France; [Roetig, Agnes] Univ Paris 05, F-75015 Paris, France; [Roetig, Agnes] INSERM, U781, F-75015 Paris, France; [Lombes, Anne] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, Unite Cardiogenet & Myogenet Mol & Cellulaire, F-75651 Paris, France	McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Shoubridge, EA (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.	eric@ericpc.mni.mcgill.ca	Rötig, Agnès/G-9592-2017; Lombes, Anne/G-4684-2014	Rötig, Agnès/0000-0003-0589-0703; Lombes, Anne/0000-0002-9064-0399; Antonicka, Hana/0000-0002-2525-2867	Canadian Institutes of Health Research; Agence Nationale de la Recherche (ANR) [MNP 2008 Mitopark: ANR-08-MNPS-020-01, ANR-08-GENOPAT-043]; Association Francaise contre les Myopathies	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This research was supported by a grant from the Canadian Institutes of Health Research to E.A.S., grants from the Agence Nationale de la Recherche (ANR; MNP 2008 Mitopark: ANR-08-MNPS-020-01) and the Association Francaise contre les Myopathies to A.L., and a grant from ANR (ANR-08-GENOPAT-043) to A.R. The antibody against EFTu/Ts was a kind gift from Linda Spremulli. E.A.S. is an International Scholar of the Howard Hughes Medical Institute. SNP genotyping, homozygosity mapping, and expression profiling were performed by The Centre for Applied Genomics and the Hospital for Sick Children, Toronto, Canada. We thank Timothy Johns and Neil Webb for technical assistance.	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Papadopoulou LC, 1999, NAT GENET, V23, P333; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; Valnot I, 2000, AM J HUM GENET, V67, P1104; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804; Zickermann V, 2010, FEBS LETT, V584, P2516, DOI 10.1016/j.febslet.2010.04.021	23	68	71	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					142	151		10.1016/j.ajhg.2011.11.027	http://dx.doi.org/10.1016/j.ajhg.2011.11.027			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22243966	Bronze, Green Published			2022-12-18	WOS:000299409100015
J	Walsh, T; Pierce, SB; Lenz, DR; Brownstein, Z; Dagan-Rosenfeld, O; Shahin, H; Roeb, W; McCarthy, S; Nord, AS; Gordon, CR; Ben-Neriah, Z; Sebat, J; Kanaan, M; Lee, MK; Frydman, M; King, MC; Avraham, KB				Walsh, Tom; Pierce, Sarah B.; Lenz, Danielle R.; Brownstein, Zippora; Dagan-Rosenfeld, Orit; Shahin, Hashem; Roeb, Wendy; McCarthy, Shane; Nord, Alex S.; Gordon, Carlos R.; Ben-Neriah, Ziva; Sebat, Jonathan; Kanaan, Moien; Lee, Ming K.; Frydman, Moshe; King, Mary-Claire; Avraham, Karen B.			Genomic Duplication and Overexpression of TJP2/ZO-2 Leads to Altered Expression of Apoptosis Genes in Progressive Nonsyndromic Hearing Loss DFNA51	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TIGHT-JUNCTION PROTEIN; INNER-EAR; DEAFNESS; MUTATIONS; MICE; ACTIVATION; AGE; PATHWAYS; CHANNEL; TARGET	Age-related hearing loss is due to death over time, primarily by apoptosis, of hair cells in the inner ear. Studies of mutant genes responsible for inherited progressive hearing loss have suggested possible mechanisms for hair cell death, but critical connections between these mutations and the causes of progressive hearing loss have been elusive. In an Israeli kindred, dominant, adult-onset, progressive nonsyndromic hearing loss DFNA51 is due to a tandem inverted genomic duplication of 270 kb that includes the entire wild-type gene encoding the tight junction protein TJP2 (ZO-2). In the mammalian inner ear, TJP2 is expressed mainly in tight junctions, and also in the cytoplasm and nuclei. TJP2 expression normally decreases with age from embryonic development to adulthood. In cells of affected family members, TJP2 transcript and protein are overexpressed, leading to decreased phosphorylation of GSK-3 beta and to altered expression of genes that regulate apoptosis. These results suggest that TJP2- and GSK-3 beta-mediated increased susceptibility to apoptosis of cells of the inner ear is the mechanism for adult-onset hearing loss in this kindred and may serve as one model for age-related hearing loss in the general population.	[Walsh, Tom; Pierce, Sarah B.; Roeb, Wendy; Nord, Alex S.; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Walsh, Tom; Pierce, Sarah B.; Roeb, Wendy; Nord, Alex S.; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Lenz, Danielle R.; Brownstein, Zippora; Dagan-Rosenfeld, Orit; Frydman, Moshe; Avraham, Karen B.] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Shahin, Hashem; Kanaan, Moien] Bethlehem Univ, Dept Biol Sci, Bethlehem, Palestine; [McCarthy, Shane; Sebat, Jonathan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Gordon, Carlos R.] Meir Med Ctr, Dept Neurol, IL-44281 Kefar Sava, Israel; [Ben-Neriah, Ziva] Hadassah Hebrew Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel; [Frydman, Moshe] Chaim Sheba Med Ctr, Danek Gertner Inst Med Genet, IL-52621 Tel Hashomer, Israel	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tel Aviv University; Sackler Faculty of Medicine; Cold Spring Harbor Laboratory; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center	King, MC (corresponding author), Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA.	mcking@uw.edu; karena@post.tau.ac.il		Sebat, Jonathan/0000-0002-9087-526X; Walsh, Tom/0000-0002-8875-0310; Avraham, Karen B/0000-0002-4913-251X; Kanaan, Moien/0000-0002-3227-4685; Gordon, Carlos/0000-0003-1576-214X; King, Mary-Claire/0000-0001-9426-1743; Nord, Alexander/0000-0003-4259-7514	National Institutes of Health, National Institute of Deafness and Communication Disorders [R01DC005641]; European Commission [LSHG-CT-2004-512063]; NIH, National Institute of Environmental Health Sciences [5T32ES007032, 1T32ES015459]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032, T32ES015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005641] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to thank the members of family T for suggesting this project and for their continued commitment to it. We also thank Amiel Dror for schematic figures of the inner ear. This work was supported by National Institutes of Health grant R01DC005641 from the National Institute of Deafness and Communication Disorders, by the European Commission FP6 Integrated Project EUROHEAR LSHG-CT-2004-512063, and by NIH training grants 5T32ES007032 (to W.R.) and 1T32ES015459 (to A.S.N.) from the National Institute of Environmental Health Sciences.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; Haake SM, 2009, HEARING RES, V255, P22, DOI 10.1016/j.heares.2009.05.003; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kwan T, 2009, ANN NY ACAD SCI, V1170, P28, DOI 10.1111/j.1749-6632.2009.04484.x; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nunes FD, 2006, J CELL SCI, V119, P4819, DOI 10.1242/jcs.03233; Nuutinen U, 2009, LEUKEMIA RES, V33, P1714, DOI 10.1016/j.leukres.2009.06.004; Park HJ, 2009, HEARING RES, V257, P53, DOI 10.1016/j.heares.2009.08.001; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Riva C, 2007, EXP GERONTOL, V42, P327, DOI 10.1016/j.exger.2006.10.014; ROCCHI M, 1991, GENOMICS, V9, P517, DOI 10.1016/0888-7543(91)90419-F; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Sha SH, 2009, HEARING RES, V254, P92, DOI 10.1016/j.heares.2009.04.019; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Suzuki T, 2001, J HISTOCHEM CYTOCHEM, V49, P573, DOI 10.1177/002215540104900504; Tadros SF, 2008, APOPTOSIS, V13, P1303, DOI 10.1007/s10495-008-0266-x; Tapia R, 2009, MOL BIOL CELL, V20, P1102, DOI 10.1091/mbc.E08-03-0277; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; ZEE DS, 1996, DISORDERS VESTIBULAR, P178	41	68	77	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					101	109		10.1016/j.ajhg.2010.05.011	http://dx.doi.org/10.1016/j.ajhg.2010.05.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20602916	Bronze, Green Published			2022-12-18	WOS:000280029200010
J	Houlihan, LM; Davies, G; Tenesa, A; Harris, SE; Luciano, M; Gow, AJ; McGhee, KA; Liewald, DC; Porteous, DJ; Starr, JM; Lowe, GD; Visscher, PM; Deary, IJ				Houlihan, Lorna M.; Davies, Gail; Tenesa, Albert; Harris, Sarah E.; Luciano, Michelle; Gow, Alan J.; McGhee, Kevin A.; Liewald, David C.; Porteous, David J.; Starr, John M.; Lowe, Gordon D.; Visscher, Peter M.; Deary, Ian J.			Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEEP-VEIN THROMBOSIS; FACTOR-XI DEFICIENCY; HEMOSTASIS PHENOTYPES; RISK-FACTORS; KININOGEN; PROTEIN; PLASMA; GENE	Activated partial thromboplastin time (aPTF) is associated with risk of thrombosis and coagulation disorders. We conducted a genome-wide association study for aPTT and identified significant associations with SNPs in three coagulation cascade genes, F12 (rs2731672, combined p = 2.16 x 10(-30)), KNG1 (rs710446, combined p = 9.52 x 10(-22)), and HRG (rs9898, combined p = 1.34 x 10(-11)). These three SNPs explain similar to 18% of phenotypic variance in aPTT in the Lothian Birth Cohorts.	[Houlihan, Lorna M.; Davies, Gail; Luciano, Michelle; Gow, Alan J.; McGhee, Kevin A.; Liewald, David C.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Tenesa, Albert] Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Harris, Sarah E.; Porteous, David J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Geriatr Med Unit, Edinburgh EH4 2DN, Midlothian, Scotland; [Lowe, Gordon D.] Univ Glasgow, Royal Infirm, Div Cardiovasc & Med Sci, Glasgow G31 2ER, Lanark, Scotland; [Visscher, Peter M.] Royal Brisbane Hosp, Queensland Stat Genet, Queensland Inst Med Res, Brisbane, Qld 4029, Australia	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Glasgow; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Houlihan, LM (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	lorna.houlihan@ed.ac.uk; ian.deary@ed.ac.uk	Lopez, Lorna M/F-7265-2010; Gow, Alan J/A-6070-2009; Porteous, David J/C-7289-2013; Porteous, David/AAA-3446-2021; Davies, Gail/F-7270-2010; Luciano, Michelle/F-7277-2010; Starr, John/C-8951-2011; Visscher, Peter/ABB-6151-2020; Deary, Ian J/C-6297-2009; Lopez, Lorna/AAR-4912-2020	Gow, Alan J/0000-0002-3320-4531; Porteous, David J/0000-0003-1249-6106; Porteous, David/0000-0003-1249-6106; Luciano, Michelle/0000-0003-0935-7682; Visscher, Peter/0000-0002-2143-8760; Deary, Ian J/0000-0002-1733-263X; Lopez, Lorna/0000-0002-0241-9783; Tenesa, Albert/0000-0003-4884-4475	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G9900991B, G0700704] Funding Source: researchfish; Chief Scientist Office [CZB/4/505] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the LBC1936 and LBC1921 participants. We thank Janie Corley, Caroline Brett, Caroline Cameron, Michelle Taylor, and Alison Pattie for data collection and data entry. We thank the study secretary Paula Davies. We thank the nurses and staff at the Wellcome Trust Clinical Research Facility, where subjects were tested and the genotyping was performed. We thank Caroline Hayward and Veronique Vitart for advice and Paul Redmond for technical assistance. We also thank the staff at the Department of Haematology, Western General Hospital for the aPTT measurements. We thank the staff at the Lothian Health Board and the staff at the Scottish Council for Research in Education Centre, University of Glasgow. This whole-genome association study was funded by the Biotechnology and Biological Sciences Research Council (BBSRC). The LBC1936 research was supported by a program grant from Research into Ageing and continues with program grants from Help the Aged and Research into Ageing (Disconnected Mind). The LBC1921 data collection was funded by the BBSRC. The study was conducted within the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, supported by the BBSRC, Engineering and Physical Sciences Research Council, Economic and Social Research Council, and Medical Research Council, as part of the cross-council Lifelong Health and Wellbeing Initiative. M.L. is a Royal Society of Edinburgh and Lloyds TSB Foundation for Scotland Personal Research Fellow. P.M.V. acknowledges support from the Australian National Health and Medical Research Council.	Barbalic M, 2009, PHYSIOL GENOMICS, V39, P56, DOI 10.1152/physiolgenomics.00061.2009; Calafell F, 2010, HUM MOL GENET, V19, P517, DOI 10.1093/hmg/ddp517; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P90; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lowe GDO, 1999, THROMB HAEMOSTASIS, V81, P918; Lowe GDO, 1999, THROMB HAEMOSTASIS, V81, P879; Merkulov S, 2008, BLOOD, V111, P1274, DOI 10.1182/blood-2007-06-092338; Mitchell M, 1999, BRIT J HAEMATOL, V107, P763, DOI 10.1046/j.1365-2141.1999.01769.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quelin F, 2004, J THROMB HAEMOST, V2, P71, DOI 10.1111/j.1538-7836.2004.00554.x; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Santamaria A, 2004, STROKE, V35, P1795, DOI 10.1161/01.STR.0000133127.68041.a3; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Tirado I, 2004, THROMB HAEMOSTASIS, V91, P899, DOI 10.1160/TH03-10-0620; Warrew DM, 2005, HUM BIOL, V77, P1, DOI 10.1353/hub.2005.0034; Zhao WY, 2009, J HYPERTENS, V27, P484, DOI 10.1097/HJH.0b013e32831e19f9	24	68	68	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					626	631		10.1016/j.ajhg.2010.02.016	http://dx.doi.org/10.1016/j.ajhg.2010.02.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20303064	Green Published, Bronze			2022-12-18	WOS:000276716800014
J	Ferreira, MAR; Mangino, M; Brumme, CJ; Zhao, ZZ; Medland, SE; Wright, MJ; Nyholt, DR; Gordon, S; Campbell, M; McEvoy, BP; Henders, A; Evans, DM; Lanchbury, JS; Pereyra, F; Walker, BD; Haas, DW; Soranzo, N; Spector, TD; de Bakker, PIW; Frazer, IH; Montgomery, GW; Martin, NG				Ferreira, Manuel A. R.; Mangino, Massimo; Brumme, Chanson J.; Zhao, Zhen Zhen; Medland, Sarah E.; Wright, Margaret J.; Nyholt, Dale R.; Gordon, Scott; Campbell, Megan; McEvoy, Brian P.; Henders, Anjali; Evans, David M.; Lanchbury, Jerry S.; Pereyra, Florencia; Walker, Bruce D.; Haas, David W.; Soranzo, Nicole; Spector, Tim D.; de Bakker, Paul I. W.; Frazer, Ian H.; Montgomery, Grant W.; Martin, Nicholas G.		Int HIV Controllers Study	Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FAMILY; SAMPLE; GENES; CELLS	Abnormal expansion or depletion of particular lymphocyte subsets is associated with clinical manifestations Such as HIV progression to AIDS and autoimmune disease. We sought to identify genetic predictors of lymphocyte levels and reasoned that these may play a role in immune-related diseases. We tested 2.3 million variants for association with five lymphocyte Subsets, measured in 2538 individuals from the general population, including CD4+T cells, CD8+ T cells, CD56+ natural killer (NK) cells, and the derived measure CD4:CD8 ratio. We identified two regions of strong association. The first was located in the major histocompatibility complex (MHC), with multiple SNPs strongly associated with CD4:CD8 ratio (rs2524054, p = 2.1 x 10(-28)). The second region was centered within a cluster of genes from the Schlafen family and was associated with NK cell levels (rs1838149, p = 6.1 x 10(-14)). The MHC association with CD4:CD8 replicated convincingly (p 1.4 x 10(-9)) in an independent panel of 988 individuals. Conditional analyses indicate that there are two major independent quantitative trait loci (QTL) in the MHC region that regulate CD4:CD8 ratio: one is located in the class 1 cluster and influences CD8 levels, whereas the second is located in the class 11 Cluster and regulates CD4 levels. jointly, both QTL explained 8% of the variance in CD4:CD8 ratio. The class I variants are also strongly associated with durable host control of HIV, and class It variants are associated with type-1 diabetes, suggesting that genetic variation at the MFIC may predispose one to immune-related diseases partly through disregulation of T cell homeostasis.	[Ferreira, Manuel A. R.; Zhao, Zhen Zhen; Medland, Sarah E.; Wright, Margaret J.; Nyholt, Dale R.; Gordon, Scott; Campbell, Megan; McEvoy, Brian P.; Henders, Anjali; Evans, David M.; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Mangino, Massimo; Lanchbury, Jerry S.; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, St Thomas Hosp, Twin Res & Genet Epidemiol Dept, London SE1 7EH, England; [Brumme, Chanson J.; Pereyra, Florencia; Walker, Bruce D.] MIT, Ragon Inst MGH, Charlestown, MA 02129 USA; [Brumme, Chanson J.; Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Charlestown, MA 02129 USA; [Brumme, Chanson J.; de Bakker, Paul I. W.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Brumme, Chanson J.; de Bakker, Paul I. W.] Harvard Univ, Cambridge, MA 02142 USA; [Pereyra, Florencia] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Haas, David W.] Vanderbilt Univ, Sch Med, Nashville, TN 37203 USA; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA; [Frazer, Ian H.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia	QIMR Berghofer Medical Research Institute; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Queensland	Ferreira, MAR (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	manuel.ferreira@qimr.edu.au	Marconi, Vincent/N-3210-2014; de Bakker, Paul IW/B-8730-2009; Allen, Todd/F-5473-2011; Nyholt, Dale Robert/J-3174-2017; Evans, David M/H-6325-2013; Montgomery, Grant W/B-7148-2008; Ferreira, Manuel A R/D-3609-2013; Medland, Sarah E/C-7630-2013; Marconi, Vincent/GRJ-4553-2022; Latour, Brooke/AAW-9199-2021; Mangino, Massimo/F-5134-2011; Wright, Margaret J/H-3308-2014; Medland, Sarah/AAT-7595-2020; Wright, Margaret Jane/A-4560-2016; Henders, Anjali/E-3126-2017; Frazer, Ian/A-1137-2007	Marconi, Vincent/0000-0001-8409-4689; de Bakker, Paul IW/0000-0001-7735-7858; Allen, Todd/0000-0002-6609-1318; Nyholt, Dale Robert/0000-0001-7159-3040; Evans, David M/0000-0003-0663-4621; Montgomery, Grant W/0000-0002-4140-8139; Ferreira, Manuel A R/0000-0001-9059-1825; Medland, Sarah E/0000-0003-1382-380X; Marconi, Vincent/0000-0001-8409-4689; Mangino, Massimo/0000-0002-2167-7470; Medland, Sarah/0000-0003-1382-380X; Wright, Margaret Jane/0000-0001-7133-4970; Le Gall, Sylvie/0000-0003-0385-926X; Ndung'u, Thumbi/0000-0003-2962-3992; Martin, Nicholas/0000-0003-4069-8020; Henders, Anjali/0000-0003-3672-1451; Brumme, Chanson/0000-0003-2722-5288; Campbell, Megan/0000-0002-6056-6140; Addo, Marylyn/0000-0003-2836-9224; Frazer, Ian/0000-0002-8002-4680; Lian, Jeffrey/0000-0001-9470-7864; Altfeld, Marcus/0000-0001-5972-2997; Soranzo, Nicole/0000-0003-1095-3852; Hladek, Melissa/0000-0002-0625-2474; Rothchild, Alissa/0000-0001-7484-1193	MRC [G0600705, G0800582] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069450, U01AI069532, UM1AI069423, UM1AI068636, UM1AI069415, UM1AI069484, U01AI069424, U01AI034835, UM1AI069434, U01AI069511, U01AI069474, UM1AI069450, U01AI069432, UM1AI069432, U01AI034853, U01AI069471, U01AI069467, U01AI046370, U01AI069452, U01AI068636, UM1AI069465, U01AI069434, U01AI069513, U01AI069556, UM1AI069472, UM1AI069467, U01AI069465, UM1AI069428, R01AI077505, U01AI069472, U01AI069495, U01AI038844, UM1AI069474, UM1AI069532, UM1AI069495, UM1AI069502, UM1AI069501, UM1AI069511, UM1AI069424, UM1AI069452, U01AI069477, U01AI069501, U01AI069502, U01AI027661, U01AI069415, U01AI069423, UM1AI069513, U01AI025859, P30AI050410, UM1AI069556, UM1AI069471, U01AI069419, UM1AI069419, UM1AI069477, U01AI069428, U01AI069484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071205] Funding Source: NIH RePORTER; Medical Research Council [G0600705, G0800582] Funding Source: Medline; NCRR NIH HHS [UL1 RR024975, RR024975] Funding Source: Medline; NIAID NIH HHS [AI069471, AI069477, AI38844, UM1 AI069467, U01 AI069452, UM1 AI069511, AI25859, AI069432, UM1 AI069419, AI069472, UM1 AI069465, U01 AI069424, UM1 AI069532, AI34835, UM1 AI069450, U01 AI025859, UM1 AI069502, U01 AI069495, U01 AI069415, AI069424, UM1 AI069452, U01 AI034853, UM1 AI069474, U01 AI068636, U01 AI046370, U01 AI069471, U01 AI069472, UM1 AI068636, P30 AI050410, AI069452, UM1 AI069556, U01 AI069511, AI069450, U01 AI069450, AI068636, AI069484, U01 AI069432, UM1 AI069477, AI069495, U01 AI069501, AI34853, AI069428, UM1 AI069484, AI27661, UM1 AI069415, U01 AI069428, AI069423, U01 AI069532, AI069502, AI069513, UM1 AI069428, U01 AI069556, UM1 AI069471, U01 AI069484, UM1 AI069495, AI069434, AI069474, AI069532, AI069501, UM1 AI069432, UM1 AI069434, U01 AI069465, R01 AI077505, UM1 AI069424, U01 AI027661, AI077505, AI46370, AI069511, AI069419, UM1 AI069513, U01 AI069423, U01 AI069467, UM1 AI069472, UM1 AI069501, AI069556, U01 AI069434, AI069465, U01 AI069474, AI069415, UM1 AI069423, AI69467, U01 AI069513, U01 AI069502, U01 AI069419, U01 AI069477] Funding Source: Medline; NIMH NIH HHS [MH071205, R01 MH071205] Funding Source: Medline; PHS HHS [AL32782] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust)		Ahmadi KR, 2001, GENES IMMUN, V2, P381, DOI 10.1038/sj.gene.6363796; Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; de la Calle-Martin O, 2001, J CLIN INVEST, V108, P117, DOI 10.1172/JCI10993; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Glisic S, 2009, GENES IMMUN, V10, P334, DOI 10.1038/gene.2009.14; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hall MA, 2000, GENES IMMUN, V1, P423, DOI 10.1038/sj.gene.6363702; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Thomas R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2446; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3	21	68	70	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					88	92		10.1016/j.ajhg.2009.12.008	http://dx.doi.org/10.1016/j.ajhg.2009.12.008			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20045101	Green Published, Bronze			2022-12-18	WOS:000274471200010
J	Quach, H; Barreiro, LB; Laval, G; Zidane, N; Patin, E; Kidd, KK; Kidd, JR; Bouchier, C; Veuille, M; Antoniewski, C; Quintana-Murci, L				Quach, Helene; Barreiro, Luis B.; Laval, Guillaume; Zidane, Nora; Patin, Etienne; Kidd, Kenneth K.; Kidd, Judith R.; Bouchier, Christiane; Veuille, Michel; Antoniewski, Christophe; Quintana-Murci, Lluis			Signatures of Purifying and Local Positive Selection in Human miRNAs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-SELECTION; HUMAN MICRORNA; RNA-INTERFERENCE; POPULATION; IDENTIFICATION; EXPRESSION; GENES; POLYMORPHISM; BIOGENESIS; ARGONAUTE2	MicroRNAs (miRNAs) are noncoding RNAs involved in posttranscriptional gene repression, and their role in diverse physiological processes is increasingly recognized. Yet, few efforts have been devoted to evolutionary studies of human miRNAs. Knowledge about the way in which natural selection has targeted miRNAs should provide insight into their functional relevance as well as their mechanisms of action. Here we used miRNAs as a model system for investigating the influence of natural selection on gene regulation by characterizing the full spectrum of naturally occurring sequence variation of 117 human miRNAs from different populations worldwide. We found that purifying selection has globally constrained the diversity of miRNA-containing regions and has Strongly targeted the mature miRNA. This observation emphasizes that mutations in these molecules are likely to be deleterious, and therefore they can have severe phenotypic consequences on human health. More importantly, we obtained evidence of population-specific events of positive selection acting on a number of miRNA-containing regions. Notably, our analysis revealed that positive selection has targeted a "small-RNA-rich island" on chromosome 14, harboring both miRNAs and small nucleolar RNAs, in Europeans and East Asians. These observations support the notion that the tuning of gene expression contributes to the processes by which populations adapt to specific environments. These findings will fuel future investigations exploring how genetic and functional variation of miRNAs under selection affects the repression of their mRNA targets, increasing our understanding of the role of gene regulation in population adaptation and human disease.	[Quach, Helene; Barreiro, Luis B.; Laval, Guillaume; Patin, Etienne; Quintana-Murci, Lluis] CNRS, Inst Pasteur, URA3012, F-75015 Paris, France; [Kidd, Kenneth K.; Kidd, Judith R.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Veuille, Michel] Museum Natl Hist Nat, Equipe Genet Popolat, Ecole Prat Hautes Etud, UMR 5202, F-75005 Paris, France; [Antoniewski, Christophe] CNRS, Inst Pasteur Genet & Epigenet Drosophila, URA 2578, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yale University; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS)	Quintana-Murci, L (corresponding author), CNRS, Inst Pasteur, URA3012, F-75015 Paris, France.	quintana@pasteur.fr	Quintana-Murci, Lluis/AAB-7468-2022; Barreiro, Luis/I-7772-2015; Antoniewski, Christophe/G-4519-2011; Patin, Etienne/G-6768-2012	Antoniewski, Christophe/0000-0001-7709-2116; Barreiro, Luis/0000-0001-9456-367X; Patin, Etienne/0000-0002-9911-4459; Quintana-Murci, Lluis/0000-0003-2429-6320; Quach, Helene/0000-0002-3493-0973				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2002, GENETICS, V162, P2025; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Pluzhnikov A, 2002, GENETICS, V161, P1209; Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Seitz H, 2006, CELL, V125, P827, DOI 10.1016/j.cell.2006.05.018; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	58	68	70	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					316	327		10.1016/j.ajhg.2009.01.022	http://dx.doi.org/10.1016/j.ajhg.2009.01.022			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19232555	Green Published, Bronze			2022-12-18	WOS:000264304200003
J	Polok, B; Escber, P; Ambresin, A; Chouery, E; Bolay, S; Meunier, I; Nan, F; Hamel, C; Munier, FL; Thilo, B; Megarbane, A; Schorderet, DF				Polok, Bozena; Escber, Pascal; Ambresin, Aude; Chouery, Eliane; Bolay, Sylvain; Meunier, Isabelle; Nan, Francis; Hamel, Christian; Munier, Francis L.; Thilo, Bernard; Megarbane, Andre; Schorderet, Daniel F.			Mutations in CNNM4 Cause Recessive Cone-Rod Dystrophy with Amelogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; PROTEINS; FAMILY; LOCUS; ACDP	Cone-rod dystrophies are inherited dystrophies of the retina characterized by the accumulation of deposits mainly localized to the cone-rich macular region of the eye. Dystrophy can be limited to the retina or be part of a syndrome. Unlike nonsyndromic cone-rod dystrophies, syndromic cone-rod dystrophies are genetically heterogeneous with mutations in genes encoding structural, cell-adhesion, and transporter proteins. Using a genome-wide single-nucleotide polymorphism (SNIP) haplotype analysis to fine map the locus and a gene-candidate approach, we Identified homozygous mutations in the ancient conserved domain protein 4 gene (CNNM4) that either generate a truncated protein or occur in highly conserved regions of the protein. Given that CNNM4 is implicated in metal ion transport, cone-rod dystrophy and amelogenesis imperfecta may originate from abnormal ion homeostasis.	[Polok, Bozena; Escber, Pascal; Bolay, Sylvain; Schorderet, Daniel F.] Inst Rech Ophtalmol, CH-1950 Sion, Switzerland; [Polok, Bozena; Escber, Pascal; Ambresin, Aude; Munier, Francis L.; Schorderet, Daniel F.] Univ Lausanne, Dept Ophthalmol, CH-1004 Lausanne, Switzerland; [Ambresin, Aude; Munier, Francis L.] Jules Gonin Eye Hosp, CH-1004 Lausanne, Switzerland; [Chouery, Eliane; Megarbane, Andre] Univ St Joseph, Fac Med, Unit Genet Med, Beirut 11042020, Lebanon; [Meunier, Isabelle; Nan, Francis; Hamel, Christian] CHRU Montpellier, Ctr Reference Affect Sensorielles Genet, F-34091 Montpellier, France; [Thilo, Bernard] Private Dent Practice, CH-1009 Pully, Switzerland; [Megarbane, Andre] Inst Jerome Lejeune, F-75015 Paris, France; [Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	University of Lausanne; Saint Joseph University Beirut; Universite de Montpellier; CHU de Montpellier; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schorderet, DF (corresponding author), Inst Rech Ophtalmol, CH-1950 Sion, Switzerland.	daniel.schorderet@irovision.ch	Chouery, Eliane/AAC-5957-2021; Megarbane, Andre/ABD-5574-2021		Swiss National Science Foundation [32-111948]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by grant 32-111948 from the Swiss National Science Foundation. We thank the families for their participation and Tatiana Favez, Celine Agosti, Carole Herkenne, Nathalie Voirol, Nicolas Lonfat, Keith Harshman, Otto Hagenbuchle, and Yann Leuba for technical assistance.	Adams NA, 2007, OPHTHALMIC GENET, V28, P113, DOI 10.1080/13816810701537424; Aleman TS, 2002, EXP EYE RES, V74, P737, DOI 10.1006/exer.2002.1169; Aoba T, 1996, ANAT REC, V245, P208, DOI 10.1002/(SICI)1097-0185(199606)245:2<208::AID-AR8>3.0.CO;2-S; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; Downey LM, 2002, EUR J HUM GENET, V10, P865, DOI 10.1038/sj.ejhg.5200884; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Guo DH, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-15; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Huysseune A, 1998, ANAT EMBRYOL, V198, P289, DOI 10.1007/s004290050185; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; JALILI IK, 1988, J MED GENET, V25, P738, DOI 10.1136/jmg.25.11.738; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Michaelides M, 2004, J MED GENET, V41, P468, DOI 10.1136/jmg.2003.015792; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Yang M, 2005, BIOCHEM J, V386, P479, DOI 10.1042/BJ20041582	20	68	70	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					259	265		10.1016/j.ajhg.2009.01.006	http://dx.doi.org/10.1016/j.ajhg.2009.01.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200527	Green Published, Bronze			2022-12-18	WOS:000263799700015
J	Noor, A; Windpassinger, C; Patel, M; Stachowiak, B; Mikhailov, A; Azam, M; Irfan, M; Siddiqui, ZK; Naeem, F; Paterson, AD; Lutfullah, M; Vincent, JB; Ayub, M				Noor, Abdul; Windpassinger, Christian; Patel, Megha; Stachowiak, Beata; Mikhailov, Anna; Azam, Matloob; Irfan, Muhammad; Siddiqui, Zahid Kamal; Naeem, Farooq; Paterson, Andrew D.; Lutfullah, Muhammad; Vincent, John B.; Ayub, Muhammad			CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							5-HT1A RECEPTOR GENE; EPIDEMIOLOGY; REPRESSOR; MUTATION; RATES; SITE	Autosomal-recessive inheritance is believed to be relatively common in mental retardation (MR), although only four genes for nonsyndromic autosomal-recessive mental retardation (ARMR) have been reported. In this study, we ascertained a consanguineous Pakistani family with ARMR in four living individuals from three branches of the family, plus an additional affected individual later identified as a phenocopy. Retinitis pigmentosa was present in affected individuals, but no other features suggestive of a syndromic form of MR were found. We used Affymetrix 500K microarrays to perform homozygosity mapping and identified a homozygous and haploidentical region of 11.2 Mb on chromosome 4p15.33-p15.2. Linkage analysis across this region produced a maximum two-point LOD score of 3.59. We sequenced genes within the critical region and identified a homozygous splice-site mutation segregating in the family, within a coiled-coil and C2 domain-containing gene, CC2D2A. This mutation leads to the skipping of exon 19, resulting in a frameshift and a truncated protein lacking the C2 domain. Conservation analysis for CC2D2A suggests a functional domain near the C terminus as well as the C2 domain. Preliminary functional studies of CC2D2A suggest a possible role in Ca2+-dependent signal transduction. Identifying the function of CC2D2A, and a possible common pathway with CC2D1A, in correct neuronal development and functioning may help identify possible therapeutic targets for MR.	[Noor, Abdul; Windpassinger, Christian; Patel, Megha; Stachowiak, Beata; Mikhailov, Anna; Vincent, John B.] Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON M5T 1R8, Canada; [Windpassinger, Christian] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Azam, Matloob] Pakistan Inst Med Sci, Islamabad 44000, Pakistan; [Irfan, Muhammad] Lahore Inst Res & Dev, Lahore 54000, Pakistan; [Siddiqui, Zahid Kamal] Postgrad Med Inst, Lahore 54000, Pakistan; [Siddiqui, Zahid Kamal] Lahore Gen Hosp, Lahore 54000, Pakistan; [Naeem, Farooq] Sheikh Zayed Hosp, Rahim Yar Khan 64200, Pakistan; [Paterson, Andrew D.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Ayub, Muhammad] St Lukes Hosp, Middlesbrough TS4 3AF, Cleveland, England; [Lutfullah, Muhammad] Mayo Hosp, Lahore 54000, Pakistan	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Medical University of Graz; Pakistan Institute of Medical Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON M5T 1R8, Canada.	john_vincent@camh.net	Paterson, Andrew D/A-4088-2011; Paterson, Andrew/AAQ-7511-2020; Naeem, Farooq/M-2310-2019; Noor, Abdul/J-2345-2016	Paterson, Andrew D/0000-0002-9169-118X; Paterson, Andrew/0000-0002-9169-118X; Naeem, Farooq/0000-0003-4760-4840; 				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curry Cynthia J, 2002, Adolesc Med, V13, P331; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Li C., 2003, ANAL GENE EXPRESSION; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; LINDEN MG, 1995, PEDIATRICS, V96, P672; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Murphy CC, 1998, MENT RETARD DEV D R, V4, P6, DOI 10.1002/(SICI)1098-2779(1998)4:1<6::AID-MRDD3>3.0.CO;2-P; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Ou XM, 2000, J BIOL CHEM, V275, P8161, DOI 10.1074/jbc.275.11.8161; Ou XM, 2003, J NEUROSCI, V23, P7415; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Rogaeva A, 2007, J BIOL CHEM, V282, P20897, DOI 10.1074/jbc.M610038200; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shea Sarah E, 2006, Semin Pediatr Neurol, V13, P262, DOI 10.1016/j.spen.2006.09.010; SHEN X, 2007, P NATL ACAD SCI USA, V102, P5969; Tonk VS, 2003, ANN GENET-PARIS, V46, P453, DOI 10.1016/S0003-3995(03)00029-7; Uyguner O, 2007, CLIN GENET, V71, P212, DOI 10.1111/j.1399-0004.2007.00762.x; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	30	68	74	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					1011	1018		10.1016/j.ajhg.2008.01.021	http://dx.doi.org/10.1016/j.ajhg.2008.01.021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18387594	Green Published, Bronze			2022-12-18	WOS:000255103900019
J	Hejtmancik, JF; Jiao, X; Li, A; Sergeev, YV; Ding, X; Sharma, AK; Chan, CC; Medina, I; Edwards, AO				Hejtmancik, J. Fielding; Jiao, Xiaodong; Li, Anren; Sergeev, Yuri V.; Ding, Xiaoyan; Sharma, Anil K.; Chan, Chi-Chao; Medina, Igor; Edwards, Albert O.			Mutations in KCNJ13 cause autosomal-dominant snowflake vitreoretinal degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINAL-PIGMENT EPITHELIUM; RECTIFIER K+ CHANNEL; POTASSIUM CHANNELS; STICKLER-SYNDROME; WAGNER-SYNDROME; EXPRESSION; KIR7.1; FAMILY	Snowflake vitreoretinal degeneration (SVD, MIM 193230) is a developmental and progressive hereditary eye disorder that affects multiple tissues within the eye. Diagnostic features of SVD include fibrillar degeneration of the vitreous humor, early-onset cataract, minute crystalline deposits in the neurosensory retina, and retinal detachment. A genome-wide scan previously localized the genetic locus for SVD to a 20 Mb region flanked by D2S2158 and D2S22O2. This region contains 59 genes, of which 20 were sequenced, disclosing a heterozygous mutation (484C > T, R162W) in KCNJ13, member 13 of subfamily J of the potassium inwardly rectifying channel family in all affected individuals. The mutation in KCNJ13, the gene encoding Kir7.1, was not present in unaffected family members and 210 control individuals. Kir7.1 localized to human retina and retinal pigment epithelium and was especially prevalent in the internal limiting membrane adjacent to the vitreous body. Molecular modeling of this mutation predicted disruption of the structure of the potassium channel in the closed state located immediately adjacent to the cell-membrane inner boundary. Functionally, unlike wild-type Kir7.1 whose overexpression in CHO-K1 cells line produces highly selective potassium current, overexpression of R162W mutant Kir7.1 produces a nonselective cation current that depolarizes transfected cells and increases their fragility. These results indicate that the KCNJ13 R162W mutation can cause SVD and further show that vitreoretinal degeneration can arise through mutations in genes whose products are not structural components of the vitreous.	[Hejtmancik, J. Fielding; Jiao, Xiaodong; Li, Anren; Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Ding, Xiaoyan; Chan, Chi-Chao] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Ding, Xiaoyan] Sun Yat sen Univ, State Key Lab Ophthalmol 5, Zhongshan Ophthalm Ctr, Guangzhou 510060, Peoples R China; [Sharma, Anil K.; Edwards, Albert O.] Mayo Clin, Coll Med, Dept Ophthalmol, Rochester, MN 55905 USA; [Medina, Igor] INMED INSERM, F-13273 Marseille, France; [Medina, Igor] Mediterranean Univ, F-13273 Marseille, France	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Sun Yat Sen University; Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Hejtmancik, JF (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	f3h@helix.nih.gov	Medina, Igor/O-5532-2016	Medina, Igor/0000-0001-6839-5414; Sharma, Anil/0000-0002-4471-7172	NEI NIH HHS [EY014467, R01 EY014467] Funding Source: Medline; NATIONAL EYE INSTITUTE [Z01EY000281, ZICEY000461, ZIAEY000281, R01EY014467, ZIAEY000476, ZIAEY000222, Z01EY000222, ZIAEY000272, Z01EY000461, Z01EY000272] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; Edwards A., 2006, RETINA-J RET VIT DIS, V4th, P519; Friedland DR, 2007, HEARING RES, V228, P31, DOI 10.1016/j.heares.2007.01.024; HIROSE T, 1980, ANN OPHTHALMOL, V12, P1135; HIROSE T, 1974, AM J OPHTHALMOL, V77, P143, DOI 10.1016/0002-9394(74)90665-5; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Jiao XD, 2004, INVEST OPHTH VIS SCI, V45, P4498, DOI 10.1167/iovs.04-0722; Kloeckener-Gruissem B, 2006, MOL VIS, V12, P350; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Meredith SP, 2007, BRIT J OPHTHALMOL, V91, P655, DOI 10.1136/bjo.2006.104406; MILLER SS, 1990, J PHYSIOL-LONDON, V424, P283, DOI 10.1113/jphysiol.1990.sp018067; MILLER SS, 1978, J MEMBRANE BIOL, V44, P259, DOI 10.1007/BF01944224; Mukhopadhyay A, 2006, INVEST OPHTH VIS SCI, V47, P3565, DOI 10.1167/iovs.06-0141; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Partiseti M, 1998, FEBS LETT, V434, P171, DOI 10.1016/S0014-5793(98)00972-7; QUINN RH, 1992, INVEST OPHTH VIS SCI, V33, P3513; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Snead MP, 1999, J MED GENET, V36, P353; Yang DL, 2003, INVEST OPHTH VIS SCI, V44, P3178, DOI 10.1167/iovs.02-1189; Yasuda K, 2003, CURR EYE RES, V27, P279, DOI 10.1076/ceyr.27.5.279.17226; [No title captured]	29	68	70	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					174	180		10.1016/j.ajhg.2007.08.002	http://dx.doi.org/10.1016/j.ajhg.2007.08.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179896	Bronze, Green Published			2022-12-18	WOS:000253223800018
J	Shen, GQ; Li, L; Girelli, D; Seidelmann, SB; Rao, S; Fan, C; Park, JE; Xi, Q; Li, J; Hu, Y; Olivieri, O; Marchant, K; Barnard, J; Corrocher, R; Elston, R; Cassano, J; Henderson, S; Hazen, SL; Plow, EF; Topol, EJ; Wang, QK				Shen, Gong-Qing; Li, Lin; Girelli, Domenico; Seidelmann, Sara B.; Rao, Shaoqi; Fan, Chun; Park, Jeong Euy; Xi, Quansheng; Li, Jing; Hu, Ying; Olivieri, Oliviero; Marchant, Kandice; Barnard, John; Corrocher, Roberto; Elston, Robert; Cassano, June; Henderson, Susan; Hazen, Stanley L.; Plow, Edward F.; Topol, Eric J.; Wang, Qing K.			An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; APOLIPOPROTEIN-E; LINKAGE DISEQUILIBRIUM; GENE; IDENTIFICATION; TESTS; PHOSPHOLIPIDS; MECHANISM; CELLS; RISK	Our previous genomewide linkage scan of 428 nuclear families (GeneQuest) identified a significant genetic susceptibility locus for premature myocardial infarction (MI) on chromosome 1p34-36. We analyzed candidate genes in the locus with a population-based association study involving probands with premature coronary artery disease (CAD) and/or MI from the GeneQuest families (381 cases) and 560 controls without stenosis detectable by coronary angiography. A nonconservative substitution, R952Q, in LRP8 was significantly associated with susceptibility to premature CAD and/or MI by use of both population-based and family-based designs. Three additional white populations were used for follow-up replication studies: another independent cohort of CAD-and/or MI-affected families (GeneQuest II: 441 individuals from 22 pedigrees), an Italian cohort with familial MI (248 cases) and 308 Italian controls, and a separate Cleveland GeneBank cohort with sporadic MI (1,231 cases) and 560 controls. The association was significantly replicated in two independent populations with a family history of CAD and/or MI, the GeneQuest II family-based replication cohort and the Italian cohort, but not in the population with sporadic disease. The R952Q variant of LRP8 increased activation of p38 mitogenactivated protein kinase by oxidized low-density lipoprotein. This extensive study, involving multiple independent populations, provides the first evidence that genetic variants in LRP8 may contribute to the development of premature and familial CAD and MI.	Cleveland Clin, Ctr Cardiovasc Genet, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; Cleveland Clin, Ctr Cardiovasc Genet, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin, Dept Clin Pathol, Cleveland, OH 44195 USA; Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy; Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea; Scripps Res Inst, Scripps Genom Med, La Jolla, CA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University of Verona; Sungkyunkwan University (SKKU); Samsung Medical Center; Scripps Research Institute	Wang, QK (corresponding author), Cleveland Clin, Ctr Cardiovasc Genet, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.	wangq2@ccf.org	Olivieri, Oliviero/A-9126-2008; Hazen, Stanley L/ABD-5845-2021; Girelli, Domenico/B-1183-2008; Seidelmann, Sara/AAD-9388-2021	Olivieri, Oliviero/0000-0001-8209-9056; Girelli, Domenico/0000-0001-9684-1899; Li, Jing/0000-0003-1160-6959; Topol, Eric/0000-0002-1478-4729; Rao, Shaoqi/0000-0001-7809-3700	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073817, P50HL077107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008991] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL073817, P50 HL77107, P50 HL077107] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, R01 GM28356] Funding Source: Medline; NLM NIH HHS [R01 LM008991, R01 LM008991-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Girelli D, 2000, NEW ENGL J MED, V343, P774, DOI 10.1056/NEJM200009143431104; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Helgadottir A, 2005, AM J HUM GENET, V76, P505, DOI 10.1086/428066; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Johns DG, 2005, PHARMACOL RES, V51, P463, DOI 10.1016/j.phrs.2004.11.008; Korporaal SJA, 2004, J BIOL CHEM, V279, P52526, DOI 10.1074/jbc.M407407200; Korschineck I, 2001, J BIOL CHEM, V276, P13192, DOI 10.1074/jbc.M011795200; Kumar P, 2004, J BIOL CHEM, V279, P43352, DOI 10.1074/jbc.M405777200; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; *S A G E, 2006, STAT AN GEN EP REL 5; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Vorchheimer DA, 2006, MAYO CLIN PROC, V81, P59, DOI 10.4065/81.1.59; Wang LY, 2007, AM J HUM GENET, V80, P650, DOI 10.1086/512981; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Wang Qing, 2005, Curr Atheroscler Rep, V7, P235, DOI 10.1007/s11883-005-0012-6	32	68	71	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					780	791		10.1086/521581	http://dx.doi.org/10.1086/521581			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847002	Bronze, Green Published			2022-12-18	WOS:000249307600018
J	Riaz, N; Steinberg, S; Ahmad, J; Pluzhnikov, A; Riazuddin, S; Cox, NJ; Drayna, D				Riaz, N; Steinberg, S; Ahmad, J; Pluzhnikov, A; Riazuddin, S; Cox, NJ; Drayna, D			Genomewide significant linkage to stuttering on chromosome 12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSPECIFIED RELATIONSHIPS; PROGRAM; TESTS	Stuttering is a common and sometimes severe communication disorder, of unknown primary etiology, that exists in populations worldwide. Many types of evidence suggest a genetic contribution to stuttering; however, the complex inheritance of this disorder has hindered identification of these factors. We have employed highly inbred families to increase the power of linkage analysis of this disorder. Forty-four Pakistani families with documented or probable consanguinity, from the city of Lahore and surrounding areas, were included. Each family contained multiple cases of stuttering, which were diagnosed using the Stuttering Severity Instrument. Using the Marshfield Weber 9 marker panel, we performed a genomewide linkage scan focused on affected individuals and their parents. The analysis included 199 genotyped individuals, 144 affected and 55 unaffected. The Pedigree Relationship Statistical Test (PREST) was used to identify pedigrees that required additional specification of inbreeding. Initial nonparametric analysis gave evidence of linkage on chromosomes 1, 5, 7, and 12. Additional genotyping was performed on chromosome 12 to a 5-cM level of resolution, and 16 additional individuals were then included, bringing the number of families to 46. Analysis of the enlarged data set provided consistent evidence of linkage on chromosome 12: the S-homoz scoring function gave a nonparametric LOD score of 4.61, and a LOD score of 3.51 was obtained using the S-all scoring function. These results suggest that a locus on chromosome 12q may contain a gene with a large effect in this sample.	Natl Inst Deafness & Other Commun Disorders, NIH, Rockville, MD USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Chicago; University of Punjab	Drayna, D (corresponding author), 5 Res Court,Room 2B-46, Rockville, MD 20850 USA.	drayna@nidcd.nih.gov	SHEIKH, RIAZUDDIN/L-2406-2015; Ahmad, Jamil/D-4130-2009		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004415, ZIADC000046, Z01DC000046] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-04415, R01 DC004415] Funding Source: Medline; PHS HHS [Z01-000046-04] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bloodstein O., 1995, HDB STUTTERING; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Drayna D, 1999, AM J HUM GENET, V65, P1473, DOI 10.1086/302625; Felsenfeld S, 1997, J SPEECH LANG HEAR R, V40, P778, DOI 10.1044/jslhr.4004.778; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GUDBJARTSSON DF, 2000, FAST MULTIPOINT LINK; HOWIE PM, 1981, J SPEECH HEAR RES, V24, P317, DOI 10.1044/jshr.2403.317; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Lange K., 2001, AM J HUM GENET S, V69, pA1886; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pluzhnikov A, 2003, AM J HUM GENET, V73, P438; RILEY GD, 1980, SSI3 STUTTERING SEVE; Shugart YY, 2004, AM J MED GENET A, V124A, P133, DOI 10.1002/ajmg.a.20347; Sun L, 2001, GENET EPIDEMIOL, V21, pS36, DOI 10.1002/gepi.2001.21.s1.s36; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yairi E, 1996, J SPEECH HEAR RES, V39, P771, DOI 10.1044/jshr.3904.771	18	68	76	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					647	651		10.1086/429226	http://dx.doi.org/10.1086/429226			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15714404	Bronze, Green Published			2022-12-18	WOS:000227516000010
J	Xu, JF; Zheng, SL; Komiya, A; Mychaleckyj, JC; Isaacs, SD; Chang, BL; Turner, AR; Ewing, CM; Wiley, KE; Hawkins, GA; Bleecker, ER; Walsh, PC; Meyers, DA; Isaacs, WB				Xu, JF; Zheng, SL; Komiya, A; Mychaleckyj, JC; Isaacs, SD; Chang, BL; Turner, AR; Ewing, CM; Wiley, KE; Hawkins, GA; Bleecker, ER; Walsh, PC; Meyers, DA; Isaacs, WB			Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-ASSOCIATED MACROPHAGES	Rare germline mutations of macrophage scavenger receptor 1 (MSR1) gene were reported to be associated with prostate cancer risk in families with hereditary prostate cancer (HPC) and in patients with non-HPC (Xu et al. 2002). To further evaluate the role of MSR1 in prostate cancer susceptibility, at Johns Hopkins Hospital, we studied five common variants of MSR1 in 301 patients with non-HPC who underwent prostate cancer treatment and in 250 control subjects who participated in prostate cancer-screening programs and had normal digital rectal examination and PSA levels (>4 ng/ml). Significantly different allele frequencies between case subjects and control subjects were observed for each of the five variants (P value range.01-.04). Haplotype analyses provided consistent findings, with a significant difference in the haplotype frequencies from a global score test (P = .01). Because the haplotype that is associated with the increased risk for prostate cancer did not harbor any of the known rare mutations, it appears that the observed association of common variants and prostate cancer risk are independent of the effect of the known rare mutations. These results consistently suggest that MSR1 may play an important role in prostate carcinogenesis.	Wake Forest Univ, Sch Med, Ctr Human Genet, Winston Salem, NC 27157 USA; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA	Wake Forest University; Johns Hopkins University; Johns Hopkins Medicine	Xu, JF (corresponding author), Wake Forest Univ, Sch Med, Ctr Human Genet, Med Ctr Blvd, Winston Salem, NC 27157 USA.				NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; NCI NIH HHS [CA58236, P50 CA058236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; EMI M, 1993, J BIOL CHEM, V268, P2120; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Nelson WG, 2001, UROLOGY, V57, P39, DOI 10.1016/S0090-4295(00)00939-0; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI13903; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shimura S, 2000, CANCER RES, V60, P5857; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Weir B., 1996, GENETIC DATA ANAL; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994	14	68	74	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					208	212		10.1086/345802	http://dx.doi.org/10.1086/345802			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12471593	Green Published, Bronze			2022-12-18	WOS:000180186800022
J	Wiltshire, S; Cardon, LR; McCarthy, MI				Wiltshire, S; Cardon, LR; McCarthy, MI			Evaluating the results of genomewide linkage scans of complex traits by locus counting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; GENETIC DISSECTION; PEDIGREES; DISEASES; MAP	The evaluation of results from primary genomewide linkage scans of complex human traits remains an area of importance and considerable debate. Apart from the usual assessment of statistical significance by use of asymptotic and empirical calculations, an additional means of evaluation-based on counting the number of distinct regions showing evidence of linkage-is possible. We have explored the characteristics of such a locus-counting method over a range of experimental conditions typically encountered during genomewide scans for complex trait loci. Under the null hypothesis, factors that have an impact on the informativeness of the data-such as map density, availability of parental data, and completeness of genotyping-are seen to markedly influence the number of regions of excess allele sharing and the empirically derived genomewide significance of the associated LOD score thresholds. In some circumstances, the expected number of regions is less than one-quarter of that predicted under the assumption of a dense map and complete extraction of inheritance information. We have applied this method to a previously analyzed data set-the Warren 2 genome scan for type 2-diabetes susceptibility- and demonstrate that more regions showing evidence for linkage were observed in the primary genome scan than would be expected by chance, across the whole range of LOD scores, even though no single linkage result achieved empirical genomewide statistical significance. Locus counting may be useful in assessing the results from genome scans for complex traits in general, especially because relatively few scans generate evidence for linkage reaching genomewide significance by dense-map criteria. By taking account of the effects of reduced data informativeness on the expected number of regions showing evidence for linkage, a more meaningful, and less conservative, evaluation of the results from such linkage studies is possible.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ London Imperial Coll Sci Technol & Med, Imperial Coll Genet, London, England; Univ London Imperial Coll Sci Technol & Med, Genome Res Inst, London, England	University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Imperial College London	Wiltshire, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		McCarthy, Mark/M-3763-2015	McCarthy, Mark/0000-0002-4393-0510				Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Gordon D, 2000, Pac Symp Biocomput, P663; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hsieh CL, 2001, AM J HUM GENET, V69, P148, DOI 10.1086/321281; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Nicolae DL, 2002, NAT GENET, V30, P3, DOI 10.1038/ng0102-3; Ott J, 1999, ANAL HUMAN GENETIC L; ROSS S, 1988, 1 COURS PROB; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355	21	68	68	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1175	1182		10.1086/342976	http://dx.doi.org/10.1086/342976			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12355401	Green Published, Bronze			2022-12-18	WOS:000178884300015
J	Angius, A; Petretto, E; Maestrale, GB; Forabosco, P; Casu, G; Piras, D; Fanciulli, M; Falchi, M; Melis, PM; Palermo, M; Pirastu, M				Angius, A; Petretto, E; Maestrale, GB; Forabosco, P; Casu, G; Piras, D; Fanciulli, M; Falchi, M; Melis, PM; Palermo, M; Pirastu, M			A new essential hypertension susceptibility locus on chromosome 2p24-p25, detected by genomewide search	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; INFLUENCING BLOOD-PRESSURE; MARKER ALLELE FREQUENCIES; EPITHELIAL SODIUM-CHANNEL; MAPPING COMPLEX TRAITS; LINKAGE ANALYSIS; GENETIC-LINKAGE; RECEPTOR LOCUS; DISEASE GENES; LOD SCORES	Essential hypertension (EH) is a complex disorder that results from the interaction of a number of susceptibility genes and environmental factors. We studied an isolated Sardinian village (Talana) in which the prevalence of hypertension is comparable to that in most Western populations. Talana exhibits features, such as slow demographic growth, high inbreeding, a low number of founders, stable lifestyle and culture, and accurate genealogical records, that make it suitable for the study of complex disorders. Clinical assessment of the entire adult population (N = similar to 1,000) identified similar to100 hypertensive subjects. For our study, we selected the individuals with the most-severe EH (i.e., diastolic blood pressure >100 mm Hg), belonging to a single deep-rooted pedigree (12 generations), whose common ancestors lived in the 17th century. We performed a three-stage genomewide search using 36 affected individuals, by means of parametric linkage and allele-sharing approaches. LOD scores >1 were observed on chromosomes 1, 2, 13, 15, 17, and 19 (stage 1). The most striking result was found in a 7.57-cM region on chromosome 2p24-p25. All five nonparametric linkage statistics estimated by the SimWalk2 program lie above the significance threshold of P <.008 for the whole region. Similar significance was obtained for 2p24-25 when parametric linkage (LOD score 1.99) and linkage disequilibrium mapping (P =.00006) were used, suggesting that a hypertension-susceptibility locus is located between D2S2278 and D2S168. This finding is strengthened by a recent report of linkage with marker D2S168 in a hypertensive sib-pair sample from China.	CNR, Ist Genet Popolaz, Alghero, Italy; Univ Sassari, Ist Endocrinol, I-07100 Sassari, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Sassari	Angius, A (corresponding author), CNR, Ist Genet Popolaz, Casella Postale, I-07040 Sassari, Italy.		maestrale, giovanni battista/AAX-8187-2020; Falchi, Mario/F-5956-2013; Angius, Andrea/P-9549-2015; Angius, Andrea/B-8966-2015; Forabosco, Paola/AAM-5540-2021	maestrale, giovanni battista/0000-0002-1052-5113; Angius, Andrea/0000-0003-2596-6461; Angius, Andrea/0000-0001-9372-1162; Falchi, Mario/0000-0002-5646-1004				Allayee H, 2001, HYPERTENSION, V38, P773, DOI 10.1161/hy1001.092617; Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Boerwinkle E, 2002, HYPERTENSION, V39, P3; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; CIULLA TA, 1988, ANAL BIOCHEM, V174, P485, DOI 10.1016/0003-2697(88)90047-4; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Disse-Nicodeme S, 2000, AM J HUM GENET, V67, P302, DOI 10.1086/303020; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Escamilla MA, 2001, AM J MED GENET, V105, P207, DOI 10.1002/ajmg.1205; FREIMER NB, 1993, AM J HUM GENET, V52, P1102; Garner C, 2001, AM J HUM GENET, V68, P1061, DOI 10.1086/319517; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hollenberg N K, 2001, Curr Hypertens Rep, V3, P7; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Hsueh WC, 2000, CIRCULATION, V101, P2810, DOI 10.1161/01.CIR.101.24.2810; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; Kato N, 2000, ARTERIOSCL THROM VAS, V20, P223, DOI 10.1161/01.ATV.20.1.223; Kato N, 1999, MAMM GENOME, V10, P259, DOI 10.1007/s003359900983; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Krushkal J, 1998, HUM MOL GENET, V7, P1379, DOI 10.1093/hmg/7.9.1379; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; NECHIPORUK A, 1993, AM J MED GENET, V48, P63, DOI 10.1002/ajmg.1320480113; NIKALI K, 1995, AM J HUM GENET, V56, P1088; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; Ombra MN, 2001, AM J HUM GENET, V68, P1119, DOI 10.1086/320105; OTT J, 1992, AM J HUM GENET, V51, P283; Pankow JS, 2000, HYPERTENSION, V36, P471, DOI 10.1161/01.HYP.36.4.471; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Sugiyama F, 2001, GENOMICS, V71, P70, DOI 10.1006/geno.2000.6401; Svetkey LP, 1997, HYPERTENSION, V29, P918, DOI 10.1161/01.HYP.29.4.918; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Timberlake DS, 2001, CURR OPIN NEPHROL HY, V10, P71, DOI 10.1097/00041552-200101000-00012; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Wright FA, 1999, HYPERTENSION, V34, P625, DOI 10.1161/01.HYP.34.4.625; Zhu DL, 2001, J HYPERTENS, V19, P55, DOI 10.1097/00004872-200101000-00008	58	68	71	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					893	905		10.1086/342929	http://dx.doi.org/10.1086/342929			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12228842	Green Published, Bronze			2022-12-18	WOS:000178613800016
J	Fields, RR; Zhou, GM; Huang, DL; Davis, JR; Moller, C; Jacobson, SG; Kimberling, WJ; Sumegi, J				Fields, RR; Zhou, GM; Huang, DL; Davis, JR; Moller, C; Jacobson, SG; Kimberling, WJ; Sumegi, J			Usher syndrome type III: Revised genomic structure of the USH3 gene and identification of novel mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROGENEITY; REGION	Usher syndrome type III is an autosomal recessive disorder characterized by progressive sensorineural hearing loss, vestibular dysfunction, and retinitis pigmentosa. The disease gene was localized to 3q25 and recently was identified by positional cloning. In the present study, we have revised the structure of the USH3 gene, including a new translation start site, 5 untranslated region, and a transcript encoding a 232-amino acid protein. The mature form of the protein is predicted to contain three transmembrane domains and 204 residues. We have found four new disease-causing mutations, including one that appears to be relatively common in the Ashkenazi Jewish population. We have also identified mouse (chromosome 3) and rat (chromosome 2) orthologues, as well as two human paralogues on chromosomes 4 and 10.	Univ Nebraska, Ctr Study Treatment Usher Syndrome, Boys Town Natl Res Hosp, Med Ctr, Omaha, NE 68131 USA; Univ Nebraska, Ctr Human Mol Genet, Med Ctr, Omaha, NE 68131 USA; Univ Nebraska, Dept Pathol & Microbiol, Med Ctr, Omaha, NE 68131 USA; Sahlgrenska Univ Hosp, Dept Audiol, Gothenburg, Sweden; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	Boys Town National Research Hospital; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Sahlgrenska University Hospital; University of Pennsylvania; Pennsylvania Medicine	Kimberling, WJ (corresponding author), Univ Nebraska, Ctr Study Treatment Usher Syndrome, Boys Town Natl Res Hosp, Med Ctr, 555 N 30th St, Omaha, NE 68131 USA.				NATIONAL EYE INSTITUTE [R01EY005627, R01EY013385, U10EY013729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813] Funding Source: NIH RePORTER; NEI NIH HHS [EY-13729, NIH EY-05627, EY-13385, R01 EY013385, U10 EY013729] Funding Source: Medline; NIDCD NIH HHS [1R01 DCO3162-01A2, P01 DC01813] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Astuto LM, 2000, AM J HUM GENET, V67, P1569, DOI 10.1086/316889; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Joensuu T, 1996, GENOMICS, V38, P255, DOI 10.1006/geno.1996.0626; Joensuu T, 2000, GENOMICS, V63, P409, DOI 10.1006/geno.1999.6096; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kimberling WJ, 2000, ADV OTO-RHINO-LARYNG, V56, P11; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1	8	68	70	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					607	617		10.1086/342098	http://dx.doi.org/10.1086/342098			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145752	Green Published, Bronze			2022-12-18	WOS:000177489600014
J	Watkins, D; Ru, M; Hwang, HY; Kim, CD; Murray, A; Philip, NS; Kim, W; Legakis, H; Wai, T; Hilton, JF; Ge, B; Dore, C; Hosack, A; Wilson, A; Gravel, RA; Shane, B; Hudson, TJ; Rosenblatt, DS				Watkins, D; Ru, M; Hwang, HY; Kim, CD; Murray, A; Philip, NS; Kim, W; Legakis, H; Wai, T; Hilton, JF; Ge, B; Dore, C; Hosack, A; Wilson, A; Gravel, RA; Shane, B; Hudson, TJ; Rosenblatt, DS			Hyperhomocysteinemia due to methionine synthase deficiency, cblG: Structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE; HOMOCYSTEINE METABOLISM; PLASMA HOMOCYSTEINE; FOLATE LEVELS; CDNA CLONING; RISK-FACTORS; COBALAMIN; PROTEIN; POLYMORPHISMS; FLAVOPROTEIN	Mutations in the MTR gene, which encodes methionine synthase on human chromosome 1p43, result in the methylcobalamin deficiency G (cblG) disorder, which is characterized by homocystinuria, hyperhomocysteinemia, and hypomethioninemia. To investigate the molecular basis of the disorder, we have characterized the structure of the MTR gene, thereby identifying exon-intron boundaries. This enabled amplification of each of the 33 exons of the gene, from genomic DNA from a panel of 21 patients with cblG. Thirteen novel mutations were identified. These included five deletions (c. 12-13delGC, c.381delA, c.2101delT, c.2669-2670delTG, and c. 2796-2800delAAGTC) and two nonsense mutations (R585X and E1204X) that would result in synthesis of truncated proteins that lack portions critical for enzyme function. One mutation was identified that resulted in conversion of A to C of the invariant A of the 3 splice site of intron 9. Five missense mutations (A410P, S437Y, S450H, H595P, and I804T) were identified. The latter mutations, as well as the splice-site mutation, were not detected in a panel of 50 anonymous DNA samples, suggesting that these sequence changes are not polymorphisms present in the general population. In addition, a previously described missense mutation, P1173L, was detected in 16 patients in an expanded panel of 24 patients with cblG. Analysis of haplotypes constructed using sequence polymorphisms identified within the MTR gene demonstrated that this mutation, a C-->T transition in a CpG island, has occurred on at least two separate genetic backgrounds.	McGill Univ, Ctr Hlth, Div Med Genet, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Montreal Genome Ctr, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; University of California System; University of California Berkeley; University of Calgary; McGill University	Watkins, D (corresponding author), McGill Univ, Ctr Hlth, Div Med Genet, Dept Med, Room H5-63,Royal Victoria Hosp Site,687 Pine Ave, Montreal, PQ H3A 1A1, Canada.	dwatkins@generation.net	Philip, Noah S/C-3714-2016	Philip, Noah S/0000-0002-4889-8775; Wai, Timothy/0000-0002-6770-6222	NHLBI NIH HHS [HL58991] Funding Source: Medline; NIDDK NIH HHS [DK42033, R01 DK042033] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042033] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANERJEE RV, 1989, J BIOL CHEM, V264, P13888; Carmel R., 2001, HOMOCYSTEINE HLTH DI; Chen J, 2001, ATHEROSCLEROSIS, V154, P667, DOI 10.1016/S0021-9150(00)00469-X; Chen LH, 1997, J BIOL CHEM, V272, P3628, DOI 10.1074/jbc.272.6.3628; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; CHRISTENSEN B, 1995, BAILLIERE CLIN HAEM, V8, P617, DOI 10.1016/S0950-3536(05)80223-9; Dekou V, 2001, THROMB HAEMOSTASIS, V85, P67, DOI 10.1055/s-0037-1612906; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; DRUMMOND JT, 1993, BIOCHEMISTRY-US, V32, P9290, DOI 10.1021/bi00087a005; Goulding CW, 1997, BIOCHEMISTRY-US, V36, P8082, DOI 10.1021/bi9705164; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; Hyndman ME, 2000, AM J CARDIOL, V86, P1144, DOI 10.1016/S0002-9149(00)01177-2; James SJ, 1999, AM J CLIN NUTR, V70, P495; Kim Y, 1999, NUTR REV, V57, P314; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Li YN, 1996, HUM MOL GENET, V5, P1851, DOI 10.1093/hmg/5.12.1851; Matthews R. G., 1999, Chemistry and biochemistry of B12., P681; Matthews RG, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P100; Morita H, 1999, ARTERIOSCL THROM VAS, V19, P298, DOI 10.1161/01.ATV.19.2.298; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Rosenblatt DS, 2001, METABOLIC MOL BASES, P3897; Rozen R, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P259; Shaw GM, 1999, J MED GENET, V36, P86; Suormala S. T., 2001, Journal of Inherited Metabolic Disease, V24, P55; Tang BQ, 2000, CANCER RES, V60, P5543; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Ueland PM, 2001, LIPIDS, V36, pS33, DOI 10.1007/s11745-001-0679-7; Wang XL, 1999, ATHEROSCLEROSIS, V146, P133, DOI 10.1016/S0021-9150(99)00111-2; WATKINS D, 1989, AM J MED GENET, V34, P427, DOI 10.1002/ajmg.1320340320; Wilson A, 1998, AM J HUM GENET, V63, P409, DOI 10.1086/301976; Wong WY, 1999, TERATOLOGY, V60, P253, DOI 10.1002/(SICI)1096-9926(199911)60:5<253::AID-TERA4>3.0.CO;2-V; Yamada K, 1998, BIOSCI BIOTECH BIOCH, V62, P2155, DOI 10.1271/bbb.62.2155	34	68	71	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					143	153		10.1086/341354	http://dx.doi.org/10.1086/341354			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12068375	Bronze, Green Published			2022-12-18	WOS:000176307700014
J	Huizing, M; Anikster, Y; Fitzpatrick, DL; Jeong, AB; D'Souza, M; Rausche, M; Toro, JR; Kaiser-Kupfer, MI; White, JG; Gahl, WA				Huizing, M; Anikster, Y; Fitzpatrick, DL; Jeong, AB; D'Souza, M; Rausche, M; Toro, JR; Kaiser-Kupfer, MI; White, JG; Gahl, WA			Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN COMPLEX; OCULOCUTANEOUS ALBINISM; GRANULOMATOUS COLITIS; LOCUS HETEROGENEITY; PULMONARY FIBROSIS; VESICLE FORMATION; TYROSINASE GENE; HPS GENE; MUTATIONS; ADAPTER	Hermansky-Pudlak syndrome (HPS), consisting of oculocutaneous albinism and a bleeding diathesis due to the absence of platelet dense granules, displays extensive locus heterogeneity. HPS1 mutations cause HPS-1 disease, and ADTB3A mutations cause HPS-2 disease, which is known to involve abnormal intracellular vesicle formation. A third HPS-causing gene, HPS3, was recently identified on the basis of homozygosity mapping of a genetic isolate of HPS in central Puerto Rico. We now describe the clinical and molecular characteristics of eight patients with HPS-3 who are of non-Puerto Rican heritage. Five are Ashkenazi Jews; three of these are homozygous for a 1303+1G -->A splice-site mutation that causes skipping of exon 5, deleting an RsaI restriction site and decreasing the amounts of mRNA found on northern blotting. The other two are heterozygous for the 1303+1G -->A mutation and for either an 1831+2T -->G or a 2621-2A -->G splicing mutation. Of 235 anonymous Ashkenazi Jewish DNA samples, one was heterozygous for the 1303+1G -->A mutation. One seven-year-old boy of German/Swiss extraction was compound heterozygous for a 2729+1G -->C mutation, causing skipping of exon 14, and resulting in a C1329T missense (R396W), with decreased mRNA production. A 15-year-old Irish/English boy was heterozygous for an 89-bp insertion between exons 16 and 17 resulting from abnormal splicing; his fibroblast HPS3 mRNA is normal in amount but is increased in size. A 12-year-old girl of Puerto Rican and Italian background has the 3,904-bp founder deletion from central Puerto Rico on one allele. All eight patients have mild symptoms of HPS; two Jewish patients had received the diagnosis of ocular, rather than oculocutaneous, albinism. These findings expand the molecular diagnosis of HPS, provide a screening method for a mutation common among Jews, and suggest that other patients with mild hypopigmentation and decreased vision should be examined for HPS.	NICHHD, NIH, Sect Human Biochem Genet, Heritable Disorders Branch, Bethesda, MD 20892 USA; NCI, NIH, Genet Epidemiol Branch, Bethesda, MD 20892 USA; NEI, Ophthalm Genet & Clin Serv Branch, Bethesda, MD 20892 USA; Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Minnesota System; University of Minnesota Twin Cities	Gahl, WA (corresponding author), NICHHD, NIH, Sect Human Biochem Genet, Heritable Disorders Branch, 10 Ctr Dr,MSC 1830,Bldg 10,Room 9s-241, Bethesda, MD 20892 USA.		Huizing, Marjan/AAR-8860-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000131] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Bailin T, 1997, J INVEST DERMATOL, V108, P923, DOI 10.1111/1523-1747.ep12294634; Brantly M, 2000, CHEST, V117, P129, DOI 10.1378/chest.117.1.129; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; GARAY SM, 1979, AM J MED, V66, P737, DOI 10.1016/0002-9343(79)91111-2; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; HARMON KR, 1994, J LAB CLIN MED, V123, P617; Hazelwood S, 1997, AM J HUM GENET, V61, P1088, DOI 10.1086/301611; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Huizing M, 2000, TRAFFIC, V1, P823, DOI 10.1034/j.1600-0854.2000.011103.x; Huizing M, 2001, MOL BIOL CELL, V12, P2075, DOI 10.1091/mbc.12.7.2075; HUIZING M, 2001, PIGM CELL RES, V14, P228; HUIZING M, IN PRESS MOL GENET M; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; Iwata F, 2000, OPHTHALMOLOGY, V107, P783, DOI 10.1016/S0161-6420(99)00150-5; KING RA, 2001, METABOLIC MOL BASES, P5587; Luria SE, 1943, GENETICS, V28, P491; MAHADEO R, 1991, J PEDIATR-US, V118, P904, DOI 10.1016/S0022-3476(05)82204-8; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Passmore LA, 1999, HUM GENET, V105, P200; Sambrook J, 1989, MOL CLONING LAB MANU; SCHINELLA RA, 1980, ANN INTERN MED, V92, P20, DOI 10.7326/0003-4819-92-1-20; Shotelersuk V, 2000, AM J MED, V108, P423, DOI 10.1016/S0002-9343(99)00436-2; Shotelersuk V, 1998, MOL GENET METAB, V65, P85, DOI 10.1006/mgme.1998.2729; SIMON JW, 1982, AM J OPHTHALMOL, V93, P71, DOI 10.1016/0002-9394(82)90701-2; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SUMMERS CG, 1988, OPHTHALMOLOGY, V95, P545; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Toro J, 1999, ARCH DERMATOL, V135, P774, DOI 10.1001/archderm.135.7.774; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; WITKOP CJ, 1987, AM J HEMATOL, V26, P305, DOI 10.1002/ajh.2830260403; WITKOP CJ, 1988, LIPOFUCHSIN 1987 STA, P413; Zlotogora J, 2000, MOL GENET METAB, V69, P169, DOI 10.1006/mgme.2000.2969	40	68	70	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1022	1032		10.1086/324168	http://dx.doi.org/10.1086/324168			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11590544	Green Published, Bronze			2022-12-18	WOS:000171413400010
J	Schork, NJ; Nath, SK; Fallin, D; Chakravarti, A				Schork, NJ; Nath, SK; Fallin, D; Chakravarti, A			Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIATION; GENETIC-MARKERS; ASSOCIATION; DISCORDANT; DISEASE; PARENTS; TESTS; PAIRS; TDT	Linkage disequilibrium (LD) mapping has been applied to many simple, monogenic, overtly Mendelian human traits, with great success. However, extensions and applications of LD mapping approaches to more complex human quantitative traits have not been straightforward. In this article, we consider the analysis of biallelic DNA marker loci and human quantitative trait loci in settings that involve sampling individuals from opposite ends of the trait distribution. The purpose of this sampling strategy is to enrich samples for individuals likely to possess land not possess) trait-influencing alleles. Simple statistical models for detecting LD between a trait-influencing allele and neighboring marker alleles are derived that make use of this sampling scheme. The power of the proposed method is investigated analytically for some hypothetical gene-effect scenarios. Our studies indicate that LD mapping of loci influencing human quantitative trait variation should be possible in certain settings. Finally, we consider possible extensions of the proposed methods, as well as areas for further consideration and improvement.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Ctr, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44109 USA; Genset Corp, Dept Stat Genomics, La Jolla, CA USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University	Schork, NJ (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Ctr, R215 Rammelkamp Bldg,2500 MetroHlth Dr, Cleveland, OH 44109 USA.	njs2@po.cwru.edu		Schork, Nicholas/0000-0003-0920-5013	NCRR NIH HHS [P41 RR003655, RR03655-11] Funding Source: Medline; NHLBI NIH HHS [P50 HL054998, HL54998-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054998] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allison DB, 1997, AM J HUM GENET, V60, P676; ALLISON DB, 1998, HUM HERED, V15, P261; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Devlin B, 1999, AM J HUM GENET, V65, pA83; EWENS WJ, 1995, AM J HUM GENET, V57, P455; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; Gu C, 1997, GENET EPIDEMIOL, V14, P791, DOI 10.1002/(SICI)1098-2272(1997)14:6<791::AID-GEPI38>3.0.CO;2-J; JORDE LB, 1995, AM J HUM GENET, V56, P11; LEWONTIN RC, 1988, GENETICS, V120, P849; LONG JC, 1995, AM J HUM GENET, V56, P799; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; McGinnis RE, 1998, ANN HUM GENET, V62, P159, DOI 10.1046/j.1469-1809.1998.6220159.x; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Nielsen DM, 1999, GENET RES, V74, P271, DOI 10.1017/S0016672399004231; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schlesselman James J., 1982, CASE CONTROL STUDIES; Schork N J, 1996, Stat Methods Med Res, V5, P155, DOI 10.1177/096228029600500204; SCHORK NJ, 2000, ADV HUMAN GENETICS; SCHORK NJ, 2000, ADV GENETICS; Slatkin M, 1999, AM J HUM GENET, V64, P1765, DOI 10.1086/302413; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405	32	68	71	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1208	1218		10.1086/321201	http://dx.doi.org/10.1086/321201			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032785	Green Published, Bronze			2022-12-18	WOS:000165091600018
J	Ciotti, P; Struewing, JP; Mantelli, M; Chompret, A; Avril, MF; Santi, PL; Tucker, MA; Bianchi-Scarra, G; Bressac-de Paillerets, B; Goldstein, AM				Ciotti, P; Struewing, JP; Mantelli, M; Chompret, A; Avril, MF; Santi, PL; Tucker, MA; Bianchi-Scarra, G; Bressac-de Paillerets, B; Goldstein, AM			A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMLINE MUTATIONS; MALIGNANT-MELANOMA; PHENOTYPE ANALYSIS; PANCREATIC-CANCER; P16 GENE; KINDREDS; P16(INK4); HAPLOTYPE; INHIBITION; NEOPLASIA	Germline mutations within the coding region of CDKN2A have been observed in affected members of melanoma-prone families. G101W is the most common CDKN2A missense mutation identified to date. It has been reported in several families from around the world, with a particularly high occurrence in France and Italy. Given the frequency of this mutation, we were interested in determining whether the mutation resulted from a single origin or represented a mutational hotspot in the CDKN2A gene. rn addition, given the geographical distribution of the mutation, we examined the date of origination of the mutation and its migratory spread. We examined 10 families from Italy, 4 families from the United States, and 6 families from France with the G101W mutation. The following eight markers were employed for the haplotype analysis: IFNA, D9S736, D9S1749, D9S942, D9S1748, D9S1604, D9S171, and D9S126. Our findings showed no significant evidence for mutational heterogeneity, suggesting that all studied families derived from a single ancestral haplotype on which the mutation arose. Using maximum-likelihood methods, we estimated the mutation to have arisen 97 generations ago (1-LOD-unit support interval 70-133 generations) providing some explanation for the wide geographical spread of this common mutation, particularly in southwestern Europe. The presence of a founder mutation in a defined geographic area can facilitate carrier detection and genetic counseling and can provide an opportunity to study disease penetrance and the effect of environmental factors on the background of a common genetic susceptibility.	NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; Ist Nazl Ric Canc, Genoa, Italy; Inst Gustave Roussy, Unite Marqueurs Genet Canc, Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Genoa; University of Genoa; IRCCS AOU San Martino IST; UNICANCER; Gustave Roussy	Goldstein, AM (corresponding author), NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,MSC 7236, Bethesda, MD 20892 USA.		Scarrà, Giovanna Bianchi/G-8933-2014; Mantelli, Marcia/Y-5961-2018; Struewing, Jeffery P/I-7502-2013; Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/C-3221-2008; Paillerets, Brigitte Bressac-de/D-8954-2018	Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Mantelli, Marcia/0000-0002-6276-8993; Struewing, Jeffery P/0000-0002-4848-3334; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608	NATIONAL CANCER INSTITUTE [Z01CP004410, ZIACP004410] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borg A, 1996, CANCER RES, V56, P2497; DIETLER M, 1995, CELTIC CHIEFDOM CELT; Dracopoli NC, 1996, CANCER SURV, V26, P115; Flores JF, 1997, ONCOGENE, V15, P2999, DOI 10.1038/sj.onc.1201470; Ghiorzo P, 1999, INT J CANCER, V83, P441, DOI 10.1002/(SICI)1097-0215(19991112)83:4<441::AID-IJC2>3.0.CO;2-R; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; GOLDSTEIN AM, 2000, IN PRESS J NATL CANC; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; Guglielmino CR, 1998, ANN HUM GENET, V62, P261, DOI 10.1046/j.1469-1809.1998.6230261.x; Harland M, 1997, HUM MOL GENET, V6, P2061, DOI 10.1093/hmg/6.12.2061; Hayward Nicholas K., 1996, Current Opinion in Oncology, V8, P136, DOI 10.1097/00001622-199603000-00011; Holland EA, 1995, ONCOGENE, V11, P2289; HUBERT H, 1974, CELTES EXPANSION CEL, V1; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; MABILLON, 1733, ACTA SANCTORUM ORDIN, V1, P3; METLAKE G, 1914, LIFE WRITINGS ST COL; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; PALLOTTINO M, 1984, STORIA PRIMA ITALIA; Parry D, 1996, MOL CELL BIOL, V16, P3844; PIAZZA A, 1988, ANN HUM GENET, P52203; Platz A, 1997, J NATL CANCER I, V89, P697, DOI 10.1093/jnci/89.10.697; Pollock PM, 1998, HUM MUTAT, V11, P424, DOI 10.1002/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.3.CO;2-U; RANADE K, 1995, NAT GENET, V10, P114, DOI 10.1038/ng0595-114; Rendine S, 1997, ANN HUM GENET, V61, P411; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Ruiz A, 1999, J MED GENET, V36, P490; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; VIOLANTE A, 1993, TENE PERIOD CELTI SU; Vitali D., 1987, ATT C INT BOL 12 14; WALKER GJ, 1995, HUM MOL GENET, V4, P1845, DOI 10.1093/hmg/4.10.1845; WHELAN AJ, 1995, NEW ENGL J MED, V333, P975, DOI 10.1056/NEJM199510123331505; [No title captured]	38	68	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					311	319		10.1086/303001	http://dx.doi.org/10.1086/303001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10869234	Bronze, Green Published			2022-12-18	WOS:000089357800008
J	Bennett, CL; Yoshioka, R; Kiyosawa, H; Barker, DF; Fain, PR; Shigeoka, AO; Chance, PF				Bennett, CL; Yoshioka, R; Kiyosawa, H; Barker, DF; Fain, PR; Shigeoka, AO; Chance, PF			X-linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WISKOTT-ALDRICH-SYNDROME; WASP GENE; COMBINED IMMUNODEFICIENCY; AUTOIMMUNE ENTEROPATHY; MUTATIONS; THROMBOCYTOPENIA; DISEASE; PROTEIN	We describe genetic analysis of a large pedigree with an X-linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea (XPID), which frequently results in death during infancy or childhood. Linkage analysis mapped the XPID gene to a 17-cM interval defined by markers DXS8083 and DXS8107 on the X chromosome, at Xp11.23-Xq13.3. The maximum LOD score was 3.99 (recombination fraction0) at DXS1235. Because this interval also harbors the gene for Wiskott-Aldrich syndrome (WAS), we investigated mutations in the WASP gene, as the molecular basis of XPID. Northern blot analysis detected the same relative amount and the same-sized WASP message in patients with XPID and in a control. Analysis of the WASP coding sequence, an alternate promoter, and an untranslated upstream first exon was carried out, and no mutations were found in patients with XPID. A C-->T transition within the alternate translation start site cosegregated with the XPID phenotype in this family; however, the same transition site was detected in a normal control male. We conclude that XPID maps to Xp11.23-Xq13.3 and that mutations of WASP are not associated with XPID.	Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev, Seattle, WA 98195 USA; Kanazawa Med Univ, Dept Hematol & Immunol, Kanazawa, Ishikawa, Japan; Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Fukushima, Japan; Univ Utah, Med Ctr, Dept Physiol, Salt Lake City, UT USA; Univ Utah, Med Ctr, Dept Pediat, Salt Lake City, UT 84132 USA; Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA	University of Washington; University of Washington Seattle; Kanazawa Medical University; Fukushima Medical University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Denver	Chance, PF (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev, Box 356320, Seattle, WA 98195 USA.	pchance@u.washington.edu	Chance, Phillip/AAX-5826-2020	Bennett, CRAIG/0000-0002-5847-1687; Barker, David/0000-0002-1438-4100				Basile GD, 1996, J PEDIATR-US, V129, P56, DOI 10.1016/S0022-3476(96)70190-7; BROOKS EG, 1990, J CLIN INVEST, V86, P1623, DOI 10.1172/JCI114884; COLLETTI RB, 1991, J PEDIATR-US, V118, P858, DOI 10.1016/S0022-3476(05)82195-X; DERRY JMJ, 1995, GENOMICS, V29, P471, DOI 10.1006/geno.1995.9979; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; DERRY JMJ, 1994, CELL, V79, P923; ELLIS D, 1982, AM J DIS CHILD, V136, P323, DOI 10.1001/archpedi.1982.03970400041013; Hagemann TL, 1999, BIOCHEM BIOPH RES CO, V256, P104, DOI 10.1006/bbrc.1999.0292; Kirchhausen T, 1998, MOL MED TODAY, V4, P300, DOI 10.1016/S1357-4310(98)01268-4; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEVYLAHAD E, 1993, AM J HUM GENET, V53, P467; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; MITTON SG, 1989, J PEDIATR GASTR NUTR, V8, P397, DOI 10.1097/00005176-198904000-00024; Nonoyama S, 1998, Rinsho Ketsueki, V39, P133; Ochs HD, 1998, SEMIN HEMATOL, V35, P332; PERRY GS, 1980, J PEDIATR-US, V97, P72, DOI 10.1016/S0022-3476(80)80133-8; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; Schindelhauer D, 1996, HUM GENET, V98, P68, DOI 10.1007/s004390050162; SEIDMAN EG, 1990, J PEDIATR-US, V117, P929, DOI 10.1016/S0022-3476(05)80140-4; SHIGEOKA AO, 1993, CLIN RES, V41, pA41; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; TASSARA C, 1995, HUM MOL GENET, V4, P1693, DOI 10.1093/hmg/4.9.1693; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; ZHU QL, 1995, BLOOD, V86, P3797, DOI 10.1182/blood.V86.10.3797.bloodjournal86103797; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689	25	68	72	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					461	468		10.1086/302761	http://dx.doi.org/10.1086/302761			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677306	Green Published, Bronze			2022-12-18	WOS:000088373100013
J	Topcu, M; Gartioux, L; Ribierre, F; Yalcinkaya, C; Tokus, E; Oztekin, N; Beckmann, JS; Ozguc, M; Seboun, E				Topcu, M; Gartioux, L; Ribierre, F; Yalcinkaya, C; Tokus, E; Oztekin, N; Beckmann, JS; Ozguc, M; Seboun, E			Vacuoliting megalencephalic leukoencephalopathy with subcortical cysts, mapped to chromosome 22q(tel)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MILD CLINICAL COURSE; LINKAGE ANALYSIS; HUMAN GENOME; LEUKODYSTROPHY; CHILDREN; CLONING; CDNA; DNA	The leukodystrophies form a complex group of orphan genetic disorders that primarily affect myelin, the main constituent of the brain white matter. Among the leukodystrophies of undetermined etiology, a new clinical entity called "vacuoliting megalencephalic leukoencephalopathy" (VL) was recently recognized. VL is characterized by diffuse swelling of the white matter, large subcortical cysts, and megalencephaly with infantile onset. Family studies in several ethnic groups have suggested an autosomal recessive mode of inheritance. We mapped the VL gene to chromosome 22q(tel), within a 3-cM linkage interval between markers D22S1161 and n66c4 (maximum LOD score 10.12 at recombination fraction .0, for marker n66c4; maximum multipoint LOD score 17 for this interval) by genome scan of 13 Turkish families. Linkage analysis under the genetic-heterogeneity hypothesis showed no genetic heterogeneity. No abnormalities were found in three tested candidate genes (fibulin-1 and glutathione S-transferases 1 and 2).	Hacettepe Univ Hosp, Dept Pediat Neurol, Sihhiye, Turkey; Inst Neurol Sci, Sihhiye, Turkey; SSK Hosp, Dept Neurol, Ankara, Turkey; Univ Hacettepe, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey; Univ Hacettepe, Fac Med, Tubitak DNA Cell Bank, TR-06100 Ankara, Turkey; Genethon, Evry, France; Univ Istanbul, Fac Med, Dept Child Neurol, Istanbul, Turkey; Univ Paris 06, Div Genet & Microbiol, Paris, France	Hacettepe University; Kocaeli Karamursel State Hospital; Hacettepe University; Hacettepe University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Istanbul University; UDICE-French Research Universities; Sorbonne Universite	Seboun, E (corresponding author), Ctr Natl Genotupage, 2 Rue Gaston Cremieux,CP 5721, F-91057 Evry, France.		Beckmann, Jacques S/A-9772-2008; Yalcinkaya, Cengiz/B-6288-2012	Beckmann, Jacques S/0000-0002-9741-1900; Yalcinkaya, Cengiz/0000-0002-3443-8524; OZGUC, Meral/0000-0003-4577-8759; Gartioux, Corine/0000-0003-4783-2835				ARGRAVES WS, 1989, CELL, V58, P623, DOI 10.1016/0092-8674(89)90097-4; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Goutieres F, 1996, J CHILD NEUROL, V11, P439, DOI 10.1177/088307389601100604; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MejaskiBosnjak V, 1997, PEDIATR NEUROL, V16, P347, DOI 10.1016/S0887-8994(97)00044-1; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Singhal BS, 1996, PEDIATR NEUROL, V14, P291, DOI 10.1016/0887-8994(96)00048-3; TAN KL, 1995, GENOMICS, V25, P381, DOI 10.1016/0888-7543(95)80037-M; Topcu M, 1998, BRAIN DEV-JPN, V20, P142, DOI 10.1016/S0387-7604(98)00002-3; VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308; Vignal Alain, 1993, V1, P211; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	16	68	74	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					733	739		10.1086/302758	http://dx.doi.org/10.1086/302758			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677334	Bronze, Green Published			2022-12-18	WOS:000088373100041
J	Dharmaraj, S; Li, YY; Robitaille, JM; Silva, E; Zhu, DP; Mitchell, TN; Maltby, LP; Baffoe-Bonnie, AB; Maumenee, IH				Dharmaraj, S; Li, YY; Robitaille, JM; Silva, E; Zhu, DP; Mitchell, TN; Maltby, LP; Baffoe-Bonnie, AB; Maumenee, IH			A novel locus for Leber congenital amaurosis maps to chromosome 6q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CAROLINA MACULAR DYSTROPHY; RECESSIVE RETINITIS-PIGMENTOSA; DISEASE GENE ABCR; CHORIORETINAL ATROPHY PBCRA; CONE-ROD DYSTROPHY; STARGARDT-DISEASE; FUNDUS-FLAVIMACULATUS; LINKAGE ANALYSIS; MUTATIONS; MCDR1		Johns Hopkins Med Inst, Wilmer Eye Inst, Johns Hopkins Ctr Hereditary Eye Dis, Baltimore, MD 21287 USA; Dalhousie Univ, IWK Grace Hlth Ctr, Halifax, NS, Canada; N Carolina Dept Hlth & Human Serv, Wilmington, NC USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Natl Human Genome Res Inst, Div Stat Genet, NIH, Bethesda, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Dalhousie University; Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Dharmaraj, S (corresponding author), Johns Hopkins Med Inst, Wilmer Eye Inst, Johns Hopkins Ctr Hereditary Eye Dis, Maumenee Bldg,Suite 517,600 N Wolfe St, Baltimore, MD 21287 USA.			Silva, Eduardo/0000-0002-2739-9854				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; BRECKVILL LT, 1972, HIST OLD ORDER RIVER; Camuzat A, 1996, HUM GENET, V97, P798; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; DEKABAN AS, 1969, AM J OPHTHALMOL, V68, P1029, DOI 10.1016/0002-9394(69)93443-6; DHARMARAJ S, 1999, INVEST OPHTH VIS SCI, V40, pA2983; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELLIS DS, 1984, AM J OPHTHALMOL, V97, P233, DOI 10.1016/S0002-9394(14)76095-7; FRANCESCHETTI A, 1954, Confin Neurol, V14, P184; Francois J, 1968, Int Ophthalmol Clin, V8, P929; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Gehrig A, 1998, J MED GENET, V35, P641, DOI 10.1136/jmg.35.8.641; Gerber S, 1998, GENOMICS, V48, P139, DOI 10.1006/geno.1997.5164; GERBER S, 1995, AM J HUM GENET, V56, P396; GRIESINGER IB, 1998, AM J HUM GENET, V63, pA30; Heckenlively JR, 1988, RETINITIS PIGMENTOSA, P125; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; Kelsell RE, 1998, AM J HUM GENET, V63, P274, DOI 10.1086/301905; KELSELL RE, 1995, HUM MOL GENET, V4, P1653, DOI 10.1093/hmg/4.9.1653; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1985, AM J HUM GENET, V37, P482; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Leber T., 1871, GRAEFES ARCH CLIN EX, V17, P314; LEBER T, 1869, A VONGRAEFES ARCH OP, V15, P1, DOI DOI 10.1007/BF02721213; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; MAINZER F, 1970, AM J MED, V49, P556, DOI 10.1016/S0002-9343(70)80051-1; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Martinez DM, 1997, STRENGTH COND J, V19, P13, DOI 10.1519/1073-6840(1997)019<0013:ISACNF>2.3.CO;2; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Ott J., 1991, ANAL HUMAN GENETICS; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Rabb MF, 1998, AM J OPHTHALMOL, V125, P502, DOI 10.1016/S0002-9394(99)80191-3; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Ruiz A, 1998, AM J HUM GENET, V62, P1452, DOI 10.1086/301866; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sauer CG, 1997, J MED GENET, V34, P961, DOI 10.1136/jmg.34.12.961; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; Small K W, 1997, Mol Vis, V3, P1; SMALL KW, 1992, GENOMICS, V13, P681, DOI 10.1016/0888-7543(92)90141-E; SMALL KW, 1993, OPHTHALMIC PAED GEN, V14, P143, DOI 10.3109/13816819309042913; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; SORSBY A, 1960, BRIT MED J, V1, P293, DOI 10.1136/bmj.1.5169.293; Stockton DW, 1998, HUM GENET, V103, P328, DOI 10.1007/s004390050825; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; WAARDENBURG PJ, 1961, GENET OPHTHALMOL, P1567; WAGNER RS, 1985, ARCH OPHTHALMOL-CHIC, V103, P1507	53	68	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					319	326		10.1086/302719	http://dx.doi.org/10.1086/302719			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631161	Bronze, Green Published			2022-12-18	WOS:000085033600032
J	Surralles, J; Hande, MP; Marcos, R; Lansdorp, PM				Surralles, J; Hande, MP; Marcos, R; Lansdorp, PM			Accelerated telomere shortening in the human inactive X chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LENGTH REGULATION; CELLS; MAMMALS	Telomeres are nucleoprotein complexes at the end of eukaryotic chromosomes, with important roles in the maintenance of genomic stability and in chromosome segregation. Normal somatic cells lose telomeric repeats with each cell division both in vivo and in vitro. To address a potential role of nuclear architecture and epigenetic factors in telomere-length dynamics, the length of the telomeres of the X chromosomes and the autosomes was measured in metaphases from blood lymphocytes of human females of various ages, by quantitative FISH with a peptide nucleic-acid telomeric probe in combination with an X-chromosome centromere-specific probe. The activation status of the X chromosomes was simultaneously visualized with antibodies against acetylated histone H4. We observed an accelerated shortening of telomeric repeats in the inactive X chromosome, which suggests that epigenetic factors modulate not only the length but also the rate of age-associated telomere shortening in human cells in vivo. This is the first evidence to show a differential rate of telomere shortening between and within homologous chromosomes in any species. Our results are also consistent with a causative role of telomere shortening in the well-documented X-chromosome aneuploidy in aging humans.	Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesi, E-08193 Barcelona, Spain; British Columbia Canc Agcy Ctr, Terry Fox Lab Haematol Oncol, Vancouver, BC, Canada	Autonomous University of Barcelona; British Columbia Cancer Agency	Surralles, J (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesi, E-08193 Barcelona, Spain.		Hande, M. Prakash/B-1645-2008; Surrallés, Jordi/AAE-7667-2020	Hande, M. Prakash/0000-0002-4511-6256; Marcos, Ricard/0000-0001-7891-357X; Surralles, Jordi/0000-0002-4041-7519; Lansdorp, Peter/0000-0001-7435-1071				Biessmann H, 1997, CHROMOSOMA, V106, P63, DOI 10.1007/s004120050225; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; di Fagagna FD, 1999, NAT GENET, V23, P76; Dietzel S, 1998, EXP CELL RES, V240, P187, DOI 10.1006/excr.1998.3934; FITZGERALD PH, 1977, HUM GENET, V39, P329, DOI 10.1007/BF00295428; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; HARLEY CB, 1995, TELOMERES, P247; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Slijepcevic P, 1997, CHROMOSOMA, V106, P413, DOI 10.1007/s004120050263; Slijepcevic P, 1998, EXP CELL RES, V244, P268, DOI 10.1006/excr.1998.4185; Surralles J, 1996, AM J HUM GENET, V59, P1091; Surralles J, 1998, MUTAT RES-GEN TOX EN, V414, P117, DOI 10.1016/S1383-5718(98)00046-1; Surralles J, 1998, CYTOGENET CELL GENET, V82, P58, DOI 10.1159/000015065; WILLARD HF, 1976, AM J HUM GENET, V28, P213; Willard HF, 1996, CELL, V86, P5, DOI 10.1016/S0092-8674(00)80071-9; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	30	68	67	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1617	1622		10.1086/302665	http://dx.doi.org/10.1086/302665			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577915	Green Published, Bronze			2022-12-18	WOS:000084282500016
J	Slaugenhaupt, SA; Acierno, JS; Helbling, LA; Bove, C; Goldin, E; Bach, G; Schiffmann, R; Gusella, JF				Slaugenhaupt, SA; Acierno, JS; Helbling, LA; Bove, C; Goldin, E; Bach, G; Schiffmann, R; Gusella, JF			Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; ABNORMAL TRANSPORT; COMPUTATIONS	Mucolipidosis type TV (MLIV) is a lysosomal storage disorder characterized by severe neurologic and ophthalmologic abnormalities. It is a rare autosomal recessive disease, and the majority of patients diagnosed, to date, are of Ashkenazi Jewish descent. We have mapped the MLIV gene to chromosome 19p13.2-13.3 by linkage analysis with 15 markers in 13 families. A maximum LOD score of 5.51 with no recombinants was observed with marker D19S873. Several markers in the linked interval also displayed significant linkage disequilibrium with the disorder. We constructed haplotypes in 26 Ashkenazi Jewish families and demonstrate the existence of two founder chromosomes in this population. The localization of MLIV to chromosome 13 will permit genetic prenatal diagnosis in affected families and will aid in the isolation of the disease gene.	Harvard Univ, Harvard Inst Human Genet, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA USA; NINDS, Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Hebrew University of Jerusalem	Slaugenhaupt, SA (corresponding author), Harvard Univ, Harvard Inst Human Genet, Sch Med, HIM Bldg,Room 422,77 Ave Louis Pasteur, Boston, MA 02115 USA.			Acierno, James/0000-0002-5301-4970	NINDS NIH HHS [NS36326] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036326] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMIR N, 1987, PEDIATRICS, V79, P953; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BACH G, 1999, ADV JEWISH GENETIC D; Bargal R, 1997, J INHERIT METAB DIS, V20, P625, DOI 10.1023/A:1005362123443; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRANDALL BF, 1982, AM J MED GENET, V12, P301, DOI 10.1002/ajmg.1320120308; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Schiffmann R, 1998, P NATL ACAD SCI USA, V95, P1207, DOI 10.1073/pnas.95.3.1207; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	16	68	71	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					773	778		10.1086/302549	http://dx.doi.org/10.1086/302549			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441585	Green Published, Bronze			2022-12-18	WOS:000082426400023
J	Auricchio, A; Griseri, P; Carpentieri, ML; Betsos, N; Staiano, A; Tozzi, A; Priolo, M; Thompson, H; Bocciardi, R; Romeo, G; Ballabio, A; Ceccherini, I				Auricchio, A; Griseri, P; Carpentieri, ML; Betsos, N; Staiano, A; Tozzi, A; Priolo, M; Thompson, H; Bocciardi, R; Romeo, G; Ballabio, A; Ceccherini, I			Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ENDOTHELIN-B RECEPTOR; MICE LACKING GDNF; TYROSINE KINASE; GERMLINE MUTATIONS; DNA POLYMORPHISMS; ENTERIC NEURONS; SILENT MUTATION; POINT MUTATIONS; GENE; PROTOONCOGENE		Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; Telethon Inst Genet & Med, Milan, Italy; Univ Federico 2, Dipartimento Pediat, Naples, Italy; Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy; Genet Canc Susceptibil Unit, Lyon, France	University of Genoa; IRCCS Istituto Giannina Gaslini; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Genoa	Ceccherini, I (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Largo G Gaslini 5, I-16148 Genoa, Italy.		Bocciardi, Renata/J-8577-2016; griseri, paola/AAJ-4823-2020; AURICCHIO, Alberto/AHE-7979-2022; Thompson, Helen L/E-7726-2017; BALLABIO, Andrea/AAL-2672-2020; Tozzi, Arturo/M-2174-2014; Ceccherini, Isabella/P-8195-2014; Staiano, Annamaria/H-3026-2011	Bocciardi, Renata/0000-0001-8415-3802; AURICCHIO, Alberto/0000-0002-0832-2472; Thompson, Helen L/0000-0003-4414-8018; BALLABIO, Andrea/0000-0003-1381-4604; Tozzi, Arturo/0000-0001-8426-4860; Ceccherini, Isabella/0000-0001-8732-1955; Staiano, Annamaria/0000-0003-0586-1339	Telethon [TGM97000, TGM06S01, E.0791] Funding Source: Medline	Telethon(Fondazione Telethon)		Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BEHRMAN RE, 1992, NELSON TXB PEDIATRIC, P954; Bidaud C, 1997, EUR J HUM GENET, V5, P247, DOI 10.1159/000484771; CECCHERINI I, 1994, ONCOGENE, V9, P3025; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DEMEIRLEIR L, 1994, PEDIATR RES, V36, P707, DOI 10.1203/00006450-199412000-00004; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Edery P, 1997, BIOESSAYS, V19, P389, DOI 10.1002/bies.950190506; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Eng C, 1997, HUM MUTAT, V9, P97, DOI 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.3.CO;2-Q; HOFSTRA R, 1998, 3 INT M HIRSCHSPR DI; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Jin Y, 1996, J CLIN INVEST, V98, P1745, DOI 10.1172/JCI118973; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Llewellyn DH, 1996, J MED GENET, V33, P437, DOI 10.1136/jmg.33.5.437; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MYERS SM, 1998, 3 INT M HIRSCHSP DIS; NAGRIST M, 1998, GENOMICS, V48, P354; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Roos M, 1998, J BIOL CHEM, V273, P924, DOI 10.1074/jbc.273.2.924; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; vanAmstel JKP, 1996, HUM GENET, V97, P51, DOI 10.1007/BF00218833	42	68	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1216	1221		10.1086/302329	http://dx.doi.org/10.1086/302329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090908	Bronze, Green Published			2022-12-18	WOS:000079632900034
J	Garner, C; Mitchell, J; Hatzis, T; Reittie, J; Farrall, M; Thein, SL				Garner, C; Mitchell, J; Hatzis, T; Reittie, J; Farrall, M; Thein, SL			Haplotype mapping of a major quantitative-trait locus for fetal hemoglobin production, on chromosome 6q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROCELLULAR HEREDITARY PERSISTENCE; MULTILOCUS LINKAGE ANALYSIS; F-CELLS; NORMAL INDIVIDUALS; GLOBIN CLUSTER; HUMAN ADULTS; GENE; SEGREGATION; EXPRESSION; HPFH	Fetal hemoglobin (Hb F) and fetal cell (FC) levels in adults show considerable variation and are influenced by several genetic variants; the major determinants appear to be unlinked to the beta-globin gene cluster. Recently, a trans-acting locus controlling Hb F and FC production has been mapped to chromosome 6q23 in an Asian Indian kindred that includes individuals with heterocellular hereditary persistence of: Hb F (HPFH) associated with beta thalassemia. We have extended the kindred by 57 members, bringing the total studied to 210, and have saturated the region with 26 additional markers, Linkage analysis showed tight linkage of the quantitative-trait locus (QTL) to the anonymous markers D6S976 (LOD score 11.3; recombination fraction .00) and D6S270 (LOD score 7.4; recombination fraction .00). Key recombination events now place this QTL within a 1-2-cM interval spanning similar to 1.5 Mb between D6S270 and D6S1626. Furthermore, haplotype analysis has led to a reevaluation of the genealogy and to the identification of additional relationships in the kindred.	John Radcliffe Hosp, Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; Wellcome Trust Ctr Human Genet, Headington, England; Gen State Hosp Piraeus, Dept Haematol, Athens, Greece	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Thein, SL (corresponding author), John Radcliffe Hosp, Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	swee.thein@imm.ox.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blau C A, 1994, Curr Opin Hematol, V1, P136; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; CRAIG JE, 1993, BRIT J HAEMATOL, V84, P106, DOI 10.1111/j.1365-2141.1993.tb03032.x; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOVER GJ, 1992, BLOOD, V80, P816; GIAMPAOLO A, 1984, HUM GENET, V66, P151, DOI 10.1007/BF00286590; GIANNI AM, 1983, EMBO J, V2, P921, DOI 10.1002/j.1460-2075.1983.tb01522.x; GILMAN JG, 1985, BLOOD, V66, P783; Green P., 1990, DOCUMENTATION CRIMAP; HASSTEDT SJ, 1994, PEDIGREE ANAL PACKAG; JEFFREYS AJ, 1986, AM J HUM GENET, V39, P11; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARTINEZ G, 1989, HUM GENET, V82, P335, DOI 10.1007/BF00273993; MIYOSHI K, 1988, BLOOD, V72, P1854; MORTON NE, 1974, AM J HUM GENET, V26, P489; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; RUTLAND PC, 1983, BRIT J HAEMATOL, V53, P673, DOI 10.1111/j.1365-2141.1983.tb07319.x; SAMPIETRO M, 1992, BLOOD, V79, P832; *SAS, 1997, STAT AN SOFTW VERS 6; SHARPE JA, 1989, LAB HAEMATOLOGY, P33; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; THEIN SL, 1994, AM J HUM GENET, V54, P214; Thein SL, 1989, HEMOGLOBIN SWITCHI B, P97; THORPE SJ, 1994, BRIT J HAEMATOL, V87, P125, DOI 10.1111/j.1365-2141.1994.tb04881.x; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; ZAGO MA, 1979, BLOOD, V53, P977	29	68	71	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1468	1474		10.1086/301859	http://dx.doi.org/10.1086/301859			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585587	Green Published, Bronze			2022-12-18	WOS:000074174700024
J	Haravuori, H; Makela-Bengs, P; Udd, B; Partanen, J; Pulkkinen, L; Somer, H; Peltonen, L				Haravuori, H; Makela-Bengs, P; Udd, B; Partanen, J; Pulkkinen, L; Somer, H; Peltonen, L			Assignment of the tibial muscular dystrophy locus to chromosome 2q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; MIYOSHI MYOPATHY; HUMAN GENOME; MAP; GENE; SARCOGLYCAN; MUTATIONS; LGMD2F	Tibial muscular dystrophy (TMD) is a rare autosomal dominant distal myopathy with late adult onset. The phenotype is relatively mild: muscle weakness manifests in the patient's ear ly 40s and remains confined to the tibial anterior muscles. Histopathological changes in muscle are compatible with muscular dystrophy, with the exception that rimmed vacuoles are a rather common finding. We performed a genomewide scan, with 279 highly polymorphic Cooperative Human Linkage Center microsatellite markers, on 11 affected individuals of one Finnish TMD family. The only evidence for Linkage emerged from markers in a 43-cM region on chromosome 2q. In further linkage analyses, which included three other Finnish TMD families and which used a denser set of markers, a maximum two-paint LOD score of 10.14 (recombination fraction of .05) was obtained with marker D2S364. Multipoint likelihood calculations, combined with the haplotype and recombination analyses, restricted the TMD locus to an similar to 1-cM critical chromosomal region without any evidence of heterogeneity. Since all the affecteds share one core haplotype, the dominance of one ancestor mutation is obvious in the Finnish TMD families, The disease locus that was found represents a novel muscular dystrophy locus, providing evidence for the involvement of one additional gene in the distal myopathy group of muscle disorders.	Natl Publ Hlth Inst, Dept Human Mol Genet, FIN-00300 Helsinki, Finland; Univ Helsinki, Inst Biomed, Dept Human Mol Genet, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; Cent Hosp, Dept Neurol, Vaasa, Finland; Kuopio Univ Hosp, Dept Clin Neurophysiol, SF-70210 Kuopio, Finland; Kuopio Univ Hosp, DNA Chromosome Lab, SF-70210 Kuopio, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	Leena.Peltonen@ktl.fi		Haravuori, Henna/0000-0002-4080-7779				Aaltonen J., 1993, European Journal of Human Genetics, V1, P164; Argov Z, 1997, ANN NEUROL, V41, P548, DOI 10.1002/ana.410410419; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; CHUMAKOV IM, 1995, NATURE, V377, P175; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; Ikeuchi T, 1997, ANN NEUROL, V41, P432, DOI 10.1002/ana.410410405; Illarioshkin SN, 1996, BRAIN, V119, P1895, DOI 10.1093/brain/119.6.1895; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; LAING NG, 1995, AM J HUM GENET, V56, P422; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Moreira ES, 1997, AM J HUM GENET, V61, P151, DOI 10.1086/513889; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Norio R., 1981, BIOCULTURAL ASPECTS, P359; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PARTANEN J, 1994, J NEUROL SCI, V125, P158, DOI 10.1016/0022-510X(94)90029-9; PassosBueno MR, 1996, HUM MOL GENET, V5, P815, DOI 10.1093/hmg/5.6.815; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; UDD B, 1991, MUSCLE NERVE, V14, P1050, DOI 10.1002/mus.880141103; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; Udd B, 1991, Neuromuscul Disord, V1, P279, DOI 10.1016/0960-8966(91)90102-X; UDD B, 1992, J NEUROL SCI, V2, P214; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Weiler T, 1996, AM J HUM GENET, V59, P872; YAMAOKA LH, 1994, NEUROMUSCULAR DISORD, V4, P471, DOI 10.1016/0960-8966(94)90086-8	41	68	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					620	626		10.1086/301752	http://dx.doi.org/10.1086/301752			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497249	Green Published, Bronze			2022-12-18	WOS:000072894400015
J	Hendrickson, EA				Hendrickson, EA			Cell-cycle regulation of mammalian DNA double-strand-break repair	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT PROTEIN-KINASE; END-JOINING REPAIR; SACCHAROMYCES-CEREVISIAE; V(D)J RECOMBINATION; ATAXIA-TELANGIECTASIA; CATALYTIC SUBUNIT; HUMAN MRE11; RAD51 GENE; MOUSE; HOMOLOGS				Hendrickson, EA (corresponding author), BROWN UNIV,DEPT MOL BIOL CELL BIOL & BIOCHEM,BOX G-J1,PROVIDENCE,RI 02912, USA.				NIAID NIH HHS [AI35763] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035763] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; FRANKENBERGSCHWAGER M, 1990, INT J RADIAT BIOL, V58, P569, DOI 10.1080/09553009014551931; FRIEDBERG EC, 1995, DNA REPAIR; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HENDRICKSON EA, 1993, AM J PATHOL, V143, P1511; Jackson SP, 1996, CURR OPIN GENET DEV, V6, P19, DOI 10.1016/S0959-437X(96)90005-2; Jongmans W, 1996, ONCOGENE, V13, P1133; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; Kanaar Roland, 1997, Genes and Function, V1, P165; Kastan MB, 1996, BIOESSAYS, V18, P617, DOI 10.1002/bies.950180804; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Lim DS, 1996, MOL CELL BIOL, V16, P7133; LIN FL, 1984, MOL CELL BIOL, V4, P1020, DOI 10.1128/MCB.4.6.1020; MASER RS, IN PRESS MOL CELL BI; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Myung K, 1997, EMBO J, V16, P3172, DOI 10.1093/emboj/16.11.3172; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Petrini J H, 1997, Semin Immunol, V9, P181, DOI 10.1006/smim.1997.0067; PETRINI JHJ, 1995, GENOMICS, V29, P80, DOI 10.1006/geno.1995.1217; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Singleton BK, 1997, MOL CELL BIOL, V17, P1264, DOI 10.1128/MCB.17.3.1264; STAMATO TD, 1983, SOMAT CELL GENET, V9, P165, DOI 10.1007/BF01543175; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; TOBEY RA, 1988, EXP CELL RES, V179, P400, DOI 10.1016/0014-4827(88)90279-0; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Weaver DT, 1997, NATURE, V388, P428, DOI 10.1038/41225; WEIBEZAHN KF, 1985, MUTAT RES, V145, P177, DOI 10.1016/0167-8817(85)90025-2; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Yamamoto A, 1996, MOL GEN GENET, V251, P1; ZDZIENICKA MZ, 1995, MUTAT RES-DNA REPAIR, V336, P203, DOI 10.1016/0921-8777(95)00003-3; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	54	68	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					795	800		10.1086/514895	http://dx.doi.org/10.1086/514895			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382087	Green Published, Bronze			2022-12-18	WOS:A1997YA59100003
J	Rogers, J; Hixson, JE				Rogers, J; Hixson, JE			Baboons as an animal model for genetic studies of common human disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIPOPROTEIN CHOLESTEROL CONCENTRATIONS; APOLIPOPROTEIN A-I; ACYLTRANSFERASE LCAT; DNA POLYMORPHISM; PAPIO-HAMADRYAS; RHESUS-MONKEYS; BONE LOSS; SIZE; IDENTIFICATION; ISOFORMS				Rogers, J (corresponding author), SW FDN BIOMED RES,DEPT GENET,POB 760549,SAN ANTONIO,TX 78245, USA.			Hixson, James/0000-0002-0849-9315				AUFDEMORTE TB, 1993, BONE, V14, P581, DOI 10.1016/8756-3282(93)90197-I; BLANGERO J, 1993, HUM BIOL, V65, P941; BLANGERO J, 1990, AM J HUM GENET, V47, P414; Blangero J, 1996, 6 SW FDN BIOM RES PO; CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x; CAREY KD, 1996, ANN M AM SOC PRIM MA; COLE SA, 1995, GENE, V161, P265, DOI 10.1016/0378-1119(95)00301-L; DYKE B, 1987, GENETICA, V73, P137; Graves J, 1995, HUMAN GENE MAPPING 1, P1351; HIGLEY JD, 1993, ARCH GEN PSYCHIAT, V50, P615; Hixson JE, 1988, GENOMICS, V2, P315, DOI 10.1016/0888-7543(88)90020-1; HIXSON JE, 1993, GENE, V128, P295, DOI 10.1016/0378-1119(93)90578-Q; HIXSON JE, 1989, J BIOL CHEM, V264, P6013; HIXSON JE, 1993, J BIOL CHEM, V268, P15667; Hixson JE, 1996, J LIPID RES, V37, P2324; HIXSON JE, 1988, GENE, V74, P483, DOI 10.1016/0378-1119(88)90181-3; HIXSON JE, 1989, ARTERIOSCLEROSIS, V9, P829, DOI 10.1161/01.ATV.9.6.829; HUGHES KP, 1995, J BONE MINER RES, V10, pS365; JEROME CP, 1986, CALCIFIED TISSUE INT, V39, P206, DOI 10.1007/BF02555119; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; KAMMERER CM, 1993, ATHEROSCLEROSIS, V98, P153, DOI 10.1016/0021-9150(93)90125-E; Kammerer CM, 1995, J MED PRIMATOL, V24, P236, DOI 10.1111/j.1600-0684.1995.tb00176.x; KAPLAN JR, 1995, AM J PRIMATOL, V35, P229, DOI 10.1002/ajp.1350350305; KONIGSBERG LW, 1991, GENET EPIDEMIOL, V8, P69, DOI 10.1002/gepi.1370080202; MACCLUER JW, 1988, AM J HUM GENET, V43, P401; MAHANEY MC, 1993, HUM BIOL, V65, P991; MCGILL HC, 1981, ARTERIOSCLEROSIS, V1, P3, DOI 10.1161/01.ATV.1.1.3; MCGILL HC, 1960, CIRC RES, V8, P670, DOI 10.1161/01.RES.8.3.670; Palmour RM, 1997, AM J HUM GENET, V61, P481, DOI 10.1086/515526; PEARSON PL, 1979, CYTOGENET CELL GENET, V25, P82, DOI 10.1159/000131403; Perelygin AA, 1996, CYTOGENET CELL GENET, V75, P207, DOI 10.1159/000134484; RAINWATER DL, 1989, J LIPID RES, V30, P549; RAINWATER DL, 1992, ARTERIOSCLER THROMB, V12, P682, DOI 10.1161/01.ATV.12.6.682; RAINWATER DL, 1994, CHEM PHYS LIPIDS, V67-8, P199, DOI 10.1016/0009-3084(94)90139-2; ROGERS J, 1995, GENOMICS, V28, P251, DOI 10.1006/geno.1995.1138; Rogers J, 1996, AM J PRIMATOL, V38, P157, DOI 10.1002/(SICI)1098-2345(1996)38:2<157::AID-AJP4>3.0.CO;2-Y; THOMPSON DD, 1992, J BONE MINER RES, V7, P951; VandeBerg JL, 1996, LAB ANIM SCI, V46, P146; WHITE AL, 1994, J BIOL CHEM, V269, P9060; WILLIAMSBLANGERO S, 1995, AM J PRIMATOL, V37, P233, DOI 10.1002/ajp.1350370305; WILLIAMSBLANGERO S, 1993, LAB ANIM SCI, V43, P535	41	68	73	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					489	493		10.1086/515527	http://dx.doi.org/10.1086/515527			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326312	Green Published, Bronze			2022-12-18	WOS:A1997XY52300004
J	BoghosianSell, L; Comings, DE; Overhauser, J				BoghosianSell, L; Comings, DE; Overhauser, J			Tourette syndrome in a pedigree with a 7;18 translocation: Identification of a YAC spanning the translocation breakpoint at 18q22.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT TRANSMISSION; GENETIC-LINKAGE MAP; PHYSICAL MAP; CHROMOSOME-18; HYPOTHESIS; DISORDERS; GENOME; FAMILY; ARM	Tourette syndrome is a neuropsychiatric disorder characterized by the presence of multiple, involuntary motor and vocal tics. Associated pathologies include attention deficit disorder and obsessive-compulsive disorder (OCD), Extensive linkage analysis based on an autosomal dominant mode of transmission with reduced penetrance has failed to show linkage with polymorphic markers, suggesting either locus heterogeneity or a polygenic origin for Tourette syndrome. An individual diagnosed with Tourette syndrome has been described carrying a constitutional (7;18) chromosome translocation (Comings et al. 1986). Other family members carrying the translocation exhibit features seen in Tourette syndrome including motor tics, vocal tics, and OCD. Since the disruption of specific genes by a chromosomal rearrangement can elicit a particular phenotype, we have undertaken the physical mapping of the 7;18 translocation such that genes mapping at the site of the breakpoint can be identified and evaluated for a possible involvement in Tourette syndrome. Using somatic cell hybrids retaining either the der(7) or the der(18), a more precise localization of the breakpoints on chromosomes 7 and 18 have been determined. Furthermore, physical mapping has identified two YAC clones that span the translocation breakpoint on chromosome 18 as determined by FISH. These YAC clones will be useful for the eventual identification of genes that map to chromosomes 7 and 18 at the site of the translocation.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOL BIOL,PHILADELPHIA,PA 19107; CITY HOPE NATL MED CTR,DEPT MED GENET,DUARTE,CA	Jefferson University; City of Hope					NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054093] Funding Source: NIH RePORTER; NIMH NIH HHS [MH54093] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BONNER TI, 1987, CYTOGENET CELL GENET, V46, P584; BURD L, 1986, J AM ACAD CHILD PSY, V25, P552, DOI 10.1016/S0002-7138(10)60016-7; CARTER AS, 1994, J AM ACAD CHILD PSY, V33, P377, DOI 10.1097/00004583-199403000-00012; CIRULLO RE, 1983, SOMAT CELL GENET, V8, P215; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; Comings D E, 1994, Ann Clin Psychiatry, V6, P235, DOI 10.3109/10401239409149010; COMINGS DE, 1989, AM J MED GENET, V34, P413, DOI 10.1002/ajmg.1320340318; COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P463; Comings DE, 1996, AM J MED GENET, V67, P264, DOI 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N; COMINGS DE, 1992, ADV NEUROL, V58, P189; COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P275; COMINGS DE, 1984, AM J HUM GENET, V36, P586; COMINGS DE, 1986, HUM GENET, P620; COMINGS DE, IN PRESS PHARMACOGEN; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DEVOR EJ, 1990, J NERV MENT DIS, V178, P669, DOI 10.1097/00005053-199011000-00001; DONNAI D, 1987, LANCET, V14, P627; EAPEN V, 1993, BRIT J PSYCHIAT, V162, P593, DOI 10.1192/bjp.162.5.593; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEUTINK P, 1990, J MED GENET, V27, P433, DOI 10.1136/jmg.27.7.433; KLINE AD, 1993, AM J HUM GENET, V52, P895; KLINE AD, 1992, GENOMICS, V13, P1, DOI 10.1016/0888-7543(92)90193-V; KUNZ J, 1994, GENOMICS, V22, P439, DOI 10.1006/geno.1994.1407; KURLAN R, 1994, ARCH NEUROL-CHICAGO, V51, P1145, DOI 10.1001/archneur.1994.00540230083017; KURLAN R, 1994, NEUROLOGY, V44, P2336, DOI 10.1212/WNL.44.12.2336; LABUDA MC, 1993, MOL BASIS NEUROLOGY, P199; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; Mahr RN, 1996, AM J MED GENET, V67, P172; MEWAR R, 1993, CYTOGENET CELL GENET, V64, P1, DOI 10.1159/000133547; PAKSTIS AJ, 1991, AM J HUM GENET, V48, P281; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; Robertson M. M., 1993, Psychiatric Genetics, V3, P95, DOI 10.1097/00041444-199322000-00005; ROJAS K, 1995, GENOMICS, V25, P329, DOI 10.1016/0888-7543(95)80153-D; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; SINGER HS, 1993, PEDIATR ANN, V22, P22, DOI 10.3928/0090-4481-19930101-06; STRATHDEE G, 1995, AM J MED GENET, V59, P476, DOI 10.1002/ajmg.1320590414; TAYLOR LD, 1991, NEUROLOGY, V41, P1513, DOI 10.1212/WNL.41.9.1513; VANDEWETERING BJM, 1993, J LAB CLIN MED, V121, P638; VERMA RS, 1989, HUMAN CHROMOSOMES MA	41	68	70	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					999	1005						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	VN900	8900226				2022-12-18	WOS:A1996VN90000005
J	Passarino, G; Semino, O; Bernini, LF; SantachiaraBenerecetti, AS				Passarino, G; Semino, O; Bernini, LF; SantachiaraBenerecetti, AS			Pre-caucasoid and caucasoid genetic features of the Indian population, revealed by mtDNA polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISMS; HUMAN-EVOLUTION; ANCIENT; HAPLOGROUPS; AFFINITIES; THARUS; HINDUS; ORIGIN; NEPAL	About 70 individuals from Punjab were examined for some mtDNA polymorphisms, namely, the RFLPs of the six classical enzymes (HpaI, BamHI, HaeII, MspI, AvaII, and HincII) and for the sites AluI(7,025), DdeI(10,394), and AluI(10,397) The AluI(7,025) polymorphic site was also investigated in 96 Indians from Uttar Pradesh and Andhra Pradesh and in 163 Mediterranean Caucasoids. Moreover, 30 Indian DdeI(10,394)AluI(10,397) (+ +) mtDNAs were typed by the ''high-resolution restriction analysis'' with 14 endonucleases to estimate their divergence time. The results obtained are the following: (1) The RFLPs analysis has displayed some Caucasoid types as in Indians of Uttar Pradesh; (2) the AluI(7,025) (-) allele, which defines the most frequent Caucasoid-specific lineage (haplogroup H), ranges from 18% to 45% in the Mediterranean Caucasoids, whereas it has shown low frequencies in Punjab (6.0%) and in Uttar Pradesh (1.8%) and was not found in Andhra Pradesh; (3) the DdeI(10,394)AluI(10,397) (+ +) haplotype, which although previously was considered an East Asian marker (haplogroup M) and was found very frequently in India, is also frequent in Punjab (27%); this frequency is, however, much lower than in Uttar Pradesh (49%) and in Andhra Pradesh (74%), and a gradient decreasing from south to north is therefore observed; (4) the divergence time of the Indian DdeI(10,394)AluI(10,397) (+ +) mtDNAs has been estimated to be 30,250-60,500 years, a value that is compatible with that of the homologous East Asian lineage. These results strongly support the hypothesis that the DdeI(10,394)AluI(10,397) (+ +) haplotype predated the Indo-European invasion and probably the split between proto-Indians and proto-Orientals. Its frequency dine well reflects the major influence of Indo-Europeans in the north and in the center of India.	UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL A BUZZATI TRAVERS,I-27100 PAVIA,ITALY; UNIV CALABRIA,DIPARTIMENTO BIOL CELLULARE,RENDE,ITALY; LEIDEN STATE UNIV,DEPT HUMAN GENET,LEIDEN,NETHERLANDS	University of Pavia; University of Calabria; Leiden University; Leiden University - Excl LUMC				SEMINO, Ornella/0000-0002-9675-9403				BALLINGER SW, 1992, GENETICS, V130, P139; Brega A, 1994, Gene Geogr, V8, P45; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 1988, MUNIBE S, V6, P129; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; CHEN YS, 1995, AM J HUM GENET, V57, P133; Corbo R M, 1991, Gene Geogr, V5, P113; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; *I ENC IT G TRECC, 1933, ENC IT LETT SCI ART; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; PASSARINO G, 1993, AM J HUM GENET, V53, P609; Passarino G, 1996, ANN HUM BIOL, V23, P121, DOI 10.1080/03014469600004342; RENFREW C, 1989, SCI AM, V261, P106, DOI 10.1038/scientificamerican1089-106; RENFREW C, 1989, CAMB ARCHAEOL J, V1, P3; Santachiara Benerecetti A S, 1988, Ann Hum Genet, V52, P39; SARTORIS S, 1988, ANN HUM GENET, V52, P327, DOI 10.1111/j.1469-1809.1988.tb01112.x; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEMINO O, 1991, ANN HUM GENET, V55, P123, DOI 10.1111/j.1469-1809.1991.tb00405.x; SWOFFORD D, 1992, PHYLOGENETIC ANAL US; TARTAGLIA M, 1995, AM J PHYS ANTHROPOL, V98, P257, DOI 10.1002/ajpa.1330980303; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591	26	68	68	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					927	934						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808610				2022-12-18	WOS:A1996VL28300024
J	Wolff, DJ; Miller, AP; VanDyke, DL; Schwartz, S; Willard, HF				Wolff, DJ; Miller, AP; VanDyke, DL; Schwartz, S; Willard, HF			Molecular definition of breakpoints associated with human Xq isochromosomes: Implications for mechanisms of formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; TURNER SYNDROME; ROBERTSONIAN TRANSLOCATIONS; PARENTAL ORIGIN; SHORT ARM; CENTROMERE; CHROMOSOME; INACTIVATION; DNA; POLYMORPHISMS	To test the centromere misdivision model of isochromosome formation, we have defined the breakpoints of cytogenetically monocentric and dicentric Xq isochromosomes (i(Xq)) from Turner syndrome probands, using FISH with cosmids and YACs derived from a contig spanning proximal Xp, Seven different pericentromeric breakpoints were identified, with 10 of 11 of the i(Xq)s containing varying amounts of material from Xp. Only one of the eight cytogenetically monocentric i(Xq)s demonstrated a single alpha-satellite (DXZ1) signal, consistent with classical models involving centromere misdivision. The remaining seven were inconsistent with such a model and had breakpoints that spanned proximal Xp11.21: one was between DXZ1 and the most proximal marker, ZXDA; one occurred between the duplicated genes, ZXDA and ZXDB; two were similar to 2 Mb from DXZ1; two were adjacent to ALAS2 located 3.5 Mb from DXZ1; and the largest had a breakpoint just distal to DXS1013E, indicating the inclusion of 8 Mb of Xp DNA between centromeres. The three cytologically dicentric i(Xq)s had breakpoints distal to DXS423E in Xp11.22 and therefore contained greater than or equal to 12 Mb of DNA between centromeres. These data demonstrate that the majority of breakpoints resulting in i(Xq) formation are in band Xp11.2 and not in the centromere itself. Therefore, we hypothesize that the predominant mechanism of i(Xq) formation involves sequences in the proximal short arm that are prone to breakage and reunion events between sister chromatids or homologous X chromosomes.	CASE WESTERN RESERVE UNIV, DEPT GENET, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, CTR HUMAN GENET, CLEVELAND, OH 44106 USA; UNIV CLEVELAND HOSP, CLEVELAND, OH 44106 USA; HENRY FORD HOSP, CTR MED GENET & BIRTH DEFECTS, DETROIT, MI 48202 USA	Case Western Reserve University; Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00107] Funding Source: Medline; NICHD NIH HHS [HD32111] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CALLEN DF, 1987, HUM GENET, V77, P236, DOI 10.1007/BF00284476; CHAPELLE AD, 1974, HEREDITAS, V76, P259; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; DELACHAPELLE A, 1965, HEREDITAS, V54, P277; EARNSHAW WC, 1989, GENOME, V31, P541, DOI 10.1139/g89-103; FLETCHER HL, 1988, HEREDITY, V60, P383, DOI 10.1038/hdy.1988.56; GRAVHOLT CH, 1992, GENOMICS, V14, P924, DOI 10.1016/S0888-7543(05)80113-2; GREIG GM, 1993, HUM MOL GENET, V2, P1611; GREIG GM, 1992, AM J HUM GENET S, V51, pA86; HAAF T, 1990, HUM GENET, V85, P486; HAN JY, 1994, AM J HUM GENET, V55, P960; HARBISON M, 1988, CYTOGENET CELL GENET, V47, P217, DOI 10.1159/000132553; HELD KR, 1992, HUM GENET, V88, P288; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; HSU LYF, 1978, J MED GENET, V15, P222, DOI 10.1136/jmg.15.3.222; Jones RN, 1982, B CHROMOSOMES; LAFRENIERE RG, 1991, GENOMICS, V10, P276, DOI 10.1016/0888-7543(91)90512-D; LORDASANCHEZ I, 1991, AM J HUM GENET, V49, P1034; MAHTANI MM, 1990, GENOMICS, V7, P607, DOI 10.1016/0888-7543(90)90206-A; MILLER AP, 1995, HUM MOL GENET, V4, P731, DOI 10.1093/hmg/4.4.731; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PALMER CG, 1976, HUM GENET, V35, P35, DOI 10.1007/BF00295617; PHELAN MC, 1988, HUM GENET, V80, P81, DOI 10.1007/BF00451462; PRIEST JH, 1975, J MED GENET, V12, P378, DOI 10.1136/jmg.12.4.378; RANKE MB, 1983, EUR J PEDIATR, V141, P81, DOI 10.1007/BF00496795; SCHWARTZ S, 1983, HUM GENET, V63, P332, DOI 10.1007/BF00274757; SEARS ER, 1952, CHROMOSOMA, V4, P535, DOI 10.1007/BF00325789; SHAFFER LG, 1991, HUM GENET, V86, P375; SHARP CB, 1990, HUM GENET, V85, P330; SMITH SG, 1950, CAN J RES C, V28, P153, DOI 10.1139/cjr50c-008; SULLIVAN BA, 1994, CHROMOSOMA, V103, P459; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; THERMAN E, 1974, AM J HUM GENET, V26, P83; Van Dyke D., 1988, CYTOGENETICS MAMMALI, P635; WANDALL A, 1994, CHROMOSOMA, V103, P56, DOI 10.1007/BF00364726; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; Wolff D. J., 1994, American Journal of Human Genetics, V55, pA37; WOLFF DJ, 1992, AM J HUM GENET, V50, P174; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x	39	68	71	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					154	160						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554051				2022-12-18	WOS:A1996TL69700019
J	MUDD, SH; LEVY, HL; TANGERMAN, A; BOUJET, C; BUIST, N; DAVIDSONMUNDT, A; HUDGINS, L; OYANAGI, K; NAGAO, M; WILSON, WG				MUDD, SH; LEVY, HL; TANGERMAN, A; BOUJET, C; BUIST, N; DAVIDSONMUNDT, A; HUDGINS, L; OYANAGI, K; NAGAO, M; WILSON, WG			ISOLATED PERSISTENT HYPERMETHIONINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHIONINE ADENOSYLTRANSFERASE DEFICIENCY; TRANSAMINATION; BALANCES; PATHWAY; HUMANS; DEFECT	New information has been obtained on 30 patients with isolated persistent hypermethioninemia, most of them previously unreported. Biopsies to confirm the presumptive diagnosis of partially deficient activity of ATP: L-methionine S-adenosyltransferase (MAT; E.C.2.5.1.6) in liver were not performed on most of these patients. However, none showed the clinical findings or the extreme elevations of serum folate previously described in other patients with isolated hypermethioninemia considered not to have hepatic MAT deficiency. Patients ascertained on biochemical grounds had no neurological abnormalities, and 27/30 had IQs or Bayley development-index scores within normal limits or were judged to have normal mental development. Methionine transamination metabolites accumulated abnormally only when plasma methionine concentrations exceeded 300-350 mu M and did so more markedly after 0.9 years of age. Data were obtained on urinary organic acids as well as plasma creatinine concentrations. Patterns of inheritance of isolated hypermethioninemia were variable. Considerations as to the optimal management of this group of patients are discussed.	HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, BOSTON, MA 02114 USA; HARVARD UNIV, CHILDRENS HOSP, SCH MED, BOSTON, MA 02115 USA; UNIV NIJMEGEN HOSP, DIV GASTROINTESTINAL & LIVER DIS, 6500 HB NIJMEGEN, NETHERLANDS; CHU GRENOBLE, BIOCHIM METAB & EXPLORAT NUTR LAB, F-38043 GRENOBLE, FRANCE; OREGON HLTH SCI UNIV, CTR CHILD DEV & REHABIL, PORTLAND, OR 97201 USA; UNIV COLORADO, CHILDRENS HOSP, HLTH SCI CTR, DENVER, CO 80218 USA; UNIV ARIZONA, HLTH SCI CTR, MARICOPA MED CTR, PHOENIX, AZ USA; ODORI CHILDRENS CLIN, SAPPORO, HOKKAIDO, JAPAN; NATL OTARU HOSP, OTARU, HOKKAIDO, JAPAN; UNIV VIRGINIA, CHILDRENS MED CTR, CHARLOTTESVILLE, VA 22903 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Radboud University Nijmegen; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Oregon Health & Science University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Arizona; University of Arizona Health Sciences; University of Virginia	MUDD, SH (corresponding author), NIMH, DIRP,LGCB,BLDG 36,ROOM 3D-06, 36 CONVENT DR, MSC 4094, BETHESDA, MD 20892 USA.							ALMARDINI H, 1988, CLIN CHIM ACTA, V176, P83, DOI 10.1016/0009-8981(88)90177-5; ARMSTRONG MD, 1956, P SOC EXP BIOL MED, V93, P418; BACKLUND PS, 1982, J BIOL CHEM, V257, P4196; BLOM HJ, 1989, METABOLISM, V38, P577, DOI 10.1016/0026-0495(89)90220-5; BLOM HJ, 1989, CLIN SCI, V76, P43, DOI 10.1042/cs0760043; BLOM HJ, 1992, J INHERIT METAB DIS, V15, P188, DOI 10.1007/BF01799629; BOUJET C, 1990, 28TH S SOC STUD INB; CONGDON PJ, 1981, J INHERIT METAB DIS, V4, P79, DOI 10.1007/BF02263600; DIAMOND A, 1994, J NEUROSCI, V14, P3072; Diamond A., 1992, Society for Neuroscience Abstracts, V18, P1063; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P1491, DOI 10.1016/0006-291X(75)90527-6; GAHL WA, 1988, J CLIN INVEST, V81, P390, DOI 10.1172/JCI113331; GAHL WA, 1987, AM J HUM GENET, V40, P39; GAULL GE, 1981, ANN NEUROL, V9, P423, DOI 10.1002/ana.410090503; GAULL GE, 1981, J PEDIATR-US, V98, P734, DOI 10.1016/S0022-3476(81)80833-5; GAULL GE, 1974, SCIENCE, V186, P59, DOI 10.1126/science.186.4158.59; GOLDSMITH LA, 1989, METABOLIC BASIS INHE, P547; GOUT JP, 1977, ARCH FR PEDIATR, V34, P416; Guizar Vazquez J, 1980, Bol Med Hosp Infant Mex, V37, P1237; JHAVERI BM, 1982, J INHERIT METAB DIS, V5, P101, DOI 10.1007/BF01800001; JONES SMA, 1986, BIOCHEM J, V237, P621, DOI 10.1042/bj2370621; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; LABRUNE P, 1990, J PEDIATR-US, V117, P220, DOI 10.1016/S0022-3476(05)80533-5; LANE JD, 1980, NATURWISSENSCHAFTEN, V67, P227, DOI 10.1007/BF01054531; LEVY HL, 1971, PEDIATRICS, V47, P128; LIVESEY G, 1980, METABOLISM CLIN IMPL, P143; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; MUDD SH, 1980, METABOLISM, V29, P707, DOI 10.1016/0026-0495(80)90192-4; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; Mudd Sh, 1989, METABOLIC BASIS INHE, V1, P693; POLLITT RJ, 1985, J INHERIT METAB DIS, V8, P75, DOI 10.1007/BF01801669; REY F, 1974, PEDIATR RES, V8, P540, DOI 10.1203/00006450-197405000-00002; SMITH I, 1990, ARCH DIS CHILD, V65, P472, DOI 10.1136/adc.65.5.472; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; STOCKLER S, 1994, PEDIATR RES, V36, P409; SURTEES R, 1991, LANCET, V338, P1550, DOI 10.1016/0140-6736(91)92373-A; Talbot NB, 1938, AM J DIS CHILD, V55, P44; TALLAN HH, 1976, BIOCHEM MED METAB B, V16, P234, DOI 10.1016/0006-2944(76)90029-6; TANGERMAN A, 1985, J LAB CLIN MED, V106, P175; TSUCHIYAMA A, 1982, TOHOKU J EXP MED, V138, P281, DOI 10.1620/tjem.138.281; UETSUJI N, 1986, J CLIN PEDIAT SAPPOR, V34, P167; WEISIGER RA, 1980, BIOCHEM PHARMACOL, V29, P2885, DOI 10.1016/0006-2952(80)90029-5	42	68	71	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					882	892						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573050				2022-12-18	WOS:A1995RV79300020
J	KHOURY, MJ; WAGENER, DK				KHOURY, MJ; WAGENER, DK			EPIDEMIOLOGIC EVALUATION OF THE USE OF GENETICS TO IMPROVE THE PREDICTIVE VALUE OF DISEASE RISK-FACTORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEART-DISEASE; ATHEROSCLEROSIS; CHOLESTEROL; CANCER	The prevention of common diseases relies on identifying risk factors and implementing intervention in high-risk groups. Nevertheless, most known risk factors have low positive predictive value (PPV) and low population-attributable fraction (PAF) for diseases (e.g., cholesterol and coronary heart disease). With advancing genetic technology, it will be possible to refine the risk-factor approach to target intervention to individuals with risk factors who also carry disease-susceptibility allele(s). We provide an epidemiological approach to assess the impact of genetic testing on the PPV and PAF associated with risk factors. Under plausible models of interaction between a risk factor and a genotype, we derive values of PPV and PAF associated with the joint effects of a risk factor and a genotype. The use of genetic testing can markedly increase the PPV of a risk factor. PPV increases with increasing genotype-risk factor interaction and increasing marginal relative risk associated with the factor, but it is inversely proportional to the prevalences of the genotype and the factor. For example, for a disease with lifetime risk of 1%, if all the risk-factor effect is confined to individuals with a susceptible genotype, a risk factor with 10% prevalence and disease relative risk of 2 in the population will have a disease PPV of 1.8%, but it will have a PPV of 91.8% among persons with a genotype of 1% prevalence. On the other hand, genetic testing and restriction of preventive measures to those susceptible may decrease the PAF of the risk factor, especially at low prevalences of the risk factor and genotype. With advances in the Human Genome Project, medicine and public health should consider the feasibility of this approach as a new paradigm for disease prevention.	CTR DIS CONTROL & PREVENT, NATL CTR HLTH STAT, OFF ANAL EPIDEMIOL & HLTH PROMOT, HYATTSVILLE, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	KHOURY, MJ (corresponding author), CTR DIS CONTROL, NATL CTR ENVIRONM HLTH, DIV BIRTH DEFECTS & DEV DISABIL, ATLANTA, GA 30333 USA.							ALLRED JB, 1993, J NUTR, V123, P1453; BADIMON JJ, 1993, CIRCULATION, V87, P3; BALANT LP, 1992, CLIN THER, V14, P328; BARON JA, 1989, J CLIN EPIDEMIOL, V42, P1013, DOI 10.1016/0895-4356(89)90167-4; CAPORASO N, 1989, CANCER RES, V49, P3675; GARVER KL, 1994, AM J HUM GENET, V54, P148; GLADER BE, 1990, PRINCIPLES PRACTICE, V2, P1343; HAMSTEN A, 1993, POSTGRAD MED J, V69, pS8; HEGELE RA, 1992, MOL CELL BIOCHEM, V113, P177; HOFFMAN EP, 1994, AM J HUM GENET, V54, P129; HOLTZMAN NA, 1992, FASEB J, V6, P2806, DOI 10.1096/fasebj.6.10.1634043; HOLTZMAN NA, 1989, PROCEED CAUTION PRED; Hubbard R., 1993, EXPLODING GENE MYTH; KHOURY MJ, 1988, AM J HUM GENET, V42, P89; KHOURY MJ, 1994, EPIDEMIOL REV, V16, P134, DOI 10.1093/oxfordjournals.epirev.a036139; KHOURY MJ, 1985, AM J PUBLIC HEALTH, V75, P1204, DOI 10.2105/AJPH.75.10.1204; KHOURY MJ, 1993, FUUNDAMENTALS GENETI; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; LAROSA JC, 1992, CLIN CARDIOL, V15, P2, DOI 10.1002/clc.4960151003; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; MOTULSKY AG, 1994, AM J HUM GENET, V55, P603; OMENN GS, 1982, J OCCUP ENVIRON MED, V24, P369, DOI 10.1097/00043764-198205000-00007; SCRIVER CR, 1989, METABOLIC BASIS INHE, V1, P495; SIMOPOULOS AP, 1993, GENETIC NUTRITION DE; STEHBENS WE, 1992, PERSPECT BIOL MED, V36, P97; Suzuki David., 1989, GENETHICS CLASH NEW; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; WOODARD DA, 1993, MED CLIN N AM, V77, P849, DOI 10.1016/S0025-7125(16)30228-0; 1994, JAMA-J AM MED ASSOC, V271, P785; 1992, MMWR-MORBID MORTAL W, V14, P1	31	68	92	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					835	844						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717394				2022-12-18	WOS:A1995QP66300004
J	HEINISCH, U; ZLOTOGORA, J; KAFERT, S; GIESELMANN, V				HEINISCH, U; ZLOTOGORA, J; KAFERT, S; GIESELMANN, V			MULTIPLE MUTATIONS ARE RESPONSIBLE FOR THE HIGH-FREQUENCY OF METACHROMATIC LEUKODYSTROPHY IN A SMALL GEOGRAPHIC AREA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAY-SACHS DISEASE; ARYLSULFATASE-A GENE; MOLECULAR ANALYSIS; ISRAEL; EXPRESSION; COMMON; SITE	Metachromatic leukodystrophy is a lysosomal storage disorder caused by the deficiency of arylsulfatase A. The disease occurs panethnically, with an estimated frequency of 1/40,000. Metachromatic leukodystrophy was found to be more frequent among Arabs living in two restricted areas in Israel. Ten families with affected children have been found, three in the Jerusalem region and seven in a small area in lower Galilee. Whereas all patients from the Jerusalem region are homozygous for a frequent mutant arylsulfatase A allele, five different mutations were found in the families from lower Galilee. In patients of Muslim Arab origin, we have found a G86-->D, a S96-->L, and a Q190-->H substitution. Two different defective arylsulfatase A alleles, characterized by a T274-->M and a R370-->W substitution, respectively, have been found among the Christian Arab patients. All mutations were introduced into the wild-type arylsulfatase A cDNA. No enzyme activity could be expressed from the mutagenized cDNAs after transfection into heterologous cells. In all instances, the patients were found to be homozygous for the mutations, and four of the five mutations occurred on different haplotypes. The clustering of this rare lysosomal storage disease in a small geographic area usually suggests a founder effect, so the finding of five different mutations is surprising.	UNIV GOTTINGEN,INST BIOCHEM 2,D-37073 GOTTINGEN,GERMANY; HADASSAH MED ORG,DEPT HUMAN GENET,JERUSALEM,ISRAEL	University of Gottingen; Hebrew University of Jerusalem; Hadassah University Medical Center				Zlotogora, Joel/0000-0001-6293-2979				ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; BACH G, 1993, AM J HUM GENET, V53, P330; BARTH ML, 1993, HUM GENET, V91, P73; DIAMOND JM, 1987, NATURE, V329, P105, DOI 10.1038/329105a0; FLINT J, 1993, HUM GENET, V91, P91; FREUNDLICH E, 1984, ISRAEL J MED SCI, V20, P1035; GIESELMANN V, 1989, P NATL ACAD SCI USA, V86, P9436, DOI 10.1073/pnas.86.23.9436; GIESELMANN V, IN PRESS HUM MUTAT; GUSTAVSON KH, 1971, ACTA PAEDIATR SCAND, V60, P585, DOI 10.1111/j.1651-2227.1971.tb06994.x; HARVEY JS, 1993, HUM MUTAT, V2, P261, DOI 10.1002/humu.1380020405; HECHTMAN P, 1990, AM J HUM GENET, V47, P815; HECHTMAN P, 1992, HUM GENET, V90, P402, DOI 10.1007/BF00220467; JABER L, 1992, AM J MED GENET, V44, P1, DOI 10.1002/ajmg.1320440102; KOLODNY EH, 1989, METABOLIC BASIS INHE, V2, P1721; KREYSING J, 1990, EUR J BIOCHEM, V191, P627, DOI 10.1111/j.1432-1033.1990.tb19167.x; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; STEIN C, 1989, J BIOL CHEM, V264, P1252; ZLOTOGORA J, 1988, AM J HUM GENET, V42, P271; ZLOTOGORA J, 1991, ISRAEL J MED SCI, V27, P196; ZLOTOGORA J, 1993, AM J HUM GENET, V52, P1014; ZLOTOGORA J, 1994, AM J MED GENET, V49, P10, DOI 10.1002/ajmg.1320490104; ZLOTOGORA J, IN PRESS J MED GENET; ZLOTOGORA J, IN PRESS HUM MUTAT; 1991, STAT ABSTR ISRAEL, V42, P18	25	68	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					51	57						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825603				2022-12-18	WOS:A1995QC10100007
J	ZERYLNICK, C; TORRONI, A; SHERMAN, SL; WARREN, ST				ZERYLNICK, C; TORRONI, A; SHERMAN, SL; WARREN, ST			NORMAL VARIATION AT THE MYOTONIC-DYSTROPHY LOCUS IN GLOBAL HUMAN-POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; CTG REPEAT; MESSENGER-RNA; GENE; EXPANSION; MUTATION; PROTEIN; IDENTIFICATION; MIGRATIONS; EXPRESSION	Myotonic dystrophy (DM) is a dominant neuromuscular disease that results from an unstable CTG-repeat expansion in the 3' UTR of the myotonin kinase gene at 19q13.3. This repeat is normally polymorphic with a trimodal distribution reflecting 5-, 11-17-, and 19-30-repeat-length alleles. An absolute association between expanded CTG alleles and the 1-kb insertion allele of an intragenic polymorphism in Caucasians has led to the proposal that the 5-repeat allele gives rise to alleles of 19-30 repeats, from which expanded alleles are derived, a transition not involving the 11-17-repeat alleles. A survey of eight global populations confirms the stability of the 11-17-repeat alleles but shows disociation between the 1-kb insertion polymorphism and both the 5- and 19-30-repeat-length alleles. These data indicate more than one ancestral allele from which expanded alleles are derived and suggest that widely variable population frequencies of DM may reflect distinct frequencies of such predisposed alleles.	EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT MOLEC & MED GENET,ATLANTA,GA 30322	Emory University; Howard Hughes Medical Institute; Emory University; Emory University; Emory University			Warren, Stephen T/A-2498-2012; Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478	NIGMS NIH HHS [GM08490] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; BALLINGER SW, 1992, GENETICS, V130, P139; BOUCHARD G, 1989, CAN J NEUROL SCI, V116, P119; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Dada T O, 1973, East Afr Med J, V50, P213; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES J, 1992, J MED GENET, V29, P766, DOI 10.1136/jmg.29.11.766; ECKHART M, 1993, AM J HUM GENET, V53, P796; Fleiss JL, 1981, STAT METHODS RATES P; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GOLDMAN A, 1994, J MED GENET, V31, P37, DOI 10.1136/jmg.31.1.37; Harper P.S., 1989, MYOTONIC DYSTROPHY; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1993, HUM MOL GENET, V2, P1221, DOI 10.1093/hmg/2.8.1221; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LAVEDAN C, 1994, J MED GENET, V31, P33, DOI 10.1136/jmg.31.1.33; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHEDEVAN MS, 1992, GENOMICS, V15, P446; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Osame M, 1983, Rinsho Shinkeigaku, V23, P1067; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SHAW DJ, 1993, GENOMICS, V18, P673, DOI 10.1016/S0888-7543(05)80372-6; SMEETS HJM, 1991, GENOMICS, V9, P257, DOI 10.1016/0888-7543(91)90250-I; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TSIFIDIS C, 1992, NAT GENET, V1, P192; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WALLACE DC, 1992, HUM BIOL, V64, P403; 1993, CELL, V72, P971	37	68	74	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					123	130						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825567				2022-12-18	WOS:A1995QC10100016
J	HOWELL, N; XU, M; HALVORSON, S; BODISWOLLNER, I; SHERMAN, J				HOWELL, N; XU, M; HALVORSON, S; BODISWOLLNER, I; SHERMAN, J			HETEROPLASMIC LHON FAMILY - TISSUE DISTRIBUTION AND TRANSMISSION OF THE 11778-MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL-DNA MUTATION; RED FIBERS MERRF; A->G(8344) MUTATION; SEGREGATION; NEURORETINOPATHY; PEDIGREES; EPILEPSY; MELAS; GENE		UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550; SUNY HLTH SCI CTR,DEPT NEUROL,BROOKLYN,NY 11203; SUNY COLL OPTOMETRY,SCHNURMACHER INST VIS RES,NEW YORK,NY 10010	University of Texas System; University of Texas Medical Branch Galveston; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; SUNY Optometry	HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,GALVESTON,TX 77550, USA.		bodis-wollner, ivan/AAH-2631-2020		NICHD NIH HHS [P01 HD08315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; DEGOTTRAU P, 1992, J CLIN NEURO-OPHTHAL, V12, P89; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1992, HUM GENET, V90, P117; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1992, AM J HUM GENET, V50, P443; HOWELL N, IN PRESS CLIN NEUROS; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN E, 1985, T OPHTHAL SOC UK, V104, P845; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; VILKKI J, 1990, AM J HUM GENET, V47, P95; YEN MY, 1992, INVEST OPHTH VIS SCI, V33, P2561; ZHU DP, 1992, AM J MED GENET, V42, P173, DOI 10.1002/ajmg.1320420208	20	68	71	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					203	206						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023847				2022-12-18	WOS:A1994NW46100028
J	BAUMER, A; ZHANG, CF; LINNANE, AW; NAGLEY, P				BAUMER, A; ZHANG, CF; LINNANE, AW; NAGLEY, P			AGE-RELATED HUMAN MTDNA DELETIONS - A HETEROGENEOUS SET OF DELETIONS ARISING AT A SINGLE PAIR OF DIRECTLY REPEATED SEQUENCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DELETION; KEARNS-SAYRE SYNDROME; DEGENERATIVE DISEASES; AGING PROCESS; TISSUES; CARDIOMYOPATHY; CARDIOMYOCYTES; REPLICATION; MYOPATHIES; MUTATIONS	Deletions in mtDNA accumulate during the human aging process, arising from either intramolecular illegitimate recombination or strand slippage during replication, which results in subgenomic mtDNA molecules. We identify here two classes of mtDNA deletions-class A deletions, which are homogeneous at the breakpoints, with all subgenomic molecules therefore being identical in size, and class B deletions, which arise from a less stringent process that gives rise to heterogeneity at the breakpoints, with the subgenomic molecules being of slightly different sizes. A novel approach is described that offers a global overview of the populations of different deletions in individual tissues. It is based on PCR cycle-sequencing reactions that are carried out directly on mtDNA segments, amplified by PCR from total cellular DNA. The results show a clear size homogeneity of the subgenomic mtDNA molecules representative of class A, which carry a commonly detected 4,977-bp deletion occurring at a pair of 13-bp directly repeated sequences. In this case, precisely one copy of the repeat is retained in the subgenomic molecules. We then describe a class B situation comprising a family of at least nine closely related 8.04-kb deletions involving the same pair of 5-bp direct repeats. In this situation, the breakpoints differ at the base-pair level (8,037-8,048-bp deletions); the subgenomic molecules retain >1 copy, 1 copy, or <1 copy of the 5-bp repeat. In different tissues from either the same individual or among different individuals, there is a widely variable occurrence of particular deletions in the subgenomic mtDNA population within this class B set. Class B deletions offer a new approach for studying the accumulation of mtDNA deletions, thereby providing insight into the independent somatic origin of mutated mtDNA molecules, both in aging and in mitochondrial diseases. We also report a convenient method for ascertaining whether a given PCR product results from the amplification of a subgenomic mtDNA template, on the basis of the selective degradation of full-length mtDNA molecules prior to PCR.	MONASH UNIV,DEPT BIOCHEM,CLAYTON,VIC 3168,AUSTRALIA; MONASH UNIV,CTR MOLEC BIOL & MED,CLAYTON,VIC,AUSTRALIA	Monash University; Monash University			Linnane, Anthony W/A-6546-2011					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493; HATTORI K, 1991, AM HEART J, V122, P866, DOI 10.1016/0002-8703(91)90542-P; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1988, LANCET, V1, P1462; IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B; LARSSON NG, 1992, AM J HUM GENET, V50, P360; LESTIENNE P, 1988, LANCET, V1, P885; LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; LINNANE AW, 1992, ADENINE NUCLEOTIDES, P137; MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H; Nagley Phillip, 1993, P137; OBERMAIERKUSSER B, 1990, BIOCHEM BIOPH RES CO, V169, P1007, DOI 10.1016/0006-291X(90)91994-4; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; ROTIG A, 1989, LANCET, V1, P902; ROTIG A, 1988, LANCET, V2, P567; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P1103, DOI 10.1159/000133724; WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L; YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0; YEN TC, 1992, BIOCHEM INT, V26, P457; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Zeviani Massimo, 1993, P85; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7; ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158	42	68	104	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					618	630						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128959				2022-12-18	WOS:A1994NC83600006
J	LERTRIT, P; NOER, AS; JEANFRANCOIS, MJB; KAPSA, R; DENNETT, X; THYAGARAJAN, D; LETHLEAN, K; BYRNE, E; MARZUKI, S				LERTRIT, P; NOER, AS; JEANFRANCOIS, MJB; KAPSA, R; DENNETT, X; THYAGARAJAN, D; LETHLEAN, K; BYRNE, E; MARZUKI, S			A NEW DISEASE-RELATED MUTATION FOR MITOCHONDRIAL ENCEPHALOPATHY LACTIC-ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) SYNDROME AFFECTS THE ND4 SUBUNIT OF THE RESPIRATORY COMPLEX-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; KEARNS-SAYRE SYNDROME; COMPLETE NUCLEOTIDE-SEQUENCE; TRANSFER RNALEU(UUR) GENE; TRANSFER RNALYS MUTATION; DNA DELETIONS; MATERNAL INHERITANCE; MYOCLONIC EPILEPSY; POINT MUTATION; ORGANIZATION	The molecular lesions in two patients exhibiting classical clinical manifestations of MELAS (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes) syndrome have been investigated. A recently reported disease-related A-->G base substitution at nt 3243 of the mtDNA, in the DHU loop of tRNA(Leu), was detected by restriction-enzyme analysis of the relevant PCR-amplified segment of the mtDNA of one patient but was not observed, by either restriction-enzyme analysis or nucleotide sequencing, in the other. To define the molecular lesion in the patient who does not have the A-->G base substitution at nt 3243, the total mitochondrial genome of the patient has been sequenced. An A-->G base substitution at nt 11084, leading to a Thr-to-Ala amino acid replacement in the ND4 subunit of the respiratory complex I, is suggested to be a disease-related mutation.	MONASH UNIV,DEPT BIOCHEM,CLAYTON,VIC 3168,AUSTRALIA; MONASH UNIV,CTR MOLEC BIOL & MED,CLAYTON,VIC 3168,AUSTRALIA; ST VINCENTS HOSP,DEPT NEUROL,FITZROY,VIC 3065,AUSTRALIA; UNIV MELBOURNE,STATE NEUROPATHOL SERV,PARKVILLE,VIC 3052,AUSTRALIA; PRINCE HENRY HOSPITAL,DEPT NEUROL,SYDNEY,AUSTRALIA	Monash University; Monash University; St Vincent's Hospital Melbourne; University of Melbourne			Kapsa, Robert/H-8916-2013	Kapsa, Robert/0000-0002-6113-5174				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BYRNE E, 1985, J NEUROL SCI, V69, P319, DOI 10.1016/0022-510X(85)90143-1; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; CASE JT, 1981, SOMAT CELL GENET, V7, P103, DOI 10.1007/BF01544751; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; DANKS PA, 1988, AUST NZ J MED, V18, P69; Davis LG, 1986, BASIC METHODS MOL BI, P42; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; EGGER J, 1983, NEW ENGL J MED, V309, P142, DOI 10.1056/NEJM198307213090304; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GARESSE R, 1988, GENETICS, V118, P649; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1990, AM J HUM GENET, V47, P629; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; HUOPONEN K, 1990, GENOMICS, V8, P583, DOI 10.1016/0888-7543(90)90049-Z; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609; LESTIENNE P, 1988, LANCET, V1, P885; MARZUKI S, 1989, BIOCHIM BIOPHYS ACTA, V975, P222, DOI 10.1016/S0005-2728(89)80252-X; MARZUKI S, 1991, HUM GENET, V88, P139; MARZUKI S, 1990, PROGR NEUROPATHOLOGY, V7, P181; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; NOER AS, 1991, AM J HUM GENET, V49, P715; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; PEARSON HA, 1979, J PEDIATR, V95, P977; ROE BA, 1985, J BIOL CHEM, V260, P9759; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SUDOYO H, 1992, J NEUROL SCI, V108, P7, DOI 10.1016/0022-510X(92)90181-J; TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YONEDA M, 1990, PROGR NEUROPATHOLOGY, V7, P169; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	49	68	71	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					457	468						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1323207				2022-12-18	WOS:A1992JJ82800002
J	MASHIMA, Y; MURAKAMI, A; WELEBER, RG; KENNAWAY, NG; CLARKE, L; SHIONO, T; INANA, G				MASHIMA, Y; MURAKAMI, A; WELEBER, RG; KENNAWAY, NG; CLARKE, L; SHIONO, T; INANA, G			NONSENSE-CODON MUTATIONS OF THE ORNITHINE AMINOTRANSFERASE GENE WITH DECREASED LEVELS OF MUTANT MESSENGER-RNA IN GYRATE ATROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE CHAIN-REACTION; SINGLE-BASE CHANGES; GENOMIC DNA; ENZYMATIC AMPLIFICATION; POINT MUTATIONS; RETINA; DEFICIENCY; VITAMIN-B6; DEFECT	A generalized deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) is the inborn error in gyrate atrophy (GA), an autosomal recessive degenerative disease of the retina and choroid of the eye. Mutations in the OAT gene show a high degree of molecular heterogeneity in GA, reflecting the genetic heterogeneity in this disease. Using the combined techniques of PCR, denaturing gradient gel electrophoresis, and direct sequencing, we have identified three nonsense-codon mutations and one nonsense codon-generating mutation of the OAT gene in GA pedigrees. Three of them are single-base substitutions, and one is a 2-bp deletion resulting in a reading frameshift. A nonsense codon created at position 79 (TGA) by a frameshift and nonsense mutations at codons 209 (TAT-->TAA) and 299 (TAC-->TAG) result in abnormally low levels of OAT mRNA in the patient's skin fibroblasts. A nonsense mutation at codon 426 (CGA-->TGA) in the last exon, however, has little effect on the mRNA level. Thus, the mRNA level can be reduced by nonsense-codon mutations, but the position of the mutation may be important, with earlier premature-translation termination having a greater effect than a later mutation.	UNIV MIAMI,SCH MED,BASCOM PALMER EYE INST,1638 NW 10TH AVE,MIAMI,FL 33136; OREGON HLTH SCI UNIV,DEPT OPHTHALMOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; TOHOKU UNIV,DEPT OPHTHALMOL,SENDAI,MIYAGI 980,JAPAN	Bascom Palmer Eye Institute; University of Miami; Oregon Health & Science University; Oregon Health & Science University; University of British Columbia; Tohoku University				Clarke, Lorne/0000-0003-0512-7281	NATIONAL EYE INSTITUTE [R01EY008904] Funding Source: NIH RePORTER; NEI NIH HHS [EY08904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKAKI Y, IN PRESS J BIOL CHEM; ATWEH GF, 1988, J CLIN INVEST, V82, P557, DOI 10.1172/JCI113632; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; FOJO SS, 1988, J BIOL CHEM, V263, P17913; HAYASAKA S, 1981, BRIT J OPHTHALMOL, V65, P478, DOI 10.1136/bjo.65.7.478; HIGGS DR, 1983, NATURE, V306, P398, DOI 10.1038/306398a0; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HOTTA Y, 1989, AM J HUM GENET, V44, P353; HUMPHRIES RK, 1984, BLOOD, V64, P23; INANA G, 1988, INVEST OPHTH VIS SCI, V29, P1001; INANA G, 1989, J BIOL CHEM, V264, P17432; KADOWAKI T, 1990, P NATL ACAD SCI USA, V87, P658, DOI 10.1073/pnas.87.2.658; KAUFMAN DL, 1990, GENOMICS, V8, P656, DOI 10.1016/0888-7543(90)90252-P; KENNAWAY NG, 1989, AM J HUM GENET, V44, P344; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; MCCLATCHEY AI, 1990, AM J HUM GENET, V47, P790; MITCHELL G, 1989, American Journal of Human Genetics, V45, pA207; MITCHELL GA, 1988, J CLIN INVEST, V81, P630, DOI 10.1172/JCI113365; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MITCHELL GA, 1989, PEDIATR RES S, V27, pA134; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NEWTON CR, 1988, NUCLEIC ACIDS RES, V16, P8233, DOI 10.1093/nar/16.17.8233; RAMESH V, 1988, P NATL ACAD SCI USA, V85, P3777, DOI 10.1073/pnas.85.11.3777; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; TAKESHITA KB, 1984, BLOOD, V64, P23; TRAYSTMAN MD, 1990, GENOMICS, V6, P293, DOI 10.1016/0888-7543(90)90569-G; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VALLE D, 1977, P NATL ACAD SCI USA, V74, P5159, DOI 10.1073/pnas.74.11.5159; VALLE D, 1989, METABOLIC BASIS INHE, P599; WELEBER RG, 1982, BIRTH DEFECTS-ORIG, V18, P219; WELEBER RG, 1986, AM J OPHTHALMOL, V101, P461, DOI 10.1016/0002-9394(86)90648-3; WELEBER RG, 1988, RETINITIS PIGMENTOSA, P198	39	68	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					81	91						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609808				2022-12-18	WOS:A1992JA46700009
J	OSHIMA, A; YOSHIDA, K; SHIMMOTO, M; FUKUHARA, Y; SAKURABA, H; SUZUKI, Y				OSHIMA, A; YOSHIDA, K; SHIMMOTO, M; FUKUHARA, Y; SAKURABA, H; SUZUKI, Y			HUMAN BETA-GALACTOSIDASE GENE-MUTATIONS IN MORQUIO-B DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Three different beta-galactosidase gene mutations-a 273Trp --> Leu (mutation F) in both families, 482Arg --> His (mutation G) in one family, and 509Trp --> Cys (mutation H) in the other family-were identified in three patients with Morquio B disease who were from two unrelated families. Restriction-site analysis using StuI, Nsp(7524)I or RsaI confirmed these mutations. In human fibroblasts mutation F expressed as much as 8% of the normal allele's enzyme activity, but the other mutations expressed no detectable enzyme activity. We conclude that the unique clinical manifestations are specifically associated with mutation F, a common two-base substitution, in this disease.			OSHIMA, A (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT CLIN GENET,3-18-22 HONKOMAGOME,BUNKYO KU,TOKYO 113,JAPAN.							NISHIMOTO J, 1991, AM J HUM GENET, V49; O'Brien JS, 1989, METABOLIC BASIS INHE, P1797; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; SAKURABA H, 1990, AM J HUM GENET, V47, P784; YOSHIDA K, 1991, AM J HUM GENET, V49, P435	5	68	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1091	1093						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928092				2022-12-18	WOS:A1991GM87300020
J	PTACEK, LJ; TYLER, F; TRIMMER, JS; AGNEW, WS; LEPPERT, M				PTACEK, LJ; TYLER, F; TRIMMER, JS; AGNEW, WS; LEPPERT, M			ANALYSIS IN A LARGE HYPERKALEMIC PERIODIC PARALYSIS PEDIGREE SUPPORTS TIGHT LINKAGE TO A SODIUM-CHANNEL LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADYNAMIA EPISODICA HEREDITARIA; MOLECULAR-STRUCTURE; GENE; DROSOPHILA; MYOTONIA; EXERCISE; SEQUENCE; BRAIN	Hyperkalemic periodic paralysis (HYPP) is an autosomal dominant muscle disease with electrophysiological abnormalities suggesting a defect in a voltage-gated sodium channel (NaCh) gene. A human NaCh gene was recently shown to cosegregate with the disease allele in a family with HYPP. Using an independent clone, we have demonstrated close genetic linkage between an NaCh gene and the HYPP locus in another family. With physiological data demonstrating abnormal NaCh function in HYPP patients, the absence of any obligate recombinations in the two families strengthens the argument that this NaCh gene is the site of the defect in this disorder.	UNIV UTAH, SCH MED, HOWARD HUGHES MED INST, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; SUNY STONY BROOK, DEPT BIOCHEM & CELL BIOL, STONY BROOK, NY 11794 USA; YALE UNIV, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06520 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University	PTACEK, LJ (corresponding author), UNIV UTAH, SCH MED, DEPT NEUROL 3R210, 50 N MED DR, SALT LAKE CITY, UT 84132 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER; NHGRI NIH HHS [8 R01 HG00367] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BARCHI RL, 1988, NEUROL CLIN, V6, P473, DOI 10.1016/S0733-8619(18)30855-7; BRADLEY WG, 1969, BRAIN, V92, P345, DOI 10.1093/brain/92.2.345; BUDOWLE B, 1990, Applied and Theoretical Electrophoresis, V1, P181; ENGEL AG, 1986, MYOLOGY, P1843; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; HILLE B, 1984, IONIC CHANNELS EXCIT, V6; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LITT M, 1989, GENOMICS, V5, P204, DOI 10.1016/0888-7543(89)90047-5; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MCMANIS PG, 1986, MUSCLE NERVE, V9, P704, DOI 10.1002/mus.880090805; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; NUMA S, 1986, ANN NY ACAD SCI, V479, P338, DOI 10.1111/j.1749-6632.1986.tb15580.x; PAULET G, 1956, ARCH INT PHARMACOD T, V106, P1; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RICKER K, 1989, MUSCLE NERVE, V12, P883, DOI 10.1002/mus.880121103; RIGGS JE, 1988, NEUROL CLIN, V6, P485, DOI 10.1016/S0733-8619(18)30856-9; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; RUDEL R, 1989, MUSCLE NERVE, V12, P281; SALKOFF L, 1987, SCIENCE, V237, P744, DOI 10.1126/science.2441469; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; SUBRAMONY SH, 1986, NEUROLOGY, V36, P173, DOI 10.1212/WNL.36.2.173; TRIMMER JS, 1989, ANNU REV PHYSIOL, V51, P401, DOI 10.1146/annurev.physiol.51.1.401; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; TYLER FH, 1951, J CLIN INVEST, V30, P492, DOI 10.1172/JCI102465	29	68	70	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					378	382						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1651050				2022-12-18	WOS:A1991GA86600014
J	TIMMERMAN, V; RAEYMAEKERS, P; DE JONGHE, P; DEWINTER, G; SWERTS, L; JACOBS, K; GHEUENS, J; MARTIN, JJ; VAN DENBERGHE, A; VANBROECKHOVEN, C				TIMMERMAN, V; RAEYMAEKERS, P; DE JONGHE, P; DEWINTER, G; SWERTS, L; JACOBS, K; GHEUENS, J; MARTIN, JJ; VAN DENBERGHE, A; VANBROECKHOVEN, C			ASSIGNMENT OF THE CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-I (CMT IA) GENE TO 17P11.2-P12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV INSTELLING ANTWERP, BORN BUNGE FDN,DEPT BIOCHEM,NEUROGENET LAB, UNIV PLEIN 1, B-2610 WILRIJK, BELGIUM; UNIV INSTELLING ANTWERP, BORN BUNGE FDN, DEPT MED, NEUROBIOL LAB, B-2610 WILRIJK, BELGIUM; UNIV INSTELLING ANTWERP, BORN BUNGE FDN, DEPT MED, NEUROPATHOL LAB, B-2610 WILRIJK, BELGIUM; IMMUNOGENET, GHENT, BELGIUM	University of Antwerp; University of Antwerp; University of Antwerp			Timmerman, Vincent/O-7283-2019; Van Broeckhoven, Christine/M-7853-2019	Timmerman, Vincent/0000-0002-2162-0933; Van Broeckhoven, Christine/0000-0003-0183-7665				BARKER D, 1987, CYTOGENET CELL GENET, V46, P576; BIRD TD, 1982, AM J HUM GENET, V34, P388; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dyck P.J., 1984, PERIPHERAL NEUROPATH, P1600; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FOUNTAIN JW, 1989, AM J HUM GENET, V44, P58; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; Haldane JBS, 1919, J GENET, V8, P299; HOFF M, 1988, NUCLEIC ACIDS RES, V16, P781, DOI 10.1093/nar/16.2.781; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEBO RV, 1989, CYTOGENET CELL GENET, V51, P1030; MIDDLETONPRICE HR, 1990, AM J HUM GENET, V46, P92; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; OCONNELL P, 1989, AM J HUM GENET, V44, P51; OTT J, 1988, American Journal of Human Genetics, V43, pA154; PATEL PI, 1990, AM J HUM GENET, V46, P801; RAEYMAEKERS P, 1988, J NEUROL SCI, V88, P145, DOI 10.1016/0022-510X(88)90212-2; RAEYMAEKERS P, 1989, AM J HUM GENET, V45, P953; SCHWARTZ CE, 1986, CYTOGENET CELL GENET, V43, P117, DOI 10.1159/000132307; SKRE H, 1974, CLIN GENET, V6, P98; SOLOMON E, 1989, CYTOGENET CELL GENET, V51, P319, DOI 10.1159/000132797; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5	27	68	70	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					680	685						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2220808				2022-12-18	WOS:A1990EB31900013
J	GREIG, GM; ENGLAND, SB; BEDFORD, HM; WILLARD, HF				GREIG, GM; ENGLAND, SB; BEDFORD, HM; WILLARD, HF			CHROMOSOME-SPECIFIC ALPHA SATELLITE DNA FROM THE CENTROMERE OF HUMAN CHROMOSOME-16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto			Slagboom, P. Eline/R-4790-2016	Slagboom, P. Eline/0000-0002-2875-4723; England, Sarah/0000-0002-0953-8136	NIGMS NIH HHS [GM 40878] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040878] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUCHAMP RS, 1979, CHROMOSOMA, V71, P153, DOI 10.1007/BF00292820; BURK RD, 1985, CHROMOSOMA, V92, P225, DOI 10.1007/BF00348698; CAVALLISFORZA LL, 1986, COLD SPRING HARB SYM, V51, P411, DOI 10.1101/SQB.1986.051.01.049; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; COOKE H, 1976, NATURE, V262, P182, DOI 10.1038/262182a0; CORNEO G, 1970, J MOL BIOL, V48, P319, DOI 10.1016/0022-2836(70)90163-4; CREMER T, 1988, EXP CELL RES, V176, P199, DOI 10.1016/0014-4827(88)90325-4; DEVILEE P, 1988, Genomics, V3, P1, DOI 10.1016/0888-7543(88)90151-6; DEVILEE P, 1986, NUCLEIC ACIDS RES, V14, P2059, DOI 10.1093/nar/14.5.2059; JABS EW, 1989, P NATL ACAD SCI USA, V86, P202, DOI 10.1073/pnas.86.1.202; JABS EW, 1988, AM J HUM GENET, V43, P69; JEANPIERRE M, 1985, HUM GENET, V70, P302, DOI 10.1007/BF00295365; JORGENSEN AL, 1986, J MOL BIOL, V187, P185, DOI 10.1016/0022-2836(86)90227-5; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; JORGENSEN AL, 1987, EMBO J, V6, P1691; KUNKEL LM, 1976, SCIENCE, V191, P1189, DOI 10.1126/science.1257744; MANUELIDIS L, 1978, CHROMOSOMA, V66, P23, DOI 10.1007/BF00285813; McKusick V., 1987, GENOMICS, V1, P1; MENEVERI R, 1985, J MOL BIOL, V186, P483, DOI 10.1016/0022-2836(85)90123-8; MITCHELL AR, 1985, CHROMOSOMA, V92, P369, DOI 10.1007/BF00327469; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; NAKAHORI Y, 1986, NUCLEIC ACIDS RES, V14, P7569, DOI 10.1093/nar/14.19.7569; OHTA T, 1983, P NATL ACAD SCI USA, V80, P4097; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; RAPPOLD GA, 1984, HUM GENET, V67, P317, DOI 10.1007/BF00291361; SPENCE JE, 1988, AM J HUM GENET, V42, P217; TYLERSMITH C, 1987, J MOL BIOL, V195, P57; WAYE J S, 1987, Genomics, V1, P43, DOI 10.1016/0888-7543(87)90103-0; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WAYE JS, 1987, MOL CELL BIOL, V7, P349, DOI 10.1128/MCB.7.1.349; WAYE JS, IN PRESS CHROMOSOMA; WAYE JS, 1989, CHROMOSOMA, V97, P475; WEVRICK R, IN PRESS P NATL ACAD; WILLARD HF, 1985, AM J HUM GENET, V37, P524; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; YUROV YB, 1987, HUM GENET, V76, P157, DOI 10.1007/BF00284914	39	68	70	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					862	872						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2573999				2022-12-18	WOS:A1989CF40300005
J	CARIELLO, NF; SCOTT, JK; KAT, AG; THILLY, WG; KEOHAVONG, P				CARIELLO, NF; SCOTT, JK; KAT, AG; THILLY, WG; KEOHAVONG, P			RESOLUTION OF A MISSENSE MUTANT IN HUMAN GENOMIC DNA BY DENATURING GRADIENT GEL-ELECTROPHORESIS AND DIRECT SEQUENCING USING INVITRO DNA AMPLIFICATION - HPRT MUNICH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CARIELLO, NF (corresponding author), MIT,DEPT APPL BIOL SCI,BLDG E-18,ROOM 666,CAMBRIDGE,MA 02139, USA.			Keohavong, Phouthone/0000-0001-7812-4925	NIEHS NIH HHS [P30 ES002109, 5-P01-ES01640, 5-P30-ES02109, 5-P01-ES00597] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, P01ES001640, P01ES000597] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CARIELLO NF, 1986, MECHANISMS DNA DAMAG, P439; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; HATTMAN S, 1978, J MOL BIOL, V126, P367, DOI 10.1016/0022-2836(78)90046-3; KEOHAVONG P, 1988, DNA-J MOLEC CELL BIO, V7, P63, DOI 10.1089/dna.1988.7.63; KESSLER C, 1985, GENE, V33, P1, DOI 10.1016/0378-1119(85)90119-2; LERMAN LS, 1984, ANNU REV BIOPHYS BIO, V13, P399; LERMAN LS, 1986, COLD SPRING HARB SYM, V51, P285, DOI 10.1101/SQB.1986.051.01.034; LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429; MANIATIS T, 1982, MOL CLONING LABORATO; Maxam A M, 1980, Methods Enzymol, V65, P499; MCMAHON G, 1987, P NATL ACAD SCI USA, V84, P4974, DOI 10.1073/pnas.84.14.4974; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3111, DOI 10.1093/nar/13.9.3111; MYERS RM, 1986, COLD SPRING HARB SYM, V51, P275, DOI 10.1101/SQB.1986.051.01.033; NOLL WW, 1987, P NATL ACAD SCI USA, V84, P3339, DOI 10.1073/pnas.84.10.3339; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SKOPEK TR, 1978, BIOCHEM BIOPH RES CO, V84, P411, DOI 10.1016/0006-291X(78)90185-7; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; THILLY WG, 1985, CARCINOGENESIS ROLE, P511; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; WILSON JM, 1983, NEW ENGL J MED, V309, P900; WILSON JM, 1984, J BIOL CHEM, V259, P27; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; WYATT GR, 1951, BIOCHEM J, V48, P581, DOI 10.1042/bj0480581	30	68	86	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					726	734						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	3358423				2022-12-18	WOS:A1988N143800008
J	HSU, LC; YOSHIDA, A; MOHANDAS, T				HSU, LC; YOSHIDA, A; MOHANDAS, T			CHROMOSOMAL ASSIGNMENT OF THE GENES FOR HUMAN ALDEHYDE DEHYDROGENASE-1 AND ALDEHYDE DEHYDROGENASE-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DIV MED GENET,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	HSU, LC (corresponding author), CITY HOPE NATL MED CTR,BECKMAN RES INT,DEPT BIOCHEM GENET,DUARTE,CA 91010, USA.				NIAAA NIH HHS [AA05763] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005763] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		CROW KE, 1974, BIOCHIM BIOPHYS ACTA, V350, P121, DOI 10.1016/0005-2744(74)90209-5; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; ECKFELDT JH, 1976, ARCH BIOCHEM BIOPHYS, V175, P717, DOI 10.1016/0003-9861(76)90564-6; GOEDDE HW, 1979, HUM GENET, V51, P331; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HOLMES RS, 1981, ANIM BLOOD GROUPS BI, V12, P1; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; IKAWA M, 1983, J BIOL CHEM, V258, P6282; KITABATAKE N, 1981, J BIOCHEM, V89, P1223; MOHANDAS T, 1979, AM J HUM GENET, V31, P586; MOHANDAS T, 1982, CYTOGENET CELL GENET, V32, P300; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SANTISTEBAN I, 1985, ANN HUM GENET, V49, P87, DOI 10.1111/j.1469-1809.1985.tb01680.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; TIMMS GP, 1981, GENETICS, V97, P327; VONBAHRLINDSTROM H, 1984, EUR J BIOCHEM, V141, P37; YEN PH, 1984, SOMAT CELL MOLEC GEN, V10, P561, DOI 10.1007/BF01535221; YOSHIDA A, 1983, AM J HUM GENET, V35, P1107; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3	20	68	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					641	648						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3013004				2022-12-18	WOS:A1986C973000003
J	NUSSBAUM, RL; LEWIS, RA; LESKO, JG; FERRELL, R				NUSSBAUM, RL; LEWIS, RA; LESKO, JG; FERRELL, R			CHOROIDEREMIA IS LINKED TO THE RESTRICTION FRAGMENT LENGTH POLYMORPHISM DXYS1 AT XQ13-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OPHTHALMOL,HOUSTON,TX 77030; UNIV PITTSBURGH,SCH PUBL HLTH,DEPT BIOSTAT,PITTSBURGH,PA 15260; HOWARD HUGHES MED INST,HOUSTON,TX	Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute								ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BELL A G, 1971, Clinical Genetics, V2, P239; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; EMERY AEH, 1976, METHODOLOGY MED GENE, P63; FORSIUS H, 1977, ACTA OPHTHALMOL, V55, P459; GOEDBLOED J, 1984, OPHTHALMOLOGICA, V104, P308; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; KRUGER KE, 1972, ACTA OPHTHALMOL, V50, P782; Mauthner L., 1872, BERL NATUR MED VER I, V2, P191; McCULLOCH C, 1948, Trans Am Acad Ophthalmol Otolaryngol, V52, P160; MCKUSICK V, 1983, MENDELIAN INHERITANC, P999; NUSSBAUM RL, 1983, P NATL ACAD SCI-BIOL, V80, P4035, DOI 10.1073/pnas.80.13.4035; OTHER A, 1968, ACTA OPHTHALMOL, V46, P79; OTT J, 1974, AM J HUM GENET, V26, P588; PAGE DC, 1984, AM J HUM GENET, V36, P565; PAI GS, 1980, P NATL ACAD SCI-BIOL, V77, P2810, DOI 10.1073/pnas.77.5.2810; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROBIN ML, 1966, ARCH OPHTHALMOL-CHIC, V76, P563, DOI 10.1001/archopht.1966.03850010565015; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SKOLNICK WH, 1983, CYTOGENET CELL GENET, V37, P210; SORSBY A, 1952, BRIT J OPHTHALMOL, V36, P547, DOI 10.1136/bjo.36.10.547; WAARDENBURG PJ, 1984, ACTA OPHTHALMOL KBH, V20, P235; WILSON JM, 1982, J CLIN INVEST, V69, P706, DOI 10.1172/JCI110499	27	68	68	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					473	481						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	2988333				2022-12-18	WOS:A1985AKE0700004
J	RAUM, D; AWDEH, Z; ANDERSON, J; STRONG, L; GRANADOS, J; TERAN, L; GIBLETT, E; YUNIS, EJ; ALPER, CA				RAUM, D; AWDEH, Z; ANDERSON, J; STRONG, L; GRANADOS, J; TERAN, L; GIBLETT, E; YUNIS, EJ; ALPER, CA			HUMAN-C4 HAPLOTYPES WITH DUPLICATED C4A OR C4B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP MED CTR, BOSTON, MA 02115 USA; DANA FARBER CANC INST, BOSTON, MA 02115 USA; PUGET SOUND BLOOD CTR, SEATTLE, WA 98104 USA; UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, HOUSTON, TX 77030 USA; HOSP TWENTIETH NOVEMBER, MEXICO CITY, DF, MEXICO	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Puget Sound Blood Center; University of Texas System; UTMD Anderson Cancer Center	RAUM, D (corresponding author), BETH ISRAEL HOSP, CTR BLOOD RES, BOSTON, MA 02215 USA.				NIADDK NIH HHS [AM-26844] Funding Source: Medline; NIAID NIH HHS [AI-14157, AI-15033] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM026844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014157, R37AI014157] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALPER CA, 1976, J EXP MED, V144, P1111, DOI 10.1084/jem.144.4.1111; ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; ALPER CA, 1983, VOX SANG, V45, P62, DOI 10.1111/j.1423-0410.1983.tb04124.x; AWDEH ZL, 1981, J CLIN INVEST, V67, P260, DOI 10.1172/JCI110021; AWDEH ZL, 1979, NATURE, V282, P205, DOI 10.1038/282205a0; AWDEH ZL, 1983, P NATL ACAD SCI-BIOL, V80, P259, DOI 10.1073/pnas.80.1.259; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; AWDEH ZL, 1980, IMMUNOBIOLOGY, V158, P35, DOI 10.1016/S0171-2985(80)80035-0; AZEN EA, 1971, CLIN RES, V19, P437; BODMER WF, 1978, HISTOCOMPATIBILITY T, P612; BRUUNPETERSEN G, 1982, HUM GENET, V61, P36, DOI 10.1007/BF00291328; DOZY AM, 1979, NATURE, V280, P605, DOI 10.1038/280605a0; GRANADOS J, 1982, 4TH INT WORKSH GEN C; HAUPTMANN A, 1982, 4TH INT WORKSH GEN C; KOMPF J, 1975, HUMANGENETIK, V27, P141; MAUFF G, 1978, VOX SANG, V34, P296, DOI 10.1111/j.1423-0410.1978.tb02485.x; MAUFF G, 1977, THESIS U KOLN KOLN, P205; NORDHAGEN R, 1981, J IMMUNOGENET, V8, P485; OLAISEN B, 1979, NATURE, V279, P736, DOI 10.1038/279736a0; OLAISEN B, 1979, HUM GENET, V50, P187, DOI 10.1007/BF00390240; ONEILL GJ, 1978, NATURE, V273, P668, DOI 10.1038/273668a0; ONEILL GJ, 1978, P NATL ACAD SCI USA, V75, P5165, DOI 10.1073/pnas.75.10.5165; ORKIN SH, 1979, CELL, V17, P33, DOI 10.1016/0092-8674(79)90292-7; ROOS MH, 1982, NATURE, V298, P854, DOI 10.1038/298854a0; ROSENFELD SI, 1969, J CLIN INVEST, V48, P2283, DOI 10.1172/JCI106194; SHREFFLER DC, 1965, ISOANTIGENS CELL INT, P11; TEISBERG P, 1977, J EXP MED, V146, P1380, DOI 10.1084/jem.146.5.1380; TEISBERG P, 1976, NATURE, V264, P253, DOI 10.1038/264253a0	28	68	68	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					72	79						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6607672				2022-12-18	WOS:A1984SC43000006
J	TSIPOURAS, P; BORRESEN, AL; DICKSON, LA; BERG, K; PROCKOP, DJ; RAMIREZ, F				TSIPOURAS, P; BORRESEN, AL; DICKSON, LA; BERG, K; PROCKOP, DJ; RAMIREZ, F			MOLECULAR HETEROGENEITY IN THE MILD AUTOSOMAL DOMINANT FORMS OF OSTEOGENESIS IMPERFECTA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT PEDIAT,PISCATAWAY,NJ 08854; UNIV OSLO,INST MED GENET,OSLO,NORWAY; UNIV MED & DENT NEW JERSEY,NEW JERSEY SCH OSTEOPATH MED,PISCATAWAY,NJ 08854; UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT OBSTET & GYNECOL,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Oslo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	TSIPOURAS, P (corresponding author), UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM032380] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-32380, AM-16516, AM-06913] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARSH GS, 1982, P NATL ACAD SCI-BIOL, V79, P3838, DOI 10.1073/pnas.79.12.3838; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BYERS PH, 1983, J CLIN INVEST, V71, P689, DOI 10.1172/JCI110815; CHANG JC, 1982, NEW ENGL J MED, V307, P30, DOI 10.1056/NEJM198207013070105; CHU ML, 1983, NATURE, V304, P78, DOI 10.1038/304078a0; CHU ML, 1983, FED PROC, V42, P1758; HOLLISTER DW, 1982, ADV HUM GENET, V12, P1; KAZAZIAN HH, 1980, BLOOD, V56, P926; LEVIN LS, 1978, LANCET, V1, P332; McKusick V.A., 1972, CLIN GENET; MYERS JC, 1981, P NATL ACAD SCI-BIOL, V78, P3516, DOI 10.1073/pnas.78.6.3516; MYERS JC, 1983, J BIOL CHEM, V258, P128; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; OTT J, 1974, AM J HUM GENET, V26, P588; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; PHILLIPS JA, 1982, J CLIN INVEST, V70, P489, DOI 10.1172/JCI110640; PROCHOWNIK EV, 1983, NEW ENGL J MED, V308, P1549, DOI 10.1056/NEJM198306303082601; SCHWARTZ S, 1984, ORAL SURG ORAL MED O, V57, P161, DOI 10.1016/0030-4220(84)90206-8; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1262, DOI 10.1172/JCI111082; WILLIAMS CJ, 1983, J BIOL CHEM, V258, P5915	23	68	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1172	1179						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6097110				2022-12-18	WOS:A1984TZ59000002
J	JASPERS, MT; WITKOP, CJ				JASPERS, MT; WITKOP, CJ			TAURODONTISM, AN ISOLATED TRAIT ASSOCIATED WITH SYNDROMES AND X-CHROMOSOMAL ANEUPLOIDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA, SCH DENT, DIV HUMAN & ORAL GENET, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	JASPERS, MT (corresponding author), UNIV MINNESOTA, SCH DENT, DIV ORAL & MAXILLOFACIAL SURG, MINNEAPOLIS, MN 55455 USA.							ACKERMAN JL, 1973, AM J PHYS ANTHROPOL, V38, P681, DOI 10.1002/ajpa.1330380305; ADLOFF P, 1907, ANAT ANZEIGER, V31, P273; Barker B C, 1976, Aust Dent J, V21, P272; BARLOW PW, 1973, DEV MED CHILD NEUROL, V15, P205; BERNICK SM, 1970, ORAL SURG ORAL MED O, V29, P549, DOI 10.1016/0030-4220(70)90465-2; BLUMBERG JE, 1971, AM J PHYS ANTHROPOL, V34, P243, DOI 10.1002/ajpa.1330340208; BLUMBERG JE, 1972, AM J PHYS ANTHROPOL, V36, P307; BRABANT H, 1961, B GROUP INT RECH SC, V4, P232; CASAMASSIMO PS, 1978, ORAL SURG ORAL MED O, V45, P107, DOI 10.1016/0030-4220(78)90232-3; CONGLETON J, 1979, ORAL SURG ORAL MED O, V48, P540, DOI 10.1016/0030-4220(79)90301-3; CRAWFORD JL, 1970, J DENT CHILD, V37, P171; Daito M, 1971, JPN J PEDODONT, V9, P94; DETERRA M, 1903, VIERTELJAHRSCHR ZAHN, V13, P11; FEICHTINGER C, 1977, ARCH ORAL BIOL, V22, P327, DOI 10.1016/0003-9969(77)90031-0; FISCHER H, 1961, DTSCH ZAHNARZTL Z, V16, P8; GAGE JP, 1978, CLIN GENET, V14, P159; Gamer S, 1967, J South Calif Dent Assoc, V35, P441; GARDNER DG, 1977, ORAL SURG ORAL MED O, V44, P271, DOI 10.1016/0030-4220(77)90279-1; GARDNER DG, 1978, J CAN DENT ASSOC, V44, P372; Gleiser I, 1955, AM J PHYS ANTHROP-NE, V13, P253, DOI 10.1002/ajpa.1330130206; GOLDSTEI.E, 1974, J AM DENT ASSOC, V89, P377, DOI 10.14219/jada.archive.1974.0381; GOLDSTEIN E, 1973, ORAL SURG ORAL MED O, V36, P131, DOI 10.1016/0030-4220(73)90274-0; GORJANOVICKRAMB.K, 1907, ANAT ANZEIGER, V31, P97; Gregory W. K., 1921, J DENT RES, V3, P87, DOI [DOI 10.1177/00220345210030011101, 10.1177/]; Gulmen S, 1976, J Endod, V2, P117, DOI 10.1016/S0099-2399(76)80149-5; HALL B, 1967, HEREDITAS, V52, P334; HAMNER J E 3rd, 1964, Oral Surg Oral Med Oral Pathol, V18, P409; Haunfelder D, 1967, DDZ, V21, P419; HIEDA T, 1971, JAPANESE J PEDODONTI, V9, P79; HRDLICKA A, 1914, 2300 SMITHS I REP; JORGENSON RJ, 1973, ORAL SURG ORAL MED O, V36, P693, DOI 10.1016/0030-4220(73)90142-4; KEELER C, 1973, J HERED, V64, P234, DOI 10.1093/oxfordjournals.jhered.a108398; KEENE HJ, 1966, AM J PHYS ANTHROPOL, V25, P208; Keith A, 1913, Proc R Soc Med, V6, P103; Keith A., 1925, ANTIQUITY MAN; KOSHIBA H, 1978, ORAL SURG ORAL MED O, V46, P376, DOI 10.1016/0030-4220(78)90403-6; Lehtinen R, 1971, Suom Hammaslaak Toim, V67, P71; LICHTENSTEIN J, 1972, AM J HUM GENET, V24, P569; LICHTENSTEIN J R, 1971, Birth Defects Original Article Series, V7, P308; LUNT DA, 1954, DENT REC, V74, P307; Lysell L, 1965, Odontol Revy, V16, P359; Mangion JJ, 1962, BR DENT, V113, P309; MANSONHING LR, 1963, ORAL SURG ORAL MED O, V16, P305; MEDNICK G A, 1973, Journal of the Michigan Dental Association, V55, P212; MELNICK M, 1977, CLIN GENET, V12, P17; MELOSKY LC, 1966, THESIS U WASHINGTON; MENA CA, 1971, ORAL SURG ORAL MED O, V32, P812, DOI 10.1016/0030-4220(71)90308-2; METRO PS, 1965, ORAL SURG ORAL MED O, V20, P236, DOI 10.1016/0030-4220(65)90196-9; MILES AEW, 1954, P ROY SOC MED, V47, P817, DOI 10.1177/003591575404701001; Miller W A, 1969, Br Dent J, V126, P456; MITTWOCH U, 1972, J MED GENET, V9, P92, DOI 10.1136/jmg.9.1.92; Mittwoch Ursula, 1973, GENETICS SEX DIFFERE; MJOR IA, 1972, J DENT CHILD, V39, P459; MOLLER KT, 1973, J SPEECH HEAR DISORD, V38, P268, DOI 10.1044/jshd.3802.268; MOORREES CFA, 1957, CORRELATIVE STUDY DE; PARKER JL, 1975, J DENT CHILD, V42, P47; PEDERSEN P. O., 1949, MEDDELELSER OM GRONLAND, V142, P1; Pettenella L, 1966, Mondo Odontostomatol, V8, P40; PICKERILL HP, 1909, P R SOC MED ODONT SE, V2, P150; POLANI PE, 1970, P ROY SOC MED, V63, P955, DOI 10.1177/003591577006300941; REGATTIERI LR, 1972, ORAL SURG ORAL MED O, V34, P691, DOI 10.1016/0030-4220(72)90355-6; ROBINSON GC, 1966, PEDIATRICS, V37, P498; SAUK JJ, 1973, ORAL SURG ORAL MED O, V36, P231, DOI 10.1016/0030-4220(73)90243-0; SHAPIRO BL, 1970, ANN NY ACAD SCI, V171, P562, DOI 10.1111/j.1749-6632.1970.tb39367.x; SHAPIRO BL, 1975, ANN HUM GENET, V38, P429, DOI 10.1111/j.1469-1809.1975.tb00632.x; Shaw JCM, 1928, J ANAT, V62, P476; SHIFMAN A, 1976, ORAL SURG ORAL MED O, V41, P400, DOI 10.1016/0030-4220(76)90153-5; SHIFMAN A, 1978, COMMUNITY DENT ORAL, V6, P200, DOI 10.1111/j.1600-0528.1978.tb01150.x; SIIRILA HS, 1962, SUOM HAMMASLAAK TOIM, V58, P35; Stenvik A, 1972, Oral Surg Oral Med Oral Pathol, V33, P841, DOI 10.1016/0030-4220(72)90454-9; STEWART RE, 1971, ORAL SURG ORAL MED O, V32, P596, DOI 10.1016/0030-4220(71)90325-2; STEWART RE, 1974, CLIN GENET, V6, P341; STOY PJ, 1960, DENT PRACT DENT REC, V10, P202; STUDT KH, 1972, THESIS U IOWA; Tennant R D, 1966, Dent Dig, V72, P355; TOBIAS P, 1955, BRIT DENT J, V98, P352; TRATMAN E. K., 1950, DENTAL REC, V70, P31; TRATMAN E K, 1950, Dent Rec (London), V70, P63; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Webster G M, 1971, Chronicle, V34, P153; WIDERMAN FH, 1971, ORAL SURG ORAL MED O, V32, P618, DOI 10.1016/0030-4220(71)90328-8; WINTER G B, 1969, British Dental Journal, V127, P157; WITKOP CJ, 1976, INT DENT J, V26, P378; WITKOP CJ, 1971, ORAL SURG ORAL MED O, V32, P278, DOI 10.1016/0030-4220(71)90232-5; WITKOP CJ, 1971, DENTAL ORAL MANIFEST, P28	85	68	68	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					396	413						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	6992564				2022-12-18	WOS:A1980JX05900010
J	JOHNSON, WG				JOHNSON, WG			METABOLIC INTERFERENCE AND THE + - HETEROZYGOTE - A HYPOTHETICAL FORM OF SIMPLE INHERITANCE WHICH IS NEITHER DOMINANT NOR RECESSIVE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											JOHNSON, WG (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032, USA.							ANDERS A, 1978, BIOCHIM BIOPHYS ACTA, V516, P61, DOI 10.1016/0304-419X(78)90004-5; HEYCK H, 1969, PROGR DYSTROPHIEN MY, P59; JOHNSON WG, 1978, AM J HUM GENET, V30, pA124; JOHNSON WG, 1978, APR S AUT DOM DIS JE; Kallman K.D., 1975, P81; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1974, NATURE, V250, P651, DOI 10.1038/250651a0; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; STURTEVANT AH, 1956, GENETICS, V44, P118; Vaillaud JC, 1968, REV PEDIATR, V4, P303	10	68	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					374	386						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	6770678				2022-12-18	WOS:A1980JX05900008
J	SING, CF; ORR, JD				SING, CF; ORR, JD			ANALYSIS OF GENETIC AND ENVIRONMENTAL SOURCES OF VARIATION IN SERUM-CHOLESTEROL IN TECUMSEH, MICHIGAN .3. IDENTIFICATION OF GENETIC EFFECTS USING 12 POLYMORPHIC GENETIC BLOOD MARKER SYSTEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104	University of Michigan System; University of Michigan				Sing, Charles/0000-0001-5872-7956				ALFRED BM, 1974, HUM BIOL, V46, P641; BAMFORD KF, 1965, LANCET, V1, P530; BEEKMAN L, 1970, LANCET, V1, P1000; EPSTEIN FH, 1965, ANN INTERN MED, V62, P1170, DOI 10.7326/0003-4819-62-6-1170; FRASER GR, 1974, HUM HERED, V24, P424, DOI 10.1159/000152679; LANGMAN MJS, 1969, LANCET, V2, P607; LANGMAN MJS, 1966, NATURE, V212, P41, DOI 10.1038/212041a0; MAYO O, 1969, HUM HERED, V19, P86, DOI 10.1159/000152204; MAYO O, 1971, LANCET, V2, P554; MEDALIE JH, 1971, ATHEROSCLEROSIS, V14, P219, DOI 10.1016/0021-9150(71)90051-7; MORTON NE, 1976, J MED GENET, V13, P81, DOI 10.1136/jmg.13.2.81; NAPIER JA, 1962, AM J PUBLIC HEALTH N, V52, P208, DOI 10.2105/AJPH.52.2.208; NAPIER JA, 1971, CASEBOOK COMMUNITY S, P25; OLIVER MF, 1969, LANCET, V2, P605; ORR JD, 1975, SOC BIOL, V22, P34, DOI 10.1080/19485565.1975.9988145; SHREFFLER DC, 1971, AM J HUM GENET, V23, P150; SING CF, 1975, AM J HUM GENET, V27, P333; SOKAL RR, 1960, BIOMETRY, P776; 1969, LANCET, V2, P625	19	68	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					453	464						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CH661	984041				2022-12-18	WOS:A1976CH66100003
J	BODMER, JG; BODMER, WF				BODMER, JG; BODMER, WF			STUDIES ON AFRICAN PYGMIES .4. A COMPARATIVE STUDY OF HL-A POLYMORPHISM IN BABINGA PYGMIES AND OTHER AFRICAN AND CAUCASIAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Bodmer, Walter/0000-0001-6244-9792				[Anonymous], 1967, HISTOCOMPATIBILITY T; [Anonymous], 1970, HISTOCOMPATIBILITY T; BAILEY NTJ, 1961, MATHEMATICAL THEORY; BALNER H, 1965, HISTOCOMPATIBILITY T; BODMER W, 1966, ANN NY ACAD SCI, V129, P473, DOI 10.1111/j.1749-6632.1966.tb12871.x; BODMER WALTER, 1967, P341; BODMER WF, 1965, HISTOCOMPATIBILITY T, P141; BODMER WF, 1969, COMPUTER APPLICATION, P117; BODMER WF, 1970, HISTOCOMPATIBILITY T; BODMER WF, 1968, VOX SANG, V14, P451; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CAVALLISFORZA LL, 1969, AM J HUM GENET, V21, P252; CAVALLISFORZA LL, 1969, 12 P INT C GEN TOK, V3, P405; CAVALLISFORZA LL, 1970, GENETICS HUMAN POPUL; CEPPELLINI R., 1967, P149; CEPPELLINI R, 1967, 12 ATT RIUN ASS GEN, V12, P3; Coetzee Greig, 2003, PRESS; DAUSSET J, 1968, NOUV REV FR HEMATOL, V8, P398; DAUSSET J, 1968, NOUV REV FR HEMATOL, V8, P841; DAUSSET J., 1967, P189; DAUSSET J, 1965, HISTOCOMPATIBILITY T, P41; GABB BW, 1968, THESIS U ADELAIDE; IVANYI P, 1966, VOX SANG, V11, P326; KISSMEYER NIELS.F, 1968, NATURE, V29, P1116; MI MP, 1966, VOX SANG, V11, P434, DOI 10.1111/j.1423-0410.1966.tb04240.x; MICKEY MR, 1969, TRANSPLANT P, V1, P347; MIGGIANO VC, 1970, HISTOCOMPATIBILITY T; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; PAYNE R, 1964, COLD SPRING HARB SYM, V29, P285, DOI 10.1101/SQB.1964.029.01.031; PAYNE R, 1970, HISTOCOMPATIBILITY T; ROOD JJ, 1962, THESIS LEIDEN; RUBENSTEIN P, 1967, HISTOCOMPATIBILITY T, P251; SINGAL DP, 1969, TRANSPLANTATION, V7, P246, DOI 10.1097/00007890-196904000-00003; SVEJGAARD A, 1968, NATURE, V219, P868, DOI 10.1038/219868a0; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; THORSBY E, 1969, VOX SANG, V17, P102, DOI 10.1111/j.1423-0410.1969.tb00379.x; THORSBY E, 1969, VOX SANG, V17, P93, DOI 10.1111/j.1423-0410.1969.tb00378.x; TURNBULL C. M., 1965, WAYWARD SERVANTS; VANROOD JJ, 1965, HISTOCOMPATIBILITY T, P37; WALFORD RL, 1968, VOX SANG, V15, P338, DOI 10.1111/j.1423-0410.1968.tb04074.x; WORKMAN PL, 1963, AM J HUM GENET, V15, P429; 1968, B WHO, V39, P483	42	68	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					396	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	4194182				2022-12-18	WOS:A1970H022700006
J	DECAPOA, A; WARBURTON, D; BREG, WR; MILLER, DA; MILLER, OJ				DECAPOA, A; WARBURTON, D; BREG, WR; MILLER, DA; MILLER, OJ			TRANSLOCATION HETEROZYGOSIS - A CAUSE OF 5 CASES OF CRI DU CHAT SYNDROME AND 2 CASES WITH A DUPLICATION OF CHROMOSOME NUMBER 5 IN 3 FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		de Grouchy J, 1965, Ann Genet, V8, P31; GUSTAVSON KH, 1964, ACTA PAEDIATR, V53, P172, DOI 10.1111/j.1651-2227.1964.tb07224.x; GUSTAVSON KH, 1964, DOWNS SYNDROME; KOULISCHER L., 1965, ACTA PAEDIAT BELG, V19, P167; KOULISCHER L, 1966, 3 INT C HUM GEN CHIC; Lejeune J, 1965, Ann Genet, V8, P11; MILLER OJ, 1966, CYTOGENETICS, V5, P137, DOI 10.1159/000129893; WARBURTON D, 1967, AM J HUM GENET, V19, P399; WOLF U, 1966, HUMANGENETIK, V2, P63, DOI 10.1007/BF00285911	9	68	68	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					586	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	98570	6036276				2022-12-18	WOS:A19679857000010
J	ROBINSON, A; PUCK, TT				ROBINSON, A; PUCK, TT			STUDIES ON CHROMOSOMAL NONDISJUNCTION IN MAN .2.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BERGEMANN E, 1961, SCHWEIZ MED WSCHR, V91, P292; BURDETTE WJ, 1962, METHODOLOGY HUMAN ED, P260; CARR DH, 1965, OBSTET GYNECOL, V26, P308; COLLMANN RD, 1962, AM J PUBLIC HEALTH N, V52, P813, DOI 10.2105/AJPH.52.5.813; CULLING CFA, 1966, SEX CHROMATIN, P104; DAY RW, 1966, AM J HUM GENET, V18, P70; HALL B, 1964, LANCET, V1, P110; HECHT F, 1964, NEW ENGL J MED, V271, P1081, DOI 10.1056/NEJM196411192712102; HEINRICHS EH, 1963, LANCET, V2, P468; Hollingshead AB, 1953, AM SOCIOL REV, V18, P163, DOI 10.2307/2087725; KLINGER H. P., 1957, ACTA ANAT, V30, P371; KLINGER HP, 1957, STAIN TECHNOL, V32, P235, DOI 10.3109/10520295709111629; LECK I, 1966, LANCET, V2, P457; LEJEUNE JEROME, 1964, PROGR MED GENET, V3, P144; MACLEAN N, 1964, LANCET, V1, P286; MACLEAN N, 1961, LANCET, V2, P406; MOORE KL, 1959, LANCET, V1, P217; MOORE KL, 1955, LANCET, V2, P57, DOI 10.1016/S0140-6736(55)92161-9; MOORE KL, 1966, SEX CHROMATIN     ED, P104; NAIK SN, 1962, SCIENCE, V136, P1116; PENROSE LS, 1938, 229 MED RES COUNC RE; PLEYDELL MJ, 1957, LANCET, V1, P1314; PUCK TT, 1962, METHODOLOGY HUMAN GE, P260; PUCK TT, IN PRESS; ROBINSON A, 1965, SCIENCE, V148, P83, DOI 10.1126/science.148.3666.83; ROBINSON A, 1964, ANIMAL CELL NEWSLETT, V5, P3; STARK CR, 1966, LANCET, V1, P1036; STOLLER A, 1965, LANCET, V2, P1221; STOLLER A, 1965, Med J Aust, V1, P1; WIESLI B, 1962, ACTA ANAT, V51, P377; 1966, CYTOGENETICS, V5, P361	31	68	68	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	2					112	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	91653	4225660				2022-12-18	WOS:A19679165300005
J	NISWANDER, JD; CHUNG, CS				NISWANDER, JD; CHUNG, CS			EFFECTS OF INBREEDING ON TOOTH SIZE IN JAPANESE CHILDREN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BROTHWELL DR, 1963, DENTAL ANTHROPOLOGY; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; GARN SM, 1963, DEC AM ASS ADV SCIEN; HANNA BL, 1963, J DENT RES, V42, P322; KRAUS BS, 1953, J DENT RES, V32, P554, DOI 10.1177/00220345530320041701; KRAUS BS, 1951, AM J HUM GENET, V3, P348; LASKER GW, 1950, COLD SPRING HARB SYM, V15, P191, DOI 10.1101/SQB.1950.015.01.021; Lerner IM, 1954, GENETIC HOMEOSTASIS; LUNDSTROM A, 1963, AM J HUM GENET, V15, P34; LUNDSTROM A, 1948, TOOTH SIZE OCCLUSION; MOORREES CFA, 1951, J DENT RES, V30, P815, DOI 10.1177/00220345510300061201; Moorrees CFA, 1954, AM J PHYS ANTHROP-NE, V12, P77, DOI 10.1002/ajpa.1330120120; OSBORNE RH, 1958, AM J HUM GENET, V10, P350; SCHULL WJ, 1963, AM J HUM GENET, V15, P106; Schull WJ, 1965, EFFECTS INBREEDING J; SCHULL WJ, 1962, USE VITAL HEALTH STA; SEIPEL CM, 1946, SVENSK TANDLAKARET S, V39; WILLIAMS EJ, 1959, REGRESSION ANALYSIS	18	68	68	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1965	17	5					390	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	67851	14334738				2022-12-18	WOS:A19656785100003
J	Wright, GEB; Collins, JA; Kay, C; McDonald, C; Dolzhenko, E; Xia, QW; Becanovic, K; Drogemoller, BI; Semaka, A; Nguyen, CM; Trost, B; Richards, F; Bijlsma, EK; Squitieri, F; Ross, CJD; Scherer, SW; Eberle, MA; Yuen, RKC; Hayden, MR				Wright, Galen E. B.; Collins, Jennifer A.; Kay, Chris; McDonald, Cassandra; Dolzhenko, Egor; Xia, Qingwen; Becanovic, Kristina; Drogemoller, Britt I.; Semaka, Alicia; Nguyen, Charlotte M.; Trost, Brett; Richards, Fiona; Bijlsma, Emilia K.; Squitieri, Ferdinando; Ross, Colin J. D.; Scherer, Stephen W.; Eberle, Michael A.; Yuen, Ryan K. C.; Hayden, Michael R.			Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGE-OF-ONSET; INTERMEDIATE ALLELES; REPEAT EXPANSIONS; TRIPLET REPEAT; HIGH-FREQUENCY; SEQUENCE; BINDING; GENE; IDENTIFICATION; PENETRANCE	Huntington disease (HD) is caused by a CAG repeat expansion in the huntingtin (HTT) gene. Although the length of this repeat is inversely correlated with age of onset (AOO), it does not fully explain the variability in AOO. We assessed the sequence downstream of the CAG repeat in HTT [reference: (CAG)n-CAA-CAG], since variants within this region have been previously described, but no study of AOO has been performed. These analyses identified a variant that results in complete loss of interrupting (LOI) adenine nucleotides in this region [(CAG)n-CAG-CAG]. Analysis of multiple HD pedigrees showed that this LOI variant is associated with dramatically earlier AOO (average of 25 years) despite the same polyglutamine length as in individuals with the interrupting penultimate CAA codon. This LOI allele is particularly frequent in persons with reduced penetrance alleles who manifest with HD and increases the likelihood of presenting clinically with HD with a CAG of 36-39 repeats. Further, we show that the LOI variant is associated with increased somatic repeat instability, highlighting this as a significant driver of this effect. These findings indicate that the number of uninterrupted CAG repeats, which is lengthened by the LOI, is the most significant contributor to AOO of HD and is more significant than polyglutamine length, which is not altered in these individuals. In addition, we identified another variant in this region, where the CAA-CAG sequence is duplicated, which was associated with later AOO. Identification of these cis-acting modifiers have potentially important implications for genetic counselling in HD-affected families.	[Wright, Galen E. B.; Collins, Jennifer A.; Kay, Chris; McDonald, Cassandra; Xia, Qingwen; Becanovic, Kristina; Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Dolzhenko, Egor; Eberle, Michael A.] Illumina Inc, San Diego, CA 92121 USA; [Becanovic, Kristina] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Drogemoller, Britt I.; Ross, Colin J. D.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada; [Semaka, Alicia] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Nguyen, Charlotte M.; Trost, Brett; Scherer, Stephen W.; Yuen, Ryan K. C.] Hosp Sick Children, Ctr Appl Genom Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Nguyen, Charlotte M.; Scherer, Stephen W.; Yuen, Ryan K. C.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Richards, Fiona] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2145, Australia; [Bijlsma, Emilia K.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 Leiden, Netherlands; [Squitieri, Ferdinando] Fdn IRCCS Casa Sollievo Sofferenza, Huntington & Rare Dis Unit, I-71013 San Giovanni Rotondo, Italy; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 0A4, Canada	University of British Columbia; Illumina; Karolinska Institutet; University of British Columbia; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Sydney; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Toronto	Hayden, MR (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Becanovic, Kristina/A-4479-2016; Collins, Jennifer/AAE-1895-2020; Scherer, Stephen W./B-3785-2013; Hayden, Michael R/D-8581-2011; Yuen, Ryan K. C./J-4876-2012; Trost, Brett/K-4127-2016; Squitieri, Ferdinando/F-1561-2016	Scherer, Stephen W./0000-0002-8326-1999; Hayden, Michael R/0000-0001-5159-1419; Yuen, Ryan K. C./0000-0001-7273-4968; Trost, Brett/0000-0003-4863-7273; Squitieri, Ferdinando/0000-0002-7397-1727; Drogemoller, Britt/0000-0002-3348-5855; Ross, Colin/0000-0003-1476-7037; Eberle, Michael/0000-0001-8965-1253	Canadian Institutes of Health Research Foundation; Centre for Molecular Medicine and Therapeutics; BCChildren's Hospital Research Institute; Centre for Applied Genomics at the Hospital for Sick Children; University of Toronto McLaughlin Centre	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Centre for Molecular Medicine and Therapeutics; BCChildren's Hospital Research Institute; Centre for Applied Genomics at the Hospital for Sick Children; University of Toronto McLaughlin Centre	This work was supported by a Canadian Institutes of Health Research Foundation grant awarded to M.R.H. S.W.S. is the GlaxoSmithKline-CIHR Chair in Genome Sciences. We would like to thank the Centre for Molecular Medicine and Therapeutics andBCChildren's Hospital Research Institute, as well as The Centre for Applied Genomics at the Hospital for Sick Children and the University of Toronto McLaughlin Centre for support. Additionally, we would like to acknowledge Leal Makaroff for his assistance with developing and validating assays for somatic instability. We also wish to thank all the individuals with HD and their families worldwide who have chosen to participate in research, including those from the Centre for Huntington Disease and the HD BioBank at UBC; Leiden University Medical Center, the Netherlands; the Children's Hospital in Westmead, Sydney, Australia; as well those collected through Lega Italiana Ricerca Huntington (LIRH) Foundation in Rome, Italy. Without the support of HD-affected families, none of this research would be possible.	Becanovic K, 2015, NAT NEUROSCI, V18, P807, DOI 10.1038/nn.4014; Charles P, 2007, NEUROLOGY, V69, P1970, DOI 10.1212/01.wnl.0000269323.21969.db; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; Costanzi-Porrini S, 2000, NEUROLOGY, V54, P491, DOI 10.1212/WNL.54.2.491; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Dolzhenko E., 2019, BIORXIV, DOI [10.1101/572545, DOI 10.1101/572545]; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kay C, 2016, NEUROLOGY, V87, P282, DOI 10.1212/WNL.0000000000002858; Kay C, 2015, MOL THER, V23, P1759, DOI 10.1038/mt.2015.128; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Keum JW, 2016, AM J HUM GENET, V98, P287, DOI 10.1016/j.ajhg.2015.12.018; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Maat-Kievit A, 2001, J Med Genet, V38, pE12, DOI 10.1136/jmg.38.4.e12; Moss DJH, 2017, LANCET NEUROL, V16, P701, DOI 10.1016/S1474-4422(17)30161-8; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; PECHEUX C, 1995, J MED GENET, V32, P399, DOI 10.1136/jmg.32.5.399; Pinto RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003930; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Rosenblatt A, 2001, AM J MED GENET, V105, P399, DOI 10.1002/ajmg.1400; Semaka A, 2010, AM J MED GENET B, V153B, P314, DOI 10.1002/ajmg.b.30970; Semaka A, 2013, AM J MED GENET B, V162, P864, DOI 10.1002/ajmg.b.32193; Semaka A, 2013, J MED GENET, V50, P696, DOI 10.1136/jmedgenet-2013-101796; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TELENIUS H, 1995, HUM MOL GENET, V4, P189, DOI 10.1093/hmg/4.2.189; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Williams LC, 2000, GENET TEST, V4, P55, DOI 10.1089/109065700316480; Yu S, 2000, CLIN GENET, V58, P469, DOI 10.1034/j.1399-0004.2000.580607.x; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524	35	67	70	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1116	1126		10.1016/j.ajhg.2019.04.007	http://dx.doi.org/10.1016/j.ajhg.2019.04.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31104771	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000470240000008
J	Liu, WJ; He, XJ; Yang, SM; Zouari, R; Wang, JX; Wu, H; Kherraf, ZE; Liu, CY; Coutton, C; Zhao, R; Tang, DD; Tang, SY; Lv, MR; Fang, YY; Li, WY; Li, H; Zhao, JY; Wang, X; Zhao, SM; Zhang, JJ; Arnoult, C; Jin, L; Zhang, ZG; Ray, PF; Cao, YX; Zhang, F				Liu, Wangjie; He, Xiaojin; Yang, Shenmin; Zouari, Raoudha; Wang, Jiaxiong; Wu, Huan; Kherraf, Zine-Eddine; Liu, Chunyu; Coutton, Charles; Zhao, Rui; Tang, Dongdong; Tang, Shuyan; Lv, Mingrong; Fang, Youyan; Li, Weiyu; Li, Hong; Zhao, Jianyuan; Wang, Xue; Zhao, Shimin; Zhang, Jingjing; Arnoult, Christophe; Jin, Li; Zhang, Zhiguo; Ray, Pierre F.; Cao, Yunxia; Zhang, Feng			Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE MORPHOLOGICAL ABNORMALITIES; INTRAFLAGELLAR TRANSPORT; MALE-INFERTILITY; MALE-FERTILITY; SPERMIOGENESIS; FLAGELLA; ANOMALIES; DISEASE; COMPLEX; CILIA	Male infertility is a major concern affecting human reproductive health. Asthenoteratospermia can cause male infertility through reduced motility and abnormal morphology of spermatozoa. Several genes, including DNAH1 and some CFAP family members, are involved in multiple morphological abnormalities of the sperm flagella (MMAF). However, these known genes only account for approximately 60% of human MMAF cases. Here, we conducted further genetic analyses by using whole-exome sequencing in a cohort of 65 Han Chinese men with MMAF. Intriguingly, bi-allelic mutations of TTC21A (tetratricopeptide repeat domain 21A) were identified in three (5%) unrelated, MMAF-affected men, including two with homozygous stop-gain mutations and one with compound heterozygous mutations of TTC21A. Notably, these men consistently presented with MMAF and additional abnormalities of sperm head-tail conjunction. Furthermore, a homozygous TTC21A splicing mutation was identified in two Tunisian cases from an independent MMAF cohort. TTC21A is preferentially expressed in the testis and encodes an intraflagellar transport (IFT)-associated protein that possesses several tetratricopeptide repeat domains that perform functions crucial for ciliary function. To further investigate the potential roles of TTC21A in spermatogenesis, we generated Ttc21a mutant mice by using CRISPR-Cas9 technology and revealed sperm structural defects of the flagella and the connecting piece. Our consistent observations across human populations and in the mouse model strongly support the notion that bi-allelic mutations in TTC21A can induce asthenoteratospermia with defects of the sperm flagella and head-tail conjunction.	[Liu, Wangjie; Liu, Chunyu; Zhao, Rui; Tang, Shuyan; Li, Weiyu; Zhao, Jianyuan; Zhao, Shimin; Jin, Li; Zhang, Feng] Fudan Univ, NHC Key Lab Reprod Regulat, Shanghai Inst Planned Parenthood Res,Sch Life Sci, Obstet & Gynecol Hosp,State Key Lab Genet Engn, Shanghai 200011, Peoples R China; [Liu, Wangjie; Liu, Chunyu; Tang, Shuyan; Li, Weiyu; Zhao, Shimin; Zhang, Feng] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Liu, Wangjie; Liu, Chunyu; Li, Weiyu; Zhang, Feng] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, State Key Lab Reprod Med, Nanjing 211116, Jiangsu, Peoples R China; [He, Xiaojin; Wu, Huan; Tang, Dongdong; Lv, Mingrong; Fang, Youyan; Zhang, Jingjing; Zhang, Zhiguo; Cao, Yunxia; Zhang, Feng] Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Anhui, Peoples R China; [He, Xiaojin; Wu, Huan; Tang, Dongdong; Lv, Mingrong; Fang, Youyan; Zhang, Jingjing; Zhang, Zhiguo; Cao, Yunxia] Anhui Med Univ, Anhui Prov Key Lab Reprod Hlth & Genet, Hefei 230022, Anhui, Peoples R China; [He, Xiaojin; Wu, Huan; Tang, Dongdong; Lv, Mingrong; Fang, Youyan; Zhang, Jingjing; Zhang, Zhiguo; Cao, Yunxia] Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Anhui, Peoples R China; [Yang, Shenmin; Wang, Jiaxiong; Li, Hong] Nanjing Med Univ, Affiliated Suzhou Hosp, State Key Lab Reprod Med, Suzhou 215002, Peoples R China; [Yang, Shenmin; Wang, Jiaxiong; Li, Hong] Suzhou Municipal Hosp, Suzhou 215002, Peoples R China; [Zouari, Raoudha] Ctr Urbain Nord, Ctr Aide Med Procreat, Polyclin Jasmins, Tunis 1003, Tunisia; [Kherraf, Zine-Eddine; Coutton, Charles; Arnoult, Christophe; Ray, Pierre F.] Univ Grenoble Alpes, CNRS, UMR 5309,Inst Adv Biosci, Genet Epigenet & Therapies Infertil,INSERM,U1209, F-38000 Grenoble, France; [Kherraf, Zine-Eddine; Ray, Pierre F.] CHU Grenoble, UM GI DPI, F-38000 Grenoble, France; [Coutton, Charles] CHU Grenoble, UM Genet Chromosomique, F-38000 Grenoble, France; [Wang, Xue] Anhui Med Univ, Affiliated Hosp 2, Dept Gynecol & Obstet, Hefei 230601, Anhui, Peoples R China	Fudan University; Nanjing Medical University; Anhui Medical University; Anhui Medical University; Nanjing Medical University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Anhui Medical University	Zhang, F (corresponding author), Fudan Univ, NHC Key Lab Reprod Regulat, Shanghai Inst Planned Parenthood Res,Sch Life Sci, Obstet & Gynecol Hosp,State Key Lab Genet Engn, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, State Key Lab Reprod Med, Nanjing 211116, Jiangsu, Peoples R China.; Cao, YX; Zhang, F (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Anhui, Peoples R China.; Cao, YX (corresponding author), Anhui Med Univ, Anhui Prov Key Lab Reprod Hlth & Genet, Hefei 230022, Anhui, Peoples R China.; Cao, YX (corresponding author), Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Anhui, Peoples R China.	caoyunxia6@126.com; zhangfeng@fudan.edu.cn	Zhang, Feng/C-7735-2009; liu, chunyu/GWQ-9357-2022; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Wang, Jiaxiong/AAE-6781-2020; Ray, Pierre F/D-7315-2019; Tang, Shuyan/K-9582-2018; KHERRAF, Zine-Eddine/F-1585-2019; Li, Weiyu/AAP-1712-2021; Wu, Huan/AAL-7095-2021; ARNOULT, christophe/E-8312-2013	Zhang, Feng/0000-0003-4556-8276; liu, chunyu/0000-0002-6732-3758; Jin, Li/0000-0002-4546-2415; Wang, Jiaxiong/0000-0002-2819-165X; Ray, Pierre F/0000-0003-1544-7449; Tang, Shuyan/0000-0003-2701-1976; KHERRAF, Zine-Eddine/0000-0003-0351-6689; Zhao, Jian-Yuan/0000-0001-9861-0330; Coutton, Charles/0000-0002-8873-8098; ARNOULT, christophe/0000-0002-3753-5901; He, Xiao-Jin/0000-0001-5919-8478	National Natural Science Foundation of China [31625015, 31521003]; Foundation of the Department of Science and Technology of Anhui Province [2017070802D150]; Foundation of the Education Department of Anhui Province [KJ2016A370]; Shanghai Medical Center of Key Programs for Female Reproductive Diseases [2017ZZ01016]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the Department of Science and Technology of Anhui Province; Foundation of the Education Department of Anhui Province; Shanghai Medical Center of Key Programs for Female Reproductive Diseases; Shanghai Municipal Science and Technology Major Project	We would like to thank the Center of Cryo-Electron Microscopy at Zhejiang University for technical support. This work was supported by the National Natural Science Foundation of China (31625015 and 31521003), the Foundation of the Department of Science and Technology of Anhui Province (2017070802D150), the Foundation of the Education Department of Anhui Province (KJ2016A370), the Shanghai Medical Center of Key Programs for Female Reproductive Diseases (2017ZZ01016), and the Shanghai Municipal Science and Technology Major Project (2017SHZDZX01).	Abbasi F, 2018, REPROD MED BIOL, V17, P3, DOI 10.1002/rmb2.12067; Auguste Y, 2018, AM J HUM GENET, V103, P413, DOI 10.1016/j.ajhg.2018.07.013; Baccetti B, 2005, HUM REPROD, V20, P2790, DOI 10.1093/humrep/dei126; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Chemes HE., 2012, CENTROSOME CELL MOL, P33; Coutton C, 2019, AM J HUM GENET, V104, P331, DOI 10.1016/j.ajhg.2018.12.013; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dong FN, 2018, AM J HUM GENET, V102, P636, DOI 10.1016/j.ajhg.2018.03.007; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; He XJ, 2019, J MED GENET, V56, P96, DOI 10.1136/jmedgenet-2018-105486; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kherraf ZE, 2018, AM J HUM GENET, V103, P400, DOI 10.1016/j.ajhg.2018.07.014; Li WY, 2019, J HUM GENET, V64, P49, DOI 10.1038/s10038-018-0520-1; Liu H, 2017, BIOL REPROD, V96, DOI 10.1093/biolre/iox029; Liu WJ, 2019, J GENET GENOMICS, V46, P53, DOI 10.1016/j.jgg.2018.09.006; Lores P, 2018, HUM MOL GENET, V27, P1196, DOI 10.1093/hmg/ddy034; Martinez G, 2018, HUM REPROD, V33, P1973, DOI 10.1093/humrep/dey264; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sha YW, 2019, ANDROLOGIA, V51, DOI 10.1111/and.13151; Shen Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08182-x; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; van Dam TJP, 2013, P NATL ACAD SCI USA, V110, P6943, DOI 10.1073/pnas.1221011110; Yang SM, 2015, ASIAN J ANDROL, V17, P513, DOI 10.4103/1008-682X.146100; Yuan SQ, 2015, P NATL ACAD SCI USA, V112, pE430, DOI 10.1073/pnas.1424648112; Zhang Y, 2018, CYTOSKELETON, V75, P70, DOI 10.1002/cm.21427; Zhang Y, 2017, DEV BIOL, V432, P125, DOI 10.1016/j.ydbio.2017.09.023; Zhang ZG, 2016, MOL BIOL CELL, V27, P3705, DOI 10.1091/mbc.E16-05-0318	37	67	74	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					738	748		10.1016/j.ajhg.2019.02.020	http://dx.doi.org/10.1016/j.ajhg.2019.02.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30929735	Green Published, Bronze			2022-12-18	WOS:000463474700014
J	Albert, S; Garanto, A; Sangermano, R; Khan, M; Bax, NM; Hoyng, CB; Zernant, J; Lee, W; Allikmets, R; Collin, RWJ; Cremers, FPM				Albert, Silvia; Garanto, Alejandro; Sangermano, Riccardo; Khan, Mubeen; Bax, Nathalie M.; Hoyng, Carel B.; Zernant, Jana; Lee, Winston; Allikmets, Rando; Collin, Rob W. J.; Cremers, Frans P. M.			Identification and Rescue of Splice Defects Caused by Two Neighboring Deep-Intronic ABCA4 Mutations Underlying Stargardt Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSPORTER GENE ABCR; CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; IN-VITRO; BINDING; VARIANTS; REVEALS; OLIGONUCLEOTIDES; MECHANISMS; ALLOWS	Sequence analysis of the coding regions and splice site sequences in inherited retinal diseases is not able to uncover similar to 40% of the causal variants. Whole-genome sequencing can identify most of the non-coding variants, but their interpretation is still very challenging, in particular when the relevant gene is expressed in a tissue-specific manner. Deep-intronic variants in ABCA4 have been associated with autosomal-recessive Stargardt disease (STGD1), but the exact pathogenic mechanism is unknown. By generating photoreceptor precursor cells (PPCs) from fibroblasts obtained from individuals with STGD1, we demonstrated that two neighboring deep-intronic ABCA4 variants (c.4539thorn2001G>A and c.4539thorn2028C>T) result in a retina-specific 345-nt pseudoexon insertion (predicted protein change: p.Arg1514Leufs*36), likely due to the creation of exonic enhancers. Administration of antisense oligonucleotides (AONs) targeting the 345-nt pseudoexon can significantly rescue the splicing defect observed in PPCs of two individuals with these mutations. Intriguingly, an AON that is complementary to c.4539thorn2001G>A rescued the splicing defect only in PPCs derived from an individual with STGD1 with this but not the other mutation, demonstrating the high specificity of AONs. In addition, a single AON molecule rescued splicing defects associated with different neighboring mutations, thereby providing new strategies for the treatment of persons with STGD1. As many genes associated with human genetic conditions are expressed in specific tissues and pre-mRNA splicing may also rely on organ-specific factors, our approach to investigate and treat splicing variants using differentiated cells derived from individuals with STGD1 can be applied to any tissue of interest.	[Albert, Silvia; Garanto, Alejandro; Sangermano, Riccardo; Khan, Mubeen; Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Albert, Silvia; Garanto, Alejandro; Khan, Mubeen; Bax, Nathalie M.; Hoyng, Carel B.; Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Sangermano, Riccardo] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Bax, Nathalie M.; Hoyng, Carel B.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 EX Nijmegen, Netherlands; [Zernant, Jana; Lee, Winston; Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Columbia University; Columbia University	Cremers, FPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands.; Cremers, FPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands.	frans.cremers@radboudumc.nl	Albert, Silvia/P-8231-2015; Khan, Mubeen/U-4569-2018; Lee, Winston/CAA-0102-2022; Garanto, Alejandro/D-5022-2014; Allikmets, Rando/ABD-4533-2021	Albert, Silvia/0000-0002-6921-0351; Garanto, Alejandro/0000-0001-5721-1560; Lee, Winston/0000-0002-1777-8519; Sangermano, Riccardo/0000-0001-8657-0810	FP7-PEOPLE-ITN programme EyeTN [317472]; Macula Vision Research Foundation; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Landelijke Stichting voor Blinden en Slechtzienden; Macula Degeneratie fonds; Stichting Blinden-Penning [Uitzicht 2016-12]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blinden-Penning; Stichting Oogfonds Nederland; Stichting Macula Degeneratie Fonds; Stichting Retina Nederland Fonds [UitZicht 2015-31]; Stichting voor Ooglijders; Stichting Dowilvo; Stichting A.F. Deutman Researchfonds Oogheelkunde; Foundation Fighting Blindness USA [PPA-0517-0717-RAD]; National Eye Institute/NIH [EY019861, EY019007]; Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [P30EY019007, R24EY019861] Funding Source: NIH RePORTER	FP7-PEOPLE-ITN programme EyeTN; Macula Vision Research Foundation; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Landelijke Stichting voor Blinden en Slechtzienden; Macula Degeneratie fonds; Stichting Blinden-Penning; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blinden-Penning; Stichting Oogfonds Nederland; Stichting Macula Degeneratie Fonds; Stichting Retina Nederland Fonds; Stichting voor Ooglijders; Stichting Dowilvo; Stichting A.F. Deutman Researchfonds Oogheelkunde; Foundation Fighting Blindness USA; National Eye Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank Saskia van der Velde-Visser, Marlie Jacobs-Camps, Anke van Dijk, Angelique Goercharn-Ramlal, Tessa van der Heijden, Hind Almushattat, Simon van Reijmersdal, and Lonneke Duijkers for technical assistance. This work was supported by the FP7-PEOPLE-2012-ITN programme EyeTN, agreement 317472 (to F.P.M.C.), the Macula Vision Research Foundation (to F.P.M.C.), the Rotterdamse Stichting Blindenbelangen, the Stichting Blindenhulp, and the Stichting tot Verbetering van het Lot der Blinden (to F.P.M.C. and S.A.), and by the Landelijke Stichting voor Blinden en Slechtzienden, Macula Degeneratie fonds, and the Stichting Blinden-Penning that contributed through Uitzicht 2016-12 (to F.P.M.C. and S.A.). This work was also supported by the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Stichting Blinden-Penning, Landelijke Stichting voor Blinden en Slechtzienden, Stichting Oogfonds Nederland, Stichting Macula Degeneratie Fonds, and Stichting Retina Nederland Fonds that contributed through UitZicht 2015-31, together with the Rotterdamse Stichting Blindenbelangen, Stichting Blindenhulp, Stichting tot Verbetering van het Lot der Blinden, Stichting voor Ooglijders, and Stichting Dowilvo (to A.G. and R.W.J.C.), and the Stichting Macula Degeneratie Fonds and the Stichting A.F. Deutman Researchfonds Oogheelkunde (to C.B.H.). This work was also supported by the Foundation Fighting Blindness USA, grant no. PPA-0517-0717-RAD (to A.G., C.B.H., F.P.M.C., R.W.J.C., and S.A.). R.A. was supported, in part, by grants from the National Eye Institute/NIH EY019861 and EY019007 (Core Support for Vision Research) and unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, Columbia University. The funding organizations had no role in the design or conduct of this research. They provided unrestricted grants. R.W.J.C., A.G., F.P.M.C., and S.A. are inventors on a filed patent (No. 16203864.0) that is related to the contents of this manuscript.	Aartsma-Rus A, 2012, METHODS MOL BIOL, V867, P117, DOI 10.1007/978-1-61779-767-5_8; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Bauwens M, 2015, HUM MUTAT, V36, P39, DOI 10.1002/humu.22716; Bax NM, 2015, HUM MUTAT, V36, P43, DOI 10.1002/humu.22717; Bonifert T, 2016, MOL THER-NUCL ACIDS, V5, P13, DOI 10.1038/mtna.2016.93; Braun TA, 2013, HUM MOL GENET, V22, P5136, DOI 10.1093/hmg/ddt367; Carss KJ, 2017, AM J HUM GENET, V100, P75, DOI 10.1016/j.ajhg.2016.12.003; Collin RWJ, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.3; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Duncker T, 2015, OPHTHALMOLOGY, V122, P345, DOI 10.1016/j.ophtha.2014.08.017; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; Flamier A., 2016, BIO-PROTOCOL, V6, pe1870, DOI [10.21769/BioProtoc.1870, DOI 10.21769/BIOPROTOC.1870, DOI 10.21769/BioProtoc.1870]; Frio TR, 2009, HUM MUTAT, V30, P1340, DOI 10.1002/humu.21071; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P6662, DOI 10.1167/iovs.13-12570; Garanto A, 2018, METHODS MOL BIOL, V1715, P61, DOI 10.1007/978-1-4939-7522-8_5; Garanto A, 2016, HUM MOL GENET, V25, P2552, DOI 10.1093/hmg/ddw118; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; Gardner JC, 2010, AM J HUM GENET, V87, P26, DOI 10.1016/j.ajhg.2010.05.019; Gerard X, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.24; Gerard X, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.21; Gerber S, 1998, GENOMICS, V48, P139, DOI 10.1006/geno.1997.5164; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Lee W, 2016, HUM GENET, V135, P9, DOI 10.1007/s00439-015-1605-y; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Liquori A, 2016, HUM MUTAT, V37, P184, DOI 10.1002/humu.22926; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Mayer AK, 2016, EUR J HUM GENET, V24, P459, DOI 10.1038/ejhg.2015.144; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Murphy D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006256; Murray SF, 2015, INVEST OPHTH VIS SCI, V56, P6362, DOI 10.1167/iovs.15-16400; Naruto T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11334; Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Roehr B, 1998, J Int Assoc Physicians AIDS Care, V4, P14; Sangermano R, 2018, GENOME RES, V28, P100, DOI 10.1101/gr.226621.117; Sangermano R, 2016, OPHTHALMOLOGY, V123, P1375, DOI 10.1016/j.ophtha.2016.01.053; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulz HL, 2017, INVEST OPHTH VIS SCI, V58, P394, DOI 10.1167/iovs.16-19936; Shroyer NF, 2001, AM J OPHTHALMOL, V131, P761, DOI 10.1016/S0002-9394(01)00838-8; Slijkerman Radulfus Wn, 2016, Mol Ther Nucleic Acids, V5, pe381, DOI 10.1038/mtna.2016.89; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker BA, 2013, ELIFE, V2, DOI 10.7554/eLife.00824; Ueyama H, 2012, BIOCHEM BIOPH RES CO, V424, P152, DOI 10.1016/j.bbrc.2012.06.094; Vache C, 2012, HUM MUTAT, V33, P104, DOI 10.1002/humu.21634; van den Hurk JAJM, 2003, HUM GENET, V113, P268, DOI 10.1007/s00439-003-0970-0; van Driel MA, 1998, OPHTHALMIC GENET, V19, P117, DOI 10.1076/opge.19.3.117.2187; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Zernant J, 2017, J MED GENET, V54, P404, DOI 10.1136/jmedgenet-2017-104540; Zernant J, 2014, HUM MOL GENET, V23, P6797, DOI 10.1093/hmg/ddu396; Zernant J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/iovs.11-8182; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047	57	67	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					517	527		10.1016/j.ajhg.2018.02.008	http://dx.doi.org/10.1016/j.ajhg.2018.02.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29526278	Green Published, Bronze			2022-12-18	WOS:000429340800001
J	Patat, O; Pagin, A; Siegfried, A; Mitchell, V; Chassaing, N; Faguer, S; Monteil, L; Gaston, V; Bujan, L; Courtade-Saidi, M; Marcelli, F; Lalau, G; Rigot, JM; Mieusset, R; Bieth, E				Patat, Olivier; Pagin, Adrien; Siegfried, Aurore; Mitchell, Valerie; Chassaing, Nicolas; Faguer, Stanislas; Monteil, Laetitia; Gaston, Veronique; Bujan, Louis; Courtade-Saidi, Monique; Marcelli, Francois; Lalau, Guy; Rigot, Jean-Marc; Mieusset, Roger; Bieth, Eric			Truncating Mutations in the Adhesion G ProteinCoupled Receptor G2 Gene ADGRG2 Cause an X-Linked Congenital Bilateral Absence of Vas Deferens	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; COUPLED RECEPTOR; CYSTIC-FIBROSIS; DUCT EPITHELIA; HE6; IDENTIFICATION; MECHANISMS; PROTEINS; EFFERENT; FLUID	In 80% of infertile men with obstructive azoospermia caused by a congenital bilateral absence of the vas deferens (CBAVD), mutations are identified in the cystic fibrosis transmembrane conductance regulator gene (CFTR). For the remaining 20%, the origin of the CBAVD is unknown. A large cohort of azoospermic men with CBAVD was retrospectively reassessed with more stringent selection criteria based on consistent clinical data, complete description of semen and reproductive excurrent ducts, extensive CFTR testing, and kidney ultrasound examination. To maximize the phenotypic prioritization, men with CBAVD and with unilateral renal agenesis were considered ineligible for the present study. We performed whole-exome sequencing on 12 CFTR-negative men with CBAVD and targeted sequencing on 14 additional individuals. We identified three protein-truncating hemizygous mutations, c.1545dupT (p.Glu516Ter), c.2845delT (p.Cys949AlafsTer81), and c.2002_2006delinsAGA (p.Leu668ArgfsTer21), in ADGRG2, encoding the epididymal-and efferent-ducts-specific adhesion G protein-coupled receptor G2, in four subjects, including two related individuals with X-linked transmission of their infertility. Previous studies have demonstrated that Adgrg2-knockout male mice develop obstructive infertility. Our study confirms the crucial role of ADGRG2 in human male fertility and brings new insight into congenital obstructive azoospermia pathogenesis. In men with CBAVD who are CFTR-negative, ADGRG2 testing could allow for appropriate genetic counseling with regard to the X-linked transmission of the molecular defect.	[Patat, Olivier; Chassaing, Nicolas; Monteil, Laetitia; Gaston, Veronique; Bieth, Eric] Ctr Hosp Univ, Hop Purpan, Serv Genet Med, F-31059 Toulouse, France; [Pagin, Adrien; Lalau, Guy] Ctr Hosp Reg Univ, Ctr Biol Pathol Genet, Serv Toxicol & Genopathies, F-59037 Lille, France; [Siegfried, Aurore; Courtade-Saidi, Monique] Ctr Hosp Univ, Inst Univ Canc Toulouse Oncopole, Dept Anat & Cytol Pathol, F-31059 Toulouse, France; [Mitchell, Valerie] Ctr Hosp Reg Univ, Hop Jeanne de Flandre, Inst Biol Reprod, Spermiol & CECOS, F-59000 Lille, France; [Mitchell, Valerie; Marcelli, Francois; Rigot, Jean-Marc] Univ Lille 2, Gametogenese & Qualite Gamete EA4308, F-59000 Lille, France; [Faguer, Stanislas] Ctr Hosp Univ, Hop Rangueil, Dept Nephrol & Transplantat Organes, F-31059 Toulouse, France; [Bujan, Louis] Ctr Hosp Univ, CECOS, Grp Activite Med Reprod, F-31059 Toulouse, France; [Bujan, Louis; Mieusset, Roger] Univ Toulouse 3, Grp Rech Fertilite Humaine, EA3694, F-31059 Toulouse, France; [Marcelli, Francois; Rigot, Jean-Marc] Ctr Hosp Reg Univ, Hop Calmette, Dept Androl, F-59000 Lille, France; [Mieusset, Roger] Ctr Hosp Univ, Hop Paule de Viguier, Dept Androl, Grp Activite Med Reprod, F-31059 Toulouse, France	CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lille - ISITE; CHU Lille; CHU de Toulouse	Bieth, E (corresponding author), Ctr Hosp Univ, Hop Purpan, Serv Genet Med, F-31059 Toulouse, France.	bieth.e@chu-toulouse.fr	Courtade-Saidi, Monique/A-7322-2015; PATAT, Olivier/AEX-2967-2022; PATAT, Olivier/AAG-7958-2022	Mieusset, Roger/0000-0001-9057-630X; Bujan, Louis/0000-0003-1540-0536; Courtade-Saidi, Monique/0000-0002-0884-4131	French Agency of Biomedicine (Agence de la Biomedecine); French Foundation for Rare Diseases (Fondation Maladies Rares)	French Agency of Biomedicine (Agence de la Biomedecine); French Foundation for Rare Diseases (Fondation Maladies Rares)	The authors thank Prof. Aleksander Edelman for critical reading of the manuscript, Drs. Samantha Leonard and Bo Anthony Heinz for correcting the manuscript, and Florent Arnauduc for his technical aid in immunohistochemistry. This work was funded in part by the French Agency of Biomedicine (Agence de la Biomedecine) and by the French Foundation for Rare Diseases (Fondation Maladies Rares).	AGARWAL A, [No title captured]; Bridges JP, 2013, AM J RESP CELL MOL, V49, P348, DOI 10.1165/rcmb.2012-0439OC; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Clulow J, 1998, J REPROD FERTIL, P1; Daudin M, 2000, FERTIL STERIL, V74, P1164, DOI 10.1016/S0015-0282(00)01625-3; Davies B, 2004, MOL CELL BIOL, V24, P8642, DOI 10.1128/MCB.24.19.8642-8648.2004; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; DUMUR V, 1995, LANCET, V345, P200; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Edelman A, 2014, INT J BIOCHEM CELL B, V52, P68, DOI 10.1016/j.biocel.2014.03.018; Gaillard DA, 1997, J UROLOGY, V158, P1549, DOI 10.1016/S0022-5347(01)64278-2; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Gottwald U, 2006, MOL CELL ENDOCRINOL, V250, P49, DOI 10.1016/j.mce.2005.12.024; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Kirchhoff C, 2008, REPRODUCTION, V136, P235, DOI 10.1530/REP-08-0078; Kujala M, 2007, REPRODUCTION, V133, P775, DOI 10.1530/rep.1.00964; Lek M, 2015, BIORXIV; Liebscher I, 2014, ANN NY ACAD SCI, V1333, P43, DOI 10.1111/nyas.12580; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McCallum TJ, 2001, HUM REPROD, V16, P282, DOI 10.1093/humrep/16.2.282; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Obermann H, 2003, MOL REPROD DEV, V64, P13, DOI 10.1002/mrd.10220; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wosnitzer MS, 2014, UROL CLIN N AM, V41, P83, DOI 10.1016/j.ucl.2013.08.013; Yu JM, 2012, HUM REPROD, V27, P25, DOI 10.1093/humrep/der377	31	67	77	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					437	442		10.1016/j.ajhg.2016.06.012	http://dx.doi.org/10.1016/j.ajhg.2016.06.012			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27476656	Green Published, Bronze			2022-12-18	WOS:000381617200015
J	Lewis, MJ; Vyse, S; Shields, AM; Boeltz, S; Gordon, PA; Spector, TD; Lehner, PJ; Walczak, H; Vyse, TJ				Lewis, Myles J.; Vyse, Simon; Shields, Adrian M.; Boeltz, Sebastian; Gordon, Patrick A.; Spector, Timothy D.; Lehner, Paul J.; Walczak, Henning; Vyse, Timothy J.			UBE2L3 Polymorphism Amplifies NF-kappa B Activation and Promotes Plasma Cell Development, Linking Linear Ubiquitination to Multiple Autoimmune Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RING DOMAIN; LUBAC; COMPLEX; RISK; CHAINS; VARIANTS; SHARPIN	UBE2L3 is associated with increased susceptibility to numerous autoimmune diseases, but the underlying mechanism is unexplained. By using data from a genome-wide association study of systemic lupus erythematosus (SLE), we observed a single risk haplotype spanning UBE2L3, consistently aligned across multiple autoimmune diseases, associated with increased UBE2L3 expression in B cells and monocytes. rs140490 in the UBE2L3 promoter region showed the strongest association. UBE2L3 is an E2 ubiquitin-conjugating enzyme, specially adapted to function with HECT and RING-in-between-RING (RBR) E3 ligases, including HOIL-1 and HOIP, components of the linear ubiquitin chain assembly complex (LUBAC). Our data demonstrate that UBE2L3 is the preferred E2 conjugating enzyme for LUBAC in vivo, and UBE2L3 is essential for LUBAC-mediated activation of NF-kappa B. By accurately quantifying NF-kappa B translocation in primary human cells from healthy individuals stratified by rs140490 genotype, we observed that the autoimmune disease risk UBE2L3 genotype was correlated with basal NF-kappa B activation in unstimulated B cells and monocytes and regulated the sensitivity of NF-kappa B to CD40 stimulation in B cells and TNF stimulation in monocytes. The UBE2L3 risk allele correlated with increased circulating plasmablast and plasma cell numbers in SLE individuals, consistent with substantially elevated UBE2L3 protein levels in plasmablasts and plasma cells. These results identify key immunological consequences of the UBE2L3 autoimmune risk haplotype and highlight an important role for UBE2L3 in plasmablast and plasma cell development.	[Lewis, Myles J.; Vyse, Simon; Shields, Adrian M.; Boeltz, Sebastian; Vyse, Timothy J.] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Gordon, Patrick A.] Kings Coll Hosp London, Rheumatol Dept, London SE5 9RS, England; [Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 9RT, England; [Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Walczak, Henning] UCL, UCL Canc Inst, Ctr Cell Death Canc & Inflammat, London WC1E 6DD, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Cambridge; University of London; University College London	Lewis, MJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Expt Med & Rheumatol, London EC1M 6BQ, England.	myles.lewis@qmul.ac.uk; tim.vyse@kcl.ac.uk	Boeltz, Sebastian/H-3594-2014; Walczak, Henning/AAV-2214-2020	Boeltz, Sebastian/0000-0001-5227-8707; Walczak, Henning/0000-0002-6312-4591; Vyse, Simon/0000-0002-0582-2869; Lewis, Myles J/0000-0001-9365-5345; Lehner, Paul Joseph/0000-0001-9383-1054; Shields, Adrian/0000-0001-5345-2156	Arthritis Research UK; Arthritis Research UK Clinician Scientist Fellowship [19631]; George Koukis Foundation; Arthritis Research UK Special Strategic Award; National Institute for Health Research (NIHR); Flow Cytometry Core Facility; Biomedical Research Centre based at Guy's & St. Thomas' National Health Service (NHS) Foundation Trust; King's College London; Wellcome Trust; European Community; Wellcome Trust Senior Investigator Award; Versus Arthritis [19289, 19631] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Arthritis Research UK Clinician Scientist Fellowship(Versus Arthritis); George Koukis Foundation; Arthritis Research UK Special Strategic Award(Versus Arthritis); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Flow Cytometry Core Facility; Biomedical Research Centre based at Guy's & St. Thomas' National Health Service (NHS) Foundation Trust; King's College London; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Wellcome Trust Senior Investigator Award(Wellcome Trust); Versus Arthritis(Versus Arthritis)	The authors thank the volunteers who participated in this study. This work was funded by Arthritis Research UK. M.J.L. holds an Arthritis Research UK Clinician Scientist Fellowship (19631) and was previously supported by the St Thomas' Lupus Trust. T.J.V. was awarded funding to perform genotyping and analysis from the George Koukis Foundation and an Arthritis Research UK Special Strategic Award. The study received support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility, the Flow Cytometry Core Facility, and the Biomedical Research Centre based at Guy's & St. Thomas' National Health Service (NHS) Foundation Trust, in partnership with King's College London. The TwinsUK study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). SNP Genotyping was performed by the Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR. H.W. is supported through a Wellcome Trust Senior Investigator Award. We are grateful to D.L. Morris for statistical advice.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu BS, 2014, CELL RES, V24, P376, DOI 10.1038/cr.2013.133; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Hostager BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023061; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Wang S, 2012, GENES IMMUN, V13, P380, DOI 10.1038/gene.2012.6; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	44	67	68	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					221	234		10.1016/j.ajhg.2014.12.024	http://dx.doi.org/10.1016/j.ajhg.2014.12.024			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25640675	Green Published, hybrid			2022-12-18	WOS:000349276700004
J	Unger, S; Gorna, MW; Le Bechec, A; Do Vale-Pereira, S; Bedeschi, MF; Geiberger, S; Grigelioniene, G; Horemuzova, E; Lalatta, F; Lausch, E; Magnan, C; Nampoothiri, S; Nishimura, G; Petrella, D; Rojas-Ringeling, F; Utsunomiya, A; Zabel, B; Pradervand, S; Harshman, K; Campos-Xavier, B; Bonafe, L; Superti-Furga, G; Stevenson, B; Superti-Furga, A				Unger, Sheila; Gorna, Maria W.; Le Bechec, Antony; Do Vale-Pereira, Sonia; Bedeschi, Maria Francesca; Geiberger, Stefan; Grigelioniene, Giedre; Horemuzova, Eva; Lalatta, Faustina; Lausch, Eldehart; Magnan, Cinzia; Nampoothiri, Sheela; Nishimura, Gen; Petrella, Duccio; Rojas-Ringeling, Francisca; Utsunomiya, Akari; Zabel, Bernhard; Pradervand, Sylvain; Harshman, Keith; Campos-Xavier, Belinda; Bonafe, Luisa; Superti-Furga, Giulio; Stevenson, Brian; Superti-Furga, Andrea			FAM111A Mutations Result in Hypoparathyroidism and Impaired Skeletal Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARATHYROID-HORMONE; KENNY SYNDROME; TUBULAR BONES; GENE; OSTEOCRANIOSTENOSIS; STENOSIS; MOTHER	Kenny-Caffey syndrome (KCS) and the similar but more severe osteocraniostenosis (OCS) are genetic conditions characterized by impaired skeletal development with small and dense bones, short stature, and primary hypoparathyroidism with hypocalcemia. We studied five individuals with KCS and five with OCS and found that all of them had heterozygous mutations in FAM111A. One mutation was identified in four unrelated individuals with KCS, and another one was identified in two unrelated individuals with OCS; all occurred de novo. Thus, OCS and KCS are allelic disorders of different severity. FAM111A codes for a 611 amino acid protein with homology to trypsin-like peptidases. Although FAM111A has been found to bind to the large T-antigen of SV40 and restrict viral replication, its native function is unknown. Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis. FAM111A appears to be crucial to a pathway that governs parathyroid hormone production, calcium homeostasis, and skeletal development and growth.	[Unger, Sheila; Do Vale-Pereira, Sonia; Campos-Xavier, Belinda; Bonafe, Luisa; Superti-Furga, Andrea] Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, CH-1011 Lausanne, Switzerland; [Unger, Sheila] Univ Lausanne, Univ Lausanne Hosp, Med Genet Serv, CH-1011 Lausanne, Switzerland; [Gorna, Maria W.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Le Bechec, Antony; Stevenson, Brian] Univ Lausanne, Swiss Inst Bioinformat, Vital IT High Performance Comp Ctr, CH-1011 Lausanne, Switzerland; [Bedeschi, Maria Francesca; Lalatta, Faustina] Fdn Osped Maggiore Policlin, Clin Genet Unit, I-20100 Milan, Italy; [Geiberger, Stefan; Grigelioniene, Giedre; Horemuzova, Eva] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Lausch, Eldehart; Zabel, Bernhard] Freiburg Univ Hosp, Ctr Paediat & Adolescent Med, Paediat Genet Div, D-79106 Freiburg, Germany; [Magnan, Cinzia] Univ Parma, Dept Neonatal, Intens Care Unit, I-43126 Parma, Italy; [Nampoothiri, Sheela] Amrita Inst Med Sci & Res Ctr, Dept Pediat Genet, AIMS Ponekkara, Cochin 682041, Kerala, India; [Nishimura, Gen] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol & Med Imaging, Kiyose 2040021, Japan; [Petrella, Duccio] Osped Niguarda Ca Granda, Dept Pathol, I-20162 Milan, Italy; [Rojas-Ringeling, Francisca] Univ Chile, Hosp Clin, Genet Clin, Santiago 8380000, Chile; [Utsunomiya, Akari] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat, Hiroshima 7348553, Japan; [Pradervand, Sylvain; Harshman, Keith] Univ Lausanne, Fac Biol & Med, Genom Technol Facil, CH-1015 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Swiss Institute of Bioinformatics; University of Lausanne; IRCCS Ca Granda Ospedale Maggiore Policlinico; Karolinska Institutet; University of Freiburg; University of Parma; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Universidad de Chile; Hiroshima University; University of Lausanne	Superti-Furga, A (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, CH-1011 Lausanne, Switzerland.	asuperti@unil.ch	Campos-Xavier, Belinda/P-9917-2019; Górna, Maria/F-4269-2014; Grigelioniene, Giedre/N-6599-2013; unger, sheila/E-9177-2015; Grigelioniene, Giedre/AAH-8408-2020; Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; superti-furga, andrea/E-9162-2015; Nampoothiri, Sheela/AAQ-4854-2021; Nakamura-Utsunomiya, Akari/AAR-2694-2020	Campos-Xavier, Belinda/0000-0002-6271-0724; Górna, Maria/0000-0002-1769-4542; Grigelioniene, Giedre/0000-0001-9601-3137; Grigelioniene, Giedre/0000-0001-9601-3137; Superti-Furga, Giulio/0000-0002-0570-1768; superti-furga, andrea/0000-0002-3543-7531; Nampoothiri, Sheela/0000-0002-9575-0722; Nakamura-Utsunomiya, Akari/0000-0002-7417-8923; Le Bechec, Antony/0000-0002-9629-0916; Rojas Ringeling, Francisca/0000-0001-8776-9768; Unger, Sheila/0000-0002-9539-8941	Swiss National Foundation; Faculty of Biology and Medicine of the University of Lausanne (Fonds de Developpement de la Recherche en Pediatrie); Leenaards Foundation in Lausanne; National Heart, Lung, and Blood Institute [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, UC2HL102925, RC2HL103010, UC2HL102926, UC2HL102923, UC2HL102924, UC2HL103010, RC2HL102926, RC2HL102925, RC2HL102924] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Faculty of Biology and Medicine of the University of Lausanne (Fonds de Developpement de la Recherche en Pediatrie); Leenaards Foundation in Lausanne; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Our thanks go to the affected individuals and their families for donating biologic samples for this study. We are also indebted to Adi Fanconi, Sergio Fanconi, Thomas Fehr, Cecilia Giunta, and Beat Steinmann for additional clinical information on individual 1. The project was supported by the Swiss National Foundation (www.snf.ch), by the Faculty of Biology and Medicine of the University of Lausanne (Fonds de Developpement de la Recherche en Pediatrie), and by the Leenaards Foundation in Lausanne (www.leenaards.ch). The authors would like to thank the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison-the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010)-as well as the exome-sequencing data from the CoLaus cohort, which was sequenced as part of a partnership among the Wellcome Trust Sanger Institute, the CoLaus principal investigators, and the Quantitative Sciences Department of GlaxoSmithKline. This work is dedicated to Tinetta and Gustav and their parents.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; CAFFEY J, 1967, AMER J ROENTGENOL RA, V100, P1; Ding CL, 2001, J CLIN INVEST, V108, P1215, DOI 10.1172/JCI13180; Elliott AM, 2006, AM J MED GENET A, V140A, P1553, DOI 10.1002/ajmg.a.31326; FANCONI S, 1986, J PEDIATR-US, V109, P469, DOI 10.1016/S0022-3476(86)80120-2; Fine DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002949; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; KENNY FM, 1966, AM J DIS CHILD, V111, P201, DOI 10.1001/archpedi.1966.02090050133013; MAJEWSKI F, 1981, EUR J PEDIATR, V136, P21, DOI 10.1007/BF00441706; Maret A, 2008, J CLIN ENDOCR METAB, V93, P1426, DOI 10.1210/jc.2007-1783; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spear GS, 2006, AM J MED GENET A, V140A, P2341, DOI 10.1002/ajmg.a.31473; VERLOES A, 1994, J MED GENET, V31, P772, DOI 10.1136/jmg.31.10.772; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; WILSON M G, 1974, Birth Defects Original Article Series, V10, P128	18	67	73	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					990	995		10.1016/j.ajhg.2013.04.020	http://dx.doi.org/10.1016/j.ajhg.2013.04.020			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23684011	Green Published, Bronze			2022-12-18	WOS:000320415300016
J	Jin, GF; Ma, HX; Wu, C; Dai, JC; Zhang, RY; Shi, YY; Lu, JC; Miao, XP; Wang, ML; Zhou, YF; Chen, JP; Li, HZ; Pan, SD; Chu, MJ; Lu, F; Yu, DK; Jiang, Y; Dong, J; Hu, LM; Chen, YJ; Xu, L; Shu, YQ; Pan, SY; Tan, W; Zhou, BS; Lu, DR; Wu, TC; Zhang, ZD; Chen, F; Wang, XR; Hu, ZB; Lin, DX; Shen, HB				Jin, Guangfu; Ma, Hongxia; Wu, Chen; Dai, Juncheng; Zhang, Ruyang; Shi, Yongyong; Lu, Jiachun; Miao, Xiaoping; Wang, Meilin; Zhou, Yifeng; Chen, Jiaping; Li, Huizhang; Pan, Shandong; Chu, Minjie; Lu, Feng; Yu, Dianke; Jiang, Yue; Dong, Jing; Hu, Lingmin; Chen, Yijiang; Xu, Lin; Shu, Yongqian; Pan, Shiyang; Tan, Wen; Zhou, Baosen; Lu, Daru; Wu, Tangchun; Zhang, Zhengdong; Chen, Feng; Wang, Xinru; Hu, Zhibin; Lin, Dongxin; Shen, Hongbing			Genetic Variants at 6p21.1 and 7p15.3 Are Associated with Risk of Multiple Cancers in Han Chinese	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR-TYPE 2B; SUSCEPTIBILITY LOCI; PROSTATE-CANCER; LUNG-CANCER; COLORECTAL-CANCER; IDENTIFIES 3; TERT-CLPTM1L LOCUS; GASTRIC-CANCER; COMMON VARIANT	Cancer susceptibility loci identified in reported genome-wide association studies (GWAS) are often tumor-specific; however, evidence of pleiotropy of some genes/loci has also been observed and biologically plausible. We hypothesized that there are important regions in the genome harboring genetic variants associated with risk of multiple types of cancer. In the current study, we attempted to map genetic variants that have consistent effects on risk of multiple cancers using our existing genome-wide scan data of lung cancer, non-cardia gastric cancer, and esophageal squamous-cell carcinoma with overall 5,368 cases and 4,006 controls (GWAS stage), followed by a further evaluation in additional 9,001 cases with one of these cancer types and 11,436 controls (replication stage). Five variants satisfying the criteria of pleiotropy with p values from 1.10 x 10(-8) to 8.96 x 10(-6) for genome-wide scans of three cancer types were further evaluated in the replication stage. We found consistent associations of rs2494938 at 6p21.1 and rs2285947 at 7p15.3 with these three cancers in both GWAS and replication stages. In combined samples of GWAS and replication stages, the minor alleles of rs2494938 and rs2285947 were significantly associated with an increased risk of the cancers (odds ratio [OR] = 1.15, 95% confidence interval [CI], 1.10-1.19 and OR = 1.17, 95% CI, 1.12-1.21), with the p values being 1.20 x 10(-12) and 1.26 x 10(-16), respectively, which are at a genome-wide significance level. Our findings highlight the potential importance of variants at 6p21.1 and 7p15.3 in the susceptibility to multiple cancers.	[Jin, Guangfu; Ma, Hongxia; Dai, Juncheng; Zhang, Ruyang; Chen, Jiaping; Li, Huizhang; Pan, Shandong; Chu, Minjie; Lu, Feng; Jiang, Yue; Dong, Jing; Hu, Lingmin; Chen, Feng; Wang, Xinru; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Dept Epidemiol & Biostat,Minist Educ, Nanjing 210029, Jiangsu, Peoples R China; [Jin, Guangfu; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sect Clin Epidemiol, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Xinru; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Wu, Chen; Yu, Dianke; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Wu, Chen; Yu, Dianke; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100021, Peoples R China; [Wu, Chen; Yu, Dianke; Tan, Wen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200240, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou 510182, Guangdong, Peoples R China; [Miao, Xiaoping; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430030, Peoples R China; [Miao, Xiaoping; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Peoples R China; [Zhou, Yifeng] Soochow Univ, Coll Med, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Chen, Yijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanjing 210029, Jiangsu, Peoples R China; [Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Key Discipline Med, Dept Oncol, Nanjing 210029, Jiangsu, Peoples R China; [Pan, Shiyang] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Diag, Nanjing 210029, Jiangsu, Peoples R China; [Xu, Lin] Nanjing Med Univ, Jiangsu Canc Hosp, Affiliated Canc Hosp, Dept Thorac Surg, Nanjing 210009, Jiangsu, Peoples R China; [Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Peoples R China; [Lu, Daru] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Ctr Fudan VARI Genet Epidemiol, Shanghai 200433, Peoples R China; [Lu, Daru] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Soochow University - China; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; China Medical University; Fudan University; Fudan University	Hu, ZB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Dept Epidemiol & Biostat,Minist Educ, Nanjing 210029, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn; lindx72@cicams.ac.cn	miao, xiaoping/C-4336-2011; Wang, Xin/AAN-8435-2021; Shu, Yongqian/ABD-5698-2021; Shi, Yongyong/GSO-1627-2022; zhang, zheng/HCH-9684-2022	miao, xiaoping/0000-0002-6818-9722; Wang, Xin/0000-0002-4457-7376; Shi, Yongyong/0000-0003-1710-1505; Jin, Guangfu/0000-0003-0249-5337; Lin, Dongxin/0000-0002-8723-8868; Wu, Chen/0000-0003-4954-1011; Dong, Jing/0000-0001-9856-5963; Shen, Hongbing/0000-0002-2581-5906; Ma, Hongxia/0000-0002-9821-6955	National Outstanding Youth Science Foundation of China [81225053]; Key Project of the National Natural Science Foundation of China [81230067]; National Key Basic Research Program Grant [2011CB503805, 2013CB911400, 2013CB910304]; National Natural Science Foundation of China [81001276, 81270044, 81130022, 81202267, 31000553, 30901233]; Jiangsu Outstanding Youth Science Foundation [BK2012042]; Jiangsu Natural Science Foundation [BK2012841, BK2012443]; US NIH [U19 CA148127]; China National High-Tech Research and Development Program Grant [2009AA022705, 2009AA022706, 2009AA022701]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); NATIONAL CANCER INSTITUTE [U19CA148127] Funding Source: NIH RePORTER	National Outstanding Youth Science Foundation of China; Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Outstanding Youth Science Foundation; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China National High-Tech Research and Development Program Grant; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the individuals who kindly participated, as well as the researchers and physicians who recruited them and collected information. This work was supported by the National Outstanding Youth Science Foundation of China (81225053), the Key Project of the National Natural Science Foundation of China (81230067), the National Key Basic Research Program Grant (2011CB503805, 2013CB911400, 2013CB910304), the National Natural Science Foundation of China (81001276, 81270044, 81130022, 81202267, 31000553, and 30901233), the Jiangsu Outstanding Youth Science Foundation (BK2012042), the Jiangsu Natural Science Foundation (BK2012841, BK2012443), the US NIH Grant (U19 CA148127), the China National High-Tech Research and Development Program Grant (2009AA022705, 2009AA022706, and 2009AA022701, and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castellanos A, 2007, EXP HEMATOL, V35, P724, DOI 10.1016/j.exphem.2007.02.004; Cheung PY, 2004, J BIOL CHEM, V279, P45308, DOI 10.1074/jbc.C400333200; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fernandes HB, 2007, J NEUROSCI, V27, P13614, DOI 10.1523/JNEUROSCI.3455-07.2007; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Khuder SA, 2001, LUNG CANCER, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Seo JH, 2011, GASTROENTEROLOGY, V141, P2064, DOI 10.1053/j.gastro.2011.08.048; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Tamura H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-220; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tramacere I, 2011, EPIDEMIOLOGY, V22, P344, DOI 10.1097/EDE.0b013e31821092cd; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	51	67	71	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					928	934		10.1016/j.ajhg.2012.09.009	http://dx.doi.org/10.1016/j.ajhg.2012.09.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23103227	Green Published, Bronze			2022-12-18	WOS:000311011400016
J	Zankl, A; Duncan, EL; Leo, PJ; Clark, GR; Glazov, EA; Addor, MC; Herlin, T; Kim, CA; Leheup, BP; McGill, J; McTaggart, S; Mittas, S; Mitchell, AL; Mortier, GR; Robertson, SP; Schroeder, M; Terhal, P; Brown, MA				Zankl, Andreas; Duncan, Emma L.; Leo, Paul J.; Clark, Graeme R.; Glazov, Evgeny A.; Addor, Marie-Claude; Herlin, Troels; Kim, Chong Ae; Leheup, Bruno P.; McGill, Jim; McTaggart, Steven; Mittas, Stephan; Mitchell, Anna L.; Mortier, Geert R.; Robertson, Stephen P.; Schroeder, Marie; Terhal, Paulien; Brown, Matthew A.			Multicentric Carpotarsal Osteolysis Is Caused by Mutations Clustering in the Amino-Terminal Transcriptional Activation Domain of MAFB	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WINCHESTER-SYNDROME; SEQUENCING DATA; SOST GENE; NEPHROPATHY; DIFFERENTIATION; MMP2; MATRIX-METALLOPROTEINASE-2; OSTEOPOROSIS; EXPRESSION; ARTHRITIS	Multicentric carpotarsal osteolysis (MCTO) is a rare skeletal dysplasia characterized by aggressive osteolysis, particularly affecting the carpal and tarsal bones, and is frequently associated with progressive renal failure. Using exome capture and next-generation sequencing in five unrelated simplex cases of MCTO, we identified previously unreported missense mutations clustering within a 51 base pair region of the single exon of MAFB, validated by Sanger sequencing. A further six unrelated simplex cases with MCTO were also heterozygous for previously unreported mutations within this same region, as were affected members of two families with autosomal-dominant MCTO. MAFB encodes a transcription factor that negatively regulates RANKL-induced osteoclastogenesis and is essential for normal renal development. Identification of this gene paves the way for development of novel therapeutic approaches for this crippling disease and provides insight into normal bone and kidney development.	[Zankl, Andreas; Duncan, Emma L.; Leo, Paul J.; Clark, Graeme R.; Glazov, Evgeny A.; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Zankl, Andreas; Duncan, Emma L.] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia; [Zankl, Andreas] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia; [Addor, Marie-Claude] Gen Med Serv, CH-1011 Lausanne, Switzerland; [Herlin, Troels] Aarhus Univ Hosp, Dept Paediat, DK-8200 Aarhus N, Denmark; [Kim, Chong Ae] Univ Sao Paulo, Inst Crianca, Fac Med, BR-05403000 Sao Paulo, Brazil; [Leheup, Bruno P.] Univ Lorraine, Ctr Hosp Univ Nancy EA 4368, Med Infantile & Genet Clin 3, F-54511 Vandoeuvre Les Nancy, France; [McGill, Jim] Royal Childrens Hosp, Dept Metab Med, Brisbane, Qld 4029, Australia; [McTaggart, Steven] Royal Childrens Hosp, Queensland Child & Adolescent Renal Serv, Brisbane, Qld 4029, Australia; [McTaggart, Steven] Mater Childrens Hosp, Queensland Child & Adolescent Renal Serv, Brisbane, Qld 4029, Australia; [Mittas, Stephan] Cantonal Hosp St Gallen, Dept Neurol, CH-9007 St Gallen, Switzerland; [Mitchell, Anna L.] Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; [Mortier, Geert R.] Univ Antwerp, Dept Med Genet, B-2650 Antwerp, Belgium; [Mortier, Geert R.] Univ Antwerp Hosp, B-2650 Antwerp, Belgium; [Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dunedin 9054, New Zealand; [Schroeder, Marie] Aarhus Univ Hosp, Dept Clin Genet, DK-8200 Aarhus N, Denmark; [Terhal, Paulien] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 Utrecht, Netherlands	University of Queensland; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; Aarhus University; Universidade de Sao Paulo; Universite de Lorraine; Royal Children's Hospital Brisbane; Royal Children's Hospital Brisbane; Kantonsspital St. Gallen; University Hospitals of Cleveland; University of Antwerp; University of Antwerp; University of Otago; Aarhus University; Utrecht University; Utrecht University Medical Center	Duncan, EL (corresponding author), Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	e.duncan@uq.edu.au; matt.brown@uq.edu.au	Leo, Paul/R-4464-2019; Duncan, Emma L/L-1224-2013; Mortier, Geert/D-2542-2012; McTaggart, Steven J/G-3963-2011; Leo, Paul J/B-3470-2011; McTaggart, Steven J/E-2855-2014; Brown, Matthew A/E-5749-2010	Duncan, Emma L/0000-0002-8143-4403; Mortier, Geert/0000-0001-9871-4578; Leo, Paul J/0000-0001-8325-4134; Brown, Matthew A/0000-0003-0538-8211; Robertson, Stephen/0000-0002-5181-7809; Kim, Chong/0000-0002-1754-1300	Royal Children's Hospital Foundation, Brisbane, Australia; National Health and Medical Research Council	Royal Children's Hospital Foundation, Brisbane, Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The affected individuals and their families who contributed clinical and genetic material are gratefully acknowledged. The assistance of Jordan Young, Linda Bradbury, and Aideen McInerney-Leo in patient recruitment and Jessica Harris and Catherine Cremin in laboratory work is gratefully acknowledged. This work was supported by a research grant from the Royal Children's Hospital Foundation, Brisbane, Australia. M.A.B. was supported by an National Health and Medical Research Council Principal Research Fellowship.	ADDOR M-C, 1986, Journal de Genetique Humaine, V34, P293; Bakker SJL, 1996, PEDIATR NEPHROL, V10, P200; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; BENNETT WM, 1980, NEPHRON, V25, P134, DOI 10.1159/000181769; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; CARNEVALE A, 1987, AM J MED GENET, V26, P877, DOI 10.1002/ajmg.1320260415; Connor A, 2007, AM J KIDNEY DIS, V50, P649, DOI 10.1053/j.ajkd.2007.06.014; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; De Ravel T J, 2000, J Med Genet, V37, pE34; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Faber MR, 2004, EUR J PEDIATR, V163, P612, DOI 10.1007/s00431-004-1502-1; FRYNS JP, 1982, J GENET HUM, V30, P423; Glazov EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002027; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; PAI GS, 1988, AM J MED GENET, V29, P929, DOI 10.1002/ajmg.1320290425; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; SHURTLEFF DB, 1964, JAMA-J AM MED ASSOC, V188, P363; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Singhal Rishi, 2005, Acta Orthop Belg, V71, P328; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Textor LC, 2007, ACTA CRYSTALLOGR F, V63, P657, DOI 10.1107/S1744309107031260; Thomas CW, 2006, CLIN RADIOL, V61, P892, DOI 10.1016/j.crad.2006.03.018; TYLER T, 1976, AM J ROENTGENOL, V126, P23, DOI 10.2214/ajr.126.1.23; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang PW, 1999, GENOMICS, V59, P275, DOI 10.1006/geno.1999.5884; Wenkert D, 2007, CLIN ORTHOP RELAT R, P80, DOI 10.1097/BLO.0b013e3180do9db8; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Zankl A, 2005, CLIN GENET, V67, P261, DOI 10.1111/j.1399-0004.2004.00402.x; Zankl A, 2007, J BONE MINER RES, V22, P329, DOI 10.1359/JBMR.061013	39	67	73	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					494	501		10.1016/j.ajhg.2012.01.003	http://dx.doi.org/10.1016/j.ajhg.2012.01.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22387013	Green Published, Bronze			2022-12-18	WOS:000301762800015
J	Kalay, E; Sezgin, O; Chellappa, V; Mutlu, M; Morsy, H; Kayserili, H; Kreiger, E; Cansu, A; Toraman, B; Abdalla, EM; Aslan, Y; Pillai, S; Akarsu, NA				Kalay, Ersan; Sezgin, Orhan; Chellappa, Vasant; Mutlu, Mehmet; Morsy, Heba; Kayserili, Hulya; Kreiger, Elmar; Cansu, Aysegul; Toraman, Bayram; Abdalla, Ebtesam Mohammed; Aslan, Yakup; Pillai, Shiv; Akarsu, Nurten A.			Mutations in RIPK4 Cause the Autosomal-Recessive Form of Popliteal Pterygium Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; BARTSOCAS-PAPAS-SYNDROME; C-ASSOCIATED KINASE; APICAL ECTODERMAL RIDGE; IKK-ALPHA; SIGNALING PATHWAYS; PROTEIN-KINASE; KERATINOCYTE DIFFERENTIATION; MICE LACKING; FAMILY	The autosomal-recessive form of popliteal pterygium syndrome, also known as Bartsocas-Papas syndrome, is a rare, but frequently lethal disorder characterized by marked popliteal pterygium associated with multiple congenital malformations. Using Affymetrix 250K SNP array genotyping and homozygosity mapping, we mapped this malformation syndrome to chromosomal region 21q22.3. Direct sequencing of RIPK4 (receptor-interacting serine/threonine kinase protein 4) showed a homozygous transversion (c.362T>A) that causes substitution of a conserved isoleucine with asparagine at amino acid position 121 (p.Ile121Asn) in the serine/threonine kinase domain of the protein. Additional pathogenic mutations-a homozygous transition (c.551C>T) that leads to a missense substitution (p.Thr184Ile) at a conserved position and a homozygous one base-pair insertion mutation (c.777_778insA) predicted to lead to a premature stop codon (p.Arg260ThrfsX14) within the kinase domain-were observed in two families. Molecular modeling of the kinase domain showed that both the Ile121 and Thr184 positions are critical for the protein's stability and kinase activity. Luciferase reporter assays also demonstrated that these mutations are critical for the catalytic activity of RIPK4. RIPK4 mediates activation of the nuclear factor-kappa B (NF-kappa B) signaling pathway and is required for keratinocyte differentiation and craniofacial and limb development. The phenotype of Ripk4(-/-) mice is consistent with the human phenotype presented herein. Additionally, the spectrum of malformations observed in the presented families is similar, but less severe than the conserved helix-loop-helix ubiquitous kinase (CHUK)-deficient human fetus phenotype; known as Cocoon syndrome; this similarity indicates that RIPK4 and CHUK might function via closely related pathways to promote keratinocyte differentiation and epithelial growth.	[Kalay, Ersan] Karadeniz Tech Univ, Fac Med, Dept Med Biol, TR-61080 Trabzon, Turkey; [Sezgin, Orhan; Toraman, Bayram] Karadeniz Tech Univ, Inst Hlth Sci, Dept Med Biol, TR-61080 Trabzon, Turkey; [Chellappa, Vasant; Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Mutlu, Mehmet; Aslan, Yakup] Karadeniz Tech Univ, Fac Med, Dept Pediat, TR-61080 Trabzon, Turkey; [Morsy, Heba; Abdalla, Ebtesam Mohammed] Univ Alexandria, Med Res Inst, Dept Human Genet, Alexandria 21661, Egypt; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34094 Istanbul, Turkey; [Kreiger, Elmar] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Cansu, Aysegul] Karadeniz Tech Univ, Fac Med, Dept Radiol, TR-61080 Trabzon, Turkey; [Akarsu, Nurten A.] Hacettepe Univ, Fac Med, Dept Med Genet, Gene Mapping Lab, TR-06100 Ankara, Turkey	Karadeniz Technical University; Karadeniz Technical University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karadeniz Technical University; Egyptian Knowledge Bank (EKB); Alexandria University; Istanbul University; Radboud University Nijmegen; Karadeniz Technical University; Hacettepe University	Kalay, E (corresponding author), Karadeniz Tech Univ, Fac Med, Dept Med Biol, TR-61080 Trabzon, Turkey.	ersankalay@hotmail.com	Kayserili, Hülya/AAA-5593-2021; TORAMAN, Bayram/A-6798-2018; ASLAN, YAKUP/AAL-6790-2021; Akarsu, Nurten/E-9758-2013; Toraman, Bayram/AAU-2772-2020; Abdalla, Ebtesam/P-1831-2016	Kayserili, Hülya/0000-0003-0376-499X; TORAMAN, Bayram/0000-0003-4500-5668; Akarsu, Nurten/0000-0001-5432-0032; Morsy, Heba/0000-0002-9047-0959; Kalay, Ersan/0000-0002-1467-2268; Abdalla, Ebtesam/0000-0002-2486-8782	Karadeniz Technical University [2009.114.001.05]; Scientific and Technological Research Council of Turkey (TUBITAK) under the E-RARE network CRANIRARE consortium [1085420, 1085418, R07197KS]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090867, R01AI064930, R01AI076505] Funding Source: NIH RePORTER	Karadeniz Technical University(Karadeniz Technical University); Scientific and Technological Research Council of Turkey (TUBITAK) under the E-RARE network CRANIRARE consortium(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all the family members that participated in this study and M. Livaoglu, N. Karacal, A. Yildirim, K. Baydar, and O. Aliyazicioglu for their indispensible technical assistance. This study was supported by the Karadeniz Technical University Research Fund (grant 2009.114.001.05 to E.K.) and the Scientific and Technological Research Council of Turkey (TUBITAK) (1085420 to N.A.A. and 1085418 to H.K.) grants under the E-RARE network CRANIRARE consortium (project no. R07197KS).	Abdalla E M, 2011, Case Rep Genet, V2011, P428714, DOI 10.1155/2011/428714; Adams S, 2007, J INVEST DERMATOL, V127, P538, DOI 10.1038/sj.jid.5700588; Adams S, 2010, EXP CELL RES, V316, P126, DOI 10.1016/j.yexcr.2009.10.006; Aslan Y, 2000, AM J MED GENET, V93, P194, DOI 10.1002/1096-8628(20000731)93:3<194::AID-AJMG6>3.0.CO;2-X; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bahr C, 2000, J BIOL CHEM, V275, P36350, DOI 10.1074/jbc.M004771200; BARTSOCAS CS, 1972, J MED GENET, V9, P222, DOI 10.1136/jmg.9.2.222; Biggs LC, 2011, J INVEST DERMATOL; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Chen LJ, 2001, J BIOL CHEM, V276, P21737, DOI 10.1074/jbc.M008069200; Dolan SM, 2003, PRENATAL DIAG, V23, P138, DOI 10.1002/pd.560; ESCOBAR V, 1978, J MED GENET, V15, P35, DOI 10.1136/jmg.15.1.35; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; GORLIN RJ, 1968, PEDIATRICS, V41, P503; HALL JG, 1984, AM J MED GENET, V17, P803, DOI 10.1002/ajmg.1320170410; HALL JG, 1982, AM J MED GENET, V12, P377, DOI 10.1002/ajmg.1320120404; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kalender AM, 2009, EUR J MED GENET, V52, P269, DOI 10.1016/j.ejmg.2009.02.001; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lahtela J, 2010, NEW ENGL J MED, V363, P1631, DOI 10.1056/NEJMoa0911698; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; Maganzini Anthony L, 2006, N Y State Dent J, V72, P34; MARTINEZFRIAS ML, 1991, AM J MED GENET, V39, P34, DOI 10.1002/ajmg.1320390109; Massoud AA, 1998, AM J MED GENET, V79, P16; Matsuzawa N, 2010, AM J MED GENET A, V152A, P2262, DOI 10.1002/ajmg.a.33338; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Moran ST, 2003, J BIOL CHEM, V278, P21526, DOI 10.1074/jbc.M301575200; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Muto A, 2002, J BIOL CHEM, V277, P31871, DOI 10.1074/jbc.M202222200; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Rountree RB, 2010, J INVEST DERMATOL, V130, P102, DOI 10.1038/jid.2009.223; Rozen S, 2000, Methods Mol Biol, V132, P365; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Thoma G, 2011, J MED CHEM, V54, P284, DOI 10.1021/jm101157q; Thomason HA, 2008, DEV BIOL, V321, P273, DOI 10.1016/j.ydbio.2008.06.030; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Veenstra-Knol HE, 2003, AM J MED GENET A, V123A, P243, DOI 10.1002/ajmg.a.20308; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang J, 2010, BIOCHEMISTRY-US, V49, P7972, DOI 10.1021/bi100409w; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	55	67	70	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					76	85		10.1016/j.ajhg.2011.11.014	http://dx.doi.org/10.1016/j.ajhg.2011.11.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22197489	Green Published, Bronze			2022-12-18	WOS:000299409100007
J	Mitchell, K; O'Sullivan, J; Missero, C; Blair, E; Richardson, R; Anderson, B; Antonini, D; Murray, JC; Shanske, AL; Schutte, BC; Romano, RA; Sinha, S; Bhaskar, SS; Black, GCM; Dixon, J; Dixon, MJ				Mitchell, Karen; O'Sullivan, James; Missero, Caterina; Blair, Ed; Richardson, Rose; Anderson, Beverley; Antonini, Dario; Murray, Jeffrey C.; Shanske, Alan L.; Schutte, Brian C.; Romano, Rose-Anne; Sinha, Satrajit; Bhaskar, Sanjeev S.; Black, Graeme C. M.; Dixon, Jill; Dixon, Michael J.			Exome Sequence Identifies RIPK4 as the Bartsocas-Papas Syndrome Locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-ASSOCIATED KINASE; NF-KAPPA-B; REPEATED-EPILATION; PROTEIN-KINASE; IKK-ALPHA; MICE LACKING; P53 HOMOLOG; CELL FATE; P63; IRF6	Pterygium syndromes are complex congenital disorders that encompass several distinct clinical conditions characterized by multiple skin webs affecting the flexural surfaces often accompanied by craniofacial anomalies. In severe forms, such as in the autosomal-recessive Bartsocas-Papas syndrome, early lethality is common, complicating the identification of causative mutations. Using exome sequencing in a consanguineous family, we identified the homozygous mutation c.1127C>A in exon 7 of RIPK4 that resulted in the introduction of the nonsense mutation p.Ser376X into the encoded ankyrin repeat-containing kinase, a protein that is essential for keratinocyte differentiation. Subsequently, we identified a second mutation in exon 2 of RIPK4 (c.242T>A) that resulted in the missense variant p.Ile81Asn in the kinase domain of the protein. We have further demonstrated that RIPK4 is a direct transcriptional target of the protein p63, a master regulator of stratified epithelial development, which acts as a nodal point in the cascade of molecular events that prevent pterygium syndromes.	[Mitchell, Karen; Richardson, Rose; Dixon, Jill; Dixon, Michael J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Mitchell, Karen; O'Sullivan, James; Richardson, Rose; Dixon, Michael J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [O'Sullivan, James; Anderson, Beverley; Bhaskar, Sanjeev S.; Black, Graeme C. M.] Cent Manchester Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Missero, Caterina; Antonini, Dario] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Blair, Ed] Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Shanske, Alan L.] Albert Einstein Coll Med, Childrens Hosp Montefiore, Ctr Craniofacial Disorders, Bronx, NY 10467 USA; [Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Romano, Rose-Anne; Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA	University of Manchester; University of Manchester; University of Manchester; CEINGE Biotecnologie Avanzate; University of Oxford; University of Iowa; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Michigan State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dixon, J (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	jill.dixon@manchester.ac.uk; mike.dixon@manchester.ac.uk	; Black, Graeme/K-7374-2015	Missero, Caterina/0000-0003-0905-5123; Black, Graeme/0000-0001-8727-6592; Richardson, Rose/0000-0001-7164-0337	Medical Research Council, UK [G0901539]; National Institute for Health Research; Manchester Biomedical Research Centre; Healing Foundation; Telethon Foundation, Italy [GGP09230]; National Institutes of Health [DE08559, DE13513]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013513, R01DE008559] Funding Source: NIH RePORTER; Medical Research Council [G0901539] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Healing Foundation; Telethon Foundation, Italy(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We express our gratitude to the family members for participating in the study. We thank Drs. J. Zhou and Hans Van Bokhoven for kindly expediting access to their ChIP-seq data set. The financial support from the Medical Research Council, UK to M.J.D. and J.D. (G0901539), the National Institute for Health Research-funded Manchester Biomedical Research Centre to G.C.M.B and M.J.D., the Healing Foundation to M.J.D., Telethon Foundation, Italy to C.M (GGP09230), and the National Institutes of Health to J.C.M. (DE08559) and B.C.S. (DE13513) is gratefully acknowledged.	Adams S, 2007, J INVEST DERMATOL, V127, P538, DOI 10.1038/sj.jid.5700588; Adams S, 2010, EXP CELL RES, V316, P126, DOI 10.1016/j.yexcr.2009.10.006; Bahr C, 2000, J BIOL CHEM, V275, P36350, DOI 10.1074/jbc.M004771200; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen LJ, 2001, J BIOL CHEM, V276, P21737, DOI 10.1074/jbc.M008069200; De Rosa L, 2009, J BIOL CHEM, V284, P30574, DOI 10.1074/jbc.M109.049619; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; GUENET JL, 1979, J HERED, V70, P90, DOI 10.1093/oxfordjournals.jhered.a109223; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Lahtela J, 2010, NEW ENGL J MED, V363, P1631, DOI 10.1056/NEJMoa0911698; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Marinari B, 2009, J INVEST DERMATOL, V129, P60, DOI 10.1038/jid.2008.202; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moran ST, 2003, J BIOL CHEM, V278, P21526, DOI 10.1074/jbc.M301575200; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Rinne T, 2008, HUM MOL GENET, V17, P1968, DOI 10.1093/hmg/ddn094; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Romano RA, 2010, DEVELOPMENT, V137, P1431, DOI 10.1242/dev.045427; Rountree RB, 2010, J INVEST DERMATOL, V130, P102, DOI 10.1038/jid.2009.223; Shanske AL, 2004, AM J MED GENET A, V128A, P431, DOI 10.1002/ajmg.a.30096; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Thomason HA, 2008, DEV BIOL, V321, P273, DOI 10.1016/j.ydbio.2008.06.030; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Veenstra-Knol HE, 2003, AM J MED GENET A, V123A, P243, DOI 10.1002/ajmg.a.20308; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zhu F, 2007, MOL CELL, V27, P214, DOI 10.1016/j.molcel.2007.05.042	48	67	72	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					69	75		10.1016/j.ajhg.2011.11.013	http://dx.doi.org/10.1016/j.ajhg.2011.11.013			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22197488	Bronze, Green Published			2022-12-18	WOS:000299409100006
J	Blaydon, DC; Nitoiu, D; Eckl, KM; Cabral, RM; Bland, P; Hausser, I; van Heel, DA; Rajpopat, S; Fischer, J; Oji, V; Zvulunov, A; Traupe, H; Hennies, HC; Kelsell, DP				Blaydon, Diana C.; Nitoiu, Daniela; Eckl, Katja-Martina; Cabral, Rita M.; Bland, Philip; Hausser, Ingrid; van Heel, David A.; Rajpopat, Shefali; Fischer, Judith; Oji, Vinzenz; Zvulunov, Alex; Traupe, Heiko; Hennies, Hans Christian; Kelsell, David P.			Mutations in CSTA, Encoding Cystatin A, Underlie Exfoliative Ichthyosis and Reveal a Role for This Protease Inhibitor in Cell-Cell Adhesion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NETHERTON-SYNDROME; ATOPIC-DERMATITIS; SKIN BARRIER; STEFIN-A; ASSOCIATION; DISEASE; LEADS; KERATINOCYTES; ENVIRONMENT; MATRIPTASE	Autosomal-recessive exfoliative ichthyosis presents shortly after birth as dry, scaly skin over most of the body with coarse peeling of non-erythematous skin on the palms and soles, which is exacerbated by excessive moisture and minor trauma. Using whole-genome homozygosity mapping, candidate-gene analysis and deep sequencing, we have identified loss-of-function mutations in the gene for protease inhibitor cystatin A (CSTA) as the underlying genetic cause of exfoliative ichthyosis. We found two homozygous mutations, a splice-site and a nonsense mutation, in two consanguineous families of Bedouin and Turkish origin. Electron microscopy of skin biopsies from affected individuals revealed that the level of detachment occurs in the basal and lower suprabasal layers. In addition, in vitro modeling suggests that in the absence of cystatin A protein, there is a cell-cell adhesion defect in human keratinocytes that is particularly prominent when cells are subject to mechanical stress. We show here evidence of a key role for a protease inhibitor in epidermal adhesion within the lower layers of the human epidermis.	[Blaydon, Diana C.; Nitoiu, Daniela; Cabral, Rita M.; Bland, Philip; van Heel, David A.; Rajpopat, Shefali; Kelsell, David P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Eckl, Katja-Martina; Hennies, Hans Christian] Univ Cologne, Cologne Ctr Genom, Div Dermatogenet, D-50931 Cologne, Germany; [Hausser, Ingrid] Univ Heidelberg Hosp, Dept Dermatol, D-69115 Heidelberg, Germany; [Fischer, Judith] Univ Hosp Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Fischer, Judith] Univ Freiburg, Ctr Biol Syst Anal, Zentrum Biosyst Anal, D-79104 Freiburg, Germany; [Oji, Vinzenz; Traupe, Heiko] Univ Hosp Munster, Dept Dermatol, D-48149 Munster, Germany; [Zvulunov, Alex] Schneider Childrens Med Ctr, Pediat Dermatol Unit, IL-49100 Petah Tiqwa, Israel; [Zvulunov, Alex] Ben Gurion Univ Negev, Med Sch Int Hlth, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Hennies, Hans Christian] Univ Cologne, Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of London; Queen Mary University London; University of Cologne; Ruprecht Karls University Heidelberg; University of Freiburg; University of Freiburg; University of Munster; Ben Gurion University; University of Cologne; University of Cologne	Kelsell, DP (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.	d.p.kelsell@qmul.ac.uk	Kelsell, David P/F-8767-2011; Fischer, Judith/E-6327-2016; Hennies, Hans C/G-9424-2014; Eckl, Katja/C-3581-2014; Cabral, Rita M/G-5706-2013	Fischer, Judith/0000-0002-8580-8118; Hennies, Hans C/0000-0001-7210-2389; Eckl, Katja/0000-0001-8838-3998; Cabral, Rita M/0000-0003-2741-8100; Blaydon, Diana/0000-0002-9998-2563; Kelsell, David/0000-0002-9910-7144; Oji, Vinzenz/0000-0003-1380-4828; van Heel, David/0000-0002-0637-2265	Barts; London Charity; German Federal Ministry for Education and Research as part of the Networks for Rare Diseases [01GM0902]; Deutsche Forschungsgemeinschaft [HE3119/5-1]; MRC [G1001158] Funding Source: UKRI; Medical Research Council [G1001158] Funding Source: researchfish	Barts; London Charity; German Federal Ministry for Education and Research as part of the Networks for Rare Diseases; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the families for their participation in this study, and we would like to acknowledge the members of The Genome Centre, Queen Mary University of London, for their assistance. This work was funded by Barts and The London Charity and supported in part by grants from the German Federal Ministry for Education and Research as part of the Networks for Rare Diseases (01GM0902) and the Deutsche Forschungsgemeinschaft (HE3119/5-1).	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bilodeau M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007500; BLAYDON DC, 2011, N ENGL J ME IN PRESS; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Eckl KM, 2011, J INVEST DERMATOL, V131, P1938, DOI 10.1038/jid.2011.126; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatsell SJ, 2003, BRIT J DERMATOL, V149, P174, DOI 10.1046/j.1365-2133.2003.05386.x; Jenko S, 2003, J MOL BIOL, V326, P875, DOI 10.1016/S0022-2836(02)01432-8; Kato T, 2005, J ALLERGY CLIN IMMUN, V116, P169, DOI 10.1016/j.jaci.2005.03.044; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Oji V, 2010, AM J HUM GENET, V87, P274, DOI 10.1016/j.ajhg.2010.07.005; Pavlova A, 2002, EUR J BIOCHEM, V269, P5649, DOI 10.1046/j.1432-1033.2002.03273.x; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renko M, 2010, FEBS J, V277, P4338, DOI 10.1111/j.1742-4658.2010.07824.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Samuelsson L, 2004, J INVEST DERMATOL, V122, P1399, DOI 10.1046/j.0022-202X.2004.12604.x; STEVEN AC, 1994, J CELL SCI, V107, P693; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Vasilopoulos Y, 2007, ALLERGY, V62, P514, DOI 10.1111/j.1398-9995.2007.01350.x; Wallin H, 2010, BIOCHIMIE, V92, P1625, DOI 10.1016/j.biochi.2010.08.011; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	30	67	70	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					564	571		10.1016/j.ajhg.2011.09.001	http://dx.doi.org/10.1016/j.ajhg.2011.09.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21944047	Green Published, Bronze			2022-12-18	WOS:000295951300010
J	Ozaltin, F; Ibsirlioglu, T; Taskiran, EZ; Baydar, DE; Kaymaz, F; Buyukcelik, M; Kilic, BD; Balat, A; Iatropoulos, P; Asan, E; Akarsu, NA; Schaefer, F; Yilmaz, E; Bakkaloglu, A				Ozaltin, Fatih; Ibsirlioglu, Tulin; Taskiran, Ekim Z.; Baydar, Dilek Ertoy; Kaymaz, Figen; Buyukcelik, Mithat; Kilic, Beltinge Demircioglu; Balat, Ayse; Iatropoulos, Paraskevas; Asan, Esin; Akarsu, Nurten A.; Schaefer, Franz; Yilmaz, Engin; Bakkaloglu, Aysin		PodoNet Consortium	Disruption of PTPRO Causes Childhood-Onset Nephrotic Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOMERULAR PROTEIN; MUTATIONS; EXPRESSION; NPHS2; GENE; PHOSPHORYLATION; NEPHRIN; GLEPP1; R229Q	Idiopathic nephrotic syndrome (INS) is a genetically heterogeneous group of disorders characterized by proteinuria, hypoalbuminemia, and edema. Because it typically results in end-stage kidney disease, the steroid-resistant subtype (SRNS) of INS is especially important when it occurs in children. The present study included 29 affected and 22 normal individuals from 17 SRNS families; genome-wide analysis was performed with Affymetrix 250K SNP arrays followed by homozygosity mapping. A large homozygous stretch on chromosomal region 12p12 was identified in one consanguineous family with two affected siblings. Direct sequencing of protein tyrosine phosphatase receptor type 0 (PTPRO; also known as glomerular epithelial protein-1 [GLEPP1]) showed homozygous c.2627+1G>T donor splice-site mutation. This mutation causes skipping of the evolutionarily conserved exon 16 (p.Glu854_Trp876del) at the RNA level. Immunohistochemistry with GLEPP1 antibody showed a similar staining pattern in the podocytes of the diseased and control kidney tissues. We used a highly polymorphic intragenic DNA marker-D12S1303-to search for homozygosity in 120 Turkish and 13 non-Turkish individuals in the PodoNet registry. This analysis yielded 17 candidate families, and a distinct homozygous c.2745+1G>A donor splice-site mutation in PTPRO was further identified via DNA sequencing in a second Turkish family. This mutation causes skipping of exon 19, and this introduces a premature stop codon at the very beginning of exon 20 (p.Asn888Lysfs*3) and causes degradation of mRNA via nonsense-mediated decay. Immunohistochemical analysis showed complete absence of immunoreactive VITRO. Ultrastructural alterations, such as diffuse foot process fusion and extensive microvillus transformation of podocytes, were observed via electron microscopy in both families. The present study introduces mutations in PTPRO as another cause of autosomal-recessive nephrotic syndrome.	[Ozaltin, Fatih; Bakkaloglu, Aysin] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Nephrol Unit, TR-06100 Ankara, Turkey; [Ozaltin, Fatih; Ibsirlioglu, Tulin] Hacettepe Univ, Fac Med, Dept Pediat, Nephrogenet Lab, TR-06100 Ankara, Turkey; [Taskiran, Ekim Z.; Yilmaz, Engin] Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey; [Baydar, Dilek Ertoy] Hacettepe Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey; [Kaymaz, Figen; Asan, Esin] Hacettepe Univ, Fac Med, Dept Histol, TR-06100 Ankara, Turkey; [Buyukcelik, Mithat; Kilic, Beltinge Demircioglu; Balat, Ayse] Gaziantep Univ, Fac Med, Pediat Nephrol Unit, TR-27310 Gaziantep, Turkey; [Iatropoulos, Paraskevas] Mario Negri Inst Pharmacol Res, I-24020 Bergamo, Italy; [Akarsu, Nurten A.] Hacettepe Univ, Fac Med, Dept Med Genet, Gene Mapping Lab, TR-06100 Ankara, Turkey; [Schaefer, Franz] Ctr Pediat & Adolescent Med, Pediat Nephrol Div, D-69120 Heidelberg, Germany	Hacettepe University; Hacettepe University; Hacettepe University; Hacettepe University; Hacettepe University; Gaziantep University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Hacettepe University	Ozaltin, F (corresponding author), Hacettepe Univ, Fac Med, Dept Pediat, Pediat Nephrol Unit, TR-06100 Ankara, Turkey.	fozaltin@hacettepe.edu.tr	Kılıç, Beltinge Demircioğlu/AAH-1412-2020; BAYDAR, DILEK/I-9610-2013; YILMAZ, Engin/W-4160-2018; Buyukcelik, Mithat/AAH-1452-2020; kaymaz, fevziye figen/AGH-3508-2022; BALAT, AYSE/AAC-5793-2021; Emma, Francesco/H-2116-2012; TASKIRAN, EKIM ZIHNI/I-9494-2013; Schaefer, Franz/G-4365-2010; YILMAZ, ENGIN/I-8278-2013; Akarsu, Nurten/E-9758-2013; ANTIGNAC, Corinne/H-8945-2017	Kılıç, Beltinge Demircioğlu/0000-0001-9408-2139; YILMAZ, Engin/0000-0001-8873-7645; Buyukcelik, Mithat/0000-0002-6815-196X; kaymaz, fevziye figen/0000-0001-8896-2471; BALAT, AYSE/0000-0002-8904-1348; Emma, Francesco/0000-0002-0383-3468; Akarsu, Nurten/0000-0001-5432-0032; ANTIGNAC, Corinne/0000-0002-9934-4940; Iatropoulos, Paraskevas/0000-0001-9406-5734	Hacettepe University [06A 101 008]; Scientific and Technological Research Council of Turkey (TUBITAK) [108S417]; European Research Area Network (E-RARE); Istituto Superiore di Sanita (E-RARE) [11]	Hacettepe University(Hacettepe University); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); European Research Area Network (E-RARE); Istituto Superiore di Sanita (E-RARE)	We thank the families for their participation in the study. The Department of Pediatrics, Nephrogenetics Laboratory, Hacettepe University Faculty of Medicine was established by the Hacettepe University Infrastructure Project (grant number 06A 101 008). This study was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) (grant number 108S417), and the consortium (PodoNet) was supported by the European Research Area Network (E-RARE). P. Iatropoulos was partially supported by the PodoNet grant from the Istituto Superiore di Sanita (E-RARE 11). Human Genome Organization approval of the name NPHS6 was obtained. Members of the PodoNet consortium (in alphabetical order by institution): Hacettepe University Faculty of Medicine, Ankara, Turkey: F. Ozaltin and A.Bakkaloglu; Mario Negri Institute for Pharmacological Research, Bergamo, Italy: M. Noris; Instituto Giannina Gaslini, Genova, Italy: G.M. Ghiggeri; University of Heidelberg, Heidelberg, Germany: F. Schaefer; Hopital Necker, Paris, France: C. Antignac; Ospedale Pediatrico Bambino Gesu, Rome, Italy: F. Emma.	[Anonymous], 1978, Kidney Int, V13, P159; [Anonymous], 1981, J PEDIATR-US, V98, P561, DOI 10.1016/s0022-3476(81)80760-3; [Anonymous], AUTOMATED SPLICE SIT; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRODEHL J, 1988, LANCET, V1, P380; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Charba DS, 2009, AM J PHYSIOL-RENAL, V297, pF138, DOI 10.1152/ajprenal.00122.2008; Clement LC, 2007, KIDNEY INT, V72, P337, DOI 10.1038/sj.ki.5002302; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; KURIHARA H, 1995, AM J PHYSIOL-RENAL, V268, pF514, DOI 10.1152/ajprenal.1995.268.3.F514; Machuca E, 2009, KIDNEY INT, V75, P727, DOI 10.1038/ki.2008.650; Mucha B, 2006, PEDIATR RES, V59, P325, DOI 10.1203/01.pdr.0000196717.94518.f0; Nalla VK, 2005, HUM MUTAT, V25, P334, DOI 10.1002/humu.20151; Rogan PK, 1998, HUM MUTAT, V12, P153, DOI 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO;2-O; Sharif K, 1998, EXP NEPHROL, V6, P234; Tian J, 2007, J INT MED RES, V35, P338, DOI 10.1177/147323000703500308; Tsukaguchi H, 2002, J CLIN INVEST, V110, P1659, DOI 10.1172/JCI200216242; Uz E, 2010, AM J HUM GENET, V86, P789, DOI 10.1016/j.ajhg.2010.04.002; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284	26	67	72	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					139	147		10.1016/j.ajhg.2011.05.026	http://dx.doi.org/10.1016/j.ajhg.2011.05.026			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21722858	Green Published, Bronze			2022-12-18	WOS:000293041700012
J	Dombroski, BA; Nayak, RR; Ewens, KG; Ankener, W; Cheung, VG; Spielman, RS				Dombroski, Beth A.; Nayak, Renuka R.; Ewens, Kathryn G.; Ankener, Wendy; Cheung, Vivian G.; Spielman, Richard S.			Gene Expression and Genetic Variation in Response to Endoplasmic Reticulum Stress in Human Cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNFOLDED PROTEIN RESPONSE; GENOME-WIDE ASSOCIATION; NF-Y CBF; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; BINDING-PROTEIN; DISEASE; ATF6; KINASE; PROTEOLYSIS	The accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) results in the condition called "ER stress," which induces the unfolded protein response (UPR), a complex cellular process that includes changes in expression of many genes. Failure to restore homeostasis ill the ER is associated with human diseases. To identify the underlying changes in gene expression in response to ER stress, we induced ER stress in human B cells and then measured gene expression at ten time points. We followed up those results by studying cells from 60 unrelated people. We rediscovered genes that were known to play a role in the ER-stress response and uncovered several thousand genes that are not known to be involved. Two of these are VLDLR and INHBE, which showed significant increase in expression after ER stress in B cells and in primary fibroblasts. To study the links between UPR and disease susceptibility, we identified ER-stress-responsive genes that are associated with human diseases and assessed individual differences in the ER-stress response. Many of the U PR genes are associated with Mendelian disorders, such as Wolfram syndrome, and complex diseases, including amyotrophic lateral sclerosis and diabetes. Data from two independent samples showed extensive individual variability in ER-stress response. Additional analyses with monozygotic twins revealed significant correlations within twin pairs in their responses to ER stress, thus showing evidence for heritable variation among individuals. These results have implications for basic understanding of ER function and its role in disease susceptibility.	[Dombroski, Beth A.; Ewens, Kathryn G.; Ankener, Wendy; Cheung, Vivian G.; Spielman, Richard S.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Cheung, Vivian G.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Nayak, Renuka R.] Univ Penn, Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Cheung, Vivian G.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute	Cheung, VG (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020		National Institutes of Health; University of Pennsylvania Diabetes and Endocrine Research Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Diabetes and Endocrine Research Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Haig Kazazian and Morris Birnbaum for comments and discussions, Alan Baizel for molecular analyses, Michael Morley and Kris Halasa for data analyses, and Colleen McGarry for manuscript preparation. This work was supported by grants from the National Institutes of Health and by a pilot grant from the University of Pennsylvania Diabetes and Endocrine Research Center.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Blaschke S, 2003, ARTHRITIS RHEUM, V48, P1858, DOI 10.1002/art.11171; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HULTIN T, 1961, BIOCHEM PHARMACOL, V5, P359, DOI 10.1016/0006-2952(61)90029-6; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Mcrae AF, 2007, HUM MOL GENET, V16, P364, DOI 10.1093/hmg/ddl456; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Ou ZL, 2002, NEPHRON, V91, P262, DOI 10.1159/000058402; Ounissi-Benkalha H, 2008, TRENDS MOL MED, V14, P268, DOI 10.1016/j.molmed.2008.04.002; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SHANDS JW, 1973, AM J PATHOL, V70, P1; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; SOKAL RR, 1995, BIOMETRY, P213; Stranger Barbara E., 2005, Human Genomics, V2, P126; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	43	67	70	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					719	729		10.1016/j.ajhg.2010.03.017	http://dx.doi.org/10.1016/j.ajhg.2010.03.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20398888	Green Published, Bronze			2022-12-18	WOS:000278045300008
J	Flanagan, JM; Cocciardi, S; Waddell, N; Johnstone, CN; Marsh, A; Henderson, S; Simpson, P; da Silva, L; Khanna, K; Lakhani, S; Boshoff, C; Chenevix-Trench, G				Flanagan, James M.; Cocciardi, Sibylle; Waddell, Nic; Johnstone, Cameron N.; Marsh, Anna; Henderson, Stephen; Simpson, Peter; da Silva, Leonard; Khanna, Kumkum; Lakhani, Sunil; Boshoff, Chris; Chenevix-Trench, Georgia		kConFab Investigators	DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESTROGEN-RECEPTOR; METHYLATION PATTERNS; COLORECTAL-CANCER; PROMOTER DNA; BRCA1; GENE; CARCINOGENESIS; EXPRESSION; GENOME; SGK1	It is now understood that epigenetic alterations occur frequently in sporadic breast carcinogenesis, but little is known about the epigenetic alterations associated with familial breast tumors. We performed genome-wide DNA-methylation profiling on familial breast cancers (n = 33) to identify patterns of methylation specific to the different mutation groups (BRCA1, BRCA2, and BRCAx) or intrinsic subtypes of breast cancer (basal, luminal A, luminal B, HER2-amplified, and normal-like). We used methylated DNA immunoprecipitation (MeDIP) on Affymetrix promoter chips to interrogate methylation profiles across 25,500 distinct transcripts. Using a support vector machine classification algorithm, we demonstrated that genome-wide methylation profiles predicted tumor mutation status with estimated error rates of 19016 (BRCA1), 31% (BRCA2), and 36% (BRCAx) but did not accurately predict the intrinsic subtypes defined by gene expression. Furthermore, using unsupervised hierarchical Clustering, we identified a distinct subgroup of BRCAx tumors defined by methylation profiles. We validated these findings in the 33 tumors in the test set, as well as in an independent validation set of 47 formalin-fixed, paraffin-embedded familial breast tumors, by pyrosequencing and Epityper. Finally, gene-expression profiling and SNP CGH array previously performed on the same samples allowed full integration of methylation, gene-expression, and copy-number data sets, revealing frequent hypermethylation of genes that also displayed loss of heterozygosity, as well as of genes that show copy-number gains, providing a potential mechanism for expression dosage compensation. Together, these data show that methylation profiles for familial breast cancers are defined by the mutation status and are distinct from the intrinsic subtypes.	[Flanagan, James M.; Henderson, Stephen; Boshoff, Chris] UCL, Inst Canc, CRUK Viral Oncol Grp, London WC1E 6BT, England; [Cocciardi, Sibylle; Waddell, Nic; Johnstone, Cameron N.; Marsh, Anna; Chenevix-Trench, Georgia] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [Simpson, Peter; da Silva, Leonard; Lakhani, Sunil] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia; [kConFab Investigators] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Khanna, Kumkum] Queensland Inst Med Res, Div Canc & Cell Biol, Brisbane, Qld 4006, Australia	University of London; University College London; QIMR Berghofer Medical Research Institute; University of Queensland; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute	Flanagan, JM (corresponding author), UCL, Inst Canc, CRUK Viral Oncol Grp, Mortimer St, London WC1E 6BT, England.	j.flanagan@imperial.ac.uk	Simpson, Peter/F-1225-2010; Khanna, Kum Kum/I-1747-2013; Da Silva, Leonard/F-6584-2010; Lakhani, Sunil R/I-1970-2018; Waddell, Nicola/H-4929-2015; Chenevix-Trench, Georgia/AAV-2014-2020; Da Silva, Leonard M/C-4562-2017	Simpson, Peter/0000-0002-4816-8289; Lakhani, Sunil R/0000-0003-4067-2760; Waddell, Nicola/0000-0002-3950-2476; Chenevix-Trench, Georgia/0000-0002-1878-2587; Da Silva, Leonard M/0000-0001-6751-6819; Flanagan, James/0000-0003-4955-1383; Thorne, Heather/0000-0003-3610-2511; Henderson, Stephen/0000-0002-9032-3828	NHMRC [145684, 288704, 454508]; Queensland Cancer Fund; Cancer Councils of New South Wales, Victoria, Tasmania and South Australia; Cancer Foundation of Western Australia; Susan Komen Foundation; Cancer Research UK [C536/A6689]; University College London Hospital Charities	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Councils of New South Wales, Victoria, Tasmania and South Australia(Cancer Council New South Wales); Cancer Foundation of Western Australia(Cancer Council Western Australia); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Cancer Research UK(Cancer Research UK); University College London Hospital Charities	The authors would like to acknowledge Lynne Reid, Patricia Keith, and Jeremy Arnold for their assistance. We would also like to acknowledge the Wolfson Institute for Biomedical Research and the UCL Cancer Institute Scientific Support Services for performing the microarray hybridizations, in particular Jacob Raby and Catherine King. We wish to thank Heather Thorne, Eveline Niedermayr, all of the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (funded by NHMRC grants 145684, 288704, and 454508) for their contributions to this resource, as well as the many families who contribute to kConFab. kConFab is supported by grants from the National Breast Cancer Foundation, funded by the National Health and Medical Research Council (NHMRC), and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. This work was funded by a Susan Komen Foundation grant to G.C.T. J.M.F. was funded in part by Cancer Research UK to C.B. and University College London Hospital Charities to J.M.F.J.M.F. is a Breast Cancer Campaign Fellow and is partly funded by Cancer Research UK program C536/A6689; G.C.T. and K.K. are NHMRC Research Fellows.	Archey WB, 2002, ONCOGENE, V21, P7034, DOI 10.1038/sj.onc.1205844; Armes JE, 1998, CANCER-AM CANCER SOC, V83, P2335, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Clark SJ, 2007, HUM MOL GENET, V16, pR88, DOI 10.1093/hmg/ddm051; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Hudelist G, 2009, J CANCER RES CLIN, V135, P191, DOI 10.1007/s00432-008-0458-3; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krop I, 2003, CANCER RES, V63, P2024; Kuijper TM, 2009, MOL CELL ENDOCRINOL, V302, P58, DOI 10.1016/j.mce.2008.12.016; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lapidus RG, 1998, CANCER RES, V58, P2515; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Ordway JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001314; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Suijkerbuijk KPM, 2008, ANN ONCOL, V19, P1870, DOI 10.1093/annonc/mdn409; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tangir J, 2004, CLIN EXP METASTAS, V21, P477, DOI 10.1007/s10585-004-4226-8; Vasilatos SN, 2009, CANCER EPIDEM BIOMAR, V18, P901, DOI 10.1158/1055-9965.EPI-08-0875; WADDELL N, 2009, BREAST CANC RES TREA; Waddell N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000080; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zheng WX, 2000, GYNECOL ONCOL, V76, P294, DOI 10.1006/gyno.1999.5664	49	67	72	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					420	433		10.1016/j.ajhg.2010.02.008	http://dx.doi.org/10.1016/j.ajhg.2010.02.008			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20206335	Bronze, Green Published			2022-12-18	WOS:000275678800013
J	Zhang, F; Potocki, L; Sampson, JB; Liu, PF; Sanchez-Valle, A; Robbins-Furman, P; Navarro, AD; Wheeler, PG; Spence, JE; Brasington, CK; Withers, MA; Lupski, JR				Zhang, Feng; Potocki, Lorraine; Sampson, Jacinda B.; Liu, Pengfei; Sanchez-Valle, Amarilis; Robbins-Furman, Patricia; Delicado Navarro, Alicia; Wheeler, Patricia G.; Spence, J. Edward; Brasington, Campbell K.; Withers, Marjorie A.; Lupski, James R.			Identification of Uncommon Recurrent Potocki-Lupski Syndrome-Associated Duplications and the Distribution of Rearrangement Types and Mechanisms in PTLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; SERIAL REPLICATION SLIPPAGE; LOW-COPY REPEATS; GENOMIC DISORDERS; HOMOLOGOUS RECOMBINATION; SEGMENTAL DUPLICATIONS; 17P <DUP(17)(P12->P11.2)>; COMPLEX REARRANGEMENTS; DNA REARRANGEMENTS; CHROMOSOME 17P11.2	Nonallelic homologous recombination (NAHR) can mediate recurrent rearrangements in the human genome and cause genomic disorders. Smith-Magenis syndrome (SMS) and Potocki-Lupski syndrome (PTLS) are genomic disorders associated with a 3.7 Mb deletion and its reciprocal duplication in 17p11.2, respectively. In addition to these common recurrent rearrangements, an uncommon recurrent 5 Mb SMS-associated deletion has been identified. However, its reciprocal duplication predicted by the NAHR mechanism had not been identified. Here we report the molecular assays on 74 subjects with PTLS-associated duplications, 35 of whom are newly investigated. By both oligonucleotide-based comparative genomic hybridization and recombination hot spot analyses, we identified two cases of the predicted 5 Mb uncommon recurrent PTLS-associated duplication. Interestingly, the crossovers Occur in proximity to a recently delineated allelic homologous recombination (AHR) hot spot-associated sequence motif, further documenting the common hot spot features shared between NAHR and AHR. An additional eight subjects with nonrecurrent PTLS duplications were identified. The smallest region of overlap (SRO) for all of the 74 PTLS duplications examined is narrowed to a 125 kb interval containing only RAI1, a gene recently further implicated in autism. Sequence complexities consistent with DNA replication-based mechanisms were identified in four of eight (50%) newly identified nonrecurrent PTLS duplications. Our findings of the uncommon recurrent PTLS-associated duplication at a relative prevalence reflecting the de novo mutation rate and the distribution of 17p11.2 duplication types in PTLS reveal insights into both the contributions of new mutations and the different underlying mechanisms that generate genomic rearrangements causing genomic disorders.	[Zhang, Feng; Potocki, Lorraine; Liu, Pengfei; Sanchez-Valle, Amarilis; Robbins-Furman, Patricia; Withers, Marjorie A.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Potocki, Lorraine; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Sampson, Jacinda B.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA; [Delicado Navarro, Alicia] Hosp Univ La Paz, Secc Genet Med, Madrid 28046, Spain; [Wheeler, Patricia G.] Nemours Childrens Clin, Div Genet & Metab, Orlando, FL 32806 USA; [Spence, J. Edward; Brasington, Campbell K.] Carolinas Med Ctr, Levine Childrens Hosp, Charlotte, NC 28232 USA; [Zhang, Feng] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Feng] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Zhang, Feng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Hospital Universitario La Paz; Carolinas Medical Center; Fudan University; Fudan University; Fudan University	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Zhang, Feng/C-7735-2009; Sanchez-Valle, Amarilis/AAS-7075-2021; Anthropology, MOE KeyLab Fudan/A-9454-2010; Liu, Pengfei/U-9743-2019	Zhang, Feng/0000-0003-4556-8276; Liu, Pengfei/0000-0002-4177-709X	National Institute of Neurological Disorders and Stroke (National Institutes of Health) [R01NS058529]; Texas Children's Hospital General Clinical Research Center [M01RR00188]; Intellectual and Developmental Disabilities Research Centers [P30HD024064]; NCET program of the Ministry of Education of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Texas Children's Hospital General Clinical Research Center; Intellectual and Developmental Disabilities Research Centers; NCET program of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all participating subjects and families for their kind cooperation in the study. This work was supported by the National Institute of Neurological Disorders and Stroke (National Institutes of Health) grant R01NS058529 to J.R.L., Texas Children's Hospital General Clinical Research Center grant M01RR00188, and Intellectual and Developmental Disabilities Research Centers grant P30HD024064. FZ. is supported by the NCET program of the Ministry of Education of China. J.R.L. is a consultant for Athena Diagnostics, 23andMe, and Ion Torrent Systems and holds multiple United States and European patents for DNA diagnostics. Furthermore, the Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular diagnostic testing (Medical Genetics Laboratories).	Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Balarin MAS, 1999, AM J MED GENET, V82, P183, DOI 10.1002/(SICI)1096-8628(19990115)82:2<183::AID-AJMG16>3.3.CO;2-8; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen JM, 2005, HUM MUTAT, V26, P125, DOI 10.1002/humu.20202; Chen JM, 2005, HUM MUTAT, V26, P362, DOI 10.1002/humu.20230; Chen JM, 2005, HUM MUTAT, V25, P207, DOI 10.1002/humu.20133; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Doco-Fenzy M, 2008, AM J MED GENET A, V146A, P917, DOI 10.1002/ajmg.a.32195; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hurles ME, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P341, DOI 10.1007/978-1-59745-039-3_24; KOZMA C, 1991, AM J MED GENET, V41, P446, DOI 10.1002/ajmg.1320410413; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; Lupski JR, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-242; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers SR, 2006, NAT GENET, V38, P1363, DOI 10.1038/ng1206-1363; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Roa BB, 1996, HUM GENET, V97, P642; Schneider MC, 2000, AM J MED GENET, V94, P296, DOI 10.1002/1096-8628(20001002)94:4<296::AID-AJMG6>3.0.CO;2-B; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2004, AM J MED GENET A, V124A, P173, DOI 10.1002/ajmg.a.20355; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Treadwell-Deering DE, 2010, J DEV BEHAV PEDIATR, V31, P137, DOI 10.1097/DBP.0b013e3181cda67e; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Vissers LELM, 2007, HUM GENET, V121, P697, DOI 10.1007/s00439-007-0359-6; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Wang BM, 2009, SCIENCE, V326, P871, DOI 10.1126/science.1177627; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	52	67	68	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					462	470		10.1016/j.ajhg.2010.02.001	http://dx.doi.org/10.1016/j.ajhg.2010.02.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20188345	Green Published, Bronze			2022-12-18	WOS:000275678800018
J	Shi, H; Tan, SJ; Zhong, H; Hu, WW; Levine, A; Xiao, CJ; Peng, Y; Qi, XB; Shou, WH; Ma, RLZ; Li, Y; Su, B; Lu, X				Shi, Hong; Tan, Si-jie; Zhong, Hua; Hu, Wenwei; Levine, Arnold; Xiao, Chun-jie; Peng, Yi; Qi, Xue-bin; Shou, Wei-hua; Ma, Run-lin Z.; Li, Yi; Su, Bing; Lu, Xin			Winter Temperature and UV Are Tightly Linked to Genetic Changes in the p53 Tumor Suppressor Pathway in Eastern Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; MDM2 PROMOTER; MOUSE MODELS; HUMANS; SELECTION; VARIANTS; CANCER; REPRODUCTION	The tumor suppressor p53 is a master sensor of stress. Two human-specific polymorphisms, p53 codon 72 and MDM2 SNP309, influence the activities of p53. There is a tight association between cold winter temperature and p53 Arg72 and between low UV intensity and MDM2 SNP309 G/G in a cohort of 4029 individuals across Eastern Asia that suggests causative selection. Moreover, the two polymorphisms are not coselected. Haplotype-based selection analysis further suggests that this is a striking example of two functional polymorphisms being strongly selected for in human populations in response to environmental stresses.	[Shi, Hong; Peng, Yi; Qi, Xue-bin; Su, Bing; Lu, Xin] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Tan, Si-jie; Xiao, Chun-jie; Shou, Wei-hua] Yunnan Univ, Ctr Human Genet, Kunming 650091, Peoples R China; [Shi, Hong; Peng, Yi; Qi, Xue-bin; Su, Bing; Lu, Xin] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming 650223, Peoples R China; [Zhong, Hua; Ma, Run-lin Z.] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Hu, Wenwei; Levine, Arnold] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08540 USA; [Li, Yi] Qujing Normal Coll, Qujing 655011, Yunnan, Peoples R China; [Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Qujing Normal University; Ludwig Institute for Cancer Research; University of Oxford	Su, B (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.	sub@mail.kiz.ac.cn	Zhong, Hua/C-1262-2017; peng, yi/J-5500-2019; peng, yi/AAR-8853-2020; Tan, Sijie/W-6260-2019	Lu, Xin/0000-0002-6587-1152; tan, Sijie/0000-0002-8389-7372	National 973 project of China [2006CB701506, 2007CB815705]; CAS/SAFEA International Partnership Program for Creative Research Team; Chinese Academy of Sciences [KSCX1-YW-R-34]; National Natural Science Foundation of China [30700445, 30630013, 30525028]; Natural Science Foundation of Yunnan Province of China; Ludwig Institute for Cancer Research	National 973 project of China(National Basic Research Program of China); CAS/SAFEA International Partnership Program for Creative Research Team(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province of China(Natural Science Foundation of Yunnan Province); Ludwig Institute for Cancer Research	We are thankful to people who provided their DNA samples, to Maureen Murphy in the Fox Chase Cancer Center, Philadelphia, PA, who provided the Soas2-ts cells for this study, and to Hua Chen from Harvard Medical School who helped in analyzing the genetic structure of the Han Chinese populations. We are also grateful to F. Murray-Zmijewski, G. Bond, and C. Beveridge for critical reading of the manuscript. This project was supported by the National 973 project of China (2006CB701506, 2007CB815705), the CAS/SAFEA International Partnership Program for Creative Research Team, Chinese Academy of Sciences (KSCX1-YW-R-34), the National Natural Science Foundation of China (30700445, 30630013, and 30525028), the Natural Science Foundation of Yunnan Province of China, and the Ludwig Institute for Cancer Research.	Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fu YX, 1997, GENETICS, V147, P915; GWAZDAUSKAS FC, 1985, J DAIRY SCI, V68, P1568, DOI 10.3168/jds.S0022-0302(85)80995-4; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jin SK, 2001, J CELL SCI, V114, P4139; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lozano G, 1998, SEMIN CANCER BIOL, V8, P337, DOI 10.1006/scbi.1998.0096; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Lu X, 2005, CURR OPIN GENET DEV, V15, P27, DOI 10.1016/j.gde.2004.12.008; LUNA RMD, 1995, NATURE, V378, P203; Ma HX, 2006, CANCER LETT, V240, P261, DOI 10.1016/j.canlet.2005.09.019; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Murphy ME, 2006, CELL DEATH DIFFER, V13, P916, DOI 10.1038/sj.cdd.4401907; Nitta M, 1997, ONCOGENE, V15, P561, DOI 10.1038/sj.onc.1201210; Ohnishi T, 1998, ONCOGENE, V16, P1507, DOI 10.1038/sj.onc.1201663; Sjalander A, 1996, HUM HERED, V46, P41, DOI 10.1159/000154324; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; [祝青林 Zhu Qinglin], 2005, [资源科学, Resources science], V27, P108	34	67	73	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					534	541		10.1016/j.ajhg.2009.03.009	http://dx.doi.org/10.1016/j.ajhg.2009.03.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19344876	Bronze, Green Published			2022-12-18	WOS:000265232800014
J	Bolor, H; Mori, T; Nishiyama, S; Ito, Y; Hosoba, E; Inagaki, H; Kogo, H; Ohye, T; Tsutsumi, M; Kato, T; Tong, M; Nishizawa, H; Pryor-Koishi, K; Kitaoka, E; Sawada, T; Nishiyama, Y; Udagawa, Y; Kurahashi, H				Bolor, Hasbaira; Mori, Terumi; Nishiyama, Sachie; Ito, Yoshimasa; Hosoba, Eriko; Inagaki, Hidehito; Kogo, Hiroshi; Ohye, Tarnae; Tsutsumi, Makiko; Kato, Takerna; Tong, Maoqing; Nishizawa, Haruki; Pryor-Koishi, Kanako; Kitaoka, Eri; Sawada, Tomio; Nishiyama, Yukio; Udagawa, Yasuhiro; Kurahashi, Hiroki			Mutations of the SYCP3 Gene in Women with Recurrent Pregnancy Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNAPTONEMAL COMPLEX PROTEIN; HUMAN ANEUPLOIDY; MICE; SCP3; SPERMATOGENESIS; NONDISJUNCTION; INTERFERENCE; MISCARRIAGE; SYNAPSIS; SPECTRUM	Aneuploidy, a chromosomal numerical abnormality in the conceptus or fetus, occurs in at least 5% of all pregnancies and is the leading cause of early pregnancy loss in humans. Accumulating evidence now suggests that the correct segregation of chromosomes is affected by events occurring in prophase during meiosis 1. These events include homologous chromosome pairing, sister-chromatid cohesion, and meiotic recombination. In our current study, we show that mutations in SYCP3, a gene encoding an essential component of the synaptonemal complex that is central to the interaction of homologous chromosomes, are associated with recurrent pregnancy loss. Two out of 26 women with recurrent pregnancy loss of unknown cause were found to carry independent heterozygous nucleotide alterations in this gene, neither of which was present among a group of 150 fertile women. Analysis of transcripts from minigenes harboring each of these two mutations revealed that both affected normal splicing, possibly resulting in the production of C-terminally mutated proteins. The mutant proteins were found to interact with their wild-type counterpart in vitro and inhibit the normal fiber formation of the SYCP3 protein when coexpressed in a heterologous system. These data suggest that these mutations are likely to generate an aberrant synaptonemal complex in a dominant-negative manner and contribute to abnormal chromosomal behavior that might lead to recurrent miscarriage. Combined with the fact that similar mutations have been previously identified in two males with azoospermia, our current data suggest that sexual dimorphism in response to meiotic disruption occurs even in humans.	[Bolor, Hasbaira; Mori, Terumi; Nishiyama, Sachie; Ito, Yoshimasa; Hosoba, Eriko; Inagaki, Hidehito; Kogo, Hiroshi; Ohye, Tarnae; Tsutsumi, Makiko; Kato, Takerna; Tong, Maoqing; Kurahashi, Hiroki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Aichi 4701192, Japan; [Kitaoka, Eri] Yachiyo Hosp, Aichi 4468510, Japan; [Nishiyama, Sachie; Nishizawa, Haruki; Pryor-Koishi, Kanako; Udagawa, Yasuhiro] Fujita Hlth Univ, Dept Obstet & Gynecol, Aichi 4701192, Japan; [Sawada, Tomio] Sawada Womens Clin, Aichi 4640819, Japan; [Nishiyama, Yukio] Nishiyama Clin, Tsu, Mie 5140103, Japan	Fujita Health University; Fujita Health University	Kurahashi, H (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Aichi 4701192, Japan.	kura@fujita-hu.ac.jp	Kogo, Hiroshi/AAB-8467-2019; Ito, Yoshimasa/GZH-1728-2022	Kogo, Hiroshi/0000-0003-0584-7158; Ito, Yoshimasa/0000-0003-0141-948X	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors wish to thank M. Yoshida, K. Tsukada, A. Nakamura, and T. Koishi for providing samples and to thank M. Suzuki for technical assistance. This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H.K.).	Baier A, 2007, SEX DEV, V1, P161, DOI 10.1159/000102105; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Costa Y, 2007, CHROMOSOME RES, V15, P579, DOI 10.1007/s10577-007-1142-1; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Eichenlaub-Ritter U, 2005, CYTOGENET GENOME RES, V111, P392, DOI 10.1159/000086917; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Hodges CA, 2001, J CELL SCI, V114, P2417; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Martin RH, 2008, REPROD BIOMED ONLINE, V16, P523, DOI 10.1016/S1472-6483(10)60459-2; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Paredes A, 2005, ENDOCRINOLOGY, V146, P5267, DOI 10.1210/en.2005-0965; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; Sage J, 1997, GENOMICS, V44, P118, DOI 10.1006/geno.1997.4832; Sherman SL, 2005, CYTOGENET GENOME RES, V111, P273, DOI 10.1159/000086900; Shoji M, 2005, DEV BIOL, V282, P524, DOI 10.1016/j.ydbio.2005.03.030; Sierra S, 2006, SEMIN REPROD MED, V24, P17, DOI 10.1055/s-2006-931797; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Warburton D, 2004, AM J HUM GENET, V75, P376, DOI 10.1086/423331; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	29	67	83	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					14	20		10.1016/j.ajhg.2008.12.002	http://dx.doi.org/10.1016/j.ajhg.2008.12.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19110213	Bronze, Green Published			2022-12-18	WOS:000262679500002
J	Alasti, F; Sadeghi, A; Sanati, MH; Farhadi, M; Stollar, E; Somers, T; Van Camp, G				Alasti, Fatemeh; Sadeghi, Abdorrahim; Sanati, Mohammad Hossein; Farhadi, Mohammad; Stollar, Elliot; Somers, Thomas; Van Camp, Guy			A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSORINEURAL HEARING-LOSS; FACIAL SOMATOSENSORY MAP; VERTEBRAL SPECTRUM OAVS; HUMAN BRAIN-STEM; MIDDLE-EAR; INNER-EAR; MUTANT MICE; MANDIBULOFACIAL DYSOSTOSIS; HOMEOTIC TRANSFORMATION; ROSTRAL HINDBRAIN	Microtia, a congenital deformity manifesting as an abnormally shaped or absent external ear, occurs in one out of 8,000-10,000 births. We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate. Genome-wide linkage analysis localized the responsible gene to chromosome 7p14.3-p15.3 with a maximum multi-point LOD score of 4.17. In this region, homeobox genes from the HOXA cluster were the most interesting candidates. Subsequent DNA sequence analysis of the HOXA 1 and HOXA2 homeobox genes from the candidate region identified an interesting HOXA2 homeodomain variant: a change in a highly conserved amino acid (p.Q186K). The variant was not found in 231 Iranian and 109 Belgian control samples. The critical contribution of HoxA2 for auditory-system development has already been shown in mouse models. We built a homology model to predict the effect of this mutation on the structure and DNA-binding activity of the homeodomain by using the program Modeler 8v2. In the model of the mutant homeodomain, the position of the mutant lysine side chain is consistently farther away from a nearby phosphate group; this altered position results in the loss of a hydrogen bond and affects the DNA-binding activity.	[Alasti, Fatemeh; Van Camp, Guy] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Alasti, Fatemeh; Sadeghi, Abdorrahim] Natl Inst Genet Engn & Biotechnol, Dept Mol Genet, Tehran, Iran; [Sadeghi, Abdorrahim] Tarbiat Modares Univ, Fac Sci, Dept Biol, Tehran, Iran; [Sanati, Mohammad Hossein] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran; [Farhadi, Mohammad] Iran Univ Med Sci, Rassoul E Akram Hosp, Iran Cochlear Implant Ctr, Tehran, Iran; [Stollar, Elliot] Hosp Sick Children, Dept Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Somers, Thomas] Univ Antwerp, St Augustinus Hosp, Univ Dept Otolaryngol, B-2020 Antwerp, Belgium	University of Antwerp; Tarbiat Modares University; Iran University of Medical Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Antwerp	Van Camp, G (corresponding author), Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium.	guy.vancamp@ua.ac.be	Van Camp, Guy/F-3386-2013	Van Camp, Guy/0000-0001-5105-9000; Farhadi, Mohammad/0000-0001-6303-1750; sanati, Mohammad Hossein/0000-0002-0292-7673				Bamiou DE, 2000, ARCH DIS CHILD, V82, P257, DOI 10.1136/adc.82.3.257; Barrow JR, 2000, DEVELOPMENT, V127, P933; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bobola N, 2003, DEVELOPMENT, V130, P3403, DOI 10.1242/dev.00554; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Castori M, 2006, AM J MED GENET A, V140A, P1573, DOI 10.1002/ajmg.a.31290; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; Couly G, 1998, DEVELOPMENT, V125, P3445; Davenne M, 1999, NEURON, V22, P677, DOI 10.1016/S0896-6273(00)80728-X; Faiella Antonio, 1998, Human Mutation, V12, P363; Forrester Mathias B., 2005, Congenital Anomalies, V45, P119, DOI 10.1111/j.1741-4520.2005.00080.x; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gavalas A, 1997, DEVELOPMENT, V124, P3693; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Harris J, 1996, J MED GENET, V33, P809, DOI 10.1136/jmg.33.10.809; Ishimoto S, 2007, LARYNGOSCOPE, V117, P461, DOI 10.1097/MLG.0b013e31802ca4d4; KAPPEN C, 1993, GENOMICS, V18, P54, DOI 10.1006/geno.1993.1426; KAUR S, 1992, J EXP ZOOL, V264, P323, DOI 10.1002/jez.1402640311; Kimitsuki T, 1999, EUR ARCH OTO-RHINO-L, V256, pS11, DOI 10.1007/PL00014144; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KOUNTAKIS SE, 1995, ARCH OTOLARYNGOL, V121, P885; Lampe X, 2004, BIOCHEM BIOPH RES CO, V316, P898, DOI 10.1016/j.bbrc.2004.02.138; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Llano-Rivas I, 1999, ARCH MED RES, V30, P120, DOI 10.1016/S0188-0128(98)00023-2; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; LYNBERG MC, 1990, TERATOLOGY, V42, P513, DOI 10.1002/tera.1420420508; Mafong DD, 2002, LARYNGOSCOPE, V112, P1, DOI 10.1097/00005537-200201000-00001; Mallo M, 1996, DEVELOPMENT, V122, P173; Mallo M, 2001, DEV BIOL, V231, P410, DOI 10.1006/dbio.2001.0154; MARK M, 1993, DEVELOPMENT, V119, P319; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; Marszalek Bozena, 2002, Journal of Applied Genetics, V43, P223; MASTROIACOVO P, 1995, J MED GENET, V32, P453, DOI 10.1136/jmg.32.6.453; MEURMAN Y, 1957, ARCHIV OTOLARYNGOL, V66, P443; Moore JK, 1998, J CHEM NEUROANAT, V16, P1, DOI 10.1016/S0891-0618(98)00057-X; Nazarali A, 2000, CELL MOL NEUROBIOL, V20, P269, DOI 10.1023/A:1007006024407; Nishikori T, 1999, ANAT EMBRYOL, V200, P19, DOI 10.1007/s004290050255; O'Gorman S, 2005, DEV DYNAM, V234, P124, DOI 10.1002/dvdy.20402; Okajima H, 1996, ACTA OTO-LARYNGOL, P18; Oury F, 2007, M S-MED SCI, V23, P247, DOI 10.1051/medsci/2007233247; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; Pelz J, 1996, AM J MED GENET, V63, P257; PHELAN ML, 1994, MOL CELL BIOL, V14, P5066, DOI 10.1128/MCB.14.8.5066; Rhodes CR, 2003, J NEUROCYTOL, V32, P1143, DOI 10.1023/B:NEUR.0000021908.98337.91; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez O, 1997, Invest Clin, V38, P203; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; Shaw GM, 2004, BIRTH DEFECTS RES A, V70, P472, DOI 10.1002/bdra.20042; Stevenson DA, 2007, AM J MED GENET A, V143A, P1053, DOI 10.1002/ajmg.a.31715; Stoll C, 1997, ANN GENET-PARIS, V40, P217; Stollar EJ, 2003, J BIOL CHEM, V278, P43699, DOI 10.1074/jbc.M308029200; Suutarla S, 2007, INT J PEDIATR OTORHI, V71, P1211, DOI 10.1016/j.ijporl.2007.04.020; Takegoshi H, 2005, OTOL NEUROTOL, V26, P803, DOI 10.1097/01.mao.0000178142.12225.d9; TAN DP, 1992, P NATL ACAD SCI USA, V89, P6280, DOI 10.1073/pnas.89.14.6280; Tasse C, 2005, EUR J MED GENET, V48, P397, DOI 10.1016/j.ejmg.2005.04.015; Tekin M, 2007, AM J HUM GENET, V80, P338, DOI 10.1086/510920; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Wang RY, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e32; Williamson Ian, 2007, Arch Dis Child Educ Pract Ed, V92, pep159	63	67	75	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					982	991		10.1016/j.ajhg.2008.02.015	http://dx.doi.org/10.1016/j.ajhg.2008.02.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18394579	Green Published, Bronze			2022-12-18	WOS:000255103900016
J	Pare, G; Serre, D; Brisson, D; Anand, SS; Montpetit, A; Tremblay, G; Engert, JC; Hudson, TJ; Gaudet, D				Pare, Guillaume; Serre, David; Brisson, Diane; Anand, Sonia S.; Montpetit, Alexandre; Tremblay, Gerald; Engert, James C.; Hudson, Thomas J.; Gaudet, Daniel			Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; RISK-FACTORS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; HEART-DISEASE; HUMAN GENOME; MECHANISM; POLYMORPHISM; METAANALYSIS; LECITHIN	Coronary artery disease ( CAD) is a major health concern in both developed and developing countries. With a heritability estimated at similar to 50%, there is a strong rationale to better define the genetic contribution to CAD. This project involves the analysis of 884 individuals from 142 families ( with average sibships of 5.7) as well as 558 case and control subjects from the Saguenay Lac St-Jean region of northeastern Quebec, with the use of 1,536 single-nucleotide polymorphisms ( SNPs) in 103 candidate genes for CAD. By use of clusters of SNPs to generate multiallelic haplotypes at candidate loci for segregation studies within families, suggestive linkage for high-density lipoprotein (HDL) cholesterol is observed on chromosome 1p36.22. Furthermore, several associations that remain significant after Bonferroni correction are observed with lipoprotein-related traits as well as plasma concentrations of adiponectin. Of note, HDL cholesterol levels are associated with an amino acid substitution (lysine/asparagine) at codon 198 (rs5370) of endothelin-1 (EDN1) in a sex-specific manner, as well as with a SNP (rs2292318) located 7.7 kb upstream of lecithin cholesterol acyl-transferase (LCAT). Whereas the other observed associations are described in the current literature, these two are new. Using an independent validation sample of 806 individuals, we confirm the EDN1 association (P < .005), whereas the LCAT association was nonsignificant (P = .12).	McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Med, Fac Med, Montreal, PQ H3A 2T5, Canada; Genome Quebec Innovat Ctr, Quebec City, PQ, Canada; Univ Montreal, Community Genom Med Ctr, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Med, Lipid Clin, Montreal, PQ H3C 3J7, Canada; McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; Ontario Inst Canc Res, Toronto, ON, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McMaster University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Hudson, TJ (corresponding author), MaRS Ctr, Ontario Inst Canc Res, S Tower,101 Coll St,Suite 500, Toronto, ON M5G 1L7, Canada.	tom.hudson@oicr.on.ca	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Engert, James/0000-0001-8411-4790				Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Asai T, 2001, HYPERTENSION, V38, P1321, DOI 10.1161/hy1101.095333; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton M, 2003, CORONARY ARTERY DIS, V14, P477, DOI 10.1097/00019501-200311000-00002; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Clarke KJ, 2003, BIOCHEM BIOPH RES CO, V312, P945, DOI 10.1016/j.bbrc.2003.11.015; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gaudet D, 1999, CLIN GENET, V55, P259, DOI 10.1034/j.1399-0004.1999.550408.x; GLOMSET JA, 1968, J LIPID RES, V9, P155; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Heijmans BT, 2005, EUR J HUM GENET, V13, P1143, DOI 10.1038/sj.ejhg.5201466; HEYER E, 1995, AM J HUM GENET, V56, P970; HICKEY KA, 1985, AM J PHYSIOL, V248, pC550, DOI 10.1152/ajpcell.1985.248.5.C550; Huang QQ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S83; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Jiang ZY, 1999, DIABETES, V48, P1120, DOI 10.2337/diabetes.48.5.1120; Jin JJ, 2003, HYPERTENSION, V41, P163, DOI 10.1161/01.HYP.0000043680.75107.CF; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Pajukanta P, 2004, J CLIN INVEST, V114, P1244, DOI 10.1172/JCI200423466; Radeau T, 2004, CLIN BIOCHEM, V37, P1072, DOI 10.1016/j.clinbiochem.2004.08.001; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Strawbridge AB, 2006, J CELL BIOCHEM, V97, P849, DOI 10.1002/jcb.20687; Strawbridge AB, 2005, DIABETES, V54, P1698, DOI 10.2337/diabetes.54.6.1698; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Tiret L, 1999, HYPERTENSION, V33, P1169, DOI 10.1161/01.HYP.33.5.1169; von Eckardstein A, 2006, ATHEROSCLEROSIS, V186, P231, DOI 10.1016/j.atherosclerosis.2005.10.033; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang Kelan, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P135; Zhu Xiao-yan, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P419	43	67	70	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					673	682		10.1086/513286	http://dx.doi.org/10.1086/513286			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357073	Bronze, Green Published			2022-12-18	WOS:000245465200008
J	Nascimento, RMP; Otto, PA; de Brouwer, APM; Vianna-Morgante, AM				Nascimento, Rafaella M. P.; Otto, Paulo A.; de Brouwer, Arjan P. M.; Vianna-Morgante, Angela M.			UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-REPAIR ENZYME; GENE; INACTIVATION; MUTATIONS; GROWTH; LOCALIZATION; METHYLATION; DEFICIENCY; EXPRESSION; DIAGNOSIS	We report a mutation of UBE2A/HR6A, which encodes a ubiquitin-conjugating enzyme (E2), a member of the ubiquitin proteasome pathway, as the cause of a novel X-linked mental retardation (XLMR) syndrome that affects three males in a two-generation family. A single-nucleotide substitution, c. 382C -> T in UBE2A, led to a premature UAG stop codon (Q128X). As a consequence, the predicted polypeptide lacks the 25 C-terminal amino acid residues. The importance of this terminal sequence for UBE2 function is inferred by its conservation in vertebrates and in Drosophila. UBE2A mutations do not appear to significantly contribute to XLMR, since no UBE2A mutations were identified in 15 families with nonsyndromic and 4 families with syndromic idiopathic XLMR previously mapped to intervals encompassing this gene. This is the first description of a mutation in a ubiquitin-conjugating enzyme gene as the cause of a human disease.	Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, BR-05422970 Sao Paulo, Brazil; Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Universidade de Sao Paulo; Radboud University Nijmegen	Vianna-Morgante, AM (corresponding author), Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, Caixa Postal 11461, BR-05422970 Sao Paulo, Brazil.	avmorgan@ib.usp.br	Otto, Paulo/L-5464-2014; de Brouwer, Arjan PM/P-5949-2015; Otto, Paulo A./AAA-8258-2022	Otto, Paulo/0000-0001-8810-6608; Otto, Paulo A./0000-0001-8810-6608				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Biancalana V, 2004, AM J MED GENET A, V129A, P218, DOI 10.1002/ajmg.a.30237; Bienvenu T, 2003, J MED GENET, V40, P357, DOI 10.1136/jmg.40.5.357; Claes S, 1996, AM J MED GENET, V64, P137, DOI 10.1002/(SICI)1096-8628(19960712)64:1<137::AID-AJMG24>3.0.CO;2-N; Claes S, 1999, AM J MED GENET, V85, P283, DOI 10.1002/(SICI)1096-8628(19990730)85:3<283::AID-AJMG19>3.0.CO;2-N; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; FISHBURN J, 1983, AM J MED GENET, V14, P713, DOI 10.1002/ajmg.1320140413; Gecz J, 1999, GENOMICS, V62, P356, DOI 10.1006/geno.1999.6032; Gu XX, 1996, J MED GENET, V33, P52, DOI 10.1136/jmg.33.1.52; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kavakebi P, 2005, MOL CELL NEUROSCI, V29, P559, DOI 10.1016/j.mcn.2005.04.008; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kishino T, 1997, NAT GENET, V15, P411, DOI 10.1038/ng0497-411d; Kleefstra T, 2005, CLIN GENET, V67, P451, DOI 10.1111/j.1399-0004.2005.00434.x; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Mandel JL, 2004, EUR J HUM GENET, V12, P689, DOI 10.1038/sj.ejhg.5201247; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Obin M, 1999, J BIOL CHEM, V274, P11789, DOI 10.1074/jbc.274.17.11789; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; Raynaud M, 1998, AM J MED GENET, V76, P255, DOI 10.1002/(SICI)1096-8628(19980319)76:3<255::AID-AJMG10>3.0.CO;2-G; Raynaud M, 2000, EUR J HUM GENET, V8, P253, DOI 10.1038/sj.ejhg.5200437; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2000, Methods Mol Biol, V132, P365; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Vervoort VS, 2002, SCIENCE, V296, P2401; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563	35	67	69	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					549	555		10.1086/507047	http://dx.doi.org/10.1086/507047			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909393	Green Published, Bronze			2022-12-18	WOS:000239830700017
J	Lugtenberg, D; Yntema, HG; Banning, MJG; Oudakker, AR; Firth, HV; Willatt, L; Raynaud, M; Kleefstra, T; Fryns, JP; Ropers, HH; Chelly, J; Moraine, C; Gecz, J; van Reeuwijk, J; Nabuurs, SB; de Vries, BBA; Hamel, BCJ; de Brouwer, APM; van Bokhoven, H				Lugtenberg, D; Yntema, HG; Banning, MJG; Oudakker, AR; Firth, HV; Willatt, L; Raynaud, M; Kleefstra, T; Fryns, JP; Ropers, HH; Chelly, J; Moraine, C; Gecz, J; van Reeuwijk, J; Nabuurs, SB; de Vries, BBA; Hamel, BCJ; de Brouwer, APM; van Bokhoven, H			ZNF674: A new Kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DNA; MUTATIONS; PROTEINS; KAP-1; COREPRESSOR; BINDING; TFIIIA; DOMAIN; BREAKPOINT	Array-based comparative genomic hybridization has proven to be successful in the identification of genetic defects in disorders involving mental retardation. Here, we studied a patient with learning disabilities, retinal dystrophy, and short stature. The family history was suggestive of an X-linked contiguous gene syndrome. Hybridization of full-coverage X-chromosomal bacterial artificial chromosome arrays revealed a deletion of similar to 1Mb in Xp11.3, which harbors RP2, SLC9A7, CHST7, and two hypothetical zinc-finger genes, ZNF673 and ZNF674. These genes were analyzed in 28 families with nonsyndromic X-linked mental retardation ( XLMR) that show linkage to Xp11.3; the analysis revealed a nonsense mutation, p.E118X, in the coding sequence of ZNF674 in one family. This mutation is predicted to result in a truncated protein containing the Kruppel-associated box domains but lacking the zinc-finger domains, which are crucial for DNA binding. We characterized the complete ZNF674 gene structure and subsequently tested an additional 306 patients with XLMR for mutations by direct sequencing. Two amino acid substitutions, p.T343M and p.P412L, were identified that were not found in unaffected individuals. The proline at position 412 is conserved between species and is predicted by molecular modeling to reduce the DNA-binding properties of ZNF674. The p.T343M transition is probably a polymorphism, because the homologous ZNF674 gene in chimpanzee has a methionine at that position. ZNF674 belongs to a cluster of seven highly related zinc-finger genes in Xp11, two of which ( ZNF41 and ZNF81) were implicated previously in XLMR. Identification of ZNF674 as the third XLMR gene in this cluster may indicate a common role for these zinc-finger genes that is crucial to human cognitive functioning.	Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; Addenbrookes Hosp, Dept Clin Genet, Cambridge, England; Hop Bretonneau, Serv Genet, Tours, France; Hop Bretonneau, INSERM, U316, Tours, France; Univ Leuven, Ctr Human Genet, Louvain, Belgium; Max Planck Inst Mol Genet, Berlin, Germany; Fac Med Cochin, INSERM 129 ICGM, Paris, France; Womens & Childrens Hosp, Dept Genet Med, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia	Radboud University Nijmegen; Radboud University Nijmegen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CHU Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Womens & Childrens Hospital Australia; University of Adelaide	de Brouwer, APM (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	A.debrouwer@antrg.umcn.nl	Yntema, H.G./L-4771-2015; Kleefstra, Tjitske/G-2619-2012; Oudakker, Astrid/AAB-7890-2019; Chelly, Jamel/J-7528-2015; Lugtenberg, Dorien/B-6338-2018; de Brouwer, Arjan PM/P-5949-2015; Gecz, Jozef/X-3469-2019; Bokhoven, J.H.L.M. van van/H-8015-2014; Raynaud, Martine/R-9811-2019; van Reeuwijk, Jeroen/P-8665-2015; van Bokhoven, Hans/D-8764-2012	Chelly, Jamel/0000-0002-0939-8719; Gecz, Jozef/0000-0002-7884-6861; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Raynaud, Martine/0000-0002-6888-6480; van Reeuwijk, Jeroen/0000-0002-0658-4399; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; American Association on Mental Retardation, 2002, MENT RET DEF CLASS S; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Carter NP, 2004, HUM MOL GENET, V13, pR297, DOI 10.1093/hmg/ddh230; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; DERRY JMJ, 1995, GENOMICS, V30, P361, DOI 10.1006/geno.1995.0031; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horn D, 2003, AM J MED GENET A, V117A, P236, DOI 10.1002/ajmg.a.10017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Kleefstra T, 2004, J MED GENET, V41, P394, DOI 10.1136/jmg.2003.016972; KNIGHT JC, 1994, GENOMICS, V21, P180, DOI 10.1006/geno.1994.1240; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Ladomery M, 2002, ANN HUM GENET, V66, P331, DOI 10.1017/S0003480002001215; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LUGTENBERG D, 2005, J MED GENET; Mandel JL, 2004, EUR J HUM GENET, V12, P689, DOI 10.1038/sj.ejhg.5201247; Raynaud M, 2000, EUR J HUM GENET, V8, P253, DOI 10.1038/sj.ejhg.5200437; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; SCHULTZ MJ, 2001, RRD IMMUNOL 1, V3, P1; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; THUKRAL SK, 1991, P NATL ACAD SCI USA, V88, P9188, DOI 10.1073/pnas.88.20.9188; THUKRAL SK, 1991, P NATL ACAD SCI USA, V90, P7908; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Veltman JA, 2004, J MED GENET, V41, P425, DOI 10.1136/jmg.2004.018531; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291	40	67	70	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					265	278		10.1086/500306	http://dx.doi.org/10.1086/500306			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16385466	Green Published, Bronze			2022-12-18	WOS:000236744900008
J	Larrabee, PB; Johnson, KL; Pestova, E; Lucas, M; Wilber, K; LeShane, ES; Tantravahi, U; Cowan, JM; Bianchi, DW				Larrabee, PB; Johnson, KL; Pestova, E; Lucas, M; Wilber, K; LeShane, ES; Tantravahi, U; Cowan, JM; Bianchi, DW			Microarray analysis of cell-free fetal DNA in amniotic fluid: A prenatal molecular karyotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CHROMOSOMAL REARRANGEMENTS; MENTAL-RETARDATION; DIAGNOSIS; PCR; END	Metaphase karyotype analysis of fetal cells obtained by amniocentesis or chorionic villus sampling is the current standard for prenatal cytogenetic diagnosis, particularly for the detection of trisomy 21. We previously demonstrated that large quantities of cell-free fetal DNA (cffDNA) are easily extracted from amniotic fluid (AF). In this study, we explored potential clinical applications of AF cffDNA by testing its ability to hybridize to DNA microarrays for comparative genomic hybridization (CGH) analysis. cffDNA isolated from 11 male fetuses showed significantly increased hybridization signals on SRY and decreased signals on X-chromosome markers, compared with female reference DNA. cffDNA isolated from six female fetuses showed the reverse when compared with male reference DNA. cffDNA from three fetuses with trisomy 21 had increased hybridization signals on the majority of the chromosome 21 markers, and cffDNA from a fetus with monosomy X (Turner syndrome) had decreased hybridization signals on most X-chromosome markers, compared with euploid female reference DNA. These results indicate that cffDNA extracted from AF can be analyzed using CGH microarrays to correctly identify fetal sex and aneuploidy. This technology facilitates rapid screening of samples for whole-chromosome changes and may augment standard karyotyping techniques by providing additional molecular information.	Tufts Univ, Sch Med, Tufts New England Med Ctr, Dept Pediat,Div Genet, Boston, MA 02111 USA; Tufts Univ, Sch Med, Tufts New England Med Ctr, Dept Pediat,Div Newborn Med, Boston, MA 02111 USA; Vysis Inc, Downers Grove, IL USA; Brown Univ, Women & Infants Hosp, Dept Pathol, Providence, RI USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Brown University; Women & Infants Hospital Rhode Island	Bianchi, DW (corresponding author), Tufts Univ, Sch Med, Tufts New England Med Ctr, Dept Pediat,Div Genet, 750 Washington St,Box 394, Boston, MA 02111 USA.	dbianchi@tufts-nemc.org		Pestova, Katerina/0000-0001-8200-2621	NICHD NIH HHS [R01 HD042053, R01 HD42053] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042053] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bianchi DW, 2001, CLIN CHEM, V47, P1867; Biesecker LG, 2002, AM J MED GENET, V107, P263, DOI 10.1002/ajmg.10160.abs; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; de Vries BBA, 2003, J MED GENET, V40, P385, DOI 10.1136/jmg.40.6.385; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Frederickson RM, 1999, PRENATAL DIAG, V19, P113, DOI 10.1002/(SICI)1097-0223(199902)19:2<113::AID-PD475>3.0.CO;2-J; Hulten MA, 2003, REPRODUCTION, V126, P279, DOI 10.1530/reprod/126.3.279; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Lee T, 2002, AM J OBSTET GYNECOL, V187, P1217, DOI 10.1067/mob.2002.127462; Pergament E, 2000, CURR OPIN OBSTET GYN, V12, P73, DOI 10.1097/00001703-200004000-00003; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; PIPER J, 2002, P 3 EUR QUANT MOL CY; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977	15	67	83	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					485	491		10.1086/423288	http://dx.doi.org/10.1086/423288			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15252756	Green Published, Bronze			2022-12-18	WOS:000223272200012
J	Verrelli, BC; Tishkoff, SA				Verrelli, BC; Tishkoff, SA			Signatures of selection and gene conversion associated with human color vision variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; HUMAN GENOME; MOLECULAR EVOLUTION; BALANCING SELECTION; TRICHROMATIC VISION; NATURAL-SELECTION; HAPLOTYPE DIVERSITY; DNA POLYMORPHISM; COMPLEX DISEASE; OPSIN GENES	Trichromatic color vision in humans results from the combination of red, green, and blue photopigment opsins. Although color vision genes have been the targets of active molecular and psychophysical research on color vision abnormalities, little is known about patterns of normal genetic variation in these genes among global human populations. The current study presents nucleotide sequence analyses and tests of neutrality for a 5.5-kb region of the X-linked long-wave "red" opsin gene (OPN1LW) in 236 individuals from ethnically diverse human populations. Our analysis of the recombination landscape across OPN1LW reveals an unusual haplotype structure associated with amino acid replacement variation in exon 3 that is consistent with gene conversion. Compared with the absence of OPN1LW amino acid replacement fixation since divergence from chimpanzee, the human population exhibits a significant excess of high-frequency OPN1LW replacements. Our results suggest that subtle changes in L-cone opsin wavelength absorption may have been adaptive during human evolution.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Arizona State Univ, Biodesign Inst, Ctr Evolutionary Funct Gen, Tempe, AZ USA	University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	tishkoff@umd.edu	Verrelli, Brian/AAW-9523-2021	Verrelli, Brian/0000-0002-9670-4920				Akashi H, 1997, GENETICS, V146, P295; Akashi H, 1999, GENETICS, V151, P221; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Boissinot S, 1998, P NATL ACAD SCI USA, V95, P13749, DOI 10.1073/pnas.95.23.13749; Carroll Joseph, 2002, J Vis, V2, P531, DOI 10.1167/2.8.1; Clark AG, 2003, CURR OPIN GENET DEV, V13, P296, DOI 10.1016/S0959-437X(03)00056-X; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; DEEB SS, 1992, AM J HUM GENET, V51, P687; DEEB SS, 1994, P NATL ACAD SCI USA, V91, P7262, DOI 10.1073/pnas.91.15.7262; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Fay JC, 2001, GENETICS, V158, P1227; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Garrigan D, 2003, EVOLUTION, V57, P1707; Hayashi T, 1999, NAT GENET, V22, P90, DOI 10.1038/8798; Hudson RR, 2000, GENETICS, V155, P2011; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Innan H, 2003, GENETICS, V163, P803; Innan H, 2002, GENETICS, V161, P865; Jameson KA, 2001, PSYCHON B REV, V8, P244, DOI 10.3758/BF03196159; JORGENSEN AL, 1990, P NATL ACAD SCI USA, V87, P6512, DOI 10.1073/pnas.87.17.6512; Li N, 2003, GENETICS, V165, P2213; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Nachman MW, 1996, GENETICS, V142, P953; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Nathans J., 1999, COLOR VISION GENES P, P3; Navarro A, 2002, GENETICS, V161, P849; Neitz J, 1999, NAT NEUROSCI, V2, P884, DOI 10.1038/13185; Nielsen R, 1999, GENETICS, V153, P497; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Ptak SE, 2004, GENETICS, V167, P387, DOI 10.1534/genetics.167.1.387; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2002, GENETICS, V162, P1849; Sharpe LT, 1998, J NEUROSCI, V18, P10053; SHYUE SK, 1994, MOL BIOL EVOL, V11, P548; Sjoberg SA, 1998, VISION RES, V38, P3213, DOI 10.1016/S0042-6989(97)00367-2; Slatkin M, 2000, GENETICS, V154, P1367; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1992, GENETICS, V130, P925; Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wall JD, 2004, NAT GENET, V36, P114, DOI 10.1038/ng0204-114; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WINDERICKX J, 1993, HUM MOL GENET, V2, P1413, DOI 10.1093/hmg/2.9.1413; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yokoyama S, 2001, GENETICS, V158, P1697; Zhou YH, 1996, MOL BIOL EVOL, V13, P780, DOI 10.1093/oxfordjournals.molbev.a025638	69	67	68	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					363	375		10.1086/423287	http://dx.doi.org/10.1086/423287			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15252758	Green Published, Bronze			2022-12-18	WOS:000223272200002
J	Slatkin, M				Slatkin, M			A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUCOLIPIDOSIS TYPE-IV; TAY-SACHS-DISEASE; GAUCHER-DISEASE; FAMILIAL DYSAUTONOMIA; TORSION DYSTONIA; DRIFT; JEWS; SELECTION; MUTATIONS; HAPLOTYPE	A founder effect can account for the presence of an allele at an unusually high frequency in an isolated population if the allele is selectively neutral and if all copies are identical by descent with a copy that either was carried by a founder individual or arose by mutation later. Here, a statistical test of both aspects of the founder-effect hypothesis is developed. The test is performed by a modified version of a program that implements the Slatkin-Bertorelle test of neutrality. The test is applied to several disease-associated alleles found predominantly in Ashkenazi Jews. Despite considerable uncertainty about the demographic history of Ashkenazi Jews and their ancestors, available genetic data are consistent with a founder effect resulting from a severe bottleneck in population size between A. D. 1100 and A. D. 1400 and an earlier bottleneck in A. D. 75, at the beginning of the Jewish Diaspora. The relatively high frequency of alleles causing four different lysosomal storage disorders, including Tay-Sachs disease and Gaucher disease, can be accounted for if the disease-associated alleles are recessive in their effects on reproductive	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Slatkin, M (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 3060 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	slatkin@socrates.berkeley.edu	Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	NIGMS NIH HHS [R01-GM40282, R01 GM040282] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; BARNAVI E, 1992, HIST ATLAS JEWISH PE; BEUTLER E, 1993, AM J HUM GENET, V52, P85; Blumenfeld A, 1999, AM J HUM GENET, V64, P1110, DOI 10.1086/302339; Colombo R, 2000, AM J HUM GENET, V66, P692, DOI 10.1086/302757; CROW JF, 1979, GENETICS S, V92, P165; DIAMOND JM, 1994, NATURE, V368, P291, DOI 10.1038/368291a0; Diaz GA, 2000, AM J HUM GENET, V66, P1821, DOI 10.1086/302946; Durst R, 2001, AM J HUM GENET, V68, P1172, DOI 10.1086/320123; Ellis NA, 1998, AM J HUM GENET, V63, P1685, DOI 10.1086/302167; ENGLEMAN UZ, 1960, JEWS THEIR HIST CULT, V2, P1172; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; Frisch A, 2004, HUM GENET, V114, P366, DOI 10.1007/s00439-003-1072-8; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HILL WG, 1972, THEOR POPUL BIOL, V3, P278, DOI 10.1016/0040-5809(72)90004-4; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; LEWONTIN RC, 1964, GENETICS, V49, P49; Luria SE, 1943, GENETICS, V28, P491; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; MOTULSKY AG, 1979, GENETIC DIS ASHKENAZ, P301; Mourant AE, 1978, BLOOD GROUPS DIS; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Niell BL, 2003, AM J HUM GENET, V73, P1250, DOI 10.1086/379926; Nordborg M., 2002, MODERN DEV THEORETIC, P194; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; RISCH N, 1995, NAT GENET, V11, P14, DOI 10.1038/ng0995-14; Risch N, 2003, AM J HUM GENET, V73, P440, DOI 10.1086/377009; Risch N, 2003, AM J HUM GENET, V72, P812, DOI 10.1086/373882; Risch N, 2001, ADV GENET, V44, P233; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; Slatkin M, 2001, GENETICS, V158, P865; SLATKIN M, 2002, MODERN DEV THEORETIC, P233; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; Thompson EA, 1996, MOL PHYLOGENET EVOL, V5, P220, DOI 10.1006/mpev.1996.0015; Thompson EA, 1997, AM J HUM GENET, V60, P197; VOGEL F, 1996, HUMAN GENETICS PROBL; Weinryb Bernard, 1972, JEWS POLAND SOCIAL E; ZLOTOGORA J, 1988, AM J HUM GENET, V42, P271; ZOOSSMANNDISKIN A, 1995, NAT GENET, V11, P13, DOI 10.1038/ng0995-13	43	67	68	0	21	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					282	293		10.1086/423146	http://dx.doi.org/10.1086/423146			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15208782	Bronze, Green Published			2022-12-18	WOS:000222702000012
J	Fain, PR; Gowan, K; LaBerge, GS; Alkhateeb, A; Steller, GL; Talbert, J; Bennett, DC; Spritz, RA				Fain, PR; Gowan, K; LaBerge, GS; Alkhateeb, A; Steller, GL; Talbert, J; Bennett, DC; Spritz, RA			A genomewide screen for generalized vitiligo: Confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; ASSOCIATION; GENE; IDENTIFICATION; EPIDEMIOLOGY; POLYMORPHISM; MUTATIONS; FAMILIES; PROGRAM	Generalized vitiligo is a common autoimmune disorder characterized by the development of white patches of skin and overlying hair due to loss of pigment-forming melanocytes from the involved areas. Family clustering of cases is not uncommon, in a pattern suggestive of multifactorial, polygenic inheritance, and there is strong association between vitiligo and other autoimmune diseases. To map genetic loci that confer susceptibility to generalized vitiligo and perhaps other autoimmune diseases, we performed a genomewide linkage scan in 71 white multiplex families with vitiligo from North America and the United Kingdom. Linkage was assessed by multipoint nonparametric linkage analyses. One linkage signal, AIS1, located at 1p31, met genomewide criteria for highly significant linkage (nonparametric LOD 5.56; P = .000000282), establishing its importance as a major vitiligo susceptibility locus. An additional seven signals, on chromosomes 1, 7, 8, 11, 19, and 22, met genomewide criteria for "suggestive linkage," and will thus be of particular importance for follow-up studies.	Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Univ London St Georges Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; St Georges University London	Spritz, RA (corresponding author), Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Box B161,4200 E 9th Ave, Denver, CO 80262 USA.	Richard.Spritz@UCHSC.edu	Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527; Alkhateeb, Asem/0000-0001-8276-5784	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46374, U19 AI046374] Funding Source: Medline; NIAMS NIH HHS [AR45584, R01 AR045584] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Alkhateeb A, 2002, HUM MOL GENET, V11, P661, DOI 10.1093/hmg/11.6.661; Arcos-Burgos M, 2002, HUM GENET, V110, P334, DOI 10.1007/s00439-002-0687-5; Bandyopadhyay D, 2000, CLIN EXP DERMATOL, V25, P152; BOLOGNIA JL, 1998, PIGMENTARY SYSTEM, P513; CARNEVALE A, 1980, REV INVEST CLIN, V32, P37; Casp CB, 2002, PIGM CELL RES, V15, P62, DOI 10.1034/j.1600-0749.2002.00057.x; DAS S K, 1985, Genetic Epidemiology, V2, P255, DOI 10.1002/gepi.1370020303; delaFuenteFernandez R, 1997, LANCET, V350, P640, DOI 10.1016/S0140-6736(05)63329-6; GOUDIE BM, 1983, SCOT MED J, V28, P338, DOI 10.1177/003693308302800405; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAFEZ M, 1983, ACTA DERM-VENEREOL, V63, P249; HANN SK, 2000, VITILIGO COMPREHENSI; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Kelly JA, 2002, GENES IMMUN, V3, pS71, DOI 10.1038/sj.gene.6363885; Kemp EH, 1999, BRIT J DERMATOL, V140, P73; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kovacs SO, 1998, J AM ACAD DERMATOL, V38, P647, DOI 10.1016/S0190-9622(98)70194-X; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Le Poole IC, 2001, PIGM CELL RES, V14, P475, DOI 10.1034/j.1600-0749.2001.140608.x; MAJUMDER PP, 1993, ARCH DERMATOL, V129, P994, DOI 10.1001/archderm.129.8.994; MAJUMDER PP, 1988, AM J HUM GENET, V43, P119; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; MEHTA NR, 1973, INDIAN J MED RES, V61, P145; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NAIR BKH, 1978, INT J DERMATOL, V17, P755, DOI 10.1111/ijd.1978.17.9.755; NATH SK, 1994, AM J HUM GENET, V55, P981; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; NEUFELD M, 1980, PEDIATR ANN, V9, P43, DOI 10.3928/0090-4481-19800401-07; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; ORECCHIA G, 1992, DERMATOLOGY, V185, P123, DOI 10.1159/000247426; Perheentupa J, 1996, HORM METAB RES, V28, P353, DOI 10.1055/s-2007-979814; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Terwilliger J., 1994, HDB HUMAN GENETIC LI; THOMSEN M, 1981, TISSUE ANTIGENS, V17, P97; Tursen U, 2002, ARCH DERMATOL RES, V294, P143, DOI 10.1007/s00403-002-0295-1; Vaidya B, 2000, J CLIN ENDOCR METAB, V85, P688, DOI 10.1210/jc.85.2.688; Vaidya B, 2002, J CLIN ENDOCR METAB, V87, P5385, DOI 10.1210/jc.2002-020492; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; WEETMAN AP, 1991, TISSUE ANTIGENS, V38, P31, DOI 10.1111/j.1399-0039.1991.tb02032.x; Woolley GW, 1941, AM NAT, V75, P507, DOI 10.1086/280994; WOOLLEY GW, 1945, J HERED, V36, P269, DOI 10.1093/oxfordjournals.jhered.a105519; Zamani M, 2001, BRIT J DERMATOL, V145, P90, DOI 10.1046/j.1365-2133.2001.04288.x	48	67	72	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1560	1564		10.1086/375451	http://dx.doi.org/10.1086/375451			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12707860	Bronze, Green Published			2022-12-18	WOS:000183275500019
J	Neitzel, H; Neumann, LM; Schindler, D; Wirges, A; Tonnies, H; Trimborn, M; Krebsova, A; Richter, R; Sperling, K				Neitzel, H; Neumann, LM; Schindler, D; Wirges, A; Tonnies, H; Trimborn, M; Krebsova, A; Richter, R; Sperling, K			Premature chromosome condensation in humans associated with microcephaly and mental retardation: A novel autosomal recessive condition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; DAMAGE CHECKPOINT; CELL-CYCLE; MITOSIS; PROPHASE; LYMPHOCYTES; MUTATION; CDC25C; VITRO; GENE	We report a novel autosomal recessive disorder characterized by premature chromosome condensation in the early G2 phase. It was observed in two siblings, from consanguineous parents, affected with microcephaly, growth retardation, and severe mental retardation. Chromosome analysis showed a high frequency of prophase-like cells (>10%) in lymphocytes, fibroblasts, and lymphoblast cell lines with an otherwise normal karyotype. H-3-thymidine-pulse labeling and autoradiography showed that, 2 h after the pulse, 28%-35% of the prophases were labeled, compared with 9%-11% in healthy control subjects, indicating that the phenomenon is due to premature chromosome condensation. Flow cytometry studies demonstrate that the entire cell cycle is not prolonged, compared with that in healthy control subjects, and compartment sizes did not differ from those in healthy control subjects. No increased reaction of the cells to X-irradiation or treatments with the clastogens bleomycin and mitomycin C was observed, in contrast to results in the cell-cycle mutants ataxia telangiectasia and Fanconi anemia. The rates of sister chromatid exchanges and the mitotic nondisjunction rates were inconspicuous. Premature entry of cells into mitosis suggests that a gene involved in cell-cycle regulation is mutated in these siblings.	Humboldt Univ, Charite, Inst Human Genet, D-13353 Berlin, Germany; Univ Wurzburg, Dept Human Genet, Wurzburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg	Neitzel, H (corresponding author), Humboldt Univ, Charite, Inst Human Genet, Campus Virchow,Augustenburger Pl 1, D-13353 Berlin, Germany.							Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Georgatos SD, 1997, J CELL SCI, V110, P2129; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; KAI R, 1986, MOL CELL BIOL, V6, P2027, DOI 10.1128/MCB.6.6.2027; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kubbies M, 1989, FLOW CYTOMETRY ADV R, V2, P6; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; SEYSCHAB H, 1992, EUR J PEDIATR, V151, P756, DOI 10.1007/BF01959085; SEYSCHAB H, 1993, HUM GENET, V92, P61, DOI 10.1007/BF00216146; Shi QH, 2000, HUM GENET, V106, P29, DOI 10.1007/s004390051005; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; SPERLING K, 1974, HUMANGENETIK, V23, P235, DOI 10.1007/BF00272508; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; TOMMERUP N, 1993, HUM GENET, V92, P339, DOI 10.1007/BF01247331; UCHIDA S, 1990, MOL CELL BIOL, V10, P577, DOI 10.1128/MCB.10.2.577; VONDERHAAR B, 1981, EXP CELL RES, V134, P477, DOI 10.1016/0014-4827(81)90450-X; ZIJNO A, 1994, MUTAGENESIS, V9, P225	25	67	70	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1015	1022		10.1086/339518	http://dx.doi.org/10.1086/339518			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11857108	Green Published, Bronze			2022-12-18	WOS:000174252100019
J	Hsieh, CL; Oakley-Girvan, I; Balise, RR; Halpern, J; Gallagher, RP; Wu, AH; Kolonel, LN; O'Brien, LE; Lin, IPG; Van den Berg, DJ; Teh, CZ; West, DW; Whittemore, AS				Hsieh, CL; Oakley-Girvan, I; Balise, RR; Halpern, J; Gallagher, RP; Wu, AH; Kolonel, LN; O'Brien, LE; Lin, IPG; Van den Berg, DJ; Teh, CZ; West, DW; Whittemore, AS			A genome screen of families with multiple cases of prostate cancer: Evidence of genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANDROGEN RECEPTOR GENE; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; CHROMOSOME 1Q42.2-43; HIGH-RISK; DOMINANT INHERITANCE; ALLELIC IMBALANCE; 1Q24-25; HPC1; 1Q	We conducted a genomewide screen for prostate cancer-susceptibility genes on the basis of data from 98 families from the United States and Canada that had three or more verified diagnoses of prostate cancer among first- and second-degree relatives. We found a statistically significant excess of markers for which affected relatives exhibited modest amounts of excess allele-sharing; however, no single chromosomal region contained markers with excess allele-sharing of sufficient magnitude to indicate unequivocal evidence of linkage. Positive linkage signals of nominal statistical significance were found in two regions (5p-q and 12p) that have been identified as weakly positive in other data sets and in region 19p, which has not been identified previously. All these signals were considerably stronger for analyses restricted to families with mean age at onset below the median than for analyses of families with mean age at onset above the median. The data provided little support for any of the putative prostate cancer-susceptibility genes identified in other linkage studies.	Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; Univ Hawaii Manoa, Canc Ctr Hawaii, Honolulu, HI 96822 USA; No Calif Canc Ctr, Union City, CA USA	Stanford University; University of Southern California; British Columbia Cancer Agency; British Columbia Cancer Agency; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa	Whittemore, AS (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Redwood Bldg,Room T204, Stanford, CA 94305 USA.		Van Den Berg, David J/G-8598-2017	Van Den Berg, David J/0000-0002-5404-5218; Balise, Raymond/0000-0002-9856-5901	NATIONAL CANCER INSTITUTE [R35CA047448, R01CA049446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049446] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA49446, R35 CA47448] Funding Source: Medline; NIAMS NIH HHS [R01 AR049446] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Azar GM, 1997, CANCER GENET CYTOGEN, V99, P116, DOI 10.1016/S0165-4608(97)00199-4; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Bock CH, 2001, AM J HUM GENET, V68, P795, DOI 10.1086/318797; Bova GS, 1996, WORLD J UROL, V14, P338; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brothman AR, 1997, CANCER GENET CYTOGEN, V95, P116, DOI 10.1016/S0165-4608(96)00302-0; Cannon L., 1982, CANCER SURV, V1, P47; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cher ML, 1998, CLIN CANCER RES, V4, P1273; Cher ML, 1996, CANCER RES, V56, P3091; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Cunningham JM, 1996, CANCER RES, V56, P4475; Dong Jin-Tang, 1997, Current Opinion in Oncology, V9, P101; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Eeles RA, 1999, EUR J CANCER, V35, P1954, DOI 10.1016/S0959-8049(99)00246-4; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Gronberg H, 1999, AM J HUM GENET, V65, P134, DOI 10.1086/302447; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Halpern J, 1999, HUM HERED, V49, P194, DOI 10.1159/000022874; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; Kibel AS, 1998, CANCER RES, V58, P5652; Kibel AS, 2000, J UROLOGY, V164, P192, DOI 10.1016/S0022-5347(05)67493-9; Kibel AS, 1999, GENE CHROMOSOME CANC, V25, P270, DOI 10.1002/(SICI)1098-2264(199907)25:3<270::AID-GCC9>3.3.CO;2-Q; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1996, AM J HUM GENET, V58, P1092; Lange EM, 1999, CLIN CANCER RES, V5, P4013; Latil A, 1996, J UROLOGY, V156, P2079, DOI 10.1016/S0022-5347(01)65439-9; Lin BY, 2000, CANCER RES, V60, P858; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MEIKLE AW, 1982, J CLIN ENDOCR METAB, V54, P1104, DOI 10.1210/jcem-54-6-1104; Neuhausen SL, 1999, HUM MOL GENET, V8, P2437, DOI 10.1093/hmg/8.13.2437; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Ozen M, 1998, CANCER GENET CYTOGEN, V106, P105, DOI 10.1016/S0165-4608(98)00051-X; Page WF, 1997, PROSTATE, V33, P240; Platz EA, 1998, CANCER EPIDEM BIOMAR, V7, P379; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; Stanford JL, 1997, CANCER RES, V57, P1194; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Vesprini D, 2001, AM J HUM GENET, V68, P912, DOI 10.1086/319502; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Whittemore AS, 1998, J AM STAT ASSOC, V93, P518; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; XU J, 2000, AM J HUM GENET, V67, P541; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807; Xu JF, 2001, AM J HUM GENET, V68, P901, DOI 10.1086/319513; Yuan B, 1997, AM J HUM GENET, V60, P459	66	67	69	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					148	158		10.1086/321281	http://dx.doi.org/10.1086/321281			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11404817	Green Published, Bronze			2022-12-18	WOS:000170108100015
J	Ballif, BC; Kashork, CD; Shaffer, LG				Ballif, BC; Kashork, CD; Shaffer, LG			The promise and pitfalls of telomere region-specific probes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							REARRANGEMENTS		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Ballif, BC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 15E, Houston, TX 77030 USA.							Bacino CA, 2000, AM J MED GENET, V92, P250; Ballif BC, 2000, EUR J HUM GENET, V8, P764, DOI 10.1038/sj.ejhg.5200536; Horsley SW, 1998, J MED GENET, V35, P722, DOI 10.1136/jmg.35.9.722; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 2000, J MED GENET, V37, P401, DOI 10.1136/jmg.37.6.401; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Knight SJL, 1997, EUR J HUM GENET, V5, P1; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Shaffer LG, 1999, AM J MED GENET, V87, P278, DOI 10.1002/(SICI)1096-8628(19991126)87:3<278::AID-AJMG19>3.0.CO;2-3; WATSON MS, 1999, STANDARDS GUIDELINES	10	67	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1356	1359						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032793				2022-12-18	WOS:000165091600036
J	Matsuura, S; Ito, E; Tauchi, H; Komatsu, K; Ikeuchi, T; Kajii, T				Matsuura, S; Ito, E; Tauchi, H; Komatsu, K; Ikeuchi, T; Kajii, T			Chromosomal instability syndrome of total premature chromatid separation with mosaic variegated aneuploidy is defective in mitotic-spindle checkpoint	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; GENES; KINETOCHORE	Skin fibroblast cells from two unrelated male infants with a chromosome-instability disorder were analyzed for their response to colcemid-induced mitotic-spindle checkpoint. The infants both had severe growth and developmental retardation, microcephaly, and Dandy-Walker anomaly; developed Wilms tumor; and one died at age 5 mo, the other at age 3 years. Their metaphases had total premature chromatid separation (total PCS) and mosaic variegated aneuploidy. Mitotic-index analysis of their cells showed the absence of mitotic block after the treatment with colcemid, a mitotic-spindle inhibitor. Bromodeoxyuridine-incorporation measurement and microscopic analysis indicated that cells treated with colcemid entered G1 and S phases without sister-chromatid segregation and cytokinesis. Preparations of short-term colcemid-treated cells contained those cells with chromosomes in total PCS and all or clusters of them encapsulated by nuclear membranes. Cell-cycle studies demonstrated the accumulation of cells with a DNA content of 8C. These findings indicate that the infants' cells were insensitive to the colcemid-induced mitotic-spindle checkpoint.	Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Biol, Minami Ku, Hiroshima 7348553, Japan; Tokyo Med & Dent Univ, Med Res Inst, Div Genet, Tokyo, Japan	Hiroshima University; Tokyo Medical & Dental University (TMDU)	Komatsu, K (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Biol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.		Matsuura, Shinya/U-4182-2017	Matsuura, Shinya/0000-0001-5294-081X				Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Dobie KW, 1999, CURR OPIN GENET DEV, V9, P206, DOI 10.1016/S0959-437X(99)80031-8; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P716, DOI 10.1006/bbrc.1999.1737; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kajii T, 1998, AM J MED GENET, V78, P245, DOI 10.1002/(SICI)1096-8628(19980707)78:3<245::AID-AJMG7>3.0.CO;2-O; Kawame H, 1999, J HUM GENET, V44, P219, DOI 10.1007/s100380050147; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Scaerou F, 1999, J CELL SCI, V112, P3757; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763	13	67	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					483	486		10.1086/303022	http://dx.doi.org/10.1086/303022			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10877982	Green Published, Bronze			2022-12-18	WOS:000089357800022
J	Appukuttan, B; Gillanders, E; Juo, SH; Freas-Lutz, D; Ott, S; Sood, R; Van Auken, A; Bailey-Wilson, J; Wang, XG; Patel, RJ; Robbins, CM; Chung, M; Annett, G; Weinberg, K; Borchert, MS; Trent, JM; Brownstein, MJ; Stout, JT				Appukuttan, B; Gillanders, E; Juo, SH; Freas-Lutz, D; Ott, S; Sood, R; Van Auken, A; Bailey-Wilson, J; Wang, XG; Patel, RJ; Robbins, CM; Chung, M; Annett, G; Weinberg, K; Borchert, MS; Trent, JM; Brownstein, MJ; Stout, JT			Localization of a gene for Duane retraction syndrome to chromosome 2q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANTERIOR-POSTERIOR AXIS; ACID RESPONSE ELEMENT; RETINOIC ACID; EMBRYONIC EXPRESSION; FUNCTIONAL-ANALYSIS; LINKAGE ANALYSIS; HOMEOBOX GENES; HOXD4 GENE; MURINE; HINDBRAIN	Duane retraction syndrome (DRS) is a congenital eye-movement disorder characterized by a failure of cranial nerve VI (the abducens nerve) to develop normally, resulting in restriction or absence of abduction, restricted adduction, and narrowing of the palpebral fissure and retraction of the globe on attempted adduction. DRS has a prevalence of similar to 0.1% in the general population and accounts for 5% of all strabismus cases. Undiagnosed DRS in children can lead to amblyopia, a permanent uncorrectable loss of vision. A large family with autosomal dominant DRS was examined and tested for genetic linkage. After exclusion of candidate regions previously associated with DRS, a genomewide search with highly polymorphic microsatellite markers was performed, and significant evidence for linkage was obtained at chromosome 2q31 (D2S2314 maximum LOD score 11.73 at maximum recombination fraction .0). Haplotype analysis places the affected gene in a 17.8-cM region between the markers D2S2330 and D2S364. No recombinants were seen with markers between these two loci. The linked region contains the homeobox D gene cluster. Three of the genes within this cluster, known to participate in hindbrain development, were sequenced in affected and control individuals. Coding sequences for these genes were normal or had genetic alterations unlikely to be responsible for the DRS phenotype. Identifying the gene responsible for DRS may lead to an improved understanding of early cranial-nerve development.	Childrens Hosp Los Angeles, Div Ophthalmol, Los Angeles, CA 90027 USA; Childrens Hosp Los Angeles, Div Res Immunol Bone Marrow Transplant, Los Angeles, CA 90027 USA; NIH, NGHRI, Canc Genet Branch, Bethesda, MD USA; NIMH, Genet Lab, NHGRI, NIH, Bethesda, MD 20892 USA; NIH, Sect Stat Genet, Ctr Inherited Dis Res, NHGRI, Baltimore, MD USA; Rockefeller Univ, Lab Stat Genet, New York, NY USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Rockefeller University	Stout, JT (corresponding author), Childrens Hosp Los Angeles, Div Ophthalmol, 4650 Sunset Blvd, Los Angeles, CA 90027 USA.		Brownstein, Michael/B-8609-2009; Juo, Suh-Hang/A-1765-2010; Juo, Suh-Hang/C-9545-2009	Bailey-Wilson, Joan/0000-0002-9153-2920	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000131] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BEDFORD M, 1995, DNA CELL BIOL, V14, P295, DOI 10.1089/dna.1995.14.295; Calabrese G, 1998, EUR J HUM GENET, V6, P187, DOI 10.1038/sj.ejhg.5200173; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; CHEW CKS, 1995, AM J OPHTHALMOL, V119, P807, DOI 10.1016/S0002-9394(14)72795-3; CHUNG M, IN PRESS OPHTHALMOLO; CROSS HE, 1972, AM J OPHTHALMOL, V73, P442, DOI 10.1016/0002-9394(72)90074-8; Cruz OA, 1995, OPHTHALMIC GENET, V16, P171, DOI 10.3109/13816819509057859; CULLEN P, 1993, AM J MED GENET, V47, P925, DOI 10.1002/ajmg.1320470623; DERESPINIS PA, 1993, SURV OPHTHALMOL, V38, P257, DOI 10.1016/0039-6257(93)90077-K; DOLLE P, 1993, P NATL ACAD SCI USA, V90, P7666, DOI 10.1073/pnas.90.16.7666; DUANE A, 1905, ARCH OPHTHALMOL-CHIC, V34, P133; DUBUOLE D, 1989, EMBO J, V8, P1497; Dupe V, 1997, DEVELOPMENT, V124, P399; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; FROHMAN MA, 1992, MECH DEVELOP, V38, P55, DOI 10.1016/0925-4773(92)90038-L; Gavalas A, 1998, DEVELOPMENT, V125, P1123; GIAMPAOLO A, 1989, DIFFERENTIATION, V40, P191, DOI 10.1111/j.1432-0436.1989.tb00598.x; Goddard JM, 1996, DEVELOPMENT, V122, P3217; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; GUANT SJ, 1991, BIOESSAYS, V13, P505; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; HUBER A, 1974, BRIT J OPHTHALMOL, V58, P293, DOI 10.1136/bjo.58.3.293; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; Marshman WE, 1998, AUST NZ J OPHTHALMOL, V26, P251, DOI 10.1111/j.1442-9071.1998.tb01321.x; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; MORONI MC, 1993, MECH DEVELOP, V44, P139, DOI 10.1016/0925-4773(93)90063-4; Ott S, 1999, AM J OPHTHALMOL, V127, P358, DOI 10.1016/S0002-9394(98)00340-7; Parsa CF, 1998, AM J OPHTHALMOL, V125, P399, DOI 10.1016/S0002-9394(99)80158-5; PFAFFENBACH DD, 1972, ARCH OPHTHALMOL-CHIC, V88, P635; Sato S., 1960, JPN J OPHTHALMOL, V4, P57; SEVEL D, 1974, ARCH OPHTHALMOL-CHIC, V91, P492, DOI 10.1001/archopht.1974.03900060506017; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; Zhang F, 1997, MECH DEVELOP, V67, P49, DOI 10.1016/S0925-4773(97)00104-4	39	67	68	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1639	1646		10.1086/302656	http://dx.doi.org/10.1086/302656			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577917	Green Published, Bronze			2022-12-18	WOS:000084282500018
J	Davey, HW; Wilkins, RJ; Waxman, DJ				Davey, HW; Wilkins, RJ; Waxman, DJ			STAT5 signaling in sexually dimorphic gene expression and growth patterns	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BINDING PROTEIN; HORMONE; TRANSCRIPTION; PHOSPHORYLATION; INHIBITION; ACTIVATION; METABOLISM; FAMILY	The past 10 years have seen enormous advances in our understanding of how cytokine signals are mediated intracellularly. Of particular significance was the discovery of a family of seven Signal Transducer and Activators of Transcription (STAT) proteins, Each of these has now been studied in detail, and appropriate gene-disrupted mouse models are available for all except STAT2 (Leonard and O'Shea 1998). Fetal lethality is observed in Stat3-deficient mice, and various immunodeficiencies characterize mice with disrupted Stat1, Stat4, and Stat6 genes, which is consistent with impaired signaling from the specific cytokines that activate each of these proteins. The recent characterization of Stat5-deficient mice has led to several unanticipated findings that point to diverse biological functions for the two STAT5 forms, STAT5a and STAT5b. These include roles for one or both STAT5 forms in the immune system, hematopoiesis, sexually dimorphic growth, mammary development, hair growth, deposition of adipose tissue, and pregnancy.. Here we review the hormone- and cytokine-activated signaling pathways in which STAT5 participates and the extensive evidence, from laboratory animals, that these factors are required for sex-specific aspects of development, including control of body size. Finally, we consider human growth disorders that may involve defects in STAT5-dependent signal transduction.	Univ Waikato, Ruakura Res Ctr, Hamilton, New Zealand; Univ Waikato, Dept Sci Biol, Hamilton, New Zealand; Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA	University of Waikato; University of Waikato; Boston University	Davey, HW (corresponding author), Univ Waikato, Ruakura Res Ctr, Hamilton, New Zealand.			Waxman, David/0000-0001-7982-9206	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033765] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK033765, DK33765] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAM A, 1981, EUR J PEDIATR, V137, P35, DOI 10.1007/BF00441167; ATTIE KM, 1995, J PEDIATR-US, V127, P244, DOI 10.1016/S0022-3476(95)70302-0; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Cheung NW, 1996, J CLIN ENDOCR METAB, V81, P1999, DOI 10.1210/jc.81.5.1999; CHOI KK, IN PRESS ENDOCRINOL; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Clayton PE, 1999, ACTA PAEDIATR, V88, P174, DOI 10.1111/j.1651-2227.1999.tb14382.x; COPELAND NG, 1995, GENOMICS, V29, P225, DOI 10.1006/geno.1995.1235; Freeth JS, 1998, ENDOCRINOLOGY, V139, P20, DOI 10.1210/en.139.1.20; Gebert CA, 1999, MOL ENDOCRINOL, V13, P213, DOI 10.1210/me.13.2.213; Gebert CA, 1999, MOL ENDOCRINOL, V13, P38, DOI 10.1210/me.13.1.38; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; John S, 1999, MOL CELL BIOL, V19, P1910; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LUCKMAN SM, 1998, SOC NEUR LOS ANG NOV; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Park SH, 1999, J BIOL CHEM, V274, P7421, DOI 10.1074/jbc.274.11.7421; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; TUSIELUNA MT, 1995, P NATL ACAD SCI USA, V92, P10796, DOI 10.1073/pnas.92.23.10796; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Waxman David J., 1995, P391; WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3; WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262; WAXMAN DJ, 1991, P NATL ACAD SCI USA, V88, P6868, DOI 10.1073/pnas.88.15.6868; Wormhoudt LW, 1999, CRIT REV TOXICOL, V29, P59, DOI 10.1080/10408449991349186; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	37	67	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					959	965		10.1086/302599	http://dx.doi.org/10.1086/302599			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486314	Green Published, Bronze			2022-12-18	WOS:000082910000004
J	Bouhouche, A; Benomar, A; Birouk, N; Mularoni, A; Meggouh, F; Tassin, J; Grid, D; Vandenberghe, A; Yahyaoui, M; Chkili, T; Brice, A; LeGuern, E				Bouhouche, A; Benomar, A; Birouk, N; Mularoni, A; Meggouh, F; Tassin, J; Grid, D; Vandenberghe, A; Yahyaoui, M; Chkili, T; Brice, A; LeGuern, E			A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21.2q21.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY MOTOR; SENSORY NEUROPATHY; DEMYELINATING NEUROPATHY; LINKAGE ANALYSIS; EARLY-CHILDHOOD; NEURONAL TYPE; HUMAN GENOME; GENE; LOCALIZATION; MUTATIONS	Charcot-Marie-Tooth disease (CMT) is a heterogeneous group of disorders that affect the peripheral nervous system. Three loci are known for the autosomal dominant forms of axonal CMT (CMT2), but none have yet been identified for autosomal recessive axonal CMT (ARCMT2). We have studied a large consanguineous Moroccan ARCMT2 family with nine affected sibs. The onset of CMT was in the 2d decade in all affected individuals who presented with a severe motor and sensory neuropathy, with proximal muscle involvement occurring in some patients. After exclusion of known loci for CMT2 and for demyelinating ARCMT2, a genomewide search was performed. Evidence for linkage was found with markers on chromosome Iq. The maximum pairwise LOD score was above the threshold value of 3.00, for markers D1S514, D1S2715, D1S2777, and D1S2721, and it reached 6.10 at the loci D1S2777, D1S2721, and D1S2624, according to multipoint LOD-score analysis. These markers defined a region of homozygosity that placed the gene in a 4.4-cM interval. Moreover, a recombination event detected in an unaffected 48-year-old individual excludes the D1S506 marker, thereby reducing the interval to 1.7 cM. In addition, the PO gene, an attractive candidate because of both its location on chromosome Iq and its role in myelin structure, was excluded by physical mapping and direct sequencing.	Hop Specialites, Serv Neurol, Neurogenet Lab, Rabat Inst, Rabat, Morocco; Hop Specialites, Serv Neurol, Neurophysiol Lab, Rabat Inst, Rabat, Morocco; Hop La Pitie Salpetriere, INSERM U289, Federat Neurol, Paris, France; Univ Lyon 1, Lab Genet Mol Humaine, F-69365 Lyon, France; Assoc Francaise Contre Myopathies, Evry, France	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bouhouche, A (corresponding author), Hop Specialites, Serv Neurol, Neurogenet Lab, Rabat Inst, Rabat, Morocco.	abouhouche@hotmail.com	brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Bouhouche, Ahmed/0000-0001-5279-8649; Mularoni, Angelique/0000-0002-3289-805X				BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BLANCHARD MM, 1994, GENET ANAL-BIOMOL E, V11, P7, DOI 10.1016/1050-3862(94)90003-5; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GABREELSFESTEN AAWM, 1993, CLIN NEUROL NEUROSUR, V95, P93, DOI 10.1016/0303-8467(93)90002-X; GABREELSFESTEN AAWM, 1991, BRAIN, V114, P1855, DOI 10.1093/brain/114.4.1855; Gelb BD, 1997, GENOMICS, V39, P409, DOI 10.1006/geno.1996.4516; Geyer D D, 1997, Mol Vis, V3, P13; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1980, J NEUROL NEUROSUR PS, V43, P669, DOI 10.1136/jnnp.43.8.669; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; KANTER HL, 1994, J MOL CELL CARDIOL, V26, P861, DOI 10.1006/jmcc.1994.1103; KWON JM, 1995, AM J HUM GENET, V57, P853; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; OUVRIER RA, 1981, J NEUROL SCI, V51, P181, DOI 10.1016/0022-510X(81)90097-6; PHAMDINH D, 1993, HUM MOL GENET, V2, P2051, DOI 10.1093/hmg/2.12.2051; Saito M, 1997, NEUROLOGY, V49, P1630, DOI 10.1212/WNL.49.6.1630; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; THOMPSON EA, 1987, IMA J MATH APPL MED, V4, P93; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	24	67	71	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					722	727		10.1086/302542	http://dx.doi.org/10.1086/302542			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441578	Green Published, Bronze			2022-12-18	WOS:000082426400016
J	Lee, HS; Sambuughin, N; Cervenakova, L; Chapman, J; Pocchiari, M; Litvak, S; Qi, HY; Budka, H; del Ser, T; Furukawa, H; Brown, P; Gajdusek, DC; Long, JC; Korczyn, AD; Goldfarb, LG				Lee, HS; Sambuughin, N; Cervenakova, L; Chapman, J; Pocchiari, M; Litvak, S; Qi, HY; Budka, H; del Ser, T; Furukawa, H; Brown, P; Gajdusek, DC; Long, JC; Korczyn, AD; Goldfarb, LG			Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYLOID PRECURSOR GENE; MACHADO-JOSEPH-DISEASE; PRION PROTEIN; LIBYAN JEWS; CODON-200 MUTATION; SLOVAKIA; SCRAPIE; LOCUS; CJD; EPIDEMIOLOGY	Creutzfeldt-Jakob disease (CJD) belongs to a group of prion diseases that may be infectious, sporadic, or hereditary. The 200K point mutation in the PRNP gene is the most frequent cause of hereditary CJD, accounting for >70% of families with CJD worldwide. Prevalence of the 200K variant of familial CJD is especially high in Slovakia, Chile, and Italy, and among populations of Libyan and Tunisian Jews. To study ancestral origins of the 200K mutation-associated chromosomes, we selected microsatellite markers flanking the PRNP gene on chromosome 20p12-pter and an intragenic single-nucleotide polymorphism at the PRNP codon 129. Haplotypes were constructed for 62 CJD families originating from 11 world populations. The results show that Libyan, Tunisian, Italian, Chilean, and Spanish families share a major haplotype, suggesting that the 200K mutation may have originated from a single mutational event, perhaps in Spain, and spread to all these populations with Sephardic migrants expelled from Spain in the Middle Ages. Slovakian families and a family of Polish origin show another unique haplotype. The haplotypes in families from Germany, Sicily, Austria, and Japan are different from the Mediterranean or eastern European haplotypes. On the bais of this study, we conclude that founder effect and independent mutational events are responsible for the current geographic distribution of hereditary CJD associated with the 200K mutation.	NINDS, Clin Neurogenet Unit, NIH, Bethesda, MD 20892 USA; NINDS, Cent Nervous Syst Studies Lab, NIH, Bethesda, MD 20892 USA; NIAAA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; Amer Red Cross, Jerome H Holland Lab, Rockville, MD 20852 USA; Tel Aviv Univ, Dept Neurol, Sieratzki Chair Neurol, Ramat Aviv, Israel; Tel Aviv Univ, Dept Physiol & Pharmacol, Ramat Aviv, Israel; Ist Super Sanita, Virol Lab, I-00161 Rome, Italy; Univ Vienna, Inst Neurol, Vienna, Austria; Hosp Severo Ochoa Leganes, Secc Neurol, Madrid, Spain; Kyushu Univ, Dept Neuropathol, Maidashi, Japan; Inst Alfred Fessard, CNRS, Gif Sur Yvette, France	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); American Red Cross; Tel Aviv University; Tel Aviv University; Istituto Superiore di Sanita (ISS); University of Vienna; Severo Ochoa University Hospital; Kyushu University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Goldfarb, LG (corresponding author), NINDS, Clin Neurogenet Unit, NIH, Room 4B37,Bldg 10,10 Ctr Dr MS 1361, Bethesda, MD 20892 USA.		Budka, Herbert/I-3486-2019; Korczyn, Amos D/C-3461-2017; del Ser, Teodoro/U-3711-2019; Chapman, Joab/E-4598-2010; Pocchiari, Maurizio/J-8443-2018	Budka, Herbert/0000-0002-1933-1577; Korczyn, Amos D/0000-0003-0125-2579; Pocchiari, Maurizio/0000-0002-7269-2486; Chapman, Joab/0000-0002-2161-9764	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000016] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALPHER J, 1986, ENCY JEWISH HIST EVE, P82; BECK E, 1987, P331; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1991, J NEUROL SCI, V105, P240, DOI 10.1016/0022-510X(91)90151-V; BROWN P, 1986, ANN NEUROL, V20, P597, DOI 10.1002/ana.410200507; BROWN P, 1992, J NEUROL SCI, V112, P65, DOI 10.1016/0022-510X(92)90133-6; COLLINGE J, 1993, BRIT MED J, V306, P301, DOI 10.1136/bmj.306.6873.301; COON CS, 1965, LIVING RACES MAN, P292; Cooper DN, 1993, HUMAN GENE MUTATION, P109; CORIA F, 1995, 5 M EUR NEUR SOC MUN; D'Alessandro M, 1998, LANCET, V352, P1989, DOI 10.1016/S0140-6736(05)61335-9; GABIZON R, 1993, AM J HUM GENET, V53, P828; GALVEZ S, 1980, ARCH NEUROL-CHICAGO, V37, P11, DOI 10.1001/archneur.1980.00500500041004; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; GOLDFARB L G, 1989, American Journal of Human Genetics, V45, pA189; GOLDFARB LG, 1990, LANCET, V336, P514, DOI 10.1016/0140-6736(90)92073-Q; GOLDFARB LG, 1995, ANNU REV MED, V46, P57; GOLDFARB LG, 1990, LANCET, V336, P174, DOI 10.1016/0140-6736(90)91693-5; GOLDFARB LG, 1990, LANCET, V336, P637, DOI 10.1016/0140-6736(90)93443-S; GOLDFARB LG, 1991, EUR J EPIDEMIOL, V7, P477, DOI 10.1007/BF00143125; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; Hainfellner JA, 1996, WIEN KLIN WOCHENSCHR, V108, P759; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Iughetti P, 1996, J MED GENET, V33, P439, DOI 10.1136/jmg.33.5.439; KORCZYN AD, 1994, BIOMED PHARMACOTHER, V48, P391, DOI 10.1016/0753-3322(94)90057-4; LONG JC, 1995, AM J HUM GENET, V56, P799; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; Meiner Z, 1997, MEDICINE, V76, P227, DOI 10.1097/00005792-199707000-00001; MITROVA E, 1991, EUR J EPIDEMIOL, V7, P439, DOI 10.1007/BF00143119; MITROVA E, 1991, EUR J EPIDEMIOL, V7, P520, DOI 10.1007/BF00143133; Miyakawa T, 1998, NEUROL RES, V20, P684; Salvatore M, 1996, J NEUROL NEUROSUR PS, V61, P111, DOI 10.1136/jnnp.61.1.111; SPARKES RS, 1986, P NATL ACAD SCI USA, V83, P7358, DOI 10.1073/pnas.83.19.7358; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204	37	67	70	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1063	1070		10.1086/302340	http://dx.doi.org/10.1086/302340			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090891	Green Published, Bronze			2022-12-18	WOS:000079632900017
J	Ohta, T; Buiting, K; Kokkonen, H; McCandless, S; Heeger, S; Leisti, H; Driscoll, DJ; Cassidy, SB; Horsthemke, B; Nicholls, RD				Ohta, T; Buiting, K; Kokkonen, H; McCandless, S; Heeger, S; Leisti, H; Driscoll, DJ; Cassidy, SB; Horsthemke, B; Nicholls, RD			Molecular mechanism of Angelman syndrome in two large families involves an imprinting mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRITICAL DELETION REGION; PRADER-WILLI SYNDROMES; DNA METHYLATION; LINKAGE ANALYSIS; SYNDROME GENE; SNRPN GENE; PROTEIN; EXPRESSION; UBE3A; E6-AP	Patients with Angelman syndrome (AS) and Prader-Willi syndrome with mutations in the imprinting process have biparental inheritance but uniparental DNA methylation and gene expression throughout band 15q11-q13. In several of these patients, microdeletions upstream of the SNRPN gene have been identified, defining an imprinting center (IC) that has been hypothesized to control the imprint switch process in the female and male germlines. We have now identified two large families (AS-O and AS-F) segregating an AS imprinting mutation, including one family originally described in the first genetic linkage of AS to 15q11-q13. This demonstrates that this original linkage is for the 15q11-q13 IC. Affected patients in the AS families have either a 5.5- or a 15-kb microdeletion, one of which narrowed the shortest region of deletion overlap to 1.15 kb in all eight cases. This small region defines a component of the IC involved in AS (ie., the paternal-to-maternal switch element). The presence of an inherited imprinting mutation in multiple unaffected members of these two families, who are at risk for transmitting the mutation to affected children or children of their daughters, raises important genetic counseling issues.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-4300 Essen, Germany; Univ Oulu, Cent Hosp, Dept Clin Genet, SF-90220 Oulu, Finland; Univ Florida, Coll Med, Dept Pediat, Div Genet,RC Philips Unit, Gainesville, FL USA	Case Western Reserve University; University Hospitals of Cleveland; University of Duisburg Essen; University of Oulu; State University System of Florida; University of Florida	Nicholls, RD (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.							Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; BOYD SG, 1988, EUR J PEDIATR, V147, P508, DOI 10.1007/BF00441976; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burger J, 1997, AM J HUM GENET, V61, P88, DOI 10.1086/513900; Burke LW, 1996, AM J HUM GENET, V58, P777; CLAYTONSMITH J, 1992, AM J MED GENET, V44, P256, DOI 10.1002/ajmg.1320440236; CLAYTONSMITH J, 1992, J MED GENET, V29, P412, DOI 10.1136/jmg.29.6.412; ConnertonMoyer KJ, 1997, AM J MED GENET, V70, P253, DOI 10.1002/(SICI)1096-8628(19970613)70:3<253::AID-AJMG8>3.0.CO;2-X; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Glenn CC, 1996, AM J HUM GENET, V58, P335; GREGER V, 1994, AM J MED GENET, V53, P396, DOI 10.1002/ajmg.1320530425; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; JONG MTC, IN PRESS HUM MOL GEN; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MICHAELIS RC, 1995, AM J MED GENET, V55, P120, DOI 10.1002/ajmg.1320550131; Minassian BA, 1998, ANN NEUROL, V43, P485, DOI 10.1002/ana.410430412; NELEN MR, 1994, AM J MED GENET, V52, P352, DOI 10.1002/ajmg.1320520320; Nicholls RD, 1998, NEURON, V21, P647, DOI 10.1016/S0896-6273(00)80577-2; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; REIS A, 1994, AM J HUM GENET, V54, P741; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schumacher A, 1998, NAT GENET, V19, P324, DOI 10.1038/1211; Tilghman SM, 1998, NAT GENET, V18, P206, DOI 10.1038/ng0398-206; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617	42	67	67	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					385	396		10.1086/302232	http://dx.doi.org/10.1086/302232			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973277	Green Published, Bronze			2022-12-18	WOS:000078740600009
J	Perrault, I; Rozet, JM; Gerber, S; Kelsell, RE; Souied, E; Cabot, A; Hunt, DM; Munnich, A; Kaplan, J				Perrault, I; Rozet, JM; Gerber, S; Kelsell, RE; Souied, E; Cabot, A; Hunt, DM; Munnich, A; Kaplan, J			A retGC-1 mutation in autosomal dominant cone-rod dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RDS GENE; DEGENERATION; LINKAGE; ASSIGNMENT; ASN244HIS; CYCLASE		Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, F-75743 Paris 15, France; UCL, Inst Ophthalmol, Dept Mol Genet, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Kaplan, J (corresponding author), Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, 149 Rue Sevres, F-75743 Paris 15, France.	munnich3@citi2.fr	Hunt, David M/K-6024-2012; ROZET, Jean-Michel/E-5737-2016; perrault, isabelle/H-3047-2017	Hunt, David M/0000-0002-9264-3948; ROZET, Jean-Michel/0000-0001-7951-7886; perrault, isabelle/0000-0002-8560-1379; GERBER, Sylvie/0000-0002-6827-1769				BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Heckenlively J R, 1987, Trans Am Ophthalmol Soc, V85, P438; Kelsell RE, 1997, HUM MOL GENET, V6, P597, DOI 10.1093/hmg/6.4.597; Kohl S, 1997, J MED GENET, V34, P620, DOI 10.1136/jmg.34.8.620; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; MOORE AT, 1992, J MED GENET, V29, P289, DOI 10.1136/jmg.29.5.289; Nakazawa M, 1996, ARCH OPHTHALMOL-CHIC, V114, P72, DOI 10.1001/archopht.1996.01100130068011; NAKAZAWA M, 1994, HUM MOL GENET, V3, P1195, DOI 10.1093/hmg/3.7.1195; Perrault I, 1998, HUM GENET, V102, P322, DOI 10.1007/s004390050699; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; RABB MF, 1986, OPHTHALMOLOGY, V93, P1443; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; WARBURG M, 1991, AM J MED GENET, V39, P288, DOI 10.1002/ajmg.1320390309	18	67	69	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					651	654		10.1086/301985	http://dx.doi.org/10.1086/301985			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683616	Green Published, Bronze			2022-12-18	WOS:000075360800041
J	Huusko, P; Paakkonen, K; Launonen, V; Poyhonen, M; Blanco, G; Kauppila, A; Puistola, U; Kiviniemi, H; Kujala, M; Leisti, J; Winqvist, R				Huusko, P; Paakkonen, K; Launonen, V; Poyhonen, M; Blanco, G; Kauppila, A; Puistola, U; Kiviniemi, H; Kujala, M; Leisti, J; Winqvist, R			Evidence of founder mutations in Finnish BRCA1 and BRCA2 families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							OVARIAN-CANCER; BREAST-CANCER; GERMLINE MUTATIONS; GENE		Univ Oulu, Dept Clin Genet, Oulu Univ Hosp, FIN-90220 Oulu, Finland; Univ Oulu, Dept Radiotherapy & Oncol, Oulu Univ Hosp, FIN-90220 Oulu, Finland; Univ Oulu, Dept Obstet & Gynecol, Oulu Univ Hosp, FIN-90220 Oulu, Finland; Univ Oulu, Dept Surg, Oulu Univ Hosp, FIN-90220 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Winqvist, R (corresponding author), Univ Oulu, Dept Clin Genet, Oulu Univ Hosp, Kajaanintie 50, FIN-90220 Oulu, Finland.		Poyhonen, Minna/K-4866-2018	Poyhonen, Minna/0000-0003-2037-2744; Winqvist, Robert/0000-0003-0932-9104				CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Easton D, 1997, NAT GENET, V16, P210, DOI 10.1038/ng0797-210; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Hakansson S, 1997, AM J HUM GENET, V60, P1068; Johannesdottir G, 1996, CANCER RES, V56, P3663; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Vehmanen P, 1997, HUM MOL GENET, V6, P2309, DOI 10.1093/hmg/6.13.2309; Vehmanen P, 1997, AM J HUM GENET, V60, P1050; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; ZeladaHedman M, 1997, CANCER RES, V57, P2474	19	67	69	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1544	1548		10.1086/301880	http://dx.doi.org/10.1086/301880			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585608	Green Published, Bronze			2022-12-18	WOS:000074174700035
J	Hart, TC; Pallos, D; Bowden, DW; Bolyard, J; Pettenati, MJ; Cortelli, JR				Hart, TC; Pallos, D; Bowden, DW; Bolyard, J; Pettenati, MJ; Cortelli, JR			Genetic linkage of hereditary gingival fibromatosis to chromosome 2p21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DRUG-INDUCED GINGIVAL; OVERGROWTH; MAPS	Gingival fibromatosis is characterized by a slowly progressive benign enlargement of the oral gingival tissues. The condition results in the teeth being partially or totally engulfed by keratinized gingiva, causing aesthetic and functional problems. Both genetic and pharmacologically induced forms of gingival fibromatosis are known. The most common genetic form, hereditary gingival fibromatosis (HGF), is usually transmitted as an autosomal dominant trait, although sporadic cases are common and autosomal recessive inheritance has been reported. The genetic basis of gingival fibromatosis is unknown. We identified an extended family (n = 32) segregating an autosomal dominant form of isolated gingival fibromatosis. Using a genomewide search strategy, we identified genetic linkage (Z(max) = 5.05, theta = .00) for the HGF phenotype to polymorphic markers in the genetic region of chromosome 2p21 bounded by the loci D2S1788 and D2S441. This is the first report of linkage for isolated HGF, and the findings have implications for identification of the underlying genetic basis of gingival fibromatosis.	Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Med Genet Sect, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Dent, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; Univ Taubate, Dept Dent, Sao Paulo, Brazil	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Universidade de Taubate	Hart, TC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Med Genet Sect, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Cortelli, Jose R/D-1771-2011; cortelli, jose/AGP-8091-2022; Pallos, Debora/AAW-5258-2021; Pallos, Debora/H-7844-2012	Cortelli, Jose R/0000-0001-5147-0705; Pallos, Debora/0000-0001-7426-1041	NIDCR NIH HHS [DE-R29-876395] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Chaib H, 1996, HUM MOL GENET, V5, P155, DOI 10.1093/hmg/5.1.155; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUESTASCARNERO R, 1988, J ORAL MAXIL SURG, V46, P415, DOI 10.1016/0278-2391(88)90229-7; DALY AK, 1993, PHARMACOL THERAPEUT, V57, P129, DOI 10.1016/0163-7258(93)90053-G; DONGARI A, 1993, ORAL SURG ORAL MED O, V76, P543, DOI 10.1016/0030-4220(93)90027-2; FRITZ ME, 1970, ORAL SURG ORAL MED O, V30, P755, DOI 10.1016/0030-4220(70)90333-6; Fryns JP, 1996, ANN GENET-PARIS, V39, P54; GORLIN RJ, 1976, SYNDROMES HEAD NECK, P329; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARTSFIELD JK, 1985, AM J MED GENET, V22, P623, DOI 10.1002/ajmg.1320220323; HASSELL T M, 1991, Critical Reviews in Oral Biology and Medicine, V2, P103; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; JORGENSO.RJ, 1974, J PERIODONTOL, V45, P472, DOI 10.1902/jop.1974.45.7.472; LABAND PETER F., 1964, ORAL SURG ORAL MED AND ORAL PATHOL, V17, P339, DOI 10.1016/0030-4220(64)90506-7; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, AM J HUM GENET, V36, P460; PALLOS D, 1997, J DENT RES, V76, P32147; PERNU HE, 1994, TRANSPLANTATION, V57, P1811; RAESTE AM, 1978, SCAND J DENT RES, V86, P357; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHIRASUNA K, 1988, J ORAL PATHOL MED, V17, P381, DOI 10.1111/j.1600-0714.1988.tb01301.x; SUJANSKY E, 1993, AM J MED GENET, V47, P512, DOI 10.1002/ajmg.1320470415; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	24	67	71	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					876	883		10.1086/301797	http://dx.doi.org/10.1086/301797			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529355	Green Published, Bronze			2022-12-18	WOS:000073514400019
J	McGee, TL; Devoto, M; Ott, J; Berson, EL; Dryja, TP				McGee, TL; Devoto, M; Ott, J; Berson, EL; Dryja, TP			Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; CHROMOSOME 19Q; BIMODAL EXPRESSIVITY; DNA POLYMORPHISM; LINKAGE ANALYSIS; JAPANESE FAMILY; RHODOPSIN GENE; YAC CONTIG; ONE FORM	A subset of families with autosomal dominant retinitis pigmentosa (RP) display reduced penetrance with some asymptomatic gene carriers showing no retinal abnormalities by ophthalmic examination or by electroretinography. Here we describe a study of three families with reduced-penetrance RP. In all three families the disease gene appears to be linked to chromosome 19q13.4, the region containing the RP11 locus, as defined by previously reported linkage studies based on five other reduced-penetrance families. Meiotic recombinants in one of the newly identified RP11 families and in two of the previously reported families serve to restrict the disease locus to a 6-cM region bounded by markers D19S572 and D19S926. We also compared the disease status of RP11 carriers with the segregation of microsatellite alleles within 19q13.4 from the noncarrier parents in the newly reported and the previously reported families. The results support the hypothesis that wild-type alleles at the RP11 locus or at a closely linked locus inherited from the noncarrier parents are a major factor influencing the penetrance of pathogenic alleles at this locus.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,OCULAR MOL GENET INST,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BERMAN GUND LAB STUDY RETINAL DEGENERAT,BOSTON,MA; ROCKEFELLER UNIV,LAB STAT GENET,NEW YORK,NY 10021; INST G GASLINI,MOL GENET LAB,GENOA,ITALY	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Rockefeller University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini			Devoto, Marcella/AAP-7595-2021	DEVOTO, MARCELLA/0000-0002-4431-5114	NATIONAL EYE INSTITUTE [R37EY000169, R01EY008683, R01EY000169, R01EY011655] Funding Source: NIH RePORTER; NEI NIH HHS [EY08683, EY11655, EY00169] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALMAGHTHEH M, 1994, HUM MOL GENET, V3, P351, DOI 10.1093/hmg/3.2.351; AlMaghtheh M, 1996, AM J HUM GENET, V59, P864; BARDIEN S, 1995, HUM MOL GENET, V4, P1459, DOI 10.1093/hmg/4.8.1459; BERSON EL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1286, DOI 10.1001/archopht.1979.01020020028006; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P226; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; EVANS K, 1995, BRIT J OPHTHALMOL, V79, P841, DOI 10.1136/bjo.79.9.841; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; GOLIATH R, 1995, AM J HUM GENET, V57, P962; GRATZER W, 1994, NATURE, V372, P620, DOI 10.1038/372620a0; GREENBERG J, 1994, HUM MOL GENET, V3, P915, DOI 10.1093/hmg/3.6.915; INGLEHEARN CF, 1993, NAT GENET, V4, P51, DOI 10.1038/ng0593-51; INGLEHEARN CF, 1994, AM J HUM GENET, V54, P675; JORDAN SA, 1993, NAT GENET, V4, P54, DOI 10.1038/ng0593-54; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KEEN TJ, 1995, GENOMICS, V28, P383, DOI 10.1006/geno.1995.1165; KIM RY, 1995, BRIT J OPHTHALMOL, V79, P23, DOI 10.1136/bjo.79.1.23; KIM SK, 1994, GENOMICS, V22, P659, DOI 10.1006/geno.1994.1446; Kojis TL, 1996, AM J HUM GENET, V58, P347; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McGuire RE, 1996, GENOME RES, V6, P255, DOI 10.1101/gr.6.4.255; MCGUIRE RE, 1995, HUM GENET, V95, P71; MILLAN JM, 1995, HUM GENET, V96, P216, DOI 10.1007/BF00207382; Mohamed Z, 1996, J MED GENET, V33, P714, DOI 10.1136/jmg.33.8.714; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Nakazawa M, 1996, ARCH OPHTHALMOL-CHIC, V114, P318, DOI 10.1001/archopht.1996.01100130314016; RANDON J, 1994, BRIT J HAEMATOL, V88, P534, DOI 10.1111/j.1365-2141.1994.tb05070.x; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Tarttelin EE, 1996, J MED GENET, V33, P518, DOI 10.1136/jmg.33.6.518; VAITHINATHAN R, 1994, GENOMICS, V21, P461, DOI 10.1006/geno.1994.1301; WILMOTTE R, 1993, J CLIN INVEST, V91, P2091, DOI 10.1172/JCI116432; Xu SY, 1996, HUM MOL GENET, V5, P1193, DOI 10.1093/hmg/5.8.1193; Xu SY, 1996, HUM GENET, V98, P741, DOI 10.1007/s004390050296; XU SY, 1995, J MED GENET, V32, P915, DOI 10.1136/jmg.32.11.915	39	67	68	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1059	1066		10.1086/301614	http://dx.doi.org/10.1086/301614			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345108	Green Published, Bronze			2022-12-18	WOS:A1997YH01700010
